PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mirheydari, M; Dey, P; Stukey, GJ; Park, Y; Han, GS; Carman, GM				Mirheydari, Mona; Dey, Prabuddha; Stukey, Geordan J.; Park, Yeonhee; Han, Gil-Soo; Carman, George M.			The Spo7 sequence LLI is required for Nem1-Spo7/Pah1 phosphatase cascade function in yeast lipid metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phospholipid; phospholipid metabolism; triglyceride; protein phosphatase; phosphatidate; phosphatase; membrane lipid; membrane protein; PA phosphatase	PROTEIN-KINASE-A; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; PHOSPHOPROTEOME REVEALS; PHOSPHORYLATION SITES; ACID PHOSPHATASE; GLOBAL ANALYSIS; MEDIATED REGULATION; MEMBRANE-PROTEINS; ORTHOLOGUE PAH1P	The Nem1-Spo7 complex in the yeastSaccharomyces cerevisiaeis a protein phosphatase that catalyzes the dephosphory-lation of Pah1 phosphatidate phosphatase, required for its translocation to the nuclear/endoplasmic reticulum membrane. The Nem1-Spo7/Pah1 phosphatase cascade plays a major role in triacylglycerol synthesis and in the regulation of phospholipid synthesis. In this work, we examined Spo7, a regulatory subunit required for Nem1 catalytic function, to identify residues that govern formation of the Nem1-Spo7 complex. By deletion analysis of Spo7, we identified a hydrophobic Leu-Leu-Ile (LLI) sequence comprising residues 54-56 as being required for the protein to complement the temperature-sensitive phenotype of anspo7 Delta mutant strain. Mutational analysis of the LLI sequence with alanine and arginine substitutions showed that its overall hydrophobicity is crucial for the formation of the Nem1-Spo7 complex as well as for the Nem1 catalytic function on its substrate, Pah1,in vivo. Consistent with the role of the Nem1-Spo7 complex in activating the function of Pah1, we found that the mutational effects of the Spo7 LLI sequence were on the Nem1-Spo7/Pah1 axis that controls lipid synthesis and related cellular processes (e.g.triacylglycerol/phospholipid synthesis, lipid droplet formation, nuclear/endoplasmic reticulum membrane morphology, vacuole fusion, and growth on glycerol medium). These findings advance the understanding of Nem1-Spo7 complex formation and its role in the phosphatase cascade that regulates the function of Pah1 phosphatidate phosphatase.	[Mirheydari, Mona; Dey, Prabuddha; Stukey, Geordan J.; Park, Yeonhee; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08903 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08903 USA.	gcarman@rutgers.edu		Carman, George/0000-0003-4951-8233; Stukey, Geordan/0000-0003-2562-5130	National Institutes of Health [GM028140, GM050679, GM136128]; United States Public Health Service	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported, in whole or in part, by National Institutes of Health grants GM028140, GM050679, and GM136128 from the United States Public Health Service. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Aulchenko YS, 2007, DIABETES, V56, P3020, DOI 10.2337/db07-0338; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRINDLEY DN, 1984, PROG LIPID RES, V23, P115, DOI 10.1016/0163-7827(84)90001-8; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2019, J LIPID RES, V60, P2, DOI 10.1194/jlr.S087452; Carman GM, 2019, J BIOL CHEM, V294, P1681, DOI 10.1074/jbc.TM118.004159; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; CASCALES C, 1984, BIOCHEM J, V219, P911, DOI 10.1042/bj2190911; CASCALES C, 1988, BIOCHIM BIOPHYS ACTA, V963, P384, DOI 10.1016/0005-2760(88)90305-0; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Dey P, 2019, J BIOL CHEM, V294, P15997, DOI 10.1074/jbc.RA119.010592; Dey P, 2017, J LIPID RES, V58, P742, DOI 10.1194/jlr.M075036; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Dubots E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104194; Eaton JM, 2013, J BIOL CHEM, V288, P9933, DOI 10.1074/jbc.M112.441493; ESPOSITO RE, 1972, MOL GEN GENET, V114, P241, DOI 10.1007/BF01788893; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Ferguson PJ, 2005, J MED GENET, V42, P551, DOI 10.1136/jmg.2005.030759; Ferguson PJ, 2007, CURR OPIN RHEUMATOL, V19, P492, DOI 10.1097/BOR.0b013e32825f5492; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P1698, DOI 10.1021/bi00536a035; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2017, J BIOL CHEM, V292, P13230, DOI 10.1074/jbc.M117.801720; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Harlow E., 1988, ANTIBODIES LAB MANUA; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Hassaninasab A, 2019, J BIOL CHEM, V294, P18256, DOI 10.1074/jbc.RA119.011314; Hayata T, 2018, GENES CELLS, V23, P345, DOI 10.1111/gtc.12575; Helbig AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-685; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Hennessy M, 2019, J BIOL CHEM, V294, P2365, DOI 10.1074/jbc.RA118.007246; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hsieh LS, 2016, J BIOL CHEM, V291, P9974, DOI 10.1074/jbc.M116.726588; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; KORN AP, 1991, PROTEINS, V9, P37, DOI 10.1002/prot.340090106; Kudo S, 2020, FASEB J, V34, P4749, DOI 10.1096/fj.201901811RR; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kwiatek JM, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.03.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIN YP, 1989, J BIOL CHEM, V264, P8641; Lundby A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003506; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Park Y, 2017, J BIOL CHEM, V292, P19580, DOI 10.1074/jbc.M117.819375; Park Y, 2015, J BIOL CHEM, V290, P25382, DOI 10.1074/jbc.M115.680314; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Rahman MA, 2018, FEBS J, V285, P1840, DOI 10.1111/febs.14448; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rose MD., 1990, METHODS YEAST GENETI; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; SMITH SW, 1957, J BIOL CHEM, V228, P915; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Su WM, 2018, J BIOL CHEM, V293, P15801, DOI 10.1074/jbc.RA118.005348; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Tsai CJ, 1997, PROTEIN SCI, V6, P53; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wiedmann S, 2008, DIABETES, V57, P209, DOI 10.2337/db07-0083; Wu R, 2011, BIOCHEMISTRY-US, V50, P3045, DOI 10.1021/bi200336b; Xu XY, 2018, BIOCHEM BIOPH RES CO, V496, P51, DOI 10.1016/j.bbrc.2017.12.163; Zanghellini J, 2008, FEBS J, V275, P5552, DOI 10.1111/j.1742-4658.2008.06681.x; Zanivan S, 2008, J PROTEOME RES, V7, P5314, DOI 10.1021/pr800599n; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang PX, 2019, J CLIN INVEST, V129, P281, DOI 10.1172/JCI122595; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003	110	5	6	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11473	11485		10.1074/jbc.RA120.014129	http://dx.doi.org/10.1074/jbc.RA120.014129			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32527729	Green Published, hybrid			2022-12-26	WOS:000563922500010
J	Motani, K; Kosako, H				Motani, Kou; Kosako, Hidetaka			BioID screening of biotinylation sites using the avidin-like protein Tamavidin 2-REV identifies global interactors of stimulator of interferon genes (STING)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						BioID; biotinylation; Tamavidin 2-REV; proteomics; interactome; stimulator of interferon genes (STING); innate immunity; antiviral defense; protein-protein interaction; macrophage; biotin; membrane trafficking; signal transduction; mass spectrometry (MS)	CYCLIC GMP-AMP; BIOTIN-BINDING; I INTERFERON; IKK-BETA; ACTIVATION; VIRUS; PALMITOYLATION; 2ND-MESSENGER; TRANSLOCATION; STREPTAVIDIN	Stimulator of interferon genes (STING) mediates cytosolic DNA-induced innate immune signaling via membrane trafficking. The global identification of proteins that spatiotemporally interact with STING will provide a better understanding of its trafficking mechanisms and of STING signaling pathways. Proximity-dependent biotin identification (BioID) is a powerful technology to identify physiologically relevant protein-protein interactions in living cells. However, biotinylated peptides are rarely detected in the conventional BioID method, which uses streptavidin beads to pull down biotinylated proteins, because the biotin-streptavidin interaction is too strong. As a result, only nonbiotinylated peptides are identified, which cannot be distinguished from peptides of nonspecifically pull-downed proteins. Here, we developed a simple method to efficiently and specifically enrich biotinylated peptides using Tamavidin 2-REV, an engineered avidin-like protein with reversible biotin-binding capability. Using RAW264.7 macrophages stably expressing TurboID-fused STING, we identified and quantified >4,000 biotinylated peptides of STING-proximal proteins. Various endoplasmic reticulum-associated proteins were biotinylated in unstimulated cells, and STING activation caused biotinylation of many proteins located in the Golgi and endosomes. These proteins included those known to interact with activated STING, such as TANK-binding kinase 1 (TBK1), several palmitoyl transferases, and p62/sequestosome 1 (SQSTM1). Furthermore, interferon-induced transmembrane protein 3 (IFITM3), an endolysosome-localized antiviral protein, bound to STING at the late activation stage. These dynamic interaction profiles will provide detailed insights into STING signaling; we propose that our approach using Tamavidin 2-REV would be useful for BioID-based and other biotinylation-based peptide identification methods.	[Motani, Kou; Kosako, Hidetaka] Tokushima Univ, Fujii Mem Inst Med Sci, Div Cell Signaling, Tokushima, Japan	Tokushima University	Kosako, H (corresponding author), Tokushima Univ, Fujii Mem Inst Med Sci, Div Cell Signaling, Tokushima, Japan.	kosako@tokushima-u.ac.jp			JSPS KAKENHI [18KK0229, 19H04966, 20K06628]; Takeda Science Foundation; Japan Foundation for Applied Enzymology	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Foundation for Applied Enzymology	This work was supported by the JSPS KAKENHI (grant numbers 17K08661 and 20K07340) and the Takeda Science Foundation (to K. M.) and by the JSPS KAKENHI (grant numbers 18KK0229, 19H04966, and 20K06628) and the Japan Foundation for Applied Enzymology (to H. K.).	Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Branon TC, 2018, NAT BIOTECHNOL, V36, P880, DOI 10.1038/nbt.4201; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Ergun SL, 2019, CELL, V178, P290, DOI 10.1016/j.cell.2019.05.036; Ernst AM, 2018, DEV CELL, V47, P479, DOI 10.1016/j.devcel.2018.10.024; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Franz KM, 2018, P NATL ACAD SCI USA, V115, pE2058, DOI 10.1073/pnas.1716937115; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gingras AC, 2019, CURR OPIN CHEM BIOL, V48, P44, DOI 10.1016/j.cbpa.2018.10.017; Gonugunta VK, 2017, CELL REP, V21, P3234, DOI 10.1016/j.celrep.2017.11.061; Gupta GD, 2015, CELL, V163, P1484, DOI 10.1016/j.cell.2015.10.065; Holm CK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10680; Hyre DE, 2000, PROTEIN SCI, V9, P878, DOI 10.1110/ps.9.5.878; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kim DI, 2018, J PROTEOME RES, V17, P759, DOI 10.1021/acs.jproteome.7b00775; Kim DI, 2016, TRENDS CELL BIOL, V26, P804, DOI 10.1016/j.tcb.2016.09.004; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kosako H., 2009, PROTOC EXCHANGE, DOI [10.1038/nprot.2009.170, DOI 10.1038/NPROT.2009.170]; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Ling SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24029; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Lopez-Pelaez M, 2014, P NATL ACAD SCI USA, V111, P17432, DOI 10.1073/pnas.1418399111; Matsui H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104957; Morag E, 1996, BIOCHEM J, V316, P193, DOI 10.1042/bj3160193; Motani K, 2018, J BIOL CHEM, V293, P7717, DOI 10.1074/jbc.RA118.002175; Motwani M, 2019, NAT REV GENET, V20, P657, DOI 10.1038/s41576-019-0151-1; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Okuda S, 2017, NUCLEIC ACIDS RES, V45, pD1107, DOI 10.1093/nar/gkw1080; Petrotchenko EV, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001420; Prabakaran T, 2018, EMBO J, V37, DOI 10.15252/embj.201797858; Ren JY, 2014, P NATL ACAD SCI USA, V111, P17438, DOI 10.1073/pnas.1418516111; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074; Shang GJ, 2019, NATURE, V567, P389, DOI 10.1038/s41586-019-0998-5; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Taguchi T, 2019, CURR OPIN CELL BIOL, V59, P1, DOI 10.1016/j.ceb.2019.02.002; Takakura Y, 2013, J BIOTECHNOL, V164, P19, DOI 10.1016/j.jbiotec.2013.01.006; Takakura Y, 2009, FEBS J, V276, P1383, DOI 10.1111/j.1742-4658.2009.06879.x; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Udeshi ND, 2017, NAT METHODS, V14, P1167, DOI 10.1038/nmeth.4465; Uezu A, 2016, SCIENCE, V353, P1123, DOI 10.1126/science.aag0821; Varnaite R, 2016, PROTEOMICS, V16, P2503, DOI 10.1002/pmic.201600123; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Wu SC, 2005, J BIOL CHEM, V280, P23225, DOI 10.1074/jbc.M501733200; Yoshinaka T, 2019, ISCIENCE, V19, P1065, DOI 10.1016/j.isci.2019.08.056; You FP, 2013, NAT IMMUNOL, V14, P1237, DOI 10.1038/ni.2756; Zhang CG, 2019, NATURE, V567, P394, DOI 10.1038/s41586-019-1000-2	57	10	11	6	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11174	11183		10.1074/jbc.RA120.014323	http://dx.doi.org/10.1074/jbc.RA120.014323			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32554809	Green Published, hybrid			2022-12-26	WOS:000562757100021
J	Marx-Blumel, L; Marx, C; Weise, F; Frey, J; Perner, B; Schlingloff, G; Lindig, N; Hampl, J; Sonnemann, J; Brauer, D; Voigt, A; Singh, S; Beck, B; Jager, UM; Wang, ZQ; Beck, JF; Schober, A				Marx-Bluemel, L.; Marx, C.; Weise, F.; Frey, J.; Perner, B.; Schlingloff, G.; Lindig, N.; Hampl, J.; Sonnemann, J.; Brauer, D.; Voigt, A.; Singh, S.; Beck, B.; Jaeger, Ute-Maria; Wang, Z. Q.; Beck, J. F.; Schober, A.			Biomimetic reconstruction of the hematopoietic stem cell niche forin vitroamplification of human hematopoietic stem cells	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; EXPANSION; BIOMATERIALS; DIFFERENTIATION; FIBRONECTIN; GENERATION; CULTURE	Hematopoietic stem cell transplantation is successfully applied since the late 1950s; however, its efficacy still needs to be increased. A promising strategy is to transplant high numbers of pluripotent hematopoietic stem cells (HSCs). Therefore, an improvedex vivoculture system that supports proliferation and maintains HSC pluripotency would override possible limitations in cell numbers gained from donors. To model the natural HSC nichein vitro, we optimized the HSC medium composition with a panel of cytokines and valproic acid and used an artificial 3D bone marrow-like scaffold made of polydimethylsiloxane (PDMS). This 3D scaffold offered a suitable platform to amplify human HSCsin vitroand, simultaneously, to support their viability, multipotency and ability for self-renewal. Silicon oxide-covering of PDMS structures further improved amplification of CD34+ cells, although the conservation of naive HSCs was better on non-covered 3D PDMS. Finally, we found that HSC cultivated on non-covered 3D PDMS generated most pluripotent colonies within colony forming unit assays. In conclusion, by combining biological and biotechnological approaches, we optimizedin vitroHSCs culture conditions, resulting in improved amplification, multipotency maintenance and vitality of HSCs.	[Marx-Bluemel, L.; Frey, J.; Lindig, N.; Voigt, A.; Beck, B.; Jaeger, Ute-Maria; Beck, J. F.] Jena Univ Hosp, Dept Paediat Haematol & Oncol, Childrens Clin, Jena, Germany; [Marx-Bluemel, L.; Frey, J.; Lindig, N.; Sonnemann, J.; Voigt, A.; Beck, B.; Jaeger, Ute-Maria] Jena Univ Hosp, Res Ctr Lobeda, Jena, Germany; [Marx, C.; Perner, B.; Wang, Z. Q.] Fritz Lipmann Inst FLI, Leibniz Inst Aging, Jena, Germany; [Weise, F.; Schlingloff, G.; Hampl, J.; Brauer, D.; Singh, S.; Schober, A.] Ilmenau Univ Technol, Inst Micro & Nanotechnol MacroNano, Nanobiosyst Technol, Ilmenau, Germany; [Wang, Z. Q.] Friedrich Schiller Univ Jena, Fac Biol Sci, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Technische Universitat Ilmenau; Friedrich Schiller University of Jena	Marx-Blumel, L (corresponding author), Jena Univ Hosp, Dept Paediat Haematol & Oncol, Childrens Clin, Jena, Germany.; Marx-Blumel, L (corresponding author), Jena Univ Hosp, Res Ctr Lobeda, Jena, Germany.	lisa.marx-bluemel@med.uni-jena.de	Marx, Christian/AAJ-5813-2021; Sonnemann, Jürgen/H-9116-2019	Marx, Christian/0000-0003-2240-8261; Sonnemann, Jürgen/0000-0003-2993-9161; Marx-Blumel, Lisa/0000-0002-9360-6559; Singh, Sukhdeep/0000-0001-6871-4294	German Federal Ministry of Education and Research (BMBF) [03VP00592]; German Jose Carreras Leukaemia Foundation [DJCLS R 13/18]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Jose Carreras Leukaemia Foundation	This project was funded by the German Federal Ministry of Education and Research (BMBF) 03VP00592 and the German Jose ' Carreras Leukaemia Foundation DJCLS R 13/18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Bug G, 2005, CANCER RES, V65, P2537, DOI 10.1158/0008-5472.CAN-04-3011; Chaurasia P, 2014, J CLIN INVEST, V124, P2378, DOI 10.1172/JCI70313; Chen BJ, 2004, BLOOD, V103, P4344, DOI 10.1182/blood-2003-07-2534; Dahlberg A, 2014, LEUKEMIA, V28, P2097, DOI 10.1038/leu.2014.181; Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037; De Felice LD, 2005, CANCER RES, V65, P1505, DOI 10.1158/0008-5472.CAN-04-3063; Dellatore SM, 2008, CURR OPIN BIOTECH, V19, P534, DOI 10.1016/j.copbio.2008.07.010; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Feng Q, 2006, J BIOMED MATER RES A, V78A, P781, DOI 10.1002/jbm.a.30829; Frisch BJ, 2014, METHODS MOL BIOL, V1130, P315, DOI 10.1007/978-1-62703-989-5_24; Hashimoto Y, 2011, BIOMATERIALS, V32, P7060, DOI 10.1016/j.biomaterials.2011.06.008; Islami M, 2018, ARTIF CELL NANOMED B, V46, P1025, DOI 10.1080/21691401.2017.1358733; Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844; Koehler KR, 2013, NATURE, V500, P217, DOI 10.1038/nature12298; Laurenti E, 2018, NATURE, V553, P418, DOI 10.1038/nature25022; Li Y, 2001, J HEMATOTH STEM CELL, V10, P355, DOI 10.1089/152581601750288966; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Moraes C, 2009, BIOMATERIALS, V30, P5241, DOI 10.1016/j.biomaterials.2009.05.066; Niederwieser D, 2016, BONE MARROW TRANSPL, V51, P778, DOI 10.1038/bmt.2016.18; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Prewitz M, 2012, MACROMOL RAPID COMM, V33, P1420, DOI 10.1002/marc.201200382; Sagar BMM, 2006, BIOCHEM BIOPH RES CO, V350, P1000, DOI 10.1016/j.bbrc.2006.09.140; Sahin AO, 2012, CELL ADHES MIGR, V6, P39, DOI 10.4161/cam.18975; Schmidt M, 2009, PROCEDIA CHEM, V1, P1523, DOI 10.1016/j.proche.2009.07.380; Steigert J, 2007, J MICROMECH MICROENG, V17, P333, DOI 10.1088/0960-1317/17/2/020; Wagner JE, 2016, CELL STEM CELL, V18, P144, DOI 10.1016/j.stem.2015.10.004; Walasek MA, 2012, ANN NY ACAD SCI, V1266, P138, DOI 10.1111/j.1749-6632.2012.06549.x; Wilkinson AC, 2019, NATURE, V571, DOI 10.1038/s41586-019-1395-9; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	32	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234638	10.1371/journal.pone.0234638	http://dx.doi.org/10.1371/journal.pone.0234638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569325	Green Published, gold			2022-12-26	WOS:000543547900005
J	Ready, E; Habecker, P; Abadie, R; Khan, B; Dombrowski, K				Ready, Elspeth; Habecker, Patrick; Abadie, Roberto; Khan, Bilal; Dombrowski, Kirk			Competing forces of withdrawal and disease avoidance in the risk networks of people who inject drugs	PLOS ONE			English	Article							NEEDLE-SHARING BEHAVIOR; HEPATITIS-C VIRUS; HIV RISK; EVERYDAY VIOLENCE; UNITED-STATES; USERS; INFECTION; EQUIPMENT; DETERMINANTS; PREDICTORS	We analyze a network of needle-sharing ties among 117 people who inject drugs (PWID) in rural Puerto Rico, using exponential random graph modeling to examine whether network members engage in partner restriction to lower their risk of contracting HIV or hepatitis C (HCV), or in informed altruism to prevent others from contracting these infections. Although sharing of used syringes is a significant risk factor for transmission of these diseases among PWID, we find limited evidence for partner restriction or informed altruism in the network of reported needle-sharing ties. We find however that sharing of needles is strongly reciprocal, and individuals with higher injection frequency are more likely to have injected with a used needle. Drawing on our ethnographic work, we discuss how the network structures we observe may relate to a decision-making rationale focused on avoiding withdrawal sickness, which leads to risk-taking behaviors in this poor, rural context where economic considerations often lead PWID to cooperate in the acquisition and use of drugs.	[Ready, Elspeth] Max Planck Inst Evolutionary Anthropol, Dept Human Behav Ecol & Culture, Leipzig, Germany; [Ready, Elspeth] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Habecker, Patrick; Abadie, Roberto; Khan, Bilal] Univ Nebraska, Dept Sociol, Lincoln, NE 68588 USA; [Dombrowski, Kirk] Univ Vermont, VP Res Admin Off, Burlington, VT USA	Max Planck Society; State University System of Florida; University of Florida; University of Nebraska System; University of Nebraska Lincoln; University of Vermont	Ready, E (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Behav Ecol & Culture, Leipzig, Germany.; Ready, E (corresponding author), Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA.	elspeth_ready@eva.mpg.de		Habecker, Patrick/0000-0003-4435-1593	National Science Foundation [1443985, 1638618]; National Institutes of Health [R01DA037117]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported in part by a grant from the National Science Foundation (www.nsf.gov) program for Enhancing Access to Radio Spectrum, grant numbers 1443985 and 1638618 (KD and BK), and in part by a grant from the National Institutes of Health (www.nih.gov) grant number R01DA037117 (KD and BK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie R, 2018, INT J DRUG POLICY, V51, P121, DOI 10.1016/j.drugpo.2017.06.011; Abadie R, 2016, HARM REDUCT J, V13, DOI 10.1186/s12954-016-0099-9; Bailey SL, 2007, DRUG ALCOHOL DEPEN, V91, pS18, DOI 10.1016/j.drugalcdep.2007.02.014; BARNARD MA, 1993, ADDICTION, V88, P805, DOI 10.1111/j.1360-0443.1993.tb02094.x; Betts KS, 2016, ADDICTION, V111, P1214, DOI 10.1111/add.13339; Bourgois P, 1998, SUBST USE MISUSE, V33, P2323, DOI 10.3109/10826089809056260; Bourgois P, 2004, HUM ORGAN, V63, P253, DOI 10.17730/humo.63.3.h1phxbhrb7m4mlv0; CDC, 2010, HIV SURV REP 2010; CDC, 2016, VIR HEP SURV US 2016; Cicero TJ, 2014, JAMA PSYCHIAT, V71, P821, DOI 10.1001/jamapsychiatry.2014.366; Colon-Lopez V, 2013, P R HEALTH SCI J, V32, P8; CURTIS R, 1995, SOC NETWORKS, V17, P229, DOI 10.1016/0378-8733(95)00264-O; Davey-Rothwell MA, 2007, J URBAN HEALTH, V84, P691, DOI 10.1007/s11524-007-9215-1; Friedman S.R., 1998, INT J DRUG POLICY, V9, P461, DOI [10.1016/S0955-3959(98)00062-0., DOI 10.1016/S0955-3959(98)00062-0]; Friedman SR, 2011, SUBST USE MISUSE, V46, P307, DOI 10.3109/10826084.2011.523316; Friedman SR, 1997, AM J PUBLIC HEALTH, V87, P1289, DOI 10.2105/AJPH.87.8.1289; GIBSON DR, 1993, INT J ADDICT, V28, P973, DOI 10.3109/10826089309062177; Handcock MS, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P229; Holtzman D, 2009, PREV MED, V49, P68, DOI 10.1016/j.ypmed.2009.04.014; Hunter DR, 2007, SOC NETWORKS, V29, P216, DOI 10.1016/j.socnet.2006.08.005; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Jarlais DCD, 2004, JAIDS-J ACQ IMM DEF, V35, P158, DOI 10.1097/00126334-200402010-00010; KLOVDAHL AS, 1994, SOC SCI MED, V38, P79, DOI 10.1016/0277-9536(94)90302-6; Krumpal I, 2013, QUAL QUANT, V47, P2025, DOI 10.1007/s11135-011-9640-9; Latkin C, 1996, J ACQ IMMUN DEF SYND, V13, P273, DOI 10.1097/00042560-199611010-00010; LATKIN C, 1995, SOC NETWORKS, V17, P219, DOI 10.1016/0378-8733(95)00263-N; Latkin CA, 2008, JAIDS-J ACQ IMM DEF, V49, P447, DOI 10.1097/QAI.0b013e31818a6546; Lee W, 2015, AIDS BEHAV, V19, P1415, DOI 10.1007/s10461-014-0930-9; LOXLEY W, 1995, AIDS CARE, V7, P337, DOI 10.1080/09540129550126551; Lundgren LM, 2005, AIDS EDUC PREV, V17, P525, DOI 10.1521/aeap.2005.17.6.525; MacRae R, 2000, AIDS CARE, V12, P505, DOI 10.1080/09540120050123909; MAGURA S, 1989, AM J PUBLIC HEALTH, V79, P459, DOI 10.2105/AJPH.79.4.459; Mandell W, 1999, AM J DRUG ALCOHOL AB, V25, P117, DOI 10.1081/ADA-100101849; MANDELL W, 1994, AM J PUBLIC HEALTH, V84, P920, DOI 10.2105/AJPH.84.6.920; Metsch LR, 2007, JAIDS-J ACQ IMM DEF, V46, pS72, DOI 10.1097/QAI.0b013e3181576818; Mizuno Y, 2011, J URBAN HEALTH, V88, P1031, DOI 10.1007/s11524-011-9578-1; NEAIGUS A, 1994, SOC SCI MED, V38, P67, DOI 10.1016/0277-9536(94)90301-8; Norman Lisa R, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P260, DOI 10.1177/1545109710393310; Perez CM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-76; R Core Team, 2018, R LANG ENV STAT MPUT; Smith BD, 2013, J INFECT DIS, V208, P1934, DOI 10.1093/infdis/jit520; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; Strathdee SA, 1997, ADDICTION, V92, P1339, DOI 10.1046/j.1360-0443.1997.9210133910.x; Strathdee SA, 2015, NEW ENGL J MED, V373, P397, DOI 10.1056/NEJMp1507252; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Sutter A., 1966, ISSUES CRIMINOL, V196, P177; Tassiopoulos K, 2013, ADDICT SCI CLIN PRAC, V8, DOI 10.1186/1940-0640-8-20; Unger JB, 2006, ADDICT BEHAV, V31, P1607, DOI 10.1016/j.addbeh.2005.12.007; Valente TW, 2001, AM J PUBLIC HEALTH, V91, P406, DOI 10.2105/AJPH.91.3.406; Verdery AM, 2017, JAIDS-J ACQ IMM DEF, V76, P26, DOI 10.1097/QAI.0000000000001485; Vlahov D, 2001, AIDS, V15, P2311, DOI 10.1097/00002030-200111230-00013; Voon P, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0050-5; Wagner KD, 2011, ADDICT BEHAV, V36, P835, DOI 10.1016/j.addbeh.2011.03.014; Wood E, 2002, AIDS, V16, P941, DOI 10.1097/00002030-200204120-00021; Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453	55	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235124	10.1371/journal.pone.0235124	http://dx.doi.org/10.1371/journal.pone.0235124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569332	Green Published, gold			2022-12-26	WOS:000543547900009
J	Skidmore, T; Roe, E				Skidmore, Tess; Roe, Emma			A semi-structured questionnaire survey of laboratory animal rehoming practice across 41 UK animal research facilities	PLOS ONE			English	Article							QUALITY-OF-LIFE; ADOPTION SUCCESS; SHELTERS; STRESS; OWNER; CATS; DOGS	If a laboratory animal survives an experiment without lasting compromised welfare, its future must be negotiated. Rehoming may be a consideration. This paper reports on research findings that provide an indication of the uptake of animal rehoming by UK facilities and the associated moral, ethical, practical and regulatory considerations that inform decisions to rehome or not. This research addresses a widely acknowledged gap in the literature to understand both the numbers, and types of animals rehomed from UK research facilities, as well as the main motivations for engaging in the practice, and the barriers for those facilities not currently rehoming. From the similar to 160 UK research facilities in the UK, 41 facilities completed the questionnaire, giving a response rate of approximately 25%. Results suggest rehoming occurs routinely, yet the numbers are small; just 2322 animals are known to have been rehomed between 2015-2017. At least 1 in 10 facilities are rehoming. There exists a clear preference for the rehoming of some species (mainly cats, dogs and horses) over others (rodents, agricultural animals and primates). Indeed, although 94.15% of species kept in laboratories are rodents, they make up under a fifth (19.14%) of all animals known to be rehomed between 2015-2017. The primary motivation for rehoming is to boost staff morale and promote a positive ethical profile for the facility. Barriers include concern for the animal's welfare following rehoming, high scientific demand for animals that leaves few to be rehomed, and, finally, certain animals (mainly those genetically modified) are simply unsuited to rehoming. The findings of this research will support facilities choosing to rehome, as well as those that are not currently engaging in the practice. By promoting the practice, the benefits to rehoming in terms of improving laboratory animal's quality of life, helping facility staff to overcome the moral stress of killing, and addressing public concern regarding the fate of laboratory animals, can be attained. It is only once an understanding of rehoming from the perspective of UK research facilities has been ascertained, that appropriate policy and support can be provided.	[Skidmore, Tess; Roe, Emma] Univ Southampton, Sch Geog & Environm Sci, Southampton, Hants, England	University of Southampton	Skidmore, T (corresponding author), Univ Southampton, Sch Geog & Environm Sci, Southampton, Hants, England.	t.a.skidmore@soton.ac.uk		Skidmore, Tess/0000-0001-8816-4082	Wellcome Trust [205393/D/16/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	T.S and E.R 205393/D/16/Z Wellcome Trust https://wellcome.ac.uk/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, NCCN PRACT GUIDEL, V2017, P1, DOI DOI 10.1155/2017/2683789; [Anonymous], 1987, AM LAW I PUBLISHERS, V1-2, P115; Association L.A.S., 2002, LASA GUID REH LAB DO; Bayne Kathryn, 2002, ILAR J, V43, P4; Birke L., 2007, SACRIFICE SCI EXPT T; Bono G, 2005, VET RES COMMUN, V29, P165, DOI 10.1007/s11259-005-0033-1; Carbone L, 2003, LAB ANIMAL, V32, P37, DOI 10.1038/laban1003-37; Clark J. L., 2014, Humanimalia: A Journal of Human/Animal Interface Studies, V6, P88; Davis R., 2013, UNDERSTANDING VOLUNT; DiGangi Brian A., 2006, Journal of Applied Animal Welfare Science, V9, P143, DOI 10.1207/s15327604jaws0902_4; Doring D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181303; Doring D, 2017, ALTEX-ALTERN ANIM EX, V34, P133, DOI 10.14573/altex.1608171; F.A.W.C. Farm Animal Welfare in Great Britain, 2009, FARM ANIMAL WELFARE, P1; Fleury E., 2017, ANIMAL STUDIES J, V6, P30; Franco NH, 2016, END OF ANIMAL LIFE: A START FOR ETHICAL DEBATE: ETHICAL AND SOCIETAL CONSIDERATIONS ON KILLING ANIMALS, P187, DOI 10.3920/978-90-8686-808-7_12; Harms CA, 2007, J AM ASSOC LAB ANIM, V46, P50; Home Office, 2016, ANN STAT SCI PROCEDU, P1; Home Office, 2017, ANN STAT SCI PROCEDU, P1; Home Office, 2015, ANN STAT SCI PROC LI, P1, DOI DOI 10.1016/J.FSIGEN.2013.09.005; Howard VJ, 2015, J ORGAN BEHAV MANAGE, V35, P296, DOI 10.1080/01608061.2015.1093052; Hua J, 2013, AM QUART, V65, P619; Kerwin Amy M., 2006, Journal of Applied Animal Welfare Science, V9, P337, DOI 10.1207/s15327604jaws0904_9; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kue J., 2011, EUTHANASIA GOOD DEAT; Luescher AU, 2009, APPL ANIM BEHAV SCI, V117, P63, DOI 10.1016/j.applanim.2008.11.001; Marchant-Forde JN, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00016; Marinelli L, 2007, APPL ANIM BEHAV SCI, V108, P143, DOI 10.1016/j.applanim.2006.11.018; McAndrew R., 2016, LAB PRIMATES THEIR L; McMillan FD, 2000, J AM VET MED ASSOC, V216, P1904, DOI 10.2460/javma.2000.216.1904; Mellor DJ, 2016, ANIMALS, V6, DOI 10.3390/ani6030021; Mondelli Francesca, 2004, Journal of Applied Animal Welfare Science, V7, P253, DOI 10.1207/s15327604jaws0704_3; Novak MA, 2013, APPL ANIM BEHAV SCI, V143, P135, DOI 10.1016/j.applanim.2012.10.012; Patronek GJ, 1996, J AM VET MED ASSOC, V209, P582; Pirrone F, 2015, J VET BEHAV, V10, P295, DOI 10.1016/j.jveb.2015.03.004; Prescott M.J., 2006, LAB PRIMATE NEWSL, V45, P5; Protopopova A, 2012, APPL ANIM BEHAV SCI, V142, P61, DOI 10.1016/j.applanim.2012.09.009; Quigley M, 2007, J MED ETHICS, V33, P655, DOI 10.1136/jme.2007.020784; Roberts M., 2018, BSAVA MANUAL CANINE, P314; Rogelberg SG, 2010, NONPROFIT MANAG LEAD, V20, P423, DOI 10.1002/nml.20003; Rohlf V, 2005, SOC ANIM, V13, P201, DOI 10.1163/1568530054927753; Seelig D, 1999, LAB PRIMATE NEWSL, V38, P1; Sinski J., 2016, COMPANION ANIMALS EV, P73; Towner S, 2010, BIOSCI HORIZ, V3, P96, DOI [10.1093/biohorizons/hzq011, DOI 10.1093/BIOHORIZONS/HZQ011, DOI 10.1093/BI0H0RIZ0NS/HZQ0]; Weary DM, 2019, ANIM WELFARE, V28, P33, DOI 10.7120/09627286.28.1.033; Weiss Emily, 2012, Animals (Basel), V2, P144, DOI 10.3390/ani2020144; Wolfensohn S., 2010, The UFAW handbook on the care and management of laboratory and other research animals, P219, DOI 10.1002/9781444318777.ch17; Yeates J, 2009, J SMALL ANIM PRACT, V50, P274, DOI 10.1111/j.1748-5827.2009.00755.x	47	5	5	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234922	10.1371/journal.pone.0234922	http://dx.doi.org/10.1371/journal.pone.0234922			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559221	Green Published, gold			2022-12-26	WOS:000543261600028
J	Kim, H; Lim, YM; Lee, EJ; Oh, YJ; Kim, KK				Kim, Hyunjin; Lim, Young-Min; Lee, Eun-Jae; Oh, Yeo Jin; Kim, Kwang-Kuk			Clinical and imaging features of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and cysteine-sparing NOTCH3 mutations	PLOS ONE			English	Article							CADASIL MUTATIONS; RATING-SCALE; HYPERINTENSITIES; MRI; AGE	Background Characteristics of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and cysteine-sparing NOTCH3 mutations are relatively unknown. This study compared clinical and imaging characteristics between patients with CADASIL and cysteine-sparing NOTCH3 mutations and those with CADASIL and cysteine-involving NOTCH3 mutations. Methods We retrospectively reviewed medical records of patients with CADASIL admitted to the Asan Medical Center between September 1999 and September 2017. We compared clinical and brain magnetic resonance imaging (MRI) characteristics based on the presence or absence of cysteine-involving NOTCH3 gene mutations. We compared white matter change frequencies and grades in specific spatial regions between the groups according to age-related white matter change (ARWMC) scores. We evaluated the presence, number, and anatomical distributions of cerebral microbleeds according to the microbleed anatomical rating scale. Results We reviewed data from 79 patients (55 cysteine-involving, 24 cysteine-sparing NOTCH3 mutations). Clinical symptoms and signs did not differ significantly between the groups. The white matter change frequency and ARWMC scores (adjusted for age and stroke risk factors) in the anterior temporal lobes were lower in cysteine-sparing patients than in cysteine-involving patients. Frequencies and grades of the other brain region's white matter changes and cerebral microbleeds were similar between the groups. Conclusions Patients with CADASIL and cysteine-sparing NOTCH3 mutations showed less involvement of the anterior temporal lobes in brain MRI than those with CADASIL and cysteine-involving NOTCH3 mutations, although both groups showed similar clinical characteristics.	[Kim, Hyunjin; Lim, Young-Min; Lee, Eun-Jae; Oh, Yeo Jin; Kim, Kwang-Kuk] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea	University of Ulsan; Asan Medical Center	Kim, KK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea.	kkkim@amc.seoul.kr		Kim, Hyunjin/0000-0003-0264-4531	Ministry of Science and ICT, South Korea [NRF-2018R1C1B6008884, NRF-2018M3A9E8066249]; Ministry of Health & Welfare, South Korea [HI18C2383]	Ministry of Science and ICT, South Korea; Ministry of Health & Welfare, South Korea	This study was supported by grants from the Ministry of Science and ICT, South Korea (NRF-2018R1C1B6008884, NRF-2018M3A9E8066249) and Ministry of Health & Welfare, South Korea (HI18C2383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Choi JE, 2006, J KOREAN SOC MED, V12, P1; Duering M, 2011, HUM MOL GENET, V20, P3256, DOI 10.1093/hmg/ddr237; Ge W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104533; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kim Y, 2006, NEUROLOGY, V66, P1511, DOI 10.1212/01.wnl.0000216259.99811.50; Lee YC, 2009, J NEUROL, V256, P249, DOI 10.1007/s00415-009-0091-3; Markus HS, 2002, NEUROLOGY, V59, P1134, DOI 10.1212/WNL.59.8.1134; Mazzei R, 2004, NEUROLOGY, V63, P561, DOI 10.1212/01.WNL.0000133399.37716.84; Muino E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091964; O'Sullivan M, 2001, NEUROLOGY, V56, P628, DOI 10.1212/WNL.56.5.628; Opherk C, 2009, HUM MOL GENET, V18, P2761, DOI 10.1093/hmg/ddp211; Rutten JW, 2014, EXPERT REV MOL DIAGN, V14, P593, DOI 10.1586/14737159.2014.922880; Scheid R, 2008, NEUROLOGY, V71, P774, DOI 10.1212/01.wnl.0000324928.44694.f7; Singhal S, 2005, AM J NEURORADIOL, V26, P2481; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; Ueda A, 2015, J NEUROL, V262, P1828, DOI 10.1007/s00415-015-7782-8; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wang ZX, 2011, J NEUROL NEUROSUR PS, V82, P534, DOI 10.1136/jnnp.2010.209247; Wollenweber FA, 2015, STROKE, V46, P786, DOI 10.1161/STROKEAHA.114.007472; Yamamoto Y, 2009, STROKE, V40, P2004, DOI 10.1161/STROKEAHA.108.528299	26	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234797	10.1371/journal.pone.0234797	http://dx.doi.org/10.1371/journal.pone.0234797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555735	Green Published, gold			2022-12-26	WOS:000543273200007
J	Waliullah, S; Bell, J; Jagdale, G; Stackhouse, T; Hajihassani, A; Brenneman, T; Ali, ME				Waliullah, Sumyya; Bell, Jessica; Jagdale, Ganpati; Stackhouse, Tammy; Hajihassani, Abolfazl; Brenneman, Timothy; Ali, Md. Emran			Rapid detection of pecan root-knot nematode,Meloidogyne partityla, in laboratory and field conditions using loop-mediated isothermal amplification	PLOS ONE			English	Article							MELOIDOGYNE SPP.; ISOZYME PHENOTYPES; DIAGNOSTIC METHOD; IDENTIFICATION; LAMP; JUVENILES; ASSAY	Meloidogyne partitylais the dominant root-knot nematode (RKN) species parasitizing pecan in Georgia. This species is known to cause a reduction in root growth and a decline in the yields of mature pecan trees. Rapid and accurate diagnosis of this RKN is required to control this nematode disease and reduce losses in pecan production. In this study, a loop-mediated isothermal amplification (LAMP) method was developed for simple, rapid, and on-site detection ofM.partitylain infested plant roots and validated to detect the nematode in laboratory and field conditions. Specific primers were designed based on the sequence distinction of the internal transcribed spacer (ITS)-18S/5.8S ribosomal RNA gene betweenM.partitylaand otherMeloidogynespp. The LAMP detection technique could detect the presence ofM.partitylagenomic DNA at a concentration as low as 1 pg, and no cross reactivity was found with DNA from other major RKN species such asM.javanica,M.incognitaandM.arenaria, andM.hapla. We also conducted a traditional morphology-based diagnostic assay and conventional polymerase chain reaction (PCR) assay to determine which of these techniques was less time consuming, more sensitive, and convenient to use in the field. The LAMP assay provided more rapid results, amplifying the target nematode species in less than 60 min at 70 degrees C, with results 100 times more sensitive than conventional PCR (similar to 2-3 hrs). Morphology-based, traditional diagnosis was highly time-consuming (2 days) and more laborious than conventional PCR and LAMP assays. These features greatly simplified the operating procedure and made the assay a powerful tool for rapid, on-site detection of pecan RKN,M.partityla. The developed LAMP assay will facilitate accurate pecan nematode diagnosis in the field and contribute to the management of the pathogen.	[Waliullah, Sumyya; Bell, Jessica; Stackhouse, Tammy; Hajihassani, Abolfazl; Brenneman, Timothy; Ali, Md. Emran] Univ Georgia, Dept Plant Pathol, Tifton, GA 31793 USA; [Jagdale, Ganpati] Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ali, ME (corresponding author), Univ Georgia, Dept Plant Pathol, Tifton, GA 31793 USA.	emran.ali@uga.edu	Waliullah, Sumyya/ABD-6693-2020	Waliullah, Sumyya/0000-0002-3838-0710; Ali, Emran/0000-0002-1957-4392	GA Commodity Commission for Pecans [FP00016892]	GA Commodity Commission for Pecans	This work was supported by a GA Commodity Commission for Pecans Grant no. FP00016892.	Adam MAM, 2007, PLANT PATHOL, V56, P190, DOI 10.1111/j.1365-3059.2006.01455.x; Aglietti C, 2019, AMB EXPRESS, V9, DOI 10.1186/s13568-019-0774-9; Almasi MA, 2019, HORTIC PLANT J, V5, P129, DOI 10.1016/j.hpj.2019.01.004; Blok VC, 2010, ROOT-KNOT NEMATODES, P98; Brito J, 2006, NEMATOLOGY CIRCULAR; Carneiro RMDG, 2004, NEMATOLOGY, V6, P287, DOI 10.1163/1568541041217942; Eisenback J. D., 1985, An advanced treatise on Meloidogyne. Volume 1: Biology and control., P95; EISENBACK JD, 1982, J NEMATOL, V14, P339; ESBENSHADE PR, 1990, J NEMATOL, V22, P10; Feng WZ, 2019, PLANT DIS, V103, P298, DOI [10.1094/PDIS-05-18-0858-RE, 10.1094/pdis-05-18-0858-re]; Ganpati BJ, 2018, J NEMATOL, V50, P641; de Oliveira CMG, 2011, TROP PLANT PATHOL, V36, P65, DOI 10.1590/S1982-56762011000200001; Harper SJ, 2010, PHYTOPATHOLOGY, V100, P1282, DOI 10.1094/PHYTO-06-10-0168; Hunt DJ, 2010, ROOT-KNOT NEMATODES, P55; Hussey R., 1973, DIS REPORT, V61, P328; Khanal C, 2016, NEMATROPICA, V46, P261; Kikuchi T, 2009, PHYTOPATHOLOGY, V99, P1365, DOI 10.1094/PHYTO-99-12-1365; KLEYNHANS K P N, 1986, Phytophylactica, V18, P103; Levin R, 2005, THESIS; Mori Y, 2013, J INFECT CHEMOTHER, V19, P404, DOI 10.1007/s10156-013-0590-0; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Niessen L, 2013, FOOD MICROBIOL, V36, P191, DOI 10.1016/j.fm.2013.04.017; Niu JH, 2012, PLANT PATHOL, V61, P809, DOI 10.1111/j.1365-3059.2011.02562.x; Niu JH, 2011, CROP PROT, V30, P1063, DOI 10.1016/j.cropro.2011.03.028; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Nyczepir A, 2004, J NEMATOL, V36, P338; Oliveira Claudio M. G., 2011, Nematologia Brasileira, V35, P36; Peng H, 2017, SCI REP-UK, V7, DOI 10.1038/srep44853; PINOCHET J, 1993, FUND APPL NEMATOL, V16, P73; POWERS TO, 1993, J NEMATOL, V25, P1; Powers TO, 2005, J NEMATOL, V37, P226; Seesao Y, 2017, J MICROBIOL METH, V138, P37, DOI 10.1016/j.mimet.2016.05.030; Starr JL, 1996, J NEMATOL, V28, P565; Thomas S. H., 2001, Plant Disease, V85, P1030, DOI 10.1094/PDIS.2001.85.9.1030B; Waliullah S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051756; Waliullah S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221903; Zhang L, 2019, PLANT DIS, V103, P12, DOI 10.1094/PDIS-01-18-0093-RE	37	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0228123	10.1371/journal.pone.0228123	http://dx.doi.org/10.1371/journal.pone.0228123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555580	gold, Green Submitted, Green Published			2022-12-26	WOS:000543273200048
J	Tompkins, EL; Beltran, TA; Gelner, EJ; Farmer, AR				Tompkins, Erin L.; Beltran, Thomas A.; Gelner, Elizabeth J.; Farmer, Aaron R.			Prevalence and risk factors forTrichomonas vaginalisinfection among adults in the US, 2013-2014	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; TRICHOMONAS-VAGINALIS; MYCOPLASMA-GENITALIUM; PREGNANT-WOMEN; UNITED-STATES; COINFECTION; COTININE; HEALTH	Objective Trichomonas vaginalis(TV) infection is common, curable, and associated with significant reproductive morbidity and risk for HIV infection. This analysis updates estimates of the prevalence of asymptomatic TV infection, and its associated risk factors, in the non-institutionalized U.S. population. Methods We analyzed data from 4057 individuals who participated in the National Health and Nutrition Examination Survey (NHANES) 2013-2014 data collection cycle. Participant interviews ascertained demographic characteristics, self-reported tobacco use, and sexual history. Self-collected urine specimens from participants aged 18 to 59 years were tested for TV infection using the Gen-Probe Aptima TV assay. Cotinine was assayed from serum to provide a biomarker of recent tobacco exposure. Weighted percentages are provided to account for unequal selection probabilities among participants and adjustments for non-response. Results Our sample included 1942 men (49.2%, 95% Confidence Interval [CI] 48.0-50.5) and 2115 women (50.8%, 95%CI 49.5-52.0). The infection prevalence among men was 0.5% (n = 16; 95%CI 0.2-1.0) and 1.8% (n = 55; 95%CI 1.1-3.1) in women. After controlling for participant characteristics associated with TV infection, females had a 5.2-fold increased odds of being infected compared to men (adjusted odds ratio (aOR) 5.2, 95% CI 2.4-11.4). Non-Hispanic blacks were more likely to be infected compared to non-Hispanic whites (aOR 11.2, 95% CI 4.6-27.2). Individuals below the federal poverty level were more likely to be infected compared to those earning >3 times the federal poverty level (aOR 6.7, 95% CI 1.7-26.6), and active smokers were more likely to be infected compared to participants with no nicotine exposure (aOR 8.7, 95% CI 4.1-18.2). Conclusion Trichomonas vaginalisinfection continues to be relatively common, especially in women, smokers, non-Hispanic blacks, and in groups of lower socioeconomic status. Identifying the demographic characteristics of populations in the United States disproportionately affected by TV could impact screening and treatment of this infection in clinical practice. Further research on whether screening and treating for asymptomatic TV infection in high-risk populations improves risk for reproductive morbidity and HIV infection is warranted.	[Tompkins, Erin L.] Walter Reed Natl Mil Med Ctr, Dept Internal Med, Bethesda, MD 20814 USA; [Beltran, Thomas A.] Womack Army Med Ctr, Dept Clin Invest, Ft Bragg, NC USA; [Gelner, Elizabeth J.] Bassett Army Community Hosp, Dept Obstet & Gynecol, Ft Wainright, AK USA; [Farmer, Aaron R.] Womack Army Med Ctr, Ft Bragg Res Inst, Dept Infect Dis, Ft Bragg, NC USA	Walter Reed National Military Medical Center; United States Department of Defense; United States Army; United States Department of Defense; United States Army	Tompkins, EL (corresponding author), Walter Reed Natl Mil Med Ctr, Dept Internal Med, Bethesda, MD 20814 USA.	Erin.L.Tompkins.mil@mail.mil		Beltran, Thomas/0000-0001-8971-1201; Gelner, Elizabeth/0000-0002-1954-9031				Allsworth JE, 2009, SEX TRANSM DIS, V36, P738, DOI 10.1097/OLQ.0b013e3181b38a4b; Anderson EJ, 2018, CLIN INFECT DIS, V67, P464, DOI 10.1093/cid/ciy142; [Anonymous], 2007, J CHROMATOGR SCI, V45, p10A; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; Centers for Disease Control and Prevention, 2017, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention: Tobacco and Volatiles Branch Division of Laboratory Sciences National Center for Environmental Health, 2016, LAB PROC MAN COT HYD; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; Davis A, 2016, SEX TRANSM DIS, V43, P617, DOI 10.1097/OLQ.0000000000000503; Ghosh I, 2017, J CLIN VIROL, V87, P43, DOI 10.1016/j.jcv.2016.12.007; Jenniskens MLM, 2017, INFECT DIS-NOR, V49, P461, DOI 10.1080/23744235.2017.1290271; Johnson CL, 2014, VITAL HLTH STAT, V2, P162; Kim JH, 2017, KOREAN J PARASITOL, V55, P213, DOI 10.3347/kjp.2017.55.2.213; Klebanoff MA, 2001, NEW ENGL J MED, V345, P487, DOI 10.1056/NEJMoa003329; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; Muzny CA, 2018, CLIN INFECT DIS, V67, P218, DOI 10.1093/cid/ciy085; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Oyeyemi OT, 2016, INT J STD AIDS, V27, P1187, DOI 10.1177/0956462415611292; Parsons VL, 2014, VITAL HLTH STAT, V2, P165; Patel EU, 2018, CLIN INFECT DIS, V67, P211, DOI 10.1093/cid/ciy079; Rogers M, 2014, AUSTRALAS DRAMA STUD, P3; Salawu Oyetunde Timothy, 2016, J Reprod Infertil, V17, P61; Schwebke JR, 2011, J CLIN MICROBIOL, V49, P4106, DOI 10.1128/JCM.01291-11; Short VL, 2010, SEX TRANSM INFECT, V86, P29, DOI 10.1136/sti.2009.037721; Sutton M, 2007, CLIN INFECT DIS, V45, P1319, DOI 10.1086/522532; The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) Trial Team, 2015, CLIN INFECT DIS S7, V61, pS685; US Department of Health and Human Services Centers for Disease Control and Prevention., NATL HLTH NUTR EX SU; Vaccarella S, 2008, INT J EPIDEMIOL, V37, P536, DOI 10.1093/ije/dyn033; von Glehn MD, 2017, J INFECT DEV COUNTR, V11, P269, DOI 10.3855/jidc.8143	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234704	10.1371/journal.pone.0234704	http://dx.doi.org/10.1371/journal.pone.0234704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544192	gold, Green Published			2022-12-26	WOS:000542957200042
J	Du, Y; Yang, YT; Tang, G; Jia, JS; Zhu, N; Yuan, WJ				Du, Yi; Yang, Yi-Tong; Tang, Gang; Jia, Jie-Shuang; Zhu, Nan; Yuan, Wei-Jie			Butyrate alleviates diabetic kidney disease by mediating the miR-7a-5p/P311/TGF-beta 1 pathway	FASEB JOURNAL			English	Article						butyrate; db; db mice; diabetic kidney disease; fibrosis; SV40-MES-13 cells	TISSUE GROWTH-FACTOR; SODIUM-BUTYRATE; DB/DB MICE; SIGNALING PATHWAY; RENAL FIBROSIS; COLON-CANCER; TGF-BETA; EXPRESSION; APOPTOSIS; INFLAMMATION	It has been reported that butyrate played an protect role in diabetic kidney disease (DKD) while the mechanism was still not clear. Transforming growth factor-beta 1 (TGF-beta 1) is the initial factor which triggers the profibrotic signaling cascades. P311 is an RNA-binding protein, which could stimulate TGF-beta 1 translation in several cell types. In our study, we found that supplementary of butyrate alleviated fibrosis and suppressed the expression of TGF-beta 1 and P311 in the kidney of db/db mice as well as high glucose (HG)-induced SV40-MES-13 cells. Overexpression of P311 offset the inhibition of butyrate on TGF-beta 1 in SV40-MES-13 cells. To make clear the mechanism of butyrate in regulating P311, microRNAs (miRNAs) of the SV40-MES-13 cells were sequenced. We found that miR-7a-5p was significantly decreased in the HG-induced SV40-MES-13 cells and the kidney of db/db mice, while giving butyrate reversed this change. Besides, miR-7a-5p could specifically target the 3' UTR of P311's mRNA and suppressed the expression of P311 in the SV40-MES-13 cells. Giving miR-7a-5p inhibitor blocked the inhibition of butyrate on P311 and TGF-beta 1. Introducing the miR-7a-5p agomir into db/db mice alleviated renal fibrosis and inhibit the expression of P311 and TGF-beta 1. In conclusion, butyrate alleviated DKD by mediating the miR-7a-5p/P311/TGF-beta 1 pathway.	[Du, Yi; Tang, Gang; Jia, Jie-Shuang; Zhu, Nan; Yuan, Wei-Jie] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Nephrol, Sch Med, 100 HaiNing Rd, Shanghai 200080, Peoples R China; [Yang, Yi-Tong] Qingdao Municipal Hosp, Dept Nephrol, Qingdao, Peoples R China	Shanghai Jiao Tong University; Qingdao Municipal Hospital	Yuan, WJ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Nephrol, Sch Med, 100 HaiNing Rd, Shanghai 200080, Peoples R China.	ywj4168@163.com		Yuan, Weijie/0000-0001-5008-4255	National Natural Science Foundation of China (NSFC) [81700621]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81700621	Alicic RZ, 2017, CLIN J AM SOC NEPHRO, V12, P2032, DOI 10.2215/CJN.11491116; Alpers CE, 2011, CURR OPIN NEPHROL HY, V20, P278, DOI 10.1097/MNH.0b013e3283451901; Andrade-Oliveira V, 2015, J AM SOC NEPHROL, V26, P1877, DOI 10.1681/ASN.2014030288; Bu HQ, 2019, ONCOTARGETS THER, V12, P7467, DOI 10.2147/OTT.S220401; Chen L, 2018, BIOMED PHARMACOTHER, V101, P670, DOI 10.1016/j.biopha.2018.02.090; Cheng T, 2017, AM J PATHOL, V187, P292, DOI 10.1016/j.ajpath.2016.10.004; COUSER WG, 1994, AM J KIDNEY DIS, V23, P193, DOI 10.1016/S0272-6386(12)80971-1; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Dong WP, 2017, J ENDOCRINOL, V232, P71, DOI 10.1530/JOE-16-0322; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Duan FF, 2019, AM J RESP CELL MOL, V60, P221, DOI 10.1165/rcmb.2018-0028OC; Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494; Guo Y, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00630; Hu SE, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0450-x; Huang Y, 2008, J AM SOC NEPHROL, V19, P329, DOI 10.1681/ASN.2007040510; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Kato M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003389; Khan S, 2014, FOOD CHEM TOXICOL, V73, P127, DOI 10.1016/j.fct.2014.08.010; Kim T, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat4285; Kolling M, 2017, MOL THER, V25, P165, DOI 10.1016/j.ymthe.2016.08.001; Loeffler I, 2018, CELL TISSUE RES, V372, P115, DOI 10.1007/s00441-017-2754-1; Machado RA, 2012, NEPHROL DIAL TRANSPL, V27, P3136, DOI 10.1093/ndt/gfr807; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Miller CG, 2014, MOL BIOL CELL, V25, P2342, DOI 10.1091/mbc.E14-03-0800; Pant K, 2017, REDOX BIOL, V12, P340, DOI 10.1016/j.redox.2017.03.006; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Sabatino A, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0841-z; Sharma K, 2003, AM J PHYSIOL-RENAL, V284, pF1138, DOI 10.1152/ajprenal.00315.2002; Sonnylal S, 2010, ARTHRITIS RHEUM-US, V62, P1523, DOI 10.1002/art.27382; Sun SF, 2018, DIABETES, V67, P731, DOI 10.2337/db17-0816; Sureshbabu A, 2016, AM J PHYSIOL-RENAL, V310, pF596, DOI 10.1152/ajprenal.00365.2015; Tang FJ, 2017, DRUG DES DEV THER, V11, P2813, DOI 10.2147/DDDT.S143805; Toda N, 2018, INFLAMM REGEN, V38, DOI 10.1186/s41232-018-0070-0; Xiao XQ, 2018, J CELL BIOCHEM, V119, P3563, DOI 10.1002/jcb.26547; Xu BH, 2020, METABOLISM, V103, DOI 10.1016/j.metabol.2019.154013; Xu YH, 2018, J ENDOCRINOL, V238, P231, DOI 10.1530/JOE-18-0137; Yao WX, 2018, TOXICOL SCI, V166, P465, DOI 10.1093/toxsci/kfy221; Yao ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17032; Yiu WH, 2016, KIDNEY INT, V89, P386, DOI 10.1038/ki.2015.331; Zanchi C, 2017, DIABETOLOGIA, V60, P1114, DOI 10.1007/s00125-017-4248-9; Zhang ZB, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00016; Zhao JJ, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0259-0	42	11	11	4	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10462	10475		10.1096/fj.202000431R	http://dx.doi.org/10.1096/fj.202000431R		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32539181	hybrid			2022-12-26	WOS:000541801700001
J	Minguez, MG; Wolters-Eisfeld, G; Lutz, D; Buck, F; Schachner, ML; Kleene, R				Girbes Minguez, Maria; Wolters-Eisfeld, Gerrit; Lutz, David; Buck, Friedrich; Schachner, Melitta; Kleene, Ralf			The cell adhesion molecule L1 interacts with nuclear proteins via its intracellular domain	FASEB JOURNAL			English	Article						cell adhesion molecule L1; DNA; RNA-binding proteins; Drosophilabehavior; human splicing (DBHS) proteins; nuclear import; proteolytic processing	X-CHROMOSOME INACTIVATION; STRAND BREAK REPAIR; HISTONE H1; BINDING-PROTEIN; PORE COMPLEX; DNA-BINDING; PRESENILIN/GAMMA-SECRETASE; IMMUNOGLOBULIN SUPERFAMILY; RECOGNITION MOLECULES; CLINICAL SPECTRUM	Proteolytic cleavage of the cell adhesion molecule L1 (L1) in brain tissue and in cultured cerebellar neurons results in the generation and nuclear import of a 30 kDa fragment comprising most of L1's C-terminal, intracellular domain. In search of molecules that interact with this domain, we performed affinity chromatography with the recombinant intracellular L1 domain and a nuclear extract from mouse brains, and identified potential nuclear L1 binding partners involved in transcriptional regulation, RNA processing and transport, DNA repair, chromatin remodeling, and nucleocytoplasmic transport. By co-immunoprecipitation and enzyme-linked immunosorbent assay using recombinant proteins, we verified the direct interaction between L1 and the nuclear binding partners non-POU domain containing octamer-binding protein and splicing factor proline/glutamine-rich. The proximity ligation assay confirmed this close interaction in cultures of cerebellar granule cells. Our findings suggest that L1 fragments regulate multiple nuclear functions in the nervous system. We discuss possible physiological and pathological roles of these interactions in regulation of chromatin structure, gene expression, RNA processing, and DNA repair.	[Girbes Minguez, Maria; Wolters-Eisfeld, Gerrit; Lutz, David; Kleene, Ralf] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Hamburg, Germany; [Buck, Friedrich] Univ Klinikum Hamburg Eppendorf, Inst Klin Chem, Zentrum Diagnost, Hamburg, Germany; [Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, 22 Xin Ling Rd, Shantou 515041, Guangdong, Peoples R China; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Shantou University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schachner, ML (corresponding author), Shantou Univ, Coll Med, Ctr Neurosci, 22 Xin Ling Rd, Shantou 515041, Guangdong, Peoples R China.	schachner@stu.edu.cn	Lutz, David/AAX-1607-2021; Girbes Minguez, Maria/AAV-4278-2020; Wolters-Eisfeld, Gerrit/H-8333-2019	Wolters-Eisfeld, Gerrit/0000-0002-2984-6515; Lutz, David/0000-0001-9171-4081; Girbes Minguez, Maria/0000-0002-9619-1299	Li Kashing Foundation	Li Kashing Foundation	We are grateful to Ute Bork for excellent technical assistance. M. Schachner is grateful to the Li Kashing Foundation for support.	Alfano L, 2016, ONCOGENE, V35, P567, DOI 10.1038/onc.2015.107; Andreyeva A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012018; APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Ausio J, 2018, EPIGENOMICS-UK, V10, P5, DOI 10.2217/epi-2017-0128; Ausio J, 2014, TRENDS MOL MED, V20, P487, DOI 10.1016/j.molmed.2014.03.004; Benegiamo G, 2018, CELL METAB, V27, P404, DOI 10.1016/j.cmet.2017.12.010; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Bowen NJ, 2004, CELL MOL LIFE SCI, V61, P2163, DOI 10.1007/s00018-004-4177-x; Breuer M, 2015, GENE DEV, V29, P1789, DOI 10.1101/gad.264341.115; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Carlston CM, 2019, AM J MED GENET A, V179, P792, DOI 10.1002/ajmg.a.61091; Cheng L, 2011, EMBO J, V30, P800, DOI 10.1038/emboj.2011.10; Cheng TL, 2014, NEUROSCI BULL, V30, P601, DOI 10.1007/s12264-014-1452-6; CIAVARRA RP, 1994, P NATL ACAD SCI USA, V91, P1751, DOI 10.1073/pnas.91.5.1751; de Paz AM, 2017, ADV EXP MED BIOL, V978, P3, DOI 10.1007/978-3-319-53889-1_1; Della Ragione F, 2016, BRIEF FUNCT GENOMICS, V15, P420, DOI 10.1093/bfgp/elw023; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Emili A, 2002, RNA, V8, P1102, DOI 10.1017/S1355838202025037; Fasolino M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8050141; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.E05-06-0587; Fox AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000687; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fransen E, 1996, AM J MED GENET, V64, P73, DOI 10.1002/(SICI)1096-8628(19960712)64:1<73::AID-AJMG11>3.0.CO;2-P; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Gao XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097174; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Grandi P, 1997, MOL BIOL CELL, V8, P2017, DOI 10.1091/mbc.8.10.2017; Guillaumond F, 2011, FASEB J, V25, P2740, DOI 10.1096/fj.10-178616; Guseva D, 2011, EXP NEUROL, V229, P339, DOI 10.1016/j.expneurol.2011.02.018; Guseva D, 2009, BRAIN, V132, P2180, DOI 10.1093/brain/awp160; Gutwein P, 2005, CLIN CANCER RES, V11, P2492, DOI 10.1158/1078-0432.CCR-04-1688; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Ha K, 2011, DNA REPAIR, V10, P252, DOI 10.1016/j.dnarep.2010.11.009; Hansen JC, 2011, J BIOL CHEM, V286, P18938, DOI 10.1074/jbc.M111.234609; Hansen JC, 2010, IUBMB LIFE, V62, P732, DOI 10.1002/iub.386; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Hill DA, 2001, BIOCHEM CELL BIOL, V79, P317, DOI 10.1139/bcb-79-3-317; Hoffbuhr KC, 2002, MENT RETARD DEV D R, V8, P99, DOI 10.1002/mrdd.10026; Horvath PM, 2018, TRENDS NEUROSCI, V41, P72, DOI 10.1016/j.tins.2017.11.005; Huang CJ, 2016, AGING-US, V8, P3356, DOI 10.18632/aging.101125; Huang J, 2018, J BIOL CHEM, V293, P6593, DOI 10.1074/jbc.RA117.001451; Huang PR, 2008, BBA-MOL CELL RES, V1783, P193, DOI 10.1016/j.bbamcr.2007.08.006; Huang PR, 2010, BBA-MOL CELL RES, V1803, P1164, DOI 10.1016/j.bbamcr.2010.06.003; Jaafar L, 2017, NUCLEIC ACIDS RES, V45, P1848, DOI 10.1093/nar/gkw1209; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Kleene R, 2010, J BIOL CHEM, V285, P28968, DOI 10.1074/jbc.M110.114876; Knott GJ, 2016, NUCLEIC ACIDS RES, V44, P3989, DOI 10.1093/nar/gkw271; Kurumaji A, 2001, AM J MED GENET, V105, P99; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; Labade AS, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0106-0; LaSalle JM, 2009, EPIGENOMICS-UK, V1, P119, DOI [10.2217/epi.09.13, 10.2217/EPI.09.13]; Lee MW, 2015, NUCLEIC ACIDS RES, V43, P3826, DOI 10.1093/nar/gkv156; Li SY, 2014, NUCLEIC ACIDS RES, V42, P9771, DOI 10.1093/nar/gku650; Lutz D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15311-x; Lutz D, 2016, MOL NEUROBIOL, V53, P3360, DOI 10.1007/s12035-015-9277-0; Lutz D, 2014, J BIOL CHEM, V289, P13503, DOI 10.1074/jbc.M113.530238; Lutz D, 2014, J NEUROCHEM, V128, P713, DOI 10.1111/jnc.12473; Lutz D, 2012, J BIOL CHEM, V287, P17161, DOI 10.1074/jbc.M112.346759; Makhina T, 2009, MOL CELL NEUROSCI, V41, P206, DOI 10.1016/j.mcn.2009.02.010; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Matsumoto-Miyai K, 2003, J NEUROSCI, V23, P7727; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Moran-Jones K, 2009, CANCER RES, V69, P9219, DOI 10.1158/0008-5472.CAN-09-1852; Nagarajan RP, 2008, AUTISM RES, V1, P169, DOI 10.1002/aur.24; Nakagawa T, 2011, MOL CELL, V43, P381, DOI 10.1016/j.molcel.2011.05.033; Nayeem N, 1999, J CELL SCI, V112, P4739; Neul Jeffrey Lorenz, 2012, Dialogues Clin Neurosci, V14, P253; Passon DM, 2012, P NATL ACAD SCI USA, V109, P4846, DOI 10.1073/pnas.1120792109; Passon DM, 2011, ACTA CRYSTALLOGR F, V67, P1231, DOI [10.1107/S1744309111026212, 10.1107/S17443091110262121231]; Petti E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08863-1; POLTORAK M, 1995, EXP NEUROL, V131, P266, DOI 10.1016/0014-4886(95)90048-9; Reinstein E, 2016, EUR J HUM GENET, V24, P1635, DOI 10.1038/ejhg.2016.72; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Rupp RAW, 2005, CELL, V123, P1178, DOI 10.1016/j.cell.2005.12.004; SADOUL K, 1988, J NEUROCHEM, V50, P510, DOI 10.1111/j.1471-4159.1988.tb02941.x; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Strekalova H, 2006, NEUROBIOL AGING, V27, P1, DOI 10.1016/j.neurobiolaging.2004.11.013; Sytnyk V, 2017, TRENDS NEUROSCI, V40, P295, DOI 10.1016/j.tins.2017.03.003; Thomas-Jinu S, 2017, NEURON, V94, P322, DOI 10.1016/j.neuron.2017.03.026; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; Udayakumar D, 2015, BIOCHEM BIOPH RES CO, V463, P473, DOI 10.1016/j.bbrc.2015.05.024; Vollmer B, 2014, BIOL CHEM, V395, P515, DOI 10.1515/hsz-2013-0285; Wakabayashi Y, 2008, PROG NEURO-PSYCHOPH, V32, P1199, DOI 10.1016/j.pnpbp.2008.03.005; Wang SW, 2011, J NEUROSCI, V31, P7275, DOI 10.1523/JNEUROSCI.6476-10.2011; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xiao BT, 2012, MOL BIOL CELL, V23, P4864, DOI 10.1091/mbc.E12-07-0518; Xiao MF, 2009, J NEUROSCI, V29, P14752, DOI 10.1523/JNEUROSCI.4860-09.2009; Yang YS, 1997, NUCLEIC ACIDS RES, V25, P2284, DOI 10.1093/nar/25.12.2284; YANG YS, 1993, MOL CELL BIOL, V13, P5593, DOI 10.1128/MCB.13.9.5593; Zhang QS, 2006, RNA, V12, P1116, DOI 10.1261/rna.58806; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465	97	2	2	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9869	9883		10.1096/fj.201902242R	http://dx.doi.org/10.1096/fj.201902242R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32533745	hybrid			2022-12-26	WOS:000541526900001
J	Ko, EJ; Seo, JW; Kim, KW; Kim, BM; Cho, JH; Kim, CD; Seok, J; Yang, CW; Lee, SH; Chung, BH				Ko, Eun Jeong; Seo, Jung-Woo; Kim, Kyoung Woon; Kim, Bo-Mi; Cho, Jang-Hee; Kim, Chan-Duck; Seok, Junhee; Yang, Chul Woo; Lee, Sang-Ho; Chung, Byung Ha			Phenotype and molecular signature of CD8(+) T cell subsets in T cell- mediated rejections after kidney transplantation	PLOS ONE			English	Article							MICROARRAYS; RECIPIENTS; CD28	We investigated the phenotype and molecular signatures of CD8(+)T cell subsets in kidney-transplant recipients (KTRs) with biopsy-proven T cell-mediated rejection (TCMR). We included 121 KTRs and divided them into three groups according to the pathologic or clinical diagnosis: Normal biopsy control (NC)(n= 32), TCMR (n= 50), and long-term graft survival (LTGS)(n= 39). We used flowcytometry and microarray to analyze the phenotype and molecular signatures of CD8(+)T cell subsets using peripheral blood from those patients and analyzed significant gene expressions according to CD8(+)T cell subsets. We investigated whether the analysis of CD8(+)T cell subsets is useful for predicting the development of TCMR. CCR7(+)CD8(+)T cells significantly decreased, but CD28(null)CD57(+)CD8(+)T cells and CCR7(-)CD45RA(+)CD8(+)T cells showed an increase in the TCMR group compared to other groups (p<0.05 for each); hence CCR7(+)CD8(+)T cells showed significant negative correlations to both effector CD8(+)T cells. We identified genes significantly associated with the change of CCR7(+)CD8(+)T, CCR7(-)CD45RA(+)CD8(+)T, and CD28(null)CD57(+)CD8(+)T cells in anex vivostudy and found that most of them were included in the significant genes onin vitroCCR7(+)CD8(+)T cells. Finally, the decrease of CCR7(+)CD8(+)T cells relative to CD28(null)CD57(+)T or CCR7(-)CD45RA(+)CD8(+)T cells can predict TCMR significantly in the whole clinical cohort. In conclusion, phenotype and molecular signature of CD8(+)T subsets showed a significant relationship to the development of TCMR; hence monitoring of CD8(+)T cell subsets may be a useful for predicting TCMR in KTRs.	[Ko, Eun Jeong; Kim, Kyoung Woon; Kim, Bo-Mi; Yang, Chul Woo; Chung, Byung Ha] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Ko, Eun Jeong; Yang, Chul Woo; Chung, Byung Ha] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Seo, Jung-Woo] Kyung Hee Univ Hosp Gangdong, Med Sci Res Inst, Dept Core Res Lab, Seoul, South Korea; [Cho, Jang-Hee; Kim, Chan-Duck] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Seok, Junhee] Korea Univ, Sch Elect Engn, Seoul, South Korea; [Lee, Sang-Ho] Kyung Hee Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Kyung Hee University; Kyung Hee University Hospital; Kyungpook National University; Korea University; Kyung Hee University	Chung, BH (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Convergent Res Consortium Immunol Dis, Seoul, South Korea.; Chung, BH (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea.; Lee, SH (corresponding author), Kyung Hee Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	lshkidney@khu.ac.kr; chungbh@catholic.ac.kr	Cho, Jang-hee/ABD-3534-2020	Cho, Jang-hee/0000-0002-7031-5214; Ko, Eun Jeong/0000-0002-5604-1296; Chung, Byung Ha/0000-0003-0048-5717	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1232]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT [2018M3A9E802151]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT	BH Chung, CD Kim, and SH Lee received a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C1232) and EJ Ko received a grant from the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science & ICT (2018M3A9E802151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Ben-Moshe NB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11257-y; Betjes MGH, 2012, TRANSPLANTATION, V94, P63, DOI 10.1097/TP.0b013e31825306ff; Bezie S, 2018, TRANSPLANTATION, V102, P1467, DOI 10.1097/TP.0000000000002258; Brouard S, 2005, AM J TRANSPLANT, V5, P330, DOI 10.1111/j.1600-6143.2004.00700.x; Calvo-Turrubiartes M, 2009, TRANSPL IMMUNOL, V21, P43, DOI 10.1016/j.trim.2009.02.002; Chen HD, 2019, CELL MOL IMMUNOL, V16, P242, DOI 10.1038/s41423-019-0214-4; Chua MS, 2003, FRONT BIOSCI, V8, pS913, DOI 10.2741/1175; Chung BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042011; Demmers MWHJ, 2014, TRANSPLANTATION, V97, P47, DOI 10.1097/01.TP.0000435697.31148.b2; Halloran PF, 2016, NAT REV NEPHROL, V12, P534, DOI 10.1038/nrneph.2016.85; Higdon LE, 2019, AM J TRANSPLANT, V19, P1278, DOI 10.1111/ajt.15316; Hough KP, 2015, MOL IMMUNOL, V68, P520, DOI 10.1016/j.molimm.2015.07.038; Ideozu JE, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-019-0529-0; Kim KW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27141-6; Kim KW, 2015, IMMUNOLOGY, V144, P68, DOI 10.1111/imm.12351; Krajewska M, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/7452019; Lee YH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37975-9; Man K, 2015, NAT REV IMMUNOL, V15, P574, DOI 10.1038/nri3874; Mancebo E, 2016, TRANSPL IMMUNOL, V34, P33, DOI 10.1016/j.trim.2016.01.001; Mou D, 2014, AM J TRANSPLANT, V14, P2460, DOI 10.1111/ajt.12937; Posselt AM, 2003, TRANSPLANTATION, V76, P190, DOI 10.1097/01.TP.0000073614.29680.A8; s NA, 2018, LANCET INFECT DIS, V18, pe228; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Suzuki M, 2012, J IMMUNOL, V189, P2118, DOI 10.4049/jimmunol.1200122; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Weintraub LA, 2006, TRANSPL INT, V19, P775, DOI 10.1111/j.1432-2277.2006.00349.x; Yap M, 2016, AM J TRANSPLANT, V16, P999, DOI 10.1111/ajt.13581; Yap M, 2014, J AM SOC NEPHROL, V25, P1856, DOI 10.1681/ASN.2013080848; Ye F, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0401-7	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234323	10.1371/journal.pone.0234323	http://dx.doi.org/10.1371/journal.pone.0234323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530943	gold, Green Published			2022-12-26	WOS:000542037200027
J	Lorenzo-Martin, LF; Rodriguez-Fdez, S; Fabbiano, S; Abad, A; Garcia-Macias, MC; Dosil, M; Cuadrado, M; Robles-Valero, J; Bustelo, XR				Francisco Lorenzo-Martin, L.; Rodriguez-Fdez, Sonia; Fabbiano, Salvatore; Abad, Antonio; Garcia-Macias, Maria C.; Dosil, Mercedes; Cuadrado, Myriam; Robles-Valero, Javier; Bustelo, Xose R.			Vav2pharmaco-mimetic mice reveal the therapeutic value and caveats of the catalytic inactivation of a Rho exchange factor	ONCOGENE			English	Article							GTP-BINDING PROTEINS; SKIN TUMOR-FORMATION; RAC ACTIVATOR TIAM1; VAV FAMILY; PATHWAY; GTPASES; CANCER; INHIBITION; TARGETS; DOMAIN	The current paradigm holds that the inhibition of Rho guanosine nucleotide exchange factors (GEFs), the enzymes that stimulate Rho GTPases, can be a valuable therapeutic strategy to treat Rho-dependent tumors. However, formal validation of this idea using in vivo models is still missing. In this context, it is worth remembering that many Rho GEFs can mediate both catalysis-dependent and independent responses, thus raising the possibility that the inhibition of their catalytic activities might not be sufficient per se to block tumorigenic processes. On the other hand, the inhibition of these enzymes can trigger collateral side effects that could preclude the practical implementation of anti-GEF therapies. To address those issues, we have generated mouse models to mimic the effect of the systemic application of an inhibitor for the catalytic activity of the Rho GEF Vav2 at the organismal level. Our results indicate that lowering the catalytic activity of Vav2 below specific thresholds is sufficient to block skin tumor initiation, promotion, and progression. They also reveal that the negative side effects typically induced by the loss of Vav2 can be bypassed depending on the overall level of Vav2 inhibition achieved in vivo. These data underscore the pros and cons of anti-Rho GEF therapies for cancer treatment. They also support the idea that Vav2 could represent a viable drug target.	[Francisco Lorenzo-Martin, L.; Rodriguez-Fdez, Sonia; Fabbiano, Salvatore; Abad, Antonio; Garcia-Macias, Maria C.; Dosil, Mercedes; Cuadrado, Myriam; Robles-Valero, Javier; Bustelo, Xose R.] Univ Salamanca, Ctr Invest Canc, CSIC, Salamanca 37007, Spain; [Francisco Lorenzo-Martin, L.; Rodriguez-Fdez, Sonia; Fabbiano, Salvatore; Abad, Antonio; Garcia-Macias, Maria C.; Dosil, Mercedes; Cuadrado, Myriam; Robles-Valero, Javier; Bustelo, Xose R.] Univ Salamanca, Inst Biol Mol & Celular Canc, CSIC, Salamanca 37007, Spain; [Francisco Lorenzo-Martin, L.; Rodriguez-Fdez, Sonia; Abad, Antonio; Dosil, Mercedes; Cuadrado, Myriam; Robles-Valero, Javier; Bustelo, Xose R.] Univ Salamanca, Ctr Invest Biomed Red Canc CIBERONC, CSIC, Salamanca 37007, Spain; [Dosil, Mercedes] Univ Salamanca, Sch Pharm, Dept Bioquim & Biol Mol, Salamanca 37007, Spain; [Fabbiano, Salvatore] Cell Press Editorial Off, Cambridge, MA 02139 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; University of Salamanca	Bustelo, XR (corresponding author), Univ Salamanca, Ctr Invest Canc, CSIC, Salamanca 37007, Spain.; Bustelo, XR (corresponding author), Univ Salamanca, Inst Biol Mol & Celular Canc, CSIC, Salamanca 37007, Spain.; Bustelo, XR (corresponding author), Univ Salamanca, Ctr Invest Biomed Red Canc CIBERONC, CSIC, Salamanca 37007, Spain.	xbustelo@usal.es	Rodriguez-Fdez, Sonia/AAD-9317-2021; Bustelo, Xose R./AAD-2081-2022; Robles-Valero, Javier/J-4069-2017; Dosil, Mercedes/A-9536-2016	Bustelo, Xose R./0000-0001-9398-6072; Abad de Blas, Antonio Luis/0000-0001-8019-2775; Fabbiano, Salvatore/0000-0003-0768-6028; Robles-Valero, Javier/0000-0001-5218-0187; Cuadrado, Myriam/0000-0001-9410-1205; Dosil, Mercedes/0000-0001-8119-8263; Lorenzo-Martin, L. Francisco/0000-0003-4717-9338; Rodriguez-Fdez, Sonia/0000-0001-5369-2969	Worldwide Cancer Research [14-1248]; Castilla-Leon Government [CSI252P18, CLC-2017-01]; Spanish Ministry of Science and Innovation (MSI) [RTI2018-096481-B-I00]; Spanish Association against Cancer [GC16173472GARC]; Programa de Apoyo a Planes Estrategicos de Investigacion de Estructuras de Investigacion de Excelencia of the Castilla-Leon autonomous government [CLC-2017-01]; MSI [BES-2010-031386, BES-2013-063573]; Spanish Ministry of Universities [CLC-2017-01, FPU13/02923]; CIBERONC; Spanish Association against Cancer; European Regional Development Fund	Worldwide Cancer Research; Castilla-Leon Government; Spanish Ministry of Science and Innovation (MSI)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Association against Cancer; Programa de Apoyo a Planes Estrategicos de Investigacion de Estructuras de Investigacion de Excelencia of the Castilla-Leon autonomous government; MSI; Spanish Ministry of Universities(Spanish Government); CIBERONC; Spanish Association against Cancer; European Regional Development Fund(European Commission)	We thank M. Blazquez for lab work and CIC facilities' personnel for technical assistance. XRB is supported by grants from Worldwide Cancer Research (14-1248), the Castilla-Leon Government (CSI252P18, CLC-2017-01), the Spanish Ministry of Science and Innovation (MSI) (RTI2018-096481-B-I00), and the Spanish Association against Cancer (GC16173472GARC). XRB's institution is supported by the Programa de Apoyo a Planes Estrategicos de Investigacion de Estructuras de Investigacion de Excelencia of the Castilla-Leon autonomous government (CLC-2017-01). SF, SR-F, and LFL-M contracts have been supported by funding from the MSI (SF, BES-2010-031386; SR-F, BES-2013-063573), the Spanish Ministry of Universities (LFL-M, FPU13/02923), and the CLC-2017-01 grant (SR-F and LFL-M). JR-V has been supported by the CIBERONC and, currently, by the Spanish Association against Cancer. Both Spanish and Castilla-Leon government-associated funding is partially supported by the European Regional Development Fund.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Amado-Azevedo J, 2014, CELL TISSUE RES, V355, P557, DOI 10.1007/s00441-014-1828-6; Arash EH, 2014, EMBO J, V33, P2997, DOI 10.15252/embj.201490230; Barreira M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004993; Bouquier N, 2009, CHEM BIOL, V16, P391, DOI 10.1016/j.chembiol.2009.02.006; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Bustelo XR, 2018, BIOCHEM SOC T, V46, P741, DOI 10.1042/BST20170531; Bustelo Xose R, 2014, Small GTPases, V5, P9, DOI 10.4161/21541248.2014.973757; Chrencik JE, 2008, J MOL BIOL, V380, P828, DOI 10.1016/j.jmb.2008.05.024; Citterio C, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002962; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Crespo P, 1996, ONCOGENE, V13, P455; Cullis J, 2014, CANCER CELL, V25, P181, DOI 10.1016/j.ccr.2014.01.025; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; Dotto GP, 2016, CANCER CELL, V29, P622, DOI 10.1016/j.ccell.2016.04.004; Dutting S, 2015, J THROMB HAEMOST, V13, P827, DOI 10.1111/jth.12861; Fabbiano S, 2014, MOL CELL BIOL, V34, P4404, DOI 10.1128/MCB.01066-14; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Lorenzo-Martin LF, 2019, ONCOGENE, V38, P209, DOI 10.1038/s41388-018-0433-7; Fujikawa K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009050; Garcia-Mariscal A, 2018, ONCOGENE, V37, P847, DOI 10.1038/onc.2017.333; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Huang YP, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0126-6; Hunter SG, 2006, MOL CELL BIOL, V26, P4830, DOI 10.1128/MCB.02215-05; Kawasaki Y, 2009, EMBO REP, V10, P1355, DOI 10.1038/embor.2009.233; Khanna N, 2013, P NATL ACAD SCI USA, V110, P15979, DOI 10.1073/pnas.1310434110; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Luch A, 2005, NAT REV CANCER, V5, P113, DOI 10.1038/nrc1546; Lyons LS, 2006, MOL ENDOCRINOL, V20, P1061, DOI 10.1210/me.2005-0346; Malliri A, 2006, J BIOL CHEM, V281, P543, DOI 10.1074/jbc.M507582200; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Menacho-Marquez M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001615; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Niebel B, 2013, BIOORGAN MED CHEM, V21, P6239, DOI 10.1016/j.bmc.2013.05.021; Que SKT, 2018, J AM ACAD DERMATOL, V78, P237, DOI 10.1016/j.jaad.2017.08.059; Rapley J, 2008, EMBO REP, V9, P655, DOI 10.1038/embor.2008.80; Robles-Valero Javier, 2020, Small GTPases, V11, P233, DOI 10.1080/21541248.2018.1423851; Robles-Valero J, 2017, CANCER CELL, V32, P608, DOI 10.1016/j.ccell.2017.10.004; Rodriguez-Fdez S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050465; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Ruggiero C, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal2464; Sauzeau V, 2006, NAT MED, V12, P841, DOI 10.1038/nm1426; Sauzeau V, 2007, MOL BIOL CELL, V18, P943, DOI 10.1091/mbc.E06-09-0877; Sauzeau V, 2010, J CLIN INVEST, V120, P315, DOI 10.1172/JCI38356; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Svensmark JH, 2019, ONCOGENE, V38, P7447, DOI 10.1038/s41388-019-0963-7; Thomas EK, 2007, CANCER CELL, V12, P467, DOI 10.1016/j.ccr.2007.10.015; Verma R, 2020, MOL CELL, V77, P446, DOI 10.1016/j.molcel.2020.01.010; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang Z, 2010, ONCOGENE, V29, P3362, DOI 10.1038/onc.2010.95; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Zandvakili I, 2017, ONCOGENE, V36, P3213, DOI 10.1038/onc.2016.473; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	55	8	8	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 9	2020	39	28					5098	5111		10.1038/s41388-020-1353-x	http://dx.doi.org/10.1038/s41388-020-1353-x		JUN 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MH4RK	32528129	Green Accepted			2022-12-26	WOS:000539817600001
J	Pei, GS; Hu, RF; Dai, YL; Zhao, ZM; Jia, PL				Pei, Guangsheng; Hu, Ruifeng; Dai, Yulin; Zhao, Zhongming; Jia, Peilin			Decoding whole-genome mutational signatures in 37 human pan-cancers by denoising sparse autoencoder neural network	ONCOGENE			English	Article							DNA-DAMAGE; SEQUENCE; MECHANISMS; DISEASE; REPAIR; P53	Millions of somatic mutations have recently been discovered in cancer genomes. These mutations in cancer genomes occur due to internal and external mutagenesis forces. Decoding the mutational processes by examining their unique patterns has successfully revealed many known and novel signatures from whole exome data, but many still remain undiscovered. Here, we developed a deep learning approach, DeepMS, to decompose mutational signatures using 52,671,908 somatic mutations from 2780 highly curated cancer genomes with whole genome sequencing (WGS) in 37 cancer types/subtypes. With rigorous model training and comparison, we characterized 54 signatures for single base substitutions (SBSs), 11 for doublet base substitutions (DBSs) and 16 for small insertions and deletions (Indels). Compared to the previous methods, DeepMS could discover 37 SBS, 5 DBS, and 9 Indel new signatures, many of which represent associations with DNA mismatch or base excision repair and cisplatin therapy mechanisms. We further developed a regression-based model to estimate the correlation between signatures and clinical and demographical phenotypes. The first deep learning model DeepMS on WGS somatic mutational profiles enable us identify more comprehensive context-based mutational signatures than traditional NMF approaches. Our work substantially expands the landscape of the naturally occurring mutational signatures in cancer genomes, and provides new insights into cancer biology.	[Pei, Guangsheng; Hu, Ruifeng; Dai, Yulin; Zhao, Zhongming; Jia, Peilin] Univ Texas Hlth Sci Ctr Houston, Ctr Precis Hlth, Sch Biomed Informat, Houston, TX 77030 USA; [Zhao, Zhongming] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Sch Publ Hlth, Houston, TX 77030 USA; [Zhao, Zhongming] Univ Texas MD Anderson Canc Ctr, UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Zhao, Zhongming] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37203 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University	Zhao, ZM; Jia, PL (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Precis Hlth, Sch Biomed Informat, Houston, TX 77030 USA.; Zhao, ZM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Sch Publ Hlth, Houston, TX 77030 USA.; Zhao, ZM (corresponding author), Univ Texas MD Anderson Canc Ctr, UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA.; Zhao, ZM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37203 USA.	zhongming.zhao@uth.tmc.edu; peilin.jia@uth.tmc.edu	Hu, Ruifeng/AAF-8619-2019	Hu, Ruifeng/0000-0001-5549-3082; dai, yulin/0000-0003-1874-7893; Pei, Guangsheng/0000-0003-1804-7598	Cancer Prevention and Research Institute of Texas [CPRIT RP180734]; National Institutes of Health [R01LM012806]	Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Cancer Prevention and Research Institute of Texas (CPRIT RP180734), National Institutes of Health (R01LM012806).	Alexandrov LB, 2020, NATURE, V578, P94, DOI 10.1038/s41586-020-1943-3; Alexandrov LB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9683; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Ardin M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1011-z; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blokzijl F, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0539-0; Boot A, 2018, GENOME RES, V28, P654, DOI 10.1101/gr.230219.117; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Chuzhanova NA, 2003, HUM MUTAT, V21, P28, DOI 10.1002/humu.10146; Cooper David N, 2010, Hum Genomics, V4, P406; Drost J, 2017, SCIENCE, V358, P234, DOI 10.1126/science.aao3130; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gehring JS, 2015, BIOINFORMATICS, V31, P3673, DOI 10.1093/bioinformatics/btv408; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Haradhvala NJ, 2016, CELL, V164, P538, DOI 10.1016/j.cell.2015.12.050; Hatakeyama K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26967-4; Jia PL, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0489-9; Jia PL, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-11; Kelley DR, 2016, GENOME RES, V26, P990, DOI 10.1101/gr.200535.115; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kucab JE, 2019, CELL, V177, P821, DOI 10.1016/j.cell.2019.03.001; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Ollila J, 1996, FEBS LETT, V396, P119, DOI 10.1016/0014-5793(96)01075-7; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Pena-Diaz J, 2012, MOL CELL, V47, P669, DOI 10.1016/j.molcel.2012.07.006; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Pfeifer GP, 1997, PHOTOCHEM PHOTOBIOL, V65, P270, DOI 10.1111/j.1751-1097.1997.tb08560.x; Pilati C, 2017, J PATHOL, V242, P10, DOI 10.1002/path.4880; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Thurau C, 2011, KNOWL INF SYST, V29, P457, DOI 10.1007/s10115-010-0352-6; Tomasetti C, 2017, SCIENCE, V355, P1330, DOI 10.1126/science.aaf9011; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Viel A, 2017, EBIOMEDICINE, V20, P39, DOI 10.1016/j.ebiom.2017.04.022; Vincent E, 2008, INT CONF ACOUST SPEE, P109, DOI 10.1109/ICASSP.2008.4517558; Vincent P, 2010, J MACH LEARN RES, V11, P3371; Zhang JJ, 2019, NAT BIOTECHNOL, V37, P367, DOI 10.1038/s41587-019-0055-9	43	6	6	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 2	2020	39	27					5031	5041		10.1038/s41388-020-1343-z	http://dx.doi.org/10.1038/s41388-020-1343-z		JUN 2020	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ME5NL	32528130	Green Accepted			2022-12-26	WOS:000539817600003
J	Zhang, JMX				Zhang, James X.			Decreasing utilization and increasing prices of brand-name oral contraceptive pills: Implications to societal costs and market competition	PLOS ONE			English	Article								The affordability of pharmaceuticals has been a major challenge in US health care. Generic substitution has been proposed as an important tool to reduce the costs, yet little is known how the prices of more expensive brand-name drugs would be affected by an increased utilization of generics. We aimed to examine the trend of overall utilization and the total costs of brand-name oral contraceptive pills (OCPs), the most widely used form of contraception, and its association with the pharmaceutical market concentration among the OCPs. Data from the Medical Expenditure Panel Survey (MEPS) 2011-2014, a nationally representative survey of healthcare utilization, were extracted on the utilization of generic and brand-name OCPs. A multiple logit regression analysis was conducted to assess the trend in utilization of brand-name OCPs over time. Total costs, including the costs to the payers and consumers, were synthesized. The Herfindahl-Hirschman Index (HHI), an index describing market concentration, was constructed, and a multiple regression analysis was conducted to evaluate the association between the brand-name OCP prices and the market share of individual brand-name drugs. The odds of utilizing brand-name drugs decreased steadily in 2012, 2013, and 2014 compared to 2012 (AOR 0.87, 0.73, 0.55, respectively, p<0.05) controlling for patient mix. Despite significant decline in total utilization, there was a 90% increase in the price of brand-name OCPs, resulting an 18% increase in revenue from 2011 to 2014 for the industry. During this time, pharmaceutical market concentration for OCPs increased (HHI increased from 1105 in 2011 to 2415 in 2014). Each percentage point increase in the market share by a brand-name OCPs was associated with a $3.12 increase in its price. Market mechanisms matter. Practitioners and policy makers need to take market mechanisms into account in order to realize the benefits of generic substitutions.	[Zhang, James X.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago	Zhang, JMX (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	xzhang1@medicine.bsd.uchicago.edu	Zhang, James/HHS-8616-2022; Zhang, James X./AFN-7901-2022	Zhang, James X./0000-0002-6251-0474				Chee M, 2020, J AM ASSOC NURSE PRA, V32, P24, DOI 10.1097/JXX.0000000000000349; Chee M, 2018, JAMA INTERN MED, V178, P561, DOI 10.1001/jamainternmed.2017.7849; Colgan S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008915; Collins SR, 2015, RISE HLTH CARE COVER; Darrow J, 2018, HLTH AFFAIRS; Dayal M, 2001, SEMIN REPROD MED, V19, P295, DOI 10.1055/s-2001-18637; Fuchs VR, 2018, JAMA-J AM MED ASSOC, V320, P971, DOI 10.1001/jama.2018.10779; Kaiser Family Foundation, OR CONTR PILLS; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V316, P858, DOI 10.1001/jama.2016.11237; Lenti G, 2019, J CLIN PHARM THER, V44, P579, DOI 10.1111/jcpt.12853; Samuelson, 2001, MICROECONOMICS; Segal JB, 2020, THER INNOV REGUL SCI, V54, P151, DOI 10.1007/s43441-019-00039-9; Shrank WH, 2009, HEALTH AFFAIR, V28, P546, DOI 10.1377/hlthaff.28.2.546; The United States Department of Justice, HERF HIRSCHM IND; The United States Department of Justice, HOR MERG GUID; The United States Department of Labor, MEAS PRIC CHANG CPI; Toverud EL, 2015, APPL HEALTH ECON HEA, V13, pS35, DOI 10.1007/s40258-014-0145-2; U.S Food and Drug Administration, GEN DRUGS QUEST ANSW; U.S. Food and Drug Administration, TYP APPL; Warraich H, 2018, JAMA INTERN MED, V178, P1140, DOI 10.1001/jamainternmed.2018.3047; World Health Organization, DRUGS MONEY PRICES A	21	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234463	10.1371/journal.pone.0234463	http://dx.doi.org/10.1371/journal.pone.0234463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525965	Green Published, gold			2022-12-26	WOS:000542036800092
J	Chen, PJ; Zelada, D; Belhasan, DC; Akaaboune, M				Chen, Po-Ju; Zelada, Diego; Belhasan, Dina Cheryne; Akaaboune, Mohammed			Phosphorylation of alpha-dystrobrevin is essential for alpha kap accumulation and acetylcholine receptor stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha kap; alpha-dystrobrevin; AChR; phosphorylation; interaction; stability; agrin-induced AChR clusters; myotubes; HEK cells; imaging; proteasome inhibitor; nicotinic acetylcholine receptors (nAChR); protein complex; protein phosphorylation; protein stability; protein degradation; muscle-specific anchoring protein; phosphorylation of alpha-dystrobrevin; proteasome inhibitor; stability of alpha kap	NEUROMUSCULAR-JUNCTION DEVELOPMENT; ANCHORING PROTEIN; MUSCLE; ISOFORM; MAINTENANCE; MATURATION; TORPEDO; COMPLEX; ROLES; AGRIN	The maintenance of a high density of the acetylcholine receptor (AChR) is the hallmark of the neuromuscular junction. Muscle-specific anchoring protein (alpha kap) encoded within the calcium/calmodulin-dependent protein kinase II alpha (CAMK2A) gene is essential for the maintenance of AChR clusters bothin vivoand in cultured muscle cells. The underlying mechanism by which alpha kap is maintained and regulated remains unknown. Here, using human cell lines, fluorescence microscopy, and pulldown and immunoblotting assays, we show that alpha-dystrobrevin (alpha-dbn), an intracellular component of the dystrophin glycoprotein complex, directly and robustly promotes the stability of alpha kap in a concentration-dependent manner. Mechanistically, we found that the phosphorylatable tyrosine residues of alpha-dbn are essential for the stability of alpha-dbn itself and its interaction with alpha kap, with substitution of three tyrosine residues in the alpha-dbn C terminus with phenylalanine compromising the alpha kap-alpha-dbn interaction and significantly reducing both alpha kap and alpha-dbn accumulation. Moreover, the alpha kap-alpha-dbn interaction was critical for alpha kap accumulation and stability. We also found that the absence of either alpha kap or alpha-dbn markedly reduces AChR alpha accumulation and that overexpression of alpha-dbn or alpha kap in cultured muscle cells promotes the formation of large agrin-induced AChR clusters. Collectively, these results indicate that the stability of alpha kap and alpha-dbn complex plays an important role in the maintenance of high-level expression of AChRs.	[Chen, Po-Ju; Belhasan, Dina Cheryne; Akaaboune, Mohammed] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Akaaboune, Mohammed] Univ Michigan, Program Neurosci, Ann Arbor, MI 48109 USA; [Zelada, Diego] Univ Concepcion, Dept Cell Biol, Concepcion, Chile	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universidad de Concepcion	Akaaboune, M (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.; Akaaboune, M (corresponding author), Univ Michigan, Program Neurosci, Ann Arbor, MI 48109 USA.	makaabou@umich.edu		Zelada, Diego/0000-0003-4793-6677	NINDS, National Institutes of Health [NS-047332, NS-103845]	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health Grants NS-047332 and NS-103845 (to M. A.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akaaboune M, 2002, NEURON, V34, P865, DOI 10.1016/S0896-6273(02)00739-0; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Balasubramanian S, 1998, FEBS LETT, V432, P133, DOI 10.1016/S0014-5793(98)00804-7; Barik A, 2014, DEV NEUROBIOL, V74, P828, DOI 10.1002/dneu.22190; Bayer KU, 1998, EMBO J, V17, P5598, DOI 10.1093/emboj/17.19.5598; Bayer KU, 2002, EMBO J, V21, P3590, DOI 10.1093/emboj/cdf360; Bayer KU, 1996, MOL CELL BIOL, V16, P29; Belhasan DC, 2020, NEUROSCI LETT, V722, DOI 10.1016/j.neulet.2020.134833; Blake DJ, 1996, J BIOL CHEM, V271, P7802, DOI 10.1074/jbc.271.13.7802; BLOUNT P, 1990, J CELL BIOL, V111, P2601, DOI 10.1083/jcb.111.6.2601; CLAUDIO T, 1989, J CELL BIOL, V108, P2277, DOI 10.1083/jcb.108.6.2277; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Gingras J, 2016, J CELL SCI, V129, P898, DOI 10.1242/jcs.181180; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Grady RM, 2003, J CELL BIOL, V160, P741, DOI 10.1083/jcb.200209045; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; GU Y, 1991, J CELL BIOL, V114, P799, DOI 10.1083/jcb.114.4.799; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Koles K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008045; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Valenzuela IMPY, 2015, J NEUROSCI, V35, P5118, DOI 10.1523/JNEUROSCI.3951-14.2015; Valenzuela IMPY, 2010, J NEUROSCI, V30, P12455, DOI 10.1523/JNEUROSCI.3309-10.2010; Messeant J, 2017, DEVELOPMENT, V144, P1712, DOI 10.1242/dev.146167; Mouslim C, 2012, J NEUROSCI, V32, P5177, DOI 10.1523/JNEUROSCI.6477-11.2012; Nori A, 2003, BIOCHEM J, V370, P873, DOI 10.1042/BJ20021624; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Peters MF, 1998, J CELL BIOL, V142, P1269, DOI 10.1083/jcb.142.5.1269; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schmidt N, 2011, J CELL BIOL, V195, P1171, DOI 10.1083/jcb.201107083; Singh P, 2009, J BIOL CHEM, V284, P28212, DOI 10.1074/jbc.M109.044990; SMITH MM, 1987, J BIOL CHEM, V262, P4367; Sun ZH, 2018, MOL BIOL CELL, V29, P1422, DOI 10.1091/mbc.E18-02-0117; Tintignac LA, 2015, PHYSIOL REV, V95, P809, DOI 10.1152/physrev.00033.2014; WAGNER KR, 1993, NEURON, V10, P511, DOI 10.1016/0896-6273(93)90338-R; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	38	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10677	10688		10.1074/jbc.RA120.013952	http://dx.doi.org/10.1074/jbc.RA120.013952			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32532815	hybrid, Green Published			2022-12-26	WOS:000560405600014
J	Bortolazzo, FO; Lucke, LD; Fujii, LD; Marqueti, RD; Ramos, GV; Theodoro, V; Bombeiro, AL; Felonato, M; Dalia, RA; Carneiro, GD; Vicente, CP; Esquisatto, MAM; Mendonca, FAS; dos Santos, GMT; Pimentel, ER; de Aro, AA				Bortolazzo, Fernanda O.; Lucke, Leticia D.; Fujii, Lucas de Oliveira; Marqueti, Rita de Cassia; Ramos, Gracielle Vicira; Theodoro, Viviane; Bombeiro, Andre L.; Felonato, Maira; Dalia, Rodrigo A.; Carneiro, Giane D.; Vicente, Cristina Pontes; Esquisatto, Marcelo A. M.; Mendonca, Fernanda A. S.; dos Santos, Glaucia Maria T.; Pimentel, Edson R.; de Aro, Andrea A.			Microcurrent and adipose-derived stem cells modulate genes expression involved in the structural recovery of transected tendon of rats	FASEB JOURNAL			English	Article						cell therapy; collagen; CTGF; electrical stimulation; tendon repair	ELECTRICAL-STIMULATION; EPITHELIAL-CELLS; FLEXOR TENDON; THERAPY; WOUNDS; REPAIR; INTERLEUKIN-10; TENDINITIS; CARTILAGE; TENASCIN	Tendon injuries are common and have a high incidence of re-rupture that can cause loss of functionality. Therapies with adipose-derived stem cells (ASC) and the microcurrent (low-intensity electrical stimulation) application present promising effects on the tissue repair. We analyzed the expression of genes and the participation of some molecules potentially involved in the structural recovery of the Achilles tendon of rats, in response to the application of both therapies, isolated and combined. The tendons were distributed in five groups: normal (N), transected (T), transected and ASC (C) or microcurrent (M) or with ASC, and microcurrent (MC). Microcurrent therapy was beneficial for tendon repair, as it was observed a statistically significant increase in the organization of the collagen fibers, with involvement of theTNC, CTGF, FN, FMDO,andCOL3A1genes as well as PCNA, IL-10, and TNF-alpha. ASC therapy significantly increased theTNCandFMDOgenes expression with no changes in the molecular organization of collagen. With the association of therapies, a significant greater collagen fibers organization was observed with involvement of theFMODgene. The therapies did not affect the expression ofCOL1A1, SMAD2,SMAD3,MKX,andEGR1genes, nor did they influence the amount of collagen I and III, caspase-3, tenomodulin (Tnmd), and hydroxyproline. In conclusion, the application of the microcurrent isolated or associated with ASC increased the organization of the collagen fibers, which can result in a greater biomechanical resistance in relation to the tendons treated only with ASC. Future studies will be needed to demonstrate the biological effects of these therapies on the functional recovery of injured tendons.	[Bortolazzo, Fernanda O.; Lucke, Leticia D.; Bombeiro, Andre L.; Carneiro, Giane D.; Vicente, Cristina Pontes; Pimentel, Edson R.; de Aro, Andrea A.] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Struct & Funct Biol, Sao Paulo, Brazil; [Marqueti, Rita de Cassia] Univ Brasilia UnB, Grad Program Rehabil Sci, Brasilia, DF, Brazil; [Marqueti, Rita de Cassia] Univ Brasilia UnB, Grad Program Sci & Technol Hlth & Rehabil Sci, Brasilia, DF, Brazil; [Ramos, Gracielle Vicira] Paulista Univ UNIP, ICESP Ctr Univ, Brasilia, DF, Brazil; [Fujii, Lucas de Oliveira; Theodoro, Viviane; Felonato, Maira; Dalia, Rodrigo A.; Esquisatto, Marcelo A. M.; Mendonca, Fernanda A. S.; dos Santos, Glaucia Maria T.; de Aro, Andrea A.] Univ Ctr Herminio Ometto Fdn FHO, Biomed Sci Grad Program, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Brasilia; Universidade de Brasilia; Universidade Paulista	de Aro, AA (corresponding author), Univ Ctr Herminio Ometto Fdn FHO, Biomed Sci Grad Program, Av Dr Maximilian Baritto,500 Jd Univ, Araras, SP, Brazil.	andreaaro80@gmail.com	Marqueti, Rita de Cassia/D-1622-2012; de Aro, Andrea Aparecida/E-3753-2012; Ramos, Gracielle/D-8926-2017	Marqueti, Rita de Cassia/0000-0001-9126-3882; de Aro, Andrea Aparecida/0000-0003-2895-0000; Ramos, Gracielle/0000-0003-4746-0357; Fujii, Lucas de Oliveira/0000-0002-5962-6804; Bombeiro, Andre Luis/0000-0003-2303-8127	Capes (Coordination for the Improvement of Higher Education Personnel); Herminio Ometto Foundation/FHO	Capes (Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Herminio Ometto Foundation/FHO	Capes (Coordination for the Improvement of Higher Education Personnel); Herminio Ometto Foundation/FHO	Ahmed AF, 2012, J ADV RES, V3, P109, DOI 10.1016/j.jare.2011.05.004; ALVAREZ OM, 1983, J INVEST DERMATOL, V81, P144, DOI 10.1111/1523-1747.ep12543498; Aro AA, 2013, INJURY, V44, P884, DOI 10.1016/j.injury.2012.08.055; Aro AA, 2012, LIFE SCI, V91, P885, DOI 10.1016/j.lfs.2012.09.002; Backer Henrik C, 2019, Foot Ankle Spec, V12, P471, DOI 10.1177/1938640018819779; Behrendt P, 2018, OSTEOARTHR CARTILAGE, V26, P264, DOI 10.1016/j.joca.2017.11.007; Bertolini F, 2012, BBA-REV CANCER, V1826, P209, DOI 10.1016/j.bbcan.2012.04.004; Biancalana A, 2010, CONNECT TISSUE RES, V51, P171, DOI 10.3109/03008200903191312; Brighton CT, 2001, J BONE JOINT SURG AM, V83A, P1514, DOI 10.2106/00004623-200110000-00009; Broughton G, 2006, PLAST RECONSTR SURG, V117, p6S, DOI 10.1097/01.prs.0000225429.76355.dd; Caetano GF, 2015, PROCEDIA ENGINEER, V110, P59, DOI 10.1016/j.proeng.2015.07.010; Callegari I, 2019, J NEUROL, V266, P2629, DOI 10.1007/s00415-019-09453-3; Carvalho AD, 2011, J EQUINE VET SCI, V31, P26, DOI 10.1016/j.jevs.2010.11.014; Castro FCB, 2012, HOMEOPATHY, V101, P147, DOI 10.1016/j.homp.2012.05.006; Chan HKF, 2007, J ORTHOP SPORT PHYS, V37, P399, DOI 10.2519/jospt.2007.2412; CHENG N, 1982, CLIN ORTHOP RELAT R, P264; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; Chithra P, 1998, J ETHNOPHARMACOL, V59, P195, DOI 10.1016/S0378-8741(97)00124-4; Cho KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165661; Ciccone CD, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-17; de Aro AA, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090127; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fonseca JH, 2019, J BIOMED MATER RES B, V107, P924, DOI 10.1002/jbm.b.34187; Frauz K, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010056; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Jorge MP, 2008, J ETHNOPHARMACOL, V118, P361, DOI 10.1016/j.jep.2008.04.024; Ju YJ, 2008, CELL TISSUE RES, V332, P469, DOI 10.1007/s00441-008-0610-z; Juhasz A, 2000, LARYNGOSCOPE, V110, P84, DOI 10.1097/00005537-200001000-00016; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kleiner DM, J ATHL TRAIN, V331998, P185; Kloth Luther C, 2005, Int J Low Extrem Wounds, V4, P23; Kreja L, 2012, J MATER SCI-MATER M, V23, P2575, DOI 10.1007/s10856-012-4710-7; Lacitignola L, 2008, VET RES COMMUN, V32, pS33, DOI 10.1007/s11259-008-9085-3; Learn GD, 2019, J BIOMED MATER RES B, V107, P1864, DOI 10.1002/jbm.b.34279; Lin YL, 2006, AM J VET RES, V67, P845, DOI 10.2460/ajvr.67.5.845; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Liu T, 2016, MOL MED REP, V13, P2053, DOI 10.3892/mmr.2016.4768; Lucke LD, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12580; Marqueti RC, 2018, FASEB J, V32, P353, DOI 10.1096/fj.201700543R; Midwood KS, 2004, MOL BIOL CELL, V15, P5670, DOI 10.1091/mbc.E04-08-0759; Murthi AM, 2019, ORTHOP CLIN N AM, V50, P103, DOI 10.1016/j.ocl.2018.08.005; Nakagaki WR, 2013, ANAT REC, V296, P1546, DOI 10.1002/ar.22759; Nixon AJ, 2008, AM J VET RES, V69, P928, DOI 10.2460/ajvr.69.7.928; Omar A, 2017, EGYPT J HISTOL, V40, P12, DOI [10.21608/ejh.2017.3693, DOI 10.21608/EJH.2017.3693]; Oshiro W, 2003, J HAND SURG-AM, V28A, P814, DOI 10.1016/S0363-5023(03)00366-6; Pajala A, 2002, J BONE JOINT SURG AM, V84A, P2016, DOI 10.2106/00004623-200211000-00017; Pankevich EV, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1276, DOI 10.1134/S0006297917110050; Passarini JR, 2012, ACTA CIR BRAS, V27, P441, DOI 10.1590/S0102-86502012000700002; Raja, 2007, Front Biosci, V12, P2849; Ricchetti ET, 2008, J HAND SURG-AM, V33A, P1843, DOI 10.1016/j.jhsa.2008.07.020; Rivera-Izquierdo M, 2019, EXPERT OPIN BIOL TH, V19, P233, DOI 10.1080/14712598.2019.1563069; Rothrauff BB, 2019, J SHOULDER ELB SURG, V28, P654, DOI 10.1016/j.jse.2018.08.044; Saini NS, 2002, J VET MED A, V49, P321, DOI 10.1046/j.1439-0442.2002.00441.x; Sakr HI, 2021, ARCH PHYSIOL BIOCHEM, V127, P136, DOI 10.1080/13813455.2019.1623263; Sensini A, 2018, MATERIALS, V11, DOI 10.3390/ma11101963; Spadari GS, 2017, CLIN ORAL INVEST, V21, P111, DOI 10.1007/s00784-016-1759-6; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132; Tai GP, 2018, BURNS TRAUMA, V6, DOI 10.1186/s41038-018-0123-2; Tang M, 2020, J CELL BIOCHEM, V121, P3720, DOI 10.1002/jcb.29529; Tangerino EP, 2016, TISSUE CELL, V48, P224, DOI 10.1016/j.tice.2016.03.004; Taye N, 2020, J ORTHOP RES, V38, P23, DOI 10.1002/jor.24440; Tofino-Vian M, 2018, CELL PHYSIOL BIOCHEM, V47, P11, DOI 10.1159/000489739; Tomiosso TC, 2009, CELL TISSUE RES, V337, P235, DOI 10.1007/s00441-009-0819-5; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Uysal CA, 2012, J PLAST RECONSTR AES, V65, P1712, DOI 10.1016/j.bjps.2012.06.011; Veronesi F, 2014, J BIOMED MATER RES A, V102, P2448, DOI 10.1002/jbm.a.34896; VIDAL BD, 1980, CELL MOL BIOL, V26, P415; Vidal BD, 2011, MICRON, V42, P283, DOI 10.1016/j.micron.2010.09.010; Vidal BD, 2010, ACTA HISTOCHEM, V112, P53, DOI 10.1016/j.acthis.2008.07.005; Vila M, 2013, J BIOMED MATER RES A, V101, P213, DOI 10.1002/jbm.a.34325; Wang JHC, 2012, J HAND THER, V25, P133, DOI 10.1016/j.jht.2011.07.004; Witko-Sarsat V, 2010, J EXP MED, V207, P2631, DOI 10.1084/jem.20092241; Yang XF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-59; Yu C, 2019, MILITARY MED RES, V6, DOI 10.1186/s40779-019-0213-x; Yu C, 2014, MILITARY MED RES, V1, DOI 10.1186/2054-9369-1-24; Zaniboni E, 2019, CLIN ORAL INVEST, V23, P4083, DOI 10.1007/s00784-019-02845-9; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zheng Y, 2017, EUR REV MED PHARMACO, V21, P5160, DOI 10.26355/eurrev_201711_13833; Zuzzi DC, 2013, TISSUE CELL, V45, P275, DOI 10.1016/j.tice.2013.02.003	81	3	3	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10011	10026		10.1096/fj.201902942RR	http://dx.doi.org/10.1096/fj.201902942RR		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32558993				2022-12-26	WOS:000541806600001
J	Veeroju, S; Mamazhakypov, A; Rai, N; Kojonazarov, B; Nadeau, V; Breuils-Bonnet, S; Li, L; Weissmann, N; Rohrbach, S; Provencher, S; Bonnet, S; Seeger, W; Schermuly, R; Novoyatleva, T				Veeroju, Swathi; Mamazhakypov, Argen; Rai, Nabham; Kojonazarov, Baktybek; Nadeau, Valerie; Breuils-Bonnet, Sandra; Li, Ling; Weissmann, Norbert; Rohrbach, Susanne; Provencher, Steve; Bonnet, Sebastien; Seeger, Werner; Schermuly, Ralph; Novoyatleva, Tatyana			Effect of p53 activation on experimental right ventricular hypertrophy	PLOS ONE			English	Article							RECEPTOR-GAMMA; CARDIAC-HYPERTROPHY; OXIDATIVE STRESS; HEME OXYGENASE-1; CELL-DEATH; PULMONARY; EXPRESSION; APOPTOSIS; CONTRACTILITY; DYSFUNCTION	The leading cause of death in Pulmonary Arterial Hypertension (PAH) is right ventricular (RV) failure. The tumor suppressor p53 has been associated with left ventricular hypertrophy (LVH) and remodeling but its role in RV hypertrophy (RVH) is unclear. The purpose of this study was to determine whether pharmacological activation of p53 by Quinacrine affects RV remodeling and function in the pulmonary artery banding (PAB) model of compensated RVH in mice. The effects of p53 activation on cellular functions were studied in isolated cardiomyocytes, cardiac fibroblasts and endothelial cells (ECs). The expression of p53 was examined both on human RV tissues from patients with compensated and decompensated RVH and in mouse RV tissues early and late after the PAB. As compared to control human RVs, there was no change in p53 expression in compensated RVH, while a marked upregulation was found in decompensated RVH. Similarly, in comparison to SHAM-operated mice, unaltered RV p53 expression 7 days after PAB, was markedly induced 21 days after the PAB. Quinacrine induced p53 accumulation did not further deteriorate RV function at day 7 after PAB. Quinacrine administration did not increase EC death, neither diminished EC number and capillary density in RV tissues. No major impact on the expression of markers of sarcomere organization, fatty acid and mitochondrial metabolism and respiration was noted in Quinacrine-treated PAB mice. p53 accumulation modulated the expression of Heme Oxygenase 1 (HO-1) and Glucose Transporter (Glut1) in mouse RVs and in adult cardiomyocytes. We conclude that early p53 activation in PAB-induced RVH does not cause substantial detrimental effects on right ventricular remodeling and function.	[Veeroju, Swathi; Mamazhakypov, Argen; Rai, Nabham; Kojonazarov, Baktybek; Weissmann, Norbert; Seeger, Werner; Schermuly, Ralph; Novoyatleva, Tatyana] Justus Liebig Univ Giessen, Univ Giessen & Marburg Lung Ctr UGMLC, Excellence Cluster Cardio Pulm Inst CPI, Giessen, Germany; [Veeroju, Swathi; Mamazhakypov, Argen; Rai, Nabham; Kojonazarov, Baktybek; Weissmann, Norbert; Seeger, Werner; Schermuly, Ralph; Novoyatleva, Tatyana] Justus Liebig Univ Giessen, German Ctr Lung Res DZL, Giessen, Germany; [Kojonazarov, Baktybek] Inst Lung Hlth, Giessen, Germany; [Nadeau, Valerie; Breuils-Bonnet, Sandra; Provencher, Steve; Bonnet, Sebastien] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Dept Med, Pulm Hypertens & Vasc Biol Res Grp, Montreal, PQ, Canada; [Li, Ling; Rohrbach, Susanne] Justus Liebig Univ Giessen, Inst Physiol, Giessen, Germany; [Seeger, Werner] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Laval University; Justus Liebig University Giessen; Max Planck Society	Schermuly, R; Novoyatleva, T (corresponding author), Justus Liebig Univ Giessen, Univ Giessen & Marburg Lung Ctr UGMLC, Excellence Cluster Cardio Pulm Inst CPI, Giessen, Germany.; Schermuly, R; Novoyatleva, T (corresponding author), Justus Liebig Univ Giessen, German Ctr Lung Res DZL, Giessen, Germany.	ralph.schermuly@innere.med.uni-giessen.de; tatyana.novovatleva@innere.med.uni-giessen.de	Mamazhakypov, Argen/AAT-7794-2021	Mamazhakypov, Argen/0000-0002-2140-4819; Seeger, Werner/0000-0003-1946-0894	Universities of Giessen and Marburg Lung Centre (UGMLC); ECCPS (Excellence Cluster Cardiopulmonary System); German Research Foundation (DFG) [CRC1213]	Universities of Giessen and Marburg Lung Centre (UGMLC); ECCPS (Excellence Cluster Cardiopulmonary System)(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG))	The authors received funding from Universities of Giessen and Marburg Lung Centre (UGMLC), ECCPS (Excellence Cluster Cardiopulmonary System), and the German Research Foundation (DFG) by the CRC1213 (Collaborative Research Center 1213), projects B03 (S.R.), B04 (T.N. and R.T.S.) and CP02 (B.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderley SR, 1999, J BIOL CHEM, V274, P5038, DOI 10.1074/jbc.274.8.5038; [Anonymous], 2018, AM J PHYSIOL-CELL PH, V314, pC404; [Anonymous], 2011, AM J PHYSIOL-HEART C, V301, pH287; ARMSTRONG SC, 1991, AM J PATHOL, V138, P545; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Cesselli D, 2001, CIRC RES, V89, P279, DOI 10.1161/hh1501.094115; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Chen YH, 2003, EXP BIOL MED, V228, P447, DOI 10.1177/15353702-0322805-03; Ding GL, 2007, CARDIOVASC RES, V76, P269, DOI 10.1016/j.cardiores.2007.06.027; DOROSHOW JH, 1983, CANCER RES, V43, P4543; Drake JI, 2011, AM J RESP CELL MOL, V45, P1239, DOI 10.1165/rcmb.2010-0412OC; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Fang L, 2001, EMBO J, V20, P1931, DOI 10.1093/emboj/20.8.1931; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gomez-Arroyo J, 2013, CIRC-HEART FAIL, V6, P136, DOI 10.1161/CIRCHEARTFAILURE.111.966127; Gottlieb E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001040; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Hoshida S, 1996, J MOL CELL CARDIOL, V28, P1845, DOI 10.1006/jmcc.1996.0177; Ikeda S, 1999, LIFE SCI, V65, P925, DOI 10.1016/S0024-3205(99)00322-7; Jacquin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131940; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Leri A, 1998, J CLIN INVEST, V101, P1326, DOI 10.1172/JCI316; Lipskaia L, 2010, EXPERT OPIN BIOL TH, V10, P29, DOI 10.1517/14712590903321462; Luitel H, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13146; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Mak TW, 2017, P NATL ACAD SCI USA, V114, P2331, DOI 10.1073/pnas.1621436114; Meyer M, 1999, AM J PHYSIOL-HEART C, V276, pH779, DOI 10.1152/ajpheart.1999.276.3.H779; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Mouraret N, 2013, CIRCULATION, V127, P1664, DOI 10.1161/CIRCULATIONAHA.113.002434; Nam SY, 2011, ONCOGENE, V30, P4476, DOI 10.1038/onc.2011.150; Novoyatleva T, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0325-x; Ongusaha PP, 2003, EMBO J, V22, P1289, DOI 10.1093/emboj/cdg129; Onodera Y, 2015, FEBS OPEN BIO, V5, P492, DOI 10.1016/j.fob.2015.06.001; Partovian C, 1998, AM J PHYSIOL-HEART C, V275, pH1948, DOI 10.1152/ajpheart.1998.275.6.H1948; Piao L, 2013, J MOL MED, V91, P333, DOI 10.1007/s00109-012-0982-0; Potus F, 2015, CIRCULATION, V132, P932, DOI 10.1161/CIRCULATIONAHA.115.016382; Provencher S, 2018, CIRC RES, V122, P1021, DOI 10.1161/CIRCRESAHA.117.312579; Ravi R, 2000, GENE DEV, V14, P34; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sajjad A, 2014, BBA-MOL CELL RES, V1843, P2556, DOI 10.1016/j.bbamcr.2014.06.019; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; SARGENT CA, 1992, J PHARMACOL EXP THER, V262, P1161; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Schmid T, 2004, BIOCHEM J, V380, P289, DOI 10.1042/BJ20031299; Song H, 1999, J HEART LUNG TRANSPL, V18, P744, DOI 10.1016/S1053-2498(98)00039-4; Sutendra G, 2013, J MOL MED, V91, P1315, DOI 10.1007/s00109-013-1059-4; Toth A, 2006, J BIOL CHEM, V281, P3679, DOI 10.1074/jbc.M509630200; Wang WG, 2005, CANCER BIOL THER, V4, P893, DOI 10.4161/cbt.4.8.2134; Yamamoto K, 2001, CIRCULATION, V104, P1670, DOI 10.1161/hc4001.097186; Yeh YH, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0577-y; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Zuckerbraun BS, 2006, J EXP MED, V203, P2109, DOI 10.1084/jem.20052267; Zungu-Edmondson M, 2016, CARDIOVASC RES, V110, P30, DOI 10.1093/cvr/cvw014	59	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234872	10.1371/journal.pone.0234872	http://dx.doi.org/10.1371/journal.pone.0234872			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559203	Green Published, gold			2022-12-26	WOS:000543261600012
J	Svalheim, RA; Aas-Hansen, O; Heia, K; Karlsson-Drangsholt, A; Olsen, SH; Johnsen, HK				Svalheim, Ragnhild Aven; Aas-Hansen, Oyvind; Heia, Karsten; Karlsson-Drangsholt, Anders; Olsen, Stein Harris; Johnsen, Helge Kreutzer			Simulated trawling: Exhaustive swimming followed by extreme crowding as contributing reasons to variable fillet quality in trawl-caught Atlantic cod (Gadus morhua)	PLOS ONE			English	Article							RAINBOW-TROUT; STORAGE-TEMPERATURE; FLESH QUALITY; BLOOD-FLOW; STRESS; CORTISOL; EXERCISE; TEXTURE	Trawl-caught Atlantic cod (Gadus morhua) often yield highly variable fillet quality that may be related to capture stress. To investigate mechanisms involved in causing variable quality, commercial-sized (3.5 +/- 0.9 kg) Atlantic cod were swum to exhaustion in a large swim tunnel and subsequently exposed to extreme crowding (736 +/- 50 kg m(-3)) for 0, 1 or 3 hours in an experimental cod-end. The fish were then recuperated for 0, 3 or 6 hours in a net pen prior to slaughter to assess the possibility to reverse the reduced fillet quality. We found that exhaustive swimming and crowding were associated with increased metabolic stress, as indicated by increased plasma cortisol, blood lactate and blood haematocrit levels, accompanied by reduced quality of the fillets due to increased visual redness and lower initial muscle pH. The observed negative effects of exhaustive swimming and crowding were only to a small degree reversed within 6 hours of recuperation. The results from this study suggest that exhaustive swimming followed by extreme crowding can reduce fillet quality, as measured by fillet redness and muscle pH, and contribute to the variable fillet quality seen in trawl-caught Atlantic cod. Recuperation for more than six hours may be required to reverse these effects.	[Svalheim, Ragnhild Aven; Aas-Hansen, Oyvind; Heia, Karsten; Olsen, Stein Harris] Nofima Food Res Inst, Tromso, Norway; [Karlsson-Drangsholt, Anders; Johnsen, Helge Kreutzer] Univ Tromso, Fac Biosci Fisheries & Econ, Norwegian Coll Fishery Sci, Tromso, Norway; [Aas-Hansen, Oyvind] Norwegian Radiat & Nucl Safety Author, Sect High North, Fram Ctr, Tromso, Norway; [Karlsson-Drangsholt, Anders] Res Council Norway, Oslo, Norway	Nofima; UiT The Arctic University of Tromso; Research Council of Norway	Svalheim, RA (corresponding author), Nofima Food Res Inst, Tromso, Norway.	ragnhild.svalheim@nofima.no			Norwegian Research Council [203477]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was part of the Centre of Research-based Innovation in Sustainable fish capture and Processing technology (CRISP) project funded by the Norwegian Research Council (https://www.forskningsradet.no/en/), Grant No. 203477. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 1997, AM J PHYSIOL, V273, pH1769; AXELSSON M, 1991, J EXP BIOL, V158, P181; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bjornevik M, 2010, AQUAC RES, V41, pe467, DOI 10.1111/j.1365-2109.2010.02498.x; Borderias AJ, 2011, J FOOD SCI, V76, pR1, DOI 10.1111/j.1750-3841.2010.01900.x; Digre H, 2017, FISH RES, V189, P42, DOI 10.1016/j.fishres.2017.01.004; DUNAJSKI E, 1980, J TEXTURE STUD, V10, P301, DOI 10.1111/j.1745-4603.1980.tb00862.x; Erikson U, 2011, J FOOD SCI, V76, pS251, DOI 10.1111/j.1750-3841.2011.02141.x; HE PG, 1991, FISH RES, V12, P65, DOI 10.1016/0165-7836(91)90050-P; Karlsson-Drangsholt A, 2018, FISH RES, V197, P96, DOI 10.1016/j.fishres.2017.09.006; LUDBROOK J, 1966, AM HEART J, V71, P635, DOI 10.1016/0002-8703(66)90313-9; Maine J, 1990, ASSESSMENT SCALE DAM, P46; Margeirsson S, 2007, J FOOD ENG, V80, P503, DOI 10.1016/j.jfoodeng.2006.05.032; McCullagh J. A., 1989, GEN LINEAR MODELS; Mitchie I., 2001, FARMED FISH QUALITY, V4, P129; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; NEUMANN P, 1983, J EXP BIOL, V105, P1; Olsen SH, 2013, FISH RES, V147, P446, DOI 10.1016/j.fishres.2013.03.009; Olsen SH, 2008, AQUACULTURE, V284, P90, DOI 10.1016/j.aquaculture.2008.07.042; Satchell GH, 1991, PHYSL FORM FISH CIRC; SCHULZ R, 1985, STEROIDS, V46, P717, DOI 10.1016/0039-128X(85)90051-0; Sigholt T, 1997, J FOOD SCI, V62, P898, DOI 10.1111/j.1365-2621.1997.tb15482.x; Skjelvareid MH, 2017, J FOOD ENG, V212, P252, DOI 10.1016/j.jfoodeng.2017.05.029; Stien LH, 2005, AQUAC RES, V36, P1197, DOI 10.1111/j.1365-2109.2005.01339.x; Suuronen P, 2005, FISH RES, V71, P151, DOI 10.1016/j.fishres.2004.08.022; Svalheim RA, 2019, FOOD BIOSCI, V28, P15, DOI 10.1016/j.fbio.2019.01.008; Svalheim RA, 2017, FISH RES, V193, P158, DOI 10.1016/j.fishres.2017.04.008; Svorken M, 2015, RASTOFFKVALITET SALG; Tveiten H, 2010, J FISH BIOL, V76, P2318, DOI 10.1111/j.1095-8649.2010.02636.x; Winger PD, 2010, FISH BEHAV NEAR BOTT, P65; WRIGHT PA, 1989, J EXP BIOL, V147, P169; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	33	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234059	10.1371/journal.pone.0234059	http://dx.doi.org/10.1371/journal.pone.0234059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555614	Green Submitted, Green Published, gold			2022-12-26	WOS:000543273200063
J	Baron, JN; Aznar, MN; Monterubbianesi, M; Martinez-Lopez, B				Baron, Jerome N.; Aznar, Maria N.; Monterubbianesi, Mariela; Martinez-Lopez, Beatriz			Application of network analysis and cluster analysis for better prevention and control of swine diseases in Argentina	PLOS ONE			English	Article							CATTLE MOVEMENTS; CENTRALITY; PATTERNS	Rationale/background Though much smaller than the bovine industry, the porcine sector in Argentina involves a large number of farms and represents a significant economic sector. In recent years Argentina has implemented a national registry of swine movements amongst other measures, in an effort to control and eventually eradicate endemic Aujesky's disease. Such information can prove valuable in assessing the risk of transmission between farms for endemic diseases but also for other diseases at risk of emergence. Methods Shipment data from 2011 to 2016 were analyzed in an effort to define strategic locations and times at which control and surveillance efforts should be focused to provide cost-effective interventions. Social network analysis (SNA) was used to characterize the network as a whole and at the individual farm and market level to help identify important nodes. Spatio-temporal trends of pig movements were also analyzed. Finally, in an attempt to classify farms and markets in different groups based on their SNA metrics, we used factor analysis for mixed data (FAMD) and hierarchical clustering. Results The network involved approximate 136,000 shipments for a total of 6 million pigs. Over 350 markets and 17,800 production units participated in shipments with another 83,500 not participating. Temporal data of shipments and network metrics showed peaks in shipments in September and October. Most shipments where within provinces, with Buenos Aires, Cordoba and Santa Fe concentrating 61% of shipments. Network analysis showed that markets are involved in relatively few shipments but hold strategic positions with much higher betweenness compared to farms. Hierarchical clustering yielded four groups based on SNA metrics and node characteristics which can be broadly described as: 1. small and backyard farms; 2. industrial farms; 3. markets; and 4. a single outlying market with extreme centrality values. Conclusion Characterizing the network structure and spatio-temporal characteristics of Argentine swine shipments provides valuable information that can guide targeted and more cost-effective surveillance and control programs. We located key nodes where efforts should be prioritized. Pig network characteristics and patterns can be used to create dynamic disease transmission models, which can both be used in assessing the impact of emerging diseases and guiding efforts to eradicate endemic ones.	[Baron, Jerome N.; Martinez-Lopez, Beatriz] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Ctr Anim Dis Modeling & Surveillance CADMS, Davis, CA 95616 USA; [Aznar, Maria N.] Inst Nacl Tecnol Agr & NTA, Buenos Aires, DF, Argentina; [Monterubbianesi, Mariela] Serv Nacl Sanidad & Calidad Agroalimentaria Repub, Buenos Aires, DF, Argentina	University of California System; University of California Davis	Baron, JN (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Ctr Anim Dis Modeling & Surveillance CADMS, Davis, CA 95616 USA.	jnbaron@ucdavis.edu	Lopez, Beatriz Martinez/AAE-6692-2021	Baron, Jerome/0000-0002-9036-1218				[Anonymous], 2013, AM J KIDNEY DIS    S, V63, pe1; [Anonymous], MAD NAT EARTH 1 50M; Aznar MN, 2011, PREV VET MED, V98, P119, DOI 10.1016/j.prevetmed.2010.11.004; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Brandes U, 2005, LECT NOTES COMPUT SC, V3418, P7; Buttner K, 2013, PREV VET MED, V110, P418, DOI 10.1016/j.prevetmed.2013.01.008; CSARDI G., 2006, INTERJOURNAL COMPLEX, V1695; Echeverria M G, 1992, Rev Sci Tech, V11, P819; Environmental Systems Research Institute (ESRI), 2017, ARCGIS PROF HELP; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; FRIEDKIN NE, 1984, SOCIOL METHOD RES, V12, P235, DOI 10.1177/0049124184012003001; Gorsich EE, 2016, PREV VET MED, V134, P82, DOI 10.1016/j.prevetmed.2016.09.023; INDEC (Instituto National de Estadistica y Censos), 2010, CENS BIC SER B, V1; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Koschutzki D, 2005, LECT NOTES COMPUT SC, V3418, P16; Kukielka EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178904; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee K, 2017, PREV VET MED, V138, P113, DOI 10.1016/j.prevetmed.2017.02.001; Leon EA, 2006, PREV VET MED, V76, P109, DOI 10.1016/j.prevetmed.2006.04.010; Martinez-Lopez B, 2009, PREV VET MED, V91, P29, DOI 10.1016/j.prevetmed.2009.05.007; Martinez-Lopez B, 2009, TRANSBOUND EMERG DIS, V56, P109, DOI 10.1111/j.1865-1682.2009.01073.x; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; OIE, WORLD AN HLTH INF DA; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Proctor C.H., 1951, RES METHODS SOCIAL R, P561; R Core Team, 2018, R LANG ENV STAT COMP; Relun A, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00004; Ribbens S, 2004, VET QUART, V26, P146, DOI 10.1080/01652176.2004.9695177; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; VanderWaal KL, 2016, PREV VET MED, V123, P12, DOI 10.1016/j.prevetmed.2015.12.003; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wint W., 2007, GRIDDED LIVESTOCK WO, pp 131	32	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234489	10.1371/journal.pone.0234489	http://dx.doi.org/10.1371/journal.pone.0234489			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555649	Green Published, gold			2022-12-26	WOS:000542759600021
J	Wolf, ER; Mabry, AR; Damania, B; Mayo, LD				Wolf, Eric R.; Mabry, Alexander R.; Damania, Blossom; Mayo, Lindsey D.			Mdm2-mediated neddylation of pVHL blocks the induction of antiangiogenic factors	ONCOGENE			English	Article							RENAL-CELL CARCINOMA; WILD-TYPE P53; TUMOR ANGIOGENESIS; HIF-ALPHA; VHL GENE; MDM2; HYPOXIA; EXPRESSION; BINDING; STABILIZATION	Mutations in the tumor suppressorTP53are rare in renal cell carcinomas. p53 is a key factor for inducing antiangiogenic genes and RCC are highly vascularized, which suggests that p53 is inactive in these tumors. One regulator of p53 is the Mdm2 oncogene, which is correlated with high-grade, metastatic tumors. However, the sole activity of Mdm2 is not just to regulate p53, but it can also function independent of p53 to regulate the early stages of metastasis. Here, we report that the oncoprotein Mdm2 can bind directly to the tumor suppressor VHL, and conjugate nedd8 to VHL within a region that is important for the p53-VHL interaction. Nedd8 conjugated VHL is unable to bind to p53 thereby preventing the induction of antiangiogenic factors. These results highlight a previously unknown oncogenic function of Mdm2 during the progression of cancer to promote angiogenesis through the regulation of VHL. Thus, the Mdm2-VHL interaction represents a pathway that impacts tumor angiogenesis.	[Wolf, Eric R.; Mabry, Alexander R.; Mayo, Lindsey D.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Damania, Blossom] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Mayo, Lindsey D.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Indiana University System; Indiana University Bloomington	Mayo, LD (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.; Mayo, LD (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.	ldmayo@iu.edu		Mayo, Lindsey/0000-0002-5997-5166; Mabry, Alex/0000-0003-1635-8800	NIH/NCI [CA172256]; Riley Children's Foundation	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Riley Children's Foundation	This research was supported by NIH/NCI CA172256 and the Riley Children's Foundation. We thank Dr. Ohh for the VHL expression plasmid, Dr. Bouck for the Thrombospondin reporter plasmid, and Dr. Ivan for the renal cell carcinoma cell lines to aid in this study.	An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Batuello CN, 2015, P NATL ACAD SCI USA, V112, P1749, DOI 10.1073/pnas.1416656112; Bohlman Stephen, 2014, Subcell Biochem, V85, P235, DOI 10.1007/978-94-017-9211-0_13; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Ding XY, 2019, CELL DEATH DIFFER, V26, P1750, DOI 10.1038/s41418-018-0242-0; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Ganguli G, 2003, MOL CANCER RES, V1, P1027; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Gurova KV, 2004, CANCER RES, V64, P1951, DOI 10.1158/0008-5472.CAN-03-1541; Haitel A, 2000, CLIN CANCER RES, V6, P1840; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Hansson LO, 2002, P NATL ACAD SCI USA, V99, P10305, DOI 10.1073/pnas.122347199; Hauck PM, 2017, ONCOTARGET, V8, P104455, DOI 10.18632/oncotarget.22320; Hauck PM, 2017, MOL CANCER RES, V15, P1598, DOI 10.1158/1541-7786.MCR-17-0174; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jin YL, 2018, CLIN CANCER RES, V24, P3741, DOI 10.1158/1078-0432.CCR-17-1703; Joerger AC, 2016, ANNU REV BIOCHEM, V85, P375, DOI 10.1146/annurev-biochem-060815-014710; Joshi S, 2014, J BIOL CHEM, V289, P22785, DOI 10.1074/jbc.M114.587493; Kadakia M, 2001, DNA CELL BIOL, V20, P321, DOI 10.1089/10445490152122433; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kamat CD, 2007, CANCER LETT, V249, P209, DOI 10.1016/j.canlet.2006.08.017; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Miled C, 2005, CANCER RES, V65, P5096, DOI 10.1158/0008-5472.CAN-04-4232; MIYASHITA T, 1995, CELL, V80, P293; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL753, DOI 10.1152/ajplung.00286.2010; MUKHOPADHYAY D, 1995, CANCER RES, V55, P6161; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; Nieminen AL, 2005, J CELL PHYSIOL, V204, P364, DOI 10.1002/jcp.20406; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; Noon AP, 2010, CANCER-AM CANCER SOC, V116, P780, DOI 10.1002/cncr.24841; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pan Y, 2004, ONCOGENE, V23, P4975, DOI 10.1038/sj.onc.1207657; Patterson DM, 2011, ANGIOGENESIS, V14, P255, DOI 10.1007/s10456-011-9210-8; Rayburn E, 2005, CURR CANCER DRUG TAR, V5, P27, DOI 10.2174/1568009053332636; Reed SM, 2015, CANCERS, V7, P30, DOI 10.3390/cancers7010030; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Russell RC, 2008, EMBO REP, V9, P486, DOI 10.1038/embor.2008.19; Sanchez-Puig N, 2005, MOL CELL, V17, P11, DOI 10.1016/j.molcel.2004.11.019; Somasundaram K, 1999, ONCOGENE, V18, P6605, DOI 10.1038/sj.onc.1203284; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; Venkatesan T, 2018, CELLS, V7, P3; Wang XQ, 2001, CANCER RES, V61, P1598; Wolf ER, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao4170; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xiong J, 2014, ANGIOGENESIS, V17, P37, DOI 10.1007/s10456-013-9376-3; Yao WT, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.21; Zbar B, 1996, HUM MUTAT, V8, P348, DOI 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhou S, 2011, MOL CELL BIOL, V31, P4928, DOI 10.1128/MCB.06085-11; Zou ZQ, 2000, J BIOL CHEM, V275, P6051, DOI 10.1074/jbc.275.9.6051	59	6	6	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 16	2020	39	29					5228	5239		10.1038/s41388-020-1359-4	http://dx.doi.org/10.1038/s41388-020-1359-4		JUN 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ML6WO	32555333	Green Submitted, Green Accepted			2022-12-26	WOS:000545371000003
J	Tu, CY; Lin, CJ; Yang, BH; Wu, A; Wu, TH				Tu, Chun-Yuan; Lin, Chung-Jung; Yang, Bang-Hung; Wu, Jay; Wu, Tung-Hsin			Cardiac catheterization real-time dynamic radiation dose measurement to estimate lifetime attributable risk of cancer	PLOS ONE			English	Article							TRANSRADIAL CORONARY-ANGIOGRAPHY; IONIZING-RADIATION; OCCUPATIONAL-EXPOSURE; OPERATOR RADIATION; PATIENT; STAFF; FLUOROSCOPY; PROTECTION; EQUIVALENT; DOSIMETRY	Cardiac catheterization procedure is the gold standard to diagnose and treat cardiovascular disease. However, radiation safety and cancer risk remain major concerns. This study aimed to real-time dynamic radiation dose measurement to estimate lifetime attributable risk (LAR) of cancer incidence and mortality in operators. Coronary angiography (CA) with percutaneous coronary intervention (PCI), CA, and others (radiofrequency ablation, pacemaker and defibrillator implantation) procedures with different beam directions, were undertaken on x-ray angiography system. A real-time electronic personal dosimeter (EPD) system was used to measure the radiation dose of staff during all procedures. We followed the Biological Effects of Ionizing Radiation (BEIR) VII report to estimate the LAR of all cancer incidence and mortality. Primary operators received radiation dose in CA with PCI, CA, and others procedures were 59.33 +/- 95.03 mu Sv, 39.81 +/- 103.85 mu Sv, and 21.92 +/- 37.04 mu Sv, respectively. As to the assistant operators were 30.03 +/- 55.67 mu Sv, 14.67 +/- 14.88 mu Sv, and 4 mu Sv, respectively. LAR of all cancer incidences for staffs aged from 18 to 65 are varied from 0.40% for males to 1.50% for females. LAR of all cancer mortality for staffs aged from 18 to 65 are varied from 0.22% for males to 0.83% for females. Our study provided an easy, real-time and dynamic radiation dose measurement to estimate LAR of cancer for staff during the cardiac catheterization procedures. The LAR for all cancer incidence is about twice that for cancer mortality. Although the radiation doses of staff are lower during each procedure, the increased years of service leads to greater radiation risk to the staff.	[Tu, Chun-Yuan; Yang, Bang-Hung; Wu, Jay; Wu, Tung-Hsin] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Tu, Chun-Yuan] Mackay Mem Hosp, Dept Radiol, Taipei, Taiwan; [Lin, Chung-Jung] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Lin, Chung-Jung] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Yang, Bang-Hung] Taipei Vet Gen Hosp, Dept Nucl Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Wu, TH (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan.	tung@ym.edu.tw						Abdelaal E, 2014, JACC-CARDIOVASC INTE, V7, P567, DOI 10.1016/j.jcin.2014.02.005; Al Kharji S, 2019, CAN J CARDIOL, V35, P535, DOI 10.1016/j.cjca.2019.01.006; Alnewaini Z, 2017, J APPL CLIN MED PHYS, V18, P144, DOI 10.1002/acm2.12036; Andreassi MG, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003273; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; Balter S, 2001, RADIAT PROT DOSIM, V94, P183, DOI 10.1093/oxfordjournals.rpd.a006468; Bushberg JT, 2011, ESSENTIAL PHYS MED I, DOI [10.1118/1.4811156, DOI 10.1118/1.4811156]; Chida K, 2012, RADIAT PROT DOSIM, V149, P410, DOI 10.1093/rpd/ncr312; Chida Koichi, 2005, Nihon Hoshasen Gijutsu Gakkai Zasshi, V61, P1632; Cho HO., 2015, RAD DOSE CANC RISK C, V16, P4; Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation. National Research Council, 2006, HLTH RISKS EXP LOW L; Eichenlaub M, 2019, HEART RHYTHM; Etzel R, 2018, EUR J RADIOL, V106, P56, DOI 10.1016/j.ejrad.2018.07.006; Farah J, 2013, RADIAT PROT DOSIM, V157, P561, DOI 10.1093/rpd/nct180; Farooq L, 2019, J PHARM RES INT, P1; Haga Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00556-3; Heilmaier C, 2016, J VASC INTERV RADIOL, V27, P584, DOI 10.1016/j.jvir.2015.11.033; Hirshfeld JW, 2018, J AM COLL CARDIOL, V71, P2829, DOI 10.1016/j.jacc.2018.02.018; Ishibashi Tooru, 2020, Nihon Hoshasen Gijutsu Gakkai Zasshi, V76, P64, DOI 10.6009/jjrt.2020_JSRT_76.1.64; Ishii H, 2019, RAD PROTECTION DOSIM; Jia QJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42077; Khaleghi Fard A, 2019, RAD PROTECTION DOSIM; Kim JB, 2017, ANN SURG TREAT RES, V92, P156, DOI 10.4174/astr.2017.92.3.156; Kim KP, 2008, HEALTH PHYS, V94, P211, DOI 10.1097/01.HP.0000290614.76386.35; Kuon E, 2004, J AM COLL CARDIOL, V44, P1420, DOI 10.1016/j.jacc.2004.06.057; Little MP, 2009, RADIOLOGY, V251, P6, DOI [10.1148/radiol.2511081686, 10.1148/radiol.1.2511081686]; Liu HL, 2014, RADIAT PROT DOSIM, V158, P412, DOI 10.1093/rpd/nct261; Marant-Micallef C, 2019, INT J CANCER, V144, P2954, DOI 10.1002/ijc.32048; Martin CJ, 2011, BRIT J RADIOL, V84, P639, DOI 10.1259/bjr/24828606; Massalha S, 2019, CURR CARDIOL REP, V21, DOI 10.1007/s11886-019-1157-1; Mateya CF, 1997, HEALTH PHYS, V72, P842, DOI 10.1097/00004032-199706000-00003; Mehta SC, 2005, INDIAN J NUCL MED, V20, P29; Mesbahi A, 2008, RADIAT PROT DOSIM, V131, P399, DOI 10.1093/rpd/ncn188; Morishima Y, 2018, DYSPHAGIA, V33, P109, DOI 10.1007/s00455-017-9839-6; Nassef MH, 2017, J TAIBAH UNIV SCI, V11, P1259, DOI 10.1016/j.jtusci.2017.01.003; NIKLASON LT, 1993, RADIOLOGY, V187, P729, DOI 10.1148/radiology.187.3.8497622; Nowak M, 2019, PHYS MEDICA, V57, P33, DOI 10.1016/j.ejmp.2018.12.001; da Silva MWO, 2017, RADIAT PROT DOSIM, V176, P439, DOI 10.1093/rpd/ncx029; Ordiales JM, 2015, RADIAT PROT DOSIM, V165, P272, DOI 10.1093/rpd/ncv090; Padovani R, 2001, RADIAT PROT DOSIM, V94, P99, DOI 10.1093/oxfordjournals.rpd.a006490; Panetta CJ, 2020, CATHETER CARDIO INTE, V95, P7, DOI 10.1002/ccd.28629; Patel C, 2019, PEDIATR CARDIOL, V40, P638, DOI 10.1007/s00246-018-2039-9; Patet C, 2019, CATHETER CARDIO INTE, V94, P387, DOI 10.1002/ccd.28130; Perisinakis K, 2016, PHYS MEDICA, V32, P386, DOI 10.1016/j.ejmp.2016.02.006; Principi S, 2015, RADIAT PROT DOSIM, V164, P79, DOI 10.1093/rpd/ncu359; Rehn E, 2015, MODELING SCATTER RAD; Richardson DB, 2018, EPIDEMIOLOGY, V29, P31, DOI [10.1097/ede.0000000000000761, 10.1097/EDE.0000000000000761]; Sailer AM, 2019, J VASC INTERV RADIOL, V30, P701, DOI 10.1016/j.jvir.2018.11.019; Schultz FW, 2008, RADIAT PROT DOSIM, V129, P311, DOI 10.1093/rpd/ncn085; Sciahbasi A, 2018, J INVASIVE CARDIOL, V30, P71; Sciahbasi A, 2015, CARDIOVASC REVASCULA, V16, P386, DOI 10.1016/j.carrev.2015.07.004; Siiskonen T, 2007, BRIT J RADIOL, V80, P460, DOI 10.1259/bjr/26692771; Tang K-T, 2019, P 2 INT S RAD DET TH; Theocharopoulos N, 2006, BRIT J RADIOL, V79, P644, DOI 10.1259/bjr/76128583; van Dijk JD, 2017, J INTERV CARD ELECTR, V48, P105, DOI 10.1007/s10840-016-0200-z; Vano E, 2015, RADIAT PROT DOSIM, V165, P235, DOI 10.1093/rpd/ncv032; Venneri L, 2009, AM HEART J, V157, P118, DOI 10.1016/j.ahj.2008.08.009; Vijayalakshmi K, 2007, HEART, V93, P370, DOI 10.1136/hrt.2006.098731; von Boetticher H, 2009, HEALTH PHYS, V97, P622, DOI 10.1097/01.HP.0000363843.01041.99	59	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234461	10.1371/journal.pone.0234461	http://dx.doi.org/10.1371/journal.pone.0234461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544209	Green Published, gold			2022-12-26	WOS:000542957200045
J	Drumm, BT; Rembetski, BE; Huynh, K; Nizar, A; Baker, SA; Sanders, KM				Drumm, Bernard T.; Rembetski, Benjamin E.; Huynh, Kaitlin; Nizar, Aqeel; Baker, Salah A.; Sanders, Kenton M.			Excitatory cholinergic responses in mouse colon intramuscular interstitial cells of Cajal are due to enhanced Ca(2+)release via M(3)receptor activation	FASEB JOURNAL			English	Article						Ca(2+)imaging; Ca(2+)stores; cholinergic; c-Kit; gastrointestinal motility; optogenetics; SIP syncytium	DEEP MUSCULAR PLEXUS; NITRERGIC NEUROMUSCULAR-TRANSMISSION; ENTERIC MOTOR NEUROTRANSMISSION; SLOW-WAVE CURRENTS; SMOOTH-MUSCLE; INHIBITORY NEUROTRANSMISSION; MUSCARINIC RECEPTORS; LOWER ESOPHAGEAL; CA2+ TRANSIENTS; SMALL-INTESTINE	Colonic intramuscular interstitial cells of Cajal (ICC-IM) are associated with cholinergic varicosities, suggesting a role in mediating excitatory neurotransmission. Ca(2+)release in ICC-IM activates Ano1, a Ca2+-activated Cl(-)conductance, causing tissue depolarization and increased smooth muscle excitability. We employed Ca(2+)imaging of colonic ICC-IM in situ, using mice expressing GCaMP6f in ICC to evaluate ICC-IM responses to excitatory neurotransmission. Expression of muscarinic type 2, 3 (M-2, M-3), and NK(1)receptors were enriched in ICC-IM. NK(1)receptor agonists had minimal effects on ICC-IM, whereas neostigmine and carbachol increased Ca(2+)transients. These effects were reversed by DAU 5884 (M(3)receptor antagonist) but not AF-DX 116 (M(2)receptor antagonist). Electrical field stimulation (EFS) in the presence of L-NNA and MRS 2500 enhanced ICC-IM Ca(2+)transients. Responses were blocked by atropine or DAU 5884, but not AF-DX 116. ICC-IM responses to EFS were ablated by inhibiting Ca(2+)stores with cyclopiazonic acid and reduced by inhibiting Ca(2+)influx via Orai channels. Contractions induced by EFS were reduced by an Ano1 channel antagonist, abolished by DAU 5884, and unaffected by AF-DX 116. Colonic ICC-IM receive excitatory inputs from cholinergic neurons via M(3)receptor activation. Enhancing ICC-IM Ca(2+)release and Ano1 activation contributes to excitatory responses of colonic muscles.	[Drumm, Bernard T.; Rembetski, Benjamin E.; Huynh, Kaitlin; Nizar, Aqeel; Baker, Salah A.; Sanders, Kenton M.] Univ Nevada, Reno Sch Med, Dept Physiol & Cell Biol, MS 352, Reno, NV 89557 USA; [Drumm, Bernard T.] Dundalk Inst Technol, Dept Life & Hlth Sci, Dundalk, Ireland	Nevada System of Higher Education (NSHE); University of Nevada Reno; Dundalk Institute of Technology	Sanders, KM (corresponding author), Univ Nevada, Reno Sch Med, Dept Physiol & Cell Biol, MS 352, Reno, NV 89557 USA.	ksanders@med.unr.edu		BAKER, SAL/0000-0002-1514-6876; Drumm, Bernard/0000-0002-4762-844X	NIDDK [R01 DK-120759]	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by R01 DK-120759 from the NIDDK.	Aranishi H, 2009, CELL TISSUE RES, V335, P323, DOI 10.1007/s00441-008-0730-5; Baker S. A., 2018, FRONT PHYSIOL, V9, P1; Baker SA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0080-18.2018; Baker SA, 2016, J PHYSIOL-LONDON, V594, P3317, DOI 10.1113/JP271699; Bayguinov PO, 2010, J PHYSIOL-LONDON, V588, P4453, DOI 10.1113/jphysiol.2010.196824; Beckett EAH, 2005, J COMP NEUROL, V493, P193, DOI 10.1002/cne.20746; Beckett EAH, 2004, J PHYSIOL-LONDON, V559, P259, DOI 10.1113/jphysiol.2004.063016; Beckett EAH, 2002, J PHYSIOL-LONDON, V543, P871, DOI 10.1113/jphysiol.2002.021915; Beckett EAH, 2017, SCI REP-UK, V7, DOI 10.1038/srep44759; Berridge M, 1999, CURR BIOL, V9, pR157, DOI 10.1016/S0960-9822(99)80101-8; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Bhetwal BP, 2013, J PHYSIOL-LONDON, V591, P2971, DOI 10.1113/jphysiol.2013.255745; Blair PJ, 2012, NEUROGASTROENT MOTIL, V24, pe437, DOI 10.1111/j.1365-2982.2012.01975.x; Blair PJ, 2012, CELL TISSUE RES, V350, P199, DOI 10.1007/s00441-012-1468-7; Burns AJ, 1996, P NATL ACAD SCI USA, V93, P12008, DOI 10.1073/pnas.93.21.12008; Cobine CA, 2014, AM J PHYSIOL-GASTR L, V307, pG1057, DOI 10.1152/ajpgi.00331.2014; Cobine CA, 2011, CELL TISSUE RES, V344, P17, DOI 10.1007/s00441-011-1138-1; DANIEL EE, 1984, AM J PHYSIOL, V246, pG305, DOI 10.1152/ajpgi.1984.246.3.G305; Drumm B. T., 2019, J VIS EXP, V2019, P1; Drumm BT, 2020, J PHYSIOL-LONDON, V598, P651, DOI 10.1113/JP279102; Drumm BT, 2019, J PHYSIOL-LONDON, V597, P3587, DOI 10.1113/JP278036; Drumm BT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39729-7; Drumm BT, 2018, CELL CALCIUM, V72, P1, DOI 10.1016/j.ceca.2018.01.003; Drumm BT, 2017, J GEN PHYSIOL, V149, P703, DOI [10.1085/jgp.20171177106142017c, 10.1085/jgp.201711771]; Duffy AM, 2012, NEUROGASTROENT MOTIL, V24, pE41, DOI 10.1111/j.1365-2982.2011.01806.x; Durnin L, 2017, AM J PHYSIOL-GASTR L, V313, pG419, DOI 10.1152/ajpgi.00045.2017; Eglen RM, 1996, PHARMACOL REV, V48, P531; Eglen RM, 2001, LIFE SCI, V68, P2573, DOI 10.1016/S0024-3205(01)01054-2; Ehlert FJ, 1997, LIFE SCI, V61, P1729, DOI 10.1016/S0024-3205(97)00433-5; Forrest AS, 2006, AM J PHYSIOL-GASTR L, V290, pG486, DOI 10.1152/ajpgi.00349.2005; Fryer AD, 1998, AM J RESP CRIT CARE, V158, pS154, DOI 10.1164/ajrccm.158.supplement_2.13tac120; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Gao N, 2016, J PHYSIOL-LONDON, V594, P3209, DOI 10.1113/JP271703; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Groneberg D, 2015, J PHYSIOL-LONDON, V593, P403, DOI 10.1113/jphysiol.2014.273540; Groneberg D, 2013, GASTROENTEROLOGY, V145, P188, DOI 10.1053/j.gastro.2013.03.042; He CL, 2000, GASTROENTEROLOGY, V118, P14, DOI 10.1016/S0016-5085(00)70409-4; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Iino S, 2006, NEUROSCIENCE, V138, P549, DOI 10.1016/j.neuroscience.2005.11.021; Iino S, 2004, J PHYSIOL-LONDON, V556, P521, DOI 10.1113/jphysiol.2003.058792; Ishikawa K, 1996, ANAT EMBRYOL, V194, P49; Kashyap P, 2011, NEUROGASTROENT MOTIL, V23, P760, DOI 10.1111/j.1365-2982.2011.01729.x; Komuro T, 1999, MICROSC RES TECHNIQ, V47, P267, DOI 10.1002/(SICI)1097-0029(19991115)47:4<267::AID-JEMT5>3.0.CO;2-O; Komuro T, 2006, J PHYSIOL-LONDON, V576, P653, DOI 10.1113/jphysiol.2006.116624; Kunze WAA, 1999, ANNU REV PHYSIOL, V61, P117, DOI 10.1146/annurev.physiol.61.1.117; Lavin ST, 1998, HISTOCHEM CELL BIOL, V110, P263, DOI 10.1007/s004180050288; Lee HT, 2009, GASTROENTEROLOGY, V136, P2226, DOI 10.1053/j.gastro.2009.02.060; Lies B, 2015, J PHYSIOL-LONDON, V593, P4589, DOI 10.1113/JP270511; Lies B, 2014, AM J PHYSIOL-GASTR L, V307, pG98, DOI 10.1152/ajpgi.00082.2014; Lyford GL, 2002, GUT, V51, P496, DOI 10.1136/gut.51.4.496; Ro S, 2010, GASTROENTEROLOGY, V138, P1068, DOI 10.1053/j.gastro.2009.11.007; RUMESSEN JJ, 1992, GASTROENTEROLOGY, V102, P56, DOI 10.1016/0016-5085(92)91784-2; Rumessen JJ, 2013, CELLS TISSUES ORGANS, V197, P322, DOI 10.1159/000346314; Sanders KM, 2014, PHYSIOL REV, V94, P859, DOI 10.1152/physrev.00037.2013; Sanders KM, 2012, NAT REV GASTRO HEPAT, V9, P633, DOI 10.1038/nrgastro.2012.168; Sanders KM, 2010, J PHYSIOL-LONDON, V588, P4621, DOI 10.1113/jphysiol.2010.196030; Sanders KM, 1996, GASTROENTEROLOGY, V111, P492, DOI 10.1053/gast.1996.v111.pm8690216; Sawyer GW, 1998, J PHARMACOL EXP THER, V284, P269; Seo Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155771; SMITH TK, 1987, AM J PHYSIOL, V252, pC290, DOI 10.1152/ajpcell.1987.252.3.C290; SMITH TK, 1987, AM J PHYSIOL, V252, pC215, DOI 10.1152/ajpcell.1987.252.2.C215; Southwell BR, 2001, GASTROENTEROLOGY, V120, P1140, DOI 10.1053/gast.2001.23251; Spencer NJ, 2020, NAT REV GASTRO HEPAT, V17, P338, DOI 10.1038/s41575-020-0271-2; Spencer NJ, 2020, AM J PHYSIOL-GASTR L, V318, pG244, DOI 10.1152/ajpgi.00317.2019; Spencer NJ, 2018, J NEUROSCI, V38, P5507, DOI 10.1523/JNEUROSCI.3489-17.2018; Sung TS, 2018, J PHYSIOL-LONDON, V596, P1549, DOI 10.1113/JP275478; Vanderwinden JM, 1996, GASTROENTEROLOGY, V111, P901, DOI 10.1016/S0016-5085(96)70057-4; Vanderwinden JM, 2000, CELL TISSUE RES, V302, P155, DOI 10.1007/s004419900170; Wang XY, 2000, CELL TISSUE RES, V302, P331, DOI 10.1007/s004410000272; Wang XY, 1999, CELL TISSUE RES, V295, P247, DOI 10.1007/s004410051231; Ward SM, 2006, J PHYSIOL-LONDON, V576, P675, DOI 10.1113/jphysiol.2006.117390; Ward SM, 2006, J PHYSIOL-LONDON, V573, P147, DOI 10.1113/jphysiol.2006.105189; Ward SM, 2000, J NEUROSCI, V20, P1393; Ward SM, 1998, GASTROENTEROLOGY, V115, P314, DOI 10.1016/S0016-5085(98)70198-2; Wedel T, 2002, GASTROENTEROLOGY, V123, P1459, DOI 10.1053/gast.2002.36600; Worth AA, 2015, J NEUROGASTROENTEROL, V21, P200, DOI 10.5056/jnm14120; YAMAMOTO M, 1977, ARCH HISTOL JAPON, V40, P171, DOI 10.1679/aohc1950.40.171; Youm JB, 2019, BIOPHYS J, V117, P767, DOI 10.1016/j.bpj.2019.07.020; ZHANG LB, 1991, MOL PHARMACOL, V40, P943; Zheng HF, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00230; Zheng HF, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aaq0918; Zhu MH, 2015, AM J PHYSIOL-CELL PH, V308, pC608, DOI 10.1152/ajpcell.00360.2014; Zhu MH, 2011, J PHYSIOL-LONDON, V589, P4565, DOI 10.1113/jphysiol.2011.211094; Zhu MH, 2009, J PHYSIOL-LONDON, V587, P4905, DOI 10.1113/jphysiol.2009.176206	84	6	6	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10073	10095		10.1096/fj.202000672R	http://dx.doi.org/10.1096/fj.202000672R		JUN 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32539213	Green Accepted, Bronze			2022-12-26	WOS:000541637800001
J	Shi, Y; Huang, CL; Yi, H; Cao, QH; Zhao, YL; Chen, JS; Chen, XM; Pollock, C				Shi, Ying; Huang, Chunling; Yi, Hao; Cao, Qinghua; Zhao, Yongli; Chen, Jason; Chen, Xinming; Pollock, Carol			RIPK3 blockade attenuates kidney fibrosis in a folic acid model of renal injury	FASEB JOURNAL			English	Article						chronic kidney disease; dabrafenib; NLRP3; renal fibrosis; RIPK3	NLRP3 INFLAMMASOME; OVERCOMING RESISTANCE; BRAF INHIBITOR; NECROPTOSIS; DABRAFENIB; CELL; DISEASE; ACTIVATION; NECROSIS; PHARMACOKINETICS	Renal fibrosis is common to all forms of progressive kidney disease. However, current therapies to limit renal fibrosis are largely ineffective. Phosphorylation of receptor-interacting serine/threonine-protein kinase (RIPK) 3 has been recently suggested to be a key regulator of the pyrin domain containing 3 (NLRP3) inflammasome, which provides new insights into mechanisms of chronic kidney disease (CKD). However, the specific effect of RIPK3 on renal cortical fibrosis has not been fully understood. To study the function of RIPK3, both genetic ablation and pharmacological inhibition of RIPK3 (dabrafenib) were used in the study. Our studies identify that RIPK3 promotes renal fibrosis via the activation of the NLRP3 inflammasome in a mouse model of folic acid-induced nephropathy. Both interventional strategies decreased the renal fibrotic response, and beneficial effects converged on the NLRP3 inflammasome. This study demonstrates a role for RIPK3 as the mediator of renal fibrosis via the upregulation of inflammasome activation. Dabrafenib, as an inhibitor of RIPK3, may be an effective treatment to limit the progression of the tubulointerstitial fibrosis.	[Shi, Ying; Huang, Chunling; Yi, Hao; Cao, Qinghua; Chen, Xinming; Pollock, Carol] Univ Sydney, Kolling Inst Med Res, Sydney Med Sch, Sydney, NSW 2065, Australia; [Zhao, Yongli] Dalian Med Univ, Dept Pediat, Affiliated Hosp 2, Dalian, Peoples R China; [Chen, Jason] Royal North Shore Hosp, Dept Anat Pathol, St Leonards, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; Dalian Medical University; Royal North Shore Hospital	Pollock, C (corresponding author), Univ Sydney, Kolling Inst Med Res, Sydney Med Sch, Sydney, NSW 2065, Australia.	carol.pollock@sydney.edu.au			Australian National Health and Medical Research Council (NSLHD) [RESP/15/206]	Australian National Health and Medical Research Council (NSLHD)	This work was supported by an Australian National Health and Medical Research Council project grant (NSLHD reference RESP/15/206)	Anders HJ, 2018, KIDNEY INT, V93, P656, DOI 10.1016/j.kint.2017.09.022; Awad AS, 2015, KIDNEY INT, V88, P722, DOI 10.1038/ki.2015.162; Buchholz B, 2011, NEPHROL DIAL TRANSPL, V26, P3458, DOI 10.1093/ndt/gfr432; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Coca SG, 2017, J AM SOC NEPHROL, V28, P2786, DOI 10.1681/ASN.2016101101; Conos SA, 2017, P NATL ACAD SCI USA, V114, pE961, DOI 10.1073/pnas.1613305114; Cruz SA, 2018, NEURAL REGEN RES, V13, P252, DOI 10.4103/1673-5374.226394; Denton CL, 2013, J CLIN PHARMACOL, V53, P955, DOI 10.1002/jcph.127; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; Fan JM, 2001, AM J KIDNEY DIS, V37, P820, DOI 10.1016/S0272-6386(01)80132-3; Farris AB, 2011, J AM SOC NEPHROL, V22, P176, DOI 10.1681/ASN.2009091005; FINK M, 1987, PATHOLOGY, V19, P143, DOI 10.3109/00313028709077125; Foresto-Neto O, 2018, LAB INVEST, V98, P773, DOI 10.1038/s41374-018-0029-4; Francois H., 2017, MATRIX BIOL, DOI [10.10161j.matbio.2017.12.013, DOI 10.10161J.MATBIO.2017.12.013]; Gerarduzzi C, 2017, J CELL PHYSIOL, V232, P202, DOI 10.1002/jcp.25412; Ghasemi H, 2019, IRAN J BASIC MED SCI, V22, P376, DOI 10.22038/ijbms.2019.31922.7674; Guo HL, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/8316560; Huang GR, 2018, TOXICOLOGY, V406, P33, DOI 10.1016/j.tox.2018.05.015; Imamura M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.94979; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328; Lau A, 2013, AM J TRANSPLANT, V13, P2805, DOI 10.1111/ajt.12447; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Lee SB, 2010, KIDNEY INT, V78, pS22, DOI 10.1038/ki.2010.418; Li JX, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.241; Li S, 2019, EXP CELL RES, V383, DOI 10.1016/j.yexcr.2019.07.001; Lorenz G, 2014, NEPHROL DIAL TRANSPL, V29, P41, DOI 10.1093/ndt/gft332; Martin-Sanchez D, 2017, J AM SOC NEPHROL, V28, P218, DOI 10.1681/ASN.2015121376; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Miao NJ, 2019, ACTA PHARMACOL SIN, V40, P790, DOI 10.1038/s41401-018-0177-5; Mittapalli RK, 2013, J PHARMACOL EXP THER, V344, P655, DOI 10.1124/jpet.112.201475; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Odogwu L, 2018, ONCOLOGIST, V23, P740, DOI 10.1634/theoncologist.2017-0642; Ouellet D, 2014, J CLIN PHARMACOL, V54, P696, DOI 10.1002/jcph.263; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Pulskens WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085775; Rao C, 2012, EUR J PUBLIC HEALTH, V22, P280, DOI 10.1093/eurpub/ckq205; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shlomovitz I, 2017, IMMUNOL CELL BIOL, V95, P166, DOI 10.1038/icb.2016.124; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Spagnolo F, 2014, ONCOTARGET, V5, P10206, DOI 10.18632/oncotarget.2602; Stallons LJ, 2014, TOXICOL LETT, V224, P326, DOI 10.1016/j.toxlet.2013.11.014; Swenson-Fields KI, 2013, KIDNEY INT, V83, P855, DOI 10.1038/ki.2012.446; Vaidhyanathan S, 2016, J PHARMACOL EXP THER, V356, P251, DOI 10.1124/jpet.115.229393; Vince JE, 2016, CELL MOL LIFE SCI, V73, P2349, DOI 10.1007/s00018-016-2205-2; Wang Shengliu, 2017, Biophys Rep, V3, P8, DOI 10.1007/s41048-017-0035-x; Wang W, 2013, J IMMUNOL, V190, P1239, DOI 10.4049/jimmunol.1201959; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Wang XL, 2014, EUR J ENTOMOL, V111, P1, DOI 10.14411/eje.2014.001; Wasung ME, 2015, CLIN CHIM ACTA, V438, P350, DOI 10.1016/j.cca.2014.08.039; Xiao X, 2017, AM J NEPHROL, V46, P131, DOI 10.1159/000478746; Yang Hai-Chun, 2010, Drug Discov Today Dis Models, V7, P13, DOI 10.1016/j.ddmod.2010.08.002; Zheng LF, 2018, NEPHROLOGY, V23, P573, DOI 10.1111/nep.13062; Zhu YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156729	55	14	14	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10286	10298		10.1096/fj.201902544RR	http://dx.doi.org/10.1096/fj.201902544RR		JUN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32542792	Bronze			2022-12-26	WOS:000541637500001
J	Ijaz, M; Asim, SM; Alamgir; Farooq, M; Khan, SA; Manzoor, S				Ijaz, Muhammad; Asim, Syed Muhammad; Alamgir; Farooq, Muhammad; Khan, Sajjad Ahmad; Manzoor, Sadaf			A Gull Alpha Power Weibull distribution with applications to real and simulated data	PLOS ONE			English	Article								In this paper, we produced a new family of distribution called Gull Alpha Power Family of distributions (GAPF). A Special case of GAPF is derived by considering the Weibull distribution as a baseline distribution called Gull Alpha Power Weibull distribution (GAPW). The suitability of the proposed distribution derives from its ability to model both the monotonic and non-monotonic hazard rate functions which are a common practice in survival analysis and reliability engineering. Various statistical properties were derived in addition to their special cases. The unknown parameters of the model are estimated using the maximum likelihood method. Moreover, the usefulness of the proposed distribution is supported by using two real lifetime data sets as well as simulated data.	[Ijaz, Muhammad; Asim, Syed Muhammad; Alamgir; Farooq, Muhammad] Univ Peshawar, Dept Stat, Peshawar, Kpk, Pakistan; [Khan, Sajjad Ahmad; Manzoor, Sadaf] Islamia Coll Peshawar, Dept Stat, Peshawar, Kpk, Pakistan	University of Peshawar; University of Peshawar	Ijaz, M (corresponding author), Univ Peshawar, Dept Stat, Peshawar, Kpk, Pakistan.	ijaz.statistics@gmail.com		Ijaz, Dr.Muhammad/0000-0003-1403-7093; Khan, Sajjad Ahmad/0000-0001-6630-7222				Abid S.H., 2017, APPL MATH, V3, P51; Al-Aqtash R., 2015, J PROBABILITY STAT S, V13, P135; Al-Aqtash R, 2014, J MOD APPL STAT METH, V13, P201, DOI 10.22237/jmasm/1414815000; Al-Hasan M, 2003, RENEW ENERG, V28, P93, DOI 10.1016/S0960-1481(01)00151-3; Aldeni M., 2017, J STAT DISTRIBUTIONS, V4, P1, DOI [DOI 10.1186/S40488-017-0081-4, 10.1186/s40488-017-0081-4]; Almalki SJ, 2014, IEEE T RELIAB, V63, P68, DOI 10.1109/TR.2014.2299691; Almalki SJ, 2013, RELIAB ENG SYST SAFE, V111, P164, DOI 10.1016/j.ress.2012.10.018; Almheidat M., 2016, J MODERN APPL STAT M, V15, P47; Alzaatreh A., 2014, J STAT DISTRIBUTIONS, V1, P18, DOI 10.1186/2195-5832-1-16; Alzaatreh A., 2016, J STAT DISTRIB APPL, V3, P12, DOI [DOI 10.1186/S40488-016-0050-3, 10.1186/s40488-016-0050-3]; Alzaatreh A, 2014, COMPUT STAT DATA AN, V69, P67, DOI 10.1016/j.csda.2013.07.035; Alzaghal A., 2013, INT J STAT PROBABILI, V2, P31, DOI [10.5539/ijsp.v2n3p31, DOI 10.5539/IJSP.V2N3P31]; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Bebbington M, 2007, RELIAB ENG SYST SAFE, V92, P719, DOI 10.1016/j.ress.2006.03.004; CANAVOS GC, 1973, OPER RES, V21, P755, DOI 10.1287/opre.21.3.755; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Cordeiro GM, 2017, COMMUN STAT-THEOR M, V46, P5685, DOI 10.1080/03610926.2015.1109665; Dahm H, 2002, J ENVIRON RADIOACTIV, V63, P207, DOI 10.1016/S0265-931X(02)00025-5; Dey S., 2017, ANN DATA SCI, V4, P31, DOI [10.1007/s40745-016-0094-8, DOI 10.1007/S40745-016-0094-8]; Fok SL, 2001, ENG FRACT MECH, V68, P1171, DOI 10.1016/S0013-7944(01)00022-4; Ghitany ME, 2007, COMMUN STAT-THEOR M, V36, P1855, DOI 10.1080/03610920601126571; Huillet T, 1999, EUR PHYS J B, V12, P457, DOI 10.1007/s100510051027; KESHAVAN MK, 1980, J MATER SCI, V15, P839, DOI 10.1007/BF00552092; Korkmaz MC, 2017, COMMUN STAT-SIMUL C, V46, P1441, DOI 10.1080/03610918.2015.1005233; Lemonte AJ, 2014, COMMUN STAT-THEOR M, V43, P2066, DOI 10.1080/03610926.2013.766343; Li QS, 2003, CEMENT CONCRETE RES, V33, P1631, DOI 10.1016/s0008-8846(03)00111-x; Nasir A., 2017, J STAT APPL PROBABIL, V6, P499, DOI [10.18576/jsap/060306, DOI 10.18576/JSAP/060306]; Okasha H. M., 2014, J EGYPTIAN MATH SOC, V22, P489; Sun J, 2016, ACCIDENT ANAL PREV, V95, P503, DOI 10.1016/j.aap.2015.12.011; TSUMOTO M, 1974, IEEE T POWER AP SYST, VPA93, P360, DOI 10.1109/TPAS.1974.293955; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293	33	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0233080	10.1371/journal.pone.0233080	http://dx.doi.org/10.1371/journal.pone.0233080			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530965	Green Published, gold			2022-12-26	WOS:000542037200031
J	Ntakaris, A; Kanniainen, J; Gabbouj, M; Iosifidis, A				Ntakaris, Adamantios; Kanniainen, Juho; Gabbouj, Moncef; Iosifidis, Alexandros			Mid-price prediction based on machine learning methods with technical and quantitative indicators	PLOS ONE			English	Article							FEATURE-SELECTION; STOCK-PRICES; RISK; EQUILIBRIUM; RETURNS	Stock price prediction is a challenging task, in which machine learning methods have recently been successfully used. In this paper, we extract over 270 hand-crafted features (factors) inspired by technical indicators and quantitative analysis and test their validity on short-term mid-price movement prediction for Nordic TotalView-ITCH stocks. The suggested feature list represents one of the most extensive studies in the field of financial feature engineering. We focus on a wrapper feature selection method using entropy, least-mean squares, and linear discriminant analysis. We also introduce a novel quantitative feature based on adaptive logistic regression for online learning. The proposed feature is consistently selected as the first feature among a large number of indicators used in this study. We further examine the best combinations of features using a high-frequency limit order book Nordic database. Our results suggest that sorting methods and classifiers can be used in such a way that one can reach the best classification performance with a combination of only a few advanced hand-crafted features.	[Ntakaris, Adamantios; Kanniainen, Juho; Gabbouj, Moncef] Tampere Univ, Fac Informat Technol & Commun Sci, Tampere, Finland; [Iosifidis, Alexandros] Aarhus Univ, Dept Engn Elect & Comp Engn, Aarhus, Denmark	Tampere University; Aarhus University	Ntakaris, A (corresponding author), Tampere Univ, Fac Informat Technol & Commun Sci, Tampere, Finland.	adamantios.ntakaris@tuni.fi	Gabbouj, Moncef/G-4293-2014; Iosifidis, Alexandros/G-2433-2013	Gabbouj, Moncef/0000-0002-9788-2323; Iosifidis, Alexandros/0000-0003-4807-1345; Ntakaris, Adamantios/0000-0002-1626-3943; Kanniainen, Juho/0000-0001-7737-659X	H2020 Project BigDataFinance MSCA-ITN-ETN [675044]	H2020 Project BigDataFinance MSCA-ITN-ETN	AN, JK, MG, AI MSCA-ITN-ETN 675044 The research leading to these results has received funding from the H2020 Project BigDataFinance MSCA-ITN-ETN 675044 (http://bigdatafinance.eu), Training for Big Data in Financial Research and Risk Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, BOLLINGER BOLLINGER; [Anonymous], 2009, P 26 ANN INT C MACH; Aspray T., 1989, TECHNICAL ANAL STOCK, V7, P56; BATTITI R, 1994, IEEE T NEURAL NETWOR, V5, P537, DOI 10.1109/72.298224; Blau W, 1991, TECHNICAL ANAL STOCK, V9; Box G. E. P., 2015, TIME SERIES ANAL FOR; Broomhead DS, 1988, ROYAL SIGNALS RADAR; Chan LKC, 1999, REV FINANC STUD, V12, P937, DOI 10.1093/rfs/12.5.937; Chande T. S., 1992, STOCK COMMODITIES, V10, P3; Chande TS, 1994, NEW TECHNICAL TRADER; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Chua S, 2006, S CHUAS DAY TRADE YO; Dash R., 2016, J FINANCE DATA SCI, V2, P42, DOI [10.1016/j.jfds.2016.03.002, DOI 10.1016/J.JFDS.2016.03.002]; Diebold FX, 1999, REV ECON STAT, V81, P661, DOI 10.1162/003465399558526; Ehlers JF, 2001, ROCKET SCI TRADERS D, V112; Elder A, 2002, COME MY TRADING ROOM, V163; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Eshel G, 2003, INTERNET RESOURCE, V2, P68; FAMA EF, 1968, J FINANC, V23, P29, DOI 10.2307/2325308; Fang Y, 2003, INT J FORECASTING, V19, P369, DOI 10.1016/S0169-2070(02)00013-4; French C.W., 2003, J INVEST MANAG, V1, P60; Gould MD, 2013, QUANT FINANC, V13, P1709, DOI 10.1080/14697688.2013.803148; Gregory-Williams J, 2012, TTRADING CHAOS MAXIM, V172; Hamilton James D., 1994, TIME SERIES ANAL, V2; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Iosifidis A, 2017, NEUROCOMPUTING, V219, P210, DOI 10.1016/j.neucom.2016.09.023; Iosifidis A, 2013, IEEE T KNOWL DATA EN, V25, P2564, DOI 10.1109/TKDE.2012.223; Iosifidis A, 2015, PATTERN RECOGN LETT, V54, P11, DOI 10.1016/j.patrec.2014.12.003; Kablan A, 2010, J DIABETES METAB, V1, DOI 10.4172/2155-6156.1000101; Keltner CW, 1960, MAKE MONEY COMMODITI; Kercheval AN, 2015, QUANT FINANC, V15, P1315, DOI 10.1080/14697688.2015.1032546; KUMARESAN R, 1990, IEEE T AERO ELEC SYS, V26, P925, DOI 10.1109/7.62245; Liu HW, 2009, PATTERN RECOGN, V42, P1330, DOI 10.1016/j.patcog.2008.10.028; Liu Y, 2012, IEEJ J IND APPL, V1, P5; Miao JY, 2016, PROCEDIA COMPUT SCI, V91, P919, DOI 10.1016/j.procs.2016.07.111; Mulloy Patrick G, 1994, STOCKS COMMODITIES, V12, P11; Muranaka K., 2000, STOCKS COMMOD, V18, P22; Murphy J, 1999, TRADING INTERMARKET; Naiman E, 2009, SMALL ENCY TRADER, V456; Ntakaris A, 2019, IEEE ACCESS, V7, P82390, DOI 10.1109/ACCESS.2019.2924353; Ntakaris A, 2018, J FORECASTING, V37, P852, DOI 10.1002/for.2543; Pagonidis AS, 2014, IBS EFFECT MEAN REVE; Passalis N, 2017, EUR SIGNAL PR CONF, P301, DOI 10.23919/EUSIPCO.2017.8081217; Patel J, 2015, EXPERT SYST APPL, V42, P259, DOI 10.1016/j.eswa.2014.07.040; PEROLD AF, 1984, MANAGE SCI, V30, P1143, DOI 10.1287/mnsc.30.10.1143; POTERBA JM, 1988, J FINANC ECON, V22, P27, DOI 10.1016/0304-405X(88)90021-9; Rayome DL, 2007, IABE ANN C 2007, P302; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schafer RW, 2011, IEEE SIGNAL PROC MAG, V28, P111, DOI 10.1109/MSP.2011.941097; Scholtus ML, 2012, HIGH FREQUENCY TECHN; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; Sirignano JA, 2019, QUANT FINANC, V19, P549, DOI 10.1080/14697688.2018.1546053; Smith C. W., 1989, J APPL CORPORATE FIN, V1, P27; Smith S. W., 1999, SCI ENG GUIDE DIGITA, V2nd; Taylor S.J., 2008, MODELLING FINANCIAL; Thanh DT, 2017, ARXIV170901268; Tillson T., 1998, DIGITAL FILTERS; Tsantekidis A, 2017, CONF BUS INFORM, V1, P7, DOI 10.1109/CBI.2017.23; Tsantekidis A, 2017, EUR SIGNAL PR CONF, P2511, DOI 10.23919/EUSIPCO.2017.8081663; Valcu D., 2004, TECH ANAL STOCKS COM, V22, P16; Wilder J.W, 1978, RESEARCH-CHINA; Wilder Jr J W, 1986, J TECHNICAL ANAL STO, V4, P343; Williams B, 1998, NEW TRADING DIMENSIO, V72, P1; Williams L., 1985, TECHNICAL ANAL STOCK, V3, P140	65	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234107	10.1371/journal.pone.0234107	http://dx.doi.org/10.1371/journal.pone.0234107			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QP	32530920	gold, Green Published, Green Submitted			2022-12-26	WOS:000542037200044
J	Wang, JJ; Liang, KL; Lin, WJ; Chen, CY; Jiang, RS				Wang, Jing-Jie; Liang, Kai-Li; Lin, Wen-Jiun; Chen, Chih-Yi; Jiang, Rong-San			Influence of age and sex on taste function of healthy subjects	PLOS ONE			English	Article							GUSTATORY FUNCTION; INTENSITY; CHINESE; NACL	The purpose of this study was to determine the influence of age and sex on the taste functions of healthy Taiwanese. Subjects were divided into groups based on their sex and age: 20-39 years, 40-59 years, or >= 60 years. We evaluated the taste functions of subjects using the whole mouth suprathreshold taste test and the taste quad test. For the whole-mouth test, subjects were instructed to sip and swish sweet, sour, salty, and bitter solutions, each at 5 different suprathreshold concentrations. Each subject was required to indicate the taste quality, and to rate the intensity and unpleasantness/pleasantness of each taste of the solutions. For the quad test, the 4 quadrants of the tongue surface were tested by applying a drop of one concentration of sweet, sour, salty, or bitter solutions 6 times. Subjects then indicated the taste quality and rated the intensity of the solution. We found that in the whole mouth test, the total correct identification score dropped with age, but the ability to identify sweet and salty qualities was not affected by age. No differences were found between males and females, except women scored better than men for sweetness in the 40-59 years age group. The intensity rating scores were higher in the 20-39 years age group, regardless of sex. With regard to the pleasantness of tastants, female subjects in the 20-39 years age group found sweet solution more pleasant than the older subjects did. In the quad test, the total correct identification score decreased with age, but there were no differences between males and females. Thus, our findings showed that both age and sex affected the taste functions of healthy Taiwanese to some extent, and differences were dependent on tongue region and taste quality.	[Wang, Jing-Jie; Chen, Chih-Yi; Jiang, Rong-San] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wang, Jing-Jie; Liang, Kai-Li; Lin, Wen-Jiun; Jiang, Rong-San] Taichung Vet Gen Hosp, Dept Otolaryngol, Taichung, Taiwan; [Liang, Kai-Li] Natl Yang Ming Med Univ, Fac Med, Taipei, Taiwan; [Liang, Kai-Li; Jiang, Rong-San] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Chih-Yi] Chung Shan Med Univ Hosp, Div Thorac Surg, Taichung, Taiwan; [Jiang, Rong-San] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Jiang, Rong-San] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan	Chung Shan Medical University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taichung Veterans General Hospital; National Chung Hsing University	Jiang, RS (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Jiang, RS (corresponding author), Taichung Vet Gen Hosp, Dept Otolaryngol, Taichung, Taiwan.; Jiang, RS (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Jiang, RS (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.; Jiang, RS (corresponding author), Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.	rsjiang@vghtc.gov.tw		Wang, Jing Jie/0000-0003-4257-9551; Jiang, Rong-San/0000-0002-8280-6029	 [TCVGH-YM1070303]		This research was supported by a grant (TCVGH-YM1070303) from the Taichung Veterans General Hospital, Taichung, and National Yang-Ming University, Taipei, Taiwan, ROC. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahne G, 2000, LARYNGOSCOPE, V110, P1396, DOI 10.1097/00005537-200008000-00033; Cecchini MP, 2015, J NEUROL, V262, P806, DOI 10.1007/s00415-014-7518-1; De Graaf C, 1999, PHYSIOL BEHAV, V67, P513, DOI 10.1016/S0031-9384(99)00090-6; Doty Richard L, 2018, World J Otorhinolaryngol Head Neck Surg, V4, P11, DOI 10.1016/j.wjorl.2018.03.001; Doty RL, 2018, OTOLARYNG CLIN N AM, V51, P815, DOI 10.1016/j.otc.2018.03.014; Doty RL, 2017, PERCEPTION, V46, P257, DOI 10.1177/0301006616685577; Doty RL, 2016, PHYSIOL BEHAV, V155, P202, DOI 10.1016/j.physbeh.2015.12.014; Doty RL, 2015, J NEUROL, V262, P547, DOI 10.1007/s00415-014-7589-z; Gudziol H, 2007, ACTA OTO-LARYNGOL, V127, P658, DOI 10.1080/00016480600951491; HYDE RJ, 1981, NEUROBIOL AGING, V2, P315, DOI 10.1016/0197-4580(81)90041-5; Liu G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013246; Manzi B, 2014, EUR ARCH OTO-RHINO-L, V271, P411, DOI 10.1007/s00405-013-2748-x; Martin LJ, 2017, J NEUROSCI RES, V95, P594, DOI 10.1002/jnr.23819; Methven L, 2012, P NUTR SOC, V71, P556, DOI 10.1017/S0029665112000742; Pavlidis P, 2013, CHEM SENSES, V38, P35, DOI 10.1093/chemse/bjs076; Pingel J, 2010, EUR ARCH OTO-RHINO-L, V267, P1911, DOI 10.1007/s00405-010-1276-1; Ribeiro JC, 2016, EUR ARCH OTO-RHINO-L, V273, P3407, DOI 10.1007/s00405-016-4037-y; Shu-Fen CL, 2018, ASIA PAC J CLIN NUTR, V27, P681, DOI 10.6133/apjcn.062017.04; Welge-Lussen A, 2011, J NEUROL, V258, P386, DOI 10.1007/s00415-010-5763-5; Whiddon ZD, 2018, CHEM SENSES, V43, P117, DOI 10.1093/chemse/bjx076; Winpenny EM, 2017, OBES REV, V18, P1336, DOI 10.1111/obr.12588; Yang L, 2010, OTOLARYNG HEAD NECK, V143, P554, DOI 10.1016/j.otohns.2010.05.010	22	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0227014	10.1371/journal.pone.0227014	http://dx.doi.org/10.1371/journal.pone.0227014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530917	Green Published, gold			2022-12-26	WOS:000542037200001
J	Baek, HE; Bandivadekar, RR; Pandit, P; Mah, M; Sehgal, RNM; Tell, LA				Baek, Hanna E.; Bandivadekar, Ruta R.; Pandit, Pranav; Mah, Michelle; Sehgal, Ravinder N. M.; Tell, Lisa A.			TaqMan quantitative real-time PCR for detecting Avipoxvirus DNA in various sample types from hummingbirds	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; WILD BIRDS; AVIAN POX; POXVIRUS; PAPILLOMAVIRUS; DIAGNOSIS; VIRUS	Background Avian pox is a viral disease documented in a wide range of bird species. Disease-related detrimental effects can cause dyspnea and dysphagia, and birds with high metabolic requirements, such as hummingbirds, are thus especially vulnerable to the pathogen. Hummingbirds have a strong presence in California, especially in urban environments. However, little is understood regarding the impact of pox virus on hummingbird populations. Currently, diagnosing a pox infection relies on obtaining a tissue biopsy, which poses significant risks to birds and challenges in the field. Understanding the ecology of hummingbird pox viral infections could be advanced by a minimally invasive ante-mortem diagnostic method. Our aim was to address whether pox infections can be diagnosed using integumentary system samples besides tissue biopsies. To meet this goal, we tested multiple integumentary sample types using a quantitative real-time PCR assay. A secondary study goal was to determine which sample types (ranging from minimally to highly invasive sampling) were optimal for identifying infected birds. Methodology and principal findings Pox-like lesion tissue, pectoral muscle, feathers, toenail clippings, blood, and swabs (both pox-like lesion tissue and non pox-like lesion tissue) were taken from live birds and carcasses of two species of hummingbirds found in California. To maximize successful diagnosis, especially for samples with low viral load, a real-time quantitative PCR assay was developed for detecting the hummingbird-specificAvipoxvirus4b core protein gene.AvipoxvirusDNA was successfully amplified from all sample types obtained from 27 individuals. These results were compared to those of conventional PCR and comparisons were also made among sample types, utilizing lesion tissue samples as the gold standard. Conclusions and significance Hummingbird avian pox can be diagnosed without relying on tissue biopsies. We identify that feather samples, of which contour feathers yielded the best results, can be used for diagnosing infected birds, thus reducing sampling risk. In sum, the real-time PCR assay detected viral DNA in various integumentary system sample types and will be useful in future studies of hummingbird disease ecology.	[Baek, Hanna E.; Sehgal, Ravinder N. M.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Bandivadekar, Ruta R.; Mah, Michelle; Tell, Lisa A.] Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA; [Pandit, Pranav] Univ Calif Davis, EpiCtr Dis Dynam, Sch Vet Med, One Hlth Inst, Davis, CA 95616 USA	California State University System; San Francisco State University; University of California System; University of California Davis; University of California System; University of California Davis	Tell, LA (corresponding author), Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA.	latell@ucdavis.edu	Pandit, Pranav/H-7484-2019	Pandit, Pranav/0000-0001-7649-0649	Hunter-Jelks Foundation; Daniel and Susan Gottlieb Foundation	Hunter-Jelks Foundation; Daniel and Susan Gottlieb Foundation	This study was supported in part by generous donations from the Hunter-Jelks Foundation, the Daniel and Susan Gottlieb Foundation, Mr. and Mrs. Thomas Jefferson and Dr. Grant Patrick.	Alehegn E., 2014, BRIT J POULTRY SCI, V3, P78; Bolte AL, 1999, AVIAN PATHOL, V28, P415, DOI 10.1080/03079459994434; BOOSINGER TR, 1982, AVIAN DIS, V26, P437, DOI 10.2307/1590119; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; Clark CJ, 2008, P R SOC B, V275, P955, DOI 10.1098/rspb.2007.1619; Deem SL, 1997, J WILDLIFE DIS, V33, P323, DOI 10.7589/0090-3558-33.2.323; EAVES G., 1955, JOUR HYG, V53, P102; Falcone E, 1997, J VIROL METHODS, V64, P125, DOI 10.1016/S0166-0934(96)02151-9; Feldman RA, 1995, MOL ECOL, V4, P663, DOI 10.1111/j.1365-294X.1995.tb00267.x; FITZNER RE, 1985, J WILDLIFE DIS, V21, P298, DOI 10.7589/0090-3558-21.3.298; Giasuddin M., 2002, International Journal of Poultry Science, V1, P197; Godoy LA, 2014, J ORNITHOL, V155, P1, DOI 10.1007/s10336-013-0990-z; Godoy LA, 2013, J WILDLIFE DIS, V49, P978, DOI 10.7589/2012-09-230; GREENWOOD AG, 1973, VET REC, V93, P468, DOI 10.1136/vr.93.17.468; Greiner M, 2000, PREV VET MED, V45, P3, DOI 10.1016/S0167-5877(00)00114-8; Gyuranecz M, 2013, J VIROL, V87, P4938, DOI 10.1128/JVI.03183-12; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Jarvi SI, 2008, CONSERV GENET, V9, P339, DOI 10.1007/s10592-007-9346-7; Lee LH, 1997, J VIROL METHODS, V63, P113, DOI 10.1016/S0166-0934(96)02119-2; Moayyedian H, 2008, J APPL POULTRY RES, V17, P556, DOI 10.3382/japr.2008-00063; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Perez-Tris J, 2011, AVIAN DIS, V55, P545, DOI 10.1637/9685-021411-Reg.1; Ruiz-Martinez J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168690; Smith L. M., 2004, BMC Ecology, V4, P4, DOI 10.1186/1472-6785-4-4; Valkiunas G, 2008, J PARASITOL, V94, P1395, DOI 10.1645/GE-1570.1; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; Weli SC, 2004, ARCH VIROL, V149, P2035, DOI 10.1007/s00705-004-0357-0; Weli SC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-49; Williams RAJ, 2014, AVIAN PATHOL, V43, P130, DOI 10.1080/03079457.2014.886326; 2010, SLUZBENI GLASNIK RS, V5, P1	30	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0230701	10.1371/journal.pone.0230701	http://dx.doi.org/10.1371/journal.pone.0230701			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32526768	Green Submitted, gold, Green Published			2022-12-26	WOS:000542036800083
J	Skerlova, J; Unterlass, J; Gottmann, M; Marttila, P; Homan, E; Helleday, T; Jemth, AS; Stenmark, P				Skerlova, Jana; Unterlass, Judith; Gottmann, Mona; Marttila, Petra; Homan, Evert; Helleday, Thomas; Jemth, Ann-Sofie; Stenmark, Pal			Crystal structures of human PAICS reveal substrate and product binding of an emerging cancer target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						de novo purine biosynthesis; nucleotide metabolism; cancer target; rational drug design; carboxyaminoimidazole ribonucleotide (CAIR); N-succinylcarboxamide-5-aminoimidazole ribonucleotide (SAICAR); phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthetase (PAICS); prostate cancer; structural biology; purine; cancer therapy; drug design; nucleoside; nucleotide biosynthesis	X-RAY-DIFFRACTION; ENZYME SAICAR SYNTHASE; ESCHERICHIA-COLI PURE; PURINE BIOSYNTHESIS; N-5-CARBOXYAMINOIMIDAZOLE RIBONUCLEOTIDE; GALLUS-GALLUS; MUTASE; IDENTIFICATION; CARBOXYLASES; SYNTHETASE	The bifunctional human enzyme phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthetase (PAICS) catalyzes two essential steps in thede novopurine biosynthesis pathway. PAICS is overexpressed in many cancers and could be a promising target for the development of cancer therapeutics. Here, using gene knockdowns and clonogenic survival and cell viability assays, we demonstrate that PAICS is required for growth and survival of prostate cancer cells. PAICS catalyzes the carboxylation of aminoimidazole ribonucleotide (AIR) and the subsequent conversion of carboxyaminoimidazole ribonucleotide (CAIR) andl-aspartate toN-succinylcarboxamide-5-aminoimidazole ribonucleotide (SAICAR). Of note, we present the first structures of human octameric PAICS in complexes with native ligands. In particular, we report the structure of PAICS with CAIR bound in the active sites of both domains and SAICAR bound in one of the SAICAR synthetase domains. Moreover, we report the PAICS structure with SAICAR and an ATP analog occupying the SAICAR synthetase active site. These structures provide insight into substrate and product binding and the architecture of the active sites, disclosing important structural information for rational design of PAICS inhibitors as potential anticancer drugs.	[Skerlova, Jana; Stenmark, Pal] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden; [Unterlass, Judith; Gottmann, Mona; Marttila, Petra; Homan, Evert; Helleday, Thomas; Jemth, Ann-Sofie] Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, Stockholm, Sweden; [Helleday, Thomas] Univ Sheffield, Dept Oncol & Metab, Weston Pk Canc Ctr, Sheffield, S Yorkshire, England; [Stenmark, Pal] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Unterlass, Judith] Evotec France, F-31036 Toulouse, France	Stockholm University; Karolinska Institutet; University of Sheffield; Lund University; Evotec	Stenmark, P (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden.; Jemth, AS (corresponding author), Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, Stockholm, Sweden.; Stenmark, P (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	annsofie.jemth@scilifelab.se; stenmark@dbb.su.se		Skerlova, Jana/0000-0002-9579-4047; Homan, Evert/0000-0002-9057-1848; Stenmark, Pal/0000-0003-4777-3417; Jemth, Ann-Sofie/0000-0002-7550-1833; Marttila, Petra/0000-0002-0115-8067	Swedish Research Council [2015-00162, 2018-03406]; Swedish Cancer Society [CAN 2018/0658, CAN 2017/716]; Torsten and Ragnar Soderberg Foundation; European Research Council [TAROX695376]; ERDF/ESF, OP RDE, project "IOCB Mobility" [CZ.02.2.69/0.0/0.0/16_027/0008477]; Crafoord foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Torsten and Ragnar Soderberg Foundation; European Research Council(European Research Council (ERC)European Commission); ERDF/ESF, OP RDE, project "IOCB Mobility"; Crafoord foundation	This work was supported by Swedish Research Council Grants 2015-00162 (to T. H.) and 2018-03406 (to P. S.), Swedish Cancer Society Grants CAN 2018/0658 (to T. H.) and CAN 2017/716 (to P. S.), Torsten and Ragnar Soderberg Foundation and European Research Council Grant TAROX695376 (to T. H.). The work of J.S. was supported from ERDF/ESF, OP RDE, project "IOCB Mobility" (No. CZ.02.2.69/0.0/0.0/16_027/0008477) granted to the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences. The work of P. S. was further supported by the Crafoord foundation.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agarwal S, 2020, TRANSL ONCOL, V13, DOI 10.1016/j.tranon.2020.100776; Antonyuk SV, 2001, CRYSTALLOGR REP+, V46, P620, DOI 10.1134/1.1387127; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barfeld SJ, 2015, ONCOTARGET, V6, P12587, DOI 10.18632/oncotarget.3494; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chakravarthi BVSK, 2018, NEOPLASIA, V20, P894, DOI 10.1016/j.neo.2018.07.006; Chakravarthi BVSK, 2017, PROSTATE, V77, P10, DOI 10.1002/pros.23243; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheung CHY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2033-z; Cifola I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063597; Constantine CZ, 2006, BIOCHEMISTRY-US, V45, P8193, DOI 10.1021/bi060465n; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Eissmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064873; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eshtad S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.72; FIRESTINE SM, 1994, BIOCHEMISTRY-US, V33, P11927, DOI 10.1021/bi00205a031; FIRESTINE SM, 1994, BIOCHEMISTRY-US, V33, P11917, DOI 10.1021/bi00205a030; Gallenne T, 2017, ONCOTARGET, V8, P20572, DOI 10.18632/oncotarget.16244; Ginder ND, 2006, J BIOL CHEM, V281, P20680, DOI 10.1074/jbc.M602109200; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Goswami MT, 2015, ONCOTARGET, V6, P23445, DOI 10.18632/oncotarget.4352; GROZIAK MP, 1988, P NATL ACAD SCI USA, V85, P7174, DOI 10.1073/pnas.85.19.7174; HARTMAN SC, 1959, J BIOL CHEM, V234, P1812; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hoskins AA, 2007, BIOCHEMISTRY-US, V46, P2842, DOI 10.1021/bi602436g; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Li SX, 2007, J MOL BIOL, V366, P1603, DOI 10.1016/j.jmb.2006.12.027; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; LUKENS LN, 1959, J BIOL CHEM, V234, P1799; Manjunath K, 2015, J STRUCT BIOL, V191, P22, DOI 10.1016/j.jsb.2015.06.006; Mathews II, 1999, STRUCTURE, V7, P1395, DOI 10.1016/S0969-2126(00)80029-5; Meng MJ, 2018, BIOL RES, V51, DOI 10.1186/s40659-018-0172-9; Meyer E, 1999, BIOCHEMISTRY-US, V38, P3012, DOI 10.1021/bi9827159; MUELLER EJ, 1994, BIOCHEMISTRY-US, V33, P2269, DOI 10.1021/bi00174a038; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pavelka A, 2016, IEEE ACM T COMPUT BI, V13, P505, DOI 10.1109/TCBB.2015.2459680; Schrodinger  L. L. C, 2010, PYMOL MOL GRAPHICS S; Serao NVL, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-49; Sun WY, 2004, CANCER LETT, V212, P83, DOI 10.1016/j.canlet.2004.03.023; Taschner M, 2013, PROTEINS, V81, P1473, DOI 10.1002/prot.24296; Tranchimand S, 2011, BIOCHEMISTRY-US, V50, P4623, DOI 10.1021/bi102033a; Urusova DV, 2006, CRYSTALLOGR REP+, V51, P824, DOI 10.1134/S1063774506050129; Urusova DV, 2003, CRYSTALLOGR REP+, V48, P763, DOI 10.1134/1.1612597; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wolf NM, 2014, ACTA CRYSTALLOGR D, V70, P841, DOI 10.1107/S139900471303366X; Yin J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01697	48	9	9	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11656	11668		10.1074/jbc.RA120.013695	http://dx.doi.org/10.1074/jbc.RA120.013695			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32571877	Green Published, hybrid			2022-12-26	WOS:000563922500023
J	Anil, KC; Basel, PL; Singh, S				Anil, K. C.; Basel, Prem Lal; Singh, Sarswoti			Low birth weight and its associated risk factors: Health facility-based case-control study	PLOS ONE			English	Article							PREGNANCY; INFANTS; WOOD	Background Low birth weight is a preventable public health problem. It is an important determinant of child survival and development, as well as long-term consequences like the onset of non-communicable disease in the life course. A large number of mortality and morbidity can be prevented by addressing the factors associated with low birth weight. The main objective of this study was to identify associated risk factors of low birth weight. Methodology A health facility-based unmatched case-control study was carried out from July 2018 to March 2019 among the mothers who delivered in health facilities of Dang district of Nepal from 17(th)August to 16(th)November 2018. The total sample size for the study was 369; 123 cases and 246 controls. Cases and controls were randomly selected independent of the exposure status in the ratio of 1:2. Information regarding exposure status was assessed through interviews and medical records. Mothers who delivered outside Dang districts were excluded from the study. Ethical clearance was obtained from the Institutional Review Committee (IRC) of the Institute of Medicine, Tribhuvan University and written consent was taken from each participant after explaining the objectives of the study. Results Multivariate logistic regression found that having the kitchen in the same living house (AOR 2.7, CI: 1.5-4.8), iron intake less than 180 tablets (AOR 3.2, CI: 1.7-5.7), maternal weight gain during second and third trimester less than 6.53 kg (AOR 2.6, CI: 1.5-4.7), co-morbidity during pregnancy (AOR 2.4, CI: 1.3-4.5), preterm birth (AOR 2.9, CI: 1.4-6.1) were the risk factors associated with low birth weight. Conclusion Having the kitchen in the same living house, iron intake less than 180 tablets during pregnancy, maternal weight gain less than 6.53 kg during the second and third trimester, co-morbidity during pregnancy and preterm birth were the risk factors associated with low birth weight.	[Anil, K. C.] Hlth Fdn Nepal, Patan, Nepal; [Basel, Prem Lal; Singh, Sarswoti] Tribhuvan Univ Teaching Hosp, Dept Community Med & Publ Hlth, Kathmandu, Nepal	Tribhuvan University; Institute of Medicine (IoM) - Nepal	Anil, KC (corresponding author), Hlth Fdn Nepal, Patan, Nepal.	kcanil707@gmail.com						African Development, 2015, AFRICAN DEV, V2, P45; Agbozo F, 2016, MIDWIFERY, V40, P200, DOI 10.1016/j.midw.2016.06.016; Al Hazzani F, 2011, ANN SAUDI MED, V31, P581, DOI 10.4103/0256-4947.87093; de Oliveira BFA, 2011, CAD SAUDE PUBLICA, V27, P1678, DOI [10.1590/S0102-311X2011000900003, 10.1590/S0102-311X2011000900016]; Ammari M, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2002846; [Anonymous], 2017, OCUL SURF, V15, P169; Atessahin E, 2015, IRAN J PUBLIC HEALTH, V44, P1299; Beard JL, 2004, MICRONUTRIENT DEFICI; Bhaskar RK, 2015, INT J PEDIAT, V2015, DOI 10.1155/2015/807373; Bondevik GT, 2001, ACTA OBSTET GYN SCAN, V80, P402, DOI 10.1034/j.1600-0412.2001.080005402.x; Boy E, 2002, ENVIRON HEALTH PERSP, V110, P109, DOI 10.1289/ehp.02110109; Chang HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131976; Coffey D, 2015, P NATL ACAD SCI USA, V112, P3302, DOI 10.1073/pnas.1416964112; Cutland CL, 2017, VACCINE, V35, P6492, DOI 10.1016/j.vaccine.2017.01.049; Fan RG, 2013, CLINICS, V68, P915, DOI 10.6061/clinics/2013(07)05; Fitzgibbons SC, 2009, J PEDIATR SURG, V44, P1072, DOI 10.1016/j.jpedsurg.2009.02.013; Gebremedhin M, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0658-1; Hassoune Samira, 2015, Pan Afr Med J, V20, P303, DOI 10.11604/pamj.2015.20.303.2659; Hosain GMM, 2006, J TROP PEDIATRICS, V52, P87, DOI 10.1093/tropej/fmi066; Kadam Yugantara Ramesh, 2013, Indian J Community Med, V38, P212, DOI 10.4103/0970-0218.120155; Karuna Laxmi Shakya NS, 2015, INT J CLIN BIOMEDICA, V1, P8; Lambers DS, 1996, SEMIN PERINATOL, V20, P115, DOI 10.1016/S0146-0005(96)80079-6; Mathewson KJ, 2017, PSYCHOL BULL, V143, P347, DOI 10.1037/bul0000091; Ministry of Health Nepal; New ERA; ICF, 2017, NEP DEM HLTH SURV 20; Muchemi OM, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.108.4831; Negrato CA, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-49; Osman NB, 2001, J TROP PEDIATRICS, V47, P30, DOI 10.1093/tropej/47.1.30; Shakya K L, 2015, J Nepal Health Res Counc, V13, P121; Sharma D, 2016, CLIN MED INSIGHTS-PE, V10, P67, DOI 10.4137/CMPed.S40070; Sharma SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123962; Sicuri E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028744; UNICEF WHO, 2004, LOW BIRTH WEIGHT COU; Washam C, 2008, ENVIRON HEALTH PERSP, V116, pA173, DOI 10.1289/ehp.116-a173a; WHO/UNICEF, 2014, GLOB NUTR TARG 2025, DOI [10.1057/9781137477699_6, DOI 10.1057/9781137477699_6]; World Health Organization, 2016, INT STAT CLASS DIS R, V10th; Yadav D K, 2011, J Nepal Health Res Counc, V9, P159	36	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234907	10.1371/journal.pone.0234907	http://dx.doi.org/10.1371/journal.pone.0234907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569281	gold, Green Published			2022-12-26	WOS:000543547900002
J	Dalhammar, K; Malmstrom, M; Schelin, M; Falkenback, D; Kristensson, J				Dalhammar, Karin; Malmstrom, Marlene; Schelin, Maria; Falkenback, Dan; Kristensson, Jimmie			The impact of initial treatment strategy and survival time on quality of end-of-life care among patients with oesophageal and gastric cancer: A population-based cohort study	PLOS ONE			English	Article							PALLIATIVE CARE; DEATH; REGISTER; AGGRESSIVENESS; CHEMOTHERAPY; SURGERY	Background Oesophageal and gastric cancer are highly lethal malignancies with a 5-year survival rate of 15-29%. More knowledge is needed about the quality of end-of-life care in order to understand the burden of the illness and the ability of the current health care system to deliver timely and appropriate end-of-life care. The aim of this study was to describe the impact of initial treatment strategy and survival time on the quality of end-of-life care among patients with oesophageal and gastric cancer. Methods This register-based cohort study included patients who died from oesophageal and gastric cancer in Sweden during 2014-2016. Through linking data from the National Register for Esophageal and Gastric Cancer, the National Cause of Death Register, and the Swedish Register of Palliative Care, 2156 individuals were included. Associations between initial treatment strategy and survival time and end-of-life care quality indicators were investigated. Adjusted risk ratios (RRs) with 95% confidence intervals were calculated using modified Poisson regression. Results Patients with a survival of <= 3 months and 4-7 months had higher RRs for hospital death compared to patients with a survival >= 17 months. Patients with a survival of <= 3 months also had a lower RR for end-of-life information and bereavement support compared to patients with a survival >= 17 months, while the risks of pain assessment and oral assessment were not associated with survival time. Compared to patients with curative treatment, patients with no tumour-directed treatment had a lower RR for pain assessment. No significant differences were shown between the treatment groups regarding hospital death, end-of-life information, oral health assessment, and bereavement support. Conclusions Short survival time is associated with several indicators of low quality end-of-life care among patients with oesophageal and gastric cancer, suggesting that a proactive palliative care approach is imperative to ensure quality end-of-life care.	[Dalhammar, Karin; Malmstrom, Marlene; Schelin, Maria; Kristensson, Jimmie] Lund Univ, Inst Palliat Care, Lund, Sweden; [Dalhammar, Karin; Malmstrom, Marlene; Kristensson, Jimmie] Lund Univ, Dept Hlth Sci, Fac Med, Lund, Sweden; [Schelin, Maria; Falkenback, Dan] Lund Univ, Dept Clin Sci, Fac Med, Lund, Sweden; [Falkenback, Dan] Skane Univ Hosp, Dept Surg, Lund, Sweden	Lund University; Lund University; Lund University; Lund University; Skane University Hospital	Dalhammar, K (corresponding author), Lund Univ, Inst Palliat Care, Lund, Sweden.; Dalhammar, K (corresponding author), Lund Univ, Dept Hlth Sci, Fac Med, Lund, Sweden.	Karin.dalhammar@med.lu.se		Malmstrom, Marlene/0000-0001-9575-0311	ALF (Swedish NHS) [ALF 2018:0092]; Sjoberg Foundation [Sjoberg F2019/210]	ALF (Swedish NHS); Sjoberg Foundation	This work was supported by the ALF (governmental founding from the Swedish NHS; grant number ALF 2018:0092; URL:https://www.med.lu.se/intramed/styrning_organisation/ekonomi_alf/alf) and the Sjoberg Foundation (grant number Sjoberg F2019/210; URL: https://sjobergstiftelsen.se) awarded to JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accordino MK, 2017, BREAST CANCER RES TR, V166, P549, DOI 10.1007/s10549-017-4420-4; Addington-Hall JM, 2009, PALLIATIVE MED, V23, P190, DOI 10.1177/0269216309102525; American Society of Clinical Oncology, 2019, QUAL ONC PRACT IN; [Anonymous], 2017, STATISTIKDATABAS DOD; Bergquist H, 2007, DIS ESOPHAGUS, V20, P523, DOI 10.1111/j.1442-2050.2007.00741.x; Bischoff KE, 2013, J AM GERIATR SOC, V61, P209, DOI 10.1111/jgs.12105; Blazeby JM, 2000, CANCER, V88, P1781; Boxer MM, 2011, CANCER-AM CANCER SOC, V117, P5112, DOI 10.1002/cncr.26149; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; British Geriatrics Society, 2010, PALL END LIF CAR OLD; Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1; Brooks GA, 2017, J PALLIAT MED, V20, P42, DOI 10.1089/jpm.2016.0231; Brooks GA, 2014, J CLIN ONCOL, V32, P496, DOI 10.1200/JCO.2013.52.4330; ECOG-ACRIN Cancer Research Group, EC PERF STAT; Ethier JL, 2018, J PALLIAT CARE, V33, P125, DOI 10.1177/0825859718762287; Gani F, 2018, J PALLIAT MED, V21, P428, DOI 10.1089/jpm.2017.0295; Gieniusz M, 2018, AM J HOSP PALLIAT ME, V35, P21, DOI 10.1177/1049909116682470; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Hong JH, 2013, CANCER RES TREAT, V45, P270, DOI 10.4143/crt.2013.45.4.270; Hunt RW, 2018, J PALLIAT CARE; Janah A, 2019, CLIN EPIDEMIOL, V11, P443, DOI 10.2147/CLEP.S198499; Janmaat VT, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004063.pub4; Johnson PC, 2019, J ONCOL PRACT, V15, pE420, DOI 10.1200/JOP.18.00595; Kauppila JH, 2020, ANN SURG, V271, P311, DOI 10.1097/SLA.0000000000002972; Kelly M, 2018, BMC PALLIAT CARE, V17, DOI 10.1186/s12904-018-0285-5; Kempf E, 2017, EUR J CANCER, V79, P31, DOI 10.1016/j.ejca.2017.03.029; Kross EK, 2014, CHEST, V145, P313, DOI 10.1378/chest.13-1351; Lee SS, 2014, INT J SURG, V12, P700, DOI 10.1016/j.ijsu.2014.05.067; Linder G, 2016, BRIT J SURG, V103, P1326, DOI 10.1002/bjs.10234; Lundstrom S, 2012, PALLIATIVE MED, V26, P313, DOI 10.1177/0269216311414758; Malmstrom M, 2013, INT J NURS STUD, V50, P44, DOI 10.1016/j.ijnurstu.2012.08.011; Martinsson L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186804; Merchant SJ, 2017, J PALLIAT CARE, V32, P92, DOI 10.1177/0825859717738464; Mokadem I, 2019, GASTRIC CANCER, V22, P1263, DOI 10.1007/s10120-019-00956-6; Morrison RS, 2013, CURR OPIN SUPPORT PA, V7, P201, DOI 10.1097/SPC.0b013e32836103e5; Olmsted CL, 2014, JAMA SURG, V149, P1169, DOI 10.1001/jamasurg.2014.2101; Prater LC, 2019, AM J HOSP PALLIAT ME, V36, P1089, DOI 10.1177/1049909119848987; Regionala Cancercentrum i Samverkan, 2016, NAT VARDPR PALL VARD; Rouvelas I, 2005, LANCET ONCOL, V6, P864, DOI 10.1016/S1470-2045(05)70347-8; Sheffield KM, 2011, CANCER-AM CANCER SOC, V117, P5003, DOI 10.1002/cncr.26115; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sohda M, 2017, ANN THORAC CARDIOVAS, V23, P1, DOI 10.5761/atcs.ra.16-00162; Svenska Palliativregistret, 2017, RSRAPP SVENSK PALL V; Task Force on Surgical Palliative care, 2005, Bull Am Coll Surg, V90, P34; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Van den Block L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-69; Wagner AD, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub4; Wang SM, 2014, AM J MANAG CARE, V20, pE353; Whitney RL, 2019, J ONCOL PRACT, V15, P37, DOI 10.1200/JOP.18.00254; Whitney RL, 2017, J CLIN ONCOL, V35, P3610, DOI 10.1200/JCO.2017.72.4963; WHO | WHO Definition of Palliative Care, 2018, WHO DEF PALL CAR; Wright AA, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1219; Wu CC, 2016, ONCOLOGIST, V21, P771, DOI 10.1634/theoncologist.2015-0445; Yamashita K, 2017, WORLD J SURG, V41, P2337, DOI 10.1007/s00268-017-4024-5; Ziegler LE, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018284	56	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235045	10.1371/journal.pone.0235045	http://dx.doi.org/10.1371/journal.pone.0235045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569329	gold, Green Published			2022-12-26	WOS:000543547900006
J	Guo, D; Zhang, D; Ren, MD; Lu, GF; Zhang, X; He, SX; Li, YR				Guo, Dan; Zhang, Dan; Ren, Mudan; Lu, Guifang; Zhang, Xu; He, Shuixiang; Li, Yarui			THBS4 promotes HCC progression by regulating ITGB1 via FAK/PI3K/AKT pathway	FASEB JOURNAL			English	Article						epithelial-mesenchymal transition; FAK; PI3K; AKT pathway; hepatocellular carcinoma development; integrin beta 1; thrombospondin 4	HUMAN HEPATOCELLULAR-CARCINOMA; EXPRESSION; CANCER; METASTASIS	Our research aims to identify the role of thrombospondin 4 (THBS4) in hepatocellular carcinoma (HCC). First, bioinformatic analysis was applied for detection the expression of THBS4 in HCC samples, and qRT-PCR and western blot were performed to explore the expression of THBS4 in HCC tissues and adjacent samples. Next, colony formation assay and cell viability assay were used to assess the function of THBS4 on HCC cells growth while transwell assay and scratch test were for metastasis. Meanwhile Xenograft tumor models were further conducted to verify the function of THBS4 in HCC. As for mechanism in deep, we investigated the influence of THBS4 on epithelial-mesenchymal transition (EMT) development and the interaction between THBS4 and integrin (ITG) family using multiple experiments, including western blot, immunofluorescence and immunoprecipitation (IP). As a result, our research discovered that the overexpression of THBS4 in both HCC patients' tissues and cell lines mediates HCC cells proliferation and metastasis in vitro and in vivo. In-depth, THBS4 regulated EMT progression and interacted with ITG family to modulate FAK/PI3K/AKT pathway. In conclusion, THBS4 as an oncogene interacts with integrin beta 1 (ITGB1) to regulate HCC development via FAK/PI3K/AKT pathway.	[Guo, Dan; Zhang, Dan; Ren, Mudan; Lu, Guifang; Zhang, Xu; He, Shuixiang; Li, Yarui] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Gastroenterol, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China	Xi'an Jiaotong University	He, SX; Li, YR (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Gastroenterol, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China.	hesx321@sina.com; liyarui0529@163.com			National Science Foundation of China [81602611]; Social Development, Scientific and Technological Research Project of Shannxi Province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development, Scientific and Technological Research Project of Shannxi Province	National Science Foundation of China, Grant/Award Number: 81602611; the Social Development, Scientific and Technological Research Project of Shannxi Province	Cannito S, 2010, ANTIOXID REDOX SIGN, V12, P1383, DOI 10.1089/ars.2009.2737; Chen CD, 2014, J PROTEOME RES, V13, P2818, DOI 10.1021/pr4012377; Chen XB, 2019, J PHYSIOL BIOCHEM, V75, P117, DOI 10.1007/s13105-019-00665-9; Forster S, 2011, MODERN PATHOL, V24, P1390, DOI 10.1038/modpathol.2011.99; Greco SA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-494; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee YH, 2011, ONCOGENE, V30, P4175, DOI 10.1038/onc.2011.126; Li CB, 2019, CELL MOL LIFE SCI, V76, P4203, DOI 10.1007/s00018-019-03215-0; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li YR, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0882-5; Lim LJ, 2019, CANCER RES, V79, P5131, DOI 10.1158/0008-5472.CAN-19-0255; Lin XD, 2016, CANCER GENET-NY, V209, P215, DOI 10.1016/j.cancergen.2016.04.003; Liu JL, 2016, MOL MED REP, V14, P1451, DOI 10.3892/mmr.2016.5443; Liu SQ, 2019, INT J ONCOL, V54, P41, DOI 10.3892/ijo.2018.4607; NAITO S, 1986, CANCER RES, V46, P4109; Niu JJ, 2016, ONCOTARGET, V7, P76169, DOI 10.18632/oncotarget.12732; Qiu LP, 2019, LIFE SCI, V231, DOI 10.1016/j.lfs.2019.116660; Reed AEM, 2013, VIRCHOWS ARCH, V463, P535, DOI 10.1007/s00428-013-1468-3; Reghupaty SC, 2019, CANCERS, V11, DOI 10.3390/cancers11091265; Rorive S, 2006, J NEUROPATH EXP NEUR, V65, P794, DOI 10.1097/01.jnen.0000228203.12292.a1; Su F, 2017, ONCOTARGET, V8, P23277, DOI 10.18632/oncotarget.15054; Suh D, 2019, J CHEM THEORY COMPUT, V15, P5829, DOI 10.1021/acs.jctc.9b00499; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Wong CH, 2020, CANCER RES, V80, P2138, DOI 10.1158/0008-5472.CAN-19-3268; Wu HF, 2019, GENE, V696, P219, DOI 10.1016/j.gene.2019.02.049; Xu ZX, 2017, ONCOL REP, V37, P259, DOI 10.3892/or.2016.5215; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y; Zha RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087665; Zhang YY, 2018, CANCER LETT, V429, P29, DOI 10.1016/j.canlet.2018.05.004	31	26	27	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10668	10681		10.1096/fj.202000043R	http://dx.doi.org/10.1096/fj.202000043R		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32567740	hybrid			2022-12-26	WOS:000543545000001
J	Borges, KS; Pignatti, E; Leng, S; Kariyawasam, D; Ruiz-Babot, G; Ramalho, FS; Taketo, MM; Carlone, DL; Breault, DT				Borges, Kleiton Silva; Pignatti, Emanuele; Leng, Sining; Kariyawasam, Dulanjalee; Ruiz-Babot, Gerard; Ramalho, Fernando Silva; Taketo, Makoto Mark; Carlone, Diana L.; Breault, David T.			Wnt/beta-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice	ONCOGENE			English	Article							BETA-CATENIN; GENOMIC CHARACTERIZATION; MOUSE MODELS; FACTOR-I; CANCER; TUMORS; MUTATIONS; EXPRESSION; PATHWAY; CELLS	Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with limited therapeutic options. The lack of mouse models that recapitulate the genetics of ACC has hampered progress in the field. We analyzed The Cancer Genome Atlas (TCGA) dataset for ACC and found that patients harboring alterations in both p53/Rb and Wnt/beta-catenin signaling pathways show a worse prognosis compared with patients that harbored alterations in only one. To model this, we utilized theCyp11b2(AS)(Cre)mouse line to generate mice with adrenocortical-specific Wnt/beta-catenin activation,Trp53deletion, or the combination of both. Mice with targeted Wnt/beta-catenin activation orTrp53deletion showed no changes associated with tumor formation. In contrast, alterations in both pathways led to ACC with pulmonary metastases. Similar to ACCs in humans, these tumors produced increased levels of corticosterone and aldosterone and showed a high proliferation index. Gene expression analysis revealed that mouse tumors exhibited downregulation ofStarandCyp11b1and upregulation ofEzh2, similar to ACC patients with a poor prognosis. Altogether, these data show that altering both Wnt/beta-catenin and p53/Rb signaling is sufficient to drive ACC in mouse. This autochthonous model of ACC represents a new tool to investigate the biology of ACC and to identify new treatment strategies.	[Borges, Kleiton Silva; Pignatti, Emanuele; Leng, Sining; Kariyawasam, Dulanjalee; Ruiz-Babot, Gerard; Carlone, Diana L.; Breault, David T.] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Borges, Kleiton Silva; Pignatti, Emanuele; Kariyawasam, Dulanjalee; Ruiz-Babot, Gerard; Carlone, Diana L.; Breault, David T.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Borges, Kleiton Silva] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pediat, Ribeirao Preto, Brazil; [Leng, Sining] Harvard Med Sch, Div Med Sci, Boston, MA 02115 USA; [Ramalho, Fernando Silva] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pathol, Ribeirao Preto, Brazil; [Taketo, Makoto Mark] Kyoto Univ, Grad Sch Med, Div Expt Therapeut, Kyoto 6068506, Japan; [Carlone, Diana L.; Breault, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Harvard University; Harvard Medical School; Universidade de Sao Paulo; Kyoto University; Harvard University	Breault, DT (corresponding author), Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA.; Breault, DT (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.; Breault, DT (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	david.breault@childrens.harvard.edu	Pignatti, Emanuele/AAF-2743-2021; Borges, Kleiton Silva/C-7214-2012; kariyawasam, dulanjalee/AAH-1867-2021; Ramalho, Fernando Silva/G-3817-2012; Breault, David/HDN-6048-2022; Borges, Kleiton/AAT-7336-2020	Borges, Kleiton Silva/0000-0003-0356-922X; Ramalho, Fernando Silva/0000-0002-7529-466X; Borges, Kleiton/0000-0003-0356-922X; breault, David/0000-0002-0402-4857; Pignatti, Emanuele/0000-0002-5372-5692	National Institutes of Health (NIH) [RO1 DK100653, R01 DK123694]; FundacAo de Amparo a Pesquisa do Estado de SAo Paulo scholarship [16/00862-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [409711/2018-7, 151760/2018-7]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FundacAo de Amparo a Pesquisa do Estado de SAo Paulo scholarship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by National Institutes of Health (NIH) grants RO1 DK100653 and R01 DK123694 (D.T.B.). K.S.B. was supported by FundacAo de Amparo a Pesquisa do Estado de SAo Paulo scholarship 16/00862-0, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), scholarship 409711/2018-7 and Grant 151760/2018-7. We thank Graziella Ribeiro Sousa for her technical assistance with IHC experiments.	Abiven G, 2006, J CLIN ENDOCR METAB, V91, P2650, DOI 10.1210/jc.2005-2730; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Assie G, 2014, NAT GENET, V46, P607, DOI 10.1038/ng.2953; Basham KJ, 2019, GENE DEV, V33, P209, DOI 10.1101/gad.317412.118; Basham KJ, 2016, MOL CELL ENDOCRINOL, V421, P82, DOI 10.1016/j.mce.2015.11.031; Batisse-Lignier M, 2017, ONCOGENE, V36, P4445, DOI 10.1038/onc.2017.54; Berthon A, 2010, HUM MOL GENET, V19, P1561, DOI 10.1093/hmg/ddq029; Bonnet-Serrano F, 2018, ENDOCR-RELAT CANCER, V25, pR131, DOI 10.1530/ERC-17-0361; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Drelon C, 2016, HUM MOL GENET, V25, P2789, DOI 10.1093/hmg/ddw136; Drelon C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12751; Drelon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044171; Else T, 2014, ENDOCR REV, V35, P282, DOI 10.1210/er.2013-1029; Else T, 2014, J CLIN ENDOCR METAB, V99, P455, DOI 10.1210/jc.2013-2856; Else T, 2012, MOL CELL ENDOCRINOL, V351, P66, DOI 10.1016/j.mce.2011.12.008; Fassnacht M, 2018, EUR J ENDOCRINOL, V179, pG1, DOI 10.1530/EJE-18-0608; Fassnacht M, 2013, J CLIN ENDOCR METAB, V98, P4551, DOI 10.1210/jc.2013-3020; Freedman BD, 2013, DEV CELL, V26, P666, DOI 10.1016/j.devcel.2013.07.016; Haluska P, 2010, CANCER CHEMOTH PHARM, V65, P765, DOI 10.1007/s00280-009-1083-9; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Heaton JH, 2012, AM J PATHOL, V181, P1017, DOI 10.1016/j.ajpath.2012.05.026; Jones RL, 2015, CLIN CANCER RES, V21, P693, DOI 10.1158/1078-0432.CCR-14-0265; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; Kim AC, 2008, DEVELOPMENT, V135, P2593, DOI 10.1242/dev.021493; Leal LF, 2011, J CLIN ENDOCR METAB, V96, P3106, DOI 10.1210/jc.2011-0363; Leccia F, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00093; Liang SH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15295-9; Lippert J, 2018, J CLIN ENDOCR METAB, V103, P4511, DOI 10.1210/jc.2018-01348; Mai PL, 2016, CANCER-AM CANCER SOC, V122, P3673, DOI 10.1002/cncr.30248; Marino S, 2000, GENE DEV, V14, P994; Mohan Dipika R, 2019, Curr Opin Endocr Metab Res, V8, P72, DOI 10.1016/j.coemr.2019.07.006; Mohan DR, 2018, J ENDOCR SOC, V2, P1259, DOI 10.1210/js.2018-00197; Mouat IC, 2019, ENDOCR-RELAT CANCER, V26, P217, DOI 10.1530/ERC-18-0385; Park JH, 2018, CANCER RES, V78, P5375, DOI 10.1158/0008-5472.CAN-18-0016; Pereira SS, 2018, EUR J ENDOCRINOL, V179, pR95, DOI 10.1530/EJE-17-0976; Pignatti E, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107524; Pinto EM, 2017, J CLIN ONCOL, V35, P3956, DOI 10.1200/JCO.2017.74.2460; Ragazzon B, 2010, CANCER RES, V70, P8276, DOI 10.1158/0008-5472.CAN-10-2014; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Sbiera S, 2010, J CLIN ENDOCR METAB, V95, pE161, DOI 10.1210/jc.2010-0653; Terzolo M, 2001, UROLOGY, V57, P176, DOI 10.1016/S0090-4295(00)00852-9; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WALDMAN T, 1995, CANCER RES, V55, P5187; Wasserman JD, 2012, MOL CELL ENDOCRINOL, V351, P101, DOI 10.1016/j.mce.2011.09.010; WEISS LM, 1984, AM J SURG PATHOL, V8, P163, DOI 10.1097/00000478-198403000-00001; Zheng SY, 2016, CANCER CELL, V29, P723, DOI 10.1016/j.ccell.2016.04.002; Zsippai A, 2011, AM J CANCER RES, V1, P618	49	15	15	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 23	2020	39	30					5282	5291		10.1038/s41388-020-1358-5	http://dx.doi.org/10.1038/s41388-020-1358-5		JUN 2020	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MO5BV	32561853	hybrid, Green Published			2022-12-26	WOS:000541308400002
J	Debnath, T; Nakamoto, T				Debnath, Tanoy; Nakamoto, Takamichi			Predicting human odor perception represented by continuous values from mass spectra of essential oils resembling chemical mixtures	PLOS ONE			English	Article							DIMENSIONALITY; FEATURES	There have been recent advances in predicting odor characteristics using molecular structure parameters of chemicals. Although the molecular structure parameters are available for each chemical, they cannot be used for chemical mixtures. This study will elucidate a computational method of predicting human odor perception from the mass spectra of chemical mixtures such as essential oils. Furthermore, a method for obtaining similarity among odor descriptors has been proposed although the dataset contains binary values only. When the database indicates a set of odor descriptors for one sample, only binary data are available and the correlation between the similar descriptors disappears. Thus, the prediction performance degrades for not considering the similarity among the odor descriptors. Since mass spectra dataset is highly dimensional, we use auto-encoder to learn the compressed representation from the mass spectra of essential oils in its bottleneck hidden layer and then accomplishes the hierarchical clustering to create odor descriptor groups with similar odor impressions using a matrix of continuous value-based correlation coefficient as well as natural language processing. This work will help to expatiate the process of overcoming binary value problem and find out the similarity among odor descriptors using machine learning with natural language semantic representation of words. To overcome the problem of disproportionate ratio of positive and negative class for both the continuous value-based correlation coefficient and word similarity based models, we use Synthetic Minority Oversampling Technique (SMOTE). This model allows us to predict human odor perception through computer simulations by forming odor descriptors group. Accordingly, this study demonstrates the feasibility of ensembling machine learning with natural language processing and SMOTE approach for predicting odor descriptor group from mass spectra of essential oils.	[Debnath, Tanoy; Nakamoto, Takamichi] Tokyo Inst Technol, Dept Informat & Commun Engn, Yokohama, Kanagawa, Japan; [Nakamoto, Takamichi] Tokyo Inst Technol, Lab Future Interdisciplinary Res Sci & Technol, Yokohama, Kanagawa, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Nakamoto, T (corresponding author), Tokyo Inst Technol, Dept Informat & Commun Engn, Yokohama, Kanagawa, Japan.; Nakamoto, T (corresponding author), Tokyo Inst Technol, Lab Future Interdisciplinary Res Sci & Technol, Yokohama, Kanagawa, Japan.	nakamoto@mn.ee.titech.ac.jp		Nakamoto, Takamichi/0000-0002-0599-226X; Debnath, Tanoy/0000-0002-2624-8923				Bojanowski Piotr, 2017, T ASSOC COMPUT LING, V5, P135, DOI 10.1162/tacl_a_00051; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Debnath T., 2019, IEEE 2019 IEEE INT S, P1, DOI [DOI 10.1109/ISOEN.2019.8823226, 10.1109/ISOEN.2019.8823226]; Goodfellow I., 2016, DEEP LEARNING, DOI DOI 10.4258/HIR.2016.22.4.351; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Keller A, 2017, SCIENCE, V355, P820, DOI 10.1126/science.aal2014; MOLLER MF, 1993, NEURAL NETWORKS, V6, P525, DOI 10.1016/S0893-6080(05)80056-5; Nakamoto T, 2013, IEEE SENS J, V13, P4305, DOI 10.1109/JSEN.2013.2267728; Nakamoto T, 2012, IEEE SENS J, V12, P3225, DOI 10.1109/JSEN.2012.2190506; Nakashizuka T, 2016, ECOL RES MONOGR, P1, DOI 10.1007/978-4-431-55954-2_1; Nozaki Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208962; Nozaki Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157030; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Shang L, 2017, ANAL CHEM, V89, P11999, DOI 10.1021/acs.analchem.7b02389; Shang L, 2018, SENSOR ACTUAT B-CHEM, V255, P508, DOI 10.1016/j.snb.2017.08.024; Torgo L., DATA MINING R LEARNI; TRUNK GV, 1979, IEEE T PATTERN ANAL, V1, P306, DOI 10.1109/TPAMI.1979.4766926	18	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234688	10.1371/journal.pone.0234688	http://dx.doi.org/10.1371/journal.pone.0234688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559255	gold, Green Published			2022-12-26	WOS:000543261600024
J	Bhatia, SM; Streilein, RD; Hall, RP				Bhatia, Sravya M.; Streilein, Robert D.; Hall, Russell P.			Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab	PLOS ONE			English	Article							FOLIACEUS FOGO SELVAGEM; THYROID AUTOIMMUNITY; ANTI-DESMOGLEIN; VULGARIS; DISEASE; ANTIBODIES; PREVALENCE; ADHESION; MICROARRAY; CELLS	Introduction Autoantibodies (autoAbs) against desmoglein-1 (DSG1) and desmoglein-3 (DSG3) have conventionally been studied and well accepted in the pathogenesis of pemphigus vulgaris (PV) and foliaceus (PF). Recent studies have suggested that non-DSG autoAbs may contribute to the pathogenesis of pemphigus, including autoAbs directed at acetylcholine receptors (AChR) and thyroid peroxidase (TPO). The purpose of this study is to retrospectively analyze PV and PF patient sera to better understand the relationship between anti-AChR and -TPO Abs to disease activity and DSG reactivity between patients treated with prednisone and steroid sparing agents (SSA; n = 22) or prednisone and rituximab (n = 21). Methods Patients were evaluated at 2 time points, T1 and T2, for disease activity using the Pemphigus Disease Area Index (PDAI), and sera were tested for the presence of TPO, DSG1, DSG3, muscarinic (M3) and nicotinic (n) AChR IgG autoAbs, as well as antibodies against Varicella Zoster Virus (VZV) by ELISA. Results Disease activity significantly decreased in patients from T1 to T2 (p < .0001). A significant difference was seen in IgG anti-DSG1 (p < .0001) and anti-DSG3 (p = .0049) levels when T1 was compared to T2 in both treatment groups. A significant increase was found between pemphigus patients and normal subjects with nAChR (p < .0001) at T1 but not with m3AChR, TPO or VZV Abs. No significant difference was seen between T1 and T2 values in patients with pemphigus for the non-desmoglein Abs TPO (p = .7559), M3AChR (p = .9003), nAChR (p = .5143) or VZV (p = .2454). These findings demonstrate that although an increase in IgG anti-nAChR autoAbs was found in PV and PF subjects, these Abs did not decrease with treatment. No other non-DSG Abs were increased or significantly changed over time in patients with pemphigus. This suggests that anti -AChR and -TPO Abs may not play a direct role in the pathogenesis of most patients with pemphigus, but does not rule out a role for non-DSG auto antibodies in distinct subsets of pemphigus patient.	[Bhatia, Sravya M.] Duke Univ, Sch Med, Durham, NC USA; [Streilein, Robert D.; Hall, Russell P.] Duke Univ, Sch Med, Dept Dermatol, Durham, NC 27708 USA; [Hall, Russell P.] Duke Univ, Med Ctr, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Hall, RP (corresponding author), Duke Univ, Sch Med, Dept Dermatol, Durham, NC 27708 USA.; Hall, RP (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.	Russell.Hall@dm.duke.edu						Abasq C, 2009, ARCH DERMATOL, V145, P529, DOI 10.1001/archdermatol.2009.9; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; AMAGAI M, 1995, J INVEST DERMATOL, V104, P146, DOI 10.1111/1523-1747.ep12613668; [Anonymous], 2012, NAT BIOTECHNOL, V30, P78; [Anonymous], 2013, J THORAC DIS S2, V5, pS168; Ansar A, 2009, J EUR ACAD DERMATOL, V23, P719, DOI 10.1111/j.1468-3083.2009.03172.x; Boulard C, 2016, BRIT J DERMATOL, V175, P142, DOI 10.1111/bjd.14405; Brown F, 2018, INFORM RES, V23; Chams-Davatchi C, 2005, INT J DERMATOL, V44, P470, DOI 10.1111/j.1365-4632.2004.02501.x; Chernyavsky A, 2015, INT IMMUNOPHARMACOL, V29, P76, DOI 10.1016/j.intimp.2015.04.046; Daneshpazhooh M, 2010, J AM ACAD DERMATOL, V62, P349, DOI 10.1016/j.jaad.2009.05.024; Desmet C, 2013, ENVIRON SCI-PROC IMP, V15, P1876, DOI 10.1039/c3em00296a; Di Zenzo G, 2012, J CLIN INVEST, V122, P3781, DOI 10.1172/JCI64413; DIAZ LA, 1989, J INVEST DERMATOL, V92, P4, DOI 10.1111/1523-1747.ep13070394; EYRE RW, 1987, J EXP MED, V165, P1719, DOI 10.1084/jem.165.6.1719; Feliciani C, 2007, INT J IMMUNOPATH PH, V20, P289, DOI 10.1177/039463200702000209; FRIEDMAN H, 1995, J AM ACAD DERMATOL, V32, P949, DOI 10.1016/0190-9622(95)91330-0; Grando SA, 2012, AUTOIMMUNITY, V45, P7, DOI 10.3109/08916934.2011.606444; Hans G, 1996, J INVEST DERMATOL, V107, P68, DOI 10.1111/1523-1747.ep12298213; Jahn-Schmid B, 2003, CLIN EXP ALLERGY, V33, P1443, DOI 10.1046/j.1365-2222.2003.01784.x; Kalantari-Dehaghi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057587; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Lakshmi MJD, 2017, J AM ACAD DERMATOL, V76, P895, DOI 10.1016/j.jaad.2016.11.039; Lin MS, 1997, J CLIN INVEST, V99, P31, DOI 10.1172/JCI119130; Marchenko S, 2010, J BIOL CHEM, V285, P3695, DOI 10.1074/jbc.M109.081570; Mihai S, 2007, J CELL MOL MED, V11, P462, DOI 10.1111/j.1582-4934.2007.00033.x; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2; Nguyen VT, 2000, J CLIN INVEST, V106, P1467, DOI 10.1172/JCI10305; Nguyen VT, 1998, ARCH DERMATOL, V134, P971, DOI 10.1001/archderm.134.8.971; Pitoia F, 2005, MEDICINA-BUENOS AIRE, V65, P307; Quan C, 2015, J NEUROIMMUNOL, V282, P45, DOI 10.1016/j.jneuroim.2015.03.016; Robbins AC, 2007, J AM ACAD DERMATOL, V56, pS82, DOI 10.1016/j.jaad.2006.10.956; ROCK B, 1990, J CLIN INVEST, V85, P296, DOI 10.1172/JCI114426; Rosenbach M, 2009, J INVEST DERMATOL, V129, P2404, DOI 10.1038/jid.2009.72; RUOCCO V, 1982, ARCH DERMATOL RES, V274, P123, DOI 10.1007/BF00510366; Ruocco V, 2013, CLIN DERMATOL, V31, P374, DOI 10.1016/j.clindermatol.2013.01.004; Sajda T, 2016, P NATL ACAD SCI USA, V113, P1859, DOI 10.1073/pnas.1525448113; Seiffert-Sinha K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00625; Sinha AA, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00218; Spindler V, 2018, J INVEST DERMATOL, V138, P32, DOI 10.1016/j.jid.2017.06.022; STANLEY JR, 1989, J CLIN INVEST, V83, P1443, DOI 10.1172/JCI114036; Tirado-Sanchez Andres, 2012, Dermatol Online J, V18, P14; Van P., 2009, J STAT MECH THEORY E, V2009, pP0254; VIGNALE R, 1993, INT J DERMATOL, V32, P307, DOI 10.1111/j.1365-4362.1993.tb04276.x; Warren SJP, 2000, NEW ENGL J MED, V343, P23, DOI 10.1056/NEJM200007063430104	45	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0233957	10.1371/journal.pone.0233957	http://dx.doi.org/10.1371/journal.pone.0233957			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555697	Green Published, gold			2022-12-26	WOS:000543273200030
J	Grzywa, TM; Klicka, K; Paskal, W; Dudkiewicz, J; Wejman, J; Pyzlak, M; Wlodarski, PK				Grzywa, Tomasz M.; Klicka, Klaudia; Paskal, Wiktor; Dudkiewicz, Julia; Wejman, Jaroslaw; Pyzlak, Michal; Wlodarski, Pawel K.			miR-410-3p is induced by vemurafenib via ER stress and contributes to resistance to BRAF inhibitor in melanoma	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TARGET; CELLS; DOWNSTREAM; SURVIVAL; CLUSTER	Despite significant development of melanoma therapies, death rates remain high. MicroRNAs, controlling posttranscriptionally gene expression, play role in development of resistance to BRAF inhibitors. The aim of the study was to assess the role of miR-410-3p in response to vemurafenib-BRAF inhibitor. FFPE tissue samples of 12 primary nodular melanomas were analyzed. With the use of Laser Capture Microdissection, parts of tumor, transient tissue, and adjacent healthy tissue were separated. In vitro experiments were conducted on human melanoma cell lines A375, G361, and SK-MEL1. IC50s of vemurafenib were determined using MTT method. Cells were transfected with miR-410-3p mimic, anti-miR-410-3p and their non-targeting controls. ER stress was induced by thapsigargin. Expression of isolated RNA was determined using qRT-PCR. We have found miR-410-3p is downregulated in melanoma tissues. Its expression is induced by vemurafenib in melanoma cells. Upregulation of miR-410-3p level increased melanoma cells resistance to vemurafenib, while its inhibition led to the decrease of resistance. Induction of ER stress increased the level of miR-410-3p. miR-410-3p upregulated the expression of AXL in vitro and correlated with markers of invasive phenotype in starBase. The study shows a novel mechanism of melanoma resistance. miR-410-3p is induced by vemurafenib in melanoma cells via ER stress. It drives switching to the invasive phenotype that leads to the response and resistance to BRAF inhibition.	[Grzywa, Tomasz M.; Klicka, Klaudia; Paskal, Wiktor; Dudkiewicz, Julia; Wlodarski, Pawel K.] Med Univ Warsaw, Lab Ctr Preclin Res, Dept Methodol, Warsaw, Poland; [Grzywa, Tomasz M.] Med Univ Warsaw, Dept Immunol, Warsaw, Poland; [Wejman, Jaroslaw; Pyzlak, Michal] Med Ctr Postgrad Educ, Dept Pathol, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Centre of Postgraduate Medical Education - Poland	Paskal, W (corresponding author), Med Univ Warsaw, Lab Ctr Preclin Res, Dept Methodol, Warsaw, Poland.	wiktor.paskal@wum.edu.pl	Grzywa, Tomasz M./AAU-7668-2020; Wejman, Jarosław/AAV-7974-2020; Paskal, Wiktor/ABF-3337-2021	Grzywa, Tomasz M./0000-0002-1809-248X; Wejman, Jarosław/0000-0003-0659-7322; Klicka, Klaudia/0000-0002-3650-5401; Paskal, Wiktor/0000-0003-3051-5446	Medical University of Warsaw [1M15/NM5/18]; Polish Ministry of Science and Higher Education [0075/DIA/2017/46]	Medical University of Warsaw; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was funded by a grant from the Medical University of Warsaw 1M15/NM5/18 (TMG) (www.wum.edu.pl) and from the Polish Ministry of Science and Higher Education 0075/DIA/2017/46 (WP) (www.mnisw.gov.pl The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Anaya J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.67; [Anonymous], 2011, NUCLEIC ACIDS RES, V39, pD214; [Anonymous], 2002, MOD THEOL, V18, P333; [Anonymous], 2015, CANC DISCOV, V5, pOF2; Arozarena I, 2019, NAT REV CANCER, V19, P377, DOI 10.1038/s41568-019-0154-4; Ascierto ML, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00152; Atkinson V, 2017, INTERN MED J, V47, P1114, DOI 10.1111/imj.13574; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Beck D, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003057; Chapman PB, 2017, ANN ONCOL, V28, P2581, DOI 10.1093/annonc/mdx339; Chen C, 2004, J BIOL CHEM, V279, P27948, DOI 10.1074/jbc.M313920200; Clark AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151515; Corella D, 2014, AM J CLIN NUTR, V100, P719, DOI 10.3945/ajcn.113.076992; Couts KL, 2013, ONCOGENE, V32, P1959, DOI 10.1038/onc.2012.209; Cubillos-Ruiz JR, 2016, CLIN CANCER RES, V22, P2121, DOI 10.1158/1078-0432.CCR-15-1570; Diaz-Martinez Marta, 2018, Oncotarget, V9, P35374, DOI 10.18632/oncotarget.26244; Diaz-Martinez M, 2018, CANCER RES, V78, P1017, DOI 10.1158/0008-5472.CAN-17-1318; Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87; Fattore L, 2019, CELL DEATH DIFFER, V26, P1267, DOI 10.1038/s41418-018-0205-5; Fattore L, 2017, ONCOTARGET, V8, P22262, DOI 10.18632/oncotarget.14763; Fattore L, 2016, P NATL ACAD SCI USA, V113, pE5005, DOI 10.1073/pnas.1607753113; Grzywa TM, 2019, ENDOCRINE, V65, P646, DOI 10.1007/s12020-019-01960-7; Grzywa TM, 2017, TRANSL ONCOL, V10, P956, DOI 10.1016/j.tranon.2017.09.007; Guy GP, 2015, MMWR-MORBID MORTAL W, V64, P591; Hachey SJ, 2016, EXP DERMATOL, V25, P497, DOI 10.1111/exd.13002; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Kato M, 2016, ENDOPLASMIC RETICULU; Kemper K, 2014, CANCER RES, V74, P5937, DOI 10.1158/0008-5472.CAN-14-1174; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim A, 2016, EXPERT OPIN DRUG DIS, V11, P907, DOI 10.1080/17460441.2016.1201057; Kozar I, 2019, BBA-REV CANCER, V1871, P313, DOI 10.1016/j.bbcan.2019.02.002; Li FZ, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00031; Liu SM, 2014, ONCOTARGET, V5, P9444, DOI 10.18632/oncotarget.2452; Ma XH, 2014, J CLIN INVEST, V124, P1406, DOI 10.1172/JCI70454; Manzano JL, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.07; McArthur GA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00161; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; NCBI Resource Coordinators, 2013, NUCLEIC ACIDS RES, V42, pD7; Restivo G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01573-6; Ross CL, 2018, J CELL PHYSIOL, V233, P5133, DOI 10.1002/jcp.26395; Sahoo A, 2019, J INVEST DERMATOL, V139, P167, DOI 10.1016/j.jid.2018.06.189; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Shiah SG, 2014, CANCER RES, V74, P7560, DOI 10.1158/0008-5472.CAN-14-0978; Snyder CM, 2013, DEVELOPMENT, V140, P31, DOI 10.1242/dev.081851; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Stark MS, 2015, ONCOTARGET, V6, P17753, DOI 10.18632/oncotarget.3924; Sun XY, 2016, ONCOTARGET, V7, P53558, DOI 10.18632/oncotarget.10669; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vergani E, 2016, ONCOTARGET, V7, P4428, DOI 10.18632/oncotarget.6599; Wen R, 2018, J CELL BIOCHEM, V119, P8737, DOI 10.1002/jcb.27251; Wong NW, 2018, BIOINFORMATICS, V34, P713, DOI 10.1093/bioinformatics/btx627; Xiong J, 2017, ONCOTARGET, V8, P6555, DOI 10.18632/oncotarget.14149; Yarza R, 2016, FRONT PHARMACOL, V6, DOI [10.3389/fphys.2015.00321, 10.3389/fphar.2015.00321]	55	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234707	10.1371/journal.pone.0234707	http://dx.doi.org/10.1371/journal.pone.0234707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555626	Green Published, gold			2022-12-26	WOS:000542759600003
J	Meng, DF; Sun, R; Liu, GY; Peng, LX; Zheng, LS; Xie, P; Lin, ST; Mei, Y; Qiang, YY; Li, CZ; Xu, L; Peng, XS; Hu, H; Lang, YH; Liu, ZJ; Wang, MD; Guo, LL; Xie, DH; Shu, DT; Li, HF; Luo, FF; Niu, XT; Huang, BJ; Qian, CN				Meng, Dong-Fang; Sun, Rui; Liu, Guo-Ying; Peng, Li-Xia; Zheng, Li-Sheng; Xie, Ping; Lin, Si-Ting; Mei, Yan; Qiang, Yuan-Yuan; Li, Chang-Zhi; Xu, Liang; Peng, Xing-Si; Hu, Hao; Lang, Yan-Hong; Liu, Zhi-Jie; Wang, Ming-Dian; Guo, Ling-Ling; Xie, De-Huan; Shu, Di-Tian; Li, Hai-Feng; Luo, Fei-Fei; Niu, Xing-Tang; Huang, Bi-Jun; Qian, Chao-Nan			S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1	ONCOGENE			English	Article							KAPPA-B; BREAST-CANCER; PROMOTES METASTASIS; ACTIVATION; EXPRESSION; PROTEINS; KINASE; PELLINO; BINDING; CELLS	Nasopharyngeal carcinoma (NPC) is a unique head and neck cancer with highly aggressive and metastatic potential in which distant metastasis is the main reason for treatment failure. Till present, the underlying molecular mechanisms of NPC metastasis remains poorly understood. Here, we identified S100 calcium-binding protein A14 (S100A14) as a functional regulator suppressing NPC metastasis by inhibiting the NF-kB signaling pathway and reversing the epithelial-mesenchymal transition (EMT). S100A14 was found to be downregulated in highly metastatic NPC cells and tissues. Immunohistochemical staining of 202 NPC samples revealed that lower S100A14 expression was significantly correlated with shorter patient overall survival (OS) and distant metastasis-free survival (DMFS). S100A14 was also found as an independent prognostic factor for favorable survival. Gain- and loss-of-function studies confirmed that S100A14 suppressed the in vitro and in vivo motility of NPC cells. Mechanistically, S100A14 promoted the ubiquitin-proteasome-mediated degradation of interleukin-1 receptor-associated kinase 1 (IRAK1) to suppress NPC cellular migration. Moreover, S100A14 and IRAK1 established a feedback loop that could be disrupted by the IRAK1 inhibitor T2457. Overall, our findings showed that the S100A14-IRAK1 feedback loop could be a promising therapeutic target for NPC metastasis.	[Meng, Dong-Fang; Sun, Rui; Liu, Guo-Ying; Peng, Li-Xia; Zheng, Li-Sheng; Lin, Si-Ting; Mei, Yan; Li, Chang-Zhi; Peng, Xing-Si; Lang, Yan-Hong; Liu, Zhi-Jie; Wang, Ming-Dian; Guo, Ling-Ling; Xie, De-Huan; Shu, Di-Tian; Luo, Fei-Fei; Huang, Bi-Jun; Qian, Chao-Nan] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Guangzhou 510060, Peoples R China; [Meng, Dong-Fang; Sun, Rui; Liu, Guo-Ying; Peng, Li-Xia; Zheng, Li-Sheng; Lin, Si-Ting; Mei, Yan; Li, Chang-Zhi; Peng, Xing-Si; Lang, Yan-Hong; Liu, Zhi-Jie; Wang, Ming-Dian; Guo, Ling-Ling; Xie, De-Huan; Shu, Di-Tian; Luo, Fei-Fei; Huang, Bi-Jun; Qian, Chao-Nan] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Peoples R China; [Meng, Dong-Fang; Sun, Rui; Liu, Guo-Ying; Peng, Li-Xia; Zheng, Li-Sheng; Lin, Si-Ting; Mei, Yan; Li, Chang-Zhi; Peng, Xing-Si; Lang, Yan-Hong; Liu, Zhi-Jie; Wang, Ming-Dian; Guo, Ling-Ling; Xie, De-Huan; Shu, Di-Tian; Luo, Fei-Fei; Huang, Bi-Jun; Qian, Chao-Nan] Sun Yat Sen Univ, Canc Ctr, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, Guangzhou 510060, Peoples R China; [Meng, Dong-Fang; Sun, Rui; Liu, Guo-Ying; Peng, Li-Xia; Zheng, Li-Sheng; Lin, Si-Ting; Mei, Yan; Li, Chang-Zhi; Peng, Xing-Si; Lang, Yan-Hong; Liu, Zhi-Jie; Wang, Ming-Dian; Guo, Ling-Ling; Xie, De-Huan; Shu, Di-Tian; Luo, Fei-Fei; Huang, Bi-Jun; Qian, Chao-Nan] Sun Yat Sen Univ, Canc Ctr, Dept Nasopharyngeal Carcinoma, Guangzhou 510060, Peoples R China; [Meng, Dong-Fang] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan 250117, Peoples R China; [Xie, Ping] Xiamen Univ, Xiangan Hosp, Sch Med, Dept Radiat Oncol, Xiamen, Peoples R China; [Qiang, Yuan-Yuan] Ningxia Med Univ, Ningxia Key Lab Cerebrocran Dis, Yinchuan 750001, Ningxia, Peoples R China; [Xu, Liang] Sun Yat Sen Univ, Inst Gastroenterol, Affiliated Hosp 6, Guangzhou 510655, Guangdong, Peoples R China; [Hu, Hao] Sun Yat Sen Univ, Dept Tradit Chinese Med, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China; [Li, Hai-Feng] Sun Yat Sen Univ, Dept Med Oncol, Canc Ctr, Guangzhou 510060, Peoples R China; [Niu, Xing-Tang] Sun Yat Sen Univ, Dept Plast Surg, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China; [Qian, Chao-Nan] Guangzhou Concord Canc Ctr, Guangzhou, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Shandong First Medical University & Shandong Academy of Medical Sciences; Xiamen University; Ningxia Medical University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Qian, CN (corresponding author), Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Guangzhou 510060, Peoples R China.; Qian, CN (corresponding author), Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Peoples R China.; Qian, CN (corresponding author), Sun Yat Sen Univ, Canc Ctr, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, Guangzhou 510060, Peoples R China.; Qian, CN (corresponding author), Sun Yat Sen Univ, Canc Ctr, Dept Nasopharyngeal Carcinoma, Guangzhou 510060, Peoples R China.; Qian, CN (corresponding author), Guangzhou Concord Canc Ctr, Guangzhou, Peoples R China.	qianchn@sysucc.org.cn	peng, li/GQH-5153-2022; HU, HAO/ABF-6803-2020; Huang, Bi-Jun/GSD-2430-2022	HU, HAO/0000-0002-4319-2706; 	National Natural Science Foundation of China [81872384, 81672872, 81472386, 81972785, 81773162, 81572901, 81902974]; Science and Technology Planning Project of Guangdong Province, China [2013B021800065]; Provincial Natural Science Foundation of Guangdong, China [2016A030311011, 2017A030313866]; Provincial Natural Science Foundation of Fujian, China [2019J05008]; Sun Yat-sen University [84000-18843409]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China; Provincial Natural Science Foundation of Guangdong, China; Provincial Natural Science Foundation of Fujian, China(Natural Science Foundation of Fujian Province); Sun Yat-sen University	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81872384, 81672872, and 81472386 to C.Q., Nos. 81972785, 81773162, and 81572901 to B.H., No. 81902974 to P.X.), the Science and Technology Planning Project of Guangdong Province, China (No. 2013B021800065 to R.S.), the Provincial Natural Science Foundation of Guangdong, China (No. 2016A030311011 to C.Q., No. 2017A030313866 to B.H.), the Provincial Natural Science Foundation of Fujian, China (No. 2019J05008 to P.X.), and a research program from Sun Yat-sen University (No. 84000-18843409 to C.Q.).	Basnet Suyog, 2019, Oncotarget, V10, P2996, DOI 10.18632/oncotarget.26861; Bigelow RLH, 2009, BREAST CANCER RES TR, V117, P31, DOI 10.1007/s10549-008-0170-7; Blanchard P, 2015, LANCET ONCOL, V16, P645, DOI 10.1016/S1470-2045(15)70126-9; Brabletz T, 2018, NAT REV CANCER, V18, P128, DOI 10.1038/nrc.2017.118; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Bulk E, 2009, CLIN CANCER RES, V15, P22, DOI 10.1158/1078-0432.CCR-08-0953; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Chen HY, 2013, MOL CANCER RES, V11, P1542, DOI 10.1158/1541-7786.MCR-13-0317; Chen HY, 2009, CANCER RES, V69, P3451, DOI 10.1158/0008-5472.CAN-08-4231; Chen YP, 2019, LANCET, V394, P64, DOI 10.1016/S0140-6736(19)30956-0; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Colevas AD, 2018, J NATL COMPR CANC NE, V16, P479, DOI 10.6004/jnccn.2018.0026; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Dumbrepatil AB, 2019, J BIOL CHEM, V294, P6888, DOI 10.1074/jbc.RA119.007719; Feng RM, 2019, CANCER COMMUN, V39, DOI 10.1186/s40880-019-0368-6; Feng SS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192208; Filipek A, 2006, CHEMOTHERAPY, V52, P32, DOI 10.1159/000090240; Gallo LH, 2017, CELL CYCLE, V16, P634, DOI 10.1080/15384101.2017.1288326; Goh JY, 2017, NAT MED, V23, P1319, DOI 10.1038/nm.4405; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Graczyk A, 2014, INT J BIOCHEM CELL B, V57, P135, DOI 10.1016/j.biocel.2014.10.007; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Jin QE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019375; Knop J, 1999, FEBS LETT, V448, P81, DOI 10.1016/S0014-5793(99)00322-1; Kwon CH, 2013, MOL CELLS, V35, P226, DOI 10.1007/s10059-013-2269-x; Lesniak W, 2007, J INVEST DERMATOL, V127, P2307, DOI 10.1038/sj.jid.5700879; Lesniak W, 2011, CLIN EPIGENETICS, V2, P77, DOI 10.1007/s13148-011-0023-9; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Li YY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14121; Li ZY, 2015, J CLIN INVEST, V125, P1081, DOI 10.1172/JCI75821; Lindsey JC, 2007, BRIT J CANCER, V97, P267, DOI 10.1038/sj.bjc.6603852; Meng DF, 2018, J CANCER, V9, P92, DOI 10.7150/jca.21357; Meng DF, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-016-0483-z; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Qian CN, 2017, CHIN J CANCER, V36, DOI 10.1186/s40880-017-0206-7; Rhyasen GW, 2013, CANCER CELL, V24, P90, DOI 10.1016/j.ccr.2013.05.006; Sapkota D, 2012, ORAL ONCOL, V48, P219, DOI 10.1016/j.oraloncology.2011.10.001; Sapkota D, 2011, EUR J CANCER, V47, P600, DOI 10.1016/j.ejca.2010.10.012; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Schneider G, 2011, AMINO ACIDS, V41, P773, DOI 10.1007/s00726-010-0498-2; Smith H, 2009, P NATL ACAD SCI USA, V106, P4584, DOI 10.1073/pnas.0900774106; Srivastava R, 2012, CANCER RES, V72, P6209, DOI 10.1158/0008-5472.CAN-12-0337; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai WC, 2006, MOL CANCER RES, V4, P539, DOI 10.1158/1541-7786.MCR-05-0266; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang XH, 2010, AM J PATHOL, V177, P586, DOI 10.2353/ajpath.2010.091217; Wee ZN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9746; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Xiong TF, 2019, MELANOMA RES, V29, P23, DOI 10.1097/CMR.0000000000000512; Xu CS, 2014, J BIOL CHEM, V289, P827, DOI 10.1074/jbc.M113.469718; Xu L, 2018, CANCER LETT, V431, P230, DOI 10.1016/j.canlet.2017.10.016; Yi M, 2018, J CELL PHYSIOL, V233, P5537, DOI 10.1002/jcp.26410; Zhang W, 2020, CANCER COMMUN, V40, P69, DOI 10.1002/cac2.12010; Zheng LS, 2017, CANCER RES, V77, P579, DOI 10.1158/0008-5472.CAN-16-1281; Zhu M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.297	60	17	20	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 23	2020	39	30					5307	5322		10.1038/s41388-020-1363-8	http://dx.doi.org/10.1038/s41388-020-1363-8		JUN 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MO5BV	32555330				2022-12-26	WOS:000545371000001
J	Alam, C; Hoque, MT; Sangha, V; Bendayan, R				Alam, Camille; Hoque, Md. Tozammel; Sangha, Vishal; Bendayan, Reina			Nuclear respiratory factor 1 (NRF-1) upregulates the expression and function of reduced folate carrier (RFC) at the blood-brain barrier	FASEB JOURNAL			English	Article						brain folate transport; folate deficiency; reduced folate carrier; transcription factor	KEARNS-SAYRE-SYNDROME; VITAMIN-D-RECEPTOR; MITOCHONDRIAL BIOGENESIS; DOWN-SYNDROME; TRANSPORTER; DEFICIENCY; AUTOANTIBODIES; DYSFUNCTION; DISEASES; SLC46A1	Folates are important for neurodevelopment and cognitive function. Folate transport across biological membranes is mediated by three major pathways: folate receptor alpha (FR alpha), proton-coupled folate transporter (PCFT), and reduced folate carrier (RFC). Brain folate transport primarily occurs at the choroid plexus through FR alpha and PCFT; inactivation of these transport systems results in suboptimal folate levels in the cerebrospinal fluid (CSF) causing childhood neurological disorders. Our group has reported that upregulation of RFC at the blood-brain barrier (BBB) through interactions with specific transcription factors, that is, vitamin D receptor (VDR) could increase brain folate delivery. This study investigates the role of nuclear respiratory factor 1 (NRF-1) in the regulation of RFC at the BBB. Activation of NRF-1/PGC-1 alpha signaling through treatment with its specific ligand, pyrroloquinoline quinone (PQQ), significantly induced RFC expression and transport activity in hCMEC/D3 cells. In contrast, transfection with NRF-1 or PGC-1 alpha targeting siRNA downregulated RFC functional expression in the same cell system. Applying chromatin immunoprecipitation (ChIP) assay, we further demonstrated that PQQ treatment increased NRF-1 binding to putative NRF-1 binding sites within theSLC19A1promoter, which encodes for RFC. Additionally, in vivo treatment of wild type mice with PQQ-induced RFC expression in isolated mouse brain capillaries. Together, these findings demonstrate that NRF-1/PGC-1 alpha activation by PQQ upregulates RFC functional expression at the BBB and could potentially enhance brain folate uptake.	[Alam, Camille; Hoque, Md. Tozammel; Sangha, Vishal; Bendayan, Reina] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, 144 Coll St,Room 1001, Toronto, ON M5S 3M2, Canada	University of Toronto	Bendayan, R (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, 144 Coll St,Room 1001, Toronto, ON M5S 3M2, Canada.	r.bendayan@utoronto.ca			Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC) [498383]	Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)	Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Grant/Award Number: 498383	Alam C, 2020, TRENDS PHARMACOL SCI, V41, P349, DOI 10.1016/j.tips.2020.02.004; Alam C, 2019, P NATL ACAD SCI USA, V116, P17531, DOI 10.1073/pnas.1907077116; Alam C, 2017, MOL PHARMACEUT, V14, P3848, DOI 10.1021/acs.molpharmaceut.7b00572; Araujo JR, 2010, BIOFACTORS, V36, P201, DOI 10.1002/biof.82; Assaraf YG, 2006, DRUG RESIST UPDATE, V9, P227, DOI 10.1016/j.drup.2006.09.001; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; Chan Gary N Y, 2017, Curr Protoc Pharmacol, V76, DOI 10.1002/cpph.21; Chow ECY, 2013, AM J PHYSIOL-ENDOC M, V304, pE977, DOI 10.1152/ajpendo.00489.2012; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; Elnakat H, 2004, ADV DRUG DELIVER REV, V56, P1067, DOI 10.1016/j.addr.2004.01.001; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Frye RE, 2011, PEDIATR RES, V69, p41R, DOI 10.1203/PDR.0b013e318212f16b; Garcia-Cazorla A, 2008, NEUROLOGY, V70, P1360, DOI 10.1212/01.wnl.0000309223.98616.e4; Gibson JH, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-53; Gonen N, 2010, J BIOL CHEM, V285, P33602, DOI 10.1074/jbc.M110.135640; Grapp M, 2012, BRAIN, V135, P2022, DOI 10.1093/brain/aws122; Halwachs S, 2010, TOXICOL APPL PHARM, V246, P100, DOI 10.1016/j.taap.2010.04.020; Kamen BA, 2004, ADV DRUG DELIVER REV, V56, P1085, DOI 10.1016/j.addr.2004.01.002; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Piccoli C, 2013, HUM MOL GENET, V22, P1218, DOI 10.1093/hmg/dds529; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P276, DOI 10.1055/s-2008-1065354; Ramaekers VT, 2013, MOL PSYCHIATR, V18, P270, DOI 10.1038/mp.2012.22; Ramaekers VT, 2005, NEW ENGL J MED, V352, P1985, DOI 10.1056/NEJMoa043160; Rucker R, 2009, ALTERN MED REV, V14, P268; Saihara K, 2017, BIOCHEMISTRY-US, V56, P6615, DOI 10.1021/acs.biochem.7b01185; Salbaum JM, 2009, BIRTH DEFECTS RES A, V85, P303, DOI 10.1002/bdra.20537; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Serrano M, 2010, MITOCHONDRION, V10, P429, DOI 10.1016/j.mito.2010.04.001; Shemesh A, 2022, STATPEARLS INTERNET; Spector Reynold, 2010, Cerebrospinal Fluid Res, V7, P14, DOI 10.1186/1743-8454-7-14; Steinfeld R, 2009, AM J HUM GENET, V85, P354, DOI 10.1016/j.ajhg.2009.08.005; Tanji K, 2000, J NEUROL SCI, V178, P29, DOI 10.1016/S0022-510X(00)00354-3; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Torres A, 2015, JIMD REP, V24, P91, DOI 10.1007/8904_2015_445; Tran T, 2005, CANCER RES, V65, P4431, DOI 10.1158/0008-5472.CAN-04-2890; Valenti D, 2014, NEUROSCI BIOBEHAV R, V46, P202, DOI 10.1016/j.neubiorev.2014.01.012; Visentin M, 2014, ANNU REV PHYSIOL, V76, P251, DOI 10.1146/annurev-physiol-020911-153251; Weissman JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003815; Wu DF, 1999, PHARMACEUT RES, V16, P415, DOI 10.1023/A:1018829920158; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109502; Zhao RB, 2017, MOL ASPECTS MED, V53, P57, DOI 10.1016/j.mam.2016.09.002; Zhao RB, 2013, MOL ASPECTS MED, V34, P373, DOI 10.1016/j.mam.2012.07.006	45	7	8	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10516	10530		10.1096/fj.202000239RR	http://dx.doi.org/10.1096/fj.202000239RR		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32543769	Bronze			2022-12-26	WOS:000541638400001
J	Ferrari, DVD; Polettini, J; de Moraes, LL; de Campos, LA; da Silva, MG; Saeki, EK; Morceli, G				de Jesus Ferrari, Denise Vasconcelos; Polettini, Jossimara; de Moraes, Lucas Lima; de Campos, Leticia Aguiar; da Silva, Marcia Guimaraes; Saeki, Erika Kushikawa; Morceli, Glilciane			Profile of pro-inflammatory cytokines in colostrum of nursing mothers at the extremes of reproductive age	PLOS ONE			English	Article							BREAST-MILK; TERM; INTERLEUKIN-8; PRETERM	Gestations at the extremes of reproductive age are characterized as high-risk pregnancies, conditions that might influence colostrum composition. This first milk secretion contains nutrients necessary for the development and immunity of the newborn; therefore, this study aims to compare adolescent and advanced maternal age mothers regarding sociodemographic, gestational, and perinatal characteristics and the colostrum levels of pro-inflammatory cytokines in these groups of study. This cross-sectional study has compared sociodemographic, gestational and perinatal data from adolescent mothers (between 10 and 24 years old) (n = 117), advanced maternal age mothers (over 35 years of age) (n = 39) and mothers considered a control group (25 to 34 years old) (n = 58). Additionally, colostrum samples were obtained from the studied and control group subjects by manual milking, between 48 and 72 hours postpartum, and the samples were analyzed for cytokine concentrations by enzyme-linked immunosorbent assay (ELISA). The majority of the studied mothers reported living a stable union, and 81.2% of the adolescent mothers did not carry out any paid activity. Mothers with advanced maternal age mainly delivered by cesarean section and presented a higher body mass index (BMI). Neonatal weight and Apgar score were not different between the groups. The concentrations of interleukin (IL)-1 beta and IL-6 were higher in the colostrum of mothers with advanced age compared to adolescent mothers, but did not differ from the control group. The concentrations of IL-8 and tumor necrosis factor alpha did not differ between the three groups. Therefore, our data demonstrated that maternal age influenced the sociodemographic and gestational characteristics as well as the composition of colostrum cytokines.	[de Jesus Ferrari, Denise Vasconcelos; Polettini, Jossimara; Morceli, Glilciane] Univ Oeste Paulista UNOESTE, Ciencias Saude, Presidente Prudente, SP, Brazil; [Polettini, Jossimara] Univ Fed Fronteira Sul UFFS, Campus Passo Fundo, Passo Fundo, RS, Brazil; [de Moraes, Lucas Lima; de Campos, Leticia Aguiar] Univ Oeste Paulista UNOESTE, Fac Ciencias Saude, Presidente Prudente, SP, Brazil; [da Silva, Marcia Guimaraes] Univ Estadual Paulista UNESP Botucatu, Fac Med Botucatu, Botucatu, SP, Brazil; [Saeki, Erika Kushikawa] Inst Adolfo Lutz IAL Presidente Prudente, Presidente Prudente, SP, Brazil; [Morceli, Glilciane] Univ Estado Minas Gerais UEMG, Campus Passos, Passos, MG, Brazil	Universidade do Oeste Paulista; Universidade Federal da Fronteira Sul; Universidade do Oeste Paulista; Universidade Estadual Paulista	Morceli, G (corresponding author), Univ Oeste Paulista UNOESTE, Ciencias Saude, Presidente Prudente, SP, Brazil.; Morceli, G (corresponding author), Univ Estado Minas Gerais UEMG, Campus Passos, Passos, MG, Brazil.	glilciane@gmail.com	de Moraes, Lucas Lima/AAT-4136-2021; Saeki, Erika K/I-2181-2016; Morceli, Glilciane/C-7487-2012; da Silva, Márcia Guimarães/M-8080-2019; Polettini, Jossimara/K-9437-2014	de Moraes, Lucas Lima/0000-0003-1613-5068; Saeki, Erika K/0000-0002-8604-0374; Morceli, Glilciane/0000-0001-8216-9931; da Silva, Márcia Guimarães/0000-0002-4663-7926; Polettini, Jossimara/0000-0002-6719-8715				Agarwal S, 2011, J HUM LACT, V27, P171, DOI 10.1177/0890334410395761; Franca MTA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208542; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Collado MC, 2015, NUTRIENTS, V7, P8577, DOI 10.3390/nu7105415; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; de Azevedo WF, 2015, EINSTEIN-SAO PAULO, V13, P618, DOI 10.1590/S1679-45082015RW3127; de Freitas NA, 2019, J MATERN-FETAL NEO M, V32, P2209, DOI 10.1080/14767058.2018.1429395; Del Ciampo LA, 2018, REV BRAS GINECOL OBS, V40, P354, DOI 10.1055/s-0038-1657766; Erbagci AB, 2005, CLIN BIOCHEM, V38, P712, DOI 10.1016/j.clinbiochem.2005.05.004; Gila-Diaz A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061307; Hashira S, 2002, BIOL NEONATE, V82, P34, DOI 10.1159/000064150; Kortekaas JC, 2020, ACTA OBSTET GYN SCAN, V99, P1022, DOI 10.1111/aogs.13828; Lean SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186287; Mehari MA, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2740-6; Ministry of Health, 2012, HIGH RISK PREGN TECH; Morceli G, 2011, ACTA PAEDIATR, V100, P550, DOI 10.1111/j.1651-2227.2010.02070.x; Munblit D, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110695; Ortiz C, 2018, SOUTH MED J, V111, P544, DOI 10.14423/SMJ.0000000000000854; Tejada CAO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171888; Polat A, 2016, BREASTFEED MED, V11, P247, DOI 10.1089/bfm.2015.0186; Rautava S, 2011, NEONATOLOGY, V99, P192, DOI 10.1159/000314109; Saso A, 2019, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00414; Sawyer SM, 2018, LANCET CHILD ADOLESC, V2, P223, DOI 10.1016/S2352-4642(18)30022-1; Sinanoglou VJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175817; Domingues RMSM, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00105113; Trend S, 2016, BRIT J NUTR, V115, P1178, DOI 10.1017/S0007114516000234; de Castro MBT, 2016, PUBLIC HEALTH NUTR, V19, P1245, DOI 10.1017/S1368980015002700; Wei W, 2019, J AGR FOOD CHEM, V67, P13922, DOI 10.1021/acs.jafc.9b04247; World Health Organization (WHO), 2000, WHO TECHN REP SER, P256, DOI DOI 10.1007/978-0-387-71799-9_454; Zambruni M, 2017, J REPROD IMMUNOL, V120, P20, DOI 10.1016/j.jri.2017.04.001	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0231882	10.1371/journal.pone.0231882	http://dx.doi.org/10.1371/journal.pone.0231882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544178	Green Published, gold			2022-12-26	WOS:000542957200002
J	Hillman, RT; Cardnell, R; Fujimoto, J; Lee, WC; Zhang, JJ; Byers, LA; Ramalingam, P; Leitao, M; Swisher, E; Futreal, PA; Frumovitz, M				Hillman, R. Tyler; Cardnell, Robert; Fujimoto, Junya; Lee, Won-Chul; Zhang, Jianjun; Byers, Lauren A.; Ramalingam, Preetha; Leitao, Mario; Swisher, Elizabeth; Futreal, P. Andrew; Frumovitz, Michael			Comparative genomics of high grade neuroendocrine carcinoma of the cervix	PLOS ONE			English	Article							CELL LUNG-CANCER; PHASE-III TRIAL; PROGNOSTIC-FACTORS; MUTATIONAL PROCESSES; UTERINE CERVIX; CYCLOPHOSPHAMIDE; VINCRISTINE; CISPLATIN; ETOPOSIDE; SURVIVAL	In order to improve treatment selection for high grade neuroendocrine carcinomas of the cervix (NECC), we performed a comparative genomic analysis between this rare tumor type and other cervical cancer types, as well as extra-cervical neuroendocrine small cell carcinomas of the lung and bladder. We performed whole exome sequencing on fresh-frozen tissue from 15 NECCs and matched normal tissue. We then identified mutations and copy number variants using standard analysis pipelines. Published mutation tables from cervical cancers and extra-cervical small cell carcinomas were used for comparative analysis. Descriptive statistical methods were used and a two-sided threshold of P < .05 was used for significance. In the NECC cohort, we detected a median of 1.7 somatic mutations per megabase (range 1.0-20.9).PIK3CAp.E545K mutations were the most frequency observed oncogenic mutation (4/15 tumors, 27%). Activating MAPK pathway mutations inKRAS(p.G12D) andGNAS(p.R201C) co-occurred in two tumors (13%). In total we identified PI3-kinase or MAPK pathway activating mutations in 67% of NECC. When compared to NECC, lung and bladder small cell carcinomas exhibited a statistically significant higher rate of coding mutations (P < .001 for lung; P = .001 for bladder). Mutation ofTP53was uncommon in NECC (13%) and was more frequent in both lung (103 of 110 tumors [94%], P < .001) and bladder (18 of 19 tumors [95%], P < .001) small cell carcinoma. These comparative genomics data suggest that NECC may be genetically more similar to common cervical cancer subtypes than to extra-cervical small cell neuroendocrine carcinomas of the lung and bladder. These results may have implications for the selection of cytotoxic and targeted therapy regimens for this rare disease.	[Hillman, R. Tyler; Frumovitz, Michael] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; [Hillman, R. Tyler; Lee, Won-Chul; Zhang, Jianjun; Byers, Lauren A.; Futreal, P. Andrew] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Cardnell, Robert; Lee, Won-Chul; Zhang, Jianjun] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Oncol, Houston, TX 77030 USA; [Fujimoto, Junya; Ramalingam, Preetha] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Leitao, Mario] Mem Sloan Kettering Canc Ctr, Dept Surg, Med Ctr, 1275 York Ave, New York, NY 10021 USA; [Swisher, Elizabeth] Univ Washington, Med Ctr, Dept Gynecol Oncol, Seattle, WA 98195 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle	Frumovitz, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA.	mfrumovitz@mdanderson.org		Hillman, Robert/0000-0002-9832-9925	NIH [P50CA83639]; NIH T32 training grant [CA101642]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The University of Texas MD Anderson Cancer Center Multidisciplinary Gynecologic Cancer Tumor Bank is supported in part by NIH P50CA83639 SPORE in Ovarian Cancer and RTH is supported by an NIH T32 training grant (CA101642).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; [Anonymous], 2021, LANG ENV STAT COMP; Burk RD, 2017, NATURE, V543, P378, DOI 10.1038/nature21386; Castle PE, 2018, GYNECOL ONCOL, V148, P422, DOI 10.1016/j.ygyno.2017.12.001; Chang MT, 2018, CLIN CANCER RES, V24, P1965, DOI 10.1158/1078-0432.CCR-17-2655; Chen J, 2008, OBSTET GYNECOL, V111, P1394, DOI 10.1097/AOG.0b013e318173570b; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cho SY, 2017, ONCOTARGET, V8, P8095, DOI 10.18632/oncotarget.14098; Ferber MJ, 2003, ONCOGENE, V22, P7233, DOI 10.1038/sj.onc.1207006; Frumovitz M, 2017, GYNECOL ONCOL, V144, P46, DOI 10.1016/j.ygyno.2016.10.040; Frumovitz M, 2016, GYNECOL ONCOL, V141, P588, DOI 10.1016/j.ygyno.2016.04.001; Frumovitz M, 2010, GYNECOL ONCOL, V117, P491, DOI 10.1016/j.ygyno.2010.02.010; FUKUOKA M, 1991, J NATL CANCER I, V83, P855, DOI 10.1093/jnci/83.12.855; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hillman RT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04950-x; Huebschmann D, 2015, YAPSA YET ANOTHER PA; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; MALMSTROM H, 1994, GYNECOL ONCOL, V52, P50, DOI 10.1006/gyno.1994.1010; McCusker ME, 2003, GYNECOL ONCOL, V88, P333, DOI 10.1016/S0090-8258(02)00150-6; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Monk BJ, 2009, J CLIN ONCOL, V27, P4649, DOI 10.1200/JCO.2009.21.8909; Norquist BM, 2016, JAMA ONCOL, V2, P482, DOI 10.1001/jamaoncol.2015.5495; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; ROTH BJ, 1992, J CLIN ONCOL, V10, P282, DOI 10.1200/JCO.1992.10.2.282; Sato S, 2009, CANCER SCI, V100, P546, DOI 10.1111/j.1349-7006.2008.01065.x; Sundstrom S, 2002, J CLIN ONCOL, V20, P4665, DOI 10.1200/JCO.2002.12.111; Tewari K, 2000, OBSTET GYNECOL, V95, P128, DOI 10.1016/S0029-7844(99)00470-6; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Wang KL, 2012, EUR J CANCER, V48, P1484, DOI 10.1016/j.ejca.2011.12.014; Xing DY, 2018, AM J SURG PATHOL, V42, P750, DOI 10.1097/PAS.0000000000001042; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zivanovic O, 2009, GYNECOL ONCOL, V112, P590, DOI 10.1016/j.ygyno.2008.11.010	37	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234505	10.1371/journal.pone.0234505	http://dx.doi.org/10.1371/journal.pone.0234505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544169	Green Published, gold			2022-12-26	WOS:000542957200044
J	Ma, ZL; Li, YN; Zhang, YY; Chen, JX; Tan, T; Fan, Y				Ma, Zhenglai; Li, Yanni; Zhang, Yingying; Chen, Jiaxin; Tan, Tao; Fan, Yong			A lncRNA-miRNA-mRNA network for human primed, naive and extended pluripotent stem cells	PLOS ONE			English	Article							SELF-RENEWAL; DERIVATION; CULTURE; STATE; ESTABLISHMENT; INDUCTION; GENE; MAINTENANCE; TRANSITION; BLASTOCYST	Human pluripotent stem cells (hPSCs) represent a promising platform for studying embryonic development, and different states of pluripotency reflect the different stages of embryo development. Here, we successfully converted three in-house-derived primed hPSC lines (H10, H24, and iPS) to a naive state and an expanded pluripotent stem cell (EPS) state. Primed, naive and EPS cells displayed state-specific morphologies and expressed pluripotent markers. The expression of SSEA4 and TRA-1-60 was downregulated in the conversion process. The H3K27me3 expression level also decreased, indicating that global methylation was reduced and that the X chromosome started to reactivate. RNA-sequencing analysis results revealed that differentially expressed genes (DEGs) were significantly enriched in both naive hPSCs and EPS cells when compared to the primed state. However, imprinted gene expression barely changed before and after state reversion. Gene ontology (GO) analyses showed that the upregulated DEGs were mostly enriched in RNA processing, DNA replication and repair, and regulation of cell cycle process, while downregulated DEGs were related to extracellular adhesion and various tissue developmental processes. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that EPS cells were enriched in the PI3K-Akt and Wnt signaling pathways. Analysis of the lncRNA-miRNA-mRNA competing endogenous RNA (ceRNA) network between primed, naive hPSCs and EPS cells revealed that hsa-miR-424-5p, has-miR-16-5p, has-miR-27b-3p, has-miR-29c-3p, and KCNQ1OT1 were crucial nodes with high degrees of connectivity. Our work may represent new insight into the intrinsic molecular features of different hPSC states.	[Ma, Zhenglai; Li, Yanni; Zhang, Yingying; Chen, Jiaxin; Fan, Yong] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstetr Dis Guangdong Prov, Key Lab Reprod & Genet,Guangdong Higher Educ Inst, Guangzhou, Peoples R China; [Tan, Tao] Kunming Univ Sci & Technol, Inst Primate Translat Med, Yunnan Key Lab Primate Biomed Res, Kunming, Yunnan, Peoples R China	Guangzhou Medical University; Kunming University of Science & Technology	Fan, Y (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstetr Dis Guangdong Prov, Key Lab Reprod & Genet,Guangdong Higher Educ Inst, Guangzhou, Peoples R China.; Tan, T (corresponding author), Kunming Univ Sci & Technol, Inst Primate Translat Med, Yunnan Key Lab Primate Biomed Res, Kunming, Yunnan, Peoples R China.	yongfan011@gzhmu.edu.cn; tant@lpbr.cn			National Key R&D Program of China [2019YFA0110804, 2018YFC1003203]; National Natural Science Foundation of China [81871162]; Guangdong Province Science and Technology Project [2017A020214005]; Guangzhou Science and Technology Project [201803010048]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Science and Technology Project; Guangzhou Science and Technology Project	This work was supported by the National Key R&D Program of China (2019YFA0110804, 2018YFC1003203), National Natural Science Foundation of China (Grant No. 81871162), Guangdong Province Science and Technology Project (2017A020214005) and the Guangzhou Science and Technology Project (201803010048).	[Anonymous], 2015, MISSION STUDIES, V32, P4; Carcamo-Orive I, 2017, CELL STEM CELL, V20, P518, DOI 10.1016/j.stem.2016.11.005; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Cheng D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051778; Collier AJ, 2017, CELL STEM CELL, V20, P874, DOI 10.1016/j.stem.2017.02.014; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fan Y, 2010, J REPROD DEVELOP, V56, P533, DOI 10.1262/jrd.09-225M; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gao XF, 2019, NAT CELL BIOL, V21, P687, DOI 10.1038/s41556-019-0333-2; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo G, 2016, STEM CELL REP, V6, P437, DOI 10.1016/j.stemcr.2016.02.005; Huang K, 2014, CELL STEM CELL, V15, P410, DOI 10.1016/j.stem.2014.09.014; Inoue A, 2017, GENE DEV, V31, P1927, DOI 10.1101/gad.304113.117; Kang XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131128; Kilens S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02107-w; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lee YY, 2012, CANCER RES, V72, DOI [10.1158/1538-7445.AM2012-4651, 10.1158/0008-5472.CAN-12-2397]; Li RD, 2018, BIOINFORMATICS, V34, P2515, DOI 10.1093/bioinformatics/bty124; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Messmer T, 2019, CELL REP, V26, P815, DOI 10.1016/j.celrep.2018.12.099; Mondal K, 2018, NEUTROSOPHIC SETS SY, V19, P47; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Pastor WA, 2016, CELL STEM CELL, V18, P323, DOI 10.1016/j.stem.2016.01.019; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith A, 2017, DEVELOPMENT, V144, P365, DOI 10.1242/dev.142679; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takashima Y, 2015, CELL, V162, P452, DOI 10.1016/j.cell.2015.06.052; Theunissen TW, 2016, CELL STEM CELL, V19, P502, DOI 10.1016/j.stem.2016.06.011; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Valamehr B, 2014, STEM CELL REP, V2, P366, DOI 10.1016/j.stemcr.2014.01.014; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Xu ZJ, 2016, P NATL ACAD SCI USA, V113, pE6382, DOI 10.1073/pnas.1613849113; Yang J, 2017, NATURE, V550, P393, DOI 10.1038/nature24052; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang Y, 2017, CELL, V169, P243, DOI 10.1016/j.cell.2017.02.005; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhao T, 2018, CELL STEM CELL, V23, P31, DOI 10.1016/j.stem.2018.05.025	43	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234628	10.1371/journal.pone.0234628	http://dx.doi.org/10.1371/journal.pone.0234628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544168	Green Published, gold			2022-12-26	WOS:000542957200043
J	Moumin, NA; Angel, MD; Karakochuk, CD; Michaux, KD; Moursi, M; Sawadogo, KAA; Foley, J; Hawes, MD; Whitfield, KC; Tugirimana, PL; Bahizire, E; Akilimali, PZ; Boy, E; Sullivan, TR; Green, TJ				Moumin, Najma A.; Angel, Moira Donahue; Karakochuk, Crystal D.; Michaux, Kristina D.; Moursi, Mourad; Sawadogo, Kossiwavi Amewono Ayassou; Foley, Jennifer; Hawes, Meaghan D.; Whitfield, Kyly C.; Tugirimana, Pierrot L.; Bahizire, Esto; Akilimali, Pierre Z.; Boy, Erick; Sullivan, Thomas R.; Green, Tim J.			Micronutrient intake and prevalence of micronutrient inadequacy among women (15-49 y) and children (6-59 mo) in South Kivu and Kongo Central, Democratic Republic of the Congo (DRC)	PLOS ONE			English	Article							FOOD; ZINC	Iron biofortified beans and carotenoid enriched cassava are proposed as a solution to combat iron and vitamin A deficiencies, respectively, in the Democratic Republic of Congo (DRC). To inform the need for biofortified foods, we conducted a survey in 2014 in two provinces of the DRC, South Kivu and Kongo Central. Unexpectedly, women of reproductive age (WRA; 15-49 y) and their children (6-59 m) had a low prevalence of biochemical iron and vitamin A deficiency, based on ferritin and retinol binding protein, respectively. To better understand the lack of biochemical deficiency of these nutrients, we examined the prevalence of inadequate intake for these and other select nutrients. Dietary intake was assessed using 24-hour recalls among 744 mother-child dyads. Repeat recalls on a non-consecutive day were conducted with a subsample of the study population to account for intra-individual variation and estimate usual intake. In WRA, the prevalence of inadequate iron intakes were 33% and 29% in South Kivu and Kongo Central, respecitvely. The prevalence of inadequate vitamin A intakes among WRA was low in South Kivu (18%) and negligible in Kongo Central (1%). Iron inadequacy was highest in infants (6-11 m) at 82% and 64% in South Kivu and Kongo Central, respectively. Among older children (12-59 m) in both provinces, the prevalence of iron inadequacy was similar at similar to 20%. There was a high prevalence of inadequate zinc intake in women and children (i.e. 79-86% among WRA and 56-91% among children 6-59 m) consistent with our findings of a high prevalence of low serum zinc in the same sample. Dietary data here corroborate the low prevalence of biochemical vitamin A deficiency but not iron. However, any change to the supply of red palm oil (primary source of vitamin A) would dramatically reduce population vitamin A intakes, thus a carotenoid enriched cassava program may be beneficial as a safety net measure. Crops biofortified with zinc also appear warranted. We caution that our findings cannot be extrapolated to the entire Congo where diverse agro-ecological landscape exist or when political and environmental shocks occur which challenge food production.	[Moumin, Najma A.; Sullivan, Thomas R.; Green, Tim J.] South Australian Hlth & Med Res Inst, Div Hlth Mothers Babies & Children, Adelaide, SA, Australia; [Moumin, Najma A.; Green, Tim J.] Univ Adelaide, Discipline Paediat, Adelaide, SA, Australia; [Angel, Moira Donahue; Moursi, Mourad; Foley, Jennifer; Boy, Erick] Int Food Policy Res Inst, HarvestPlus, Washington, DC 20036 USA; [Karakochuk, Crystal D.; Michaux, Kristina D.; Hawes, Meaghan D.; Green, Tim J.] Univ British Columbia, Food Nutr & Hlth, Vancouver, BC, Canada; [Sawadogo, Kossiwavi Amewono Ayassou] Initiat Conseil Int Sante, Ouagadougou, Burkina Faso; [Whitfield, Kyly C.] Mt St Vincent Univ, Dept Appl Human Nutr, Halifax, NS, Canada; [Tugirimana, Pierrot L.] Univ Goma, Fac Med, Goma, DEM REP CONGO; [Tugirimana, Pierrot L.] Univ Rwanda, Coll Med & Hlth Sci, Dept Clin Biol, Kigali, Rwanda; [Bahizire, Esto] Univ Catholique Bukavu, Fac Med, Bukavu, DEM REP CONGO; [Bahizire, Esto] Ctr Res Nat Sci Lwiro, Bukavu, DEM REP CONGO; [Bahizire, Esto] Univ Libre Bruxelles, Ctr Res Epidemiol Biostat & Clin Res, Brussels, Belgium; [Akilimali, Pierre Z.] Univ Kinshasa, Kinshasa Sch Publ Hlth, Dept Nutr, Kinshasa, DEM REP CONGO; [Sullivan, Thomas R.] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia	South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; CGIAR; International Food Policy Research Institute (IFPRI); University of British Columbia; Mount Saint Vincent University; University of Rwanda; Universite Libre de Bruxelles; Universite de Kinshasa; University of Adelaide	Green, TJ (corresponding author), South Australian Hlth & Med Res Inst, Div Hlth Mothers Babies & Children, Adelaide, SA, Australia.; Green, TJ (corresponding author), Univ Adelaide, Discipline Paediat, Adelaide, SA, Australia.; Green, TJ (corresponding author), Univ British Columbia, Food Nutr & Hlth, Vancouver, BC, Canada.	tim.green@sahmri.com	Green, Tim/AAA-8601-2019; Boy, Erick/HDO-0821-2022	Green, Tim/0000-0002-0667-4300; Bahizire, Esto/0000-0002-7205-7730; Moumin, Najma/0000-0002-3336-3153; Michaux, Kristina D./0000-0002-1384-5577; Moursi, Mourad/0000-0002-5071-8534; Sullivan, Thomas/0000-0002-6930-5406	Bill and Melinda Gates Foundation [OPP1019962]; HarvestPlus [2014H8307]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); HarvestPlus	The funds for the study were made available from the Bill and Melinda Gates Foundation to HarvestPlus through Grant No. OPP1019962, and funds were made available from HarvestPlus to UBC through agreement 2014H8307. MDA, MM, JF and EB are HarvestPlus employees and were involved in the design, collection, analysis and/or preparation of the manuscript. TG had primary responsibility for the final content.	Agostoni C, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3844; Barker MK, 2017, J NUTR, V147, P1785, DOI 10.3945/jn.117.252635; Blair MW, 2013, J AGR FOOD CHEM, V61, P8287, DOI 10.1021/jf400774y; Burri BJ, 2012, COMPR REV FOOD SCI F, V11, P221, DOI 10.1111/j.1541-4337.2011.00181.x; Campion B, 2009, THEOR APPL GENET, V118, P1211, DOI 10.1007/s00122-009-0975-8; Famine Early Warning Systems Network (FEWS NET), 2015, DEM REP CONG STAPL F; Gibson RS, 2016, FOOD NUTR BULL, V37, P443, DOI 10.1177/0379572116652252; Gibson RS, 2008, INTERACTIVE 24 HOUR; Gorstein J, 2007, INDICATORS METHODS C; Hambidge KM, 2011, INT J VITAM NUTR RES, V81, P72, DOI [10.1024/0300-9831/a000052, 10.1024/0300-9831/a00052]; Harvey-Leeson S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020098; Hotz C., 2012, FOOD COMPOSITION TAB; Hotz C, 2012, J NUTR, V142, P1871, DOI 10.3945/jn.111.151829; Houghton LA, 2016, J NUTR, V146, P1670, DOI 10.3945/jn.116.235127; Institute of Medicine (IOM), 2000, DIET REF INT APPL DI; Iowa State University, 2015, INT MOD ASS PLANN PR; Iowa State University, 2015, PC SOFTW INT DISTR E; Marivoet W, 2019, WORLD DEV, V120, P62, DOI 10.1016/j.worlddev.2019.04.003; Mikobi TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123568; Murphy E., 2015, USAID OFFICE FOOD PE; National Institutes of Health, DIET ASS PRIM 24 HOU; Nusser SM, 1996, SEMIPARAMETRIC TRANS, V91; Petry N, 2016, J NUTR, V146, P970, DOI 10.3945/jn.115.223693; Serpro SA, 2009, CS DIETARY SYSTEM 3; Shim JS, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014009; StataCorp, 2019, STAT REL 16 STAT SOF; Taleon V, 2019, J SCI FOOD AGR, V99, P1434, DOI 10.1002/jsfa.9347; The Ministry of Monitoring Planning and Implementation of the Modern Revolution The Ministry of Public Health ICF International, 2014, DEM REP CONG DEM HLT; USDA, 2016, USDA FOOD COMP DAT; Verbowski V, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12581; WHO, 1998, COMPLEMENTARY FEEDIN; World Health Organization, 2011, SER FERR CONC ASS IR; 2014, REG ANESTH PAIN MED, V9	33	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0223393	10.1371/journal.pone.0223393	http://dx.doi.org/10.1371/journal.pone.0223393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530922	gold, Green Published, Green Submitted			2022-12-26	WOS:000542037200033
J	Nagata, S; Ozawa, F; Nie, MH; Takeuchi, S				Nagata, Shogo; Ozawa, Fumisato; Nie, Minghao; Takeuchi, Shoji			3D culture of functional human iPSC-derived hepatocytes using a core-shell microfiber	PLOS ONE			English	Article							CELL-SURFACE MARKER; LIVER; TRANSPLANTATION; EXPRESSION	Human iPSC-derived hepatocytes hold great promise as a cell source for cell therapy and drug screening. However, the culture method for highly-quantified hepatocytes has not yet been established. Herein, we have developed an encapsulation and 3D cultivation method for iPSC-hepatocytes in core-shell hydrogel microfibers (a.k.a. cell fiber). In the fiber-shaped 3D microenvironment consisting of abundant extracellular matrix (ECM), the iPSC-hepatocytes exhibited many hepatic characteristics, including the albumin secretion, and the expression of the hepatic marker genes (ALB,HNF4 alpha,ASGPR1,CYP2C19, andCYP3A4). Furthermore, we found that the fibers were mechanically stable and can be applicable to hepatocyte transplantation. Three days after transplantation of the microfibers into the abdominal cavity of immunodeficient mice, human albumin was detected in the peripheral blood of the transplanted mice. These results indicate that the iPSC-hepatocyte fibers are promising either asin vitromodels for drug screening or as implantation grafts to treat liver failure.	[Nagata, Shogo; Ozawa, Fumisato; Takeuchi, Shoji] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Nie, Minghao; Takeuchi, Shoji] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Mechanoinformat, Tokyo, Japan; [Takeuchi, Shoji] Univ Tokyo, Inst Adv Study UTIAS, Int Res Ctr Neurointelligence IRCN, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Takeuchi, S (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.; Takeuchi, S (corresponding author), Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Mechanoinformat, Tokyo, Japan.; Takeuchi, S (corresponding author), Univ Tokyo, Inst Adv Study UTIAS, Int Res Ctr Neurointelligence IRCN, Tokyo, Japan.	takeuchi@iis.u-tokyo.ac.jp	Nie, Minghao/AAT-4363-2021	Nie, Minghao/0000-0003-3836-6318; Takeuchi, Shoji/0000-0001-6946-0409	JSPS KAKENHI [16H06329]; Japan Agency for Medical Research and Development (AMED), Research Center Network for Realization of Regenerative Medicine [16bm0304005h0004, 18bm0404021h0001]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED), Research Center Network for Realization of Regenerative Medicine	S.N. is partly supported by JSPS KAKENHI (https://www.jsps.go.jp/j-grantsinaid/12_ kiban/index.html, Grant Number 16H06329), and the Japan Agency for Medical Research and Development (AMED), Research Center Network for Realization of Regenerative Medicine (https://www.amed.go.jp/program/list/01/02/001.html, 16bm0304005h0004 and 18bm0404021h0001).	[Anonymous], 2011, THER ADV MED ONCOL, V3, pS7; Bell CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25187; Borlak J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124867; Couvelard A, 1998, HEPATOLOGY, V27, P839, DOI 10.1002/hep.510270328; Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; Fitzpatrick E, 2009, J INTERN MED, V266, P339, DOI 10.1111/j.1365-2796.2009.02152.x; Goldman O, 2016, CELL STEM CELL, V18, P703, DOI 10.1016/j.stem.2016.05.019; Iansante V, 2018, PEDIATR RES, V83, P232, DOI 10.1038/pr.2017.284; Kido T, 2015, STEM CELL REP, V5, P508, DOI 10.1016/j.stemcr.2015.08.008; Kim JH, 2016, TOXICOL SCI, V149, P269, DOI 10.1093/toxsci/kfv248; Meyburg J, 2009, TRANSPLANTATION, V87, P636, DOI 10.1097/TP.0b013e318199936a; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Onoe H, 2013, NAT MATER, V12, P584, DOI [10.1038/NMAT3606, 10.1038/nmat3606]; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Peters DT, 2016, DEVELOPMENT, V143, P1475, DOI 10.1242/dev.132209; Pujan DK, 2017, INT J MOL SCI, V18, P1085; Rapisarda V, 2017, CELL REP, V18, P2480, DOI 10.1016/j.celrep.2017.02.012; Sgroi A, 2011, CELL TRANSPLANT, V20, P1791, DOI 10.3727/096368911X564976; Smets FN, 2002, MOL GENET METAB, V75, P344, DOI 10.1016/S1096-7192(02)00004-5; Song W, 2015, SCI REP-UK, V5, DOI 10.1038/srep16884; Takayama K, 2013, BIOMATERIALS, V34, P1781, DOI 10.1016/j.biomaterials.2012.11.029; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Toivonen S, 2016, TISSUE ENG PT A, V22, P971, DOI [10.1089/ten.tea.2016.0127, 10.1089/ten.TEA.2016.0127]; Wang B, 2016, STEM CELL TRANSL MED, V5, P1257, DOI 10.5966/sctm.2015-0235; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37427; Yoon SM, 2011, HEPATOLOGY, V53, P964, DOI 10.1002/hep.24122	27	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234441	10.1371/journal.pone.0234441	http://dx.doi.org/10.1371/journal.pone.0234441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525941	Green Published, gold			2022-12-26	WOS:000542036800046
J	Kozlov, G; Funato, Y; Chen, YS; Zhang, ZD; Illes, K; Miki, H; Gehring, K				Kozlov, Guennadi; Funato, Yosuke; Chen, Yu Seby; Zhang, Zhidian; Illes, Katalin; Miki, Hiroaki; Gehring, Kalle			PRL3 pseudophosphatase activity is necessary and sufficient to promote metastatic growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophosphorylation; magnesium; metastasis; cancer; phosphocysteine; cysteine phosphorylation; protein phosphatase; dual-specificity phosphoprotein phosphatase; pseudophosphatase; pseudoenzyme	PROTEIN-TYROSINE-PHOSPHATASE; CONE-ROD DYSTROPHY; REGENERATING LIVER; MAGNESIUM; DIFFERENTIATION; THIENOPYRIDONE; PRENYLATION; INHIBITION; MUTATIONS; MECHANISM	Phosphatases of regenerating liver (PRLs) are markers of cancer and promote tumor growth. They have been implicated in a variety of biochemical pathways but the physiologically relevant target of phosphatase activity has eluded 20 years of investigation. Here, we show that PRL3 catalytic activity is not required in a mouse model of metastasis. PRL3 binds and inhibits CNNM4, a membrane protein associated with magnesium transport. Analysis of PRL3 mutants specifically defective in either CNNM-binding or phosphatase activity demonstrate that CNNM binding is necessary and sufficient to promote tumor metastasis. As PRLs do have phosphatase activity, they are in factpseudo-pseudophosphatases. Phosphatase activity leads to formation of phosphocysteine, which blocks CNNM binding and may play a regulatory role. We show levels of PRL cysteine phosphorylation vary in response to culture conditions and in different tissues. Examination of related protein phosphatases shows the stability of phosphocysteine is a unique and evolutionarily conserved property of PRLs. The demonstration that PRL3 functions as a pseudophosphatase has important ramifications for the design of PRL inhibitors for cancer.	[Kozlov, Guennadi; Chen, Yu Seby; Zhang, Zhidian; Illes, Katalin; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Kozlov, Guennadi; Chen, Yu Seby; Zhang, Zhidian; Illes, Katalin; Gehring, Kalle] McGill Univ, Ctr Rech Biol Struct, Montreal, PQ, Canada; [Funato, Yosuke; Miki, Hiroaki] Osaka Univ, Res Inst Microbial Dis, Dept Cellular Regulat, Suita, Osaka, Japan	McGill University; McGill University; Osaka University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.; Gehring, K (corresponding author), McGill Univ, Ctr Rech Biol Struct, Montreal, PQ, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013	Gehring, Kalle/0000-0001-6500-1184; Chen, Yu/0000-0002-0793-2391	National Science Foundation Award [DMR-0225180]; National Institutes of Health, NCRR Grant [RR-01646]	National Science Foundation Award(National Science Foundation (NSF)); National Institutes of Health, NCRR Grant	We thank Nassima Fodil (Gros laboratory) and Sebastien Tabaries (Siegel laboratory) for assistance with the mouse tissues. Crystallographic data were acquired at the Canadian Light Source (CLS) and at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source (CHESS). CHESS is supported by National Science Foundation Award DMR-0225180 and National Institutes of Health, NCRR Grant RR-01646.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Aidaroos AQO, 2010, J CELL BIOCHEM, V111, P1087, DOI 10.1002/jcb.22913; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Bai YP, 2016, CANCER RES, V76, P4805, DOI 10.1158/0008-5472.CAN-15-2323; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Cates CA, 1996, CANCER LETT, V110, P49, DOI 10.1016/S0304-3835(96)04459-X; Chen MJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag1796; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Diamond RH, 1996, AM J PHYSIOL-GASTR L, V271, pG121, DOI 10.1152/ajpgi.1996.271.1.G121; Duciel L, 2019, J MOL BIOL, V431, P3056, DOI 10.1016/j.jmb.2019.06.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frankson R, 2017, CANCER RES, V77, P5701, DOI 10.1158/0008-5472.CAN-17-1510; Funato Y, 2019, J BIOCHEM, V165, P219, DOI 10.1093/jb/mvy095; Funato Y, 2017, J HYPERTENS, V35, P585, DOI 10.1097/HJH.0000000000001211; Funato Y, 2014, J CLIN INVEST, V124, P5398, DOI 10.1172/JCI76614; Funato Y, 2014, METHODS, V65, P184, DOI 10.1016/j.ymeth.2013.06.032; Gimenez-Mascarell P, 2017, J BIOL CHEM, V292, P786, DOI 10.1074/jbc.M116.759944; GUAN KL, 1991, J BIOL CHEM, V266, P17026; Gulerez I, 2016, EMBO REP, V17, P1890, DOI 10.15252/embr.201643393; Guo PF, 2019, ISCIENCE, V19, P291, DOI 10.1016/j.isci.2019.07.026; Hardy S, 2015, ONCOGENE, V34, P986, DOI 10.1038/onc.2014.33; Hardy S, 2019, P NATL ACAD SCI USA, V116, P2925, DOI 10.1073/pnas.1815361116; Hashizume O, 2020, ANTIOXID REDOX SIGN, V33, P20, DOI 10.1089/ars.2019.7951; Hirata Y, 2014, J BIOL CHEM, V289, P14731, DOI 10.1074/jbc.M114.551176; Ishii T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006276; Jeong DG, 2005, J MOL BIOL, V345, P401, DOI 10.1016/j.jmb.2004.10.061; Kim SH, 2009, ONCOL RES, V17, P601, DOI 10.3727/096504009789745494; Kozlov G, 2004, J BIOL CHEM, V279, P11882, DOI 10.1074/jbc.M312905200; Lazo JS, 2019, J PHARMACOL EXP THER, V371, P652, DOI 10.1124/jpet.119.262188; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Peters GH, 1998, BIOCHEMISTRY-US, V37, P5383, DOI 10.1021/bi971187i; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; Qian F, 2007, MOL MED, V13, P151, DOI 10.2119/2006-00076.Qian; Reiterer V, 2014, TRENDS CELL BIOL, V24, P489, DOI 10.1016/j.tcb.2014.03.008; RUBIN H, 1975, P NATL ACAD SCI USA, V72, P3551, DOI 10.1073/pnas.72.9.3551; Rubio T, 2016, BIOCHEM SOC T, V44, P1305, DOI 10.1042/BST20160146; Sacchetti C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01168-1; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Salamoun JM, 2016, ORG BIOMOL CHEM, V14, P6398, DOI 10.1039/c6ob00946h; Skinner AL, 2009, BIOCHEMISTRY-US, V48, P4262, DOI 10.1021/bi900241k; Stanford SM, 2017, TRENDS PHARMACOL SCI, V38, P524, DOI 10.1016/j.tips.2017.03.004; Stanford SM, 2017, NAT CHEM BIOL, V13, P624, DOI 10.1038/nchembio.2344; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Sun JP, 2005, BIOCHEMISTRY-US, V44, P12009, DOI 10.1021/bi0509191; Thura M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10127-x; Wu XP, 2004, AM J PATHOL, V164, P2039, DOI 10.1016/S0002-9440(10)63763-7; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Yamazaki D, 2016, J CELL SCI, V129, P1940, DOI 10.1242/jcs.182220; Yamazaki D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003983; Yoshida A, 2018, BIOCHEM J, V475, P1129, DOI 10.1042/BCJ20170756; Yu ZH, 2018, CHEM REV, V118, P193, DOI 10.1021/acs.chemrev.7b00105; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zeng Q, 2003, CANCER RES, V63, P2716; Zeng Q, 1998, BIOCHEM BIOPH RES CO, V244, P421, DOI 10.1006/bbrc.1998.8291; Zhang HZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00147-2; Zhang ZD, 2019, MEDCHEMCOMM, V10, P791, DOI 10.1039/c9md00175a; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012; ZHANG ZY, 1994, P NATL ACAD SCI USA, V91, P1624, DOI 10.1073/pnas.91.5.1624	61	12	12	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11682	11692		10.1074/jbc.RA120.014464	http://dx.doi.org/10.1074/jbc.RA120.014464			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32571875	Green Published, hybrid			2022-12-26	WOS:000563922500025
J	do Nascimento, LM; Terrao, M; Marucha, KK; Liu, B; Egler, F; Clayton, C				Melo do Nascimento, Larissa; Terrao, Monica; Marucha, Kevin Kamanyi; Liu, Bin; Egler, Franziska; Clayton, Christine			The RNA-associated proteins MKT1 and MKT1L form alternative PBP1-containing complexes inTrypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Trypanosoma brucei; mRNA; ataxia telangiectasia; ataxin-2; ribonuclear protein (RNP); eukaryotic translation initiation factor 4E (eIF4E); eukaryotic translation initiation factor 4G (eIF4G); MKT1; ataxia telangiectasia	TRYPANOSOMA-BRUCEI; POSTTRANSCRIPTIONAL REGULATION; BINDING-PROTEIN; MESSENGER-RNAS; WIDE ANALYSIS; EXPRESSION; GENOME; GENES; IDENTIFICATION; ADAPTATION	Control of gene expression in kinetoplastids such as trypanosomes depends heavily on RNA-binding proteins that influence mRNA decay and translation. We previously showed that the trypanosome protein MKT1 forms a multicomponent protein complex: MKT1 interacts with PBP1, which in turn recruits LSM12 and poly(A)-binding protein. MKT1 is recruited to mRNAs by sequence-specific RNA-binding proteins, resulting in stabilization of the bound mRNA. We here show that PBP1, LSM12, and a 117-residue protein, XAC1 (Tb927.7.2780), are present in complexes that contain either MKT1 or an MKT1-like protein, MKT1L (Tb927.10.1490). All five proteins are present predominantly in the complexes, and we found evidence for a minor subset of complexes containing both MKT1 and MKT1L. XAC1-containing complexes reproducibly contained RNA-binding proteins that were previously found associated with MKT1. Moreover, XAC1- or MKT1-containing complexes specifically recruited one of the two poly(A)-binding proteins, PABP2, and one of the six cap-binding translation initiation complexes, EIF4E6-EIF4G5. Yeast two-hybrid assay results indicated that MKT1 directly interacts with EIF4G5. MKT1-PBP1 complexes can therefore interact with mRNAs via their poly(A) tails and caps, as well as through sequence-specific RNA-binding proteins. Correspondingly, MKT1 is associated with many mRNAs, although not with those encoding ribosomal proteins. Meanwhile, MKT1L resembles MKT1 at the C terminus but additionally features an N-terminal extension with low-complexity regions. Although MKT1L depletion inhibited cell proliferation, we found no evidence that it specifically interacts with RNA-binding proteins or mRNA. We speculate that MKT1L may compete with MKT1 for PBP1 binding and thereby modulate the function of MKT1-containing complexes.	[Melo do Nascimento, Larissa; Terrao, Monica; Marucha, Kevin Kamanyi; Liu, Bin; Egler, Franziska; Clayton, Christine] Heidelberg Univ, Ctr Mol Biol ZMBH, Heidelberg, Germany; [Terrao, Monica] CSL Behring, Marburg, Germany; [Marucha, Kevin Kamanyi] Kisii Univ, Dept Med Biochem, Kisii, Kenya; [Liu, Bin] Hebei Viroad Biotechnol Co Ltd, Shijiazhuang, Hebei, Peoples R China	Ruprecht Karls University Heidelberg; CSL	Clayton, C (corresponding author), Heidelberg Univ, Ctr Mol Biol ZMBH, Heidelberg, Germany.	cclayton@zmbh.uni-heidelberg.de		Marucha, Kevin/0000-0003-1438-2735; Melo do Nascimento, Larissa/0000-0003-4359-3558; Clayton, Christine/0000-0002-6384-0731	Deutsche Forschungsgemeinschaft [Cl112/17-2]; State of Baden-Wurttemberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); State of Baden-Wurttemberg	This work was supported by Deutsche Forschungsgemeinschaft Grant Cl112/17-2 (to C. C.) and by core support from the State of Baden-Wurttemberg. B. L. was supported in part by a Humboldt stipend, and F. E. received a stipend from the Heidelberg Biosciences Graduate School (HBIGS).	Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Antwi EB, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2624-3; Archer SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000565; Ben-Ari G, 2006, PLOS GENET, V2, P1815, DOI 10.1371/journal.pgen.0020195; Benz C, 2007, MOL BIOCHEM PARASIT, V156, P217, DOI 10.1016/j.molbiopara.2007.08.005; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Clayton CE, 1999, PARASITOL TODAY, V15, P372, DOI 10.1016/S0169-4758(99)01498-2; Clayton C, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190072; Coller J, 2002, METHODS, V26, P142, DOI 10.1016/S1046-2023(02)00016-6; Coller JM, 1998, GENE DEV, V12, P3226, DOI 10.1101/gad.12.20.3226; Das A, 2015, MOL BIOCHEM PARASIT, V199, P1, DOI 10.1016/j.molbiopara.2015.02.003; Dean S, 2017, TRENDS PARASITOL, V33, P80, DOI 10.1016/j.pt.2016.10.009; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; Dejung M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005439; Delhi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025112; Demogines A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000123; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497; Droll D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003286; Erben ED, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004178; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Fadda A, 2014, MOL MICROBIOL, V94, P307, DOI 10.1111/mmi.12764; Fernandez-Moya SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048870; Freire ER, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6040055; Freire ER, 2014, RNA, V20, P1272, DOI 10.1261/rna.045534.114; Freire ER, 2014, EUKARYOT CELL, V13, P896, DOI 10.1128/EC.00071-14; Gou LK, 2019, GENETICS, V211, P731, DOI 10.1534/genetics.118.301609; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Gupta S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005195; Jeacock L, 2018, ELIFE, V7, DOI [10.7554/eLife.32496, 10.7554/elife.32496]; Jensen BC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-911; Khong A, 2020, RNA, V26, P229, DOI 10.1261/rna.073601.119; Klein C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177901; Klein C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135973; Kohn LM, 2014, EUKARYOT CELL, V13, P1200, DOI 10.1128/EC.00122-14; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee J, 2017, MOL CELL, V66, P129, DOI 10.1016/j.molcel.2017.03.004; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Ling AS, 2011, J BIOL CHEM, V286, P20152, DOI 10.1074/jbc.M110.139261; Liu B, 2020, MOL MICROBIOL, V113, P430, DOI 10.1111/mmi.14429; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lueong S, 2016, MOL MICROBIOL, V100, P457, DOI 10.1111/mmi.13328; Michaeli S, 2011, FUTURE MICROBIOL, V6, P459, DOI [10.2217/fmb.11.20, 10.2217/FMB.11.20]; Minia I, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004982; Muller LSM, 2018, NATURE, V563, P121, DOI 10.1038/s41586-018-0619-8; Mugo E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006560; Nascimento JD, 2018, ELIFE, V7, DOI 10.7554/eLife.32467; Ostrowski LA, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060157; Parreiras LS, 2011, EUKARYOT CELL, V10, P1348, DOI 10.1128/EC.05083-11; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Savage AF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168877; Shen SY, 2001, MOL BIOCHEM PARASIT, V113, P171, DOI 10.1016/S0166-6851(00)00383-2; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Silva AL, 2008, RNA, V14, P563, DOI 10.1261/rna.815108; Singh A, 2014, NUCLEIC ACIDS RES, V42, P4652, DOI 10.1093/nar/gkt1416; Sinha H, 2006, PLOS GENET, V2, P140, DOI 10.1371/journal.pgen.0020013; Stern MZ, 2009, RNA, V15, P648, DOI 10.1261/rna.1230209; Swinnen S, 2012, GENOME RES, V22, P975, DOI 10.1101/gr.131698.111; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Tadauchi T, 2004, MOL CELL BIOL, V24, P3670, DOI 10.1128/MCB.24.9.3670-3681.2004; Tschudi C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-427; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vasquez JJ, 2014, NUCLEIC ACIDS RES, V42, P3623, DOI 10.1093/nar/gkt1386; Vigneron A, 2020, P NATL ACAD SCI USA, V117, P2613, DOI 10.1073/pnas.1914423117; Voncken F, 2003, J BIOL CHEM, V278, P35299, DOI 10.1074/jbc.M301811200; Wedel C, 2017, EMBO J, V36, P2581, DOI 10.15252/embj.201695323; Wippel HH, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1505-8; Zoltner M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006679	70	9	15	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					10940	10955		10.1074/jbc.RA120.013306	http://dx.doi.org/10.1074/jbc.RA120.013306			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32532821	hybrid, Green Published			2022-12-26	WOS:000562757100006
J	Hatsuda, Y; Ishizaka, T; Koizumi, N; Yasui, Y; Saito, T; Maki, S; Omotani, S; Mukai, J; Tachi, T; Teramachi, H; Myotoku, M				Hatsuda, Yasutoshi; Ishizaka, Toshihiko; Koizumi, Naonori; Yasui, Yukako; Saito, Takako; Maki, Syou; Omotani, Sachiko; Mukai, Junji; Tachi, Tomoya; Teramachi, Hitomi; Myotoku, Michiaki			Influence of analysis conditions for antimicrobial susceptibility test data on susceptibility rates	PLOS ONE			English	Article							ANTIBIOGRAM	Background To support effective antibiotic selection in empirical treatments, infection control interventions, and antimicrobial resistance containment strategies, many medical institutions collect antimicrobial susceptibility test data conducted at their facilities to prepare cumulative antibiograms. Aim To evaluate how the setpoints of duplicate isolate removal period and data collection period affect the calculated susceptibility rates in antibiograms. Methods The Sakai City Medical Center is a regional core hospital for tertiary emergency medical care with 480 beds for general clinical care. In this study, all thePseudomonas aeruginosa,Escherichia coli, andKlebsiella pneumoniaeisolates collected at the Sakai City Medical Center Clinical Laboratory between July 2013 and December 2018 were subjected to antimicrobial susceptibility tests and the resulting data was analyzed. Findings The longer the duplicate isolate removal period, the fewer the isolates are available for every bacterial species. Differences in the length of the duplicate isolate removal period affectedP.aeruginosasusceptibility rates to beta-lactam antibiotics by up to 10.8%. The setpoint of the data collection period affected the antimicrobial susceptibility rates by up to 7.3%. We found that a significant change in susceptibility could be missed depending on the setting of the data collection period, in preparing antibiogram of beta-lactam antibiotics forP.aeruginosa. Conclusions When referring to antibiograms, medical professionals involved in infectious disease treatment should be aware that the parameter values, such as the duplicate isolate removal period and the data collection period, affectP.aeruginosasusceptibility rates especially to beta-lactam antibiotics. And antibiogram should be updated within the shortest time period that is practically possible, taking into account restrictions such as numbers of specimen.	[Hatsuda, Yasutoshi; Maki, Syou; Omotani, Sachiko; Mukai, Junji; Myotoku, Michiaki] Osaka Ohtani Univ, Fac Pharm, Tondabayashi, Osaka, Japan; [Ishizaka, Toshihiko; Koizumi, Naonori; Yasui, Yukako; Saito, Takako; Omotani, Sachiko] Sakai City Med Ctr, Sakai, Osaka, Japan; [Tachi, Tomoya; Teramachi, Hitomi] Gifu Pharmaceut Univ, Gifu, Gifu, Japan	Gifu Pharmaceutical University	Hatsuda, Y (corresponding author), Osaka Ohtani Univ, Fac Pharm, Tondabayashi, Osaka, Japan.	hatuday@osaka-ohtani.ac.jp	Tachi, Tomoya/AAM-8441-2020	Tachi, Tomoya/0000-0002-5380-0218				CLSI, 2014, M39A4 CLSI, VFourth; CLSI, 2016, M100S CLSI, V26th; Hindler JF, 2007, CLIN INFECT DIS, V44, P867, DOI 10.1086/511864; Ishimaki, 2019, INT J BIOMEDICAL SOF, V24, P39; Joshi S, 2010, INDIAN J MED MICROBI, V28, P277, DOI 10.4103/0255-0857.71802; Kohlmann R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147965; Lax S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6500; Moehring RW, 2015, J CLIN MICROBIOL, V53, P2977, DOI 10.1128/JCM.01077-15; Mulvey MR, 2009, CAN MED ASSOC J, V180, P408, DOI 10.1503/cmaj.080239; Simpao AF, 2018, APPL CLIN INFORM, V9, DOI 10.1055/s-0037-1615787; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1	11	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235059	10.1371/journal.pone.0235059	http://dx.doi.org/10.1371/journal.pone.0235059			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574199	Green Published, gold			2022-12-26	WOS:000544972400034
J	Deng, GY; Yue, XF; Miao, L; Lu, FY				Deng, Guangyao; Yue, Xiaofang; Miao, Lu; Lu, Fengying			Identification of key sectors of water resource utilization in China from the perspective of water footprint	PLOS ONE			English	Article							DECOMPOSITION ANALYSIS; ECONOMIC-GROWTH; OUTPUT; TRADE; CONSUMPTION; EFFICIENCY; EMISSIONS; ENERGY; CARBON; RIVER	We identified the key sectors of water resource use in China from the perspective of the water footprint to improve the use of water resources. The empirical results showed that there were six key sectors (including Crop Cultivation; Forestry; Livestock and Livestock Products; Fishery, Technical Services for Agriculture, Forestry, Livestock and Fishing; Other Food Products, and Scrap and Waste) for water consumption in China in 2015.We analyzed the use of green water, blue water, and grey water. These six sectors accounted for 66.15% of the total impact and 90.76% of the direct impact. Seven key sectors (the six sectors above plus Steel Processing)for the consumption of blue water in China can explain 59.70% of the total impact and 86.94% of the direct effect in 2015. Eight key sectors (Crop cultivation, Other food products, Scrap and Waste, Railway Freight Transport, Highway Freight and Passengers Transport, Water Freight and Passengers Transport, Pipeline Transport, and Health Services) responsible for the consumption of grey water in China in 2015 can explain 81.28% of the total impact and 95.73% of the direct impact. Therefore, the Chinese government should focus on the departments that manage water resources in these sectors when designing water-saving policies and improving water-use efficiency, such as promoting water-saving irrigation technology (including sprinkler irrigation and drip irrigation) in the agricultural sector.	[Deng, Guangyao; Lu, Fengying] Lanzhou Univ Finance & Econ, Sch Stat, Lanzhou, Peoples R China; [Yue, Xiaofang; Miao, Lu] Shenzhen Univ, China Ctr Special Econ Zone Res, Shenzhen, Peoples R China	Lanzhou University of Finance & Economics; Shenzhen University	Yue, XF (corresponding author), Shenzhen Univ, China Ctr Special Econ Zone Res, Shenzhen, Peoples R China.	harborangel@163.com	Miao, Lu/GNH-1924-2022	Miao, Lu/0000-0002-6468-4195	Natural Science Foundation of China [71704070]; Ministry of Education for the Humanities and Social Sciences Research Young Fund on the West and Borderland Project [17XJC790002]; Guangdong Provincial Natural Science Foundation of China [2017A030313443]; Program of Lanzhou University of Finance and Economics [Lzufe2018B-06]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education for the Humanities and Social Sciences Research Young Fund on the West and Borderland Project; Guangdong Provincial Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Program of Lanzhou University of Finance and Economics	This work was supported by the Natural Science Foundation of China under Grant [number 71704070]; Ministry of Education for the Humanities and Social Sciences Research Young Fund on the West and Borderland Project [number 17XJC790002]; Guangdong Provincial Natural Science Foundation of China under Grant [number 2017A030313443];and Program of Lanzhou University of Finance and Economics under Grant [number Lzufe2018B-06].	Alcantara V, 2003, ENERG POLICY, V31, P1673, DOI 10.1016/S0301-4215(02)00233-1; Alcantara V., 2006, WORKING PAPERS; Allan J., 1993, PRIORITIES WATER RES; [Anonymous], 2016, REV CAMBIOS PERMANEN, V7, P113; Antonelli M, 2012, WATER RESOUR MANAG, V26, P4133, DOI 10.1007/s11269-012-0135-9; Chen WM, 2017, ECOL INDIC, V74, P321, DOI 10.1016/j.ecolind.2016.11.037; Deng GY, 2018, ECOL INDIC, V93, P1302, DOI 10.1016/j.ecolind.2018.06.019; Deng GY, 2016, J CLEAN PROD, V112, P4674, DOI 10.1016/j.jclepro.2015.07.129; Deng GY, 2015, WATER RESOUR MANAG, V29, P2947, DOI 10.1007/s11269-015-0980-4; Hirschman A., 1958, STRATEGY EC DEV; Hoekstra A.Y., 2011, WATER FOOTPRINT ASSE, DOI DOI 10.1080/0969160X.2011.593864; Hoekstra AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032688; Hou SY, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10082822; Huang HP, 2018, WATER-SUI, V10, DOI 10.3390/w10111664; Huang Y, 2017, WATER POLICY, V19, P197, DOI 10.2166/wp.2016.002; Lenzen M, 2013, ECON SYST RES, V25, P20, DOI 10.1080/09535314.2013.769938; Lenzen M, 2012, ENVIRON SCI TECHNOL, V46, P8374, DOI 10.1021/es300171x; Long HY, 2019, SCI TOTAL ENVIRON, V690, P1321, DOI 10.1016/j.scitotenv.2019.06.311; Long XL, 2018, ENVIRON SCI POLLUT R, V25, P13093, DOI 10.1007/s11356-018-1549-6; Long XL, 2015, RENEW SUST ENERG REV, V52, P680, DOI 10.1016/j.rser.2015.07.176; Long XL, 2015, ENERG POLICY, V81, P61, DOI 10.1016/j.enpol.2015.02.012; Long XL, 2013, J CLEAN PROD, V39, P161, DOI 10.1016/j.jclepro.2012.08.005; Lu SB, 2020, ENVIRON GEOCHEM HLTH, V42, P863, DOI 10.1007/s10653-019-00315-5; Luo YS, 2017, J CLEAN PROD, V159, P220, DOI 10.1016/j.jclepro.2017.05.076; Metulini R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153982; Okadera T, 2014, ECON SYST RES, V26, P444, DOI 10.1080/09535314.2014.934324; Rasmusen P, 1956, STUDIES INTERSECTORA; Salman M, 2019, SCI TOTAL ENVIRON, V686, P1019, DOI 10.1016/j.scitotenv.2019.06.019; Schyns JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099705; Steen-Olsen K, 2012, ENVIRON SCI TECHNOL, V46, P10883, DOI 10.1021/es301949t; Wahba SM, 2018, J CLEAN PROD, V198, P1526, DOI 10.1016/j.jclepro.2018.06.266; Wang HX, 2018, WATER-SUI, V10, DOI [10.3390/w10040494, 10.3390/w1004]; Wang XM, 2016, ECOL INDIC, V69, P26, DOI 10.1016/j.ecolind.2016.03.029; Wang ZY, 2013, J CLEAN PROD, V42, P172, DOI 10.1016/j.jclepro.2012.11.007; Winter JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093084; Xu M, 2018, J CLEAN PROD, V176, P1283, DOI 10.1016/j.jclepro.2017.11.203; Zhang C, 2014, ECOL ECON, V100, P159, DOI 10.1016/j.ecolecon.2014.02.006; Zhang Y, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0315-9; ZHANG YY, 2019, WATER-SUI, V11, DOI DOI 10.3390/W11010034; Zhao DD, 2017, J CLEAN PROD, V167, P919, DOI 10.1016/j.jclepro.2017.07.012; Zhao X, 2009, ECOL MODEL, V220, P245, DOI 10.1016/j.ecolmodel.2008.09.016; Zhi Y, 2014, HYDROL EARTH SYST SC, V18, P1549, DOI 10.5194/hess-18-1549-2014	42	2	2	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234307	10.1371/journal.pone.0234307	http://dx.doi.org/10.1371/journal.pone.0234307			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569328	Green Published, gold			2022-12-26	WOS:000543547900052
J	Grundel, R; Dulin, GS; Pavlovic, NB				Grundel, Ralph; Dulin, Gary S.; Pavlovic, Noel B.			Changes in conservation value from grasslands to savannas to forests: How a temperate canopy cover gradient affects butterfly community composition	PLOS ONE			English	Article							HABITAT STRUCTURE; OAK SAVANNAS; MANAGEMENT; DIVERSITY; BIODIVERSITY; RESTORATION; ABANDONMENT; RESOURCES; WOODLANDS; ABUNDANCE	Temperate savannas and grasslands are globally threatened. In the Midwest United States of America (USA), for example, oak savannas persist today at a small percentage of recent historic coverage. Therefore, restoration of habitats of low and intermediate canopy cover is a landscape conservation priority that often emphasizes returning tree density to a savanna-like target value. Understanding how animal species react to such changes in vegetation structure is important for assessing the value of these restoration plans. We examined how butterfly community attributes in northwest Indiana USA, including community composition, richness, and abundance responded to a grassland-to-forest gradient of canopy cover. Butterfly community composition under intermediate canopy cover differed significantly from community composition in the most open or closed-canopy habitats. Composition of the plant community in flower was a significant predictor of three assessed attributes of the butterfly community-composition, richness, and abundance. Phenology, expressed as day-of-the-year, was also a strong predictor of these butterfly community attributes. Few butterfly species were habitat specialists as adults although canopy cover was a more important predictor of adult community composition than of richness or abundance of butterflies. Therefore, adult butterfly community differences along the canopy cover gradient were less about butterfly communities filled with habitat specialists for different canopy-defined habitats and more about gradual changes in community composition along this gradient. Overall, butterfly community richness was predicted to peak at about 34% canopy cover, butterfly abundance at about 53% canopy cover, community conservation value at about 59% canopy cover, and a combination of desirable conservation attributes-high diversity, high abundance, and high conservation value-was predicted to reach a peak of co-occurrence at about 67% canopy cover suggesting that habitats of intermediate canopy cover might be particularly effective for butterfly conservation in this region.	[Grundel, Ralph; Pavlovic, Noel B.] US Geol Survey, Great Lakes Sci Ctr, Chesterton, IN 46304 USA; [Dulin, Gary S.] Valparaiso Univ, Dept Biol, Valparaiso, IN 46383 USA	United States Department of the Interior; United States Geological Survey; Valparaiso University	Grundel, R (corresponding author), US Geol Survey, Great Lakes Sci Ctr, Chesterton, IN 46304 USA.	rgrundel@usgs.gov		Grundel, Ralph/0000-0002-2949-7087	U.S. Geological Survey's Grassland's Research Initiative	U.S. Geological Survey's Grassland's Research Initiative	This project was supporting by funding from the U.S. Geological Survey's Grassland's Research Initiative to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MD, 2019, ANN FOREST SCI, V76, DOI 10.1007/s13595-018-0790-y; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson RC, 1999, SAVANNAS BARRENS ROC; Anderson Roger C., 1998, Transactions of the Wisconsin Academy of Sciences Arts and Letters, V86, P1; [Anonymous], 2015, PC ORD MULTIVARIATE; [Anonymous], 1989, YALE J CRIT, V3, P103; AUCLAIR AN, 1976, ECOLOGY, V57, P431, DOI 10.2307/1936429; Benes J, 2006, FOREST ECOL MANAG, V237, P353, DOI 10.1016/j.foreco.2006.09.058; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blowes SA, 2019, SCIENCE, V366, P339, DOI 10.1126/science.aaw1620; Broome A, 2011, BIODIVERS CONSERV, V20, P729, DOI 10.1007/s10531-010-9974-y; Brudvig LA, 2017, J APPL ECOL, V54, P1013, DOI 10.1111/1365-2664.12940; Buckland S.T., 2001, pi; Buisson E, 2018, BIOL REV; Capmourteres V, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1476; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Colwell RK, 2013, ESTIMATES STAT ESTIM; De Marco P, 2008, BIOL LETTERS, V4, P577, DOI 10.1098/rsbl.2008.0210; De'ath G, 1999, PLANT ECOL, V144, P191, DOI 10.1023/A:1009763730207; Dey DC, 2017, J FOREST, V115, P202, DOI 10.5849/jof.15-152; Diniz JAF, 2008, GLOBAL ECOL BIOGEOGR, V17, P479, DOI 10.1111/j.1466-8238.2008.00395.x; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elzinga C.L., 1998, 17301 BUR LAND MAN; ESRI, 2016, ARCGIS DESKT VERS 10; Fahey Robert T., 2015, OAK ECOSYSTEMS RECOV; Fartmann T, 2013, BIOL CONSERV, V159, P396, DOI 10.1016/j.biocon.2012.11.024; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grundel R, 1998, OECOLOGIA, V114, P243, DOI 10.1007/s004420050442; Grundel R, 1998, BIOL CONSERV, V85, P47, DOI 10.1016/S0006-3207(97)00165-1; Grundel R, 2008, J APPL ECOL, V45, P315, DOI 10.1111/j.1365-2664.2007.01422.x; Grundel R, 2007, CONDOR, V109, P734, DOI 10.1650/0010-5422(2007)109[734:ROBSDT]2.0.CO;2; Grundel R, 2007, AUK, V124, P969, DOI 10.1642/0004-8038(2007)124[969:DUAVOM]2.0.CO;2; Grundel R, 2007, BIOL CONSERV, V135, P135, DOI 10.1016/j.biocon.2006.10.003; Grundel R, 2015, BIODIVERS CONSERV, V24, P1089, DOI 10.1007/s10531-014-0844-x; Grundel R, 2010, ECOL APPL, V20, P1678, DOI 10.1890/08-1792.1; Hijmans RJ., 2017, DISMO SPECIES DISTRI, V9, P1; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Kleckova I, 2014, J THERM BIOL, V41, P50, DOI 10.1016/j.jtherbio.2014.02.002; Ladwig LM, 2018, ECOL EVOL, V8, P8458, DOI 10.1002/ece3.4251; Lawler JJ, 2015, CONSERV BIOL, V29, P618, DOI 10.1111/cobi.12505; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; McCleery R, 2018, BIOL CONSERV, V226, P54, DOI 10.1016/j.biocon.2018.07.020; Miller LD, 1981, J LEPID SOC; MK Leach, 1995, MIDWEST OAK SAVANNA; Mullerova J, 2015, FOREST ECOL MANAG, V343, P88, DOI 10.1016/j.foreco.2015.02.003; Mullerova J, 2014, FOREST ECOL MANAG, V331, P104, DOI 10.1016/j.foreco.2014.07.032; NatureServe, 2017, NATURESERVE EXPL ONL; Nielsen TF, 2019, ECOL LETT, V22, P1650, DOI 10.1111/ele.13361; NUZZO V A, 1986, Natural Areas Journal, V6, P6; Ogle D.H., 2019, FSA FISHERIES STOCK; Ohwaki A, 2017, EUR J ENTOMOL, V114, P533, DOI 10.14411/eje.2017.068; Patterson TA, 2020, CONSERV SCI PRACT, V2, DOI 10.1111/csp2.147; R Core Team, 2018, R LANG ENV STAT COMP; Ramilo P, 2017, ENVIRON ENTOMOL, V46, P1235, DOI 10.1093/ee/nvx140; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; Sebek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060456; Simpson GL, 2014, COCORRESP COCORRESPO; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Stuhldreher G, 2018, ECOL INDIC, V94, P83, DOI 10.1016/j.ecolind.2018.06.043; Systat Software Inc, 2008, SIGMAPLOT V 11 2; ter Braak CJF, 2004, ECOLOGY, V85, P834, DOI 10.1890/03-0021; Thomas M, 2009, J HOMEL SECUR EMERG, V6; Touboul JD, 2018, P NATL ACAD SCI USA, V115, pE1336, DOI 10.1073/pnas.1712356115; Transeau EN, 1935, ECOLOGY, V16, P423, DOI 10.2307/1930078; Tulowiecki SJ, 2020, ANN AM ASSOC GEOGR, V110, P184, DOI 10.1080/24694452.2019.1629871; Ubach A, 2020, INSECT CONSERV DIVER, V13, P151, DOI 10.1111/icad.12397; Verdasca MJ, 2012, BIOL CONSERV, V146, P14, DOI 10.1016/j.biocon.2011.10.031; Walsh C., 2011, PCURVE PRINCIPAL CUR; Weerakoon B. M. B., 2015, Journal of Tropical Forestry and Environment, V5, P41; WIKLUND C, 1977, OIKOS, V28, P56, DOI 10.2307/3543323; Wilcox CA, 2005, AM MIDL NAT, V154, P11, DOI 10.1674/0003-0031(2005)154[0011:ROBOQV]2.0.CO;2	76	2	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234139	10.1371/journal.pone.0234139	http://dx.doi.org/10.1371/journal.pone.0234139			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559760	Green Published, gold			2022-12-26	WOS:000543261600044
J	Korth, B; Kretzschmar, J; Bartz, M; Kuchenbuch, A; Harnisch, F				Korth, Benjamin; Kretzschmar, Joerg; Bartz, Manuel; Kuchenbuch, Anne; Harnisch, Falk			Determining incremental coulombic efficiency and physiological parameters of early stage Geobacter spp. enrichment biofilms	PLOS ONE			English	Article							MICROBIAL FUEL-CELLS; ANODIC ELECTRON-TRANSFER; ACETATE OXIDATION; SULFATE REDUCERS; SP-NOV; SULFURREDUCENS; TRANSPORT; REDUCTION; PERFORMANCE; GROWTH	Geobacterspp. enrichment biofilms were cultivated in batch using one-chamber and two-chamber bioelectrochemical reactors. Time-resolved substrate quantification was performed to derive physiological parameters as well as incremental coulombic efficiency (i.e., coulombic efficiency during one batch cycle, here every 6h) during early stage biofilm development. The results of one-chamber reactors revealed an intermediate acetate increase putatively due to the presence of acetogens. Total coulombic efficiencies of two-chamber reactors were considerable lower (19.6 +/- 8.3% and 49.3 +/- 13.2% for 1(st)and 2(nd)batch cycle, respectively) compared to usually reported values of matureGeobacterspp. enrichment biofilms presumably reflecting energetic requirements for biomass production (i.e., cells and extracellular polymeric substances) during early stages of biofilm development. The incremental coulombic efficiency exhibits considerable changes during batch cycles indicating shifts between phases of maximizing metabolic rates and maximizing biomass yield. Analysis based on Michaelis-Menten kinetics yielded maximum substrate uptake rates (v(max,Ac),v(max,I)) and half-saturation concentration coefficients (K-M,K-Ac,K-M,K-I) based on acetate uptake or current production, respectively. The latter is usually reported in literature but neglects energy demands for biofilm growth and maintenance as well as acetate and electron storage. From 1(st)to 2(nd)batch cycle,v(max,Ac)andK(M,Ac), decreased from 0.0042-0.0051 mmol Ac(-)h(-1)cm(-2)to 0.0031-0.0037 mmol Ac(-)h(-1)cm(-2)and 1.02-2.61 mM Ac(-)to 0.28-0.42 mM Ac-, respectively. Furthermore, differences betweenK(M,Ac)/K(M,I)andv(max,Ac)/v(max,I)were observed providing insights into the physiology ofGeobacterspp. enrichment biofilms. Notably,K(M,I)considerably scattered whilev(max,Ac)/v(max,I)andK(M,Ac)remained rather stable indicating that acetate transport within biofilm only marginally affects reaction rates. The observed data variation mandates the requirement of a more detailed analysis with an improved experimental system, e.g., using flow conditions and a comparison withGeobacterspp. pure cultures.	[Korth, Benjamin; Bartz, Manuel; Kuchenbuch, Anne; Harnisch, Falk] UFZ Helmholtz Ctr Environm Res, Dept Environm Microbiol, Leipzig, Germany; [Kretzschmar, Joerg] DBFZ Deutsch Biomasseforschungszentrum Gemeinnutz, Biochem Convers Dept, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Harnisch, F (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Environm Microbiol, Leipzig, Germany.	falk.harnisch@ufz.de	Harnisch, Falk/J-5888-2012; Korth, Benjamin/E-1291-2015; Kretzschmar, Jörg JK/M-5672-2016	Harnisch, Falk/0000-0002-0014-4640; Korth, Benjamin/0000-0002-5105-2439; Kretzschmar, Jörg JK/0000-0001-5970-6399; Kuchenbuch, Anne/0000-0002-6287-1974	Helmholtz Association within the Research Program Renewable Energies; German ministry of economy affairs and energy within the research program "Biomass Energy Use" [03KB115]	Helmholtz Association within the Research Program Renewable Energies; German ministry of economy affairs and energy within the research program "Biomass Energy Use"	This work was supported by the Helmholtz Association within the Research Program Renewable Energies. JK gratefully acknowledges funding by the German ministry of economy affairs and energy within the research program "Biomass Energy Use" (Project "OptiMand", Project ID 03KB115). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, J CLIN GASTROENTE S1, V48, pS96; [Anonymous], 2019, FRONTIERS PLANT SCI; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Baudler A, 2014, FRONT ENERGY RES, DOI 10.3389/fenrg.2014.00030; Birkett J, 1999, MICROBIOLOGY CHEM EN; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Call DF, 2009, APPL ENVIRON MICROB, V75, P7579, DOI 10.1128/AEM.01760-09; Cao XX, 2009, ENVIRON SCI TECHNOL, V43, P7148, DOI 10.1021/es901950j; Chadwick GL, 2019, P NATL ACAD SCI USA, V116, P20716, DOI 10.1073/pnas.1912498116; Commault AS, 2015, BIOELECTROCHEMISTRY, V106, P150, DOI 10.1016/j.bioelechem.2015.04.011; Cusick RD, 2011, APPL MICROBIOL BIOT, V89, P2053, DOI 10.1007/s00253-011-3130-9; Elferink SJWHO, 1998, APPL ENVIRON MICROB, V64, P2301; Esteve-Nunez A, 2005, ENVIRON MICROBIOL, V7, P641, DOI 10.1111/j.1462-2920.2005.00731.x; Esteve-Nunez A, 2008, ENVIRON MICROBIOL, V10, P497, DOI 10.1111/j.1462-2920.2007.01470.x; Fernandes TM, 2018, BIOCHEM J, V475, P2861, DOI 10.1042/BCJ20180457; Fricke K, 2008, ENERG ENVIRON SCI, V1, P144, DOI 10.1039/b802363h; Geelhoed JS, 2011, ENVIRON SCI TECHNOL, V45, P815, DOI 10.1021/es102842p; Gimkiewicz C, 2013, JOVE-J VIS EXP, DOI 10.3791/50800; Harnisch F, 2012, CHEMSUSCHEM, V5, P1027, DOI 10.1002/cssc.201100817; Illanes Andrs, 2008, P155, DOI 10.1007/978-1-4020-8361-7_4; Jung S, 2007, APPL MICROBIOL BIOT, V77, P393, DOI 10.1007/s00253-007-1162-y; Kim JR, 2005, APPL MICROBIOL BIOT, V68, P23, DOI 10.1007/s00253-004-1845-6; Kimura Z, 2013, ISME J, V7, P1472, DOI 10.1038/ismej.2013.40; Klupfel L, 2014, NAT GEOSCI, V7, P195, DOI 10.1038/NGEO2084; Koch C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01890; Koch C, 2016, CHEMELECTROCHEM, V3, P1282, DOI 10.1002/celc.201600079; Koch C, 2014, CHEMELECTROCHEM, V1, P1923, DOI 10.1002/celc.201402216; Korth B, 2016, ENERG ENVIRON SCI, V9, P2539, DOI 10.1039/c6ee01428c; Korth B, 2015, BIOELECTROCHEMISTRY, V106, P194, DOI 10.1016/j.bioelechem.2015.03.010; Kretzschmar J, 2016, CHEM ENG TECHNOL, V39, P637, DOI 10.1002/ceat.201500406; Kubannek F, 2018, BIOELECTROCHEMISTRY, V121, P160, DOI 10.1016/j.bioelechem.2018.01.014; Kumar A, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0024; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee HS, 2010, ENVIRON SCI TECHNOL, V44, P948, DOI 10.1021/es9025358; Lee HS, 2009, ENVIRON SCI TECHNOL, V43, P7971, DOI 10.1021/es900204j; Lee HS, 2009, ENVIRON SCI TECHNOL, V43, P7571, DOI 10.1021/es9015519; LEFFELAAR PA, 1988, SOIL SCI, V146, P335, DOI 10.1097/00010694-198811000-00006; Levar CE, 2017, ISME J, V11, P741, DOI 10.1038/ismej.2016.146; Logan BE, 2019, NAT REV MICROBIOL, V17, P307, DOI 10.1038/s41579-019-0173-x; Logan BE, 2012, SCIENCE, V337, P686, DOI 10.1126/science.1217412; Lovley DR, 2017, ANNU REV MICROBIOL, V71, P643, DOI 10.1146/annurev-micro-030117-020420; LOVLEY DR, 1987, NATURE, V330, P252, DOI 10.1038/330252a0; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Ly HK, 2013, CHEMSUSCHEM, V6, P487, DOI 10.1002/cssc.201200626; Malvankar NS, 2012, ENERG ENVIRON SCI, V5, P5790, DOI 10.1039/c2ee03388g; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; Molenaar SD, 2018, CHEMSUSCHEM, V11, P2171, DOI 10.1002/cssc.201800589; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Nevin KP, 2008, ENVIRON MICROBIOL, V10, P2505, DOI 10.1111/j.1462-2920.2008.01675.x; Ortiz-Medina JF, 2019, FRONT ENERGY RES, V7, DOI 10.3389/fenrg.2019.00103; Paitier A, 2017, BIOSENS BIOELECTRON, V92, P357, DOI 10.1016/j.bios.2016.10.096; Parameswaran P, 2011, BIORESOURCE TECHNOL, V102, P263, DOI 10.1016/j.biortech.2010.03.133; Pfeffer C, 2012, NATURE, V491, P218, DOI 10.1038/nature11586; Popat SC, 2016, BIORESOURCE TECHNOL, V215, P265, DOI 10.1016/j.biortech.2016.04.136; Qian XL, 2011, BBA-BIOENERGETICS, V1807, P404, DOI 10.1016/j.bbabio.2011.01.003; Rabaey K, 2005, ENVIRON SCI TECHNOL, V39, P3401, DOI 10.1021/es048563o; Santos TC, 2015, DALTON T, V44, P9335, DOI 10.1039/c5dt00556f; Scholten JCM, 2002, FEMS MICROBIOL ECOL, V42, P375, DOI 10.1111/j.1574-6941.2002.tb01027.x; SCHONHEIT P, 1982, ARCH MICROBIOL, V132, P285, DOI 10.1007/BF00407967; Schroder U, 2007, PHYS CHEM CHEM PHYS, V9, P2619, DOI 10.1039/b703627m; Schroder U, 2015, ENERG ENVIRON SCI, V8, P513, DOI 10.1039/c4ee03359k; Snider RM, 2012, P NATL ACAD SCI USA, V109, P15467, DOI 10.1073/pnas.1209829109; Spaans SK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00742; Speers AM, 2012, APPL ENVIRON MICROB, V78, P437, DOI 10.1128/AEM.06782-11; Sun D, 2014, INT J SYST EVOL MICR, V64, P3485, DOI 10.1099/ijs.0.061598-0; von Canstein H, 2008, APPL ENVIRON MICROB, V74, P615, DOI 10.1128/AEM.01387-07; von Stockar U, 2010, J NON-EQUIL THERMODY, V35, P415, DOI 10.1515/JNETDY.2010.024; Yi HN, 2009, BIOSENS BIOELECTRON, V24, P3498, DOI 10.1016/j.bios.2009.05.004; Yoho RA, 2014, CHEMSUSCHEM, V7, P3413, DOI 10.1002/cssc.201402589; Zacharoff L, 2016, BIOELECTROCHEMISTRY, V107, P7, DOI 10.1016/j.bioelechem.2015.08.003; Zarabadi MP, 2019, CHEMELECTROCHEM, V6, P2715, DOI 10.1002/celc.201900732; Zhu XP, 2013, BIOELECTROCHEMISTRY, V90, P30, DOI 10.1016/j.bioelechem.2012.10.004	73	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234077	10.1371/journal.pone.0234077	http://dx.doi.org/10.1371/journal.pone.0234077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559199	Green Published, gold			2022-12-26	WOS:000543261600011
J	Butolo, NP; Azevedo, P; de Alencar, LD; Domingues, CEC; Miotelo, L; Malaspina, O; Nocelli, RCF				Butolo, Nicole Pavan; Azevedo, Patricia; de Alencar, Luciano Delmondes; Domingues, Caio E. C.; Miotelo, Lucas; Malaspina, Osmar; Ferreira Nocelli, Roberta Cornelio			A high quality method for hemolymph collection from honeybee larvae	PLOS ONE			English	Article							APIS-MELLIFERA HYMENOPTERA; MALPIGHIAN TUBULES; FAT-BODY; BEE; THIAMETHOXAM; PROTEIN; SURVIVAL; SYSTEM; EYE	The drastic decline of bees is associated with several factors, including the immune system suppression due to the increased exposure to pesticides. A widely used method to evaluate these effects on these insects' immune systems is the counting of circulating hemocytes in the hemolymph. However, the extraction of hemolymph from larvae is quite difficult, and the collected material is frequently contaminated with other tissues and gastrointestinal fluids, which complicates counting. Therefore, the present work established a high quality and easily reproducible method of extracting hemolymph from honeybee larvae(Apis mellifera), the extraction with ophthalmic scissors. Extraction methods with the following tools also were tested: 30G needle, fine-tipped forceps, hypodermic syringe, and capillaries tubes. The hemolymph was obtained via an incision on the larvae's right side for all methods, except for the extraction with ophthalmic scissors, in which the hemolymph was extracted from the head region. To assess the purity of the collected material, turbidity analyses of the samples using a turbidimeter were proposed, tested, and evaluated. The results showed that the use of ophthalmic scissors provided the clearest samples and was free from contamination. A reference range between 22,432.35 and 24,504.87 NTU (nephelometric turbidity units) was established, in which the collected samples may be considered of high quality and free from contamination.	[Butolo, Nicole Pavan; Domingues, Caio E. C.; Miotelo, Lucas; Malaspina, Osmar; Ferreira Nocelli, Roberta Cornelio] Univ Estadual Paulista Julio de Mesquita Filho UN, Ctr Estudos Insetos Sociais CEIS, Inst Biociencias, Programa Pos Grad Biol Celular & Mol, Rio Claro, SP, Brazil; [Azevedo, Patricia; de Alencar, Luciano Delmondes] Univ Estadual Campinas UNICAMP SP, Inst Biol, Grp Genet & Genom Conservacao, Programa Pos Grad Genet & Biol Mol, Campinas, SP, Brazil; [Ferreira Nocelli, Roberta Cornelio] Univ Fed Sao Carlos UFSCar SP, Ctr Ciencias Agr, Dept Ciencias Nat Matemat & Educ, Araras, SP, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas	Butolo, NP (corresponding author), Univ Estadual Paulista Julio de Mesquita Filho UN, Ctr Estudos Insetos Sociais CEIS, Inst Biociencias, Programa Pos Grad Biol Celular & Mol, Rio Claro, SP, Brazil.; Azevedo, P (corresponding author), Univ Estadual Campinas UNICAMP SP, Inst Biol, Grp Genet & Genom Conservacao, Programa Pos Grad Genet & Biol Mol, Campinas, SP, Brazil.	nicole.butolo@gmail.com; azevedo.p89@gmail.com	Malaspina, Osmar/AAL-9167-2021; Miotelo, Lucas/ABB-1559-2020; Nocelli, elvis0307%/AAD-7652-2022; Domingues, Caio Eduardo C/V-4142-2017; Alencar, Luciano Delmondes de/M-5334-2018	Malaspina, Osmar/0000-0002-1650-257X; Miotelo, Lucas/0000-0003-3211-5534; Domingues, Caio Eduardo C/0000-0001-8575-2735; Azevedo, Patricia/0000-0003-4866-9478; Alencar, Luciano Delmondes de/0000-0002-4190-575X	Coordination of Superior Level Staff Improvement - CAPES [001, 88887.318480/2019-00, 88887.464706/2019-00]; Sao Paulo Research Foundation - FAPESP [2016/15743-7]; Sao Paulo Research Foundation -FAPESP [17/21097-3]; Braziian National Council for Scientific and Technological Development - CNPQ [400540/2018-5]	Coordination of Superior Level Staff Improvement - CAPES; Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo Research Foundation -FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Braziian National Council for Scientific and Technological Development - CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	BUTOLO N. P., AZEVEDO P., ALENCAR L. D. received scholarship from Coordination of Superior Level Staff Improvement - CAPES (grant numbers: 001; 88887.318480/2019-00 and 88887.464706/2019-00) (url:http://www.capes.gov.br) and DOMINGUES C. E. C. received scholarship from Sao Paulo Research Foundation - FAPESP (grant number: 2016/15743-7). This work was supported by Sao Paulo Research Foundation -FAPESP (grant number: 17/21097-3) (url:https://bv.fapesp.br/pt/auxilios/101901/interacoes-abelha-agricultura-perspectivas-para-a-utilizacao-sustentavel/) and by Braziian National Council for Scientific and Technological Development - CNPQ (grant number: 400540/2018-5)(url:http://www.cnpq.br/web/guest/chamadas-publicas?p_p_id=resultadosportlet_WAR_resultadoscnpqportlet_ INSTANCE_0ZaM&filtro=encerradas&detalha= chamadaDetalhada&exibe=exibe&idResultado=47-1073-5328&id=47-1073-5328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljedani Dalal M., 2018, Journal of Entomology, V15, P114, DOI 10.3923/je.2018.114.124; Balsamo PJ, 2020, J APICULT RES, V59, P350, DOI 10.1080/00218839.2019.1686575; Bania J, 1999, EUR J BIOCHEM, V262, P680, DOI 10.1046/j.1432-1327.1999.00406.x; Battefeld M, 2017, U.S. Patent, Patent No. [9,851,297, 9851297]; Beasley CM, 2019, J BIOPHARM STAT, V29, P516, DOI 10.1080/10543406.2019.1579223; Beye M, 2002, INSECT MOL BIOL, V11, P527, DOI 10.1046/j.1365-2583.2002.00361.x; BINDOKAS V, 1984, BIOELECTROMAGNETICS, V5, P305, DOI 10.1002/bem.2250050303; Borsuk G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170487; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04734-1; Brandt A, 2016, J INSECT PHYSIOL, V86, P40, DOI 10.1016/j.jinsphys.2016.01.001; Brasil. Ministerio do Meio Ambiente, 2020, BOL AN PROD IMP EXP; Burritt NL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167752; Catae AF, 2014, MICROSC RES TECHNIQ, V77, P274, DOI 10.1002/jemt.22339; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Cruz-Landim C., 2009, ABELHAS MORFOLOGIA F; Domingues CEC, 2017, CHEMOSPHERE, V186, P994, DOI 10.1016/j.chemosphere.2017.07.133; Dorigo AS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213109; Erban T, 2016, APIDOLOGIE, V47, P805, DOI 10.1007/s13592-016-0437-7; Fine JD, 2017, SCI REP-UK, V7, DOI 10.1038/srep40499; Furtado WCA, 2013, MICROSC MICROANAL, V19, P1502, DOI 10.1017/S1431927613013445; FYG W. von, 1942, SCHWEIZ BIENEN ZEITUNG, V65, P120; Garido MP, 2013, J APICULT RES, V52, P67; GILLIAM M, 1970, EXPERIENTIA, V26, P908; GILLIAM M, 1967, J INVERTEBR PATHOL, V9, P387, DOI 10.1016/0022-2011(67)90074-2; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Gregorc A, 2018, INSECTS, V9, DOI 10.3390/insects9020055; Gregorc A, 2016, CHEMOSPHERE, V147, P328, DOI 10.1016/j.chemosphere.2015.12.030; Higes M, 2020, VET PATHOL, V57, P132, DOI 10.1177/0300985819864302; Hung KLJ, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2140; Iqbal J, 2019, SAUDI J BIOL SCI, V26, P563, DOI 10.1016/j.sjbs.2018.08.002; Koleoglu G, 2018, PARASITOL RES, V117, P1175, DOI 10.1007/s00436-018-5796-8; Kruger NJ, 2009, SPRINGER PROTOC HAND, P17, DOI 10.1007/978-1-59745-198-7_4; Kucharski R, 1998, GENE, V211, P343, DOI 10.1016/S0378-1119(98)00114-0; Larsen A, 2019, REV MEX CIENC PECU, V10, P705, DOI 10.22319/rmcp.v10i3.4785; Liao LH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15066-5; Locke B, 2016, APIDOLOGIE, V47, P467, DOI 10.1007/s13592-015-0412-8; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Ma LT, 2016, J ASIA-PAC ENTOMOL, V19, P769, DOI 10.1016/j.aspen.2016.07.005; Macedo TC., 2017, MANUAL AVALIACAO RIS, P105; Martins GF, 2011, TISSUE CELL, V43, P83, DOI 10.1016/j.tice.2010.12.003; Mondet F, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4668-z; Nazzi F, 2016, ANNU REV ENTOMOL, V61, P417, DOI 10.1146/annurev-ento-010715-023731; Oliveira RA, 2014, ENVIRON TOXICOL, V29, P1122, DOI 10.1002/tox.21842; Paes-de-Oliveira Vagner Tadeu, 2006, Brazilian Journal of Morphological Sciences, V23, P385; PALLI SR, 1987, INSECT BIOCHEM, V17, P711, DOI 10.1016/0020-1790(87)90041-2; Perveen N, 2017, SAUDI J BIOL SCI, V24, P1016, DOI 10.1016/j.sjbs.2016.12.011; Poiani SB, 2012, MICRON, V43, P475, DOI 10.1016/j.micron.2011.11.006; Potts S. G., 2016, SUMMARY POLICYMAKERS, P36; Ramsey SD, 2019, P NATL ACAD SCI USA, V116, P1792, DOI 10.1073/pnas.1818371116; Randolt K, 2008, ARCH INSECT BIOCHEM, V69, P155, DOI 10.1002/arch.20269; Richardson RT, 2018, APIDOLOGIE, V49, P397, DOI 10.1007/s13592-018-0566-2; Roat TC, 2013, ARCH ENVIRON CON TOX, V64, P456, DOI 10.1007/s00244-012-9849-1; Roat TC, 2010, MICRON, V41, P382, DOI 10.1016/j.micron.2010.01.003; Rossi CD, 2013, MICROSC RES TECHNIQ, V76, P552, DOI 10.1002/jemt.22199; Sadar MJ, 1998, TECHNICAL INFORM SER, V11; Silva-Zacarin E.C.M., 2012, CURRENT MICROSCOPY C, P696; Snodgrass R.E., 1956, ANATOMY HONEYBEE; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tavares DA, 2017, ENVIRON POLLUT, V229, P386, DOI 10.1016/j.envpol.2017.05.092; Trajano M. C., 2019, DIAGNOSTICO CRIACAO, P56; TRIPATHI RK, 1968, CAN J ZOOLOG, V46, P1013, DOI 10.1139/z68-141; Walton A, 2016, BEHAV ECOL SOCIOBIOL, V70, P999, DOI 10.1007/s00265-016-2084-4; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Xuereb B, 2009, AQUAT TOXICOL, V93, P225, DOI 10.1016/j.aquatox.2009.05.006	67	2	2	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234637	10.1371/journal.pone.0234637	http://dx.doi.org/10.1371/journal.pone.0234637			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555675	Green Published, gold			2022-12-26	WOS:000543273200012
J	Tun, MMN; Muthugala, R; Nabeshima, T; Soe, AM; Dumre, SP; Rajamanthri, L; Jayawardana, D; Attanayake, S; Inoue, S; Morita, K				Tun, Mya Myat Ngwe; Muthugala, Rohitha; Nabeshima, Takeshi; Soe, Aung Min; Dumre, Shyam Prakash; Rajamanthri, Lakmali; Jayawardana, Dulani; Attanayake, Shanthi; Inoue, Shingo; Morita, Kouichi			Complete genome analysis and characterization of neurotropic dengue virus 2 cosmopolitan genotype isolated from the cerebrospinal fluid of encephalitis patients	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEUROLOGICAL MANIFESTATIONS; JAPANESE ENCEPHALITIS; INFECTION; INVOLVEMENT; PERFORMANCE; DIAGNOSIS; ALIGNMENT; CHILDREN; MYANMAR	Dengue virus (DENV) infection remains a major public health concern in many parts of the world, including Southeast Asia and the Americas. Sri Lanka experienced its largest dengue outbreak in 2017. Neurological symptoms associated with DENV infection have increasingly been reported in both children and adults. Here, we characterize DENV type 2 (DENV-2) strains, which were isolated from cerebrospinal fluid (CSF) and/or serum of patients with dengue encephalitis. Acute serum and CSF samples from each patient were subjected to dengue-specific non-structural protein 1 (NS1) antigen test, IgM and IgG enzyme-linked immunosorbent assay (ELISA), virus isolation, conventional and real-time polymerase chain reaction (PCR), and next-generation sequencing (NGS). Among the 5 dengue encephalitis patients examined, 4 recovered and 1 died. DENV-2 strains were isolated from serum and/or CSF samples of 3 patients. The highest viral genome levels were detected in the CSF and serum of the patient who succumbed to the illness. A phylogenetic tree revealed that the DENV-2 isolates belonged to a new clade of cosmopolitan genotype and were genetically close to strains identified in China, South Korea, Singapore, Malaysia, Thailand, and the Philippines. According to the NGS analysis, greater frequencies of nonsynonymous and synonymous mutations per gene were identified in the nonstructural genes. The full genomes of serum- and CSF-derived DENV-2 from the same patient shared 99.7% similarity, indicating that the virus spread across the blood-brain barrier. This is the first report to describe neurotropic DENV-2 using whole-genome analysis and to provide the clinical, immunological, and virological characteristics of dengue encephalitis patients during a severe dengue outbreak in Sri Lanka in 2017.	[Tun, Mya Myat Ngwe; Nabeshima, Takeshi; Soe, Aung Min; Inoue, Shingo; Morita, Kouichi] Nagasaki Univ, Inst Trop Med, Dept Virol, Nagasaki, Japan; [Muthugala, Rohitha; Rajamanthri, Lakmali; Jayawardana, Dulani; Attanayake, Shanthi] Teaching Hosp Kandy, Dept Virol, Kandy, Sri Lanka; [Dumre, Shyam Prakash] Nagasaki Univ, Inst Trop Med, Dept Immunogenet, Nagasaki, Japan	Nagasaki University; Nagasaki University	Tun, MMN; Morita, K (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Virol, Nagasaki, Japan.	myamyat@tm.nagasaki-u.ac.jp; moritak@nagasaki-u.ac.jp		Dumre, Shyam Prakash/0000-0002-4072-0745	Japan Initiative for Global Research Network on Infectious Diseases (JGRID) of the Japan Science and Technology Agency (JST) [JP19fm0108001]; Research Program on Emerging and Re-emerging Infectious Diseases of the Agency for Research and Development (AMED) [19fk0108035h1203]	Japan Initiative for Global Research Network on Infectious Diseases (JGRID) of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Research Program on Emerging and Re-emerging Infectious Diseases of the Agency for Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by grants from the Japan Initiative for Global Research Network on Infectious Diseases (JGRID) of the Japan Science and Technology Agency (JST) (Grant number JP19fm0108001), and Research Program on Emerging and Re-emerging Infectious Diseases of the Agency for Research and Development (AMED, 19fk0108035h1203).	Ali SKA, 2017, INFECT DIS HLTH, V23, P114; American Institute of Ultrasound in Medicine, 2009, J Ultrasound Med, V28, P114; Araujo FMC, 2011, J VIROL METHODS, V177, P128, DOI 10.1016/j.jviromet.2011.07.003; Araujo F, 2012, EMERG INFECT DIS, V18, P677, DOI [10.3201/eid1804.111522, 10.3201/eid1804.111552]; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BUNDO K, 1985, J VIROL METHODS, V11, P15, DOI 10.1016/0166-0934(85)90120-X; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Oliveira DB, 2016, REV SOC BRAS MED TRO, V49, P125, DOI 10.1590/0037-8682-0208-2015; Dhenni R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006198; Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040; Gomez-Barrena E, 2015, BONE, V70, P93, DOI 10.1016/j.bone.2014.07.033; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hapuarachchi HC, 2013, J CLIN VIROL, V57, P91, DOI 10.1016/j.jcv.2012.12.021; Inoue S, 2010, VECTOR-BORNE ZOONOT, V10, P143, DOI 10.1089/vbz.2008.0153; Ito M, 2004, J CLIN MICROBIOL, V42, P5935, DOI 10.1128/JCM.42.12.5935-5937.2004; Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9; Jiang XY, 2010, CRIT CARE, V14, pR66; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kumar R, 2008, J NEUROL SCI, V269, P41, DOI 10.1016/j.jns.2007.12.018; Kyaw AK, 2017, EPIDEMIOL INFECT, V145, P1886, DOI 10.1017/S0950268817000735; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Li GH, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00449; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Massad E, 2011, LANCET, V377, P1630, DOI 10.1016/S0140-6736(11)60470-4; Misra UK, 2015, J CLIN VIROL, V72, P146, DOI 10.1016/j.jcv.2015.08.021; MORITA K, 1991, J CLIN MICROBIOL, V29, P2107, DOI 10.1128/JCM.29.10.2107-2110.1991; Tun MMN, 2016, INFECT GENET EVOL, V43, P31, DOI 10.1016/j.meegid.2016.04.025; Tun MMN, 2013, J MED VIROL, V85, P1258, DOI 10.1002/jmv.23577; Saini L, 2017, NEUROL INDIA, V65, P636, DOI [10.4103/neuroindia.NI_1367_15, 10.4103/neuroindia.ni_1367_15]; Scherer FM, 2001, HEALTH AFFAIR, V20, P216, DOI 10.1377/hlthaff.20.5.216; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068; Soares CN, 2011, J NEUROL SCI, V303, P75, DOI 10.1016/j.jns.2011.01.012; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; Srey VH, 2002, AM J TROP MED HYG, V66, P200, DOI 10.4269/ajtmh.2002.66.200; Thisyakorn Usa, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P504; Tun MMN, 2014, EMERG INFECT DIS, V20, P1378, DOI 10.3201/eid2008.131431; Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 1997, DENG GUID DIAGN TREA; 2010, LASER PHOTON REV, V4, pE854; 2011, PHILOS PUBLIC AFFAIR, V39, P3	49	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234508	10.1371/journal.pone.0234508	http://dx.doi.org/10.1371/journal.pone.0234508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555732	Green Published, gold			2022-12-26	WOS:000543273200003
J	Kim, W; Choi, H; Kweon, J; Yang, DH; Kim, YH				Kim, Woojin; Choi, Haecheon; Kweon, Jihoon; Yang, Dong Hyun; Kim, Young-Hak			Effects of pannus formation on the flow around a bileaflet mechanical heart valve	PLOS ONE			English	Article							FLUID-STRUCTURE INTERACTION; ROW COMPUTED-TOMOGRAPHY; PULSATILE BLOOD-FLOW; JUDE MEDICAL VALVES; SUBPROSTHETIC PANNUS; NUMERICAL-SIMULATION; AORTIC POSITION; PROSTHESIS; REPLACEMENT; OBSTRUCTION	Some patients with a bileaflet mechanical heart valve (BMHV) show significant increases in the transvalvular pressure drop and abnormal leaflet motion due to a pannus (an abnormal fibrovascular tissue) formed on the ventricular side, even in the absence of physical contact between the pannus and leaflets. We investigate the effects of the pannus shape (circular or semi-circular ring), implantation location and height on the leaflet motion, flow structure and transvalvular pressure drop using numerical simulations. The valve model considered resembles a 25 mm masters HP valve. The mean systolic pressure drop is significantly increased with increasing pannus height, irrespective of its implantation orientation. Near the peak inflow rate, the flow behind the pannus becomes highly turbulent, and the transvalvular pressure drop is markedly increased by the pannus. At the end of valve opening and the start of valve closing, oscillatory motions of the leaflets occur due to periodic shedding of vortex rings behind the pannus, and their amplitudes become large with increasing pannus height. When the pannus shape is asymmetric (e.g., a semi-circular ring) and its height reaches about 0.1D(D(= 25 mm) is the diameter of an aorta), abnormal leaflet motions occur: two leaflets move asymmetrically, and valve closing is delayed in time or incomplete, which increases the regurgitation volume. The peak energy loss coefficients due to panni are obtained from simulation data and compared with those predicted by a one-dimensional model. The comparison indicates that the one-dimensional model is applicable for the BMHV with and without pannus.	[Kim, Woojin; Choi, Haecheon] Seoul Natl Univ, Dept Mech Engn, Seoul, South Korea; [Choi, Haecheon] Seoul Natl Univ, Inst Adv Machines & Design, Seoul, South Korea; [Kweon, Jihoon; Kim, Young-Hak] Univ Ulsan, Asan Med Ctr, Dept Cardiol, Coll Med, Seoul, South Korea; [Yang, Dong Hyun] Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Choi, H (corresponding author), Seoul Natl Univ, Dept Mech Engn, Seoul, South Korea.; Choi, H (corresponding author), Seoul Natl Univ, Inst Adv Machines & Design, Seoul, South Korea.	choi@snu.ac.kr	Choi, Haecheon/D-1016-2011	Choi, Haecheon/0000-0003-0696-847X	National Research Foundation through the Ministry of Science and ICT [2019R1A2C2086237]	National Research Foundation through the Ministry of Science and ICT	HC receives a fund from the National Research Foundation through the Ministry of Science and ICT (no. 2019R1A2C2086237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbite O, 2014, MAGN RESON MATER PHY, V27, P227, DOI 10.1007/s10334-013-0408-1; Akselvoll K, 1996, J COMPUT PHYS, V125, P454, DOI 10.1006/jcph.1996.0107; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Aoyagi S, 2000, J THORAC CARDIOV SUR, V120, P142, DOI 10.1067/mtc.2000.106524; Bach DS, 2010, JACC-CARDIOVASC IMAG, V3, P296, DOI 10.1016/j.jcmg.2009.11.009; Bang JS, 2006, ASAIO J, V52, P234, DOI 10.1097/01.mat.0000219072.80294.82; Barbetseas J, 1998, J AM COLL CARDIOL, V32, P1410, DOI 10.1016/S0735-1097(98)00385-4; Borazjani I, 2008, J COMPUT PHYS, V227, P7587, DOI 10.1016/j.jcp.2008.04.028; Borazjani I, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002491; Borazjani I, 2010, ANN BIOMED ENG, V38, P326, DOI 10.1007/s10439-009-9807-x; Bouabdallaoui N, 2015, EUR HEART J-ACUTE CA, V4, P298, DOI 10.1177/2048872614551543; Choi Jong Hyun, 2013, J Cardiovasc Ultrasound, V21, P189, DOI 10.4250/jcu.2013.21.4.189; CHUNG J, 1993, J APPL MECH-T ASME, V60, P371, DOI 10.1115/1.2900803; CORNAK J. U. Stefan, 2012, SCI MILITARY, V1, P50; Dasi LP, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2743261; Dasi LP, 2008, J BIOMECH, V41, P1166, DOI 10.1016/j.jbiomech.2008.01.024; Dasi LP, 2009, CLIN EXP PHARMACOL P, V36, P225, DOI 10.1111/j.1440-1681.2008.05099.x; de Tullio MD, 2011, J BIOMECH, V44, P1684, DOI 10.1016/j.jbiomech.2011.03.036; de Tullio MD, 2011, ACTA MECH, V216, P147, DOI 10.1007/s00707-010-0361-2; De Tullio MD, 2009, J FLUID MECH, V622, P259, DOI 10.1017/S0022112008005156; De Vita F, 2016, THEOR COMP FLUID DYN, V30, P129, DOI 10.1007/s00162-015-0369-2; Dumont K, 2007, J BIOMECH ENG-T ASME, V129, P558, DOI 10.1115/1.2746378; Feng ZG, 2002, ARTIF ORGANS, V26, P32, DOI 10.1046/j.1525-1594.2002.06833.x; Cianciulli TF, 2009, EUR J ECHOCARDIOGR, V10, P446, DOI 10.1093/ejechocard/jen320; Galli CA, 2007, J AM SOC ECHOCARDIOG, V20, DOI 10.1016/j.echo.2007.02.031; Garcia D, 2000, CIRCULATION, V101, P765, DOI 10.1161/01.CIR.101.7.765; Giroux SK, 2010, J AM SOC ECHOCARDIOG, V23, DOI 10.1016/j.echo.2009.07.003; Griffith BE, 2012, INT J NUMER METH BIO, V28, P317, DOI 10.1002/cnm.1445; Han K, 2015, RADIOLOGY, V276, P724, DOI 10.1148/radiol.2015142400; Hartrumpf M, 2003, EUR J CARDIO-THORAC, V23, P283, DOI 10.1016/S1010-7940(02)00804-7; Hong T, 2011, J HYDRODYN, V23, P607, DOI 10.1016/S1001-6058(10)60156-4; Hurwitz SE, 2009, J AM SOC ECHOCARDIOG, V22, DOI 10.1016/j.echo.2009.04.001; Irons B. M., 1969, International Journal for Numerical Methods in Engineering, V1, P275, DOI 10.1002/nme.1620010306; Ismeno G, 2001, J THORAC CARDIOV SUR, V121, P723, DOI 10.1067/mtc.2001.113023; Kim CN, 2012, J MECH SCI TECHNOL, V26, P819, DOI 10.1007/s12206-011-1240-z; Kim J, 2001, J COMPUT PHYS, V171, P132, DOI 10.1006/jcph.2001.6778; Kleine P, 2000, EUR J CARDIO-THORAC, V17, P20, DOI 10.1016/S1010-7940(99)00351-6; Kondruweit M, 2008, J THORAC CARDIOV SUR, V136, P213, DOI 10.1016/j.jtcvs.2008.01.008; Kuniyoshi Yukio, 2003, J Artif Organs, V6, P179, DOI 10.1007/s10047-003-0226-8; Lee J, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3459156; Mittal R, 2005, ANNU REV FLUID MECH, V37, P239, DOI 10.1146/annurev.fluid.37.061903.175743; Moldovan Maria-Sinziana, 2016, Clujul Med, V89, P169, DOI 10.15386/cjmed-510; Mullenix PS, 2008, J HEART VALVE DIS, V17, P666; Nishida T, 2015, CIRC J, V79, P2193, DOI 10.1253/circj.CJ-15-0268; Nishimura RA, 2002, CIRCULATION, V106, P770, DOI 10.1161/01.CIR.0000027621.26167.5E; Park N, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2401626; Pibarot P, 2009, CIRCULATION, V119, P1034, DOI 10.1161/CIRCULATIONAHA.108.778886; REUL H, 1990, J BIOMECH, V23, P181, DOI 10.1016/0021-9290(90)90351-3; Roudaut R, 2007, HEART, V93, P137, DOI 10.1136/hrt.2005.071183; SILBER H, 1993, CIRCULATION, V87, P30, DOI 10.1161/01.CIR.87.1.30; Smadi O, 2010, J BIOMECH, V43, P1565, DOI 10.1016/j.jbiomech.2010.01.029; Sotiropoulos F, 2016, ANNU REV FLUID MECH, V48, P259, DOI 10.1146/annurev-fluid-122414-034314; Stergiopulos N, 1999, AM J PHYSIOL-HEART C, V276, pH81; Teshima H, 2004, ANN THORAC SURG, V77, P523, DOI 10.1016/S0003-4975(03)01531-5; Teshima Hideki, 2005, J Artif Organs, V8, P270, DOI 10.1007/s10047-005-0317-9; Teshima H, 2014, J ARTIF ORGANS, V17, P162, DOI 10.1007/s10047-013-0751-z; Teshima H, 2010, ARTIF ORGANS, V34, P210, DOI 10.1111/j.1525-1594.2009.00800.x; Le TB, 2013, J COMPUT PHYS, V244, P41, DOI 10.1016/j.jcp.2012.08.036; Ueda T, 2013, CIRC J, V77, P418, DOI 10.1253/circj.CJ-12-0290; Yagi Takanobu, 2011, Journal of Biomechanical Science and Engineering, V6, P12, DOI 10.1299/jbse.6.64; Yoganathan AP, 2004, ANNU REV BIOMED ENG, V6, P331, DOI 10.1146/annurev.bioeng.6.040803.140111; Yun BM, 2014, J FLUID MECH, V754, P122, DOI 10.1017/jfm.2014.393	62	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234341	10.1371/journal.pone.0234341	http://dx.doi.org/10.1371/journal.pone.0234341			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530931	Green Published, gold			2022-12-26	WOS:000542037200053
J	Liu, SH; Zhang, XD; Wang, Y; Feng, GM				Liu, Suhui; Zhang, Xiaodong; Wang, Ying; Feng, Guoming			Recurrent convolutional neural kernel model for stock price movement prediction	PLOS ONE			English	Article							SENTIMENT; IMPACT	Stock price movement prediction plays important roles in decision making for investors. It was usually regarded as a binary classification task. In this paper, a recurrent convolutional neural kernel (RCNK) model was proposed, which learned complementary features from different sources of data, namely, historical price data and text data in the message board, to predict the stock price movement. It integrated the advantage of technical analysis and sentiment analysis. Different from previous studies, the text data was treated as sequential data and utilized the RCNK model to train sentiment embeddings with the temporal features. Besides, in the classification section of the model, the explicit kernel mapping layer was used to replace several full-connected layers. This operation reduced the parameters of the model and the risk of overfitting. In order to test the impact of treating the sentiment data as sequential data, the effectiveness of explicit kernel mapping layer and the usefulness integrating the technical analysis and sentiment analysis, the proposed model was compared with the other two deep learning models (recurrent convolutional neural network model and convolutional neural kernel model) and the models with only one source of data as input. The result showed that the proposed model outperformed the other models.	[Liu, Suhui; Zhang, Xiaodong; Wang, Ying; Feng, Guoming] Univ Sci & Technol Beijing, Donlinks Sch Econ & Management, Beijing, Peoples R China	University of Science & Technology Beijing	Zhang, XD; Wang, Y (corresponding author), Univ Sci & Technol Beijing, Donlinks Sch Econ & Management, Beijing, Peoples R China.	xdzhang@manage.ustb.edu.cn; wangy@manage.ustb.edu.cn		liu, su hui/0000-0001-8046-2165	National Natural Science Foundation of China [71871018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China under grant No. 71871018.	[Anonymous], 2005, INDEX IMOTI, V7, P21; [Anonymous], 2000, P 6 ACM SIGKDD WORKS; Baccianella S., 2010, P 7 INT C LANG RES O, V10, P2200, DOI DOI citeulike-article-id:9238846; Bengio Y, 2003, J MACH LEARN RES, V3, P1137, DOI 10.1162/153244303322533223; BROCK W, 1992, J FINANC, V47, P1731, DOI 10.2307/2328994; Chen MY, 2019, FUTURE GENER COMP SY, V96, P692, DOI 10.1016/j.future.2017.10.028; Ding X, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P2327; FAMA EF, 1965, J BUS, V38, P34, DOI 10.1086/294743; Feuerriegel S, 2018, DECIS SUPPORT SYST, V112, P88, DOI 10.1016/j.dss.2018.06.008; Hagenau M, 2013, DECIS SUPPORT SYST, V55, P685, DOI 10.1016/j.dss.2013.02.006; Hommes CH, 2006, HANDB ECON, V13, P1109; Hoseinzade E, 2019, EXPERT SYST APPL, V129, P273, DOI 10.1016/j.eswa.2019.03.029; Kim SH, 2014, J ECON BEHAV ORGAN, V107, P708, DOI 10.1016/j.jebo.2014.04.015; Kim T, 2019, PLOS ONE, V14; Kim Y., 2014, 2014 C EMP METH NAT; Kumar BS, 2016, KNOWL-BASED SYST, V114, P128, DOI 10.1016/j.knosys.2016.10.003; Lai RK, 2009, EXPERT SYST APPL, V36, P3761, DOI 10.1016/j.eswa.2008.02.025; Li XD, 2014, KNOWL-BASED SYST, V69, P14, DOI 10.1016/j.knosys.2014.04.022; Le L, 2019, NEUROCOMPUTING, V339, P292, DOI 10.1016/j.neucom.2019.02.037; Liu G, 2019, ENG APPL ARTIF INTEL, V82, P1, DOI 10.1016/j.engappai.2019.03.019; Long W, 2019, KNOWL-BASED SYST, V164, P163, DOI 10.1016/j.knosys.2018.10.034; Mehrkanoon S, 2019, NEURAL NETWORKS, V116, P46, DOI 10.1016/j.neunet.2019.03.011; Mehrkanoon S, 2018, NEUROCOMPUTING, V298, P46, DOI 10.1016/j.neucom.2017.12.065; Mikolov T., 2013, 27 ANN C NEUR INF PR, P3111; Mikolov T, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P1045; Oliveira N, 2017, EXPERT SYST APPL, V73, P125, DOI 10.1016/j.eswa.2016.12.036; Paiva FD, 2019, EXPERT SYST APPL, V115, P635, DOI 10.1016/j.eswa.2018.08.003; Peng Yangtuo, 2016, P NAACL HLT, P374, DOI DOI 10.18653/V1/N16-1041; Qian B., 2004, P 2 IASTED INT C FIN, P203; Qiu J, 2020, PLOS ONE, V15; Rahimi A, 2007, 21 ANN C NEUR INF PR; Si J., 2013, P 51 ANN M ASS COMP, P24; Nguyen TH, 2015, EXPERT SYST APPL, V42, P9603, DOI 10.1016/j.eswa.2015.07.052; Vargas MR, 2017, IEEE INT CONF COMP, P60, DOI 10.1109/CIVEMSA.2017.7995302; Xing FZ, 2018, ARTIF INTELL REV, V50, P49, DOI 10.1007/s10462-017-9588-9; Xu B, 2018, LECT NOTES ARTIF INT, V11109, P166, DOI 10.1007/978-3-319-99501-4_14; Yang FM, 2019, APPL SOFT COMPUT, V80, P820, DOI 10.1016/j.asoc.2019.03.028; Yang L, 2018, P 5 IEEE INT C CLOUD; Yao JT, 2009, APPL SOFT COMPUT, V9, P1000, DOI 10.1016/j.asoc.2009.01.003; Zhang Y, 2016, ARXIV151003820CSCL	40	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234206	10.1371/journal.pone.0234206	http://dx.doi.org/10.1371/journal.pone.0234206			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530923	gold, Green Published			2022-12-26	WOS:000542037200022
J	Lennon, M; Liao, YT; Salvador, A; Lauzon, CR; Wu, VCH				Lennon, Marion; Liao, Yen-Te; Salvador, Alexandra; Lauzon, Carol R.; Wu, Vivian C. H.			Bacteriophages specific to Shiga toxin-producing Escherichia coli exist in goat feces and associated environments on an organic produce farm in Northern California, USA	PLOS ONE			English	Article							FEEDLOT CATTLE; POTENTIAL BIOCONTROL; LYTIC BACTERIOPHAGES; PHAGE; FIELD; POPULATIONS; SALMONELLA; PREVALENCE; COLIPHAGES; DIVERSITY	Shiga toxin-producing Escherichia coli (STECs) contamination of produce, as a result of contact with ruminant fecal material, has been associated with serious foodborne illness. Bacteriophages (phages) that infect STECs have primarily been reported to be of cattle origin. However, they likely exist in other environments or in animals that share habitats with cattle, such as goats. To explore the presence and diversity of phages specific to STEC O157 and the top six non-O157 STECs in goat-associated environments, environmental samples consisting of feces (goat and cattle) and soil samples were collected monthly for six months from an organic produce farm. A variety of phages belonging to theMyoviridae,Siphoviridae, andPodoviridaefamilies were isolated from all goat fecal and half of the soil samples. The most commonly isolated phages belonged toMyoviridaeand were lytic against STEC O103. The isolated phages had different host ranges, but collectively, showed lytic activity against O157 and the top six non-O157 STEC strains excluding O121. Two non-O157 STECs (O174: H21 and O-antigen-negative: H18) were isolated from soil and cattle feces, respectively. Although prior studies have reported that goats shed STEC into the environment, the findings of the current study suggest that goat feces may also contain lytic STEC-specific phages. The phages of goat origin have the capacity to infect STECs implicated in causing foodborne outbreaks, making them potential candidates for biocontrol pending additional characterization steps. Further work is needed to determine if the addition of goats to the farm environment could potentially reduce the presence of STECs.	[Lennon, Marion; Liao, Yen-Te; Salvador, Alexandra; Wu, Vivian C. H.] ARS, Produce Safety & Microbiol Res Unit, USDA, Western Reg Res Ctr, Albany, CA 94710 USA; [Lennon, Marion; Lauzon, Carol R.] Calif State Univ East Bay, Dept Biol Sci, Hayward, CA USA	United States Department of Agriculture (USDA); California State University System; California State University East Bay	Wu, VCH (corresponding author), ARS, Produce Safety & Microbiol Res Unit, USDA, Western Reg Res Ctr, Albany, CA 94710 USA.	vivian.wu@usda.gov		Wu, Vivian C.H./0000-0002-1525-1078	U.S. Department of Agriculture, Agricultural Research Service, CRIS project [2030-42000-050-00D]	U.S. Department of Agriculture, Agricultural Research Service, CRIS project	The research was funded by the U.S. Department of Agriculture, Agricultural Research Service, CRIS project 2030-42000-050-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors: Marion Lennon, Yen-Te Liao, Alexandra Salvador, and Vivian C.H. Wu received a salary from the U.S. Department of Agriculture, Agricultural Research Service (the funder).	Ackermann Hans-W., 2009, V501, P113, DOI 10.1007/978-1-60327-164-6_12; BEUTIN L, 1993, J CLIN MICROBIOL, V31, P2483, DOI 10.1128/JCM.31.9.2483-2488.1993; Boulanger Pascale, 2009, V502, P227, DOI 10.1007/978-1-60327-565-1_13; Callaway TR, 2008, FOODBORNE PATHOG DIS, V5, P183, DOI 10.1089/fpd.2007.0057; CALLAWAY TR, 2013, AGR FOOD ANAL BACTER, V3, P39; Callaway TR, 2013, MICROBIAL SAFETY FRE, V3, P39; *CDCP, 2020, REP SEL E COL OUTBR; *CDCP, 2017, PNL05 CDCP; Centers for Disease Control and Prevention, 2020, CSCL PHAG PREPS; Centers for Disease Control and Prevention, 2017, QUEST ANSW E COL ESC; Cooley MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065716; Dini C, 2010, J APPL MICROBIOL, V109, P873, DOI 10.1111/j.1365-2672.2010.04714.x; Goodburn C, 2013, FOOD CONTROL, V32, P418, DOI 10.1016/j.foodcont.2012.12.012; Hallewell J, 2014, APPL ENVIRON MICROB, V80, P3819, DOI 10.1128/AEM.00708-14; Hansen VM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-90; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Koskella B, 2013, VIRUSES-BASEL, V5, P806, DOI 10.3390/v5030806; Krog JS, 2017, HYDROGEOL J, V25, P1045, DOI 10.1007/s10040-016-1530-8; La Ragione RM, 2009, FEMS MICROBIOL REV, V33, P394, DOI 10.1111/j.1574-6976.2008.00138.x; Lamba K, 2016, EMERG INFECT DIS, V22, P679, DOI 10.3201/eid2204.151825; Liao YT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190534; LIN A, 2013, STEC MOL SEROTYPING; Lingohr Erika, 2009, V502, P19, DOI 10.1007/978-1-60327-565-1_3; Litt PK, 2018, J FOOD PROTECT, V81, P785, DOI 10.4315/0362-028X.JFP-17-460; Mamiatis T., 1982, MOL CLONING LAB MANU; Miller MEB, 2012, ENVIRON MICROBIOL, V14, P207, DOI 10.1111/j.1462-2920.2011.02593.x; Mukherjee A, 2004, J FOOD PROTECT, V67, P894, DOI 10.4315/0362-028X-67.5.894; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Niu YD, 2009, APPL ENVIRON MICROB, V75, P1271, DOI 10.1128/AEM.02100-08; Niu YD, 2012, CAN J MICROBIOL, V58, P923, DOI [10.1139/w2012-063, 10.1139/W2012-063]; Nobrega FL, 2018, NAT REV MICROBIOL, V16, P760, DOI 10.1038/s41579-018-0070-8; Pausz Clemens, 2009, V502, P255, DOI 10.1007/978-1-60327-565-1_15; PERSAD AK, 2014, PEERJ, V2; Pihkala N., 2012, RISK PROFILE PATHOGE; Pires SM, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S095026881900116X, 10.1017/s095026881900116x]; Quiros P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08169-6; Raya Raul R., 2009, V501, P23, DOI 10.1007/978-1-60327-164-6_3; Sabouri S, 2017, INT J FOOD MICROBIOL, V243, P52, DOI 10.1016/j.ijfoodmicro.2016.12.004; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Switt AIM, 2013, FOOD MICROBIOL, V36, P275, DOI 10.1016/j.fm.2013.06.014; Tanji Y, 2003, WATER RES, V37, P1136, DOI 10.1016/S0043-1354(02)00464-5; Van Twest Rohan, 2009, V501, P15, DOI 10.1007/978-1-60327-164-6_2; Venegas-Vargas C, 2016, APPL ENVIRON MICROB, V82, P5049, DOI 10.1128/AEM.00829-16; Verheust C., 2010, APPL BIOSAF, V15, P32, DOI [10.1177/153567601001500106, DOI 10.1177/153567601001500106]; Viazis S, 2011, J APPL MICROBIOL, V110, P1323, DOI 10.1111/j.1365-2672.2011.04989.x; Villafane Robert, 2009, V501, P223, DOI 10.1007/978-1-60327-164-6_20; Wang JY, 2015, CAN J MICROBIOL, V61, P467, DOI 10.1139/cjm-2015-0163	47	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234438	10.1371/journal.pone.0234438	http://dx.doi.org/10.1371/journal.pone.0234438			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525945	Green Published, gold			2022-12-26	WOS:000542036800019
J	Tang, J; Xie, J; Chen, W; Tang, CY; Wu, JJ; Wang, YP; Zhou, XD; Zhou, HD; Li, YP				Tang, Jun; Xie, Jing; Chen, Wei; Tang, Chenyi; Wu, Jinjin; Wang, Yiping; Zhou, Xue-Dong; Zhou, Hou-De; Li, Yi-Ping			Runt-related transcription factor 1 is required for murine osteoblast differentiation and bone formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Runt-related transcription factor 1 (Runx1); Runx2; osterix; osteocalcin; osteoblast; chondrocyte; bone homeostasis; osteoporosis; gene regulation; cell differentiation; bone marrow; cartilage; cell biology; osteoclast	AUTOSOMAL SEX REVERSAL; SKELETAL DEVELOPMENT; CLEIDOCRANIAL DYSPLASIA; CAMPOMELIC DYSPLASIA; CBF-BETA; GROWTH; HEDGEHOG; OSTERIX; MICE; CARTILAGE	Despite years of research investigating osteoblast differentiation, the mechanisms by which transcription factors regulate osteoblast maturation, bone formation, and bone homeostasis is still unclear. It has been reported that runt-related transcription factor 1 (Runx1) is expressed in osteoblast progenitors, pre-osteoblasts, and mature osteoblasts; yet, surprisingly, the exact function of RUNX1 in osteoblast maturation and bone formation remains unknown. Here, we generated and characterized a pre-osteoblast and differentiating chondrocyte-specificRunx1conditional knockout mouse model to study RUNX1's function in bone formation.Runx1ablation in osteoblast precursors and differentiating chondrocytes via osterix-Cre (Osx-Cre) resulted in an osteoporotic phenotype and decreased bone density in the long bones and skulls ofRunx1(f/f)Osx-Cremice compared withRunx1(f/f)andOsx-Cremice. RUNX1 deficiency reduced the expression of SRY-box transcription factor 9 (SOX9), Indian hedgehog signaling molecule (IHH), Patched (PTC), and cyclin D1 in the growth plate, and also reduced the expression of osteocalcin (OCN), OSX, activating transcription factor 4 (ATF4), and RUNX2 in osteoblasts. ChIP assays and promoter activity mapping revealed that RUNX1 directly associates with theRunx2gene promoter and up-regulatesRunx2expression. Furthermore, the ChIP data also showed that RUNX1 associates with theOcnpromoter. In conclusion, RUNX1 up-regulates the expression ofRunx2and multiple bone-specific genes, and plays an indispensable role in bone formation and homeostasis in both trabecular and cortical bone. We propose that stimulatingRunx1activity may be useful in therapeutic approaches for managing some bone diseases such as osteoporosis.	[Tang, Jun; Zhou, Hou-De] Cent South Univ, Hunan Prov Key Lab Metab Bone Dis, Natl Clin Res Ctr Metab Dis, Dept Metab & Endocrinol,Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Tang, Jun; Xie, Jing; Chen, Wei; Tang, Chenyi; Wu, Jinjin; Wang, Yiping; Li, Yi-Ping] Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL 35233 USA; [Xie, Jing; Zhou, Xue-Dong] Sichuan Univ, West China Coll Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China	Central South University; University of Alabama System; University of Alabama Birmingham; Sichuan University	Zhou, HD (corresponding author), Cent South Univ, Hunan Prov Key Lab Metab Bone Dis, Natl Clin Res Ctr Metab Dis, Dept Metab & Endocrinol,Xiangya Hosp 2, Changsha, Hunan, Peoples R China.; Chen, W; Li, YP (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL 35233 USA.	weichen@uabmc.edu; houdezhou@csu.edu.cn; yipingli@uabmc.edu	Tang, Jun/GRX-1749-2022	Zhou, Xuedong/0000-0002-9319-7302; Xie, Jing/0000-0001-8156-0322; Tang, Jun/0000-0002-6908-1027; Zhou, Hou-De/0000-0001-9131-4141	Center for Metabolic Bone Disease at the University of Alabama at Birmingham [P30 AR046031];  [P30 NS0474666]	Center for Metabolic Bone Disease at the University of Alabama at Birmingham; 	We thank Abigail McVicar for excellent assistance with the manuscript, and Matthew McConnell for bioinformatics analysis assistance. We appreciate the assistance provided by the Center for Metabolic Bone Disease at the University of Alabama at Birmingham supported by Grant P30 AR046031. We are also grateful for the assistance from the Small Animal Phenotyping Core, Metabolism Core, and Neuroscience Molecular Detection Core Laboratory at the University of Alabama at Birmingham supported by Grant P30 NS0474666.	Allende-Vega N, 2013, ONCOGENE, V32, P1, DOI 10.1038/onc.2012.38; Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Berendsen AD, 2015, BONE, V80, P14, DOI 10.1016/j.bone.2015.04.035; Brommage R, 2018, BEST PRACT RES CL EN, V32, P329, DOI 10.1016/j.beem.2018.02.006; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Chen S, 2009, J DENT RES, V88, P904, DOI 10.1177/0022034509342873; Chen W, 2007, HUM MOL GENET, V16, P410, DOI 10.1093/hmg/ddl474; Chen W, 2014, P NATL ACAD SCI USA, V111, P8482, DOI 10.1073/pnas.1310617111; Cheng SH, 2013, PHYSIOL GENOMICS, V45, P917, DOI 10.1152/physiolgenomics.00111.2013; Cohen MM, 2013, J CRANIOFAC SURG, V24, P130, DOI 10.1097/SCS.0b013e3182636b7e; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Huang W, 2015, TRANSGENIC RES, V24, P167, DOI 10.1007/s11248-014-9828-6; Jing J, 2014, J DENT RES, V93, P1014, DOI 10.1177/0022034514549379; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kimura A, 2010, DEVELOPMENT, V137, P1159, DOI 10.1242/dev.045005; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Koh CP, 2013, LEUKEMIA, V27, P1793, DOI 10.1038/leu.2013.200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Komori T, 2018, HISTOCHEM CELL BIOL, V149, P313, DOI 10.1007/s00418-018-1640-6; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Liakhovitskaia A, 2010, DEV BIOL, V340, P539, DOI 10.1016/j.ydbio.2010.02.005; Lian JB, 2003, J CELL PHYSIOL, V196, P301, DOI 10.1002/jcp.10316; Liu F, 2013, J BONE MINER RES, V28, P2414, DOI 10.1002/jbmr.1971; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Long FX, 2001, DEVELOPMENT, V128, P5099; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Miyamoto T., 2018, CLIN CALCIUM, V28, P301, DOI CliCa1803301305; Myllyharju J, 2014, CURR OSTEOPOROS REP, V12, P439, DOI 10.1007/s11914-014-0232-1; Nam M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26322-7; Okuda T, 2001, INT J HEMATOL, V74, P252, DOI 10.1007/BF02982057; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; POCKWINSE SM, 1992, J CELL BIOCHEM, V49, P310, DOI 10.1002/jcb.240490315; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Smith N, 2005, J CELL PHYSIOL, V203, P133, DOI 10.1002/jcp.20210; Soltanoff CS, 2009, CRIT REV EUKAR GENE, V19, P1; Soung DY, 2012, J BONE MINER RES, V27, P1585, DOI 10.1002/jbmr.1601; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074255; Wang L, 2015, CALCIFIED TISSUE INT, V96, P129, DOI 10.1007/s00223-014-9945-5; Wang YJ, 2005, J BONE MINER RES, V20, P1624, DOI 10.1359/JBMR.050516; Wu MR, 2014, BONE, V65, P49, DOI 10.1016/j.bone.2014.04.031; Yang SY, 2007, GENE DEV, V21, P1803, DOI 10.1101/gad.1544107	52	25	28	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11669	11681		10.1074/jbc.RA119.007896	http://dx.doi.org/10.1074/jbc.RA119.007896			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32571873	Green Published, hybrid			2022-12-26	WOS:000563922500024
J	Thouvenel, L; Prevot, G; Chiaradia, L; Parra, J; Mouton-Barbosa, E; Locard-Paulet, M; Marcoux, J; Tropis, M; Burlet-Schiltz, O; Daffe, M; Guilhot, C; Etienne, G; Chalut, C				Thouvenel, Laurie; Prevot, Gautier; Chiaradia, Laura; Parra, Julien; Mouton-Barbosa, Emmanuelle; Locard-Paulet, Marie; Marcoux, Julien; Tropis, Maryelle; Burlet-Schiltz, Odile; Daffe, Mamadou; Guilhot, Christophe; Etienne, Gilles; Chalut, Christian			The final assembly of trehalose polyphleates takes place within the outer layer of the mycobacterial cell envelope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; acyltransferase; lipid synthesis; lipid transport; membrane biogenesis; Mycobacterium smegmatis; protein export; proteomics; subcellular fractionation; trehalose polyphleate; glycolipid	GENE FUSIONS; TUBERCULOSIS; WALL; IDENTIFICATION; BIOSYNTHESIS; PROTEIN; SMEGMATIS; SURFACE; LIPIDS; EXPORT	Trehalose polyphleates (TPP) are high-molecular-weight, surface-exposed glycolipids present in a broad range of nontuberculous mycobacteria. These compounds consist of a trehalose core bearing polyunsaturated fatty acyl substituents (called phleic acids) and a straight-chain fatty acid residue and share a common basic structure with trehalose-based glycolipids produced byMycobacterium tuberculosis. TPP production starts in the cytosol with the formation of a diacyltrehalose intermediate. An acyltransferase, called PE, subsequently catalyzes the transfer of phleic acids onto diacyltrehalose to form TPP, and an MmpL transporter promotes the export of TPP or its precursor across the plasma membrane. PE is predicted to be an anchored membrane protein, but its topological organization is unknown, raising questions about the subcellular localization of the final stage of TPP biosynthesis and the chemical nature of the substrates that are translocated by the MmpL transporter. Here, using genetic, biochemical, and proteomic approaches, we established that PE ofMycobacterium smegmatisis exported to the cell envelope following cleavage of its signal peptide and that this process is required for TPP biosynthesis, indicating that the last step of TPP formation occurs in the outer layers of the mycobacterial cell envelope. These results provide detailed insights into the molecular mechanisms controlling TPP formation and transport to the cell surface, enabling us to propose an updated model of the TPP biosynthetic pathway. Because the molecular mechanisms of glycolipid production are conserved among mycobacteria, these findings obtained with PE fromM. smegmatismay offer clues to glycolipid formation inM. tuberculosis.	[Thouvenel, Laurie; Prevot, Gautier; Chiaradia, Laura; Parra, Julien; Mouton-Barbosa, Emmanuelle; Locard-Paulet, Marie; Marcoux, Julien; Tropis, Maryelle; Burlet-Schiltz, Odile; Daffe, Mamadou; Guilhot, Christophe; Etienne, Gilles; Chalut, Christian] Univ Toulouse, Inst Pharmacol & Biol Struct, UPS, CNRS, Toulouse, France; [Locard-Paulet, Marie] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark; [Prevot, Gautier] Eligo Biosci, Paris, France; [Chiaradia, Laura] Ctr Hosp Terr Gaston Bourret, Dumbea Sur Mer, New Caledonia; [Parra, Julien] Evotec, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Copenhagen; Evotec	Chalut, C (corresponding author), Univ Toulouse, Inst Pharmacol & Biol Struct, UPS, CNRS, Toulouse, France.	christian.chalut@ipbs.fr		Chiaradia, Laura/0000-0001-7683-6857; Marcoux, Julien/0000-0001-7321-7436; Locard-Paulet, Marie/0000-0003-2879-9224; Thouvenel, Laurie/0000-0003-0019-1794; Chalut, Christian/0000-0002-4849-1369	Fondation pour la Recherche Medicale (FRM) [DEQ20160334879]; CNRS; French Ministry of Research with the "Investissement d'Avenir, Infrastructures Nationales en Biologie et Sante" Program Grant [ANR-10-INBS-08]; Ministry of Teaching and Scientific Research; Novo Nordisk Foundation Grant [NNF14CC0001]	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research with the "Investissement d'Avenir, Infrastructures Nationales en Biologie et Sante" Program Grant; Ministry of Teaching and Scientific Research; Novo Nordisk Foundation Grant	This work was supported by the Fondation pour la Recherche Medicale (FRM) Grant DEQ20160334879, CNRS, and the French Ministry of Research with the "Investissement d'Avenir, Infrastructures Nationales en Biologie et Sante" Program Grant ANR-10-INBS-08 (ProFI, Proteomics French Infrastructure project) (to O. B.-S.). L. T. is the recipient of a fellowship from the Ministry of Teaching and Scientific Research. M. L.-P. was supported by Novo Nordisk Foundation Grant NNF14CC0001. L. C. was a fellow of Province-Sud of New Caledonia.	ABOUZEID C, 1988, J GEN MICROBIOL, V134, P531; Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; ASSELINEAU C, 1969, EUR J BIOCHEM, V10, P580, DOI 10.1111/j.1432-1033.1969.tb00728.x; ASSELINEAU CP, 1972, EUR J BIOCHEM, V28, P102, DOI 10.1111/j.1432-1033.1972.tb01889.x; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; Ates LS, 2020, MOL MICROBIOL, V113, P4, DOI 10.1111/mmi.14409; Auclair SM, 2012, PROTEIN SCI, V21, P13, DOI 10.1002/pro.757; Barry Clifton E., 2007, Infectious Disorders - Drug Targets, V7, P182; Belanova M, 2008, J BACTERIOL, V190, P1141, DOI 10.1128/JB.01326-07; Belardinelli JM, 2017, TUBERCULOSIS, V105, P13, DOI 10.1016/j.tube.2017.04.001; Belardinelli JM, 2014, J BIOL CHEM, V289, P27952, DOI 10.1074/jbc.M114.581199; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bouyssie D, 2020, BIOINFORMATICS, V36, P3148, DOI 10.1093/bioinformatics/btaa118; Burbaud S, 2016, CELL CHEM BIOL, V23, P278, DOI 10.1016/j.chembiol.2015.11.013; Chalut C, 2016, TUBERCULOSIS, V100, P32, DOI 10.1016/j.tube.2016.06.004; Chiaradia L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12718-4; Daffe M, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0027-2018; Daffe M, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0021-2013; Deshayes C, 2010, MOL MICROBIOL, V78, P989, DOI 10.1111/j.1365-2958.2010.07385.x; Etienne G, 2009, J BACTERIOL, V191, P2613, DOI 10.1128/JB.01235-08; Fay A, 2019, MBIO, V10, DOI 10.1128/mBio.00850-19; Fenn K, 2020, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00149; Flores AR, 2005, MICROBIOL-SGM, V151, P521, DOI 10.1099/mic.0.27629-0; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; GUTIERREZ C, 1989, NUCLEIC ACIDS RES, V17, P3999, DOI 10.1093/nar/17.10.3999; Hermann C, 2019, J PROTEOMICS, V191, P166, DOI 10.1016/j.jprot.2018.02.019; Jain P, 2005, MOL MICROBIOL, V58, P1392, DOI 10.1111/j.1365-2958.2005.04908.x; Kocincova D, 2004, FEMS MICROBIOL LETT, V231, P191, DOI 10.1016/S0378-1097(03)00964-9; Le Dantec C, 2001, J BACTERIOL, V183, P2157, DOI 10.1128/JB.183.7.2157-2164.2001; Li W, 2006, BIOCHEM BIOPH RES CO, V342, P170, DOI 10.1016/j.bbrc.2006.01.130; Llorens-Fons M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01402; Malaga W, 2003, FEMS MICROBIOL LETT, V219, P261, DOI 10.1016/S0378-1097(03)00003-X; Manca C, 1997, INFECT IMMUN, V65, P4951, DOI 10.1128/IAI.65.12.4951-4957.1997; Manca C, 1997, INFECT IMMUN, V65, P16, DOI 10.1128/IAI.65.1.16-23.1997; McCann JR, 2007, MICROBIOL-SGM, V153, P3350, DOI 10.1099/mic.0.2007/008516-0; NAGAI S, 1991, INFECT IMMUN, V59, P372, DOI 10.1128/IAI.59.1.372-382.1991; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OrtaloMagne A, 1996, J BACTERIOL, V178, P456, DOI 10.1128/jb.178.2.456-461.1996; Palmer T, 2020, MOL MICROBIOL, V113, P861, DOI 10.1111/mmi.14461; PALZKILL T, 1994, J BACTERIOL, V176, P563, DOI 10.1128/jb.176.3.563-568.1994; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Plocinski P, 2012, J BACTERIOL, V194, P6398, DOI 10.1128/JB.01005-12; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Roche PW, 1996, CLIN EXP IMMUNOL, V103, P226, DOI 10.1046/j.1365-2249.1996.d01-613.x; Schaeffer ML, 1999, J BIOL CHEM, V274, P31625, DOI 10.1074/jbc.274.44.31625; Seeliger J, 2016, CELL CHEM BIOL, V23, P207, DOI 10.1016/j.chembiol.2016.02.004; Seeliger JC, 2012, J BIOL CHEM, V287, P7990, DOI 10.1074/jbc.M111.315473; Simeone R, 2015, TUBERCULOSIS, V95, pS150, DOI 10.1016/j.tube.2015.02.019; Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x; Sultana R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016745; TIMM JL, 1994, J BACTERIOL, V176, P6749, DOI 10.1128/JB.176.21.6749-6753.1994; Touchette MH, 2017, BBA-MOL CELL BIOL L, V1862, P1340, DOI 10.1016/j.bbalip.2017.01.005; Touchette MH, 2015, J BACTERIOL, V197, P201, DOI 10.1128/JB.02015-14; Trefzer C, 2012, J AM CHEM SOC, V134, P912, DOI 10.1021/ja211042r; Upadhyay A, 2015, ACS CENTRAL SCI, V1, P292, DOI 10.1021/acscentsci.5b00212; Wiker HG, 2000, MICROBIOL-SGM, V146, P1525, DOI 10.1099/00221287-146-7-1525; Wirth SE, 2012, MOL MICROBIOL, V83, P654, DOI 10.1111/j.1365-2958.2011.07958.x	57	1	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11184	11194		10.1074/jbc.RA120.013299	http://dx.doi.org/10.1074/jbc.RA120.013299			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32554804	Green Published, hybrid			2022-12-26	WOS:000562757100022
J	Gao, HW; Bai, PR; Xiao, L; Shen, MJ; Yu, QX; Lei, YY; Huang, WT; Lin, X; Zheng, XY; Wei, T; Jiang, Y; Ye, F; Bu, H				Gao, Hongwei; Bai, Peirong; Xiao, Lin; Shen, Mengjia; Yu, Qiuxiao; Lei, Yuanyuan; Huang, Wenting; Lin, Xiang; Zheng, Xinyi; Wei, Tao; Jiang, Yong; Ye, Feng; Bu, Hong			Mediator complex subunit 16 is down-regulated in papillary thyroid cancer, leading to increased transforming growth factor-beta signaling and radioiodine resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mediator complex subunit 16 (MED16); epithelial-mesenchymal transition (EMT); radioactive iodine (RAI) resistance; SMAD transcription factor; papillary thyroid cancer; transforming growth factor beta (TGF-beta); sodium; iodide symporter (NIS); tumor therapy; gene regulation; radioactive iodine (RAI) refractory	EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; DISTANT METASTASES; REPRESSION; CARCINOMA; ACTIVATION; EXPRESSION; PROGNOSIS; CELLS; BRAF	Mediator complex subunit 16 (MED16) is a component of the mediator complex and functions as a coactivator in transcriptional events at almost all RNA polymerase II-dependent genes. In this study, we report that the expression of MED16 is markedly decreased in papillary thyroid cancer (PTC) tumors compared with normal thyroid tissues.In vitro, MED16 overexpression in PTC cells significantly inhibited cell migration, enhanced sodium/iodide symporter expression and iodine uptake, and decreased resistance to radioactive(131)I (RAI). Conversely, PTC cells in which MED16 had been further knocked down (MED16(KD)) exhibited enhanced cell migration, epithelial-mesenchymal transition, and RAI resistance, accompanied by decreased sodium/iodide symporter levels. Moreover, cell signaling through transforming growth factor beta (TGF-beta) was highly activated after the MED16 knockdown. Similar results were obtained in MED12(KD)PTC cells, and a co-immunoprecipitation experiment verified interactions between MED16 and MED12 and between MED16 and TGF-beta R2. Of note, the application of LY2157299, a potent inhibitor of TGF-beta signaling, significantly attenuated MED16(KD)-induced RAI resistance bothin vitroandin vivo. In conclusion, our findings indicate that MED16 reduction in PTC contributes to tumor progression and RAI resistance via the activation of the TGF-beta pathway.	[Gao, Hongwei; Bai, Peirong; Xiao, Lin; Shen, Mengjia; Lin, Xiang; Zheng, Xinyi; Ye, Feng; Bu, Hong] Sichuan Univ, West China Hosp, Lab Pathol, Chengdu, Peoples R China; [Gao, Hongwei; Bai, Peirong; Ye, Feng; Bu, Hong] Sichuan Univ, West China Hosp, Key Lab Transplant Engn & Immunol, Minist Hlth, Chengdu, Peoples R China; [Shen, Mengjia; Jiang, Yong; Bu, Hong] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China; [Yu, Qiuxiao; Lei, Yuanyuan; Huang, Wenting] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc Canc Hosp & Shenzhen Hosp, Shenzhen, Peoples R China; [Wei, Tao] Sichuan Univ, Dept Thyroid Surg, West China Hosp, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Sichuan University	Ye, F; Bu, H (corresponding author), Sichuan Univ, West China Hosp, Lab Pathol, Chengdu, Peoples R China.; Ye, F; Bu, H (corresponding author), Sichuan Univ, West China Hosp, Key Lab Transplant Engn & Immunol, Minist Hlth, Chengdu, Peoples R China.; Bu, H (corresponding author), Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China.	fengye@scu.edu.cn; hongbu@scu.edu.cn	lei, yuan/GXW-0547-2022	Zheng, Xinyi/0000-0002-8299-9684	National Natural Science Foundation of China [81972498]; 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University [ZYGD18012, 2020HXFH009]; Science and Technology Department of Sichuan Province [2019YFS0324]; Chengdu Science and Technology Bureau [2018-YF05-01177-SN]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University; Science and Technology Department of Sichuan Province; Chengdu Science and Technology Bureau	This work was supported by Grant 81972498 from the National Natural Science Foundation of China; Grant ZYGD18012 and 2020HXFH009 from the 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University; Grant 2019YFS0324 from the Research Supporting Project from Science and Technology Department of Sichuan Province; and Grant 2018-YF05-01177-SN from the Chengdu Science and Technology Bureau.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bravo SB, 2003, ONCOGENE, V22, P7819, DOI 10.1038/sj.onc.1207029; Brunen D, 2013, CELL CYCLE, V12, P2960, DOI 10.4161/cc.26034; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Costamagna E, 2004, J BIOL CHEM, V279, P3439, DOI 10.1074/jbc.M307138200; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Franzen A, 1999, ENDOCRINOLOGY, V140, P4300, DOI 10.1210/en.140.9.4300; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; GRUBECKLOEBENSTEIN B, 1989, J CLIN INVEST, V83, P764, DOI 10.1172/JCI113955; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Liu JR, 2019, ENDOCRINOL METAB, V34, P215, DOI 10.3803/EnM.2019.34.3.215; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Ma SY, 2016, TUMOR BIOL, V37, P989, DOI 10.1007/s13277-015-3848-6; McConkey DJ, 2009, CANCER METAST REV, V28, P335, DOI 10.1007/s10555-009-9194-7; Mittal V, 2018, ANNU REV PATHOL-MECH, V13, P395, DOI 10.1146/annurev-pathol-020117-043854; Nixon IJ, 2012, THYROID, V22, P884, DOI 10.1089/thy.2011.0535; Ochiai H, 2010, ONCOGENE, V29, P2681, DOI 10.1038/onc.2010.22; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Riesco-Eizaguirre G, 2009, CANCER RES, V69, P8317, DOI 10.1158/0008-5472.CAN-09-1248; Saxena M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.61; Schiano C, 2014, BBA-REV CANCER, V1845, P66, DOI 10.1016/j.bbcan.2013.12.001; Shoup M, 2003, J AM COLL SURGEONS, V197, P191, DOI 10.1016/S1072-7515(03)00332-6; Syring I, 2016, ONCOTARGET, V7, P23043, DOI 10.18632/oncotarget.8469; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wartofsky L, 2010, HORM-INT J ENDOCRINO, V9, P103, DOI 10.14310/horm.2002.1260; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987; Zhao L, 2015, INT J MOL MED, V36, P645, DOI 10.3892/ijmm.2015.2268; Zhu XY, 2015, MOL MED REP, V11, P3729, DOI 10.3892/mmr.2015.3180	33	5	6	3	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10726	10740		10.1074/jbc.RA119.012404	http://dx.doi.org/10.1074/jbc.RA119.012404			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32532820	Green Published, hybrid			2022-12-26	WOS:000560405600017
J	Gulamhussene, G; Joeres, F; Rak, M; Pech, M; Hansen, C				Gulamhussene, Gino; Joeres, Fabian; Rak, Marko; Pech, Maciej; Hansen, Christian			4D MRI: Robust sorting of free breathing MRI slices for use in interventional settings	PLOS ONE			English	Article							RESPIRATORY MOTION; IMAGE; 4D-MRI; RECONSTRUCTION; ACQUISITIONS	Purpose We aim to develop a robust 4D MRI method for large FOVs enabling the extraction of irregular respiratory motion that is readily usable with all MRI machines and thus applicable to support a wide range of interventional settings. Method We propose a 4D MRI reconstruction method to capture an arbitrary number of breathing states. It uses template updates in navigator slices and search regions for fast and robust vessel cross-section tracking. It captures FOVs of 255 mm x 320 mm x 228 mm at a spatial resolution of 1.82 mm x 1.82 mm x 4mm and temporal resolution of 200ms. A total of 37 4D MRIs of 13 healthy subjects were reconstructed to validate the method. A quantitative evaluation of the reconstruction rate and speed of both the new and baseline method was performed. Additionally, a study with ten radiologists was conducted to assess the subjective reconstruction quality of both methods. Results Our results indicate improved mean reconstruction rates compared to the baseline method (79.4% vs. 45.5%) and improved mean reconstruction times (24s vs. 73s) per subject. Interventional radiologists perceive the reconstruction quality of our method as higher compared to the baseline (262.5 points vs. 217.5 points, p = 0.02). Conclusions Template updates are an effective and efficient way to increase 4D MRI reconstruction rates and to achieve better reconstruction quality. Search regions reduce reconstruction time. These improvements increase the applicability of 4D MRI as a base for seamless support of interventional image guidance in percutaneous interventions.	[Gulamhussene, Gino; Joeres, Fabian; Rak, Marko; Hansen, Christian] Otto von Guericke Univ, Fac Comp Sci, Magdeburg, Germany; [Pech, Maciej] Univ Hosp Magdeburg, Clin Radiol & Nucl Med, Magdeburg, Germany	Otto von Guericke University; University Hospital Magdeburg	Hansen, C (corresponding author), Otto von Guericke Univ, Fac Comp Sci, Magdeburg, Germany.	hansen@isg.cs.uni-magdeburg.de		Gulamhussene, Gino/0000-0003-0026-0032; Hansen, Christian/0000-0002-5734-7529; Joeres, Fabian/0000-0001-8105-9263	Investitionsbank Sachsen-Anhalt [1704/00038]	Investitionsbank Sachsen-Anhalt	This study was supported by funding from the Investitionsbank Sachsen-Anhalt (https://www.ib-sachsen-anhalt.de/) to GG with the grant number 1704/00038. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Barth M, 2016, MAGN RESON MED, V75, P63, DOI 10.1002/mrm.25897; Bled E, 2011, CONTRAST MEDIA MOL I, V6, P275, DOI 10.1002/cmmi.429; Bradski G., 2000, DOBBS J SOFTWARE TOO; Cai J, 2011, MED PHYS, V38, P6384, DOI 10.1118/1.3658737; Celicanin Z, 2015, MAGN RESON MED, V73, P669, DOI 10.1002/mrm.25134; Colvill E, 2016, RADIOTHER ONCOL, V119, P159, DOI 10.1016/j.radonc.2016.03.006; Deng ZX, 2016, MAGN RESON MED, V75, P1574, DOI 10.1002/mrm.25753; Giger A, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aaca1d; Gulamhussene G, 2D MRI LIVER SLICES, DOI [10.24352/UB.OVGU-2019-093, DOI 10.24352/UB.0VGU-2019-093]; Han F, 2018, RADIOTHER ONCOL, V127, P467, DOI 10.1016/j.radonc.2018.04.029; Han F, 2017, MED PHYS, V44, P1359, DOI 10.1002/mp.12139; Kim YC, 2014, MAGN RESON MED, V71, P1501, DOI 10.1002/mrm.24808; Lee D, 2019, J MED IMAG RADIAT ON, V63, P360, DOI 10.1111/1754-9485.12877; Merchavy S, 2016, OTOLARYNG HEAD NECK, V154, P446, DOI 10.1177/0194599815618199; Mickevicius NJ, 2017, PHYS MED BIOL, V62, P2910, DOI 10.1088/1361-6560/aa54f2; Pang J, 2016, INT J RADIAT ONCOL, V96, pS62, DOI 10.1016/j.ijrobp.2016.06.160; Preiswerk F, 2017, MAGN RESON MED, V78, P897, DOI 10.1002/mrm.26467; Rank CM, 2017, MAGN RESON MED, V77, P1170, DOI 10.1002/mrm.26206; Romaguera LV, 2019, INT J COMPUTER ASSIS, P1; Stemkens B, 2015, INT J RADIAT ONCOL, V91, P571, DOI 10.1016/j.ijrobp.2014.10.050; Tong Y, 2017, MED IMAGE ANAL, V35, P345, DOI 10.1016/j.media.2016.08.001; von Siebenthal M, 2007, PHYS MED BIOL, V52, P1547, DOI 10.1088/0031-9155/52/6/001; von Siebenthal M, 2005, LECT NOTES COMPUT SC, V3750, P336, DOI 10.1007/11566489_42	23	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235175	10.1371/journal.pone.0235175	http://dx.doi.org/10.1371/journal.pone.0235175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569335	Green Published, gold, Green Submitted			2022-12-26	WOS:000543547900024
J	Park, S; Moon, S; Pai, H; Kim, B				Park, Seonghun; Moon, Shinje; Pai, Hyunjoo; Kim, Bongyoung			Appropriate duration of peripherally inserted central catheter maintenance to prevent central line-associated bloodstream infection	PLOS ONE			English	Article							CENTRAL VENOUS CATHETERS; GUIDELINES; RISK	Background/aim Prolonged maintenance of central venous catheters, including peripherally inserted central catheters (PICCs), is a major risk factor for central line-associated bloodstream infection (CLABSI). This study was conducted to evaluate the appropriate duration of PICC maintenance to prevent CLABSI. Methods A single-center retrospective study was conducted at an 824-bed tertiary hospital in Korea between January 2010 and December 2017. All hospitalized patients who underwent ultrasound-guided PICC insertion were enrolled. CLABSI was diagnosed according to the definitions of the National Health Safety Network. CLABSI caused by PICC was defined as PICC-associated bloodstream infection (PABSI). To identifying statistical correlations between catheter days and PABSI, the odds ratio for PABSI on the basis of the continuous value of catheter days was analyzed using restricted cubic spline splits with five knots. The optimal cut-off value for catheter days was identified by maximizing the area under the receiver operating characteristic (ROC) curve (AUC). Results A total of 1,053 patients underwent ultrasound-guided PICC insertion during the study period. Among them, 36 were confirmed as having a PABSI (3.5%, 36/1014; 1.14 per 1000 catheter days). In the restricted cubic spline regression, catheter days showed a dose-dependent relationship with the risk of PABSI. The AUC of the ROC curve for developing a PABSI according to the duration of catheter maintenance was 0.715 (95% CI, 0.639-0.790); the calculated optimal cut-off value was 25 days. Conclusion The incidence of PABSI was 1.14 per 1000 catheter days and the optimal cut-off value of catheter days to avoid a PABSI was 25 days.	[Park, Seonghun] Hanyang Univ, Coll Med, Sch Med, Seoul, South Korea; [Moon, Shinje] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea; [Pai, Hyunjoo; Kim, Bongyoung] Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Hanyang University; Hallym University; Hanyang University	Kim, B (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	sobakas@hanyang.ac.kr	Kim, Bongyoung/H-3409-2018	Kim, Bongyoung/0000-0002-5029-6597				Chopra V, 2015, ANN INTERN MED, V163, pS1, DOI 10.7326/M15-0744; Chopra V, 2014, AM J MED, V127, P319, DOI 10.1016/j.amjmed.2014.01.001; Chopra V, 2013, INFECT CONT HOSP EP, V34, P908, DOI 10.1086/671737; Chopra V, 2013, J HOSP MED, V8, P309, DOI 10.1002/jhm.2031; COBB DK, 1992, NEW ENGL J MED, V327, P1062, DOI 10.1056/NEJM199210083271505; EYER S, 1990, CRIT CARE MED, V18, P1073, DOI 10.1097/00003246-199010000-00005; Fallouh N, 2015, AM J MED, V128, P722, DOI 10.1016/j.amjmed.2015.01.027; Frykholm P, 2014, ACTA ANAESTH SCAND, V58, P508, DOI 10.1111/aas.12295; Gahlot Rupam, 2014, Int J Crit Illn Inj Sci, V4, P162, DOI 10.4103/2229-5151.134184; GIL RT, 1989, ARCH INTERN MED, V149, P1139, DOI 10.1001/archinte.149.5.1139; Johansson E, 2013, ACTA ONCOL, V52, P886, DOI 10.3109/0284186X.2013.773072; LOUGHRAN SC, 1995, JPEN-PARENTER ENTER, V19, P133, DOI 10.1177/0148607195019002133; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; Safdar N, 2005, CHEST, V128, P489, DOI 10.1378/chest.128.2.489; Seo HK, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e280	17	6	8	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234966	10.1371/journal.pone.0234966	http://dx.doi.org/10.1371/journal.pone.0234966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569313	Green Published, gold			2022-12-26	WOS:000543547900022
J	Rivera, JN; Kierski, TM; Kasoji, SK; Abrantes, AS; Dayton, PA; Chang, SX				Rivera, Judith N.; Kierski, Thomas M.; Kasoji, Sandeep K.; Abrantes, Anthony S.; Dayton, Paul A.; Chang, Sha X.			Conventional dose rate spatially-fractionated radiation therapy (SFRT) treatment response and its association with dosimetric parameters-A preclinical study in a Fischer 344 rat model	PLOS ONE			English	Article							SYNCHROTRON MICROBEAM; RADIOTHERAPY; FEASIBILITY; IRRADIATION	Purpose To identify key dosimetric parameters that have close associations with tumor treatment response and body weight change in SFRT treatments with a large range of spatial-fractionation scale at dose rates of several Gy/min. Methods Six study arms using uniform tumor radiation, half-tumor radiation, 2mm beam array radiation, 0.3mm minibeam radiation, and an untreated arm were used. All treatments were delivered on a 320kV x-ray irradiator. Forty-two female Fischer 344 rats with fibrosarcoma tumor allografts were used. Dosimetric parameters studied are peak dose and width, valley dose and width, peak-to-valley-dose-ratio (PVDR), volumetric average dose, percentage volume directly irradiated, and tumor- and normal-tissue EUD. Animal survival, tumor volume change, and body weight change (indicative of treatment toxicity) are tested for association with the dosimetric parameters using linear regression and Cox Proportional Hazards models. Results The dosimetric parameters most closely associated with tumor response are tumor EUD (R-2= 0.7923, F-stat = 15.26*; z-test = -4.07***), valley (minimum) dose (R-2= 0.7636, F-stat = 12.92*; z-test = -4.338***), and percentage tumor directly irradiated (R-2= 0.7153, F-stat = 10.05*; z-test = -3.837***) per the linear regression and Cox Proportional Hazards models, respectively. Tumor response is linearly proportional to valley (minimum) doses and tumor EUD. Average dose (R-2= 0.2745, F-stat = 1.514 (no sig.); z-test = -2.811**) and peak dose (R-2= 0.04472, F-stat = 0.6874 (not sig.); z-test = -0.786 (not sig.)) show the weakest associations to tumor response. Only the uniform radiation arm did not gain body weight post-radiation, indicative of treatment toxicity; however, body weight change in general shows weak association with all dosimetric parameters except for valley (minimum) dose (R-2= 0.3814, F-stat = 13.56**), valley width (R-2= 0.2853, F-stat = 8.783**), and peak width (R-2= 0.2759, F-stat = 8.382**). Conclusions For a single-fraction SFRT at conventional dose rates, valley, not peak, dose is closely associated with tumor treatment response and thus should be used for treatment prescription. Tumor EUD, valley (minimum) dose, and percentage tumor directly irradiated are the top three dosimetric parameters that exhibited close associations with tumor response.	[Rivera, Judith N.; Kierski, Thomas M.; Kasoji, Sandeep K.; Dayton, Paul A.; Chang, Sha X.] Joint Program Univ North Carolina Chapel Hill & N, Dept Biomed Engn, Chapel Hill, NC 27515 USA; [Abrantes, Anthony S.] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27515 USA; [Chang, Sha X.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Chang, SX (corresponding author), Joint Program Univ North Carolina Chapel Hill & N, Dept Biomed Engn, Chapel Hill, NC 27515 USA.; Chang, SX (corresponding author), Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27515 USA.	sha_chang@med.unc.edu						Allison M, 2010, NY TIMES BK REV, P5; [Anonymous], 2014, EARLY HUM DEV S1, V90, pS35; [Anonymous], [No title captured]; [Anonymous], 2015, AM J PHARM BENEFITS, V7, pe141; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Bazyar S, 2017, PHYS MED BIOL, V62, P8924, DOI 10.1088/1361-6560/aa926b; Billena C, 2019, INT J RADIAT ONCOL, V104, P177, DOI 10.1016/j.ijrobp.2019.01.073; Bouchet A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081874; Brauer-Krisch E, 2010, MUTAT RES-REV MUTAT, V704, P160, DOI 10.1016/j.mrrev.2009.12.003; Bravin A, 2015, PHYS MEDICA, V31, P561, DOI 10.1016/j.ejmp.2015.06.002; Chang SX, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-5051; Dilmanian FA, 2015, INT J RADIAT ONCOL, V92, P469, DOI 10.1016/j.ijrobp.2015.01.018; Eling L, 2019, RADIOTHER ONCOL, V139, P56, DOI 10.1016/j.radonc.2019.06.030; Faustino-Rocha A, 2013, LAB ANIMAL, V42, P217, DOI 10.1038/laban.254; Favaudon V, 2015, CANCER RADIOTHER, V19, P526, DOI 10.1016/j.canrad.2015.04.006; Fontanella AN, 2015, RAD RES, P183; Gessner RC, 2013, INT JURNAL BIOMEDICA, V2013, DOI [10.1155/2013/154860, DOI 10.1155/2013/154860]; Ha JK, 2006, MED PHYS, V33, P76, DOI 10.1118/1.2140116; Hickman DL, 2010, J AM ASSOC LAB ANIM, V49, P155; Ibahim MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100547; Kasoji SK, 2018, THERANOSTICS, V8, P156, DOI 10.7150/thno.19703; Kutner M., 2005, APPL LINEAR STAT MOD; Laissue JA, 2012, Z MED PHYS, V22, P90, DOI 10.1016/j.zemedi.2011.07.002; Martinez-Rovira I, 2017, MED PHYS, V44, P4223, DOI 10.1002/mp.12383; Mavroidis P, 2001, PHYS MED BIOL, V46, P2607, DOI 10.1088/0031-9155/46/10/307; Montay-Gruel P, 2018, RADIOTHER ONCOL, V129, P582, DOI 10.1016/j.radonc.2018.08.016; Narayanasamy G, 2017, ACTA ONCOL, V56, P1043, DOI 10.1080/0284186X.2017.1299219; Neuner G, 2012, INT J RADIAT ONCOL, V82, P1642, DOI 10.1016/j.ijrobp.2011.01.065; Niemierko A, 1997, MED PHYS, V24, P103, DOI 10.1118/1.598063; Piccolo R, 2017, CATHETER CARDIOVASC, V90, pE73, DOI 10.1002/ccd.26921; Prezado Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17543-3; Prezado Y, 2015, RADIAT RES, V184, P314, DOI 10.1667/RR14018.1; Prezado Y, 2012, J SYNCHROTRON RADIAT, V19, P60, DOI 10.1107/S0909049511047042; Priyadarshika RCU, 2011, BRIT J RADIOL, V84, P833, DOI 10.1259/bjr/58503354; Schroeder T, 2005, CANCER RES, V65, P5163, DOI 10.1158/0008-5472.CAN-04-3900; Serduc R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009028; Serduc R, 2009, PHYS MED BIOL, V54, P6711, DOI 10.1088/0031-9155/54/21/017; Society C-SbNCITR, 2018, WORKSH UND HIGH DOS; Terahara A, 1999, INT J RADIAT ONCOL, V45, P351, DOI 10.1016/S0360-3016(99)00146-7; Wu QW, 2002, INT J RADIAT ONCOL, V52, P224, DOI 10.1016/S0360-3016(01)02585-8; Yang YQ, 2019, RADIOTHER ONCOL, V133, P93, DOI 10.1016/j.radonc.2019.01.006; Zhang X, 2013, MED INNOVATION CHINA, V9, P5	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0229053	10.1371/journal.pone.0229053	http://dx.doi.org/10.1371/journal.pone.0229053			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569277	Green Published, Green Submitted, gold			2022-12-26	WOS:000543547900033
J	Chandrashekar, DS; Golonka, RM; San Yeoh, B; Gonzalez, DJ; Heikenwalder, M; Gerwirtz, AT; Varambally, S; Vijay-Kumar, M				Chandrashekar, Darshan Shimoga; Golonka, Rachel M.; San Yeoh, Beng; Gonzalez, David J.; Heikenwaelder, Mathias; Gerwirtz, Andrew T.; Varambally, Sooryanarayana; Vijay-Kumar, Matam			Fermentable fiber-induced hepatocellular carcinoma in mice recapitulates gene signatures found in human liver cancer	PLOS ONE			English	Article							MAJOR URINARY PROTEIN; GUT-MICROBIOTA; MOUSE MODELS; IDENTIFICATION; POLYMORPHISMS; PROGRESSION; GUIDE	Hepatocellular carcinoma (HCC), the most malignant form of primary liver cancer, is the fourth most prevalent cause of cancer mortality globally. It was recently discovered that the dietary fermentable fiber, inulin, can reprogram the murine liver to favor HCC development in a gut microbiota-dependent manner. Determining the molecular pathways that are either over expressed or repressed during inulin-induced HCC would provide a platform of potential therapeutic targets. In the present study, we have combined analysis of the novel inulin-induced HCC murine model and human HCC samples to identify differentially expressed genes (DEGs) in hepatocarcinogenesis. Hepatic transcriptome profiling revealed that there were 674 DEGs in HCC mice compared to mice safeguarded from HCC. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis uncovered enrichment in ECM-receptor interaction, steroid hormone biosynthesis, PPAR signaling pathway, focal adhesion and protein digestion and absorption during inulin-induced HCC. Tandem mass tag based quantitative, multiplexed proteomic analysis delineated 57 differentially expressed proteins, where the over-expressed proteins were associated with cell adhesion molecules, valine, leucine and isoleucine degradation and ECM-receptor interaction. After obtaining the human orthologs of the mouse genes, we did a comparison analysis to level 3 RNA-seq data found in the Cancer Genome Atlas (TCGA) database, corresponding to human HCC (n = 361) and healthy liver (n = 50) samples. Out of the 549 up-regulated and 68 down-regulated human orthologs identified, 142 genes (137 significantly over-expressed and 5 significantly under-expressed) were associated with human HCC. Using univariate survival analysis, we found 27 over-expressed genes involved in cell-cell adhesion and cell division that were associated with poor HCC patient survival. Overall, the genetic and proteomics signatures highlight potential underlying mechanisms in inulin-induced HCC and support that this murine HCC model is human relevant.	[Chandrashekar, Darshan Shimoga; Varambally, Sooryanarayana] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Golonka, Rachel M.; San Yeoh, Beng; Vijay-Kumar, Matam] Univ Toledo, Dept Physiol & Pharmacol, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Gonzalez, David J.] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Gonzalez, David J.] Univ Calif San Diego, Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Heikenwaelder, Mathias] German Canc Res Ctr, Div Chron Inflammat & Canc, Heidelberg, Germany; [Gerwirtz, Andrew T.] Georgia State Univ, Ctr Inflammat Immun & Infect, Inst Biomed Sci, Atlanta, GA 30303 USA; [Varambally, Sooryanarayana] Univ Alabama Birmingham, Comprehens Canc Ctr, Birmingham, AL 35294 USA; [Vijay-Kumar, Matam] Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA	University of Alabama System; University of Alabama Birmingham; University System of Ohio; University of Toledo; University of California System; University of California San Diego; University of California System; University of California San Diego; Helmholtz Association; German Cancer Research Center (DKFZ); University System of Georgia; Georgia State University; University of Alabama System; University of Alabama Birmingham; University System of Ohio; University of Toledo	Varambally, S (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.; Vijay-Kumar, M (corresponding author), Univ Toledo, Dept Physiol & Pharmacol, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.; Varambally, S (corresponding author), Univ Alabama Birmingham, Comprehens Canc Ctr, Birmingham, AL 35294 USA.; Vijay-Kumar, M (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.	svarambally@uabmc.edu; MatamVijay.Kumar@UToledo.edu			R01 grant from the National Institutes of Health (NIH) [CA219144]	R01 grant from the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	MVK is supported by R01 grant from the National Institutes of Health (NIH) [grant number CA219144]. Funders website: https://www.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhdar H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167543; [Anonymous], 2017, LANCET HIV, V2017, pPE475; Bakiri L, 2013, MOL ONCOL, V7, P206, DOI 10.1016/j.molonc.2013.01.005; Chen C, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0919-8; Chen X, 2015, CANCER SCI, V106, P972, DOI 10.1111/cas.12700; Cusato J, 2018, CANCER CHEMOTH PHARM, V81, P615, DOI 10.1007/s00280-018-3520-0; Davis-Turak J, 2017, EXPERT REV MOL DIAGN, V17, P225, DOI 10.1080/14737159.2017.1282822; Debes JD, 2019, ANN HEPATOL, V18, P786, DOI 10.1016/j.aohep.2019.07.009; Dennis G, 2003, GENOME BIOL, V4; Dow M, 2018, P NATL ACAD SCI USA, V115, pE9879, DOI 10.1073/pnas.1811029115; DRAGANI TA, 1989, MOL CARCINOGEN, V2, P355, DOI 10.1002/mc.2940020610; Elchuri S, 2007, PROTEOMICS, V7, P2121, DOI 10.1002/pmic.200601011; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fan CY, 1996, J BIOL CHEM, V271, P24698, DOI 10.1074/jbc.271.40.24698; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Golonka RM, 2020, AM J PHYSIOL-GASTR L, V318, pG955, DOI 10.1152/ajpgi.00349.2019; Hackl H, 2016, NAT REV GENET, V17, P441, DOI 10.1038/nrg.2016.67; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Hsu HT, 2014, J HEPATOCELL CARCINO, V1, P127, DOI 10.2147/JHC.S48512; Jin X, 2019, J CELL PHYSIOL, V234, P16592, DOI 10.1002/jcp.28331; Kew MC, 2013, J GASTROINTEST LIVER, V22, P305; Kraus WE, 2015, J CARDIOVASC TRANSL, V8, P449, DOI 10.1007/s12265-015-9648-y; Leung WKC, 2011, ONCOGENE, V30, P4464, DOI 10.1038/onc.2011.161; Li L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080637, 10.1371/journal.pone.0075104]; Li MJ, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0208-8; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Liu G, 2019, FASEB J, V33, P10089, DOI 10.1096/fj.201802619RR; Liu XJ, 2020, J CANCER, V11, P83, DOI 10.7150/jca.36495; Ma HP, 2019, CANCERS, V11, DOI 10.3390/cancers11060786; Marshall A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059459; Nath A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14752; Navarro VJ, 2017, HEPATOLOGY, V65, P363, DOI 10.1002/hep.28813; Newell P, 2008, J HEPATOL, V48, P858, DOI 10.1016/j.jhep.2008.01.008; Okada H, 2005, INT J ONCOL, V26, P369; Olsen LR, 2014, CANCER IMMUNOL IMMUN, V63, P1235, DOI 10.1007/s00262-014-1627-7; Rosenthal N, 2007, NAT CELL BIOL, V9, P993, DOI 10.1038/ncb437; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Schroder PC, 2011, FUNCT INTEGR GENOMIC, V11, P419, DOI 10.1007/s10142-011-0230-7; Singh V, 2018, CELL, V175, P679, DOI 10.1016/j.cell.2018.09.004; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Torres CM, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1644; Tung YT, 2017, INT J MED SCI, V14, P257, DOI 10.7150/ijms.17792; U.S. Food and Drug Administration,, 2018, DECL CERT IS SYNTH N; Uehara Takeki, 2014, Curr Protoc Pharmacol, V66, DOI 10.1002/0471141755.ph1430s66; Vandamme TF, 2014, J PHARM BIOALLIED SC, V6, P2, DOI 10.4103/0975-7406.124301; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300; Wan MLY, 2018, HEPATOBIL SURG NUTR, V7, P11, DOI 10.21037/hbsn.2017.12.07; Wang B, 2017, INT J MED SCI, V14, P880, DOI 10.7150/ijms.19620; Wang ZN, 2016, METHODS MOL BIOL, V1418, P111, DOI 10.1007/978-1-4939-3578-9_6; Xiong Y, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20182384; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y; Yau YK, 2013, J GASTROEN HEPATOL, V28, P1076, DOI 10.1111/jgh.12193; Yi QY, 2020, GENE, V725, DOI 10.1016/j.gene.2019.144159; Zavadil JA, 2019, MOL CARCINOGEN, V58, P309, DOI 10.1002/mc.22929; Zhou YJ, 2010, VITAM HORM, V83, P151, DOI 10.1016/S0083-6729(10)83006-7; Zhu Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0894-1; Zhu YT, 2014, NAT METHODS, V11, P599, DOI 10.1038/nmeth.2956	60	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234726	10.1371/journal.pone.0234726	http://dx.doi.org/10.1371/journal.pone.0234726			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559205	Green Published, gold			2022-12-26	WOS:000543261600025
J	Clem, CS; Sparbanie, TM; Luro, AB; Harmon-Threatt, AN				Clem, C. Scott; Sparbanie, Taylor M.; Luro, Alec B.; Harmon-Threatt, Alexandra N.			Can anthophilous hover flies (Diptera: Syrphidae) discriminate neonicotinoid insecticides in sucrose solution?	PLOS ONE			English	Article							ENVIRONMENTAL RISKS; ERISTALIS-TENAX; EXPOSURE; INSECTS; POLLEN; COLORS; PLANTS; CROPS; BEES	Understanding how neonicotinoid insecticides affect non-target arthropods, especially pollinators, is an area of high priority and popular debate. Few studies have considered how pollinators interact and detect neonicotinoids, and almost none have examined for these effects in anthophilous Diptera such as hover flies (Syrphidae). We investigated behavioral responses of two species of hover flies,Eristalis arbustorumL. (Eristalinae) andToxomerus marginatusSay (Syrphinae), when given a choice between artificial flowers with uncontaminated sucrose solution and neonicotinoid-contaminated (clothianidin) sucrose solution at field-realistic levels 2.5 ppb (average) and 150 ppb (high). We examined for 1) evidence that wild-caught flies could detect the insecticide gustatorily by analyzing amount of time spent feeding on floral treatments, and 2) whether flies could discriminate floral treatments visually by comparing visitation rates, spectral reflectance differences, and hover fly photoreceptor sensitivities. We did not find evidence that either species fed more or less on either of the treatment solutions. Furthermore,T.marginatusdid not appear to visit one of the flower choices over the other.Eristalis arbustorum, however, visited uncontaminated flowers more often than contaminated flowers. Spectral differences between the flower treatments overlap withEristalisphotoreceptor sensitivities, opening the possibility thatE.arbustorumcould discriminate sucrose-clothianidin solution visually. The relevance of our findings in field settings are uncertain but they do highlight the importance of visual cues in lab-based choice experiments involving insecticides. We strongly encourage further research in this area and the consideration of both behavioral responses and sensory mechanisms when determining insecticidal impacts on beneficial arthropods.	[Clem, C. Scott; Harmon-Threatt, Alexandra N.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Sparbanie, Taylor M.] Ohio Univ, Environm & Plant Biol Dept, Athens, OH 45701 USA; [Luro, Alec B.] Univ Illinois, Dept Evolut Ecol & Behav, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University System of Ohio; Ohio University; University of Illinois System; University of Illinois Urbana-Champaign	Clem, CS (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL 61801 USA.	carlc2@illinois.edu	Clem, Scott/AFH-2758-2022	Clem, Scott/0000-0001-9104-193X; Sparbanie, Taylor/0000-0002-1261-4689	USDA NIFA EWD [2019-67011-29504]; USDA [2018-67013-27537]; U.S. Department of Education Graduates Assistance in Areas of Need Fellowship through the University of Illinois School of Integrative Biology	USDA NIFA EWD; USDA(United States Department of Agriculture (USDA)); U.S. Department of Education Graduates Assistance in Areas of Need Fellowship through the University of Illinois School of Integrative Biology	Funding to CSC provided by USDA NIFA EWD grant 2019-67011-29504. Funding to AHT and TS by USDA grant 2018-67013-27537. Funding to CSC and ABL also provided by the U.S. Department of Education Graduates Assistance in Areas of Need Fellowship through the University of Illinois School of Integrative Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovic BF, 2010, CHEMOSPHERE, V81, P114, DOI 10.1016/j.chemosphere.2010.07.016; An LN, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.184788; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2013, TEXTS STAT SCI SERIE; [Anonymous], INSECTS ARACHNIDS 18; Arce AN, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0655; Arnold SEJ, 2009, ARTHROPOD-PLANT INTE, V3, P27, DOI 10.1007/s11829-009-9056-9; Basley K, 2018, PEERJ, V6, DOI 10.7717/peerj.4258; BISHOP LG, 1974, J COMP PHYSIOL, V91, P267, DOI 10.1007/BF00698058; Botias C, 2016, SCI TOTAL ENVIRON, V566, P269, DOI 10.1016/j.scitotenv.2016.05.065; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Bugg R.L, 2008, AGR NATURAL RESOURCE, V8285, P1; Calvo-Agudo M, 2019, P NATL ACAD SCI USA, V116, P16817, DOI 10.1073/pnas.1904298116; Cloyd RA, 2011, PEST MANAG SCI, V67, P3, DOI 10.1002/ps.2015; Easton AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054819; Federoff NE, 2005, EFED REGISTRATION CH; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Guedes RNC, 2017, CURR OPIN INSECT SCI, V21, P47, DOI 10.1016/j.cois.2017.04.010; Hannah L, 2019, CURR ZOOL, V65, P483, DOI 10.1093/cz/zoz008; Hennemeyer M, 2008, SENSORS-BASEL, V8, P10, DOI 10.3390/s8010010; Hladik ML, 2018, ENVIRON SCI TECHNOL, V52, P3329, DOI 10.1021/acs.est.7b06388; Hladik ML, 2014, ENVIRON POLLUT, V193, P189, DOI 10.1016/j.envpol.2014.06.033; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Kruschke JK, 2018, ADV METH PRACT PSYCH, V1, P270, DOI 10.1177/2515245918771304; Larson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066375; Linnaeus C., 1753, SPECIES PLANTARUM, P968, DOI [10.5962/bhl.title.669, DOI 10.5962/BHL.TITLE.669]; Linnaeus C., 1758, SYSTEMA NATURAE REGN, DOI [10.5962/bhl.title.542, DOI 10.5962/BHL.TITLE.542]; LUNAU K, 1994, J COMP PHYSIOL A, V174, P575, DOI 10.1007/BF00217378; Lunau K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194167; Lunau K, 2014, J COMP PHYSIOL A, V200, P497, DOI 10.1007/s00359-014-0895-1; Lundin O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136928; Makowski D, 2019, INDICES EFFECT EXIST, DOI [10.31234/osf.io/2zexr, DOI 10.31234/OSF.IO/2ZEXR]; Mengual X, 2015, CLADISTICS, V31, P491, DOI 10.1111/cla.12105; Muller C, 2018, BASIC APPL ECOL, V30, P1, DOI 10.1016/j.baae.2018.05.001; Mulligan RA, 2015, PEST MANAG SCI, V71, P1419, DOI 10.1002/ps.3946; Orford KA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2934; Ottenheim MM, 1995, NETH J ZOOL, V45, P305; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Pohorecka K, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0029-3; Primante C, 2010, J CHEM ECOL, V36, P1207, DOI 10.1007/s10886-010-9871-6; Rader R, 2016, P NATL ACAD SCI USA, V113, P146, DOI 10.1073/pnas.1517092112; Ramsden M, 2017, AGR FOREST ENTOMOL, V19, P139, DOI 10.1111/afe.12191; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Say T., 1823, J ACAD NATURAL SCI P, V3, P9; Shrestha M, 2019, PLANT BIOLOGY, V21, P745, DOI 10.1111/plb.12968; Shrestha M, 2016, PLANT BIOLOGY, V18, P842, DOI 10.1111/plb.12456; Skevington J.H., 2019, FIELD GUIDE FLOWER F; Ssymank Axel, 2008, Biodiversity (Ottawa), V9, P86; Stan Development Team, 2018, RSTAN R INT STAN R P; Wacht S, 1996, ENTOMOL EXP APPL, V80, P50, DOI 10.1007/BF00194723; Wacht S, 2000, J COMP PHYSIOL A, V186, P193, DOI 10.1007/s003590050019	53	0	0	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234820	10.1371/journal.pone.0234820	http://dx.doi.org/10.1371/journal.pone.0234820			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559247	Green Published, gold			2022-12-26	WOS:000543261600056
J	Ordonez, A; Eikvil, L; Salberg, AB; Harbitz, A; Murray, SM; Kampffmeyer, MC				Ordonez, Alba; Eikvil, Line; Salberg, Arnt-Borre; Harbitz, Alf; Murray, Sean Meling; Kampffmeyer, Michael C.			Explaining decisions of deep neural networks used for fish age prediction	PLOS ONE			English	Article							GREENLAND HALIBUT; OTOLITHS	Age-reading of fish otoliths (ear stones) is important for the sustainable management of fish resources. However, the procedure is challenging and requires experienced readers to carefully examine annual growth zones. In a recent study, convolutional neural networks (CNNs) have been demonstrated to perform reasonably well on automatically predicting fish age from otolith images. In the present study, we carefully investigate the prediction rule learned by such neural networks to provide insight into the features that identify certain fish age ranges. For this purpose, a recent technique for visualizing and analyzing the predictions of the neural networks was applied to different versions of the otolith images. The results indicate that supplementary knowledge about the internal structure improves the results for the youngest age groups, compared to using only the contour shape attribute of the otolith. However, the contour shape and size attributes are, in general, sufficient for older age groups. In addition, within specific age ranges we find that the network tends to focus on particular areas of the otoliths and that the most discriminating factors seem to be related to the central part and the outer edge of the otolith. Explaining age predictions from otolith images as done in this study will hopefully help build confidence in the potential of deep learning algorithms for automatic age prediction, as well as improve the quality of the age estimation.	[Ordonez, Alba; Eikvil, Line; Salberg, Arnt-Borre; Murray, Sean Meling] Norwegian Comp Ctr, Dept Stat Anal Machine Learning & Image Anal, Oslo, Norway; [Harbitz, Alf] Inst Marine Res, Dept Deep Water Species & Cartilaginous Fish, Tromso, Norway; [Kampffmeyer, Michael C.] Univ Tromso, Dept Phys & Technol, Tromso, Norway	Institute of Marine Research - Norway; UiT The Arctic University of Tromso	Ordonez, A (corresponding author), Norwegian Comp Ctr, Dept Stat Anal Machine Learning & Image Anal, Oslo, Norway.	albao@nr.no		Kampffmeyer, Michael/0000-0002-7699-0405; Ordonez, Alba/0000-0002-8720-0288	Research Council of Norway [270966]	Research Council of Norway(Research Council of Norway)	This work was supported by the Research Council of Norway, grant 270966. There was no additional external funding received for this study. The founders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber M, 2018, ARXIV180804260V1; Albert OT, 2016, MAR FRESHWATER RES, V67, P937, DOI 10.1071/MF15089; Albert O. T., 2009, J NW ATLANTIC FISHER, V40, P81, DOI DOI 10.2960/J.V40.M659; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; CAMPANA SE, 1995, T AM FISH SOC, V124, P131, DOI 10.1577/1548-8659(1995)124<0131:GASMFD>2.3.CO;2; Chinchor N, 1992, P 4 MESS UND C; Chollet F, 2018, KERAS 2 1 3; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Frie AK, 2011, ICES J MAR SCI, V68, P1942, DOI 10.1093/icesjms/fsr116; FRIGGE M, 1989, AM STAT, V43, P50, DOI 10.2307/2685173; Harbitz A, 2005, ICES J MAR SCI, V72, P2090; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Lapuschkin S, 2019, ARXIV190210178; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Madhun A.S., 2020, RAPPORT HAVFORSKNING; Moen E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204713; Montavon G., 2019, EXPLAINABLE INTERPRE, P193, DOI DOI 10.1007/978-3-030-28954-6_10; Montavon G, 2017, ARXIV170607979; Montavon G, 2015, ARXIV151202479; Morison AK, 2005, MAR FRESHWATER RES, V56, P773, DOI 10.1071/MF04217; Noh H, 2015, IEEE I CONF COMP VIS, P1520, DOI 10.1109/ICCV.2015.178; Ribeiro MT, 2016, ARXIV160204938V3; Samek W, 2017, IEEE T NEUR NET LEAR, V28, P2660, DOI 10.1109/TNNLS.2016.2599820; Simonyan K., 2013, 13126034 ARXIV, DOI DOI 10.1038/S41591-018-0335-9; Springenberg JT, 2014, ARXIV; Stransky C, 2008, FISH RES, V90, P26, DOI 10.1016/j.fishres.2007.09.009; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; Treble Margaret A., 2008, Northwest Atlantic Fisheries Organization Scientific Council Studies, V41, P1, DOI 10.2960/S.v41.m1; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Von Luxburg UV, 2007, ARXIV07110189; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53	34	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0235013	10.1371/journal.pone.0235013	http://dx.doi.org/10.1371/journal.pone.0235013			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559222	gold, Green Published			2022-12-26	WOS:000543261600038
J	Sano, M; Ichihara, G; Katsumata, Y; Hiraide, T; Hirai, A; Momoi, M; Tamura, T; Ohata, S; Kobayashi, E				Sano, Motoaki; Ichihara, Genki; Katsumata, Yoshinori; Hiraide, Takahiro; Hirai, Akeo; Momoi, Mizuki; Tamura, Tomoyoshi; Ohata, Shigeo; Kobayashi, Eiji			Pharmacokinetics of a single inhalation of hydrogen gas in pigs	PLOS ONE			English	Article							MOLECULAR-HYDROGEN; RAT MODEL; CONSUMPTION; ANTIOXIDANT; INFARCTION; SAFETY; BODY	The benefits of inhaling hydrogen gas (H-2) have been widely reported but its pharmacokinetics have not yet been sufficiently analyzed. We developed a new experimental system in pigs to closely evaluate the process by which H(2)is absorbed in the lungs, enters the bloodstream, and is distributed, metabolized, and excreted. We inserted and secured catheters into the carotid artery (CA), portal vein (PV), and supra-hepatic inferior vena cava (IVC) to allow repeated blood sampling and performed bilateral thoracotomy to collapse the lungs. Then, using a hydrogen-absorbing alloy canister, we filled the lungs to the maximum inspiratory level with 100% H-2. The pig was maintained for 30 seconds without resuming breathing, as if they were holding their breath. We collected blood from the three intravascular catheters after 0, 3, 10, 30, and 60 minutes and measured H(2)concentration by gas chromatography. H(2)concentration in the CA peaked immediately after breath holding; 3 min later, it dropped to 1/40 of the peak value. Peak H(2)concentrations in the PV and IVC were 40% and 14% of that in the CA, respectively. However, H(2)concentration decay in the PV and IVC (half-life: 310 s and 350 s, respectively) was slower than in the CA (half-life: 92 s). At 10 min, H(2)concentration was significantly higher in venous blood than in arterial blood. At 60 min, H(2)was detected in the portal blood at a concentration of 6.9-53 nL/mL higher than at steady state, and in the SVC 14-29 nL/mL higher than at steady state. In contrast, H(2)concentration in the CA decreased to steady state levels. This is the first report showing that inhaled H(2)is transported to the whole body by advection diffusion and metabolized dynamically.	[Sano, Motoaki; Ichihara, Genki; Katsumata, Yoshinori; Hiraide, Takahiro; Hirai, Akeo; Momoi, Mizuki; Kobayashi, Eiji] Keio Univ, Dept Cardiol, Sch Med, Shinjuku Ku, Tokyo, Japan; [Sano, Motoaki; Ichihara, Genki; Katsumata, Yoshinori; Tamura, Tomoyoshi; Kobayashi, Eiji] Keio Univ, Ctr Mol Hydrogen Med, Minato Ku, Tokyo, Japan; [Tamura, Tomoyoshi] Keio Univ, Dept Emergency & Crit Care Med, Shinjuku Ku, Tokyo, Japan; [Kobayashi, Eiji] Keio Univ, Dept Organ Fabricat, Sch Med, Shinjuku Ku, Tokyo, Japan; [Ohata, Shigeo] Juntendo Univ, Dept Neurol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan	Keio University; Keio University; Keio University; Keio University; Juntendo University	Sano, M (corresponding author), Keio Univ, Dept Cardiol, Sch Med, Shinjuku Ku, Tokyo, Japan.; Sano, M (corresponding author), Keio Univ, Ctr Mol Hydrogen Med, Minato Ku, Tokyo, Japan.	msano@a8.keio.jp	Katsumata, Yoshinori/AAC-4159-2021; Sano, Motoaki/L-3405-2013	Katsumata, Yoshinori/0000-0001-5576-5789; Sano, Motoaki/0000-0003-1771-8310	SESA Corporation	SESA Corporation	This work was supported by grants from SESA Corporation (E.K.) Sou Hashimoto (Doctors Man Co., Ltd.) provided us with the H2 filling device. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinese Non-government Medical Institutions Association, 2020, REC US HYDR OX AT CL; Hayashida K, 2014, CIRCULATION, V130, P2173, DOI 10.1161/CIRCULATIONAHA.114.011848; Hayashida K, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003459; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Katsumata Y, 2017, CIRC J, V81, P940, DOI 10.1253/circj.CJ-17-0105; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kobayashi E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222863; Matsuoka T, 2017, J TRAUMA ACUTE CARE, V83, P469, DOI 10.1097/TA.0000000000001620; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta S, 2015, METHOD ENZYMOL, V555, P289, DOI 10.1016/bs.mie.2014.11.038; Ono H, 2017, J STROKE CEREBROVASC, V26, P2587, DOI 10.1016/j.jstrokecerebrovasdis.2017.06.012; Pedersen SF, 2020, J CLIN INVEST, V130, P2202, DOI 10.1172/JCI137647; Sano M, 2018, ACUTE MED SURG, V5, P113, DOI 10.1002/ams2.320; Shimouchi A, 2013, ADV EXP MED BIOL, V789, P315, DOI 10.1007/978-1-4614-7411-1_42; Shimouchi A, 2012, ADV EXP MED BIOL, V737, P245, DOI 10.1007/978-1-4614-1566-4_36; Suzuki Y, 2009, FEBS LETT, V583, P2157, DOI 10.1016/j.febslet.2009.05.052; Tamaki I, 2018, LIVER TRANSPLANT, V24, P1589, DOI 10.1002/lt.25326; Tamura T, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2246-3; Tamura T, 2016, CIRC J, V80, P1870, DOI 10.1253/circj.CJ-16-0127; Tamura1 T., 2020, SHOCK; Yamamoto R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38180-4	21	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234626	10.1371/journal.pone.0234626	http://dx.doi.org/10.1371/journal.pone.0234626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559239	gold, Green Published			2022-12-26	WOS:000543261600059
J	Wood, D; Besnard, G; Beerling, DJ; Osborne, CP; Christin, PA				Wood, Daniel; Besnard, Guillaume; Beerling, David J.; Osborne, Colin P.; Christin, Pascal-Antoine			Phylogenomics indicates the "living fossil"Isoetesdiversified in the Cenozoic	PLOS ONE			English	Article							CHLOROPLAST DNA-SEQUENCE; DIVERGENCE TIMES; EVOLUTIONARY HISTORY; ISOETES ISOETACEAE; LAND PLANTS; CALIBRATION UNCERTAINTY; FOSSIL CALIBRATIONS; MOLECULAR EVOLUTION; GENOME SEQUENCE; ABSOLUTE RATES	The fossil record provides an invaluable insight into the temporal origins of extant lineages of organisms. However, establishing the relationships between fossils and extant lineages can be difficult in groups with low rates of morphological change over time. Molecular dating can potentially circumvent this issue by allowing distant fossils to act as calibration points, but rate variation across large evolutionary scales can bias such analyses. In this study, we apply multiple dating methods to genome-wide datasets to infer the origin of extant species ofIsoetes, a group of mostly aquatic and semi-aquatic isoetalean lycopsids, which closely resemble fossil forms dating back to the Triassic. Rate variation observed in chloroplast genomes hampers accurate dating, but genome-wide nuclear markers place the origin of extant diversity within this group in the mid-Paleogene, 45-60 million years ago. Our genomic analyses coupled with a careful evaluation of the fossil record indicate that despite resembling forms from the Triassic, extantIsoetesspecies do not represent the remnants of an ancient and widespread group, but instead have spread around the globe in the relatively recent past.	[Wood, Daniel; Beerling, David J.; Osborne, Colin P.; Christin, Pascal-Antoine] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield, S Yorkshire, England; [Besnard, Guillaume] Univ Toulouse, CNRS, UMR 5174, IRD,EDB,Lab Evolut & Diversite Biol, Toulouse, France; [Wood, Daniel] Bangor Univ, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales	University of Sheffield; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Bangor University	Wood, D (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield, S Yorkshire, England.; Wood, D (corresponding author), Bangor Univ, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales.	daniel.wood@bangor.ac.uk	Besnard, Guillaume/B-9785-2008; Beerling, David/C-2840-2009	Besnard, Guillaume/0000-0003-2275-6012; Beerling, David/0000-0003-1869-4314	Royal Society University Research Fellowships [URF120119]; University of Sheffield Faculty Scholarship [149440211]	Royal Society University Research Fellowships(Royal Society of London); University of Sheffield Faculty Scholarship	PAC is supported by a Royal Society University Research Fellowships (number URF120119). https://royalsociety.org/grantsschemes-awards/grants/university-research/.DW was funded by a University of Sheffield Faculty Scholarship, 149440211, https://www.sheffield.ac.uk/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Helene Holota for help with the sequencing, Luke T. Dunning, Jill K. Olofsson, Jose J. Moreno-Villano and Matheus E. Bianconi for advice in DNA sequencing and computational analyses, Charles Wellman for advice on phylogenetic assignment of cryptospores, Hannah Sewell for assistance in live plant collection and Dan Brunton for advice regarding the putative I. nuttallii specimen and comments on the manuscript. Catarina Rydin kindly provided the alignment from Larsen and Rydin (2015). PAC is supported by a Royal Society University Research Fellowships (number URF120119).	Abadi S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08822-w; [Anonymous], 2014, PARAGRAPH, V37, p[372, 376]; [Anonymous], 2019, DTBI S, V1, P1, DOI DOI 10.36811/RJCSE.2019.110001; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2012, REGEN MED S3, V7, pS14; Arakaki M, 2011, P NATL ACAD SCI USA, V108, P8379, DOI 10.1073/pnas.1100628108; ASH SR, 1991, AM J BOT, V78, P1636, DOI 10.2307/2444844; Aya K, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu184; Bakker FT, 2016, BIOL J LINN SOC, V117, P33, DOI 10.1111/bij.12642; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Banks JA, 2009, ANNU REV PLANT BIOL, V60, P223, DOI 10.1146/annurev.arplant.59.032607.092851; Belshaw R, 2005, BIOINFORMATICS, V21, P122, DOI 10.1093/bioinformatics/bth459; Berry CM, 2015, GEOLOGY, V43, P1043, DOI 10.1130/G37000.1; Besnard G, 2018, BOT LETT, V165, P419, DOI 10.1080/23818107.2018.1469429; Bieker VC, 2018, BOT LETT, V165, P409, DOI 10.1080/23818107.2018.1458651; BOSTON HL, 1983, AQUAT BOT, V15, P381, DOI 10.1016/0304-3770(83)90006-2; BOUSQUET J, 1992, P NATL ACAD SCI USA, V89, P7844, DOI 10.1073/pnas.89.16.7844; Brandley MC, 2011, SYST BIOL, V60, P3, DOI 10.1093/sysbio/syq045; Britton DM, 1999, AM FERN J, V89, P133, DOI 10.2307/1547347; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Bromham L, 2019, TRENDS ECOL EVOL, V34, P474, DOI 10.1016/j.tree.2019.01.017; Bromham L, 2018, BIOL REV, V93, P1165, DOI 10.1111/brv.12390; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Brunton DF, 2001, CHINQUAPIN, V9, P24; Canales J, 2014, PLANT BIOTECHNOL J, V12, P286, DOI 10.1111/pbi.12136; Cavin L, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00049; Choi KS, 2016, FRONT PLANT SCI, V7, DOI [10.3359/fpls.2016.00355, 10.3389/fpls.2016.00355]; Christin PA, 2014, SYST BIOL, V63, P153, DOI 10.1093/sysbio/syt072; Cressler WL, 2005, AM J BOT, V92, P1131, DOI 10.3732/ajb.92.7.1131; Darwin C, 1859, ORIGIN SPECIES MEANS; Der J. P., 2010, THESIS; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Desmet P, 2013, PHYTOKEYS, V25, P55, DOI 10.3897/phytokeys.25.3100; Dierckxsens N, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw955; dos Reis M, 2015, CURR BIOL, V25, P2939, DOI 10.1016/j.cub.2015.09.066; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duchene S, 2014, MOL PHYLOGENET EVOL, V78, P277, DOI 10.1016/j.ympev.2014.05.032; Dunning LT, 2017, EVOLUTION, V71, P1541, DOI 10.1111/evo.13250; EDWARDS D, 1983, BOT J LINN SOC, V86, P19, DOI 10.1111/j.1095-8339.1983.tb00715.x; EDWARDS D, 1980, NATURE, V287, P41, DOI 10.1038/287041a0; Felsenstein J., 2002, PHYLIP PHYLOGENY INF; Fisher AE, 2016, MOL PHYLOGENET EVOL, V105, P1, DOI 10.1016/j.ympev.2016.08.011; Freund FD, 2018, AM J BOT, V105, P275, DOI 10.1002/ajb2.1024; Freund FD, 2016, AM FERN J, V106, P87; GARRATT MJ, 1984, BOT J LINN SOC, V89, P355, DOI 10.1111/j.1095-8339.1984.tb02566.x; Goodall-Copestake WP, 2009, BOT J LINN SOC, V159, P363, DOI 10.1111/j.1095-8339.2009.00948.x; Goremykin VV, 2004, MOL BIOL EVOL, V21, P1445, DOI 10.1093/molbev/msh147; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hao SG, 2007, INT J PLANT SCI, V168, P1161, DOI 10.1086/520727; Hetherington AJ, 2017, NEW PHYTOL, V215, P538, DOI 10.1111/nph.14324; Hilton EJ, 2006, J PALEONTOL, V80, P672, DOI 10.1666/0022-3360(2006)80[672:ROTFRO]2.0.CO;2; Hipsley CA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00138; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Hohmann N, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4673-2; Hoot SB, 2006, SYST BOT, V31, P449, DOI 10.1600/036364406778388511; Hug LA, 2007, MOL BIOL EVOL, V24, P1889, DOI 10.1093/molbev/msm115; Kadarusman, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57042-1; Karol KG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-321; KARRFALT E, 1984, AM J BOT, V71, P1023, DOI 10.2307/2443376; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KEELEY JE, 1981, AM J BOT, V68, P420, DOI 10.2307/2442779; Kemp A, 2017, PALAEOGEOGR PALAEOCL, V471, P209, DOI 10.1016/j.palaeo.2016.12.051; Kenrick P, 2003, NATURE, V425, P248, DOI 10.1038/425248a; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kim C, 2016, J PLANT BIOL, V59, P386, DOI 10.1007/s12374-016-0123-3; Klaus KV, 2017, CLADISTICS, V33, P469, DOI 10.1111/cla.12184; Laenen B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6134; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsen E, 2016, INT J PLANT SCI, V177, P157, DOI 10.1086/684179; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Leebens-Mack JH, 2019, NATURE, V16, P1; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li X, HIGH THROUGHPUT MULT; Libertin M, 2018, NAT PLANTS, V4, P269, DOI 10.1038/s41477-018-0140-y; Lidgard S, 2015, STASIS OXFORD BIBLIO; Linder HP, 2005, MOL PHYLOGENET EVOL, V35, P569, DOI 10.1016/j.ympev.2004.12.006; Liu ZY, 2018, MOL PHYLOGENET EVOL, V127, P723, DOI 10.1016/j.ympev.2018.06.020; Lundgren MR, 2015, ECOL LETT, V18, P1021, DOI 10.1111/ele.12484; Magallon S, 2015, NEW PHYTOL, V207, P437, DOI 10.1111/nph.13264; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Magallon S, 2010, SYST BIOL, V59, P384, DOI 10.1093/sysbio/syq027; Mao KS, 2012, P NATL ACAD SCI USA, V109, P7793, DOI 10.1073/pnas.1114319109; Ming R, 2015, NAT GENET, V47, P1435, DOI 10.1038/ng.3435; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Morris JL, 2018, P NATL ACAD SCI USA, V115, pE2274, DOI 10.1073/pnas.1719588115; Nagalingum NS, 2011, SCIENCE, V334, P796, DOI 10.1126/science.1209926; Nashima K, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0892-8; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Obst M, 2012, MOL PHYLOGENET EVOL, V62, P21, DOI 10.1016/j.ympev.2011.08.025; Olierook HKH, 2016, EARTH PLANET SC LETT, V440, P20, DOI 10.1016/j.epsl.2016.02.008; Oliver MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-143; Olofsson JK, 2016, MOL ECOL, V25, P6107, DOI 10.1111/mec.13914; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Patil SM, 2017, PLANT SCI TODAY, V4, P213, DOI 10.14719/pst.2017.4.4.339; PATTERSON C, 1981, ANNU REV ECOL SYST, V12, P195, DOI 10.1146/annurev.es.12.110181.001211; Pereira JBS, 2017, BOT J LINN SOC, V185, P253, DOI 10.1093/botlinnean/box057; Pfeiffer NB, 1922, ANN MO BOT GARD, V9, DOI [10.2307/2990000, DOI 10.2307/2990000]; Pigg KB, 2001, AM FERN J, V91, P99, DOI 10.1640/0002-8444(2001)091[0099:ILEFTD]2.0.CO;2; PIGG KB, 1992, ANN MO BOT GARD, V79, P589, DOI 10.2307/2399754; Poinar G. O. Jr., 2015, Advances in Parasitology, V90, P53; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Renne PR, 2013, SCIENCE, V339, P684, DOI 10.1126/science.1230492; Retallack GJ, 1997, J PALEONTOL, V71, P500, DOI 10.1017/S0022336000039524; Rolle F., 1885, ENCY NATURWISSENSCHA, V12, P211; Ronquist F, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0136; Rothfels CJ, 2015, AM J BOT, V102, P1089, DOI 10.3732/ajb.1500089; Rowe T, 2008, P NATL ACAD SCI USA, V105, P1238, DOI 10.1073/pnas.0706385105; Rubinstein CV, 2010, NEW PHYTOL, V188, P365, DOI 10.1111/j.1469-8137.2010.03433.x; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Rutschmann F, 2007, SYST BIOL, V56, P591, DOI 10.1080/10635150701491156; Rydin C, 2002, TAXON, V51, P83, DOI 10.2307/1554965; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Satler JD, 2013, SYST BIOL, V62, P805, DOI 10.1093/sysbio/syt041; Sauquet H, 2013, CR PALEVOL, V12, P355, DOI 10.1016/j.crpv.2013.07.003; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Schafran PW, 2019, THESIS; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Schuettpelz E, 2006, SYST BOT, V31, P258, DOI 10.1600/036364406777585856; Schuettpelz E, 2016, J SYST EVOL, V54, P563, DOI 10.1111/jse.12229; SHIMADA H, 1991, NUCLEIC ACIDS RES, V19, P983, DOI 10.1093/nar/19.5.983; SKOG JE, 1992, ANN MO BOT GARD, V79, P648, DOI 10.2307/2399758; Smith JLB, 1939, NATURE, V143, P455, DOI 10.1038/143455a0; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Soares AER, 2012, BIOINFORM BIOL INSIG, V6, P129, DOI 10.4137/BBI.S9677; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stein WE, 2012, NATURE, V483, P78, DOI 10.1038/nature10819; Sugiura C, 2003, NUCLEIC ACIDS RES, V31, P5324, DOI 10.1093/nar/gkg726; Szovenyi P, 2015, MOL ECOL RESOUR, V15, P203, DOI 10.1111/1755-0998.12284; TAYLOR WC, 1992, ANN MO BOT GARD, V79, P613, DOI 10.2307/2399755; Testo W, 2018, J BIOGEOGR, V45, P1929, DOI 10.1111/jbi.13373; Testo W, 2016, MOL PHYLOGENET EVOL, V105, P200, DOI 10.1016/j.ympev.2016.09.003; Troia A, 2016, PHYTOTAXA, V277, P101, DOI 10.11646/phytotaxa.277.2.1; Troia Angelo, 2016, Webbia, V71, P277, DOI 10.1080/00837792.2016.1191171; TSUDZUKI J, 1994, CURR GENET, V26, P153, DOI 10.1007/BF00313804; Tsuji S, 2007, J PLANT RES, V120, P281, DOI 10.1007/s10265-006-0055-y; van Tuinen M, 2004, J PALEONTOL, V78, P45, DOI 10.1666/0022-3360(2004)078<0045:TEOEAI>2.0.CO;2; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang Y, 2003, PALAEONTOLOGY, V46, P1297, DOI 10.1046/j.0031-0239.2003.00342.x; Welch JJ, 2005, TRENDS ECOL EVOL, V20, P320, DOI 10.1016/j.tree.2005.02.007; Wellman CH, 2015, PALAEONTOLOGY, V58, P601, DOI 10.1111/pala.12172; Wellman CH, 2010, NEW PHYTOL, V188, P306, DOI 10.1111/j.1469-8137.2010.03471.x; Werth AJ, 2014, AM SCI, V102, P434, DOI 10.1511/2014.111.434; Wickett, 2014, P NATL ACAD SCI USA, P1; Wickett NJ, 2008, MOL BIOL EVOL, V25, P393, DOI 10.1093/molbev/msm267; Wolf PG, 2005, GENE, V350, P117, DOI 10.1016/j.gene.2005.01.018; Wood DP, 2018, BOT LETT, V165, P476, DOI 10.1080/23818107.2018.1505545; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xiang QY, 2011, MOL PHYLOGENET EVOL, V59, P123, DOI 10.1016/j.ympev.2011.01.016; Xu HH, 2012, PALAEONTOLOGY, V55, P957, DOI 10.1111/j.1475-4983.2012.01177.x; Yang T, 2016, PLANT MOL BIOL REP, V34, P136, DOI 10.1007/s11105-015-0906-6; Zhu AD, 2016, NEW PHYTOL, V209, P1747, DOI 10.1111/nph.13743	155	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0227525	10.1371/journal.pone.0227525	http://dx.doi.org/10.1371/journal.pone.0227525			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555586	Green Published, gold, Green Accepted			2022-12-26	WOS:000543273200021
J	Yougang, AP; Kamgang, B; Tedjou, AN; Wilson-Bahun, TA; Njiokou, F; Wondji, CS				Yougang, Aurelie P.; Kamgang, Basile; Tedjou, Armel N.; Wilson-Bahun, Theodel A.; Njiokou, Flobert; Wondji, Charles S.			Nationwide profiling of insecticide resistance inAedes albopictus(Diptera: Culicidae) in Cameroon	PLOS ONE			English	Article							CHIKUNGUNYA-VIRUS; PYRETHROID RESISTANCE; ALBOPICTUS DIPTERA; AEDES-AEGYPTI; VECTOR; SKUSE; CONGO; GABON	The Asian mosquito,Aedes albopictus(Skuse), is an invasive mosquito which has become one of the most important vectors of dengue, Zika, and chikungunya viruses worldwide. This species was reported for the first time in Cameroon in early 2000s and became the dominantAedesspecies in the urban areas in the southern part of Cameroon but remain poorly characterized. Here, we assessed the susceptibility profile ofA.albopictuscollected throughout Cameroon and investigated the potential resistance mechanisms involved. Immature stages ofA.albopictuswere collected between March and July 2017 in 15 locations across Cameroon and reared until G1/G2 generation. Larval, adult bioassays, and synergists [piperonyl butoxide (PBO) and diethyl maleate (DEM)] assays were carried out according to WHO recommendations. F1534C mutation was genotyped in field collected adults (Go) using allele specific PCR. All tested populations were susceptible to both larvicides, temephos andBacillus thuringiensis israelensis(Bti), after larval bioassays. Adult bioassays revealed a high level of resistance ofA.albopictusto 4% DDT with mortality rates ranging from 12.42% in Bafang to 75.04% in Kumba. The resistance was reported also in 0.05% deltamethrin, 0.25% permethrin, and 0.1% propoxur in some locations. A loss of susceptibility to 0.1% bendiocarb was found in one of three populations analysed. A full susceptibility to 1% fenitrothion were observed across the country. A full recovery or partial of susceptibility was observed inA.albopictuswhen pre-exposed to PBO or DEM and then to DDT and permethrin, respectively. The F1534Ckdrmutation was not detected inA.albopictus. This study showed that the susceptibility profile ofA.albopictusto insecticide vary according to the sampling location and insecticides used. These findings are useful to planning vector control program against arbovirus vectors in Cameroon and can be used as baseline data for further researches.	[Yougang, Aurelie P.; Kamgang, Basile; Tedjou, Armel N.; Wilson-Bahun, Theodel A.; Wondji, Charles S.] Ctr Res Infect Dis, Yaounde, Cameroon; [Yougang, Aurelie P.; Tedjou, Armel N.; Njiokou, Flobert] Univ Yaounde I, Dept Anim Biol & Physiol, Parasitol & Ecol Lab, Fac Sci, Yaounde, Cameroon; [Wilson-Bahun, Theodel A.] Marien Ngouabi Univ, Fac Sci & Technol, Lab Vertebrate & Invertebrate Bioecol, Brazzaville, Rep Congo; [Wondji, Charles S.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England	University of Yaounde I; Liverpool School of Tropical Medicine	Yougang, AP; Kamgang, B (corresponding author), Ctr Res Infect Dis, Yaounde, Cameroon.; Yougang, AP (corresponding author), Univ Yaounde I, Dept Anim Biol & Physiol, Parasitol & Ecol Lab, Fac Sci, Yaounde, Cameroon.	aurelie.yougang@crid-cam.net; basile.kamgang@crid-cam.net	Kamgang, Basile/ABC-8345-2021	Kamgang, Basile/0000-0002-8883-4557; YOUGANG, Aurelie Prisca/0000-0002-4040-7919	Wellcome Trust Training Fellowship in Public Health and Tropical Medicine [204862/Z/16/Z]	Wellcome Trust Training Fellowship in Public Health and Tropical Medicine	This study was supported by a Wellcome Trust Training Fellowship in Public Health and Tropical Medicine (204862/Z/16/Z) awarded to BK. BK, APY, ANT, and TAW received salaries from the funder. The funder had no role in study design, data collection or analysis, decision to publish or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Abeyrathna W, 2019, INSECTICIDE SUSCEPTI; Aguirre-Obando OA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2089-5; [Anonymous], 2016, ENT SURV AED SPP CON; [Anonymous], 2018, J MORAL THEOLOGY, V7, P86; [Anonymous], 2020, CLIN DIABETOLOGY, V9, P1; Auteri M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3098575; Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969; Building Party, 2018, PARTY BUILDING, V11, P4; Chuaycharoensuk T, 2011, J VECTOR ECOL, V36, P204, DOI 10.1111/j.1948-7134.2011.00158.x; Chunying Lu, 2014, REV PRACTICAL PHILOS, V1, P35; Macoris MDD, 2014, REV SOC BRAS MED TRO, V47, P573, DOI 10.1590/0037-8682-0141-2014; Edwards F.W., 1941, MOSQUITOES ETHIOPIAN; Fontenille D, 2001, EMERG INFECT DIS, V7, P1066, DOI 10.3201/eid0706.010631; Fritz M, 2019, INT J INFECT DIS, V84, P99, DOI 10.1016/j.ijid.2019.05.013; Giner M, 1999, WIN DL VERSION 2 0; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Grigoraki L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003771; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Ishak IH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24707; Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2; Jirakanjanakit N, 2007, J ECON ENTOMOL, V100, P545, DOI 10.1603/0022-0493(2007)100[545:IRSIAS]2.0.CO;2; Jupp P. G., 1996, Mosquitoes of southern Africa: Culicinae and Toxorhynchitinae.; Kamgang B, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2408-x; Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79; Kasai S, 2019, EUROSURVEILLANCE, V24, P48, DOI 10.2807/1560-7917.ES.2019.24.5.1700847; Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/s1473-3099(16)30513-8, 10.1016/S1473-3099(16)30513-8]; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664; LIVAK KJ, 1984, GENETICS, V107, P611; Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992; Moyen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115938; Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625; Ngoagouni C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1887-5; Ngoagouni C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0808-3; Pastorino B, 2004, J MED VIROL, V74, P277, DOI 10.1002/jmv.20168; Paul A, 2005, J AM MOSQUITO CONTR, V21, P305, DOI 10.2987/8756-971X(2005)21[305:IRICPF]2.0.CO;2; Peng HJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-83; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; Peyrefitte CN, 2008, J MED VIROL, V80, P430, DOI 10.1002/jmv.21090; Peyrefitte CN, 2007, EMERG INFECT DIS, V13, P768, DOI 10.3201/eid1305.061500; Rahim J, 2017, REV BRAS ENTOMOL, V61, P312, DOI 10.1016/j.rbe.2017.08.001; Simo FBN, 2019, INTERVIROLOGY, V61, P265, DOI 10.1159/000499465; Tedjou AN, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007137; Valle D, 2015, DENGUE TEORIAS PRATI; WHO, 2016, WHOZIKVVC16410, P10; WHO, 2016, WHOZIKVVC161, V16, P7; Xu JB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004696; Yousseu FBS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204143; 2019, J CROHNS COLITIS S1, V13; 2019, J CROHNS COLITIS S1, V13	54	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234572	10.1371/journal.pone.0234572	http://dx.doi.org/10.1371/journal.pone.0234572			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555588	gold, Green Published, Green Accepted			2022-12-26	WOS:000543273200059
J	Brain, D; Mitchell, J; O'Beirne, J				Brain, David; Mitchell, Jonathan; O'Beirne, James			Cost-effectiveness analysis of an outreach model of Hepatitis C Virus (HCV) assessment to facilitate HCV treatment in primary care	PLOS ONE			English	Article							ANTIVIRAL TREATMENT; SYRINGE PROGRAMS; INFECTION; AUSTRALIA; PEOPLE; NEEDLE	The effects of hepatitis C virus (HCV), such as morbidity and mortality associated with cirrhosis and liver cancer, is a major public health issue in Australia. Highly effective treatment has recently been made available to all Australians living with HCV. A decision-analytic model was developed to evaluate the cost-effectiveness of the hepatology partnership, compared to usual care. A Markov model was chosen, as it is state-based and able to include recursive events, which accurately reflects the natural history of the chronic and repetitive nature of HCV. Cost-effectiveness of the new model of care is indicated by the incremental cost-effectiveness ratio (ICER), where the mean change to costs associated with the new model of care is divided by the mean change in quality adjusted life-years (QALYs). Ten thousand iterations of the model were run, with the majority (73%) of ICERs representing cost-savings. In comparison to usual care, the intervention improves health outcomes (22.38 QALYs gained) and reduces costs by $42,122 per patient. When compared to usual care, a partnership approach to management of HCV is cost-effective and good value for money, even when key model parameters are changed in scenario analyses. Reduction in costs is driven by improved efficiency of the new model of care, where more patients are treated in a timely manner, away from the expensive tertiary setting. From an economic perspective, a reduction in hospital-based care is a positive outcome and represents a good investment for decision-makers who wish to maximise health gain per dollar spent.	[Brain, David] Australian Ctr Hlth Serv Innovat, Melbourne, Vic, Australia; [Brain, David] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia; [Mitchell, Jonathan; O'Beirne, James] Sunshine Coast Univ Hosp, Britinya, Australia; [Mitchell, Jonathan; O'Beirne, James] Univ Sunshine Coast, Sunshine Coast Hlth Inst, Britinya, Australia	Queensland University of Technology (QUT); University of the Sunshine Coast	Brain, D (corresponding author), Australian Ctr Hlth Serv Innovat, Melbourne, Vic, Australia.; Brain, D (corresponding author), Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia.	david.brain@qut.edu.au	O'Beirne, James/I-8251-2019	O'Beirne, James/0000-0003-3400-2816; Brain, David/0000-0002-6612-348X				[Anonymous], 2008, PAIN PHYS S, V11, pS5; Belperio PS, 2019, J HEPATOL, V70, P15, DOI 10.1016/j.jhep.2018.09.018; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Briggs A, 2006, DECISION MODELLING H; Clemens S, 2014, QUAL LIFE RES, V23, P2375, DOI 10.1007/s11136-014-0676-x; Cunningham EB, 2018, INT J DRUG POLICY, V62, P14, DOI 10.1016/j.drugpo.2018.08.013; D'Ambrosio R, 2019, J HEPATOL, V70, P379, DOI 10.1016/j.jhep.2018.11.011; Dore GJ, 2018, INFECT DIS CLIN N AM, V32, P269, DOI 10.1016/j.idc.2018.02.006; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; Edney LC, 2018, PHARMACOECONOMICS, V36, P239, DOI 10.1007/s40273-017-0585-2; Grebely J, 2016, CLIN INFECT DIS, V63, P1479, DOI 10.1093/cid/ciw579; Hainsworth SW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198336; Hajarizadeh B, 2018, J VIRAL HEPATITIS, V25, P640, DOI 10.1111/jvh.12852; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hellard ME, 2012, MED J AUSTRALIA, V196, P638, DOI 10.5694/mja11.10981; Husereau D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1049; Iversen J, 2013, AM J PUBLIC HEALTH, V103, P1436, DOI 10.2105/AJPH.2012.301206; Kwon JA, 2019, J VIRAL HEPATITIS, V26, P83, DOI 10.1111/jvh.13013; Kwon JA, 2012, AIDS, V26, P2201, DOI 10.1097/QAD.0b013e3283578b5d; Martin NK, 2016, J HEPATOL, V65, P17, DOI 10.1016/j.jhep.2016.02.007; Midgard H, 2016, J HEPATOL, V64, P1020, DOI 10.1016/j.jhep.2016.01.001; Page K, 2013, J HOSP INFECT, V84, P200, DOI 10.1016/j.jhin.2013.03.006; Pharmaceutical Benefits Advisory Committee, 2013, GUID PREP SUBM PHARM; Scott N, 2015, J GASTROEN HEPATOL, V31, P872; Scott N, 2017, GUT, V66, P1507, DOI 10.1136/gutjnl-2016-311504; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09; The Kirby Institute, 2019, MON HEP C TREATM UPT; Tsuchiya A, 2001, EC EVALUATION HLTH C, P22; Visconti AJ, 2012, J GASTROEN HEPATOL, V28, P707; Waziry R, 2016, J HEPATOL, V65, P1086, DOI 10.1016/j.jhep.2016.08.010; York Health Economics Consortium, 2016, PERSPECTIVE	31	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234577	10.1371/journal.pone.0234577	http://dx.doi.org/10.1371/journal.pone.0234577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555696	Green Published, gold			2022-12-26	WOS:000542759600035
J	Dadi, AF; Miller, ER; Woodman, RJ; Azale, T; Mwanri, L				Dadi, Abel Fekadu; Miller, Emma R.; Woodman, Richard J.; Azale, Telake; Mwanri, Lillian			Effect of antenatal depression on adverse birth outcomes in Gondar town, Ethiopia: A community-based cohort study	PLOS ONE			English	Article							POISSON REGRESSION APPROACH; COMMON MENTAL-DISORDERS; RISK-FACTORS; PRENATAL DEPRESSION; MATERNAL DEPRESSION; PRETERM BIRTH; POSTNATAL-DEPRESSION; PERINATAL-MORTALITY; PREGNANCY; WEIGHT	Background The impact of antenatal depression on pregnancy outcomes has been well investigated in developed countries, but few studies have been conducted in low-income countries. As depression is significantly affected by socio-economic and cultural factors, it would be difficult to generalize evidence from high-income countries to low-income countries. We conducted a community-based cohort study to estimate the incidence of adverse birth outcomes and the direct and indirect pathways via which depression and other psychosocial risk factors may impact such birth outcomes within Gondar town, Ethiopia. Methods The study followed 916 pregnant women who were screened for antenatal depression using the Edinburgh Postnatal Depression Scale (EPDS). We also assessed the incidence of preterm births, Low Birth Weight (LBW) and stillbirths. Modified Poisson regression was used to estimate the relative risk of predictors on adverse birth outcomes and a Generalized Structural Equation Model (GSEM) was used to estimate the direct and indirect effect of antenatal depression and other psychological risk factors on adverse birth outcomes. Results The cumulative incidence of stillbirth, LBW and preterm was 1.90%, 5.25%, and 16.42%, respectively. The risk of preterm birth was 1.61, 1.46, 1.49, and 1.77 times higher among participants who identified as Muslim, reported being fearful of delivery, were government employee's, and who had no antenatal care services, respectively. Partner support moderated the association between depression, preterm birth, and LBW. Depression had no direct effect on birth outcomes but indirectly affected preterm birth via partner support. Religion had both direct and indirect effects on preterm birth, while occupation and fear of delivery had direct effects. The risk of LBW was 9.44 and 2.19 times higher among preterm births and those who had exposure to tobacco, respectively. Stress coping was indirectly associated, and preterm birth and tobacco exposure were directly associated with LBW. The risk of stillbirth was 3.22 times higher in women with antenatal depression and 73% lower in women with higher coping abilities. Conclusions There was a high incidence of all adverse birth outcomes in Gondar Town. Depression and psychosocial risk factors had important indirect negative effects on risk, while partner support provided a positive indirect effect on the incidence of adverse birth outcomes. Interventions that focus on increasing partner engagement and participation in antenatal support may help reduce adverse birth outcomes by enhancing maternal resilience.	[Dadi, Abel Fekadu] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Dadi, Abel Fekadu; Miller, Emma R.; Mwanri, Lillian] Flinders Univ S Australia, Coll Med & Publ Hlth, Bedford Pk, SA, Australia; [Woodman, Richard J.] Flinders Univ S Australia, Coll Med & Publ Hlth, Ctr Epidemiol & Biostat, Bedford Pk, SA, Australia; [Azale, Telake] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Hlth Promot & Behav Sci, Gondar, Ethiopia	University of Gondar; Flinders University South Australia; Flinders University South Australia; University of Gondar	Dadi, AF (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia.; Dadi, AF (corresponding author), Flinders Univ S Australia, Coll Med & Publ Hlth, Bedford Pk, SA, Australia.	Fekten@yahoo.com	Miller, Emma/GXW-3128-2022; Miller, Emma R/G-9615-2018; Dadi, Abel Fekadu/AAU-3433-2020; Mwanri, Lillian/AGG-3711-2022	Miller, Emma R/0000-0002-6373-5720; Dadi, Abel Fekadu/0000-0001-9967-7713; Mwanri, Lillian/0000-0002-5792-7785; Woodman, Richard/0000-0002-4094-1222				Accortt EE, 2015, MATERN CHILD HLTH J, V19, P1306, DOI 10.1007/s10995-014-1637-2; Adam Z, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2315-6; Adane AA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-90; Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; [Anonymous], 2013, PANCREATOLOGY, V13, pe1; [Anonymous], 2017, FUEL CELLS B, V2017, P7, DOI [10.1016/S1464-2859(17)30385-1, DOI 10.1016/S1464-2859(17)30385-1]; [Anonymous], 2016, ADDIT POLYM, V2016, P5; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2016, LANCET, V387, pe9; BARKER DJP, 1986, LANCET, V1, P1077; Behrman RE, 2007, PRETERM BIRTH CAUSES; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P29, DOI 10.4314/ejhs.v24i0.4S; Berhie Kidanemariam Alem, 2016, Matern Health Neonatol Perinatol, V2, P10, DOI 10.1186/s40748-016-0038-5; Biratu A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0092-x; Bitew T, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1462-4; Bitew T, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1383-8; Bitew T, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1099-1; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Bobo FT, 2018, BMC RES NOTES, V11, P1; Bonari L, 2004, CAN J PSYCHIAT, V49, P726, DOI 10.1177/070674370404901103; Buis ML, 2010, STATA J, V10, P11, DOI 10.1177/1536867X1001000104; Central Statistical Agency Addis Ababa Ethiopia, 2016, ETH DEM HLTH SURV KE; Chatillon O, 2010, ENCEPHALE, V36, P443, DOI 10.1016/j.encep.2010.02.004; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Corraini P, 2017, CLIN EPIDEMIOL, V9, P331, DOI 10.2147/CLEP.S129728; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; CSA, 2007, POP HOUS CENS REP ET; de Bernabe JV, 2004, EUR J OBSTET GYN R B, V116, P3, DOI 10.1016/j.ejogrb.2004.03.007; Dean AG, 2010, EPI INFO OPENEPI EPI; Delnord M, 2015, CURR OPIN OBSTET GYN, V27, P133, DOI 10.1097/GCO.0000000000000156; Deressa AT, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1957-0; Diabelkova J, 2018, CENT EUR J PUBL HEAL, V26, pS25, DOI 10.21101/cejph.a5273; Diego MA, 2009, EARLY HUM DEV, V85, P65, DOI 10.1016/j.earlhumdev.2008.07.002; Dunkel Schetter C, 2012, PREGNANCY BIRTH OUTC; Dunkel-Schetter C., 2011, HDB STRESS SCI BIOL, P321; East CE, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000198.pub3; Engmann C, 2012, J PERINATOL, V32, P585, DOI 10.1038/jp.2011.154; Ethiopia FMoHE, 2015, HLTH SECT TRANSF PLA; Federal ministry of health, 2015, ETH PROF PRET LOW BI; Feingold A, 2019, ADDICT BEHAV, V94, P26, DOI 10.1016/j.addbeh.2018.12.018; GAIL MH, 1984, BIOMETRIKA, V71, P431; Gebremedhin M, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0658-1; Gelaye B, 2016, LANCET PSYCHIAT, V3, P973, DOI 10.1016/S2215-0366(16)30284-X; Gilles M, 2018, PSYCHONEUROENDOCRINO, V94, P152, DOI 10.1016/j.psyneuen.2018.04.022; Goedhart G, 2010, PSYCHOSOM MED, V72, P769, DOI 10.1097/PSY.0b013e3181ee4a62; Gondar town health office, 2016, ZON HLTH OFF HLTH SE; Grace J. B., 2005, B ECOL SOC AM, V15, P283, DOI [10.1890/0012-9623(2005)86[283:ITRFMR]2.0.CO;2, DOI 10.1890/0012-9623(2005)86[283:ITRFMR]2.0.CO;2]; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Hanlon C, 2008, J AFFECT DISORDERS, V108, P251, DOI 10.1016/j.jad.2007.10.023; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Hawsawi AM, 2015, RESP CARE, V60, P135, DOI 10.4187/respcare.02798; Heazell AEP, 2016, LANCET, V387, P604, DOI 10.1016/S0140-6736(15)00836-3; Herrero T, 2020, J MATERN-FETAL NEO M, V33, P212, DOI 10.1080/14767058.2018.1488162; Kassahun EA, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4387-9; Kharrazi M, 2004, EPIDEMIOLOGY, V15, P660, DOI 10.1097/01.ede.0000142137.39619.60; Kinney MV, 2015, SEMIN PERINATOL, V39, P326, DOI 10.1053/j.semperi.2015.06.004; Kupek Emil, 2006, BMC Med Res Methodol, V6, P13, DOI 10.1186/1471-2288-6-13; Kuruvilla S, 2016, B WORLD HEALTH ORGAN, V94, P398, DOI 10.2471/BLT.16.170431; Lakew D, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1573-4; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lewis AJ, 2016, J DEV ORIG HLTH DIS, V7, P416, DOI 10.1017/S2040174416000076; Lindtjorn B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197708; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lucas A, 1991, CIBA F SYMP; Luiza JW, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0466-7; Mamica ., 2018, EC ENV STUD, V18, P265, DOI [10.25167/ees.2018.45.15, DOI 10.25167/EES.2018.45.15]; McDonnell BP, 2019, EUR J OBSTET GYN R B, V232, P1, DOI 10.1016/j.ejogrb.2018.11.005; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Megabiaw BM, 2012, PAN AFR MED J, V4, P11; Mekonen DG, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-018-4037-7; Meltzer H., 2003, EUROHIS DEV COMMON I; Milgrom J, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16081426; Mochache K, 2018, ANN GEN PSYCHIATR, V17, DOI 10.1186/s12991-018-0202-6; Moore KA, 2017, LANCET GLOB HEALTH, V5, pE1101, DOI 10.1016/S2214-109X(17)30340-6; MUTHEN B, 1984, PSYCHOMETRIKA, V49, P115, DOI 10.1007/BF02294210; Nasreen HE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-515; National forum on early childhood program evaluation, 82009 NAT EARL CHILD; Nazzari S, 2019, PSYCHONEUROENDOCRINO, V101, P253, DOI 10.1016/j.psyneuen.2018.11.018; Neggers Y, 2006, ACTA OBSTET GYN SCAN, V85, P277, DOI 10.1080/00016340600566121; Negrato CA, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-49; NEUHAUS JM, 1993, BIOMETRIKA, V80, P807, DOI 10.2307/2336872; NHMRC, 2007, NAT STAT ETH COND HU; Nylen KJ, 2013, J BEHAV MED, V36, P427, DOI 10.1007/s10865-012-9436-y; Omidvar S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191723; Orta OR, 2018, ARCH WOMEN MENT HLTH, V21, P43, DOI 10.1007/s00737-017-0777-y; Osborne S, 2018, PSYCHONEUROENDOCRINO, V98, P211, DOI 10.1016/j.psyneuen.2018.06.017; Reinebrant HE, 2018, BJOG-INT J OBSTET GY, V125, P212, DOI 10.1111/1471-0528.14971; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Araujo DMR, 2010, CAD SAUDE PUBLICA, V26, P219, DOI 10.1590/S0102-311X2010000200002; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; Seth S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0915-y; Sion MY, 2016, J MATERN-FETAL NEO M, V29, P863, DOI 10.3109/14767058.2015.1023708; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Smith J. A., 2021, INTERPRETATIVE PHENO, V2nd; Staneva A, 2015, WOMEN BIRTH, V28, P179, DOI 10.1016/j.wombi.2015.02.003; Stewart RC, 2007, MATERN CHILD NUTR, V3, P94, DOI 10.1111/j.1740-8709.2007.00088.x; Szegda K, 2014, J MATERN-FETAL NEO M, V27, P960, DOI 10.3109/14767058.2013.845157; Talie A, 2019, J PREGNANCY, V2019, DOI 10.1155/2019/3587239; Tang SF, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061232; Teklay Girmay, 2018, BMC Res Notes, V11, P571, DOI 10.1186/s13104-018-3693-y; Tsegaye B, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0631-3; Tshotetsi L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213058; University of Washington, 2008, OP DAT KIT ODK; Ververs Mija-Tesse, 2013, PLoS Curr, V5, DOI 10.1371/currents.dis.54a8b618c1bc031ea140e3f2934599c8; Vidaeff AC, 2006, AM J PERINAT, V23, P75, DOI 10.1055/s-2006-931803; Weng SC, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3254-z; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2004, UN CHILDR FUND LOW B; WHO, 2014, WHONMHNHD145; WHO, 2016, PRET BIRTH FACT SHEE; WHO, 2001, WHO PUBLICATION; Woldeyohannes D., 2019, CLIN MOTHER CHILD HL, V16, P2; Woreta Town Administration Agriculture Office, 2016, WORETA TOWN ADM ANIM; Yali AM, 1999, J PSYCHOSOM OBST GYN, V20, P39, DOI 10.3109/01674829909075575; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183; Yismaw Ayenew Engida, 2018, BMC Res Notes, V11, P867, DOI 10.1186/s13104-018-3970-9; Zerfu TA, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0060-y; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	120	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234728	10.1371/journal.pone.0234728	http://dx.doi.org/10.1371/journal.pone.0234728			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB7DG	32555631	Green Published, gold			2022-12-26	WOS:000542759600029
J	Kohvakka, A; Sattari, M; Shcherban, A; Annala, M; Urbanucci, A; Kesseli, J; Tammela, TLJ; Kivinummi, K; Latonen, L; Nykter, M; Visakorpi, T				Kohvakka, Annika; Sattari, Mina; Shcherban, Anastasia; Annala, Matti; Urbanucci, Alfonso; Kesseli, Juha; Tammela, Teuvo L. J.; Kivinummi, Kati; Latonen, Leena; Nykter, Matti; Visakorpi, Tapio			AR and ERG drive the expression of prostate cancer specific long noncoding RNAs	ONCOGENE			English	Article							ANDROGEN RECEPTOR CISTROME; TMPRSS2-ERG GENE FUSION; DNA ELEMENTS; OVEREXPRESSION; ENCYCLOPEDIA; PROGRESSION; BINDING; PTEN	Long noncoding RNAs (lncRNAs) play pivotal roles in cancer development and progression, and some function in a highly cancer-specific manner. However, whether the cause of their expression is an outcome of a specific regulatory mechanism or nonspecific transcription induced by genome reorganization in cancer remains largely unknown. Here, we investigated a group of lncRNAs that we previously identified to be aberrantly expressed in prostate cancer (PC), called TPCATs. Our high-throughput real-time PCR experiments were integrated with publicly available RNA-seq and ChIP-seq data and revealed that the expression of a subset of TPCATs is driven by PC-specific transcription factors (TFs), especially androgen receptor (AR) and ETS-related gene (ERG). Our in vitro validations confirmed that AR and ERG regulated a subset of TPCATs, most notably forEPCART. Knockout ofEPCARTwas found to reduce migration and proliferation of the PC cells in vitro. The high expression ofEPCARTand two other TPCATs (TPCAT-3-174133andTPCAT-18-31849) were also associated with the biochemical recurrence of PC in prostatectomy patients and were independent prognostic markers. Our findings suggest that the expression of numerous PC-associated lncRNAs is driven by PC-specific mechanisms and not by random cellular events that occur during cancer development. Furthermore, we report three prospective prognostic markers for the early detection of advanced PC and showEPCARTto be a functionally relevant lncRNA in PC.	[Kohvakka, Annika; Sattari, Mina; Shcherban, Anastasia; Annala, Matti; Kesseli, Juha; Tammela, Teuvo L. J.; Kivinummi, Kati; Nykter, Matti; Visakorpi, Tapio] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland; [Kohvakka, Annika; Sattari, Mina; Shcherban, Anastasia; Annala, Matti; Kesseli, Juha; Tammela, Teuvo L. J.; Kivinummi, Kati; Nykter, Matti; Visakorpi, Tapio] Tampere Univ Hosp, Tays Canc Ctr, Tampere, Finland; [Urbanucci, Alfonso] Oslo Univ Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Tammela, Teuvo L. J.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Latonen, Leena] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Visakorpi, Tapio] Fimlab Labs Ltd, Tampere Univ Hosp, Tampere, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Oslo; Tampere University; Tampere University Hospital; University of Eastern Finland; Tampere University; Tampere University Hospital	Visakorpi, T (corresponding author), Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland.; Visakorpi, T (corresponding author), Tampere Univ Hosp, Tays Canc Ctr, Tampere, Finland.; Visakorpi, T (corresponding author), Fimlab Labs Ltd, Tampere Univ Hosp, Tampere, Finland.	tapio.visakorpi@tuni.fi	Urbanucci, Alfonso/S-4450-2019	Urbanucci, Alfonso/0000-0003-2931-3652; Nykter, Matti/0000-0001-6956-2843; Sattari, Mina/0000-0001-7358-616X	Academy of Finland [317755, 310829, 317871]; Sigrid Juselius Foundation; Cancer Society of Finland; Business Finland; Finnish Cultural Foundation; European Union [721746]; Norwegian Cancer Society [AU 198016-2018]; Research collegium of the University of Tampere/IASR	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Business Finland; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); European Union(European Commission); Norwegian Cancer Society(Norwegian Cancer Society); Research collegium of the University of Tampere/IASR	This study was supported by grants from the Academy of Finland (TV 317755, MN 310829, and LL 317871), Sigrid Juselius Foundation (TV and LL), Cancer Society of Finland, Business Finland, the Finnish Cultural Foundation (AK), the European Union's Horizon 2020 (MS, TransPot - 721746), Norwegian Cancer Society grant (AU 198016-2018), Research collegium of the University of Tampere/IASR (KK). The authors want to thank Jenni Jouppila, Paula Kosonen, Riina Kylatie, Paivi Martikainen, Hanna Selin, and Marika Vaha-Jaakkola for their technical assistance and Tampere Imaging Facility (TIF) for their service. The results published here are in part based upon data generated by The Cancer Genome Atlas project (dbGaP Study Accession: phs000178.v9.p8) established by the NCI and NHGRI. Information about TCGA can be found at http://cancergenome.nih.gov. We acknowledge ENCODE Consortium and the ENCODE production laboratories for generating the DNase-seq data.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Boormans JL, 2011, EUR UROL, V60, P183, DOI 10.1016/j.eururo.2011.03.028; Bottcher R, 2015, ONCOTARGET, V6, P4036; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Cerveira N, 2006, NEOPLASIA, V8, P826, DOI 10.1593/neo.06427; Chawla K, 2013, BIOINFORMATICS, V29, P2519, DOI 10.1093/bioinformatics/btt432; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Hessels D, 2003, EUR UROL, V44, P8, DOI 10.1016/S0302-2838(03)00201-X; Kron KJ, 2017, NAT GENET, V49, P1336, DOI 10.1038/ng.3930; Linja MJ, 2001, CANCER RES, V61, P3550; Martens-Uzunova ES, 2014, EUR UROL, V65, P1140, DOI 10.1016/j.eururo.2013.12.003; Nam RK, 2007, CANCER BIOL THER, V6, P40, DOI 10.4161/cbt.6.1.3489; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Prensner JR, 2014, LANCET ONCOL, V15, P1469, DOI 10.1016/S1470-2045(14)71113-1; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Sahu A, 2015, TRENDS CANCER, V1, P93, DOI 10.1016/j.trecan.2015.08.010; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Shukla S, 2016, NEOPLASIA, V18, P489, DOI 10.1016/j.neo.2016.07.001; Su XP, 2014, ONCOTARGET, V5, P9864, DOI 10.18632/oncotarget.2454; Takayama K, 2013, EMBO J, V32, P1665, DOI 10.1038/emboj.2013.99; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Urbanucci A, 2012, ONCOGENE, V31, P2153, DOI 10.1038/onc.2011.401; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; White NM, 2017, EUR UROL, V71, P257, DOI 10.1016/j.eururo.2016.07.012; White NM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0429-8; Yan XH, 2015, CANCER CELL, V28, P529, DOI 10.1016/j.ccell.2015.09.006; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Ylipaa A, 2015, CANCER RES, V75, P4026, DOI 10.1158/0008-5472.CAN-15-0217; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhang A, 2015, CELL REP, V13, P209, DOI 10.1016/j.celrep.2015.08.069; Zhang YJ, 2018, NAT GENET, V50, P814, DOI 10.1038/s41588-018-0120-1	38	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 23	2020	39	30					5241	5251		10.1038/s41388-020-1365-6	http://dx.doi.org/10.1038/s41388-020-1365-6		JUN 2020	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MO5BV	32555329	Green Accepted			2022-12-26	WOS:000545371000005
J	Shin, SH; Ye, MK; Lee, DW; Chae, MH; Choi, SY				Shin, Seung-Heon; Ye, Mi-Kyung; Lee, Dong-Won; Chae, Mi-Hyun; Choi, Sung-Yong			Development and immunopathological characteristics of anAlternaria-induced chronic rhinosinusitis mouse model	PLOS ONE			English	Article							EOSINOPHILIC CHRONIC RHINOSINUSITIS; ALTERNARIA-ALTERNATA; EPITHELIAL-CELLS; NASAL POLYP; PROTEASE; ASPERGILLUS; ALLERGY	Airborne fungi are associated with upper and lower airway inflammatory diseases.Alternariais commonly found in nasal secretions and induces the production of chemical mediators from sinonasal mucosa. This study aimed to establish anAlternaria-induced chronic rhinosinusitis (CRS) mouse model and determine the influence of host allergic background on the immunopathological characteristics of CRS. BALB/c mice were used for establishing the CRS model.Alternariawas intranasally instilled for 8 or 16 weeks with or without ovalbumin (OVA) presensitization. Total serum IgE andAlternaria-specific IgE levels were measured by enzyme-linked immunosorbent assay (ELISA). Interleukin (IL)-4, IL-10, interferon (IFN)-gamma, and tumor necrosis factor (TNF)-alpha levels in nasal lavage fluid (NLF) and splenocytes were measured by ELISA and their mRNAs and levels of associated transcription factors in sinonasal mucosa were determined with quantitative reverse-transcriptase polymerase chain reaction (RT-PCR). Hematoxylin-eosin staining and periodic acid-Schiff staining were performed to evaluate histological changes. Total serum IgE was increased in both allergic and non-allergic CRS. IL-4 was strongly expressed in NLF in both allergic and non-allergic CRS at 16 weeks and not only eosinophils but also neutrophils were increased in NLF of non-allergic CRS mice. The levels of Th1, Th2, and Treg cytokines and transcription factor mRNAs were significantly increased in sinonasal mucosa of non-allergic CRS mice. Both inflammatory cell infiltration and goblet cell hyperplasia were increased in CRS mice. Repeated intranasal instillation ofAlternaria results in sinonasal inflammation with inflammatory cell infiltration. The sinonasal mucosal immune responses againstAlternariawere shown to differ depending on the host allergic background.	[Shin, Seung-Heon; Ye, Mi-Kyung; Lee, Dong-Won; Chae, Mi-Hyun; Choi, Sung-Yong] Catholic Univ Daegu, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea	Catholic University of Daegu	Shin, SH (corresponding author), Catholic Univ Daegu, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea.	hsseung@cu.ac.kr			National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT) [2019R1F1A1047757]	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science and ICT) (2019R1F1A1047757) to PI, SH Shin.	Ahn BH, 2009, AURIS NASUS LARYNX, V36, P422, DOI 10.1016/j.anl.2008.08.009; [Anonymous], 2011, J PEDIATR HEALTH CAR, V25, pA9; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Balenga NA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7763; Cao PP, 2019, ANN ALLERG ASTHMA IM, V122, P33, DOI 10.1016/j.anai.2018.10.014; Del Bono E., 2016, ECON J, V126, pF96; Hirotsu M, 2014, LARYNGOSCOPE, V124, pE347, DOI 10.1002/lary.24655; Kennedy JL, 2013, AM J RHINOL ALLERGY, V27, P367, DOI 10.2500/ajra.2013.27.3906; Kim HK, 2013, EXP LUNG RES, V39, P399, DOI 10.3109/01902148.2013.835009; Kim HC, 2017, EUR ARCH OTO-RHINO-L, V274, P3899, DOI 10.1007/s00405-017-4717-2; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Lawrence LA, 2015, AM J RHINOL ALLERGY, V29, P89, DOI 10.2500/ajra.2015.29.4155; Lehmann S, 2017, THER ADV RESPIR DIS, V11, P30, DOI 10.1177/1753465816680786; Marcus S, 2019, LARYNGOSCOPE INVEST, V4, P13, DOI 10.1002/lio2.236; Matsuwaki Y, 2012, INT ARCH ALLERGY IMM, V158, P19, DOI 10.1159/000337756; Murai H, 2015, BIOCHEM BIOPH RES CO, V464, P969, DOI 10.1016/j.bbrc.2015.05.076; Nagata Y, 2019, AM J RHINOL ALLERGY, V33, P378, DOI 10.1177/1945892419835333; Park SC, 2019, EUR ARCH OTO-RHINO-L, V276, P2273, DOI 10.1007/s00405-019-05465-x; Shin SH, 2007, AM J RHINOL, V21, P556, DOI 10.2500/ajr.2007.21.3065; Shin SH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082693; Valladao AC, 2016, J IMMUNOL, V197, P4541, DOI 10.4049/jimmunol.1600007; Wise SK, 2018, INT FORUM ALLERGY RH, V8, P108, DOI 10.1002/alr.22073; Wu DW, 2018, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00538	23	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234731	10.1371/journal.pone.0234731	http://dx.doi.org/10.1371/journal.pone.0234731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544181	Green Published, gold			2022-12-26	WOS:000542957200024
J	Finley, EP; Schneegans, S; Curtis, ME; Bebarta, VS; Maddry, JK; Penney, L; McGeary, D; Potter, JS				Finley, Erin P.; Schneegans, Suyen; Curtis, Megan E.; Bebarta, Vikhyat S.; Maddry, Joseph K.; Penney, Lauren; McGeary, Don; Potter, Jennifer Sharpe			Confronting challenges to opioid risk mitigation in the US health system: Recommendations from a panel of national experts	PLOS ONE			English	Article							CHRONIC PAIN; PRIMARY-CARE; SATISFACTION; STRATEGIES; MANAGEMENT; SPECIALTY; INSURANCE; ACCESS; MISUSE; ABUSE	Background Amid the ongoing U.S. opioid crisis, achieving safe and effective chronic pain management while reducing opioid-related morbidity and mortality is likely to require multi-level efforts across health systems, including the Military Health System (MHS), Department of Veterans Affairs (VA), and civilian sectors. Objective We conducted a series of qualitative panel discussions with national experts to identify core challenges and elicit recommendations toward improving the safety of opioid prescribing in the U.S. Design We invited national experts to participate in qualitative panel discussions regarding challenges in opioid risk mitigation and how best to support providers in delivery of safe and effective opioid prescribing across MHS, VA, and civilian health systems. Participants Eighteen experts representing primary care, emergency medicine, psychology, pharmacy, and public health/policy participated. Approach Six qualitative panel discussions were conducted via teleconference with experts. Transcripts were coded using team-based qualitative content analysis to identify key challenges and recommendations in opioid risk mitigation. Key results Panelists provided insight into challenges across multiple levels of the U.S. health system, including the technical complexity of treating chronic pain, the fraught national climate around opioids, the need to integrate surveillance data across a fragmented U.S. health system, a lack of access to non-pharmacological options for chronic pain care, and difficulties in provider and patient communication. Participating experts identified recommendations for multi-level change efforts spanning policy, research, education, and the organization of healthcare delivery. Conclusions Reducing opioid risk while ensuring safe and effective pain management, according to participating experts, is likely to require multi-level efforts spanning military, veteran, and civilian health systems. Efforts to implement risk mitigation strategies at the patient level should be accompanied by efforts to increase education for patients and providers, increase access to non-pharmacological pain care, and support use of existing clinical decision support, including state-level prescription drug monitoring programs.	[Finley, Erin P.; Schneegans, Suyen; Curtis, Megan E.; Penney, Lauren; McGeary, Don; Potter, Jennifer Sharpe] UT Hlth San Antonio, San Antonio, TX 78229 USA; [Finley, Erin P.; Penney, Lauren] South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Bebarta, Vikhyat S.] Univ Colorado, Sch Med, Aurora, CO USA; [Maddry, Joseph K.] Brooke Army Med Ctr, Emergency Dept, San Antonio, TX USA; [Maddry, Joseph K.] 59th Med Wing Sci & Technol Cell, San Antonio, TX USA; [Maddry, Joseph K.] San Antonio Uniformed Serv Hlth Educ Consortium, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; San Antonio Military Medical Center; United States Department of Defense; United States Army; San Antonio Military Medical Center	Finley, EP (corresponding author), UT Hlth San Antonio, San Antonio, TX 78229 USA.; Finley, EP (corresponding author), South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA.	finleye@uthscsa.edu	Potter, Jennifer Sharpe/C-6720-2008	Potter, Jennifer Sharpe/0000-0002-7250-4422; Finley, Erin/0000-0003-4497-7721; Penney, Lauren/0000-0002-8285-7352	NIH NIDA [U10 020024]; Substance Abuse Working Group (SAWG) of the Joint Program Committee 5 (JPC-5)/Military Operational Medicine Research Program (MOMRP), US Army Medical Research and Materiel Command (USAMRMC) [FA8650-15-C-6588]	NIH NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Substance Abuse Working Group (SAWG) of the Joint Program Committee 5 (JPC-5)/Military Operational Medicine Research Program (MOMRP), US Army Medical Research and Materiel Command (USAMRMC)	We gratefully acknowledge support awarded to UT Health San Antonio, PI Jennifer Sharpe Potter, PhD, MPH (NIH NIDA U10 020024) and funding (FA8650-15-C-6588) received through the Substance Abuse Working Group (SAWG) of the Joint Program Committee 5 (JPC-5)/Military Operational Medicine Research Program (MOMRP), US Army Medical Research and Materiel Command (USAMRMC). The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Annual Surveillance Report of Drug-Related Risks and Outcomes-United States, 2017, 1 US DEP HHS; [Anonymous], 2018, VOX             0919; [Anonymous], 2010, VA DOD CLIN PRACT GU; [Anonymous], ATL TI 7 0 SOFTW; Baldini Angee, 2012, Prim Care Companion CNS Disord, V14, DOI 10.4088/PCC.11m01326; Becker WC, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0608-2; Berg KM, 2009, J GEN INTERN MED, V24, P482, DOI 10.1007/s11606-009-0908-x; Center for Disease Control & Prevention, APPL CDCS GUID PRESC; Centers for Disease Control and Prevention, 2019, 2019 ANN SURV REP DR, P128; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Coulter Ian, 2016, BMC Res Notes, V9, P16, DOI 10.1186/s13104-015-1802-8; Cummings JR, 2017, JAMA PSYCHIAT, V74, P476, DOI 10.1001/jamapsychiatry.2017.0303; Donohoe H, 2012, AM J HEALTH EDUC, V43, P38, DOI 10.1080/19325037.2012.10599216; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr6501e1, 10.1001/jama.2016.1464, 10.15585/mmwr.rr7103a1]; Dunn RL, 2015, MATERN CHILD HLTH J, V19, P6, DOI 10.1007/s10995-014-1488-x; Eibner Christine, 2016, Rand Health Q, V5, P13; Finley EP, 2019, J BEHAV HEALTH SER R, V46, P217, DOI 10.1007/s11414-018-9613-z; Finley EP, 2018, J AM MED INFORM ASSN, V25, P515, DOI 10.1093/jamia/ocx075; Finley EP, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2354-5; Garcia MC, 2016, MMWR-MORBID MORTAL W, V65, P1125, DOI 10.15585/mmwr.mm6541a1; Gomes T, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0217; Gudin Jeffrey, 2012, J Pain Palliat Care Pharmacother, V26, P136, DOI 10.3109/15360288.2012.679724; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hughes HK, 2015, PATIENT EDUC COUNS, V98, P453, DOI 10.1016/j.pec.2014.12.003; Institute of Medicine (US), 2002, FUT PUBL HLTH 21 CEN; Institute of Medicine (US) Committee on Advancing Pain Research Care and Education, 2011, REL PAIN AM BLUEPR T; Kazanis W, 2018, MIL MED, V183, pE157, DOI 10.1093/milmed/usx014; Kolodny A, 2015, ANNU REV PUBL HEALTH, V36, P559, DOI 10.1146/annurev-publhealth-031914-122957; Lin LWA, 2017, PAIN, V158, P833, DOI 10.1097/j.pain.0000000000000837; MacDowell M, 2010, RURAL REMOTE HEALTH, V10; Matthias MS, 2014, EUR J PAIN, V18, P835, DOI 10.1002/j.1532-2149.2013.00426.x; Matthias MS, 2010, PAIN MED, V11, P1688, DOI 10.1111/j.1526-4637.2010.00980.x; Moore M, 2016, ENHANCING MILITARY C; Mundell BF, 2013, HEALTH AFFAIR, V32, P1949, DOI 10.1377/hlthaff.2013.0586; Pacini Davide, 2016, Korean J Thorac Cardiovasc Surg, V49, P413; Penney LS, 2017, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0566-0; Saloner B, 2018, PUBLIC HEALTH REP, V133, p24S, DOI 10.1177/0033354918793627; Samuels K, 2001, TRANSFORMING RURAL H; Schatman ME, 2011, PAIN MED, V12, P415, DOI 10.1111/j.1526-4637.2011.01061.x; Schottenfeld JR, 2018, J LAW MED ETHICS, V46, P220, DOI 10.1177/1073110518782923; Simmonds Maureen, PAIN MED; Sites BD, 2018, ANN FAM MED, V16, P6, DOI 10.1370/afm.2148; Smith RJ, 2015, ANN EMERG MED, V66, P246, DOI 10.1016/j.annemergmed.2015.03.025; Tick H, 2018, EXPLORE-NY, V14, P177, DOI 10.1016/j.explore.2018.02.001; Trafton JA, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-26; Volkow N, 2018, ANNU REV MED, V69, P451, DOI 10.1146/annurev-med-011817-044739; Volkow ND, 2016, NEW ENGL J MED, V374, P1253, DOI 10.1056/NEJMra1507771; Waltz TJ, 2015, IMPLEMENT SCI, V10; Weisberg DF, 2014, INT J DRUG POLICY, V25, P1124, DOI 10.1016/j.drugpo.2014.07.009; Wiznia DH, 2017, REGION ANESTH PAIN M, V42, P39, DOI 10.1097/AAP.0000000000000502; Zgierska A, 2012, JAMA-J AM MED ASSOC, V307, P1377, DOI 10.1001/jama.2012.419	51	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234425	10.1371/journal.pone.0234425	http://dx.doi.org/10.1371/journal.pone.0234425			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB6AZ	32542028	Green Published, gold			2022-12-26	WOS:000542685100023
J	Maldonado, JA; Firneno, TJ; Roelke, CE; Rains, ND; Mwgiri, J; Fujita, MK				Maldonado, Jose A.; Firneno, Thomas J., Jr.; Roelke, Corey E.; Rains, Nathan D.; Mwgiri, Juliet; Fujita, Matthew K.			Transcriptome sequencing reveals signatures of positive selection in the Spot-Tailed Earless Lizard	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; NUCLEAR-PROTEIN; GENOMICS; ANNOTATION; EVOLUTION; MUTATION; DAMAGE; LBH	The continual loss of threatened biodiversity is occurring at an accelerated pace. High-throughput sequencing technologies are now providing opportunities to address this issue by aiding in the generation of molecular data for many understudied species of high conservation interest. Our overall goal of this study was to begin building the genomic resources to continue investigations and conservation of the Spot-Tailed Earless lizard. Here we leverage the power of high-throughput sequencing to generate the liver transcriptome for the Northern Spot-Tailed Earless Lizard (Holbrookia lacerata) and Southern Spot-Tailed Earless Lizard (Holbrookia subcaudalis), which have declined in abundance in the past decades, and their sister species, the Common Lesser Earless Lizard (Holbrookia maculata). Our efforts produced high quality and robust transcriptome assemblies validated by1) quantifying the number of processed reads represented in the transcriptome assembly and2) quantifying the number of highly conserved single-copy orthologs that are present in our transcript set using the BUSCO pipeline. We found 1,361 1-to-1 orthologs among the threeHolbrookiaspecies,Anolis carolinensis, andSceloporus undulatus. We carried out dN/dS selection tests using a branch-sites model and identified a dozen genes that experienced positive selection in theHolbrookialineage with functions in development, immunity, and metabolism. Our single-copy orthologous sequences additionally revealed significant pairwise sequence divergence (similar to.73%) between the NorthernH.lacerataand SouthernH.subcaudalisthat further supports the recent elevation of the Southern Spot-Tailed Earless Lizard to full species.	[Maldonado, Jose A.; Firneno, Thomas J., Jr.; Roelke, Corey E.; Mwgiri, Juliet; Fujita, Matthew K.] Univ Texas Arlington, Dept Biol, Amphibian & Reptile Divers Res Ctr, Arlington, TX 76019 USA; [Rains, Nathan D.] Texas Parks & Wildlife Dept, Austin, TX USA	University of Texas System; University of Texas Arlington	Fujita, MK (corresponding author), Univ Texas Arlington, Dept Biol, Amphibian & Reptile Divers Res Ctr, Arlington, TX 76019 USA.	mkfujita@uta.edu		Maldonado, Jose/0000-0002-0879-8366	Texas Parks & Wildlife Section Six Grant [TPWD 474241]	Texas Parks & Wildlife Section Six Grant	This work was funded by a Texas Parks & Wildlife Section Six Grant awarded to Corey E. Roelke and Matthew K. Fujita (TPWD 474241).; We thank the biologists of the Texas Parks and Wildlife Department. We thank the many landowners and land managers, both public and private, who granted us access to their land for lizard surveys. This work was funded by a Texas Parks & Wildlife Section Six Grant awarded to Corey E. Roelke and Matthew K. Fujita (TPWD 474241).	Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; [Anonymous], 1996, J APPL ECOL, DOI DOI 10.2307/2404927; Axtell RW, 1956, SOLUTION LONG NEGLEC; Blankers T, 2013, BIOL J LINN SOC, V108, P127, DOI 10.1111/j.1095-8312.2012.01988.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Briegel KJ, 2001, DEV BIOL, V233, P291, DOI 10.1006/dbio.2001.0225; Carruthers M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4379-x; Cheng TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122837; Chopra R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115055; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Cope ED., 1900, CROCODILIANS LIZARDS; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Duan JJ, 2017, GIGASCIENCE, V6, P1, DOI 10.1093/gigascience/gix057; Duran M, 2010, REPORT SUBMITTED TEX; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Flanagan SP, 2018, EVOL APPL, V11, P1035, DOI 10.1111/eva.12569; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Fuchs SA, 2006, ANN NEUROL, V60, P476, DOI 10.1002/ana.20977; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Garner BA, 2016, TRENDS ECOL EVOL, V31, P81, DOI 10.1016/j.tree.2015.10.009; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grant GA, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00110; Haas B, 2015, OTHERS TRANSDECODER; Henschel R., 2012, P 1 C EXTREME SCI EN, P1, DOI [10.1145/2335755.2335842, DOI 10.1145/2335755.2335842]; Hibbitts TJ, 2019, ZOOTAXA, V4619, P139, DOI 10.11646/zootaxa.4619.1.6; Hoglund J, 2009, EVOLUTIONARY CONSERVATION GENETICS, P1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imazu T, 1999, ONCOGENE, V18, P4523, DOI 10.1038/sj.onc.1202722; Ingram M, 2017, ENDANGERED SPECIES A; Iovine B, 2011, INT J BIOCHEM CELL B, V43, P1664, DOI 10.1016/j.biocel.2011.09.001; Kristensen TN, 2006, GENETICS, V173, P1329, DOI 10.1534/genetics.105.054486; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; MacManes MD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00013; McGaugh SE, 2015, P NATL ACAD SCI USA, V112, P7055, DOI 10.1073/pnas.1419659112; Miller HC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-439; Ney PA, 2015, BBA-MOL CELL RES, V1853, P2775, DOI 10.1016/j.bbamcr.2015.02.022; Pamplona R, 2011, AM J PHYSIOL-REG I, V301, pR843, DOI 10.1152/ajpregu.00034.2011; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Pierre JP, 2018, ENVIRON MANAGE, V61, P805, DOI 10.1007/s00267-018-1000-2; Powder KE, 2014, MOL BIOL EVOL, V31, P3113, DOI 10.1093/molbev/msu267; Primmer CR, 2009, ANN NY ACAD SCI, V1162, P357, DOI 10.1111/j.1749-6632.2009.04444.x; Ranwez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022594; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Roelke CE, 2018, J NAT HIST, V52, P1017, DOI 10.1080/00222933.2018.1436726; Schunter C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-167; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Stejneger L, 1891, N AM FAUNA, P109; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; Tabatabaie L, 2009, HUM MUTAT, V30, P749, DOI 10.1002/humu.20934; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tollis M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177708; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Visser EA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2277-7; Waterhouse RM, 2018, MOL BIOL EVOL, V35, P543, DOI 10.1093/molbev/msx319; WATKINS JF, 1993, MOL CELL BIOL, V13, P7757, DOI 10.1128/MCB.13.12.7757; Wolaver BD, 2018, ENVIRON MANAGE, V62, P323, DOI 10.1007/s00267-018-1042-5; Wolaver BD, 2018, ENVIRON EARTH SCI, V77, DOI 10.1007/s12665-018-7323-8; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	63	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234504	10.1371/journal.pone.0234504	http://dx.doi.org/10.1371/journal.pone.0234504			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542006	Green Published, gold			2022-12-26	WOS:000542685100034
J	Stoss, C; Laschinger, M; Wang, BC; Lu, M; Altmayr, F; Hartmann, D; Huser, N; Holzmann, B				Stoess, Christian; Laschinger, Melanie; Wang, Baocai; Lu, Miao; Altmayr, Felicitas; Hartmann, Daniel; Hueser, Norbert; Holzmann, Bernhard			TLR3 promotes hepatocyte proliferation after partial hepatectomy by stimulating uPA expression and the release of tissue-bound HGF	FASEB JOURNAL			English	Article						HGF; liver regeneration; stellate cells; TLR3; urokinase-type plasminogen activator	TOLL-LIKE RECEPTOR-3; GROWTH-FACTOR RECEPTOR; LIVER-REGENERATION; CELLS; INNATE; MET; RNA; RECOGNITION; ACTIVATION; NECROSIS	TLR3 is implicated in anti-viral immune responses, but may also act as a sensor of tissue damage in the absence of infection. Here, we provide evidence for an essential role of TLR3 in liver regeneration after an acute loss of tissue due to partial hepatectomy. Mice lacking TLR3 had a severe and sustained defect in the restoration of liver tissue with reduced liver-to-body weight ratios even after an extended recovery period of 2 weeks. Hepatocyte cell cycle progression into S phase was impaired in TLR3-deficient mice. Mechanistic analyses revealed that TLR3-deficient mice had markedly reduced systemic levels of active HGF, but had increased amounts of inactive tissue-bound HGF. Importantly, expression of uPA, which orchestrates the processing and release of HGF from the hepatic extracellular matrix, was reduced in regenerating livers of TLR3-deficient mice. In addition, expression of the HGF maturation factor HGFAC was transiently diminished in TLR3-deficient mice. In vitro, engagement of TLR3 directly stimulated expression of uPA by hepatic stellate cells. Thus, TLR3 supports liver regeneration through upregulation of uPA, which promotes the release of preformed HGF from extracellular matrix stores.	[Stoess, Christian; Laschinger, Melanie; Wang, Baocai; Lu, Miao; Altmayr, Felicitas; Hartmann, Daniel; Hueser, Norbert; Holzmann, Bernhard] Tech Univ Munich, Sch Med, Dept Surg, Ismaninger Str 22, D-81675 Munich, Germany	Technical University of Munich	Holzmann, B (corresponding author), Tech Univ Munich, Sch Med, Dept Surg, Ismaninger Str 22, D-81675 Munich, Germany.	bernhard.holzmann@tum.de		Stoess, Christian/0000-0002-0682-8808	Technical University of Munich	Technical University of Munich	Technical University of Munich	Alison MR, 2016, J PATHOL, V238, P371, DOI 10.1002/path.4667; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Campbell JS, 2006, J IMMUNOL, V176, P2522, DOI 10.4049/jimmunol.176.4.2522; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Crispe IN, 2016, J IMMUNOL, V196, P17, DOI 10.4049/jimmunol.1501668; DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Estornes Y, 2012, CELL DEATH DIFFER, V19, P1482, DOI 10.1038/cdd.2012.22; Factor VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012739; Faure-Dupuy S, 2018, J INNATE IMMUN, V10, P339, DOI 10.1159/000489966; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kocabayoglu P, 2016, LIVER INT, V36, P874, DOI 10.1111/liv.12933; Leyland H, 1996, HEPATOLOGY, V24, P1172, DOI 10.1002/hep.510240532; MARS WM, 1995, HEPATOLOGY, V21, P1695, DOI 10.1016/0270-9139(95)90477-8; Mei XP, 2011, NEUROSIGNALS, V19, P44, DOI 10.1159/000324293; Michalopoulos GK, 2017, HEPATOLOGY, V65, P1384, DOI 10.1002/hep.28988; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Modares NF, 2019, HEPATOLOGY, V70, P2075, DOI 10.1002/hep.30774; Mohammed FF, 2005, TRENDS CELL BIOL, V15, P555, DOI 10.1016/j.tcb.2005.08.009; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Nelson AM, 2015, CELL STEM CELL, V17, P139, DOI 10.1016/j.stem.2015.07.008; Paranjpe S, 2007, HEPATOLOGY, V45, P1471, DOI 10.1002/hep.21570; Paranjpe S, 2016, HEPATOLOGY, V64, P1711, DOI 10.1002/hep.28721; Paranjpe S, 2010, AM J PATHOL, V176, P2669, DOI 10.2353/ajpath.2010.090605; Pediaditakis P, 2001, HEPATOLOGY, V34, P688, DOI 10.1053/jhep.2001.27811; Perales-Linares R, 2013, IMMUNOLOGY, V140, P153, DOI 10.1111/imm.12143; Riehle KJ, 2011, J GASTROEN HEPATOL, V26, P203, DOI 10.1111/j.1440-1746.2010.06539.x; Roselli HT, 1998, AM J PHYSIOL-GASTR L, V275, pG1472, DOI 10.1152/ajpgi.1998.275.6.G1472; Schulze S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29924-3; Schuppan D, 1998, GASTROENTEROLOGY, V114, P139, DOI 10.1016/S0016-5085(98)70642-0; Seki E, 2005, HEPATOLOGY, V41, P443, DOI 10.1002/hep.20603; Seo W, 2016, HEPATOLOGY, V64, P616, DOI 10.1002/hep.28644; Shimizu M, 2001, HEPATOLOGY, V33, P569, DOI 10.1053/jhep.2001.22650; Sun R, 2004, GASTROENTEROLOGY, V127, P1525, DOI 10.1053/j.gastro.2004.08.055; Sun R, 2006, HEPATOLOGY, V44, P955, DOI 10.1002/hep.21344; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Toscano F, 2013, J IMMUNOL, V190, P764, DOI 10.4049/jimmunol.1202173; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Vaquero J, 2011, HEPATOLOGY, V54, P597, DOI 10.1002/hep.24420; WAKE K, 1971, AM J ANAT, V132, P429, DOI 10.1002/aja.1001320404; Wang L, 2012, J CLIN INVEST, V122, P1567, DOI 10.1172/JCI58789; Wilson CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083391; Zorde-Khvalevsky E, 2009, HEPATOLOGY, V50, P198, DOI 10.1002/hep.22973	54	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10387	10397		10.1096/fj.202000904R	http://dx.doi.org/10.1096/fj.202000904R		JUN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32539223	hybrid			2022-12-26	WOS:000541802400001
J	Yamamuro, D; Takahashi, M; Nagashima, S; Wakabayashi, T; Yamazaki, H; Takei, A; Takei, S; Sakai, K; Ebihara, K; Iwasaki, Y; Yada, T; Ishibashi, S				Yamamuro, Daisuke; Takahashi, Manabu; Nagashima, Shuichi; Wakabayashi, Tetsuji; Yamazaki, Hisataka; Takei, Akihito; Takei, Shoko; Sakai, Kent; Ebihara, Ken; Iwasaki, Yusaku; Yada, Toshihiko; Ishibashi, Shun			Peripheral circadian rhythms in the liver and white adipose tissue of mice are attenuated by constant light and restored by time-restricted feeding	PLOS ONE			English	Article							HIGH-FAT-DIET; HORMONE-SENSITIVE LIPASE; COENZYME-A REDUCTASE; MESSENGER-RNA; ENERGY-METABOLISM; MAMMALIAN CLOCK; PPAR-ALPHA; EXPRESSION; GENES; MOUSE	Disturbance of circadian rhythms underlies various metabolic diseases. Constant light exposure (LL) is known to disrupt both central and peripheral circadian rhythms. Here, we attempted to determine whether the effects of LL are different between various peripheral tissues and whether time-restricted feeding restores the circadian rhythms especially in white adipose tissue (WAT). Six-week-old mice were subjected to three feeding regimes:ad libitumfeeding under light/dark phase (LD),ad libitumfeeding under LL cycle, and restricted feeding at night-time under LL cycle with a normal chow. After 3 weeks, we compared body weight, food intake, plasma levels of lipids and glucose, and the expression patterns of the clock genes and the genes involved in lipid metabolism in the liver and WAT. The mice kept under LL with or without time-restricted feeding were 5.2% heavier (p<0.001, n = 16) than the mice kept under LD even though the food intakes of the two groups were the same. Food intake occurred mostly in the dark phase. LL disrupted this pattern, causing disruptions in circadian rhythms of plasma levels of triglycerides (TG) and glucose. Time-restricted feeding partially restored the rhythms. LL eliminated the circadian rhythms of the expression of the clock genes as well as most of the genes involved in lipid metabolism in both liver and WAT. More notably, LL markedly decreased not only the amplitude but also the average levels of the expression of the genes in the liver, but not in the WAT, suggesting that transcription in the liver is sensitive to constant light exposure. Time-restricted feeding restored the circadian rhythms of most of the genes to various degrees in both liver and WAT. In conclusion, LL disrupted the peripheral circadian rhythms more severely in liver than in WAT. Time-restricted feeding restored the circadian rhythms in both tissues.	[Yamamuro, Daisuke; Takahashi, Manabu; Nagashima, Shuichi; Wakabayashi, Tetsuji; Yamazaki, Hisataka; Takei, Akihito; Takei, Shoko; Sakai, Kent; Ebihara, Ken; Ishibashi, Shun] Jichi Med Univ, Dept Med, Div Endocrinol & Metab, Shimotsuke, Tochigi, Japan; [Iwasaki, Yusaku; Yada, Toshihiko] Jichi Med Univ, Sch Med, Dept Physiol, Div Integrat Physiol, Shimotsuke, Tochigi, Japan; [Sakai, Kent] Univ Miami, Miami Itch Ctr, Div Dermatol & Cutaneous Surg, Miami, FL USA; [Iwasaki, Yusaku] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Lab Anim Sci, Sakyo Ku, Kyoto, Japan; [Yada, Toshihiko] Kansai Elect Power Med Res Inst, Div Integrat Physiol, Chuo Ku, Kobe, Hyogo, Japan	Jichi Medical University; Jichi Medical University; University of Miami; Kyoto Prefectural University	Ishibashi, S (corresponding author), Jichi Med Univ, Dept Med, Div Endocrinol & Metab, Shimotsuke, Tochigi, Japan.	ishibash@jichi.ac.jp		Sakai, Kent/0000-0002-8247-4036	MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Ministry of Education, Culture, Sports, Science and Technology of Japan	MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-inAid for Scientific Research and MEXT-Supported Program for the Strategic Research Foundation at Private Universities 2011-2015 "Cooperative Basic and Clinical Research on Circadian Medicine" from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Adamovich Y, 2014, CELL METAB, V19, P319, DOI 10.1016/j.cmet.2013.12.016; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Brewer M, 2005, J BIOL RHYTHM, V20, P195, DOI 10.1177/0748730405275952; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Chang WC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-94; Chen RM, 2008, J NEUROSCI, V28, P11839, DOI 10.1523/JNEUROSCI.2191-08.2008; Chitraju C, 2013, J LIPID RES, V54, P2185, DOI 10.1194/jlr.M037952; CLARKE CF, 1984, J BIOL CHEM, V259, P439; Coomans CP, 2013, FASEB J, V27, P1721, DOI 10.1096/fj.12-210898; Cornelissen G, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-16; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; FUKUDA H, 1991, BIOCHIM BIOPHYS ACTA, V1086, P261, DOI 10.1016/0005-2760(91)90168-H; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Hatori M, 2011, P NATL ACAD SCI USA, V108, P4864, DOI 10.1073/pnas.1015959108; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hsieh MC, 2010, INT J OBESITY, V34, P227, DOI 10.1038/ijo.2009.228; KANDUTSCH AA, 1969, J BIOL CHEM, V244, P2299; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Landgraf D, 2015, ELIFE, V4, DOI 10.7554/eLife.06253; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Nagashima S, 2011, J ATHEROSCLER THROMB, V18, P190, DOI 10.5551/jat.6478; Nakao R, 2017, MOL GENET METAB, V121, P190, DOI 10.1016/j.ymgme.2017.04.001; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Okazaki H, 2002, DIABETES, V51, P3368, DOI 10.2337/diabetes.51.12.3368; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Panda S, 2016, SCIENCE, V354, P1008, DOI 10.1126/science.aah4967; Polidarova L, 2011, CHRONOBIOL INT, V28, P204, DOI 10.3109/07420528.2010.548615; Sabath E, 2015, OBES REV, V16, P871, DOI 10.1111/obr.12308; Sekiya M, 2008, J LIPID RES, V49, P1829, DOI 10.1194/jlr.M800198-JLR200; Shetty A, 2018, DIGEST DIS SCI, V63, P3187, DOI 10.1007/s10620-018-5242-x; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Shostak A, 2013, DIABETES, V62, P2195, DOI 10.2337/db12-1449; Srivastava RAK, 2009, EUR J PHARMACOL, V607, P258, DOI 10.1016/j.ejphar.2009.02.024; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Sudo M, 2003, NEUROSCIENCE, V121, P493, DOI 10.1016/S0306-4522(03)00457-3; Sun XJ, 2015, J BIOL CHEM, V290, P2189, DOI 10.1074/jbc.M114.612358; Tahara Y, 2011, J BIOL RHYTHM, V26, P230, DOI 10.1177/0748730411405958; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhang DG, 2018, HEAD NECK-J SCI SPEC, V40, P2476, DOI 10.1002/hed.25371; Zhang YX, 2017, GENE DEV, V31, P1202, DOI 10.1101/gad.302323.117; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	46	16	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234439	10.1371/journal.pone.0234439	http://dx.doi.org/10.1371/journal.pone.0234439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530967	Green Published, gold			2022-12-26	WOS:000542037200006
J	Jensen, MK; Samelson, AJ; Steward, A; Clarke, J; Marqusee, S				Jensen, Madeleine K.; Samelson, Avi J.; Steward, Annette; Clarke, Jane; Marqusee, Susan			The folding and unfolding behavior of ribonuclease H on the ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; ribosome; kinetics; translation; proteolysis; ribosome-stalled nascent chain; unfolding kinetics; force-profile analysis; RNase H; co-translational folding	ESCHERICHIA-COLI; NASCENT CHAIN; QUANTITATIVE-DETERMINATION; RNASE-H; PROTEIN; INTERMEDIATE	The health of a cell depends on accurate translation and proper protein folding, whereas misfolding can lead to aggregation and disease. The first opportunity for a protein to fold occurs during translation, when the ribosome and surrounding environment can affect the nascent chain energy landscape. However, quantifying these environmental effects is challenging because ribosomal proteins and rRNA preclude most spectroscopic measurements of protein energetics. Here, we have applied two gel-based approaches, pulse proteolysis and force-profile analysis, to probe the folding and unfolding pathways of RNase H (RNH) nascent chains stalled on the prokaryotic ribosomein vitro. We found that ribosome-stalled RNH has an increased unfolding rate compared with free RNH. Because protein stability is related to the ratio of the unfolding and folding rates, this increase completely accounts for the observed change in protein stability and indicates that the folding rate is unchanged. Using arrest peptide-based force-profile analysis, we assayed the force generated during the folding of RNH on the ribosome. Surprisingly, we found that population of the RNH folding intermediate is required to generate sufficient force to release a stall induced by the SecM stalling sequence and that readthrough of SecM directly correlates with the stability of the RNH folding intermediate. Together, these results imply that the folding pathway of RNH is unchanged on the ribosome. Furthermore, our findings indicate that the ribosome promotes RNH unfolding while the nascent chain is proximal to the ribosome, which may limit the deleterious effects of RNH misfolding and assist in folding fidelity.	[Jensen, Madeleine K.; Samelson, Avi J.; Marqusee, Susan] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Marqusee, Susan] Univ Calif Berkeley, Inst Quantitat Biosci QB3 Berkeley, Berkeley, CA 94720 USA; [Marqusee, Susan] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Steward, Annette; Clarke, Jane] Univ Cambridge, Dept Chem, Cambridge, England; [Samelson, Avi J.] Univ Calif San Francisco, Dept Biochem & Biophys, Inst Neurodegenerat Dis, San Francisco, CA USA; [Samelson, Avi J.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Cambridge; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marqusee, S (corresponding author), Univ Calif Berkeley, Inst Quantitat Biosci QB3 Berkeley, Berkeley, CA 94720 USA.; Marqusee, S (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	marqusee@berkeley.edu		Marqusee, Susan/0000-0001-7648-2163	National Institutes of Health [R01-GM050945]; National Science Foundation Graduate Research Fellowships Program Grant [DGE1106400]; Wellcome Trust [WT095195]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowships Program Grant; Wellcome Trust(Wellcome Trust)	This work was supported by National Institutes of Health Grant R01-GM050945 (to S. M.) and National Science Foundation Graduate Research Fellowships Program Grant DGE1106400 (to M. K. J.). S. M. is a Chan Zuckerberg Biohub Investigator. This work is also supported by Wellcome Trust Grant WT095195 (to J. C.). J. C. is a Wellcome Trust Senior Research Fellow. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Clark PL, 2004, TRENDS BIOCHEM SCI, V29, P527, DOI 10.1016/j.tibs.2004.08.008; Connell KB, 2009, J MOL BIOL, V391, P450, DOI 10.1016/j.jmb.2009.05.085; Connell KB, 2009, J MOL BIOL, V391, P461, DOI 10.1016/j.jmb.2009.05.084; DABORA JM, 1994, PROTEIN SCI, V3, P1401, DOI 10.1002/pro.5560030906; Deckert A, 2016, P NATL ACAD SCI USA, V113, P5012, DOI 10.1073/pnas.1519124113; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Farias-Rico JA, 2018, P NATL ACAD SCI USA, V115, pE9280, DOI 10.1073/pnas.1812756115; Floor S., 2018, HORN PCR CLONING PRO, DOI [10.17504/protocols.io.rf2d3qe, DOI 10.17504/PROTOCOLS.IO.RF2D3QE]; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; Goldman DH, 2015, SCIENCE, V348, P457, DOI 10.1126/science.1261909; Guinn EJ, 2018, P NATL ACAD SCI USA, V115, P12206, DOI 10.1073/pnas.1810517115; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Holtkamp W, 2015, SCIENCE, V350, P1104, DOI 10.1126/science.aad0344; Hu WB, 2013, P NATL ACAD SCI USA, V110, P7684, DOI 10.1073/pnas.1305887110; Ismail N, 2012, NAT STRUCT MOL BIOL, V19, P1018, DOI 10.1038/nsmb.2376; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; KANAYA S, 1990, BIOCHEM J, V271, P59, DOI 10.1042/bj2710059; Kemp G, 2019, J MOL BIOL, V431, P1308, DOI 10.1016/j.jmb.2019.01.043; Leininger SE, 2019, P NATL ACAD SCI USA, V116, P5523, DOI 10.1073/pnas.1813003116; Liu KX, 2017, PROTEIN SCI, V26, P1439, DOI 10.1002/pro.3189; Mercier E, 2018, BIOCHEMISTRY-US, V57, P3460, DOI 10.1021/acs.biochem.8b00293; Na YR, 2009, PROTEIN SCI, V18, P268, DOI 10.1002/pro.29; Nilsson OB, 2017, NAT STRUCT MOL BIOL, V24, P221, DOI 10.1038/nsmb.3355; Nilsson OB, 2016, J MOL BIOL, V428, P1356, DOI 10.1016/j.jmb.2016.02.014; Nilsson OB, 2015, CELL REP, V12, P1533, DOI 10.1016/j.celrep.2015.07.065; Ozkan SB, 2001, NAT STRUCT BIOL, V8, P765, DOI 10.1038/nsb0901-765; Park C., 2006, CURR PROTOC PROTEIN; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Raschke TM, 1999, NAT STRUCT BIOL, V6, P825; Rosen LE, 2015, J MOL BIOL, V427, P443, DOI 10.1016/j.jmb.2014.10.003; Rosen LE, 2014, P NATL ACAD SCI USA, V111, P14746, DOI 10.1073/pnas.1410630111; Samelson AJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas9098; Samelson AJ, 2016, P NATL ACAD SCI USA, V113, P13402, DOI 10.1073/pnas.1610272113; Sander IM, 2014, J AM CHEM SOC, V136, P858, DOI 10.1021/ja411302m; Spudich GM, 2004, J MOL BIOL, V335, P609, DOI 10.1016/j.jmb.2003.10.052; Tian PF, 2018, P NATL ACAD SCI USA, V115, pE11284, DOI 10.1073/pnas.1810523115; Waudby CA, 2018, P NATL ACAD SCI USA, V115, P9744, DOI 10.1073/pnas.1716252115	38	12	12	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11410	11417		10.1074/jbc.RA120.013909	http://dx.doi.org/10.1074/jbc.RA120.013909			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32527724	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000563922500004
J	Bibo-Verdugo, B; Snipas, SJ; Kolt, S; Poreba, M; Salvesen, GS				Bibo-Verdugo, Betsaida; Snipas, Scott J.; Kolt, Sonia; Poreba, Marcin; Salvesen, Guy S.			Extended subsite profiling of the pyroptosis effector protein gasdermin D reveals a region recognized by inflammatory caspase-11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pyroptosis; inflammatory caspase; caspase-1; caspase-11; substrate specificity; gasdermin D; interleukin-1 (IL1); cell death; cysteine protease; innate immunity; inflammation; caspase cytokine	GAMMA-INDUCING FACTOR; SUBSTRATE-SPECIFICITY; ACTIVATION; FAMILY; INFLAMMASOMES; MECHANISMS; CLEAVAGE; PEPTIDE; GSDMD	Pyroptosis is the caspase-dependent inflammatory cell death mechanism that underpins the innate immune response against pathogens and is dysregulated in inflammatory disorders. Pyroptosis occurs via two pathways: the canonical pathway, signaled by caspase-1, and the noncanonical pathway, regulated by mouse caspase-11 and human caspase-4/5. All inflammatory caspases activate the pyroptosis effector protein gasdermin D, but caspase-1 mostly activates the inflammatory cytokine precursors prointerleukin-18 and prointerleukin-1 beta (pro-IL18/pro-IL1 beta). Here,in vitrocleavage assays with recombinant proteins confirmed that caspase-11 prefers cleaving gasdermin D over the pro-ILs. However, we found that caspase-11 recognizes protein substrates through a mechanism that is different from that of most caspases. Results of kinetics analysis with synthetic fluorogenic peptides indicated that P1 '-P4 ', the C-terminal gasdermin D region adjacent to the cleavage site, influences gasdermin D recognition by caspase-11. Furthermore, introducing the gasdermin D P1 '-P4 ' region into pro-IL18 enhanced catalysis by caspase-11 to levels comparable with that of gasdermin D cleavage. Pro-IL1 beta cleavage was only moderately enhanced by similar substitutions. We conclude that caspase-11 specificity is mediated by the P1 '-P4 ' region in its substrate gasdermin D, and similar experiments confirmed that the substrate specificities of the human orthologs of caspase-11,i.e.caspase-4 and caspase-5, are ruled by the same mechanism. We propose that P1 '-P4 '-based inhibitors could be exploited to specifically target inflammatory caspases.	[Bibo-Verdugo, Betsaida; Snipas, Scott J.; Salvesen, Guy S.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Kolt, Sonia; Poreba, Marcin] Wroclaw Univ Sci & Technol, Wroclaw, Poland	Sanford Burnham Prebys Medical Discovery Institute; Wroclaw University of Science & Technology	Salvesen, GS (corresponding author), Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.	gsalvesen@sbpdiscovery.org		Kolt, Sonia/0000-0003-4076-0445	National Institutes of Health [R01 GM99040, P30 CA30199]; National Science Centre in Poland [UMO-2018/29/B/NZ1/02249]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Centre in Poland(National Science Centre, Poland)	This work was supported by National Institutes of Health grant R01 GM99040 and P30 CA30199 (to G. S. S.) and by the National Science Centre in Poland (grant OPUS, UMO-2018/29/B/NZ1/02249) (to M. P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Akita K, 1997, J BIOL CHEM, V272, P26595, DOI 10.1074/jbc.272.42.26595; Baker PJ, 2018, J BIOL CHEM, V293, P7068, DOI 10.1074/jbc.H118.002802; Baker PJ, 2015, EUR J IMMUNOL, V45, P2918, DOI 10.1002/eji.201545655; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boucher D, 2012, P NATL ACAD SCI USA, V109, P5669, DOI 10.1073/pnas.1200934109; Boxer MB, 2010, CHEMMEDCHEM, V5, P730, DOI 10.1002/cmdc.200900531; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Casson CN, 2015, P NATL ACAD SCI USA, V112, P6688, DOI 10.1073/pnas.1421699112; Cavalli G, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01157; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; de Zoete MR, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016287; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Groborz K, 2020, CELL DEATH DIFFER, V27, P451, DOI 10.1038/s41418-019-0364-z; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Julien O, 2017, CELL DEATH DIFFER, V24, P1380, DOI 10.1038/cdd.2017.44; Kajiwara Y, 2014, J IMMUNOL, V193, P335, DOI 10.4049/jimmunol.1303424; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Lin XY, 2000, J BIOL CHEM, V275, P39920, DOI 10.1074/jbc.M007255200; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; MacPherson DJ, 2019, J BIOL CHEM, V294, P71, DOI 10.1074/jbc.RA118.005914; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Man SM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45126; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Poreba M, 2017, CELL CHEM BIOL, V24, P550, DOI 10.1016/j.chembiol.2017.05.001; Poreba M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43135; Poreba M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008680; Ramirez MLG, 2018, J BIOL CHEM, V293, P7058, DOI 10.1074/jbc.RA117.001329; Rogers C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14128; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schlesinger N, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-013-0398-z; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; SLEATH PR, 1990, J BIOL CHEM, V265, P14526; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Stennicke HR, 2000, METHOD ENZYMOL, V322, P91; Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009; Talanian RV, 1997, J BIOL CHEM, V272, P9677; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761; Wang K, 2020, CELL, V180, P941, DOI 10.1016/j.cell.2020.02.002; Yang J, 2018, P NATL ACAD SCI USA, V115, P6792, DOI 10.1073/pnas.1800562115; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	56	15	16	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11292	11302		10.1074/jbc.RA120.014259	http://dx.doi.org/10.1074/jbc.RA120.014259			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32554464	hybrid, Green Published			2022-12-26	WOS:000562757100029
J	Klein, PW; Cohen, SM; Jacobson, EU; Li, ZH; Clark, G; Fanning, M; Sterling, R; Young, SR; Sansom, S; Hauck, H				Klein, Pamela W.; Cohen, Stacy M.; Uzun Jacobson, Evin; Li, Zihao; Clark, Glenn; Fanning, Miranda; Sterling, Rene; Young, Steven R.; Sansom, Stephanie; Hauck, Heather			A mathematical model to estimate the state-specific impact of the Health Resources and Services Administration's Ryan White HIV/AIDS Program	PLOS ONE			English	Article							UNITED-STATES; CARE; TRANSMISSION; THERAPY	Background Access to and engagement in high-quality HIV medical care and treatment is essential for ending the HIV epidemic. The Health Resources and Services Administration's (HRSA) Ryan White HIV/AIDS Program (RWHAP) plays a critical role in ensuring that people living with diagnosed HIV (PLWH) are linked to and consistently engaged in high quality care and receive HIV medication in a timely manner. State variation in HIV prevalence, the proportion of PLWH served by the RWHAP, and local health care environments could influence the state-specific impact of the RWHAP. This analysis sought to measure the state-specific impact of the RWHAP on the HIV service delivery system and health outcomes for PLWH, and presents template language to communicate this impact for state planning and stakeholder engagement. Methods and findings The HRSA's HIV/AIDS Bureau (HAB) and the Centers for Disease Control and Prevention's Division of HIV/AIDS Prevention (CDC DHAP) have developed a mathematical model to estimate the state-specific impact of the RWHAP. This model was parameterized using RWHAP data, HIV surveillance data, an existing CDC model of HIV transmission and disease progression, and parameters from the literature. In this study, the model was used to analyze the hypothetical scenario of an absence of the RWHAP and to calculate the projected impact of this scenario on RWHAP clients, RWHAP-funded providers, mortality, new HIV cases, and costs compared with the current state inclusive of the RWHAP. To demonstrate the results of the model, we selected two states, representing high HIV prevalence and low HIV prevalence areas. These states serve to demonstrate the functionality of the model and how state-specific results can be translated into a state-specific impact statement using template language. Conclusions In the example states presented, the RWHAP provides HIV care, treatment, and support services to a large proportion of PLWH in each state. The absence of the RWHAP in these states could result in substantially more deaths and HIV cases than currently observed, resulting in considerable lifetime HIV care and treatment costs associated with additional HIV cases. State-specific impact statements may be valuable in the development of state-level HIV prevention and care plans or for communications with planning bodies, state health department leadership, and other stakeholders. State-specific impact statements will be available to RWHAP Part B recipients upon request from HRSA's HIV/AIDS Bureau.	[Klein, Pamela W.; Cohen, Stacy M.; Clark, Glenn; Fanning, Miranda; Sterling, Rene; Young, Steven R.; Hauck, Heather] Hlth Resources & Serv Adm, HIV AIDS Bur, Rockville, MD 20851 USA; [Uzun Jacobson, Evin; Li, Zihao; Sansom, Stephanie] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA	United States Health Resources & Service Administration (HRSA); Centers for Disease Control & Prevention - USA	Klein, PW (corresponding author), Hlth Resources & Serv Adm, HIV AIDS Bur, Rockville, MD 20851 USA.	pklein@hrsa.gov		Klein, Pamela/0000-0003-4613-3725; Cohen, Stacy/0000-0002-0475-1122				Bradley H, 2019, AIDS BEHAV, V23, P557, DOI 10.1007/s10461-019-02442-7; Centers for Disease Control and Prevention, 2018, HIV SURV REP 2017; Centers for Disease Control and Prevention, NCHHSTP ATL UPD; Centers for Disease Control and Prevention Health Resources and Services Administration, 2015, INT HIV PREV CAR PLA; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Davies C, 2019, J ACQUIRED IMMUNE DE; Eisinger RW, 2019, JAMA-J AM MED ASSOC, V321, P451, DOI 10.1001/jama.2018.21167; Fanning M, 2018, CONDITIONAL PROBABIL; Farnham PG, 2013, JAIDS-J ACQ IMM DEF, V64, P183, DOI 10.1097/QAI.0b013e3182973966; Gopalappa C, 2017, MED DECIS MAKING, V37, P224, DOI 10.1177/0272989X16668509; Health Resources and Services Administration Ryan White HIV/AIDS Program, 2018, RYAN WHIT HIV AIDS P; Khurana N, 2018, JAIDS-J ACQ IMM DEF, V78, P399, DOI 10.1097/QAI.0000000000001707; Li ZH, 2019, MMWR-MORBID MORTAL W, V68, P267; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V73, P39, DOI 10.1097/QAI.0000000000001014; National Academy for State Health Policy, 2018, ROOLK STAT STRAT IMP; Weiser J, 2015, JAMA INTERN MED, V175, P1650, DOI 10.1001/jamainternmed.2015.4095	17	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234652	10.1371/journal.pone.0234652	http://dx.doi.org/10.1371/journal.pone.0234652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569330	Green Published, gold			2022-12-26	WOS:000543547900038
J	Mwakawanga, DL; Mselle, LT				Mwakawanga, Dorkasi Lushindiho; Mselle, Lilian Teddy			Early or delayed umbilical cord clamping? Experiences and perceptions of nurse-midwives and obstetricians at a regional referral hospital in Tanzania	PLOS ONE			English	Article							PRETERM INFANTS; VENTILATION; ATTITUDES; BIRTH	Background Umbilical cord clamping is a crucial step during the third stage of labour that separates the newborn from the placenta. Despite the available evidence that delayed umbilical cord clamping is more beneficial to infants, as well as the existence of 2014 WHO recommendation that the umbilical cord should be clamped between 1 and 3 minutes, its implementation is still low in many countries including Tanzania. Objective This study describes the experiences and perceptions of nurse-midwives`and obstetricians`about the timing of umbilical cord clamping at a regional referral hospital in Tanzania. Methods A descriptive qualitative study design that adopted a purposeful sampling strategy to recruit 19 participants was used. Nine semi-structured interviews with six nurse-midwives`and three obstetricians`, as well as one focus group discussion with ten nurse-midwives`were conducted. Thematic analysis guided the analysis of data. Results Three main themes generated from the data, each having 2 to 5 subthemes. 1. Experiences about the timing of umbilical cord clamping. 2. Perceptions about the umbilical cord clamping. 3. Factors influencing the practice of delayed umbilical cord clamping to improve newborn health outcomes. Conclusion Although the nurse-midwives`and obstetricians`commonly practiced clamping the umbilical cord immediately after delivery, they understood that delayed cord clamping has a potential benefit of oxygenation to the newborn in the event of the need for resuscitation. To move forward with the good practice in maternal and newborn care, proper pre-service and providers training on matters underlying childbirth is essential to address the gap of knowledge. Delayed cord clamping should be practiced widely to improve the health outcomes of the newborn.	[Mwakawanga, Dorkasi Lushindiho] Muhimbili Univ Hlth & Allied Sci, Sch Nursing, Dept Community Hlth Nursing, Dar Es Salaam, Tanzania; [Mselle, Lilian Teddy] Muhimbili Univ Hlth & Allied Sci, Sch Nursing, Dept Clin Nursing, Dar Es Salaam, Tanzania	Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences	Mwakawanga, DL (corresponding author), Muhimbili Univ Hlth & Allied Sci, Sch Nursing, Dept Community Hlth Nursing, Dar Es Salaam, Tanzania.	dorkasmwakawanga@gmail.com		Lushindiho Mwakawanga, Dorkasi/0000-0003-0975-4493				Andersson O, 2015, JAMA PEDIATR, V169, P631, DOI 10.1001/jamapediatrics.2015.0358; Andersson O, 2013, ACTA OBSTET GYN SCAN, V92, P567, DOI 10.1111/j.1600-0412.2012.01530.x; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2000, BENTON COUNTY PIONEE, V45, P4; Ashish KC, 2017, JAMA PEDIATR, V171, P264, DOI 10.1001/jamapediatrics.2016.3971; Bayer K, 2016, ADV NEONAT CARE, V16, P68, DOI 10.1097/ANC.0000000000000247; beda A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0127296; Bhatt S, 2013, J PHYSIOL-LONDON, V591, P2113, DOI 10.1113/jphysiol.2012.250084; Boere I, 2015, NEONATOLOGY, V107, P50, DOI 10.1159/000365836; Bohren MA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001847; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chiruvolu A, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.016; Clarke V, 2013, PSYCHOLOGIST, V26, P120; Creswell J. W., 2013, QUALITATIVE INQUIRY; Ersdal HL, 2016, BJOG-INT J OBSTET GY, V123, P1370, DOI 10.1111/1471-0528.13778; FAAIR Scientific Advisory Panel, 2002, CLIN INFECT DIS S3, V34, pS76; Fogarty M, 2018, AM J OBSTET GYNECOL, V218, P1, DOI 10.1016/j.ajog.2017.10.231; Heale Roberta, 2013, Evid Based Nurs, V16, P98, DOI 10.1136/eb-2013-101494; Hege A, 2017, PEDIATRICS, V134, P265; Hutton EK, 2013, BIRTH-ISS PERINAT C, V40, P39, DOI 10.1111/birt.12027; Ibrahim NO, 2017, ANN SAUDI MED, V37, P216, DOI 10.5144/0256-4947.2017.216; Jelin AC, 2014, J MATERN-FETAL NEO M, V27, P1457, DOI 10.3109/14767058.2013.864275; Katheria AC, 2017, J PERINATOL, V37, P105, DOI 10.1038/jp.2016.151; Katheria AC, 2017, J PEDIATR-US, V187, P313, DOI 10.1016/j.jpeds.2017.04.033; Leshchyns'ka I, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6427537; Lundberg Camilla, 2013, Tidsskr Nor Laegeforen, V133, P2369, DOI 10.4045/tidsskr.12.0707; McAdams Ryan M, 2015, Matern Health Neonatol Perinatol, V1, P10, DOI 10.1186/s40748-015-0011-8; McDonald S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004741.pub2; McDonald Susan J, 2014, Evid Based Child Health, V9, P303, DOI 10.1002/ebch.1971; Ministry of Health, 2016, TANZ DEM HLTH SURV M; Mohammad K, 2021, J MATERN-FETAL NEO M, V34, P231, DOI 10.1080/14767058.2019.1602603; Nancarrow L, 2015, J PERINAT MED; O'Sullivan T, 2014, J SWINE HEALTH PROD, V22, P63; Polglase GR, 2018, ARCH DIS CHILD-FETAL, V103, pF530, DOI 10.1136/archdischild-2017-313657; Polit D.F., 2008, NURSING RES PRINCIPL, V8th edn; Radlowski EC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00585; Ranjit T, 2015, INDIAN J PEDIATR, V82, P29, DOI 10.1007/s12098-013-1329-8; Rheenen P Van, 2011, BMJ-BRIT MED J, V7127, P1; Ryan F, 2009, INT J THER REHABIL, V16, P309, DOI 10.12968/ijtr.2009.16.6.42433; Schneider Z WD, 2013, NURSING MIDWIFERY RE; Shimoda K, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-017-0447-6; Stranak Z, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00039; Temeke Regional Referral Hospital, 2017, ANN MAT REP SUMM BOO; Temple B., 2004, QUALITATIVE RES, V4, P161, DOI [10.1177/1468794104044430, DOI 10.1177/1468794104044430]; Weeks A D, 2015, BMJ Innov, V1, P53; World Health Organization,, 2012, GUID BAS NEWB RES; World Health Organization, 2014, GUID DEL UMB CORD CL; 2016, CANC DISCOV, V6, pe1140; 2016, CIRE ANTILLES GUYANE, V4, P1	49	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234854	10.1371/journal.pone.0234854	http://dx.doi.org/10.1371/journal.pone.0234854			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569338	Green Published, gold			2022-12-26	WOS:000543547900029
J	Ruiz, CF; Montal, ED; Haley, JA; Bott, AJ; Haley, JD				Ruiz, Christian F.; Montal, Emily D.; Haley, John A.; Bott, Alex J.; Haley, John D.			SREBP1 regulates mitochondrial metabolism in oncogenic KRAS expressing NSCLC	FASEB JOURNAL			English	Article						cancer metabolism; de novo lipogenesis; electron transport chain; oxidative phosphorylation	CELL LUNG-CANCER; LIPID-METABOLISM; PANCREATIC-CANCER; TUMOR-GROWTH; COPY NUMBER; RAS-ERK; STEROL; MUTANT; CHOLESTEROL; CONTRIBUTES	Cancer cells require extensive metabolic reprograming in order to provide the bioenergetics and macromolecular precursors needed to sustain a malignant phenotype. MutantKRASis a driver oncogene that is well-known for its ability to regulate the ERK and PI3K signaling pathways. However, it is now appreciated that KRAS can promote the tumor growth via upregulation of anabolic metabolism. We recently reported that oncogenic KRAS promotes a gene expression program of de novolipogenesisin non-small cell lung cancer (NSCLC). To define the mechanism(s) responsible, we focused on the lipogenic transcription factor SREBP1. We observed that KRAS increases SREBP1 expression and genetic knockdown of SREBP1 significantly inhibited the cell proliferation of mutantKRAS-expressing cells. Unexpectedly, lipogenesis was not significantly altered in cells subject to SREBP1 knockdown. Carbon tracing metabolic studies showed a significant decrease in oxidative phosphorylation and RNA-seq data revealed a significant decrease in mitochondrial encoded subunits of the electron transport chain (ETC). Taken together, these data support a novel role, distinct from lipogenesis, of SREBP1 on mitochondrial function in mutantKRASNSCLC.	[Ruiz, Christian F.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Montal, Emily D.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Haley, John A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Bott, Alex J.] Univ Utah, Dept Biochem, Salt Lake City, UT USA; [Haley, John D.] SUNY Stony Brook, Sch Med, Dept Pathol, Stony Brook, NY 11794 USA	Yale University; Memorial Sloan Kettering Cancer Center; University of Massachusetts System; University of Massachusetts Worcester; Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ruiz, CF (corresponding author), Yale Univ, Sch Med, Yale Canc Biol Inst, Dept Genet, West Campus Adv Biosci Ctr 840 West Campus Dr, West Haven, CT 06516 USA.	Christian.f.ruiz@yale.edu	Bott, Alex/AAM-5538-2021	Bott, Alex/0000-0003-2273-8922	HHS \ NIH \ National Cancer Institute (NCI) [1F31CA210626-01, K00CA212445]	HHS \ NIH \ National Cancer Institute (NCI)	HHS vertical bar NIH vertical bar National Cancer Institute (NCI), Grant/Award Number: F31 Grant 1F31CA210626-01 and K00CA212445	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Assmann N, 2017, NAT IMMUNOL, V18, P1197, DOI 10.1038/ni.3838; Bao JS, 2016, ONCOL LETT, V12, P2409, DOI 10.3892/ol.2016.4988; Barshad G, 2018, TRENDS GENET, V34, P682, DOI 10.1016/j.tig.2018.05.009; Bridges JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091376; BRUNET A, 1994, ONCOGENE, V9, P3379; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Canon J, 2019, NATURE, V575, P217, DOI 10.1038/s41586-019-1694-1; Carter CA, 2016, ANN ONCOL, V27, P693, DOI 10.1093/annonc/mdw008; Daemen S, 2013, GENES NUTR, V8, P289, DOI 10.1007/s12263-013-0342-x; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Deng Y, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.974465; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gouw AM, 2017, P NATL ACAD SCI USA, V114, P4300, DOI 10.1073/pnas.1617709114; Griffiths B, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-3; Guo DL, 2014, CURR PHARM DESIGN, V20, P2619, DOI 10.2174/13816128113199990486; Guo DL, 2011, CANCER DISCOV, V1, P442, DOI 10.1158/2159-8290.CD-11-0102; Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Humpton TJ, 2019, CANCER DISCOV, V9, P1268, DOI 10.1158/2159-8290.CD-18-1409; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Karachaliou N, 2013, CLIN LUNG CANCER, V14, P205, DOI 10.1016/j.cllc.2012.09.007; Kerr EM, 2018, FEBS J, V285, P28, DOI 10.1111/febs.14125; Kerr EM, 2016, NATURE, V531, P110, DOI 10.1038/nature16967; Knebel B, 2014, ARCH PHYSIOL BIOCHEM, V120, P216, DOI 10.3109/13813455.2014.973418; Kolde R., PHEATMAP PRETTY HEAT; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Madison BB, 2016, J LIPID RES, V57, P333, DOI 10.1194/jlr.C066712; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Min HY, 2018, BIOMOL THER, V26, P45, DOI 10.4062/biomolther.2017.211; Montal ED, 2015, MOL CELL, V60, P571, DOI 10.1016/j.molcel.2015.09.025; Mullard A, 2019, NAT REV DRUG DISCOV, V18, P887, DOI 10.1038/d41573-019-00195-5; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Pai JT, 1998, J BIOL CHEM, V273, P26138, DOI 10.1074/jbc.273.40.26138; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Park HJ, 2008, J CLIN INVEST, V118, P259, DOI 10.1172/JCI32011; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; R Core Team, 2019, R LANG ENV STAT COMP; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Singh A, 2018, FASEB J, V32, P7018, DOI 10.1096/fj.201800204; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1; Suda K, 2010, CANCER METAST REV, V29, P49, DOI 10.1007/s10555-010-9209-4; Sun Y, 2015, TUMOR BIOL, V36, P4133, DOI 10.1007/s13277-015-3047-5; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Tan ZQ, 2016, MOL CANCER THER, V15, P774, DOI 10.1158/1535-7163.MCT-15-0621; Tong XM, 2009, P NATL ACAD SCI USA, V106, P21660, DOI 10.1073/pnas.0911316106; Wen YA, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0330-6; White E, 2013, GENE DEV, V27, P2065, DOI 10.1101/gad.228122.113; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43; Zhang J, 2017, ONCOTARGET, V8, P59008, DOI 10.18632/oncotarget.19779; Zhang J, 2016, ACTA BIOCH BIOPH SIN, V48, P11, DOI 10.1093/abbs/gmv118	65	7	7	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10574	10589		10.1096/fj.202000052R	http://dx.doi.org/10.1096/fj.202000052R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32568455	Green Accepted, Bronze, Green Submitted			2022-12-26	WOS:000543545400001
J	Villanova, F; Barreiros, M; Leal, E				Villanova, Fabiola; Barreiros, Marta; Leal, Elcio			Is the tryptophan codon of genevifthe Achilles' heel of HIV-1?	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIF; APOBEC3G	To evaluate the impact of hypermutation on the HIV-1 dissemination at the population level we studied 7072 sequences HIV-1 genevifretrieved from the public databank. From this dataset 854 sequences were selected because they had associated values of CD4+ T lymphocytes counts and viral loads and they were used to assess the correlation between clinical parameters and hypermutation. We found that the frequency of stop codons at sites 5, 11 and 79 ranged from 2.8x10(-4)to 4.2x10(-4). On the other hand, at codons 21, 38, 70, 89 and 174 the frequency of stop codons ranged from 1.4x10(-3)to 2.5x10(-3). We also found a correlation between clinical parameters and hypermutation where patients harboring proviruses with one or more stop codons at the tryptophan sites of the genevifhad higher CD4+ T lymphocytes counts and lower viral loads compared to the population. Our findings indicate that A3 activity potentially restrains HIV-1 replication because individuals with hypermutated proviruses tend to have lower numbers of RNA copies. However, owing to the low frequency of hypermutated sequences observed in the databank (44 out of 7072), it is unlikely that A3 has a significant impact to curb HIV-1 dissemination at the population level.	[Villanova, Fabiola; Barreiros, Marta; Leal, Elcio] Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil; [Barreiros, Marta] Univ Fed Maranhao, Dept Elect Engn, Sao Luis, Maranhao, Brazil	Universidade Federal do Para; Universidade Federal do Maranhao	Leal, E (corresponding author), Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil.	elcioleal@gmail.com	Leal, Elcio/M-5275-2019; VILLANOVA, FABIOLA E/E-7437-2013; Leal, Elcio/J-6236-2016	Leal, Elcio/0000-0003-3463-0492; Leal, Elcio/0000-0003-3463-0492	Coordenacao de Aperfeicoamento de Pessoal de Nivel; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq [302677/2019-4]	Coordenacao de Aperfeicoamento de Pessoal de Nivel; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	M.B was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel; EL is supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq (#302677/2019-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005921; [Anonymous], 2014, ALZHEIMERS DEMENT J, V10, pe47; Ara A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004024; Arias JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00275; Armitage AE, 2008, J VIROL, V82, P8743, DOI 10.1128/JVI.00584-08; Binning JM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006830; Bizinoto MC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-173; Chen J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005471; Colson P, 2014, CLIN MICROBIOL INFEC, V20, P1280, DOI 10.1111/1469-0691.12807; Cuevas JM, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002251; Ebrahimi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087679; Eyzaguirre LM, 2013, VIROLOGY, V443, P306, DOI 10.1016/j.virol.2013.05.019; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Kobayashi T, 2014, J VIROL, V88, P5881, DOI 10.1128/JVI.00062-14; Land AM, 2008, J VIROL, V82, P8172, DOI 10.1128/JVI.01115-08; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leal E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039776; Moris A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00534; Mussil B, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-77; Ronsard L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15438; Russell RA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-16; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Sato K, 2010, J VIROL, V84, P9546, DOI 10.1128/JVI.00823-10; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Stanley BJ, 2008, J VIROL, V82, P8656, DOI 10.1128/JVI.00767-08; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Venkatesan S, 2018, ANN ONCOL, V29, P563, DOI 10.1093/annonc/mdy003; Villanova F, 2017, AIDS RES HUM RETROV, V33, P952, DOI [10.1089/aid.2016.0230, 10.1089/AID.2016.0230]; Wolfe LS, 2010, J VIROL, V84, P7135, DOI 10.1128/JVI.00031-10; Yamashita T, 2008, MICROBES INFECT, V10, P1142, DOI 10.1016/j.micinf.2008.06.003; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0225563	10.1371/journal.pone.0225563	http://dx.doi.org/10.1371/journal.pone.0225563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32570272	Green Submitted, gold, Green Published			2022-12-26	WOS:000543547900043
J	Fofana, F; Bazeley, P; Regnault, A				Fofana, Fatoumata; Bazeley, Pat; Regnault, Antoine			Applying a mixed methods design to test saturation for qualitative data in health outcomes research	PLOS ONE			English	Article							SAMPLE-SIZE; PATIENT	Saturation, a core concept in qualitative research, suggests when data collection might end. It is reached when no new relevant information emerges with additional interviews. The aim of this research was to explore whether a mixed methods design could contribute to the demonstration of saturation. Firstly, saturation was conceptualized mathematically using set theory. Secondly, a conversion mixed design was conducted: a set of codes derived from qualitative interviews were quantitized and analyzed using partial least squares (PLS) regression to document whether saturation was reached. A qualitative study conducted by other researchers prior to this work (i.e. none of the present authors was involved in this study) was used to test saturation using PLS regression. This illustrative qualitative study aimed to investigate the impact ofClostridium difficileinfection (CDI) on nurses' work in the hospital and the results were published elsewhere (Guillemin et al. 2015). Semi-structured interviews were conducted with 12 nurses. Saturation was characterized by the cumulative percentage of variability accounted for by PLS factors. After 12 interviews, this percentage was 51% which suggests that saturation was achieved at least on main themes. Two main themes identifying similarities in the experience of nurses caring for patients with CDI were identified:Organization/Coordination of the working dayandTime-consuming work. Although dependent on the coding of qualitative data, PLS regression of quantitized data from qualitative interviews generated useful information for the determination of saturation.	[Fofana, Fatoumata] ICON Plc, Patient Ctr Outcomes, Lyon, France; [Fofana, Fatoumata] Univ Tours, Univ Nantes, SPHERE MethodS Patients Ctr Outcomes & Hlth Res, UMR 1246,INSERM, Nantes, France; [Bazeley, Pat] Western Sydney Univ, Sydney, NSW, Australia; [Regnault, Antoine] Modus Outcomes, Lyon, France	ICON plc; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite de Tours; Western Sydney University	Fofana, F (corresponding author), ICON Plc, Patient Ctr Outcomes, Lyon, France.; Fofana, F (corresponding author), Univ Tours, Univ Nantes, SPHERE MethodS Patients Ctr Outcomes & Hlth Res, UMR 1246,INSERM, Nantes, France.	ffofana.cisse@outlook.com		Bazeley, Pat/0000-0002-4047-5962; Fofana, Fatoumata/0000-0003-3051-0098	French National Association of Research and Technology ('Association Nationale de la Recherche et de la Technologie' [ANRT]) [2012/0326]	French National Association of Research and Technology ('Association Nationale de la Recherche et de la Technologie' [ANRT])	This work was conducted as part of FF's PhD program. The PhD was supported by the 'Conventions Industrielles de Formation par la REcherche' (CIFRE) program (no 2012/0326) from the French National Association of Research and Technology ('Association Nationale de la Recherche et de la Technologie' [ANRT]). Modus Outcomes provided funding for the payment of publication fees. The funder of the illustrative qualitative study did not play any role in the study design, quantitative data analysis, decision to publish, or preparation of the present manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Abdi H, 2011, PARTIAL LEAST SQUARE; [Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; Arbuckle R, 2019, VALUE HEALTH, V22, P340, DOI 10.1016/j.jval.2018.09.2845; Bazeley P., 2018, INTEGRATING ANAL MIX; Bharmal M, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0835-1; Brod M, 2009, QUAL LIFE RES, V18, P1263, DOI 10.1007/s11136-009-9540-9; Coon CD, 2016, THER INNOV REGUL SCI, V50, P22, DOI 10.1177/2168479015622667; Creswell J.W., 2007, DESIGNING CONDUCTING; Curry L., 2015, MIXED METHODS HLTH S; Eriksson L., 2001, MULTI MEGAVARIATE DA; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Guevel MR, 2012, SANTE PUBLIQUE, V24, P23, DOI 10.3917/spub.121.0023; Guillemin I, 2015, INT J NURS PRACT, V21, P38, DOI 10.1111/ijn.12166; Hennink MM, 2019, QUAL HEALTH RES, V29, P1483, DOI 10.1177/1049732318821692; Kerr C, 2010, EXPERT REV PHARM OUT, V10, P269, DOI 10.1586/ERP.10.30; Lowe A, 2018, FIELD METHOD, V30, P191, DOI 10.1177/1525822X17749386; Martens H., 2001, MULTIVARIATE ANAL QU; Mason M., 2010, FORUM QUAL SOC RES, V11; Morse JM, 1998, QUAL HEALTH RES, V8, P147, DOI 10.1177/104973239800800201; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; Onwuegbuzie AJ, 2007, QUAL QUANT, V41, P105, DOI 10.1007/s11135-005-1098-1; Parker S, 2019, MOL GENET METAB, V126, pS115, DOI 10.1016/j.ymgme.2018.12.292; Regnault A, 2018, J PATIENT-REP OUTCOM, V2, DOI 10.1186/s41687-018-0043-8; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Sandelowski M, 2009, J MIX METHOD RES, V3, P208, DOI 10.1177/1558689809334210; Sartorius-Umetrics Suite, 2020, SART UM SUIT; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Sivesind KH, 1999, QUAL QUANT, V33, P361, DOI 10.1023/A:1004691318311; Tashakkori A., 2009, FDN MIXED METHODS RE; Tashakkori A, 2007, J MIX METHOD RES, DOI [10.1177/1558689807302453, DOI 10.1177/1558689807302453]; Tenenhaus M, 2005, FOOD QUAL PREFER, V16, P315, DOI 10.1016/j.foodqual.2004.05.013; Tenenhaus M, 1998, REGRESSION PLS THERO; Tran VT, 2016, J CLIN EPIDEMIOL, V80, P88, DOI 10.1016/j.jclinepi.2016.07.014; Turner-Bowker DM, 2018, VALUE HEALTH, V21, P839, DOI 10.1016/j.jval.2017.11.014; US Food and Drug Administration, PAT FOC DRUG DEV COL; van Rijnsoever FJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181689; Tran VT, 2017, J CLIN EPIDEMIOL, V82, P71, DOI 10.1016/j.jclinepi.2016.10.001; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052	40	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234898	10.1371/journal.pone.0234898	http://dx.doi.org/10.1371/journal.pone.0234898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559246	Green Published, gold			2022-12-26	WOS:000543261600042
J	Fullar, A; Karaszi, K; Hollosi, P; Lendvai, G; Olah, L; Reszegi, A; Papp, Z; Sobel, G; Dudas, J; Kovalszky, I				Fullar, Alexandra; Karaszi, Katalin; Hollosi, Peter; Lendvai, Gabor; Olah, Laszlone; Reszegi, Andrea; Papp, Zoltan; Sobel, Gabor; Dudas, Jozsef; Kovalszky, Ilona			Two ways of epigenetic silencing of TFPI2 in cervical cancer	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR-2; TUMOR MICROENVIRONMENT; BIG ROLE; EXPRESSION; FIBROBLASTS; MICRORNAS; PREECLAMPSIA; ACTIVATION; GROWTH; GENES	Objective Comparison of human mRNA microarray results from tumor-associated and normal cervical fibroblasts revealed significantTFPI2downregulation in tumor-associated fibroblasts isolated from cervical cancer, indicating thatTFPI2downregulation may play an important role in the pathogenesis of the disease. In the present work, we investigated the mechanism ofTFPI2downregulation in tumor-associated fibroblasts and tumor cells. Methods In vitromodels of monocultures and co-cultures were established with tumor cells and fibroblasts to explore the changes of TFPI-2 expression and epigenetic modifications of theTFPI2gene. Results TheTFPI2gene was hypermethylated only in tumor cells. Reduction of TFPI-2 protein levels in tumor-associated fibroblasts, although the gene was not methylated, suggested alternative regulatory mechanisms of gene expression, such as inhibition by microRNAs. The expression pattern ofmiR-23a, a gene thought to inhibitTFPI2translation, showed changes strongly correlated to detected TFPI-2 protein alterations. Transfections withmiR-23amimics resulted in a decrease of TFPI-2 protein expression whereasmiR-23ainhibitors increased the TFPI-2 amount. Due to downregulation ofmiR-23aexpression by HPV in cancer cells,TFPI2was silenced by promoter methylation. In contrary,miR-23awas active in HPV-free fibroblasts and inactivatedTFPI2. Conclusion These results indicate dual epigenetic inhibition ofTFPI2on the transcription level by promoter methylation in cancer cells and on the translation level bymiR-23ain tumor-associated fibroblasts. As a consequence, inactivation of theTFPI2gene plays a strategic role in the progression of cervical cancer.	[Fullar, Alexandra; Karaszi, Katalin; Hollosi, Peter; Olah, Laszlone; Reszegi, Andrea; Kovalszky, Ilona] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, Budapest, Hungary; [Hollosi, Peter] Hungarian Acad Sci, Tumor Progress Res Grp, Budapest, Hungary; [Lendvai, Gabor] Semmelweis Univ, Dept Pathol 2, Budapest, Hungary; [Papp, Zoltan] Matern Obstet & Gynecol Private Clin, Budapest, Hungary; [Papp, Zoltan; Sobel, Gabor] Semmelweis Univ, Dept Obstet & Gynecol, Budapest, Hungary; [Dudas, Jozsef] Med Univ Innsbruck, Dept Otorhinolaryngol, Innsbruck, Austria	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; Medical University of Innsbruck	Kovalszky, I (corresponding author), Semmelweis Univ, Dept Pathol & Expt Canc Res 1, Budapest, Hungary.	kovalszky.ilona@med.semmelweis-univ.hu	Dudás, József/AAY-9352-2020; Lendvai, Gabor/GZL-5723-2022; Kovalszky, Ilona/ABH-2832-2020	Dudás, József/0000-0002-9877-3399; Kovalszky, Ilona/0000-0002-0179-3378; Reszegi, Andrea/0000-0001-6902-7883; Olah, Laszlone/0000-0002-1388-2204; Fullar, Alexandra/0000-0003-4368-1523	Hungarian Scientific Research Fund [67925, 100904, 119283]; "Development of the Scientific Workshops of Medical, Health Science and Pharmacist Education" predoctoral fellowship [EFOP-3.6.3-VEKOP-16-201700009, HRDOP-3.6.3-CCHOP-16]; Austrian Science Fund [FWF P 22287-B13]; European Union Horizon 2020 Marie Sklodowska-Curie Actions (MSCA) Research and Innovation Staff Exchange Evaluations (RISE) project [645756 GLYCANC]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); "Development of the Scientific Workshops of Medical, Health Science and Pharmacist Education" predoctoral fellowship; Austrian Science Fund(Austrian Science Fund (FWF)); European Union Horizon 2020 Marie Sklodowska-Curie Actions (MSCA) Research and Innovation Staff Exchange Evaluations (RISE) project	This work was supported in part by the Hungarian Scientific Research Fund, grants 67925, 100904 and 119283 (to IK) -https://nkfih.gov.hu, by the EFOP-3.6.3-VEKOP-16-201700009 (HRDOP-3.6.3-CCHOP-16: Human Resources Development Operational Programme, Competitive Central Hungary Operational Programme)"Development of the Scientific Workshops of Medical, Health Science and Pharmacist Education" predoctoral fellowship (to KK) -https://ec.europa.eu/, by the Austrian Science Fund, grant FWF P 22287-B13 (to JD) -https://ec.europa.eu/and European Union Horizon 2020 Marie Sklodowska-Curie Actions (MSCA) Research and Innovation Staff Exchange Evaluations (RISE) project 645756 GLYCANC -Matrix glycans as multifunctional pathogenesis factors and therapeutic targets in cancer. (to IK) -https://ec.europa.eu/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (Maternity Obstetrics and Gynecology Private Clinic) provided support in the form of author's salaries for author (ZP), but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific role of this author is articulated in the `author contributions' section.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baghy K, 2011, LAB INVEST, V91, P439, DOI 10.1038/labinvest.2010.172; BOHN H, 1977, ARCH GYNAKOL, V223, P179, DOI 10.1007/BF00667387; Burk RD, 2017, NATURE, V543, P378, DOI 10.1038/nature21386; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Chou J, 2012, CANCER DISCOV, V2, P1078, DOI 10.1158/2159-8290.CD-12-0465; Dey P, 2011, INDIAN J CANCER, V48, P507, DOI 10.4103/0019-509X.92246; Dong YL, 2015, INT J CLIN EXP PATHO, V8, P1844; Fule T, 2006, GYNECOL ONCOL, V100, P570, DOI 10.1016/j.ygyno.2005.09.019; Fullar A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1272-3; Fullar A, 2012, EXP CELL RES, V318, P1517, DOI 10.1016/j.yexcr.2012.03.023; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gocze K, 2015, ANTICANCER RES, V35, P523; Hazelbag S, 2001, GYNECOL ONCOL, V83, P235, DOI 10.1006/gyno.2001.6378; Honegger A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004712; Huang FY, 2015, ONCOTARGET, V6, P34941, DOI 10.18632/oncotarget.5472; Huisman C, 2016, MOL THER, V24, P536, DOI 10.1038/mt.2015.226; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karaszi K, 2019, PLACENTA, V76, P30, DOI 10.1016/j.placenta.2019.01.011; Kempaiah P, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-20; KISIEL W, 1994, BLOOD, V84, P4384, DOI 10.1182/blood.V84.12.4384.bloodjournal84124384; Kunita A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27128-3; Li XN, 2013, J BIOL CHEM, V288, P18121, DOI 10.1074/jbc.M113.478560; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Ma S, 2011, CANCER RES, V71, P583, DOI 10.1158/0008-5472.CAN-10-2587; Mitra AK, 2012, CANCER DISCOV, V2, P1100, DOI 10.1158/2159-8290.CD-12-0206; Ogawa M, 2007, PLACENTA, V28, P224, DOI 10.1016/j.placenta.2006.01.023; Poyyakkara A, 2018, J CELL BIOCHEM, V119, P4907, DOI 10.1002/jcb.26718; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Rao CN, 1996, ARCH BIOCHEM BIOPHYS, V335, P82, DOI 10.1006/abbi.1996.0484; Rathore MG, 2012, INT J BIOCHEM CELL B, V44, P1448, DOI 10.1016/j.biocel.2012.05.011; Rollin J, 2007, LUNG CANCER, V56, P273, DOI 10.1016/j.lungcan.2006.11.021; Soon P, 2013, ENDOCR-RELAT CANCER, V20, pR257, DOI 10.1530/ERC-13-0119; Toth M, 2003, BIOCHEM BIOPH RES CO, V308, P386, DOI 10.1016/S0006-291X(03)01405-0; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang GL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14148-8; Wang N, 2019, CANCERS, V11, DOI 10.3390/cancers11010007; Wojtukiewicz MZ, 2003, THROMB HAEMOSTASIS, V90, P140; Yang N, 2010, CELL ONCOL, V32, P131, DOI 10.3233/CLO-2009-0510; Zhang Q, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-1; Zheng HX, 2014, CARCINOGENESIS, V35, P173, DOI 10.1093/carcin/bgt274	43	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234873	10.1371/journal.pone.0234873	http://dx.doi.org/10.1371/journal.pone.0234873			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559232	Green Published, gold			2022-12-26	WOS:000543261600015
J	Teng, CF; Tsai, HW; Li, TC; Wang, T; Wang, J; Shyu, WC; Wu, HC; Su, IJ; Jeng, LB				Teng, Chiao-Fang; Tsai, Hung-Wen; Li, Tsai-Chung; Wang, Ting; Wang, John; Shyu, Woei-Cherng; Wu, Han-Chieh; Su, Ih-Jen; Jeng, Long-Bin			Detection of hepatitis B virus pre-S mutants in plasma by a next-generation sequencing-based platform determines their patterns in liver tissues	PLOS ONE			English	Article							GROUND GLASS HEPATOCYTES; HEPATOCELLULAR-CARCINOMA; MANAGEMENT; INFECTION; DELETION	Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related death worldwide. Patients with hepatitis B virus (HBV) pre-S mutants in liver tissues or blood have been regarded as a high-risk population for HCC development and recurrence. Detection of pre-S mutants in clinical specimens is thus important for early diagnosis and prognosis of HCC to improve patient survival. Recently, we have developed a next-generation sequencing (NGS)-based platform that can quantitatively detect pre-S mutants in patient plasma with superior sensitivity and accuracy. In this study, we compared the pre-S genotyping results from plasma by the NGS-based analysis with those from liver tissues by the immunohistochemistry (IHC)-based analysis in 30 HBV-related HCC patients. We demonstrated that the detection rate of pre-S mutants was significantly higher by NGS- than by IHC-based analysis. There was a moderate to good agreement between both analyses in detection of pre-S mutants. Compared with the IHC, the NGS-based detection of pre-S mutants in patient plasma could determine the patterns of pre-S mutants in liver tissues more efficiently in a noninvasive manner. Our data suggest that the NGS-based platform may represent a promising approach for detection of pre-S mutants as biomarkers of HBV-related HCC in clinical practice.	[Teng, Chiao-Fang; Shyu, Woei-Cherng] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Teng, Chiao-Fang; Wang, Ting; Jeng, Long-Bin] China Med Univ Hosp, Organ Transplantat Ctr, Taichung, Taiwan; [Teng, Chiao-Fang] China Med Univ, Res Ctr Canc Biol, Taichung, Taiwan; [Tsai, Hung-Wen] Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan, Taiwan; [Li, Tsai-Chung] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Coll Med & Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan; [Wang, John] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Shyu, Woei-Cherng] Asia Univ, Dept Occupat Therapy, Taichung, Taiwan; [Shyu, Woei-Cherng] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Shyu, Woei-Cherng] China Med Univ Hosp, Translat Med Res Ctr, Taichung, Taiwan; [Wu, Han-Chieh] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan; [Su, Ih-Jen] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Health Research Institutes - Taiwan; Southern Taiwan University of Science & Technology	Jeng, LB (corresponding author), China Med Univ Hosp, Organ Transplantat Ctr, Taichung, Taiwan.; Su, IJ (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	chiaofangteng@gmail.com; suihjen0704@mail.stust.edu.tw; longbin.cmuh@gmail.com	Teng, Chiao-Fang/L-6679-2013; Wu, Han-Chieh/K-6928-2013	Wu, Han-Chieh/0000-0003-2638-7883; Teng, Chiao-Fang/0000-0002-5218-0571	China Medical University, Taichung, Taiwan [CMU107-N-09]	China Medical University, Taichung, Taiwan(China Medical University)	This work was supported by the China Medical University, Taichung, Taiwan (Grant Number CMU107-N-09) (to CFT). The funder had no role in study design, data collection and analysis, decision to publish, or preparation the manuscript.	BEASLEY RP, 1984, SEMIN LIVER DIS, V4, P113, DOI 10.1055/s-2008-1040651; Bosetti C, 2014, BEST PRACT RES CL GA, V28, P753, DOI 10.1016/j.bpg.2014.08.007; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Cheng KC, 2016, BIOMEDICINE-TAIWAN, V6, DOI 10.7603/s40681-016-0016-2; Fan YF, 2001, HEPATOLOGY, V33, P277, DOI 10.1053/jhep.2001.21163; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Kubo S, 2015, WORLD J GASTROENTERO, V21, P8249, DOI 10.3748/wjg.v21.i27.8249; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee Hannah M, 2019, Curr Treat Options Gastroenterol, V17, P271, DOI 10.1007/s11938-019-00236-3; Llovet JM, 2000, BEST PRACT RES CL GA, V14, P991, DOI 10.1053/bega.2000.0143; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Marin-Hargreaves G, 2003, CRIT REV ONCOL HEMAT, V47, P13, DOI 10.1016/S1040-8428(02)00213-5; Pollicino T, 2014, J HEPATOL, V61, P408, DOI 10.1016/j.jhep.2014.04.041; Poon RTP, 1999, ANN SURG, V229, P216, DOI 10.1097/00000658-199902000-00009; Sinn DH, 2013, DIGEST DIS SCI, V58, P751, DOI 10.1007/s10620-012-2408-9; Su IJ, 2008, J GASTROEN HEPATOL, V23, P1169, DOI 10.1111/j.1440-1746.2008.05348.x; Teng CF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33051-4; Teng CF, 2017, CELL TRANSPLANT, V26, P429, DOI 10.3727/096368916X694382; Teng YC, 2017, J PATHOL, V241, P463, DOI 10.1002/path.4850; Thampanitchawong P, 1999, WORLD J GASTROENTERO, V5, P301; Tsai HW, 2016, ONCOTARGET, V7, P27724, DOI 10.18632/oncotarget.8388; Tsai HW, 2011, CANCER-AM CANCER SOC, V117, P2951, DOI 10.1002/cncr.25837; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wall WJ, 2000, LIVER TRANSPLANT, V6, pS16, DOI 10.1053/jlts.2000.19010; Wang HC, 2003, AM J PATHOL, V163, P2441, DOI 10.1016/S0002-9440(10)63599-7; Yen CJ, 2018, HEPATOLOGY, V68, P815, DOI 10.1002/hep.29790; Zamor PJ, 2017, J GASTROINTEST ONCOL, V8, P229, DOI 10.21037/jgo.2017.03.14	29	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234773	10.1371/journal.pone.0234773	http://dx.doi.org/10.1371/journal.pone.0234773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559248	gold, Green Published			2022-12-26	WOS:000543261600052
J	Zheng, QY; Xu, F; Yang, Y; Sun, DD; Zhong, Y; Wu, S; Li, GQ; Gao, WW; Wang, T; Xu, GL; Liang, SJ				Zheng, Quan-you; Xu, Feng; Yang, Yi; Sun, Dao-dong; Zhong, Yu; Wu, Shun; Li, Gui-qing; Gao, Wei-wu; Wang, Tao; Xu, Gui-lian; Liang, Shen-ju			C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from gamma delta-T cells	FASEB JOURNAL			English	Article						complement system; C5a; C5aR1; imiquimod; PI3K-Akt signaling; gamma delta-T cells	INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; COMPLEMENT ACTIVATION; MURINE MODEL; DOUBLE-BLIND; C5A; MECHANISMS; RECEPTOR; C3A; PATHOGENESIS; USTEKINUMAB	Psoriasis is a chronic relapsing inflammatory skin disease, affecting up to 3% of the global population. Accumulating evidence suggests that the complement system is involved in its pathogenesis. Our previous study revealed that the C5a/C5aR1 pathway is crucial for disease development. However, the underlying mechanisms remain largely unknown. To explore potential mechanisms, psoriatic skin lesions and histological changes were assessed following imiquimod (IMQ) cream treatment. Inflammatory cytokine expression was tested by real-time RT-PCR. Immunohistochemistry and flow cytometry were used to identify inflammatory cell infiltration and interleukin (IL-17A) IL-17A expression. A C5aR1 antagonist (C5aR1a) and PI3K inhibitor (wortmannin) were used for blocking experiments (both in vivo and in vitro) to explore the mechanism. C5a/C5aR1-pathway inhibition significantly attenuated psoriasis-like skin lesions with decreased epidermal hyperplasia, downregulated type 17-related inflammatory gene expression, and reduced IL-17A-producing gamma delta-T cell responses. Mechanistically, C5a/C5aR1 promoted the latter phenotype via PI3K-Akt signaling. Consistently, C5aR1 deficiency clearly ameliorated IMQ-induced chronic psoriasiform dermatitis, with a significant decrease in IL-17A expression. Finally, blocking C5aR1 signaling further decreased psoriasiform skin inflammation in IL-17-deficient mice. Results suggest that C5a/C5aR1 mediates experimental psoriasis and skin inflammation by upregulating IL-17A expression from gamma delta-T cells. Blocking C5a/C5aR1/IL-17A axis is expected to be a promising strategy for psoriasis treatment.	[Zheng, Quan-you; Sun, Dao-dong; Zhong, Yu] Army Med Univ, Southwest Hosp, Hosp 958, Dept Urol, Chongqing, Peoples R China; [Zheng, Quan-you; Xu, Feng; Li, Gui-qing; Gao, Wei-wu; Xu, Gui-lian] Army Med Univ, Dept Immunol Basical Med Coll, 30 Gaotanyan St, Chongqing 400038, Peoples R China; [Yang, Yi; Liang, Shen-ju] Army Med Univ, Daping Hosp, Dept Rheumatism & Immunol, 10 Changjiangzhi Rd, Chongqing 400042, Peoples R China; [Wu, Shun] Army Med Univ, Southwest Hosp, Dept Nephrol, Chongqing, Peoples R China; [Wang, Tao] Army Med Univ, Daping Hosp, Dept Gastroenterol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University; Army Medical University	Xu, GL (corresponding author), Army Med Univ, Dept Immunol Basical Med Coll, 30 Gaotanyan St, Chongqing 400038, Peoples R China.; Liang, SJ (corresponding author), Army Med Univ, Daping Hosp, Dept Rheumatism & Immunol, 10 Changjiangzhi Rd, Chongqing 400042, Peoples R China.	xuguilian@tmmu.edu.cn; shenju7890@163.com			National Natural Science Foundation of China [81873881, 81900628]; Natural Science Foundation of Chongqing [cstc2018jcyjAX0260]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	This work was supported by the National Natural Science Foundation of China (No. 81873881 and No. 81900628) and the Natural Science Foundation of Chongqing (cstc2018jcyjAX0260). The funders had no role in the design of the study, data collection and analysis, interpretation or the writing of this manuscript	Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Choudhry N, 2016, KIDNEY INT, V90, P540, DOI 10.1016/j.kint.2016.04.023; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; El Malki K, 2013, J INVEST DERMATOL, V133, P441, DOI 10.1038/jid.2012.318; Fleming CJ, 1996, CLIN EXP DERMATOL, V21, P415, DOI 10.1111/j.1365-2230.1996.tb00144.x; Fragoulis GE, 2016, ANNU REV MED, V67, P337, DOI 10.1146/annurev-med-051914-021944; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gordon KB, 2016, NEW ENGL J MED, V375, P345, DOI 10.1056/NEJMoa1512711; Greb JE, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.82; Griffiths CEM, 2015, LANCET, V386, P541, DOI 10.1016/S0140-6736(15)60125-8; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hajishengallis G, 2017, NAT IMMUNOL, V18, P1288, DOI 10.1038/ni.3858; Han GC, 2011, IMMUNOLOGY, V133, P340, DOI 10.1111/j.1365-2567.2011.03445.x; Hawkes JE, 2017, J ALLERGY CLIN IMMUN, V140, P645, DOI 10.1016/j.jaci.2017.07.004; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; KAPP A, 1985, ARCH DERMATOL RES, V277, P359, DOI 10.1007/BF00509233; Kim J, 2017, ANNU REV MED, V68, P255, DOI 10.1146/annurev-med-042915-103905; Kulig P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13466; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Mabuchi T, 2011, J IMMUNOL, V187, P5026, DOI 10.4049/jimmunol.1101817; Mrowietz U, 2001, EXP DERMATOL, V10, P238, DOI 10.1034/j.1600-0625.2001.100403.x; Muenstermann M, 2019, VIRULENCE, V10, P677, DOI 10.1080/21505594.2019.1640035; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; OHKOHCHI K, 1988, TOHOKU J EXP MED, V154, P315, DOI 10.1620/tjem.154.315; OHKOHCHI K, 1985, BRIT J DERMATOL, V113, P189, DOI 10.1111/j.1365-2133.1985.tb02064.x; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Peng Q, 2012, J AM SOC NEPHROL, V23, P1474, DOI 10.1681/ASN.2011111072; Peng Q, 2009, J IMMUNOL, V183, P6058, DOI 10.4049/jimmunol.0804186; Qin L, 2016, AM J TRANSPLANT, V16, P2865, DOI 10.1111/ajt.13834; Ramirez-Valle F, 2015, P NATL ACAD SCI USA, V112, P8046, DOI 10.1073/pnas.1508990112; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Shibata S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8687; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wagner EF, 2010, NAT REV RHEUMATOL, V6, P704, DOI 10.1038/nrrheum.2010.157; Xu RN, 2016, CELL MOL IMMUNOL, V13, P103, DOI 10.1038/cmi.2014.136; Yu SL, 2019, J BIOL CHEM, V294, P8384, DOI 10.1074/jbc.RA118.006508; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zheng QY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01866	47	4	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10590	10604		10.1096/fj.202000384R	http://dx.doi.org/10.1096/fj.202000384R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32557852	hybrid			2022-12-26	WOS:000541761400001
J	Lanza, E; Masetti, C; Messana, G; Muglia, R; Pugliese, N; Ceriani, R; de Nalda, AL; Rimassa, L; Torzilli, G; Poretti, D; D'Antuono, F; Politi, LS; Pedicini, V; Aghemo, A				Lanza, Ezio; Masetti, Chiara; Messana, Gaia; Muglia, Riccardo; Pugliese, Nicola; Ceriani, Roberto; de Nalda, Ana Lleo; Rimassa, Lorenza; Torzilli, Guido; Poretti, Dario; D'Antuono, Felice; Politi, Letterio Salvatore; Pedicini, Vittorio; Aghemo, Alessio		Humanitas HCC Multidisciplinary Gr	Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma	PLOS ONE			English	Article								Sarcopenia has been associated with lower overall survival in patients with cirrhosis and hepatocellular carcinoma (HCC) undergoing surgical resection, TACE, TARE, or transplantation. This monocentric study evaluated the prognostic significance of sarcopenia in patients affected by HCC who received bland transarterial embolization (TAE) therapy, by analyzing its impact on survival and treatment-related complications. All consecutive patients who underwent the 1st TAE between March 1st 2011 and July 1st 2019 in our Institution were retrospectively studied. To evaluate sarcopenia, the skeletal muscle index (SMI) was calculated by normalizing the cross-sectional muscle area at the level of L3 on an abdominal CT scan prior to embolization (cm2) by patient height (m2). SMI cut-off values for sarcopenia were considered <= 39 cm2/m2 for women and <= 55 cm2/m2 for men. Data about age, gender, body mass index (BMI), underlying liver disease, liver function, MELD score, Child-Pugh score, multifocal disease, performance status, previous interventions, length of stay (LOS), complications after the procedure, readmission rate within 30 days, survival time from TAE and total number and type of TAE received following the first procedure were collected. From 2011 to 2019, 142 consecutive patients underwent 305 TAEs. Observation time ranged from 1.4 to 100.5 months (median 20.1 SD = 22). Sarcopenia at baseline was present in 121 (85%) patients. Overall 87 (61.2%) patients died during follow-up with survival rates at 1-, 2-, 3-, 4-, and 5-year of 71%, 41%, 22%, 16% and 11% respectively. After multivariate analysis sarcopenia (HR = 2.22, p = 0.046), previous ablation/resection (HR = 0.51, p = 0.005) and multifocal disease (HR = 1.84, p = 0.02) were associated with reduced survival. Sarcopenia did not influence the safety of TAE in terms of LOS (2 days vs 1.5 days, p = 0.2), early complications rate (8% vs 5%, p = 0.5) and readmission rate within 30 days (7% vs 5%, p = 0.74). Sarcopenia, estimated by the L3SMI method, is an emerging prognostic factor in patients with HCC undergoing bland TAE therapy as it is associated with increased mortality, without impairing the safety of the locoregional treatment. Measures to ameliorate the SMI, such as nutritional support and physical exercise, should be evaluated in clinical trials for HCC patients receiving liver embolization to determine their impact on overall survival.	[Lanza, Ezio; Muglia, Riccardo; Poretti, Dario; D'Antuono, Felice; Pedicini, Vittorio] Humanitas Res Hosp IRCCS, Dept Radiol, Div Intervent Radiol, Rozzano, Italy; [Masetti, Chiara; Muglia, Riccardo; Pugliese, Nicola; Ceriani, Roberto; de Nalda, Ana Lleo; Aghemo, Alessio] Humanitas Res Hosp IRCCS, Dept Gastroenterol, Div Internal Med & Hepatol, Rozzano, Italy; [Messana, Gaia; Muglia, Riccardo; Pugliese, Nicola; de Nalda, Ana Lleo; Rimassa, Lorenza; Politi, Letterio Salvatore; Aghemo, Alessio] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Rimassa, Lorenza; Politi, Letterio Salvatore] Humanitas Clin & Res Ctr IRCCS, Humanitas Canc Ctr, Med Oncol & Hematol Unit, Milan, Italy; [Torzilli, Guido; Politi, Letterio Salvatore] Humanitas Clin & Res Ctr IRCCS, Dept Surg, Div Hepatobiliary & Gen Surg, Rozzano, Italy; [Politi, Letterio Salvatore] Humanitas Clin & Res Ctr IRCCS, Dept Radiol, Rozzano, Italy	IRCCS Humanitas Research Hospital; IRCCS Humanitas Research Hospital; Humanitas University	Lanza, E (corresponding author), Humanitas Res Hosp IRCCS, Dept Radiol, Div Intervent Radiol, Rozzano, Italy.	eziolanza@gmail.com; guido.torzilli@humanitas.it	Rimassa, Lorenza/N-4884-2016; Aghemo, Alessio/ABE-5976-2021; Lanza, Ezio/AAO-8516-2020; D'Antuono, Felice/AAV-2822-2020; pugliese, nicola/ABC-7622-2020; Politi, Letterio Salvatore/AAB-1092-2021; LLEO, Ana/AAA-5759-2019	Rimassa, Lorenza/0000-0001-9957-3615; Aghemo, Alessio/0000-0003-0941-3226; Lanza, Ezio/0000-0003-1889-8798; D'Antuono, Felice/0000-0002-9973-0593; pugliese, nicola/0000-0001-6466-1412; Politi, Letterio Salvatore/0000-0002-6190-6688; Messana, Gaia/0000-0002-3212-5305; pedicini, vittorio/0000-0001-7830-6307; LLEO, Ana/0000-0002-0561-7902; Ceriani, Roberto/0000-0003-4838-7366; Masetti, Chiara/0000-0002-1689-4876				Chang KV, 2018, LIVER CANCER, V7, P90, DOI 10.1159/000484950; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dimitroulis D, 2017, WORLD J GASTROENTERO, V23, P5282, DOI 10.3748/wjg.v23.i29.5282; Dolan E, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9110642; Donadon M, 2019, UPDATES SURG, V71, P57, DOI 10.1007/s13304-019-00626-3; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Foerster F, 2018, EUR J INTERN MED, V55, P57, DOI 10.1016/j.ejim.2018.05.024; Forner A, 2019, JHEP REP, V1, P17, DOI 10.1016/j.jhepr.2019.02.003; Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258; Ikeda M, 2018, JPN J CLIN ONCOL, V48, P103, DOI 10.1093/jjco/hyx180; Kaido T, 2019, HEPATOBIL SURG NUTR, V8, P59, DOI 10.21037/hbsn.2018.11.05; Katsanos K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184597; Koya S, 2019, J GASTROEN HEPATOL, V34, P580, DOI 10.1111/jgh.14538; Lanza E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227711; Lanza E, 2017, NUCL MED COMMUN, V38, P826, DOI 10.1097/MNM.0000000000000719; Lanza E, 2017, LIVER CANCER, V6, P27, DOI 10.1159/000449347; Liguori I, 2018, CLIN INTERV AGING, V13, P913, DOI 10.2147/CIA.S149232; Loosen SH, 2019, CANCERS, V11, DOI 10.3390/cancers11101503; Martinez-Arnau FM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102504; Menyhart O, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.181006; Nishikawa H, 2017, ONCOL LETT, V14, P1637, DOI 10.3892/ol.2017.6287; Phu S, 2015, J CLIN DENSITOM, V18, P488, DOI 10.1016/j.jocd.2015.04.011; Portal D, 2019, CANCER MANAG RES, V11, P2579, DOI 10.2147/CMAR.S195869; Tamandl D, 2016, EUR RADIOL, V26, P1359, DOI 10.1007/s00330-015-3963-1	24	18	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0232371	10.1371/journal.pone.0232371	http://dx.doi.org/10.1371/journal.pone.0232371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555707	gold, Green Published			2022-12-26	WOS:000542759600010
J	Ali, AR; Li, JP; O'Shea, SJ				Ali, Abder-Rahman; Li, Jingpeng; O'Shea, Sally Jane			Towards the automatic detection of skin lesion shape asymmetry, color variegation and diameter in dermoscopic images	PLOS ONE			English	Article							MELANOMA; CLASSIFICATION; SEGMENTATION; DIAGNOSIS; NEVI	Asymmetry, color variegation and diameter are considered strong indicators of malignant melanoma. The subjectivity inherent in the first two features and the fact that 10% of melanomas tend to be missed in the early diagnosis due to having a diameter less than 6mm, deem it necessary to develop an objective computer vision system to evaluate these criteria and aid in the early detection of melanoma which could eventually lead to a higher 5-year survival rate. This paper proposes an approach for evaluating the three criteria objectively, whereby we develop a measure to find asymmetry with the aid of a decision tree which we train on the extracted asymmetry measures and then use to predict the asymmetry of new skin lesion images. A range of colors that demonstrate the suspicious colors for the color variegation feature have been derived, and Feret's diameter has been utilized to find the diameter of the skin lesion. The decision tree is 80% accurate in determining the asymmetry of skin lesions, and the number of suspicious colors and diameter values are objectively identified.	[Ali, Abder-Rahman; Li, Jingpeng] Univ Stirling, Div Comp Sci & Math, Stirling, Scotland; [O'Shea, Sally Jane] Mater Private Hosp, Dublin, Ireland	University of Stirling; Mater Private Hospital	Ali, AR (corresponding author), Univ Stirling, Div Comp Sci & Math, Stirling, Scotland.	abder@cs.stir.ac.uk		Li, Jingpeng/0000-0002-6758-0084; Ali, Abder-Rahman/0000-0002-5450-5472				Ali A., 2019, INT JOINT C NEUR NET; Ali A., 2020, PEERJ COMPUTER SCI; Ali AR, 2019, LECT NOTES ARTIF INT, V11489, P373, DOI 10.1007/978-3-030-18305-9_32; Andreassi L, 1999, ARCH DERMATOL, V135, P1459, DOI 10.1001/archderm.135.12.1459; [Anonymous], 1993, JAMA, V268; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; BLOOMBERG DS, 1995, P SOC PHOTO-OPT INS, V2422, P302, DOI 10.1117/12.205832; Braun RP, 2005, J AM ACAD DERMATOL, V52, P109, DOI 10.1016/j.jaad.2001.11.001; Butenko S., 2009, WORLD SCI; Chen QF, 2013, IEEE T PATTERN ANAL, V35, P2175, DOI 10.1109/TPAMI.2013.18; CIE, 1978, CIE PUBLICATION, V15; Clawson K. M., 2007, Proceedings 2007 IEEE International Conference on Image Processing, ICIP 2007, P453; Codella N. C., 2017, SKIN LESION ANAL MEL; Cohn BA, 2006, ARCH DERMATOL, V142, P528, DOI 10.1001/archderm.142.4.528-b; d'Amico M, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P1155; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Feret L. R., 1931, ASS INT ESSAI MAT ZU; Garnavi R, 2012, IEEE T INF TECHNOL B, V16, P1239, DOI 10.1109/TITB.2012.2212282; Grammatikopoulos G., 2007, WSEAS Transactions on Information Science and Applications, V4, P460; Grammatikopoulos G., 2006, P 5 INT C DAT NETW C; Groenen P.J., 2007, ADV FUZZY CLUSTERING; Hintz-Madsen M., 1998, THESIS; HU M, 1962, IRE T INFORM THEOR, V8, P179, DOI 10.1109/tit.1962.1057692; Jahanifar M., 2018, IEEE J BIOMEDICAL HL; Kalwa U, 2019, SYMMETRY-BASEL, V11, DOI 10.3390/sym11060790; Kasmi R, 2016, IET IMAGE PROCESS, V10, P448, DOI 10.1049/iet-ipr.2015.0385; Li C, 2016, CONTENT BASED MICROS; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Ma L., 2009, 2 INT C IM SIGN PROC; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; NACHBAR F, 1994, J AM ACAD DERMATOL, V30, P551, DOI 10.1016/S0190-9622(94)70061-3; Neville B, 2015, ORAL MAXILLOFACIAL P, V4th; Ng V, 1997, IEEE SYS MAN CYBERN, P4211, DOI 10.1109/ICSMC.1997.637360; Ng VTY, 2005, COMPUT BIOL MED, V35, P103, DOI 10.1016/j.compbiomed.2003.11.004; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ronneberger O., 2015, U NET CONVOLUTIONAL, P234; Sebestyen G., 1962, DECISION MAKING PROC, V227, P413; Seidenari S, 1999, MELANOMA RES, V9, P163, DOI 10.1097/00008390-199904000-00009; Seidenari S, 2013, HEAD NECK ONCOL, V5, P32; SETHI IK, 1990, P IEEE, V78, P1605, DOI 10.1109/5.58346; STOECKER WV, 1992, COMPUT MED IMAG GRAP, V16, P191, DOI 10.1016/0895-6111(92)90073-I; Sun YX, 2019, IEEE T AUTOM SCI ENG, V16, P1596, DOI 10.1109/TASE.2019.2893414; Sung J.M., 2014, P SPIE INT SOC OPTIC; Tenenhaus A, 2010, SKIN RES TECHNOL, V16, P85, DOI 10.1111/j.1600-0846.2009.00385.x; Tschandl Philipp, 2018, ARXIV180310417; UMBAUGH SE, 1989, IEEE ENG MED BIOL, V8, P43, DOI 10.1109/51.45955; WALTON WH, 1948, NATURE, V162, P329, DOI 10.1038/162329b0; Wang JD, 2017, INT J COMPUT VISION, V123, P251, DOI 10.1007/s11263-016-0977-3; Zaqout I., 2016, INT J SIGNAL PROCESS, V9, P189, DOI [10.14257/ijsip.2016.9.9.18, DOI 10.14257/IJSIP.2016.9.9.18]	49	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234352	10.1371/journal.pone.0234352	http://dx.doi.org/10.1371/journal.pone.0234352			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544197	Green Published, gold			2022-12-26	WOS:000542957200006
J	Kemp, BM; Bingham, B; Frome, R; Labonte, M; Palmer, E; Parsons, ES; Gobalet, KW; Rosenthal, J				Kemp, Brian M.; Bingham, Brittany; Frome, Ryan; Labonte, Marie; Palmer, Erica; Parsons, Ella S.; Gobalet, Kenneth W.; Rosenthal, Jeffrey			Subduing the influence of PCR inhibitors on amplifying aged, degraded, and low copy number DNA: PCR enhancer cocktail-p and rescue PCR	PLOS ONE			English	Article							SALMONIDS ONCORHYNCHUS SPP.; ANCIENT DNA; SPECIES IDENTIFICATION; REMOVAL; AMPLIFICATION; EXTRACTION; FISHERIES; EFFICACY	PCR inhibitors are a formidable problem to the study of aged, degraded, and/or low copy number DNA. As a result, there is a need to find alternate methods that ameliorate the efficacy of PCR. In this study, we attempted to use genetic methods to identify the species of salmonid (Oncorhynchusspp.) remains recovered from archaeological sites along the Feather River located in northern California, United States. In the process of doing so, we compared the efficacy of a PCR enhancer cocktail called "PEC-P" and a reagent rich PCR recipe called "rescue PCR" over standard PCR. Across all treatments (full concentration and 1:10 dilute eluates subjected to standard PCR, PEC-P, and rescue PCR) species identification was possible for 74 of 93 archaeological fish specimens (79.6%). Overall, six of the 93 samples (6.5%) consistently yielded species identification across all treatments. The species of ten specimens (10.8%) were uniquely identified from amplicons produced with either PEC-P or rescue PCR or both. Notably, the species of seven samples (7.5%) were uniquely identified with standard PCR over the alternative treatments. Considering both full concentration and 1:10 dilute eluates (N = 186), standard PCR performed as well as PEC-P (p = 0.1451) and rescue (p = 0.6753). Yet, considering results from full concentration eluates alone (N = 93), PEC-P (60.2%) outperformed both standard PCR (44.1%; p = 0.0277) and rescue PCR (40.9%; p = 0.0046). Stochasticity observed in our study cautions us against choosing a "best" performing method of those explored here and suggests their respective potentials to improve success may be sample dependent. When working with samples compromised by PCR inhibitors, it is useful to have alternative methodologies for subduing the problem. Both PEC-P and rescue PCR represent useful alternative methods for the study of aged, degraded, and/or low copy number DNA samples compromised by PCR inhibitors.	[Kemp, Brian M.] Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA; [Kemp, Brian M.; Bingham, Brittany; Frome, Ryan; Labonte, Marie; Palmer, Erica; Parsons, Ella S.] Univ Oklahoma, Labs Mol Anthropol & Microbiome Res, Norman, OK 73019 USA; [Gobalet, Kenneth W.] Calif State Univ, Bakersfield, CA USA; [Rosenthal, Jeffrey] Far Western Anthropol Res Grp, Davis, CA USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; California State University System; California State University Bakersfield	Kemp, BM (corresponding author), Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA.; Kemp, BM (corresponding author), Univ Oklahoma, Labs Mol Anthropol & Microbiome Res, Norman, OK 73019 USA.	bmkemp@ou.edu		Kemp, Brian/0000-0003-3945-3392	Sutter-Butte Flood Control Agency; University of Oklahoma; Estom Yumeka Maidu Tribe of Enterprise Rancheria	Sutter-Butte Flood Control Agency; University of Oklahoma; Estom Yumeka Maidu Tribe of Enterprise Rancheria	This work was supported by funds from the Sutter-Butte Flood Control Agency (http://www.sutterbutteflood.org/) to J.R. and the University of Oklahoma (http://www.ou.edu/) to B.M.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study of archaeological salmon remains from ancestral sites on the Feather River is supported by the Estom Yumeka Maidu Tribe of Enterprise Rancheria. Thanks to Cara Monroe for assistance in the laboratory.	Alaeddini R, 2012, FORENSIC SCI INT-GEN, V6, P297, DOI 10.1016/j.fsigen.2011.08.006; Alaeddini R, 2010, FORENSIC SCI INT-GEN, V4, P148, DOI 10.1016/j.fsigen.2009.09.007; Baar C, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1360; Barta JL, 2014, J ARCHAEOL SCI, V46, P281, DOI 10.1016/j.jas.2014.03.030; Barta JL, 2013, FORENSIC SCI INT, V231, P340, DOI 10.1016/j.forsciint.2013.06.004; Bidwell J, 1847, DISENO RANCHO BOGA; Brown KH, 2006, COMP BIOCHEM PHYS D, V1, P219, DOI 10.1016/j.cbd.2005.11.004; CASTEEL RW, 1974, COPEIA, P305; Casteel RW, 1976, FISH REMAINS ARCHAEO; Chiou FS, 2001, J FORENSIC SCI, V46, P1174; Demeke T, 2010, ANAL BIOANAL CHEM, V396, P1977, DOI 10.1007/s00216-009-3150-9; Funes-Huacca ME, 2011, ELECTROPHORESIS, V32, P1084, DOI 10.1002/elps.201000584; Gilbert MTP, 2006, NUCL ACID M, V18, P91; Gobalet KW, 2004, T AM FISH SOC, V133, P801, DOI 10.1577/T02-084.1; Grier C, 2013, J ARCHAEOL SCI, V40, P544, DOI 10.1016/j.jas.2012.07.013; Gudde EG, 1933, Q CALIF HIST SOC, V12, P279; Halffman CM, 2015, P NATL ACAD SCI USA, V112, P12344, DOI 10.1073/pnas.1509747112; HALLOCK RJ, 1967, CALIF FISH GAME, V53, P5; HANNI C, 1995, NUCLEIC ACIDS RES, V23, P881, DOI 10.1093/nar/23.5.881; Hash J.M., 2015, J CALIFORNIA GREAT B, V35, P87; Huber HR, 2011, J ARCHAEOL SCI, V38, P136, DOI 10.1016/j.jas.2010.08.020; Johnson BM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190059; Johnson BM, 2017, J ARCHAEOL SCI-REP, V11, P683, DOI 10.1016/j.jasrep.2017.01.006; Jordan LG, 2010, MOL ECOL RESOUR, V10, P225, DOI 10.1111/j.1755-0998.2009.02739.x; Kemp BM, 2006, J ARCHAEOL SCI, V33, P1680, DOI 10.1016/j.jas.2006.02.015; Kemp BM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178882; Kemp BM, 2014, J ARCHAEOL SCI, V42, P373, DOI 10.1016/j.jas.2013.11.023; King CE, 2009, BIOTECHNIQUES, V47, P941, DOI 10.2144/000113244; Monroe C, 2013, FORENSIC SCI INT, V228, P142, DOI 10.1016/j.forsciint.2013.02.029; Moss ML, 2014, J ARCHAEOL SCI, V41, P879, DOI 10.1016/j.jas.2013.10.017; Opel KL, 2010, J FORENSIC SCI, V55, P25, DOI 10.1111/j.1556-4029.2009.01245.x; Palmer E, 2018, J ARCHAEOL SCI, V99, P143, DOI 10.1016/j.jas.2018.09.014; Pionzio AM, 2014, FORENSIC SCI INT-GEN, V9, P55, DOI 10.1016/j.fsigen.2013.10.010; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Sorensen E, 2003, INT J LEGAL MED, V117, P245, DOI 10.1007/s00414-003-0375-6; Wilbur ME, 1941, ADVENTURES HEINRICH; Ye J, 2004, J FORENSIC SCI, V49, P754; Yoshiyama R.M., 2001, FISH B-NOAA, V179, P71; Zhang Z, 2010, J MOL DIAGN, V12, P152, DOI 10.2353/jmoldx.2010.090070	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234745	10.1371/journal.pone.0234745	http://dx.doi.org/10.1371/journal.pone.0234745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB9ZQ	32544213	gold, Green Published			2022-12-26	WOS:000542957200037
J	Zhang, YH; Shi, WN; Wu, SH; Miao, RR; Sun, SY; Luo, DD; Wan, SB; Guo, ZK; Wang, WY; Yu, XF; Cui, SX; Qu, XJ				Zhang, Yu-Hang; Shi, Wen-Na; Wu, Shu-Hua; Miao, Rong-Rong; Sun, Shi-Yue; Luo, Dong-Dong; Wan, Sheng-Biao; Guo, Zhi-Kun; Wang, Wen-Yu; Yu, Xin-Feng; Cui, Shu-Xiang; Qu, Xian-Jun			SphK2 confers 5-fluorouracil resistance to colorectal cancer via upregulating H3K56ac-mediated DPD expression	ONCOGENE			English	Article							IN-VITRO; SPHINGOSINE KINASE-1; SPHINGOSINE-1-PHOSPHATE; CHEMOTHERAPY; INHIBITOR; ABC294640; FLUOROURACIL; SENSITIVITY; STRATEGIES; TOXICITY	Aberrant sphingolipid metabolism has been implicated in chemoresistance, but the underlying mechanisms are still poorly understood. Herein we revealed a previously unrecognized mechanism of 5-fluorouracil (5-FU) resistance contributed by high SphK2-upregulated dihydropyrimidine dehydrogenase (DPD) in colorectal cancer (CRC), which is evidenced from human CRC specimens, animal models, and cancer cell lines. TMA samples from randomly selected 60 CRC specimens firstly identified the clinical correlation between high SphK2 and increased DPD (p < 0.001). Then the regulatory mechanism was explored in CRC models of villin-SphK2 Tg mice,SphK2(-/-)mice, and human CRC cells xenografted nude mice. Assays of ChIP-Seq and luciferase reporter gene demonstrated that high SphK2 upregulated DPD through promoting the HDAC1-mediated H3K56ac, leading to the degradation of intracellular 5-FU into inactive alpha-fluoro-beta-alanine (FBAL). Lastly, inhibition of SphK2 by SLR080811 exhibited excellent inhibition on DPD expression and potently reversed 5-FU resistance in colorectal tumors of villin-SphK2 Tg mice. Overall, this study manifests that SphK2(high)conferred 5-FU resistance through upregulating tumoral DPD, which highlights the strategies of blocking SphK2 to overcome 5-FU resistance in CRC.	[Zhang, Yu-Hang; Miao, Rong-Rong; Sun, Shi-Yue; Wang, Wen-Yu; Yu, Xin-Feng; Qu, Xian-Jun] Capital Med Univ, Dept Pharmacol, Sch Basic Med Sci, Beijing, Peoples R China; [Shi, Wen-Na] Shandong First Med Univ & Shandong Acad Med Sci, Dept Pharm, Shandong Canc Hosp & Inst, Jinan, Peoples R China; [Wu, Shu-Hua] Hosp Binzhou Med Univ, Dept Pathol, Yantai, Shandong, Peoples R China; [Luo, Dong-Dong; Wan, Sheng-Biao] Ocean Univ China, Qingdao Natl Lab Marine Sci & Technol, Key Lab Marine Drugs, Lab Marine Drugs & Bioprod,Minist Educ,Sch Med &, Qingdao, Peoples R China; [Guo, Zhi-Kun; Cui, Shu-Xiang] Capital Med Univ, Dept Toxicol & Sanit Chem, Sch Publ Hlth, Beijing, Peoples R China	Capital Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Binzhou Medical University; Ocean University of China; Qingdao National Laboratory for Marine Science & Technology; Capital Medical University	Qu, XJ (corresponding author), Capital Med Univ, Dept Pharmacol, Sch Basic Med Sci, Beijing, Peoples R China.; Cui, SX (corresponding author), Capital Med Univ, Dept Toxicol & Sanit Chem, Sch Publ Hlth, Beijing, Peoples R China.	sxccui@ccmu.edu.cn; qxj@ccmu.edu.cn		zhang, yuhang/0000-0001-9752-983X; luo, dongdong/0000-0001-6428-9729; Guo, Zhikun/0000-0003-1639-4342	National Natural Science Foundation of China [91629303/81673449/81872884/81973350]; Beijing Natural Science Foundation and Scientific Research Program of Municipal Commission of Education [KZ201710025020/KZ201810025033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation and Scientific Research Program of Municipal Commission of Education	This work was supported by National Natural Science Foundation of China (91629303/81673449/81872884/81973350) and Beijing Natural Science Foundation and Scientific Research Program of Municipal Commission of Education (KZ201710025020/KZ201810025033).	Adjei AA, 2002, J CLIN ONCOL, V20, P1683, DOI 10.1200/JCO.20.6.1683; Afzal S, 2011, CLIN CANCER RES, V17, P3822, DOI 10.1158/1078-0432.CCR-11-0304; Amstutz U, 2018, CLIN PHARMACOL THER, V103, P210, DOI 10.1002/cpt.911; Britten CD, 2017, CLIN CANCER RES, V23, P4642, DOI 10.1158/1078-0432.CCR-16-2363; Camp ER, 2017, CANCER BIOL THER, V18, P640, DOI 10.1080/15384047.2017.1345396; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Fitzpatrick Leo R., 2011, Inflammopharmacology, V19, P75, DOI 10.1007/s10787-010-0060-6; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; Grassi S, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00807; Guillermet-Guibert J, 2009, MOL CANCER THER, V8, P809, DOI 10.1158/1535-7163.MCT-08-1096; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; Kharel Y, 2012, BIOCHEM J, V447, P149, DOI 10.1042/BJ20120609; Kidder BL, 2011, NAT IMMUNOL, V12, P918, DOI 10.1038/ni.2117; Lee AM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju298; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Manca A, 2012, VALUE HEALTH, V15, P22, DOI 10.1016/j.jval.2011.07.008; Micoli G, 2001, J CHROMATOGR B, V750, P25, DOI 10.1016/S0378-4347(00)00377-7; Min JX, 2005, EUKARYOT CELL, V4, P178, DOI 10.1128/EC.4.1.178-189.2005; O'Sullivan S, 2017, NEUROPHARMACOLOGY, V113, P597, DOI 10.1016/j.neuropharm.2016.11.006; Offer SM, 2013, CANCER RES, V73, P1958, DOI 10.1158/0008-5472.CAN-12-3858; Parang B, 2016, METHODS MOL BIOL, V1422, P297, DOI 10.1007/978-1-4939-3603-8_26; Peters GJ, 2002, BBA-MOL BASIS DIS, V1587, P194, DOI 10.1016/S0925-4439(02)00082-0; Rosa R, 2013, CLIN CANCER RES, V19, P138, DOI 10.1158/1078-0432.CCR-12-1050; Rosmarin D, 2015, GUT, V64, P111, DOI 10.1136/gutjnl-2013-306571; Salas A, 2011, BLOOD, V117, P5941, DOI 10.1182/blood-2010-08-300772; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Seymour MT, 2007, LANCET, V370, P143, DOI 10.1016/S0140-6736(07)61087-3; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sun CC, 2014, PATHOL RES PRACT, V210, P668, DOI 10.1016/j.prp.2014.06.016; Van Cutsem E, 2001, J CLIN ONCOL, V19, P4097, DOI 10.1200/JCO.2001.19.21.4097; Venant H, 2015, MOL CANCER THER, V14, P2744, DOI 10.1158/1535-7163.MCT-15-0279; Xun C, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0205-y	34	9	10	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 16	2020	39	29					5214	5227		10.1038/s41388-020-1352-y	http://dx.doi.org/10.1038/s41388-020-1352-y		JUN 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ML6WO	32546724				2022-12-26	WOS:000540679400001
J	Abu-Shawer, O; Abu-Shawer, M; Shurman, A; Lattouf, A; Haimour, A; Hamdan, O; Mansour, R; Altamimi, T; Al-Hussaini, M				Abu-Shawer, Osama; Abu-Shawer, Mohammad; Shurman, Abdullah; Lattouf, Ali; Haimour, Ayman; Hamdan, Omar; Mansour, Razan; Altamimi, Tamer; Al-Hussaini, Maysa			The clinical value of peripheral immune cell counts in pancreatic cancer	PLOS ONE			English	Article							NEUTROPHIL-LYMPHOCYTE RATIO; CHEMOTHERAPY	Background Elevated neutrophil-lymphocyte ratio (NLR) is linked to poor overall survival (OS) in pancreatic cancer. We aim to investigate the association of the various hematologic markers, in particular NLR among others, with distant metastases, a common feature in pancreatic cancer. Methods Clinical data from 355 pancreatic cancer patients managed at King Hussein Cancer Center (Amman-Jordan) have been reviewed. We examined the relationship between absolute neutrophil count (ANC), absolute lymphocyte count (ALC), absolute eosinophilic count (AEC), absolute monocytic count (AMC), NLR, monocyte to lymphocyte ratio (MLR) and platelet to lymphocyte ratio (PLR) with the presence of baseline distant metastases and OS. Receiver Operating Characteristic (ROC) curve analysis was plotted to identify the NLR optimum cutoff value indicative of its association with distant metastases. Results On univariate and multivariate analyses patients whom on presentation had high NLR (>= 3.3) showed more baseline distant metastases compared to patients with low NLR (<3.3), (p-value: <0.0001 and <0.0001, respectively). Patients with high baseline ANC (>= 5500/mu L), AMC (>= 600/mu L), MLR (>= 0.3) had more baseline distant metastases in comparison to patients with lower values (p-value: 0.02, 0.001, and <0.0001, respectively). High ANC, NLR, MLR, and PLR and low ALC were associated with poorer OS, (p-value: <0.0001, <0.0001, <0.0001, 0.04, and 0.01, respectively). Conclusion This study presents additional evidence of the association of some of the hematologic markers; in particular ANC, NLR, AMC, and MLR, with baseline distant metastases and poor outcome in pancreatic cancer. Whether these immune phenomena can help in identifying patients at higher risk for the subsequent development of distant metastases is unknown.	[Abu-Shawer, Osama] Harvard Med Sch, Boston, MA 02115 USA; [Abu-Shawer, Mohammad] Istiklal Hosp, Amman, Jordan; [Shurman, Abdullah; Lattouf, Ali; Hamdan, Omar; Mansour, Razan; Altamimi, Tamer] Univ Jordan, Sch Med, Amman, Jordan; [Haimour, Ayman] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Al-Hussaini, Maysa] King Hussein Canc Ctr, Dept Pathol & Lab Med, Amman, Jordan	Harvard University; Harvard Medical School; University of Jordan; University of Victoria; King Hussein Cancer Center	Al-Hussaini, M (corresponding author), King Hussein Canc Ctr, Dept Pathol & Lab Med, Amman, Jordan.	mhussaini@khcc.jo		Abu-Shawer, Osama/0000-0003-3904-2673				Abu-Shawer M, 2019, J GASTROINTEST CANC, V50, P428, DOI 10.1007/s12029-018-0089-0; Abu-Shawer O, 2019, J GASTROINTEST ONCOL, V10, P529, DOI 10.21037/jgo.2019.01.12; [Anonymous], 2017, LANCET HIV, V2017, pPE475; Dirican A, 2015, INT J CLIN ONCOL, V20, P70, DOI 10.1007/s10147-014-0672-8; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Khunger M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197743; Koh YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep38585; Liu D, 2018, CELL PHYSIOL BIOCHEM, V46, P1595, DOI 10.1159/000489207; Luchini C, 2019, CANCERS, V11, DOI 10.3390/cancers11081152; Minardi D, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1036-1; Moore MM, 2010, CLIN PHARMACOL THER, V87, P504, DOI 10.1038/clpt.2009.254; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Tanaka H, 2018, ANTICANCER RES, V38, P3745, DOI 10.21873/anticanres.12655; Templeton AJ, 2016, EUR UROL, V70, P358, DOI 10.1016/j.eururo.2016.02.033; Xie D, 2018, EUR J CARDIO-THORAC, V53, P1214, DOI 10.1093/ejcts/ezx462; Yang JJ, 2015, WORLD J GASTROENTERO, V21, P2807, DOI 10.3748/wjg.v21.i9.2807; Zhang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111906	17	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0232043	10.1371/journal.pone.0232043	http://dx.doi.org/10.1371/journal.pone.0232043			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542007	Green Published, gold			2022-12-26	WOS:000542685100043
J	Cao, ZX; Guo, CJ; Song, XMT; He, JL; Tan, L; Yu, S; Zhang, RQ; Peng, F; Peng, C; Li, YZ				Cao, Zhi-Xing; Guo, Chuan-Jie; Song, Xiaominting; He, Jun-Lin; Tan, Lu; Yu, Si; Zhang, Ruo-Qi; Peng, Fu; Peng, Cheng; Li, Yu-Zhi			Erlotinib is effective against FLT3-ITD mutant AML and helps to overcome intratumoral heterogeneity via targeting FLT3 and Lyn	FASEB JOURNAL			English	Article						AML; erlotinib; FLT3; intratumoral heterogeneity; Lyn	ACUTE MYELOID-LEUKEMIA; MINIMAL RESIDUAL DISEASE; THERAPEUTIC TARGET; PANCREATIC-CANCER; KINASE; CELLS; CHEMOTHERAPY; PROGRESSION; RESISTANCE; PATHWAY	Erlotinib has potential therapeutic effect on acute myeloid leukemia (AML) in patients, but the mechanism is not clear. Effective tumor biomarkers for erlotinib in the treatment of AML remain poorly defined. Here, we demonstrate that erlotinib in vitro significantly inhibits the growth of the FLT3-ITD mutant AML cell MV4-11 and Ba/F3-FLT3-ITD cell via targeting FLT3, a certified valid target for the effective treatment of AML. In vivo, oral administration of erlotinib at 100 mg/kg/day induced rapid MV4-11 tumor regression and significantly prolonged the survival time of bone marrow engraftment AML mice via inhibiting the FLT3 signal. Thus, the therapeutic benefits of erlotinib on AML are due to its ability to target FLT3. FLT3-ITD mutation is an effective biomarker for erlotinib during AML treatment. In addition, we also demonstrate that erlotinib inhibits the activity of AML cell KG-1 (no FLT3 expression) by targeting Lyn. Recently, single cell analysis demonstrated that intratumoral heterogeneity are one of the contributors in the relapse and FLT3 inhibitor resistance. Erlotinib could effectively inhibit the MV4-11 cells via targeting FLT3, and inhibit KG-1 cells via targeting Lyn. Therefore, Erlotinib also has the potential to overcome intratumoral heterogeneity via targeting FLT3 and Lyn.	[Cao, Zhi-Xing; Guo, Chuan-Jie; Song, Xiaominting; He, Jun-Lin; Tan, Lu; Yu, Si; Zhang, Ruo-Qi; Peng, Cheng; Li, Yu-Zhi] Chengdu Univ Tradit Chinese Med, Pharm Coll,Key Lab Systemat Res Dev & Utilizat Ch, Minist Educ,Key Lab Standardizat Chinese Herbal M, Key Lab Breeding Base Sichuan Prov & MOST Chengdu, Chengdu, Peoples R China; [Peng, Fu] Sichuan Univ, West China Sch Pharm, Chengdu, Peoples R China	Chengdu University of Traditional Chinese Medicine; Sichuan University	Peng, C; Li, YZ (corresponding author), Chengdu Univ Tradit Chinese Med, Coll Pharm, 1166 Liutai Rd, Chengdu 611137, Sichuan, Peoples R China.	pengchengchengdu@126.com; pengchengchengdu@126.com		Peng, Cheng/0000-0003-3303-906X	National Natural Science Foundation of China [81300437, 81403149, 81973189]; National Major Scientific and Technological Special Project of China [2017ZX09201001-008]; Sichuan Science and Technology Program [2018SZDZX0017]; Youth Scientific Research Fund of CDUTCM [ZRQN1764, ZRQN1770]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific and Technological Special Project of China; Sichuan Science and Technology Program; Youth Scientific Research Fund of CDUTCM	This study was supported by the National Natural Science Foundation of China (81300437, 81403149, 81973189), National Major Scientific and Technological Special Project of China (2017ZX09201001-008), Sichuan Science and Technology Program (2018SZDZX0017). Youth Scientific Research Fund of CDUTCM (ZRQN1764, ZRQN1770).	Abou Dalle I, 2018, ACTA HAEMATOL-BASEL, V140, P30, DOI 10.1159/000490092; Ampasavate C, 2019, J CLIN LAB ANAL, V33, DOI 10.1002/jcla.22859; Boehrer S, 2008, BLOOD, V111, P2170, DOI 10.1182/blood-2007-07-100362; Chan G, 2007, BLOOD, V110, P1079, DOI 10.1182/blood-2007-01-069856; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Dos Santos C, 2008, BLOOD, V111, P2269, DOI 10.1182/blood-2007-04-082099; Frolov A, 2007, CANCER BIOL THER, V6, P548, DOI 10.4161/cbt.6.4.3849; Ger M, 2018, ANTICANCER RES, V38, P5759, DOI 10.21873/anticanres.12914; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Giotopoulos G, 2018, CANCER CELL, V34, P533, DOI 10.1016/j.ccell.2018.09.004; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Harashima A, 2002, BLOOD, V100, P4440, DOI 10.1182/blood-2002-03-0864; Iida M, 2013, ONCOGENE, V32, P759, DOI 10.1038/onc.2012.90; Jongen-Lavrencic M, 2018, NEW ENGL J MED, V378, P1189, DOI 10.1056/NEJMoa1716863; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Levis MJ, 2018, BLOOD ADV, V2, P825, DOI 10.1182/bloodadvances.2018015925; Mann KM, 2016, NAT BIOTECHNOL, V34, P962, DOI 10.1038/nbt.3637; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Okamoto M, 2007, LEUKEMIA, V21, P403, DOI 10.1038/sj.leu.2404547; Nguyen PH, 2016, CANCER CELL, V30, P610, DOI 10.1016/j.ccell.2016.09.007; Sayar H, 2015, LEUKEMIA RES, V39, P170, DOI 10.1016/j.leukres.2014.11.022; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Sellar RS, 2018, NAT MED, V24, P904, DOI 10.1038/s41591-018-0114-7; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Sidaway Peter, 2018, Nat Rev Clin Oncol, V15, P532, DOI 10.1038/s41571-018-0061-8; Skrzypczynska KM, 2016, IMMUNITY, V45, P1232, DOI 10.1016/j.immuni.2016.10.013; Smith CC, 2017, BLOOD, V130, P48, DOI 10.1182/blood-2016-04-711820; Stone RM, 2017, NEW ENGL J MED, V377, P454, DOI 10.1056/NEJMoa1614359; Tada J, 1999, BLOOD, V93, P3723, DOI 10.1182/blood.V93.11.3723.411k02_3723_3735; Thepot S, 2014, LEUKEMIA RES, V38, P1430, DOI 10.1016/j.leukres.2014.09.014; Tornillo G, 2018, CELL REP, V25, P3674, DOI 10.1016/j.celrep.2018.11.103; Zhang QQ, 2019, J CANCER, V10, P1197, DOI 10.7150/jca.28908	34	3	3	5	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10182	10190		10.1096/fj.201902922RR	http://dx.doi.org/10.1096/fj.201902922RR		JUN 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32543003	Bronze			2022-12-26	WOS:000541638200001
J	Alrefaei, AF; Munsterberg, AE; Wheeler, GN				Alrefaei, Abdulmajeed Fahad; Munsterberg, Andrea E.; Wheeler, Grant N.			FZD10 regulates cell proliferation and mediates Wnt1 induced neurogenesis in the developing spinal cord	PLOS ONE			English	Article							NEURAL-TUBE CLOSURE; FRIZZLED GENES; BETA-CATENIN; EXPRESSION; MOUSE; SPECIFICATION; POLARITY; PATHWAY; MEMBERS; TISSUE	Wnt/FZD signalling activity is required for spinal cord development, including the dorsal-ventral patterning of the neural tube, where it affects proliferation and specification of neurons. Wnt ligands initiate canonical, beta -catenin-dependent, signaling by binding to Frizzled receptors. However, in many developmental contexts the cognate FZD receptor for a particular Wnt ligand remains to be identified. Here, we characterized FZD10 expression in the dorsal neural tube where it overlaps with both Wnt1 and Wnt3a, as well as markers of dorsal progenitors and interneurons. We show FZD10 expression is sensitive to Wnt1, but not Wnt3a expression, and FZD10 plays a role in neural tube patterning. Knockdown approaches show that Wnt1 induced ventral expansion of dorsal neural markes, Pax6 and Pax7, requires FZD10. In contrast, Wnt3a induced dorsalization of the neural tube is not affected by FZD10 knockdown. Gain of function experiments show that FZD10 is not sufficient on its own to mediate Wnt1 activityin vivo. Indeed excess FZD10 inhibits the dorsalizing activity of Wnt1. However, addition of the Lrp6 co-receptor dramatically enhances the Wnt1/FZD10 mediated activation of dorsal markers. This suggests that the mechanism by which Wnt1 regulates proliferation and patterning in the neural tube requires both FZD10 and Lrp6.	[Alrefaei, Abdulmajeed Fahad; Munsterberg, Andrea E.; Wheeler, Grant N.] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich, Norfolk, England; [Alrefaei, Abdulmajeed Fahad] Univ Umm Al Qura, Jamoum Univ Coll, Dept Biol, Mecca, Saudi Arabia	University of East Anglia; Umm Al Qura University	Wheeler, GN (corresponding author), Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich, Norfolk, England.	grant.wheeler@uea.ac.uk	Munsterberg, Andrea E/E-2205-2011	Munsterberg, Andrea E/0000-0002-4577-4240; Wheeler, Grant/0000-0002-4335-8577; Alrefaei, Abdulmajeed fahad/0000-0003-0804-2339	Umm Al-Qura University; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/K003437/1, BB/I022252/1]; BBSRC [BB/K003437/1, BB/I022252/1] Funding Source: UKRI	Umm Al-Qura University; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AFA was funded by Umm Al-Qura University (https://uqu.edu.sa/en).AM and GW were supported by the Biotechnology and Biological Sciences Research Council (BBSRC, https://bbsrc.ukri.org/) (grant numbers BB/K003437/1 and BB/I022252/1 respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elhamd A, 2015, DEV BIOL, V402, P61, DOI 10.1016/j.ydbio.2015.02.024; Abu-Elmagd M, 2010, DEV BIOL, V337, P211, DOI 10.1016/j.ydbio.2009.10.023; Allache R, 2014, HUM MOL GENET, V23, P1687, DOI 10.1093/hmg/ddt558; Alvarez-Medina R, 2008, DEVELOPMENT, V135, P237, DOI 10.1242/dev.012054; [Anonymous], 2018, DEVELOPMENT, V145, pe0201; Aviles E.C., 2015, DEV NEUROBIOLOGY; Bonner J, 2008, DEV BIOL, V313, P398, DOI 10.1016/j.ydbio.2007.10.041; Carmon KS, 2010, ANAL BIOCHEM, V401, P288, DOI 10.1016/j.ab.2010.03.009; Chacon MA, 2008, J CELL PHYSIOL, V217, P215, DOI 10.1002/jcp.21497; Chapman SC, 2004, DEV DYNAM, V229, P668, DOI 10.1002/dvdy.10491; Chesnutt C, 2004, DEV BIOL, V274, P334, DOI 10.1016/j.ydbio.2004.07.019; DICKINSON ME, 1994, DEVELOPMENT, V120, P1453; Fuhrmann S, 2003, GENE EXPR PATTERNS, V3, P659, DOI 10.1016/S1567-133X(03)00107-8; Galli LM, 2014, DEV DYNAM, V243, P833, DOI 10.1002/dvdy.24123; Garcia-Morales C, 2009, DEV BIOL, V335, P143, DOI 10.1016/j.ydbio.2009.08.021; Goljanek-Whysall K, 2014, DEVELOPMENT, V141, P3378, DOI 10.1242/dev.108787; Gray JD, 2013, HUM MOL GENET, V22, P4267, DOI 10.1093/hmg/ddt277; Hartmann C, 2000, DEVELOPMENT, V127, P3141; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E; Houston DW, 2002, MECH DEVELOP, V117, P337, DOI 10.1016/S0925-4773(02)00205-8; Hua ZL, 2014, P NATL ACAD SCI USA, V111, pE3005, DOI 10.1073/pnas.1406399111; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Ille F, 2007, DEV BIOL, V304, P394, DOI 10.1016/j.ydbio.2006.12.045; Kawakami Y, 2000, DEV GROWTH DIFFER, V42, P561; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Le Dreau G, 2012, DEV NEUROBIOL, V72, P1471, DOI 10.1002/dneu.22015; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; Megason SG, 2002, DEVELOPMENT, V129, P2087; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Moriwaki J, 2000, BIOCHEM BIOPH RES CO, V278, P377, DOI 10.1006/bbrc.2000.3808; Muroyama Y, 2002, GENE DEV, V16, P548, DOI 10.1101/gad.937102; Nakamura Y, 2016, DEVELOPMENT, V143, P1914, DOI 10.1242/dev.131664; Nikaido M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054833; Quinlan R, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-35; Schmidt M, 2004, DEV DYNAM, V229, P703, DOI 10.1002/dvdy.20010; Stark MR, 2000, MECH DEVELOP, V93, P195, DOI 10.1016/S0925-4773(00)00263-X; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Theodosiou NA, 2003, DEV BIOL, V259, P258, DOI 10.1016/S0012-1606(03)00185-4; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wheeler GN, 1999, MECH DEVELOP, V86, P203, DOI 10.1016/S0925-4773(99)00117-3; Yan Y, 2009, GENE EXPR PATTERNS, V9, P173, DOI 10.1016/j.gep.2008.11.001; Yu HM, 2010, DEVELOPMENT, V137, P3707, DOI 10.1242/dev.052001; Zechner D, 2007, DEV BIOL, V303, P181, DOI 10.1016/j.ydbio.2006.10.045	47	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0219721	10.1371/journal.pone.0219721	http://dx.doi.org/10.1371/journal.pone.0219721			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32531778	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000542037200041
J	Ang, NB; Saera-Vila, A; Walsh, C; Hitchcock, PF; Kahana, A; Thummel, R; Nagashima, M				Ang, Nicholas B.; Saera-Vila, Alfonso; Walsh, Caroline; Hitchcock, Peter F.; Kahana, Alon; Thummel, Ryan; Nagashima, Mikiko			Midkine-a functions as a universal regulator of proliferation during epimorphic regeneration in adult zebrafish	PLOS ONE			English	Article							MULLER GLIA; NEURONAL PROGENITORS; STEM-CELLS; MUSCLE REGENERATION; FIN REGENERATION; GOLDFISH RETINA; EXPRESSION; ROD; DEDIFFERENTIATION; BLASTEMA	Zebrafish have the ability to regenerate damaged cells and tissues by activating quiescent stem and progenitor cells or reprogramming differentiated cells into regeneration-competent precursors. Proliferation among the cells that will functionally restore injured tissues is a fundamental biological process underlying regeneration. Midkine-a is a cytokine growth factor, whose expression is strongly induced by injury in a variety of tissues across a range of vertebrate classes. Using a zebrafish Midkine-a loss of function mutant, we evaluated regeneration of caudal fin, extraocular muscle and retinal neurons to investigate the function of Midkine-a during epimorphic regeneration. In wildtype zebrafish, injury among these tissues induces robust proliferation and rapid regeneration. In Midkine-a mutants, the initial proliferation in each of these tissues is significantly diminished or absent. Regeneration of the caudal fin and extraocular muscle is delayed; regeneration of the retina is nearly completely absent. These data demonstrate that Midkine-a is universally required in the signaling pathways that convert tissue injury into the initial burst of cell proliferation. Further, these data highlight differences in the molecular mechanisms that regulate epimorphic regeneration in zebrafish.	[Ang, Nicholas B.; Thummel, Ryan] Wayne State Univ, Sch Med, Dept Ophthalmol Visual & Anat Sci, Detroit, MI USA; [Saera-Vila, Alfonso; Walsh, Caroline; Hitchcock, Peter F.; Kahana, Alon; Nagashima, Mikiko] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA	Wayne State University; University of Michigan System; University of Michigan	Nagashima, M (corresponding author), Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	mikiko@umich.edu	Hitchcock, Peter/AAY-9559-2020; Saera-Vila, Alfonso/O-7438-2017	Hitchcock, Peter/0000-0001-9454-2684; Saera-Vila, Alfonso/0000-0003-0106-2353; Nagashima, Mikiko/0000-0003-0993-0012	National Institutes of Health (NEI) [R01EY07060, R01EY026551, P30EY07003, P30EY04068]; Research to Prevent Blindness; NIH-NCRR [P40 RR01]	National Institutes of Health (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health (NEI); R01EY07060 (to PFH) and R01EY026551 (to RT). Histology and imaging core resources were supported by vision core grants (P30EY07003 (to PFH) and P30EY04068 (to RT)) and an unrestricted grant from Research to Prevent Blindness to each department. Fish lines and reagents provided by ZIRC were supported by NIH-NCRR Grant P40 RR01. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Antos CL, 2010, ADV EXP MED BIOL, V695, P184, DOI 10.1007/978-1-4419-7037-4_13; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Calinescu AA, 2009, J COMP NEUROL, V514, P1, DOI 10.1002/cne.21999; Chablais F, 2010, DEVELOPMENT, V137, P871, DOI 10.1242/dev.043885; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Gramage E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121789; Jazwinska A, 2007, CURR BIOL, V17, P1390, DOI 10.1016/j.cub.2007.07.019; Jazwinska A, 2016, J PATHOL, V238, P233, DOI 10.1002/path.4644; KADOMATSU K, 1990, J CELL BIOL, V110, P607, DOI 10.1083/jcb.110.3.607; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Lenkowski JR, 2014, PROG RETIN EYE RES, V40, P94, DOI 10.1016/j.preteyeres.2013.12.007; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louie KW, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4236-y; Luo J, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-33; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; Mirkin BL, 2005, ONCOGENE, V24, P4965, DOI 10.1038/sj.onc.1208671; Mitchell DM, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1185-6; Morgan, 1901, REGENERATION, DOI [10.5962/bhl.title.87895, DOI 10.5962/BHL.TITLE.87895]; Morris AC, 2008, DEV NEUROBIOL, V68, P605, DOI 10.1002/dneu.20610; Muneoka Ken, 2008, Birth Defects Research, V84, P265, DOI 10.1002/bdrc.20137; Nagashima M, 2020, J NEUROSCI, V40, P1232, DOI 10.1523/JNEUROSCI.1675-19.2019; Nagashima M, 2013, DEVELOPMENT, V140, P4510, DOI 10.1242/dev.090738; Nakatani Y, 2008, DEV GROWTH DIFFER, V50, P71, DOI 10.1111/j.1440-169x.2007.00977.x; Otteson DC, 2001, DEV BIOL, V232, P62, DOI 10.1006/dbio.2001.0163; Owlarn S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02338-x; Pfefferli C, 2015, REGENERATION, V2, P72, DOI 10.1002/reg2.33; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Ranski AH, 2018, PEERJ, V6, DOI 10.7717/peerj.5646; RAYMOND PA, 1987, DEV BIOL, V122, P120, DOI 10.1016/0012-1606(87)90338-1; RAYMOND PA, 1988, J NEUROBIOL, V19, P431, DOI 10.1002/neu.480190504; Saera-Vila A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192214; Saera-Vila A, 2016, AUTOPHAGY, V12, P1864, DOI 10.1080/15548627.2016.1207015; Saera-Vila A, 2016, CELL SIGNAL, V28, P1196, DOI 10.1016/j.cellsig.2016.06.001; Saera-Vila A, 2015, INVEST OPHTH VIS SCI, V56, P4977, DOI 10.1167/iovs.14-16103; Sakakima H, 2004, J NEUROTRAUM, V21, P471, DOI 10.1089/089771504323004610; Sakamoto K, 2012, PATHOL INT, V62, P445, DOI 10.1111/j.1440-1827.2012.02815.x; Sallin P, 2015, DEV BIOL, V399, P27, DOI 10.1016/j.ydbio.2014.12.002; Sato W, 2002, NEPHROL DIAL TRANSPL, V17, P52, DOI 10.1093/ndt/17.suppl_9.52; Sehring IM, 2016, CURR OPIN GENET DEV, V40, P48, DOI 10.1016/j.gde.2016.05.011; Senut MC, 2004, J NEUROSCI, V24, P7663, DOI 10.1523/JNEUROSCI.2281-04.2004; Sorrelle N, 2017, J LEUKOCYTE BIOL, V102, P277, DOI 10.1189/jlb.3MR1116-475R; Sousa S, 2011, DEVELOPMENT, V138, P3897, DOI 10.1242/dev.064717; Stenkamp DL, 2011, PROG RETIN EYE RES, V30, P395, DOI 10.1016/j.preteyeres.2011.06.004; Thomas JL, 2018, EXP EYE RES, V166, P106, DOI 10.1016/j.exer.2017.10.003; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Thummel R, 2008, EXP EYE RES, V87, P433, DOI 10.1016/j.exer.2008.07.009; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Wehner D, 2015, TRENDS GENET, V31, P336, DOI 10.1016/j.tig.2015.03.012; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Winkler C, 2014, BRIT J PHARMACOL, V171, P905, DOI 10.1111/bph.12462; Winkler C, 2003, GENOME RES, V13, P1067, DOI 10.1101/gr.1097503; Wu CC, 2016, DEV CELL, V36, P36, DOI 10.1016/j.devcel.2015.12.010; Yao X, 2010, ACTA PHARMACOL SIN, V31, P629, DOI 10.1038/aps.2010.39; Yoshida Y, 2014, BRIT J PHARMACOL, V171, P924, DOI 10.1111/bph.12497	64	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0232308	10.1371/journal.pone.0232308	http://dx.doi.org/10.1371/journal.pone.0232308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530962	Green Submitted, Green Published, gold			2022-12-26	WOS:000542037200032
J	Eroglu, GB; Inan, C; Nalcacioglu, R; Demirbag, Z				Eroglu, Gozde Busra; Inan, Cihan; Nalcacioglu, Remziye; Demirbag, Zihni			Genome sequence analysis of a Helicoverpa armigera single nucleopolyhedrovirus (HearNPV-TR) isolated fromHeliothis peltigera in Turkey	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; PHYLOGENETIC ANALYSIS; DNA-REPLICATION; BACULOVIRUS; GENE; IDENTIFICATION; ORGANIZATION; ZEA	The entire genome of Helicoverpa armigera single nucleopolyhedrovirus (HearNPV-TR) was sequenced, and compared to genomes of other existing isolates. HearNPV-TR genome is 130.691 base pairs with a 38.9% G+C content and has 137 open reading frames (ORFs) of >= 150 nucleotides. Five homologous repeated sequences (hrs) and two baculovirus repeated ORFs (bro-a andbro-b) were identified. Phylogenetic analysis showed that HearNPV-TR is closer to HaSNPV-C1, HaSNPV-G4, HaSNPV-AU and HasNPV. However, there are significant differences inhr3,hr5 regions and inbro-a gene. Pairwise Kimura-2 parameter analysis of 38 core genes sequences of HearNPV-TR and other Helicoverpa NPVs showed that the genetic distances for these sequences were below 0.015 substitutions/site. Genomic differences as revealed by restriction profiles indicated thathr3,hr5regions andbro-a gene may play a role in the virulence of HearNPV-TR.	[Eroglu, Gozde Busra; Nalcacioglu, Remziye; Demirbag, Zihni] Karadeniz Tech Univ, Fac Sci, Dept Biol, Trabzon, Turkey; [Inan, Cihan] Karadeniz Tech Univ, Fac Sci, Dept Mol Biol & Genet, Trabzon, Turkey	Karadeniz Technical University; Karadeniz Technical University	Demirbag, Z (corresponding author), Karadeniz Tech Univ, Fac Sci, Dept Biol, Trabzon, Turkey.	zihni@ktu.edu.tr	Eroglu, Gozde Busra/AAR-3178-2020; inan, cihan/AAT-5624-2020; Nalcacioglu, Remziye/E-3970-2015; Demirbag, Zihni/E-3860-2015	Nalcacioglu, Remziye/0000-0003-0527-9541; Demirbag, Zihni/0000-0001-5487-1977; inan, cihan/0000-0003-0288-5917	Scientific and Research Council of Turkey (TUBITAK) [118Z003]	Scientific and Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This study was financially supported by the Scientific and Research Council of Turkey (TUBITAK) (Project No: 118Z003). The grant was received by Gozde Busra Eroglu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2015, ARCH VIROL, V160, P1837, DOI 10.1007/s00705-015-2425-z; Ardisson-Araujo DM, 2015, VIRUS REV RES, V20, P4; Arrizubieta M, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00548-15; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Bideshi DK, 2003, J GEN VIROL, V84, P2531, DOI 10.1099/vir.0.19256-0; Black B.C., 1997, BACULOVIRUSES, DOI [10.1007/978-1-4899-1834-5_13, DOI 10.1007/978-1-4899-1834-5_13]; Bulach DM, 1999, J INVERTEBR PATHOL, V73, P59, DOI 10.1006/jipa.1998.4797; Chen XW, 2002, J GEN VIROL, V83, P673, DOI 10.1099/0022-1317-83-3-673; Clem RJ, 2001, CELL DEATH DIFFER, V8, P137, DOI 10.1038/sj.cdd.4400821; COCHRAN MA, 1982, J VIROL, V41, P940, DOI 10.1128/JVI.41.3.940-946.1982; Contreras-Gomez A, 2014, BIOTECHNOL PROGR, V30, P1, DOI 10.1002/btpr.1842; Cunningham JC, 1998, INSECT VIRUSES PEST, P313; Eroglu GB, 2019, TURK J BIOL, V43, P340, DOI 10.3906/biy-1902-64; Escasa SR, 2006, J GEN VIROL, V87, P1917, DOI 10.1099/vir.0.81792-0; GarciaMaruniak A, 1996, VIRUS RES, V41, P123, DOI 10.1016/0168-1702(95)01264-8; Grzywacz D, 2004, PRODUCTION MANUAL, P107; GUARINO LA, 1986, J VIROL, V60, P215, DOI 10.1128/JVI.60.1.215-223.1986; Harrison RL, 2003, J GEN VIROL, V84, P1827, DOI 10.1099/vir.0.19146-0; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; HEMATI S. A., 2013, J CROP PROT, V2, P193; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Herniou EA, 2001, J VIROL, V75, P8117, DOI 10.1128/JVI.75.17.8117-8126.2001; Hilton S, 2007, J GEN VIROL, V88, P1496, DOI 10.1099/vir.0.82760-0; Hu ZH, 1998, J GEN VIROL, V79, P2841, DOI 10.1099/0022-1317-79-11-2841; HUGHES PR, 1986, J INVERTEBR PATHOL, V48, P187, DOI 10.1016/0022-2011(86)90122-9; IJkel WFJ, 1999, J GEN VIROL, V80, P3289, DOI 10.1099/0022-1317-80-12-3289; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; KOOL M, 1995, J GEN VIROL, V76, P2103, DOI 10.1099/0022-1317-76-9-2103; Kuzio J, 1999, VIROLOGY, V253, P17, DOI 10.1006/viro.1998.9469; Lange M, 2003, VIROLOGY, V317, P220, DOI 10.1016/S0042-6822(03)00515-4; Lauzon HAM, 2004, J VIROL, V78, P7023, DOI 10.1128/JVI.78.13.7023-7035.2004; Luque T, 2001, J GEN VIROL, V82, P2531, DOI 10.1099/0022-1317-82-10-2531; MCCLINTOCK JT, 1988, J GEN VIROL, V69, P2303, DOI 10.1099/0022-1317-69-9-2303; Moscardi F, 2011, MICROBES AND MICROBIAL TECHNOLOGY: AGRICULTURAL AND ENVIRONMENTAL APPLICATIONS, P415, DOI 10.1007/978-1-4419-7931-5_16; Munoz D, 1999, VIRUS RES, V59, P61, DOI 10.1016/S0168-1702(98)00125-7; Munoz D, 1997, APPL ENVIRON MICROB, V63, P3025; Nagarkatti S., 1974, Technical Bull Commonw Inst biol Control, VNo. 17, P169; Nakai M, 2003, VIROLOGY, V316, P171, DOI 10.1016/j.virol.2003.08.002; Noune C, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110280; Noune C, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01083-15; Ogembo JG, 2009, VIRUS GENES, V39, P261, DOI 10.1007/s11262-009-0389-3; Raghavendra Ashika T., 2017, VirusDisease, V28, P61, DOI 10.1007/s13337-016-0352-6; Reddy T, 2011, SCIENCES, V1, P105; Reed C, 2003, J INVERTEBR PATHOL, V84, P104, DOI 10.1016/j.jip.2003.08.002; Rowley DL, 2011, J INVERTEBR PATHOL, V107, P112, DOI 10.1016/j.jip.2011.03.007; Santos ER, 2018, VIRUS RES, V249, P76, DOI 10.1016/j.virusres.2018.03.009; SMITH IRL, 1988, VIROLOGY, V166, P240, DOI 10.1016/0042-6822(88)90165-1; Sun XL, 2015, VIRUSES-BASEL, V7, P306, DOI 10.3390/v7010306; THEILMANN DA, 1992, VIROLOGY, V187, P97, DOI 10.1016/0042-6822(92)90298-4; van Oers MM, 2005, J GEN VIROL, V86, P2069, DOI 10.1099/vir.0.80964-0; van Regenmortel M. H. V., 2000, VIRUS TAXONOMY CLASS; VLAK JM, 1982, J VIROL, V41, P1118, DOI 10.1128/JVI.41.3.1118-1121.1982; Wang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155134; Ward VK, 2002, ADV MICROBIAL CONTRO, P127; Wennmann JT, 2018, J GEN VIROL, V99, P1307, DOI 10.1099/jgv.0.001100; Willis LG, 2005, VIROLOGY, V338, P209, DOI 10.1016/j.virol.2005.04.041; Woo SD, 2006, J BIOSCIENCES, V31, P329, DOI 10.1007/BF02704105; Wormleaton S, 2003, VIROLOGY, V311, P350, DOI 10.1016/S0042-6822(03)00149-1; Wu FF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010064; XIE WD, 1995, VIROLOGY, V209, P409, DOI 10.1006/viro.1995.1273; Zemskov EA, 2000, J VIROL, V74, P6784, DOI 10.1128/JVI.74.15.6784-6789.2000; Zhang CX, 2005, VIROLOGY, V333, P190, DOI 10.1016/j.virol.2004.12.028; Zhang H, 2014, ARCH VIROL, V159, P595, DOI 10.1007/s00705-013-1823-3	64	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234635	10.1371/journal.pone.0234635	http://dx.doi.org/10.1371/journal.pone.0234635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530959	gold, Green Published			2022-12-26	WOS:000542037200002
J	Khurshid, R; Ullah, MA; Tungmunnithum, D; Drouet, S; Shah, M; Zaeem, A; Hameed, S; Hano, C; Abbasi, BH				Khurshid, Razia; Ullah, Muhammad Asad; Tungmunnithum, Duangjai; Drouet, Samantha; Shah, Muzamil; Zaeem, Afifa; Hameed, Safia; Hano, Christophe; Abbasi, Bilal Haider			Lights triggered differential accumulation of antioxidant and antidiabetic secondary metabolites in callus culture ofEclipta albaL.	PLOS ONE			English	Article							CELL-SUSPENSION CULTURES; DIFFERENT SPECTRAL LIGHTS; HAIRY ROOT CULTURES; ECLIPTA-ALBA; OXIDATIVE STRESS; RED-LIGHT; BIOCHEMICAL VARIATIONS; BIOMASS ACCUMULATION; PHENOLIC-COMPOUNDS; GROWTH	Eclipta albaL., also known as false daisy, is well known and commercially attractive plant with excellent hepatotoxic and antidiabetic activities. Light is considered a key modulator in plant morphogenesis and survival by regulating important physiological cascades. Current study was carried out to investigate growth and developmental aspects ofE.albaunder differential effect of multispectral lights.In vitroderived callus culture ofE.albawas exposed to multispectral monochromatic lights under controlled aseptic conditions. Maximum dry weight was recorded in culture grown under red light (11.2 g/L) whereas negative effect was observed under exposure of yellow light on callus growth (4.87 g/L). Furthermore, red light significantly enhanced phenolics and flavonoids content (TPC: 57.8 mg/g, TFC: 11.1 mg/g) in callus cultures compared to rest of lights. HPLC analysis further confirmed highest accumulation of four major compounds i.e. coumarin (1.26 mg/g), eclalbatin (5.00 mg/g), wedelolactone (32.54 mg/g) and demethylwedelolactone (23.67 mg/g) and two minor compounds (beta-amyrin: 0.38 mg/g, luteolin: 0.39 mg/g) in red light treated culture whereas stigmasterol was found optimum (0.22 mg/g) under blue light.In vitrobased biological activities including antioxidant, antidiabetic and lipase inhibitory assays showed optimum values in cultures exposed to red light, suggesting crucial role of these phytochemicals in the enhancement of the therapeutic potential ofE.alba. These results clearly revealed that the use of multispectral lights inin vitrocultures could be an effective strategy for enhanced production of phytochemicals.	[Khurshid, Razia; Ullah, Muhammad Asad; Shah, Muzamil; Zaeem, Afifa; Hameed, Safia; Abbasi, Bilal Haider] Quaid I Azam Univ, Dept Biotechnol, Islamabad, Pakistan; [Tungmunnithum, Duangjai; Drouet, Samantha; Hano, Christophe] Univ Orleans, Lab Biol Ligneux & Grandes Cultures LBLGC, INRA USC1328, Orleans, France; [Tungmunnithum, Duangjai] Mahidol Univ, Fac Pharm, Dept Pharmaceut Bot, Bangkok, Thailand; [Drouet, Samantha; Hano, Christophe] CNRS GDR3711, COSMACTIFS Bioactifs & Cosmet, Orleans, France	Quaid I Azam University; INRAE; Universite de Orleans; Mahidol University	Abbasi, BH (corresponding author), Quaid I Azam Univ, Dept Biotechnol, Islamabad, Pakistan.	bhabbasi@qau.edu.pk	Tungmunnithum, Duangjai/GLS-1386-2022; Abbasi, Bilal Haider/J-1810-2019; , Hano/V-2630-2019	Tungmunnithum, Duangjai/0000-0002-4552-6191; Abbasi, Bilal Haider/0000-0002-6529-2134; , Hano/0000-0001-9938-0151; Drouet, Samantha/0000-0003-3318-8831; ., Afifa Zaeem/0000-0002-7070-9280; Ullah, Muhammad Asad/0000-0002-1501-0549	Le Studium-Institute for Advanced Studies, Loire Valley, Orleans, France; French government via the French Embassy in Thailand	Le Studium-Institute for Advanced Studies, Loire Valley, Orleans, France; French government via the French Embassy in Thailand	B.H.A. acknowledges research fellowship of Le Studium-Institute for Advanced Studies, Loire Valley, Orleans, France. D.T. gratefully acknowledges the support of the French government via the French Embassy in Thailand in the form of Junior Research Fellowship Program 2018.	Abbasi BH, 2007, PLANT CELL REP, V26, P1367, DOI 10.1007/s00299-007-0344-5; Abbasi BH, 2010, PLANT CELL TISS ORG, V101, P371, DOI 10.1007/s11240-010-9692-x; Adil M, 2019, J PHOTOCH PHOTOBIO B, V196, DOI 10.1016/j.jphotobiol.2019.05.006; Adil M, 2015, PLANT CELL TISS ORG, V123, P405, DOI 10.1007/s11240-015-0844-x; Ahmad N, 2016, J PHOTOCH PHOTOBIO B, V154, P51, DOI 10.1016/j.jphotobiol.2015.11.015; Ahmad N, 2010, PLANT CELL TISS ORG, V102, P129, DOI 10.1007/s11240-010-9712-x; Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Ali M, 2014, J PHOTOCH PHOTOBIO B, V140, P223, DOI 10.1016/j.jphotobiol.2014.08.008; AMIOT MJ, 1986, J AGR FOOD CHEM, V34, P823, DOI 10.1021/jf00071a014; [Anonymous], [No title captured]; Ashry N. A., 2011, World Journal of Agricultural Sciences, V7, P78; Balasundram N, 2006, FOOD CHEM, V99, P191, DOI 10.1016/j.foodchem.2005.07.042; Baliga MS, 2004, BRIT J RADIOL, V77, P1027, DOI 10.1259/bjr/83720350; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Chen TG, 2017, MOLECULES, V22, DOI 10.3390/molecules22050795; Chokotia L. S., 2013, International Journal of Research and Development in Pharmacy and Life Sciences, V2, P499; Cioc M, 2018, PLANT CELL TISS ORG, V132, P433, DOI 10.1007/s11240-017-1340-2; Diogo LC, 2009, BASIC CLIN PHARMACOL, V104, P293, DOI 10.1111/j.1742-7843.2008.00350.x; Djeridane A, 2006, FOOD CHEM, V97, P654, DOI 10.1016/j.foodchem.2005.04.028; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fazal H, 2016, J PHOTOCH PHOTOBIO B, V159, P1, DOI 10.1016/j.jphotobiol.2016.03.008; Forbes Josephine M, 2005, Clin Biochem Rev, V26, P123; Grillo MA, 2008, AMINO ACIDS, V35, P29, DOI 10.1007/s00726-007-0606-0; Gupta SD, 2013, PLANT BIOTECHNOL REP, V7, P211, DOI 10.1007/s11816-013-0277-0; Hano C, 2013, BIOORG MED CHEM LETT, V23, P3007, DOI 10.1016/j.bmcl.2013.03.029; Hussain K., 2010, ETHNOBOTANICAL LEAFL, V14, P807; Jadhav V.M., 2009, J PHARM RES, V2, P1129; Jang C, 2011, KOREAN J PHYSIOL PHA, V15, P299, DOI 10.4196/kjpp.2011.15.5.299; Kaewseejan N, 2015, IND CROP PROD, V74, P271, DOI 10.1016/j.indcrop.2015.05.019; Kapoor S, 2018, J PHOTOCH PHOTOBIO B, V183, P258, DOI 10.1016/j.jphotobiol.2018.04.018; Karthikumar S, 2007, SCI RES ESSAYS, V2, P101; Khurshid R, 2018, PLANT CELL TISS ORG, V135, P287, DOI 10.1007/s11240-018-1463-0; Kim DO, 2003, J AGR FOOD CHEM, V51, P6509, DOI 10.1021/jf0343074; KREUZALER F, 1973, PHYTOCHEMISTRY, V12, P1149, DOI 10.1016/0031-9422(73)85031-9; Kuo TCY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0537-y; Li FS, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.109; Li Q, 2009, ENVIRON EXP BOT, V67, P59, DOI 10.1016/j.envexpbot.2009.06.011; Liu CZ, 2006, APPL MICROBIOL BIOT, V72, P11, DOI 10.1007/s00253-006-0452-0; Liu CZ, 2002, PROCESS BIOCHEM, V38, P581, DOI 10.1016/S0032-9592(02)00165-6; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MORAN JF, 1994, PLANTA, V194, P346, DOI 10.1007/BF00197534; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nadeem M, 2018, J PHOTOCH PHOTOBIO B; Organization WH, 2000, WHO TECHN REP SER; Pereira A. M. S., 1998, Journal of Herbs, Spices & Medicinal Plants, V6, P43, DOI 10.1300/J044v06n01_06; Phillipson JD, 2001, PHYTOCHEMISTRY, V56, P237, DOI 10.1016/S0031-9422(00)00456-8; Roy RK, 2008, ARCH DERMATOL RES, V300, P357, DOI 10.1007/s00403-008-0860-3; Samuoliene G, 2010, ZEMDIRBYSTE, V97, P99; Shah M, 2019, MOLECULES, V24, DOI 10.3390/molecules24071207; Shohael AM, 2006, PROCESS BIOCHEM, V41, P1179, DOI 10.1016/j.procbio.2005.12.015; Singh VP, 2014, KOREAN J PHYSIOL PHA, V18, P1, DOI 10.4196/kjpp.2014.18.1.1; Singleton VL., 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5; Szopa A, 2018, J PHOTOCH PHOTOBIO B, V179, P91, DOI 10.1016/j.jphotobiol.2018.01.005; Tagliazucchi D, 2010, FOOD CHEM, V120, P599, DOI 10.1016/j.foodchem.2009.10.030; Tariq U, 2014, J PHOTOCH PHOTOBIO B, V130, P264, DOI 10.1016/j.jphotobiol.2013.11.026; Treadway S., 1998, CLIN NUTR INSIGHTS, V6, P1; TRIVEDI RN, 1984, CYTOLOGIA, V49, P731, DOI 10.1508/cytologia.49.731; Ullah MA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071787; Upadhyay RK, 2001, J ASIAN NAT PROD RES, V3, P213, DOI 10.1080/10286020108041393; Victorio C. P., 2015, Journal of Medicinal Plants Research, V9, P111; WAGNER H, 1986, PLANTA MED, P370, DOI 10.1055/s-2007-969188; Wang YC, 2001, BIOTECHNOL LETT, V23, P1971, DOI 10.1023/A:1013786332363; Yang LQ, 2010, NAT PROD REP, V27, P1469, DOI 10.1039/c005378c; Younas M, 2018, J PHOTOCH PHOTOBIO B, V184, P61, DOI 10.1016/j.jphotobiol.2018.05.018; Yu KW, 2005, BIOCHEM ENG J, V23, P53, DOI 10.1016/j.bej.2004.07.001; Yu TW, 1997, MUTAT RES-FUND MOL M, V379, P201, DOI 10.1016/S0027-5107(97)00141-3; Yue W, 2016, CRIT REV BIOTECHNOL, V36, P215, DOI 10.3109/07388551.2014.923986; Zahir A, 2014, APPL BIOCHEM BIOTECH, V174, P693, DOI 10.1007/s12010-014-1098-5; ZHONG JJ, 1991, BIOTECHNOL BIOENG, V38, P653, DOI 10.1002/bit.260380610; Zhou Y, 2002, PLANT GROWTH REGUL, V38, P165, DOI 10.1023/A:1021322418740	70	22	22	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0233963	10.1371/journal.pone.0233963	http://dx.doi.org/10.1371/journal.pone.0233963			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530961	gold, Green Published			2022-12-26	WOS:000542037200035
J	Miguel, TP; Laurienzo, CE; Faria, EF; Sarri, AJ; Castro, IQ; Affonso, RJ; Andrade, CEMD; Vieira, MD; dos Reis, R				Miguel, Tais Pereira; Laurienzo, Carla Elaine; Faria, Eliney Ferreira; Sarri, Almir Jose; Castro, Isabela Queiroz; Affonso Junior, Renato Jose; Mattos da Cunha Andrade, Carlos Eduardo; Vieira, Marcelo de Andrade; dos Reis, Ricardo			Chemoradiation for cervical cancer treatment portends high risk of pelvic floor dysfunction	PLOS ONE			English	Article							RECEPTOR ISOFORM-ALPHA; BETA MESSENGER RNA; URINARY-INCONTINENCE; SEXUAL FUNCTION; MUSCLE FUNCTION; VAGINAL TISSUE; RADIOTHERAPY; PREMENOPAUSAL; EXPRESSION; CARCINOMA	Goal To assess the impact of chemoradiation on pelvic floor (PF) muscle function after the treatment of cervical cancer (CC). Methods We performed a prospective cohort study of women between the ages of 20 and 70 years old who had a diagnosis of CC. Patients were treated with chemoradiation at the Barretos Cancer Hospital (BCH), between August 2016 and July 2017. We performed three evaluations at different time points after chemoradiation treatment to compare changes in muscle function. Pelvic floor muscle function was assessed through perineometry (PNM) and surface electromyography (EMG) at the following time points: Pretreatment Moment 1 (M1): evaluated before chemoradiation; Moment 2 (M2): at the first follow-up medical visit (usually 3 to 4 months after treatment); and Moment 3 (M3): at the second follow-up medical visit (usually after 6 to 9 months after treatment). Mean vaginal squeeze pressure levels were determined by PNM and muscle electromyographic activity by EMG and the results were evaluated by Generalized Linear Model comparisons. Results Forty-nine patients were evaluated at M1; 35 at M2; and 32 at M3, so that 32 patients had all three muscle evaluations performed. There was a statistically significant increase in the frequency of women with urgency urinary incontinence at the M2 evaluation time (41.9%), compared to pretreatment M1 (18.6%), p<0.001. The means of the vaginal squeeze pressures reduced through M1 to M3 in the phasic (M1: 17.7 mmHg; M3: 11.27mmHg) and tonic contractions (M1: 10.56 mmHg; M3: 7.52mmHg),p= 0.01 andp= 0.03 respectively. There was no difference in pelvic floor function in the three evaluations M1-M3, measured by EMG. The pelvic floor strength assessed by PMN and their interactions with anthropometric, parity and hormonal status variables, showed that a high body mass index (BMI) significantly influenced decreases in pelvic floor muscle function before and after treatment. Conclusion These results show that chemoradiation causes reduction of muscle function of the pelvic floor, especially in the late phase after the end of treatment. Both the high BMI and urgent urinary incontinence symptoms were related to decreased muscle strength.	[Miguel, Tais Pereira; Laurienzo, Carla Elaine; Sarri, Almir Jose] Barretos Canc Hosp, Dept Physiotherapy, Sao Paulo, Brazil; [Faria, Eliney Ferreira] Barretos Canc Hosp, Dept Urol, Sao Paulo, Brazil; [Castro, Isabela Queiroz] Barretos Canc Hosp, Dept Epidemiol & Biostat, Sao Paulo, Brazil; [Affonso Junior, Renato Jose] Barretos Canc Hosp, Dept Radiat Theraphy, Sao Paulo, Brazil; [Mattos da Cunha Andrade, Carlos Eduardo; Vieira, Marcelo de Andrade; dos Reis, Ricardo] Barretos Canc Hosp, Dept Gynecol Oncol, Barretos, SP, Brazil	Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos	Miguel, TP (corresponding author), Barretos Canc Hosp, Dept Physiotherapy, Sao Paulo, Brazil.	taispereiramiguel@hotmail.com	Faria, Eliney/ABA-3296-2021	Miguel, Tais/0000-0002-0474-8900; Faria, Eliney Ferreira/0000-0002-8297-3417				Baracho E, 2012, FISIOTERAPIA APLICAD; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Batista RLA, 2011, BRAZ J PHYS THER, V15, P386, DOI 10.1590/S1413-35552011005000026; Bernard S, 2017, PHYS THER, V97, P438, DOI 10.1093/ptj/pzx012; Bland DR, 2001, AM J OBSTET GYNECOL, V185, P1330; Bo K, 2005, PHYS THER, V85, P269; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; de Noronha AF, 2013, INT BRAZ J UROL, V39, P46, DOI 10.1590/S1677-5538.IBJU.2013.01.07; Dursun M, 2014, INT UROL NEPHROL, V46, P2297, DOI 10.1007/s11255-014-0832-9; Neto IJFC, 2017, OBES SURG, V27, P1822, DOI 10.1007/s11695-017-2559-z; Frigato S, 2003, REV BRASILEIRA CANCE, V49, P209; Gebhart JB, 2001, AM J OBSTET GYNECOL, V185, P1325, DOI 10.1067/mob.2001.119627; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hazewinkel MH, 2010, GYNECOL ONCOL, V117, P281, DOI 10.1016/j.ygyno.2010.01.034; Hermens H.J.M.R.F.B., 1999, SENIAM EUROPEAN RECO; Howick J, 2011, 2011 OXFORD CEBM EVI, DOI [10.1136/ebm1155, DOI 10.1136/EBM1155]; Jensen PT, 2015, TRANSL ANDROL UROL, V4, P186, DOI 10.3978/j.issn.2223-4683.2015.04.06; Kanat O, 2017, WORLD J CLIN ONCOL, V8, P329, DOI 10.5306/wjco.v8.i4.329; Morin M, 2004, NEUROUROL URODYNAM, V23, P668, DOI 10.1002/nau.20069; Mutch DG., 2009, GYNECOL ONCOL, V115, P325, DOI [10.1016/j.ygyno.2009.10.050, DOI 10.1016/J.YGYNO.2009.10.050, DOI 10.1016/J.YGYN0.2009.10.050]; Oh JK, 2012, INT NEUROUROL J, V16, P91, DOI 10.5213/inj.2012.16.2.91; Petignat P, 2007, BMJ-BRIT MED J, V335, P765, DOI 10.1136/bmj.39337.615197.80; Pomian A, 2016, MED SCI MONITOR, V22, P1880, DOI 10.12659/MSM.896331; Rossetti SR, 2016, ARCH ITAL UROL ANDRO, V88, P28, DOI 10.4081/aiua.2016.1.28; Santos Jr. Júlio César Monteiro dos, 2006, Rev bras. colo-proctol., V26, P348, DOI 10.1590/S0101-98802006000300019; Smeenk RJ, 2012, INT J RADIAT ONCOL, V83, P636, DOI 10.1016/j.ijrobp.2011.08.007; Vomvas D, 2012, ANTICANCER RES, V32, P657; Wente K, 2018, CURRENT GERIATRICS R; WHO, BMI CLASSIFICATION, DOI DOI 11/44679/INDEX.HTM; Yeoh E, 1996, INT J RADIAT ONCOL, V35, P1003, DOI 10.1016/0360-3016(96)00147-2; Yeoh EEK, 2004, AM J GASTROENTEROL, V99, P361, DOI 10.1111/j.1572-0241.2004.04037.x	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234389	10.1371/journal.pone.0234389	http://dx.doi.org/10.1371/journal.pone.0234389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530941	Green Published, gold			2022-12-26	WOS:000542037200057
J	Sebera, F; Vissoci, JRN; Umwiringirwa, J; Teuwen, DE; Boon, PE; Dedeken, P				Sebera, Fidele; Vissoci, Joao Ricardo Nickenig; Umwiringirwa, Josiane; Teuwen, Dirk E.; Boon, Paul E.; Dedeken, Peter			Validity, reliability and cut-offs of the Patient Health Questionnaire-9 as a screening tool for depression among patients living with epilepsy in Rwanda	PLOS ONE			English	Article							RATING-SCALE; PRIMARY-CARE; PHQ-9; ANXIETY; PEOPLE; TRANSLATION; VALIDATION; ADULTS; SYMPTOMS; DISORDER	Background Patients with epilepsy (PwE) have an increased risk of active and lifetime depression. Two in 10 patients experience depression. Lack of trained psychiatric staff in low- and middle-income countries (LMIC) creates a need for screening tools that enable detection of depression in PwE. We describe the translation, validity and reliability assessment of the Patient Health Questionnaire-9 (PHQ-9) as a screening tool for depression among PwE in Rwanda. Method PHQ-9 was translated to Kinyarwanda using translation-back translation and validated by a discussion group. For validation, PwE of >= 15 years of age were administered the PHQ-9 and Hamilton Depression Rating Scale (HDRS) by trained psychiatry staff at Visit 1. A random sample of 20% repeated PHQ-9 and HDRS after 14 days to assess temporal stability and intra-rater reliability. Internal structure, reliability and external validity were assessed using confirmatory factor analysis, reliability coefficients and HDRS-correlation, respectively. Maximal Youden's index was considered for cut-offs. Results Four hundred and thirty-four PwE, mean age 30.5 years (SD +/- 13.3), were included of whom 33.6%, 37.9%, 13.4%, and 15.1% had no, mild, moderate and severe depression, respectively. PHQ-9 performed well on a one-factor model (unidimensional model), with factor loadings of 0.63-0.86. Reliability coefficients above 0.80 indicated strong internal consistency. Good temporal stability was observed (0.79 [95% CI: 0.68-0.87]). A strong correlation (R = 0.66, p = 0.01) between PHQ-9 and HDRS summed scores demonstrated robust external validity. The optimal cut-off for the PHQ-9 was similar (>= 5) for mild and moderate depression and >= 7 for severe depression. Conclusion PHQ-9 validation in Kinyarwanda creates the capacity to screen PwE in Rwanda at scores of >= 5 for mild or moderate and >= 7 for severe depression. The availability of validated tools for screening and diagnosis for depression is a forward step for holistic care in a resource-limited environment.	[Sebera, Fidele; Umwiringirwa, Josiane] CARAES Neuropsychiat Hosp, Ndera, Kigali, Rwanda; [Sebera, Fidele] CHUK, Kigali, Rwanda; [Vissoci, Joao Ricardo Nickenig] Duke Univ, Med Sch, Dept Surg, Durham, NC USA; [Vissoci, Joao Ricardo Nickenig] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Teuwen, Dirk E.; Dedeken, Peter] UCB Pharma, Brussels, Belgium; [Boon, Paul E.; Dedeken, Peter] Ghent Univ Hosp, Ghent, Belgium; [Dedeken, Peter] Heilig Hart Hosp, Lier, Belgium	Duke University; Duke University; UCB Pharma SA; Ghent University; Ghent University Hospital	Dedeken, P (corresponding author), UCB Pharma, Brussels, Belgium.; Dedeken, P (corresponding author), Ghent Univ Hosp, Ghent, Belgium.; Dedeken, P (corresponding author), Heilig Hart Hosp, Lier, Belgium.	info.dedekenneurologie@gmail.com	Dedeken, Peter/AAA-6777-2021	Dedeken, Peter/0000-0001-8493-6276; Teuwen, Dirk/0000-0003-0668-600X	UCB Pharma; research department of the CARAES hospital, Ndera, Rwanda	UCB Pharma(UCB Pharma SA); research department of the CARAES hospital, Ndera, Rwanda	This study was supported with an unrestricted educational grant from UCB Pharma (website: https://www.ucb.com/).FS received the study funding through the research department of the CARAES hospital, Ndera, Rwanda. JNRV received a consultancy fee for the statistical analysis. The funder provided support in the form of salaries for author DET and consultancy fees for author PD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We acknowledge and thank the patients participating in this study for rising above the stigma associated with both epilepsy and depression. The authors acknowledge Fabien Debailleul, PhD (UCB Pharma, Brussels, Belgium) for managing the development of the manuscript, and Jayna Patel, PhD (Evidence Scientific Solutions, Horsham, UK) for editorial assistance, which was funded by UCB Pharma.	Adewuya AO, 2006, J AFFECT DISORDERS, V96, P89, DOI 10.1016/j.jad.2006.05.021; [Anonymous], 2016, FORTUNE, V15, pF29; [Anonymous], 2018, FED REGISTER, V78, P1; Azah M, 2005, INT MED J, V12, P259; Beck CT, 2003, RES NURS HEALTH, V26, P64, DOI 10.1002/nur.10066; Bhana A, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0503-0; Brodtkorb E, 2006, NEUROLOGY, V67, pS39, DOI 10.1212/WNL.67.12_suppl_4.S39; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Cholera R, 2014, J AFFECT DISORDERS, V167, P160, DOI [10.1016/j.jad.2014.06.003, 10.1016/]; Costa MV, 2016, REV BRAS PSIQUIATR, V38, P154, DOI 10.1590/1516-4446-2015-1818; Dawson -Sanders B., 1994, BASIC CLIN BIOSTATIS; Dessie G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0202613; DeVellis R., 2017, SCALE DEV THEORY APP, V4; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fiest KM, 2016, NEUROL CLIN, V34, P351, DOI 10.1016/j.ncl.2015.11.003; Fiest KM, 2014, EPILEPSIA, V55, P1642, DOI 10.1111/epi.12754; Fiest KM, 2013, NEUROLOGY, V80, P590, DOI 10.1212/WNL.0b013e31827b1ae0; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Gelaye B, 2013, PSYCHIAT RES, V210, P653, DOI 10.1016/j.psychres.2013.07.015; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Gill SJ, 2017, EPILEPSIA, V58, P695, DOI 10.1111/epi.13651; Hair JF, 2005, ANALISE MULTIVARIADA, Vfifth; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hanlon C, 2015, J AFFECT DISORDERS, V186, P32, DOI 10.1016/j.jad.2015.07.015; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huang FY, 2006, J GEN INTERN MED, V21, P547, DOI 10.1111/j.1525-1497.2006.00409.x; Inoue T, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-73; Jones JE, 2005, EPILEPSIA, V46, P731, DOI 10.1111/j.1528-1167.2005.49704.x; Jones PS, 2001, NURS RES, V50, P300, DOI 10.1097/00006199-200109000-00008; Kane JC, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1250-8; Kanner AM, 2012, EPILEPSIA, V53, P1104, DOI 10.1111/j.1528-1167.2012.03488.x; Kline R.B., 2011, PRINCIPLES PRACTICE; Kochhar PH, 2007, J POSTGRAD MED, V53, P102, DOI 10.4103/0022-3859.32209; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Kwon OY, 2014, J CLIN NEUROL, V10, P175, DOI 10.3988/jcn.2014.10.3.175; Kwon OY, 2013, EPILEPSY BEHAV, V26, P51, DOI 10.1016/j.yebeh.2012.10.020; Lamers F, 2008, J CLIN EPIDEMIOL, V61, P679, DOI 10.1016/j.jclinepi.2007.07.018; Leaffer EB, 2014, EPILEPSY BEHAV, V37, P104, DOI 10.1016/j.yebeh.2014.06.006; Lotrakul M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-46; Manea L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015247; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Marc LG, 2014, J GEN INTERN MED, V29, P1679, DOI 10.1007/s11606-014-2951-5; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Moriarty AS, 2015, GEN HOSP PSYCHIAT, V37, P567, DOI 10.1016/j.genhosppsych.2015.06.012; Nubukpo P, 2004, EPILEPSY BEHAV, V5, P722, DOI 10.1016/j.yebeh.2004.07.001; Omoro SAO, 2006, INT J PSYCHIAT MED, V36, P367, DOI 10.2190/8W7Y-0TPM-JVGV-QW6M; Onwuekwe IO, 2012, ANN MED HEALTH SCI R, V2, P10, DOI 10.4103/2141-9248.96929; Pence BW, 2012, J AFFECT DISORDERS, V143, P208, DOI 10.1016/j.jad.2012.05.056; Perucca P, 2011, NEUROLOGY, V76, P273, DOI 10.1212/WNL.0b013e318207b073; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Rathore JS, 2014, EPILEPSY BEHAV, V37, P215, DOI 10.1016/j.yebeh.2014.06.030; Ruhe HG, 2005, COMPR PSYCHIAT, V46, P417, DOI 10.1016/j.comppsych.2005.03.001; Sebera F, 2015, EPILEPSY BEHAV, V46, P126, DOI 10.1016/j.yebeh.2015.03.028; Sezibera V., 2013, RWANDA J, V1, P67, DOI [10.4314/rj.v1i1.5F, DOI 10.4314/RJ.V1I1.5F]; Shi Y, 2017, EPILEPSY BEHAV, V70, P198, DOI 10.1016/j.yebeh.2017.02.022; Simoni JM, 2011, AIDS BEHAV, V15, P376, DOI 10.1007/s10461-010-9836-3; The Lancet HIV, 2016, LANCET HIV, V3, pe191; Trajkovic G, 2011, PSYCHIAT RES, V189, P1, DOI 10.1016/j.psychres.2010.12.007; Tsegabrhan H, 2014, NEUROL INDIA, V62, P649, DOI 10.4103/0028-3886.149391; Udedi M, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2062-2; Vankar Jagdish R, 2014, Indian J Psychol Med, V36, P246, DOI 10.4103/0253-7176.135372; VANSTEENBERGENWEIJ, 2010, BMC HEALTH SERV RES, V10, DOI DOI 10.1186/1472-6963-10-235; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112; WHO, 2018, GLOB HLTH EST 2019 D; Williams JBW, 2001, EUR ARCH PSY CLIN N, V251, P6, DOI 10.1007/BF03035120; Woldetensay YK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191782; Wulsin Lawson, 2002, Prim Care Companion J Clin Psychiatry, V4, P191; Yu XN, 2012, COMPR PSYCHIAT, V53, P95, DOI 10.1016/j.comppsych.2010.11.002; Zhang YY, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0580-0; Zhong QY, 2014, J AFFECT DISORDERS, V162, P1, DOI 10.1016/j.jad.2014.03.028; Zimmerman M, 2013, J AFFECT DISORDERS, V150, P384, DOI 10.1016/j.jad.2013.04.028; Zuithoff NPA, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-98	75	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234095	10.1371/journal.pone.0234095	http://dx.doi.org/10.1371/journal.pone.0234095			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QP	32530968	Green Published, gold			2022-12-26	WOS:000542037200030
J	Wang, CJ; Thanarut, C; Sun, PL; Chung, WH				Wang, Chao-Jen; Thanarut, Chinnapan; Sun, Pei-Lun; Chung, Wen-Hsin			Colonization of human opportunisticFusarium oxysporum(HOFo) isolates in tomato and cucumber tissues assessed by a specific molecular marker	PLOS ONE			English	Article							FUSARIUM-OXYSPORUM; FUNGAL PATHOGENS; RESISTANCE; PLANTS; IDENTIFICATION; INFECTION; DIAGNOSIS; OUTBREAK; BIOLOGY; SPP.	Fusarium oxysporumis a large complex cosmopolitan species composed of plant pathogens, human opportunistic pathogens, and nonpathogenic isolates. Many plant pathogenic strains are known based on host plant specificity and the large number of plant species attacked.F.oxysporumis an opportunistic pathogen in humans with a compromised immune system. The objectives of this study were: (1) to develop a specific marker to detect human opportunisticF.oxysporum(HOFo) isolates; (2) to determine whether or not HOFo isolates can colonize and cause disease symptoms in plants; and (3) to assess Taiwan isolates sensitivity to two agro-fungicides. The primer pair, Primer 5/ST33-R, specifically amplifying Taiwan and international reference HOFo isolates was developed and used to detect and assess the distribution of a Taiwan isolate in inoculated tomato plants and tomato and cucumber fruit. Taiwan HOFo isolate MCC2074 was shown to colonize tomato roots, hypocotyls, and cotyledons, but did not show any visible symptoms. Four days after surface inoculation of tomato and cucumber fruit with the same isolate, MCC2074 was detected in the pericarp and locular cavities of both tomato and cucumber fruit and in columella of tomato fruit. Three Taiwan HOFo isolates were found to be moderately sensitive to azoxystrobin and highly sensitive to difenconazole.	[Wang, Chao-Jen; Chung, Wen-Hsin] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung, Taiwan; [Thanarut, Chinnapan] Maejo Univ, Fac Agr Prod, Div Pomol, Chiangmai, Thailand; [Sun, Pei-Lun] Mackay Mem Hosp, Dept Dermatol, Taipei, Taiwan; [Wang, Chao-Jen] COA, Taichung Dist Agr Res & Extent Stn, Div Plant Protect, Changhua, Taiwan	National Chung Hsing University; Maejo University; Mackay Memorial Hospital	Chung, WH (corresponding author), Natl Chung Hsing Univ, Dept Plant Pathol, Taichung, Taiwan.	wenchung@nchu.edu.tw		Chung, Wen-Hsin/0000-0002-8517-6368	Ministry of Science and Technology (MOST); Ministry of Education (MOE) [MOST-105-2313-B-005-011, 108S0022H]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Ministry of Education (MOE)(Ministry of Education, Singapore)	We got two financial support from Ministry of Science and Technology (MOST) and Ministry of Education (MOE) with funding serial numbers of MOST-105-2313-B-005-011 and 108S0022H, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios GN, 2005, PLANT PATHOL, P134; Al-Maqtoofi M, 2016, ENVIRON MICROBIOL, V18, P3620, DOI 10.1111/1462-2920.13233; Alpas H, 2017, PLANT PATH 21ST, V8, P77, DOI 10.1007/978-3-319-46897-6_4; Babic MN, 2015, FUNGAL BIOL-UK, V119, P95, DOI 10.1016/j.funbio.2014.10.007; Behravesh CB, 2011, NEW ENGL J MED, V364, P918, DOI 10.1056/NEJMoa1005741; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Beuchat L.R., 1998, SURFACE DECONTAMINAT; Bowen A, 2006, EPIDEMIOL INFECT, V134, P675, DOI 10.1017/S0950268805005480; Burgess TI, 1981, FUSARIUM DIS BIOL TA, P225; Chen LS, 2010, J AGR FOREST, V59, P231; Chen M, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.95; Consigny S, 2003, CLIN INFECT DIS, V37, P311, DOI 10.1086/375842; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Doczi I, 2004, CLIN MICROBIOL INFEC, V10, P773, DOI 10.1111/j.1469-0691.2004.00909.x; Dornbusch HJ, 2005, J CLIN MICROBIOL, V43, P1998, DOI 10.1128/JCM.43.4.1998-2001.2004; Dubos T, 2011, EUR J PLANT PATHOL, V130, P239, DOI 10.1007/s10658-011-9749-7; Edel-Hermann V, 2019, PHYTOPATHOLOGY, V109, P512, DOI 10.1094/PHYTO-08-18-0320-RVW; Erickson MC, 2012, ANNU REV FOOD SCI T, V3, P283, DOI 10.1146/annurev-food-022811-101211; Evans J, 2004, VET PATHOL, V41, P510, DOI 10.1354/vp.41-5-510; Fletcher J, 2013, PHYTOPATHOLOGY, V103, P306, DOI 10.1094/PHYTO-09-12-0236-IA; Fourie G, 2011, INFECT GENET EVOL, V11, P533, DOI 10.1016/j.meegid.2011.01.012; Fravel D, 2003, NEW PHYTOL, V157, P493, DOI 10.1046/j.1469-8137.2003.00700.x; Gauthier GM, 2013, FUNGAL GENET BIOL, V61, P146, DOI 10.1016/j.fgb.2013.08.016; Gisi U, 2002, PEST MANAG SCI, V58, P859, DOI 10.1002/ps.565; Godoy P, 2004, MYCOPATHOLOGIA, V157, P287, DOI 10.1023/B:MYCO.0000024186.32367.d4; Gupta SK, 2007, EPIDEMIOL INFECT, V135, P1165, DOI 10.1017/S0950268807007911; Hong DK, 2017, PRINCIPLES PRACTICE, P487; Huang LW, 2014, PLANT PATHOL, V63, P539, DOI 10.1111/ppa.12133; Ishii H, 2009, PEST MANAG SCI, V65, P916, DOI 10.1002/ps.1773; Kaneko I, 2009, J GEN PLANT PATHOL, V75, P388, DOI 10.1007/s10327-009-0178-9; Kawakami H, 2015, MED MYCOL, V53, P603, DOI 10.1093/mmy/myv016; Kim YS, 2003, PHYTOPATHOLOGY, V93, P891, DOI 10.1094/PHYTO.2003.93.7.891; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; Kuck KH, 2007, PESTICIDE CHEM CROP, P275; Lynch MF, 2009, BACTERIAL INFECT HUM; Macia-Vicente JG, 2008, FEMS MICROBIOL ECOL, V64, P90, DOI 10.1111/j.1574-6941.2007.00443.x; Mbofung GY, 2007, PHYTOPATHOLOGY, V97, P87, DOI 10.1094/PHYTO-97-0087; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Meldrum RA, 2012, AUSTRALAS PLANT PATH, V41, P551, DOI 10.1007/s13313-012-0122-x; NELSON PE, 1994, CLIN MICROBIOL REV, V7, P479, DOI 10.1128/CMR.7.4.479-504.1994; Ninet B, 2005, DERMATOLOGY, V210, P21, DOI 10.1159/000081478; Nucci M, 2002, CLIN INFECT DIS, V35, P909, DOI 10.1086/342328; O'Donnell K, 2009, FUNGAL GENET BIOL, V46, P936, DOI 10.1016/j.fgb.2009.08.006; Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004; Osterholm MT, 2009, J FOOD PROTECT, V72, P1509, DOI 10.4315/0362-028X-72.7.1509; Paterson RRM, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5030044; Rep M, 2005, FEMS MICROBIOL LETT, V253, P19, DOI 10.1016/j.femsle.2005.09.014; Rep M, 2004, MOL MICROBIOL, V53, P1373, DOI 10.1111/j.1365-2958.2004.04177.x; Schafer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089920; Short DPG, 2011, J CLIN MICROBIOL, V49, P4264, DOI 10.1128/JCM.05468-11; Smith S. N., 2007, Plant Pathology Bulletin, V16, P97; Springer DJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171695; Suguitan Jr AL, 2011, PLOS ONE, V6; Torriani SFF, 2009, PEST MANAG SCI, V65, P155, DOI 10.1002/ps.1662; Tortorano AM, 2014, CLIN MICROBIOL INFEC, V20, P27, DOI 10.1111/1469-0691.12465; Triest D, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005940; Triest D, 2015, MYCOLOGIA, V107, P46, DOI 10.3852/14-174; Walsh JL, 2010, FUNGAL DIVERS, V44, P149, DOI 10.1007/s13225-010-0035-3; Wang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065093; Wiedemann A, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00791; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005	61	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234517	10.1371/journal.pone.0234517	http://dx.doi.org/10.1371/journal.pone.0234517			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530955	gold, Green Published			2022-12-26	WOS:000542037200004
J	Weil, AA; Debela, MD; Muyanja, DM; Kakuhikire, B; Baguma, C; Bangsberg, DR; Tsai, AC; Lai, PS				Weil, Ana A.; Debela, Meti D.; Muyanja, Daniel M.; Kakuhikire, Bernard; Baguma, Charles; Bangsberg, David R.; Tsai, Alexander C.; Lai, Peggy S.			Gut carriage of antimicrobial resistance genes in women exposed to small-scale poultry farms in rural Uganda: A feasibility study	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; FOOD INSECURITY; DEPRESSION; ANIMALS	Background Antibiotic use for livestock is presumed to be a contributor to the acquisition of antimicrobial resistance (AMR) genes in humans, yet studies do not capture AMR data before and after livestock introduction. Methods We performed a feasibility study by recruiting a subset of women in a delayed-start randomized controlled trial of small-scale chicken farming to examine the prevalence of clinically-relevant AMR genes. Stool samples were obtained at baseline and one year post-randomization from five intervention women who received chickens at the start of the study, six control women who did not receive chickens until the end of the study, and from chickens provided to the control group at the end of the study. Stool was screened for 87 clinically significant AMR genes using a commercially available qPCR array (Qiagen). Results Chickens harbored 23 AMR genes from classes found in humans as well as additional vancomycin and beta-lactamase resistance genes. AMR patterns between intervention and control women appeared more similar at baseline than one year post randomization (PERMANOVA R-2= 0.081, p = 0.61 at baseline, R-2= 0.186, p = 0.09 at 12 months) Women in the control group who had direct contact with the chickens sampled in the study had greater similarities in AMR gene patterns to chickens than those in the intervention group who did not have direct contact with chickens sampled (p = 0.01). However, at one year there was a trend towards increased similarity in AMR patterns between humans in both groups and the chickens sampled (p = 0.06). Conclusions Studies designed to evaluate human AMR genes in the setting of animal exposure should account for high baseline AMR rates. Concomitant collection of animal, human, and environmental samples over time is recommended to determine the directionality and source of AMR genes.	[Weil, Ana A.; Debela, Meti D.; Lai, Peggy S.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Weil, Ana A.; Tsai, Alexander C.; Lai, Peggy S.] Harvard Med Sch, Boston, MA 02115 USA; [Muyanja, Daniel M.; Kakuhikire, Bernard; Baguma, Charles; Bangsberg, David R.; Tsai, Alexander C.] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Bangsberg, David R.] Oregon Hlth & Sci Univ, Portland State Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Tsai, Alexander C.] Harvard Ctr Populat & Dev Studies, Cambridge, MA USA; [Tsai, Alexander C.] Massachusetts Gen Hosp, Ctr Global Hlth & Mongan Inst, Boston, MA 02114 USA; [Lai, Peggy S.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02114 USA; [Weil, Ana A.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Mbarara University of Science & Technology; Oregon Health & Science University; Portland State University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle	Lai, PS (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Lai, PS (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Lai, PS (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02114 USA.	pslai@hsph.harvard.edu	Tsai, Alexander C./F-4247-2015	Tsai, Alexander C./0000-0001-6397-7917; Lai, Peggy/0000-0001-9501-8606	National Institutes of Health [K23 ES023700, P30 00002, K23 MH096620, K08AI123494]; Harvard School of Public Health-National Institute of Environmental Health Sciences and Center for Environmental Health [P30ES000002]; Pilot Project Grant; American Lung Association Biomedical Research Grant [RG-346990]; Harvard Catalyst Early Clinical Data Support Pilot Grant [UL1 TR001102]; Friends of a Healthy Uganda	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard School of Public Health-National Institute of Environmental Health Sciences and Center for Environmental Health; Pilot Project Grant; American Lung Association Biomedical Research Grant; Harvard Catalyst Early Clinical Data Support Pilot Grant; Friends of a Healthy Uganda	Funding was provided by National Institutes of Health grants K23 ES023700 (PSL), P30 00002, and K23 MH096620 (ACT), and K08AI123494 (AAW) (https://www.nih.gov/), Harvard School of Public Health-National Institute of Environmental Health Sciences and Center for Environmental Health (P30ES000002) Pilot Project Grant (PSL) (https://www.hsph.harvard.edu/niehs/), American Lung Association Biomedical Research Grant RG-346990 (PSL) (https://www.lung.org/), Harvard Catalyst (UL1 TR001102) Early Clinical Data Support Pilot Grant (PSL) (https://catalyst.harvard.edu/), and Friends of a Healthy Uganda (DRB, ACT) (https://attackpoverty.org/locations/friends-of-uganda/).The funders had no role in study design, data collection, analysis, decision to submit the work for publication, or preparation of the manuscript.	Agga GE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132586; Ahmed MO, 2018, MICROB DRUG RESIST, V24, P590, DOI 10.1089/mdr.2017.0147; Aidara-Kane A, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-017-0294-9; Alonso CA, 2017, LETT APPL MICROBIOL, V64, P318, DOI 10.1111/lam.12724; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2014, GLOB REP SURV ANT RE; [Anonymous], 1980, COMM STUD HUM HLTH E; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Antunes NT, 2014, ANTIMICROB AGENTS CH, V58, P2119, DOI 10.1128/AAC.02522-13; Apostol TM, 2003, AM MATH MON, V110, P516, DOI 10.2307/3647907; Bittinger K., 2017, USEDIST DISTANCE MAT; Food and Agriculture Organization, 2017, FAOSTAT LIV PRIM 201; Food and Agriculture Organization, 2005, LIV SECT BRIEF 2005; Gandra S, 2014, CLIN MICROBIOL INFEC, V20, P973, DOI 10.1111/1469-0691.12798; Gasparrini AJ, 2019, NAT MICROBIOL, V4, P2285, DOI 10.1038/s41564-019-0550-2; Hooper DC, 2015, ANN NY ACAD SCI, V1354, P12, DOI 10.1111/nyas.12830; Huijbers PMC, 2015, VET MICROBIOL, V176, P120, DOI 10.1016/j.vetmic.2014.12.010; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jorgensen PS, 2016, NATURE, V537, P159, DOI 10.1038/537159a; Kakuhikire B, 2016, SAHARA J-J SOC ASP H, V13, P162, DOI 10.1080/17290376.2016.1230072; Kruse H, 1999, MICROB DRUG RESIST, V5, P135, DOI 10.1089/mdr.1999.5.135; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mosites E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171017; O'Neill J., 2016, Tackling drug-resistant infections globally: final report and recommendations; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Okubo T, 2019, TRANSBOUND EMERG DIS, V66, P317, DOI 10.1111/tbed.13024; Perkins JM, 2018, PUBLIC HEALTH NUTR, V21, P838, DOI 10.1017/S1368980017002154; R Core Team, 2021, R LANGUAGE ENV STAT; Sieber RN, 2018, MBIO, V9, DOI 10.1128/mBio.02142-18; The Lancet Planetary Health, 2017, LANCET PLANET HEALTH, V1, pe209; Tsai AC, 2016, J WATER HEALTH, V14, P280, DOI 10.2166/wh.2015.165; Tsai AC, 2012, SOC SCI MED, V74, P2012, DOI 10.1016/j.socscimed.2012.02.033; Vandendriessche S, 2013, J ANTIMICROB CHEMOTH, V68, P1510, DOI 10.1093/jac/dkt047; Wang LZ, 2015, FUTURE GENER COMP SY, V43-44, P38, DOI 10.1016/j.future.2014.11.001; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood SN, 2016, J AM STAT ASSOC, V111, P1548, DOI 10.1080/01621459.2016.1180986; Woolhouse M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0083; Xia J, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00008-19	40	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0229699	10.1371/journal.pone.0229699	http://dx.doi.org/10.1371/journal.pone.0229699			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525954	gold, Green Submitted, Green Published			2022-12-26	WOS:000542036800052
J	Jonker, SS; Giraud, GD; Chang, EI; Elman, MR; Louey, S				Jonker, Sonnet S.; Giraud, George D.; Chang, Eileen, I; Elman, Miriam R.; Louey, Samantha			Coronary vascular growth matches IGF-1-stimulated cardiac growth in fetal sheep	FASEB JOURNAL			English	Article						adenosine; angiogenesis; contracture; coronary autoregulation; developmental origins; nitric oxide	SMOOTH-MUSCLE-CELLS; MICROVASCULAR RAREFACTION; MYOCARDIAL FIBROSIS; ENDOTHELIAL-CELLS; HEART-FAILURE; FACTOR-I; IGF-I; PROLIFERATION; INSULIN; FLOW	As loss of contractile function in heart disease could often be mitigated by increased cardiomyocyte number, expansion of cardiomyocyte endowment paired with increased vascular supply is a desirable therapeutic goal. Insulin-like growth factor 1 (IGF-1) administration increases fetal cardiomyocyte proliferation and heart mass, but how fetal IGF-1 treatment affects coronary growth and function is unknown. Near-term fetal sheep underwent surgical instrumentation and were studied from 127 to 134 d gestation (term = 147 d), receiving either IGF-1 LR3 or vehicle. Coronary growth and function were interrogated using pressure-flow relationships, an episode of acute hypoxia with progressive blockade of adenosine receptors and nitric oxide synthase, and by modeling the determinants of coronary flow. The main findings were that coronary conductance was preserved on a per-gram basis following IGF-1 treatment, adenosine and nitric oxide contributed to hypoxia-mediated coronary vasodilation similarly in IGF-1-treated and Control fetuses, and the relationships between coronary flow and blood oxygen contents were similar between groups. We conclude that IGF-1-stimulated fetal myocardial growth is accompanied by appropriate expansion and function of the coronary vasculature. These findings support IGF-1 as a potential strategy to increase cardiac myocyte and coronary vascular endowment at birth.	[Jonker, Sonnet S.; Giraud, George D.; Chang, Eileen, I; Louey, Samantha] Oregon Hlth & Sci Univ, Ctr Dev Hlth, Knight Cardiovasc Inst, 3303 SW Bond Ave,CH14T, Portland, OR 97239 USA; [Giraud, George D.] VA Portland Hlth Care Syst, Div Cardiol, Portland, OR USA; [Elman, Miriam R.] Oregon Hlth & Sci Univ, Portland State Univ, Sch Publ Hlth, Portland, OR 97201 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Portland State University	Jonker, SS (corresponding author), Oregon Hlth & Sci Univ, Ctr Dev Hlth, Knight Cardiovasc Inst, 3303 SW Bond Ave,CH14T, Portland, OR 97239 USA.	Jonker5@ohsu.edu	; Louey, Samantha/A-1381-2009	Chang, Eileen/0000-0002-3444-7260; Louey, Samantha/0000-0002-2628-0085; Jonker, Sonnet/0000-0002-1097-2562	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01HD071068, P01HD034430]; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [T32HL094294]	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01HD071068 and P01HD034430; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: T32HL094294	ANDERSON DF, 1985, J PHYSIOL-LONDON, V365, P29, DOI 10.1113/jphysiol.1985.sp015757; Bach LA, 2015, J MOL ENDOCRINOL, V54, pR1, DOI 10.1530/JME-14-0215; Back K, 2012, J ENDOCRINOL, V215, P89, DOI 10.1530/JOE-12-0261; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Burrell JH, 2003, ANAT REC PART A, V274A, P952, DOI 10.1002/ar.a.10110; Campbell DJ, 2015, CIRCULATION, V132, pE205, DOI 10.1161/CIRCULATIONAHA.115.016091; Charytan DM, 2018, KIDNEY INT, V93, P501, DOI 10.1016/j.kint.2017.07.025; Chattergoon NN, 2014, AM J PHYSIOL-HEART C, V307, pH1216, DOI 10.1152/ajpheart.00833.2013; Chien KR, 2019, NAT BIOTECHNOL, V37, P232, DOI 10.1038/s41587-019-0042-1; Chisalita SI, 2004, AM J PHYSIOL-ENDOC M, V286, pE896, DOI 10.1152/ajpendo.00327.2003; Coulombe KLK, 2014, ANNU REV BIOMED ENG, V16, P1, DOI 10.1146/annurev-bioeng-071812-152344; FLANAGAN MF, 1994, J AM COLL CARDIOL, V24, P1786, DOI 10.1016/0735-1097(94)90188-0; Goodwill AG, 2017, COMPR PHYSIOL, V7, P321, DOI 10.1002/cphy.c160016; HARDING JE, 1994, ENDOCRINOLOGY, V134, P1509, DOI 10.1210/en.134.3.1509; Huttenbach Y, 2001, CARDIOVASC PATHOL, V10, P119, DOI 10.1016/S1054-8807(01)00065-5; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P422, DOI 10.1111/j.1440-1711.2006.01449.x; Jonker SS, 2016, J ENDOCRINOL, V228, pR1, DOI 10.1530/JOE-15-0309; Jonker SS, 2018, J ENDOCRINOL, V239, P253, DOI 10.1530/JOE-18-0382; Jonker SS, 2018, AM J PHYSIOL-HEART C, V315, pH1393, DOI 10.1152/ajpheart.00314.2018; Jonker SS, 2015, FASEB J, V29, P4346, DOI 10.1096/fj.15-272013; KAIJSER L, 1990, CLIN PHYSIOL, V10, P259, DOI 10.1111/j.1475-097X.1990.tb00094.x; KIM HD, 1992, J MOL CELL CARDIOL, V24, P949, DOI 10.1016/0022-2828(92)91862-Y; Li ZJ, 2017, BIOCHEM BIOPH RES CO, V487, P15, DOI 10.1016/j.bbrc.2017.03.055; Liu K, 2015, INT J MOL MED, V36, P817, DOI 10.3892/ijmm.2015.2277; LLANOS AJ, 1986, AM J OBSTET GYNECOL, V155, P893, DOI 10.1016/S0002-9378(86)80046-1; Massion P B, 2001, Curr Opin Crit Care, V7, P323, DOI 10.1097/00075198-200110000-00003; Mohammed SF, 2015, CIRCULATION, V131, P550, DOI 10.1161/CIRCULATIONAHA.114.009625; Nakagawa S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0213; National Research Council (U.S.). Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Institute for Laboratory Animal Research (U.S.) National Academies Press (U.S.), 2011, GUIDE CARE USE LAB A, pxxv; Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410; Porrello ER, 2008, CLIN EXP PHARMACOL P, V35, P1358, DOI 10.1111/j.1440-1681.2008.05036.x; Pries AR, 2017, EUR HEART J, V38, P478, DOI 10.1093/eurheartj/ehv760; Riksen Niels P, 2011, Handb Exp Pharmacol, P413, DOI 10.1007/978-3-642-13443-2_16; Robertson SS, 1996, DEV PSYCHOBIOL, V29, P667, DOI 10.1002/(SICI)1098-2302(199612)29:8<667::AID-DEV3>3.0.CO;2-R; Shinozuka N, 2000, AM J PHYSIOL-HEART C, V278, pH41, DOI 10.1152/ajpheart.2000.278.1.H41; Shuang T, 2018, BIOCHEM PHARMACOL, V149, P143, DOI 10.1016/j.bcp.2017.12.009; SUNDERJI SG, 1984, AM J OBSTET GYNECOL, V149, P408, DOI 10.1016/0002-9378(84)90155-8; Sundgren NC, 2003, AM J PHYSIOL-REG I, V285, pR1481, DOI 10.1152/ajpregu.00232.2003; Tarantini S, 2016, AGE, V38, P273, DOI 10.1007/s11357-016-9931-0; van de Hoef TP, 2012, J MOL CELL CARDIOL, V52, P786, DOI 10.1016/j.yjmcc.2011.07.025; Wagner BA, 2011, FREE RADICAL BIO MED, V51, P700, DOI 10.1016/j.freeradbiomed.2011.05.024; Wilburn AN, 2018, AM J PHYSIOL-REG I, V315, pR1038, DOI 10.1152/ajpregu.00198.2018; Xiao Y, 2018, CARDIOVASC TOXICOL, V18, P304, DOI 10.1007/s12012-017-9438-7; Zhu BH, 2001, ENDOCRINOLOGY, V142, P3598, DOI 10.1210/en.142.8.3598	45	2	2	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10041	10055		10.1096/fj.202000215R	http://dx.doi.org/10.1096/fj.202000215R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32573852	Green Accepted, Bronze			2022-12-26	WOS:000543552400001
J	Younis, S; Naboulsi, R; Wang, X; Cao, XF; Larsson, M; Sargsyan, E; Bergsten, P; Welsh, N; Andersson, L				Younis, Shady; Naboulsi, Rakan; Wang, Xuan; Cao, Xiaofang; Larsson, Marten; Sargsyan, Ernest; Bergsten, Peter; Welsh, Nils; Andersson, Leif			The importance of the ZBED6-IGF2 axis for metabolic regulation in mouse myoblast cells	FASEB JOURNAL			English	Article						IGF2; mitochondria; myogenesis and gene editing; ZBED6	SKELETAL-MUSCLE; DIFFERENTIATION; GROWTH; MASS; RNA; CYCLE	The transcription factor ZBED6 acts as a repressor of Igf2 and affects directly or indirectly the transcriptional regulation of thousands of genes. Here, we use gene editing in mouse C2C12 myoblasts and show that ZBED6 regulates Igf2 exclusively through its binding site 5 '-GGCTCG-3 ' in intron 1 of Igf2. Deletion of this motif (Igf2(Delta GGCT)) or complete ablation of Zbed6 leads to similar to 20-fold upregulation of the IGF2 protein. Quantitative proteomics revealed an activation of Ras signaling pathway in both Z bed6(-/-) and Igf2(Delta GGCT) myoblasts, and a significant enrichment of mitochondrial membrane proteins among proteins showing altered expression in Z bed6(-/-)myoblasts. BothZbed6(-/-)andIgf2(Delta GGCT)myoblasts showed a faster growth rate and developed myotube hypertrophy. These cells exhibited an increased O-2 consumption rate, due to IGF2 upregulation. Transcriptome analysis revealed similar to 30% overlap between differentially expressed genes in Z bed6(-/-) and Igf2(Delta GGCT) myotubes, with an enrichment of upregulated genes involved in muscle development. In contrast, ZBED6-overexpression in myoblasts led to cell apoptosis, cell cycle arrest, reduced mitochondrial activities, and ceased myoblast differentiation. The similarities in growth and differentiation phenotypes observed in Z bed6(-/-)and Igf2(Delta GGCT) myoblasts demonstrates that ZBED6 affects mitochondrial activity and myogenesis largely through its regulation of IGF2 expression. This study adds new insights how the ZBED6-Igf2 axis affects muscle metabolism.	[Younis, Shady; Naboulsi, Rakan; Cao, Xiaofang; Larsson, Marten; Andersson, Leif] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden; [Wang, Xuan; Sargsyan, Ernest; Bergsten, Peter; Welsh, Nils] Uppsala Univ, Dept Med Cell Biol, Sci Life Lab, Uppsala, Sweden; [Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Andersson, Leif] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	Uppsala University; Uppsala University; Swedish University of Agricultural Sciences; Texas A&M University System; Texas A&M University College Station	Andersson, L (corresponding author), Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden.	leif.andersson@imbim.uu.se	Naboulsi, Rakan/GWM-4355-2022	Naboulsi, Rakan/0000-0002-3610-4341; Younis, Shady/0000-0002-4319-1738; Larsson, Marten/0000-0002-7855-9539	Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation); Swedish Research Council	Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation), Grant/Award Number: KAW Scholar; Swedish Research Council, Grant/Award Number: Radsprofessur	Ali MA, 2015, P NATL ACAD SCI USA, V112, P7743, DOI 10.1073/pnas.1509193112; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Butter F, 2010, EMBO REP, V11, P305, DOI 10.1038/embor.2010.6; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duguez S, 2004, EXP CELL RES, V299, P27, DOI 10.1016/j.yexcr.2004.05.017; Dunglison GF, 1999, MECH DEVELOP, V87, P11, DOI 10.1016/S0925-4773(99)00134-3; Filigheddu N, 2007, MOL BIOL CELL, V18, P986, DOI 10.1091/mbc.E06-05-0402; FLORINI JR, 1991, J BIOL CHEM, V266, P15917; HERZBERG NH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P63, DOI 10.1016/0925-4439(93)90091-E; Hsu YC, 2016, SEMIN CELL DEV BIOL, V52, P119, DOI 10.1016/j.semcdb.2016.02.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Jiang LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084578; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lee KY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9054; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; REHFELDT C, 1993, BIOSCIENCE REP, V13, P213, DOI 10.1007/BF01123503; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; STOCKDALE FE, 1992, DEV BIOL, V154, P284, DOI 10.1016/0012-1606(92)90068-R; Stohr G, 2011, RSC CHROMATOGR MONOG, P104, DOI 10.1039/9781849733144-00104; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Velloso CP, 2008, BRIT J PHARMACOL, V154, P557, DOI 10.1038/bjp.2008.153; Wang X, 2019, FASEB J, V33, P88, DOI 10.1096/fj.201600835R; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Younis S, 2018, P NATL ACAD SCI USA, V115, pE3808, DOI 10.1073/pnas.1722333115; Younis S, 2018, P NATL ACAD SCI USA, V115, pE2048, DOI 10.1073/pnas.1719278115	40	5	6	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10250	10266		10.1096/fj.201901321R	http://dx.doi.org/10.1096/fj.201901321R		JUN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32557799	hybrid, Green Published			2022-12-26	WOS:000541805900001
J	Zaeh, SE; Hayes, MM; Eakin, MN; Rand, CS; Turnbull, AE				Zaeh, Sandra E.; Hayes, Margaret M.; Eakin, Michelle N.; Rand, Cynthia S.; Turnbull, Alison E.			Housestaff perceptions on training and discussing the Maryland Orders for Life Sustaining Treatment Form (MOLST)	PLOS ONE			English	Article							RESUSCITATE ORDERS; PHYSICIAN ORDERS; MEDICAL ORDERS; CODE STATUS; RESIDENTS; COMMUNICATION; PROGRAM; SKILLS	Background On-line tutorials are being increasingly used in medical education, including in teaching housestaff skills regarding end of life care. Recently an on-line tutorial incorporating interactive clinical vignettes and communication skills was used to prepare housestaff at Johns Hopkins Hospital to use the Maryland Orders for Life Sustaining Treatment (MOLST) form, which documents patient preferences regarding end of life care. 40% of housestaff who viewed the module felt less than comfortable discussing choices on the MOLST with patients. We sought to understand factors beyond knowledge that contributed to housestaff discomfort in MOLST discussions despite successfully completing an on-line tutorial. Methods We conducted semi-structured telephone interviews with 18 housestaff who completed the on-line MOLST training module. Housestaff participants demonstrated good knowledge of legal and regulatory issues related to the MOLST compared to their peers, but reported feeling less than comfortable discussing the MOLST with patients. Transcripts of interviews were coded using thematic analysis to describe barriers to using the MOLST and suggestions for improving housestaff education about end of life care discussions. Results Qualitative analysis showed three major factors contributing to lack of housestaff comfort completing the MOLST form: [1] physician barriers to completion of the MOLST, [2] perceived patient barriers to completion of the MOLST, and [3] design characteristics of the MOLST form. Housestaff recommended a number of adaptations for improvement, including in-person training to improve their skills conducting conversations regarding end of life preferences with patients. Conclusions Some housestaff who scored highly on knowledge tests after completing a formal on-line curriculum on the MOLST form reported barriers to using a mandated form despite receiving training. On-line modules may be insufficient for teaching communication skills to housestaff. Additional training opportunities including in-person training mechanisms should be incorporated into housestaff communication skills training related to end of life care.	[Zaeh, Sandra E.; Eakin, Michelle N.; Rand, Cynthia S.; Turnbull, Alison E.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21218 USA; [Hayes, Margaret M.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Hayes, Margaret M.] Harvard Med Sch, Shapiro Inst Educ & Res, Boston, MA 02115 USA; [Hayes, Margaret M.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Turnbull, Alison E.] Johns Hopkins Univ, Outcomes Crit Illness & Surg OACIS Grp, Baltimore, MD USA; [Turnbull, Alison E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zaeh, SE (corresponding author), Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21218 USA.	szaeh1@jhmi.edu		Hayes, Margaret M/0000-0002-5848-6088; Zaeh, Sandra/0000-0002-5091-1975	Johns Hopkins Department of Medical Affairs; National Heart, Blood, and Lung Institute [T32HL007534-36]	Johns Hopkins Department of Medical Affairs; National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Turnbull was supported by the Johns Hopkins Department of Medical Affairs. Dr. Zaeh was supported by the National Heart, Blood, and Lung Institute under Grant T32HL007534-36. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Buss Mary Kathleen, 2005, J Palliat Med, V8, P363, DOI 10.1089/jpm.2005.8.363; Calam B, 2000, CAN MED ASSOC J, V163, P1255; Dimeff LA, 2009, BEHAV RES THER, V47, P921, DOI 10.1016/j.brat.2009.07.011; Farrelly CA, COMMUNICATION; Fromme EK, 2012, JAMA-J AM MED ASSOC, V307, P34, DOI 10.1001/jama.2011.1956; Gorman TE, 2005, ACAD MED, V80, P622, DOI 10.1097/00001888-200507000-00004; Hickman SE, 2015, J AM GERIATR SOC, V63, P341, DOI 10.1111/jgs.13248; Hickman SE, 2011, J AM GERIATR SOC, V59, P2091, DOI 10.1111/j.1532-5415.2011.03656.x; Hope AA, 2015, ANN AM THORAC SOC, V12, P505, DOI 10.1513/AnnalsATS.201501-040OC; KOLB 8DAVID A., 2015, EXPERIENTIAL LEARNIN; Mann Karen V, 2002, J Contin Educ Health Prof, V22, P69, DOI 10.1002/chp.1340220202; Mirarchi FL, 2015, J PATIENT SAF, V11, P1, DOI 10.1097/PTS.0000000000000165; Moore KA, 2016, JAMA-J AM MED ASSOC, V315, P259, DOI 10.1001/jama.2015.17362; National POLST Paradigm, POLST PAR FUND; Office of Health Care Quality, MAR MOLST MED ORD LI; Schwartz Charles E, 2003, J Palliat Med, V6, P37, DOI 10.1089/10966210360510109; Siddiqui MF, 2011, AM J HOSP PALLIAT ME, V28, P94, DOI 10.1177/1049909110374599; Stevens L, 2002, CRIT CARE MED, V30, P290, DOI 10.1097/00003246-200202000-00004; Sulmasy DP, 1996, J GEN INTERN MED, V11, P657, DOI 10.1007/BF02600156; Szmuilowicz E, 2012, J PALLIAT MED, V15, P768, DOI 10.1089/jpm.2011.0446; Tarzian AJ, 2017, J PALLIAT MED, V20, P939, DOI 10.1089/jpm.2016.0440; Turnbull AE, 2016, ANN AM THORAC SOC, V13, P926, DOI 10.1513/AnnalsATS.201511-738OC; van den Eertwegh V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125958; Williams DM, 2011, AM J HOSP PALLIAT ME, V28, P328, DOI 10.1177/1049909110391646; Wittenberg-Lyles E, 2014, J PALLIAT MED, V17, P400, DOI 10.1089/jpm.2013.0270; Zante B, 2019, J INTENSIVE CARE MED, V34, P301, DOI 10.1177/0885066617716057	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234973	10.1371/journal.pone.0234973	http://dx.doi.org/10.1371/journal.pone.0234973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559244	gold, Green Published			2022-12-26	WOS:000543261600046
J	Wawrzyniak, MK; Kalemba, EM; Ratajczak, E; Chmielarz, P				Wawrzyniak, Mikolaj Krzysztof; Kalemba, Ewa Marzena; Ratajczak, Ewelina; Chmielarz, Pawel			Oxidation processes related to seed storage and seedling growth ofMalus sylvestris, Prunus aviumandPrunus padus	PLOS ONE			English	Article							ACTIVE OXYGEN; HYDROGEN-PEROXIDE; THEORETICAL BASIS; ASCORBATE SYSTEM; CELL-DEATH; PLANT; GLUTATHIONE; STRESS; L.; RECALCITRANT	Seeds stored in controlled conditions in gene banks, faster or slower lose their viability. The effects of seed moisture content levels (ca. 5, 8, 11%) combined with storage temperatures (-3 degrees, -18 degrees, -196 degrees C) were investigated in terms of the description of seeds defined as orthodox under oxidative stress after seed storage, during germination, and initial seedling growth. Hydrogen peroxide (H2O2), thiobarbituric acid reactive substances (TBARS) and ascorbate (Asc) were analyzed in relation to seed germinability and seedlings emergence in three species:Malus sylvestrisL.,Prunus aviumL. andPrunus padusL. The effect of seed storage conditions on H(2)O(2)levels appeared in germinated seeds after the third year of storage in each species. The H(2)O(2)levels were negatively correlated with the germination and seedling emergence ofP.aviumseeds after three years of storage under all examined combinations. The emergence ofP.padusseedlings was not linked to any of the stress markers tested. TheP.padusseed biochemical traits were least altered by storage conditions, and the seeds produced tolerant seedlings of relatively high levels of H(2)O(2)and TBARS. To cope with different H(2)O(2)levels, TBARS levels, and Asc levels in seeds of three species varying storage conditions different molecular responses, i.e. repairing mechanisms, were applied during stratification to compensate for the storage conditions and, as a result, seeds remained viable and seedlings were successfully established.	[Wawrzyniak, Mikolaj Krzysztof; Kalemba, Ewa Marzena; Ratajczak, Ewelina; Chmielarz, Pawel] Polish Acad Sci, Inst Dendrol, Kornik, Poland	Polish Academy of Sciences	Wawrzyniak, MK (corresponding author), Polish Acad Sci, Inst Dendrol, Kornik, Poland.	mikwaw@man.poznan.pl	Wawrzyniak, Mikołaj/AAL-9779-2021; Ratajczak, Ewelina/AAF-1257-2021; Kalemba, Ewa/M-8301-2019	Wawrzyniak, Mikołaj/0000-0002-4297-5741; Ratajczak, Ewelina/0000-0003-2710-4638; Kalemba, Ewa/0000-0002-0092-0339	General Directorate of State Forests in Warsaw, Poland [OR 2717-2/12]; Institute of Dendrology of the Polish Academy of Sciences	General Directorate of State Forests in Warsaw, Poland; Institute of Dendrology of the Polish Academy of Sciences	General Directorate of State Forests in Warsaw, Poland OR 2717-2/12 prof Pawel Chmielarz with additional support provided by the Institute of Dendrology of the Polish Academy of Sciences.	Akram NA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00613; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2018, DIABETES CARE, V40, pS1; Arguedas M, 2018, ACTA PHYSIOL PLANT, V40, DOI 10.1007/s11738-018-2695-7; ARRIGONI O, 1992, PLANT PHYSIOL, V99, P235, DOI 10.1104/pp.99.1.235; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Bailly C, 2008, CR BIOL, V331, P806, DOI 10.1016/j.crvi.2008.07.022; Ballesteros D, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00920; BARCELO RA, 1998, ANN BOT, V82, P97, DOI DOI 10.1006/ANBO.1998.0655; Benamirouche S, 2018, REV ECOL-TERRE VIE, V73, P80; Bewley JD., 2012, SEEDS PHYSL DEV GERM; Bilska K, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8120645; Chmielarz P, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009020; Chmielowska-Bak J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00405; Coart E, 2006, MOL ECOL, V15, P2171, DOI 10.1111/j.1365-294X.2006.02924.x; Colville L, 2012, J EXP BOT, V63, P6519, DOI 10.1093/jxb/ers307; Cui K, 2014, CROP SCI, V54, P1748, DOI 10.2135/cropsci2013.10.0680; Cui XX, 2018, J THORAC DIS, V10, P3088, DOI 10.21037/jtd.2018.05.92; Danna CH, 2003, PLANT PHYSIOL, V132, P2116, DOI 10.1104/pp.103.021717; De Tullio MC, 2003, SEED SCI RES, V13, P249, DOI 10.1079/SSR2003143; del Campo AD, 2010, NEW FOREST, V39, P19, DOI 10.1007/s11056-009-9152-9; Di Cara G, 2013, ANTICANCER RES, V33, P489; Ebone LA, 2019, PLANT PHYSIOL BIOCH, V145, P34, DOI 10.1016/j.plaphy.2019.10.028; erny M., 2018, INT J MOL SCI, V19, DOI [10.3390/ijms19092812, DOI 10.3390/ijms19092812]; Fellenberg U, 2000, ACTA HORTIC, P63, DOI 10.17660/ActaHortic.2000.538.5; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Gest N, 2013, J EXP BOT, V64, P33, DOI 10.1093/jxb/ers297; Gladyshev VN, 2014, ANTIOXID REDOX SIGN, V20, P727, DOI 10.1089/ars.2013.5228; Grossnickle SC, 2012, NEW FOREST, V43, P711, DOI 10.1007/s11056-012-9336-6; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HENDRY GAF, 1992, NEW PHYTOL, V122, P273, DOI 10.1111/j.1469-8137.1992.tb04231.x; Hu D, 2012, PLANT CELL ENVIRON, V35, P2045, DOI 10.1111/j.1365-3040.2012.02535.x; Kaewnaree P, 2001, SEEDS BIOTECHNOL, V10, P175, DOI [10.3923/biotech2011175182, DOI 10.3923/BIOTECH201117518]; Kalemba EM, 2018, J PLANT PHYSIOL, V223, P72, DOI 10.1016/j.jplph.2018.02.010; Kalemba EM, 2015, FUNCT PLANT BIOL, V42, P630, DOI 10.1071/FP14336; KAMPFENKEL K, 1995, ANAL BIOCHEM, V225, P165, DOI 10.1006/abio.1995.1127; Kew RBG, 2019, SEED INFORM DATABASE; Kibinza S, 2006, PHYSIOL PLANTARUM, V128, P496, DOI 10.1111/j.1399-3054.2006.00771.x; Kocsy G, 2015, PLANT CELL ENVIRON, V38, P1008, DOI 10.1111/pce.12515; Kong QM, 2010, CELL MOL LIFE SCI, V67, P1817, DOI 10.1007/s00018-010-0277-y; Kranner I, 2006, FREE RADICAL BIO MED, V40, P2155, DOI 10.1016/j.freeradbiomed.2006.02.013; Kranner I, 2010, NEW PHYTOL, V188, P655, DOI 10.1111/j.1469-8137.2010.03461.x; Kumar SPJ, 2015, ANN BOT-LONDON, V116, P663, DOI 10.1093/aob/mcv098; Kurek K, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8060174; Laxa M, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8040094; Li D, 2019, POSTHARVEST BIOL TEC, P15379, DOI [10.1016/jpostharvbio201903012, DOI 10.1016/JPOSTHARVBIO201903012]; Li M, 2016, J AM SOC HORTIC SCI, V136, P231, DOI [10.21273/JASHS1364231, DOI 10.21273/JASHS1364231]; Li Y, 2007, J INTEGR PLANT BIOL, V49, P569, DOI 10.1111/j.1744-7909.2007.00452.x; LISO R, 1985, FEBS LETT, V187, P141, DOI 10.1016/0014-5793(85)81230-8; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Marshall AH, 2004, SEED SCI TECHNOL, V32, P493, DOI 10.15258/sst.2004.32.2.19; Michalak M, 2015, SEED SCI TECHNOL, V43, P480, DOI 10.15258/sst.2015.43.3.20; Michalak M, 2015, OPEN LIFE SCI, V10, P354, DOI 10.1515/biol-2015-0036; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Oliver AE, 2001, CRYOBIOLOGY, V43, P151, DOI 10.1006/cryo.2001.2359; Lopez-Fernandez MP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35476-3; Pignocchi C, 2006, PLANT PHYSIOL, V141, P423, DOI 10.1104/pp.106.078469; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Popova E, 2016, CAN J FOREST RES, V46, P766, DOI 10.1139/cjfr-2016-0020; Potters G, 2004, PLANT PHYSIOL, V134, P1479, DOI 10.1104/pp.103.033548; Powell B, 2013, ROLE FORESTS TREES W, P1; Pukacka S, 2007, SEED SCI RES, V17, P45, DOI 10.1017/S0960258507629432; Pukacka S, 2010, PLANT GROWTH REGUL, V62, P77, DOI 10.1007/s10725-010-9492-7; R Core Team, 2021, R LANGUAGE ENV STAT; Rahman MS, 2015, J FOOD SCI TECH MYS, V52, P1691, DOI 10.1007/s13197-013-1173-x; Ren Y, 2018, J TRANSL RES, V2, P11; ROBERTS E H, 1973, Seed Science and Technology, V1, P499; SAGISAKA S, 1976, PLANT PHYSIOL, V57, P308, DOI 10.1104/pp.57.2.308; Sallon S, 2008, SCIENCE, DOI [10.1126/science1153600, DOI 10.1126/SCIENCE1153600]; Scartazza A, 2016, TREE PHYSIOL, V36, P1060, DOI 10.1093/treephys/tpw038; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Shelar V. R., 2008, Agricultural Reviews, V29, P125; SHENMILLER J, 1995, AM J BOT, V82, P1367, DOI 10.2307/2445863; Sies H, 2017, REDOX BIOL, V11, P613, DOI 10.1016/j.redox.2016.12.035; SIMON EW, 1974, NEW PHYTOL, V73, P377, DOI 10.1111/j.1469-8137.1974.tb02118.x; Stephan BR, 2003, EUFORGEN TECHNICAL G; Suszka B., 1996, SEEDS FOREST BROADLE; Tommasi F, 1999, PHYSIOL PLANTARUM, V105, P193, DOI 10.1034/j.1399-3054.1999.105202.x; Veljovi-Jovanovi S, 2017, ASCORBATE KEY PLAYER; VERTUCCI CW, 1987, PLANT PHYSIOL, V85, P224, DOI 10.1104/pp.85.1.224; VERTUCCI CW, 1994, ANN BOT-LONDON, V74, P531, DOI 10.1006/anbo.1994.1151; VERTUCCI CW, 1990, PLANT PHYSIOL, V94, P1019, DOI 10.1104/pp.94.3.1019; Walters C, 2007, S AFR J BOT, V73, P495, DOI 10.1016/j.sajb.2007.04.035; Walters C, 2005, SEED SCI RES, V15, P1, DOI 10.1079/SSR2004195; Wawrzyniak M, 2020, ANN FOR SCI; Wei T, 2017, R PACKAGE CORRPLOT V; Wojtyla L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00066	87	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234510	10.1371/journal.pone.0234510	http://dx.doi.org/10.1371/journal.pone.0234510			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555619	gold, Green Published			2022-12-26	WOS:000543273200016
J	Wubishet, BL; Harris, ML; Forder, PM; Byles, JE				Wubishet, Befikadu L.; Harris, Melissa L.; Forder, Peta M.; Byles, Julie E.			Age and cohort rise in diabetes prevalence among older Australian women: Case ascertainment using survey and healthcare administrative data	PLOS ONE			English	Article							LIFE-STYLE; EPIDEMIOLOGY; TRENDS; ADULTS; LIMITATIONS; ADJUSTMENT	Background Due to the absence and or costliness of biological measures such as glycated haemoglobin, diabetes case ascertainment and prevalence studies are usually conducted using surveys or routine health service use databases. However, the use of each of these sources is associated with its limitations potentially impacting the quality of the case ascertainment and prevalence estimation. This study aimed at ascertaining diabetes cases and estimating prevalence among mid- and older-age women through simultaneous use of a longitudinal survey and multiple healthcare administrative data sources. Methods Data were available for 12,432 and 13,714 women born in 1921-26 and 1946-51 from the Australian Longitudinal Study on Women's Health (ALSWH). Diabetes was ascertained using the ALSWH survey, health service use, and cause of death data. Parsimonious multiple logistic regression analyses tested associations between sociodemographic and health variables and the presence of diabetes. Results In both cohorts, two or more of the sources captured more than 80% of the women with diabetes. The point prevalence of diabetes increased from 8.4% when the mean age of the women were aged 73, to 22.0% of surviving women at age 90 in the 1921-26 cohort; and from 2.6% at age 48 to 15.8% at age 68 in the 1946-51 cohort. In the 1921-26 cohort, women who were obese (OR: 3.56; 95 CI: 3.04-4.17) and women who were sedentary (OR: 1.18; 95 CI: 1.09-1.40) were more likely to have diabetes compared to those who had a normal weight and engaged in a moderate level of physical activity. In the 1946-51 cohort, the odds of diabetes increased three times (OR: 2.99; 95 CI: 2.54-3.52) for overweight women and nine times (OR: 8.78; 95 CI: 7.46-10.33) for obese women compared to those who had normal weight. Conclusions The simultaneous use of multiple data sources improved the validity of diabetes case ascertainment. Application of this methodology in future studies may have important benefits including estimation of disease burden, health service needs, and resource allocation with improved precision. Diabetes prevalence increased with age, was much higher in the 1946-51 cohort than in 1921-26 at similar ages, and was significantly associated with physical inactivity and obesity. Interventions to promote physical activity and a healthy weight are needed to prevent the rising prevalence of diabetes across successive generations.	[Wubishet, Befikadu L.; Harris, Melissa L.; Forder, Peta M.; Byles, Julie E.] Univ Newcastle, Hunter Med Res Inst, Res Ctr Generat Hlth & Ageing, Newcastle, NSW, Australia; [Wubishet, Befikadu L.] Mekelle Univ, Sch Pharm, Mekelle, Tigray, Ethiopia	Hunter Medical Research Institute; University of Newcastle; Mekelle University	Wubishet, BL (corresponding author), Univ Newcastle, Hunter Med Res Inst, Res Ctr Generat Hlth & Ageing, Newcastle, NSW, Australia.; Wubishet, BL (corresponding author), Mekelle Univ, Sch Pharm, Mekelle, Tigray, Ethiopia.	BefikaduLegesse.Wubishet@uon.edu.au	Wubishet, Befikadu/AAI-6038-2020	Wubishet, Befikadu/0000-0001-9896-8893	Australian Government Department of Health [G1700929]; University of Newcastle; Australian Research Council Centre of Excellence in Population Ageing Research [CE170100005]; Population Health Research Network	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); University of Newcastle; Australian Research Council Centre of Excellence in Population Ageing Research(Australian Research Council); Population Health Research Network	The research on which this paper is based was conducted as part of the Australian Longitudinal Study on Women's Health (ALSWH) by the University of Queensland and the University of Newcastle. ALSWH is funded by the Australian Government Department of Health (https://www.health.gov.au/) (G1700929). BLW is a recipient of a University of Newcastle PhD scholarship and a topup scholarship from the Australian Research Council Centre of Excellence in Population Ageing Research (https://www.neura.edu.au/project/arc-centre-of-excellence-in-population-ageing-research/) (project number CE170100005).; The authors also acknowledge 1) Centre for Health Record Linkage (CHeReL), NSW Ministry of Health and ACT Health for the NSW and ACT Admitted Patients Data Collections; 2) Queensland Health, including the Statistical Services Branch, for the QLD Hospital Admitted Patient Data Collection; 3) Department of Health Western Australia, including the Data Linkage Branch, and the WA Hospital Morbidity Data Collection; 4) SA NT Datalink and SA Health for the SA Public Hospital Separations Data Collection. This project is supported by the Population Health Research Network which is a capability of the Australian Government National Collaborative Research Infrastructure Strategy and Education Investment Fund Super Science Initiative.	Akushevich I, 2018, J DIABETES COMPLICAT, V32, P362, DOI 10.1016/j.jdiacomp.2017.12.014; Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; Amed S, 2010, DIABETES CARE, V33, P786, DOI 10.2337/dc09-1013; Andersson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104033; Anwar H, 2011, DIABETIC MED, V28, P1514, DOI 10.1111/j.1464-5491.2011.03432.x; Australian Institute of Health and Welfare, 2017, NAT DEATH IND NDI AI; Australian Institute of Health Welfare, AUSTR HLTH 2016; Bannier K, 2015, J DIABETES COMPLICAT, V29, P1130, DOI 10.1016/j.jdiacomp.2015.08.010; Bloomgarden Z, 2013, J DIABETES, V5, P369, DOI 10.1111/1753-0407.12086; Brown W, 2007, PHYS ACTIVITY HLTH M; Bullard KM, 2018, MMWR-MORBID MORTAL W, V67, P359, DOI 10.15585/mmwr.mm6712a2; Byles J, 2015, CHRONIC CONDITIONS P; Centre for Health Record Linkage, ICD 10 AM ACHI ACS; Cheng SW, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011602; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; DeFronzo RA, 2011, DIABETES CARE, V34, pS202, DOI 10.2337/dc11-s221; Deshpande AD, 2008, PHYS THER, V88, P1254, DOI 10.2522/ptj.20080020; Dobson AJ, 2015, INT J EPIDEMIOL, V44, DOI 10.1093/ije/dyv110; Duckett S., 2015, AUSTR HLTH CARE SYST, V5th ed.; Fang M, 2018, AM J PREV MED, V55, P497, DOI 10.1016/j.amepre.2018.05.018; Fishman EI, 2014, DIABETES CARE, pDC_131982; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Harvey J. N., 2002, Journal of Epidemiology and Community Health, V56, P18, DOI 10.1136/jech.56.1.18; Haut ER, 2012, JAMA-J AM MED ASSOC, V307, P2589, DOI 10.1001/jama.2012.6626; Huang XB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170250; International Diabetes Federation, 2019, ADV GUID IDF DIAB AT; Iwasa T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160632; Joshy G, 2009, J EPIDEMIOL COMMUN H, V63, P386, DOI 10.1136/jech.2008.078873; Kleefstra N, 2016, J DIABETES, V8, P863, DOI 10.1111/1753-0407.12370; Knott RJ, 2015, AUST ECON REV, V48, P122, DOI 10.1111/1467-8462.12103; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Leikauf J, 2009, J AM GERIATR SOC, V57, P1219, DOI 10.1111/j.1532-5415.2009.02313.x; Lin S, 2016, J DIABETES, V8, P533, DOI 10.1111/1753-0407.12326; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382; Mendis S, 2011, PRIORITIZED RES AGEN; Meza R, 2015, PREV MED, V81, P445, DOI 10.1016/j.ypmed.2015.10.015; Mishra G, 2016, FUTURE HLTH SERVICE; Morgan CL, 2000, DIABETIC MED, V17, P141, DOI 10.1046/j.1464-5491.2000.00221.x; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Papoz L, 1996, INT J EPIDEMIOL, V25, P474, DOI 10.1093/ije/25.3.474; Ramke J, 2012, J DIABETES, V4, P392, DOI 10.1111/j.1753-0407.2012.00217.x; Taylor AW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125233; Taylor R, 2016, J DIABETES, V8, P766, DOI 10.1111/1753-0407.12447; Van Netten JJ, 2017, AUSTR DIABETES RELAT; Waller M, 2017, EMERG THEMES EPIDEMI, V14, P1, DOI 10.1186/s12982-017-0057-3; Webbie K, 2006, BULLETIN, V47; WHO, 2016, GLOB REP PSOR; World Health Organization, 2019, CLASS DIAB MELL; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	50	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234812	10.1371/journal.pone.0234812	http://dx.doi.org/10.1371/journal.pone.0234812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555738	Green Published, gold			2022-12-26	WOS:000543273200055
J	Cao, ZH; Li, TZ; Liang, LC; Wang, HB; Wei, FL; Meng, S; Cai, MT; Zhang, YL; Xu, H; Zhang, JY; Jin, RH				Cao, Zhenhuan; Li, Tongzeng; Liang, Lianchun; Wang, Haibo; Wei, Feili; Meng, Sha; Cai, Miaotian; Zhang, Yulong; Xu, Hui; Zhang, Jiaying; Jin, Ronghua			Clinical characteristics of Coronavirus Disease 2019 patients in Beijing, China	PLOS ONE			English	Article							WUHAN	The outbreak of Coronavirus Disease (COVID-19) in Wuhan have affected more than 250 countries and regions worldwide. However, most of the clinical studies have been focused on Wuhan, and little is known about the disease outside of Wuhan in China. In this retrospective cohort study, we report the early clinical features of 80 patients with COVID-19 admitted to the hospital in Beijing. The results show that 27 (33.8%) patients had severe illness. Six (7.5%) patients were admitted to the ICU, and 3 (3.8%) patients died. Forty-eight percent (39/80) of the patients had a history of living/traveling in Wuhan. Patients with severe- illness were significantly older (average age, 71 years old vs 44 years old) and had a high incidence of expectoration (59.3% vs 34.0%), shortness of breath (92.6% vs 9.4%), anorexia (51.9% vs 18.9%) and confusion(18.5% vs 0%) compared with nonsevere patients. The systolic blood pressure (median, 130 mmHg vs 120 mmHg) was higher and the oxygen saturation (median, 98.3% vs 92.0%) was significantly lower in severe patients than nonsevere patients. In addition, myoglobin (median, 56.0 ng/mL vs 35.0 ng/mL), troponin I (median, 0.02 pg/mL vs 0.01 pg/mL), C-reactive protein (median, 69.7 mg/L vs 12.9 mg/L) and neutrophils (median, 3.3x10(9)/L vs 2.2x10(9)/L) were significantly increased, while lymphocytes (median, 0.8x10(9)/L vs 1.2x10(9)/L), albumin (mean, 32.8 g/L vs 36.8 g/L) and the creatinine clearance rate (median, 91.2 vs 108.2 ml/min/1.73m(2)) were significantly decreased among severe patients. Our study revealed that older patients with high levels of C-reactive protein, myoglobin, troponin I, and neutrophil and high systolic blood pressure as well as low levels of lymphocytes, and albumin and a low creatinine clearance rate and oxygen saturation were more likely to have severe disease.	[Cao, Zhenhuan; Li, Tongzeng; Liang, Lianchun; Cai, Miaotian; Zhang, Yulong; Xu, Hui; Zhang, Jiaying; Jin, Ronghua] Capital Med Univ, Beijing Youan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Wang, Haibo] Peking Univ, Clin Res Inst, Beijing, Peoples R China; [Wei, Feili] Beijing Inst Hepatol, Beijing, Peoples R China; [Meng, Sha] Capital Med Univ, Beijing Youan Hosp, Dept Sci & Technol, Beijing, Peoples R China	Capital Medical University; Peking University; Capital Medical University	Jin, RH (corresponding author), Capital Med Univ, Beijing Youan Hosp, Dept Infect Dis, Beijing, Peoples R China.	93353503@qq.com		Cao, Zhenhuan/0000-0003-4204-1049				Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Chang D, 2020, JAMA-J AM MED ASSOC, V323, P1092, DOI 10.1001/jama.2020.1623; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; McCloskey B, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000254; National Health Commission of the People' Republic of China, 2020, DIAGN TREATM PNEUM I; Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757; Ryan Michael, 2020, COMMUNICATION   0213; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	12	29	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234764	10.1371/journal.pone.0234764	http://dx.doi.org/10.1371/journal.pone.0234764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555674	gold, Green Published			2022-12-26	WOS:000542759600020
J	Imeah, B; Penz, E; Rana, M; Trask, C				Imeah, Biaka; Penz, Erika; Rana, Masud; Trask, Catherine		Needle-Less Injector Study Team	Economic analysis of new workplace technology including productivity and injury: The case of needle-less injection in swine	PLOS ONE			English	Article							MILKING SYSTEM; WORK; UNCERTAINTY; COSTS	Increasing intensification in swine production has led to new and specialized technologies, but the occupational health and safety impacts are rarely quantified in the business plans for adoption. Needle-less injection has potential to increase productivity and eliminate needle stick injury in workers, but it is not clear whether these benefits offset high capital investment and potential increases in musculoskeletal loads. This economic evaluation employed probabilistic scenario analysis using injury, cost, and production data gathered from interviews with swine producers in Manitoba and Saskatchewan. After adoption of needle-less injection, rates of needle-stick injury went down with no measureable effect on upper limb musculoskeletal disorders, resulting in lower health and safety costs for needle-less injectors. Needle-less injection duration was 40% faster once workers acclimatized, but large start-up costs mean economic benefits are realized only after the first year. The incremental benefit cost ratio promoted adoption of needle-less injectors over conventional needles for the base case of a 1200 sow barn; the conventional method is beneficial for barns with 600 sows or less. Findings indicate that well-designed technologies have the potential to achieve the dual ergonomics goals of enhancing human wellbeing and system performance. We anticipate that the economic and decision models developed in this study can be applied to other new technologies in agriculture and animal production.	[Imeah, Biaka; Trask, Catherine] Univ Saskatchewan, Coll Med, Canadian Ctr Hlth & Safety Agr, Saskatoon, SK, Canada; [Penz, Erika] Univ Saskatchewan, Coll Med, Saskatoon, SK, Canada; [Rana, Masud] Univ Saskatchewan, Collaborat Program Biostat, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Trask, C (corresponding author), Univ Saskatchewan, Coll Med, Canadian Ctr Hlth & Safety Agr, Saskatoon, SK, Canada.	catherine.trask@usask.ca	Penz, Erika/AAZ-9541-2020	Penz, Erika/0000-0003-2610-8450; Trask, Catherine/0000-0003-0799-1735	Canada Research Chairs program [228136]; Workers Compensation Board of Manitoba	Canada Research Chairs program(Canada Research Chairs); Workers Compensation Board of Manitoba	CT & EP: Workers Compensation Board of Manitoba https://www.wcb.mb.ca/research-andworkplace-innovation-program-0 CT: Canada Research Chairs program [#228136] http://www.chairs-chaires.gc.ca/chairholders-titulaires/profileeng.aspx?profileId=3030 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2020, FAO STAT ONL DAT; Bath B, 2019, PHYSIOTHER CAN, V71, P24, DOI 10.3138/ptc.2017-65; Blaha T.G., 2001, PREHARVEST FOOD SAFE; Daniels C., 2009, PREVALENCE CARCASS D; Douphrate DI, 2009, J AGROMEDICINE, V14, P406, DOI 10.1080/10599240903260444; Drugs C.A.f., 2006, GUIDELINES EC EVALUA; Escorpizo R, 2008, INT J IND ERGONOM, V38, P291, DOI 10.1016/j.ergon.2007.10.018; EVANS JS, 1994, REGUL TOXICOL PHARM, V20, P15, DOI 10.1016/S0273-2300(05)80003-0; FAO, 2012, STAT YB 2012; FAO F.a.A.O., 2007, SUST AGR RUR DEV SAR; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Government of Saskatchewan, 2017, SASK VAR GUID 2017 S; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Hafer A. L., 1996, Swine Health and Production, V4, P128; Houser T., 2003, FEASIBILITY TRANSDER; Jakob M, 2011, J AGROMEDICINE, V16, P280, DOI 10.1080/1059924X.2011.605713; Janssen B, 2017, J AGROMEDICINE, V22, P47, DOI [10.1080/1059924X.2016.1249444, 10.1080/1059924x.2016.1249444]; Khushrushahi N., INVESTOR GUIDANCE OC; Lash TL, 2014, INT J EPIDEMIOL, V43, P1969, DOI 10.1093/ije/dyu149; Lash TL, 2011, APPL QUANTITATIVE BI; Leigh JP, 2001, PUBLIC HEALTH REP, V116, P235, DOI 10.1093/phr/116.3.235; Leigh JP, 1997, ARCH INTERN MED, V157, P1557, DOI 10.1001/archinte.157.14.1557; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Mousel MR, 2008, J ANIM SCI, V86, P1468, DOI 10.2527/jas.2007-0839; Nonnenmann MW, 2010, J OCCUP ENVIRON HYG, V7, P483, DOI 10.1080/15459624.2010.487036; Peters JC, 2008, J ANIM SCI, V86, P2261, DOI 10.2527/jas.2007-0577; Rey M, 2015, CAN VET J, V56, P405; Saia M, 2010, BIOMED INT, V1, P41; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Stal M, 2003, ANN AGR ENV MED, V10, P67; StatisticsCanada, 2015, CHANG FAC CAN HOG IN; Temple D, 2017, PORCINE HEALTH MANAG, V3, DOI 10.1186/s40813-017-0056-3; Vansickle J., 2001, BROKEN NEEDLES ONE I; Wohl M., 1984, TRANSPORTATION INVES; Wu JY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1018; Zeng XK, 2018, CAN VET J, V59, P871; Zhang Y., 2008, PLOS ONE, V3, pe3933; 2013, ANCIENT NEAR E MONOG, V5, P14	39	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0233599	10.1371/journal.pone.0233599	http://dx.doi.org/10.1371/journal.pone.0233599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB7DG	32555636	Green Published, gold			2022-12-26	WOS:000542759600022
J	Al-Sari, N; Suvitaival, T; Mattila, I; Ali, A; Ahonen, L; Trost, K; Henriksen, TF; Pociot, F; Dragsted, LO; Legido-Quigley, C				Al-Sari, Naba; Suvitaival, Tommi; Mattila, Ismo; Ali, Ashfaq; Ahonen, Linda; Trost, Kajetan; Henriksen, Trine Foged; Pociot, Flemming; Dragsted, Lars Ove; Legido-Quigley, Cristina			Lipidomics of human adipose tissue reveals diversity between body areas	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; LIPIDS; EXTRACTION; METABOLOMICS; BIOMARKERS; OBESITY; PLASMA; SERUM; RISK	Background and aims Adipose tissue plays a pivotal role in storing excess fat and its composition reflects the history of person's lifestyle and metabolic health. Broad profiling of lipids with mass spectrometry has potential for uncovering new knowledge on the pathology of obesity, metabolic syndrome, diabetes and other related conditions. Here, we developed a lipidomic method for analyzing human subcutaneous adipose biopsies. We applied the method to four body areas to understand the differences in lipid composition between these areas. Materials and methods Adipose tissue biopsies from 10 participants were analyzed using ultra-high-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry. The sample preparation optimization included the optimization of the lipid extraction, the sample amount and the sample dilution factor to detect lipids in an appropriate concentration range. Lipidomic analyses were performed for adipose tissue collected from the abdomen, breast, thigh and lower back. Differences in lipid levels between tissues were visualized with heatmaps. Results Lipidomic analysis on human adipose biopsies lead to the identification of 186lipids in 2 mg of sample. Technical variation of the lipid-class specific internal standards were below 5%, thus indicating acceptable repeatability. Triacylglycerols were highly represented in the adipose tissue samples, and lipids from 13 lipid classes were identified. Long polyunsaturated triacylglycerols in higher levels in thigh (q<0.05), when compared with the abdomen, breast and lower back, indicating that the lipidome was area-specific. Conclusion The method presented here is suitable for the analysis of lipid profiles in 2 mg of adipose tissue. The amount of fat across the body is important for health but we argue that also the distribution and the particular profile of the lipidome may be relevant for metabolic outcomes. We suggest that the method presented in this paper could be useful for detecting such aberrations.	[Al-Sari, Naba; Suvitaival, Tommi; Mattila, Ismo; Ali, Ashfaq; Ahonen, Linda; Trost, Kajetan; Pociot, Flemming; Legido-Quigley, Cristina] Steno Diabet Ctr Copenhagen, Gentofte, Denmark; [Al-Sari, Naba; Pociot, Flemming] Univ Copenhagen, Dept Clin Med, Gentofte, Denmark; [Henriksen, Trine Foged] Capio CFR, Lyngby, Denmark; [Dragsted, Lars Ove] Univ Copenhagen, Dept Nutr Exercise & Sports, Gentofte, Denmark; [Legido-Quigley, Cristina] Kings Coll London, Inst Pharmaceut Sci, London, England; [Ali, Ashfaq] Natl Bioinformat Infrastruct Sweden, Uppsala, Sweden; [Ahonen, Linda] Biosyntia ApS, Copenhagen, Denmark	Steno Diabetes Center; University of Copenhagen; University of Copenhagen; University of London; King's College London	Suvitaival, T (corresponding author), Steno Diabet Ctr Copenhagen, Gentofte, Denmark.	tommi.raimo.leo.suvitaival@regionh.dk	Suvitaival, Tommi/AAZ-3518-2020; Dragsted, Lars Ove/N-3384-2014	Suvitaival, Tommi/0000-0002-2583-4912; Mattila, Ismo/0000-0001-9597-7831; , Naba/0000-0003-3988-4846; Legido-Quigley, Cristina/0000-0002-4018-214X; Ali, Ashfaq/0000-0002-0164-2166; Pociot, Flemming/0000-0003-3274-5448; Dragsted, Lars Ove/0000-0003-0609-6317	Steno Diabetes Center Copenhagen; Capio CFR	Steno Diabetes Center Copenhagen; Capio CFR	The authors received no specific funding for this work. The work was carried out at and paid by Steno Diabetes Center Copenhagen. Capio CFR provided sample material but did not provide funding. Biosyntia ApS did not provide funding and was not involved in the study at the time of carrying out the study. Apart from Trine Foged Henriksen, all authors were employees of Steno Diabetes Center Copenhagen at the time out the study. Capio CFR and Biosyntia ApS did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Baker RC, 2014, METHOD ENZYMOL, V538, P89, DOI 10.1016/B978-0-12-800280-3.00006-2; Baylin A, 2006, CURR OPIN LIPIDOL, V17, P22, DOI 10.1097/01.mol.0000199814.46720.83; Bergmann K, 2013, CLIN CHEM LAB MED, V51, P177, DOI 10.1515/cclm-2012-0490; Bowden JA, 2017, J LIPID RES, V58, P2275, DOI 10.1194/jlr.M079012; Christinat N, 2017, J PROTEOME RES, V16, P2947, DOI 10.1021/acs.jproteome.7b00236; de Mello VD, 2017, SCI REP-UK, V7, DOI 10.1038/srep46337; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Fallahian F, 2018, J SURG RES, V222, P48, DOI 10.1016/j.jss.2017.09.040; FOLCH J, 1957, J BIOL CHEM, V226, P497; Folch-Fortuny A, 2016, MOL BIOSYST, V12, P253, DOI 10.1039/c5mb00507h; Frasca D, 2017, FRONT IMMUNOL, V8, DOI [10.3389/fimmu.2017.01745, 10.3389/fimmu.2017.01003]; Fuel Cells Bulletin, 2015, FUEL CELLS B, V2015, P1, DOI DOI 10.1155/2015/528103; Gadde KM, 2018, J AM COLL CARDIOL, V71, P69, DOI 10.1016/j.jacc.2017.11.011; Gealekman O, 2011, CIRCULATION, V123, P186, DOI 10.1161/CIRCULATIONAHA.110.970145; Huang XY, 2014, NEPHROL DIAL TRANSPL, V29, P128, DOI 10.1093/ndt/gfs478; Karastergiou K, 2013, J CLIN ENDOCR METAB, V98, P362, DOI 10.1210/jc.2012-2953; Lamichhane S, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.250; Lamichhane S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28907-8; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee HC, 2018, BIOCHEM BIOPH RES CO, V504, P576, DOI 10.1016/j.bbrc.2018.03.081; Li-Gao Ruifang, 2018, Metabolomics, V14, P13, DOI 10.1007/s11306-017-1307-7; Liesenfeld DB, 2015, AM J CLIN NUTR, V102, P433, DOI 10.3945/ajcn.114.103804; Lopez-Bascon MA, 2018, TALANTA, V177, P86, DOI 10.1016/j.talanta.2017.09.017; Luukkonen PK, 2017, J HEPATOL, V67, P128, DOI 10.1016/j.jhep.2017.02.014; Mardinoglu A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.5; Moreno-Navarrete JM, 2018, CELL PHYSIOL BIOCHEM, V51, P142, DOI 10.1159/000495170; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Mzmine A, 2012, BMC BIOINFORMATICS, P2005; National Comprehensive Cancer Network, 2018, J NATL COMPR CANC NE, V16, P1, DOI DOI 10.1186/s12915-017-0471-6; O'Gorman A, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.211; Pandey V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26257-z; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; Qiu GK, 2016, INT J EPIDEMIOL, V45, P1507, DOI 10.1093/ije/dyw221; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Rahn S, 2018, CANCER LETT, V415, P129, DOI 10.1016/j.canlet.2017.12.004; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts LD, 2014, METHOD ENZYMOL, V538, P211, DOI 10.1016/B978-0-12-800280-3.00012-8; Scupakova K, 2018, ANAL CHEM, V90, P5130, DOI 10.1021/acs.analchem.7b05215; Sedger LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154650; Sepulveda-Cisternas Ignacio, 2018, Sci Rep, V8, P3149, DOI 10.1038/s41598-018-21302-3; SLOMIANY A, 1981, J BIOCHEM BIOPH METH, V5, P229, DOI 10.1016/0165-022X(81)90047-6; Snowden SG, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002266; Succurro E, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002098; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tobin L, 2011, CLIN PHYSIOL FUNCT I, V31, P458, DOI 10.1111/j.1475-097X.2011.01041.x; Tomasova P, 2019, J CHROMATOGR B, V1113, P50, DOI 10.1016/j.jchromb.2019.03.006; Whiley L, 2012, ANAL CHEM, V84, P5992, DOI 10.1021/ac300716u; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wolk A, 2001, J NUTR, V131, P828, DOI 10.1093/jn/131.3.828; Zhang HZ, 2017, ANAL BIOANAL CHEM, V409, P5349, DOI 10.1007/s00216-017-0483-7	51	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0228521	10.1371/journal.pone.0228521	http://dx.doi.org/10.1371/journal.pone.0228521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544198	gold, Green Submitted, Green Published			2022-12-26	WOS:000542957200022
J	Huang, ZL; Mao, CX; Wei, YZ; Gu, XY; Cai, QR; Shen, XG; Ding, HZ				Huang, Zilong; Mao, Chunxiao; Wei, Yanzhe; Gu, Xiaoyan; Cai, Qinren; Shen, Xiangguang; Ding, Huanzhong			Analysis of the mutant selection window and killing ofMycoplasma hyopneumoniaefor doxycycline, tylosin, danofloxacin, tiamulin, and valnemulin	PLOS ONE			English	Article							MYCOPLASMA-HYOPNEUMONIAE; IN-VITRO; PREVENTION CONCENTRATION; STAPHYLOCOCCUS-AUREUS; SUSCEPTIBILITY; FLUOROQUINOLONE; RESISTANCE; PHARMACOKINETICS; ENROFLOXACIN; INFECTIONS	Mycoplasma hyopneumoniaeis the major pathogenic microorganism causing enzootic pneumonia in pigs. With increasing resistance ofM.hyopneumoniaeto conventional antibiotics, treatment is becoming complicated. Herein, we investigated the mutant selection window (MSW) of doxycycline, tylosin, danofloxacin, tiamulin, and valnemulin for treating theM.hyopneumoniaetype strain (ATCC 25934) to determine the likelihood of promoting resistance with continued use of these antibiotics. Minimum inhibitory concentration (MIC) values againstM.hyopneumoniaewere determined for each antimicrobial agent based on microdilution broth and agar dilution methods (bacterial numbers ranged from 10(5)colony-forming units (CFU)/mL to 10(9)CFU/mL). The minimal concentration inhibiting colony formation by 99% (MIC99) and the mutant prevention concentration (MPC) were determined by the agar dilution method with three inoculum sizes. Antimicrobial killing was determined based on MIC(99)and MPC values for all five agents. MIC values ranged from 0.001 to 0.25 mu g/mL based on the microdilution broth method, and from 0.008 to 1.0 mu g/mL based on the agar dilution method. MPC values ranged from 0.0016 to 10.24 mu g/mL. MPC/MIC(99)values were ordered tylosin > doxycycline > danofloxacin > tiamulin > valnemulin. MPC achieved better bactericidal action than MIC99. Based on pharmacodynamic analyses, danofloxacin, tylosin, and doxycycline are more likely to select resistant mutants than tiamulin and valnemulin.	[Huang, Zilong; Mao, Chunxiao; Wei, Yanzhe; Gu, Xiaoyan; Shen, Xiangguang; Ding, Huanzhong] South China Agr Univ, Guangdong Key Lab Vet Drug Dev & Safety Evaluat, Guangzhou, Peoples R China; [Cai, Qinren] Zhuhai Entry Exit Inspect & Quarantine Bur, Tech Ctr Inspect & Quarantine, Zhuhai, Peoples R China	South China Agricultural University	Ding, HZ (corresponding author), South China Agr Univ, Guangdong Key Lab Vet Drug Dev & Safety Evaluat, Guangzhou, Peoples R China.	hzding@sacu.edu.cn			National Key Research and Development Program of China [2016YFD0501300, 2016YFD0501310]	National Key Research and Development Program of China	This work was supported by the National Key Research and Development Program of China (grant numbers 2016YFD0501300 and 2016YFD0501310).he funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, PEOPLE, V70, P99; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Blondeau JM, 2015, AM J VET RES, V76, P860, DOI 10.2460/ajvr.76.10.860; Blondeau JM, 2009, VET DERMATOL, V20, P383, DOI 10.1111/j.1365-3164.2009.00856.x; Bordallo-Cardona Ma, 2018, ANTIMICROB AGENTS CH, V62; Charleston B, 1998, AVIAN PATHOL, V27, P190, DOI 10.1080/03079459808419322; Dimitrova D., 2011, Agricultural Science and Technology, V3, P229; Dong YZ, 1999, ANTIMICROB AGENTS CH, V43, P1756, DOI 10.1128/AAC.43.7.1756; Drlica K, 2003, J ANTIMICROB CHEMOTH, V52, P11, DOI 10.1093/jac/dkg269; Drlica K, 2007, CLIN INFECT DIS, V44, P681, DOI 10.1086/511642; Firsov AA, 2003, ANTIMICROB AGENTS CH, V47, P1604, DOI 10.1128/AAC.47.5.1604-1613.2003; Garau J, 1999, ANTIMICROB AGENTS CH, V43, P2736, DOI 10.1128/AAC.43.11.2736; Gutierrez L, 2014, J VET PHARMACOL THER, V37, P83, DOI 10.1111/jvp.12066; Hannan PCT, 1997, RES VET SCI, V63, P157, DOI 10.1016/S0034-5288(97)90010-2; HANNAN PCT, 1989, RES VET SCI, V46, P202, DOI 10.1016/S0034-5288(18)31146-9; Harada Y, 2014, CLIN MICROBIOL INFEC, V20, pO831, DOI 10.1111/1469-0691.12677; LaPlante KL, 2004, ANTIMICROB AGENTS CH, V48, P4665, DOI 10.1128/AAC.48.12.4665-4672.2004; Maes D, 2008, VET MICROBIOL, V126, P297, DOI 10.1016/j.vetmic.2007.09.008; Marois C, 2009, VET MICROBIOL, V135, P283, DOI 10.1016/j.vetmic.2008.09.061; Nakai H, 2018, J INFECT CHEMOTHER, V24, P83, DOI 10.1016/j.jiac.2017.08.009; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Price LB, 2007, ENVIRON HEALTH PERSP, V115, P1035, DOI 10.1289/ehp.10050; Quinn B, 2007, J ANTIMICROB CHEMOTH, V60, P1380, DOI 10.1093/jac/dkm375; Stakenborg T, 2005, MICROB DRUG RESIST, V11, P290, DOI 10.1089/mdr.2005.11.290; TANNER AC, 1993, VET MICROBIOL, V36, P301, DOI 10.1016/0378-1135(93)90096-P; Thongkamkoon P, 2013, J VET MED SCI, V75, P1067, DOI 10.1292/jvms.12-0520; Vicca J, 2007, MICROB DRUG RESIST, V13, P166, DOI 10.1089/mdr.2007.716; Wang CM, 2009, VET RES COMMUN, V33, P1013, DOI 10.1007/s11259-009-9320-6; WILLIAMS PP, 1978, ANTIMICROB AGENTS CH, V14, P210, DOI 10.1128/AAC.14.2.210; Xiong MP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00874; Zhang Z, 2011, J ANIM VET ADV, V10, P1824, DOI 10.3923/javaa.2011.1824.1828; Zhao XL, 2002, J INFECT DIS, V185, P561, DOI 10.1086/338571; Zhu YL, 2012, J ANTIMICROB CHEMOTH, V67, P2700, DOI 10.1093/jac/dks280	33	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0220350	10.1371/journal.pone.0220350	http://dx.doi.org/10.1371/journal.pone.0220350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544163	Green Published, Green Submitted, gold			2022-12-26	WOS:000542957200035
J	Ma, NA; Tie, CR; Yu, B; Zhang, W; Wan, J				Ma, Nana; Tie, Changrui; Yu, Bo; Zhang, Wei; Wan, Jun			Circular RNAs regulate its parental genes transcription in the AD mouse model using two methods of library construction	FASEB JOURNAL			English	Article						Alzheimer's disease (AD); APP; PS1 mouse; circRNA; library construction; RNA-sequencing	ALZHEIMERS-DISEASE; NONCODING RNAS; ANNOTATION; EXPRESSION; ABUNDANT; REVEALS	Circular RNA (circRNA) is an important class of noncoding RNA. Current, protocols to detected circRNAs have utilized nonpolyadenylated RNAs, ribosomal RNA-depleted RNA samples (rRNA- library), and rRNA-depleted RNA that has been treated with RNase R to digest linear RNA (rRNA- RNase R+ library). Accumulating evidence suggests the participation of circRNAs in Alzheimer's disease (AD)-associated pathophysiology, but the details remain largely unknown. Here, we elucidated the brain circRNAs profiles of AD-model and WT mice using two methods of library construction (rRNA- RNase R+ libraries and rRNA- libraries). We focused on the construction of libraries that best allow the identification of circRNAs from next-generation RNA sequencing data. We obtained a significantly higher abundance of circRNAs in the rRNA- RNase R+ libraries than in the rRNA- libraries. Additionally, the rRNA- RNase R+ libraries more clearly revealed differentially expressed circRNAs. We performed a correlation analysis between differentially expressed circRNAs and their parental genes and performed KEGG analysis of the parental genes to explore the role of circRNA in AD. Our results identified significantly dysregulated circRNAs and KEGG analysis revealed that the identified circRNAs are involved in regulating AD development from distinct origins, including cAMP signaling, MAPK signaling, insulin secretion, Axon guidance, Long-term potentiation, dopaminergic synapse, and ErBb signaling pathways. Following rigorous selection, we identified several important circRNAs and mRNAs and propose the circRNAs regulate parental gene transcription or affect variable splicing, which were discovered to be mainly involved in A beta production and cognitive performance (TRPC6) and neuronal differentiation and development (NME7). These newly identified circRNAs should serve as a valuable resource for the future development of potential biomarkers and therapeutic targets for AD.	[Ma, Nana; Tie, Changrui; Zhang, Wei; Wan, Jun] Hong Kong Univ Sci & Technol, Shenzhen Peking Univ, Biomed Res Inst, Shenzhen Key Lab Neuronal Struct Biol,Med Ctr, Shenzhen 518000, Peoples R China; [Yu, Bo] Hong Kong Univ Sci & Technol, Shenzhen Peking Univ, Biomed Res Inst, Shenzhen Key Lab Translat Med Dermatol,Med Ctr, Shenzhen, Peoples R China; [Yu, Bo] Peking Univ, Shenzhen Hosp, Dept Dermatol, Shenzhen, Peoples R China; [Zhang, Wei; Wan, Jun] Shenzhen Bay Lab, Greater Bay Biomed Innoctr, Shenzhen, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Peking University; Shenzhen Bay Laboratory	Zhang, W; Wan, J (corresponding author), Hong Kong Univ Sci & Technol, Shenzhen Peking Univ, Biomed Res Inst, Shenzhen Key Lab Neuronal Struct Biol,Med Ctr, Shenzhen 518000, Peoples R China.	zhangweispace@163.com; wanj@ust.hk			National Key R&D Program of China [2016YFA0501903]; National Natural Science Foundation of China (NSFC) [81673053]; Natural Scientific Foundation of Guangdong Province [2016A030312016]; Shenzhen Basic Research Grant [JCYJ20160229153100269, JCYJ20170411090739316, JCYJ20170815153617033, JCYJ20180507182657867, JCYJ20170306161450254, JCYJ20170306161807726]	National Key R&D Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Scientific Foundation of Guangdong Province; Shenzhen Basic Research Grant	National Key R&D Program of China Grant, Grant/Award Number: 2016YFA0501903; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81673053; Natural Scientific Foundation of Guangdong Province, Grant/Award Number: 2016A030312016; Shenzhen Basic Research Grant, Grant/Award Number: JCYJ20160229153100269, JCYJ20170411090739316, JCYJ20170815153617033, JCYJ20180507182657867, JCYJ20170306161450254 and JCYJ20170306161807726	Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Braunschweig U, 2014, GENOME RES, V24, P1774, DOI 10.1101/gr.177790.114; Canter RG, 2016, NATURE, V539, P187, DOI 10.1038/nature20412; Charalambous DC, 2013, CELL MOL LIFE SCI, V70, P335, DOI 10.1007/s00018-012-1108-0; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Du WW, 2017, EUR HEART J, V38, P1402, DOI 10.1093/eurheartj/ehw001; Gao Y, 2018, BRIEF BIOINFORM, V19, P803, DOI 10.1093/bib/bbx014; Gruner H, 2016, SCI REP-UK, V6, DOI 10.1038/srep38907; Guarnerio J, 2016, CELL, V166, P1055, DOI 10.1016/j.cell.2016.07.035; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Holdt Lesca M, 2018, Noncoding RNA Res, V3, P75, DOI 10.1016/j.ncrna.2018.05.002; Huang S, 2017, GENOMICS, V109, P401, DOI 10.1016/j.ygeno.2017.06.005; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Lonskaya I, 2013, J ALZHEIMERS DIS, V33, P231, DOI 10.3233/JAD-2012-121141; Lu R, 2018, MOL PSYCHIATR, V23, P767, DOI 10.1038/mp.2017.136; Lukiw Walter J., 2013, Frontiers in Genetics, V4, P307, DOI [10.3389/fgene.2013.00307, 10.3389/fgene.2013.00077]; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Sando R, 2019, SCIENCE, V363, P837, DOI 10.1126/science.aav7969; Schroeder J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00501; Tatro ET, 2013, AM J GERIAT PSYCHIAT, V21, P461, DOI 10.1016/j.jagp.2012.09.005; Tay MLI, 2017, CURR BIOL, V27, P1062, DOI 10.1016/j.cub.2017.02.040; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Wang JF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9876; Wang K, 2016, EUR HEART J, V37, P2602, DOI 10.1093/eurheartj/ehv713; Werfel S, 2016, J MOL CELL CARDIOL, V98, P103, DOI 10.1016/j.yjmcc.2016.07.007; Westholm JO, 2014, CELL REP, V9, P1966, DOI 10.1016/j.celrep.2014.10.062; Yang Y, 2017, CELL RES, V27, P626, DOI 10.1038/cr.2017.31; Zadori D, 2018, J ALZHEIMERS DIS, V62, P523, DOI 10.3233/JAD-170929; Zeng Y, 2017, THERANOSTICS, V7, P3842, DOI 10.7150/thno.19764; Zhang XP, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102897; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017	46	7	7	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10342	10356		10.1096/fj.201903157R	http://dx.doi.org/10.1096/fj.201903157R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32530085	hybrid			2022-12-26	WOS:000541524800001
J	Meindl, C; Hochadel, M; Frankenstein, L; Bruder, O; Pauschinger, M; Hambrecht, R; von Scheidt, W; Pfister, O; Hartmann, A; Maier, LS; Senges, J; Unsold, B				Meindl, Christine; Hochadel, Matthias; Frankenstein, Lutz; Bruder, Oliver; Pauschinger, Matthias; Hambrecht, Rainer; von Scheidt, Wolfgang; Pfister, Otmar; Hartmann, Andreas; Maier, Lars S.; Senges, Jochen; Unsoeld, Bernhard			The role of diabetes in cardiomyopathies of different etiologies-Characteristics and 1-year follow-up results of the EVITA-HF registry	PLOS ONE			English	Article							HEART-FAILURE PATIENTS; VENTRICULAR DIASTOLIC DYSFUNCTION; MYOCARDIAL-INFARCTION; EJECTION FRACTION; MELLITUS; OUTCOMES; DISEASE; EMPAGLIFLOZIN; ABNORMALITIES; LISINOPRIL	Background Type 2 diabetes is a major risk factor for cardiovascular diseases, e.g. coronary artery disease (CAD). But it has also been shown that diabetes can cause heart failure independently of ischemic heart disease (IHD) by causing diabetic cardiomyopathy. In contrast to diabetes and IHD, limited data exist regarding patients with diabetes and dilated cardiomyopathy (DCM). Methods EVIdence based TreAtment in Heart Failure (EVITA-HF) comprises web-based case report data on demography, diagnostic measures, adverse events and 1-year follow-up of patients hospitalized for chronic heart failure and an ejection fraction <= 40%. In the present study we focused on the results of patients with diabetes and heart failure. Results Between February 2009 and November 2015, 4101 patients with chronic heart failure were included in 16 tertiary care centers in Germany. The mortality in patients with diabetes and DCM (n = 323) was more than double (15.2%) than that of DCM patients without diabetes (6.5%, p<0.001, n = 885). In contrast the mortality rate of patients withIHDwas not influenced by the presence of diabetes (17.6% in patients withIHDand diabetes n = 945, vs. 14.7% in patients withIHDand no diabetes, n = 1236, p = 0.061). The results also remained stable after performing a multivariable analysis (unadjusted p-value for interaction = 0.002, adjusted p = 0.046). Conclusion The influence of diabetes on the mortality rate is only significant in patients with DCM not in patients with CAD. Therefore, the underlying mechanisms of this effect should be studied in greater detail to improve patient care and outcome.	[Meindl, Christine; Maier, Lars S.; Unsoeld, Bernhard] Univ Hosp Regensburg, Dept Internal Med 2, Regensburg, Germany; [Hochadel, Matthias; Senges, Jochen] Stiftung Inst Herzinfarktforsch Ludwigshafen, Ludwigshafen, Germany; [Frankenstein, Lutz] Univ Hosp Heidelberg, Dept Internal Med 3, Heidelberg, Germany; [Bruder, Oliver] Elisabeth Hosp Essen, Dept Cardiol & Angiol, Essen, Germany; [Pauschinger, Matthias] Nurnberg Hosp, Dept Internal Med 8, Nurnberg, Germany; [Hambrecht, Rainer] Hosp Links Weser, Dept Internal Med 2, Bremen, Germany; [von Scheidt, Wolfgang] Univ Hosp Augsburg, Dept Internal Med 1, Augsburg, Germany; [Pfister, Otmar] Univ Hosp Basel, Dept Cardiol, Basel, Switzerland; [Hartmann, Andreas] St Georg Hosp Leipzig, Dept Cardiol & Internal Intens Care, Leipzig, Germany	University of Regensburg; Institute Heart Attack Research; Ruprecht Karls University Heidelberg; University of Basel	Meindl, C (corresponding author), Univ Hosp Regensburg, Dept Internal Med 2, Regensburg, Germany.	christine.meindl@ukr.de	Maier, Lars/AAQ-8313-2021; Pfister, Otmar/AAB-4752-2022; Unsöld, Berhard/M-7165-2019; Unsöld, Bernhard W/D-9067-2014	Maier, Lars/0000-0001-9915-4429; Unsöld, Bernhard W/0000-0002-9889-1264; Meindl, Christine/0000-0001-7086-0469	EU HORIZON 2020 (SILICOFCM) [777204]; Deutsche Forschungsgemeinschaft [MA 1982/5-1, MA 1982/7-1, SFB 1350 TP A6]	EU HORIZON 2020 (SILICOFCM); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Dr. Maier is supported by EU HORIZON 2020 (SILICOFCM ID777204) as well as by grants from the Deutsche Forschungsgemeinschaft MA 1982/5-1 and MA 1982/7-1 and SFB 1350 TP A6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CAN J DIABETES S3, V37, pS357; Banks AZ, 2016, J CARD FAIL, V22, P485, DOI 10.1016/j.cardfail.2015.12.007; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3; Fantoni C, 2008, EUR J HEART FAIL, V10, P298, DOI 10.1016/j.ejheart.2008.01.006; Frieler RA, 2015, CIRCULATION, V131, P1019, DOI 10.1161/CIRCULATIONAHA.114.008788; Galderisi M, 2006, J AM COLL CARDIOL, V48, P1548, DOI 10.1016/j.jacc.2006.07.033; Ghali JK, 2007, J CARD FAIL, V13, P769, DOI 10.1016/j.cardfail.2007.06.723; Haas SJ, 2003, AM HEART J, V146, P848, DOI 10.1016/S0002-8703(03)00403-4; Hueb T, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0320-y; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kristensen SL, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002560; Litwin SE, 2013, DIABETES, V62, P3329, DOI 10.2337/db13-0683; MacDonald MR, 2008, EUR HEART J, V29, P1377, DOI 10.1093/eurheartj/ehn153; Mahaffey KW, 2018, CIRCULATION, V137, P323, DOI 10.1161/CIRCULATIONAHA.117.032038; Mann DL, 2015, CIRC RES, V116, P1254, DOI 10.1161/CIRCRESAHA.116.302317; McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Mustroph J, 2018, ESC HEART FAIL, V5, P642, DOI 10.1002/ehf2.12336; Pabel S, 2018, EUR J HEART FAIL, V20, P1690, DOI 10.1002/ejhf.1328; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Ryden L, 2000, EUR HEART J, V21, P1967, DOI 10.1053/euhj.2000.2311; Seferovic PM, 2018, EUR J HEART FAIL, V20, P853, DOI 10.1002/ejhf.1170; Seferovic PM, 2015, EUR HEART J, V36, P1718, DOI 10.1093/eurheartj/ehv134; Shimabukuro M, 2007, DIABETES OBES METAB, V9, P323, DOI 10.1111/j.1463-1326.2006.00607.x; Suskin N, 2000, EUR HEART J, V21, P1368, DOI 10.1053/euhj.1999.2043; Swedberg K, 2010, REV PORT CARDIOL, V29, P1273, DOI 10.1016/S0140-6736(10)61198-1; Testa M, 1996, J AM COLL CARDIOL, V28, P964, DOI 10.1016/S0735-1097(96)00268-9; Thrainsdottir IS, 2005, DIABETES CARE, V28, P612, DOI 10.2337/diacare.28.3.612; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Valle R, 2006, EUR J ECHOCARDIOGR, V7, P40, DOI 10.1016/j.euje.2005.03.009; van Heerebeek L, 2008, CIRCULATION, V117, P43, DOI 10.1161/CIRCULATIONAHA.107.728550; Vasan RS, 2003, CIRCULATION, V107, P1486, DOI 10.1161/01.CIR.0000057810.48709.F6; von Scheidt W, 2014, CLIN RES CARDIOL, V103, P1006, DOI 10.1007/s00392-014-0743-x; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	39	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234260	10.1371/journal.pone.0234260	http://dx.doi.org/10.1371/journal.pone.0234260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525964	Green Published, gold			2022-12-26	WOS:000542036800069
J	Mopidevi, B; Sivankutty, I; Hao, SJ; Ferreri, NR; Kumar, A				Mopidevi, Brahmaraju; Sivankutty, Indu; Hao, Shoujin; Ferreri, Nicholas R.; Kumar, Ashok			Effects of intron conversion in the human CYP11B2 gene on its transcription and blood pressure regulation in transgenic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transgenic mice; aldosterone synthase; single-nucleotide polymorphism (SNP; ); gene expression; genetics; hypertension; cardiovascular disease; renin-angiotensin system; intron conversion	ALDOSTERONE SYNTHASE GENE; HUMAN ANGIOTENSINOGEN GENE; STEROID 11-BETA-HYDROXYLASE; ESSENTIAL-HYPERTENSION; POLYMORPHISM; ASSOCIATION; SYSTEM; EXPRESSION; HAPLOTYPE; POPULATION	The human cytochrome P450 family 11 subfamily B member 2 (hCYP11B2) gene encodes aldosterone synthase, the rate-limiting enzyme in the biosynthesis of aldosterone. In some humans,hCYP11B2undergoes a unique intron conversion whose function is largely unclear. The intron conversion is formed by a replacement of the segment of DNA within intron 2 ofhCYP11B2with the corresponding region of thehCYP11B1gene. We show here that the intron conversion is located in an open chromatin form and binds more strongly to the transcriptional regulators histone acetyltransferase P300 (p300), NF kappa B, and CCAAT enhancer-binding protein alpha (CEBP alpha). Reporter constructs containing the intron conversion had increased promoter activity on transient transfection in H295R cells compared with WT intron 2. We generated humanized transgenic (TG) mice containing all the introns, exons, and 5 '- and 3 '-flanking regions of thehCYP11B2gene containing either the intron conversion or WT intron 2. We found that TG mice containing the intron conversion have (a) increased plasma aldosterone levels, (b) increasedhCYP11B2mRNA and protein levels, and (c) increased blood pressure compared with TG mice containing WT intron 2. Results of a ChIP assay showed that chromatin obtained from the adrenals of TG mice containing the intron conversion binds more strongly to p300, NF kappa B, and CEBP alpha than to WT intron 2. These results uncover a functional role of intron conversion inhCYP11B2and suggest a new paradigm in blood pressure regulation.	[Mopidevi, Brahmaraju; Sivankutty, Indu; Kumar, Ashok] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; [Hao, Shoujin; Ferreri, Nicholas R.] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA	New York Medical College; New York Medical College	Kumar, A (corresponding author), New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA.	akumar5@nymc.edu	Mopidevi, Brahmaraju/D-6003-2015	Mopidevi, Brahmaraju/0000-0003-1231-7796	NHLBI, National Institutes of Health [RO1 HL 122742, RO1 HL 130344]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health Grants RO1 HL 122742 and RO1 HL 130344 (to A. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez-Madrazo S, 2013, HYPERTENSION, V61, P232, DOI 10.1161/HYPERTENSIONAHA.112.200741; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Brand E, 1998, HYPERTENSION, V32, P198, DOI 10.1161/01.HYP.32.2.198; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Calhoun DA, 2002, HYPERTENSION, V40, P892, DOI 10.1161/01.HYP.0000040261.30455.B6; Casiglia E, 2005, J HYPERTENS, V23, P1991, DOI 10.1097/01.hjh.0000183119.92455.a7; Castellano M, 2003, J HYPERTENS, V21, P1853, DOI 10.1097/00004872-200310000-00012; CHUA SC, 1987, P NATL ACAD SCI USA, V84, P7193, DOI 10.1073/pnas.84.20.7193; Cvetkovic B, 2000, J BIOL CHEM, V275, P1073, DOI 10.1074/jbc.275.2.1073; Cvetkovic B, 2002, PHYSIOL GENOMICS, V11, P253, DOI 10.1152/physiolgenomics.00076.2002; Davies E, 2003, J HYPERTENS, V21, P1249, DOI 10.1097/00004872-200307000-00008; Davies E, 1999, HYPERTENSION, V33, P703, DOI 10.1161/01.HYP.33.2.703; Evangelou E, 2018, NAT GENET, V50, P1412, DOI 10.1038/s41588-018-0205-x; Galis ZS, 2013, HYPERTENSION, V61, P757, DOI 10.1161/HYPERTENSIONAHA.111.00770; GRIENDLING KK, 1993, CIRCULATION, V87, P1816, DOI 10.1161/01.CIR.87.6.1816; Gu HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00461-9; Hautanen A, 1998, J INTERN MED, V244, P11, DOI 10.1046/j.1365-2796.1998.00308.x; Henderson SO, 2004, AM J MED SCI, V328, P266, DOI 10.1097/00000441-200411000-00006; Iwai N, 2007, HYPERTENSION, V49, P825, DOI 10.1161/01.HYP.0000258796.52134.26; Jain S, 2010, J BIOL CHEM, V285, P41172, DOI 10.1074/jbc.M110.167585; Jain S, 2008, AM J PHYSIOL-REG I, V295, pR1849, DOI 10.1152/ajpregu.90637.2008; KAWAMOTO T, 1992, P NATL ACAD SCI USA, V89, P1458, DOI 10.1073/pnas.89.4.1458; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Luft FC, 1998, J HYPERTENS, V16, P1871, DOI 10.1097/00004872-199816121-00004; Luft FC, 1999, HYPERTENSION, V33, P212, DOI 10.1161/01.HYP.33.1.212; Makhanova N, 2008, HYPERTENSION, V51, P134, DOI 10.1161/HYPERTENSIONAHA.107.098897; Makhanova N, 2006, HYPERTENSION, V48, P1151, DOI 10.1161/01.HYP.0000249902.09036.e7; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; Mopidevi B, 2015, CIRC-CARDIOVASC GENE, V8, P30, DOI 10.1161/CIRCGENETICS.114.000694; MORNET E, 1989, J BIOL CHEM, V264, P20961; Mulatero P, 2004, J CLIN ENDOCR METAB, V89, P1045, DOI 10.1210/jc.2003-031337; Munshi A, 2010, J NEUROL SCI, V296, P34, DOI 10.1016/j.jns.2010.06.013; Nicod J, 2003, J CLIN ENDOCR METAB, V88, P2495, DOI 10.1210/jc.2002-021598; Paillard F, 1999, HYPERTENSION, V34, P423, DOI 10.1161/01.HYP.34.3.423; Parati G, 2007, J HYPERTENS, V25, P2377, DOI 10.1097/HJH.0b013e32801143b3; Rajan S, 2010, INDIAN J MED RES, V132, P379; Romero DG, 2007, PHYSIOL GENOMICS, V32, P117, DOI 10.1152/physiolgenomics.00145.2007; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Russo P, 2002, J HYPERTENS, V20, P1785, DOI 10.1097/00004872-200209000-00023; Sookoian S, 2007, J HYPERTENS, V25, P5, DOI 10.1097/01.hjh.0000254372.88488.a9; STACHENKO J, 1959, ENDOCRINOLOGY, V64, P730, DOI 10.1210/endo-64-5-730; Tiago AD, 2003, AM J HYPERTENS, V16, P1006, DOI 10.1016/j.amjhyper.2003.07.010; WAGNER MJ, 1991, GENOMICS, V10, P114, DOI 10.1016/0888-7543(91)90491-V; Warren HR, 2017, NAT GENET, V49, P403, DOI 10.1038/ng.3768; WHITE PC, 1995, ENDOCR RES, V21, P437, DOI 10.3109/07435809509030459; Young WF, 2007, CLIN ENDOCRINOL, V66, P607, DOI 10.1111/j.1365-2265.2007.02775.x; Zhou JH, 2015, HYPERTENSION, V65, P1103, DOI 10.1161/HYP.0000000000000025	50	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11068	11081		10.1074/jbc.RA120.013047	http://dx.doi.org/10.1074/jbc.RA120.013047			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32540969	Green Published, hybrid			2022-12-26	WOS:000562757100014
J	Chehayeb, RJ; Wang, J; Stiegler, AL; Boggon, TJ				Jaber Chehayeb, Rachel; Wang, Jessica; Stiegler, Amy L.; Boggon, Titus J.			The GTPase-activating protein p120RasGAP has an evolutionarily conserved "FLVR-unique" SH2 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Src homology 2 domain (SH2 domain); X-ray crystallography; protein structure; phosphotyrosine; protein-protein interaction; GTPase-activating protein (GAP); RASA1; p120RasGAP; RasGAP; FLVR motif	AFFINITY PHOSPHOTYROSYL PEPTIDE; SRC HOMOLOGY-2 DOMAIN; STRUCTURAL BASIS; TRANSFORMING ACTIVITY; CRYSTAL-STRUCTURES; BINDING; RECOGNITION; RAS; SPECIFICITY; GAP	The Src homology 2 (SH2) domain has a highly conserved architecture that recognizes linear phosphotyrosine motifs and is present in a wide range of signaling pathways across different evolutionary taxa. A hallmark of SH2 domains is the arginine residue in the conserved FLVR motif that forms a direct salt bridge with bound phosphotyrosine. Here, we solve the X-ray crystal structures of the C-terminal SH2 domain of p120RasGAP (RASA1) in its apo and peptide-bound form. We find that the arginine residue in the FLVR motif does not directly contact pTyr(1087)of a bound phosphopeptide derived from p190RhoGAP; rather, it makes an intramolecular salt bridge to an aspartic acid. Unexpectedly, coordination of phosphotyrosine is achieved by a modified binding pocket that appears early in evolution. Using isothermal titration calorimetry, we find that substitution of the FLVR arginine R377A does not cause a significant loss of phosphopeptide binding, but rather a tandem substitution of R398A (SH2 position beta D4) and K400A (SH2 position beta D6) is required to disrupt the binding. These results indicate a hitherto unrecognized diversity in SH2 domain interactions with phosphotyrosine and classify the C-terminal SH2 domain of p120RasGAP as "FLVR-unique."	[Jaber Chehayeb, Rachel; Wang, Jessica] Yale Coll, New Haven, CT USA; [Jaber Chehayeb, Rachel; Wang, Jessica; Boggon, Titus J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Stiegler, Amy L.; Boggon, Titus J.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Boggon, Titus J.] Yale Univ, Yale Canc Ctr, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Boggon, TJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.; Boggon, TJ (corresponding author), Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA.; Boggon, TJ (corresponding author), Yale Univ, Yale Canc Ctr, New Haven, CT 06520 USA.	titus.boggon@yale.edu		Jaber Chehayeb, Rachel/0000-0002-2117-7433	National Institutes of Health [R01GM102262, S10OD018007, P41GM103403]; Department of Energy Office of Science [DE-AC02-06CH11357]; Rosenfeld Science Scholarship; Yale College Dean's Office; American Heart Association [19IPLOI34740007]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Science(United States Department of Energy (DOE)); Rosenfeld Science Scholarship; Yale College Dean's Office; American Heart Association(American Heart Association)	This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by National Institutes of Health Grant P41GM103403. This work used resources of the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. R. J. C. was supported in part by Mr. Morton and Mrs. Maggie Rosenfeld, the Rosenfeld Science Scholarship, and the Yale College Dean's Office. This work was also supported by National Institutes of Health Grants R01GM102262 and S10OD018007 and American Heart Association Grant 19IPLOI34740007 (to T. J. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; BIBBINS KB, 1993, MOL CELL BIOL, V13, P7278, DOI 10.1128/MCB.13.12.7278; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Bradshaw JM, 1999, J MOL BIOL, V293, P971, DOI 10.1006/jmbi.1999.3190; Bradshaw JM, 1998, BIOCHEMISTRY-US, V37, P9083, DOI 10.1021/bi973147k; BRYANT SS, 1995, J BIOL CHEM, V270, P17947, DOI 10.1074/jbc.270.30.17947; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Chehayeb RJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226113; Chen CH, 2013, BIOPOLYMERS, V99, P897, DOI 10.1002/bip.22371; Dail M, 2006, J CELL SCI, V119, P1244, DOI 10.1242/jcs.02842; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; ECK MJ, 1995, STRUCTURE, V3, P421, DOI 10.1016/S0969-2126(01)00173-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frese S, 2006, J BIOL CHEM, V281, P18236, DOI 10.1074/jbc.M512917200; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Harris TW, 2020, NUCLEIC ACIDS RES, V48, pD762, DOI 10.1093/nar/gkz920; Haslam NJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003372; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Hause RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044471; HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0; Hernandez SE, 2004, CURR BIOL, V14, P691, DOI 10.1016/j.cub.2004.03.062; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Hwang PM, 2002, EMBO J, V21, P314, DOI 10.1093/emboj/21.3.314; Kaneko T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06943-2; Kaneko T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003021; Kaneko T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000796; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kraskouskaya D, 2013, CHEM SOC REV, V42, P3337, DOI 10.1039/c3cs35449k; Kulkarni SV, 2000, J CELL BIOL, V149, P457, DOI 10.1083/jcb.149.2.457; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Ladbury JE, 2011, METHOD ENZYMOL, P147, DOI 10.1016/B978-0-12-381268-1.00007-0; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Li J, 2016, P NATL ACAD SCI USA, V113, P13015, DOI 10.1073/pnas.1611228113; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Liu BA, 2012, PHILOS T R SOC B, V367, P2556, DOI 10.1098/rstb.2012.0107; Liu BA, 2012, FEBS LETT, V586, P2597, DOI 10.1016/j.febslet.2012.04.054; Liu HD, 2019, MOL CELL PROTEOMICS, V18, P372, DOI 10.1074/mcp.RA118.001123; MAYER BJ, 1992, MOL CELL BIOL, V12, P609, DOI 10.1128/MCB.12.2.609; MAYER BJ, 1995, STRUCTURE, V3, P977, DOI 10.1016/S0969-2126(01)00232-5; Mayer BJ, 2012, FEBS LETT, V586, P2575, DOI 10.1016/j.febslet.2012.05.002; MCCORMICK F, 1988, COLD SPRING HARB SYM, V53, P849, DOI 10.1101/SQB.1988.053.01.097; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKercher MA, 2017, BIOCHEMISTRY-US, V56, P2225, DOI 10.1021/acs.biochem.7b00023; McNally R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156218; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; Morlacchi P, 2014, FUTURE MED CHEM, V6, P1909, DOI 10.4155/fmc.14.120; Nash PD, 2012, FEBS LETT, V586, P2572, DOI 10.1016/j.febslet.2012.04.049; Oh D, 2012, P NATL ACAD SCI USA, V109, P14024, DOI 10.1073/pnas.1203397109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OVERDUIN M, 1992, CELL, V70, P697, DOI 10.1016/0092-8674(92)90437-H; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Poy F, 1999, MOL CELL, V4, P555, DOI 10.1016/S1097-2765(00)80206-3; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Sfakianos MK, 2007, J NEUROSCI, V27, P10982, DOI 10.1523/JNEUROSCI.0793-07.2007; Shah NH, 2018, CRIT REV BIOCHEM MOL, V53, P535, DOI 10.1080/10409238.2018.1495173; Shi ZD, 2003, BIOCHEM BIOPH RES CO, V310, P378, DOI 10.1016/j.bbrc.2003.09.029; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Suga H, 2014, MOL BIOL EVOL, V31, P517, DOI 10.1093/molbev/mst241; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thurmond J, 2019, NUCLEIC ACIDS RES, V47, pD759, DOI 10.1093/nar/gky1003; Tinti M, 2013, CELL REP, V3, P1293, DOI 10.1016/j.celrep.2013.03.001; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; vanderGeer P, 1997, MOL CELL BIOL, V17, P1840, DOI 10.1128/MCB.17.4.1840; Virdee S, 2010, CHEM BIOL, V17, P274, DOI 10.1016/j.chembiol.2010.01.015; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; Waksman Gabriel, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007331; Wallweber HJA, 2014, NAT STRUCT MOL BIOL, V21, P443, DOI 10.1038/nsmb.2807; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; Zadjali F, 2011, J BIOL CHEM, V286, P480, DOI 10.1074/jbc.M110.173526; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	84	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10511	10521		10.1074/jbc.RA120.013976	http://dx.doi.org/10.1074/jbc.RA120.013976			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32540970	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000560405600001
J	Liu, W; Yin, Y; Wang, MJ; Fan, T; Zhu, YY; Shen, LH; Peng, S; Gao, J; Deng, GL; Meng, XB; Kong, LD; Feng, GS; Guo, WJ; Xu, Q; Sun, Y				Liu, Wen; Yin, Ye; Wang, Meijing; Fan, Ting; Zhu, Yuyu; Shen, Lihong; Peng, Shuang; Gao, Jian; Deng, Guoliang; Meng, Xiangbao; Kong, Lingdong; Feng, Gen-Sheng; Guo, Wenjie; Xu, Qiang; Sun, Yang			Disrupting phosphatase SHP2 in macrophages protects mice from high-fat diet-induced hepatic steatosis and insulin resistance by elevating IL-18 levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Src homology 2 domain containing tyrosine phosphatase-2 (SHP2); hepatic steatosis; insulin resistance; caspase-1; interleukin 18 (IL-18); fatty liver; metabolic disorder; inflammation; cytokine signaling; caspase 1 (CASP1); tyrosine-protein phosphatase (tyrosine phosphatase); macrophage	TYROSINE-PHOSPHATASE; NLRP3 INFLAMMASOME; ENERGY-BALANCE; BODY-WEIGHT; INTERLEUKIN-18; OBESITY; INHIBITION; IL-1-BETA; CYTOKINES; DELETION	Chronic low-grade inflammation plays an important role in the pathogenesis of type 2 diabetes. Src homology 2 domain-containing tyrosine phosphatase-2 (SHP2) has been reported to play diverse roles in different tissues during the development of metabolic disorders. We previously reported that SHP2 inhibition in macrophages results in increased cytokine production. Here, we investigated the association between SHP2 inhibition in macrophages and the development of metabolic diseases. Unexpectedly, we found that mice with a conditional SHP2 knockout in macrophages (cSHP2-KO) have ameliorated metabolic disorders. cSHP2-KO mice fed a high-fat diet (HFD) gained less body weight and exhibited decreased hepatic steatosis, as well as improved glucose intolerance and insulin sensitivity, compared with HFD-fed WT littermates. Further experiments revealed that SHP2 deficiency leads to hyperactivation of caspase-1 and subsequent elevation of interleukin 18 (IL-18) levels, bothin vivoandin vitro. Of note, IL-18 neutralization and caspase-1 knockout reversed the amelioration of hepatic steatosis and insulin resistance observed in the cSHP2-KO mice. Administration of two specific SHP2 inhibitors, SHP099 and Phps1, improved HFD-induced hepatic steatosis and insulin resistance. Our findings provide detailed insights into the role of macrophagic SHP2 in metabolic disorders. We conclude that pharmacological inhibition of SHP2 may represent a therapeutic strategy for the management of type 2 diabetes.	[Liu, Wen; Wang, Meijing; Fan, Ting; Zhu, Yuyu; Shen, Lihong; Peng, Shuang; Gao, Jian; Deng, Guoliang; Kong, Lingdong; Guo, Wenjie; Xu, Qiang; Sun, Yang] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Biotechnol & Pharmaceut Sci, Sch Life Sci, Nanjing, Peoples R China; [Yin, Ye] Nanjing Med Univ, Dept Biochem & Mol Biol, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Peoples R China; [Meng, Xiangbao] Peking Univ, Sch Pharmaceut Sci, Dept Biol Chem, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China; [Feng, Gen-Sheng] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Feng, Gen-Sheng] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Sun, Yang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China; [Sun, Yang] Nanjing Univ, Chem & Biomed Innovat Ctr ChemBIC, Nanjing, Peoples R China	Nanjing University; Nanjing Medical University; Peking University; University of California System; University of California San Diego; University of California System; University of California San Diego; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Nanjing University	Guo, WJ; Xu, Q; Sun, Y (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Biotechnol & Pharmaceut Sci, Sch Life Sci, Nanjing, Peoples R China.; Sun, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China.; Sun, Y (corresponding author), Nanjing Univ, Chem & Biomed Innovat Ctr ChemBIC, Nanjing, Peoples R China.	guowj@nju.edu.cn; molpharm@163.com; yangsun@nju.edu.cn	Gao, Jian/AAU-8293-2021	Gao, Jian/0000-0002-2722-7067; Peng, Shuang/0000-0002-5875-5858	National Natural Science Foundation of China [91853109, 81872877, 81730100, 81922067, 81673436, 81970709]; Open Fund of State Key Laboratory of Drug Research [SIMM1903KF-10]; Fundamental Research Funds for the Central Universities [14380114, 14380128]; Mountain-Climbing Talents Project of Nanjing University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Fund of State Key Laboratory of Drug Research; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Mountain-Climbing Talents Project of Nanjing University	This work was supported by National Natural Science Foundation of China (91853109, 81872877, 81730100, 81922067, 81673436, and 81970709), Open Fund of State Key Laboratory of Drug Research (SIMM1903KF-10), Fundamental Research Funds for the Central Universities (14380114, 14380128), and Mountain-Climbing Talents Project of Nanjing University.	Bettaieb A, 2011, METABOLISM, V60, P1193, DOI 10.1016/j.metabol.2011.01.004; Bhaskar V, 2011, ATHEROSCLEROSIS, V216, P313, DOI 10.1016/j.atherosclerosis.2011.02.026; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; do Carmo JM, 2014, AM J PHYSIOL-REG I, V307, pR1438, DOI 10.1152/ajpregu.00131.2014; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Finucane OM, 2015, DIABETES, V64, P2116, DOI 10.2337/db14-1098; Fortanet JG, 2016, J MED CHEM, V59, P7773, DOI 10.1021/acs.jmedchem.6b00680; Fruhbeck G, 2007, TRENDS ENDOCRIN MET, V18, P177, DOI 10.1016/j.tem.2007.04.001; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Guo WJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02351-0; He Z, 2012, MOL CELL BIOL, V32, P1867, DOI 10.1128/MCB.06712-11; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kaiser C, 2012, RHEUMATOL INT, V32, P295, DOI 10.1007/s00296-011-2096-3; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Lakhani HV, 2018, INT J MED SCI, V15, P1591, DOI 10.7150/ijms.27953; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lindegaard B, 2013, DIABETES, V62, P3064, DOI 10.2337/db12-1095; Maedler K, 2009, EXPERT OPIN BIOL TH, V9, P1177, DOI 10.1517/14712590903136688; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Matsuo K, 2010, J BIOL CHEM, V285, P39750, DOI 10.1074/jbc.M110.153734; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Mridha AR, 2017, J HEPATOL, V66, P1037, DOI 10.1016/j.jhep.2017.01.022; Murphy AJ, 2016, CELL METAB, V23, P155, DOI 10.1016/j.cmet.2015.09.024; Nagata N, 2012, ENDOCRINOLOGY, V153, P3158, DOI 10.1210/en.2012-1406; National Research Council, 2011, GUIDE CARE USE LAB A; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Princen F, 2009, MOL CELL BIOL, V29, P378, DOI 10.1128/MCB.01661-08; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Tack CJ, 2012, IMMUNOL REV, V249, P239, DOI 10.1111/j.1600-065X.2012.01145.x; Tajan M, 2014, P NATL ACAD SCI USA, V111, pE4494, DOI 10.1073/pnas.1406107111; Tilg H, 2016, HEPATOLOGY, V64, P955, DOI 10.1002/hep.28456; Xu H, 2013, DRUG DISCOV TODAY DI, V10, P21, DOI DOI 10.1016/J.DDMEC.2013.03.006; Yasuda K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030649; Zhang JH, 2014, GENE, V537, P230, DOI 10.1016/j.gene.2013.12.062; Zhao MX, 2019, ACTA PHARM SIN B, V9, P304, DOI 10.1016/j.apsb.2018.08.009; Zhu QF, 2017, J IMMUNOL, V198, P4210, DOI 10.4049/jimmunol.1700352; Zorrilla EP, 2014, BRAIN BEHAV IMMUN, V37, P45, DOI 10.1016/j.bbi.2013.12.001	43	13	13	5	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10842	10856		10.1074/jbc.RA119.011840	http://dx.doi.org/10.1074/jbc.RA119.011840			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32546483	Green Published, hybrid			2022-12-26	WOS:000560405600026
J	Goodliffe, J; Rubakovic, A; Chang, WE; Pathak, D; Luebke, J				Goodliffe, Joseph; Rubakovic, Anastasia; Chang, Wayne; Pathak, Dhruba; Luebke, Jennifer			Structural and functional features of medium spiny neurons in the BACHD Delta N17 mouse model of Huntington's Disease	PLOS ONE			English	Article							HUMAN MUTANT HUNTINGTIN; BASAL GANGLIA; PROJECTION NEURONS; DIFFERENTIAL LOSS; PREFERENTIAL LOSS; N-17 DOMAIN; AGGREGATION; PROTEIN; DOPAMINE; NUCLEAR	In the BACHD mouse model of Huntington's disease (HD), deletion of the N17 domain of the Huntingtin gene (BACHD Delta N17, Q97) has been reported to lead to nuclear accumulation of mHTT and exacerbation of motor deficits, neuroinflammation and striatal atrophy (Gu et al., 2015). Here we characterized the effect of N17 deletion on dorsolateral striatal medium spiny neurons (MSNs) in BACHD Delta N17 (Q97) and BACWT Delta N17 (Q31) mice by comparing them to MSNs in wildtype (WT) mice. Mice were characterized on a series of motor tasks and subsequently whole cell patch clamp recordings with simultaneous biocytin filling of MSNs in in vitro striatal slices from these mice were used to comprehensively assess their physiological and morphological features. Key findings include that: Q97 mice exhibit impaired gait and righting reflexes but normal tail suspension reflexes and normal coats while Q31 mice do not differ from WT; intrinsic membrane and action potential properties are altered -but differentially so- in MSNs from Q97 and from Q31 mice; excitatory and inhibitory synaptic currents exhibit higher amplitudes in Q31 but not Q97 MSNs, while excitatory synaptic currents occur at lower frequency in Q97 than in WT and Q31 MSNs; there is a reduced total dendritic length in Q31 -but not Q97- MSNs compared to WT, while spine density and number did not differ in MSNs in the three groups. The findings that Q31 MSNs differed from Q97 and WT neurons with regard to some physiological features and structurally suggest a novel role of the N17 domain in the function of WT Htt. The motor phenotype seen in Q97 mice was less robust than that reported in an earlier study (Gu et al., 2015), and the alterations to MSN physiological properties were largely consistent with changes reported previously in a number of other mouse models of HD. Together this study indicates that N17 plays a role in the modulation of the properties of MSNs in both mHtt and WT-Htt mice, but does not markedly exacerbate HD-like pathogenesis in the BACHD model.	[Goodliffe, Joseph; Rubakovic, Anastasia; Chang, Wayne; Pathak, Dhruba; Luebke, Jennifer] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA	Boston University	Goodliffe, J (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.	jwg@bu.edu		Pathak, Dhruba/0000-0002-4005-2900	CHDI Foundation; CHDI	CHDI Foundation; CHDI	The CHDI Foundation funded this work. The funders had no role in the study design, data collecion, and analysis, decision to publish, or preparation of the manuscript.; We thank CHDI for financial support of this project and Drs. Maya Medalla and Christina Weaver for helpful comments.	Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; ALBIN RL, 1992, ANN NEUROL, V31, P425, DOI 10.1002/ana.410310412; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Aldaz T, 2019, J NEUROL, V266, P1340, DOI 10.1007/s00415-019-09263-7; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andre VM, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00046; Ariano MA, 2005, J NEUROSCI RES, V80, P634, DOI 10.1002/jnr.20492; Ariano MA, 2005, J NEUROPHYSIOL, V93, P2565, DOI 10.1152/jn.00791.2004; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Aylward EH, 2011, J NEUROL NEUROSUR PS, V82, P405, DOI 10.1136/jnnp.2010.208264; Barry J, 2018, J NEUROSCI, V38, P4678, DOI 10.1523/JNEUROSCI.0434-18.2018; Blum D, 2015, HUM MOL GENET, V24, P76, DOI 10.1093/hmg/ddu421; Cepeda C, 2003, J NEUROSCI, V23, P961; Cepeda C, 2013, J NEUROSCI, V33, P7393, DOI 10.1523/JNEUROSCI.2137-12.2013; Cepeda C, 2010, ASN NEURO, V2, DOI 10.1042/AN20090058; Chan EYW, 2002, HUM MOL GENET, V11, P1939, DOI 10.1093/hmg/11.17.1939; Deng YP, 2004, J CHEM NEUROANAT, V27, P143, DOI 10.1016/j.jchemneu.2004.02.005; DiProspero NA, 2004, J NEUROCYTOL, V33, P517, DOI 10.1007/s11068-004-0514-8; Fernandez-Nogales M, 2016, BRAIN PATHOL, V26, P772, DOI 10.1111/bpa.12430; Futter M, 2009, J MED GENET, V46, P438, DOI 10.1136/jmg.2009.066399; Glass M, 2000, NEUROSCIENCE, V97, P505, DOI 10.1016/S0306-4522(00)00008-7; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Goodliffe JW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200626; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gu XF, 2015, NEURON, V85, P726, DOI 10.1016/j.neuron.2015.01.008; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Guo ZH, 2012, MOVEMENT DISORD, V27, P1379, DOI 10.1002/mds.25159; Haddad MS, 1997, PSYCHIAT CLIN N AM, V20, P791, DOI 10.1016/S0193-953X(05)70345-2; Hatzipetros T, 2015, JOVE-J VIS EXP, DOI 10.3791/53257; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hodges JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101770; Indersmitten T, 2015, J NEUROPHYSIOL, V113, P2953, DOI 10.1152/jn.01056.2014; Karam A, 2015, NEUROBIOL DIS, V80, P15, DOI 10.1016/j.nbd.2015.05.008; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; KEMP JM, 1971, PHILOS T R SOC B, V262, P429, DOI 10.1098/rstb.1971.0105; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Langfelder P, 2016, NAT NEUROSCI, V19, P623, DOI 10.1038/nn.4256; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Luesse HG, 2001, BEHAV BRAIN RES, V126, P185, DOI 10.1016/S0166-4328(01)00261-3; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; McColgan P, 2018, EUR J NEUROL, V25, P24, DOI 10.1111/ene.13413; Medalla M, 2017, J NEUROSCI, V37, P4717, DOI 10.1523/JNEUROSCI.3757-16.2017; Medalla M, 2015, J NEUROSCI, V35, P112, DOI 10.1523/JNEUROSCI.3426-14.2015; Mishra R, 2012, J MOL BIOL, V424, P1, DOI 10.1016/j.jmb.2012.09.011; Niccolini F, 2018, J NEUROL NEUROSUR PS, V89, P185, DOI 10.1136/jnnp-2017-316633; Ochaba J, 2016, NEURON, V90, P507, DOI 10.1016/j.neuron.2016.03.016; Paulsen JS, 2010, BRAIN RES BULL, V82, P201, DOI 10.1016/j.brainresbull.2010.04.003; Phan J, 2009, HUM MOL GENET, V18, P1006, DOI 10.1093/hmg/ddn428; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Richfield EK, 1995, ANN NEUROL, V38, P852, DOI 10.1002/ana.410380605; RICHFIELD EK, 1995, ANN NEUROL, V37, P335, DOI 10.1002/ana.410370309; Rocher AB, 2016, NEUROBIOL DIS, V86, P131, DOI 10.1016/j.nbd.2015.10.016; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Rosas HD, 2006, MOVEMENT DISORD, V21, P1317, DOI 10.1002/mds.20979; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Sebastianutto I, 2017, NEUROBIOL DIS, V105, P117, DOI 10.1016/j.nbd.2017.05.011; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Smith GS, 1998, NEUROPSYCHOPHARMACOL, V18, P18; Southwell AL, 2016, HUM MOL GENET, V25, P3654, DOI 10.1093/hmg/ddw212; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Tousley A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212337; Tousley A, 2019, J HUNTINGTONS DIS, V8, P53, DOI 10.3233/JHD-180311; Tyler WA, 2015, J NEUROSCI, V35, P6142, DOI 10.1523/JNEUROSCI.0335-15.2015; Van Raamsdonk JM, 2006, HUM MOL GENET, V15, P1513, DOI 10.1093/hmg/ddl072; Veldman MB, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0063-2; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wilson H, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00011; Younes L, 2014, HUM BRAIN MAPP, V35, P792, DOI 10.1002/hbm.22214; Yushchenko T, 2018, BIOPHYS J, V114, P1847, DOI 10.1016/j.bpj.2018.02.037; Zheng ZQ, 2013, J BIOL CHEM, V288, P6063, DOI 10.1074/jbc.M112.413575	78	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234394	10.1371/journal.pone.0234394	http://dx.doi.org/10.1371/journal.pone.0234394			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574176	Green Published, gold			2022-12-26	WOS:000544972400017
J	Geervliet, M; Lute, LCP; Jansen, CA; Rutten, VPMG; Savelkoul, HFJ; Tijhaar, E				Geervliet, Mirelle; Lute, Laura C. P.; Jansen, Christine A.; Rutten, Victor P. M. G.; Savelkoul, Huub F. J.; Tijhaar, Edwin			Differential immunomodulation of porcine bone marrow derived dendritic cells byE.coliNissle 1917 and beta-glucans	PLOS ONE			English	Article							ESCHERICHIA-COLI NISSLE; HUMAN ROTAVIRUS; CRYOPRESERVATION; MONOCYTES; IMMATURE; RECOGNITION; MATURATION; DECTIN-1; INNATE	In early life and around weaning, pigs are at risk of developing infectious diseases which compromise animal welfare and have major economic consequences for the pig industry. A promising strategy to enhance resistance against infectious diseases is immunomodulation by feed additives. To assess the immune stimulating potential of feed additivesin vitro, bone marrow-derived dendritic cells were used. These cells play a central role in the innate and adaptive immune system and are the first cells encountered by antigens that pass the epithelial barrier. Two different feed additives were tested on dendritic cells cultured from fresh and cryopreserved bone marrow cells; a widely used commercial feed additive based on yeast-derived beta-glucans and the gram-negative probiotic strainE.coliNissle 1917.E.coliNissle 1917, but not beta-glucans, induced a dose-dependent upregulation of the cell maturation marker CD80/86, whereas both feed additives induced a dose-dependent production of pro- and anti-inflammatory cytokines, including TNF alpha, IL-1 beta, IL-6 and IL-10. Furthermore,E.coliNissle 1917 consistently induced higher levels of cytokine production than beta-glucans. These immunomodulatory responses could be assessed by fresh as well as cryopreservedin vitrocultured porcine bone marrow-derived dendritic cells. Taken together, these results demonstrate that both beta-glucans andE.coliNissle 1917 are able to enhance dendritic cell maturation, but in a differential manner. A more mature dendritic cell phenotype could contribute to a more efficient response to infections. Moreover, both fresh and cryopreserved bone marrow-derived dendritic cells can be used asin vitropre-screening tools which enable an evidence based prediction of the potential immune stimulating effects of different feed additives.	[Geervliet, Mirelle; Lute, Laura C. P.; Savelkoul, Huub F. J.; Tijhaar, Edwin] Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, Wageningen, Netherlands; [Jansen, Christine A.; Rutten, Victor P. M. G.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Rutten, Victor P. M. G.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Pretoria, South Africa	Wageningen University & Research; Utrecht University; University of Pretoria	Tijhaar, E (corresponding author), Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, Wageningen, Netherlands.	edwin.tijhaar@wur.nl	Rutten, Victor PMG/AAB-6833-2022	Rutten, Victor PMG/0000-0002-6171-1805; Geervliet, Mirelle/0000-0001-8011-4144	Dutch Research Council (NWO); Vereniging Diervoeders Nederland (VDN); NWO Top Sector Project [868.15.033]	Dutch Research Council (NWO)(Netherlands Organization for Scientific Research (NWO)); Vereniging Diervoeders Nederland (VDN); NWO Top Sector Project	This research was funded by The Dutch Research Council (NWO) and Vereniging Diervoeders Nederland (VDN). The award was received by H.F.J. (Huub) Savelkoul (grant number: 868.15.033, NWO Top Sector Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL: https://www.nwo.nl/en.	Adam E, 2010, EUR J IMMUNOL, V40, P1995, DOI 10.1002/eji.200939913; [Anonymous], 2008, Sentinel Event Alert, P1; Batbayar S, 2012, BIOMOL THER, V20, P433, DOI 10.4062/biomolther.2012.20.5.433; BLECHA F, 1994, VET IMMUNOL IMMUNOP, V43, P269, DOI 10.1016/0165-2427(94)90147-3; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; Bullido R, 1997, DEV COMP IMMUNOL, V21, P311, DOI 10.1016/S0145-305X(97)00008-6; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Dudek AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00438; Duncker SC, 2006, VET IMMUNOL IMMUNOP, V111, P239, DOI 10.1016/j.vetimm.2006.01.017; Facci MR, 2010, IMMUNOLOGY, V129, P396, DOI 10.1111/j.1365-2567.2009.03192.x; Geervliet M, 2020, DIFFERENTIAL IMMUNOM, DOI [10.4121/uuid:f27e43c4-ab38-41a2-be4d-c0753855b508, DOI 10.4121/UUID:F27E43C4-AB38-41A2-BE4D-C0753855B508]; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Hayden H, 2009, J IMMUNOTHER, V32, P638, DOI 10.1097/CJI.0b013e3181a5bc13; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; John J, 2003, J IMMUNOL METHODS, V272, P35, DOI 10.1016/S0022-1759(02)00430-1; Kandasamy S, 2016, J IMMUNOL, V196, P1780, DOI 10.4049/jimmunol.1501705; Li CF, 2009, CHINESE J CANCER RES, V21, P122, DOI 10.1007/s11670-009-0122-8; Matsuura M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00109; Meijerink M, 2011, J IMMUNOL METHODS, V373, P136, DOI 10.1016/j.jim.2011.08.010; Pardali E, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0232-5; Shin DI, 1999, IMMUNOL INVEST, V28, P165, DOI 10.3109/08820139909061145; Silveira GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071291; Sonck E, 2011, CLIN VACCINE IMMUNOL, V18, P1441, DOI 10.1128/CVI.00080-11; Sonck E, 2009, VET IMMUNOL IMMUNOP, V130, P131, DOI 10.1016/j.vetimm.2009.01.010; Stagg AJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02883; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Stier H, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-38; Summerfield A, 1997, J LEUKOCYTE BIOL, V62, P176, DOI 10.1002/jlb.62.2.176; Summerfield A, 2009, DEV COMP IMMUNOL, V33, P299, DOI 10.1016/j.dci.2008.05.005; Summerfield A, 2015, ANNU REV ANIM BIOSCI, V3, P533, DOI 10.1146/annurev-animal-022114-111009; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Tsukida K, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0160-1; VanderWaal K, 2018, P NATL ACAD SCI USA, V115, P11495, DOI 10.1073/pnas.1806068115; Vetvicka Vaclav, 2014, Open Biochem J, V8, P89, DOI 10.2174/1874091X01408010089; Vlasova AN, 2016, EUR J IMMUNOL, V46, P2426, DOI 10.1002/eji.201646498; Volman JJ, 2008, PHYSIOL BEHAV, V94, P276, DOI 10.1016/j.physbeh.2007.11.045; Vreman S, 2018, DEV COMP IMMUNOL, V84, P361, DOI 10.1016/j.dci.2018.03.012; Wassenaar TM, 2016, EUR J MICROBIOL IMMU, V6, P147, DOI 10.1556/1886.2016.00029; Zhang Y., 2005, EXPT MATH PEDAGOGY T, P1	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0233773	10.1371/journal.pone.0233773	http://dx.doi.org/10.1371/journal.pone.0233773			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559198	gold, Green Published			2022-12-26	WOS:000543261600062
J	Bleser, WK; Salmon, DA; Miranda, PY				Bleser, William K.; Salmon, Daniel A.; Miranda, Patricia Y.			A hidden vulnerable population: Young children up-to-date on vaccine series recommendations except influenza vaccines	PLOS ONE			English	Article							CHRONIC MEDICAL CONDITIONS; AGED 19-35 MONTHS; PARENTAL PERSPECTIVES; UNITED-STATES; CONFIRMED INFLUENZA; US CHILDREN; IMMUNIZATION; COVERAGE; COMMUNITY; ATTITUDES	Very young children (under 2 years old) have high risk for influenza-related complications. Children 6 months or older in the US are recommended to receive influenza vaccination annually, yet uptake is substantially lower than other routinely-recommended vaccines. Existing nationally-representative studies on very young child influenza vaccine uptake has several limitations: few examine provider-verified influenza vaccination (relying on parental report), few contain parental vaccine attitudes variables (known to be crucial to vaccine uptake), and none to our knowledge consider intersectionality of social disadvantage nor how influenza vaccine determinants differ from those of other recommended vaccines. This nationally-representative study examines provider-verified data on 7,246 children aged 6-23 months from the most recent (2011) National Immunization Survey to include the restricted Parental Concerns module, focusing on children up-to-date on a series of vaccines (the 4:3:1:3:3:1:4 series) but not influenza vaccines ("hidden vulnerability to influenza"). About 71% of children were up-to-date on the series yet only 33% on influenza vaccine recommendations by their second birthday; 44% had hidden vulnerability to influenza. Independent of parental history of vaccine refusal and a myriad of health services use factors, no parental history of delaying vaccination was associated with 7.5% (2.6-12.5) higher probability of hidden vulnerability to influenza despite being associated with 15.5% (10.8-20.2) lower probability of being up-to-date on neither the series nor influenza vaccines. Thus, parental compliance with broad child vaccine recommendations and lack of vaccine hesitancy may not indicate choice to vaccinate children against influenza. Examination of intersectionality suggests that maternal college education may not confer improved vaccination among non-Hispanic Black and Hispanic children despite that it does for non-Hispanic White children. Policymakers and researchers from public health, sociology, and other sectors need to collaborate to further examine how vaccine hesitancy and intersectional social disadvantage interact to affect influenza vaccine uptake in young US children.	[Bleser, William K.] Duke Univ, Robert J Margolis MD Ctr Hlth Policy, Washington, DC 20004 USA; [Salmon, Daniel A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Bleser, William K.; Miranda, Patricia Y.] Penn State Univ, Dept Hlth Policy & Adm, University Pk, PA 16802 USA	Duke University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bleser, WK (corresponding author), Duke Univ, Robert J Margolis MD Ctr Hlth Policy, Washington, DC 20004 USA.; Bleser, WK (corresponding author), Penn State Univ, Dept Hlth Policy & Adm, University Pk, PA 16802 USA.	william.bleser@duke.edu		Bleser, William/0000-0002-4640-8680	NIH [2R24HD041025-11]; National Center for Advancing Translational Sciences (NCATS) [UL1 TR000127, KL2 TR000126]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	There was no external funding received for this study. We acknowledge indirect support provided by Pennsylvania State University's Department of Health Policy and Administration, Demography program, and Population Research Institute. The Population Research Institute is supported by an infrastructure grant from NIH (2R24HD041025-11). This publication was also supported, in part, by Grant UL1 TR000127 and KL2 TR000126 from the National Center for Advancing Translational Sciences (NCATS). The funders provided support in the form of salaries or infrastructure for authors WKB and PYM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Aldrich J.H., 1984, SAGE U PAPER SERIES; Allison MA, 2010, PEDIATR INFECT DIS J, V29, P751, DOI 10.1097/INF.0b013e3181d8562c; Allison P., 2014, LISTWISE DELETION IT; Andersen RM., 2007, CHANGING US HLTH CAR; Angrist JD, 2001, J BUS ECON STAT, V19, P2, DOI 10.1198/07350010152472571; [Anonymous], 2015, EPIDEMIOLOGY PREVENT; [Anonymous], 2006, PLAST RECONSTR SURG, V117, p45S; [Anonymous], 1999, LANCET, V354, P1277; [Anonymous], 2012, DRUG DISCOV TODAY TE; Bauer GR, 2014, SOC SCI MED, V110, P10, DOI 10.1016/j.socscimed.2014.03.022; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Bleser WK, 2019, AM J PREV MED, V56, P251, DOI 10.1016/j.amepre.2018.09.013; Brambor T, 2006, POLIT ANAL, V14, P63, DOI 10.1093/pan/mpi014; Centers for Disease Control, 2019, 2010 11 2018 19 INFL; Centers for Disease Control and Prevention, 2014, VACC CHILDR PROGR VF; Centers for Disease Control and Prevention, 2014, KEY FACTS SEAS FLU V; Centers for Disease Control and Prevention, 2013, INF VACC SAF; Centers for Disease Control and Prevention, 2014, WHAT AR BEN FLU VACC; Centers for Disease Control and Prevention, 2013, CHILDR FLU FLU VACC; Centers for Disease Control and Prevention, 2015, PEOPL HIGH RIS DEV F; Centers for Disease Control and Prevention NORC at the University of Chicago, 2012, NAT IMM SURV US GUID; Chatterjee Archana, 2010, Expert Rev Vaccines, V9, P497, DOI 10.1586/erv.10.36; Collins P.H., 2000, BLACK FEMINIST THOUG; COLLINS Patricia Hill, 1990, BLACK FEMINIST THOUG; Daley MF, 2006, PEDIATRICS, V117, pE268, DOI 10.1542/peds.2005-1752; Daley MF, 2005, ARCH PEDIAT ADOL MED, V159, P986, DOI 10.1001/archpedi.159.10.986; DeVoe JE, 2003, AM J PUBLIC HEALTH, V93, P786, DOI 10.2105/AJPH.93.5.786; Dill B.T., 2009, EMERGING INTERSECTIO; Elam-Evans LD, 2014, MMWR-MORBID MORTAL W, V63, P741; Ferdinands JM, 2014, J INFECT DIS, V210, P674, DOI 10.1093/infdis/jiu185; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Flood EM, 2010, CLIN THER, V32, P1448, DOI 10.1016/j.clinthera.2010.06.020; Fraaij PLA, 2011, VACCINE, V29, P7524, DOI 10.1016/j.vaccine.2011.08.010; Gnanasekaran SK, 2006, PUBLIC HEALTH REP, V121, P181, DOI 10.1177/003335490612100213; Gnanasekaran SK, 2006, AMBUL PEDIATR, V6, P1, DOI 10.1016/j.ambp.2005.08.004; Gusten R, 2006, ZOOTAXA, P1; Heckman JJ, 1997, RAND J ECON, V28, pS142, DOI 10.2307/3087459; Hemingway CO, 2004, PEDIATRICS, V114, P948, DOI 10.1542/peds.2003-0509-F; Hill HA, 2018, MMWR-MORBID MORTAL W, V67, P1123, DOI 10.15585/mmwr.mm6740a4; Jordan R, 2006, VACCINE, V24, P1047, DOI 10.1016/j.vaccine.2005.09.017; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Lin CJ, 2006, J URBAN HEALTH, V83, P874, DOI 10.1007/s11524-006-9084-z; Lin CJ, 2006, J NATL MED ASSOC, V98, P148; Malosh R, 2014, VACCINE, V32, P1841, DOI 10.1016/j.vaccine.2014.01.075; Meng Y., 2013, THESIS; Mirza A, 2008, SOUTH MED J, V101, P1101, DOI 10.1097/SMJ.0b013e318182ee8d; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; NORC at the University of Chicago, 2011, NIS CHILD HARD COP Q; Nowalk MP, 2007, J NATL MED ASSOC, V99, P636; Nowalk MP, 2005, AM J PREV MED, V29, P210, DOI 10.1016/j.amepre.2005.05.010; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Poehling KA, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e99; Poland GA, 2001, VACCINE, V19, P2440, DOI 10.1016/S0264-410X(00)00469-2; Principi N, 2003, PEDIATR INFECT DIS J, V22, pS207, DOI 10.1097/01.inf.0000092188.48726.e4; Rudolph L, 2013, HLTH ALL POLICIES GU; Salleras L, 2006, VACCINE, V24, P6638, DOI 10.1016/j.vaccine.2006.05.034; Salmon DA, 2015, AM J PREV MED, V49, pS391, DOI 10.1016/j.amepre.2015.06.009; Santibanez TA, 2006, PEDIATRICS, V118, P1167, DOI 10.1542/peds.2006-0831; Santibanez TA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3280; Schwartz JL, 2011, PRIMARY CARE, V38, P717, DOI 10.1016/j.pop.2011.07.009; StataCorp, 2013, STAT REL 13; SZILAGYI PG, 1992, PEDIATRICS, V90, P871; Teo SSS, 2005, ARCH DIS CHILD, V90, P532, DOI 10.1136/adc.2004.051896; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; U.S. Department of Health and Human Services, 2012, AFF CAR ACT IMM; Uwemedimo OT, 2012, J COMMUN HEALTH, V37, P663, DOI 10.1007/s10900-011-9497-9; Vesikari T, 2006, PEDIATRICS, V118, P2298, DOI 10.1542/peds.2006-0725; Warner DF, 2011, SOC SCI MED, V72, P1236, DOI 10.1016/j.socscimed.2011.02.034; WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025; Zhao Z, 2013, VACCINE, V31, P2324, DOI 10.1016/j.vaccine.2013.03.018; Zhao Z, 2010, AM J PREV MED, V38, P127, DOI 10.1016/j.amepre.2009.10.035	73	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234466	10.1371/journal.pone.0234466	http://dx.doi.org/10.1371/journal.pone.0234466			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555653	Green Published, gold			2022-12-26	WOS:000543273200082
J	Del Valle, JC; Buide, ML; Whittall, JB; Valladares, F; Narbona, E				Carlos Del Valle, Jose; Luisa Buide, Ma; Whittall, Justen B.; Valladares, Fernando; Narbona, Eduardo			UV radiation increases phenolic compound protection but decreases reproduction inSilene littorea	PLOS ONE			English	Article							ULTRAVIOLET-B RADIATION; GLANDULAR TRICHOMES; FUNCTIONAL ROLES; STRESS TOLERANCE; EXCESS LIGHT; SEED YIELD; LEAVES; FLAVONOIDS; RESPONSES; PLANTS	Plants respond to changes in ultraviolet (UV) radiation both morphologically and physiologically. Among the variety of plant UV-responses, the synthesis of UV-absorbing flavonoids constitutes an effective non-enzymatic mechanism to mitigate photoinhibitory and photooxidative damage caused by UV stress, either reducing the penetration of incident UV radiation or acting as quenchers of reactive oxygen species (ROS). In this study, we designed a UV-exclusion experiment to investigate the effects of UV radiation inSilene littorea. We spectrophotometrically quantified concentrations of both anthocyanins and UV-absorbing phenolic compounds in petals, calyces, leaves and stems. Furthermore, we analyzed the UV effect on the photosynthetic activity in hours of maximum solar radiation and we tested the impact of UV radiation on male and female reproductive performance. We found that anthocyanin concentrations showed a significant decrease of about 20% with UV-exclusion in petals and stems, and a 30% decrease in calyces. The concentrations of UV-absorbing compounds under UV-exclusion decreased by approximately 25% in calyces and stems, and 12% in leaves. Photochemical efficiency of plants grown under UV decreased at maximum light stress, reaching an inhibition of 58% of photosynthetic activity, but their ability to recover after light-stress was not affected. In addition, exposure to UV radiation did not affect ovule production or seed set per flower, but decreased pollen production and total seed production per plant by 31% and 69%, respectively. Our results demonstrate that UV exposure produced opposing effects on the accumulation of plant phenolic compounds and reproduction. UV radiation increased the concentration of phenolic compounds, suggesting a photoprotective role of plant phenolics against UV light, yet overall reproduction was compromised.	[Carlos Del Valle, Jose; Luisa Buide, Ma; Narbona, Eduardo] Univ Pablo Olavide, Dept Biol Mol & Ingn Bioquim, Seville, Spain; [Whittall, Justen B.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA; [Valladares, Fernando] CSIC, Inst Recursos Nat, Ctr Ciencias Medioambientales, Madrid, Spain	Universidad Pablo de Olavide; Santa Clara University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Ciencias Medioambientales (CCMA); CSIC - Instituto de Recursos Naturales (IRN)	Del Valle, JC (corresponding author), Univ Pablo Olavide, Dept Biol Mol & Ingn Bioquim, Seville, Spain.	jcdelgar@upo.es	del Valle, José Carlos/F-8918-2019; Fernández, Francisco Eduardo Narbona/G-5276-2015; del Real, María Luisa Buide/H-5509-2015; Valladares, Fernando/K-9406-2014	del Valle, José Carlos/0000-0001-6023-6208; Fernández, Francisco Eduardo Narbona/0000-0003-1790-6821; del Real, María Luisa Buide/0000-0001-9029-0782; Valladares, Fernando/0000-0002-5374-4682	Spanish Government MINECO [CGL2012-37646, CGL2015-63827-P, BES-2013-062610]	Spanish Government MINECO(Spanish Government)	This work was supported by the Spanish Government MINECO projects (CGL2012-37646 and CGL2015-63827-P) and a Predoctoral Training Program grant to JCDV (BES-2013-062610). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2007, NEW PHYTOL, V174, P77, DOI 10.1111/j.1469-8137.2007.01986.x; Agati G, 2013, PLANT PHYSIOL BIOCH, V72, P35, DOI 10.1016/j.plaphy.2013.03.014; Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Agati G, 2010, NEW PHYTOL, V186, P786, DOI 10.1111/j.1469-8137.2010.03269.x; Albert KR, 2011, ENVIRON EXP BOT, V73, P10, DOI 10.1016/j.envexpbot.2011.08.003; Albert NW, 2014, PLANT CELL, V26, P962, DOI 10.1105/tpc.113.122069; Andersen OM, 2010, PHYTOCHEMISTRY, V71, P1558, DOI 10.1016/j.phytochem.2010.05.025; Aragon CF, 2008, J ECOL, V96, P222, DOI 10.1111/j.1365-2745.2007.01320.x; Barnes PW, 2016, OECOLOGIA, V181, P55, DOI 10.1007/s00442-016-3558-9; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bi XL, 2014, FOOD CHEM, V152, P205, DOI 10.1016/j.foodchem.2013.11.088; Bidel LPR, 2015, PLANTA, V242, P545, DOI 10.1007/s00425-015-2291-7; Brown JE, 1998, BIOCHEM J, V330, P1173; Burchard P, 2000, PLANT CELL ENVIRON, V23, P1373, DOI 10.1046/j.1365-3040.2000.00633.x; Del Valle JC, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-2082-6; Del Valle JC, 2018, ENVIRON EXP BOT, V153, P100, DOI 10.1016/j.envexpbot.2018.05.014; Crawley M.J., 2007, R BOOK; Davies KM, 2018, ANN PLANT REV ONLINE, V1, P21, DOI 10.1002/9781119312994.apr0604; Day TA, 1996, ENVIRON EXP BOT, V36, P447, DOI 10.1016/0098-8472(95)00048-8; Day TA, 2001, J PHOTOCH PHOTOBIO B, V62, P78, DOI 10.1016/S1011-1344(01)00161-0; Day TA, 1996, VEGETATIO, V127, P109, DOI 10.1007/BF00044635; del Valle JC, 2018, ECOL EVOL, V8, P3064, DOI 10.1002/ece3.3804; del Valle JC, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00939; Demchik SM, 1996, AM J BOT, V83, P573, DOI 10.2307/2445915; Feng HY, 2000, ENVIRON EXP BOT, V43, P45, DOI 10.1016/S0098-8472(99)00042-8; Frohnmeyer H, 2003, PLANT PHYSIOL, V133, P1420, DOI 10.1104/pp.103.030049; Gould K., 2009, ANTHOCYANINS BIOSYNT; Gould K.S., 2002, ANTHOCYANINS LEAVES; Gould KS, 2000, J EXP BOT, V51, P1107, DOI 10.1093/jexbot/51.347.1107; Hakala-Yatkin M, 2010, PLANT CELL PHYSIOL, V51, P1745, DOI 10.1093/pcp/pcq133; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hofmann RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018949; Hofmann RW, 2003, PLANT CELL ENVIRON, V26, P603, DOI 10.1046/j.1365-3040.2003.00996.x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jansen MAK, 2002, PHYSIOL PLANTARUM, V116, P423, DOI 10.1034/j.1399-3054.2002.1160319.x; Jiang N, 2016, PLANTS-BASEL, V5, DOI 10.3390/plants5020027; Kohler H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00921; Koski MH, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.7, 10.1038/NPLANTS.2014.7]; Koski MH, 2014, FUNCT ECOL, V28, P868, DOI 10.1111/1365-2435.12242; Koti S, 2005, J EXP BOT, V56, P725, DOI 10.1093/jxb/eri044; Landi M, 2015, ENVIRON EXP BOT, V119, P4, DOI 10.1016/j.envexpbot.2015.05.012; Lichtenthaler HK, 2005, PHOTOSYNTHETICA, V43, P379, DOI 10.1007/s11099-005-0062-6; Llorens L, 2015, PERSPECT PLANT ECOL, V17, P243, DOI 10.1016/j.ppees.2015.03.001; Buide ML, 2018, ENVIRON EXP BOT, V146, P54, DOI 10.1016/j.envexpbot.2017.10.016; Manetas Y, 2003, FUNCT PLANT BIOL, V30, P265, DOI 10.1071/FP02226; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mouradov A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00620; Narbona E, 2018, PLANT BIOLOGY, V20, P968, DOI 10.1111/plb.12875; Narbona E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020668; Neill S, 1999, CAN J BOT, V77, P1777, DOI 10.1139/cjb-77-12-1777; Neugart S, 2013, PLANT PHYSIOL BIOCH, V72, P161, DOI 10.1016/j.plaphy.2013.04.002; Nielsen SL, 2011, PHOTOSYNTHETICA, V49, P346, DOI 10.1007/s11099-011-0042-y; Papiorek S, 2013, NATURWISSENSCHAFTEN, V100, P633, DOI 10.1007/s00114-013-1060-3; Paul ND, 2003, TRENDS ECOL EVOL, V18, P48, DOI 10.1016/S0169-5347(02)00014-9; Petropoulou Y, 2001, NEW PHYTOL, V152, P85, DOI 10.1046/j.0028-646x.2001.00241.x; Pollastri S, 2011, ANN BOT-LONDON, V108, P1225, DOI 10.1093/aob/mcr234; R Core Team, R LANG ENV STAT COMP; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; Robson TM, 2015, PLANT CELL ENVIRON, V38, P856, DOI 10.1111/pce.12374; Rozema J., 2001, Plant Ecology, V154, P11; Stephanou M, 1998, PLANT ECOL, V134, P91, DOI 10.1023/A:1009773105854; Steyn WJ, 2002, NEW PHYTOL, V155, P349, DOI 10.1046/j.1469-8137.2002.00482.x; Takahashi S, 2011, TRENDS PLANT SCI, V16, P53, DOI 10.1016/j.tplants.2010.10.001; Tattini M, 2000, NEW PHYTOL, V148, P69, DOI 10.1046/j.1469-8137.2000.00743.x; Tattini M, 2007, PLANT BIOLOGY, V9, P411, DOI 10.1055/s-2006-924662; Tattini M, 2004, NEW PHYTOL, V163, P547, DOI 10.1111/j.1469-8137.2004.01126.x; Tattini M, 2014, PHYSIOL PLANTARUM, V152, P585, DOI 10.1111/ppl.12201; Treutter D, 2006, ENVIRON CHEM LETT, V4, P147, DOI 10.1007/s10311-006-0068-8; VANBREDERODE J, 1982, EXPERIENTIA, V38, P929; Verdaguer D, 2017, PLANT SCI, V255, P72, DOI 10.1016/j.plantsci.2016.11.014; von Wettberg EJ, 2010, EVOL ECOL RES, V12, P457; Zhou B, 2007, J EXP BOT, V58, P1771, DOI 10.1093/jxb/erm036	73	21	21	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0231611	10.1371/journal.pone.0231611	http://dx.doi.org/10.1371/journal.pone.0231611			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555603	Green Published, Green Submitted, gold			2022-12-26	WOS:000543273200031
J	Keller, M; Roth, WT; Petrowski, K				Keller, Marius; Roth, Walton T.; Petrowski, Katja			Supplementing sleep actigraphy with button pressing while awake	PLOS ONE			English	Article							WRIST ACTIGRAPHY; ONSET; AGREEMENT; ACCURACY; WAKE	Objective/background Wrist-worn sleep actigraphs are limited for evaluating sleep, especially in sleepers who lie awake in bed without moving for extended periods. Sleep logs depend on the accuracy of perceiving and remembering times of being awake. Here we evaluated pressing an event-marker button while lying awake under two conditions: self-initiated pressing every 5 to 10 minutes or pressing when signaled every 5 minutes by a vibration pulse from a wristband. We evaluated the two conditions for acceptability and their concordance with actigraphically scored sleep. Participants and methods Twenty-nine adults wore actigraphs on six nights. On nights 1 and 4, they pressed the marker to a vibration signal, and on nights 2 and 5, they self-initiated presses without any signal. On nights 3 and 6, they were told not to press the marker. Every morning they filled out a sleep log about how they had slept. Results The vibration band was unacceptable to 42% of the participants, who judged it too disturbing to their sleep. Self-initiated pressing was acceptable to all, although it reduced log reported sleep depth compared to a no pressing condition. Estimations of sleep onset latency were considerably longer by button pressing than by actigraphy. Agreement of epoch-by-epoch sleep scoring by actigraphy and by button pressing was poor (kappa = 0.23) for self-initiated pressing and moderate (kappa = 0.46) for pressing in response to a vibration. Conclusions Self-initiated button pressing to indicate being awake while lying in bed is acceptable to many, interferes little with sleep, and adds substantially to the information given by actigraphy.	[Keller, Marius; Petrowski, Katja] Johannes Gutenberg Univ Mainz, Med Psychol & Med Sociol, Univ Med Ctr, Mainz, Germany; [Keller, Marius] Elblandklinikum Meissen, Dept Neurol, Meissen, Germany; [Roth, Walton T.] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA USA; [Roth, Walton T.] VA Palo Alto Hlth Care Syst, War Related Illness & Injury Ctr, Palo Alto, CA USA; [Petrowski, Katja] Tech Univ Dresden, Med Sch, Dept Psychotherapy & Psychosomat Med, Dresden, Germany	Johannes Gutenberg University of Mainz; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Technische Universitat Dresden	Keller, M (corresponding author), Johannes Gutenberg Univ Mainz, Med Psychol & Med Sociol, Univ Med Ctr, Mainz, Germany.; Keller, M (corresponding author), Elblandklinikum Meissen, Dept Neurol, Meissen, Germany.	keller.marius@outlook.com		Keller, Marius/0000-0002-3532-6348				Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; [Anonymous], ULUSLARARASI ILISKIL; Beattie Z, 2017, PHYSIOL MEAS, V38, P1968, DOI 10.1088/1361-6579/aa9047; Blackwell T, 2011, J CLIN SLEEP MED, V7, P357, DOI 10.5664/JCSM.1190; Blake H, 1939, J NEUROPHYSIOL, V2, P48, DOI 10.1152/jn.1939.2.1.48; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boyne K, 2013, SLEEP BREATH, V17, P411, DOI 10.1007/s11325-012-0709-z; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Casagrande M, 1997, SLEEP, V20, P301, DOI 10.1093/sleep/20.4.301; Cellini N, 2013, CHRONOBIOL INT, V30, P691, DOI 10.3109/07420528.2013.782312; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Danker-Hopfe H, 2009, J SLEEP RES, V18, P74, DOI 10.1111/j.1365-2869.2008.00700.x; de Souza L, 2003, SLEEP, V26, P81, DOI 10.1093/sleep/26.1.81; European Food Safety Authority (EFSA), 2015, EFSA J, V13, pe4138, DOI 10.2903/j.efsa.2015.4138; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Gruwez A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210569; HAURI PJ, 1992, SLEEP, V15, P293, DOI 10.1093/sleep/15.4.293; Hauri PJ, 1999, SLEEP, V22, P1110, DOI 10.1093/sleep/22.8.1110; Jean-Louis G, 2001, J NEUROSCI METH, V105, P185, DOI 10.1016/S0165-0270(00)00364-2; Johnson NL, 2007, SLEEP, V30, P899, DOI 10.1093/sleep/30.7.899; Kleitman N, 1965, SLEEP WAKEFULNESS RE, P108; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee J, 2015, STUD HEALTH TECHNOL, V210, P458, DOI 10.3233/978-1-61499-512-8-458; Levendowski DJ, 2017, J CLIN SLEEP MED, V13, P791, DOI 10.5664/jcsm.6618; Miller KE, 2019, J CLIN SLEEP MED, V15, P1675, DOI 10.5664/jcsm.8038; Ogilvie RD, 2001, SLEEP MED REV, V5, P247, DOI 10.1053/smrv.2001.0145; OGILVIE RD, 1989, SLEEP, V12, P458, DOI 10.1093/sleep/12.5.458; OGILVIE RD, 1984, PSYCHOPHYSIOLOGY, V21, P510, DOI 10.1111/j.1469-8986.1984.tb00234.x; Paquet J, 2007, SLEEP, V30, P1362, DOI 10.1093/sleep/30.10.1362; Thurman SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191883	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234060	10.1371/journal.pone.0234060	http://dx.doi.org/10.1371/journal.pone.0234060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555652	gold, Green Published			2022-12-26	WOS:000543273200069
J	Mehtala, A; Villberg, J; Blomqvist, M; Huotari, P; Jaakkola, T; Koski, P; Lintunen, T; Mononen, K; Ng, K; Palomaki, S; Saakslahti, A; Tammelin, T; Vasankari, T; Kokko, S				Mehtala, Anette; Villberg, Jari; Blomqvist, Minna; Huotari, Pertti; Jaakkola, Timo; Koski, Pasi; Lintunen, Taru; Mononen, Kaisu; Ng, Kwok; Palomaki, Sanna; Saakslahti, Arja; Tammelin, Tuija; Vasankari, Tommi; Kokko, Sami			Individual- and environmental-related correlates of moderate-to-vigorous physical activity in 11-, 13-, and 15-year-old Finnish children	PLOS ONE			English	Article							ACTIVITY GUIDELINES; REPORT CARD; YOUTH; ADOLESCENTS; SELF; DISABILITIES; ASSOCIATION; PERCEPTIONS; SCHOOLS	The objective of this study was to analyze the associations of various individual- and environmental-related factors with subgroups of daily, frequent, moderate and low moderate-to-vigorous physical activity (MVPA) among children and adolescents. Data were obtained from the Finnish School-age Physical Activity (FSPA) study 2016 from 4677 national representative 11-, 13-, and 15-year-old children and adolescents. MVPA and individual- and environmental-related factors were assessed by a questionnaire and analyzed by two-level logistic regression. Seventeen of the twenty-one variables were statistically significantly associated with MVPA. However, only three variables were statistically significant in all MVPA subgroups, whereby self-directed PA at least twice a week, fewer perceived barriers, and higher peer support increased the odds of participating in more MVPA. The results from this study showed essential differences among the MVPA subgroups, also supporting previous findings, whereby various individual- and environmental-based factors are associated with children and adolescents' levels of MVPA. Challenges to designing and implementing effective interventions are based on the need to account for individual differences within the population, as well as the varied connections between PA with different social and physical environments where children and adolescents' PA takes place. PA interventions with various actions at multiple levels are warranted.	[Mehtala, Anette; Villberg, Jari; Huotari, Pertti; Jaakkola, Timo; Lintunen, Taru; Palomaki, Sanna; Saakslahti, Arja; Kokko, Sami] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland; [Mehtala, Anette; Tammelin, Tuija] LIKES Res Ctr Phys Act & Hlth, Jyvaskyla, Finland; [Blomqvist, Minna; Mononen, Kaisu] KIHU Res Inst Olymp Sports, Jyvaskyla, Finland; [Koski, Pasi] Univ Turku, Fac Educ, Rauma, Finland; [Ng, Kwok] Univ Eastern Finland, Sch Educ Sci & Psychol, Joensuu, Finland; [Ng, Kwok] Univ Limerick, Dept Phys Educ & Sport Sci, Phys Act Hlth Res Cluster, Limerick, Ireland; [Vasankari, Tommi] Urho Kaleva Kekkonen Inst Hlth Promot Res, Tampere, Finland	University of Jyvaskyla; University of Turku; University of Eastern Finland; University of Limerick	Mehtala, A (corresponding author), Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland.; Mehtala, A (corresponding author), LIKES Res Ctr Phys Act & Hlth, Jyvaskyla, Finland.	anette.mehtala@likes.fi	Ng, Kwok/K-6648-2013; Lintunen, Taru/G-2838-2011	Ng, Kwok/0000-0002-5461-7706; Saakslahti, Arja/0000-0003-4354-0990; Mehtala, Anette/0000-0002-9299-473X; Jaakkola, Timo/0000-0003-1227-2460; Lintunen, Taru/0000-0001-5191-2251; Kokko, Sami/0000-0001-9436-5681	Finnish Ministry of Education and Culture [OKM/89/626/2015, OKM/130/626/2018]; Strategic Research Council at the Academy of Finland through the project "Healthy Lifestyles to Boost Sustainable Growth (STYLE) [320399, 320400, 320403]	Finnish Ministry of Education and Culture; Strategic Research Council at the Academy of Finland through the project "Healthy Lifestyles to Boost Sustainable Growth (STYLE)	The work was funded by the Finnish Ministry of Education and Culture [Grant numbers: OKM/89/626/2015 and OKM/130/626/2018] and the Strategic Research Council at the Academy of Finland through the project "Healthy Lifestyles to Boost Sustainable Growth (STYLE) [Grant numbers: 320399, 320400 and 320403] to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangsbo J, 2016, BRIT J SPORT MED, V50, P1177, DOI 10.1136/bjsports-2016-096325; Beets MW, 2006, AM J HEALTH BEHAV, V30, P278, DOI 10.5993/AJHB.30.3.6; Biddle SJH, 2011, INT REV SPORT EXER P, V4, P25, DOI 10.1080/1750984X.2010.548528; Cardon GM, 2012, HEALTH EDUC RES, V27, P470, DOI 10.1093/her/cys043; Chadwick S., 2012, THESIS; Davison K. K., 2006, International Journal of Behavioral Nutrition and Physical Activity, V3; Davison KK, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-5; De Cocker K, 2011, PUBLIC HEALTH NUTR, V14, P246, DOI 10.1017/S1368980010000558; ECCLES J, 1993, CHILD DEV, V64, P830, DOI 10.1111/j.1467-8624.1993.tb02946.x; Elmesmari R, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1031-0; Ferreira I, 2007, OBES REV, V8, P129, DOI 10.1111/j.1467-789X.2006.00264.x; Geidne S, 2013, SCAND J PUBLIC HEALT, V41, P269, DOI 10.1177/1403494812473204; Gomes TN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16525-9; Grasten A, 2016, MEAS PHYS EDUC EXERC, V20, P220, DOI 10.1080/1091367X.2016.1217412; Guthold R, 2020, LANCET CHILD ADOLESC, V4, P23, DOI 10.1016/S2352-4642(19)30323-2; Hamari L, 2017, J SCHOOL HEALTH, V87, P236, DOI 10.1111/josh.12490; Harvey A, 2017, CAN J PUBLIC HEALTH, V108, pE348, DOI [10.17269/cjph.108.5925, 10.17269/CJPH.108.5925]; Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2; Hume C, 2005, HEALTH EDUC RES, V20, P1, DOI 10.1093/her/cyg095; Husu P, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3006-0; Inchley J., 2016, Growing up unequal: gender and socioeconomic differences in young people's health and well-being. Health Behaviour in School-aged Children (HBSC) study: international report from the 2013/2014 survey; Janssen I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-554; Kirby J, 2011, J PHYS ACT HEALTH, V8, P785, DOI 10.1123/jpah.8.6.785; Kokko S, 2016, LASTEN JA NUORTEN LU, V2016, P4; LeBlanc AGW, 2010, PEDIATR EXERC SCI, V22, P523, DOI 10.1123/pes.22.4.523; Lenhart CM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4756-z; Li R, 2016, PREV MED, V89, P184, DOI 10.1016/j.ypmed.2016.05.029; Murphy MH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2418-6; Ng K, 2019, ARCH PUBLIC HEALTH, V77, DOI 10.1186/s13690-019-0335-3; Ng K, 2016, J PHYS ACT HEALTH, V13, P816, DOI 10.1123/jpah.2015-0539; Oliveira A.F., 2014, ARCH EXERCISE HLTH D, V4, P254, DOI [DOI 10.5628/AEHD.V4I2.158, 10.5628/aehd.v4i2.158]; Pawlowski CS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-639; Pereira S, 2017, Scand J Med Sci Sports, V27, P842, DOI 10.1111/sms.12671; Perry CK, 2011, PEDIATR EXERC SCI, V23, P521, DOI 10.1123/pes.23.4.521; Physical Activity Guidelines Advisory Committee, 2018, 2018 PHYS ACT GUID A; Prochaska JJ, 2001, ARCH PEDIAT ADOL MED, V155, P554, DOI 10.1001/archpedi.155.5.554; Ridgers ND, 2012, J SCI MED SPORT, V15, P136, DOI 10.1016/j.jsams.2011.09.003; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Stanley RM, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-50; Statistics Finland, 2018, LANG GEND COUNT MUN; Sterdt E, 2014, HEALTH EDUC J, V73, P72, DOI 10.1177/0017896912469578; Tammelin TH, 2016, J PHYS ACT HEALTH, V13, pS157, DOI 10.1123/jpah.2016-0297; Telama R, 2014, MED SCI SPORT EXER, V46, P955, DOI 10.1249/MSS.0000000000000181; Timo J, 2016, J SCI MED SPORT, V19, P750, DOI 10.1016/j.jsams.2015.11.003; Tremblay MS, 2016, J PHYS ACT HEALTH, V13, pS343, DOI 10.1123/jpah.2016-0594; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Yang XL, 2014, PREV MED, V59, P5, DOI 10.1016/j.ypmed.2013.10.019; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5	50	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234686	10.1371/journal.pone.0234686	http://dx.doi.org/10.1371/journal.pone.0234686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555590	Green Published, gold			2022-12-26	WOS:000543273200040
J	Milali, MP; Kiware, SS; Govella, NJ; Okumu, F; Bansal, N; Bozdag, S; Charlwood, JD; Maia, MF; Ogoma, SB; Dowell, FE; Corliss, GF; Sikulu-Lord, MT; Povinelli, RJ				Milali, Masabho P.; Kiware, Samson S.; Govella, Nicodem J.; Okumu, Fredros; Bansal, Naveen; Bozdag, Serdar; Charlwood, Jacques D.; Maia, Marta F.; Ogoma, Sheila B.; Dowell, Floyd E.; Corliss, George F.; Sikulu-Lord, Maggy T.; Povinelli, Richard J.			An autoencoder and artificial neural network-based method to estimate parity status of wild mosquitoes from near-infrared spectra	PLOS ONE			English	Article							MALARIA TRANSMISSION; SENSITIVITY; AGE	After mating, female mosquitoes need animal blood to develop their eggs. In the process of acquiring blood, they may acquire pathogens, which may cause different diseases in humans such as malaria, zika, dengue, and chikungunya. Therefore, knowing the parity status of mosquitoes is useful in control and evaluation of infectious diseases transmitted by mosquitoes, where parous mosquitoes are assumed to be potentially infectious. Ovary dissections, which are currently used to determine the parity status of mosquitoes, are very tedious and limited to few experts. An alternative to ovary dissections is near-infrared spectroscopy (NIRS), which can estimate the age in days and the infectious state of laboratory and semi-field reared mosquitoes with accuracies between 80 and 99%. No study has tested the accuracy of NIRS for estimating the parity status of wild mosquitoes. In this study, we train an artificial neural network (ANN) models on NIR spectra to estimate the parity status of wild mosquitoes. We use four different datasets:An.arabiensiscollected from Minepa, Tanzania (Minepa-ARA);An.gambiae s.scollected from Muleba, Tanzania (Muleba-GA);An.gambiae s.scollected from Burkina Faso (Burkina-GA); andAn.gambiae s.sfrom Muleba and Burkina Faso combined (Muleba-Burkina-GA). We train ANN models on datasets with spectra preprocessed according to previous protocols. We then use autoencoders to reduce the spectra feature dimensions from 1851 to 10 and re-train the ANN models. Before the autoencoder was applied, ANN models estimated parity status of mosquitoes in Minepa-ARA, Muleba-GA, Burkina-GA and Muleba-Burkina-GA with out-of-sample accuracies of 81.9 +/- 2.8 (N = 274), 68.7 +/- 4.8 (N = 43), 80.3 +/- 2.0 (N = 48), and 75.7 +/- 2.5 (N = 91), respectively. With the autoencoder, ANN models tested on out-of-sample data achieved 97.1 +/- 2.2% (N = 274), 89.8 +/- 1.7% (N = 43), 93.3 +/- 1.2% (N = 48), and 92.7 +/- 1.8% (N = 91) accuracies for Minepa-ARA, Muleba-GA, Burkina-GA, and Muleba-Burkina-GA, respectively. These results show that a combination of an autoencoder and an ANN trained on NIR spectra to estimate the parity status of wild mosquitoes yields models that can be used as an alternative tool to estimate parity status of wild mosquitoes, especially since NIRS is a high-throughput, reagent-free, and simple-to-use technique compared to ovary dissections.	[Milali, Masabho P.; Kiware, Samson S.; Bansal, Naveen; Corliss, George F.; Povinelli, Richard J.] Marquette Univ, Dept Math & Stat Sci, Milwaukee, WI 53233 USA; [Milali, Masabho P.; Kiware, Samson S.; Govella, Nicodem J.; Okumu, Fredros] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania; [Bozdag, Serdar] Marquette Univ, Dept Comp Sci, Milwaukee, WI 53233 USA; [Charlwood, Jacques D.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Maia, Marta F.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Maia, Marta F.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Maia, Marta F.] Univ Basel, Basel, Switzerland; [Ogoma, Sheila B.] Clinton Hlth Access Initiat, Nairobi, Kenya; [Dowell, Floyd E.] ARS, Ctr Grain & Anim Hlth Res, USDA, Manhattan, KS USA; [Corliss, George F.; Povinelli, Richard J.] Marquette Univ, Dept Elect & Comp Engn, Milwaukee, WI 53233 USA; [Sikulu-Lord, Maggy T.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia	Marquette University; Ifakara Health Institute; Marquette University; Liverpool School of Tropical Medicine; Kenya Medical Research Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; United States Department of Agriculture (USDA); Marquette University; University of Queensland	Milali, MP (corresponding author), Marquette Univ, Dept Math & Stat Sci, Milwaukee, WI 53233 USA.; Milali, MP (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania.	pmasabho@ihi.or.tz		Povinelli, Richard/0000-0001-8439-0146; Bozdag, Serdar/0000-0002-4813-4310; Ferreira Maia, Marta/0000-0003-3302-5610	Grand Challenges Canada Stars for Global Health - government of Canada [043901]; DFID/MRC/Wellcome Trust through the Joint Health Trials Scheme [MR/L004437/1]; National Institute of Allergy and Infectious Diseases [R01-AI094349-01A1]; Marquette University Graduate School	Grand Challenges Canada Stars for Global Health - government of Canada; DFID/MRC/Wellcome Trust through the Joint Health Trials Scheme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Marquette University Graduate School	Data collection was funded by: Grand Challenges Canada Stars for Global Health funded by the government of Canada grant 043901 awarded to MTSL; DFID/MRC/Wellcome Trust through the Joint Health Trials Scheme awarded to JDC (Award Number MR/L004437/1); National Institute of Allergy and Infectious Diseases grant R01-AI094349-01A1; and Marquette University Graduate School, for studentship awarded to MPM.	Abdi H., 2003, ENCY RES METHODS SOC, P792; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; [Anonymous], 1992, REPRESENTATIONS, V37, P1; [Anonymous], 2017, DRUG SAF UPDATE, DOI DOI 10.1186/s13104-016-2345-3; Baldi P., 2012, P ICML WORKSH UNS TR, P37; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Bourlard H, 2000, AUTOASSOCIATION MULT; Chicco D., 2014, P 5 ACM C BIOINF COM, P533; Coleman S, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1971-0; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; Detinova T. S., 1945, MEDITSINSKA PARAZITOLOG[IMAGE] I PARAZITARNYE BOLEZNI [MED PARASITOL AND PARASITIC DIS], V14, P45; Dietterich TG, 1997, AI MAG, V18, P97; Domingos P, 2012, COMMUN ACM, V55, P78, DOI 10.1145/2347736.2347755; Dowell FE, 2011, AM J TROP MED HYG, V85, P1093, DOI 10.4269/ajtmh.2011.11-0438; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; Kingma Diederik P., 2013, ABS13126114 CORR; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; LeClair C, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1972-z; Liou CY, 2008, NEUROCOMPUTING, V71, P3150, DOI 10.1016/j.neucom.2008.04.030; Liou CY, 2014, NEUROCOMPUTING, V139, P84, DOI 10.1016/j.neucom.2013.09.055; Liu Y, 2018, PROCEDIA COMPUT SCI, V139, P529, DOI 10.1016/j.procs.2018.10.237; MAGESA SM, 1991, ACTA TROP, V49, P97, DOI 10.1016/0001-706X(91)90057-Q; Maia MF, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2719-9; Mayagaya VS, 2009, AM J TROP MED HYG, V81, P622, DOI 10.4269/ajtmh.2009.09-0192; Mayagaya VS, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0661-4; Milali MP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209451; Milali MP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198245; Milali MP, 2018, ARABIENSIS USING NEA, P490326; Mouazen AM, 2010, GEODERMA, V158, P23, DOI 10.1016/j.geoderma.2010.03.001; Ntamatungiro AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-298; PASKEWITZ SM, 1990, MED VET ENTOMOL, V4, P367, DOI 10.1111/j.1365-2915.1990.tb00453.x; Polovodova V. P., 1941, Medical Parasitology and Parasitic Diseases Moscow, V10, P387; Powers D. M, 2011, ARXIV201016061; ROBERT V, 1991, B WORLD HEALTH ORGAN, V69, P735; Shlens J., 2014, ARXIV; Sikulu M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-49; Sikulu MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090657; Sikulu-Lord MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005040; Sikulu-Lord MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004759; Smith CJ, 2012, PHLEBOLOGY, V27, P250, DOI 10.1258/phleb.2012.012J05; Stone P, 2000, EUR C MACH LEARN; Storkey A, 2009, NEURAL INF PROCESS S, P3; Xu QS, 2004, J CHEMOMETR, V18, P112, DOI 10.1002/cem.858	47	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234557	10.1371/journal.pone.0234557	http://dx.doi.org/10.1371/journal.pone.0234557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555660	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000543273200004
J	Cunanan, J; Deacon, E; Cunanan, K; Yang, ZF; Ask, A; Morikawa, L; Todorova, E; Bridgewater, D				Cunanan, Joanna; Deacon, Erin; Cunanan, Kristina; Yang, Zifan; Ask, Antje; Morikawa, Lily; Todorova, Ekaterina; Bridgewater, Darren			Quercetin treatment reduces the severity of renal dysplasia in a beta-catenin dependent manner	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; KIDNEY DEVELOPMENT; E-CADHERIN; HYPERTENSION; PATHWAY; CELLS; INVASIVENESS; DYSFUNCTION; INHIBITOR; VIMENTIN	Renal dysplasia, the major cause of childhood renal failure, is characterized by defective branching morphogenesis and nephrogenesis. Beta-catenin, a transcription factor and cell adhesion molecule, is markedly increased in the nucleus of kidney cells in human renal dysplasia and contributes to its pathogenesis by altering target genes that are essential for kidney development. Quercetin, a naturally occurring flavonoid, reduces nuclear beta-catenin levels and reduces beta-catenin transcriptional activity. In this study, we utilized wild type and dysplastic mouse kidney organ explants to determine if quercetin reduces beta-catenin activity during kidney development and whether it improves the severity of renal dysplasia. In wild type kidney explants, quercetin treatment resulted in abnormal branching morphogenesis and nephrogenesis in a dose dependent manner. In wild type embryonic kidneys, quercetin reduced nuclear beta-catenin expression and decreased expression of beta-catenin target genesPax2,Six2, andGdnf, which are essential for kidney development. OurRD(B)mouse model of renal dysplasia recapitulates the overexpression of beta-catenin and histopathological changes observed in human renal dysplasia.RD(B)kidneys treated with quercetin resulted in improvements in the overall histopathology, tissue organization, ureteric branching morphogenesis, and nephrogenesis. Quercetin treatment also resulted in reduced nuclear beta-catenin and reducedPax2expression. These improvements were associated with the proper organization of vimentin, NCAM, and E-cadherin, and a 45% increase in the number of developing and maturing nephrons. Further, our results show that in human renal dysplasia, beta-catenin, vimentin, and e-cadherin also have abnormal expression patterns. Taken together, these data demonstrate that quercetin treatment reduces nuclear beta-catenin and this is associated with improved epithelial organization of developing nephrons, resulting in increased developing nephrons and a partial rescue of renal dysplasia.	[Cunanan, Joanna; Deacon, Erin; Cunanan, Kristina; Yang, Zifan; Ask, Antje; Morikawa, Lily; Todorova, Ekaterina; Bridgewater, Darren] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University	Bridgewater, D (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	bridgew@mcmaster.ca		Cunanan, Joanna/0000-0001-9587-4533	Canadian Institutes of Health Research; Kidney Foundation of Canada; National Science and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	DB-Canadian Institutes of Health Research; DB-Kidney Foundation of Canada; DB-National Science and Engineering Research Council.	[Anonymous], 2012, J OPT COMMUN NETW, V4, pB94; Aygul A, 2019, PHYTOMEDICINE, V57, P65, DOI 10.1016/j.phymed.2018.12.014; Balakrishnan S, 2016, CELL PROLIFERAT, V49, P678, DOI 10.1111/cpr.12296; Barker N, 2012, CELL REP, V2, P540, DOI 10.1016/j.celrep.2012.08.018; Bhat FA, 2014, J NUTR BIOCHEM, V25, P1132, DOI 10.1016/j.jnutbio.2014.06.008; Boivin FJ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00081; Boivin FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120347; Boyle SC, 2011, DEVELOPMENT, V138, P4245, DOI 10.1242/dev.070433; Bridgewater D, 2008, DEV BIOL, V317, P83, DOI 10.1016/j.ydbio.2008.02.010; Bridgewater D, 2011, J AM SOC NEPHROL, V22, P718, DOI 10.1681/ASN.2010050562; Cain JE, 2010, PEDIATR RES, V68, P91, DOI 10.1203/00006450-201011001-00175; Cao CN, 2015, PANCREAS, V44, P1334, DOI 10.1097/MPA.0000000000000400; Cebrian C, 2004, DEV DYNAM, V231, P601, DOI 10.1002/dvdy.20143; Chaw SY, 2012, ORAL ONCOL, V48, P997, DOI 10.1016/j.oraloncology.2012.05.011; Chen DQ, 2019, THER ADV CHRONIC DIS, V10, DOI 10.1177/2040622319869116; Chen DQ, 2018, TRENDS PHARMACOL SCI, V39, P937, DOI 10.1016/j.tips.2018.09.002; Chen DQ, 2017, REDOX BIOL, V12, P505, DOI 10.1016/j.redox.2017.03.017; Chen H, 2018, PHYTOMEDICINE, V42, P207, DOI 10.1016/j.phymed.2018.03.034; Chen RY, 2015, ARCH PATHOL LAB MED, V139, P547, DOI 10.5858/arpa.2013-0660-RS; Chong E, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/760580; Ding A, 2019, J DEV ORIG HLTH DIS, V10, P154, DOI 10.1017/S2040174418000673; Dressler GR, 1999, INT J DEV BIOL, V43, P463; Drukker A, 2002, ISRAEL MED ASSOC J, V4, P191; Fanos V, 2019, AM J PERINAT, V36, pS33, DOI 10.1055/s-0039-1691798; Feng JH, 2018, BIOCHEM BIOPH RES CO, V498, P132, DOI 10.1016/j.bbrc.2018.02.044; Feng YL, 2020, MED RES REV, V40, P54, DOI 10.1002/med.21596; Fosang AJ, 2015, J BIOL CHEM, V290, P29692, DOI 10.1074/jbc.E115.000002; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hermankova E, 2019, FREE RADICAL BIO MED, V143, P240, DOI 10.1016/j.freeradbiomed.2019.08.001; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; Hu MC, 2003, DEVELOPMENT, V130, P2753, DOI 10.1242/dev.00478; Hu Y, 2019, FREE RADICAL BIO MED, V145, P146, DOI 10.1016/j.freeradbiomed.2019.09.024; Kakkar N, 2006, FETAL PEDIATR PATHOL, V25, P73, DOI 10.1080/15513810600788764; Kee JY, 2016, PHYTOMEDICINE, V23, P1680, DOI 10.1016/j.phymed.2016.09.011; Lewinska A, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101337; Lin YS, 2011, CANCER SCI, V102, P1829, DOI 10.1111/j.1349-7006.2011.02035.x; Liu D, 2019, BIOMED PHARMACOTHER, V117, DOI 10.1016/j.biopha.2019.108990; Luo WR, 2012, INT J CANCER, V131, P1863, DOI 10.1002/ijc.27467; Mah SP, 2000, DEV BIOL, V223, P38, DOI 10.1006/dbio.2000.9738; Marose TD, 2008, DEV BIOL, V314, P112, DOI 10.1016/j.ydbio.2007.11.016; MCGRAW M, 1984, INT J PED NEPHROL, V5, P67; McMahon AP, 2016, CURR TOP DEV BIOL, V117, P31, DOI 10.1016/bs.ctdb.2015.10.010; Metsuyanim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006709; Miller JR, 1997, DEV BIOL, V192, P310, DOI 10.1006/dbio.1997.8739; Moritz KM, 2002, HYPERTENSION, V39, P1071, DOI 10.1161/01.HYP.0000019131.77075.54; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Orsulic S, 1999, J CELL SCI, V112, P1237; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Postoev VA, 2016, BIRTH DEFECTS RES A, V106, P185, DOI 10.1002/bdra.23475; Ren JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep23968; Rezabakhsh A, 2019, PHYTOMEDICINE, V56, P183, DOI 10.1016/j.phymed.2018.11.008; Roper JC, 2018, ELIFE, V7, DOI 10.7554/eLife.33381; Sanna-Cherchi S, 2007, PEDIATR NEPHROL, V22, P1675, DOI 10.1007/s00467-007-0479-1; Sarin S, 2014, AM J PATHOL, V184, P1395, DOI 10.1016/j.ajpath.2014.01.018; Srinivasan A, 2016, MOL CARCINOGEN, V55, P743, DOI 10.1002/mc.22318; Tafrihi M, 2017, NUTR CANCER, V69, P702, DOI 10.1080/01635581.2017.1320415; Vivante A, 2016, NAT REV NEPHROL, V12, P133, DOI 10.1038/nrneph.2015.205; Vrolijk MF, 2020, BRIT J PHARMACOL, V177, P1841, DOI 10.1111/bph.14955; Wang M, 2018, BRIT J PHARMACOL, V175, P2689, DOI 10.1111/bph.14333; Wang M, 2018, J AGR FOOD CHEM, V66, P1828, DOI 10.1021/acs.jafc.8b00099; Wang YP, 2018, PROG MOL BIOL TRANSL, V153, P181, DOI 10.1016/bs.pmbts.2017.11.019; Woods LL, 1999, AM J PHYSIOL-REG I, V276, pR974, DOI 10.1152/ajpregu.1999.276.4.R974; Yang Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24618-2; You WJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55654-1	65	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234375	10.1371/journal.pone.0234375	http://dx.doi.org/10.1371/journal.pone.0234375			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555682	Green Published, gold			2022-12-26	WOS:000542759600046
J	Morishita, N; Sakamori, R; Yamada, T; Kai, Y; Tahata, Y; Urabe, A; Yamada, R; Kodama, T; Hikita, H; Doi, Y; Tamura, S; Hagiwara, H; Imai, Y; Iio, S; Tatsumi, T; Takehara, T				Morishita, Naoki; Sakamori, Ryotaro; Yamada, Tomomi; Kai, Yugo; Tahata, Yuki; Urabe, Ayako; Yamada, Ryoko; Kodama, Takahiro; Hikita, Hayato; Doi, Yoshinori; Tamura, Shinji; Hagiwara, Hideki; Imai, Yasuharu; Iio, Sadaharu; Tatsumi, Tomohide; Takehara, Tetsuo			Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis C virus infection	PLOS ONE			English	Article							RESISTANCE-ASSOCIATED SUBSTITUTIONS; THERAPY; ASSAY	Background L31 and Y93 in the NS5A region of the hepatitis C virus (HCV) are the most important substitution positions associated with resistance to direct-acting antiviral (DAA) treatment. Methods We analyzed the frequency of NS5A L31M/V and Y93/H in NS5A inhibitor-naive HCV genotype 1 patients who received asunaprevir plus daclatasvir combination treatment using a conventional sequencing method and a deep sequencing method that can distinguish a single substitution at either position and a double substitution at both positions with a 0.1% detection threshold. Results The frequency of substitutions at both sites using the conventional method was very low, with 1 in 14 non-responders and 0 in 42 randomly selected responder patients. On the other hand, for the deep sequencing method, cases with double substitutions in the tandem sequence were detected in 8/14 non-responders and 1/42 responders (p<0.0001). For the conventional method, substitutions were detected at any position in 6/14 non-responders and 2/42 responders (p = 0.0019), with a clear difference between the two groups. The difference was also clear with the deep sequencing method, with 11/14 non-responders and 8/42 responders. Interestingly, for the deep sequencing method, the single substitution of L31 was found in 6/14 non-responders and 7/42 responders, whereas single substitutions of Y93 or double substitutions were found in 7/14 vs. 1/42 and 8/14 vs. 1/42 patients, respectively. Conclusions NS5A L31 and Y93 substitutions were detected in tandem by the deep sequencing methods in several genotype 1 patients, who may be more resistant to DAA treatment containing an NS5A inhibitor.	[Morishita, Naoki; Sakamori, Ryotaro; Kai, Yugo; Tahata, Yuki; Urabe, Ayako; Yamada, Ryoko; Kodama, Takahiro; Hikita, Hayato; Tatsumi, Tomohide; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan; [Yamada, Tomomi] Osaka Univ Hosp, Dept Med Innovat, Suita, Osaka, Japan; [Doi, Yoshinori] KKR Otemae Hosp, Osaka, Osaka, Japan; [Tamura, Shinji] Minoh City Hosp, Mino, Osaka, Japan; [Hagiwara, Hideki] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan; [Imai, Yasuharu] Ikeda Municipal Hosp, Ikeda, Osaka, Japan; [Iio, Sadaharu] Hyogo Prefectural Nishinomiya Hosp, Nishinomiya, Hyogo, Japan	Osaka University; Osaka University; Kansai Rosai Hospital	Takehara, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan.	takehara@gh.med.osaka-u.ac.jp	Sakamori, Ryotaro/B-4406-2014	Sakamori, Ryotaro/0000-0002-1580-607X; Kodama, Takahiro/0000-0002-6250-1324	Gilead Sciences, Inc.; Ministry of Health, Labour and Welfare of Japan; Japan Agency for Medical Research and Development [JP18fk0210021, JP18fk0210025]; Clinical Investigator's Research Project of Osaka University Graduate School of Medicine; Janssen Pharmaceutical K. K.	Gilead Sciences, Inc.(Gilead Sciences); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Clinical Investigator's Research Project of Osaka University Graduate School of Medicine; Janssen Pharmaceutical K. K.	This study is partially supported by grants from Gilead Sciences, Inc., Janssen Pharmaceutical K. K., and a Grant-in-Aid for Research on Hepatitis from the Ministry of Health, Labour and Welfare of Japan and the Japan Agency for Medical Research and Development (JP18fk0210021, T.T., R.S. and H.H.; JP18fk0210025, R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Other hospitals that attended the Osaka Liver Forum included: Osaka International Cancer Institute, Osaka Rosai Hospital, Osaka Police Hospital, Japan Community Healthcare Organization Osaka Hospital, Osaka General Medical Center, Toyonaka Municipal Hospital, Suita Municipal Hospital, Yao Municipal Hospital, Itami City Hospital, Higashiosaka City Medical Center, Nishinomiya Municipal Central Hospital, Kaizuka City Hospital, Sumitomo Hospital, Saso Hospital, and NTT West Osaka Hospital. The present study was supported by the Clinical Investigator's Research Project of Osaka University Graduate School of Medicine.	Dietz J, 2018, GASTROENTEROLOGY, V154, P976, DOI 10.1053/j.gastro.2017.11.007; Eis PS, 2001, NAT BIOTECHNOL, V19, P673, DOI 10.1038/90290; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Honda K, 2018, HEPATOL RES, V48, P255, DOI 10.1111/hepr.12994; Kai Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep41660; Kai Y, 2015, J GASTROENTEROL, V50, P1145, DOI 10.1007/s00535-015-1108-6; Kanda T, 2019, HEPATOL INT, V13, P103, DOI 10.1007/s12072-018-9915-5; Karino Y, 2015, KANZO JAPANESE, V56, P113; Keskin F, 2017, CLIN LAB, V63, P1439, DOI 10.7754/Clin.Lab.2017.170312; Kinugasa H, 2016, ANTIVIR THER, V21, P37, DOI 10.3851/IMP2976; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; Manos MM, 2012, J MED VIROL, V84, P1744, DOI 10.1002/jmv.23399; Olivier M, 2005, MUTAT RES-FUND MOL M, V573, P103, DOI 10.1016/j.mrfmmm.2004.08.016; Suzuki Y, 2013, J HEPATOL, V58, P655, DOI 10.1016/j.jhep.2012.09.037; Tadokoro K, 2014, KANZO, V55, P720; World Health Organization, 2019, HEP C; Yeon JE, 2018, CLIN MOL HEPATOL, V24, P169, DOI 10.3350/cmh.2018.1004; Yoshimi S, 2015, J MED VIROL, V87, P1913, DOI 10.1002/jmv.24255; Yoshimi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130022	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234811	10.1371/journal.pone.0234811	http://dx.doi.org/10.1371/journal.pone.0234811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544182	Green Published, gold			2022-12-26	WOS:000542957200023
J	Hansson, LK; Hansen, RB; Pletscher-Frankild, S; Berzins, R; Hansen, DH; Madsen, D; Christensen, SB; Christiansen, MR; Boulund, U; Wolf, XA; Kjaerulff, SK; van de Bunt, M; Tulin, S; Jensen, TS; Wernersson, R; Jensen, JN				Hansson, Lena K.; Hansen, Rasmus Borup; Pletscher-Frankild, Sune; Berzins, Rudolfs; Hansen, Daniel Hvidberg; Madsen, Dennis; Christensen, Sten B.; Christiansen, Malene Revsbech; Boulund, Ulrika; Wolf, Xenia Asbaek; Kjaerulff, Sonny Kim; van de Bunt, Martijn; Tulin, Soren; Jensen, Thomas Skot; Wernersson, Rasmus; Jensen, Jan Nygaard			Semantic text mining in early drug discovery for type 2 diabetes	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; HORMONE ADIPONECTIN; BETATROPHIN; IDENTIFICATION; RECORDS; KEGG	Background Surveying the scientific literature is an important part of early drug discovery; and with the ever-increasing amount of biomedical publications it is imperative to focus on the most interesting articles. Here we present a project that highlights new understanding (e.g. recently discovered modes of action) and identifies potential drug targets, via a novel, data-driven text mining approach to score type 2 diabetes (T2D) relevance. We focused on monitoring trends and jumps in T2D relevance to help us be timely informed of important breakthroughs. Methods We extracted over 7 millionn-grams from PubMed abstracts and then clustered around 240,000 linked to T2D into almost 50,000 T2D relevant 'semantic concepts'. To score papers, we weighted the concepts based on co-mentioning with core T2D proteins. A protein's T2D relevance was determined by combining the scores of the papers mentioning it in the five preceding years. Each week all proteins were ranked according to their T2D relevance. Furthermore, the historical distribution of changes in rank from one week to the next was used to calculate the significance of a change in rank by T2D relevance for each protein. Results We show that T2D relevant papers, even those not mentioning T2D explicitly, were prioritised by relevant semantic concepts. Well known T2D proteins were therefore enriched among the top scoring proteins. Our 'high jumpers' identified important past developments in the apprehension of how certain key proteins relate to T2D, indicating that our method will make us aware of future breakthroughs. In summary, this project facilitated keeping up with current T2D research by repeatedly providing short lists of potential novel targets into our early drug discovery pipeline.	[Hansson, Lena K.; Jensen, Jan Nygaard] Novo Nordisk Ltd, Novo Nordisk Res Ctr Oxford, Oxford, England; [Hansen, Rasmus Borup; Pletscher-Frankild, Sune; Berzins, Rudolfs; Hansen, Daniel Hvidberg; Christiansen, Malene Revsbech; Boulund, Ulrika; Wolf, Xenia Asbaek; Kjaerulff, Sonny Kim; Jensen, Thomas Skot; Wernersson, Rasmus] Intomics AS, Lyngby, Denmark; [Madsen, Dennis; Christensen, Sten B.; Kjaerulff, Sonny Kim; van de Bunt, Martijn; Tulin, Soren] Novo Nordisk AS, Bagsvaerd, Denmark; [Wernersson, Rasmus] Tech Univ Denmark, DTU Hlth Tech, Lyngby, Denmark; [Christiansen, Malene Revsbech] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth, Copenhagen, Denmark; [Boulund, Ulrika] Univ Amsterdam, Lab Expt Vasc Med, Acad Med Ctr, Amsterdam, Netherlands; [Jensen, Jan Nygaard] Boehringer Ingelheim GmbH & Co KG, Biberach, Germany	Novo Nordisk; Novo Nordisk; Technical University of Denmark; Novo Nordisk Foundation; University of Copenhagen; University of Amsterdam; Academic Medical Center Amsterdam; Boehringer Ingelheim	Wernersson, R (corresponding author), Intomics AS, Lyngby, Denmark.; Wernersson, R (corresponding author), Tech Univ Denmark, DTU Hlth Tech, Lyngby, Denmark.	rwe@intomics.com	Christiansen, Malene/GXF-5190-2022	Christiansen, Malene Revsbech/0000-0002-9772-3576; Hansen, Rasmus Borup/0000-0002-5899-0356; Madsen, Dennis/0000-0003-2099-6880; Wernersson, Rasmus/0000-0003-4417-9842	Novo Nordisk Ltd	Novo Nordisk Ltd(Novo Nordisk)	The work presented was sponsored by Novo Nordisk Ltd with part of it being carried out by Novo Nordisk employees and part of it by subcontracting to Intomics A/S. Novo Nordisk supplied internal data as well as taking part in the study design and overall supervision and guidance of the project, with special focus on evaluation of biological relevance. Intomics was responsible for the technical implementation, statistical analysis and benchmarking of results. The decision to publish was initiated by Novo Nordisk Ltd but in agreement with Intomics A/S.	Alvarado-Villa GE, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6436-7; Andrulionyte L, 2007, DIABETES, V56, P1181, DOI 10.2337/db06-1110; [Anonymous], 2012, CLIN CANC RES, V18, pPR61; [Anonymous], 2012, AM J PHYSIOL-ENDOC M, V303, pE410; [Anonymous], 2013, NUCL ACIDS RES, V41, pD43; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Cho YJ, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3321-4; Corrado G, 2013, 1 INT C LEARN REPR; Cummings BP, 2013, DIABETES OBES METAB, V15, P607, DOI 10.1111/dom.12048; Devlin J., 2019, BERT PRE TRAINING DE; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Ebert T, 2014, J CLIN ENDOCR METAB, V99, pE2510, DOI 10.1210/jc.2013-4349; El-Kishky A, 2014, PROC VLDB ENDOW, V8, P305, DOI 10.14778/2735508.2735519; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Eriksson R, 2014, DRUG SAFETY, V37, P237, DOI 10.1007/s40264-014-0145-z; Fano R M, 1961, AM J PHYS, V29, P793, DOI DOI 10.1119/1.1937609; Fischer S, 2002, ACTA DIABETOL, V39, P105, DOI 10.1007/s005920200027; Francini F, 2019, MINI-REV MED CHEM, V19, P880, DOI 10.2174/1389557519666181128120726; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Guo KF, 2016, SURG OBES RELAT DIS, V12, P1343, DOI 10.1016/j.soard.2016.01.024; Han H, 2018, CELL STRESS, V2, P325, DOI 10.15698/cst2018.11.164; Henry Sam, 2019, AMIA Jt Summits Transl Sci Proc, V2019, P582; Inzucchi SE, 2013, DIABETES CARE, V36, P490, DOI 10.2337/dc13-er02; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kilicoglu H, 2012, BIOINFORMATICS, V28, P3158, DOI 10.1093/bioinformatics/bts591; Kogan E, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-019-1010-x; Koscielny G, 2017, NUCLEIC ACIDS RES, V45, pD985, DOI 10.1093/nar/gkw1055; Kuusisto Finn, 2017, AMIA Jt Summits Transl Sci Proc, V2017, P166; Lee MR, 2019, PHYTOMEDICINE, V55, P14, DOI 10.1016/j.phymed.2018.07.008; Lee MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05721-4; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Nguyen LT, 2019, J PHYSIOL-LONDON, V597, P467, DOI 10.1113/JP276957; Pletscher-Frankild S, 2015, METHODS, V74, P83, DOI 10.1016/j.ymeth.2014.11.020; Poliseno L, 2012, SCI SIGNAL, V5, pre5; Renaux A, 2018, NUCLEIC ACIDS RES, V46, P2699, DOI 10.1093/nar/gky092; Schvartz D., 2015, TRANSLATIONAL PROTEO, V8-9, P1, DOI [10.1016/j.trprot.2015.03.001, DOI 10.1016/J.TRPROT.2015.03.001]; Simon C, 2019, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-019-2607-x; Slenter DN, 2018, NUCLEIC ACIDS RES, V46, pD661, DOI 10.1093/nar/gkx1064; Swanson DR, 1999, LIBR TRENDS, V48, P48; Sybrandt J, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1633, DOI 10.1145/3097983.3098057; Tshitoyan V, 2019, NATURE, V571, P95, DOI 10.1038/s41586-019-1335-8; Vallon V, 2011, J AM SOC NEPHROL, V22, P104, DOI 10.1681/ASN.2010030246; Vatner DF, 2018, DIABETOLOGIA, V61, P1435, DOI 10.1007/s00125-018-4579-1; Wang M, 2019, CRIT REV FOOD SCI, V59, pS116, DOI 10.1080/10408398.2018.1544542; Xun GX, 2017, IEEE DATA MINING, P535, DOI 10.1109/ICDM.2017.63; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yi P, 2017, CELL, V168, P326, DOI 10.1016/j.cell.2016.12.017; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038; Zheng S, 2019, METHODS MOL BIOL, V1939, P231, DOI 10.1007/978-1-4939-9089-4_13	54	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0233956	10.1371/journal.pone.0233956	http://dx.doi.org/10.1371/journal.pone.0233956			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542027	Green Published, gold			2022-12-26	WOS:000542685100030
J	Liu, HB; Hilliard, S; Kelly, E; Chen, CH; Saifudeen, Z; El-Dahr, SS				Liu, Hongbing; Hilliard, Sylvia; Kelly, Elizabeth; Chen, Chao-Hui; Saifudeen, Zubaida; El-Dahr, Samir S.			The polycomb proteins EZH1 and EZH2 co-regulate chromatin accessibility and nephron progenitor cell lifespan in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nephron progenitors; polycomb; histone methylation; development; kidney; epigenetics; chromatin; enhancer of zeste (Ezh); SIX homeobox 2 (SIX2); nephrology	GENE-EXPRESSION; MOUSE; SIX2; MAINTAIN; RENEWAL	SIX2 (SIX homeobox 2)-positive nephron progenitor cells (NPCs) give rise to all epithelial cell types of the nephron, the filtering unit of the kidney. NPCs have a limited lifespan and are depleted near the time of birth. Epigenetic factors are implicated in the maintenance of organ-restricted progenitors such as NPCs, but the chromatin-based mechanisms are incompletely understood. Here, using a combination of gene targeting, chromatin profiling, and single-cell RNA analysis, we examined the role of the murine histone 3 Lys-27 (H3K27) methyltransferases EZH1 (enhancer of zeste 1) and EZH2 in NPC maintenance. We found that EZH2 expression correlates with NPC growth potential and that EZH2 is the dominant H3K27 methyltransferase in NPCs and epithelial descendants. Surprisingly, NPCs lacking H3K27 trimethylation maintained their progenitor state but cycled slowly, leading to a smaller NPC pool and formation of fewer nephrons. UnlikeEzh2loss of function, dual inactivation ofEzh1andEzh2triggered overexpression of the transcriptional repressor Hes-related family BHLH transcription factor with YRPW motif 1 (Hey1), down-regulation ofSix2, and unscheduled activation of Wnt4-driven differentiation, resulting in early termination of nephrogenesis and severe renal dysgenesis. Double-mutant NPCs also overexpressed the SIX family memberSix1. However, in this context, SIX1 failed to maintain NPC stemness. At the chromatin level, EZH1 and EZH2 restricted accessibility to AP-1-binding motifs, and their absence promoted a regulatory landscape akin to differentiated and nonlineage cells. We conclude that EZH2 is required for NPC renewal potential and that tempering of the differentiation program requires cooperation of both EZH1 and EZH2.	[Liu, Hongbing; Hilliard, Sylvia; Kelly, Elizabeth; Chen, Chao-Hui; Saifudeen, Zubaida; El-Dahr, Samir S.] Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70112 USA; [Kelly, Elizabeth] Tulane Univ, Sch Med, Dept Obstet & Gynecol, 1430 Tulane Ave, New Orleans, LA 70112 USA	Tulane University; Tulane University	El-Dahr, SS (corresponding author), Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70112 USA.	seldahr@tulane.edu		El-Dahr, Samir/0000-0001-7571-4292	National Institutes of Health [1RO1 DK114500, 1P50 DK096373]; American Heart Association [17SDG33660072]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by National Institutes of Health Grants 1RO1 DK114500 and 1P50 DK096373 and American Heart Association Grant 17SDG33660072. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aiden AP, 2010, CELL STEM CELL, V6, P591, DOI 10.1016/j.stem.2010.03.016; [Anonymous], 2018, J AM SOC NEPHROL, DOI DOI 10.1681/ASN.2017080887; [Anonymous], 2019, ANAT REC 1006; Bae WK, 2015, FASEB J, V29, P1653, DOI 10.1096/fj.14-261537; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Brunskill EW, 2014, DEVELOPMENT, V141, P3093, DOI 10.1242/dev.110601; Brunskill EW, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-15; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chung E, 2017, DEVELOPMENT, V144, P4530, DOI 10.1242/dev.156661; Combes AN, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.178673; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Deevy O, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.181354; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; Denner DR, 2013, DEV BIOL, V375, P105, DOI 10.1016/j.ydbio.2012.11.018; Dupret B, 2017, BBA-GENE REGUL MECH, V1860, P1079, DOI 10.1016/j.bbagrm.2017.08.011; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fujimura S, 2010, J AM SOC NEPHROL, V21, P803, DOI 10.1681/ASN.2009040353; Hilliard S, 2019, BIOL OPEN, V8, DOI 10.1242/bio.042754; Hilliard SA, 2014, DEV BIOL, V387, P1, DOI 10.1016/j.ydbio.2014.01.009; Kavaliauskaite D, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6326053; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kouznetsova VL, 2019, PROTEIN SCI, V28, P1387, DOI 10.1002/pro.3647; Li SY, 2019, J AM SOC NEPHROL, V30, P594, DOI 10.1681/ASN.2018070687; Little MH, 2015, DEV CELL, V35, P5, DOI 10.1016/j.devcel.2015.09.023; Liu HB, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.153619; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McLaughlin N, 2013, EPIGENETICS-US, V8, P970, DOI 10.4161/epi.25753; Mu WP, 2017, DEV BIOL, V424, P198, DOI 10.1016/j.ydbio.2017.02.017; Muthukrishnan D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10027; O'Brien LL, 2016, DEVELOPMENT, V143, P595, DOI 10.1242/dev.127175; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Park JS, 2012, DEV CELL, V23, P637, DOI 10.1016/j.devcel.2012.07.008; Piechaczyk M, 2008, BIOCHEM SOC T, V36, P864, DOI 10.1042/BST0360864; Schanstra JP, 2007, KIDNEY INT, V72, P442, DOI 10.1038/sj.ki.5002172; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Short KM, 2014, DEV CELL, V29, P188, DOI 10.1016/j.devcel.2014.02.017; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Wanner N, 2019, J AM SOC NEPHROL, V30, P63, DOI 10.1681/ASN.2018070736; Xu JY, 2014, DEVELOPMENT, V141, P1442, DOI 10.1242/dev.103283; Yan NH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33887; Zhang L, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.157149; Zohdi V, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/136942	45	11	11	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11542	11558		10.1074/jbc.RA120.013348	http://dx.doi.org/10.1074/jbc.RA120.013348			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32554463	Green Published, hybrid			2022-12-26	WOS:000563922500015
J	Alford, RF; Smolin, N; Young, HS; Gray, JJ; Robia, SL				Alford, Rebecca F.; Smolin, Nikolai; Young, Howard S.; Gray, Jeffrey J.; Robia, Seth L.			Protein docking and steered molecular dynamics suggest alternative phospholamban-binding sites on the SERCA calcium transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium ATPase; calcium transport; molecular docking; molecular dynamics; protein-protein interaction; membrane protein; membrane biophysics; phospholamban; binding site; micropeptides	CARDIAC SARCOPLASMIC-RETICULUM; SODIUM-POTASSIUM PUMP; PARTICLE MESH EWALD; CA2+ PUMP; CRYSTAL-STRUCTURE; CROSS-LINKING; PHOSPHORYLATION; CA2+-ATPASE; ATPASE; STIMULATION	The transport activity of the sarco(endo)plasmic reticulum calcium ATPase (SERCA) in cardiac myocytes is modulated by an inhibitory interaction with a transmembrane peptide, phospholamban (PLB). Previous biochemical studies have revealed that PLB interacts with a specific inhibitory site on SERCA, and low-resolution structural evidence suggests that PLB interacts with distinct alternative sites on SERCA. High-resolution details of the structural determinants of SERCA regulation have been elusive because of the dynamic nature of the regulatory complex. In this study, we used computational approaches to develop a structural model of SERCA-PLB interactions to gain a mechanistic understanding of PLB-mediated SERCA transport regulation. We combined steered molecular dynamics and membrane protein-protein docking experiments to achieve both a global search and all-atom force calculations to determine the relative affinities of PLB for candidate sites on SERCA. We modeled the binding of PLB to several SERCA conformations, representing different enzymatic states sampled during the calcium transport catalytic cycle. The results of the steered molecular dynamics and docking experiments indicated that the canonical PLB-binding site (comprising transmembrane helices M2, M4, and M9) is the preferred site. This preference was even more stringent for a superinhibitory PLB variant. Interestingly, PLB-binding specificity became more ambivalent for other SERCA conformers. These results provide evidence for polymorphic PLB interactions with novel sites on M3 and with the outside of the SERCA helix M9. Our findings are compatible with previous physical measurements that suggest that PLB interacts with multiple binding sites, conferring dynamic responsiveness to changing physiological conditions.	[Alford, Rebecca F.; Gray, Jeffrey J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Smolin, Nikolai; Robia, Seth L.] Loyola Univ Chicago, Stritch Sch Med, Cardiovasc Res Inst, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	Johns Hopkins University; Loyola University Chicago; University of Alberta	Robia, SL (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Cardiovasc Res Inst, Dept Cell & Mol Physiol, Maywood, IL 60153 USA.	srobia@luc.edu			Loyola University Chicago Cardiovascular Research Institute; Hertz Foundation Fellowship; National Science Foundation Graduate Research Fellowship; National Institutes of Health Grant [GM-078221, HL-092321, HL-143816]	Loyola University Chicago Cardiovascular Research Institute; Hertz Foundation Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Loyola University Chicago Cardiovascular Research Institute. R. F. A. was funded by a Hertz Foundation Fellowship and a National Science Foundation Graduate Research Fellowship. J. J. G. was supported by National Institutes of Health Grant GM-078221. H. S. Y. and S. L. R. were supported by National Institutes of Health Grants HL-092321 and HL-143816. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrol N, 2015, J BIOL CHEM, V290, P7130, DOI 10.1074/jbc.M114.630319; Afara MR, 2008, BIOCHEMISTRY-US, V47, P9522, DOI 10.1021/bi800880q; Akin BL, 2013, J BIOL CHEM, V288, P30181, DOI 10.1074/jbc.M113.501585; Akin BL, 2012, J BIOL CHEM, V287, P7582, DOI 10.1074/jbc.M111.334987; Akin BL, 2010, J BIOL CHEM, V285, P28540, DOI 10.1074/jbc.M110.151779; Alford RF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004398; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Arbesu M, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00039; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Chen JL, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a035113; Chen ZH, 2003, J BIOL CHEM, V278, P48348, DOI 10.1074/jbc.M309545200; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dong XQ, 2014, BIOCHEM BIOPH RES CO, V449, P196, DOI 10.1016/j.bbrc.2014.04.166; Dyla M, 2019, BIOCHEM SOC T, V47, P1247, DOI 10.1042/BST20190124; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Glaves JP, 2020, BIOPHYS J, V118, P518, DOI 10.1016/j.bpj.2019.11.3385; Glaves JP, 2019, BIOPHYS J, V116, P633, DOI 10.1016/j.bpj.2019.01.013; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; Gorski PA, 2015, CELL METAB, V21, P183, DOI 10.1016/j.cmet.2015.01.005; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gumbart J, 2006, BIOPHYS J, V90, P2356, DOI 10.1529/biophysj.105.075291; Gustavsson M, 2013, P NATL ACAD SCI USA, V110, P17338, DOI 10.1073/pnas.1303006110; Guzman DL, 2008, POLYMER, V49, P3892, DOI 10.1016/j.polymer.2008.06.047; Harayama T, 2018, NAT REV MOL CELL BIO, V19, P281, DOI 10.1038/nrm.2017.138; Hendrickson WA, 2016, NAT STRUCT MOL BIOL, V23, P464, DOI 10.1038/nsmb.3215; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hurwitz N, 2016, BIOINFORMATICS, V32, P2444, DOI 10.1093/bioinformatics/btw184; Izrailev S., 1999, COMPUTATIONAL MOL DY, P39, DOI [10.1007/978-3-642-58360-5_2, DOI 10.1007/978-3-642-58360-5_2]; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Kimura Y, 1996, J BIOL CHEM, V271, P21726, DOI 10.1074/jbc.271.36.21726; KIRCHBERGER MA, 1982, J BIOL CHEM, V257, P5685; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; KRANIAS EG, 1982, NATURE, V298, P182, DOI 10.1038/298182a0; Lazaridis T, 2003, PROTEINS, V52, P176, DOI 10.1002/prot.10410; Lensink MF, 2017, PROTEINS, V85, P359, DOI 10.1002/prot.25215; Li JH, 2004, BIOCHEMISTRY-US, V43, P3870, DOI 10.1021/bi036183u; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; Mahaney JE, 2005, BIOCHEMISTRY-US, V44, P7713, DOI 10.1021/bi048011i; Martin PD, 2018, BIOPHYS J, V114, P2573, DOI 10.1016/j.bpj.2018.04.035; Marze NA, 2018, BIOINFORMATICS, V34, P3461, DOI 10.1093/bioinformatics/bty355; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; MOVSESIAN MA, 1984, J BIOL CHEM, V259, P8029; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; Negash S, 2000, BIOCHEM J, V351, P195, DOI 10.1042/0264-6021:3510195; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Pallikkuth S, 2013, BIOPHYS J, V105, P1812, DOI 10.1016/j.bpj.2013.08.045; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Primeau JO, 2018, SUBCELL BIOCHEM, V87, P229, DOI 10.1007/978-981-10-7757-9_8; Reddy LG, 2003, BIOCHEMISTRY-US, V42, P4585, DOI 10.1021/bi026995a; Roy Burman S. S., 2019, NOVEL SAMPLING STRAT, DOI [10.1101/749317, DOI 10.1101/749317]; Salmaso V, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00923; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sitsel A, 2019, EMBO J, V38, DOI 10.15252/embj.2018100020; Stokes DL, 2006, BIOPHYS J, V90, P4213, DOI 10.1529/biophysj.105.079640; Stranges PB, 2013, PROTEIN SCI, V22, P74, DOI 10.1002/pro.2187; Stroik DR, 2020, J MOL CELL CARDIOL, V138, P59, DOI 10.1016/j.yjmcc.2019.11.147; TADA M, 1974, J BIOL CHEM, V249, P6174; Teriete P, 2009, BBA-BIOMEMBRANES, V1788, P2462, DOI 10.1016/j.bbamem.2009.09.001; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Tyka MD, 2011, J MOL BIOL, V405, P607, DOI 10.1016/j.jmb.2010.11.008; Viswanath S, 2015, PROTEINS, V83, P2170, DOI 10.1002/prot.24934; Widge AS, 2007, LANGMUIR, V23, P10672, DOI 10.1021/la070214v; Zima AV, 2014, PFLUG ARCH EUR J PHY, V466, P1129, DOI 10.1007/s00424-014-1469-3	82	5	5	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11262	11274		10.1074/jbc.RA120.012948	http://dx.doi.org/10.1074/jbc.RA120.012948			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32554805	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000562757100027
J	Di Lorenzo, F; Speciale, I; Silipo, A; Alias-Villegas, C; Acosta-Jurado, S; Rodriguez-Carvajal, MA; Dardanelli, MS; Palmigiano, A; Garozzo, D; Ruiz-Sainz, JE; Molinaro, A; Vinardell, JM				Di Lorenzo, Flaviana; Speciale, Immacolata; Silipo, Alba; Alias-Villegas, Cynthia; Acosta-Jurado, Sebastian; Rodriguez-Carvajal, Miguel-Angel; Dardanelli, Marta S.; Palmigiano, Angelo; Garozzo, Domenico; Ruiz-Sainz, Jose-Enrique; Molinaro, Antonio; Vinardell, Jose-Maria			Structure of the unusualSinorhizobium frediiHH103 lipopolysaccharide and its role in symbiosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; Sinorhizobium fredii; symbiosis; lipopolysaccharide (LPS); pseudaminic acid; carbohydrate structure; antibody; soybean; Macroptilium; Cajanus; microbiology	SINORHIZOBIUM-FREDII HH103; FAST-GROWING RHIZOBIA; CAPSULAR POLYSACCHARIDE; MASS-SPECTROMETRY; BRADYRHIZOBIUM-JAPONICUM; LOTUS-BURTTII; SP NGR234; INFECTION; ANTIGEN; GENE	Rhizobia are soil bacteria that form important symbiotic associations with legumes, and rhizobial surface polysaccharides, such as K-antigen polysaccharide (KPS) and lipopolysaccharide (LPS), might be important for symbiosis. Previously, we obtained a mutant ofSinorhizobium frediiHH103,rkpA, that does not produce KPS, a homopolysaccharide of a pseudaminic acid derivative, but whose LPS electrophoretic profile was indistinguishable from that of the WT strain. We also previously demonstrated that the HH103rkpLMNOPQoperon is responsible for 5-acetamido-3,5,7,9-tetradeoxy-7-(3-hydroxybutyramido)-l-glycero-l-manno-nonulosonic acid [Pse5NAc7(3OHBu)] production and is involved in HH103 KPS and LPS biosynthesis and that an HH103rkpMmutant cannot produce KPS and displays an altered LPS structure. Here, we analyzed the LPS structure of HH103rkpA, focusing on the carbohydrate portion, and found that it contains a highly heterogeneous lipid A and a peculiar core oligosaccharide composed of an unusually high number of hexuronic acids containing beta-configured Pse5NAc7(3OHBu). This pseudaminic acid derivative, in its alpha-configuration, was the only structural component of theS. frediiHH103 KPS and, to the best of our knowledge, has never been reported from any other rhizobial LPS. We also show that Pse5NAc7(3OHBu) is the complete or partial epitope for a mAb, NB6-228.22, that can recognize the HH103 LPS, but not those of most of theS. frediistrains tested here. We also show that the LPS from HH103rkpMis identical to that of HH103rkpAbut devoid of any Pse5NAc7(3OHBu) residues. Notably, thisrkpMmutant was severely impaired in symbiosis with its host,Macroptilium atropurpureum.	[Di Lorenzo, Flaviana; Speciale, Immacolata; Silipo, Alba; Molinaro, Antonio] Univ Naples Federico II, Dept Chem Sci, Naples, Italy; [Alias-Villegas, Cynthia; Acosta-Jurado, Sebastian; Ruiz-Sainz, Jose-Enrique; Vinardell, Jose-Maria] Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain; [Rodriguez-Carvajal, Miguel-Angel] Univ Seville, Fac Chem, Dept Organ Chem, Seville, Spain; [Dardanelli, Marta S.] Univ Nacl Rio Cuarto INBIAS, Fac Ciencias Exactas Fis Quim & Nat, Dept Biol Mol, CONICET, Cordoba, Argentina; [Palmigiano, Angelo; Garozzo, Domenico] CNR, Ist Polimeri Compositi & Biomat IPCB, Catania, Italy	University of Naples Federico II; University of Sevilla; University of Sevilla; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consiglio Nazionale delle Ricerche (CNR); Istituto per i Polimeri, Compositi e Biomateriali (IPCB-CNR)	Molinaro, A (corresponding author), Univ Naples Federico II, Dept Chem Sci, Naples, Italy.; Vinardell, JM (corresponding author), Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain.	molinaro@unina.it; jvinar@us.es	Carvajal, Miguel Ángel Rodríguez/F-2577-2012; Jurado, Sebastián Acosta/ABH-3676-2020; Silipo, Alba/L-5929-2014; Garozzo, Domenico/I-8839-2014	Carvajal, Miguel Ángel Rodríguez/0000-0002-2131-6448; Acosta Jurado, Sebastian/0000-0002-5505-2508; Speciale, Immacolata/0000-0003-4363-7450; Garozzo, Domenico/0000-0002-9087-9818	Andalusian Government [P11-CVI-7500]; Ministry of Economy and Competitiveness (Spanish Government) [BIO2016-78409-R]; CONICET [PIP 112-201501-00232]	Andalusian Government; Ministry of Economy and Competitiveness (Spanish Government); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was funded by grants P11-CVI-7500 from the Andalusian Government, and BIO2016-78409-R from the Ministry of Economy and Competitiveness (Spanish Government). M. S. D. is a Career Member of CONICET and worked thanks to grant CONICET PIP 112-201501-00232.	Acosta-Jurado S, 2020, ENVIRON MICROBIOL, V22, P1104, DOI 10.1111/1462-2920.14897; Acosta-Jurado S, 2017, PLANT SOIL, V417, P415, DOI 10.1007/s11104-017-3268-z; Acosta-Jurado S, 2016, MOL PLANT MICROBE IN, V29, P925, DOI 10.1094/MPMI-09-16-0195-R; Acosta-Jurado S, 2016, MOL PLANT MICROBE IN, V29, P700, DOI 10.1094/MPMI-06-16-0116-R; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bourassa DV, 2017, MOL PLANT MICROBE IN, V30, P161, DOI 10.1094/MPMI-11-16-0230-R; Brewin NJ, 1993, ADV MOL GENETICS PLA, V2, P369; Buendia-Claveria AM, 2003, MICROBIOL-SGM, V149, P1807, DOI 10.1099/mic.0.26099-0; Campbell GRO, 2003, J BACTERIOL, V185, P3853, DOI 10.1128/JB.185.13.3853-3862.2003; Campbell GRO, 2002, P NATL ACAD SCI USA, V99, P3938, DOI 10.1073/pnas.062425699; Carlson RW, 2010, SUBCELL BIOCHEM, V53, P339, DOI 10.1007/978-90-481-9078-2_16; CARLSON RW, 1987, J BACTERIOL, V169, P4923, DOI 10.1128/jb.169.11.4923-4928.1987; CASSE F, 1979, J GEN MICROBIOL, V113, P229, DOI 10.1099/00221287-113-2-229; CAVA JR, 1989, J BACTERIOL, V171, P8, DOI 10.1128/jb.171.1.8-15.1989; Chataigne G, 2008, J CHROMATOGR A, V1185, P241, DOI 10.1016/j.chroma.2008.01.065; Crespo-Rivas JC, 2016, ENVIRON MICROBIOL, V18, P2392, DOI 10.1111/1462-2920.13101; Crespo-Rivas JC, 2009, MOL PLANT MICROBE IN, V22, P575, DOI 10.1094/MPMI-22-5-0575; De Castro C, 2010, METHOD ENZYMOL, V480, P89, DOI 10.1016/S0076-6879(10)80005-9; Di Lorenzo F, 2017, CHEMISTRYOPEN, V6, P541, DOI 10.1002/open.201700074; Di Lorenzo F, 2017, CHEM-EUR J, V23, P3637, DOI 10.1002/chem.201604379; Di Lorenzo F, 2015, RSC DRUG DISCOV, V43, P38; Di Lorenzo F, 2013, CHEMBIOCHEM, V14, P1105, DOI 10.1002/cbic.201300062; DOWDLE SF, 1985, APPL ENVIRON MICROB, V50, P1171, DOI 10.1128/AEM.50.5.1171-1176.1985; FINAN TM, 1991, MOL PLANT MICROBE IN, V4, P386, DOI 10.1094/MPMI-4-386; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Gao MS, 2001, MOL PLANT MICROBE IN, V14, P857, DOI 10.1094/MPMI.2001.14.7.857; Gil-Serrano AM, 1999, BIOCHEM J, V342, P527, DOI 10.1042/0264-6021:3420527; Gudlavalleti SK, 2003, J BIOL CHEM, V278, P3957, DOI 10.1074/jbc.M210491200; Hidalgo A, 2010, MICROBIOL-SGM, V156, P3398, DOI 10.1099/mic.0.042499-0; Holst O, 2000, METH MOL B, V145, P345; Janczarek M, 2015, APPL SOIL ECOL, V85, P94, DOI 10.1016/j.apsoil.2014.08.010; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kasimova AA, 2017, BIOCHEMISTRY-MOSCOW+, V82, P483, DOI 10.1134/S0006297917040101; Kawaharada Y, 2015, NATURE, V523, P308, DOI 10.1038/nature14611; Kawaharada Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14534; Kereszt A, 1998, J BACTERIOL, V180, P5426, DOI 10.1128/JB.180.20.5426-5431.1998; KEYSER HH, 1982, SCIENCE, V215, P1631, DOI 10.1126/science.215.4540.1631; Kiss E, 2001, MOL PLANT MICROBE IN, V14, P1395, DOI 10.1094/MPMI.2001.14.12.1395; Knirel YA, 2003, ADV CARBOHYD CHEM BI, V58, P371, DOI 10.1016/S0065-2318(03)58007-6; Krol Elizaveta, 2009, P189; Lagares A, 2001, J BACTERIOL, V183, P1248, DOI 10.1128/JB.183.4.1248-1258.2001; LAGARES A, 1992, J BACTERIOL, V174, P5941, DOI 10.1128/jb.174.18.5941-5952.1992; Lamrabet Y, 1999, MOL PLANT MICROBE IN, V12, P207, DOI 10.1094/MPMI.1999.12.3.207; Le Quere AJL, 2006, J BIOL CHEM, V281, P28981, DOI 10.1074/jbc.M513639200; LEONTEIN K, 1978, CARBOHYD RES, V62, P359, DOI 10.1016/S0008-6215(00)80882-4; Lopez-Baena FJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050755; Madinabeitia N, 2002, MOL PLANT MICROBE IN, V15, P150, DOI 10.1094/MPMI.2002.15.2.150; Margaret I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074717; Margaret I, 2012, MOL PLANT MICROBE IN, V25, P825, DOI 10.1094/MPMI-10-11-0262; Margaret I, 2011, J BIOTECHNOL, V155, P11, DOI 10.1016/j.jbiotec.2011.03.016; Margaret-Oliver I, 2012, ARCH MICROBIOL, V194, P87, DOI 10.1007/s00203-011-0729-2; NOEL KD, 1986, J BACTERIOL, V168, P1392, DOI 10.1128/jb.168.3.1392-1401.1986; Noel KD, 2000, J BACTERIOL, V182, P5317, DOI 10.1128/JB.182.19.5317-5324.2000; Noh JG, 2015, INT J MOL SCI, V16, P16778, DOI 10.3390/ijms160816778; Parada M, 2006, MOL PLANT MICROBE IN, V19, P43, DOI 10.1094/MPMI-19-0043; PEROTTO S, 1994, MOL PLANT MICROBE IN, V7, P99, DOI 10.1094/MPMI-7-0099; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; Rance M, 2012, BIOCHEM BIOPH RES CO, V425, P527, DOI 10.1016/j.bbrc.2012.08.019; Reuhs BL, 1998, APPL ENVIRON MICROB, V64, P4930; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Rodriguez-Navarro DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115391; Silipo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6106; Silipo A, 2011, ANGEW CHEM INT EDIT, V50, P12610, DOI 10.1002/anie.201106548; STACEY G, 1991, MOL PLANT MICROBE IN, V4, P332, DOI 10.1094/MPMI-4-332; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Stern AS, 2002, J AM CHEM SOC, V124, P1982, DOI 10.1021/ja011669o; Sturiale L, 2005, RAPID COMMUN MASS SP, V19, P1829, DOI 10.1002/rcm.1994; Sturiale L, 2011, J MASS SPECTROM, V46, P1135, DOI 10.1002/jms.2000; Thomas-Oates J, 2003, SYST APPL MICROBIOL, V26, P453, DOI 10.1078/072320203322497491; TRINICK MJ, 1980, J APPL BACTERIOL, V49, P39, DOI 10.1111/j.1365-2672.1980.tb01042.x; Vinardell JM, 2004, MOL PLANT MICROBE IN, V17, P676, DOI 10.1094/MPMI.2004.17.6.676; Vinardell JM, 2015, MOL PLANT MICROBE IN, V28, P811, DOI 10.1094/MPMI-12-14-0397-FI; Vincent JM, 1970, MANUAL PRACTICAL STU, P144; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83	74	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					10969	10987		10.1074/jbc.RA120.013393	http://dx.doi.org/10.1074/jbc.RA120.013393			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32546484	hybrid, Green Published			2022-12-26	WOS:000562757100008
J	Su, HA; Hsu, YC; Siao, FY; Yen, HH				Su, Hsuan-An; Hsu, Yu-Chun; Siao, Fu-Yuan; Yen, Hsu-Heng			Diagnosis and management of jejunoileal diverticular haemorrhage: An update on the experience in a single centre	PLOS ONE			English	Article							DOUBLE-BALLOON ENTEROSCOPY; CLINICAL-SIGNIFICANCE; DISEASE; DECADE	Introduction Jejunoileal diverticular haemorrhage is a rare disease that is difficult to diagnose and treat. Despite advances in endoscopic technology, recommendations on diagnosis and management for jejunoileal diverticular haemorrhage have remained unchanged and these new options have not been compared against traditional surgical management. Materials and methods We retrospectively reviewed the diagnosis, management, and outcome for jejunoileal diverticular haemorrhage cases at our institution over the past 20 years. Data were organized and analysed by chi-square test, studentt-test and Kaplan-Meier survival analysis. Results The most utilised diagnostic procedure was computed tomography, followed by enteroscopy, angiography, small bowel flow-through and surgery. Primary treatments included, in a decreasing order, medical therapy, surgery, endoscopy and radiology. Surgical treatment was not associated with rebleeding, but it did result in longer hospital stays and larger blood transfusions than non-surgical treatments. The bleeding-related mortality rate was very low. Notably, there was also little change in the diagnosis and treatment between decades. Conclusion We presented our experience with the diagnosis and management of jejunoileal diverticular haemorrhage, as well as long-term follow-up after treatments that have not been reported previously. Surgical treatment continues to dominate management for jejunoileal diverticular haemorrhage, but we support increasing the role of endoscopy for select patient groups.	[Su, Hsuan-An] Kaohsiung Chang Gung Mem Hosp, Dept Med Educ, Kaohsiung, Taiwan; [Hsu, Yu-Chun; Yen, Hsu-Heng] Changhua Christian Hosp, Endoscopy Ctr, Changhua, Taiwan; [Siao, Fu-Yuan] Changhua Christian Hosp, Dept Emergency Med, Changhua, Taiwan; [Yen, Hsu-Heng] Chien Kuo Technol Univ, Gen Educ Ctr, Changhua, Taiwan; [Yen, Hsu-Heng] Chung Shan Med Univ, Coll Med, Taichung, Taiwan; [Yen, Hsu-Heng] Taiwan Assoc Study Small Intestinal Dis TASSID, Taipei, Taiwan	Chang Gung Memorial Hospital; Changhua Christian Hospital; Chienkuo Technology University; Chung Shan Medical University	Yen, HH (corresponding author), Changhua Christian Hosp, Endoscopy Ctr, Changhua, Taiwan.; Yen, HH (corresponding author), Chien Kuo Technol Univ, Gen Educ Ctr, Changhua, Taiwan.; Yen, HH (corresponding author), Chung Shan Med Univ, Coll Med, Taichung, Taiwan.; Yen, HH (corresponding author), Taiwan Assoc Study Small Intestinal Dis TASSID, Taipei, Taiwan.	blaneyen@gmail.com		Su, Hsuan-An/0000-0002-6710-9911; Yen, Hsu-Heng/0000-0002-3494-2245	Changhua Christian Hospital [106CCHIRP-030, 108-CCHIRP-018, 105-CCH-IRP-071]	Changhua Christian Hospital	The authors received funding from Changhua Christian Hospital (http://www2.cch.org.tw/cch_english/) for this work: numbers 106CCHIRP-030 and 108-CCHIRP-018 for Dr HsuHeng Yen, and number 105-CCH-IRP-071 for Dr Fu-Yuan Siao. The funder played NO role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardelt M, 2017, AM SURGEON, V83, pE455; Bosanquet DC, 2010, BRIT J HOSP MED, V71, P552, DOI 10.12968/hmed.2010.71.10.78937; Chauhan SS, 2015, GASTROINTEST ENDOSC, V82, P975, DOI 10.1016/j.gie.2015.06.012; Chen TH, 2010, WORLD J GASTROENTERO, V16, P5616, DOI 10.3748/wjg.v16.i44.5616; Chen YY, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/564536; de Bree E, 1998, AM J GASTROENTEROL, V93, P2523, DOI 10.1016/S0002-9270(98)00486-9; Eun SH, 2009, ENDOSCOPY, V41, pE29, DOI 10.1055/s-2007-967053; Forcione DG, 2009, NEW ENGL J MED, V360, P1239, DOI 10.1056/NEJMcpc0810836; Heise CP, 2008, J GASTROINTEST SURG, V12, P1309, DOI 10.1007/s11605-008-0492-0; Horesh N, 2016, J LAPAROENDOSC ADV S, V26, P596, DOI 10.1089/lap.2016.0066; Iwamuro M, 2011, WORLD J GASTRO ENDOS, V3, P154, DOI 10.4253/wjge.v3.i7.154; Jeyarajah R., 2016, SLEISENGER FORDTRANS, P397; LONGO WE, 1992, DIS COLON RECTUM, V35, P381, DOI 10.1007/BF02048119; Su W.W., 2005, DOUBLE BALLOON ENTER, V22, P310; TAYLOR MT, 1969, AM J SURG, V118, P117, DOI 10.1016/0002-9610(69)90106-8; Xin L, 2011, GASTROINTEST ENDOSC, V74, P563, DOI 10.1016/j.gie.2011.03.1239; Yang CW, 2009, J LAPAROENDOSC ADV S, V19, P637, DOI 10.1089/lap.2009.0157; Yaqub S, 2011, WORLD J EMERG SURG, V6, DOI 10.1186/1749-7922-6-17; Yen HH, 2007, GUT, V56, P167, DOI 10.1136/gut.2006.093757; Yen HH, 2006, GASTROINTEST ENDOSC, V63, P328, DOI 10.1016/j.gie.2005.06.063; Yen HH, 2012, J DIGEST DIS, V13, P316, DOI 10.1111/j.1751-2980.2012.00591.x; Yen HH, 2010, DIGEST DIS SCI, V55, P3473, DOI 10.1007/s10620-010-1211-8	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234417	10.1371/journal.pone.0234417	http://dx.doi.org/10.1371/journal.pone.0234417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574171	Green Published, gold			2022-12-26	WOS:000544972400043
J	Metfies, K; Hessel, J; Klenk, R; Petersen, W; Wiltshire, KH; Kraberg, A				Metfies, Katja; Hessel, Johanna; Klenk, Robin; Petersen, Wilhelm; Wiltshire, Karen Helen; Kraberg, Alexandra			Uncovering the intricacies of microbial community dynamics at Helgoland Roads at the end of a spring bloom using automated sampling and 18S meta-barcoding	PLOS ONE			English	Article							NORTH-SEA; CLIMATE-CHANGE; PHYTOPLANKTON; DIVERSITY; PRESERVATION; VARIABILITY; PHENOLOGY; PATTERNS; FERRYBOX; DIATOMS	In May 2016, the remote-controlledAutomatedFiltration System forMarine Microbes (AUTOFIM) was implemented in parallel to the Long Term Ecological Research (LTER) observatory Helgoland Roads in the German Bight. We collected samples for characterization of dynamics within the eukaryotic microbial communities at the end of a phytoplankton bloom via 18S meta-barcoding. Understanding consequences of environmental change for key marine ecosystem processes, such as phytoplankton bloom dynamics requires information on biodiversity and species occurrences with adequate temporal and taxonomic resolution via time series observations. Sampling automation and molecular high throughput methods can serve these needs by improving the resolution of current conventional marine time series observations. A technical evaluation based on an investigation of eukaryotic microbes using the partial 18S rRNA gene suggests that automated filtration with the AUTOFIM device and preservation of the plankton samples leads to highly similar 18S community profiles, compared to manual filtration and snap freezing. The molecular data were correlated with conventional microscopic counts. Overall, we observed substantial change in the eukaryotic microbial community structure during the observation period. A simultaneous decline of diatom and ciliate sequences succeeded a peak ofMiracula helgolandica, suggesting a potential impact of these oomycete parasites on diatom bloom dynamics and phenology in the North Sea. As oomycetes are not routinely counted at Helgoland Roads LTER, our findings illustrate the benefits of combining automated filtration with metabarcodingto augment classical time series observations, particularly for taxa currently neglected due to methodological constraints.	[Metfies, Katja; Hessel, Johanna] Helmholtz Ctr Polar & Marine, Alfred Wegener Inst, Helmholtz Young Investigators Grp PLANKTOSENS, Bremerhaven, Germany; [Metfies, Katja] Univ Oldenburg HIFMB, Helmholtz Inst Funct Marine Biodivers, Oldenburg, Germany; [Klenk, Robin; Wiltshire, Karen Helen; Kraberg, Alexandra] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Shelf Sea Syst Ecol, Biol Anstalt Helgoland, Helgoland, Germany; [Petersen, Wilhelm] Helmholtz Zentrum Geesthacht Ctr Mat & Coastal Re, Inst Coastal Res, Geesthacht, Germany; [Wiltshire, Karen Helen] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Biol Anstalt Helgoland Coastal Ecol, List Auf Sylt, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Metfies, K (corresponding author), Helmholtz Ctr Polar & Marine, Alfred Wegener Inst, Helmholtz Young Investigators Grp PLANKTOSENS, Bremerhaven, Germany.; Metfies, K (corresponding author), Univ Oldenburg HIFMB, Helmholtz Inst Funct Marine Biodivers, Oldenburg, Germany.	Katja.Metfies@awi.de		Petersen, Wilhelm/0000-0003-4287-1544	Alfred -Wegener-Institut HelmholtzZentrum fur Polar-und Meeresforschung, Germany; Helmholtz Association [VHNG-500]	Alfred -Wegener-Institut HelmholtzZentrum fur Polar-und Meeresforschung, Germany; Helmholtz Association(Helmholtz Association)	This work was supported by institutional funds of the Alfred -Wegener-Institut HelmholtzZentrum fur Polar-und Meeresforschung, Germany and funds of the Helmholtz Association for financing the Helmholtz-University Young Investigators Group PLANKTOSENS (Grant VHNG-500).	Andersen K. S., 2018, BIORXIV; Anthony TB, 2017, MYCOL PROG, V16, P1041, DOI 10.1007/s11557-017-1345-6; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Breier JA, 2009, DEEP-SEA RES PT I, V56, P1579, DOI 10.1016/j.dsr.2009.04.005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carstensen J, 2015, ESTUAR COAST SHELF S, V162, P98, DOI 10.1016/j.ecss.2015.05.005; Cermeno P, 2014, J PLANKTON RES, V36, P1135, DOI 10.1093/plankt/fbu033; Clay BL, 1999, BOT J LINN SOC, V131, P131, DOI 10.1006/bojl.1999.0259; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Ebenezer V, 2012, MAR BIOTECHNOL, V14, P129, DOI 10.1007/s10126-011-9427-y; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; ELWOOD HJ, 1985, MOL BIOL EVOL, V2, P399; Frenken T, 2016, GLOBAL CHANGE BIOL, V22, P299, DOI 10.1111/gcb.13095; Gescher C, 2008, APPL ENVIRON MICROB, V74, P5305, DOI 10.1128/AEM.01271-08; Gray MA, 2013, FEMS MICROBIOL ECOL, V83, P468, DOI 10.1111/1574-6941.12008; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; Haller M, 2015, OCEAN SCI, V11, P879, DOI 10.5194/os-11-879-2015; Hardge K, 2017, MAR ECOL PROG SER, V571, P43, DOI 10.3354/meps12134; Hoppenrath M, 2004, HELGOLAND MAR RES, V58, P243, DOI 10.1007/s10152-004-0190-6; Hoppenrath M, 2007, EUR J PHYCOL, V42, P271, DOI 10.1080/09670260701352288; Houliez E, 2017, J MARINE SYST, V169, P40, DOI 10.1016/j.jmarsys.2017.01.007; Kilias E, 2014, POLAR BIOL, V37, P1271, DOI 10.1007/s00300-014-1519-5; Kraberg A, 2010, PHOTO GUIDE NO EUROP, P204; Loder MGJ, 2012, HELGOLAND MAR RES, V66, P11, DOI 10.1007/s10152-010-0242-z; McQuillan JS, 2017, CURR OPIN BIOTECH, V45, P43, DOI 10.1016/j.copbio.2016.11.022; Metfies K, 2005, METHOD ENZYMOL, V395, P258, DOI 10.1016/S0076-6879(05)95016-7; Metfies K, 2007, J PLANKTON RES, V29, P1071, DOI 10.1093/plankt/fbm080; Metfies K, 2016, OCEAN SCI, V12, P1237, DOI 10.5194/os-12-1237-2016; Metfies K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148512; Metfies K, 2010, J PHYCOL, V46, P1152, DOI 10.1111/j.1529-8817.2010.00902.x; MILLS DK, 1994, NETH J SEA RES, V33, P65, DOI 10.1016/0077-7579(94)90052-3; Ottesen EA, 2016, CURR OPIN MICROBIOL, V31, P132, DOI 10.1016/j.mib.2016.03.012; Ottesen EA, 2011, ISME J, V5, P1881, DOI 10.1038/ismej.2011.70; Peacock EE, 2014, MAR ECOL PROG SER, V503, P1, DOI 10.3354/meps10784; Petersen W, 2014, J MARINE SYST, V140, P4, DOI 10.1016/j.jmarsys.2014.07.003; Renshaw MA, 2015, MOL ECOL RESOUR, V15, P168, DOI 10.1111/1755-0998.12281; Scharfe M, 2019, ECOL MODEL, V404, P46, DOI 10.1016/j.ecolmodel.2019.01.001; Schnepf E, 1977, HELGOLAND MARINE RES, V54, P237; Scholz B, 2016, FUNGAL ECOL, V19, P59, DOI 10.1016/j.funeco.2015.09.002; Southward AJ, 2005, ADV MAR BIOL, V47, P1; Stern RF, 2015, PROG OCEANOGR, V137, P409, DOI 10.1016/j.pocean.2015.04.015; Thines M, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-015-1099-y; Wiltshire KH, 2010, ESTUAR COAST, V33, P295, DOI 10.1007/s12237-009-9228-y; Wiltshire KH, 2004, HELGOLAND MAR RES, V58, P269, DOI 10.1007/s10152-004-0196-0; Wolf C, 2013, ANTARCTIC SCI, DOI [10.1017/S0954102013000308, DOI 10.1017/S0954102013000308]; Wolf C, 2014, MAR BIOL RES, V10, P771, DOI 10.1080/17451000.2013.852685; Wollschlager J, 2015, J SEA RES, V99, P83, DOI 10.1016/j.seares.2015.02.005; Wollschlager J, 2014, J PLANKTON RES, V36, P695, DOI 10.1093/plankt/fbu003; Wulff T, 2016, DEEP-SEA RES PT I, V115, P253, DOI 10.1016/j.dsr.2016.07.001; Yang JP, 2015, J SEA RES, V101, P19, DOI 10.1016/j.seares.2014.07.010	53	1	1	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0233921	10.1371/journal.pone.0233921	http://dx.doi.org/10.1371/journal.pone.0233921			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569285	gold, Green Published			2022-12-26	WOS:000543547900034
J	Ibabe, A; Rayon, F; Martinez, JL; Garcia-Vazquez, E				Ibabe, Aitor; Rayon, Fernando; Martinez, Jose Luis; Garcia-Vazquez, Eva			Environmental DNA from plastic and textile marine litter detects exotic and nuisance species nearby ports	PLOS ONE			English	Article							MICROPLASTIC DEBRIS; SARGASSUM-MUTICUM; DEEP-SEA; INVASION; DISPERSAL; DIVERSITY; VECTOR; LIFE; BIODIVERSITY; COMMUNITIES	Marine debris is currently a significant source of environmental and economic problems. Floating litter can be employed by marine organisms as a surface to attach to and use as spreading vector. Human activities are promoting the expansion of potentially harmful species into novel ecosystems, endangering autochthonous communities. In this project, more than 1,000 litter items were collected and classified from five beaches eastwards the port of Gijon, in Asturias, Spain. Next generation sequencing was employed to study biofouling communities attached to items of different materials. A dominance of DNA from Florideophyceae, Dinophyceae and Arthropoda was found, and four non-indigenous species (NIS) were identified. Results showed a clear preference of Florideophyceae and Bryozoa to attach on textile surfaces versus plastic ones. Considering that these taxa contain several highly invasive species described to date, these data emphasize the potential of textile marine debris as a vector for dispersal of NIS. Moreover, the closest beaches to the port contained a more similar biota profile than the farther ones, confirming that both plastic and textile marine litter can be vectors for species dispersal from ports.	[Ibabe, Aitor; Rayon, Fernando; Martinez, Jose Luis; Garcia-Vazquez, Eva] Univ Oviedo, Dept Funct Biol, C Julian Claveria S-N, Oviedo, Spain	University of Oviedo	Ibabe, A (corresponding author), Univ Oviedo, Dept Funct Biol, C Julian Claveria S-N, Oviedo, Spain.	ibabeaitor@gmail.com	Rayón Viña, Fernando/AAE-4989-2022; Martínez Fernández, Jose Luis/AAW-5618-2021	Rayón Viña, Fernando/0000-0002-1622-2180; Martínez Fernández, Jose Luis/0000-0001-7716-2428	Spanish Ministry of Economy and Competitiveness [CGL-2016-79209-R]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was funded by the Spanish Ministry of Economy and Competitiveness, Grant CGL-2016-79209-R.	Alexandrov B., 2004, GLOBALLAST MON SER, V7; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; [Anonymous], 2006, Health News, V12, P14; [Anonymous], 2002, J AM PHARM ASS, V42, pS60; Barboza LGA, 2018, MAR POLLUT BULL, V133, P336, DOI 10.1016/j.marpolbul.2018.05.047; Appeltans W, 2012, WORLD REGISTER MARIN; Ardura A, 2015, J MOLLUS STUD, V81, P495, DOI 10.1093/mollus/eyv022; Autoridad Portuaria de Gijon, 2017, PUERT GIJ AUT PORT G; Ayuntamiento de Gijon, 2016, SEND VERD CONC GIJ; Barnes DKA, 2002, NATURE, V416, P808, DOI 10.1038/416808a; Bax N, 2001, CONSERV BIOL, V15, P1234, DOI 10.1046/j.1523-1739.2001.99487.x; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; BOTAS J A, 1989, Scientia Marina, V53, P755; Boudouresque CF, 2002, MAR POLLUT BULL, V44, P32, DOI 10.1016/S0025-326X(01)00150-3; Bouillon Jean, 2006, Memoires du Museum National d'Histoire Naturelle, V194, P1; Bravo M, 2011, MAR ECOL PROG SER, V439, P1, DOI 10.3354/meps09344; Breitenbach M, 2002, CHEM IMMUNOL, V81, P48; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Bugoni L, 2001, MAR POLLUT BULL, V42, P1330, DOI 10.1016/S0025-326X(01)00147-3; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlton JT, 2017, SCIENCE, V357, P1402, DOI 10.1126/science.aao1498; Carlton JT, 1996, BIOL CONSERV, V78, P97, DOI 10.1016/0006-3207(96)00020-1; CARR A, 1987, MAR POLLUT BULL, V18, P352, DOI 10.1016/S0025-326X(87)80025-5; Carson HS, 2013, MAR POLLUT BULL, V75, P126, DOI 10.1016/j.marpolbul.2013.07.054; Corinaldesi C, 2008, MOL ECOL, V17, P3939, DOI 10.1111/j.1365-294X.2008.03880.x; Cornelius P.F.S., 1981, Porcupine Newsletter, V2, P47; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Deiner K, 2016, NAT COMMUN, V7, P1, DOI 10.1038/ncomms12544; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dyrynda PEJ, 2000, J NAT HIST, V34, P1993, DOI 10.1080/00222930050144828; FERNANDEZ C, 1990, BOT MAR, V33, P423, DOI 10.1515/botm.1990.33.5.423; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; FOWLER CW, 1987, MAR POLLUT BULL, V18, P326, DOI 10.1016/S0025-326X(87)80020-6; Garate-Lizarraga I, 2009, MAR POLLUT BULL, V58, P145, DOI 10.1016/j.marpolbul.2008.09.016; Garcia-Vazquez E, 2018, MAR POLLUT BULL, V131, P314, DOI 10.1016/j.marpolbul.2018.04.037; Goldstein MC, 2012, BIOL LETTERS, V8, P817, DOI 10.1098/rsbl.2012.0298; Gong J, 2013, PROTIST, V164, P369, DOI 10.1016/j.protis.2012.11.006; Graham A., 1988, MOLLUSCS PROSOBRANCH, V2; Grassle J.F., 1991, BIOL INT, V23, P1; GREVE W, 1994, ICES J MAR SCI, V51, P355, DOI 10.1006/jmsc.1994.1037; GRIIS, 2016, GLOB REG INTR INV SP; Guiry MD, 2014, SEAWEED SITE INFORM; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvey CT, 2009, DIVERS DISTRIB, V15, P429, DOI 10.1111/j.1472-4642.2008.00550.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hering D., 2018, WATER RES; Howard D. H., 2002, PATHOGENIC FUNGI HUM; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Jang YC, 2014, MAR POLLUT BULL, V81, P49, DOI 10.1016/j.marpolbul.2014.02.021; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kershaw P. J., 2017, SOURCES FATE EFFECTS; Kiessling T, 2015, MARINE ANTHROPOGENIC LITTER, P141, DOI 10.1007/978-3-319-16510-3_6; Kogame K, 2017, S AFR J BOT, V108, P337, DOI 10.1016/j.sajb.2016.08.013; Kudryavtsev A, 2013, PROTIST, V164, P13, DOI 10.1016/j.protis.2012.07.003; Laroche O, 2017, PEERJ, V5, DOI 10.7717/peerj.3347; Le Gall L, 2010, J PHYCOL, V46, P374, DOI 10.1111/j.1529-8817.2010.00807.x; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Lindsay DS, 1997, CLIN MICROBIOL REV, V10, P19, DOI 10.1128/CMR.10.1.19; MacKenzie D. I., 2006, OCCUPANCY ESTIMATION; Maso M, 2003, SCI MAR, V67, P107, DOI 10.3989/scimar.2003.67n1107; Mattlin R.H., 1986, NZ ENV, V51, P3; Miralles L, 2016, MAR POLLUT BULL, V112, P183, DOI 10.1016/j.marpolbul.2016.08.022; Miralles L, 2018, J NAT CONSERV, V42, P12, DOI 10.1016/j.jnc.2018.01.005; Moestrup O, 2009, IOC UNESCO TAXONOMIC; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; MOSER ML, 1992, COLON WATERBIRD, V15, P83, DOI 10.2307/1521357; Mouat J., 2010, EC IMPACTS MARINE LI; Nyberg CD, 2005, BIOL INVASIONS, V7, P265, DOI 10.1007/s10530-004-0738-z; Oshikata C, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-16; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pochon X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187636; Pochon X, 2015, BIOFOULING, V31, P241, DOI 10.1080/08927014.2015.1028923; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rech S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191859; Rech S, 2016, MAR POLLUT BULL, V113, P40, DOI 10.1016/j.marpolbul.2016.08.032; Reisser J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100289; Rey A, 2018, J SEA RES, V133, P134, DOI 10.1016/j.seares.2017.06.001; Robba L, 2006, AM J BOT, V93, P1101, DOI 10.3732/ajb.93.8.1101; ROUSE G.W., 2001, POLYCHAETES; Ryland J.S., 1977, Synopses of the British Fauna New Series, P1; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sanchez I, 2005, J PHYCOL, V41, P942, DOI 10.1111/j.1529-8817.2005.00122.x; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Sliwa Cathryn, 2009, V204, P425; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Somervuo P, 2017, METHODS ECOL EVOL, V8, P398, DOI 10.1111/2041-210X.12721; Stern RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013991; Van der Land J., 2008, UNESCO IOC REGISTER; Verlaque M, 2001, OCEANOL ACTA, V24, P29, DOI 10.1016/S0399-1784(00)01127-0; VERLAQUE M, 1994, OCEANOL ACTA, V17, P1; Walton WC, 2002, J EXP MAR BIOL ECOL, V272, P171, DOI 10.1016/S0022-0981(02)00127-2; Watts PC, 1998, PHILOS T R SOC B, V353, P453, DOI 10.1098/rstb.1998.0222; Weigand H., 2019, DNA BARCODE REFERENC, V576553; Williams SL, 2007, ANNU REV ECOL EVOL S, V38, P327, DOI 10.1146/annurev.ecolsys.38.091206.095543; Winston Judith E., 1997, P81; Wonham MJ, 2001, MAR ECOL PROG SER, V215, P1, DOI 10.3354/meps215001; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	99	15	15	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0228811	10.1371/journal.pone.0228811	http://dx.doi.org/10.1371/journal.pone.0228811			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555686	Green Published, gold			2022-12-26	WOS:000543273200020
J	Krenzlin, H; Bettag, C; Rohde, V; Ringel, F; Keric, N				Krenzlin, Harald; Bettag, Christoph; Rohde, Veit; Ringel, Florian; Keric, Naureen			Involuntary ambulatory triage during the COVID-19 pandemic - A neurosurgical perspective	PLOS ONE			English	Article								Background The coronavirus disease 2019 (COVID-19) pandemic poses an unprecedented challenge to health-care systems around the world. As approximately one-third of the world ' s population is living under "lockdown" conditions, medical resources are being reallocated and hospital admissions are limited to emergencies. We examined the decision-making impact of these actions and their effects on access to hospital treatment in patients with neurosurgical conditions. Methods This retrospective cohort study analyzes hospital admissions of two major neurosurgical services in Germany during the nationwide lockdown period (March 16(th)to April 16(th), 2020). Spinal or cranial conditions requiring immediate hospital admission and treatment constituted emergencies. Results A total of 243 in-patients were treated between March 16(th)and April 16(th)2020 (122 patients at the University Medical Center Mainz, 121 patients at the University Medical Center Gottingen). Of these, 38.0 +/- 16% qualified as emergency admission. Another 1,688 admissions were reviewed during the same periods in 2018 and 2019, providing a frame of reference. Overall, emergency admissions declined by 44.7 +/- 0.7% during lockdown. Admissions for cranial emergencies fell by 48.1 +/- 4.44%, spinal emergencies by 30.9 +/- 14.6%. Conclusion Above findings indicate that in addition to postponing elective procedures, emergency admissions were dramatically curtailed during the COVID-19 lockdown. As this surely is unexpected and unintended, reasons are undoubtedly complex. As consequences in morbidity and mortality are still unpredictable, efforts should be made to accommodate all patients in need of hospital access going forward.	[Krenzlin, Harald; Ringel, Florian; Keric, Naureen] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurosurg, Mainz, Rhineland Palat, Germany; [Bettag, Christoph; Rohde, Veit] Georg August Univ, Univ Med Hosp, Dept Neurosurg, Gottingen, Lower Saxony, Germany	Johannes Gutenberg University of Mainz; University of Gottingen	Krenzlin, H (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurosurg, Mainz, Rhineland Palat, Germany.	harald.krenzlin@unimedizin-mainz.de	Ringel, Florian/E-4933-2014; Krenzlin, Harald/AAS-7602-2020					Baracchini C, 2020, NEUROL SCI, V41, P1003, DOI 10.1007/s10072-020-04375-9; Cascella M, 2020, FEATURES EVALUATION, V1st, DOI DOI 10.1016/j.autrev.2016.07.022; Caso V, 2020, NEUROL SCI, V41, P999, DOI 10.1007/s10072-020-04389-3; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Group C-S, 2020, CHAR COVID 19 PAT DY; Hu YJ, 2020, J NEURO-ONCOL, V148, P199, DOI 10.1007/s11060-020-03489-6; Khosravani Houman, 2020, Stroke, V51, P1891, DOI 10.1161/STROKEAHA.120.029838; Kim SYH, 2020, NEUROLOGY, V94, P1007, DOI 10.1212/WNL.0000000000009520; Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6; Mohile NA, 2020, NEURO-ONCOLOGY, V22, P912, DOI 10.1093/neuonc/noaa090; Ramakrishna R, 2020, J NEURO-ONCOL, V147, P525, DOI 10.1007/s11060-020-03488-7	11	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234956	10.1371/journal.pone.0234956	http://dx.doi.org/10.1371/journal.pone.0234956			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555723	Green Published, gold			2022-12-26	WOS:000543273200011
J	Pristov, JB; Opacic, M; Bajcetic, M; Mandic, V; Maglic, D; Mikovic, Z; Spasojevic, I				Pristov, Jelena Bogdanovic; Opacic, Milos; Bajcetic, Milica; Mandic, Vesna; Maglic, Dragana; Mikovic, Zeljko; Spasojevic, Ivan			Oxidative status of maternal blood in pregnancies burdened by inherited thrombophilias	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; CORD BLOOD; STRESS; PREECLAMPSIA; REDOX; WOMEN; CATALASE; CELLS	Oxidative status of maternal blood represents an important parameter of pregnancy that is involved in both, regulation of physiological processes and (if significantly altered) development of different pregnancy complications. Inherited thrombophilias represent genetic disorders that increase the risk of thromboembolism in pregnancy. Little is known about the impact of thrombophilia on the oxidative status of maternal blood. In this study, we analyzed oxidative status of blood of 56 women with pregnancies burdened by inherited thrombophilias. The status was established at three different trimesters using biochemical assays and electrochemical measurements, and it was compared to 10 age- and trimester-matching controls. Activities of superoxide dismutase, catalase, and glutathione reductase in the 1(st)and the 2(nd)trimester of thrombophilic pregnancy were lower than controls. Also, there was less oxidation in the plasma, according to higher concentration of reduced thiols and lower oxidation-reduction potential. Therefore, it appears that thrombophilic mothers do not experience oxidative stress in the circulation in the first two trimesters. However, the rise in GPx, GR and SOD activities in the 3(rd)trimester of thrombophilic pregnancy implies that the risk of oxidative stress is increased during the late pregnancy. These results are important for developing antioxidative treatment that could tackle thrombophilia-related pregnancy complications.	[Pristov, Jelena Bogdanovic; Opacic, Milos; Spasojevic, Ivan] Univ Belgrade, Inst Multidisciplinary Res, Life Sci Dept, Belgrade, Serbia; [Bajcetic, Milica] Univ Belgrade, Sch Med, Dept Pharmacol Clin Pharmacol & Toxicol, Belgrade, Serbia; [Bajcetic, Milica] Univ Childrens Hosp, Clin Pharmacol Unit, Belgrade, Serbia; [Mandic, Vesna; Maglic, Dragana; Mikovic, Zeljko] Univ Clin Gynecol & Obstet Narodni Front, Dept High Risk Pregnancies, Belgrade, Serbia; [Mandic, Vesna; Maglic, Dragana; Mikovic, Zeljko] Univ Belgrade, Fac Med, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade	Spasojevic, I (corresponding author), Univ Belgrade, Inst Multidisciplinary Res, Life Sci Dept, Belgrade, Serbia.	redoxsci@gmail.com		Spasojevic, Ivan/0000-0002-3150-3087	Ministry of Education, Science and Technological Development of the Republic of Serbia [III43010, OI173014]	Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	The study was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia, grant No III43010 (MO) and OI173014 (MB, VM, ZM, IS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; [Anonymous], 2009, CTC SENTINEL, V2, P14; [Anonymous], 2018, OBSTET GYNECOL, V132, pe18; Arguelles S, 2006, FREE RADICAL RES, V40, P565, DOI 10.1080/10715760500519834; Bienert GP, 2014, BBA-GEN SUBJECTS, V1840, P1596, DOI 10.1016/j.bbagen.2013.09.017; Calderwood CJ, 2009, OBSTET GYNECOL REPRO, V19, P339; Chilelli NC, 2018, CLIN CHEM LAB MED, V56, pE101, DOI 10.1515/cclm-2017-0721; Claiborne A., 1985, HDB METHODS OXYGEN R; Crimi E, 2007, FREE RADICAL RES, V41, P1364, DOI 10.1080/10715760701732830; Duhig K, 2016, OBSTET MED, V9, P113, DOI 10.1177/1753495X16648495; Duvekot J J, 1994, Obstet Gynecol Surv, V49, pS1, DOI 10.1097/00006254-199412011-00001; Egan K, 2015, BIOCHEM SOC T, V43, P696, DOI 10.1042/BST20140310; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Freedman JE, 2008, ARTERIOSCL THROM VAS, V28, pS11, DOI 10.1161/ATVBAHA.107.159178; Ghaffari S, 2008, ANTIOXID REDOX SIGN, V10, P1923, DOI 10.1089/ars.2008.2142; GLATZLE D, 1974, EXPERIENTIA, V30, P665; Gu SX, 2015, BLOOD, V125, P3851, DOI 10.1182/blood-2015-01-544676; HU XQ, 2019, CIRCULATION, V2019, DOI DOI 10.1155/2019/9194269; Ishihara O, 2004, FREE RADICAL RES, V38, P913, DOI 10.1080/10715760412331273421; Kupferminc Michael J, 2003, Reprod Biol Endocrinol, V1, P111, DOI 10.1186/1477-7827-1-111; Laude I, 2001, THROMB HAEMOSTASIS, V85, P18, DOI 10.1055/s-0037-1612657; Mannaerts D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202919; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mohanty JG, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00084; Moore TA, 2019, BIOL RES NURS, V21, P485, DOI 10.1177/1099800419858670; Nagababu E, 2003, BBA-GEN SUBJECTS, V1620, P211, DOI 10.1016/S0304-4165(02)00537-8; Napso T, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01091; Nikoli-Kokic A, 2010, J MED BIOCHEM, V29, P189, DOI 10.2478/v10011-010-0018-7; Oliveira PVS, 2018, CLIN SCI, V132, P1257, DOI 10.1042/CS20180157; Opacic M, 2018, ANTIOXID REDOX SIGN, V28, P1570, DOI 10.1089/ars.2017.7433; Ormesher L, 2016, WOMENS HEALTH, V12, P433, DOI 10.1177/1745505716653702; Pabinger I, 2001, ARTERIOSCL THROM VAS, V21, P874, DOI 10.1161/01.ATV.21.5.874; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pereira RD, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/814543; Pristov JB, 2012, THROMB RES, V130, P826, DOI 10.1016/j.thromres.2012.08.310; Rael LT, 2007, BIOCHEM BIOPH RES CO, V361, P561, DOI 10.1016/j.bbrc.2007.07.078; Raijmakers MTM, 2000, OBSTET GYNECOL, V95, P180, DOI 10.1016/S0029-7844(99)00514-1; Ramiro-Cortijo D, 2016, PLACENTA, V47, P37, DOI 10.1016/j.placenta.2016.08.090; Rodger MA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000292; Roudier N, 1998, J BIOL CHEM, V273, P8407, DOI 10.1074/jbc.273.14.8407; Sarig G, 2004, LANCET, V363, P96, DOI 10.1016/S0140-6736(03)15309-3; Sha XY, 2011, ACTA PHARMACOL SIN, V32, P716, DOI 10.1038/aps.2011.59; Tsantes AE, 2006, ANTIOXID REDOX SIGN, V8, P1205, DOI 10.1089/ars.2006.8.1205; Violi F, 2012, THROMB RES, V129, P378, DOI 10.1016/j.thromres.2011.12.002; Walker ID, 2000, J CLIN PATHOL, V53, P573, DOI 10.1136/jcp.53.8.573; Wang Y, 2010, VASCULAR BIOL PLACEN; WINTERBOURN CC, 1987, J CLIN INVEST, V80, P1486, DOI 10.1172/JCI113230; Yang FL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02317; Yuksel S, 2015, TURK J MED SCI, V45, P454, DOI 10.3906/sag-1311-72	49	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234253	10.1371/journal.pone.0234253	http://dx.doi.org/10.1371/journal.pone.0234253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555583	Green Published, gold			2022-12-26	WOS:000542759600044
J	Zhou, YK; Fan, JF; Wang, XY				Zhou, Yuke; Fan, Junfu; Wang, Xiaoying			Assessment of varying changes of vegetation and the response to climatic factors using GIMMS NDVI3g on the Tibetan Plateau	PLOS ONE			English	Article							QINGHAI-TIBET; MANN-KENDALL; TREND ANALYSIS; TIME-SERIES; PRECIPITATION; DYNAMICS; CHINA; TEMPERATURE; HOMOGENEITY; PHENOLOGY	Under the context of global climate change, vegetation on the Tibetan Plateau (TP) has experienced significant changes during the past three decades. In this study, the spatiotemporal changes of growing season vegetation index (GSVI) on the TP were analyzed using various methods from pixel level to ecoregion level. In addition, a relative importance approach was employed to investigate the regulating effect of temperature and precipitation on vegetation. During the period of 1982-2012, vegetation on the TP was generally experiencing a greening trend, but with pronounced fluctuations. The interannual variation of the long-term GSVI was most significant in the Qaidam Basin and southern forest. At ecoregion scale, vegetation in the arid and frigid arid zones showed a browning tendency, with other ecoregions presenting greener trends. Over a large proportion of the TP, there exist change points in the GSVI time series, which were mainly concentered around the year 1996 and 2000. The Hurst exponent identified that a majority (88%) of the vegetation on the plateau would maintain a persistent trend in the future, which would mainly consist of undetermined development and greening trends. TP vegetation during the 1990s experienced more greening than in the 1980s or 2000s according to the interdecadal analysis. The long-term change in growing season vegetation was most positively correlated with the temperature during the same period, followed by the temperature in the preseason and postseason periods. There were more negative relationships of vegetation change with precipitation than with temperature. The relative contribution of the temperature to the vegetation changes exhibited an opposite spatial pattern to that of precipitation. Overall, the findings in this work provide an essential archive of decade-scale vegetation dynamics that may be helpful for projecting the future ecosystem dynamics on the Tibetan Plateau, such as the consistent greening.	[Zhou, Yuke] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Zhou, Yuke] Southern Marine Sci & Engn Guangdong Lab Guangzho, Guangzhou, Peoples R China; [Fan, Junfu] Shandong Univ Technol, Sch Civil & Architectural Engn, Zibo, Peoples R China; [Wang, Xiaoying] CMA, Inst Atmospher Environm, Shenyang, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Hong Kong Branch of the Southern Marine Science & Engineering Guangdong Laboratory (Guangzhou); Shandong University of Technology; China Meteorological Administration	Fan, JF (corresponding author), Shandong Univ Technol, Sch Civil & Architectural Engn, Zibo, Peoples R China.	fanjf@sdut.edu.cn	FAN, Junfu/L-8975-2014	FAN, Junfu/0000-0001-8987-7930	National Key R&D Program of China [2018YFB0505301, 2016YFC0500103, 2017YFB0503500]; Key Special Project for Introduced Talents Team of Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou) [GML2019ZD0301]	National Key R&D Program of China; Key Special Project for Introduced Talents Team of Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou)	This study was supported by National Key R&D Program of China (Grant No.2018YFB0505301, 2016YFC0500103, 2017YFB0503500). The publish charge is partly provided by the Key Special Project for Introduced Talents Team of Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), No. GML2019ZD0301.	ALEXANDERSSON H, 1986, J CLIMATOL, V6, P661, DOI 10.1002/joc.3370060607; [Anonymous], 2005, KRITIKA, V6, P789; [Anonymous], 2006, PROGR HUMAN GEOGRAPH, V30, P1; [Anonymous], 2013, LANCET GLOB HLTH; [Anonymous], 2012, INNOVATION, V3, P52, DOI DOI 10.1016/J.ENVDEV.2012.04.002; [Anonymous], 2005, KENDALL RANK CORRELA; [Anonymous], 2011, GEORGE WASHINGTON J, V2, P2; Anyamba A, 2014, REMOTE SENS-BASEL, V6, P3101, DOI 10.3390/rs6043101; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Brown MH, 1998, SOFTWARE VISUALIZATION, P155; BUISHAND TA, 1982, J HYDROL, V58, P11, DOI 10.1016/0022-1694(82)90066-X; Chen C, 2019, NAT SUSTAIN, V2, P122, DOI 10.1038/s41893-019-0220-7; Chen XQ, 2015, GLOBAL CHANGE BIOL, V21, P3635, DOI 10.1111/gcb.12954; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Churkina G, 2005, GLOBAL CHANGE BIOL, V11, P1777, DOI 10.1111/j.1365-2486.2005.001012.x; Cong N, 2017, INT J BIOMETEOROL, V61, P1433, DOI 10.1007/s00484-017-1321-5; Ding MJ, 2007, J GEOGR SCI, V17, P259, DOI 10.1007/s11442-007-0259-7; Du MY, 2004, GLOBAL PLANET CHANGE, V41, P241, DOI 10.1016/j.gloplacha.2004.01.010; Eastman JR, 2009, INT J REMOTE SENS, V30, P2721, DOI 10.1080/01431160902755338; Eklundh L, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016772; Feldman B., 2005, RELATIVE IMPORTANCE, DOI [10.2139/ssrn.2255827, DOI 10.2139/SSRN.2255827]; Forkel M, 2013, REMOTE SENS-BASEL, V5, P2113, DOI 10.3390/rs5052113; Gerten D, 2004, J HYDROL, V286, P249, DOI 10.1016/j.jhydrol.2003.09.029; Gocic M, 2013, GLOBAL PLANET CHANGE, V100, P172, DOI 10.1016/j.gloplacha.2012.10.014; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Hamed KH, 1998, J HYDROL, V204, P182, DOI 10.1016/S0022-1694(97)00125-X; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Huang C, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12071163; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Jin HJ, 2008, COLD REG SCI TECHNOL, V53, P317, DOI 10.1016/j.coldregions.2007.07.005; JINGSHENG W, 2013, J RESOURCES ECOLOGY, V4, P43, DOI DOI 10.5814/J.ISSN.1674-764X.2013.01.006; Kaufmann RK, 2000, IEEE T GEOSCI REMOTE, V38, P2584, DOI 10.1109/36.885205; Lamsal Pramod, 2017, Global and Planetary Change, V159, P77, DOI 10.1016/j.gloplacha.2017.09.010; Liu YS, 2013, PLANT SOIL, V366, P491, DOI 10.1007/s11104-012-1442-x; Meybeck M, 2001, MT RES DEV, V21, P34, DOI 10.1659/0276-4741(2001)021[0034:ANTFMA]2.0.CO;2; Morton K, 2011, SURVIVAL, V53, P121, DOI 10.1080/00396338.2011.555606; Neeti N, 2011, T GIS, V15, P599, DOI 10.1111/j.1467-9671.2011.01280.x; Ni J, 2000, MT RES DEV, V20, P80, DOI 10.1659/0276-4741(2000)020[0080:ASOBOT]2.0.CO;2; NORTH GR, 1984, J ATMOS SCI, V41, P879, DOI 10.1175/1520-0469(1984)041<0879:EOFANM>2.0.CO;2; Peng J, 2012, ECOL INDIC, V14, P28, DOI 10.1016/j.ecolind.2011.08.011; PENUELAS J, 1993, REMOTE SENS ENVIRON, V46, P110, DOI 10.1016/0034-4257(93)90088-F; Pettitt A. N., 1979, Applied Statistics, V28, P126, DOI 10.2307/2346729; Piao SL, 2006, CLIMATIC CHANGE, V74, P253, DOI 10.1007/s10584-005-6339-8; Piao SL, 2012, GLOBAL PLANET CHANGE, V98-99, P73, DOI 10.1016/j.gloplacha.2012.08.009; Pinzon JE, 2014, REMOTE SENS-BASEL, V6, P6929, DOI 10.3390/rs6086929; Qian B., 2004, P 2 IASTED INT C FIN, P203; Sayemuzzaman M, 2014, ATMOS RES, V137, P183, DOI 10.1016/j.atmosres.2013.10.012; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Shen MG, 2015, P NATL ACAD SCI USA, V112, P9299, DOI 10.1073/pnas.1504418112; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Suguitan Jr AL, 2011, PLOS ONE, V6; Verbesselt J, 2010, REMOTE SENS ENVIRON, V114, P2970, DOI 10.1016/j.rse.2010.08.003; Verbesselt J, 2010, REMOTE SENS ENVIRON, V114, P106, DOI 10.1016/j.rse.2009.08.014; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wang JB, 2014, REMOTE SENS-BASEL, V6, P2108, DOI 10.3390/rs6032108; Wang XF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10235-8; Weron R, 2002, PHYSICA A, V312, P285, DOI 10.1016/S0378-4371(02)00961-5; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Woodward FI, 1997, GLOBAL ECOL BIOGEOGR, V6, P413, DOI 10.2307/2997350; Wu DH, 2015, GLOBAL CHANGE BIOL, V21, P3520, DOI 10.1111/gcb.12945; Wu JJ, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-01700-9, 10.1038/s41598-017-15530-2]; [吴绍洪 Wu Shaohong], 2003, [地理学报, Acta Geographica Sinica], V58, P686; Xu C, 2012, ENVIRON MONIT ASSESS, V184, P1275, DOI 10.1007/s10661-011-2039-1; Xu WX, 2007, CHINESE GEOGR SCI, V17, P151, DOI 10.1007/s11769-007-0151-5; Xu XJ, 2019, J ENVIRON MANAGE, V246, P605, DOI 10.1016/j.jenvman.2019.06.023; Xu XK, 2008, CHINESE SCI BULL, V53, P915, DOI 10.1007/s11434-008-0115-x; Xue X, 2009, GEOMORPHOLOGY, V108, P182, DOI 10.1016/j.geomorph.2009.01.004; Yang K, 2014, GLOBAL PLANET CHANGE, V112, P79, DOI 10.1016/j.gloplacha.2013.12.001; Yang K, 2011, CLIMATIC CHANGE, V109, P517, DOI 10.1007/s10584-011-0099-4; Yang Q-Y, 2002, ADV NATURAL SCI, V12, P287; Yeh ET, 2009, GEOFORUM, V40, P884, DOI 10.1016/j.geoforum.2009.06.004; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Yue S, 2002, J HYDROL, V259, P254, DOI 10.1016/S0022-1694(01)00594-7; Zheng D., 1999, STUDY ECOGEOGRAPHIC; Zhong L, 2010, CLIMATIC CHANGE, V103, P519, DOI 10.1007/s10584-009-9787-8; Zhu ZC, 2013, REMOTE SENS-BASEL, V5, P927, DOI 10.3390/rs5020927; Zhuang Q, 2010, GLOBAL ECOL BIOGEOGR, V19, P649, DOI 10.1111/j.1466-8238.2010.00559.x; Zuo ZY, 2011, CLIM DYNAM, V36, P1207, DOI 10.1007/s00382-010-0863-6	78	10	10	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234848	10.1371/journal.pone.0234848	http://dx.doi.org/10.1371/journal.pone.0234848			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555722	gold, Green Published			2022-12-26	WOS:000542759600023
J	Tourki, B; Kain, V; Shaikh, SR; Leroy, X; Serhan, CN; Halade, GV				Tourki, Bochra; Kain, Vasundhara; Shaikh, Saame Raza; Leroy, Xavier; Serhan, Charles N.; Halade, Ganesh, V			Deficit of resolution receptor magnifies inflammatory leukocyte directed cardiorenal and endothelial dysfunction with signs of cardiomyopathy of obesity	FASEB JOURNAL			English	Article						obesogenic aging; non-resolving inflammation; inflammatory macrophage; kidney function	PRESERVED EJECTION FRACTION; HEART-FAILURE; MYOCARDIAL-INFARCTION; CARDIAC-FUNCTION; MACROPHAGES; CHANNELS; DISEASE; RISK	Chronic unresolved inflammation is the primary determinant of cardiovascular disease. Precise mechanisms that define the genesis of unresolved inflammation in heart failure with preserved ejection fraction (HFpEF) are of interest due to the obesity epidemic. To examine the obesity phenotype and its direct/indirect consequences, multiple approaches were employed using the lipoxin receptor (abbreviated as ALX) dysfunction mouse model. Indirect calorimetry analyses revealed that the deletion of ALX dysregulated energy metabolism driving toward age-related obesity. Heart function data suggest that obesity-prone ALX deficient mice had impaired myocardium strain. Comprehensive measurement of chemokines, extracellular matrix, and arrhythmogenic arrays confirmed the dysregulation of multiple ion channels gene expression with amplified inflammatory chemokines and cytokines response at the age of 4 months compared with WT counterparts. Quantitative analyses of leukocytes demonstrated an increase of proinflammatory Ly6C(hi)CCR2(+)macrophages in the spleen and heart at a steady-state resulting in an inflamed splenocardiac axis. Signs of subtle inflammation were marked with cardiorenal, endothelial defects with decreased CD31 and eNOS and an increased iNOS and COX2 expression. Thus, ALX receptor deficiency serves as an experimental model that defines multiple cellular and molecular mechanisms in HFpEF that could be a target for the development of HFpEF therapy in cardiovascular medicine.	[Tourki, Bochra; Kain, Vasundhara; Halade, Ganesh, V] Univ S Florida, Dept Med, Div Cardiovasc Sci, 546 Channelside Dr, Tampa, FL 33602 USA; [Shaikh, Saame Raza] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Shaikh, Saame Raza] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA; [Leroy, Xavier] Domain Therapeut, Steinsoultz, France; [Serhan, Charles N.] Harvard Med Sch, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Brigham & Womens Hosp, Boston, MA 02115 USA	State University System of Florida; University of South Florida; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Halade, GV (corresponding author), Univ S Florida, Dept Med, Div Cardiovasc Sci, 546 Channelside Dr, Tampa, FL 33602 USA.	ghalade@usf.edu	Kain, Vasundhara/AAL-7371-2021		National Institutes of Health [HL132989, HL144788, AT008375, GM038765]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: HL132989, HL144788, AT008375 and GM038765	Aizpurua AB, 2018, AM J PHYSIOL-HEART C, V315, pH1670, DOI 10.1152/ajpheart.00024.2018; Alberts P., 2006, CURR PROTOC NEUROSCI, V36, P9, DOI [10.1002/0471142301.ns0923ds36, DOI 10.1002/0471142301.NS0923DS36]; Alex L, 2018, AM J PHYSIOL-HEART C, V315, pH934, DOI 10.1152/ajpheart.00238.2018; Alpert CM, 2017, HEART FAIL REV, V22, P25, DOI 10.1007/s10741-016-9581-4; Altara R, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00160; Aromolaran AS, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00431; Barth AS, 2009, CIRC-ARRHYTHMIA ELEC, V2, P327, DOI 10.1161/CIRCEP.108.817320; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Carbone S, 2018, JACC-BASIC TRANSL SC, V3, P157, DOI 10.1016/j.jacbts.2018.01.004; Castellon X, 2016, AGING DIS, V7, DOI 10.14336/AD.2015.0803; Corminboeuf O, 2015, J MED CHEM, V58, P537, DOI 10.1021/jm501051x; Dehghani-Samani A, 2019, ACTA CARDIOL SIN, V35, P99, DOI 10.6515/ACS.201903_35(2).20181028A; Dunlay SM, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2017.65; FIORE S, 1994, J EXP MED, V180, P253, DOI 10.1084/jem.180.1.253; Frasca D, 2017, FRONT IMMUNOL, V8, DOI [10.3389/fimmu.2017.01745, 10.3389/fimmu.2017.01003]; Ge YJ, 2020, FASEB J, V34, P6920, DOI 10.1096/fj.201903206R; Gorski PA, 2015, CELL METAB, V21, P183, DOI 10.1016/j.cmet.2015.01.005; Haass M, 2011, CIRC-HEART FAIL, V4, P324, DOI 10.1161/CIRCHEARTFAILURE.110.959890; Halade GV, 2019, METABOLISM, V96, P22, DOI 10.1016/j.metabol.2019.04.011; Halade GV, 2018, FASEB J, V32, P3717, DOI 10.1096/fj.201701173RR; Halade GV, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao1818; Halade GV, 2018, AM J PHYSIOL-HEART C, V314, pH255, DOI 10.1152/ajpheart.00528.2017; Halade GV, 2016, AGING-US, V8, P2611, DOI 10.18632/aging.101077; Halade GV, 2013, AM J PHYSIOL-HEART C, V305, pH1830, DOI 10.1152/ajpheart.00224.2013; House AA, 2019, KIDNEY INT, V95, P1304, DOI 10.1016/j.kint.2019.02.022; Kain V, 2019, PHARMACOL RES, V146, DOI 10.1016/j.phrs.2019.104295; Kain V, 2018, AM J PHYSIOL-HEART C, V314, pH160, DOI 10.1152/ajpheart.00297.2017; Kain V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10441-8; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; Kalucka J, 2017, PFLUG ARCH EUR J PHY, V469, P473, DOI 10.1007/s00424-017-1946-6; Kelly JP, 2015, J AM COLL CARDIOL, V65, P1668, DOI 10.1016/j.jacc.2015.03.043; Kjeldsen SE, 2019, HYPERTENSION; Lakdawala NK, 2010, CIRCULATION, V122, P527, DOI 10.1161/CIRCULATIONAHA.109.892240; Lazzerini PE, 2017, HEART, V103, P1821, DOI 10.1136/heartjnl-2016-311079; Lieve KV, 2017, INT J CARDIOL, V236, P187, DOI 10.1016/j.ijcard.2017.01.113; Masarone D, 2017, J CARDIOVASC DEV DIS, V4, DOI 10.3390/jcdd4010003; Matsushita K, 2020, KIDNEY INT, V97, P95, DOI 10.1016/j.kint.2019.06.022; Meyer Carola W, 2015, Curr Protoc Mouse Biol, V5, P205, DOI 10.1002/9780470942390.mo140216; NELSON MT, 1990, AM J PHYSIOL, V259, pC3; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Ogna A, 2016, EUR J NUTR, V55, P1089, DOI 10.1007/s00394-015-0923-0; Packer M, 2018, JACC-HEART FAIL, V6, P633, DOI 10.1016/j.jchf.2018.01.009; de Heredia FP, 2012, P NUTR SOC, V71, P332, DOI 10.1017/S0029665112000092; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Pieske B, 2019, EUR HEART J, V40, P3297, DOI 10.1093/eurheartj/ehz641; Premer Courtney, 2019, Mayo Clin Proc Innov Qual Outcomes, V3, P1, DOI 10.1016/j.mayocpiqo.2018.12.006; Redfield MM, 2017, NEW ENGL J MED, V376, P897, DOI 10.1056/NEJMc1615918; Remmerie A, 2018, CELL IMMUNOL, V330, P27, DOI 10.1016/j.cellimm.2018.01.020; Sabbatini AR, 2020, J AM COLL CARDIOL, V75, P1074, DOI 10.1016/j.jacc.2019.12.049; Sandmann S, 2001, J CARDIOVASC PHARM, V37, P64, DOI 10.1097/00005344-200101000-00008; Savji N, 2018, JACC-HEART FAIL, V6, P701, DOI 10.1016/j.jchf.2018.05.018; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Stunault MI, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/2426138; Tourki B, 2020, MOL METAB, V31, P138, DOI 10.1016/j.molmet.2019.10.008; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Upadhya B, 2017, HEART FAIL CLIN, V13, P485, DOI 10.1016/j.hfc.2017.02.005; Wang YG, 2010, J MOL CELL CARDIOL, V48, P619, DOI 10.1016/j.yjmcc.2010.01.009; Yang YB, 2014, OBESITY, V22, P2147, DOI 10.1002/oby.20811; Yanovski SZ, 2011, NEW ENGL J MED, V364, P987, DOI 10.1056/NEJMp1009229; Zannad F, 2018, CIRCULATION, V138, P929, DOI 10.1161/CIRCULATIONAHA.117.028814; Zhuang YW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14728-9	61	12	12	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10560	10573		10.1096/fj.202000495RR	http://dx.doi.org/10.1096/fj.202000495RR		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32543720	Bronze, Green Accepted			2022-12-26	WOS:000541769300001
J	Bastaraud, A; Perthame, E; Rakotondramanga, JM; Mahazosaotra, J; Ravaonindrina, N; Jambou, R				Bastaraud, Alexandra; Perthame, Emeline; Rakotondramanga, Jean-Marius; Mahazosaotra, Jackson; Ravaonindrina, Noro; Jambou, Ronan			The impact of rainfall on drinking water quality in Antananarivo, Madagascar	PLOS ONE			English	Article							CLIMATE-CHANGE; WEATHER EVENTS; TRENDS; SYSTEM	Low-income cities that are subject to high population pressure and vulnerable to climate events often have a low capacity to continuously deliver safe drinking water. Here we reported the results of a 32-year survey on the temporal dynamics of drinking water quality indicators in the city of Antananarivo. We analyzed the long-term evolution of the quality of the water supplied and characterized the interactions between climatic conditions and the full-scale water supply system. A total of 25,467 water samples were collected every week at different points in the supplied drinking water system. Samples were analyzed for total coliforms (TC),Escherichia coli(EC), intestinal Enterococci (IE), and Spores of Sulphite-Reducing Clostridia (SSRC). Nine-hundred-eighty-one samples that were identified as positive for one or more indicators were unevenly distributed over time. The breakpoint method identified four periods when the time series displayed changes in the level and profile of contamination (i) and the monthly pattern of contamination (ii), with more direct effects of rainfall on the quality of supplied drinking water. The modeling showed significantly different lags among indicators of bacteria occurrence after cumulative rainfall, which range from 4 to 8 weeks. Among the effects of low-income urbanization, a rapid demographic transition and the degradation of urban watersheds have gradually affected the quality of the water supplied and resulted in the more direct effects of rainfall events. We focused on the need to adopt an alternative perspective of drinking water and urban watersheds management.	[Bastaraud, Alexandra; Mahazosaotra, Jackson; Ravaonindrina, Noro] Inst Pasteur Madagascar, Food Hyg & Envionmr Lab, Antananarivo, Madagascar; [Perthame, Emeline] Inst Pasteur Paris, Ctr Bioinformat Biostat & Integrat Biol C3BI, Paris, France; [Rakotondramanga, Jean-Marius] Inst Pasteur Madagascar, Epidemiol Dept, Antananarivo, Madagascar; [Jambou, Ronan] Inst Pasteur Paris, Global Hlth Dept, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Jambou, R (corresponding author), Inst Pasteur Paris, Global Hlth Dept, Paris, France.	rjambou@pasteur.fr	JAMBOU, RONAN/CAG-3718-2022	Rakotondramanga, Jean Marius/0000-0003-0490-7665; Perthame, Emeline/0000-0002-8266-5908				AFNOR, 2000, 78992 ISO; AFNOR, 1996, T90416 XP; AFNOR, 2014, 93082 ISO; AFNOR, 1985, T90415 NF; AFNOR, 2000, 93081 ISO; AFNOR, 1993, 264612 NF; AFNOR, 1985, T90414 MF; AFNOR Certification, 2013, ENT DW QUANT TRAY QU; Aldegheri M, 1972, RIVERS STREAMS MADAG, P261; Alexander KA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002688; Amanidaz N, 2015, IRAN J PUBLIC HEALTH, V44, P1685; Bastaraud A, 2018, WATER-SUI, V10, DOI 10.3390/w10101450; Blackford JU, 2009, CHRONOBIOL INT, V26, P258, DOI 10.1080/07420520902772221; Boehm A., 2014, ENTEROCOCCI INDICATO; Brown R, 2009, IWRM SURVEY STATUS R; Byappanahalli MN, 2012, MICROBIOL MOL BIOL R, V76, P685, DOI 10.1128/MMBR.00023-12; Cann KF, 2013, EPIDEMIOL INFECT, V141, P671, DOI 10.1017/S0950268812001653; Chang A.C.-S., 2018, TESOL ENCY ENGLISH L, P1, DOI [DOI 10.1002/9781118784235.EELT0576, https://doi.org/10.1002/9781118784235.eelt0576]; Chaperon P, 1993, MONOGRAPHIE HYDROLOG, V10, P883; Cox R, 2009, J GEOL, V117, P363, DOI 10.1086/598945; Day T, 2014, LAKES RIVERS, V258; Delpla I, 2009, ENVIRON INT, V35, P1225, DOI 10.1016/j.envint.2009.07.001; EAST, 2016, ET DIAGN AEP 3 5 ARR; Edberg SC, 2000, J APPL MICROBIOL, V88, p106S, DOI 10.1111/j.1365-2672.2000.tb05338.x; Edition F. WHO, 2018, WHO GUIDELINES DRINK; Gleason JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173794; Goransson G, 2013, HYDROL EARTH SYST SC, V17, P2529, DOI 10.5194/hess-17-2529-2013; Haagsma J, 2016, REV SCI TECH L OIE, V10, P749; Hannah L, 2008, BIOL LETTERS, V4, P590, DOI 10.1098/rsbl.2008.0270; Howard G, 2016, ANNU REV ENV RESOUR, V41, P253, DOI 10.1146/annurev-environ-110615-085856; Hrdinka T, 2012, J HYDRO-ENVIRON RES, V6, P145, DOI 10.1016/j.jher.2012.01.008; Hwang C, 2012, APPL ENVIRON MICROB, V78, P7856, DOI 10.1128/AEM.01892-12; Hyndman RJ, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i03; Jachimowski A, 2017, J ECOL ENG, V18, P110, DOI 10.12911/22998993/74288; Jacobsen M, 2012, FUTURE WATER AFRICAN, DOI [10.1596/978-0-8213-9721-3, DOI 10.1596/978-0-8213-9721-3]; Figueras MJ, 2010, INT J ENV RES PUB HE, V7, P4179, DOI 10.3390/ijerph7124179; Khan SJ, 2015, WATER RES, V85, P124, DOI 10.1016/j.watres.2015.08.018; Kistemann T, 2002, APPL ENVIRON MICROB, V68, P2188, DOI 10.1128/AEM.68.5.2188-2197.2002; Liu G, 2017, WATER RES, V116, P135, DOI 10.1016/j.watres.2017.03.031; Mahdi E, 2012, J TIME SER ANAL, V33, P211, DOI 10.1111/j.1467-9892.2011.00752.x; McCarthy DT, 2009, WATER SCI TECHNOL, V60, P2749, DOI 10.2166/wst.2009.374; McDonald RI, 2011, P NATL ACAD SCI USA, V108, P6312, DOI 10.1073/pnas.1011615108; Moors E, 2013, SCI TOTAL ENVIRON, P468, DOI DOI 10.1016/JSCITOTENV.2013.07.02; Oloruntoba EO, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.32; Payet E, 2012, VERTIGO, V11; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pendergrass AG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17966-y; Prest EI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164445; Raharimahefa T, 2010, J EARTH SCI-CHINA, V21, P210, DOI 10.1007/s12583-010-0019-y; Ramette M, 1995, ETUDE PROTECTION CON; Ratan R, 2013, WATER RESOUR RES, V49, P3830, DOI 10.1002/wrcr.20275; Razafindratsimba Dominique T, QUELQUES ASPECTS GES; Razavi T, 2016, CLIM RISK MANAG, V13, P43, DOI 10.1016/j.crm.2016.06.002; Ricci PF, 2010, GLOBAL WATER QUALITY, P443; Rosario-Ortiz FL, 2007, WATER RES, V41, P4115, DOI 10.1016/j.watres.2007.05.045; Sathish S, 2009, INDIAN J MED MICROBI, V27, P311, DOI 10.4103/0255-0857.55443; Stanfield G, 2003, TREATMENT EFFICIENCY, P159; Stelma GN, 2018, J WATER HEALTH, V16, P491, DOI 10.2166/wh.2018.013; Taxak AK, 2014, WEATHER CLIM EXTREME, V4, P50, DOI 10.1016/j.wace.2014.04.005; UN, 2019, 2018 REVISION WORLD; Van der Bruggen B, 2010, WATER RESOUR MANAG, V24, P1885, DOI 10.1007/s11269-009-9529-8; Zeileis A, 2003, COMPUT STAT DATA AN, V44, P109, DOI 10.1016/S0167-9473(03)00030-6	63	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0218698	10.1371/journal.pone.0218698	http://dx.doi.org/10.1371/journal.pone.0218698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542001	Green Published, gold, Green Submitted			2022-12-26	WOS:000542685100016
J	Saleh, M; Friedl, A; Srivastava, M; Soliman, H; Secombes, CJ; El-Matbouli, M				Saleh, Mona; Friedl, Adina; Srivastava, Mitaly; Soliman, Hatem; Secombes, Christopher J.; El-Matbouli, Mansour			STAT3/SOCS3 axis contributes to the outcome of salmonid whirling disease	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; REGULATORY T-CELLS; MYXOBOLUS-CEREBRALIS; IMMUNE-RESPONSE; CAUSATIVE AGENT; IL-6; SUSCEPTIBILITY; RESISTANCE; EXPRESSION; STRAINS	There are differences in disease susceptibility to whirling disease (WD) among strains of rainbow trout. The North American strain Trout Lodge (TL) is highly susceptible, whereas the German Hofer (HO) strain is more resistant. The suppressor of cytokine signaling (SOCS) proteins are key in inhibiting cytokine signaling. Their role in modulating the immune response against whirling disease is not completely clear. This study aimed at investigating the transcriptional response of SOCS1 and SOCS3 genes toMyxobolus cerebralisalong with that of several upstream regulators and immune response genes.M.cerebralisinduced the expression of SOCS1, the IL-6-dependent SOCS3, the anti-inflammatory cytokine IL-10 and the Treg associated transcription factor FOXP3 in TL fish at multiple time points, which likely caused a restricted STAT1 and STAT3 activity affecting the Th17/Treg17 balance. The expression of SOCS1 and the IL-6-dependent SOCS3 was induced constraining the activation of STAT1 and STAT3 in TL fish, thereby causing Th17/Treg17 imbalance and leaving the fish unable to establish a protective immune response againstM.cerebralisor control inflammatory reactions increasing susceptibility to WD. Conversely, in HO fish, the expression of SOCS1 and SOCS3 was restrained, whereas the expression of STAT1 and IL-23-mediated STAT3 was induced potentially enabling more controlled immune responses, accelerating parasite clearance and elevating resistance. The induced expression of STAT1 and IL-23-mediated STAT3 likely maintained a successful Th17/Treg17 balance and enabled fish to promote effective immune responses favouring resistance against WD. The results provide insights into the role of SOCS1 and SOCS3 in regulating the activation and magnitude of host immunity in rainbow trout, which may help us understand the mechanisms that underlie the variation in resistance to WD.	[Saleh, Mona; Friedl, Adina; Srivastava, Mitaly; Soliman, Hatem; El-Matbouli, Mansour] Univ Vet Med Vienna, Clin Div Fish Med, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Secombes, Christopher J.] Univ Aberdeen, Scottish Fish Immunol Res Ctr, Sch Biol Sci, Aberdeen, Scotland	University of Veterinary Medicine Vienna; University of Aberdeen	Saleh, M (corresponding author), Univ Vet Med Vienna, Clin Div Fish Med, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria.	mona.saleh@vetmeduni.ac.at		Saleh, Mona/0000-0001-9273-1502; Soliman, Hatem/0000-0003-1641-6759	Austrian Science Fund (FWF) [P29294-B25]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was funded by the Austrian Science Fund (FWF) project no. P29294-B25 to ME.	Adalid-Peralta L, 2011, INT J BIOL SCI, V7, P1412, DOI 10.7150/ijbs.7.1412; Baerwald MR, 2011, HEREDITY, V106, P920, DOI 10.1038/hdy.2010.137; Baerwald MR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-37; Baerwald MR, 2013, FISH SHELLFISH IMMUN, V35, P965, DOI 10.1016/j.fsi.2013.07.008; Bailey C, 2017, FISH SHELLFISH IMMUN, V63, P424, DOI 10.1016/j.fsi.2017.02.039; Baldwin TJ, 2000, J VET DIAGN INVEST, V12, P312, DOI 10.1177/104063870001200403; Bellemore SM, 2015, CLIN EXP IMMUNOL, V182, P261, DOI 10.1111/cei.12691; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Piazzon MC, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3007-1; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Dionne M, 2009, PHILOS T R SOC B, V364, P1555, DOI 10.1098/rstb.2009.0011; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; El-Matbouli M., 2002, 4 INT S AQ AN HLTH, P1; ELMATBOULI M, 1995, J FISH BIOL, V46, P919, DOI 10.1111/j.1095-8649.1995.tb01397.x; Fetherman ER, 2012, DIS AQUAT ORGAN, V102, P97, DOI 10.3354/dao02543; Fu SH, 2011, PLOS NEGLECT TROP D, V5, pe1231; Goncalves-de-Albuquerque SD, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01437; Gorgoglione B, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-55; Hedrick RP, 1999, DIS AQUAT ORGAN, V37, P173, DOI 10.3354/dao037173; Hedrick RP, 1998, IMMUNOL REV, V166, P365, DOI 10.1111/j.1600-065X.1998.tb01276.x; Hedrick RP, 2003, DIS AQUAT ORGAN, V55, P37, DOI 10.3354/dao055037; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Jiang YS, 2015, MOL IMMUNOL, V66, P216, DOI 10.1016/j.molimm.2015.03.014; Jung MK, 2017, IMMUNE NETW, V17, P276, DOI 10.4110/in.2017.17.5.276; Katara GK, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-52; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Kotob MH, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2912-7; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Maisey K, 2016, J IMMUNOL, V196, P4150, DOI 10.4049/jimmunol.1500439; Ministerio da Saude-MS, 2019, B EPIDEMIOLOGICO, V50, P1; Nakanishi Teruyuki, 2015, Biology-Basel, V4, P640, DOI 10.3390/biology4040640; Narita Y, 2013, J IMMUNOL, V190, P812, DOI 10.4049/jimmunol.1103797; Nath S, 2006, IMMUNOGENETICS, V58, P443, DOI 10.1007/s00251-006-0094-5; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; OGRODNICK JJ, 1979, T AM FISH SOC, V108, P187, DOI 10.1577/1548-8659(1979)108&lt;187:SOVSTW&gt;2.0.CO;2; Oshima Y, 2005, CARDIOVASC RES, V65, P428, DOI 10.1016/j.cardiores.2004.10.021; Ribeiro CMS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013012; Rodriguez PC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00093; Rucker U, 2007, DIS AQUAT ORGAN, V76, P223, DOI 10.3354/dao076223; Saleh M, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3505-9; Semple SL, 2019, IMMUNOGENETICS, V71, P407, DOI 10.1007/s00251-019-01115-y; Severin VIC, 2007, PARASITOL RES, V101, P1019, DOI 10.1007/s00436-007-0582-z; Severin VIC, 2010, PARASITOL RES, V106, P325, DOI 10.1007/s00436-009-1661-0; Silver JS, 2011, J IMMUNOL, V187, P350, DOI 10.4049/jimmunol.1004144; Singh B, 2013, INDIAN J MED RES, V138, P591; Sitja-Bobadilla A, 2015, MYXOZOAN EVOLUTION E; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Takahashi R, 2011, J EXP MED, V208, P2055, DOI 10.1084/jem.20110428; Takizawa F, 2016, J IMMUNOL, V196, P4522, DOI 10.4049/jimmunol.1600222; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; Tsukamoto H, 2018, CANCER SCI, V109, P523, DOI 10.1111/cas.13433; Wang HZ, 2011, J IMMUNOL, V187, P6410, DOI 10.4049/jimmunol.1101436; Wang Tiehui, 2011, J Signal Transduct, V2011, P905813, DOI 10.1155/2011/905813; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang L, 2006, MOL CELL BIOCHEM, V288, P179, DOI 10.1007/s11010-006-9137-3	61	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234479	10.1371/journal.pone.0234479	http://dx.doi.org/10.1371/journal.pone.0234479			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542025	gold, Green Published			2022-12-26	WOS:000542685100004
J	Summers, ME; Richmond, BW; Menon, S; Sheridan, RM; Kropski, JA; Majka, SA; Taketo, MM; Bastarache, JA; West, JD; De Langhe, S; Geraghty, P; Klemm, DJ; Chu, HW; Friedman, RS; Tao, YKK; Foronjy, RF; Majka, SM				Summers, Megan E.; Richmond, Bradley W.; Menon, Swapna; Sheridan, Ryan M.; Kropski, Jonathan A.; Majka, Sarah A.; Taketo, M. Mark; Bastarache, Julie A.; West, James D.; De Langhe, Stijn; Geraghty, Patrick; Klemm, Dwight J.; Chu, Hong Wei; Friedman, Rachel S.; Tao, Yuankai K.; Foronjy, Robert F.; Majka, Susan M.			Resident mesenchymal vascular progenitors modulate adaptive angiogenesis and pulmonary remodeling via regulation of canonical Wnt signaling	FASEB JOURNAL			English	Article						adaptive angiogenesis; emphysema; mesenchymal vascular progenitor cell; microvascular niche; Wnt signaling	ENDOTHELIAL GROWTH-FACTOR; SIDE POPULATION CELLS; STEM-CELLS; BETA-CATENIN; MOLECULAR-MECHANISMS; ARTERIAL STIFFNESS; LUNG; EMPHYSEMA; INJURY; VEGF	Adaptive angiogenesis is necessary for tissue repair, however, it may also be associated with the exacerbation of injury and development of chronic disease. In these studies, we demonstrate that lung mesenchymal vascular progenitor cells (MVPC) modulate adaptive angiogenesis via lineage trace, depletion of MVPC, and modulation of beta-catenin expression. Single cell sequencing confirmed MVPC as multipotential vascular progenitors, thus, genetic depletion resulted in alveolar simplification with reduced adaptive angiogenesis. Following vascular endothelial injury, Wnt activation in MVPC was sufficient to elicit an emphysema-like phenotype characterized by increased MLI, fibrosis, and MVPC driven adaptive angiogenesis. Lastly, activation of Wnt/beta-catenin signaling skewed the profile of human and murine MVPC toward an adaptive phenotype. These data suggest that lung MVPC drive angiogenesis in response to injury and regulate the microvascular niche as well as subsequent distal lung tissue architecture via Wnt signaling.	[Summers, Megan E.; Majka, Sarah A.; Chu, Hong Wei; Majka, Susan M.] Natl Jewish Hlth, Div Pulm Crit Care & Sleep Med, Dept Med, 1400 Jackson St,K810, Denver, CO 80206 USA; [Richmond, Bradley W.; Kropski, Jonathan A.; Bastarache, Julie A.; West, James D.] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med Cardiol, Nashville, TN USA; [Menon, Swapna; Tao, Yuankai K.] AnalyzeDat Consulting Serv, Pulm Vasc Res Inst Kochi, Ernakulam, India; [Sheridan, Ryan M.] Univ Colorado, Sch Med, RNA Biosci Initiat, Dept Biochem & Mol Genet, Aurora, CO USA; [Taketo, M. Mark] Kyoto Univ, Grad Sch Med, Div Expt Therapeut, Kyoto, Japan; [De Langhe, Stijn] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Geraghty, Patrick; Foronjy, Robert F.] SUNY Downstate Med Ctr, Div Pulm & Crit Care Med, Brooklyn, NY 11203 USA; [Klemm, Dwight J.] Univ Colorado, Dept Med Pulm & Crit Care Med, Aurora, CO USA; [Klemm, Dwight J.; Majka, Susan M.] Univ Colorado, Gates Ctr Regenerat Med & Stem Cell Biol, Aurora, CO USA; [Friedman, Rachel S.; Majka, Susan M.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO USA; [Majka, Susan M.] Vanderbilt Univ, Biomed Engn, 221 Kirkland Hall, Nashville, TN 37235 USA	National Jewish Health; Vanderbilt University; University of Colorado System; University of Colorado Anschutz Medical Campus; Kyoto University; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; Vanderbilt University	Majka, SM (corresponding author), Natl Jewish Hlth, Div Pulm Crit Care & Sleep Med, Dept Med, 1400 Jackson St,K810, Denver, CO 80206 USA.	susanmajka@mac.com	menon, swapna/ABH-4241-2020; De Langhe, Stijn/ABH-6876-2020; menon, swapna/ABH-1717-2020; West, James/E-2960-2010	menon, swapna/0000-0002-0429-2472; De Langhe, Stijn/0000-0003-3867-4572; Sheridan, Ryan/0000-0003-4012-3147; West, James/0000-0002-6004-0202; Geraghty, Patrick/0000-0003-1647-5505	NIH [R01HL136449, R01HL116597]; National Center for Research Resources [UL1 RR024975-01]; National Center for Advancing Translational Sciences [2 UL1 TR000445-06]; University of Colorado [NCI P30 CA 46934-14, P30-CA046934 NCI]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Colorado	This work was funded by grants to SM Majka from the NIH R01HL116597 and NIH R01HL136449. The project was also supported in part by the National Center for Research Resources, Grant UL1 RR024975-01 and is now at the National Center for Advancing Translational Sciences, Grant 2 UL1 TR000445-06. Experiments were performed using the University of Colorado Cancer Center Microarray Core (NCI P30 CA 46934-14) and Shared Flow Cytometry Resource (P30-CA046934 NCI).	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Akeson AL, 2000, DEV DYNAM, V217, P11, DOI 10.1002/(SICI)1097-0177(200001)217:1<11::AID-DVDY2>3.0.CO;2-L; Alford SK, 2010, P NATL ACAD SCI USA, V107, P7485, DOI 10.1073/pnas.0913880107; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Asakura A, 2002, EXP HEMATOL, V30, P1339, DOI 10.1016/S0301-472X(02)00954-2; Awad KS, 2016, PULM CIRC, V6, P285, DOI 10.1086/688034; BAARSMA HA, 2014, EUR RESPIR J S58, V44, P1835; Baarsma HA, 2017, J EXP MED, V214, P143, DOI 10.1084/jem.20160675; Baarsma HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025450; Barr RG, 2007, AM J RESP CRIT CARE, V176, P1200, DOI 10.1164/rccm.200707-980OC; Bellusci S, 1997, DEVELOPMENT, V124, P53; Bingle L, 1997, MEDIAT INFLAMM, V6, P345, DOI 10.1080/09629359791488; Birdsey GM, 2015, DEV CELL, V32, P82, DOI 10.1016/j.devcel.2014.11.016; Bloodworth NC, 2018, CIRC RES, V123, pE51, DOI 10.1161/CIRCRESAHA.118.313397; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Case D, 2007, AM J PHYSIOL-LUNG C, V292, pL154, DOI 10.1152/ajplung.00192.2006; Chen CY, 2016, CELL ADHES MIGR, V10, P66, DOI 10.1080/19336918.2015.1108510; CHETTY A, 1995, EXP LUNG RES, V21, P889, DOI 10.3109/01902149509031769; Chilosi M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-3; Chow K, 2013, PULM CIRC, V3, P31, DOI 10.4103/2045-8932.109912; Condliffe Robin, 2015, F1000Prime Rep, V7, P06, DOI 10.12703/P7-06; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Cossu G, 2003, CURR OPIN GENET DEV, V13, P537, DOI 10.1016/j.gde.2003.08.001; Cottin V, 2011, ARTHRITIS RHEUM-US, V63, P295, DOI 10.1002/art.30077; Dell'Aringa M, 2018, METHODS MOL BIOL, V1799, P225, DOI 10.1007/978-1-4939-7896-0_17; Dikalov S, 2019, AM J PHYSIOL-HEART C, V316, pH639, DOI 10.1152/ajpheart.00595.2018; DiPietro LA, 2013, CURR OPIN RHEUMATOL, V25, P87, DOI 10.1097/BOR.0b013e32835b13b6; Dufourcq P, 2008, STEM CELLS, V26, P2991, DOI 10.1634/stemcells.2008-0372; El Agha E, 2017, CELL STEM CELL, V21, P166, DOI 10.1016/j.stem.2017.07.011; Ellis LV, 2020, DEV CELL, V52, P617, DOI 10.1016/j.devcel.2020.01.009; Fatima S, 2012, STEM CELLS, V30, P210, DOI 10.1002/stem.1002; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Fong TAT, 1999, CANCER RES, V59, P99; Franco CA, 2009, CURR OPIN GENET DEV, V19, P476, DOI 10.1016/j.gde.2009.09.004; Gaskill C, 2017, PULM CIRC, V7, P108, DOI 10.1177/2045893217702346; Gaskill C, 2016, PULM CIRC, V6, P483, DOI 10.1086/688314; Gaskill CF, 2017, J CLIN INVEST, V127, P2262, DOI 10.1172/JCI88629; Gebb SA, 2000, DEV DYNAM, V217, P159, DOI 10.1002/(SICI)1097-0177(200002)217:2<159::AID-DVDY3>3.0.CO;2-9; Han HC, 2012, J VASC RES, V49, P185, DOI 10.1159/000335123; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Travisano SI, 2019, ELIFE, V8, DOI 10.7554/eLife.49977; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Jun D, 2011, STEM CELLS, V29, P725, DOI 10.1002/stem.604; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kestler HA, 2011, J CELL BIOL, V193, P431, DOI 10.1083/jcb.201103167; Kneidinger N, 2011, AM J RESP CRIT CARE, V183, P723, DOI 10.1164/rccm.200910-1560OC; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Kumar A, 2017, CELL REP, V19, P1902, DOI 10.1016/j.celrep.2017.05.019; Kumar ME, 2014, SCIENCE, V346, P827, DOI 10.1126/science.1258810; Lee Chun Geun, 2011, Proc Am Thorac Soc, V8, P512, DOI 10.1513/pats.201102-018MW; Li RS, 2014, ARTERIOSCL THROM VAS, V34, P2268, DOI 10.1161/ATVBAHA.114.303345; Liu WH, 2013, CELL TRANSPLANT, V22, P1859, DOI 10.3727/096368912X657206; Loganathan K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189433; Mack JJ, 2018, CURR OPIN HEMATOL, V25, P212, DOI 10.1097/MOH.0000000000000425; Majka S, 2006, AM J PHYSIOL-LUNG C, V290, pL1183, DOI 10.1152/ajplung.00175.2005; Marriott S, 2014, AM J PHYSIOL-CELL PH, V307, pC684, DOI 10.1152/ajpcell.00114.2014; Martin J, 2008, CYTOTHERAPY, V10, P140, DOI 10.1080/14653240801895296; Martowicz A, 2019, ARTERIOSCL THROM VAS, V39, P2273, DOI 10.1161/ATVBAHA.119.312749; McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC; McGrath-Morrow SA, 2004, AM J RESP CELL MOL, V30, P635, DOI 10.1165/rcmb.2003-0049OC; Mendez JJ, 2015, BIOMATERIALS, V40, P61, DOI 10.1016/j.biomaterials.2014.11.011; Mofarrahi M, 2013, J APPL PHYSIOL, V114, P1309, DOI 10.1152/japplphysiol.00954.2012; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Newcomb DC, 2013, THORAX, V68, P717, DOI 10.1136/thoraxjnl-2012-202404; Ng ML, 2018, WORLD J STEM CELLS, V10, P119, DOI 10.4252/wjsc.v10.i9.119; Nicolls MR, 2016, CURR OPIN ORGAN TRAN, V21, P279, DOI 10.1097/MOT.0000000000000307; Patel J, 2017, ONCOTARGET, V8, P84618, DOI 10.18632/oncotarget.21389; Patel J, 2017, CIRCULATION, V135, P786, DOI 10.1161/CIRCULATIONAHA.116.024754; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Pill Karoline, 2015, Cell Regen, V4, P8, DOI 10.1186/s13619-015-0025-8; Polosukhin VV, 2012, EXP LUNG RES, V38, P135, DOI 10.3109/01902148.2012.658595; Polverino F, 2018, PULM CIRC, V8, DOI 10.1177/2045894018758528; Rama N, 2015, NAT MED, V21, P483, DOI 10.1038/nm.3849; Rao S, 2007, DEVELOPMENT, V134, P4449, DOI 10.1242/dev.012187; Sabit R, 2007, AM J RESP CRIT CARE, V175, P1259, DOI 10.1164/rccm.200701-067OC; Schachtner SK, 2000, AM J RESP CELL MOL, V22, P157, DOI 10.1165/ajrcmb.22.2.3766; Schrimpf C, 2014, J VASC RES, V51, P247, DOI 10.1159/000365149; Secomb TW, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002983; Seimetz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129327; Shu WG, 2002, DEVELOPMENT, V129, P4831; Smadja DM, 2010, ARTERIOSCL THROM VAS, V30, P2544, DOI 10.1161/ATVBAHA.110.213751; Summer R, 2007, AM J RESP CELL MOL, V37, P152, DOI 10.1165/rcmb.2006-0386OC; Suzuki M, 2008, INHAL TOXICOL, V20, P349, DOI 10.1080/08958370701866412 ; Tadjali M, 2006, STEM CELLS, V24, P1556, DOI 10.1634/stemcells.2005-0562; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Tanjore H, 2013, AM J RESP CRIT CARE, V187, P630, DOI 10.1164/rccm.201205-0972OC; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P752; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Vitali SH, 2014, PULM CIRC, V4, P619, DOI 10.1086/678508; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Wang RYR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022060; Xie T, 2018, CELL REP, V22, P3625, DOI 10.1016/j.celrep.2018.03.010; Xie T, 2016, J CLIN INVEST, V126, P3063, DOI 10.1172/JCI85328; Yin Y, 2008, DEV BIOL, V319, P426, DOI 10.1016/j.ydbio.2008.04.009; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Yu N, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005095; Zhang WM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-111; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	107	8	8	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10267	10285		10.1096/fj.202000629R	http://dx.doi.org/10.1096/fj.202000629R		JUN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32533805	Green Published, hybrid			2022-12-26	WOS:000541525300001
J	Garbe, L; Rau, R; Toppe, T				Garbe, Lisa; Rau, Richard; Toppe, Theo			Influence of perceived threat of Covid-19 and HEXACO personality traits on toilet paper stockpiling	PLOS ONE			English	Article								Following the fast spread of Covid-19 across Europe and North America in March 2020, many people started stockpiling commodities like toilet paper. Despite the high relevance for public authorities to adequately address stockpiling behavior, empirical studies on the psychological underpinnings of toilet paper stockpiling are still scarce. In this study, we investigated the relation between personality traits, perceived threat of Covid-19, and stockpiling of toilet paper in an online survey (N= 996) across 22 countries. Results suggest that people who felt more threatened by Covid-19 stockpiled more toilet paper. Further, a predisposition towards Emotionality predicted the perceived threat of Covid-19 and affected stockpiling behavior indirectly. Finally, Conscientiousness was related to toilet paper stockpiling, such that individuals higher in Conscientiousness tended to stockpile more toilet paper. These results emphasize the importance of clear communication by public authorities acknowledging anxiety and, at the same time, transmitting a sense of control.	[Garbe, Lisa] Univ St Gallen, Sch Econ & Polit Sci, Inst Polit Sci, St Gallen, Switzerland; [Rau, Richard] Univ Munster, Dept Psychol, Munster, Germany; [Toppe, Theo] Max Planck Inst Evolutionary Anthropol, Dept Comparat Cultural Psychol, Leipzig, Germany	University of St Gallen; University of Munster; Max Planck Society	Toppe, T (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Comparat Cultural Psychol, Leipzig, Germany.	theo_toppe@eva.mpg.de		Rau, Richard/0000-0002-1490-8584				Alford H, NEW YORKER; [Anonymous], 2012, INT J COMPUTER APPL, V48, p[0975, 1]; [Anonymous], 2020, BBC NEWS; [Anonymous], 2020, INDEPENDENT; Arslan R. C., 2018, FORMR STUDY FRAMEWOR; Ashton MC, 2014, PERS SOC PSYCHOL REV, V18, P139, DOI 10.1177/1088868314523838; Bavel JJV, 2020, NAT HUM BEHAV, P1, DOI [10.1038/s41562-020-0818-9, DOI 10.1038/S41562-020-0818-9]; Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006; Chadwick J, 2020, MAIL ONLINE; Columbus S, 2020, WHO HOARDS HONESTY H, DOI [10.31234/osf.io/8e62v, DOI 10.31234/0SF.IO/8E62V]; Corona-Krise, COR KRIS EXP DAT ZEI; de Vries RE, 2013, J RES PERS, V47, P871, DOI 10.1016/j.jrp.2013.09.003; Ellson A, CORONAVIRUS PANDEMIC; HEWITT PL, 1991, J PERS SOC PSYCHOL, V60, P456, DOI 10.1037/0022-3514.60.3.456; Jones SC, 2010, J BUS RES, V63, P126, DOI 10.1016/j.jbusres.2009.02.009; Kroh M, 2007, PUBLIC OPIN QUART, V71, P204, DOI 10.1093/poq/nfm009; Lee K, 2008, J PERS, V76, P1001, DOI 10.1111/j.1467-6494.2008.00512.x; Meyerhardt JA, 2020, JNCI CANCER SPECT, V4, DOI 10.1093/jncics/pkz096; Murphy K, 2020, NEW YORK TIMES  0403; Paulhus DL, 2002, J RES PERS, V36, P556, DOI 10.1016/S0092-6566(02)00505-6; R Core Team, 2018, R LANG ENV STAT COMP; Thielmann I, 2020, PSYCHOL BULL, V146, P30, DOI 10.1037/bul0000217; Timsit A., QUARTZ; Timsit A, 2020, QUARTZ; Wood KA, 2020, PSYCHOANALYSIS TOILE; Writer RKB, HUFFPOST	26	89	90	8	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234232	10.1371/journal.pone.0234232	http://dx.doi.org/10.1371/journal.pone.0234232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QP	32530911	Green Published, gold, Green Submitted			2022-12-26	WOS:000542037200012
J	Velazhahan, V; Glaza, P; Herrera, AI; Prakash, O; Zolkiewski, M; Geisbrecht, BV; Schrick, K				Velazhahan, Vaithish; Glaza, Przemyslaw; Herrera, Alvaro I.; Prakash, Om; Zolkiewski, Michal; Geisbrecht, Brian V.; Schrick, Kathrin			Dietary flavonoid fisetin binds human SUMO1 and blocks sumoylation of p53	PLOS ONE			English	Article							SHOCK TRANSCRIPTION FACTOR-1; KAPPA-B PATHWAYS; HEAT-SHOCK; CANCER PREVENTION; INSIGHTS; INHIBITION; APOPTOSIS; RECEPTOR	Flavonoids are plant-derived compounds that occur abundantly in fruits and vegetables and have been shown to possess potent anti-cancer, antioxidant, and anti-inflammatory properties. However, their direct targets and molecular mechanism of action are not well characterized, hampering exploitation of the beneficial properties of flavonoids for drug development. Small ubiquitin-related modifier 1 (SUMO1) is attached to target proteins as part of a post-translational modification system implicated in a myriad of cellular processes from nuclear trafficking to transcriptional regulation. Using a combination of surface plasmon resonance, differential scanning fluorimetry and fluorescence quenching studies, we provide evidence for direct binding of the dietary flavonoid fisetin to human SUMO1. Our NMR chemical shift perturbation analyses reveal that binding to fisetin involves four conserved amino acid residues (L65, F66, E67, M82) previously shown to be important for conjugation of SUMO1 to target proteins.In vitrosumoylation experiments indicate that fisetin blocks sumoylation of tumor suppressor p53, consistent with fisetin negatively affecting post-translational modification and thus the biological activity of p53. A series of differential scanning fluorimetry experiments suggest that high concentrations of fisetin result in destabilization and unfolding of SUMO1, presenting a molecular mechanism by which flavonoid binding affects its activity. Overall, our data establish a novel direct interaction between fisetin and SUMO1, providing a mechanistic explanation for the ability of fisetin to modulate multiple key signaling pathways inside cells.	[Velazhahan, Vaithish; Schrick, Kathrin] Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA; [Velazhahan, Vaithish; Glaza, Przemyslaw; Herrera, Alvaro I.; Prakash, Om; Zolkiewski, Michal; Geisbrecht, Brian V.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Schrick, Kathrin] Kansas State Univ, Mol Cellular & Dev Biol, Manhattan, KS 66506 USA; [Velazhahan, Vaithish] Med Res Council Lab Mol Biol, Cambridge, England; [Herrera, Alvaro I.] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA	Kansas State University; Kansas State University; Kansas State University; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Auburn University System; Auburn University	Schrick, K (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.; Schrick, K (corresponding author), Kansas State Univ, Mol Cellular & Dev Biol, Manhattan, KS 66506 USA.	kschrick@ksu.edu		Herrera, Alvaro I./0000-0002-2108-0957; Glaza, Przemyslaw/0000-0003-3532-1085; Velazhahan, Vaithish/0000-0001-8028-8486	Johnson Cancer Research Center (JCRC) at Kansas State University (KSU); National Science Foundation [MCB 1616818]; National Institute of General Medical Sciences of the National Institute of Health [P20GM103418]; USDA National Institute of Food and Agriculture, Hatch/Multi-State project [1013013]; Barry M. Goldwater Scholarship; JCRC Cancer Research Awards; Sigma Xi Grant in Aid of Research; KSU Office of Undergraduate Research and Creative Inquiry Scholarships	Johnson Cancer Research Center (JCRC) at Kansas State University (KSU); National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences of the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); USDA National Institute of Food and Agriculture, Hatch/Multi-State project; Barry M. Goldwater Scholarship; JCRC Cancer Research Awards; Sigma Xi Grant in Aid of Research; KSU Office of Undergraduate Research and Creative Inquiry Scholarships	Funding was provided to KS by Innovative Research Awards from the Johnson Cancer Research Center (JCRC) at Kansas State University (KSU) (https://cancer.k-state.edu/), the National Science Foundation (MCB 1616818) (https://www.nsf.gov/div/index.jsp?div=MCB), the National Institute of General Medical Sciences of the National Institute of Health under Award no. P20GM103418 (https://www.nigms.nih.gov/), the USDA National Institute of Food and Agriculture, Hatch/Multi-State project 1013013 (https://nifa.usda.gov/multi-state-research-groups-communityvitality-and-family-well-being), and the following awards to V.V.: Barry M. Goldwater Scholarship (https://goldwater.scholarsapply.org/), JCRC Cancer Research Awards (https://cancer.k-state.edu/), Sigma Xi Grant in Aid of Research (https://www.sigmaxi.org/programs/grants-in-aid, and KSU Office of Undergraduate Research and Creative Inquiry Scholarships (https://www.k-state.edu/undergradresearch/).This is contribution no. 20-079-J from the Kansas Agricultural Experiment Station (https://online.ksre.ksu.edu/kaes).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Biggins S, 2001, GENETICS, V159, P453; Birt DF, 2001, PHARMACOL THERAPEUT, V90, P157, DOI 10.1016/S0163-7258(01)00137-1; Chahar Maheep K, 2011, Pharmacogn Rev, V5, P1, DOI 10.4103/0973-7847.79093; Chaudhuri S, 2013, CURR DRUG METAB, V14, P491, DOI 10.2174/1389200211314040011; Constantin RP, 2010, CELL BIOCHEM FUNCT, V28, P149, DOI 10.1002/cbf.1635; Flotho A, 2012, METHODS MOL BIOL, V832, P93, DOI 10.1007/978-1-61779-474-2_5; Grotewold E., 2008, SCI FLAVONOIDS, pvii; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Han ZJ, 2018, INT J ONCOL, V52, P1081, DOI 10.3892/ijo.2018.4280; Hentze N, 2016, ELIFE, V5, DOI 10.7554/eLife.11576; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hilgarth RS, 2003, BIOCHEM BIOPH RES CO, V303, P196, DOI 10.1016/S0006-291X(03)00312-7; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Khan N, 2013, ANTIOXID REDOX SIGN, V19, P151, DOI 10.1089/ars.2012.4901; Kim JA, 2015, CARCINOGENESIS, V36, P696, DOI 10.1093/carcin/bgv045; Kim SC, 2012, IMMUNOPHARM IMMUNOT, V34, P645, DOI 10.3109/08923973.2011.648270; Klimaszewska-Wisniewska A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030661; Lall RK, 2016, MOL NUTR FOOD RES, V60, P1396, DOI 10.1002/mnfr.201600025; Lee JS, 2017, ADV EXP MED BIOL, V963, P283, DOI 10.1007/978-3-319-50044-7_17; Lee S, 2018, CYTOKINE, V108, P247, DOI 10.1016/j.cyto.2018.01.004; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Li J, 2011, BASIC CLIN PHARMACOL, V108, P84, DOI 10.1111/j.1742-7843.2010.00613.x; Mabb AM, 2007, CELL MOL LIFE SCI, V64, P1979, DOI 10.1007/s00018-007-7005-2; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Min KJ, 2017, MOLECULES, V22, DOI 10.3390/molecules22081285; Nabavi SF, 2016, CURR TOP MED CHEM, V16, P1910, DOI 10.2174/1568026616666160204121725; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pandey RP, 2013, APPL ENVIRON MICROB, V79, P6833, DOI 10.1128/AEM.02057-13; Pichler Andrea, 2017, BioMolecular Concepts, V8, P13, DOI 10.1515/bmc-2016-0030; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roy AS, 2013, MOL BIOL REP, V40, P3239, DOI 10.1007/s11033-012-2399-9; Sahu BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105070; Sak Katrin, 2014, Pharmacogn Rev, V8, P122, DOI 10.4103/0973-7847.134247; Santiago A, 2013, MOL BIOL CELL, V24, P2739, DOI 10.1091/mbc.E12-10-0771; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Sutinen P, 2014, NUCLEIC ACIDS RES, V42, P8310, DOI 10.1093/nar/gku543; Takahashi Y, 1999, BIOCHEM BIOPH RES CO, V259, P582, DOI 10.1006/bbrc.1999.0821; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Tempe D, 2014, ONCOGENE, V33, P921, DOI 10.1038/onc.2013.4; Touil YS, 2011, CANCER CHEMOTH PHARM, V68, P445, DOI 10.1007/s00280-010-1505-8; Wimmer P, 2012, J VIROL, V86, P642, DOI 10.1128/JVI.06227-11; Wu SY, 2009, EPIGENETICS-US, V4, P445, DOI 10.4161/epi.4.7.10030; Wu SY, 2009, EMBO J, V28, P1246, DOI 10.1038/emboj.2009.83; Zhang HJ, 2013, CELL BIOCHEM BIOPHYS, V67, P1081, DOI 10.1007/s12013-013-9612-x; Zhao XL, 2018, MOL CELL, V71, P409, DOI 10.1016/j.molcel.2018.07.027	48	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234468	10.1371/journal.pone.0234468	http://dx.doi.org/10.1371/journal.pone.0234468			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530958	gold, Green Published			2022-12-26	WOS:000542037200047
J	Frett, T; Green, DA; Arz, M; Noppe, A; Petrat, G; Kramer, A; Kuemmel, J; Tegtbur, U; Jordan, J				Frett, Timo; Green, David Andrew; Arz, Michael; Noppe, Alexandra; Petrat, Guido; Kramer, Andreas; Kuemmel, Jakob; Tegtbur, Uwe; Jordan, Jens			Motion sickness symptoms during jumping exercise on a short-arm centrifuge	PLOS ONE			English	Article							SOPITE SYNDROME; SUSCEPTIBILITY; QUESTIONNAIRE	Artificial gravity elicited through short-arm human centrifugation combined with physical exercise, such as jumping, is promising in maintaining health and performance during space travel. However, motion sickness symptoms could limit the tolerability of the approach. Therefore, we determined the feasibility and tolerability, particularly occurrence of motion sickness symptoms, during reactive jumping exercises on a short-arm centrifuge. In 15 healthy men, we assessed motion sickness induced by jumping exercises during short-arm centrifugation at constant +1Gzor randomized variable +0.5, +0.75, +1, +1.25 and +1.5Gzalong the body axis referenced to center of mass. Jumping in the upright position served as control intervention. Test sessions were conducted on separate days in a randomized and cross-over fashion. All participants tolerated jumping exercises against terrestrial gravity and on the short-arm centrifuge during 1Gzor variableGzat the center of mass without disabling motion sickness symptoms. While head movements markedly differed, motion sickness scores were only modestly increased with jumping on the short-arm centrifuge compared with vertical jumps. Our study demonstrates that repetitive jumping exercises are feasible and tolerable during short-arm centrifugation. Since jumping exercises maintain muscle and bone mass, our study enables further development of exercise countermeasures in artificial gravity.	[Frett, Timo; Arz, Michael; Noppe, Alexandra; Petrat, Guido; Jordan, Jens] German Aerosp Ctr, Inst Aerosp Med, Cologne, Germany; [Green, David Andrew] European Space Agcy, European Astronaut Ctr, Space Med Team HRE OM, Cologne, Germany; [Green, David Andrew] KBRwyle GmbH, Cologne, Germany; [Green, David Andrew] Kings Coll London, London, England; [Kramer, Andreas; Kuemmel, Jakob] Univ Konstanz, Inst Sport Sci, Constance, Germany; [Tegtbur, Uwe] Hannover Med Sch, Inst Sports Med, Hannover, Germany; [Jordan, Jens] Univ Cologne, Chair Aerosp Med, Cologne, Germany	Helmholtz Association; German Aerospace Centre (DLR); European Space Agency; University of London; King's College London; University of Konstanz; Hannover Medical School; University of Cologne	Frett, T (corresponding author), German Aerosp Ctr, Inst Aerosp Med, Cologne, Germany.	Timo.frett@dlr.de		Frett, Timo/0000-0002-5572-1177	Space Administration of the German Aerospace Center	Space Administration of the German Aerospace Center	The study was part of the German National Centrifuge Program 2 financed by the Space Administration of the German Aerospace Center. KBRwyle GmbH provided the salary for D.G but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnauld E, 2016, SPACE PHYSL MED EVID; Bertolini G, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00014; Clement G., 2007, ARTIFICIAL GRAVITY, V20; Custaud MA, 2002, AUTON NEUROSCI-BASIC, V100, P66, DOI 10.1016/S1566-0702(02)00132-7; Gianaros PJ, 2001, AVIAT SPACE ENVIR MD, V72, P115; Golding JF, 1998, BRAIN RES BULL, V47, P507, DOI 10.1016/S0361-9230(98)00091-4; Golding JF, 2006, PERS INDIV DIFFER, V41, P237, DOI 10.1016/j.paid.2006.01.012; GRAYBIEL A, 1976, AVIAT SPACE ENVIR MD, V47, P873; Hall T. W., 1999, J BR INTERPLANET SOC, V52, P290; Kaderka J, 2010, ACTA ASTRONAUT, V67, P1090, DOI 10.1016/j.actaastro.2010.06.032; Kramer A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13659-8; Lawson BD, 1998, ACTA ASTRONAUT, V43, P181, DOI 10.1016/S0094-5765(98)00153-2; Lee AG, 2018, EYE, V32, P1164, DOI 10.1038/s41433-018-0070-y; Piotrowski T, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01759; Roberts DR, 2017, NEW ENGL J MED, V377, P1746, DOI 10.1056/NEJMoa1705129; ROLNICK A, 1991, ERGONOMICS, V34, P867, DOI 10.1080/00140139108964831; Van Ombergen A, 2016, INT J AUDIOL, V55, P189, DOI 10.3109/14992027.2015.1111526; Young LR, 2003, J VESTIBUL RES-EQUIL, V13, P65	18	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234361	10.1371/journal.pone.0234361	http://dx.doi.org/10.1371/journal.pone.0234361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525946	Green Published, gold			2022-12-26	WOS:000542036800038
J	Diez-Hermano, S; Mejias, A; Sanchez, D; Gutierrez, G; Ganfornina, MD				Diez-Hermano, Sergio; Mejias, Andres; Sanchez, Diego; Gutierrez, Gabriel; Ganfornina, Maria D.			Control of the neuroprotective Lipocalin Apolipoprotein D expression by alternative promoter regions and differentially expressed mRNA 5' UTR variants	PLOS ONE			English	Article							GENE-EXPRESSION; IDENTIFICATION; PREDICTION; MODULATION; PROTECTION; REDUCTION; EVOLUTION; ELEMENTS; BIOLOGY	The Lipocalin Apolipoprotein D (ApoD) is one of the few genes consistently overexpressed in the aging brain, and in most neurodegenerative and psychiatric diseases. Its functions include metabolism regulation, myelin management, neuroprotection, and longevity regulation. Knowledge of endogenous regulatory mechanisms controlling brain disease-triggered ApoD expression is relevant if we want to boost pharmacologically its neuroprotecting potential. In addition to classical transcriptional control, Lipocalins have a remarkable variability in mRNA 5'UTR-dependent translation efficiency. Using bioinformatic analyses, we uncover strong selective pressures preserving ApoD 5'UTR properties, indicating unexpected functional conservation. PCR amplifications demonstrate the production of five 5'UTR variants (A-E) in mouse ApoD, with diverse expression levels across tissues and developmental stages. Importantly, Variant E is specifically expressed in the oxidative stress-challenged brain. Predictive analyses of 5'UTR secondary structures and enrichment in elements restraining translation, point to Variant E as a tight regulator of ApoD expression. We find two genomic regions conserved in human and mouse ApoD: a canonical (alpha) promoter region and a previously unknown region upstream of Variant E that could function as an alternative mouse promoter (beta). Luciferase assays demonstrate that both alpha and beta promoter regions can drive expression in cultured mouse astrocytes, and that Promoter beta activity responds proportionally to incremental doses of the oxidative stress generator Paraquat. We postulate that Promoter beta works in association with Variant E 5'UTR as a regulatory tandem that organizes ApoD gene expression in the nervous system in response to oxidative stress, the most common factor in aging and neurodegeneration.	[Diez-Hermano, Sergio; Sanchez, Diego; Ganfornina, Maria D.] Univ Valladolid, Inst Biol & Genet Mol, Dept Bioquim & Biol Mol & Fisiol, CSIC, Valladolid, Spain; [Diez-Hermano, Sergio] Univ Complutense, Dept Matemat Aplicada, Madrid, Spain; [Mejias, Andres; Gutierrez, Gabriel] Univ Seville, Dept Genet, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Complutense University of Madrid; University of Sevilla	Ganfornina, MD (corresponding author), Univ Valladolid, Inst Biol & Genet Mol, Dept Bioquim & Biol Mol & Fisiol, CSIC, Valladolid, Spain.	opabinia@ibgm.uva.es	Diez-Hermano, Sergio/ABC-4198-2021; Ganfornina, Maria D/N-5743-2014; Gutierrez Pozo, Gabriel/S-7646-2017	Diez-Hermano, Sergio/0000-0003-3830-7297; Ganfornina, Maria D/0000-0002-8567-4826; Gutierrez Pozo, Gabriel/0000-0002-1354-2883	Ministerio de Ciencia e Innovacion [BFU2015-68149-R]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	M.D.G. adn D.S. BFU2015-68149-R Ministerio de Ciencia e Innovacion http://www.ciencia.gob.es/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom Bo, 2006, P1; [Anonymous], 2006, TENZONE REV ASOCIACI, V7, P114; [Anonymous], 2006, CIRCULATION, V114, pe257; Bajo-Graneras R, 2011, GLIA, V59, P1551, DOI 10.1002/glia.21200; Bajo-Graneras R, 2011, J NEUROCHEM, V117, P949, DOI 10.1111/j.1471-4159.2011.07266.x; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Bellaousov S, 2013, NUCLEIC ACIDS RES, V41, pW471, DOI 10.1093/nar/gkt290; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Bhatia S, 2019, J MOL NEUROSCI, V67, P125, DOI 10.1007/s12031-018-1217-9; Bhatia S, 2012, BIOCHEM J, V442, P713, DOI 10.1042/BJ20111166; Byun Y, 2006, NUCLEIC ACIDS RES, V34, pW416, DOI 10.1093/nar/gkl210; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Castrignano T, 2008, BIOINFORMATICS, V24, P1300, DOI 10.1093/bioinformatics/btn113; Dassati S, 2014, NEUROBIOL AGING, V35, P1632, DOI 10.1016/j.neurobiolaging.2014.01.148; Davuluri RV, 2000, GENOME RES, V10, P1807, DOI 10.1101/gr.GR-1460R; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Do Carmo S, 2002, J BIOL CHEM, V277, P5514, DOI 10.1074/jbc.M105057200; Do Carmo S, 2007, BBA-MOL CELL RES, V1773, P954, DOI 10.1016/j.bbamcr.2007.03.007; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ganfornina M.D., 2006, LIPOCALINS, P17; Ganfornina MD, 2008, AGING CELL, V7, P506, DOI 10.1111/j.1474-9726.2008.00395.x; Ganfornina MD, 2010, GLIA, V58, P1320, DOI 10.1002/glia.21010; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; Garcia-Mateo N, 2018, GLIA, V66, P670, DOI 10.1002/glia.23274; Garcia-Mateo N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00374; Giegerich R, 2004, NUCLEIC ACIDS RES, V32, P4843, DOI 10.1093/nar/gkh779; He X, 2009, NEUROSCI LETT, V455, P183, DOI 10.1016/j.neulet.2009.03.038; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Hochsmann M, 2004, IEEE ACM T COMPUT BI, V1, P53, DOI 10.1109/TCBB.2004.11; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Kim WS, 2009, J NEUROCHEM, V109, P1053, DOI 10.1111/j.1471-4159.2009.06031.x; Klingenhoff A, 1999, BIOINFORMATICS, V15, P180, DOI 10.1093/bioinformatics/15.3.180; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; LAMBERT J, 1993, BIOCHIM BIOPHYS ACTA, V1172, P190, DOI 10.1016/0167-4781(93)90292-L; Leppek K, 2018, NAT REV MOL CELL BIO, V19, P158, DOI 10.1038/nrm.2017.103; Levros LC, 2010, BBA-MOL CELL RES, V1803, P1062, DOI 10.1016/j.bbamcr.2010.04.011; Liu HL, 2012, GENE, V507, P106, DOI 10.1016/j.gene.2012.07.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui M, 2007, FEBS LETT, V581, P4184, DOI 10.1016/j.febslet.2007.07.057; Mejias A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213206; Nguyen T, 2008, INT J DEV NEUROSCI, V26, P141, DOI 10.1016/j.ijdevneu.2007.10.004; Pascua-Maestro R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006603; Pulido-Salgado M, 2015, PROG NEUROBIOL, V132, P1, DOI 10.1016/j.pneurobio.2015.06.003; Rabani M, 2008, P NATL ACAD SCI USA, V105, P14885, DOI 10.1073/pnas.0803169105; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Reindl M, 2001, J NEUROIMMUNOL, V119, P327, DOI 10.1016/S0165-5728(01)00378-2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sanchez D, 2003, MOL BIOL EVOL, V20, P775, DOI 10.1093/molbev/msg079; Sanchez D., 2006, MOL BIOL INTELLIGENC, P5; Sanchez D, 2015, EXP GERONTOL, V67, P19, DOI 10.1016/j.exger.2015.04.003; Solovyev VV, 2010, METHODS MOL BIOL, V674, P57, DOI 10.1007/978-1-60761-854-6_5; Suresh S, 1998, J NEUROCHEM, V70, P242; Thomas EA, 2001, P NATL ACAD SCI USA, V98, P4066, DOI 10.1073/pnas.071056198; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Wang M, 2006, GENE, V366, P219, DOI 10.1016/j.gene.2005.07.015; Wang XK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-12; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zuker M, 2000, CURR OPIN STRUC BIOL, V10, P303, DOI 10.1016/S0959-440X(00)00088-9	64	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234857	10.1371/journal.pone.0234857	http://dx.doi.org/10.1371/journal.pone.0234857			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559215	Green Published, Green Accepted, gold			2022-12-26	WOS:000543261600050
J	Genet, C; Andualem, T; Melese, A; Mulu, W; Mekonnen, F; Abera, B				Genet, Chalachew; Andualem, Tesfaye; Melese, Addisu; Mulu, Wondemagegn; Mekonnen, Feleke; Abera, Bayeh			Quality of care for tuberculosis patients in public health facilities of Debre Tabor town, Northwest Ethiopia	PLOS ONE			English	Article								Background Even though there are different tuberculosis (TB) prevention and control measures implemented globally including Ethiopia, TB is still major public health problem. This is partly due to compromised quality of care delivered for tuberculosis patients in health facilities (HFs) during diagnosis, treatment and follows-up. Thus this study is intended to determine the quality of care delivered for TB patients in all public HFs of Debre Tabor town, Northwest Ethiopia. Methods Cross sectional study was conducted from January to May 2018. Data were collected with face-to-face interview and TB registration book review using structured questionnaire and checklist respectively. Collected data was entered and processed using SPSS and P value <0.05 was considered statistically significant. The quality of care for each HF was graded as very good, good, moderate, poor and very poor if HFs achieve [90-100%], [80-90%), [70-80%), [60-70%) and <60% of performance indicators respectively using Donabedian structure, process and outcome model of health care quality. Results All HFs have sputum collection area, enough microscopic slide, at least one functional microscope and sufficient anti TB drug supply. But HFs lack backup laboratory stains. Overall structural aspects of quality of care in all HFs were very poor achieving 42.5-52.9% structural performance indicators out of 100%. Similarly the overall process aspects of quality of care was poor in all public HFs which achieved 60-68.9% of the scores out of 100%. In the study; 68.9%, 54.5% and 80.6% of Medical Laboratory, pharmacy and other healthcare workers (HWs) provided correct response respectively on TB causative agent, risk factor, transmission, treatment, prevention, case management and case finding strategies. HWs who knew at least two TB case finding strategies in DTH was significantly higher than those HWs working in Health Centers (P = 0.004). On the other hand, except Ginbot 20 HC, HFs was graded as good by scoring 86.6-89.3% of performance indicators on the outcome aspects of quality of care. In all HFs studied, all TB patients' unit TB registration number, sex, age, TB category, treatment initiation date and intensive phase treatment start year were properly registered. Moreover 110 (78%) and 147 (69%) contact person address in DTH and HCs was properly registered on TB unit register book respectively with no statistical difference in hospital and HCs (P = 0.063). There was proper TB patients' address registration in hospital than HCs studied (P< 0.001). Conclusions The outcome aspects of quality of care for TB patients in all HFs were promising. But structural & process aspects of quality of care was compromised which necessitate different corrective actions to be taken by different stakeholders to enhance quality of care for TB patients in public HFs studied. Moreover based on the study findings, continuous supply of drugs, laboratory equipment and reagents, availing current guideline/s in HFs, providing up-to-date training for HWs on TB and proper documentation are important to improve quality of care provided for TB patients.	[Genet, Chalachew; Melese, Addisu; Mulu, Wondemagegn; Mekonnen, Feleke; Abera, Bayeh] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Bahir Dar, Ethiopia; [Andualem, Tesfaye] Debre Tabor Univ, Coll Hlth Sci, Dept Med Lab Sci, Debre Tabor, Ethiopia	Bahir Dar University	Genet, C (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Bahir Dar, Ethiopia.	chaliegenet@gmail.com	Abera, Bayeh/AAU-8754-2020; Melese, Addisu/S-3175-2017	Melese, Addisu/0000-0002-2362-5500; Andualem, Tesafye/0000-0001-5984-4281; Genet, Chalachew/0000-0001-8631-5094				Blobel B, 2015, HEALTHCARE, V3, P6; Bulage L, 2014, TUBERCULOSIS RES TRE, DOI [10.1155/2014/685982, DOI 10.1155/2014/685982]; Desalegn D, 2016, J MICROBIOL INFECT D, V6, P156; Ethiopian MOH, 2016, NAT COMPR TUB LEPR T; FMOH, 2012, GUID CLIN PROGR MAN, V5; Gebrekidan Gezahegn, 2014, Tuberc Res Treat, V2014, P720432, DOI 10.1155/2014/720432; Geremew T, 2011, ETHIOP J HEALTH SCI, V21, P39; Megene S. L., 2018, Journal of Public Health and Epidemiology, V10, P332; Mesfin MM, 2009, HEALTH POLICY PLANN, V24, P457, DOI 10.1093/heapol/czp030; Tobin-West CI, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.60.8497; WHO, 2017, GLOB TUB REP; WHO, DOTS STRAT WHO; World health organization, 2016, 2016 WORLD HLTH STAT	13	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234988	10.1371/journal.pone.0234988	http://dx.doi.org/10.1371/journal.pone.0234988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559256	gold, Green Published			2022-12-26	WOS:000543261600058
J	Gonzalez-Feliciano, JA; Akamine, P; Capo-Velez, CM; Delgado-Velez, M; Dussupt, V; Krebs, SJ; Wojna, V; Polonis, VR; Baerga-Ortiz, A; Lasalde-Dominicci, JA				Gonzalez-Feliciano, Jose A.; Akamine, Pearl; Capo-Velez, Coral M.; Delgado-Velez, Manuel; Dussupt, Vincent; Krebs, Shelly J.; Wojna, Valerie; Polonis, Victoria R.; Baerga-Ortiz, Abel; Lasalde-Dominicci, Jos A.			A recombinant gp145 Env glycoprotein from HIV-1 expressed in two different cell lines: Effects on glycosylation and antigenicity	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; ENVELOPE GLYCOPROTEIN; RATIONAL DESIGN; VACCINE; GP120; PROTEINS; TRIMERS; PROTECTION; INFECTION; SUBTYPE	The envelope glycoprotein (Env) of the human immunodeficiency virus (HIV), has been the primary target for the development of a protective vaccine against infection. The extensiveN-linked glycosylation on Env is an important consideration as it may affect efficacy, stability, and expression yields. The expression host has been shown to influence the extent and type of glycosylation that decorates the protein target. Here, we report the glycosylation profile of the candidate subtype C immunogen CO6980v0c22 gp145, which is currently in Phase I clinical trials, produced in two different host cells: CHO-K1 and Expi293F. The amino acid sequence for both glycoproteins was confirmed to be identical by peptide mass fingerprinting. However, the isoelectric point of the proteins differed; 4.5-5.5 and 6.0-7.0 for gp145 produced in CHO-K1 and Expi293F, respectively. These differences in pI were eliminated by enzymatic treatment with sialidase, indicating a large difference in the incorporation of sialic acid between hosts. This dramatic difference in the number of sialylated glycans between hosts was confirmed by analysis of PNGase F-released glycans using MALDI-ToF MS. These differences in glycosylation, however, did not greatly translate into differences in antibody recognition. Biosensor assays showed that gp145 produced in CHO-K1 had similar affinity toward the broadly neutralizing antibodies, 2G12 and PG16, as the gp145 produced in Expi293F. Additionally, both immunogens showed the same reactivity against plasma of HIV-infected patients. Taken together, these results support the notion that there are sizeable differences in the glycosylation of Env depending on the expression host. How these differences translate to vaccine efficacy remains unknown.	[Gonzalez-Feliciano, Jose A.; Akamine, Pearl; Capo-Velez, Coral M.; Delgado-Velez, Manuel; Baerga-Ortiz, Abel; Lasalde-Dominicci, Jos A.] Univ Puerto Rico, Mol Sci Res Ctr Inc, San Juan, PR 00936 USA; [Dussupt, Vincent; Krebs, Shelly J.; Polonis, Victoria R.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Dussupt, Vincent; Krebs, Shelly J.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Wojna, Valerie] Univ Puerto Rico, Internal Med Dept, Div Neurol, Med Sci Campus, San Juan, PR 00936 USA; [Wojna, Valerie] Univ Puerto Rico, NeuroHIV Res Program, Med Sci Campus, San Juan, PR 00936 USA; [Baerga-Ortiz, Abel] Univ Puerto Rico, Dept Biochem, Med Sci Campus, San Juan, PR 00936 USA; [Lasalde-Dominicci, Jos A.] Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA	University of Puerto Rico; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras	Baerga-Ortiz, A; Lasalde-Dominicci, JA (corresponding author), Univ Puerto Rico, Mol Sci Res Ctr Inc, San Juan, PR 00936 USA.; Baerga-Ortiz, A (corresponding author), Univ Puerto Rico, Dept Biochem, Med Sci Campus, San Juan, PR 00936 USA.; Lasalde-Dominicci, JA (corresponding author), Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA.	abel.baerga@upr.edu; jose.lasalde@upr.edu	; Krebs, Shelly/D-8015-2016	Wojna, Valerie/0000-0002-4014-9921; Delgado-Velez, Manuel/0000-0002-2146-1071; Capo-Velez, Coral/0000-0002-2384-8376; Baerga-Ortiz, Abel/0000-0001-9487-1015; Krebs, Shelly/0000-0003-1136-1760	National Institutes of Health (NIH) [R01AI122935]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DoD) [W81XWH-07-2-0067]; US Civilian Research and Development Foundation (CRDF) [OISE9531011-NIH]; NIH [U54NS43011, S11NS046278, U54MD007587]; Puerto Rico Science, Technology Research Trust	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DoD)(United States Department of Defense); US Civilian Research and Development Foundation (CRDF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Puerto Rico Science, Technology Research Trust	This work was supported by the National Institutes of Health (NIH) grant R01AI122935 to JAL-D and AB-O. This work was also supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DoD). JAL-D wants to acknowledge the US Civilian Research and Development Foundation (CRDF) for providing the necessary funds (funding agreement OISE9531011-NIH) to establish the Clinical Bioreagent Center (CBC). Additional support from NIH grants U54NS43011, S11NS046278, and U54MD007587 to VW enabled the patient sample repository. The authors also acknowledge the Puerto Rico Science, Technology & Research Trust, for financing the acquisition of key instruments.	Aldon Y, 2018, CELL REP, V24, P3324, DOI 10.1016/j.celrep.2018.08.051; BERMAN PW, 1990, NATURE, V345, P622, DOI 10.1038/345622a0; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; CLELAND JL, 1994, AIDS RES HUM RETROV, V10, pS21; Crawford JM, 1999, J VIROL, V73, P10199, DOI 10.1128/JVI.73.12.10199-10207.1999; Crooks ET, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007024; de Taeye SW, 2016, TRENDS IMMUNOL, V37, P221, DOI 10.1016/j.it.2016.01.007; Doores KJ, 2015, FEBS J, V282, P4679, DOI 10.1111/febs.13530; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Etemad-Moghadam B, 1999, J VIROL, V73, P8873, DOI 10.1128/JVI.73.10.8873-8879.1999; Go EP, 2015, J VIROL, V89, P8245, DOI 10.1128/JVI.00628-15; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Joseph S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00149; Khayat R, 2013, J VIROL, V87, P9865, DOI 10.1128/JVI.01222-13; Kiptoo M, 2011, CHANGING TRENDS HIV, DOI [10.5772/19591, DOI 10.5772/19591]; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Lu ML, 2019, NATURE, V568, P415, DOI 10.1038/s41586-019-1101-y; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; O'Rourke SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197656; Ozorowski G, 2017, NATURE, V547, P360, DOI 10.1038/nature23010; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pitisuttithum P, 2004, JAIDS-J ACQ IMM DEF, V37, P1160, DOI 10.1097/01.qai.0000136091.72955.4b; Pritchard LK, 2015, J VIROL, V89, P8932, DOI 10.1128/JVI.01190-15; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ringe RP, 2015, J VIROL, V89, P12189, DOI 10.1128/JVI.01768-15; Sanders RW, 2017, IMMUNOL REV, V275, P161, DOI 10.1111/imr.12481; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Seabright GE, 2019, J MOL BIOL, V431, P2223, DOI 10.1016/j.jmb.2019.04.016; Sharma SK, 2015, CELL REP, V11, P539, DOI 10.1016/j.celrep.2015.03.047; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Stadtmueller BM, 2018, IMMUNITY, V49, P235, DOI 10.1016/j.immuni.2018.06.017; Struwe WB, 2018, CELL REP, V24, P1958, DOI 10.1016/j.celrep.2018.07.080; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Verrier F, 2000, J VIROL, V74, P10025, DOI 10.1128/JVI.74.21.10025-10033.2000; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wang XD, 2017, MABS-AUSTIN, V9, P319, DOI 10.1080/19420862.2016.1261774; Werner RG, 2007, ACTA PAEDIATR, V96, P17, DOI 10.1111/j.1651-2227.2007.00199.x; Wibmer CK, 2015, CURR OPIN HIV AIDS, V10, P135, DOI 10.1097/COH.0000000000000153; Wieczorek L, 2015, J VIROL, V89, P7478, DOI 10.1128/JVI.00412-15; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043903	51	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0231679	10.1371/journal.pone.0231679	http://dx.doi.org/10.1371/journal.pone.0231679			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559193	Green Published, Green Submitted, gold			2022-12-26	WOS:000543261600060
J	Ong, CJ; Orfanoudaki, A; Zhang, R; Caprasse, FPM; Hutch, M; Ma, L; Fard, D; Balogun, O; Miller, MI; Minnig, M; Saglam, H; Prescott, B; Greer, DM; Smirnakis, S; Bertsimas, D				Ong, Charlene Jennifer; Orfanoudaki, Agni; Zhang, Rebecca; Caprasse, Francois Pierre M.; Hutch, Meghan; Ma, Liang; Fard, Darian; Balogun, Oluwafemi; Miller, Matthew, I; Minnig, Margaret; Saglam, Hanife; Prescott, Brenton; Greer, David M.; Smirnakis, Stelios; Bertsimas, Dimitris			Machine learning and natural language processing methods to identify ischemic stroke, acuity and location from radiology reports	PLOS ONE			English	Article							ANNOTATION	Accurate, automated extraction of clinical stroke information from unstructured text has several important applications. ICD-9/10 codes can misclassify ischemic stroke events and do not distinguish acuity or location. Expeditious, accurate data extraction could provide considerable improvement in identifying stroke in large datasets, triaging critical clinical reports, and quality improvement efforts. In this study, we developed and report a comprehensive framework studying the performance of simple and complex stroke-specific Natural Language Processing (NLP) and Machine Learning (ML) methods to determine presence, location, and acuity of ischemic stroke from radiographic text. We collected 60,564 Computed Tomography and Magnetic Resonance Imaging Radiology reports from 17,864 patients from two large academic medical centers. We used standard techniques to featurize unstructured text and developed neurovascular specific word GloVe embeddings. We trained various binary classification algorithms to identify stroke presence, location, and acuity using 75% of 1,359 expert-labeled reports. We validated our methods internally on the remaining 25% of reports and externally on 500 radiology reports from an entirely separate academic institution. In our internal population, GloVe word embeddings paired with deep learning (Recurrent Neural Networks) had the best discrimination of all methods for our three tasks (AUCs of 0.96, 0.98, 0.93 respectively). Simpler NLP approaches (Bag of Words) performed best with interpretable algorithms (Logistic Regression) for identifying ischemic stroke (AUC of 0.95), MCA location (AUC 0.96), and acuity (AUC of 0.90). Similarly, GloVe and Recurrent Neural Networks (AUC 0.92, 0.89, 0.93) generalized better in our external test set than BOW and Logistic Regression for stroke presence, location and acuity, respectively (AUC 0.89, 0.86, 0.80). Our study demonstrates a comprehensive assessment of NLP techniques for unstructured radiographic text. Our findings are suggestive that NLP/ML methods can be used to discriminate stroke features from large data cohorts for both clinical and research-related investigations.	[Ong, Charlene Jennifer; Hutch, Meghan; Ma, Liang; Fard, Darian; Balogun, Oluwafemi; Miller, Matthew, I; Minnig, Margaret; Greer, David M.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Ong, Charlene Jennifer; Hutch, Meghan; Balogun, Oluwafemi; Prescott, Brenton; Greer, David M.] Boston Med Ctr, Boston, MA 02118 USA; [Ong, Charlene Jennifer; Saglam, Hanife; Smirnakis, Stelios] Harvard Med Sch, Boston, MA 02115 USA; [Ong, Charlene Jennifer; Orfanoudaki, Agni; Zhang, Rebecca; Caprasse, Francois Pierre M.; Bertsimas, Dimitris] MIT, Operat Res Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bertsimas, Dimitris] MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Boston University; Boston Medical Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ong, CJ (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.; Ong, CJ (corresponding author), Boston Med Ctr, Boston, MA 02118 USA.; Ong, CJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Ong, CJ (corresponding author), MIT, Operat Res Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cjong@bu.edu	Sağlam, Hacı/GLN-8241-2022	Sağlam, Hacı/0000-0002-6598-8262; Saglam, Hanife/0000-0003-3256-1227; Balogun, Oluwafemi/0000-0002-6578-1851				Banerjee I, 2018, J BIOMED INFORM, V77, P11, DOI 10.1016/j.jbi.2017.11.012; Bertsimas D., 2019, MACHINE LEARNING MOD; Bertsimas D, 2017, MACH LEARN, V106, P1039, DOI 10.1007/s10994-017-5633-9; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; D Damayanti D., 2018, BULLWHIP EFFECT SUPP, V1, P1, DOI DOI 10.1080/09593330.2018.1526217; Devlin J., 2018, ARXIV181004805; Dietterich T, 1996, 1 OR STAT U, V1, P1; Fox GN, 2003, J FAM PRACTICE, V52, P706; Garg R, 2019, J STROKE CEREBROVASC, V28, P2045, DOI 10.1016/j.jstrokecerebrovasdis.2019.02.004; Goldberg Y., 2017, SYNTHESIS LECT HUMAN, V10, P1, DOI DOI 10.2200/S00762ED1V01Y201703HLT037; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Haykin S., 1994, NEURAL NETWORKS COMP; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jones SA, 2014, STROKE, V45, P3219, DOI 10.1161/STROKEAHA.114.006316; Joulin Armand, 2016, ARXIV160701759; Kim C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212778; Lai SW, 2015, AAAI CONF ARTIF INTE, P2267; Lancet Global Health, 2019, LANCET GLOBAL HLTH, V7, pe1; Liang ZH, 2019, COMPUT METH PROG BIO, V174, P17, DOI 10.1016/j.cmpb.2018.05.008; Manning C.D., 1999, FDN STAT NATURAL LAN; Mendelow AD, 2015, STROKE PATHOPHYSIOLO; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pennington J., 2014, P 2014 C EMPIRICAL M, P1532, DOI DOI 10.3115/V1/D14-1162; Pons E, 2016, RADIOLOGY, V279, P329, DOI 10.1148/radiol.16142770; Rao GZ, 2018, NEUROCOMPUTING, V308, P49, DOI 10.1016/j.neucom.2018.04.045; Rumeng L, 2017, AMIA ANN S P; Sanderson M, 2010, NAT LANG ENG, V16, P100, DOI 10.1017/S1351324909005129; Shi Tianze, 2014, ARXIV14115595; Taggart M, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.3451; Wu S, 2020, J AM MED INFORM ASSN, V27, P457, DOI 10.1093/jamia/ocz200; Yin W., 2017, ARXIV170201923; Yousem DM, 2010, NEURORADIOLOGY REQUI; Zech J, 2018, RADIOLOGY, V287, P570, DOI 10.1148/radiol.2018171093	38	27	27	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234908	10.1371/journal.pone.0234908	http://dx.doi.org/10.1371/journal.pone.0234908			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559211	Green Published, gold			2022-12-26	WOS:000543261600002
J	Schmidt, K; Forkmann, K; Elsenbruch, S; Bingel, U				Schmidt, Katharina; Forkmann, Katarina; Elsenbruch, Sigrid; Bingel, Ulrike			Enhanced pain-related conditioning for face compared to hand pain	PLOS ONE			English	Article							FEAR-AVOIDANCE MODEL; NEURAL CIRCUITRY; EXTINCTION; REINSTATEMENT; RETURN; ACQUISITION; RESPONSES; VALENCE; FIBROMYALGIA; PATHWAY	Pain is evolutionarily hardwired to signal potential danger and threat. It has been proposed that altered pain-related associative learning processes, i.e., emotional or fear conditioning, might contribute to the development and maintenance of chronic pain. Pain in or near the face plays a special role in pain perception and processing, especially with regard to increased pain-related fear and unpleasantness. However, differences in pain-related learning mechanisms between the face and other body parts have not yet been investigated. Here, we examined body-site specific differences in associative emotional conditioning using electrical stimuli applied to the face and the hand. Acquisition, extinction, and reinstatement of cue-pain associations were assessed in a 2-day emotional conditioning paradigm using a within-subject design. Data of 34 healthy subjects revealed higher fear of face pain as compared to hand pain. During acquisition, face pain (as compared to hand pain) led to a steeper increase in pain-related negative emotions in response to conditioned stimuli (CS) as assessed using valence ratings. While no significant differences between both conditions were observed during the extinction phase, a reinstatement effect for face but not for hand pain was revealed on the descriptive level and contingency awareness was higher for face pain compared to hand pain. Our results indicate a stronger propensity to acquire cue-pain-associations for face compared to hand pain, which might also be reinstated more easily. These differences in learning and resultant pain-related emotions might play an important role in the chronification and high prevalence of chronic facial pain and stress the evolutionary significance of pain in the head and face.	[Schmidt, Katharina; Forkmann, Katarina; Bingel, Ulrike] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany; [Elsenbruch, Sigrid] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany; [Elsenbruch, Sigrid] Ruhr Univ Bochum, Dept Med Psychol & Med Sociol, Bochum, Germany	University of Duisburg Essen; University of Duisburg Essen; Ruhr University Bochum	Schmidt, K (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany.	Katharina.schmidt@uk-essen.de		Schmidt, Katharina/0000-0001-9397-5285; Elsenbruch, Sigrid/0000-0002-6528-2665	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [316803389 - SFB 1280]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - project number 316803389 - SFB 1280. Grant given to KF and UB.	Bates D, 2014, ARXIV14065823; Benson S., 2019, PAIN; Biggs EE, 2017, J PAIN, V18, P1505, DOI 10.1016/j.jpain.2017.08.002; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Bufacchi RJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12466-5; Burch R, 2018, HEADACHE, V58, P496, DOI 10.1111/head.13281; Claassen J, 2017, CEREBELLUM, V16, P508, DOI 10.1007/s12311-016-0832-7; Crombez G, 2012, CLIN J PAIN, V28, P475, DOI 10.1097/AJP.0b013e3182385392; De Peuter S, 2011, EUR J PAIN, V15, P889, DOI 10.1016/j.ejpain.2011.03.002; Dirikx T, 2004, LEARN MEMORY, V11, P549, DOI 10.1101/lm.78004; Domjan M, 2005, ANNU REV PSYCHOL, V56, P179, DOI 10.1146/annurev.psych.55.090902.141409; Dour HJ, 2016, J BEHAV THER EXP PSY, V50, P277, DOI 10.1016/j.jbtep.2015.09.010; Drexler SM, 2014, BEHAV NEUROSCI, V128, P474, DOI 10.1037/a0036688; Duits P, 2015, DEPRESS ANXIETY, V32, P239, DOI 10.1002/da.22353; Flor H, 2012, CURR OPIN PSYCHIATR, V25, P109, DOI 10.1097/YCO.0b013e3283503510; Fullana MA, 2016, MOL PSYCHIATR, V21, P500, DOI 10.1038/mp.2015.88; Gawronski B, 2014, COGNITION EMOTION, V28, P577, DOI 10.1080/02699931.2013.843506; Gescheider GA, 1997, PSYCHOPHYSICS FUNDAM; Giustino TF, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00043; Glogan E, 2019, J PAIN, V20, P325, DOI 10.1016/j.jpain.2018.09.010; Gramsch C, 2014, NEUROBIOL LEARN MEM, V116, P36, DOI 10.1016/j.nlm.2014.08.003; Haaker J, 2014, LEARN MEMORY, V21, P424, DOI 10.1101/lm.036053.114; Harvie DS, 2017, J PAIN, V18, P889, DOI 10.1016/j.jpain.2017.02.430; Harvie DS, 2016, PSYCHOPHYSIOLOGY, V53, P921, DOI 10.1111/psyp.12631; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Hofmann W, 2010, PSYCHOL BULL, V136, P390, DOI 10.1037/a0018916; Hosoba T, 2001, BEHAV RES THER, V39, P465, DOI 10.1016/S0005-7967(00)00025-5; Icenhour A, 2015, NEUROGASTROENT MOTIL, V27, P114, DOI 10.1111/nmo.12489; Icenhour A, 2015, HUM BRAIN MAPP, V36, P3179, DOI 10.1002/hbm.22837; Kattoor J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051149; Klinger R, 2010, PAIN, V150, P66, DOI 10.1016/j.pain.2010.03.036; Koenen LR, 2018, PSYCHOSOMATIC MED; Labrenz F, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00318; Lautenbacher S, 2009, CLIN J PAIN, V25, P92, DOI 10.1097/AJP.0b013e3181850dce; Laux L, 1992, STATE TRAIT ANGSTINV; Lonsdorf TB, 2017, NEUROSCI BIOBEHAV R, V77, P247, DOI 10.1016/j.neubiorev.2017.02.026; Lovibond PF, 2002, J EXP PSYCHOL-ANIM B, V28, P3, DOI 10.1037//0097-7403.28.1.3; MCCRACKEN LM, 1992, PAIN, V50, P67, DOI 10.1016/0304-3959(92)90113-P; Mertens G, 2020, NEUROSCI BIOBEHAV R, V108, P254, DOI 10.1016/j.neubiorev.2019.11.012; Meulders A, 2017, J PAIN, V18, P79, DOI 10.1016/j.jpain.2016.10.004; Meulders A, 2015, J EXP PSYCHOPATHOL, V6, P206, DOI 10.5127/jep.043614; Meulders A, 2015, PAIN, V156, P108, DOI 10.1016/j.pain.0000000000000016; Nees F, 2018, NEUROSCIENCE, V387, P72, DOI 10.1016/j.neuroscience.2017.08.051; Nishiyama R, 2020, LEARN MOTIV, V69, DOI 10.1016/j.lmot.2019.101600; Pace-Schott EF, 2015, PSYCHOL BULL, V141, P835, DOI 10.1037/bul0000014; Porreca F, 2017, PAIN, V158, pS43, DOI 10.1097/j.pain.0000000000000798; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; RESCORLA RA, 1988, AM PSYCHOL, V43, P151, DOI 10.1037/0003-066X.43.3.151; Sambo CF, 2012, J NEUROSCI, V32, P12921, DOI 10.1523/JNEUROSCI.0607-12.2012; Sambo CF, 2012, J NEUROPHYSIOL, V107, P880, DOI 10.1152/jn.00731.2011; Schiller D, 2008, LEARN MEMORY, V15, P394, DOI 10.1101/lm.909208; Schmidt K, 2016, NEUROIMAGE; Schmidt K, 2019, J PAIN OFFICIAL J AM; Schmidt K, 2018, J PAIN, V19, P135, DOI 10.1016/j.jpain.2017.09.005; Schmidt K, 2015, J PAIN, V16, P781, DOI 10.1016/j.jpain.2015.05.003; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Sussman TJ, 2016, BIOL PSYCHOL, V121, P160, DOI 10.1016/j.biopsycho.2016.08.006; Traxler J, 2019, PEERJ, V7, DOI 10.7717/peerj.6486; Turk DC, 2010, CURR PAIN HEADACHE R, V14, P88, DOI 10.1007/s11916-010-0094-x; van den Akker K, 2015, J BEHAV THER EXP PSY, V48, P50, DOI 10.1016/j.jbtep.2015.02.001; van ME, 2017, PEDIAT PHYS THER S3, V29, pS73; Vervliet B, 2013, ANNU REV CLIN PSYCHO, V9, P215, DOI 10.1146/annurev-clinpsy-050212-185542; Vlaeyen JWS, 2016, PAIN, V157, P1588, DOI 10.1097/j.pain.0000000000000574; Vlaeyen JWS, 2015, PAIN, V156, pS86, DOI 10.1097/j.pain.0000000000000107; Volders S, 2015, CLIN J PAIN, V31, P933, DOI 10.1097/AJP.0000000000000187; Walter B, 2002, SCHMERZ, V16, P83; Wicking M, 2016, NEUROBIOL LEARN MEM, V136, P116, DOI 10.1016/j.nlm.2016.09.016; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010; Wise T, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007341; Zaman J, 2015, NEUROSCI BIOBEHAV R, V51, P118, DOI 10.1016/j.neubiorev.2015.01.009	72	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234160	10.1371/journal.pone.0234160	http://dx.doi.org/10.1371/journal.pone.0234160			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559202	Green Published, gold			2022-12-26	WOS:000543261600016
J	Xu, P; Zhu, YM; Liang, XS; Gong, CM; Xu, YF; Huang, CH; Liu, XL; Zhou, JC				Xu, Ping; Zhu, Yumei; Liang, Xiongshun; Gong, Chunmei; Xu, Yuanfei; Huang, Changhua; Liu, Xiao-Li; Zhou, Ji-Chang			Genetic polymorphisms of superoxide dismutase 1 are associated with the serum lipid profiles of Han Chinese adults in a sexually dimorphic manner	PLOS ONE			English	Article							SEX-SPECIFIC ASSOCIATION; SOD1 GENE; DIABETIC-NEPHROPATHY; ALLELIC VARIATIONS; METABOLISM; RISK; DYSLIPIDEMIA; ACCUMULATION; PREVALENCE; LIVER	Inspired by the mechanistic correlations between superoxide dismutase 1 (SOD1) and lipid metabolism, the associations ofSOD1single nucleotide polymorphisms (SNPs) with circulating lipid levels were explored. In 2621 Chinese Han adults, randomly recruited from a health examination center without organic diseases, cancers, and pregnancy, three tag SNPs, rs4998557, rs1041740, and rs17880487 selected by Haploview software were genotyped with a probe-based real-time quantitative PCR method. In both genders, most parameters of the dyslipidemia adults were inferior (P< 0.001) to those of the non-dyslipidemia adults, and genotype frequencies of rs4998557 and rs17880487 were significantly different (P< 0.05) between the normal and abnormal subgroups of total cholesterol (TC) or high-density lipoprotein cholesterol (HDLC). Adjusted for confounding factors, logistic regression analyses revealed that in males rs4998557A, rs1041740T, and rs17880487T reduced the risk of high TC and/or LDLC (P< 0.05), and rs4998557A and rs17880487T increased the risk of low HDLC (P< 0.05); but in females, none of the SNPs had associations with any of the lipid parameters (P> 0.05). Conclusively, characterized by a sexual dimorphism, theSOD1polymorphisms were associated with the lipid disorders in the adult males but not females of the Chinese Han population.	[Xu, Ping; Zhou, Ji-Chang] Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Shenzhen, Guangdong, Peoples R China; [Zhu, Yumei; Liang, Xiongshun; Gong, Chunmei; Xu, Yuanfei; Liu, Xiao-Li; Zhou, Ji-Chang] Shenzhen Ctr Chron Dis Control, Shenzhen, Guangdong, Peoples R China; [Huang, Changhua] Shenzhen Qilinshan Sanat, Shenzhen, Guangdong, Peoples R China; [Zhou, Ji-Chang] Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Guangdong, Peoples R China; [Zhou, Ji-Chang] Guangdong Prov Engn Lab Nutr Translat, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Zhou, JC (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Shenzhen, Guangdong, Peoples R China.; Zhou, JC (corresponding author), Shenzhen Ctr Chron Dis Control, Shenzhen, Guangdong, Peoples R China.; Zhou, JC (corresponding author), Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Guangdong, Peoples R China.; Zhou, JC (corresponding author), Guangdong Prov Engn Lab Nutr Translat, Guangzhou, Guangdong, Peoples R China.	zhoujch8@mail.sysu.edu.cn	Liu, Xiaoli/HGE-7614-2022	Zhou, Ji-Chang/0000-0003-4177-614X	National Natural Science Foundation of China [81973038]; Healthcare Research Projects of Shenzhen, China [SZGW2017010, SZGW2017015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Healthcare Research Projects of Shenzhen, China	The study was partly supported by the National Natural Science Foundation of China (grant number 81973038 to JCZ) and Healthcare Research Projects of Shenzhen, China (grant number SZGW2017010 to JCZ and SZGW2017015 to CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Website of the National Natural Science Foundation of China: http://www.nsfc.gov.cn/.Website of the Shenzhen Municipal Health Commission: http://wjw.sz.gov.cn/.These were all the sources of funding supporting this study, and there was no additional external funding received for it.	[Anonymous], 2013, THYROID S1, V23, pA13; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2016, J GERIATR CARDIOL; Aung LHH, 2014, INT J MED SCI, V11, P471, DOI 10.7150/ijms.8489; Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019; Bartosz G, 2005, HANDB ENVIRON CHEM, V2, P109; Battistini S, 2010, J NEUROL SCI, V293, P112, DOI 10.1016/j.jns.2010.03.009; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Paes AMD, 2019, ADV EXP MED BIOL, V1127, P97, DOI 10.1007/978-3-030-11488-6_7; Eskandari-Nasab Ebrahim, 2014, Acta Med Iran, V52, P591; Fetherolf MM, 2017, METALLOMICS, V9, P1047, DOI 10.1039/c6mt00298f; Flekac M, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-30; Ghattas MH, 2012, DNA CELL BIOL, V31, P1598, DOI 10.1089/dna.2012.1739; Guo T, 2016, INT J CLIN EXP PATHO, V9, P12942; Guo T, 2015, INT J CLIN EXP PATHO, V8, P665; Hernandez-Guerrero C, 2016, ARCH MED RES, V47, P331, DOI 10.1016/j.arcmed.2016.08.007; [胡盛寿 Hu Shengshou], 2019, [中国循环杂志, Chinese Circulation Journal], V34, P209; Huang YX, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0028-7; Icli A, 2016, ANGIOLOGY, V67, P146, DOI 10.1177/0003319715579781; Kitoh R, 2016, ACTA OTO-LARYNGOL, V136, P465, DOI 10.3109/00016489.2015.1116047; Kolovou V, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-62; Kurahashi T, 2015, BIOCHEM BIOPH RES CO, V467, P866, DOI 10.1016/j.bbrc.2015.10.052; Li S, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0240-3; Lim HJ, 2015, PLATELETS, V26, P758, DOI 10.3109/09537104.2014.995613; Mittendorfer B, 2005, J NUTR, V135, P681, DOI 10.1093/jn/135.4.681; Mohammedi K, 2011, MOL GENET METAB, V104, P654, DOI 10.1016/j.ymgme.2011.08.033; Mondola P, 2002, BIOCHEM BIOPH RES CO, V295, P603, DOI 10.1016/S0006-291X(02)00720-9; Mondola P, 2000, FEBS LETT, V467, P57, DOI 10.1016/S0014-5793(00)01123-6; Mondola P, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00594; Neves AL, 2012, MOL GENET METAB, V106, P359, DOI 10.1016/j.ymgme.2012.04.023; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Otaki Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164732; Palmisano BT, 2018, MOL METAB, V15, P45, DOI 10.1016/j.molmet.2018.05.008; Pan L, 2016, ATHEROSCLEROSIS, V248, P2, DOI 10.1016/j.atherosclerosis.2016.02.006; Panduru NM, 2010, ROM J MORPHOL EMBRYO, V51, P37; Ramasamy I, 2016, CLIN CHIM ACTA, V454, P143, DOI 10.1016/j.cca.2015.10.033; Reusch JEB, 2018, ENDOCRINOLOGY, V159, P9, DOI 10.1210/en.2017-03019; Schwab S, 2017, EUR J GASTROEN HEPAT, V29, P800, DOI 10.1097/MEG.0000000000000878; Seo E, 2019, AGING CELL, V18, DOI 10.1111/acel.12895; Shastry BS, 2007, J HUM GENET, V52, P871, DOI 10.1007/s10038-007-0200-z; Spisak K, 2014, NEUROL NEUROCHIR POL, V48, P342, DOI 10.1016/j.pjnns.2014.09.002; Traglia M, 2017, GENETICS, V205, P979, DOI 10.1534/genetics.116.193623; Tsang CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4446; Uchiyama S, 2006, J BIOL CHEM, V281, P31713, DOI 10.1074/jbc.M603422200; Wang L, 2012, FREE RADICAL BIO MED, V53, P1689, DOI 10.1016/j.freeradbiomed.2012.08.570; Wang XW, 2011, J CLIN ENDOCR METAB, V96, P885, DOI 10.1210/jc.2010-2061; Wang Y, 2018, J CELL BIOL, V217, P1915, DOI 10.1083/jcb.201708007; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yi JF, 2010, WORLD J GASTROENTERO, V16, P4738, DOI 10.3748/wjg.v16.i37.4738; Zhang M, 2018, INT J CARDIOL, V260, P196, DOI 10.1016/j.ijcard.2017.12.069; Zhang Y.L., 2011, GOLD, V32, P9, DOI [10.3969/j.issn.1001-1277.2011.09.003, DOI 10.3969/J.ISSN.1001-1277.2011.09.003]; Zhou JC, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0332-0	53	1	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							SICI 10.1371/journal.pone.0234716.r003	10.1371/journal.pone.0234716	http://dx.doi.org/10.1371/journal.pone.0234716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559230	Green Published, gold			2022-12-26	WOS:000543261600008
J	Chowdhury, R; Taneja, S; Dhabhai, N; Mazumder, S; Upadhyay, RP; Sharma, S; Tupaki-Sreepurna, A; Dewan, R; Mittal, P; Chellani, H; Bahl, R; Bhan, MK; Bhandari, N				Chowdhury, Ranadip; Taneja, Sunita; Dhabhai, Neeta; Mazumder, Sarmila; Upadhyay, Ravi Prakash; Sharma, Sitanshi; Tupaki-Sreepurna, Ananya; Dewan, Rupali; Mittal, Pratima; Chellani, Harish; Bahl, Rajiv; Bhan, Maharaj Kishan; Bhandari, Nita			Burden of preconception morbidity in women of reproductive age from an urban setting in North India	PLOS ONE			English	Article							PREGNANCY; OBESITY; HEALTH; VALIDATION; ORIGINS; ANEMIA	Background There is a growing interest in the life course approach for the prevention, early detection and subsequent management of morbidity in women of reproductive age to ensure optimal health and nutrition when they enter pregnancy. Reliable estimates of such morbidities are lacking. We report the prevalence of health or nutrition-related morbidities, specifically, anemia, undernutrition, overweight and obesity, sexually transmitted infections (STIs) or reproductive tract infections (RTIs), diabetes or prediabetes, hypothyroidism, hypertension, and depressive symptoms, during the preconception period among women aged 18 to 30 years. Methods A cross-sectional study was conducted among 2000 nonpregnant married women aged 18 to 30 years with no or one child who wished to have more children in two low- to middle-income urban neighborhoods in Delhi, India, in the context of a randomized controlled trial. STIs and RTIs were measured by symptoms and signs, blood pressure by a digital device, height by stadiometer and weight by a digital weighing scale. A blood specimen was taken to screen for anemia, diabetes, thyroid disorders and syphilis. Maternal depressive symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9). Multivariable logistic regression analysis was performed to identify sociodemographic factors associated with individual morbidity. Results Overall, 58.7% of women were anemic; 16.5%, undernourished; 26%, overweight or obese; 13.2%, hypothyroid; and 10.5% with both symptoms and signs of STIs/RTIs. There was an increased risk of RTI/STI symptoms and signs in undernourished women and an increased risk of diabetes or prediabetes in overweight or obese women. An increased risk of undernutrition was also observed in women from lower categories of wealth quintiles. A decreased risk of moderate to severe anemia was seen in overweight women and those who completed at least secondary education. Conclusions Our findings show a high burden of undernutrition, anemia, RTIs, hypothyroidism and prediabetes among women in the study. This information will aid policymakers in planning special programs for women of reproductive age.	[Chowdhury, Ranadip; Taneja, Sunita; Dhabhai, Neeta; Mazumder, Sarmila; Upadhyay, Ravi Prakash; Sharma, Sitanshi; Tupaki-Sreepurna, Ananya; Bhandari, Nita] Ctr Hlth Res & Dev, Soc Appl Studies, New Delhi, India; [Dewan, Rupali; Mittal, Pratima; Chellani, Harish] Vardhman Mahavir Med Coll, New Delhi, India; [Dewan, Rupali; Mittal, Pratima; Chellani, Harish] Safdarjang Hosp, New Delhi, India; [Bahl, Rajiv] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland; [Bhan, Maharaj Kishan] Govt India, Dept Biotechnol, Biotechnol Ind Res Assistance Council BIRAC, Knowledge Integrat & Translat Platform KnIT, New Delhi, India	Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital; World Health Organization; Biotechnology Industry Research Assistance Council (BIRAC); Department of Biotechnology (DBT) India	Bhandari, N (corresponding author), Ctr Hlth Res & Dev, Soc Appl Studies, New Delhi, India.	nita.bhandari@sas.org.in	Tupaki-Sreepurna, Ananya/GMW-9192-2022	Tupaki-Sreepurna, Ananya/0000-0001-6665-1488	Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology, Government of India under the Grand Challenges India-All Children Thriving initiative [BIRAC/GCI/0085/03/14-ACT]; Bill & Melinda Gates Foundation, USA [OPP1191052]; Department of Maternal, Newborn, Child and Adolescent Health, World Health Organization, Geneva (WHO Collaborating Centre) [IND-158]; Centre for Intervention Science in Maternal and Child Health (RCN), Centre for International Health, University of Bergen (Norway) [223269]	Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology, Government of India under the Grand Challenges India-All Children Thriving initiative; Bill & Melinda Gates Foundation, USA(Bill & Melinda Gates Foundation); Department of Maternal, Newborn, Child and Adolescent Health, World Health Organization, Geneva (WHO Collaborating Centre); Centre for Intervention Science in Maternal and Child Health (RCN), Centre for International Health, University of Bergen (Norway)	N Initials of the authors who received each award: NB Grant numbers awarded to each author: BIRAC/GCI/0085/03/14-ACT) and Grant ID OPP1191052 The full name of each funder: Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology, Government of India under the Grand Challenges India-All Children Thriving initiative and the Bill & Melinda Gates Foundation, USA. URL of each funder website: https://birac.nic.in/; https://www.gatesfoundation.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Society for Applied Studies acknowledges the core support provided by the Department of Maternal, Newborn, Child and Adolescent Health, World Health Organization, Geneva (WHO Collaborating Centre IND-158) and the Centre for Intervention Science in Maternal and Child Health (RCN Project No. 223269), Centre for International Health, University of Bergen (Norway). We are thankful to Dr. Nikhil Tandon (Professor and Head, Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi), Dr. Anju Virmani (Senior Consultant Endocrinologist) and Dr. Navin Dang (Senior Consultant Microbiologist) for their technical advice on diagnostic criteria and management of thyroid disorders. We are also thankful to Dr. Deepak More for supervising the quality assurance for the different assays. All authors approved the final version of the manuscript.	American Diabetes AssociationStandards of Medical Care in Diabetes, 2018, CLIN DIABETES, V36, P14, DOI DOI 10.2337/cd17-0119; [Anonymous], 2016, IND FACT SHEET NAT F; [Anonymous], 2017, BMJ-BRIT MED J, V358, pj3545, DOI 10.1136/bmj.j3545; Centers for Disease Control USA, LAB PROC MAN; De-Regil Luz Maria, 2015, Cochrane Database Syst Rev, pCD007950, DOI 10.1002/14651858.CD007950.pub3; Dean SV, 2014, REPROD HEALTH, V11, DOI [10.1186/1742-4755-11-S3-S1, 10.1186/1742-4755-11-S3-S3]; Dzakpasu S, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0452-0; Fernandez T., 2001, LAB HEMATOLOGY, V7, P217; Fleming TP, 2018, LANCET, V391, P1842, DOI [10.1016/S0140-6736(18)30312-X, 10.1016/s0140-6736(18)30312-x]; Fleming TP, 2015, REPROD FERT DEVELOP, V27, P684, DOI 10.1071/RD14455; Government of India, 2015, HOUS HOUS CENS DAT 2; Government of India: Ministry of Health and Family Welfare, 2016, NAT MENT HLTH SURV I; Government of India: Ministry of Health and Family Welfare, 2018, INT NAT IR PLUS IN 1; Hambidge KM, 2019, AM J CLIN NUTR, V109, P457, DOI 10.1093/ajcn/nqy228; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Khan MN, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0181-0; Kochhar PH, 2007, J POSTGRAD MED, V53, P102, DOI 10.4103/0022-3859.32209; Kordas K, 2013, J NUTR, V143, P175, DOI 10.3945/jn.112.167767; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S3-S5; Maraka S, 2016, THYROID, V26, P580, DOI 10.1089/thy.2015.0418; McDonald SD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3428; Meng LH, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-015-0177-z; Ministry of Health and Family Welfare Government of India, 2014, NAT GUID PREV MAN CO; Msemo OA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208413; Nicholas LM, 2016, INT J OBESITY, V40, P229, DOI 10.1038/ijo.2015.178; Nicholas LM, 2013, FASEB J, V27, P3786, DOI 10.1096/fj.13-227918; Pfizer Inc, PAT HLTH QUEST PHQ 9; Poonam Muttreja, 2018, Indian Journal of Medical Research, V148, P1; Ray K, 2009, INT J INFECT DIS, V13, pE352, DOI 10.1016/j.ijid.2008.11.021; Reisin E, 2014, J AM SOC NEPHROL, V25, P2419, DOI 10.1681/ASN.2014040371; Ronnenberg AG, 2004, J NUTR, V134, P2586, DOI 10.1093/jn/134.10.2586; Ruebel ML, 2017, J CLIN ENDOCR METAB, V102, P2029, DOI 10.1210/jc.2016-3524; Sahay Rakesh Kumar, 2012, Indian J Endocrinol Metab, V16, P364, DOI 10.4103/2230-8210.95667; Satia J, 2018, INDIAN J COMMUN MED, V43, P1, DOI 10.4103/ijcm.IJCM_331_18; Seca Germany, SEC 213; Short MW, 2013, AM FAM PHYSICIAN, V87, P98; Siemens Healthcare Private Limited, ADVIA CENT XP IMM SY; Stephenson J, 2018, LANCET, V391, P1830, DOI [10.1016/S0140-6736(18)30311-8, 10.1016/s0140-6736(18)30311-8]; Tosoh Europe NV, HPLC AN; Tripathy JP, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0207-3; University of California San Franciso, ADVIA CENT SYST FERR; Unnikrishnan Ambika Gopalakrishnan, 2013, Indian J Endocrinol Metab, V17, P647, DOI 10.4103/2230-8210.113755; WHO, 2011, SER FERR CONC ASS IR; Witt WP, 2012, MATERN CHILD HLTH J, V16, P1525, DOI 10.1007/s10995-011-0916-4; World Health Organization, 2011, VITAMIN MINERAL NUTR; Wyman A, 2008, ENDOCRINOLOGY, V149, P466, DOI 10.1210/en.2007-1273	46	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234768	10.1371/journal.pone.0234768	http://dx.doi.org/10.1371/journal.pone.0234768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555694	gold, Green Published			2022-12-26	WOS:000543273200033
J	Stainback, GA; Lai, JH; Pienaar, EF; Adam, DC; Wiederholt, R; Vorseth, C				Stainback, G. Andrew; Lai, John H.; Pienaar, Elizabeth F.; Adam, Damian C.; Wiederholt, Ruscena; Vorseth, Chloe			Public preferences for ecological indicators used in Everglades restoration	PLOS ONE			English	Article							ECOSYSTEM SERVICES APPROACH; CHOICE EXPERIMENT; CLIMATE-CHANGE; WETLAND ATTRIBUTES; NON-ATTENDANCE; FLORIDA BAY; VALUATION; CONSERVATION; BENEFITS; HABITAT	The Everglades is one of the largest wetland ecosystems in the world covering almost 18,000 square miles from central Florida southward to Florida Bay. Over the 20th century, efforts to drain the Everglades for agriculture and development severely damaged the ecosystem so that today roughly 50% of the historic flow of water through the Everglades has been diverted elsewhere. In an attempt to restore the Everglades, the U.S. Congress authorized the Comprehensive Everglades Restoration Plan (CERP) in 2000, expected to cost over $16 billion and to take several decades to complete. We used the results from a stated preference choice experiment (SPCE) survey of Florida households to estimate the willingness to pay for several ecological attributes related to CERP performance indicators likely to be impacted by Everglades restoration. We also used a latent class model (LCM) to explore preference heterogeneity among respondents. On average, survey respondents were willing to pay for improvements in all of the attributes included in the survey, namely increased populations of wading birds, American alligators, endangered snail kites, and spotted seatrout, and reduced polluted discharges from Lake Okeechobee to the Caloosahatchee and St. Lucie rivers. Willingness to pay was highest for reduced polluted discharges from Lake Okeechobee.	[Stainback, G. Andrew; Wiederholt, Ruscena] Everglades Fdn, Palmetto Bay, FL 33157 USA; [Lai, John H.; Adam, Damian C.] Univ Florida, Food & Resource Econ Dept, Gainesville, FL USA; [Pienaar, Elizabeth F.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Pienaar, Elizabeth F.] Univ Pretoria, Mammal Res Inst, Pretoria, South Africa; [Adam, Damian C.] Sch Forest Resources & Conservat, Gainesville, FL USA; [Vorseth, Chloe] Florida Int Univ, Dept Earth & Environm, Miami, FL 33199 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Pretoria; State University System of Florida; Florida International University	Stainback, GA (corresponding author), Everglades Fdn, Palmetto Bay, FL 33157 USA.	astainback@evergladesfoundation.org		Stainback, George/0000-0003-1063-2709; Pienaar, Elizabeth/0000-0003-0343-080X	Everglades Foundation	Everglades Foundation	The Everglades Foundation funded and conducted the survey used in this study. Two of the authors (including the lead author) are employed by the Everglades Foundation.; The authors would like to thank The Everglades Foundation for funding the survey and providing support for this work.	[Anonymous], 2016, SAS VERS 9 4; [Anonymous], 2005, CANC BIOL THERAPY, V4, pv; [Anonymous], 2014, LANCET ONCOL, V15, pe475; [Anonymous], 2007, JACN SUPPLEMENT J AR; [Anonymous], 2007, SPINE J S, V7, p1S; Aronson J, 2013, RESTOR ECOL, V21, P293, DOI 10.1111/rec.12011; Barnes T, 2005, WETLANDS, V25, P884, DOI 10.1007/BF03173126; Bateman I, 2009, WORKING PAPER; Beerens JM, 2015, ECOL EVOL, V5, P5685, DOI 10.1002/ece3.1813; BenDor TK, 2015, RESTOR ECOL, V23, P209, DOI 10.1111/rec.12206; Bennetts RE, 1994, SNAIL KITE FLORIDA E; Birol E, 2006, ECOL ECON, V60, P145, DOI 10.1016/j.ecolecon.2006.06.002; Borger T, 2014, ECOL ECON, V108, P229, DOI 10.1016/j.ecolecon.2014.10.006; Brandt LA, 2016, ECOL INDIC, V67, P441, DOI 10.1016/j.ecolind.2016.03.003; Campbell D, 2011, J ENVIRON PLANN MAN, V54, P1061, DOI 10.1080/09640568.2010.549367; Carlsson F, 2003, ECOL ECON, V47, P95, DOI 10.1016/j.ecolecon.2002.09.003; CARSON RT, 1993, AM J AGR ECON, V75, P1263, DOI 10.2307/1243469; Colombo S, 2013, ECOL ECON, V96, P25, DOI 10.1016/j.ecolecon.2013.08.016; Cruz SM, 2017, J ENVIRON PSYCHOL, V53, P81, DOI 10.1016/j.jenvp.2017.06.010; Daley HE, 2010, ECOLOGICAL EC PRINCI; Darby PC, 2015, LANDSCAPE ECOL, V30, P1497, DOI 10.1007/s10980-015-0205-5; Dewsbury BM, 2016, ECOSYST SERV, V18, P68, DOI 10.1016/j.ecoser.2016.02.010; DUNLAP RE, 1978, J ENVIRON EDUC, V9, P10, DOI 10.1080/00958964.1978.10801875; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Dunlap RE, 2008, J ENVIRON EDUC, V40, P3, DOI 10.3200/JOEE.40.1.3-18; Forkink A, 2019, J ENVIRON PLANN MAN, V62, P1949, DOI 10.1080/09640568.2018.1523786; Forkink A, 2017, J ENVIRON PLANN MAN, V60, P2071, DOI 10.1080/09640568.2016.1273098; Fourqurean JW, 1999, ESTUARIES, V22, P345, DOI 10.2307/1353203; Heidenreich S, 2018, HEALTH ECON, V27, P157, DOI 10.1002/hec.3524; Hole A., 2016, STAT SOFTWARE COMPON; Hole A.R., 2016, STAT SOFTWARE COMPON; Hole AR, 2007, STATA J, V7, P388, DOI 10.1177/1536867X0700700306; Hole AR, 2012, EMPIR ECON, V42, P445, DOI 10.1007/s00181-011-0500-1; Holmes T.P., 2003, PRIMER NONMARKET VAL, P171, DOI [DOI 10.1007/978-94-007-0826-6_6, 10.1007/978-94-007-0826-6_6, DOI 10.1007/978-94-007-0826-6]; Huertas-Garcia R, 2016, EUR J MANAG BUS ECON, V25, P142, DOI 10.1016/j.redee.2015.10.001; Iftekhar MS, 2017, CONSERV BIOL, V31, P261, DOI 10.1111/cobi.12778; Jerath M, 2016, ENVIRON SCI POLICY, V66, P160, DOI 10.1016/j.envsci.2016.09.005; Kearney KA, 2015, ENVIRON MANAGE, V55, P836, DOI 10.1007/s00267-014-0336-5; King AJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1055; Kortenkamp KV, 2006, PERS SOC PSYCHOL B, V32, P603, DOI 10.1177/0146167205284006; Ladenburg J, 2014, RESOUR ENERGY ECON, V37, P39, DOI 10.1016/j.reseneeco.2014.05.002; Lew DK, 2011, ENVIRON RESOUR ECON, V48, P1, DOI 10.1007/s10640-010-9394-1; Manski CF, 2001, SCAND J ECON, V103, P217, DOI 10.1111/1467-9442.00241; Matta JR, 2009, LAND ECON, V85, P132, DOI 10.3368/le.85.1.132; Mazzotti FJ, 1994, ECOLOGY AM ALLIGATOR; McCright AM, 2011, GLOBAL ENVIRON CHANG, V21, P1163, DOI 10.1016/j.gloenvcha.2011.06.003; Milon JW, 2006, ECOL ECON, V56, P162, DOI 10.1016/j.ecolecon.2005.01.009; MITCHELL TJ, 1974, TECHNOMETRICS, V16, P203, DOI 10.2307/1267940; National Academy of Sciences E and Medicine, 2018, PROGR REST EV 7 BIEN; NEWSOM JD, 1987, HABITAT SUITABILITY; Ntanos S, 2019, ENERGIES, V12, DOI 10.3390/en12020239; Ogunbode Charles A., 2013, Environment Development and Sustainability, V15, P1477, DOI 10.1007/s10668-013-9446-0; Olander LP, 2018, ECOL INDIC, V85, P1262, DOI 10.1016/j.ecolind.2017.12.001; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Pattison J, 2011, CAN J AGR ECON, V59, P223, DOI 10.1111/j.1744-7976.2010.01217.x; Pienaar EF, 2019, ECOL ECON, V159, P24, DOI 10.1016/j.ecolecon.2019.01.011; Richardson L, 2014, ECOL ECON, V107, P366, DOI 10.1016/j.ecolecon.2014.09.011; Richardson L, 2009, ECOL ECON, V68, P1535, DOI 10.1016/j.ecolecon.2008.10.016; Rohr JR, 2018, ECOL SOC, V23, DOI 10.5751/ES-09876-230215; Scarpa R, 2008, AM J AGR ECON, V90, P994, DOI 10.1111/j.1467-8276.2008.01155.x; Schiller A, 2001, CONSERV ECOL, V5; Schultz ET, 2012, RESTOR ECOL, V20, P304, DOI 10.1111/j.1526-100X.2011.00854.x; Seeteram NA, 2018, SCI TOTAL ENVIRON, V627, P792, DOI 10.1016/j.scitotenv.2018.01.152; Shinde D, 2014, ALLIGATOR PRODUCTION; Shoyama K, 2013, LAND USE POLICY, V34, P282, DOI 10.1016/j.landusepol.2013.04.003; Sime P, 2005, WETLANDS, V25, P898, DOI 10.1672/0277-5212(2005)025[0898:SLEAIR]2.0.CO;2; StataCorp, 2016, STAT STAT SOFTW REL; TEEB, 2011, EC ECOSYSTEMBIODIV; The Lancet HIV, 2015, LANCET HIV, V2, pe115; Train K., 2005, DISCRETE CHOICE MODE, P1; U.S. Fish and Wildlife Service, 2008, AM ALL ALL MISS; Ugarte CA, 2013, J WILDLIFE MANAGE, V77, P192, DOI 10.1002/jwmg.463; Veisten K, 2004, J ENVIRON MANAGE, V73, P317, DOI 10.1016/j.jenvman.2004.07.008; Veldwijk J, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0140-4; Yoo H.I., 2019, 97014 MPRA U LIB MUN; 2006, PLOS MED, V5	76	4	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234051	10.1371/journal.pone.0234051	http://dx.doi.org/10.1371/journal.pone.0234051			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555611	Green Published, gold			2022-12-26	WOS:000543273200042
J	Yamamoto, HW; Kawahara, M; Tanaka, A				Yamamoto, Hisako W.; Kawahara, Misako; Tanaka, Akihiro			Audiovisual emotion perception develops differently from audiovisual phoneme perception during childhood	PLOS ONE			English	Article							VISUAL SPEECH; RECOGNITION; VOICE; FACE	This study investigated the developmental paths in the use of audiovisual information for the perception of emotions and phonemes by Japanese speakers. Children aged 5 to 12 years and adults aged 30 to 39 years engaged in an emotion perception task in which speakers expressed their emotions through their faces and voices, and a phoneme perception task using phonemic information in speakers' lip movements and speech sounds. Results indicated that Japanese children's judgement of emotions by using auditory information increased with increasing age, whereas the use of audiovisual information for judging phonemes remained constant with increasing age. Moreover, adults were affected by visual information more than children. We discuss whether these differences in developmental patterns are due to differential integration processes for information indicative of emotions and phonemes, as well as possible cultural / linguistic reasons for these differences.	[Yamamoto, Hisako W.; Kawahara, Misako; Tanaka, Akihiro] Tokyo Womans Christian Univ, Suginami Ku, Tokyo, Japan; [Yamamoto, Hisako W.; Kawahara, Misako] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	Japan Society for the Promotion of Science	Tanaka, A (corresponding author), Tokyo Womans Christian Univ, Suginami Ku, Tokyo, Japan.	akihiro@lab.twcu.ac.jp		Yamamoto, Hisako/0000-0001-5505-5971	JSPS KAKENHI [15H02714, 18K13124, 17H06345]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (No. 15H02714 and No. 18K13124), the Scholarship Fund for Young/Women Researchers, and Grant-in-Aid for Scientific Research on Innovative Areas No. 17H06345 "Construction of the Face-Body Studies in Transcultural Conditions." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; Ekman Paul, 1972, NEBRASKA S MOTIVATIO, V19, P207, DOI DOI 10.1037/0022-3514.53.4.712; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Johnstone T., 2000, HDB EMOTION, V2, P220; Kawahara M, 2017, P 14 INT C AUD VIS S, P109; McDuff D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173942; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Orbelo DM, 2005, J GERIATR PSYCH NEUR, V18, P25, DOI 10.1177/0891988704272214; Paulmann S, 2008, BRAIN LANG, V104, P262, DOI 10.1016/j.bandl.2007.03.002; PELL MD, 2002, BRAIN COGNITION, V48, P499, DOI DOI 10.1006/BRCG.2001.1406; Sauter DA, 2013, BRIT J DEV PSYCHOL, V31, P97, DOI 10.1111/j.2044-835X.2012.02081.x; SEKIYAMA K, 1991, J ACOUST SOC AM, V90, P1797, DOI 10.1121/1.401660; Sekiyama K, 2008, DEVELOPMENTAL SCI, V11, P306, DOI 10.1111/j.1467-7687.2008.00677.x; Sekiyama K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00323; Tanaka A, 2011, NEUROREPORT, V22, P684, DOI 10.1097/WNR.0b013e32834a2724; Tanaka A, 2010, PSYCHOL SCI, V21, P1259, DOI 10.1177/0956797610380698	19	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234553	10.1371/journal.pone.0234553	http://dx.doi.org/10.1371/journal.pone.0234553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555620	gold, Green Published			2022-12-26	WOS:000543273200015
J	Ros, AFH; Basen, T; Teschner, RJ; Brinker, A				Ros, Albert F. H.; Basen, Timo; Teschner, Ruben J.; Brinker, Alexander			Morphological and molecular data show no evidence of the proposed replacement of endemicPomphorhynchus tereticollisby invasiveP.laevisin salmonids in southern Germany	PLOS ONE			English	Article							POMPHORHYNCHUS-LAEVIS MULLER; CHONDROSTOMA-NASUS L.; ACANTHOCEPHALA POMPHORHYNCHIDAE; PHYLOGENETIC-RELATIONSHIPS; RAINBOW-TROUT; N.-SP; PARASITES; FISH; BEHAVIOR; MONTICELLI	Changes in parasite communities might result in new host-parasite dynamics and may threaten local fish populations. This phenomenon has been suggested for acanthocephalan parasites in the river Rhine and Danube where the speciesPomphorhynchus tereticollisis becoming replaced by the Ponto-CaspianP.laevis. Developing knowledge on morphologic, genetic and behavioural differences between such species is important to follow such changes. However, disagreements on the current phylogeny of these two acanthocephalan species are producing conflicts that is affecting their correct identification. This study is offering a clearer morphological and genetic distinction between these two species. AsP.tereticollisis found in rhithral tributaries of the Rhine, it was questioned whether the local salmonid populations were hosts for this species and whetherP.laeviswas expanding into the Rhine watershed as well. In order to test for this, brown trout,Salmo trutta, and grayling,Thymallus thymallusfrom South-Western Germany watersheds have been samples and screened for the occurrence of acanthocephalan parasites. For the first time, both species were confirmed to be hosts forP.tereticollisin continental Europe.P.tereticolliswas found to be common, whereasP.leaviswas found only at a single location in the Danube. This pattern suggest either that the expansion ofP.laevisthrough salmonid hosts into rhithral rivers has not yet occurred, or that not yet ascertained biotic or abiotic features of rhithral rivers hinderP.laevisto spread into these areas.	[Ros, Albert F. H.; Basen, Timo; Teschner, Ruben J.; Brinker, Alexander] LAZBW, Fisheries Res Stn Baden Wurttemberg, Langenargen, Germany		Ros, AFH (corresponding author), LAZBW, Fisheries Res Stn Baden Wurttemberg, Langenargen, Germany.	albert.ros@lazbw.bwl.de	Brinker, Alexander/ABF-4644-2020; Ros, Albert/I-7726-2015	Brinker, Alexander/0000-0002-2433-5652; Basen, Timo/0000-0001-6242-312X; Ros, Albert/0000-0003-3241-9722				Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Alcantar-Escalera FJ, 2013, MOL ECOL RESOUR, V13, P1116, DOI 10.1111/1755-0998.12090; Amin OM, 2003, SYST PARASITOL, V54, P229, DOI 10.1023/A:1022654921523; Andujar C, 2018, MOL ECOL, V27, P3968, DOI 10.1111/mec.14844; Antognazza CM, IS POMPHORHYNCHUS TE; Baer J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183769; Bakker TCM, 1997, ECOLOGY, V78, P1098, DOI 10.1890/0012-9658(1997)078[1098:PICIBA]2.0.CO;2; Brandner J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190777; Brinker A, 2000, BULL EUR ASSN FISH P, V20, P256; BRITTAIN JE, 1988, HYDROBIOLOGIA, V166, P77, DOI 10.1007/BF00017485; Cevrimel DS, 2017, SU URUN DERG, V34, P255, DOI 10.12714/egejfas.2017.34.3.02; Chambouvet A, 2015, PARASITE DIVERSITY AND DIVERSIFICATION: EVOLUTIONARY ECOLOGY MEETS PHYLOGENETICS, P93; David GM, 2018, PARASITOLOGY, V145, P1020, DOI 10.1017/S0031182017002177; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dianne L, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-166; Du ling U, 2014, HDB ANGEW LIMNOLOGIE, P1, DOI [10.1002/9783527678488.hbal2004006, DOI 10.1002/9783527678488.HBAL2004006]; Dussling U, 2018, GROSSE BUCH FISCHE B; Emde S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109971; Emde S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053218; Escobar LE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01174; Francova K, 2011, J APPL ICHTHYOL, V27, P879, DOI 10.1111/j.1439-0426.2010.01582.x; Fredrich F, 2003, J FISH BIOL, V63, P710, DOI 10.1046/j.1095-8649.2003.00184.x; Garcia-Varela M, 2006, MOL PHYLOGENET EVOL, V40, P61, DOI 10.1016/j.ympev.2006.02.010; HINE PM, 1974, J FISH BIOL, V6, P665, DOI 10.1111/j.1095-8649.1974.tb05108.x; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Hohenadler MAA, 2018, BIOL INVASIONS, V20, P207, DOI 10.1007/s10530-017-1527-9; Jirsa F, 2011, J HELMINTHOL, V85, P255, DOI 10.1017/S0022149X10000490; KENNEDY CR, 1984, J FISH BIOL, V24, P135, DOI 10.1111/j.1095-8649.1984.tb04785.x; Kennedy CR, 2006, ECOLOGY OF THE ACANTHOCEPHALA, P1, DOI 10.2277/ 0521850088; Kral'ova-Hromadova I, 2003, SYST PARASITOL, V56, P141, DOI 10.1023/A:1026127219358; Lewis SE, 2012, BEHAV PROCESS, V91, P159, DOI 10.1016/j.beproc.2012.07.009; Lucas MC, 1996, J APPL ECOL, V33, P1345, DOI 10.2307/2404775; Lymbery Alan J., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P171, DOI 10.1016/j.ijppaw.2014.04.002; Malyarchuk B, 2014, PARASITOL INT, V63, P100, DOI 10.1016/j.parint.2013.09.012; Nadler SA, 2011, PARASITOLOGY, V138, P1688, DOI 10.1017/S003118201000168X; Nedic Z., 2019, Bulletin of the European Association of Fish Pathologists, V39, P93; Ondrackova M, 2015, HYDROBIOLOGIA, V746, P233, DOI 10.1007/s10750-014-1967-5; Ovidio M, 2008, J APPL ICHTHYOL, V24, P256, DOI 10.1111/j.1439-0426.2008.01050.x; Perrot-Minnot MJ, 2019, INT J PARASITOL-PAR, V8, P135, DOI 10.1016/j.ijppaw.2019.01.007; Perrot-Minnot MJ, 2018, J BIOGEOGR, V45, P101, DOI 10.1111/jbi.13118; Perrot-Minnot MJ, 2004, INT J PARASITOL, V34, P45, DOI 10.1016/j.ijpara.2003.10.005; PIPPY JHC, 1969, J FISH RES BOARD CAN, V26, P909, DOI 10.1139/f69-088; Poulin R, 2011, ADV PARASIT, V74, P1, DOI 10.1016/B978-0-12-385897-9.00001-X; Purty R.S., 2016, AUSTIN J BIOTECHNOL, V3, P1059; Reier S, 2019, INT J PARASITOL-PAR, V8, P145, DOI 10.1016/j.ijppaw.2019.01.009; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schreiber A, 2005, ECOL FRESHW FISH, V14, P1, DOI 10.1111/j.1600-0633.2004.00072.x; Smrzlic IV, 2015, PARASITOL INT, V64, P243, DOI 10.1016/j.parint.2015.02.004; Sobecka E, 2012, J HELMINTHOL, V86, P16, DOI 10.1017/S0022149X10000891; Spakulova M, 2011, HELMINTHOLOGIA, V48, P268, DOI 10.2478/s11687-011-0038-y; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Taraschewski H, 2006, J HELMINTHOL, V80, P99, DOI 10.1079/JOH2006364; Teletchea F., 2018, BIOL RESOURCES WATER, P75, DOI [10.5772/intechopen.73408, DOI 10.5772/INTECHOPEN.73408]; WANSTALL ST, 1986, Z PARASITENKD, V72, P105, DOI 10.1007/BF00927741; Wayland MT, 2015, ZOOKEYS, P25, DOI 10.3897/zookeys.484.9132; Westram AM, 2011, INFECT GENET EVOL, V11, P1083, DOI 10.1016/j.meegid.2011.03.024; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	58	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234116	10.1371/journal.pone.0234116	http://dx.doi.org/10.1371/journal.pone.0234116			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544162	Green Published, gold			2022-12-26	WOS:000542957200004
J	Shang, CW; Zhou, HY; Liu, W; Shen, T; Luo, Y; Huang, SL				Shang, Chaowei; Zhou, Hongyu; Liu, Wang; Shen, Tao; Luo, Yan; Huang, Shile			Iron chelation inhibits mTORC1 signaling involving activation of AMPK and REDD1/Bnip3 pathways	ONCOGENE			English	Article							PROTEIN-KINASE; ANTITUMOR-ACTIVITY; MAMMALIAN TARGET; UPSTREAM KINASE; PHOSPHATASE 2A; ENERGY-SENSOR; GENE-PRODUCTS; CELL-GROWTH; TGF-BETA; CANCER	The mammalian target of rapamycin (mTOR) functions as two complexes (mTORC1 and mTORC2), regulating cell growth and metabolism. Aberrant mTOR signaling occurs frequently in cancers, so mTOR has become an attractive target for cancer therapy. Iron chelators have emerged as promising anticancer agents. However, the mechanisms underlying the anticancer action of iron chelation are not fully understood. Particularly, reports on the effects of iron chelation on mTOR complexes are inconsistent or controversial. Here, we found that iron chelators consistently inhibited mTORC1 signaling, which was blocked by pretreatment with ferrous sulfate. Mechanistically, iron chelation-induced mTORC1 inhibition was not related to ROS induction, copper chelation, or PP2A activation. Instead, activation of AMPK pathway mainly and activation of both HIF-1/REDD1 and Bnip3 pathways partially contribute to iron chelation-induced mTORC1 inhibition. Our findings indicate that iron chelation inhibits mTORC1 via multiple pathways and iron is essential for mTORC1 activation.	[Shang, Chaowei; Zhou, Hongyu; Liu, Wang; Shen, Tao; Luo, Yan; Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA; [Shang, Chaowei; Shen, Tao; Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Huang, SL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA.; Huang, SL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71130 USA.	shuan1@lsuhsc.edu	Huang, Shile/I-1632-2019	Huang, Shile/0000-0002-3239-1072; Zhou, Hongyu/0000-0001-5852-3953	National Institutes of Health [CA115414]; American Cancer Society [RSG-08-135-01-CNE]; Feist-Weiller Cancer Center Idea Award; Carroll Feist Predoctoral Fellowship; Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center in Shreveport, LA	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Feist-Weiller Cancer Center Idea Award; Carroll Feist Predoctoral Fellowship; Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center in Shreveport, LA	We thank Michael N. Hall for reading the manuscript and helpful discussions, and Yu Jiang for generously providing Rheb-Q64L plasmid. This work was supported by the National Institutes of Health (CA115414; SH), American Cancer Society (RSG-08-135-01-CNE; SH), Feist-Weiller Cancer Center Idea Award (SH), and Carroll Feist Predoctoral Fellowship (CS and TS), Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center in Shreveport, LA.	Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Bystrom LM, 2015, FREE RADICAL BIO MED, V79, P337, DOI 10.1016/j.freeradbiomed.2014.04.035; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Coombs GS, 2012, ONCOGENE, V31, P213, DOI 10.1038/onc.2011.228; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Dennis MD, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005103; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; DONFRANCESCO A, 1990, CANCER RES, V50, P4929; Eberhard Y, 2009, BLOOD, V114, P3064, DOI 10.1182/blood-2009-03-209965; ESTROV Z, 1987, BLOOD, V69, P757; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Glick D, 2012, MOL CELL BIOL, V32, P2570, DOI 10.1128/MCB.00167-12; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Heberle AM, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970489; Huang X, 2003, MUTAT RES-FUND MOL M, V533, P153, DOI 10.1016/j.mrfmmm.2003.08.023; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kazyken D, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav3249; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lane DJR, 2014, BBA-REV CANCER, V1845, P166, DOI 10.1016/j.bbcan.2014.01.005; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Li Y, 2007, J BIOL CHEM, V282, P35803, DOI 10.1074/jbc.M705231200; Lin A, 2014, ONCOGENE, V33, P3183, DOI 10.1038/onc.2013.273; Linden T, 2003, FASEB J, V17, P761, DOI 10.1096/fj.02-0586fje; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Ohyashiki JH, 2009, CANCER SCI, V100, P970, DOI 10.1111/j.1349-7006.2009.01131.x; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scitranslmed.3001127, 10.1126/scisignal.3001127]; Rao VA, 2009, CANCER RES, V69, P948, DOI 10.1158/0008-5472.CAN-08-1437; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shen T, 2016, CURR PHARM DESIGN, V22, P4443, DOI 10.2174/1381612822666160530151209; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Siddiqui N, 2015, BIOCHEM SOC T, V43, P763, DOI 10.1042/BST20150126; Singh M, 2011, APPL IMMUNOHISTO M M, V19, P417, DOI 10.1097/PAI.0b013e318209716e; Song S, 2011, CANCER RES, V71, P7628, DOI 10.1158/0008-5472.CAN-11-2745; Sowter HM, 2001, CANCER RES, V61, P6669; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; VAUGHN CB, 1987, CANCER INVEST, V5, P7, DOI 10.3109/07357908709020300; Voss M, 2011, CELL SIGNAL, V23, P114, DOI 10.1016/j.cellsig.2010.08.010; WANG GL, 1993, BLOOD, V82, P3610; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Watson A, 2016, CELL SIGNAL, V28, P412, DOI 10.1016/j.cellsig.2016.01.014; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Yu JS, 1998, J BIOCHEM, V124, P225, DOI 10.1093/oxfordjournals.jbchem.a022084; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zhou HY, 2016, BIOCHEM PHARMACOL, V116, P39, DOI 10.1016/j.bcp.2016.07.005; Zhou HY, 2014, ONCOTARGET, V5, P10140, DOI 10.18632/oncotarget.2471; Zhou HY, 2010, INT J CANCER, V127, P2467, DOI 10.1002/ijc.25255	76	13	13	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 16	2020	39	29					5201	5213		10.1038/s41388-020-1366-5	http://dx.doi.org/10.1038/s41388-020-1366-5		JUN 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ML6WO	32541839	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000540391900001
J	Shen, Z; Zheng, XD; Yang, HL				Shen, Zheng; Zheng, Xiaodong; Yang, Hualei			The fertility effects of public pension: Evidence from the new rural pension scheme in China	PLOS ONE			English	Article							SOCIAL-SECURITY; CHILDREN; MODEL	Public pension insurance has become a major form of social protection around the world. However, little is known about the association between public pension expansion and individuals' fertility in developing economies. In this paper, we examine the effects of the New Rural Pension Scheme (NRPS) on the fertility of married women in rural China. Using data from the China Family Panel Studies (CFPS), the difference-in-differences approach is employed to estimate the impact of NRPS expansion on fertility outcomes. The robustness of results is checked through additional estimations, including difference-in-differences with propensity score matching, fixed-effects model, and instrumental variable approach. Results show that the NRPS expansion has a significantly negative effect on the number of children, and it reduces the likelihood of having a second child. The fertility-reducing effect of the NRPS is larger for the younger, well-educated women and those in high-income families. Considerations of the fertility effects and their population differences are needed in the impact evaluations of relevant public pension reform.	[Shen, Zheng] Zhejiang A&F Univ, Sch Econ & Management, Hangzhou, Peoples R China; [Shen, Zheng] Zhejiang A&F Univ, Key Cultivating Think Tank Zhejiang Prov, Res Acad Rural Revitalizat Zhejiang Prov, Hangzhou, Peoples R China; [Zheng, Xiaodong] Zhejiang Gongshang Univ, Sch Econ, Hangzhou, Peoples R China; [Yang, Hualei] Zhongnan Univ Econ & Law, Sch Publ Adm, Wuhan, Peoples R China	Zhejiang A&F University; Zhejiang A&F University; Zhejiang Gongshang University; Zhongnan University of Economics & Law	Yang, HL (corresponding author), Zhongnan Univ Econ & Law, Sch Publ Adm, Wuhan, Peoples R China.	home@zuel.edu.cn	Shen, Zheng/ABF-2163-2021	Shen, Zheng/0000-0001-8178-2419	National Natural Science Foundation of China [71903177]; Scientific Research Foundation of Zhejiang AF University [2018FR023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Zhejiang AF University	Zheng Shen acknowledges funding support from National Natural Science Foundation of China (Grant number: 71903177) and Scientific Research Foundation of Zhejiang A&F University (Grant number: 2018FR023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2016, Pediatr Dent, V38, P204; BARRO RJ, 1989, ECONOMETRICA, V57, P481, DOI 10.2307/1912563; BECKER GS, 1988, Q J ECON, V103, P1, DOI 10.2307/1882640; Boldrin M, 2015, J DEMOGR ECON, V81, P261, DOI 10.1017/dem.2014.14; Boyle MA, 2016, J HEALTH ECON, V45, P63, DOI 10.1016/j.jhealeco.2015.11.005; branch CSoDP, 2014, CHINESE J DERMATOL, V47, P3, DOI DOI 10.1016/J.JBIOMECH.2013.09.021; Cheng L, 2016, J COMP ECON, V46, P53, DOI [DOI 10.1016/j.jce.2016.12.002, DOI 10.1016/J.JCE.2016.12.002]; Cheng LG, 2018, J POPUL ECON, V31, P155, DOI 10.1007/s00148-017-0655-y; Chuankun K, 2018, FINANCE EC, P7; CIGNO A, 1992, J POPUL ECON, V5, P175; Cigno A., 1993, EUR J POLIT ECON, V9, P505, DOI DOI 10.1016/0176-2680(93)90036-T; Ehrlich I, 1998, AM ECON REV, V88, P151; Ehrlich I, 2007, REV ECON DYNAM, V10, P55, DOI 10.1016/j.red.2006.09.002; ENTWISLE B, 1984, ECON DEV CULT CHANGE, V32, P331, DOI 10.1086/451388; FELDSTEIN M, 1974, J POLIT ECON, V82, P905, DOI 10.1086/260246; Feng J, 2011, J COMP ECON, V39, P470, DOI 10.1016/j.jce.2011.01.002; Fenge R, 2017, J POPUL ECON, V30, P93, DOI 10.1007/s00148-016-0608-x; Galasso V, 2009, INT TAX PUBLIC FINAN, V16, P538, DOI 10.1007/s10797-009-9104-5; Hayford SR, 2008, SOC FORCES, V86, P1163, DOI 10.1353/sof.0.0000; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Lehrer EL, 1996, J POPUL ECON, V9, P173, DOI 10.1007/s001480050013; Lugauer S, 2019, CHINA ECON REV, V57, DOI 10.1016/j.chieco.2017.08.005; Miyazaki K, 2013, J POPUL ECON, V26, P1233, DOI 10.1007/s00148-012-0451-7; MODIGLIANI F, 1957, OXFORD B ECON STAT, V19, P99; Ning MX, 2019, CHINA AGR ECON REV, V11, P411, DOI 10.1108/CAER-02-2017-0019; Rokicki S, 2014, DEMOGRAPHY, V51, P2229, DOI 10.1007/s13524-014-0339-0; Shen Z, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16214214; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Wang LR, 2015, ECON LETT, V133, P19, DOI 10.1016/j.econlet.2015.05.014; Zeng Y, 2016, LANCET, V388, P1930, DOI 10.1016/S0140-6736(16)31405-2; Zheng XD, 2020, J DEV STUD, V56, P545, DOI 10.1080/00220388.2019.1577387	32	4	4	9	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234657	10.1371/journal.pone.0234657	http://dx.doi.org/10.1371/journal.pone.0234657			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QP	32530927	Green Published, gold			2022-12-26	WOS:000542037200036
J	Yun, CS; Nishimoto, K; Motoyama, T; Shimizu, T; Hino, T; Dohmae, N; Nagano, S; Osada, H				Yun, Choong-Soo; Nishimoto, Kazuki; Motoyama, Takayuki; Shimizu, Takeshi; Hino, Tomoya; Dohmae, Naoshi; Nagano, Shingo; Osada, Hiroyuki			Unique features of the ketosynthase domain in a nonribosomal peptide synthetase-polyketide synthase hybrid enzyme, tenuazonic acid synthetase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; polyketide; mycotoxin; fungi; natural product	CRYSTAL-STRUCTURE; TETRAMIC ACID; THIOESTERASE; CYCLIZATION; BIOSYNTHESIS; ANTIBIOTICS; ENZYMOLOGY; DISCOVERY; INSIGHTS; LOGIC	Many microbial secondary metabolites are produced by multienzyme complexes comprising nonribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs). The ketosynthase (KS) domains of polyketide synthase normally catalyze the decarboxylative Claisen condensation of acyl and malonyl blocks to extend the polyketide chain. However, the terminal KS domain in tenuazonic acid synthetase 1 (TAS1) from the fungusPyricularia oryzaeconducts substrate cyclization. Here, we report on the unique features of the KS domain in TAS1. We observed that this domain is monomeric, not dimeric as is typical for KSs. Analysis of a 1.68-angstrom resolution crystal structure suggests that the substrate cyclization is triggered via proton abstraction from the active methylene moiety in the substrate by a catalytic His-322 residue. Additionally, we show that TAS1 KS promiscuously accepts aminoacyl substrates and that this promiscuity can be increased by a single amino acid substitution in the substrate-binding pocket of the enzyme. These findings provide insight into a KS domain that accepts the amino acid-containing substrate in an NRPS-PKS hybrid enzyme and provide hints to the substrate cyclization mechanism performed by the KS domain in the biosynthesis of the mycotoxin tenuazonic acid.	[Yun, Choong-Soo; Motoyama, Takayuki; Shimizu, Takeshi; Osada, Hiroyuki] RIKEN, Chem Biol Res Grp, Ctr Sustainable Resource Sci, Wako, Saitama, Japan; [Nishimoto, Kazuki; Hino, Tomoya; Nagano, Shingo] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori, Japan; [Dohmae, Naoshi] RIKEN, Biomol Characterizat Unit, Ctr Sustainable Resource Sci, Wako, Saitama, Japan	RIKEN; Tottori University; RIKEN	Osada, H (corresponding author), RIKEN, Chem Biol Res Grp, Ctr Sustainable Resource Sci, Wako, Saitama, Japan.; Nagano, S (corresponding author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori, Japan.	snagano@bio.tottori-u.ac.jp; cb-secretary@ml.riken.jp	Dohmae, Naoshi/C-2040-2011	Dohmae, Naoshi/0000-0002-5242-9410; YUN, Choong-Soo/0000-0001-7128-2584	JSPS KAKENHI [JP17H06412, JP17K07784, JP18H03945]; NARO Bio-oriented Technology Research Advancement Institution (Research program on development of innovative technology)	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NARO Bio-oriented Technology Research Advancement Institution (Research program on development of innovative technology)	This work was supported by JSPS KAKENHI Grants JP17H06412, JP17K07784, and JP18H03945 and by the NARO Bio-oriented Technology Research Advancement Institution (Research program on development of innovative technology) (to H. O.).	Abdalla MA, 2018, MOLECULES, V23, DOI 10.3390/molecules23082080; Awakawa T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05877-z; Blodgett JAV, 2010, P NATL ACAD SCI USA, V107, P11692, DOI 10.1073/pnas.1001513107; Boettger D, 2013, CHEMBIOCHEM, V14, P28, DOI 10.1002/cbic.201200624; Bozhuyuk KAJ, 2018, NAT CHEM, V10, P275, DOI [10.1038/nchem.2890, 10.1038/NCHEM.2890]; Bretschneider T, 2013, NATURE, V502, P124, DOI 10.1038/nature12588; Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590; Dutta S, 2014, NATURE, V510, P512, DOI 10.1038/nature13423; Ehmann DE, 2000, CHEM BIOL, V7, P765, DOI 10.1016/S1074-5521(00)00022-3; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Gao X, 2012, NAT CHEM BIOL, V8, P823, DOI 10.1038/NCHEMBIO.1047; GATENBECK S, 1973, ANTIMICROB AGENTS CH, V3, P308, DOI 10.1128/AAC.3.2.308; Gay DC, 2016, J STRUCT BIOL, V193, P196, DOI 10.1016/j.jsb.2015.12.011; Gui C, 2015, ORG LETT, V17, P628, DOI 10.1021/ol5036497; He HY, 2014, J AM CHEM SOC, V136, P4488, DOI 10.1021/ja500942y; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Kao CM, 1996, BIOCHEMISTRY-US, V35, P12363, DOI 10.1021/bi9616312; Katsuyama Y, 2012, METHOD ENZYMOL, V515, P359, DOI 10.1016/B978-0-12-394290-6.00017-3; Keatinge-Clay AT, 2012, NAT PROD REP, V29, P1050, DOI 10.1039/c2np20019h; Klaus M, 2018, NAT PROD REP, V35, P1070, DOI 10.1039/c8np00030a; Kohlhaas C, 2013, CHEM SCI, V4, P3212, DOI 10.1039/c3sc50540e; Liu XY, 2009, BIOCHEMISTRY-US, V48, P8746, DOI 10.1021/bi901123r; Lohman JR, 2015, P NATL ACAD SCI USA, V112, P12693, DOI 10.1073/pnas.1515460112; Lou LL, 2011, J AM CHEM SOC, V133, P643, DOI 10.1021/ja105732c; MARSHALL FJ, 1956, J ORG CHEM, V21, P245, DOI 10.1021/jo01108a605; Mo XH, 2014, RSC ADV, V4, P50566, DOI 10.1039/c4ra09047k; Mori T, 2015, J BIOL CHEM, V290, P5214, DOI 10.1074/jbc.M114.626416; Muthusamy S, 2013, TETRAHEDRON LETT, V54, P6810, DOI 10.1016/j.tetlet.2013.10.007; Robbins T, 2016, BIOCHEMISTRY-US, V55, P4476, DOI 10.1021/acs.biochem.6b00639; Sambrook J, 2001, MOL CLONING LAB MANU; Sims JW, 2008, J AM CHEM SOC, V130, P11149, DOI 10.1021/ja803078z; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Trauger JW, 2000, NATURE, V407, P215, DOI 10.1038/35025116; Tsai SC, 2009, METHOD ENZYMOL, V459, P17, DOI 10.1016/S0076-6879(09)04602-3; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Weissman KJ, 2015, NAT PROD REP, V32, P436, DOI 10.1039/c4np00098f; Whicher JR, 2013, CHEM BIOL, V20, P1340, DOI 10.1016/j.chembiol.2013.09.015; Williams GJ, 2013, CURR OPIN STRUC BIOL, V23, P603, DOI 10.1016/j.sbi.2013.06.012; Witkowski A, 2004, BIOCHEMISTRY-US, V43, P10458, DOI 10.1021/bi048988n; Wu QQ, 2012, J AM CHEM SOC, V134, P17342, DOI 10.1021/ja304829g; Yun CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9758; Zhang GT, 2014, ANGEW CHEM INT EDIT, V53, P4840, DOI 10.1002/anie.201402078; Zhao CH, 2010, J BIOL CHEM, V285, P20097, DOI 10.1074/jbc.M109.090092; Zorzi A, 2017, CURR OPIN CHEM BIOL, V38, P24, DOI 10.1016/j.cbpa.2017.02.006	45	13	13	2	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11602	11612		10.1074/jbc.RA120.013105	http://dx.doi.org/10.1074/jbc.RA120.013105			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32565425	Green Published, hybrid			2022-12-26	WOS:000563922500019
J	Cai, YH; Yu, XH; Chai, J; Liu, CJ; Shanklin, J				Cai, Yuanheng; Yu, Xiao-Hong; Chai, Jin; Liu, Chang-Jun; Shanklin, John			A conserved evolutionary mechanism permits Delta 9 desaturation of very-long-chain fatty acyl lipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						very-long-chain fatty acid; Delta 9 integral membrane desaturase; stearoyl-CoA desaturase; structural determinants; chain length specificity; phospholipid; fatty acid metabolism; metalloenzyme; enzyme; enzyme mutation; substrate specificity; desaturase; monoene	CARRIER PROTEIN DESATURASE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; COA DESATURASE; BIOSYNTHESIS; DETERMINANTS; SYNTHETASE; COMPONENTS; COENZYME	Delta 9 fatty acyl desaturases introduce acis-double bond between C9 and C10 of saturated fatty acyl chains. From the crystal structure of the mouse stearoyl-CoA desaturase (mSCD1) it was proposed that Tyr-104, a surface residue located at the distal end of the fatty acyl binding pocket plays a key role in specifying 18C selectivity. We created mSCD1-Y104G to test the hypothesis that eliminating this bulky side chain would create an opening and permit the substrate's methyl end to protrude through the enzyme into the lipid bilayer, facilitating the desaturation of very-long-chain (VLC) substrates. Consistent with this hypothesis, Y104G acquired the ability to desaturate 24C and 26C acyl-CoAs while maintaining its Delta 9-regioselectivity. We also investigated two distantly related very-long-chain fatty acyl (VLCFA) desaturases from Arabidopsis, ADS1.2 and ADS1.4, which have Ala and Gly, respectively, in place of the gatekeeping Tyr found in mSCD1. Substitution of Tyr for Ala and Gly in ADS1.2 and ADS1.4, respectively, blocked their ability to desaturate VLCFAs. Further, we identified a pair of fungal desaturase homologs which contained either an Ile or a Gly at this location and showed that only the Gly-containing desaturase was capable of very-long-chain desaturation. The conserved desaturase architecture wherein a surface residue with a single bulky side chain forms the end of the substrate binding cavity predisposes them to single amino acid substitutions that enable a switch between long- and very-long-chain selectivity. The data presented here show that such changes have independently occurred multiple times during evolution.	[Cai, Yuanheng; Yu, Xiao-Hong; Shanklin, John] SUNY Stony Brook, Biochem & Cell Biol Dept, Stony Brook, NY 11794 USA; [Chai, Jin; Liu, Chang-Jun; Shanklin, John] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory	Shanklin, J (corresponding author), SUNY Stony Brook, Biochem & Cell Biol Dept, Stony Brook, NY 11794 USA.; Shanklin, J (corresponding author), Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.	shanklin@bnl.gov			Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy Grant [DOE KC0304000]; National Science Foundation Plant Genome [IOS-13-39385]; Biological and Environmental Research (BER) program, U.S. Department of Energy [DE-SC0018254]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy Grant(United States Department of Energy (DOE)); National Science Foundation Plant Genome(National Science Foundation (NSF)); Biological and Environmental Research (BER) program, U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy Grant DOE KC0304000 (to Y. C., J. C., C.-J. L., and J. S.), the National Science Foundation Plant Genome IOS-13-39385 (to Y. C., X.-H. Y., and J. S.), and the Biological and Environmental Research (BER) program, U.S. Department of Energy, Award number DE-SC0018254 (to Y. C. and J. S.).	Aguilar PS, 2006, MOL MICROBIOL, V62, P1507, DOI 10.1111/j.1365-2958.2006.05484.x; ALjohani AM, 2017, TRENDS ENDOCRIN MET, V28, P831, DOI 10.1016/j.tem.2017.10.003; Bai YH, 2015, NATURE, V524, P252, DOI 10.1038/nature14549; Cahoon EB, 1998, PLANT PHYSIOL, V117, P593, DOI 10.1104/pp.117.2.593; Cahoon EB, 1997, P NATL ACAD SCI USA, V94, P4872, DOI 10.1073/pnas.94.10.4872; Cai YH, 2018, J BIOL CHEM, V293, P19844, DOI 10.1074/jbc.RA118.005972; CERDAOLMEDO E, 1994, PROG LIPID RES, V33, P185, DOI 10.1016/0163-7827(94)90021-3; Christie W.W., 2012, LIPID ANAL, P145, DOI [10.1533/9780857097866.145, DOI 10.1533/9780857097866.145]; Domergue F, 2003, J BIOL CHEM, V278, P35115, DOI 10.1074/jbc.M305990200; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Fukuchi-Mizutani M, 1998, PLANT CELL PHYSIOL, V39, P247, DOI 10.1093/oxfordjournals.pcp.a029364; Guy JE, 2007, J BIOL CHEM, V282, P19863, DOI 10.1074/jbc.M702520200; HARWOOD J, 1989, CRIT REV PLANT SCI, V8, P1, DOI 10.1080/07352680490273310; Heilmann I, 2004, P NATL ACAD SCI USA, V101, P10266, DOI 10.1073/pnas.0402200101; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LEE RF, 1970, SCIENCE, V167, P1510, DOI 10.1126/science.167.3924.1510; Li DD, 2016, COMPUT STRUCT BIOTEC, V14, P341, DOI 10.1016/j.csbj.2016.08.003; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; Liu XQ, 2011, ADV NUTR, V2, P15, DOI 10.3945/an.110.000125; Mansilla MC, 2004, J BACTERIOL, V186, P6681, DOI 10.1128/JB.186.20.6681-6688.2004; Meesapyodsuk D, 2014, ACS CHEM BIOL, V9, P922, DOI 10.1021/cb400675d; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Riezman H, 2007, CELL, V130, P587, DOI 10.1016/j.cell.2007.08.008; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; Smith MA, 2013, PLANT PHYSIOL, V161, P81, DOI 10.1104/pp.112.202325; Wang H, 2015, NAT STRUCT MOL BIOL, V22, P581, DOI 10.1038/nsmb.3049; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yang XP, 2017, PLANT PHYSIOL, V173, P1109, DOI 10.1104/pp.16.01956; Yao KN, 2003, PLANT BIOTECHNOL J, V1, P221, DOI 10.1046/j.1467-7652.2003.00021.x; Zou ZY, 2003, J BIOL CHEM, V278, P16414, DOI 10.1074/jbc.M210557200	33	3	3	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11337	11345		10.1074/jbc.RA120.014258	http://dx.doi.org/10.1074/jbc.RA120.014258			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32527722	hybrid, Green Published			2022-12-26	WOS:000562757100033
J	Qin, N; Sun, HH; Lu, MK; Wang, JH; Tang, T; Liu, FS				Qin, Nan; Sun, Hehe; Lu, Meike; Wang, Jianhui; Tang, Ting; Liu, Fengsong			A single von Willebrand factor C-domain protein acts as an extracellular pattern-recognition receptor in the river prawnMacrobrachium nipponense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pathogen-associated molecular pattern (PAMP); pattern recognition receptor (PRR); innate immunity; insect; phagocytosis; agglutination; crustacean; single von Willebrand factor C-domain protein; Macrobrachium nipponense	GENE-EXPRESSION; INNATE IMMUNITY; DROSOPHILA; SHRIMP; LECTIN; FAMILY; IDENTIFICATION; COMPONENTS; SYSTEM; SVC	The single von Willebrand factor C-domain proteins (SVWCs) are mainly found in arthropods. Their expression may be regulated by several environmental stresses, including nutritional status and bacterial and viral infections. However, the underlying regulatory mechanism is unclear. In the present study, we identified a member of the SVWC family from the river prawnMacrobrachium nipponenseas a soluble and bacteria-inducible pattern-recognition receptor (designated MnSVWC).In vitro, recombinant MnSVWC exhibited pronounced binding and Ca2+-dependent agglutinating abilities against diverse microbes, including Gram-negative bacteria (i.e. Escherichia coliandAeromonas victoria), Gram-positive bacteria (Staphylococcus aureusandBacillus subtilis), and yeast (Pichia pastoris). ELISA assays revealed that recombinant MnSVWC recognizes a broad range of various pathogen-associated molecular patterns (PAMPs) and has high affinity to lipopolysaccharide and lysine-type and diaminopimelic acid?type peptidylglycan andd-galactose and low affinity tod-mannan and ?-1,3-glucan. Mutant MnSVWC(P57A)with an impaired Glu-Pro-Asn (EPN) motif displayed reduced affinity to all these PAMPs to varying extent. Moreover, MnSVWC bound to the surface of hemocytes and promoted their phagocytic activity and clearance of invasive bacteria. RNAi-mediated MnSVWC knockdown in prawn reduced the ability to clear invading bacteria, but did not block the activities of the Toll pathway or the arthropod immune deficiency (IMD) pathway, or the expression of antimicrobial peptide genes. These results indicate that MnSVWC functions as an extracellular pattern-recognition receptor inM. nipponensethat mediates cellular immune responses by recognizing PAMPs, agglutinating invasive microbes, and promoting phagocytosis in hemocytes.	[Qin, Nan; Sun, Hehe; Lu, Meike; Tang, Ting; Liu, Fengsong] Hebei Univ, Coll Life Sci, Key Lab Zool Systemat & Applicat, Baoding, Peoples R China; [Wang, Jianhui] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Tang, Ting; Liu, Fengsong] Hebei Univ, Inst Life Sci & Green Dev, Baoding, Peoples R China	Hebei University; Yale University; Hebei University	Tang, T; Liu, FS (corresponding author), Hebei Univ, Coll Life Sci, Key Lab Zool Systemat & Applicat, Baoding, Peoples R China.; Tang, T; Liu, FS (corresponding author), Hebei Univ, Inst Life Sci & Green Dev, Baoding, Peoples R China.	tangting@hbu.edu.cn; liufengsong@hbu.edu.cn		Liu, Fengsong/0000-0001-6634-7152; wang, jianhui/0000-0002-6261-4863	National Natural Science Foundation of China [31572327]; Natural Science Foundation of Hebei Province [C2019201194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This work was supported by National Natural Science Foundation of China Grant no. 31572327 (to F. L.) and Natural Science Foundation of Hebei Province Grant no. C2019201194 (to F. L.).	DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; DRICKAMER K, 1993, PROG NUCLEIC ACID RE, V45, P207, DOI 10.1016/S0079-6603(08)60870-3; Goh YS, 2011, IMMUNOLOGY, V133, P74, DOI 10.1111/j.1365-2567.2011.03411.x; Haider M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220867; Han F, 2017, INSECT MOL BIOL, V26, P308, DOI 10.1111/imb.12293; Huang X, 2017, MOL IMMUNOL, V87, P141, DOI 10.1016/j.molimm.2017.04.009; Jiang S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01607; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kleinjung J, 2004, NUCLEIC ACIDS RES, V32, P2464, DOI 10.1093/nar/gkh566; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li FH, 2013, DEV COMP IMMUNOL, V39, P11, DOI 10.1016/j.dci.2012.03.016; Litvack ML, 2010, INNATE IMMUN-LONDON, V16, P191, DOI 10.1177/1753425910369271; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Shagin DA, 2002, GLYCOBIOLOGY, V12, P463, DOI 10.1093/glycob/cwf056; Sheldon TJ, 2007, FEBS LETT, V581, P5268, DOI 10.1016/j.febslet.2007.10.016; Shi XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091794; Shi XZ, 2012, INSECT BIOCHEM MOLEC, V42, P545, DOI 10.1016/j.ibmb.2012.04.002; Smit AB, 2004, FASEB J, V18, P845, DOI 10.1096/fj.03-0590fje; Sullivan JT, 2012, INFECT IMMUN, V80, P996, DOI 10.1128/IAI.05987-11; Tang T, 2017, FISH SHELLFISH IMMUN, V70, P327, DOI 10.1016/j.fsi.2017.09.010; Tassanakajon A, 2013, FISH SHELLFISH IMMUN, V34, P954, DOI 10.1016/j.fsi.2012.09.021; Tian YY, 2009, DEV COMP IMMUNOL, V33, P772, DOI 10.1016/j.dci.2009.01.002; Wang HD, 2018, DEV COMP IMMUNOL, V81, P152, DOI 10.1016/j.dci.2017.11.011; Wang HD, 2017, INSECT BIOCHEM MOLEC, V91, P10, DOI 10.1016/j.ibmb.2017.10.002; Wang XW, 2017, J IMMUNOL, V198, P3045, DOI 10.4049/jimmunol.1602002; Wang XW, 2013, FISH SHELLFISH IMMUN, V34, P981, DOI 10.1016/j.fsi.2012.08.008; Wang XW, 2009, DEV COMP IMMUNOL, V33, P1039, DOI 10.1016/j.dci.2009.05.004; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	33	6	6	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10468	10477		10.1074/jbc.RA120.013270	http://dx.doi.org/10.1074/jbc.RA120.013270			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32532819	Green Published, hybrid			2022-12-26	WOS:000556713400028
J	Alhassan, RK; Karley, QOB; Ackah, EF; Adodoaji, I				Alhassan, Robert Kaba; Karley, Quarshie-Odoo Benedicta; Ackah, Ennin Francis; Adodoaji, Irene			Implementation of the policy protocol for management of surgical and non-surgical wounds in selected public health facilities in Ghana: An analytic case study	PLOS ONE			English	Article							CARE	Background It is estimated that millions of patients are affected by healthcare associated infections (HAIs) each year. In Ghana, high prevalence of HAIs in relation to non-surgical (also called contaminated wounds) and surgical wounds (also called sterile wounds) is largely attributed to poor adherence to policy protocols for wound management by frontline clinical staff especially nurses. Objective Investigate the extent to which nursing staff adhere to the policy protocol for management of non-surgical and surgical wounds in selected public health facilities in Ghana. Methodology This is an analytic case study among nursing staff (n = 140) in three government facilities in the Volta region of Ghana. Subjective and objective performance scores of staff on adherence proxies were compared using the Wilcoxon Signed-rank test, and univariate ordered logistic regression analysis used to predict staff likelihood of adherence to policy protocols on non-surgical and surgical wound management. Findings Overall, staff self-rated themselves higher on subjective performance proxies relative to their objective scores (p<0.05). Staff with more years of work experience did not translate into a higher likelihood of adhering to standard protocol on wound management (Coef. = -0.49, CI = -0.93-0.05, p = 0.036). Being a senior nursing officer relative to lower nursing ranks increased staff likelihood of complying particularly with standard policy protocol for management of non-surgical wounds (Coef. 5.27, CI = 0.59 9.95, p = 0.027). Conclusion There is the need for accelerated in-service training for staff on standard protocols for wound management coupled with supportive supervisions. Staff adherence to standard quality care protocols should be a pre-requisite for licensing of health facilities by regulatory bodies like Health Facilities Regulatory Agency and National Health Insurance Authority.	[Alhassan, Robert Kaba] Univ Hlth & Allied Sci, Inst Hlth Res, Ho, Ghana; [Karley, Quarshie-Odoo Benedicta; Ackah, Ennin Francis; Adodoaji, Irene] Univ Hlth & Allied Sci, Sch Nursing & Midwifery, Dept Nursing, Ho, Ghana		Alhassan, RK (corresponding author), Univ Hlth & Allied Sci, Inst Hlth Res, Ho, Ghana.	arkabason@gmail.com		Alhassan, Robert Kaba/0000-0003-4227-4854				Abdullah F, 2011, J SURG RES, V171, P461, DOI 10.1016/j.jss.2010.04.016; Ackumey MM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001187; Addison NO, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005331; Adugbire BA, 2018, BMC NURS, V17, DOI 10.1186/s12912-018-0299-6; Alhassan RK, 2019, TROP MED HEALTH, V47, DOI 10.1186/s41182-019-0163-8; Alhassan RK, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3931-6; Allegranzi B, 2013, LANCET INFECT DIS, V13, P843, DOI 10.1016/S1473-3099(13)70163-4; Ameyaw J. A. O., 2014, THESIS; [Anonymous], 2009, CARDIOVASCULAR THERA, V8, pS4; [Anonymous], 2019, OPTICS EXPRESS, V27, pA581; Apanga S., 2014, INT J RES HLTH SCI, V2, P207; Avoka Asamani James, 2014, Br J Nurs, V23, P48; BaMohammed A., 2018, IOSR J NURSING HLTH, V7, P01; Carroll E, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.5.FOCUS19250; Clegg-Lamptey J N A, 2007, East Afr Med J, V84, P561; Deal Jr J. B., 2019, J HAND SURG; Dinh A, 2019, MED MALADIES INFECT, V49, P9, DOI 10.1016/j.medmal.2018.05.004; Dobson MW, 2011, COLORECTAL DIS, V13, P811, DOI 10.1111/j.1463-1318.2010.02302.x; Faraway J., 2004, LINEAR MODELS R; Ghana Health Service (GHS), 2019, FACTAND FIG; Gonzaga de Faria GB, 2016, REV ENFERM UFPE, V10, P4532, DOI DOI 10.5205/1981-8963-V10I12A11520P4532-4538-2016; Grouzard V., 2018, MED SANS FRONTIERES; Judson R. T., 2019, TXB SURG, P45; Kpeli GS, 2019, CHAM, V29, P227, DOI DOI 10.1007/978-3-030-11114-4_13; Krejcie R.V., 1960, EDUC PSYCHOL MEAS, V30, P607; Labi AK, 2019, J HOSP INFECT, V101, P60, DOI 10.1016/j.jhin.2018.04.019; McCluskey P, 2012, WOUNDS UK, V8, P37; Nursing and Midwifery Council (NMC) of Ghana, 2015, REV CURR REG GEN NUR; Ranjeva SL, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000347; Stewart BT, 2015, INT J SURG, V21, P168, DOI 10.1016/j.ijsu.2015.08.002; Tindall B, 2014, BAILLIERES NURSES DI; Velding K, 2014, AM J TROP MED HYG, V91, P313, DOI 10.4269/ajtmh.13-0255; Welsh L, 2018, INT WOUND J, V15, P53, DOI 10.1111/iwj.12822; World Health Organization, 2018, GLOB GUID PREV SURG; 2019, J WOUND CARE, V28, pS	35	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234874	10.1371/journal.pone.0234874	http://dx.doi.org/10.1371/journal.pone.0234874			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574200	Green Published, gold			2022-12-26	WOS:000544972400008
J	Giao, DM; Wang, Y; Rojas, R; Takaba, K; Badathala, A; Spaulding, KA; Soon, G; Zhang, Y; Wang, VY; Haraldsson, H; Liu, J; Saloner, D; Guccione, JM; Ge, L; Wallace, AW; Ratcliffe, MB				Giao, Duc M.; Wang, Yan; Rojas, Renan; Takaba, Kiyoaki; Badathala, Anusha; Spaulding, Kimberly A.; Soon, Gilbert; Zhang, Yue; Wang, Vicky Y.; Haraldsson, Henrik; Liu, Jing; Saloner, David; Guccione, Julius M.; Ge, Liang; Wallace, Arthur W.; Ratcliffe, Mark B.			Left ventricular geometry during unloading and the end-systolic pressure volume relationship: Measurement with a modified real-time MRI-based method in normal sheep	PLOS ONE			English	Article							HEART-FAILURE; WALL STRESS; CONTRACTILITY; FERUMOXYTOL; DYSFUNCTION; MYOCARDIUM; STIFFNESS; RISK	The left ventricular (LV) end-systolic (ES) pressure volume relationship (ESPVR) is the cornerstone of systolic LV function analysis. We describe a 2D real-time (RT) MRI-based method (RTPVR) with separate software tools for 1) semi-automatic level set-based shape prior method (LSSPM) of the LV, 2) generation of synchronized pressure area loops and 3) calculation of the ESPVR. We used the RTPVR method to measure ventricular geometry, ES pressure area relationship (ESPAR) and ESPVR during vena cava occlusion (VCO) in normal sheep. 14 adult sheep were anesthetized and underwent measurement of LV systolic function. Ten of the 14 sheep underwent RTMRI and eight of the 14 underwent measurement with conductance catheter; 4 had both RTMRI and conductance measurements. 2D cross sectional RTMRI were performed at apex, mid-ventricle and base levels during separate VCOs. The Dice similarity coefficient was used to compare LSSPM and manual image segmentation and thus determine LSSPM accuracy. LV cross-sectional area, major and minor axis length, axis ratio, major axis orientation angle and ESPAR were measured at each LV level. ESPVR was calculated with a trapezoidal rule. The Dice similarity coefficient between LSSPM and manual segmentation by two readers was 87.31 +/- 2.51% and 88.13 +/- 3.43%. All cross sections became more elliptical during VCO. The major axis orientation shifted during VCO but remained in the septo-lateral direction. LV chamber obliteration at the apical level occurred during VCO in 7 of 10 sheep that underwent RTMRI. ESPAR was non-linear at all levels. Finally, ESPVR was non-linear because of apical collapse. ESPVR measured by conductance catheter (E-ES,E-Index= 2.23 +/- 0.66 mmHg/ml/m(2)) and RT (E-ES,E-Index= 2.31 +/- 0.31 mmHg/ml/m(2)) was not significantly different. LSSPM segmentation of 2D RT MRI images is accurate and allows calculation of LV geometry, ESPAR and ESPVR during VCO. In the future, RTPVR will facilitate determination of regional systolic material parameters underlying ESPVR.	[Giao, Duc M.; Rojas, Renan; Takaba, Kiyoaki; Badathala, Anusha; Spaulding, Kimberly A.; Soon, Gilbert; Zhang, Yue; Wang, Vicky Y.; Saloner, David; Guccione, Julius M.; Ge, Liang; Wallace, Arthur W.; Ratcliffe, Mark B.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Giao, Duc M.; Rojas, Renan; Takaba, Kiyoaki; Badathala, Anusha; Spaulding, Kimberly A.; Soon, Gilbert; Zhang, Yue; Wang, Vicky Y.; Guccione, Julius M.; Ge, Liang; Wallace, Arthur W.; Ratcliffe, Mark B.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Giao, Duc M.; Rojas, Renan; Takaba, Kiyoaki; Badathala, Anusha; Spaulding, Kimberly A.; Soon, Gilbert; Zhang, Yue; Wang, Vicky Y.; Guccione, Julius M.; Ge, Liang; Ratcliffe, Mark B.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Wang, Yan; Haraldsson, Henrik; Liu, Jing; Saloner, David] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Wallace, Arthur W.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ratcliffe, MB (corresponding author), Vet Affairs Med Ctr, San Francisco, CA 94121 USA.; Ratcliffe, MB (corresponding author), Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA.; Ratcliffe, MB (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.	Mark.Ratcliffe@va.gov	Wang, Vicky Y./O-9043-2018	Wang, Vicky Y./0000-0003-0895-3132; Zhang, Yue/0000-0003-3835-9409; Saloner, David/0000-0002-6989-8547; Giao, Duc/0000-0002-4053-7692	National Heart, Lung and Blood Institute [R01-HL084431]	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Heart, Lung and Blood Institute Grant R01-HL084431 (M. Ratcliffe).	[Anonymous], 2005, AM J PHYSIOL-HEART C, V289, pH1898; BAAN J, 1984, CIRCULATION, V70, P812, DOI 10.1161/01.CIR.70.5.812; Bai WJ, 2018, J CARDIOVASC MAGN R, V20, DOI 10.1186/s12968-018-0471-x; Bashir MR, 2015, J MAGN RESON IMAGING, V41, P884, DOI 10.1002/jmri.24691; Bernard O, 2018, IEEE T MED IMAGING, V37, P2514, DOI 10.1109/TMI.2018.2837502; Biederman Robert W W, 2015, J Biomed Sci Eng, V8, P213; Contijoch FJ, 2016, ANN THORAC SURG, V102, P796, DOI 10.1016/j.athoracsur.2016.02.055; Dahle GO, 2016, AM J PHYSIOL-HEART C, V310, pH1330, DOI 10.1152/ajpheart.00947.2015; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Farman GP, 2011, AM J PHYSIOL-HEART C, V300, pH2155, DOI 10.1152/ajpheart.01221.2010; Ferziger H, 1981, NUMERICAL METHODS EN; GLOWER DD, 1985, CIRCULATION, V71, P994, DOI 10.1161/01.CIR.71.5.994; GORDON AM, 1980, CIRC RES, V47, P610, DOI 10.1161/01.RES.47.4.610; GUCCIONE JM, 1991, J BIOMECH ENG-T ASME, V113, P42, DOI 10.1115/1.2894084; GUCCIONE JM, 1993, J BIOMECH ENG-T ASME, V115, P72, DOI 10.1115/1.2895473; Hope MD, 2015, AM J ROENTGENOL, V205, pW366, DOI 10.2214/AJR.15.14534; Kane GC, 2011, JAMA-J AM MED ASSOC, V306, P856, DOI 10.1001/jama.2011.1201; KASS DA, 1989, CIRCULATION, V79, P167, DOI 10.1161/01.CIR.79.1.167; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Knutsen AK, 2012, ANN THORAC SURG, V93, P1121, DOI 10.1016/j.athoracsur.2011.12.067; Kono A, 1984, CIRCULATION, V65, P988; KRAMER CM, 1993, CIRCULATION, V88, P1279, DOI 10.1161/01.CIR.88.3.1279; Lam CSP, 2011, CIRCULATION, V124, P24, DOI 10.1161/CIRCULATIONAHA.110.979203; LEUNG JM, 1994, ANESTHESIOLOGY, V81, P1102, DOI 10.1097/00000542-199411000-00003; Maniar HS, 2014, J THORAC CARDIOV SUR, V148, P1694, DOI 10.1016/j.jtcvs.2014.05.088; NAKANO K, 1990, CIRCULATION, V82, P1352, DOI 10.1161/01.CIR.82.4.1352; OLSEN CO, 1983, CIRC RES, V52, P85, DOI 10.1161/01.RES.52.1.85; OLSEN CO, 1981, CIRC RES, V49, P843, DOI 10.1161/01.RES.49.4.843; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Pak PH, 1996, CIRCULATION, V94, P52, DOI 10.1161/01.CIR.94.1.52; RANKIN JS, 1977, CIRC RES, V41, P37, DOI 10.1161/01.RES.41.1.37; RATCLIFFE MB, 1995, IEEE T BIO-MED ENG, V42, P587, DOI 10.1109/10.387198; SAGAWA K, 1981, CIRCULATION, V63, P1223, DOI 10.1161/01.CIR.63.6.1223; Shimkunas R, 2013, ANN THORAC SURG, V95, P1619, DOI 10.1016/j.athoracsur.2013.02.005; SPRATT JA, 1987, CIRCULATION, V75, P1295, DOI 10.1161/01.CIR.75.6.1295; SUGA H, 1974, CIRC RES, V35, P117, DOI 10.1161/01.RES.35.1.117; Sun K, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3148464; Tulner SAF, 2006, J THORAC CARDIOV SUR, V132, P610, DOI 10.1016/j.jtcvs.2005.12.016; Turk G, 1999, P 26 ANN C COMP GRAP; TYSON GS, 1984, CIRC RES, V54, P173, DOI 10.1161/01.RES.54.2.173; VANDERVELDE ET, 1991, CIRCULATION, V83, P315, DOI 10.1161/01.CIR.83.1.315; Wang WJ, 2019, IEEE ACCESS, V7, P47918, DOI 10.1109/ACCESS.2019.2907564; Wang Y, 2016, MED PHYS, V43, P1777, DOI 10.1118/1.4943375; Wang YH, 2018, INT J OCCUP ENV MED, V9, P10, DOI 10.15171/ijoem.2018.1143; Wissmann L, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0063-3; Witschey WRT, 2014, ANN THORAC SURG, V97, P1597, DOI 10.1016/j.athoracsur.2014.01.010; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Zhang P, 2005, J THORAC CARDIOV SUR, V130, P1032, DOI 10.1016/j.jtcvs.2005.05.039; Zhang S, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-39; Zhang ZY, 2020, INFORM SCIENCES, V506, P1, DOI 10.1016/j.ins.2019.08.003; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	51	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234896	10.1371/journal.pone.0234896	http://dx.doi.org/10.1371/journal.pone.0234896			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569290	Green Published, gold			2022-12-26	WOS:000543547900032
J	Gluszek, S; Ciesla, E; Gluszek-Osuch, M; Koziel, D; Kiebzak, W; Wypchlo, L; Suliga, E				Gluszek, Stanislaw; Ciesla, Elzbieta; Gluszek-Osuch, Martyna; Koziel, Dorota; Kiebzak, Wojciech; Wypchlo, Lukasz; Suliga, Edyta			Anthropometric indices and cut-off points in the diagnosis of metabolic disorders	PLOS ONE			English	Article							CARDIOMETABOLIC RISK-FACTORS; BODY-MASS INDEX; WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; OBESITY; DYSLIPIDEMIA; BMI; ADIPOSITY; VALUES	Objective Identifying metabolic disorders at the earliest phase of their development allows for an early intervention and the prevention of serious consequences of diseases. However, it is difficult to determine which of the anthropometric indices of obesity is the best tool for diagnosing metabolic disorders. The aims of this study were to evaluate the usefulness of selected anthropometric indices and to determine optimal cut-off points for the identification of single metabolic disorders that are components of metabolic syndrome (MetS). Design Cross-sectional study. Participants We analyzed the data of 12,328 participants aged 55.7 +/- 5.4 years. All participants were of European descent. Primary outcome measure Four MetS components were included: high glucose concentration, high blood triglyceride concentration, low high-density lipoprotein cholesterol concentration, and elevated blood pressure. The following obesity indices were considered: waist circumference (WC), body mass index (BMI), waist-to-height ratio (WHtR), body fat percentage (%BF), Clinica Universidad de Navarra-body adiposity estimator (CUN-BAE), body roundness index (BRI), and a body shape index (ABSI). Results The following indices had the highest discriminatory power for the identification of at least one MetS component: CUN-BAE, BMI, and WC in men (AUC = 0.734, 0.728, and 0.728, respectively) and WHtR, CUN-BAE, and WC in women (AUC = 0.715, 0.714, and 0.712, respectively) (p<0.001 for all). The other indices were similarly useful, except for the ABSI. Conclusions For the BMI, the optimal cut-off point for the identification of metabolic abnormalities was 27.2 kg/m(2)for both sexes. For the WC, the optimal cut-off point was of 94 cm for men and 87 cm for women. Prospective studies are needed to identify those indices in which changes in value predict the occurrence of metabolic disorders best.	[Gluszek, Stanislaw; Wypchlo, Lukasz] Jan Kochanowski Univ Humanities & Sci, Inst Med Sci, Med Coll, Kielce, Poland; [Ciesla, Elzbieta; Gluszek-Osuch, Martyna; Koziel, Dorota; Kiebzak, Wojciech; Suliga, Edyta] Jan Kochanowski Univ Humanities & Sci, Inst Hlth Sci, Med Coll, Kielce, Poland	Jan Kochanowski University; Jan Kochanowski University	Suliga, E (corresponding author), Jan Kochanowski Univ Humanities & Sci, Inst Hlth Sci, Med Coll, Kielce, Poland.	edyta.suliga@ujk.edu.pl		Koziel, Dorota/0000-0001-8114-1814; Gluszek, Stanislaw/0000-0001-7752-0459; Gluszek-Osuch, Martyna/0000-0001-5287-0962	 [024/RID/2018/19]		The project was supported under the program of the Minister of Science and Higher Education under the name "Regional Initiative of Excellence" in 2019-2022, project number: 024/RID/2018/19, financing amount: 11.999.000,00PLN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2013, AM J CLIN NUTR, V98, P637, DOI 10.3945/ajcn.112.047506; Al-Rubean K, 2017, ANN SAUDI MED, V37, P21, DOI 10.5144/0256-4947.2017.21; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2014, TRIALS, V15, P243; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010159; Au WS, 2003, DIABETES, V52, P1073, DOI 10.2337/diabetes.52.5.1073; Bays HE, 2013, J CLIN LIPIDOL, V7, P304, DOI 10.1016/j.jacl.2013.04.001; Bhaskaran K, 2018, LANCET DIABETES ENDO, V6, P944, DOI [10.1016/S2213-8587(18)30288-2, 10.1016/s2213-8587(18)30288-2]; Biskup M, 2019, MED STUD, V35, P32, DOI 10.5114/ms.2019.84049; Anchuelo AC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216877; Davila-Batista V, 2019, EUR J NUTR, V58, P1853, DOI 10.1007/s00394-018-1743-9; Di Daniele N, 2017, ONCOTARGET, V8, P8947, DOI 10.18632/oncotarget.13553; Dlamini Z, 2019, DIABETES METAB SYNDR, V12, P1597, DOI 10.2147/DMSO.S188680; Fenwick PH, 2019, CRIT REV FOOD SCI, V59, P2028, DOI 10.1080/10408398.2018.1437022; Gomez-Ambrosi J, 2012, DIABETES CARE, V35, P383, DOI 10.2337/dc11-1334; Gomez-Marcos MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209992; Gomez-Peralta F, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0323-8; Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697; Heymsfield SB, 2016, OBES REV, V17, P262, DOI 10.1111/obr.12358; Hosseini-Esfahani F, 2018, INT J ENDOCRINOL MET, V16, DOI 10.5812/ijem.84772; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Khader YS, 2010, DIABETES METAB SYNDR, V3, P395, DOI [10.2147/DMSOTT.S15154, 10.2147/DMSO.S15154]; Kilpelainen TO, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08008-w; Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Mongraw-Chaffin M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139559; Myers J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071652; Ofer K, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014712; Rashid S, 2007, OBESITY, V15, P2875, DOI 10.1038/oby.2007.342; Rost S, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5350-8; Salazar MR, 2014, J AM COLL NUTR, V33, P32, DOI 10.1080/07315724.2014.869982; Song X, 2015, NUTR METAB CARDIOVAS, V25, P295, DOI 10.1016/j.numecd.2014.09.004; Stefanescu A, 2019, J INT MED RES, V48, P1; Suliga E, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112764; Suliga E, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112598; Suliga E, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121366; Suliga E, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0045-9; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HLTH, V8, pe545; Thomas DM, 2013, OBESITY, V21, P2264, DOI 10.1002/oby.20408; TIAN S, 2016, MEDICINE, V95, P34; Vinknes KJ, 2017, CLIN EPIDEMIOL, V9, P555, DOI 10.2147/CLEP.S145130; Wang F, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0754-z; World Cancer Research Fund/American Institute for Cancer Research, 2018, DIET NUT PHYS ACT CA; World Health Organization, 2016, OB OV FACT SHEET; Wu X, 2019, CLIN EXP HYPERTENS, V41, P373, DOI 10.1080/10641963.2018.1489546; Yung JHM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030706; Zaid M, 2017, J PHYSIOL ANTHROPOL, V36, DOI 10.1186/s40101-017-0134-x; Zhang J, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/1067603	50	15	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235121	10.1371/journal.pone.0235121	http://dx.doi.org/10.1371/journal.pone.0235121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569336	Green Published			2022-12-26	WOS:000543547900008
J	Lal, MM; Bosserelle, C; Kishore, P; Southgate, PC				Lal, Monal M.; Bosserelle, Cyprien; Kishore, Pranesh; Southgate, Paul C.			Understanding marine larval dispersal in a broadcast-spawning invertebrate: A dispersal modelling approach for optimising spat collection of the Fijian black-lip pearl oysterPinctada margaritifera	PLOS ONE			English	Article							OYSTER PINCTADA-MARGARITIFERA; PARTICLE-TRACKING; WILD SPAT; CONNECTIVITY; RECRUITMENT; AQUACULTURE; SUITABILITY; COORDINATE; PATTERNS; FOOD	Fisheries and aquaculture industries worldwide remain reliant on seed supply from wild populations, with their success and sustainability dependent on consistent larval recruitment. Larval dispersal and recruitment in the marine environment are complex processes, influenced by a multitude of physical and biological factors. Biophysical modelling has increasingly been used to investigate dispersal and recruitment dynamics, for optimising management of fisheries and aquaculture resources. In the Fiji Islands, culture of the black-lip pearl oyster (Pinctada margaritifera) is almost exclusively reliant on wild-caught juvenile oysters (spat), through a national spat collection programme. This study used a simple Lagrangian particle dispersal model to investigate current-driven larval dispersal patterns, identify potential larval settlement areas and compare simulated with physical spat-fall, to inform targeted spat collection efforts. Simulations successfully identified country-wide patterns of potential larval dispersal and settlement from 2012-2015, with east-west variations between bi-annual spawning peaks and circulation associated with El Nino Southern Oscillation. Localised regions of larval aggregation were also identified and compared to physical spat-fall recorded at 28 spat collector deployment locations. Significant and positive correlations at these sites across three separate spawning seasons (r(26) = 0.435;r(26) = 0.438;r(26) = 0.428 respectively,p= 0.02), suggest high utility of the model despite its simplicity, for informing future spat collector deployment. Simulation results will further optimise black-lip pearl oyster spat collection activity in Fiji by informing targeted collector deployments, while the model provides a versatile and highly informative toolset for the fishery management and aquaculture of other marine taxa with similar life histories.	[Lal, Monal M.; Kishore, Pranesh; Southgate, Paul C.] Univ Sunshine Coast, Australian Ctr Pacific Isl Res, Sch Sci & Engn, Maroochydore, Qld, Australia; [Lal, Monal M.; Kishore, Pranesh] Univ South Pacific, Fac Sci Technol & Environm, Sch Marine Studies, Suva, Fiji; [Bosserelle, Cyprien] Natl Inst Water & Atmospher Res, Christchurch, New Zealand; [Bosserelle, Cyprien] Pacific Community SPC, Geosci Energy & Maritime Div, Suva, Fiji	University of the Sunshine Coast; University of the South Pacific; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Lal, MM (corresponding author), Univ Sunshine Coast, Australian Ctr Pacific Isl Res, Sch Sci & Engn, Maroochydore, Qld, Australia.; Lal, MM (corresponding author), Univ South Pacific, Fac Sci Technol & Environm, Sch Marine Studies, Suva, Fiji.	mlal1@usc.edu.au		Lal, Monal/0000-0002-8545-2887; Kishore, Pranesh/0000-0002-7421-8892	Australian Centre for International Agricultural Research (ACIAR) [FIS/2009/057]; ACIAR John Allwright Fellowship	Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res); ACIAR John Allwright Fellowship(Australian Ctr Intl Agr Res)	This study was conducted within and funded by the Australian Centre for International Agricultural Research (ACIAR -www.aciar.gov.au/) project FIS/2009/057: "Developing pearl industry based livelihoods in the western Pacific" led by PS at the University of the Sunshine Coast. The research was carried out during an ACIAR John Allwright Fellowship awarded to ML. The funding source (ACIAR) had no direct involvement in the study design, collection, analysis and interpretation of the data, nor the decision to submit this article for publication.	ALAGARSWAMI K, 1989, AQUACULTURE, V76, P43, DOI 10.1016/0044-8486(89)90250-0; Andrefouet S, 2006, MAR POLLUT BULL, V52, P1138, DOI 10.1016/j.marpolbul.2006.07.014; Arnold WS, 2017, J SHELLFISH RES, V36, P101, DOI 10.2983/036.036.0112; Atalah J, 2017, AQUACULT ENV INTERAC, V9, P103, DOI 10.3354/aei00216; Berry O, 2012, MOL ECOL, V21, P2145, DOI 10.1111/j.1365-294X.2012.05520.x; Bidegain G, 2013, ECOL MODEL, V268, P78, DOI 10.1016/j.ecolmodel.2013.07.020; Chassignet EP, 2007, J MARINE SYST, V65, P60, DOI 10.1016/j.jmarsys.2005.09.016; Cole RG, 2000, NEW ZEAL J MAR FRESH, V34, P317, DOI 10.1080/00288330.2000.9516935; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Cummings JA, 2005, Q J ROY METEOR SOC, V131, P3583, DOI 10.1256/qj.05.105; Doroudi Mehdi S., 2003, Molluscan Research, V23, P101, DOI 10.1071/MR02015; Dupont L, 2007, MAR ECOL PROG SER, V349, P125, DOI 10.3354/meps07098; Freedland M, 2006, IND LAW J, V35, P1, DOI 10.1093/indlaw/dwj001; Friedman KJ, 1999, J SHELLFISH RES, V18, P159; Friedman KJ, 1998, AQUACULTURE, V167, P283, DOI 10.1016/S0044-8486(98)00286-5; Friedman KJ, 1999, AQUACULTURE, V178, P273, DOI 10.1016/S0044-8486(99)00129-5; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Ganachaud A, 2007, CLIVAR PUBLICATION S; Gosling EM, 2015, MARINE BIVALVE MOLLU, P270; Halliwell GR, 2004, OCEAN MODEL, V7, P285, DOI 10.1016/j.ocemod.2003.10.002; Hays GC, 2017, CURR BIOL, V27, pR470, DOI 10.1016/j.cub.2017.01.044; Jeung HD, 2014, FISHERIES SCI, V80, P451, DOI 10.1007/s12562-014-0706-1; Kishore P, 2018, AQUACULT REP, V9, P46, DOI 10.1016/j.aqrep.2017.12.004; Lal MM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3410-y; Lazure P, 2008, ADV WATER RESOUR, V31, P233, DOI 10.1016/j.advwatres.2007.06.010; Lucas JS, 2008, PEARL OYSTER, P187, DOI 10.1016/B978-0-444-52976-3.00006-1; Lundquist CJ, 2009, NEW ZEAL J MAR FRESH, V43, P735, DOI 10.1080/00288330909510038; Markey KL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147628; Miyake Y, 2009, MAR ECOL PROG SER, V387, P205, DOI 10.3354/meps08086; Neo ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058819; Neuwirth E., 2014, RCOLORBREWER COLORBR; Nydam ML, 2017, BIOL J LINN SOC, V120, P879; Oengpepa C, 2006, J SHELLFISH RES, V25, P955; Oke PR, 2014, COASTAL SHELF OCEANO, P1; Pineda J, 2009, POPUL ECOL, V51, P17, DOI 10.1007/s10144-008-0118-0; Saucedo PE, 2008, PEARL OYSTER, P131, DOI 10.1016/B978-0-444-52976-3.00005-X; Secretariat of the Pacific Community, 2018, MEMB FIJ; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Simpson SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107610; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Song ZY, 2015, ACTA OCEANOL SIN, V34, P67, DOI 10.1007/s13131-015-0787-4; Southgate PC, 2008, PEARL OYSTER, P303, DOI 10.1016/B978-0-444-52976-3.00009-7; Team RC, 2016, R LANG ENV STAT COMP; Tebano T, 2000, ATOLL RES B, V488, P1; Thomas Y, 2012, MAR POLLUT BULL, V65, P441, DOI 10.1016/j.marpolbul.2011.12.027; Thomas Y, 2016, ESTUAR COAST SHELF S, V182, P283, DOI 10.1016/j.ecss.2016.03.010; Thomas Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095050; Tidwell JH, 2001, EMBO REP, V2, P958, DOI 10.1093/embo-reports/kve236; Tomaru Y, 1999, FISHERIES SCI, V65, P358, DOI 10.2331/fishsci.65.358; Truelove NK, 2017, CORAL REEFS, V36, P233, DOI 10.1007/s00338-016-1516-y; Varotsos CA, 2016, ATMOS CHEM PHYS, V16, P2007, DOI 10.5194/acp-16-2007-2016; Viikmae B, 2013, OCEAN DYNAM, V63, P589, DOI 10.1007/s10236-013-0615-3; Warnes GR, 2020, GENTLEMAN R R PACKAG; Wessel Paul, 2013, Eos, Transactions American Geophysical Union, V94, P409, DOI 10.1002/2013EO450001; Wood S, 2014, GLOBAL ECOL BIOGEOGR, V23, P1, DOI 10.1111/geb.12101	57	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234605	10.1371/journal.pone.0234605	http://dx.doi.org/10.1371/journal.pone.0234605			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555587	gold, Green Published			2022-12-26	WOS:000543273200029
J	Mizuki, I; Ito, H; Yamasaki, M; Fukumoto, S; Okamoto, Y; Katsuki, M; Fukushima, K; Sakai, M; Sakaguchi, S; Fujiki, D; Nakagawa, H; Ishihara, MI; Takayanagi, A				Mizuki, Inoue; Ito, Hiroki; Yamasaki, Michimasa; Fukumoto, Shigeru; Okamoto, Yuuki; Katsuki, Masaya; Fukushima, Keitaro; Sakai, Masaru; Sakaguchi, Shota; Fujiki, Daisuke; Nakagawa, Hikaru; Ishihara, Masae Iwamoto; Takayanagi, Atsushi			Seasonal and annual fluctuations of deer populations estimated by a Bayesian state-space model	PLOS ONE			English	Article							SIKA-DEER; CARRYING-CAPACITY; EASTERN HOKKAIDO; RED DEER; DYNAMICS; MIGRATION; IMPACTS; HABITAT; WEATHER; FOREST	Deer overabundance is a contributing factor in the degradation of plant communities and ecosystems worldwide. The management and conservation of the deer-affected ecosystems requires us to urgently grasp deer population trends and to identify the factors that affect them. In this study, we developed a Bayesian state-space model to estimate the population dynamics of sika deer (Cervus nippon) in a cool-temperate forest in Japan, where wolves (Canis lupus hodophilax) are extinct. The model was based on field data collected from block count surveys, road count surveys by vehicles, mortality surveys during the winter, and nuisance control for 12 years (2007-2018). We clarified the seasonal and annual fluctuation of the deer population. We found a peak of deer abundance (2010) over 12 years. In 2011 the estimated deer abundance decreased drastically and has remained at a low level then. The deer abundance gradually increased from April to December during 2013-2018. The seasonal fluctuation we detected could reflect the seasonal migration pattern of deer and the population recruitment through fawn births in early summer. In our model, snowfall accumulation, which can be a lethal factor for deer, may have slightly affected their mortality during the winter. Although we could not detect a direct effect of snow on population dynamics, snowfall decrease due to global warming may decelerate the winter migration of deer; subsequently, deer staying on-site may intensively forage evergreen perennial plants during the winter season. The nuisance control affected population dynamics. Even in wildlife protection areas and national parks where hunting is regulated, nuisance control could be effective in buffering the effect of deer browsing on forest ecosystems.	[Mizuki, Inoue; Okamoto, Yuuki; Katsuki, Masaya] Nihon Univ, Coll Humanities & Sci, Dept Biosci, Tokyo, Japan; [Ito, Hiroki] Forestry & Forest Prod Res Inst, Hokkaido Res Ctr, Sapporo, Hokkaido, Japan; [Yamasaki, Michimasa; Takayanagi, Atsushi] Kyoto Univ, Grad Sch Agr, Lab Forest Biol, Kyoto, Japan; [Fukumoto, Shigeru] Gen Off Hirano Cho, Osaka, Japan; [Fukushima, Keitaro] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Sakai, Masaru] Natl Inst Environm Studies, Fukushima Branch, Tsukuba, Ibaraki, Japan; [Sakaguchi, Shota] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan; [Fujiki, Daisuke] Univ Hyogo, Inst Nat & Environm Sci, Sanda, Hyogo, Japan; [Nakagawa, Hikaru] Kyoto Univ, Ctr Southeast Asian Studies, Kyoto, Japan; [Ishihara, Masae Iwamoto] Kyoto Univ, Field Sci Educ & Res Ctr, Kyoto, Japan	Nihon University; Forestry & Forest Products Research Institute - Japan; Kyoto University; Kyoto University; National Institute for Environmental Studies - Japan; Kyoto University; University of Hyogo; Kyoto University; Kyoto University	Mizuki, I (corresponding author), Nihon Univ, Coll Humanities & Sci, Dept Biosci, Tokyo, Japan.	mizuki@chs.nihon-u.ac.jp	Fukushima, Keitaro/J-9598-2017; Yamasaki, Michimasa/I-1757-2019; Nakagawa, Hikaru/HGC-7805-2022; Sakai, Masaru/R-3927-2018	Fukushima, Keitaro/0000-0001-5968-5938; Nakagawa, Hikaru/0000-0001-8908-2011; Ito, Hiroki/0000-0003-2243-1007; MIZUKI, INOUE/0000-0001-7390-3655; Sakai, Masaru/0000-0001-5361-0978; Yamasaki, Michimasa/0000-0002-0724-9234	28th PRO NATURA FUND from Pro Natura Foundation Japan	28th PRO NATURA FUND from Pro Natura Foundation Japan	Financial support was provided by the 28th PRO NATURA FUND from Pro Natura Foundation Japan (http://www.pronaturajapan.com/foundation/pronaturafund/30pnfbosyu).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi N, 1999, FOREST ECOL MANAG, V113, P75, DOI 10.1016/S0378-1127(98)00415-0; [Anonymous], 2013, TEXTS STAT SCI SERIE; Bonardi A, 2017, INTEGR ZOOL, V12, P61, DOI 10.1111/1749-4877.12237; Calder C, 2003, ECOLOGY, V84, P1395, DOI 10.1890/0012-9658(2003)084[1395:IMSOSI]2.0.CO;2; Ciach M, 2018, INT J BIOMETEOROL, V62, P2173, DOI 10.1007/s00484-018-1619-y; Clark JS, 2004, ECOLOGY, V85, P3140, DOI 10.1890/03-0520; Commandeur J. J. F., 2007, INTRO STATE SPACE TI; Coulson T, 2004, ECOLOGY, V85, P411, DOI 10.1890/03-0009; Filazzola A, 2014, FOREST ECOL MANAG, V313, P10, DOI 10.1016/j.foreco.2013.10.040; Fujiki D, 2018, J FOREST RES-JPN, V23, P260, DOI 10.1080/13416979.2018.1488653; Fujiki D, 2010, J FOREST RES-JPN, V15, P140, DOI 10.1007/s10310-009-0172-2; Fukuda A., 2008, Forest Research, Kyoto, P5; Fuller RJ, 2001, FORESTRY, V74, P193, DOI 10.1093/forestry/74.3.193; Gabry J, 2019, J R STAT SOC A STAT, V182, P389, DOI 10.1111/rssa.12378; GILL RMA, 1992, FORESTRY, V65, P145, DOI 10.1093/forestry/65.2.145; Goda R., 2008, Forest Research, Kyoto, P89; Hagen R, 2018, EUR J WILDLIFE RES, V64, DOI 10.1007/s10344-018-1204-z; HOBBS NT, 1985, J WILDLIFE MANAGE, V49, P814, DOI 10.2307/3801716; Igota H, 2004, ECOL RES, V19, P169, DOI 10.1111/j.1440-1703.2003.00621.x; Iijima H, 2016, J MAMMAL, V97, P734, DOI 10.1093/jmammal/gyw001; Iijima H, 2013, J WILDLIFE MANAGE, V77, P1038, DOI 10.1002/jwmg.556; KAJI K, 1988, ACTA THERIOL, V33, P187, DOI 10.4098/AT.arch.88-15; KATO M, 1990, Contributions from the Biological Laboratory Kyoto University, V27, P309; Kato Makoto, 2004, Contributions from the Biological Laboratory Kyoto University, V29, P437; Kawase H, 2015, J METEOROL SOC JPN, V93, P571, DOI 10.2151/jmsj.2015-034; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Loison A, 1998, OECOLOGIA, V116, P489, DOI 10.1007/s004420050614; Marshal JP, 2016, EUR J WILDLIFE RES, V62, P549, DOI 10.1007/s10344-016-1027-8; Mizuki I, 2013, J FOREST RES-JPN, V18, P491, DOI 10.1007/s10310-012-0379-5; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Pellerin M, 2017, WILDLIFE BIOL, DOI 10.2981/wlb.00274; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Royle J. A., 2008, HIERARCHICAL MODELIN; Sakaguchi S., 2012, Forest Research, Kyoto, P71; Stan Development Team, 2019, RSTAN VERS 2 18 2 SO; TAKATSUKI S, 1994, ECOL RES, V9, P215, DOI 10.1007/BF02347497; Takatsuki S, 2009, BIOL CONSERV, V142, P1922, DOI 10.1016/j.biocon.2009.02.011; Takeshita K, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2398; Takeshita K, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-017-1128-z; Takii A, 2012, MAMM STUDY, V37, P331, DOI 10.3106/041.037.0407; Tanaka Y., 2008, Forest Research, Kyoto, P13; Trenkel VM, 2000, J AM STAT ASSOC, V95, P363, DOI 10.2307/2669373; Ueno M, 2018, WILDLIFE RES, V45, P143, DOI 10.1071/WR17103; Uno H, 2006, ECOL RES, V21, P624, DOI 10.1007/s11284-006-0158-x; Valente AM, 2016, EUR J WILDLIFE RES, V62, P577, DOI 10.1007/s10344-016-1030-0	45	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0225872	10.1371/journal.pone.0225872	http://dx.doi.org/10.1371/journal.pone.0225872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555639	gold, Green Published, Green Submitted			2022-12-26	WOS:000543273200002
J	Tan, A; Blakeway, LV; Taha; Yang, YD; Zhou, YQ; Atack, JM; Peak, IR; Seib, KL				Tan, Aimee; Blakeway, Luke V.; Taha; Yang, Yuedong; Zhou, Yaoqi; Atack, John M.; Peak, Ian R.; Seib, Kate L.			Moraxella catarrhalisphase-variable loci show differences in expression during conditions relevant to disease	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SURFACE-PROTEINS A1; PHASE VARIATION; NEISSERIA-MENINGITIDIS; TETRANUCLEOTIDE REPEAT; CONTINGENCY LOCI; EPITHELIAL-CELLS; USPA1 PROTEIN; OTITIS-MEDIA; DNA REPEATS	Moraxella catarrhalisis a human-adapted, opportunistic bacterial pathogen of the respiratory mucosa. Although asymptomatic colonization of the nasopharynx is common,M.catarrhaliscan ascend into the middle ear, where it is a prevalent causative agent of otitis media in children, or enter the lower respiratory tract, where it is associated with acute exacerbations of chronic obstructive pulmonary disease in adults. Phase variation is the high frequency, random, reversible switching of gene expression that allows bacteria to adapt to different host microenvironments and evade host defences, and is most commonly mediated by simple DNA sequence repeats. Bioinformatic analysis of five closedM.catarrhalisgenomes identified 17 unique simple DNA sequence repeat tracts that were variable between strains, indicating the potential to mediate phase variable expression of the associated genes. Assays designed to assess simple sequence repeat variation under conditions mimicking host infection demonstrated that phase variation ofuspA1(ubiquitous surface protein A1) from high to low expression occurs over 72 hours of biofilm passage, while phase variation ofuspA2(ubiquitous surface protein A2) to high expression variants occurs during repeated exposure to human serum, as measured by mRNA levels. We also identify and confirm the variable expression of two novel phase variable genes encoding a Type III DNA methyltransferase (modO), and a conserved hypothetical permease (MC25239_RS00020). These data reveal the repertoire of phase variable genes mediated by simple sequence repeats inM.catarrhalisand demonstrate that modulation of expression under conditions mimicking human infection is attributed to changes in simple sequence repeat length.	[Tan, Aimee; Blakeway, Luke V.; Taha; Yang, Yuedong; Zhou, Yaoqi; Atack, John M.; Peak, Ian R.; Seib, Kate L.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Peak, Ian R.] Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia; [Tan, Aimee] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Yang, Yuedong] Sun Yat Sen Univ, Sch Data & Comp Sci, Guangzhou, Peoples R China	Griffith University; Griffith University; University of Melbourne; Sun Yat Sen University	Seib, KL (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.	k.seib@griffith.edu.au	Seib, Kate L/B-4670-2015; Tan, Aimee/AAJ-5171-2021; Zhou, Yaoqi/ABD-1125-2020; Zhou, Yaoqi/B-3284-2009; Peak, Ian R/C-5677-2009	Seib, Kate L/0000-0002-7094-3528; Tan, Aimee/0000-0002-7257-1051; Zhou, Yaoqi/0000-0002-9958-5699; 	Australian National Health and Medical Research Council (NHMRC) [1099279]; Garnett Passe and Rodney Williams Memorial Foundation; Australian Government Research Training Program Scholarship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Garnett Passe and Rodney Williams Memorial Foundation; Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by the Australian National Health and Medical Research Council (NHMRC) [Career Development Fellowship to KLS; Project Grant 1099279 to KLS, JMA], the Garnett Passe and Rodney Williams Memorial Foundation [Fellowship to AT and Grant in Aid Supplementation to KLS and JMA], and an Australian Government Research Training Program Scholarship to LVB. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. https://www.nhmrc.gov.au/funding https://gprwmf.org.au/https://www.education.gov.au/research-training-program	Aebi C, 1998, INFECT IMMUN, V66, P3113, DOI 10.1128/IAI.66.7.3113-3119.1998; [Anonymous], 2014, PEERJ, V2, pe447; [Anonymous], 2017, LANCET GLOBAL HLTH, V5, pe428; Atack JM, 2018, NUCLEIC ACIDS RES, V46, P3532, DOI 10.1093/nar/gky192; Atack JM, 2015, J INFECT DIS, V212, P645, DOI 10.1093/infdis/jiv103; Attia AS, 2006, J BACTERIOL, V188, P7840, DOI 10.1128/JB.01204-06; Attia AS, 2006, INFECT IMMUN, V74, P1597, DOI 10.1128/IAI.74.3.1597-1611.2006; Bayliss CD, 2006, NUCLEIC ACIDS RES, V34, P4046, DOI 10.1093/nar/gkl568; Berne C, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0018-2015; Berrington AW, 2002, FEMS IMMUNOL MED MIC, V34, P267, DOI 10.1016/S0928-8244(02)00369-3; Blakeway LV, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1660-y; Blakeway LV, 2014, FASEB J, V28, P5197, DOI 10.1096/fj.14-256578; Blakeway LV, 2018, GENOME BIOL EVOL; Blakeway LV, 2017, MICROBIOLOGY; BOSWELL JB, 1995, ANN OTO RHINOL LARYN, V104, P542, DOI 10.1177/000348949510400708; Brooks MJ, 2008, INFECT IMMUN, V76, P5330, DOI 10.1128/IAI.00573-08; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dawid S, 1999, P NATL ACAD SCI USA, V96, P1077, DOI 10.1073/pnas.96.3.1077; De Bolle X, 2000, MOL MICROBIOL, V35, P211, DOI 10.1046/j.1365-2958.2000.01701.x; de Vries SPW, 2010, J BACTERIOL, V192, P3574, DOI 10.1128/JB.00121-10; Fox KL, 2007, NUCLEIC ACIDS RES, V35, P5242, DOI 10.1093/nar/gkm571; Gally DL, 1996, MOL MICROBIOL, V21, P725, DOI 10.1046/j.1365-2958.1996.311388.x; Hill DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045452; Hood DW, 1996, P NATL ACAD SCI USA, V93, P11121, DOI 10.1073/pnas.93.20.11121; Idicula WK, 2016, LARYNGOSCOPE, V126, P1946, DOI 10.1002/lary.25826; Jen FEC, 2019, METHODS MOL BIOL, V1969, P93, DOI 10.1007/978-1-4939-9202-7_6; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lafontaine ER, 2000, J BACTERIOL, V182, P1364, DOI 10.1128/JB.182.5.1364-1373.2000; Lafontaine ER, 2001, J BACTERIOL, V183, P1540, DOI 10.1128/JB.183.5.1540-1551.2001; Lehmann D, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-32; Liguori A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005557; Manso AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6055; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; Martin P, 2003, MOL MICROBIOL, V50, P245, DOI 10.1046/j.1365-2958.2003.03678.x; Metruccio MME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000710; Mollenkvist A, 2003, J BACTERIOL, V185, P2285, DOI 10.1128/JB.185.7.2285-2295.2003; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Murphy TF, 2019, J INFECT DIS, V219, P1448, DOI 10.1093/infdis/jiy680; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Pearson MM, 2006, INFECT IMMUN, V74, P1588, DOI 10.1128/IAI.74.3.1588-1596.2006; Pearson MM, 2002, INFECT IMMUN, V70, P4523, DOI 10.1128/IAI.70.8.4523-4533.2002; Perez AC, 2017, HUM VACC IMMUNOTHER, V13, P2322, DOI [10.1080/21645515.2017.1374522, 10.1080/21645515.2017.1356951]; Pettigrew MM, 2017, OTOLARYNG HEAD NECK, V156, pS76, DOI 10.1177/0194599816632178; Phillips ZN, 2019, BIOCH SOC T; Pichichero ME, 2000, PEDIATR INFECT DIS J, V19, P911, DOI 10.1097/00006454-200009000-00034; Poole J, 2013, J INFECT DIS, V208, P720, DOI 10.1093/infdis/jit240; Post J Christopher, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P185, DOI 10.1097/01.moo.0000124936.46948.6a; Power PM, 2009, INFECT GENET EVOL, V9, P216, DOI 10.1016/j.meegid.2008.11.006; SARKARI J, 1994, MOL MICROBIOL, V13, P207, DOI 10.1111/j.1365-2958.1994.tb00416.x; Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x; Seib KL, 2011, FASEB J, V25, P3622, DOI 10.1096/fj.11-183590; Seib KL, 2002, FEMS IMMUNOL MED MIC, V32, P159; Snyder LAS, 2001, MICROBIOL-SGM, V147, P2321, DOI 10.1099/00221287-147-8-2321; Srikhanta YN, 2005, P NATL ACAD SCI USA, V102, P5547, DOI 10.1073/pnas.0501169102; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Suissa S, 2012, THORAX, V67, P957, DOI 10.1136/thoraxjnl-2011-201518; Tan A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39374-0; Tan A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00586; Tan TT, 2006, J INFECT DIS, V194, P493, DOI 10.1086/505581; Tan TT, 2005, J INFECT DIS, V192, P1029, DOI 10.1086/432759; Thornton RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053837; van der Ende A, 2000, INFECT IMMUN, V68, P6685, DOI 10.1128/IAI.68.12.6685-6690.2000; VANEECHOUTTE M, 1990, J CLIN MICROBIOL, V28, P2674, DOI 10.1128/JCM.28.12.2674-2680.1990; Wang W, 2007, INFECT IMMUN, V75, P2035, DOI 10.1128/IAI.00609-06; WATSON DS, 1992, AUST J PUBLIC HEALTH, V16, P26; Wirth T, 2007, GENOME RES, V17, P1647, DOI 10.1101/gr.6122607; World Health Organisation, 2012, TOP 10 CAUS DEATH; 2014, REG ANESTH PAIN MED, V9	71	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234306	10.1371/journal.pone.0234306	http://dx.doi.org/10.1371/journal.pone.0234306			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555615	Green Published, gold			2022-12-26	WOS:000543273200077
J	Cornelius, DC; Travis, OK; Tramel, RW; Borges-Rodriguez, M; Baik, CH; Greer, M; Giachelli, CA; Tardo, GA; Williams, JM				Cornelius, Denise C.; Travis, Olivia K.; Tramel, Robert W.; Borges-Rodriguez, Marivee; Baik, Cedar H.; Greer, Mallory; Giachelli, Chelsea A.; Tardo, Geilda A.; Williams, Jan M.			NLRP3 inflammasome inhibition attenuates sepsis-induced platelet activation and prevents multi-organ injury in cecal-ligation puncture	PLOS ONE			English	Article							FLUORESCEIN-LABELED SINISTRIN; ACUTE KIDNEY INJURY; ACUTE LUNG INJURY; PROTECTS; MARKER; ROLES	Sepsis is characterized by organ dysfunction due to a dysregulated immune response to infection. Currently, no effective treatment for sepsis exists. Platelets are recognized as mediators of the immune response and may be a potential therapeutic target for the treatment of sepsis. We previously demonstrated that NLRP3 inflammasome activation in sepsis-induced activated platelets was associated with multi-organ injury in the cecal-ligation puncture (CLP) rat model of sepsis. In this study, we tested the hypothesis that inhibition of NLRP3 would inhibit platelet activation and attenuate multi-organ injury in the CLP rat. CLP (n = 10) or Sham (n = 10) surgery were performed in male and female Sprague-Dawley rats. A subset of CLP rats were treated with MCC950 (50mg/kg/d), a specific NLRP3 inhibitor (CLP+MCC950, n = 10). At 72 hrs. post-CLP, blood and organs were harvested for analysis of platelet activation, NLRP3 activation, inflammation and end organ damage. Platelet activation increased from 8 +/- 0.8% in Sham to 16 +/- 1% in CLP, and was reduced to 9 +/- 1% in CLP+M rats (p<0.05). NLRP3 activation was also increased in platelets of CLP vs Sham. NLRP3 expression was unchanged in kidney and lung after CLP, but Caspase 1 expression and IL-1 beta were increased. MCC950 treatment attenuated NLRP3 activation in platelets. Plasma, kidney, and lung levels of NLRP3 inflammasome associated cytokines, IL-1ss and IL-18, were significantly increased in CLP compared to Sham rats. Inhibition of NLRP3 normalized cytokine levels. Glomerular injury, pulmonary edema, and endothelial dysfunction markers were increased in CLP rats vs Sham. MCC950 treatment significantly decreased renal and pulmonary injury and endothelial dysfunction in CLP+M. Our results demonstrate a role for NLRP3 in contributing to platelet activation and multi-organ injury in sepsis.	[Cornelius, Denise C.; Tramel, Robert W.; Baik, Cedar H.; Greer, Mallory; Giachelli, Chelsea A.; Tardo, Geilda A.] Univ Mississippi, Med Ctr, Dept Emergency Med, Jackson, MS 39216 USA; [Cornelius, Denise C.; Travis, Olivia K.; Williams, Jan M.] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Cornelius, Denise C.; Travis, Olivia K.; Williams, Jan M.] Univ Mississippi, Med Ctr, Cardiovasc Renal Res Ctr, Jackson, MS 39216 USA; [Borges-Rodriguez, Marivee] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Cornelius, DC (corresponding author), Univ Mississippi, Med Ctr, Dept Emergency Med, Jackson, MS 39216 USA.; Cornelius, DC (corresponding author), Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA.; Cornelius, DC (corresponding author), Univ Mississippi, Med Ctr, Cardiovasc Renal Res Ctr, Jackson, MS 39216 USA.	dcornelius@umc.edu		Tramel, Robert/0000-0002-5489-1086; Travis, Olivia/0000-0001-7392-9054; Williams, Jan/0000-0002-7078-9567; Cornelius, Denise/0000-0002-6730-6499	NHLBI/NIH [HL103456]; NIGMS/NIH [P20GM104357]; NIDDK/NIH [DK109133]; IDeA COBRE award from the NIGMS/NIH [GM103328]	NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); IDeA COBRE award from the NIGMS/NIH	DCC is supported by funds from the NHLBI/NIH HL103456 and NIGMS/NIH P20GM104357. JMW is supported by funds from the NIDDK/NIH DK109133. A portion of this research was conducted in the Imaging Core of the Center for Psychiatric Neuroscience, funded through an IDeA COBRE award from the NIGMS/NIH (GM103328).	Abderrazak A, 2015, REDOX BIOL, V4, P296, DOI 10.1016/j.redox.2015.01.008; Bagshaw SM, 2009, INTENS CARE MED, V35, P871, DOI 10.1007/s00134-008-1367-2; Brown GT, 2013, J IMMUNOL, V191, P5196, DOI 10.4049/jimmunol.1300354; Cornelius DC, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14073; de Stoppelaar SF, 2014, THROMB HAEMOSTASIS, V112, P666, DOI 10.1160/TH14-02-0126; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Gong ZZ, 2015, MOL NUTR FOOD RES, V59, P2132, DOI 10.1002/mnfr.201500316; Greco E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102200; Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Jiao JH, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00037; Kalbitz M, 2016, FASEB J, V30, P3997, DOI 10.1096/fj.201600728R; Layios N, 2017, INTENS CARE MED EXP, V5, DOI 10.1186/s40635-017-0145-2; Long HB, 2016, AM J EMERG MED, V34, P772, DOI 10.1016/j.ajem.2015.12.075; Luo YP, 2014, INT IMMUNOPHARMACOL, V20, P24, DOI 10.1016/j.intimp.2014.02.017; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Miyashita T, 2016, IN VIVO, V30, P341; Moon JS, 2015, J CLIN INVEST, V125, P665, DOI 10.1172/JCI78253; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; Pill J, 2005, EUR J MED CHEM, V40, P1056, DOI 10.1016/j.ejmech.2005.03.020; Pill J, 2006, N-S ARCH PHARMACOL, V373, P204, DOI 10.1007/s00210-006-0067-0; Poston JT, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k4891; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Russwurm S, 2002, SHOCK, V17, P263, DOI 10.1097/00024382-200204000-00004; Schock-Kusch D, 2009, NEPHROL DIAL TRANSPL, V24, P2997, DOI 10.1093/ndt/gfp225; Shao BZ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00262; Steinhagen F, PHARM THER, V2020, P107476; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Umbro I, 2016, J INFECTION, V72, P131, DOI 10.1016/j.jinf.2015.11.008; Vincent JL, 2011, CRIT CARE MED, V39, P1050, DOI 10.1097/CCM.0b013e31820eda29; Wang P, 2015, INT J MOL SCI, V16, P20595, DOI 10.3390/ijms160920595; Wang RQ, 2017, LAB INVEST, V97, P922, DOI 10.1038/labinvest.2017.30; Xu KY, 2018, BIOCHEM BIOPH RES CO, V503, P3031, DOI 10.1016/j.bbrc.2018.08.089; Zhang C, 2012, HYPERTENSION, V60, P154, DOI 10.1161/HYPERTENSIONAHA.111.189688; Zhang XY, 2018, DIGEST DIS SCI, V63, P81, DOI 10.1007/s10620-017-4801-x; Zhong YJ, 2020, MOL IMMUNOL, V122, P80, DOI 10.1016/j.molimm.2020.03.020	37	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234039	10.1371/journal.pone.0234039	http://dx.doi.org/10.1371/journal.pone.0234039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555710	Green Published, gold			2022-12-26	WOS:000542759600007
J	Fabianska, I; Pesch, L; Koebke, E; Gerlach, N; Bucher, M				Fabianska, Izabela; Pesch, Lina; Koebke, Eva; Gerlach, Nina; Bucher, Marcel			Neighboring plants divergently modulate effects of loss-of-function in maize mycorrhizal phosphate uptake on host physiology and root fungal microbiota	PLOS ONE			English	Article							TRANSPORTER; GENE; DIVERSITY; PATHWAY; GROWTH; SOIL; COLONIZATION; ABUNDANCE; RESPONSES; NITROGEN	Maize, a main crop worldwide, establishes a mutualistic symbiosis with arbuscular mycorrhizal (AM) fungi providing nutrients to the roots from soil volumes which are normally not in reach of the non-colonized root. The mycorrhizal phosphate uptake pathway (MPU) spans from extraradical hyphae to root cortex cells housing fungal arbuscules and promotes the supply of phosphate to the mycorrhizal host in exchange for photosynthetic carbon. This symbiotic association with the mycobiont has been shown to affect plant host nutritional status and growth performance. However, whether and how the MPU affects the root microbial community associated with mycorrhizal hosts in association with neighboring plants, remains to be demonstrated. Here the maize germinal Mu transposon insertion mutantpht1;6, defective in mycorrhiza-specific Pi transporterPHT1;6gene, and wild type B73 (wt) plants were grown in mono- and mixed culture and examined under greenhouse and field conditions. Disruption of the MPU inpht1;6resulted in strongly diminished growth performance, in reduced P allocation to photosynthetic source leaves, and in imbalances in leaf elemental composition beyond P. At the microbial community level a loss of MPU activity had a minor effect on the root-associated fungal microbiome which was almost fully restricted to AM fungi of the Glomeromycotina. Moreover, while wt grew better in presence ofpht1;6,pht1;6accumulated little biomass irrespective of whether it was grown in mono- or mixed culture and despite of an enhanced fungal colonization of its roots in co-culture with wt. This suggested that a functional MPU is prerequisite to maintain maize growth and that neighboring plants competed for AM fungal Pi in low P soil. Thus future strategies towards improving yield in maize populations on soils with low inputs of P fertilizer could be realized by enhancing MPU at the individual plant level while leaving the root-associated fungal community largely unaffected.	[Fabianska, Izabela; Pesch, Lina; Koebke, Eva; Gerlach, Nina; Bucher, Marcel] Univ Cologne, Inst Plant Sci, Cologne Bioctr, Cologne, Germany; [Bucher, Marcel] Univ Cologne, Cluster Excellence Plant Sci, Cologne, Germany	University of Cologne; University of Cologne	Bucher, M (corresponding author), Univ Cologne, Inst Plant Sci, Cologne Bioctr, Cologne, Germany.; Bucher, M (corresponding author), Univ Cologne, Cluster Excellence Plant Sci, Cologne, Germany.	m.bucher@uni-koeln.de	Bucher, Marcel/D-4596-2013	Bucher, Marcel/0000-0003-1680-9413; Fabianska, Izabela/0000-0002-8440-682X; Pesch, Lina/0000-0002-1828-7447	University of Cologne; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Initiative [EXC-1028]	University of Cologne; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Initiative(German Research Foundation (DFG))	This project has been funded by University of Cologne and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany ' s Excellence Initiative (EXC-1028). There was no additional external funding received for this study	[Anonymous], 2018, DTSCH ARZTEBL, V115, pA; [Anonymous], 2007, NPSA, V22, P1; [Anonymous], 2017, DTSCH ZRZTEBLATT JG, V114, pA741; [Anonymous], 2016, LANCET ONCOL, V17, pe198; [Anonymous], 2017, EUR J TRANSL MYOL, V27, p7X; [Anonymous], 2018, DTSCH ARZTEBL, V115, pA; Banhara A, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.2015.00667, 10.3389/fpfs.2015.00667]; Berg G, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00148, 10.3389/fmicb.2014.00491]; Bucher M, 2007, NEW PHYTOL, V173, P11, DOI 10.1111/j.1469-8137.2006.01935.x; Carmichael SK, 2015, ENV MICROBIOL REP, V7, P592, DOI 10.1111/1758-2229.12291; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Delaux PM, 2015, P NATL ACAD SCI USA, V112, P13390, DOI 10.1073/pnas.1515426112; Engelmoer DJP, 2015, NEW PHYTOL, V205, P1485, DOI 10.1111/nph.13086; Fabianska I, 2019, CURR OPIN MICROBIOL, V49, P90, DOI 10.1016/j.mib.2019.10.004; Fabianska Izabela, 2019, New Phytol, V221, P2123, DOI 10.1111/nph.15538; Fuentes-Arderiu X, 2013, BIOCHEM MEDICA, V23, P141, DOI 10.11613/BM.2013.017; Gerlach N, 2015, PLANT CELL ENVIRON, V38, P1591, DOI 10.1111/pce.12508; Gilbert N, 2009, NATURE, V461, P716, DOI 10.1038/461716a; Giovannetti M, 2004, NEW PHYTOL, V164, P175, DOI 10.1111/j.1469-8137.2004.01145.x; Gomes EA, 2018, PHYTOBIOMES J, V2, P129, DOI 10.1094/PBIOMES-03-18-0012-R; Groten K, 2015, PLANT CELL ENVIRON, V38, P2398, DOI 10.1111/pce.12561; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Hassani MA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0445-0; Hiruma K, 2016, CELL, V165, P464, DOI 10.1016/j.cell.2016.02.028; Hohnjec N, 2003, MOL PLANT MICROBE IN, V16, P903, DOI 10.1094/MPMI.2003.16.10.903; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Javot H, 2011, PLANT J, V68, P954, DOI 10.1111/j.1365-313X.2011.04746.x; Jiang YN, 2017, SCIENCE, V356, P1172, DOI 10.1126/science.aam9970; Karandashov V, 2004, P NATL ACAD SCI USA, V101, P6285, DOI 10.1073/pnas.0306074101; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Kobae Y, 2010, PLANT CELL PHYSIOL, V51, P341, DOI 10.1093/pcp/pcq013; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lota F, 2013, PLANT J, V74, P280, DOI 10.1111/tpj.12120; Loth-Pereda V, 2011, PLANT PHYSIOL, V156, P2141, DOI 10.1104/pp.111.180646; Luginbuehl LH, 2017, SCIENCE, V356, P1175, DOI 10.1126/science.aan0081; Lynn Margulis, 1991, SYMBIOGENESIS SYMBIO, P1; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Nagy R, 2006, PLANT BIOLOGY, V8, P186, DOI 10.1055/s-2005-873052; Nagy R, 2009, NEW PHYTOL, V181, P950, DOI 10.1111/j.1469-8137.2008.02721.x; Okubo A, 2009, ECOL RES, V24, P1399, DOI 10.1007/s11284-009-0602-9; Paszkowski U, 2002, P NATL ACAD SCI USA, V99, P13324, DOI 10.1073/pnas.202474599; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Pimprikar P, 2018, PLANT CELL PHYSIOL, V59, P678, DOI 10.1093/pcp/pcy024; Rausch C, 2004, PLANT J, V39, P13, DOI 10.1111/j.1365-313X.2004.02106.x; Rausch C, 2001, NATURE, V414, P462, DOI 10.1038/35106601; Saravanakumar K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01680-w; Sawers RJH, 2017, NEW PHYTOL, V214, P632, DOI 10.1111/nph.14403; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Schluter U, 2012, PLANT PHYSIOL, V160, P1384, DOI 10.1104/pp.112.204420; Simon JC, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0619-4; Smith SE, 2004, NEW PHYTOL, V162, P511, DOI 10.1111/j.1469-8137.2004.01039.x; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; Spatafora JW, 2016, MYCOLOGIA, V108, P1028, DOI 10.3852/16-042; The Gene Ontology Consortium, 2019, NUCL ACIDS RES, V47, pD330; Thiergart T, 2019, MBIO, V10, DOI 10.1128/mBio.01833-19; Tkacz A, 2015, ISME J, V9, P2349, DOI 10.1038/ismej.2015.41; Toju H, 2018, NAT PLANTS, V4, P247, DOI 10.1038/s41477-018-0139-4; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Wagner MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12151; Walder F, 2012, PLANT PHYSIOL, V159, P789, DOI 10.1104/pp.112.195727; Walters WA, 2018, P NATL ACAD SCI USA, V115, P7368, DOI 10.1073/pnas.1800918115; Willmann M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00533; Xue L, 2019, NEW PHYTOL, V224, P409, DOI 10.1111/nph.15958; Yu P, 2018, NEW PHYTOL, V217, P1240, DOI 10.1111/nph.14893; [No title captured]	66	3	3	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0232633	10.1371/journal.pone.0232633	http://dx.doi.org/10.1371/journal.pone.0232633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555651	Green Published, gold			2022-12-26	WOS:000542759600038
J	Newton, A; Predina, J; Mison, M; Runge, J; Bradley, C; Stefanovski, D; Singhal, S; Holt, D				Newton, Andrew; Predina, Jarrod; Mison, Michael; Runge, Jeffrey; Bradley, Charles; Stefanovski, Darko; Singhal, Sunil; Holt, David			Intraoperative near-infrared imaging can identify canine mammary tumors, a spontaneously occurring, large animal model of human breast cancer	PLOS ONE			English	Article							CARCINOMA-IN-SITU; EUROPEAN ORGANIZATION; CONSERVING THERAPY; MARGIN ASSESSMENT; LUNG-CANCER; FLUORESCENCE; SURGERY; LUMPECTOMY; CONSERVATION; BIOPSY	Introduction Current methods of intraoperative margin assessment in breast conserving surgery are impractical, unreliable, or time consuming. We hypothesized that intraoperative near-infrared (NIR) imaging with an FDA-approved NIR optical contrast agent could identify canine mammary tumors, a spontaneous large animal model of human breast cancer, during surgery. Methods Dogs with mammary tumors underwent a standard of care lumpectomy or mastectomy with wide surgical margins 20 hours after indocyanine green administration (3 mg/kg IV). During surgery, NIR imaging was performed on tumors and wound marginsin situand tumors and lymph nodesex vivo. Following resection, the wound bed was examined for residual fluorescence. Fluorescence intensity was determined by signal-to-background ratio (SBR). All tumors, areas of residual fluorescence, and lymph nodes underwent histopathologic analysis. Results There were 41 mammary tumors in 16 female dogs. Twenty tumors were malignant and 21 were benign. Twenty-eight tumors were fluorescent (mean SBR 1.5 +/- 0.2). Sensitivity of fluorescence for all malignant tumors was 80% (16/20) and 93.3% (14/15) for malignant tumors > 2 cm. Specificity for malignancy was low (< 2cm = 55%; > 2cm = 30%). Tumors > 2 cm were more likely to be fluorescent (OR 6.05, 95% CI 1.50-24.44, P = 0.011) but not more likely to be malignant (OR 3.09, 95% CI 0.86-11.14, P = 0.085) than tumors <= 2 cm. Four out of seven inguinal lymph nodes excised in the mastectomy specimen fluoresced. All four drained malignant tumors; however only 2/4 contained metastatic disease. Conclusion Systemic ICG accumulates reliably in malignant canine mammary tumors > 2 cm. Although no tumor margins fluoresced, a wider margin of normal tissue is removed in canine mastectomy, making direct comparisons with breast conserving surgery difficult. Targeted NIR imaging agents are likely required to improve detection of smaller tumors and improve the specificity of NIR imaging for residual disease and metastatic lymph node detection.	[Newton, Andrew; Predina, Jarrod; Singhal, Sunil] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mison, Michael; Runge, Jeffrey; Holt, David] Univ Penn, Sch Vet Med, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA; [Bradley, Charles] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Stefanovski, Darko] Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Kennett Sq, PA 19348 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Holt, D (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA.	dholt@vet.upenn.edu			Mari Lowe Center for Comparative Oncology, University of Pennsylvania School of Veterinary Medicine	Mari Lowe Center for Comparative Oncology, University of Pennsylvania School of Veterinary Medicine	This study was funded by the Mari Lowe Center for Comparative Oncology, University of Pennsylvania School of Veterinary Medicine.	Abadie J, 2018, BREAST CANCER RES TR, V167, P459, DOI 10.1007/s10549-017-4542-8; ABE O, 1995, NEW ENGL J MED, V333, P1444; Baliski CR, 2017, ANN SURG ONCOL, V24, P632, DOI 10.1245/s10434-016-5678-1; Bijker N, 2001, J CLIN ONCOL, V19, P2263, DOI 10.1200/JCO.2001.19.8.2263; Boogerd LSF, 2016, ONCOTARGET, V7, P17442, DOI 10.18632/oncotarget.7856; Bos R, 2011, JNCI-J NATL CANCER I, V93, P309; Camp MS, 2013, AM J SURG, V206, P526, DOI 10.1016/j.amjsurg.2013.01.046; Chi CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083927; de Boer E, 2015, BRIT J SURG, V102, pE56, DOI 10.1002/bjs.9713; Esbona K, 2012, ANN SURG ONCOL, V19, P3236, DOI 10.1245/s10434-012-2492-2; Fidel J, 2015, CANCER RES, V75, P4283, DOI 10.1158/0008-5472.CAN-15-0471; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Goyal A, 2006, BREAST CANCER RES TR, V99, P203, DOI 10.1007/s10549-006-9192-1; Graham JC, 1999, J VET INTERN MED, V13, P416, DOI 10.1892/0891-6640(1999)013&lt;0416:TPSOAI&gt;2.3.CO;2; Gray RJ, 2001, ANN SURG ONCOL, V8, P711; Gurfinkel M, 2000, PHOTOCHEM PHOTOBIOL, V72, P94, DOI 10.1562/0031-8655(2000)072<0094:POIAHC>2.0.CO;2; Heneweer C, 2011, J NUCL MED, V52, P625, DOI 10.2967/jnumed.110.083998; Holt D, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.7.076002; Holt D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103342; Jeevan R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4505; Keating J, 2016, J SURG ONCOL, V113, P508, DOI 10.1002/jso.24167; Keating JJ, 2017, CANCER-AM CANCER SOC, V123, P1051, DOI 10.1002/cncr.30419; KleinJan GH, 2016, EUR J NUCL MED MOL I, V43, P1857, DOI 10.1007/s00259-016-3372-y; Kosaka N, 2011, INT J CANCER, V129, P1671, DOI 10.1002/ijc.26113; Krekel NMA, 2013, LANCET ONCOL, V14, P48, DOI 10.1016/S1470-2045(12)70527-2; Langhans L, 2017, JAMA SURG, V152, P378, DOI 10.1001/jamasurg.2016.4751; Liu DL, 2014, CANCER RES, V74, P5045, DOI 10.1158/0008-5472.CAN-14-0392; Madajewski B, 2012, CLIN CANCER RES, V18, P5741, DOI 10.1158/1078-0432.CCR-12-1188; Maeda H, 2011, ADV DRUG DELIVER REV, V63, P129, DOI 10.1016/j.addr.2010.05.001; MATSUMURA Y, 1986, CANCER RES, V46, P6387; McCahill LE, 2012, JAMA-J AM MED ASSOC, V307, P467, DOI 10.1001/jama.2012.43; Moore MM, 2001, ANN SURG, V233, P761, DOI 10.1097/00000658-200106000-00005; Valejo FAM, 2013, REV BRAS GINECOL OBS, V35, P221, DOI 10.1590/S0100-72032013000500006; Nguyen F, 2018, BREAST CANCER RES TR, V167, P635, DOI 10.1007/s10549-017-4548-2; Olsen MA, 2015, ANN SURG ONCOL, V22, P2003, DOI 10.1245/s10434-014-4200-x; Queiroga FL, 2011, IN VIVO, V25, P455; Reynolds JS, 1999, PHOTOCHEM PHOTOBIOL, V70, P87, DOI 10.1111/j.1751-1097.1999.tb01953.x; Samorani D, 2015, EJSO-EUR J SURG ONC, V41, P64, DOI 10.1016/j.ejso.2014.10.047; Schnabel F, 2014, ANN SURG ONCOL, V21, P1589, DOI 10.1245/s10434-014-3602-0; Schulman AM, 2017, ANN SURG ONCOL, V24, P52, DOI 10.1245/s10434-016-5516-5; Siegel R. L., 2017, CA CANC J CLIN; Sleeckx N, 2014, J COMP PATHOL, V150, P175, DOI 10.1016/j.jcpa.2013.09.005; Sorenmo KU, 2011, VET PATHOL, V48, P85, DOI 10.1177/0300985810389480; Stang A, 2013, EUR J EPIDEMIOL, V28, P689, DOI 10.1007/s10654-013-9816-9; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; Verbeek FPR, 2014, BREAST CANCER RES TR, V143, P333, DOI 10.1007/s10549-013-2802-9; Weng EY, 2000, CANCER, V88, P1643, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1643::AID-CNCR19>3.0.CO;2-O; Wilke LG, 2014, JAMA SURG, V149, P1296, DOI 10.1001/jamasurg.2014.926	49	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234791	10.1371/journal.pone.0234791	http://dx.doi.org/10.1371/journal.pone.0234791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555698	gold, Green Published			2022-12-26	WOS:000542759600009
J	Pineda, P; Deluque, A; Pena, M; Diaz, OL; Allepuz, A; Casal, J				Pineda, Pilar; Deluque, Adriana; Pena, Mario; Lucia Diaz, Olga; Allepuz, Alberto; Casal, Jordi			Descriptive epidemiology of classical swine fever outbreaks in the period 2013-2018 in Colombia	PLOS ONE			English	Article							TRANSMISSION; VIRUS	Classical swine fever (CSF) is an infectious viral disease caused by an RNA virus belonging to the Pestivirus genus. A total of 134 outbreaks of CSF have occurred in the last seven years in the North of Colombia. The objective of this study was the characterization of the herds affected by CSF from 2013 to 2018. Most of the outbreaks (95%) occured in backyard piggeries. The principal causes of transmission of CSF were the introduction of infected pigs (38%), movements of people (37%) and unknown origin (13%). The epidemiological relationships with 15 affected farms explained 31 outbreaks. The overall attack and mortality rates were 39% and 32%, respectively. The main clinical signs were high fever (67%), incoordination of movements (54%), and prostration (52%). Seventy-three percent of the herds had not been vaccinated against CSF and 17% had been only partially vaccinated. A spatio-temporal analysis, using a Poisson regression model, revealed two clusters with high risk; the first and largest one from 2014 to 2016 had a relative risk (RR) of 13.4 and included part of the departments of Atlantico, Bolivar, Cesar, La Guajira, Norte de Santander, Magdalena and Sucre; and the second cluster (RR = 9.6 in 2016) included municipalities in the north of the department of Cordoba.	[Pineda, Pilar; Allepuz, Alberto; Casal, Jordi] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Barcelona, Catalunya, Spain; [Deluque, Adriana; Pena, Mario; Lucia Diaz, Olga] Colombian Agr & Livestock Inst ICA, Bogota, Cundinamarca, Colombia; [Allepuz, Alberto; Casal, Jordi] UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Campus Univ Autonoma Barcelona, Barcelona, Catalunya, Spain; [Deluque, Adriana; Pena, Mario] Colombian Pork Producers Assoc PorkColombia, Bogota, Cundinamarca, Colombia	Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA	Pineda, P; Casal, J (corresponding author), Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Barcelona, Catalunya, Spain.; Casal, J (corresponding author), UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Campus Univ Autonoma Barcelona, Barcelona, Catalunya, Spain.	mariadelpilar.pineda@uab.cat; Jordi.casal@uab.cat	Casal, Jordi/F-3020-2016; Allepuz, Alberto/N-2398-2014	Casal, Jordi/0000-0002-6909-9366; Pineda, Maria del Pilar/0000-0001-9752-3438; Allepuz, Alberto/0000-0003-3518-1991	program PIF fellowship of the Universitat Autonoma de Barcelona (UAB) of Spain	program PIF fellowship of the Universitat Autonoma de Barcelona (UAB) of Spain	The PhD of PP was funded by the program PIF fellowship of the Universitat Autonoma de Barcelona (UAB) of Spain. The author (s) received no specific funding for this work.	Allepuz A, 2007, VET REC, V160, P398, DOI 10.1136/vr.160.12.398; Beltran-Alcrudo D, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1800-5; Blome S, 2017, VET MICROBIOL, V206, P10, DOI 10.1016/j.vetmic.2017.01.001; Blome S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040086; Elbers ARW, 2010, VET MICROBIOL, V142, P108, DOI 10.1016/j.vetmic.2009.09.051; Elbers ARW, 1999, PREV VET MED, V42, P157, DOI 10.1016/S0167-5877(99)00074-4; FAO-Food and Agriculture Organization of the United Nations, 2000, CLASS SWIN FEV ER PL, P22; Fonseca O, 2018, SPAN J AGRIC RES, V16, DOI 10.5424/sjar/2018162-12487; Fritzemeier J, 2000, VET MICROBIOL, V77, P29, DOI 10.1016/S0378-1135(00)00254-6; ICA- Direccion Tecnica de Vigilancia Epidemiologica, 2019, B EP SEM AL ACC INM; ICA- Direccion Tecnica de Vigilancia Epidemiologica, 2019, CENS PORC NAC 2018; ICA-Instituto Colombiano Agropecuario, 2018, PROGR ERR PEST PORC; IPVS 2008, 2008, IPVS 2008; Laevens H, 1998, VET QUART, V20, P41; Luo YZ, 2014, VET MICROBIOL, V172, P1, DOI 10.1016/j.vetmic.2014.04.004; Martinez-Lopez B, 2013, VET MICROBIOL, V165, P79, DOI 10.1016/j.vetmic.2013.01.045; Moennig V, 2003, VET J, V165, P11, DOI 10.1016/S1090-0233(02)00112-0; OIE, 2009, TECH DIS CARD; OIE, WAHIS LIST COUNTR DI; OIE, LIST CSF FREE MEMB C; Penrith ML, 2011, TRANSBOUND EMERG DIS, V58, P187, DOI 10.1111/j.1865-1682.2011.01205.x; POLFA F and CP of C, 2019, COMMUNICATION; Porkcolombia/FNP, 2018, INF PROYECT INV; Postel A, 2018, TRANSBOUND EMERG DIS, V65, P248, DOI 10.1111/tbed.12676; Ribbens S, 2004, VET QUART, V26, P146, DOI 10.1080/01652176.2004.9695177; Sabogal ZY, 2006, VIRUS RES, V115, P99, DOI 10.1016/j.virusres.2005.06.016; Staubach C, 1997, EPIDEMIOL SANTE ANIM, P31; Stegeman JA, 2002, EPIDEMIOL INFECT, V128, P285, DOI 10.1017/S0950268801006483; Suradhat S, 2007, VET MICROBIOL, V119, P1, DOI 10.1016/j.vetmic.2006.10.003; Teran MV, 2004, ANN NY ACAD SCI, V1026, P54, DOI 10.1196/annals.1307.007	30	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234490	10.1371/journal.pone.0234490	http://dx.doi.org/10.1371/journal.pone.0234490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555613	Green Published, gold			2022-12-26	WOS:000542759600026
J	Talmor-Barkan, Y; Chezar-Azerrad, C; Kruchin, B; Leshem-Lev, D; Levi, A; Hadar, E; Kornowski, R; Tenenbaum-Gavish, K; Porter, A				Talmor-Barkan, Yeela; Chezar-Azerrad, Chava; Kruchin, Boris; Leshem-Lev, Dorit; Levi, Amos; Hadar, Eran; Kornowski, Ran; Tenenbaum-Gavish, Kinneret; Porter, Avital			Elevated galectin-3 in women with gestational diabetes mellitus, a new surrogate for cardiovascular disease in women	PLOS ONE			English	Article							MACROPHAGES; METABOLISM; EXPRESSION; FAILURE; RISK	Background Gestational diabetes mellitus (GDM) is associated with future cardiovascular morbidity and recognized as a women-specific risk factor for cardiovascular disease. The mechanisms for this association are not well established. Therefore, we aimed to evaluate the cardiovascular-related biomarkers, galectin-3 (Gal-3) and protein convertase subtilisin/kexin (PCSK) type 9, in women with GDM. Methods Blood samples were drawn in the third trimester from 31 women diagnosed with GDM and from 35 women with normal pregnancies. Blood levels of Gal-3 and PCSK-9 were measured using a quantitative sandwich enzyme immunoassay. In addition, we measured Gal-3 levels in 24 pregnant women in the first trimester who later developed GDM and in 36 healthy controls. Continuous variables were compared using student's t-test and categorical variables by chi-square/fisher's exact tests. Results We found increased levels of Gal-3 in women diagnosed with GDM compared to women without GDM (124.6 +/- 32% versus control; pv = 0.001). Furthermore, we demonstrated elevated levels of Gal-3 during the first trimester among women who later developed GDM compared with women who did not develop any gestational morbidity (125.7 +/- 32% versus control; pv = 0.004). Third-trimester levels of PCSK-9 did not differ between women with and without GDM (560 +/- 45ng/mL versus 553 +/- 33ng/mL; pv = 0.4). Conclusions The results suggest a possible mechanism that may link GDM to the future increased cardiovascular risk in these patients. Additionally, increased Gal-3 levels during the first trimester may suggest a new early predictor for GDM.	[Talmor-Barkan, Yeela; Chezar-Azerrad, Chava; Kruchin, Boris; Levi, Amos; Kornowski, Ran; Porter, Avital] Rabin Med Ctr, Dept Cardiol, Petah Tiqwa, Israel; [Talmor-Barkan, Yeela; Chezar-Azerrad, Chava; Kruchin, Boris; Levi, Amos; Hadar, Eran; Kornowski, Ran; Tenenbaum-Gavish, Kinneret; Porter, Avital] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Leshem-Lev, Dorit] FMRCFelsenstein Med Ctr, Petah Tiqwa, Israel; [Hadar, Eran; Tenenbaum-Gavish, Kinneret] Helen Schneider Hosp Women, Rabin Med Ctr, Petah Tiqwa, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center	Chezar-Azerrad, C (corresponding author), Rabin Med Ctr, Dept Cardiol, Petah Tiqwa, Israel.; Chezar-Azerrad, C (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	cchezar@gmail.com	Hadar, Eran/AAU-2577-2020	Hadar, Eran/0000-0002-3101-2827				Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0; Feingold KR, 2008, BIOCHEM BIOPH RES CO, V374, P341, DOI 10.1016/j.bbrc.2008.07.023; Ferri N, 2012, ATHEROSCLEROSIS, V220, P381, DOI 10.1016/j.atherosclerosis.2011.11.026; Gongora MC, 2015, INT J MOL SCI, V16, P23905, DOI 10.3390/ijms161023905; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Herrera E, 2016, HORM MOL BIOL CLIN I, V26, P109, DOI 10.1515/hmbci-2015-0025; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Lan H, 2010, J CELL PHYSIOL, V224, P273, DOI 10.1002/jcp.22130; Li PP, 2016, CELL, V167, P973, DOI 10.1016/j.cell.2016.10.025; MacKinnon AC, 2012, AM J RESP CRIT CARE, V185, P537, DOI 10.1164/rccm.201106-0965OC; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Nanda S, 2011, PRENATAL DIAG, V31, P135, DOI 10.1002/pd.2636; Plagemann A, 2011, EARLY HUM DEV, V87, P743, DOI 10.1016/j.earlhumdev.2011.08.018; Rolnik DL, 2017, NEW ENGL J MED, V377, P613, DOI 10.1056/NEJMoa1704559; Sharma UC, 2004, CIRCULATION, V110, P3121, DOI 10.1161/01.CIR.0000147181.65298.4D; Smirnakis KV, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.011; Suthahar N, 2018, THERANOSTICS, V8, P593, DOI 10.7150/thno.22196; Tamayo T, 2014, DIABETES RES CLIN PR, V103, P206, DOI 10.1016/j.diabres.2013.11.007; Tinius Rachel A, 2015, Integr Obes Diabetes, V2, P168; Tobias DK, 2017, JAMA INTERN MED, V177, P1735, DOI 10.1001/jamainternmed.2017.2790; WRITING COMMITTEE MEMBERS, 2013, Circulation, V128, pe240, DOI 10.1161/CIR.0b013e31829e8776; Yilmaz H, 2015, J ENDOCRINOL INVEST, V38, P527, DOI 10.1007/s40618-014-0222-2	24	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234732	10.1371/journal.pone.0234732	http://dx.doi.org/10.1371/journal.pone.0234732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555606	gold, Green Published			2022-12-26	WOS:000542759600039
J	Ayanda, AF; Jusop, S; Ishak, CF; Othman, R				Ayanda, Arolu Fatai; Jusop, Shamshuddin; Ishak, Che Fauziah; Othman, Radziah			Utilization of magnesium-rich synthetic gypsum as magnesium fertilizer for oil palm grown on acidic soil	PLOS ONE			English	Article							LIMESTONE	A study was conducted to determine the impact of applying different sources of Mg, namely kieserite, ground magnesium limestone (GML) and Mg-rich synthetic gypsum (MRSG) on an acid tropical soil, oil palm growth and production. Besides high amount of Mg and Ca, MRSG contains S. Exchangeable Ca in the untreated soil of the plantation was 0.64 cmol(c)kg(-1), but its critical level to sustain oil palm growth was 0.9 cmol(c)kg(-1). MRSG was applied in the plantation as Mg-fertilizer; however, since Ca is also a limiting nutrient, oil palm growth was correlated (r = 0.69) with Ca supplied by the MRSG. Mg needed to sustain oil palm production is normally supplied by kieserite. Its requirement can be met at a lower cost compared to that of the kieserite by using MRSG. Due to MRSG treatment, exchangeable Ca in the soil increased steadily to satisfy the requirement of oil palm for fruit bunches production. From the glasshouse and field study, it was observed that MRSG applied at 1.5 times the recommended rate gave results comparable to that of the kieserite. MRSG treatment resulted in the increase of soil pH to >5 that precipitated Al(3+)as inert Al-hydroxides, which eventually enhanced oil palm seedlings growth. Thus, MRSG can also replace GML to increase soil pH and satisfy the Ca and Mg requirement of oil palm. It can be concluded that MRSG has the potential to be used as a source of Mg as well as Ca for oil palm grown on acidic soil.	[Ayanda, Arolu Fatai; Jusop, Shamshuddin; Ishak, Che Fauziah; Othman, Radziah] Univ Putra Malaysia, Dept Land Management, Fac Agr, Serdang, Selangor, Malaysia	Universiti Putra Malaysia	Jusop, S (corresponding author), Univ Putra Malaysia, Dept Land Management, Fac Agr, Serdang, Selangor, Malaysia.	shamshud@upm.edu.my		FATAI, AROLU/0000-0001-5277-2684; Shamshuddin, Jusop/0000-0001-9283-9484	Universiti Putra Malaysia	Universiti Putra Malaysia	The research grant was awarded to Universiti Putra Malaysia with Shamshuddin J as the lead researcher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVA AK, 1986, AUST J AGR RES, V37, P375, DOI 10.1071/AR9860375; [Anonymous], 1991, IPI B; AUXTERO EA, 1991, PLANT SOIL, V137, P243, DOI 10.1007/BF00011203; Azham M, 2003, THESIS; Corley R, 2003, OIL PALM, P133; Fageria NK, 2008, ADV AGRON, V99, P345, DOI 10.1016/S0065-2113(08)00407-0; Fairhurst T, 2003, OIL PALM MANAGEMENT, V234, P45; Goh K.J., 2003, OIL PALM MANAGEMENT, P279; IPNI NEWFLASH, 2013, SULF LONG NEGL NUTR; Landon J. R., 2014, ROUTLEDGE; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Najihah NI, 2015, CROP PROT, V67, P151, DOI 10.1016/j.cropro.2014.10.004; National Research Centre of Oil Palm, 2008, USDA TECHNICAL B; Sahibin AR, 2019, SCI TOTAL ENVIRON, V652, P573, DOI 10.1016/j.scitotenv.2018.10.232; SHAMSHUDDIN J, 1995, SOIL SCI SOC AM J, V59, P106, DOI 10.2136/sssaj1995.03615995005900010017x; SHAMSHUDDIN J, 1991, PLANT SOIL, V134, P45, DOI 10.1007/BF00010716; Shamshuddin J, 2018, ULTISOLS OXISOLS ENH; Sidhu M., 2014, OIL PALM B, V69, P27; Soil Survey Staff, 2018, COMM SOILS PEN MAL S; Soil Survey Staff, 2014, KEYS SOIL TAXONOMY; US EPA, 2018, 3050B US EPA	21	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234045	10.1371/journal.pone.0234045	http://dx.doi.org/10.1371/journal.pone.0234045			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544208	Green Published, gold			2022-12-26	WOS:000542957200020
J	Dong, YP; Xu, JL; Gu, CW				Dong, Yaping; Xu, Jinliang; Gu, Chenwei			Modelling carbon emissions of diesel trucks on longitudinal slope sections in China	PLOS ONE			English	Article								Carbon emissions are the primary reason that contributes to global warming. The gradient has a significant impact on the carbon dioxide (CO2) emissions produced by trucks. The aim of the current paper is to propose a carbon emission quantification model for diesel trucks on longitudinal slope sections and investigate the influence of gradient on the carbon emissions of trucks for use in the low-carbon highway design. The law of conservation of mechanical energy, the first law of thermodynamics, and the vehicle longitudinal dynamics theory were adopted for deriving the carbon emission model of the trucks on the flat, uphill, downhill and round-trip longitudinal slope segments. Three kinds of common trucks were chosen to conduct the field test. Following the test data, the model demonstrates a high accuracy. The minimum gradient which is expected to impact carbon emissions of trucks on the round-trip longitudinal slope sections was the balance gradient as revealed. The gradient of the longitudinal slope is required to be avoided to be greater in comparison with the balance gradient for the achievement of the two-way traffic low carbon operation on a highway. The results of this study are valuable to researchers interested in low carbon road design and low carbon transportation control.	[Dong, Yaping; Xu, Jinliang; Gu, Chenwei] Changan Univ, Sch Highway, Xian, Peoples R China	Chang'an University	Xu, JL (corresponding author), Changan Univ, Sch Highway, Xian, Peoples R China.	xujinliang@chd.edu.cn		Dong, Yaping/0000-0002-4859-5096	National Key Research and Development Program of China [2016YFC0802208]	National Key Research and Development Program of China	This research was funded in part by the National Key Research and Development Program of China (No. 2016YFC0802208) to JX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Senna H, 2013, J AIR WASTE MANAGE, V63, P819, DOI 10.1080/10962247.2013.795918; [Anonymous], 2014, TECHNICAL STANDARDS; Barth M., 2005, DEV HEAVY DUTY DIESE; Boriboonsomsin K, 2009, TRANSPORT RES REC, P21, DOI 10.3141/2139-03; Chang DJ, 2005, J TRANSP ENG-ASCE, V131, P173, DOI 10.1061/(ASCE)0733-947X(2005)131:3(173); Chen F, 2020, J CLEAN PROD, V256, DOI 10.1016/j.jclepro.2020.120669; Chen F, 2019, TUNN UNDERGR SP TECH, V92, DOI 10.1016/j.tust.2019.103034; Chen F, 2019, TRANSPORT RES C-EMER, V103, P17, DOI 10.1016/j.trc.2019.04.001; Chinese Government, 1 2 YEAR UPD REP CLI; Corporate Strategies Inc. CSI, 1995, PROF TRANSP SOFTW SE; Demir E, 2011, TRANSPORT RES D-TR E, V16, P347, DOI 10.1016/j.trd.2011.01.011; DONG YP, 2019, SUSTAINABILITY-BASEL, V11, DOI DOI 10.3390/SU11041156; DONG YP, 2019, SUSTAINABILITY-BASEL, V11, DOI DOI 10.3390/su11102824; Egglestone H. S., 2006, GUIDELINES NATL GREE, V2; Ehsani M, 2013, RENEW SUST ENERG REV, V53, P1638; Gillespie T. D, 1992, FUNDAMENTALS VEHICLE; Hu J.B., 2017, TRAFFIC INJ PREV, V1538-9588, P1; HUCHO WH, 1993, ANNU REV FLUID MECH, V25, P485, DOI 10.1146/annurev.fl.25.010193.002413; Jia X., 2017, J RESIDUALS SCI TECH, V14, P177, DOI [10.12783/issn.1544-8053/14/1/22, DOI 10.12783/ISSN.1544-8053/14/1/22]; Kang MW, 2013, TRANSPORT RES C-EMER, V31, P99, DOI 10.1016/j.trc.2013.03.002; Ko M, 2013, TRANSPORT RES REC, P53; Loulizi A, 2017, INT J SUSTAIN TRANSP, P56; Ma Yintao, 2008, Acta Scientiarum Naturalium Universitatis Pekinensis, V44, P308; Mashadi B, 2012, VEHICLE POWERTRAIN SYSTEMS, P1, DOI 10.1002/9781119958376; Ministry of Communications of the People's Republic of China, 2013, GTS14522013 MIN COMM; Ministry of Ecology and Environment the People's Republic of China, 2005, 176912005 GB; Ministry of Energy of the People's Republic of China, 2016, 191472016 GB; National Development and Reform Commission Department of Climate Change, 2015, LAND TRANSP COMP GRE; Rakha H, 2001, J TRANSP ENG-ASCE, V127, P418, DOI 10.1061/(ASCE)0733-947X(2001)127:5(418); Ruzzenenti F, 2009, ENERG POLICY, V37, P4079, DOI 10.1016/j.enpol.2009.04.050; Wong J. Y., 2008, THEORY GROUND VEHICL; Yan MH, 2018, MATH PROBL ENG, V2018, DOI 10.1155/2018/4587673; Zhang LL, 2020, J ADV TRANSPORT, V2020, DOI 10.1155/2020/2604012	33	3	3	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234789	10.1371/journal.pone.0234789	http://dx.doi.org/10.1371/journal.pone.0234789			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544196	gold, Green Published			2022-12-26	WOS:000542957200038
J	Liu, XJ; Feng, B; Vats, A; Tang, H; Seibel, W; Swaroop, M; Tawa, G; Zheng, W; Byrne, L; Schurdak, M; Chen, YN				Liu, Xujie; Feng, Bing; Vats, Abhishek; Tang, Hong; Seibel, William; Swaroop, Manju; Tawa, Gregory; Zheng, Wei; Byrne, Leah; Schurdak, Mark; Chen, Yuanyuan			Pharmacological clearance of misfolded rhodopsin for the treatment ofRHO-associated retinitis pigmentosa	FASEB JOURNAL			English	Article						high-throughput screening; methotrexate; misfolded protein degradation	CILIARY NEUROTROPHIC FACTOR; PHOTORECEPTOR CELLS; RIBOZYME RESCUE; VISUAL FUNCTION; GENE-THERAPY; IN-VIVO; DEGRADATION; MUTATIONS; METHOTREXATE; SURVIVAL	Rhodopsin mutation and misfolding is a common cause of autosomal dominant retinitis pigmentosa (RP). Using a luciferase reporter assay, we undertook a small-molecule high-throughput screening (HTS) of 68, 979 compounds and identified nine compounds that selectively reduced the misfolded P23H rhodopsin without an effect on the wild type (WT) rhodopsin protein. Further, we found five of these compounds, including methotrexate (MTX), promoted P23H rhodopsin degradation that also cleared out other misfolded rhodopsin mutant proteins. We showed MTX increased P23H rhodopsin degradation via the lysosomal but not the proteasomal pathway. Importantly, one intravitreal injection (IVI) of 25 pmol MTX increased electroretinogram (ERG) response and rhodopsin level in the retinae ofRho(P23H/+)knock-in mice at 1 month of age. Additionally, four weekly IVIs increased the photoreceptor cell number in the retinae ofRho(P23H/+)mice compared to vehicle control. Our study indicates a therapeutic potential of repurposing MTX for the treatment of rhodopsin-associated RP.	[Liu, Xujie; Feng, Bing; Vats, Abhishek; Byrne, Leah; Chen, Yuanyuan] Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15260 USA; [Liu, Xujie; Feng, Bing; Vats, Abhishek; Byrne, Leah; Chen, Yuanyuan] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Tang, Hong; Seibel, William] Univ Cincinnati, Drug Discovery Ctr, Cincinnati, OH USA; [Seibel, William] Cincinnati Childrens Hosp Med Ctr, Oncol Dept, Cincinnati, OH 45229 USA; [Swaroop, Manju; Tawa, Gregory; Zheng, Wei] NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA; [Schurdak, Mark] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, YN (corresponding author), BST-3 Rm10043,3501 Fifth Ave, Pittsburgh, PA 15213 USA.	cheny1@pitt.edu	Zheng, Wei/GOE-5990-2022; Zheng, Wei/GQQ-8951-2022; Zheng, Wei/J-8889-2014	Zheng, Wei/0000-0003-1034-0757; Chen, Yuanyuan/0000-0001-9625-1610; Swaroop, Manju/0000-0002-0576-1664	NIH [EY024992]; CORE [EY008098]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CORE(Luxembourg National Research Fund)	NIH, Grant/Award Number: EY024992; CORE, Grant/Award Number: EY008098	Aguila M, 2014, HUM MOL GENET, V23, P2164, DOI 10.1093/hmg/ddt613; Ait-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023; [Anonymous], CID4438424 NAT CTR B, P4438424; Athanasiou D, 2018, PROG RETIN EYE RES, V62, P1, DOI 10.1016/j.preteyeres.2017.10.002; Athanasiou Dimitra, 2017, Hum Mol Genet, V26, P4896, DOI 10.1093/hmg/ddx370; Auld D, 2004, ASSAY INTERFERENCE C; Auricchio A, 2017, HUM GENE THER, V28, P982, DOI 10.1089/hum.2017.164; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; Bok D, 2002, EXP EYE RES, V74, P719, DOI 10.1006/exer.2002.1176; Chen YY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04261-1; Chen YY, 2015, INVEST OPHTH VIS SCI, V56, P2553, DOI 10.1167/iovs.14-16298; Chen Yuanyuan, 2015, Methods Mol Biol, V1271, P369, DOI 10.1007/978-1-4939-2330-4_24; Chiang WC, 2015, MOL NEUROBIOL, V52, P679, DOI 10.1007/s12035-014-8881-8; Chow B. Y., 2013, SCI TRANSL MED, V5, P175; Dalkara D, 2016, HUM GENE THER, V27, P134, DOI 10.1089/hum.2015.147; Di Pierdomenico J, 2018, INVEST OPHTH VIS SCI, V59, P4392, DOI 10.1167/iovs.18-24621; Dryja TP, 2000, INVEST OPHTH VIS SCI, V41, P3124; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; El Gendy HA, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/8501842; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Gorbatyuk M, 2007, VISION RES, V47, P1202, DOI 10.1016/j.visres.2006.11.026; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Kinoshita Junzo, 2018, Curr Protoc Mouse Biol, V8, P1, DOI 10.1002/cpmo.39; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; LaVail MM, 2000, P NATL ACAD SCI USA, V97, P11488, DOI 10.1073/pnas.210319397; Leveillard T, 2014, CR BIOL, V337, P207, DOI 10.1016/j.crvi.2013.12.002; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Liang FQ, 2001, MOL THER, V3, P241, DOI 10.1006/mthe.2000.0252; Lin JH, 2010, ADV EXP MED BIOL, V664, P115, DOI 10.1007/978-1-4419-1399-9_14; Lobanova ES, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04117-8; Lobanova ES, 2013, P NATL ACAD SCI USA, V110, P9986, DOI 10.1073/pnas.1305521110; Luo YHL, 2016, PROG RETIN EYE RES, V50, P89, DOI 10.1016/j.preteyeres.2015.09.003; Maeda A, 2019, ANNU REV GENOM HUM G, V20, P201, DOI 10.1146/annurev-genom-083118-015043; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; Midorikawa R, 2010, J NEUROSCI, V30, P10703, DOI 10.1523/JNEUROSCI.2061-10.2010; Nakagawa S, 2016, RETINA-J RET VIT DIS, V36, P1340, DOI 10.1097/IAE.0000000000000904; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Opefi CA, 2013, J BIOL CHEM, V288, P33912, DOI 10.1074/jbc.M113.483032; Ozkan EB, 2013, INDIAN J OPHTHALMOL, V61, P329, DOI 10.4103/0301-4738.109518; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parfitt DA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.214; Peters JC, 2015, INVEST OPHTH VIS SCI, V56, P3860, DOI 10.1167/iovs.14-16220; Petrs-Silva H, 2012, ADV EXP MED BIOL, V723, P215, DOI 10.1007/978-1-4614-0631-0_29; Rosenblad A, 2009, STAT MED, V28, P360; Sahel J, 2010, DEV OPHTHALMOL, V47, P160, DOI 10.1159/000320079; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Saliba RS, 2002, J CELL SCI, V115, P2907; Schlichtenbrede FC, 2003, GENE THER, V10, P523, DOI 10.1038/sj.gt.3301929; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Taylor SRJ, 2012, OPHTHALMOLOGY, V119, P878, DOI 10.1016/j.ophtha.2011.12.015; Taylor SRJ, 2009, OPHTHALMOLOGY, V116, P797, DOI 10.1016/j.ophtha.2008.10.033; Tochitsky I, 2015, CURR OPIN NEUROBIOL, V34, P74, DOI 10.1016/j.conb.2015.01.018; Vasireddy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021193; Wang JG, 2017, NAT PROTOC, V12, P279, DOI 10.1038/nprot.2016.160; Wilson JH, 2003, MOL NEUROBIOL, V28, P149, DOI 10.1385/MN:28:2:149; Yao JY, 2018, AUTOPHAGY, V14, P1226, DOI 10.1080/15548627.2018.1463121; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zarbin M, 2016, TRENDS MOL MED, V22, P115, DOI 10.1016/j.molmed.2015.12.007; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zode GS, 2015, J CLIN INVEST, V125, P3303, DOI 10.1172/JCI82799	69	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10146	10167		10.1096/fj.202000282R	http://dx.doi.org/10.1096/fj.202000282R		JUN 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32536017	hybrid, Green Accepted			2022-12-26	WOS:000541515100001
J	Elchaninov, AV; Fatkhudinov, TK; Vishnyakova, PA; Nikitina, MP; Lokhonina, AV; Makarov, AV; Arutyunyan, IV; Kananykhina, EY; Poltavets, AS; Butov, KR; Baranov, II; Goldshtein, DV; Bolshakova, GB; Glinkina, VV; Sukhikh, GT				Elchaninov, Andrey, V; Fatkhudinov, Timur Kh; Vishnyakova, Polina A.; Nikitina, Maria P.; Lokhonina, Anastasiya, V; Makarov, Andrey, V; Arutyunyan, Irina, V; Kananykhina, Evgeniya Y.; Poltavets, Anastasiya S.; Butov, Kirill R.; Baranov, Igor I.; Goldshtein, Dmitry, V; Bolshakova, Galina B.; Glinkina, Valeria V.; Sukhikh, Gennady T.			Molecular mechanisms of splenectomy-induced hepatocyte proliferation	PLOS ONE			English	Article							LIVER-REGENERATION; TRANSFORMING GROWTH-FACTOR-BETA-1; GROWTH-FACTOR; SHEAR-STRESS; SPLEEN; HYPERSPLENISM; CIRRHOSIS; FIBROSIS; MICE	Functional and anatomical connection between the liver and the spleen is most clearly manifested in various pathological conditions of the liver (cirrhosis, hepatitis). The mechanisms of the interaction between the two organs are still poorly understood, as there have been practically no studies on the influence exerted by the spleen on the normal liver. Mature male Sprague-Dawley rats of 250-260 g body weight, 3 months old, were splenectomized. The highest numbers of Ki67+ hepatocytes in the liver of splenectomized rats were observed at 24 h after the surgery, simultaneously with the highest index of Ki67-positive hepatocytes. After surgical removal of the spleen, expression of certain genes in the liver tissues increased. A number of genes were upregulated in the liver at a single time point of 24 h, includingCcne1,Egf,Tnfa,Il6,Hgf,Met,Tgfb1r2andNos2. The expression ofCcnd1,Tgfb1,Tgfb1r1andIl10in the liver was upregulated over the course of 3 days after splenectomy. Monitoring of the liver macrophage populations in splenectomized animals revealed a statistically significant increase in the proportion of CD68-positive cells in the liver (as compared with sham-operated controls) detectable at 24 h and 48 h after the surgery. The difference in the liver content of CD68-positive cells between splenectomized and sham-operated animals evened out by day 3 after the surgery. No alterations in the liver content of CD163-positive cells were observed in the experiments. A decrease in the proportion of CD206-positive liver macrophages was observed at 48 h after splenectomy. The splenectomy-induced hepatocyte proliferation is described by us for the first time. Mechanistically, the effect is apparently induced by the removal of spleen as a major source of Tgfb1 (hepatocyte growth inhibitor) and subsequently supported by activation of proliferation factor-encoding genes in the liver.	[Elchaninov, Andrey, V; Vishnyakova, Polina A.; Lokhonina, Anastasiya, V; Makarov, Andrey, V; Arutyunyan, Irina, V; Poltavets, Anastasiya S.; Baranov, Igor I.; Sukhikh, Gennady T.] Natl Med Res Ctr Obstet Gynecol & Perinatol, Lab Regenerat Med, Moscow, Russia; [Elchaninov, Andrey, V; Fatkhudinov, Timur Kh] Peoples Friendship Univ Russia, RUDN Univ, Histol Dept, Moscow, Russia; [Makarov, Andrey, V; Butov, Kirill R.; Glinkina, Valeria V.] Pirogov Russian Natl Res Med Univ, Minist Healthcare Russian Federat, Histol Dept, Moscow, Russia; [Fatkhudinov, Timur Kh; Nikitina, Maria P.; Kananykhina, Evgeniya Y.; Bolshakova, Galina B.] Res Inst Human Morphol, Lab Growth & Dev, Moscow, Russia; [Goldshtein, Dmitry, V] Res Ctr Med Genet, Lab Stem Cells Genet, Moscow, Russia	Russian Academy of Medical Sciences; Research Center for Obstetrics, Gynecology & Perinatology; Peoples Friendship University of Russia; Pirogov Russian National Research Medical University; Russian Academy of Medical Sciences; Research Institute of Human Morphology; Research Centre for Medical Genetics	Elchaninov, AV (corresponding author), Natl Med Res Ctr Obstet Gynecol & Perinatol, Lab Regenerat Med, Moscow, Russia.; Elchaninov, AV (corresponding author), Peoples Friendship Univ Russia, RUDN Univ, Histol Dept, Moscow, Russia.	elchandrey@yandex.ru	Elchaninov, Andrey V./B-5320-2013; Kananykhina, Evgeniya Y/A-8228-2014; Butov, Kirill/AAR-1891-2020; Glinkina, Valeriya/AAC-9976-2022; Vishnyakova, Polina/M-7730-2014; Poltavets, Anastasiya/AAC-6867-2019; Arutyunyan, Irina V/A-5939-2014; Vishnyakova, Polina/GVU-3030-2022; Nikitina, Maria/X-8154-2018; Goldshtein, Dmitry/AAK-8313-2021; Makarov, Andrey V/A-4130-2014	Elchaninov, Andrey V./0000-0002-2392-4439; Kananykhina, Evgeniya Y/0000-0002-9779-2918; Butov, Kirill/0000-0002-4664-6953; Vishnyakova, Polina/0000-0001-8650-8240; Poltavets, Anastasiya/0000-0002-1619-3500; Arutyunyan, Irina V/0000-0002-4344-8943; Nikitina, Maria/0000-0001-8820-1840; Makarov, Andrey V/0000-0003-2133-2293	Russian Science Foundation [17-15-01419]; Russian Science Foundation [20-15-18003] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	The work of AVE, TKF, PAV, MPN, AVL, AVM, IVA, EYK was supported by the Russian Science Foundation (https://rscf.ru/en/, grant number 17-15-01419). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahoshi T, 2002, J GASTROEN HEPATOL, V17, P59, DOI 10.1046/j.1440-1746.2002.02667.x; ALBRECHT JH, 1995, BIOCHEM BIOPH RES CO, V209, P648, DOI 10.1006/bbrc.1995.1548; Asanoma M, 2014, HEPATOL RES, V44, P1217, DOI 10.1111/hepr.12267; Babaeva AG, ONTOGENEZ, V20, P453; Barriere C, 2007, MOL ONCOL, V1, P72, DOI 10.1016/j.molonc.2007.03.001; Bashour FN, 2000, AM J GASTROENTEROL, V95, P2936, DOI 10.1016/S0002-9270(00)01117-5; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Elchaninov A, 2020, CELL BIOL INT, V44, P80, DOI 10.1002/cbin.11203; Elchaninov A, 2018, WORLD J HEPATOL, V10, P287, DOI 10.4254/wjh.v10.i2.287; Engin A, 2017, ADV EXP MED BIOL, V960, P345, DOI 10.1007/978-3-319-48382-5_15; Hohmann N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093207; Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880; Kim J, 2012, J KOREAN SURG SOC, V82, P238, DOI 10.4174/jkss.2012.82.4.238; Kuriyama N, 2012, LIVER TRANSPLANT, V18, P1361, DOI 10.1002/lt.23519; Lee SC, 2015, J SURG RES, V196, P270, DOI 10.1016/j.jss.2015.02.025; Li LA, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1214-8; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Michalopoulos GK, 2014, EXPERT REV GASTROENT, V8, P897, DOI 10.1586/17474124.2014.934358; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Murata K, 2001, HEPATO-GASTROENTEROL, V48, P1022; Nomura Y, 2014, HEPATOL RES, V44, pE100, DOI 10.1111/hepr.12234; Noronha BT, 2005, DIABETES, V54, P1082, DOI 10.2337/diabetes.54.4.1082; Sato Y, 1999, SURG TODAY, V29, P1, DOI 10.1007/BF02482962; Schoen JM, 2001, NITRIC OXIDE-BIOL CH, V5, P453, DOI 10.1006/niox.2001.0373; Tarantino G, 2013, WORLD J GASTROENTERO, V19, P3534, DOI 10.3748/wjg.v19.i23.3534; Ueda S, 2003, LAB INVEST, V83, P1595, DOI 10.1097/01.LAB.0000095686.10639.C8; Virdis A, 2011, J AM COLL CARDIOL, V58, P238, DOI 10.1016/j.jacc.2011.01.050; Wang YJ, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5756189; Yada A, 2015, J HEPATOL, V63, P905, DOI 10.1016/j.jhep.2015.05.010; Yin S, 2011, AM J PATHOL, V178, P1614, DOI 10.1016/j.ajpath.2011.01.001; Zeng DB, 2019, GASTROENT RES PRACT, V2019, DOI 10.1155/2019/5459427	33	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0233767	10.1371/journal.pone.0233767	http://dx.doi.org/10.1371/journal.pone.0233767			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32531779	Green Published, gold			2022-12-26	WOS:000542037200038
J	Kadry, YA; Maisuria, EM; Huet-Calderwood, C; Calderwood, DA				Kadry, Yasmin A.; Maisuria, Eesha M.; Huet-Calderwood, Clotilde; Calderwood, David A.			Differences in self-association between kindlin-2 and kindlin-3 are associated with differential integrin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kindlin; integrin; cell adhesion; oligomerization; focal adhesion; protein-protein interaction; scaffold protein; cell signaling; self-association; cytoskeleton; adhesion	CELL; LOCALIZATION; ACTIVATION; UNC-112; COACTIVATOR; MECHANISM; PROMOTES; FAMILY; ACTIN; GENE	The integrin family of transmembrane adhesion receptors coordinates complex signaling networks that control the ability of cells to sense and communicate with the extracellular environment. Kindlin proteins are a central cytoplasmic component of these networks, directly binding integrin cytoplasmic domains and mediating interactions with cytoskeletal and signaling proteins. The physiological importance of kindlins is well established, but how the scaffolding functions of kindlins are regulated at the molecular level is still unclear. Here, using a combination of GFP nanotrap association assays, pulldown and integrin-binding assays, and live-cell imaging, we demonstrate that full-length kindlins can oligomerize (self-associate) in mammalian cells, and we propose that this self-association inhibits integrin binding and kindlin localization to focal adhesions. We show that both kindlin-2 and kindlin-3 can self-associate and that kindlin-3 self-association is more robust. Using chimeric mapping, we demonstrate that the F2PH and F3 subdomains are important for kindlin self-association. Through comparative sequence analysis of kindlin-2 and kindlin-3, we identify kindlin-3 point mutations that decrease self-association and enhance integrin binding, affording mutant kindlin-3 the ability to localize to focal adhesions. Our results support the notion that kindlin self-association negatively regulates integrin binding.	[Kadry, Yasmin A.; Huet-Calderwood, Clotilde; Calderwood, David A.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Maisuria, Eesha M.] Yale Univ, Dept Mol Biophys & Biochem, Yale Coll, New Haven, CT USA; [Calderwood, David A.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Calderwood, DA (corresponding author), Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA.; Calderwood, DA (corresponding author), Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA.	david.calderwood@yale.edu		Calderwood, David/0000-0002-0791-4142	National Institutes of Health [R01-NS093704]; National Science Foundation Graduate Research Fellowship [DGE1122492]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This work was supported by the National Institutes of Health grants R01-NS093704 (to D. A. C.). Y. A. K. was supported by a National Science Foundation Graduate Research Fellowship (DGE1122492). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Azorin P, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0955-4; Bai JW, 2008, DEVELOPMENT, V135, P1439, DOI 10.1242/dev.012849; Bandyopadhyay A, 2012, J CELL SCI, V125, P2172, DOI 10.1242/jcs.096214; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Bledzka K, 2016, J CELL BIOL, V213, P97, DOI 10.1083/jcb.201501006; Bottcher RT, 2017, J CELL BIOL, V216, P3785, DOI 10.1083/jcb.201701176; Bouaouina M, 2012, J BIOL CHEM, V287, P6979, DOI 10.1074/jbc.M111.330845; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Catterson JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062958; Dong JM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf3572; Fukuda K, 2014, J BIOL CHEM, V289, P28363, DOI 10.1074/jbc.M114.596692; Gao J, 2017, J CELL SCI, V130, P3764, DOI 10.1242/jcs.205641; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Huet-Calderwood C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00646-w; Huet-Calderwood C, 2014, J CELL SCI, V127, P4308, DOI 10.1242/jcs.155879; Kadry YA, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183206; Kadry YA, 2018, J CELL SCI, V131, DOI 10.1242/jcs.221184; Klapproth S, 2019, J CELL BIOL, V218, P3436, DOI 10.1083/jcb.201903109; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; Li HD, 2017, P NATL ACAD SCI USA, V114, P9349, DOI 10.1073/pnas.1703064114; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Meller J, 2015, MOL BIOL CELL, V26, P786, DOI 10.1091/mbc.E14-08-1294; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Mory A, 2008, BLOOD, V112, P2591, DOI 10.1182/blood-2008-06-163162; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Plow EF, 2019, CIRC RES, V124, P202, DOI 10.1161/CIRCRESAHA.118.314362; Qadota H, 2012, J BIOL CHEM, V287, P28537, DOI 10.1074/jbc.M112.354852; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Rognoni E, 2016, J CELL SCI, V129, P17, DOI 10.1242/jcs.161190; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Shen ZL, 2013, J SURG ONCOL, V108, P106, DOI 10.1002/jso.23353; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Stiegler AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055591; Theodosiou M, 2016, ELIFE, V5, DOI 10.7554/eLife.10130; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Yates LA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.415208; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050; Zhao T, 2013, CANCER LETT, V330, P208, DOI 10.1016/j.canlet.2012.11.043	43	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11161	11173		10.1074/jbc.RA120.013618	http://dx.doi.org/10.1074/jbc.RA120.013618			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32546480	hybrid, Green Published			2022-12-26	WOS:000562757100020
J	Murtagh, CF; Brownlee, TE; Rienzi, E; Roquero, S; Moreno, S; Huertas, G; Lugioratto, G; Baumert, P; Turner, DC; Lee, D; Dickinson, P; Lyon, KA; Sheikhsaraf, B; Biyik, B; O'Boyle, A; Morgans, R; Massey, A; Drust, B; Erskine, RM				Murtagh, Conall F.; Brownlee, Thomas E.; Rienzi, Edgardo; Roquero, Sebastian; Moreno, Sacha; Huertas, Gustavo; Lugioratto, Giovani; Baumert, Philipp; Turner, Daniel C.; Lee, Dongsun; Dickinson, Peter; Lyon, K. Amber; Sheikhsaraf, Bahare; Biyik, Betul; O'Boyle, Andrew; Morgans, Ryland; Massey, Andrew; Drust, Barry; Erskine, Robert M.			The genetic profile of elite youth soccer players and its association with power and speed depends on maturity status	PLOS ONE			English	Article							AMP-DEAMINASE DEFICIENCY; VITAMIN-D; ACTN3 GENOTYPE; TALENT IDENTIFICATION; POLYMORPHISM; PERFORMANCE; ALPHA-ACTININ-3; FOOTBALL; ENDURANCE; STRENGTH	We investigated the association of multiple single nucleotide polymorphisms (SNPs) with athlete status and power/speed performance in elite male youth soccer players (ESP) and control participants (CON) at different stages of maturity. ESP (n = 535; aged 8-23 years) and CON (n = 151; aged 9-26 years) were genotyped for 10 SNPs and grouped according to years from predicted peak-height-velocity (PHV), i.e. pre- or post-PHV, to determine maturity status. Participants performed bilateral vertical countermovement jumps, bilateral horizontal-forward countermovement jumps, 20m sprints and modified 505-agility tests. Compared to CON, pre-PHV ESP demonstrated a higherACTN3(rs1815739) XX ('endurance') genotype frequency distribution, while post-PHV ESP revealed a higher frequency distribution of thePPARA(rs4253778) C-allele,AGT(rs699) GG genotype andNOS3(rs2070744) T-allele ('power' genotypes/alleles).BDNF(rs6265) CC,COL5A1(rs12722) CC andNOS3TT homozygotes sprinted quicker than A-allele carriers, CT heterozygotes and CC homozygotes, respectively.COL2A1(rs2070739) CC andAMPD1(rs17602729) GG homozygotes sprinted faster than their respective minor allele carrier counterparts in CON and pre-PHV ESP, respectively.BDNFCC homozygotes jumped further than T-allele carriers, while ESPCOL5A1CC homozygotes jumped higher than TT homozygotes. To conclude, we have shown for the first time that pre- and post-PHV ESP have distinct genetic profiles, with pre-PHV ESP more suited for endurance, and post-PHV ESP for power and speed (the latter phenotypes being crucial attributes for post-PHV ESP). We have also demonstrated that power, acceleration and sprint performance were associated with five SNPs, both individually and in combination, possibly by influencing muscle size and neuromuscular activation.	[Murtagh, Conall F.; Brownlee, Thomas E.; Baumert, Philipp; Turner, Daniel C.; Lee, Dongsun; Dickinson, Peter; Lyon, K. Amber; Sheikhsaraf, Bahare; Biyik, Betul; O'Boyle, Andrew; Drust, Barry; Erskine, Robert M.] Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool, Merseyside, England; [Rienzi, Edgardo; Roquero, Sebastian; Moreno, Sacha; Huertas, Gustavo] Estadio Campeon Siglo, Club Atlet Penarol, Montevideo, Uruguay; [Lugioratto, Giovani] Defensor Sporting Club, Montevideo, Uruguay; [O'Boyle, Andrew] Premier League, London, England; [Morgans, Ryland] Cardiff Metropolitan Univ, Sch Sport & Hlth, Cardiff, Wales; [Massey, Andrew] Liverpool Football Club, Liverpool, Merseyside, England; [Erskine, Robert M.] UCL, Inst Sport Exercise & Hlth ISEH, London, England	Liverpool John Moores University; Cardiff Metropolitan University; University of London; University College London	Erskine, RM (corresponding author), Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool, Merseyside, England.; Erskine, RM (corresponding author), UCL, Inst Sport Exercise & Hlth ISEH, London, England.	R.M.Erskine@ljmu.ac.uk	Baumert, Philipp/AAF-4749-2019; Baumert, Philipp/AAZ-7436-2020; Drust, Barry/AAM-9776-2020; Brownlee, Thomas/ABD-6493-2021	Baumert, Philipp/0000-0002-5463-1954; Baumert, Philipp/0000-0002-5463-1954; Drust, Barry/0000-0003-2092-6962; Brownlee, Thomas/0000-0002-3355-1867; Turner, Daniel/0000-0002-7786-4152; massey, andrew/0000-0002-8253-932X; Erskine, Robert/0000-0002-5705-0207				Ahmetov II, 2011, EXP PHYSIOL, V96, P1302, DOI 10.1113/expphysiol.2011.060293; [Anonymous], 2019, THESIS; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIRK DE, 1990, J CELL SCI, V95, P649; Brazilian Society of Cardiology Brazilian Society of Hypertension Brazilian Society of Nephrology, 2010, J BRAS NEFROL, V95, P1, DOI DOI 10.1590/S0066-782X2010001700001; Brown T, 2019, SCAND J OCCUP THER, V26, P475, DOI 10.1080/11038128.2018.1473489; Casamichana D, 2012, J STRENGTH COND RES, V26, P837, DOI 10.1519/JSC.0b013e31822a61cf; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cieszczyk P, 2012, J SPORT SCI, V30, P31, DOI 10.1080/02640414.2011.623710; Coelho DB, 2016, J SPORT MED PHYS FIT, V56, P241; Colin EM, 2000, CLIN ENDOCRINOL, V52, P211, DOI 10.1046/j.1365-2265.2000.00909.x; De Moor MHM, 2007, TWIN RES HUM GENET, V10, P812, DOI 10.1375/twin.10.6.812; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Egorova ES, 2014, J SPORT SCI, V32, P1286, DOI 10.1080/02640414.2014.898853; Erskine RM, 2014, SCAND J MED SCI SPOR, V24, P642, DOI 10.1111/sms.12055; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Foster BP, 2014, EUR J APPL PHYSIOL, V114, P1393, DOI 10.1007/s00421-014-2868-z; Gilliver SF, 2009, EXP PHYSIOL, V94, P1070, DOI 10.1113/expphysiol.2009.048314; Gineviciene V, 2014, EUR J SPORT SCI, V14, pS289, DOI 10.1080/17461391.2012.691117; Gomez-Gallego F, 2009, APPL PHYSIOL NUTR ME, V34, P1108, DOI 10.1139/H09-108; Gomez-Gallego F, 2009, EUR J APPL PHYSIOL, V107, P565, DOI 10.1007/s00421-009-1166-7; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Gordon SE, 2001, AM J PHYSIOL-ENDOC M, V280, pE150, DOI 10.1152/ajpendo.2001.280.1.E150; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Kubo K, 1999, J APPL PHYSIOL, V87, P2090, DOI 10.1152/jappl.1999.87.6.2090; Kubo K, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-343; Kumagai K, 2000, J APPL PHYSIOL, V88, P811, DOI 10.1152/jappl.2000.88.3.811; Kuntz LA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189668; Maciejewska-Skrendo A, 2019, J HUM KINET, V68, P17, DOI 10.2478/hukin-2019-0053; Maxwell S.E., 2018, DESIGNING EXPT ANAL, V3rd; Micheli ML, 2011, J STRENGTH COND RES, V25, P2084, DOI 10.1519/JSC.0b013e31820238aa; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Morin JB, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00404; MORISAKI T, 1992, P NATL ACAD SCI USA, V89, P6457, DOI 10.1073/pnas.89.14.6457; Morse CI, 2007, EUR J APPL PHYSIOL, V100, P267, DOI 10.1007/s00421-007-0429-4; Murtagh CF, 2019, RES Q EXERCISE SPORT, V90, P234, DOI 10.1080/02701367.2019.1576838; Murtagh CF, 2018, EUR J APPL PHYSIOL, V118, P1737, DOI 10.1007/s00421-018-3905-0; Murtagh CF, 2018, INT J SPORT PHYSIOL, V13, P604, DOI 10.1123/ijspp.2017-0589; Murtagh CF, 2018, J STRENGTH COND RES, V32, P297, DOI 10.1519/JSC.0000000000002367; Murtagh CF, 2017, J SCI MED SPORT, V20, P1018, DOI 10.1016/j.jsams.2017.03.016; Nakayama M, 2000, AM J CARDIOL, V86, P628, DOI 10.1016/S0002-9149(00)01041-9; NORMAN B, 1995, MUSCLE NERVE, V18, P239, DOI 10.1002/mus.880180216; North KN, 1996, NEUROMUSCULAR DISORD, V6, P229, DOI 10.1016/0960-8966(96)00361-6; Owens DJ, 2015, AM J PHYSIOL-ENDOC M, V309, pE1019, DOI 10.1152/ajpendo.00375.2015; Pimenta EM, 2013, J STRENGTH COND RES, V27, P3286, DOI 10.1519/JSC.0b013e3182915e66; Reeves ND, 2004, EUR J APPL PHYSIOL, V91, P116, DOI 10.1007/s00421-003-0961-9; Ruiz JR, 2010, J APPL PHYSIOL, V108, P561, DOI 10.1152/japplphysiol.01242.2009; Sarmento H, 2018, SPORTS MED, V48, P907, DOI 10.1007/s40279-017-0851-7; Sethi AA, 2003, ARTERIOSCL THROM VAS, V23, P1269, DOI 10.1161/01.ATV.0000079007.40884.5C; Seto JT, 2013, J CLIN INVEST, V123, P4255, DOI 10.1172/JCI67691; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Stafilidis S, 2007, J SPORT SCI, V25, P1035, DOI 10.1080/02640410600951589; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Venturelli M, 2008, INT J SPORT PHYSIOL, V3, P558, DOI 10.1123/ijspp.3.4.558; Whitfield GK, 2001, MOL CELL ENDOCRINOL, V177, P145; Williams AG, 2008, J PHYSIOL-LONDON, V586, P113, DOI 10.1113/jphysiol.2007.141887; Williams AM, 2000, J SPORT SCI, V18, P657, DOI 10.1080/02640410050120041; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Zarebska A, 2013, J STRENGTH COND RES, V27, P2898, DOI 10.1519/JSC.0b013e31828155b5; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	64	12	12	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234458	10.1371/journal.pone.0234458	http://dx.doi.org/10.1371/journal.pone.0234458			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569264	Green Published, Green Accepted, gold			2022-12-26	WOS:000543547900030
J	Gitsels, LA; Cortina-Borja, M; Rahi, JS				Gitsels, Lisanne Andra; Cortina-Borja, Mario; Rahi, Jugnoo Sangeeta			Is amblyopia associated with school readiness and cognitive performance during early schooling? Findings from the Millennium Cohort Study	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; VISUAL IMPAIRMENT; VISION; CHILDREN; PREVALENCE; HEALTH; LIFE; EYE	Background Amblyopia is a neurodevelopmental condition causing reduced vision, for which programmes of whole population child vision screening exist throughout the world. There is an ongoing debate about the value of screening due to the lack of evidence about meaningful functional impacts of amblyopia. Our objective was to determine whether amblyopia is associated with school readiness and early cognitive performance. Methods and findings Data from the prospective Millennium Cohort Study of children born in the United Kingdom in 2000-01 and followed-up to age 7 years (n= 13,967). Using parental self-report on eye conditions and treatment coded by clinical reviewers, participants were grouped into no eye conditions, strabismus alone, refractive amblyopia, or strabismic/mixed (refractive plus strabismic) amblyopia. The outcomes were poor school readiness using Bracken School Readiness Assessment <25th percentile (age 3); and cognitive tests and their age-related trajectories using British Ability Scale II Naming Vocabulary (ages 3/5) and Pattern Construction (ages 5/7). Multivariable analyses showed that compared to children without any eye conditions, only those with strabismic/mixed amblyopia had an increased risk of poor school readiness (OR = 2.04, 95%CI 1.09-3.82). Small differences in mean scores for NV and PC of children with amblyopia (all types) compared to those without any eye condition were not clinically significant (>10 points) irrespective of whether treatment had already started. The age-related cognitive trajectories of children with amblyopia did not differ from those without any eye conditions for either NV (p= 0.62) or PC (p= 0.51). These associations are at population rather than individual level, so it might be that some individuals with amblyopia did experience significant adverse outcomes that are not captured by summary statistics. Conclusions Amblyopia is not significantly associated with adverse cognitive performance and trajectories in early schooling and there is no evidence that this is due to a mediating effect of treatment. Although amblyopia combined with strabismus is associated with poor school readiness, this is not translated into poor cognitive performance. These novel findings may explain the lack of association reported between amblyopia and educational outcomes in adult life and suggest that the impact of amblyopia on education is not of itself a justification for whole population child vision screening aimed at detecting this disorder.	[Gitsels, Lisanne Andra; Cortina-Borja, Mario; Rahi, Jugnoo Sangeeta] UCL, Populat Policy & Practice Res & Teaching Dept, Great Ormond St Inst Child Hlth, London, England; [Gitsels, Lisanne Andra; Rahi, Jugnoo Sangeeta] UCL, Great Ormond St Inst Child Hlth, Ulverscroft Vis Res Grp, London, England; [Rahi, Jugnoo Sangeeta] Great Ormond St Hosp Children NHS Fdn Trust, London, England; [Rahi, Jugnoo Sangeeta] UCL, Inst Ophthalmol, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Rahi, JS (corresponding author), UCL, Populat Policy & Practice Res & Teaching Dept, Great Ormond St Inst Child Hlth, London, England.; Rahi, JS (corresponding author), UCL, Great Ormond St Inst Child Hlth, Ulverscroft Vis Res Grp, London, England.; Rahi, JS (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, London, England.; Rahi, JS (corresponding author), UCL, Inst Ophthalmol, London, England.	j.rahi@ucl.ac.uk		Rahi, Jugnoo/0000-0002-5718-9209; /0000-0001-9066-3702	National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Ulverscroft Vision Research Group	National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Ulverscroft Vision Research Group	JSR is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. All research at Great Ormond Street Hospital NHS Foundation Trust and UCL Great Ormond Street Institute of Child Health is made possible by the NIHR Great Ormond Street Hospital Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. LAG is supported by the Ulverscroft Vision Research Group.	Abreu L, 2016, CHILDRENS EARLY YEAR; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; Bracken B. A., 2002, SCH READINESS ASSESS; Chia EM, 2006, OPHTHAL EPIDEMIOL, V13, P371, DOI 10.1080/09286580600864794; Chua B, 2004, BRIT J OPHTHALMOL, V88, P1119, DOI 10.1136/bjo.2004.041863; Cox's Bazar Bangladesh, 2019, GEND PROF NO 2 ROH R, V11, P1; Cumberland PM, 2010, OPHTHALMOLOGY, V117, P2184, DOI 10.1016/j.ophtha.2010.03.004; Editorial, 2016, NAT CLIM CHANGE, V6, P1, DOI [10.1038/nclimate2911, DOI 10.1038/s41598-016-0001-8]; Eicher S, 2019, J CHINESE HIST, V3, P1, DOI 10.1017/jch.2017.39; Elflein HM, 2019, J PEDIAT OPHTH STRAB, V56, P397, DOI 10.3928/01913913-20190925-01; Elliott C.D., 1997, BRIT ABILITY SCALES; Hansen K., 2014, MILLENNIUM COHORT ST; Hrisos S, 2006, BRIT J OPHTHALMOL, V90, P836, DOI 10.1136/bjo.2006.090910; Kelly KR, 2015, J AAPOS, V19, P515, DOI 10.1016/j.jaapos.2015.09.002; Londra M, 2006, MILLENNIUM COHORT ST; Majeed M, 2008, BRIT J OPHTHALMOL, V92, P965, DOI 10.1136/bjo.2007.134841; Pathai S, 2010, ARCH PEDIAT ADOL MED, V164, P250, DOI 10.1001/archpediatrics.2009.297; Public Health England, 2019, CHILD VIS SCREEN SER; R Core Team, 2019, R VERS 3 5 3 LANG EN; Rahi JS, 2006, BRIT MED J, V332, P820, DOI 10.1136/bmj.38751.597963.AE; Rahi JS, 2003, LANCET, V362, P1359, DOI 10.1016/S0140-6736(03)14631-4; Rahi JS, 2002, LANCET, V360, P621, DOI 10.1016/S0140-6736(02)09775-1; Rahi JS., 2019, CHILDHOOD VISION SCR; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Sloot F, 2015, J MED SCREEN, V22, P55, DOI 10.1177/0969141315572403; Solebo AL, 2015, LANCET, V385, P2308, DOI 10.1016/S0140-6736(14)60522-5; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Stifter E, 2005, BRIT J OPHTHALMOL, V89, P1324, DOI 10.1136/bjo.2005.066688; Webber AL, 2018, CLIN EXP OPTOM, V101, P443, DOI 10.1111/cxo.12663; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Williams C, 2008, BRIT J OPHTHALMOL, V92, P959, DOI 10.1136/bjo.2007.134700; Wilson GA, 2013, CLIN EXP OPHTHALMOL, V41, P127, DOI 10.1111/j.1442-9071.2012.02842.x	32	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234414	10.1371/journal.pone.0234414	http://dx.doi.org/10.1371/journal.pone.0234414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559208	Green Published, gold			2022-12-26	WOS:000543261600041
J	Ribeiro, HMN; Civiero, M; Kebreab, E				Ribeiro-Filho, Henrique M. N.; Civiero, Mauricio; Kebreab, Ermias			Potential to reduce greenhouse gas emissions through different dairy cattle systems in subtropical regions	PLOS ONE			English	Article							SPECIAL TOPICS-MITIGATION; NITROUS-OXIDE EMISSIONS; ENTERIC METHANE EMISSIONS; LIFE-CYCLE ASSESSMENT; TOTAL MIXED RATION; CARBON FOOTPRINT; MILK-PRODUCTION; ENVIRONMENTAL IMPACTS; CLIMATE-CHANGE; FARM SYSTEMS	Carbon (C) footprint of dairy production, expressed in kg C dioxide (CO2) equivalents (CO(2)e) (kg energy-corrected milk (ECM))(-1), encompasses emissions from feed production, diet management and total product output. The proportion of pasture on diets may affect all these factors, mainly in subtropical climate zones, where cows may access tropical and temperate pastures during warm and cold seasons, respectively. The aim of the study was to assess the C footprint of a dairy system with annual tropical and temperate pastures in a subtropical region. The system boundary included all processes up to the animal farm gate. Feed requirement during the entire life of each cow was based on data recorded from Holstein x Jersey cow herds producing an average of 7,000 kg ECM lactation(-1). The milk production response as consequence of feed strategies (scenarios) was based on results from two experiments (warm and cold seasons) using lactating cows from the same herd. Three scenarios were evaluated: total mixed ration (TMR)ad libitumintake, 75, and 50% ofad libitumTMR intake with access to grazing either a tropical or temperate pasture during lactation periods. Considering IPCC and international literature values to estimate emissions from urine/dung, feed production and electricity, the C footprint was similar between scenarios, averaging 1.06 kg CO(2)e (kg ECM)(-1). Considering factors from studies conducted in subtropical conditions and actual inputs for on-farm feed production, the C footprint decreased 0.04 kg CO(2)e (kg ECM)(-1)in scenarios including pastures compared toad libitumTMR. Regardless of factors considered, emissions from feed production decreased as the proportion of pasture went up. In conclusion, decreasing TMR intake and including pastures in dairy cow diets in subtropical conditions have the potential to maintain or reduce the C footprint to a small extent.	[Ribeiro-Filho, Henrique M. N.; Kebreab, Ermias] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Ribeiro-Filho, Henrique M. N.; Civiero, Mauricio] Univ Estado Santa Catarina, Programa Posgrad Ciencia Anim, Lages, SC, Brazil	University of California System; University of California Davis; Universidade do Estado de Santa Catarina	Ribeiro, HMN (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.; Ribeiro, HMN (corresponding author), Univ Estado Santa Catarina, Programa Posgrad Ciencia Anim, Lages, SC, Brazil.	henrique.ribeiro@udesc.br	Ribeiro-Filho, Henrique/D-1178-2014	Ribeiro-Filho, Henrique/0000-0002-4455-6866	Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior - Brazil (CAPES) [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq) [403754/2016-0]; Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) [TR 584 2019]	Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior - Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC)(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	HRF Grant number (Finance code) 001, Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior - Brazil (CAPES) https://www.capes.gov.br; Grant number 403754/2016-0, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq) http://www.cnpq.br; Grant number TR 584 2019, Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) http://www.fapesc.sc.gov.br.The funders had no role in study design, ata collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JGR, 2020, ANIMAL, V14, P1184, DOI 10.1017/S1751731119003057; [Anonymous], 2006, 14044 ISO, V2006, P46; [Anonymous], 2016, ENV PERF LARG RUM SU; Baek CY, 2014, J CLEAN PROD, V70, P50, DOI 10.1016/j.jclepro.2014.02.010; Bargo F, 2002, J DAIRY SCI, V85, P2948, DOI 10.3168/jds.S0022-0302(02)74381-6; Barros MV, 2018, ENERGIES, V11, DOI 10.3390/en11061412; Scaravelli Luciene Fernanda Barros, 2007, Cienc. Rural, V37, P841, DOI 10.1590/S0103-84782007000300037; Boddey RM, 2010, GLOBAL CHANGE BIOL, V16, P784, DOI 10.1111/j.1365-2486.2009.02020.x; Camargo GGT, 2013, BIOSCIENCE, V63, P263, DOI 10.1525/bio.2013.63.4.6; Chobtang J, 2017, J IND ECOL, V21, P1139, DOI 10.1111/jiec.12484; Civiero M, 2019, 7 GREENH GAS AN AGR, P141; Clark CEF, 2018, J DAIRY SCI, V101, P5454, DOI 10.3168/jds.2017-13388; Dall-Orsoletta AC, 2019, ANIM FEED SCI TECH, V253, P65, DOI 10.1016/j.anifeedsci.2019.05.009; Dall-Orsoletta AC, 2016, J DAIRY SCI, V99, P4374, DOI 10.3168/jds.2015-10396; de Leis CM, 2015, INT J LIFE CYCLE ASS, V20, P46, DOI 10.1007/s11367-014-0813-3; Delagarde R, 2011, GRASS FORAGE SCI, V66, P45, DOI 10.1111/j.1365-2494.2010.00770.x; Dickhoefer U, 2018, LIVEST SCI, V216, P109, DOI 10.1016/j.livsci.2018.08.004; Duchini PG, 2016, CROP PASTURE SCI, V67, P574, DOI 10.1071/CP15170; Eggleston H.S., 2006, IPCC GUIDLINES NATL; Eugene M, 2019, J ENVIRON MANAGE, V231, P982, DOI 10.1016/j.jenvman.2018.10.086; FAOSTAT, 2017, US; Fernandes HC, 2008, CIENC AGROTEC, V32, P1582, DOI 10.1590/S1413-70542008000500034; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Garg MR, 2016, ANIM PROD SCI, V56, P423, DOI 10.1071/AN15464; Gollnow S, 2014, INT DAIRY J, V37, P31, DOI 10.1016/j.idairyj.2014.02.005; Herrero M, 2016, NAT CLIM CHANGE, V6, P452, DOI [10.1038/nclimate2925, 10.1038/NCLIMATE2925]; Herzog A, 2018, AGR ECOSYST ENVIRON, V267, P174, DOI 10.1016/j.agee.2018.07.029; Hristov AN, 2013, J ANIM SCI, V91, P5045, DOI 10.2527/jas.2013-6583; Hristov AN, 2013, J ANIM SCI, V91, P5095, DOI 10.2527/jas.2013-6585; INRA, 2007, AL BOV OV CAPR BES A; IPCC, 2019, FOOD SECUR; Jayasundara S, 2019, J CLEAN PROD, V229, P1018, DOI 10.1016/j.jclepro.2019.04.013; da Silva MSJ, 2015, REV BRAS ZOOTECN, V44, P303, DOI 10.1590/S1806-92902015000900001; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Ledgard SF, 2019, AGR WATER MANAGE, V213, P155, DOI 10.1016/j.agwat.2018.10.009; Lizarralde C., 2014, SUSTAIN AGR RES, V3, P1, DOI [10.5539/sar.v3n2p1, DOI 10.5539/SAR.V3N2P1, DOI 10.5539/sar.v3n2p1]; Lorenz H, 2019, J CLEAN PROD, V211, P161, DOI 10.1016/j.jclepro.2018.11.113; Ludington D, 2003, NEW YORK STATE ENERG; Ma BL, 2012, NUTR CYCL AGROECOSYS, V94, P15, DOI 10.1007/s10705-012-9522-0; McConkey B. G., 2014, CANADIAN AGR GREENHO; Mendoza A, 2016, J DAIRY SCI, V99, P1938, DOI 10.3168/jds.2015-10257; Montes F, 2013, J ANIM SCI, V91, P5070, DOI 10.2527/jas.2013-6584; Mostert PF, 2018, AGR SYST, V167, P206, DOI 10.1016/j.agsy.2018.09.006; Mostert PF, 2018, J CLEAN PROD, V171, P773, DOI 10.1016/j.jclepro.2017.10.019; Naranjo A, 2020, J DAIRY SCI, V103, P3760, DOI 10.3168/jds.2019-16576; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Niu M, 2016, ANIM PROD SCI, V56, P312, DOI 10.1071/AN15498; Niu M, 2018, GLOBAL CHANGE BIOL, V24, P3368, DOI 10.1111/gcb.14094; Noizere P, 2018, INRA FEEDING SYSTEM, DOI [10.3920/978-90-8686-872-8, DOI 10.3920/978-90-8686-872-8]; O'Brien D, 2016, ANIM PROD SCI, V56, P495, DOI 10.1071/AN15490; O'Brien D, 2014, J DAIRY SCI, V97, P1835, DOI 10.3168/jds.2013-7174; O'Brien D, 2014, INT J LIFE CYCLE ASS, V19, P1469, DOI 10.1007/s11367-014-0755-9; O'Brien D, 2012, AGR SYST, V107, P33, DOI 10.1016/j.agsy.2011.11.004; Pachauri R.K., 2014, AR5 SYNTH REP CLIM C; Pirlo G, 2019, J CLEAN PROD, V211, P962, DOI 10.1016/j.jclepro.2018.11.070; Ramalho B, 2020, EUR J SOIL SCI, V71, P1106, DOI 10.1111/ejss.12933; Raucci GS, 2015, J CLEAN PROD, V96, P418, DOI 10.1016/j.jclepro.2014.02.064; Reed KF, 2015, J DAIRY SCI, V98, P3025, DOI 10.3168/jds.2014-8397; Rivera-Ferre MG, 2016, WIRES CLIM CHANGE, V7, P869, DOI 10.1002/wcc.421; Rotz CA, 2010, J DAIRY SCI, V93, P1266, DOI 10.3168/jds.2009-2162; Salou T, 2017, J CLEAN PROD, V140, P445, DOI 10.1016/j.jclepro.2016.05.019; Sbrissia AF, 2018, CROP SCI, V58, P945, DOI 10.2135/cropsci2017.07.0447; Schwab CG, 2017, J DAIRY SCI, V100, P10094, DOI 10.3168/jds.2017-13320; Simon PL, 2018, AGR ECOSYST ENVIRON, V267, P74, DOI 10.1016/j.agee.2018.08.013; Sordi A, 2014, AGR ECOSYST ENVIRON, V190, P94, DOI 10.1016/j.agee.2013.09.004; SOU, 2006, STATENS OFFENTLIGA U, V2006, P1, DOI DOI 10.1109/EC0C.2006.4801430; Thoma G, 2013, INT DAIRY J, V31, pS41, DOI 10.1016/j.idairyj.2012.08.012; van Zanten HHE, 2016, INT J LIFE CYCLE ASS, V21, P747, DOI 10.1007/s11367-015-0944-1; Vibart RE, 2008, J DAIRY RES, V75, P471, DOI 10.1017/S0022029908003361; Vogeler I, 2016, SCI TOTAL ENVIRON, V565, P564, DOI 10.1016/j.scitotenv.2016.05.006; Waghorn GC, 2019, ANIM PROD SCI, V59, P1261, DOI [10.1071/AN18018, 10.1071/an18018]; Wales WJ, 2013, ANIM PROD SCI, V53, P1167, DOI 10.1071/AN13207; Wang MQ, 2007, GREET 1 8A SPREADSHE; Wang XQ, 2018, SCI TOTAL ENVIRON, V625, P486, DOI 10.1016/j.scitotenv.2017.12.259; Wilkinson JM, 2020, GRASS FORAGE SCI, V75, P1, DOI 10.1111/gfs.12458; Williams SRO, 2014, INT J LIFE CYCLE ASS, V19, P69, DOI 10.1007/s11367-013-0619-8	76	6	6	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234687	10.1371/journal.pone.0234687	http://dx.doi.org/10.1371/journal.pone.0234687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555654	gold, Green Published			2022-12-26	WOS:000543273200027
J	Kogure, A; Naito, Y; Yamamoto, Y; Yashiro, M; Kiyono, T; Yanagihara, K; Hirakawa, K; Ochiya, T				Kogure, Akiko; Naito, Yutaka; Yamamoto, Yusuke; Yashiro, Masakazu; Kiyono, Tohru; Yanagihara, Kazuyoshi; Hirakawa, Kosei; Ochiya, Takahiro			Cancer cells with high-metastatic potential promote a glycolytic shift in activated fibroblasts	PLOS ONE			English	Article							TUMOR MICROENVIRONMENT; AEROBIC GLYCOLYSIS; METABOLISM; GROWTH; MYOFIBROBLASTS; BIOLOGY; STROMA	Cancer-associated fibroblasts (CAFs) are activated fibroblasts and are the major stromal component in various types of malignancies. CAFs often undergo metabolic reprogramming to create an appropriate microenvironment for cancer progression. However, it remains unclear whether the metastatic properties of cancer cells affect aerobic glycolysis in stromal cells. Here, we show that gastric cancer (GC) cells with high metastatic potential strongly promote the metabolic switch from oxidative phosphorylation to aerobic glycolysis in fibroblasts. Transcriptome analysis showed that the expression of glycolysis-related genes, such as LDHA and ENO2, significantly changed in fibroblasts when they were cocultured with cancer cells with high metastatic potential compared to fibroblasts incubated with cancer cells with low metastatic potential. Glucose uptake, lactate production and oxygen consumption in fibroblasts were changed by coculture with GC cells with high metastatic potential. Thus, metabolic reprogramming in CAFs may reflect the metastatic properties of GC cells.	[Kogure, Akiko; Ochiya, Takahiro] Tokyo Med Univ, Inst Med Sci, Dept Mol & Cellular Med, Tokyo, Japan; [Naito, Yutaka] Francis Crick Inst, Tumor Cell Biol Lab, London, England; [Yamamoto, Yusuke] Natl Canc Ctr, Div Cellular Signaling, Tokyo, Japan; [Yashiro, Masakazu; Hirakawa, Kosei] Osaka City Univ, Mol Oncol & Therapeut, Grad Sch Med, Osaka, Japan; [Kiyono, Tohru] Natl Canc Ctr, Div Carcinogenesis & Canc Prevent, Tokyo, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Biomarker Discovery, Tokyo, Japan	Tokyo Medical University; Francis Crick Institute; National Cancer Center - Japan; Osaka Metropolitan University; National Cancer Center - Japan; National Cancer Center - Japan	Ochiya, T (corresponding author), Tokyo Med Univ, Inst Med Sci, Dept Mol & Cellular Med, Tokyo, Japan.	tochiya@tokyo-med.ac.jp	Asada, Akiko/ABF-7324-2020		JSPS KAKENHI [15K21646, 17H04991, 17K19625]; Japan Agency for Medical Research and Developmentfrom, AMED [16ae0101011h0003]; JSPS [15J10473];  [16cm0106402h0001]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Developmentfrom, AMED; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported by JSPS KAKENHI Grant Number 15K21646, 17H04991 and 17K19625, and JSPS Fellows 15J10473 and in part by a Grant-in-Aid for the Project for Cancer Research And Therapeutic Evolution (P-CREATE, Grant Number 16cm0106402h0001) and the Project focused on developing key technology for discovering and manufacturing drugs for nextgeneration treatment and diagnosis (Grant Number 16ae0101011h0003) from the Japan Agency for Medical Research and Developmentfrom, AMED.	Belli C, 2018, CANCER TREAT REV, V65, P22, DOI 10.1016/j.ctrv.2018.02.004; Chen F, 2019, NAT CELL BIOL, V21, P498, DOI 10.1038/s41556-019-0299-0; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Fiaschi T, 2012, CANCER RES, V72, P5130, DOI 10.1158/0008-5472.CAN-12-1949; Fong MY, 2015, NAT CELL BIOL, V17, P183, DOI 10.1038/ncb3094; Givel AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03348-z; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Naito Y, 2019, ONCOGENE, V38, P5566, DOI 10.1038/s41388-019-0832-4; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Ramamonjisoa N, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00003; Raz Y, 2018, J EXP MED, V215, P3075, DOI 10.1084/jem.20180818; Roswall P, 2018, NAT MED, V24, P463, DOI 10.1038/nm.4494; Sounni NE, 2013, CLIN CHEM, V59, P85, DOI 10.1373/clinchem.2012.185363; Vaughan RA, 2013, INT J CANCER, V133, P2504, DOI 10.1002/ijc.28264; Vaughan RA, 2013, PROSTATE, V73, P1538, DOI 10.1002/pros.22703; Yan W, 2018, NAT CELL BIOL, V20, P597, DOI 10.1038/s41556-018-0083-6; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; Zhang DX, 2015, CELL REP, V10, P1335, DOI 10.1016/j.celrep.2015.02.006; Zhao HY, 2016, ELIFE, V5, DOI 10.7554/eLife.10250	24	6	6	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234613	10.1371/journal.pone.0234613	http://dx.doi.org/10.1371/journal.pone.0234613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555715	Green Published, gold			2022-12-26	WOS:000542759600033
J	Lee, SW; Kim, HK; Naidansuren, P; Ham, KA; Choi, HS; Ahn, HY; Kim, M; Kang, DH; Kang, SW; Joe, YA				Lee, Seung-Woo; Kim, Hyun-Kyung; Naidansuren, Purevjargal; Ham, Kyung A.; Choi, Hong Seok; Ahn, Hyun-Young; Kim, Myungshin; Kang, Dong Hoon; Kang, Sang Won; Joe, Young Ae			Peroxidasin is essential for endothelial cell survival and growth signaling by sulfilimine crosslink-dependent matrix assembly	FASEB JOURNAL			English	Article							EXTRACELLULAR-MATRIX; COLLAGEN-IV; BASEMENT-MEMBRANE; MECHANISM; PROTEIN; IDENTIFICATION; PROLIFERATION; FIBRONECTIN; MUTATIONS; SCAFFOLDS	Peroxidasin (PXDN) has been reported to crosslink the C-terminal non-collagenous domains of collagen IV (Col IV) by forming covalent sulfilimine bond. Here, we explored the physiological role of PXDN and its mechanism of action in endothelial cell survival and growth. Silencing of PXDN using siRNAs decreased cell proliferation without increase of the number of detached cells and decreased cell viability under serum-starved condition with increased fragmented nuclei and caspase 3/7 activity. Conditioned medium (CM) containing wild-type PXDN restored the proliferation of PXDN-depleted cells, but CM containing mutant PXDN with deletion of either N-terminal extracellular matrix (ECM) motifs or peroxidase domain failed to restore PXDN function. Accordingly, anti-PXDN antibody [raised against IgC2 (3-4) subdomain within ECM motifs] and peroxidase inhibitor phloroglucinol prevented the rescue of the PXDN-depleted cells by PXDN-containing CM. PXDN depletion resulted in loss of sulfilimine crosslinks, and decreased dense fibrillar network assembly of not only Col IV, but also fibronectin and laminin like in Col IV knockdown. Exogenous PXDN-containing CM restored ECM assembly as well as proliferation of PXDN-depleted cells. Accordingly, purified recombinant PXDN protein restored the proliferation and ECM assembly, and prevented cell death of the PXDN-depleted cells. PXDN depletion also showed reduced growth factors-induced phosphorylation of FAK and ERK1/2. In addition, siPXDN-transfected cell-derived matrix failed to provide full ECM-mediated activation of FAK and ERK1/2. These results indicate that both the ECM motifs and peroxidase activity are essential for the cellular function of PXDN and that PXDN is crucial for ECM assembly for survival and growth signaling.	[Lee, Seung-Woo; Kim, Hyun-Kyung; Naidansuren, Purevjargal; Ham, Kyung A.; Choi, Hong Seok; Joe, Young Ae] Catholic Univ Korea, Canc Res Inst, Coll Med, 222 Banpo Daero, Seoul 06519, South Korea; [Lee, Seung-Woo; Kim, Hyun-Kyung; Naidansuren, Purevjargal; Ham, Kyung A.; Choi, Hong Seok; Joe, Young Ae] Catholic Univ Korea, Coll Med, Dept Med Life Sci, 222 Banpo Daero, Seoul 06519, South Korea; [Lee, Seung-Woo; Kim, Hyun-Kyung; Naidansuren, Purevjargal; Ham, Kyung A.; Choi, Hong Seok; Joe, Young Ae] Catholic Univ Korea, Coll Med, Canc Evolut Res Ctr, Seoul, South Korea; [Ham, Kyung A.; Choi, Hong Seok; Joe, Young Ae] Catholic Univ Korea, Dept Biomed & Hlth Sci, Seoul, South Korea; [Ahn, Hyun-Young] Catholic Univ Korea, Coll Med, Dept Gynecol, Div Maternal Fetal Med, Seoul, South Korea; [Kim, Myungshin] Catholic Univ Korea, Coll Med, Dept Lab Med, Seoul, South Korea; [Kang, Dong Hoon; Kang, Sang Won] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Kang, Dong Hoon; Kang, Sang Won] Ewha Womans Univ, Res Ctr Cell Homeostasis, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Ewha Womans University; Ewha Womans University	Joe, YA (corresponding author), Catholic Univ Korea, Canc Res Inst, Coll Med, 222 Banpo Daero, Seoul 06519, South Korea.; Joe, YA (corresponding author), Catholic Univ Korea, Coll Med, Dept Med Life Sci, 222 Banpo Daero, Seoul 06519, South Korea.	youngjoe@catholic.ac.kr			National Research Foundation of Korea - Korean Government [2016R1A2B2013712, NRF-313-2008-2-C00904, NRF-2012R1A5A2047939, NRF-2019R1H1A2080013]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This work was supported by National Research Foundation of Korea grants funded by the Korean Government (2016R1A2B2013712, NRF-313-2008-2-C00904, NRF-2012R1A5A2047939, and NRF-2019R1H1A2080013)	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Brizzi MF, 2012, CURR OPIN CELL BIOL, V24, P645, DOI 10.1016/j.ceb.2012.07.001; Cheng GJ, 2011, FREE RADICAL BIO MED, V51, P1445, DOI 10.1016/j.freeradbiomed.2011.07.002; Cheng GJ, 2008, FREE RADICAL BIO MED, V45, P1682, DOI 10.1016/j.freeradbiomed.2008.09.009; Chernousov MA, 1998, J CELL SCI, V111, P2763; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Ero-Tolliver IA, 2015, J BIOL CHEM, V290, P21741, DOI 10.1074/jbc.M115.673996; Fidler AL, 2014, P NATL ACAD SCI USA, V111, P331, DOI 10.1073/pnas.1318499111; Gotenstein JR, 2010, DEVELOPMENT, V137, P3603, DOI 10.1242/dev.049189; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Khan K, 2011, AM J HUM GENET, V89, P464, DOI 10.1016/j.ajhg.2011.08.005; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Kim HK, 2003, BIOCHEM BIOPH RES CO, V304, P740, DOI 10.1016/S0006-291X(03)00656-9; Lazar E, 2015, FREE RADICAL BIO MED, V83, P273, DOI 10.1016/j.freeradbiomed.2015.02.015; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; Medfai H, 2019, CARDIOVASC RES, V115, P463, DOI 10.1093/cvr/cvy179; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; Paumann-Page M, 2017, J BIOL CHEM, V292, P4583, DOI 10.1074/jbc.M117.775213; Peterfi Z, 2014, TRENDS BIOCHEM SCI, V39, P305, DOI 10.1016/j.tibs.2014.05.005; Peterfi Z, 2009, AM J PATHOL, V175, P725, DOI 10.2353/ajpath.2009.080693; Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108; Shi RZ, 2011, CARDIOVASC RES, V91, P27, DOI 10.1093/cvr/cvr042; Sirokmany G, 2018, REDOX BIOL, V16, P314, DOI 10.1016/j.redox.2018.03.009; Tapias LF, 2014, CURR OPIN ORGAN TRAN, V19, P145, DOI 10.1097/MOT.0000000000000051; Van Agtmael T, 2005, HUM MOL GENET, V14, P3161, DOI 10.1093/hmg/ddi348; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; Wijelath ES, 2006, CIRC RES, V99, P853, DOI 10.1161/01.RES.0000246849.17887.66; Yan XH, 2014, HUM MOL GENET, V23, P5597, DOI 10.1093/hmg/ddu274; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zheng YZ, 2018, ANN DIAGN PATHOL, V34, P161, DOI 10.1016/j.anndiagpath.2018.03.002	34	6	6	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10228	10241		10.1096/fj.201902899R	http://dx.doi.org/10.1096/fj.201902899R		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32543734	Bronze			2022-12-26	WOS:000546426300001
J	Yu, FY; Zhang, Y; Cheng, C; Wang, WQ; Zhou, ZS; Rang, WL; Yu, H; Wei, YX; Wu, QJ; Zhang, Y				Yu, Fengyun; Zhang, Yu; Cheng, Chao; Wang, Wenqing; Zhou, Zisong; Rang, Wenliang; Yu, Han; Wei, Yaxun; Wu, Qijia; Zhang, Yi			Poly(A)-seq: A method for direct sequencing and analysis of the transcriptomic poly(A)-tails	PLOS ONE			English	Article							MESSENGER-RNA DECAY; TAIL LENGTH; ALTERNATIVE POLYADENYLATION; CELLULAR SENESCENCE; SEQ; REVEALS; DYNAMICS; INSIGHTS; HEALTH	Poly(A) tails at the 3' end of eukaryotic messenger RNAs control mRNA stability and translation efficiency. Facilitated by various NGS methods, alternative polyadenylation sites determining the 3MODIFIER LETTER PRIME-UTR length of gene transcripts have been extensively studied. However, poly(A) lengths demonstrating dynamic and developmental regulation remain largely unexplored. The recently developed NGS-based methods for genome-wide poly(A) profiling have promoted the study of genom-wide poly(A) dynamics. Here we present a straight forward NGS-method for poly(A) profiling, which applies a direct 3'-end adaptor ligation and the template switching for 5'-end adaptor ligation for cDNA library construction. Poly(A) lengths are directly calculated from base call data using a self-developed pipeline pA-finder. The libraries were directly sequenced from the 3MODIFIER LETTER PRIME-UTR regions into the followed poly(A) tails, firstly on NextSeq 500 to produce single-end 300-nt reads, demonstrating the method feasibility and that optimization of the fragmented RNA size for cDNA library construction could detecting longer poly (A) tails. We next applied Poly(A)-seq cDNA libraries containing 40-nt and 120-nt poly(A) tail spike-in RNAs on HiSeq X-ten and NovaSeq 6000 to obtain 150-nt and 250-nt pair-end reads. The sequencing profiles of the spike-in RNAs demonstrated both high accuracy and high quality score in reading poly(A) tails. The poly(A) signal bleeding into the 3' adaptor sequence and a sharp decreased quality score at the junction were observed, allowing the modification of pA-finder to remove homopolymeric signal bleeding. We hope that wide applications of Poly(A)-seq help facilitate the study of the development- and disease-related poly(A) dynamics and regulation, and of the recent emerging mixed tailing regulation.	[Yu, Fengyun; Rang, Wenliang; Yu, Han; Wu, Qijia; Zhang, Yi] ABLife Inc, Lab Genom Regulat & Human Hlth, Wuhan, Peoples R China; [Yu, Fengyun; Cheng, Chao; Zhang, Yi] ABLife BioBigData Inst, Wuhan, Peoples R China; [Zhang, Yu; Cheng, Chao; Wang, Wenqing; Zhou, Zisong; Wei, Yaxun; Zhang, Yi] ABLife Inc, Ctr Genom Anal, Wuhan, Peoples R China; [Wu, Qijia] Seqhlth Technol Co Ltd, Wuhan, Peoples R China		Zhang, Y (corresponding author), ABLife Inc, Lab Genom Regulat & Human Hlth, Wuhan, Peoples R China.; Zhang, Y (corresponding author), ABLife BioBigData Inst, Wuhan, Peoples R China.; Zhang, Y (corresponding author), ABLife Inc, Ctr Genom Anal, Wuhan, Peoples R China.	yizhang@ablife.cc		Zhang, Yu/0000-0003-0982-7584	ABLife Inc. [ABL2015-JK002]	ABLife Inc.	This work was supported by ABLife Inc. [grant number ABL2015-JK002]. The funder provided support in the form of salaries for authors [F.Y., Yu.Z., C.C., W.W., Z.Z, W.R., H.Y., Y.W., Q. W., and Yi.Z], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2019, FRONTIERS PLANT SCI; Batra R, 2015, RNA BIOL, V12, P597, DOI 10.1080/15476286.2015.1040974; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Chang H, 2014, MOL CELL, V53, P1044, DOI 10.1016/j.molcel.2014.02.007; Curinha A, 2014, NUCLEUS-PHILA, V5, P508, DOI 10.4161/nucl.36360; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906; Gruber AR, 2014, WIRES RNA, V5, P183, DOI 10.1002/wrna.1206; Harbers M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-665; Harrison PF, 2015, RNA, V21, P1502, DOI 10.1261/rna.048355.114; Ivshina M, 2014, ANNU REV CELL DEV BI, V30, P393, DOI 10.1146/annurev-cellbio-101011-155831; Janicke A, 2012, RNA, V18, P1289, DOI 10.1261/rna.031898.111; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; Legnini I, 2019, NAT METHODS, V16, P879, DOI 10.1038/s41592-019-0503-y; Lim J, 2018, SCIENCE, V361, P701, DOI 10.1126/science.aam5794; Lim J, 2016, GENE DEV, V30, P1671, DOI 10.1101/gad.284802.116; Moore MJ, 2000, METHOD ENZYMOL, V317, P109; Morgan M, 2017, NATURE, V548, P347, DOI 10.1038/nature23318; Murray EL, 2008, METHOD ENZYMOL, V448, P483, DOI 10.1016/S0076-6879(08)02624-4; Nilsen Timothy W, 2015, Cold Spring Harb Protoc, V2015, P413, DOI 10.1101/pdb.prot081034; Norbury CJ, 2013, NAT REV MOL CELL BIO, V14, P643, DOI 10.1038/nrm3645; Salles FJ, 1999, METHODS, V17, P38, DOI 10.1006/meth.1998.0705; Scott DD, 2013, BBA-GENE REGUL MECH, V1829, P654, DOI 10.1016/j.bbagrm.2013.01.009; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311; Woo YM, 2018, CELL REP, V24, P3630, DOI 10.1016/j.celrep.2018.08.084; Workman RE, 2018, NANOPORE NATIVE RNA; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Zhao TL, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1799-8; Zheng D, 2014, TRENDS BIOCHEM SCI, V39, P255, DOI 10.1016/j.tibs.2014.04.002	35	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234696	10.1371/journal.pone.0234696	http://dx.doi.org/10.1371/journal.pone.0234696			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544193	Green Published, gold			2022-12-26	WOS:000542957200030
J	Salahou, MK; Jiao, XY; Lu, HS; Guo, WH				Salahou, Mohamed Khaled; Jiao, Xiyun; Lu, Haishen; Guo, Weihua			An improved approach to estimating the infiltration characteristics in surface irrigation systems	PLOS ONE			English	Article							HYDRAULIC CONDUCTIVITY; FURROW IRRIGATION; SCALE DEPENDENCY; VOLUME-BALANCE; STEADY-STATE; ADVANCE DATA; PERFORMANCE; PARAMETERS; TIME	The most common methods for estimating the infiltration function are measurements through a double-ring infiltrometer (DRI) and empirical models. Infiltration data always exhibit different kinds of scatter, which affect the accuracy of the estimated infiltration function. This study presents a new methodology to calibrate the infiltration function. The suggested approach is based on combining the DRI method with the changes in the measured soil water content. Furrow irrigation experiments were conducted to estimate the infiltration function using different methods and to investigate the effect of data scatter on the reliability of the estimated infiltration function. Furrow elevations were observed, and for each irrigation event advance times, recession times, and inflow rates were observed. The infiltration depths were measured as a function of the change in the soil water content before and after irrigation event. Infiltration parameters were estimated using DRI treatment, empirical model (Kostiakov model), and suggested approach. Measured and simulated infiltration depths using the described methods were compared. The results show that the infiltration depths estimated using a DRI were lower than the observed infiltration depths, while the infiltration depths estimated using the empirical model were higher than the observed infiltration depths. The results indicate that the infiltration function estimated using the recommended approach was more accurate and reasonable than the infiltration function estimated using the DRI, and empirical (Kostiakov model) methods. In addition, the proposed approach can reduce the required measurements during the irrigation event, and can also reduce the potential scatter in the estimated infiltration function that results from soil variability and measurement errors.	[Salahou, Mohamed Khaled; Jiao, Xiyun; Lu, Haishen] Hohai Univ, State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Peoples R China; [Guo, Weihua] Hohai Univ, Coll Agr Engn, Nanjing, Peoples R China	Hohai University; Hohai University	Salahou, MK; Jiao, XY (corresponding author), Hohai Univ, State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Peoples R China.	salahou3@hotmail.com; xyjiao@hhu.edu.cn		SALAHOU, Mohamed Khaled/0000-0001-5604-8589	National Natural Science Foundation of China [51879073]; The National Natural Science Foundation of China [41830752, 41571015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Jiao Xiyun: The National Natural Science Foundation of China (51879073); Lu Haishen: The National Natural Science Foundation of China (grant numbers: 41830752 and 41571015).	Amer AM, 2010, SOIL WATER RES, V5, P75, DOI 10.17221/47/2009-SWR; Amer AM, 2011, AGR WATER MANAGE, V98, P815, DOI 10.1016/j.agwat.2010.12.006; [Anonymous], 2016, BALKAN J GEOM APPL, V21, piii; Anwar AA, 2016, IRRIGATION SCI, V34, P379, DOI 10.1007/s00271-016-0509-5; BACHU S, 1990, WATER RESOUR RES, V26, P863, DOI 10.1029/WR026i005p00863; Bautista E, 2017, T ASABE, V60, P1223, DOI 10.13031/trans.12117; Bautista E, 2016, J IRRIG DRAIN ENG, V142, DOI 10.1061/(ASCE)IR.1943-4774.0000938; Bautista E, 2012, J IRRIG DRAIN ENG, V138, P715, DOI 10.1061/(ASCE)IR.1943-4774.0000461; Bautista E, 2009, J IRRIG DRAIN ENG, V135, P579, DOI 10.1061/(ASCE)IR.1943-4774.0000018; Bautista E, 2009, J IRRIG DRAIN ENG, V135, P566, DOI 10.1061/(ASCE)IR.1943-4774.0000054; Bautista E, 2009, AGR WATER MANAGE, V96, P1146, DOI 10.1016/j.agwat.2009.03.007; Bautista E, 2009, AGR WATER MANAGE, V96, P1162, DOI 10.1016/j.agwat.2009.03.009; BLAIR AW, 1988, J IRRIG DRAIN ENG, V114, P18, DOI 10.1061/(ASCE)0733-9437(1988)114:1(18); BONDURANT J. A., 1957, Agric. Engng., V38, P602; Chen B, 2013, IRRIGATION SCI, V31, P715, DOI 10.1007/s00271-012-0338-0; CHILDS JL, 1993, J IRRIG DRAIN ENG, V119, P74, DOI 10.1061/(ASCE)0733-9437(1993)119:1(74); CLEMMENS AJ, 1981, AGR WATER MANAGE, V3, P251, DOI 10.1016/0378-3774(81)90010-X; Davis J, 1963, T ASAE, V6, P318; ELLIOTT RL, 1983, T ASAE, V26, P1722; Esfandiari M, 1997, AGR WATER MANAGEMENT; FANGMEIER DD, 1979, T ASAE, V22, P93, DOI 10.13031/2013.34972; Gillies MH, 2015, IRRIGATION SCI, V33, P339, DOI 10.1007/s00271-015-0470-8; Gillies MH, 2005, IRRIGATION SCI, V24, P25, DOI 10.1007/s00271-005-0004-x; GUIMERA J, 1995, GEOPHYS RES LETT, V22, P1449, DOI 10.1029/95GL01493; Holzapfel EA, 2004, AGR WATER MANAGE, V68, P19, DOI 10.1016/j.agwat.2004.03.002; HUME IH, 1993, AGR WATER MANAGE, V23, P23, DOI 10.1016/0378-3774(93)90018-6; IZADI B, 1988, T ASAE, V31, P1159, DOI 10.13031/2013.30838; Klute A., 1986, METHODS SOIL ANAL PA, P413, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C15; Kostiakov A.N., 1932, T 6 C INT SOIL SCI S, P17, DOI DOI 10.1139/CJSS-2016-0003; Kutilek M, 1994, SOIL HYDROLOGY TXB S; Lai J, 2007, SOIL SCI SOC AM J, V71, P1667, DOI 10.2136/sssaj2006.0227; Mateos L, 2005, AGR WATER MANAGE, V76, P62, DOI 10.1016/j.agwat.2005.01.013; Merriam J.L., 1987, FARM IRRIGATION SYST; Morris MR, 2015, AGR WATER MANAGE, V155, P76, DOI 10.1016/j.agwat.2015.03.017; Nance LA, 1970, T ASAE, V13, P792; Nie WB, 2017, J IRRIG DRAIN ENG, V143, DOI 10.1061/(ASCE)IR.1943-4774.0001174; Philipp A, 2013, J HYDRAUL ENG, V139, P1234, DOI 10.1061/(ASCE)HY.1943-7900.0000766; ROVEY CW, 1995, GROUND WATER, V33, P769, DOI 10.1111/j.1745-6584.1995.tb00023.x; Salahou MK, 2018, AGR WATER MANAGE, V201, P27, DOI 10.1016/j.agwat.2018.01.014; SCALOPPI EJ, 1995, J IRRIG DRAIN ENG, V121, P57, DOI 10.1061/(ASCE)0733-9437(1995)121:1(57); SCHMITZ GH, 1992, J IRRIG DRAIN ENG, V118, P1, DOI 10.1061/(ASCE)0733-9437(1992)118:1(1); Schulze-Makuch D, 1999, GROUND WATER, V37, P904, DOI 10.1111/j.1745-6584.1999.tb01190.x; SHEPARD JS, 1993, T ASAE, V36, P395; SHOUSE PJ, 1994, SOIL SCI, V157, P129, DOI 10.1097/00010694-199403000-00001; Shull H, 1961, BY PASS FURROW INFIL; SMERDON ET, 1988, J IRRIG DRAIN ENG, V114, P4, DOI 10.1061/(ASCE)0733-9437(1988)114:1(4); Smith RJ, 2018, AGR WATER MANAGE, V206, P78, DOI 10.1016/j.agwat.2018.03.014; Smith RJ, 2016, IRRIGATION SCI, V34, P175, DOI 10.1007/s00271-016-0494-8; TABUADA MA, 1995, AGR WATER MANAGE, V27, P105, DOI 10.1016/0378-3774(95)01136-7; TABUADA MA, 1995, AGR WATER MANAGE, V28, P201, DOI 10.1016/0378-3774(95)01177-K; U.S. Dept. of Agriculture-Natural Resources Conservation Service (USDA-NRCS), 1997, NAT IRR HDB 652; Uddin J, 2018, J IRRIG DRAIN ENG, V144, DOI 10.1061/(ASCE)IR.1943-4774.0001282; Valiantzas JD, 2001, AGR WATER MANAGE, V52, P17, DOI 10.1016/S0378-3774(01)00128-7; WALKER WR, 1990, J IRRIG DRAIN ENG, V116, P299, DOI 10.1061/(ASCE)0733-9437(1990)116:3(299); Yang J., 2015, INORGANIC CHEM IND, V3, P45; Yin N, 2016, WATER-SUI, V8, DOI 10.3390/w8100452; Yue B, 2012, WORKING PAPER; Zhang M, 1997, HYDROPOWER '97, P383	58	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234480	10.1371/journal.pone.0234480	http://dx.doi.org/10.1371/journal.pone.0234480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542022	Green Published, gold			2022-12-26	WOS:000542685100018
J	Al-Hajj, S; Nehme, R; Hatoum, F; Zheng, A; Pike, I				Al-Hajj, Samar; Nehme, Ricardo; Hatoum, Firas; Zheng, Alex; Pike, Ian			Child school injury in Lebanon: A study to assess injury incidence, severity and risk factors	PLOS ONE			English	Article							UNITED-STATES; EPIDEMIOLOGY; SUPERVISION; SCHOOLCHILDREN; ADOLESCENTS; EQUIPMENT	Background School-based injuries represent a sizeable portion of child injuries. This study investigated the rates of school-based injuries in Lebanon, examining injury mechanisms, outcomes and associated risk factors. Methods Data were prospectively collected by intern school nurses at 11 private schools for the 2018-2019 academic year. Descriptive and inferential analyses were performed. Chi-square comparisons were conducted to determine the significance of any differences in injury rates between boys and girls for each category of school. Results 4,619 injury cases were collected. The yearly rate for school injuries was 419.1 per 1,000 children for the year 2018-2019. Boys demonstrated a significantly higher injury rate for all mechanisms of injuries, with the exception of being injured while walking, injured in the gym/sports areas, and other areas outside the playground and classroom. Elementary school children had the highest rate of injuries, nearly 2.4 times higher than kindergarten, 2.8 times higher than middle school, and 14.5 times higher than high school. Injuries to the face, upper extremities, and lower extremities were nearly 3 times more common than injuries to other areas of the body. Bumps/hits and bruises were most common-almost 3 times more likely than all other injury types. Injuries were mainly minor or moderate in severity-severe injuries were about 10 times less likely. Most injuries were unintentional, with rates nearly 5 times higher than those with unclear intent and 12 times higher than intentional injuries. Conclusions School injuries represent a relatively common problem. Compliance with playground safety standards coupled with the implementation of injury prevention strategies and active supervision at schools can curtail child injuries and ensure a safe and injury-free school environment.	[Al-Hajj, Samar] Amer Univ Beirut, Hlth Management & Policy Dept, Beirut, Lebanon; [Nehme, Ricardo; Hatoum, Firas] Amer Univ Beirut, Dept Biol, Beirut, Lebanon; [Zheng, Alex; Pike, Ian] BC Childrens Hosp, Res Inst, BC Injury Res & Prevent Unit, Vancouver, BC, Canada; [Pike, Ian] Univ British Columbia, Fac Med, Dept Pediat, Vancouver, BC, Canada	American University of Beirut; American University of Beirut; BC Childrens Hospital; University of British Columbia; University of British Columbia	Al-Hajj, S (corresponding author), Amer Univ Beirut, Hlth Management & Policy Dept, Beirut, Lebanon.	sh137@aub.edu.lb		Nehme, Ricardo/0000-0002-3892-7413; Pike, Ian/0000-0002-6860-7760				Adelson SL, 2018, CLIN PEDIATR, V57, P584, DOI 10.1177/0009922817732144; Al-Hajj S, 2021, J PUBLIC HEALTH-UK, V43, pE24, DOI 10.1093/pubmed/fdaa043; Al-Hajj S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08523-w; Altmann A., 1996, HAZARD, V29, P1; Amanullah S, 2014, PEDIATRICS, V133, P254, DOI 10.1542/peds.2013-2155; [Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; [Anonymous], 2019, LEBANON ED SYSTEM OV; [Anonymous], 2012, J QUALITY PARTICIPAT, V34, P37; [Anonymous], 2017, J MANAG CARE SPEC PH, V23, ps6; Bergeron N, 2019, CAN FAM PHYSICIAN, V65, pE121; Birken Catherine S, 2004, Paediatr Child Health, V9, P323; Burchard R, 2017, TECHNOL HEALTH CARE, V25, P1053, DOI 10.3233/THC-170931; Canadian Standard Organization, 2019, CHILDR PLAYGR EQ; Centre for Disese Control, 2019, HEADS; Concussion Awareness Training Tool (CATT), 2019, CONCUSSION RESOURCES; El Bcheraoui C., 2012, Eastern Mediterranean Health Journal, V18, P1011; Foster C, 2018, CLIN OBES, V8, P68, DOI 10.1111/cob.12230; Giannotti M, 2011, PEDIATR EMERG CARE, V27, P81, DOI 10.1097/PEC.0b013e3182094340; Guilfoyle SM, 2012, J CHILD HEALTH CARE, V16, P141, DOI 10.1177/1367493511423855; HADDON W, 1980, PUBLIC HEALTH REP, V95, P411; Hesham E, 2012, INJURY PREV, V18, pA117, DOI 10.1136/injuryprev-2012-040590d.64; Hirschhorn RM, 2018, J ATHL TRAINING, V53, P906, DOI 10.4085/1062-6050-340-17; Hong J, 2010, ACCIDENT ANAL PREV, V42, P313, DOI 10.1016/j.aap.2009.08.010; Howard AW, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000195; Jildeh C, 2013, INT J POPULATION RES, V2013, DOI [10.1155/2013/624245, DOI 10.1155/2013/624245]; Johnson BK, 2017, CLIN J SPORT MED, V27, P388, DOI 10.1097/JSM.0000000000000351; Josse JM, 2009, J SCHOOL HEALTH, V79, P45, DOI 10.1111/j.1746-1561.2008.00375.x; Khamis V, 2015, CHILD ABUSE NEGLECT, V39, P137, DOI 10.1016/j.chiabu.2014.08.005; Laforest S, 2001, Inj Prev, V7, P35, DOI 10.1136/ip.7.1.35; Landen MG, 2003, PEDIATRICS, V111, P328, DOI 10.1542/peds.111.2.328; Limbos MAP, 2003, J SCHOOL HEALTH, V73, P101, DOI 10.1111/j.1746-1561.2003.tb03582.x; Lithander J, 1999, ACTA OPHTHALMOL SCAN, V77, P697, DOI 10.1034/j.1600-0420.1999.770619.x; Livny A, 2010, DENT TRAUMATOL, V26, P330, DOI 10.1111/j.1600-9657.2010.00922.x; Morrongiello BA, 2016, HEALTH PSYCHOL, V35, P523, DOI 10.1037/hea0000275; Morrongiello BA, 2010, AM J LIFESTYLE MED, V4, P65, DOI 10.1177/1559827609348475; Orton E, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010246.pub2; Ozkan O, 2016, PEDIATR INT, V58, P732, DOI 10.1111/ped.12909; Petridou E, 2002, ACTA PAEDIATR, V91, P691, DOI 10.1080/080352502760069133; Peyton Richard P, 2017, Oman Med J, V32, P98, DOI 10.5001/omj.2017.19; Potter BK, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-132; Raisanen AM, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-1969-y; Roach R, 2003, PHYS THER SPORT, V4, P58, DOI 10.1016/S1466-853X(02)00114-1; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Schneuer Francisco J, 2018, Inj Epidemiol, V5, P45, DOI 10.1186/s40621-018-0175-6; US Consumer Product Safety Commission, 2015, PUBL PLAYGR SAF HDB; Vollman D, 2009, CLIN PEDIATR, V48, P66, DOI 10.1177/0009922808321898; Wahdan MM, 2016, INJURY, V47, P2650, DOI 10.1016/j.injury.2016.09.024; Welton KL, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967117745788; Zagel AL, 2019, J SCHOOL HEALTH, V89, P38, DOI 10.1111/josh.12711	49	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0233465	10.1371/journal.pone.0233465	http://dx.doi.org/10.1371/journal.pone.0233465			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QP	32530949	Green Published, gold			2022-12-26	WOS:000542037200011
J	Nam, D; Matsumoto, Y; Uchida, T; O'Brian, MR; Ishimori, K				Nam, Dayeon; Matsumoto, Yuki; Uchida, Takeshi; O'Brian, Mark R.; Ishimori, Koichiro			Mechanistic insights into heme-mediated transcriptional regulation via a bacterial manganese-binding iron regulator, iron response regulator (Irr)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron metabolism; iron; DNA binding protein; metalloprotein; metal ion-protein interaction; protein-DNA interaction; heme; protein motif; Bradyrhizobium japonicum; gene regulation	FERRIC UPTAKE REGULATOR; DEPENDENT DIMERIZATION; METAL-BINDING; FUR PROTEINS; DEGRADATION; HOMEOSTASIS; OXIDATION; ACTIVATION; REPRESSOR; SEQUENCE	The transcription factor iron response regulator (Irr) is a key regulator of iron homeostasis in the nitrogen-fixating bacteriumBradyrhizobium japonicum. Irr acts by binding to target genes, including the iron control element (ICE), and is degraded in response to heme binding. Here, we examined this binding activity using fluorescence anisotropy with a 6-carboxyfluorescein-labeled ICE-like oligomer (FAM-ICE). In the presence of Mn2+, Irr addition increased the fluorescence anisotropy, corresponding to formation of the Irr-ICE complex. The addition of EDTA to the Irr-ICE complex reduced fluorescence anisotropy, but fluorescence was recovered after Mn(2+)addition, indicating that Mn(2+)binding is a prerequisite for complex formation. Binding activity toward ICE was lost upon introduction of substitutions in a His-cluster region of Irr, revealing that Mn(2+)binds to this region. We observed that the His-cluster region is also the heme binding site; results from fluorescence anisotropy and electrophoretic mobility shift analyses disclosed that the addition of a half-equivalent of heme dissociates Irr from ICE, likely because of Mn(2+)release due to heme binding. We hypothesized that heme binding to another heme binding site, Cys-29, would also inhibit the formation of the Irr-ICE complex because it is proximal to the ICE binding site, which was supported by the loss of ICE binding activity in a Cys-29-mutated Irr. These results indicate that Irr requires Mn(2+)binding to form the Irr-ICE complex and that the addition of heme dissociates Irr from ICE by replacing Mn(2+)with heme or by heme binding to Cys-29.	[Nam, Dayeon; Matsumoto, Yuki; Uchida, Takeshi; Ishimori, Koichiro] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido, Japan; [Uchida, Takeshi; Ishimori, Koichiro] Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido, Japan; [O'Brian, Mark R.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY USA	Hokkaido University; Hokkaido University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Ishimori, K (corresponding author), Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido, Japan.; Ishimori, K (corresponding author), Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido, Japan.	koichiro@sci.hokudai.ac.jp	Uchida, Takeshi/A-6455-2017; Ishimori, Koichiro/AAQ-4434-2021; Ishimori, Koichiro/S-1247-2016	Uchida, Takeshi/0000-0001-9270-8329; Ishimori, Koichiro/0000-0002-5868-0462; Ishimori, Koichiro/0000-0002-5868-0462; NAM, Dayeon/0000-0002-9991-2450; O'Brian, Mark/0000-0001-5196-7594	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [19H05769]; National Institutes of Health [R01 GM122947]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (19H05769) and a National Institutes of Health Grant (R01 GM122947). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad R, 2009, PROTEINS, V75, P373, DOI 10.1002/prot.22247; Aisen P, 2001, INT J BIOCHEM CELL B, V33, P940, DOI 10.1016/S1357-2725(01)00063-2; Botello-Morte L, 2016, ANTIOXID REDOX SIGN, V24, P173, DOI 10.1089/ars.2014.6175; Bsat N, 1999, J BACTERIOL, V181, P4299, DOI 10.1128/JB.181.14.4299-4307.1999; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; D'Autreaux B, 2007, BIOCHEMISTRY-US, V46, P1329, DOI 10.1021/bi061636r; Deng ZQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8642; Dian C, 2011, MOL MICROBIOL, V79, P1260, DOI 10.1111/j.1365-2958.2010.07517.x; Eady RR, 1996, CHEM REV, V96, P3013, DOI 10.1021/cr950057h; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; Ishikawa H, 2011, BIOCHEMISTRY-US, V50, P1016, DOI 10.1021/bi101895r; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; Jacquamet L, 2009, MOL MICROBIOL, V73, P20, DOI 10.1111/j.1365-2958.2009.06753.x; Jaggavarapu S, 2014, MOL MICROBIOL, V92, P609, DOI 10.1111/mmi.12584; Kitatsuji C, 2016, SCI REP-UK, V6, DOI 10.1038/srep18703; Kobayashi K, 2016, BIOCHEMISTRY-US, V55, P4047, DOI 10.1021/acs.biochem.6b00512; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; Nishitani Y, 2019, J INORG BIOCHEM, V198, DOI 10.1016/j.jinorgbio.2019.110726; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pecqueur L, 2006, J BIOL CHEM, V281, P21286, DOI 10.1074/jbc.M601278200; Perard J, 2016, BIOCHEMISTRY-US, V55, P1503, DOI 10.1021/acs.biochem.5b01061; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Puri S, 2010, P NATL ACAD SCI USA, V107, P10691, DOI 10.1073/pnas.1002342107; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Rodionov DA, 2006, PLOS COMPUT BIOL, V2, P1568, DOI 10.1371/journal.pcbi.0020163; Rudolph G, 2006, J BACTERIOL, V188, P733, DOI 10.1128/JB.188.2.733-744.2006; SAITO T, 1991, EUR J BIOCHEM, V197, P29, DOI 10.1111/j.1432-1033.1991.tb15878.x; Sangwan I, 2008, J BACTERIOL, V190, P5172, DOI 10.1128/JB.00495-08; SCHLUTER H, 1993, J CHROMATOGR, V639, P17, DOI 10.1016/0021-9673(93)83083-5; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Yang JH, 2006, MOL MICROBIOL, V60, P427, DOI 10.1111/j.1365-2958.2006.05101.x; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200; Yang JH, 2008, MOL CELL BIOL, V28, P4697, DOI 10.1128/MCB.00236-08; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	39	4	4	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11316	11325		10.1074/jbc.RA119.011855	http://dx.doi.org/10.1074/jbc.RA119.011855			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32554810	Green Published, hybrid			2022-12-26	WOS:000562757100031
J	Ronan, T; Garnett, R; Naegle, KM				Ronan, Tom; Garnett, Roman; Naegle, Kristen M.			New analysis pipeline for high-throughput domain-peptide affinity experiments improves SH2 interaction data	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; phosphotyrosine signaling; phosphotyrosine; Src homology 2 domain (SH2 domain); mathematical modeling; peptide interaction; epidermal growth factor receptor (EGFR); affinity; high-throughput; best practices; protein-protein interaction; kinetics	PROTEIN-PROTEIN INTERACTIONS; INTERACTION NETWORK; CAUTIONARY NOTE; BINDING; PREDICTION; ERBB; PHOSPHORYLATION; IDENTIFICATION; SPECIFICITY; MODELS	Protein domain interactions with short linear peptides, such as those of the Src homology 2 (SH2) domain with phosphotyrosine-containing peptide motifs (pTyr), are ubiquitous and important to many biochemical processes of the cell. The desire to map and quantify these interactions has resulted in the development of high-throughput (HTP) quantitative measurement techniques, such as microarray or fluorescence polarization assays. For example, in the last 15 years, experiments have progressed from measuring single interactions to covering 500,000 of the 5.5 million possible SH2-pTyr interactions in the human proteome. However, high variability in affinity measurements and disagreements about positive interactions between published data sets led us here to reevaluate the analysis methods and raw data of published SH2-pTyr HTP experiments. We identified several opportunities for improving the identification of positive and negative interactions and the accuracy of affinity measurements. We implemented model-fitting techniques that are more statistically appropriate for the nonlinear SH2-pTyr interaction data. We also developed a method to account for protein concentration errors due to impurities and degradation or protein inactivity and aggregation. Our revised analysis increases the reported affinity accuracy, reduces the false-negative rate, and increases the amount of useful data by adding reliable true-negative results. We demonstrate improvement in classification of bindingversusnonbinding when using machine-learning techniques, suggesting improved coherence in the reanalyzed data sets. We present revised SH2-pTyr affinity results and propose a new analysis pipeline for future HTP measurements of domain-peptide interactions.	[Ronan, Tom; Naegle, Kristen M.] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA; [Garnett, Roman] Washington Univ, Dept Comp Sci & Engn, St Louis, MO 63110 USA; [Naegle, Kristen M.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA; [Naegle, Kristen M.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA	Washington University (WUSTL); Washington University (WUSTL); University of Virginia; University of Virginia	Naegle, KM (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA.; Naegle, KM (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.; Naegle, KM (corresponding author), Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA.	kmn4mj@virginia.edu		Naegle, Kristen/0000-0001-7146-9592	Center for Biological Systems Engineering	Center for Biological Systems Engineering	The work was supported in part by the Center for Biological Systems Engineering (to T. R).	AlQuraishi M, 2014, NAT GENET, V46, P1363, DOI 10.1038/ng.3138; ANDERSONSPRECHER R, 1994, AM STAT, V48, P113, DOI 10.2307/2684259; Birtwistle MR, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1215; Boisguerin P, 2004, CHEM BIOL, V11, P449, DOI 10.1016/j.chembiol.2004.03.010; Bornhorst JA, 2000, METHOD ENZYMOL, V326, P245; Campbell J, 2016, CELL REP, V14, P2490, DOI 10.1016/j.celrep.2016.02.023; Carducci M, 2012, BIOTECHNOL ADV, V30, P4, DOI 10.1016/j.biotechadv.2011.06.012; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Clark AJC, 1926, J PHYSIOL-LONDON, V61, P530, DOI 10.1113/jphysiol.1926.sp002314; Gaseitsiwe S, 2009, METHODS MOL BIOL, V524, P417, DOI 10.1007/978-1-59745-450-6_30; Gong WM, 2008, NUCLEIC ACIDS RES, V36, pD679, DOI 10.1093/nar/gkm854; Gordus A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.72; Haj AK, 2020, J IMMUNOL, V204, P1689, DOI 10.4049/jimmunol.1900889; Hause RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044471; Jadwin JA, 2018, J BIOL CHEM, V293, P623, DOI 10.1074/jbc.M117.794412; Jiang S., 2017, P 34 INT C MACH LEAR P 34 INT C MACH LEAR, P1714; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; JULIANO SA, 1987, J ANIM ECOL, V56, P641, DOI 10.2307/5074; Jung C, 2019, JOVE-J VIS EXP, DOI 10.3791/58763; Kaushansky A, 2008, CHEM BIOL, V15, P808, DOI 10.1016/j.chembiol.2008.07.006; Kaushansky A, 2008, MOL BIOSYST, V4, P643, DOI 10.1039/b801018h; Kaushansky A, 2010, NAT PROTOC, V5, P773, DOI 10.1038/nprot.2010.36; Kennedy SP, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00088; Koytiger G, 2013, MOL CELL PROTEOMICS, V12, P1204, DOI 10.1074/mcp.M112.025858; Kundu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062732; KVALSETH TO, 1985, AM STAT, V39, P279, DOI 10.2307/2683704; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Leong SH, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0012-3; Leung KK, 2014, MOL CELL PROTEOMICS, V13, P1705, DOI 10.1074/mcp.M113.034876; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; Machida K, 2005, BBA-PROTEINS PROTEOM, V1747, P1, DOI 10.1016/j.bbapap.2004.10.005; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Matlock MK, 2015, NUCLEIC ACIDS RES, V43, pD521, DOI 10.1093/nar/gku1154; Mazerolle M. J., 2007, THESIS, P1; Miaou S.P., 1996, TRANSPORT RES REC, V1542, P6, DOI 10.3141/1542-02; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pol Ewa, 2010, J Vis Exp, DOI 10.3791/1746; Ruiz-Saenz A, 2018, CANCER RES, V78, P3645, DOI 10.1158/0008-5472.CAN-18-0430; Sanchez IE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000052; Spiess Andrej-Nikolai, 2010, BMC Pharmacology, V10, P6, DOI 10.1186/1471-2210-10-6; Stern HM, 2015, CLIN CANCER RES, V21, P2065, DOI 10.1158/1078-0432.CCR-14-2993; Stites EC, 2015, BIOPHYS J, V108, P1819, DOI 10.1016/j.bpj.2015.02.030; Tian F, 2009, AMINO ACIDS, V36, P535, DOI 10.1007/s00726-008-0116-8; Tinti M, 2013, CELL REP, V3, P1293, DOI 10.1016/j.celrep.2013.03.001; Tsai CJ, 2019, BIOPHYS J, V117, P5, DOI 10.1016/j.bpj.2019.05.021; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; WILLETT JB, 1988, AM STAT, V42, P236, DOI 10.2307/2685031; Wunderlich Z, 2009, NUCLEIC ACIDS RES, V37, P4629, DOI 10.1093/nar/gkp394; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zuo Z, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao1799	54	2	2	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11346	11363		10.1074/jbc.RA120.012503	http://dx.doi.org/10.1074/jbc.RA120.012503			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32540967	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000562757100034
J	Prendergast, L; Hong, E; Safina, A; Poe, D; Gurova, K				Prendergast, Laura; Hong, Erin; Safina, Alfiya; Poe, Dante; Gurova, Katerina			Histone chaperone FACT is essential to overcome replication stress in mammalian cells	ONCOGENE			English	Article							CHROMATIN TRANSCRIPTION FACT; FUNCTIONAL COOPERATION; MCM-HELICASE; DNA-DAMAGE; COMPLEX; NUCLEOSOME; PROTEIN; MECHANISM; SPT16; YEAST	The histone chaperone FACT is upregulated during mammary tumorigenesis and necessary for the viability and growth of breast tumor cells. We established that only proliferating tumor cells are sensitive to FACT knockdown, suggesting that FACT functions during DNA replication in tumor cells but not in normal cells. We hypothesized that the basal level of replication stress defines the FACT dependence of cells. Using genetic and chemical tools, we demonstrated that FACT is needed to overcome replication stress. In the absence of FACT during replication stress, the MCM2-7 helicase dissociates from chromatin, resulting in the absence of ssDNA accumulation, RPA binding, and activation of the ATR/CHK1 checkpoint response. Without this response, stalled replication forks are not stabilized, and new origin firing cannot be prevented, leading to the accumulation of DNA damage and cell death. Thus, we propose a novel role for FACT as a factor preventing helicase dissociation from chromatin during replication stress.	[Prendergast, Laura; Hong, Erin; Safina, Alfiya; Poe, Dante; Gurova, Katerina] Roswell Pk Comprehens Canc Ctr, Dept Cell Stress Biol, Buffalo, NY 14263 USA		Gurova, K (corresponding author), Roswell Pk Comprehens Canc Ctr, Dept Cell Stress Biol, Buffalo, NY 14263 USA.	katerina.gurova@roswellpark.org		Prendergast, Laura/0000-0003-0467-657X; Poe, Dante/0000-0002-4813-3035; Gurova, Katerina/0000-0001-9189-0712	NCI NIH HHS [P30 CA016056, R01 CA197967] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe T, 2011, J BIOL CHEM, V286, P30504, DOI 10.1074/jbc.M111.264721; Attwood K, 2017, BREAST CANCER-TARGET, V9, P301, DOI 10.2147/BCTT.S126390; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Carter DR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1803; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Corpet A, 2011, EMBO J, V30, P480, DOI 10.1038/emboj.2010.335; Dermawan JKT, 2016, CANCER RES, V76, P2432, DOI 10.1158/0008-5472.CAN-15-2162; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Fleyshman D, 2017, ONCOTARGET, V8, P20525, DOI 10.18632/oncotarget.15656; Forment JV, 2015, NAT PROTOC, V10, P1297, DOI 10.1038/nprot.2015.066; Garcia H, 2013, CELL REP, V4, P159, DOI 10.1016/j.celrep.2013.06.013; Garcia H, 2011, ONCOTARGET, V2, P783; Gasparian AV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002530; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Gurova K, 2018, BBA-GENE REGUL MECH, V1861, P892, DOI 10.1016/j.bbagrm.2018.07.008; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herrera-Moyano E, 2014, GENE DEV, V28, P735, DOI 10.1101/gad.234070.113; Hertel L, 1999, EXP CELL RES, V250, P313, DOI 10.1006/excr.1999.4495; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Kim ST, 1999, J BIOL CHEM, V8, P49; Klusmann I, 2016, CELL REP, V17, P1845, DOI 10.1016/j.celrep.2016.10.036; Koman IE, 2012, CANCER PREV RES, V5, P1025, DOI 10.1158/1940-6207.CAPR-11-0529; Kulaeva OI, 2013, BBA-GENE REGUL MECH, V1829, P76, DOI 10.1016/j.bbagrm.2012.08.015; Kurat CF, 2017, MOL CELL, V65, P117, DOI 10.1016/j.molcel.2016.11.016; Liu Y, 2020, NATURE, V577, P426, DOI 10.1038/s41586-019-1820-0; Lolas IB, 2010, PLANT J, V61, P686, DOI 10.1111/j.1365-313X.2009.04096.x; Lolis AA, 2013, J BIOL CHEM, V288, P7676, DOI 10.1074/jbc.M112.426718; Mejlvang J, 2014, J CELL BIOL, V204, P29, DOI 10.1083/jcb.201305017; Mylonas C, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800085; O'Donnell AF, 2004, NUCLEIC ACIDS RES, V32, P5894, DOI 10.1093/nar/gkh922; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Prado F, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020049; Qiu ZJ, 2018, RADIOTHER ONCOL, V126, P450, DOI 10.1016/j.radonc.2017.09.043; Safina A, 2013, CELL CYCLE, V12, P2423, DOI 10.4161/cc.25452; Sandlesh P, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101177; Sandlesh P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199785; Schlesinger MB, 2000, GENETICS, V155, P1593; Shen ZL, 2018, STEM CELLS DEV, V27, P1693, DOI 10.1089/scd.2018.0150; SOULE HD, 1990, CANCER RES, V50, P6075; Spiesser TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010203; Tan BCM, 2006, EMBO J, V25, P3975, DOI 10.1038/sj.emboj.7601271; Tan BCM, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-11; Toledo L, 2017, MOL CELL, V66, P735, DOI 10.1016/j.molcel.2017.05.001; True JD, 2016, J BIOL CHEM, V291, P15307, DOI 10.1074/jbc.M116.735134; Tsunaka Y, 2016, GENE DEV, V30, P673, DOI 10.1101/gad.274183.115; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Voth WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084092; Wang T, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800107; Wittmeyer J, 1999, BIOCHEMISTRY-US, V38, P8961, DOI 10.1021/bi982851d; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Yang JY, 2016, CELL REP, V14, P1128, DOI 10.1016/j.celrep.2015.12.096; YARBRO JW, 1992, SEMIN ONCOL, V19, P1; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Yeo CQX, 2016, CELL REP, V15, P132, DOI 10.1016/j.celrep.2016.03.011; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	56	10	10	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 9	2020	39	28					5124	5137		10.1038/s41388-020-1346-9	http://dx.doi.org/10.1038/s41388-020-1346-9			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MH4RK	32533099	Green Published, hybrid			2022-12-26	WOS:000546718100004
J	Dun, H; Ye, L; Zhu, YH; Wong, BW				Dun, Hao; Ye, Li; Zhu, Yuehui; Wong, Brian W.			Combined abdominal heterotopic heart and aorta transplant model in mice	PLOS ONE			English	Article							CARDIAC TRANSPLANTATION; CHRONIC REJECTION; INVESTIGATE	Background Allograft vasculopathy (AV) remains a major obstacle to long-term allograft survival. While the mouse aortic transplantation model has been proven as a useful tool for study of the pathogenesis of AV, simultaneous transplantation of the aorta alongside the transplantation of another organ may reveal more clinically relevant mechanisms that contribute to the pathogenesis of chronic allograft rejection. Therefore, we developed a combined abdominal heart and aorta transplantation model in mice which benefits from reducing animal and drug utilization, while providing an improved model to study the progressive nature of AV. Methods The middle of the infrarenal aorta of the recipient mouse was ligatured between the renal artery and its bifurcation. Proximal and distal aortotomies were performed at this site above and below the ligature, respectively, for the subsequent anastomoses of the donor aorta and heart grafts to the recipient infrarenal aorta in an end-to-side fashion. The distal anastomotic site of the recipient infrarenal aorta was connected with the outlet of the donor aorta. Uniquely, the proximal anastomotic site on the recipient infrarenal aorta was shared to connect with both the inlet of the donor aorta and the inflow tract to the donor heart. The outflow tract from the donor heart was connected to the recipient inferior vena cava (IVC). Results The median times for harvesting the heart graft, aorta graft, recipient preparation and anastomosis were 11.5, 8.0, 9.0 and 40.5 min, respectively, resulting in a total median ischemic time of 70 min. The surgery survival rate was more than 96% (29/30). Both the syngeneicC57Bl/6aorta and heart grafts survived more than 90 days in 29C57Bl/6recipients. Further,Balb/ctoC57Bl/6allografts treated with anti-CD40L and CTLA4.Ig survived more than 90 days with a 100% (3/3) survival rate. (3/3). Conclusions This model is presented as a new tool for researchers to investigate transplant immunology and assess immunosuppressive strategies. It is possible to share a common anastomotic stoma on the recipient abdominal aorta to reconstruct both the aorta graft entrance and heart graft inflow tract. This allows for the study of allogeneic effects on both the aorta and heart from the same animal in a single survival surgery.	[Dun, Hao; Ye, Li; Zhu, Yuehui; Wong, Brian W.] Washington Univ, Sch Med, Dept Surg, Lab Lymphat Metab Epigenet, St Louis, MO 63110 USA	Washington University (WUSTL)	Wong, BW (corresponding author), Washington Univ, Sch Med, Dept Surg, Lab Lymphat Metab Epigenet, St Louis, MO 63110 USA.	brian.wong@wustl.edu	Wong, Brian/B-6168-2009	Wong, Brian/0000-0001-8447-3064	Joel D. Cooper Career Development Award from the International Society of Heart and Lung Transplantation (BWW)	Joel D. Cooper Career Development Award from the International Society of Heart and Lung Transplantation (BWW)	This work was supported by the Joel D. Cooper Career Development Award from the International Society of Heart and Lung Transplantation (BWW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 1995, World Health Forum, V16, P110; [Anonymous], 2007, NEPHROL DIAL TRANSPL, V22, P12; [Anonymous], 2017, ISMP MED SAFETY ALER, V22, P1, DOI DOI 10.1016/j.ebiom.2017.07.026; AZUMA H, 1994, CURR OPIN IMMUNOL, V6, P770, DOI 10.1016/0952-7915(94)90083-3; Baldwin WM, 2014, CURR OPIN ORGAN TRAN, V19, P525, DOI 10.1097/MOT.0000000000000113; Chereshnev I, 2003, J SURG RES, V111, P171, DOI 10.1016/S0022-4804(03)00039-8; Chih S, 2016, J AM COLL CARDIOL, V68, P80, DOI 10.1016/j.jacc.2016.04.033; Chong AS, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015495; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; Ensminger SM, 2000, J HEART LUNG TRANSPL, V19, P1039, DOI 10.1016/S1053-2498(00)00195-9; Gilson CR, 2009, J IMMUNOL, V183, P1625, DOI 10.4049/jimmunol.0900339; Lee MS, 2018, CATHETER CARDIO INTE, V92, pE527, DOI 10.1002/ccd.27893; Lund LH, 2017, J HEART LUNG TRANSPL, V36, P1037, DOI 10.1016/j.healun.2017.07.019; Mao MJ, 2009, J HEART LUNG TRANSPL, V28, P1102, DOI 10.1016/j.healun.2009.05.025; Perico N, 1997, DRUGS, V54, P533, DOI 10.2165/00003495-199754040-00003; Qin LF, 2013, JOVE-J VIS EXP, DOI 10.3791/50290; Ryll M, 2019, JOVE-J VIS EXP, DOI 10.3791/59983; Sho M, 2002, J IMMUNOL, V169, P3744, DOI 10.4049/jimmunol.169.7.3744; Soleimani B, 2008, J HEART LUNG TRANSPL, V27, P450, DOI 10.1016/j.healun.2008.01.015; Solini S, 2012, TRANSPL INT, V25, P347, DOI 10.1111/j.1432-2277.2011.01425.x; Su S, 2011, ASIAN J SURG, V34, P86, DOI 10.1016/S1015-9584(11)60025-0; Sun H, 1998, MICROSURG, V18, P368, DOI 10.1002/(SICI)1098-2752(1998)18:6<368::AID-MICR5>3.0.CO;2-F; Tejani A, 2002, AM J TRANSPLANT, V2, P142, DOI 10.1034/j.1600-6143.2002.020205.x; Tepperman E, 2010, CAN J SURG, V53, P57; US FDA, 2016, FED REGISTER, V2, P22; Zheng XX, 1999, J IMMUNOL, V162, P4983	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0230649	10.1371/journal.pone.0230649	http://dx.doi.org/10.1371/journal.pone.0230649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569305	Green Published, gold, Green Submitted			2022-12-26	WOS:000543547900028
J	Jonesco, DS; Karsdal, MA; Henriksen, K				Jonesco, Ditte S.; Karsdal, Morten A.; Henriksen, Kim			The CNS-specific proteoglycan, brevican, and its ADAMTS4-cleaved fragment show differential serological levels in Alzheimer's disease, other types of dementia and non-demented controls: A cross-sectional study	PLOS ONE			English	Article							ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; THROMBOSPONDIN MOTIFS; NATIONAL INSTITUTE; MEMORY; TAU; EXPRESSION; PROTECT; METALLOPROTEINASE; RECOMMENDATIONS	Evidence indicate that the brain-specific protein, brevican, is proteolytically cleaved during neurodegeneration, hence positioning fragments of brevican as potential blood biomarkers of neurodegenerative diseases, such as dementia. We aimed to develop two assays capable of detecting the brevican N-terminal (N-Brev) and the ADAMTS4-generated fragment (Brev-A), cleaved at Ser(401), in serum and to perform a preliminary assessment of their diagnostic potential in dementias. Monoclonal antibodies against N-Brev and Brev-A were used to develop two ELISAs detecting each epitope. A comparison of brevican fragments in serum from individuals with AD (n = 28), other dementia (OD) (n = 41), and non-dementia-related memory complaints (NDCs) (n = 48) was conducted. Anti-N-Brev and anti-Brev-A antibodies selectively recognized their targets and dilution and spike recoveries were within limits of +/- 20%. Intra- and inter-assay CVs were below limits of 10% and 15%, respectively. For the N-Brev biomarker, serum from patients with OD showed significantly lower levels than those with AD (p= 0.05) and NDCs (p< 0.01). The opposite pattern was evident for Brev-A: serum levels in patients with OD were significantly higher than for AD (p= 0.04) and NDCs (p= 0.01). For both N-Brev and Brev-A, levels did not differ between AD and NDCs. The ratio of N-Brev/Brev-A resulted in increased significant differences between OD and AD (p< 0.01) and between OD and NDCs (p< 0.0001). The ratio discriminated between NDCs and OD (AUC: 0.75, 95% CI: 0.65-0.85,p< 0.0001) and between OD and AD (AUC: 0.72, 95% CI: 0.59-0.85,p< 0.01). In conclusion, we developed the first assays detecting the N-terminal of brevican as well as an ADAMTS4-cleaved fragment of brevican in blood. Differential levels of N-Brev and Brev-A between AD and OD allow for these biomarkers to possibly distinguish between different forms of dementias.	[Jonesco, Ditte S.; Karsdal, Morten A.; Henriksen, Kim] Nord Biosci, Biomarkers & Res, Herlev, Denmark	Nordic Bioscience	Jonesco, DS (corresponding author), Nord Biosci, Biomarkers & Res, Herlev, Denmark.	kh@nordicbio.com		Karsdal, Morten/0000-0001-5026-8740; Jonesco, Ditte/0000-0002-3211-9335	Danish research foundation "Den Danske Forskningsfond"	Danish research foundation "Den Danske Forskningsfond"	The Danish research foundation "Den Danske Forskningsfond" supported this study by funding DSJ PhD project. DSJ, KH and MAK are employed by Nordic Bioscience and thus received support in the form of a salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Ajmo JM, 2010, J NEUROCHEM, V71, P233; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; [Anonymous], 1998, Neurobiol Aging, V19, P109; [Anonymous], 2017, PLASMONICS, V12, P1; [Anonymous], 2012, REGEN MED S3, V7, pS14; Barascuk N, 2010, CLIN BIOCHEM, V43, P899, DOI 10.1016/j.clinbiochem.2010.03.012; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Blennow K, 2018, J INTERN MED, V284, P643, DOI 10.1111/joim.12816; Brakebusch C, 2002, MOL CELL BIOL, V22, P7417, DOI 10.1128/MCB.22.21.7417-7427.2002; Combet C., 2000, COMPUT CORNER, P147; de Souza LC, 2011, J NEUROL NEUROSUR PS, V82, P240, DOI 10.1136/jnnp.2010.207183; Martin-de-Saavedra MD, 2011, NEUROCHEM INT, V58, P676, DOI 10.1016/j.neuint.2011.02.006; GEFTER ML, 1977, SOMAT CELL GENET, V3, P231, DOI 10.1007/BF01551818; Gogolla N, 2016, SCI AAAS, V325, P1258; Gottschall PE, 2015, MATRIX BIOL, V44-46, P70, DOI 10.1016/j.matbio.2015.01.014; Gundelfinger ED, 2010, EUR J NEUROSCI, V31, P2156, DOI 10.1111/j.1460-9568.2010.07253.x; Hampel H, 2018, NAT REV NEUROL, V14, P639, DOI 10.1038/s41582-018-0079-7; Happel M. F., 2016, COMPOSITION FUNCTION, P143, DOI DOI 10.5772/62452; Hellwig K, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0161-y; Henriksen K, 2015, J ALZHEIMERS DIS, V43, P1331, DOI 10.3233/JAD-140984; Henriksen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064990; Howell MD, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0233-z; Inekci D, 2015, CURR ALZHEIMER RES, V12, P829, DOI 10.2174/1567205012666150710111211; Inekci D, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00090; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Karsdal MA, 2010, CLIN BIOCHEM, V43, P793, DOI 10.1016/j.clinbiochem.2010.03.015; Kvartsberg H, 2015, ALZHEIMERS DEMENT, V11, P1180, DOI 10.1016/j.jalz.2014.10.009; Lendvai D, 2013, ACTA NEUROPATHOL, V125, P215, DOI 10.1007/s00401-012-1042-0; Lewczuk P, 2015, J ALZHEIMERS DIS, V43, P183, DOI 10.3233/JAD-140771; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; Mayer J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-52; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Minta K, 2019, CLIN CHEM LAB MED, P1, DOI [10.1515/cclm-2019-0625, DOI 10.1515/CCLM-2019-0625]; Minta K, 2019, J ALZHEIMERS DIS, V69, P1213, DOI 10.3233/JAD-190187; Miyata S, 2007, BRAIN RES, V1150, P200, DOI 10.1016/j.brainres.2007.02.066; Molinuevo JL, 2018, ACTA NEUROPATHOL, V136, P821, DOI 10.1007/s00401-018-1932-x; Morawski M, 2004, EXP NEUROL, V188, P309, DOI 10.1016/j.expneurol.2004.04.017; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; Ogawa T, 2001, J COMP NEUROL, V432, P285, DOI 10.1002/cne.1103; OKAMOTO M, 1994, NEUROSCI LETT, V172, P51, DOI 10.1016/0304-3940(94)90660-2; PORTELIUS E, 2015, BRAIN 11, V138, DOI DOI 10.1093/BRAIN/AWV267; Portelius E, 2018, ACTA NEUROPATHOL, V136, P363, DOI 10.1007/s00401-018-1851-x; Preische O, 2019, NAT MED, V25, P277, DOI 10.1038/s41591-018-0304-3; Romberg C, 2013, J NEUROSCI, V33, P7057, DOI 10.1523/JNEUROSCI.6267-11.2013; Saroja SR, 2014, J NEUROCHEM, V130, P797, DOI 10.1111/jnc.12783; Satoh K, 2000, NEUROSCI LETT, V289, P177, DOI 10.1016/S0304-3940(00)01285-4; Schoonenboom NSM, 2012, NEUROLOGY, V78, P47, DOI 10.1212/WNL.0b013e31823ed0f0; Seidenbecher CI, 2002, J NEUROCHEM, V83, P738, DOI 10.1046/j.1471-4159.2002.01183.x; Sheikh-Bahaei N, 2017, J ALZHEIMERS DIS REP, V1, P71, DOI 10.3233/ADR-170013; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P1, DOI DOI 10.1016/J.JALZ.2011.03.005; Thon N, 2000, EUR J NEUROSCI, V12, P2547, DOI 10.1046/j.1460-9568.2000.00109.x; Vegh MJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0076-z; Wang P, 2016, SCI REP, V6, P1, DOI DOI 10.1038/s41598-016-0001-8; Wellington H, 2016, NEUROLOGY, V86, P829, DOI 10.1212/WNL.0000000000002423; Yang S, 2015, EXP NEUROL, V265, P48, DOI 10.1016/j.expneurol.2014.11.013; Yuan W, 2002, NEUROSCIENCE, V114, P1091, DOI 10.1016/S0306-4522(02)00347-0; Zhang H, 1998, J NEUROSCI, V18, P2370	59	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234632	10.1371/journal.pone.0234632	http://dx.doi.org/10.1371/journal.pone.0234632			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559242	gold, Green Published			2022-12-26	WOS:000543261600004
J	Odafe, S; Onotu, D; Fagbamigbe, JO; Ene, U; Rivadeneira, E; Carpenter, D; Omoigberale, AI; Adamu, Y; Lawal, I; James, E; Boyd, AT; Dirlokov, E; Swaminathan, M				Odafe, Solomon; Onotu, Dennis; Fagbamigbe, Johnson Omodele; Ene, Uzoma; Rivadeneira, Emilia; Carpenter, Deborah; Omoigberale, Austin, I; Adamu, Yakubu; Lawal, Ismail; James, Ezekiel; Boyd, Andrew T.; Dirlokov, Emilio; Swaminathan, Mahesh			Increasing pediatric HIV testing positivity rates through focused testing in high-yield points of service in health facilities-Nigeria, 2016-2017	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; SCREENING TOOL; PREVALENCE	Background In 2017, UNAIDS estimated that 140,000 children aged 0-14 years are living with HIV in Nigeria, but only 35% have been diagnosed and are receiving antiretroviral therapy. Children are tested primarily in outpatient clinics, which show low HIV-positive rates. To demonstrate efficient facility-based HIV testing among children aged 0-14 years, we evaluated pediatric HIV-positivity rates in points of service in select health facilities in Nigeria. Methods We conducted a retrospective analysis of HIV testing and case identification among children aged 0-14 years at all points of service at nine purposively sampled hospitals (November 2016-March 2017). Points of service included family index testing, pediatric outpatient department (POPD), tuberculosis (TB) clinics, immunization clinics, and pediatric inpatient ward. Eligibility for testing at POPD was done using a screening tool while all children with unknown status were eligible for HIV test at other points of service. The main outcome was HIV positivity rates stratified by the testing point of service and by age group. Predictors of an HIV-positive result were assessed using logistic regression. All analyses were done using Stata 15 statistical software. Results Of 2,180 children seen at all facility points of service with unknown HIV status, 1,822 (83.6%) were tested for HIV, of whom 43 (2.4%) tested HIV positive. The numbers of children tested by age group were <1 years = 230 (12.6%); 1-4 years = 752 (41.3%); 5-9 years = 520 (28.5%); and 10-14 years = 320 (17.6%). The number of children tested by point of service were POPD = 906 (49.7%); family index testing = 693 (38.0%); pediatric inpatient ward = 192 (10.5%); immunization clinic = 16 (0.9%); and TB clinic = 15 (0.8%). HIV positivity rates by point of service were TB clinic = 6.7% (95% Confidence Interval (CI): 0.9-35.2%); pediatric inpatient ward = 4.7% (95%CI: 2.5-8.8%); family index testing = 3.5% (95%CI: 2.3-5.1%); POPD = 1.0% (95%CI: 0.5-1.9%); and immunization clinic = 0%. The percentage contribution to total HIV positive children found by point of services was: family index testing = 55.8% (95%CI: 40.9-69.8%); POPD = 20.9% (95%CI: 11.3-35.6%); inpatient ward = 20.9 (95%CI: 11.3-35.6%) and TB Clinic = 2.3% (95%CI: 0.3-14.8%). Compared with the POPD, the adjusted odds ratio (95% CI) for finding an HIV positive child by point of service were TB clinic = 7.2 (95% CI: 0.9-60.9); pediatric inpatient ward = 4.9 (95% CI: 1.9-12.8); and family index testing = 3.7 (95% CI: 1.5-8.8). HIV-positivity rates did not significantly differ by age group. Conclusion In Nigeria, to improve facility-based HIV positivity rates among children aged 0-14 years, an increased focus on HIV testing among children seeking care in pediatric inpatient wards, through family index testing, and perhaps TB clinics is appropriate.	[Odafe, Solomon; Onotu, Dennis; Fagbamigbe, Johnson Omodele; Ene, Uzoma; Swaminathan, Mahesh] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Abuja, Nigeria; [Rivadeneira, Emilia; Carpenter, Deborah; Boyd, Andrew T.; Dirlokov, Emilio] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Atlanta, GA USA; [Omoigberale, Austin, I] Univ Benin, Dept Pediat, Teaching Hosp, Benin, Nigeria; [Adamu, Yakubu; Lawal, Ismail] Walter Reed Army Inst Res, Mil HIV Res Program, Abuja, Nigeria; [James, Ezekiel] US Agcy Int Dev, HIV AIDS Care & Treatment, Washington, DC 20523 USA	Centers for Disease Control & Prevention - USA; University of Benin; United States Agency for International Development (USAID)	Odafe, S (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Abuja, Nigeria.	wsp7@cdc.gov		Dirlikov, Emilio/0000-0003-4631-2643; Odafe, Solomon/0000-0002-2452-0532	President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC) [GH002097, GH002098, GH002099, GH002100]	President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC) under the terms of GH002097, GH002098, GH002099 and GH002100.	[Anonymous], 2012, J AM COLL CARDIOL, V60, pe44; [Anonymous], 2013, AIDS, V27, pS159; Auld AF, 2017, MMWR-MORBID MORTAL W, V66, P558, DOI 10.15585/mmwr.mm6621a3; Bandason T, 2016, AIDS, V30, P779, DOI 10.1097/QAD.0000000000000959; Chamla D, 2015, PAEDIATR INT CHILD H, V35, P298, DOI 10.1080/20469047.2015.1109233; Dalhatu I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170912; Division HA, 2016, NAT ACC PLAN PAED HI; Federal Ministry of Health, 2016, NAT ACC PLAN PAED HI; Gautier SV, 2013, VESTNIK TRANSPLANTOL, VXV, P8; Govindasamy D, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20182; Health CfG, 2015, STRAT ID LINK HIV IN, P4; Kankasa C, 2009, JAIDS-J ACQ IMM DEF, V51, P202, DOI 10.1097/QAI.0b013e31819c173f; Luyirika E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069548; Moucheraud C, 2018, JAIDS-J ACQ IMM DEF, V79, P352, DOI 10.1097/QAI.0000000000001804; Odafe S, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17424; Oluwagbemiga Adeyemi Ezekiel, 2007, SAHARA J, V4, P668; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Sau Mealiny Sokun, 2016, J Int Assoc Provid AIDS Care, V15, P345, DOI 10.1177/2325957415599208; Shamu S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210826; Thorne C, 2016, LANCET HIV, V3, pE5, DOI 10.1016/S2352-3018(15)00243-X; Tilahun G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3193-8; UNAIDS, 2019, HIV AIDS EST; UNAIDS, 2019, COUNTR HIV FACTSH; UNAIDS, 2019, COUNTR FACTSH; UNAIDS, 2014, 90 90 90 AMB TREATM; UNICEF, 2019, PAED CAR TREATM; UNICEF, 2020, KEY DEM IND CHILD SU; van Lettow M, 2018, B WORLD HEALTH ORGAN, V96, P256, DOI 10.2471/BLT.17.203265; Vrazo AC, 2018, GLOB HEALTH-SCI PRAC, V6, P249, DOI 10.9745/GHSP-D-17-00097; World Health Organization, 2015, HIV TEST SERV 5CS CO, P91; Yumo HA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214251; Yumo HA, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1276-7; 2016, AM J HLTH SYST PH S2, V73, pE83	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234717	10.1371/journal.pone.0234717	http://dx.doi.org/10.1371/journal.pone.0234717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559210	gold, Green Published			2022-12-26	WOS:000543261600017
J	Tedoldi, A; Ludwig, P; Fulgenzi, G; Takeshima, H; Pedarzani, P; Stocker, M				Tedoldi, Angelo; Ludwig, Petra; Fulgenzi, Gianluca; Takeshima, Hiroshi; Pedarzani, Paola; Stocker, Martin			Calcium-induced calcium release and type 3 ryanodine receptors modulate the slow afterhyperpolarising current, sI(AHP), and its potentiation in hippocampal pyramidal neurons	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CURRENT; MUTANT MICE LACKING; DEPENDENT PROTEIN-KINASE; CA2+ RELEASE; SARCOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; SENSITIVE STORES; CHANNELS; ACTIVATION; MECHANISMS	The slow afterhyperpolarising current, sI(AHP), is a Ca2+-dependent current that plays an important role in the late phase of spike frequency adaptation. sI(AHP)is activated by voltage-gated Ca(2+)channels, while the contribution of calcium from ryanodine-sensitive intracellular stores, released by calcium-induced calcium release (CICR), is controversial in hippocampal pyramidal neurons. Three types of ryanodine receptors (RyR1-3) are expressed in the hippocampus, with RyR3 showing a predominant expression in CA1 neurons. We investigated the specific role of CICR, and particularly of its RyR3-mediated component, in the regulation of the sI(AHP)amplitude and time course, and the activity-dependent potentiation of the sI(AHP)in rat and mouse CA1 pyramidal neurons. Here we report that enhancement of CICR by caffeine led to an increase in sI(AHP)amplitude, while inhibition of CICR by ryanodine caused a small, but significant reduction of sI(AHP). Inhibition of ryanodine-sensitive Ca(2+)stores by ryanodine or depletion by the SERCA pump inhibitor cyclopiazonic acid caused a substantial attenuation in the sI(AHP)activity-dependent potentiation in both rat and mouse CA1 pyramidal neurons. Neurons from mice lacking RyR3 receptors exhibited a sI(AHP)with features undistinguishable from wild-type neurons, which was similarly reduced by ryanodine. However, the lack of RyR3 receptors led to a faster and reduced activity-dependent potentiation of sI(AHP). We conclude that ryanodine receptor-mediated CICR contributes both to the amplitude of the sI(AHP)at steady state and its activity-dependent potentiation in rat and mouse hippocampal pyramidal neurons. In particular, we show that RyR3 receptors play an essential and specific role in shaping the activity-dependent potentiation of the sI(AHP). The modulation of activity-dependent potentiation of sI(AHP)by RyR3-mediated CICR contributes to plasticity of intrinsic neuronal excitability and is likely to play a critical role in higher cognitive functions, such as learning and memory.	[Tedoldi, Angelo; Ludwig, Petra; Fulgenzi, Gianluca; Pedarzani, Paola; Stocker, Martin] UCL, Res Dept Neurosci Physiol & Pharmacol, London, England; [Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto, Japan; [Tedoldi, Angelo] Univ Auckland, Dept Physiol, Auckland, New Zealand; [Fulgenzi, Gianluca] NCI, Neural Dev Sect, Mouse Canc Genet Program, Ctr Canc Res,NIH, Frederick, MD 21701 USA	University of London; University College London; Kyoto University; University of Auckland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pedarzani, P; Stocker, M (corresponding author), UCL, Res Dept Neurosci Physiol & Pharmacol, London, England.	m.stocker@ucl.ac.uk; p.pedarzani@ucl.ac.uk	Stocker, Martin/C-1844-2008; Tedoldi, Angelo/I-5704-2017	Tedoldi, Angelo/0000-0001-5601-0353; Pedarzani, Paola/0000-0002-2665-7911	Medical Research Council - MRC-CASE PhD Studentship; UK Medical Research Council [CEG G0100066]; Wellcome Trust [061198/Z/00A]; JSPS Core-to-core program (Japan Society for the Promotion of Science); MRC [G0100066] Funding Source: UKRI	Medical Research Council - MRC-CASE PhD Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); JSPS Core-to-core program (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Medical Research Council - MRC-CASE PhD Studentship to A. T. -https://mrc.ukri.org/Career Establishment Grant from the UK Medical Research Council to P. P. (CEG G0100066) https://mrc.ukri.org/Wellcome Trust Senior Research fellowship to M. S. (061198/Z/00A) - https://wellcome.ac.uk/JSPS Core-to-core program (Japan Society for the Promotion of Science) to H. T. -https://www.jsps.go.jp/english/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita T, 2000, J GEN PHYSIOL, V116, P697, DOI 10.1085/jgp.116.5.697; ALGER BE, 1980, SCIENCE, V210, P1122, DOI 10.1126/science.7444438; Balschun D, 1999, EMBO J, V18, P5264, DOI 10.1093/emboj/18.19.5264; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Borde M, 1999, PFLUG ARCH EUR J PHY, V437, P261, DOI 10.1007/s004240050778; BORDE M, 1995, J NEUROPHYSIOL, V74, P1714, DOI 10.1152/jn.1995.74.4.1714; Borde M, 2000, HIPPOCAMPUS, V10, P198; BOTELHO LHP, 1988, J BIOL CHEM, V263, P5301; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; BUTCHER RW, 1962, J BIOL CHEM, V237, P1244; Chen SRW, 1997, J BIOL CHEM, V272, P24234, DOI 10.1074/jbc.272.39.24234; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; Chen-Engerer HJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11207-8; Cordoba-Rodriguez R, 1999, P NATL ACAD SCI USA, V96, P7650, DOI 10.1073/pnas.96.14.7650; Davies PJ, 1996, J PHYSIOL-LONDON, V495, P353, DOI 10.1113/jphysiol.1996.sp021599; FURUICHI T, 1994, J NEUROSCI, V14, P4794; Galeotti N, 2008, J NEUROCHEM, V106, P2385, DOI 10.1111/j.1471-4159.2008.05581.x; Galeotti N, 2008, LEARN MEMORY, V15, P315, DOI 10.1101/lm.929008; Gamelli AE, 2011, HIPPOCAMPUS, V21, P133, DOI 10.1002/hipo.20728; Gant JC, 2006, J NEUROSCI, V26, P3482, DOI 10.1523/JNEUROSCI.4171-05.2006; Gant JC, 2011, J NEUROSCI, V31, P1693, DOI 10.1523/JNEUROSCI.4805-10.2011; Garaschuk O, 1997, J PHYSIOL-LONDON, V502, P13, DOI 10.1111/j.1469-7793.1997.013bl.x; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Hillsley K, 2000, J NEUROPHYSIOL, V84, P2777, DOI 10.1152/jn.2000.84.6.2777; HOTSON JR, 1980, J NEUROPHYSIOL, V43, P409, DOI 10.1152/jn.1980.43.2.409; Huddleston AT, 2008, J NEUROPHYSIOL, V99, P1565, DOI 10.1152/jn.00659.2007; Jahromi BS, 1999, NEUROSCIENCE, V88, P719, DOI 10.1016/S0306-4522(98)00203-6; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; JOBLING P, 1993, J AUTONOM NERV SYST, V42, P251, DOI 10.1016/0165-1838(93)90370-A; Kaczorowski CC, 2011, EUR J NEUROSCI, V34, P1756, DOI 10.1111/j.1460-9568.2011.07899.x; Kong HH, 2007, BIOPHYS J, V92, P2757, DOI 10.1529/biophysj.106.100545; Kouzu Y, 2000, MOL BRAIN RES, V76, P142, DOI 10.1016/S0169-328X(99)00344-7; Kumar A, 2004, J NEUROPHYSIOL, V91, P2437, DOI 10.1152/jn.01148.2003; LANCASTER B, 1986, J NEUROPHYSIOL, V55, P1268, DOI 10.1152/jn.1986.55.6.1268; Lima PA, 2007, BRAIN RES, V1150, P74, DOI 10.1016/j.brainres.2007.02.067; Liu J, 2014, CHANNELS, V8, DOI 10.4161/chan.27471; MADISON DV, 1982, NATURE, V299, P636, DOI 10.1038/299636a0; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Matsuo N, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.003.2009; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; Meissner G, 2017, J GEN PHYSIOL, V149, P1065, DOI 10.1085/jgp.201711878; More JY, 2018, ANTIOXID REDOX SIGN, V29, P1125, DOI 10.1089/ars.2017.7277; Mori F, 2000, NEUROSCI LETT, V285, P57, DOI 10.1016/S0304-3940(00)01046-6; MOYER JR, 1992, J NEUROPHYSIOL, V68, P2100, DOI 10.1152/jn.1992.68.6.2100; Murayama T, 1997, J BIOL CHEM, V272, P24030, DOI 10.1074/jbc.272.38.24030; Naylor J., 2009, OPEN DRUG DISCOV J, V1, P36, DOI [10.2174/1877381800901010036, DOI 10.2174/1877381800901010036]; Pedarzani P, 1998, J NEUROPHYSIOL, V79, P3252, DOI 10.1152/jn.1998.79.6.3252; PEDARZANI P, 1993, NEURON, V11, P1023, DOI 10.1016/0896-6273(93)90216-E; Pineda JC, 1999, NEUROREPORT, V10, P1951, DOI 10.1097/00001756-199906230-00029; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Qin ZH, 2012, J NEUROSCI, V32, P4271, DOI 10.1523/JNEUROSCI.6271-11.2012; Rankovic V, 2010, EUR J NEUROSCI, V31, P439, DOI 10.1111/j.1460-9568.2010.07081.x; RASCOL O, 1991, FUNDAM CLIN PHARM, V5, P299, DOI 10.1111/j.1472-8206.1991.tb00725.x; Rothman JS, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00014; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; Saar D, 2003, EUR J NEUROSCI, V17, P2727, DOI 10.1046/j.1460-9568.2003.02699.x; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sah P, 1996, J NEUROSCI, V16, P4537; SAH P, 1991, NEURON, V7, P257, DOI 10.1016/0896-6273(91)90264-Z; Sahu G, 2019, CELL REP, V28, P2427, DOI 10.1016/j.celrep.2019.07.075; Sandler VM, 1999, J NEUROSCI, V19, P4325; SAWYNOK J, 1993, PHARMACOL REV, V45, P43; Shah M, 2000, J NEUROPHYSIOL, V83, P2554, DOI 10.1152/jn.2000.83.5.2554; Shimuta M, 2001, MOL CELL NEUROSCI, V17, P921, DOI 10.1006/mcne.2001.0981; SITSAPESAN R, 1990, J PHYSIOL-LONDON, V423, P425, DOI 10.1113/jphysiol.1990.sp018031; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Takeshima H, 1996, J BIOL CHEM, V271, P19649, DOI 10.1074/jbc.271.33.19649; Tanabe M, 1998, J NEUROPHYSIOL, V80, P2268, DOI 10.1152/jn.1998.80.5.2268; Thomas NL, 2012, WILEY INTERDISCIP RE, V1, P383, DOI DOI 10.1002/WMTS.34; Tinker A, 1996, BIOPHYS J, V70, P2110, DOI 10.1016/S0006-3495(96)79777-1; Torres GE, 1996, MOL PHARMACOL, V50, P1316; van de Vrede Y, 2007, PFLUG ARCH EUR J PHY, V455, P297, DOI 10.1007/s00424-007-0277-4; Vogalis F, 2001, J NEUROPHYSIOL, V85, P1941, DOI 10.1152/jn.2001.85.5.1941; Wan K, 1999, BIOCHEM BIOPH RES CO, V266, P588, DOI 10.1006/bbrc.1999.1871; Wang Z., 2010, 2010 2 INT C MECH EL, V2; YOSHIZAKI K, 1995, J PHYSIOL-LONDON, V486, P177, DOI 10.1113/jphysiol.1995.sp020801; Zhang L, 1995, J NEUROPHYSIOL, V74, P2225, DOI 10.1152/jn.1995.74.6.2225; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	79	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0230465	10.1371/journal.pone.0230465	http://dx.doi.org/10.1371/journal.pone.0230465			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559219	Green Published, gold, Green Submitted			2022-12-26	WOS:000543261600055
J	Rebourcet, D; Mackay, R; Darbey, A; Curley, M; Jorgensen, A; Frederiksen, H; Mitchell, R; O'Shaughnessy, P; Nef, S; Smith, LB				Rebourcet, Diane; Mackay, Rosa; Darbey, Annalucia; Curley, Michael; Jorgensen, Anne; Frederiksen, Hanne; Mitchell, Rod T.; O'Shaughnessy, Peter; Nef, Serge; Smith, Lee B.			Ablation of the canonical testosterone production pathway via knockout of the steroidogenic enzyme HSD17B3, reveals a novel mechanism of testicular testosterone production	FASEB JOURNAL			English	Article						androgens; Leydig cell; testis; testosterone	LEYDIG-CELL DEVELOPMENT; SERTOLI-CELLS; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-3; MALE PSEUDOHERMAPHRODITISM; PROGRAMMING WINDOW; ANDROGEN; MOUSE; EXPRESSION; RATS; MASCULINIZATION	Male development, fertility, and lifelong health are all androgen-dependent. Approximately 95% of circulating testosterone is synthesized by the testis and the final step in this canonical pathway is controlled by the activity of the hydroxysteroid-dehydrogenase-17-beta-3 (HSD17B3). To determine the role of HSD17B3 in testosterone production and androgenization during male development and function we have characterized a mouse model lacking HSD17B3. The data reveal that developmental masculinization and fertility are normal in mutant males. Ablation of HSD17B3 inhibits hyperstimulation of testosterone production by hCG, although basal testosterone levels are maintained despite the absence of HSD17B3. Reintroduction of HSD17B3 via gene-delivery to Sertoli cells in adulthood partially rescues the adult phenotype, showing that, as in development, different cell-types in the testis are able to work together to produce testosterone. Together, these data show that HS17B3 acts as a rate-limiting-step for the maximum level of testosterone production by the testis but does not control basal testosterone production. Measurement of other enzymes able to convert androstenedione to testosterone identifies HSD17B12 as a candidate enzyme capable of driving basal testosterone production in the testis. Together, these findings expand our understanding of testosterone production in males.	[Rebourcet, Diane; Darbey, Annalucia; Smith, Lee B.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Mackay, Rosa; Curley, Michael; Mitchell, Rod T.; Smith, Lee B.] Univ Edinburgh, Ctr Reprod Hlth, Queens Med Res Inst, MRC, Edinburgh, Midlothian, Scotland; [Jorgensen, Anne] Univ Copenhagen, Rigshosp, Dept Growth & Reprod, Copenhagen, Denmark; [Jorgensen, Anne; Frederiksen, Hanne] Univ Copenhagen, Rigshosp, Int Ctr Res & Res Training Endocrine Disrupt Male, Copenhagen, Denmark; [O'Shaughnessy, Peter] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Nef, Serge] Univ Geneva, Fac Med, Dept Genet Med & Dev, Geneva, Switzerland	University of Newcastle; University of Edinburgh; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Glasgow; University of Geneva	Smith, LB (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.	L.B.Smith@newcastle.edu.au	Jørgensen, Anne/S-8681-2016; Frederiksen, Hanne/N-8632-2013; Nef, Serge/AAV-6445-2020	Jørgensen, Anne/0000-0002-6409-198X; Frederiksen, Hanne/0000-0002-3180-9879; Nef, Serge/0000-0001-5462-0676; Darbey, Annalucia/0000-0001-8541-5472; Smith, Lee/0000-0002-4103-3074	Department of Health | National Health and Medical Research Council (NHMRC) [APP1158344]; RCUK | Medical Research Council (MRC) [MR/N002970/1]; MRC [MR/N002970/1] Funding Source: UKRI	Department of Health | National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); RCUK | Medical Research Council (MRC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Department of Health | National Health and Medical Research Council (NHMRC), Grant/Award Number: APP1158344; RCUK | Medical Research Council (MRC), Grant/Award Number: MR/N002970/1	Bellemare V, 2010, HORM MOL BIOL CLIN I, V2, P311, DOI 10.1515/HMBCI.2010.036; Blanchard PG, 2007, J ENDOCRINOL, V194, P449, DOI 10.1677/JOE-07-0144; Blomquist CH, 2002, J STEROID BIOCHEM, V81, P343, DOI 10.1016/S0960-0760(02)00117-6; Curley M, 2019, FASEB J, V33, P978, DOI 10.1096/fj.201800612R; Dean A, 2012, INT J ANDROL, V35, P330, DOI 10.1111/j.1365-2605.2011.01236.x; Djureinovic D, 2014, MOL HUM REPROD, V20, P476, DOI 10.1093/molehr/gau018; Dungan HM, 2006, ENDOCRINOLOGY, V147, P1154, DOI 10.1210/en.2005-1282; Fluck CE, 2011, AM J HUM GENET, V89, P201, DOI 10.1016/j.ajhg.2011.06.009; Galli-Tsinopoulou A, 2018, J CLIN RES PEDIATR E, V10, P74, DOI 10.4274/jcrpe.4829; GEISSLER WM, 1994, NAT GENET, V7, P34, DOI 10.1038/ng0594-34; Hakkarainen J, 2018, FASEB J, V32, P3229, DOI 10.1096/fj.201700921R; HICKEY GJ, 1989, ENDOCRINOLOGY, V125, P1673, DOI 10.1210/endo-125-3-1673; Jost A, 1973, Adv Biosci, V10, P3; JOST A, 1947, P SOC EXP BIOL MED, V66, P302, DOI 10.3181/00379727-66-16071; Kreisman MJ, 2017, ENDOCRINOLOGY, V158, P2884, DOI 10.1210/en.2017-00285; Lindqvist A, 2001, J CLIN ENDOCR METAB, V86, P921, DOI 10.1210/jc.86.2.921; Liu FJ, 2019, MOL CELL PROTEOMICS, V18, P1070, DOI 10.1074/mcp.RA119.001416; Luu-The V, 2006, MOL ENDOCRINOL, V20, P437, DOI 10.1210/me.2005-0058; Mahendroo M, 2004, MOL CELL ENDOCRINOL, V222, P113, DOI 10.1016/j.mce.2004.04.009; Mendonca BB, 2000, MEDICINE, V79, P299, DOI 10.1097/00005792-200009000-00003; Mendonca BB, 2017, J STEROID BIOCHEM, V165, P79, DOI 10.1016/j.jsbmb.2016.05.002; Mindnich R, 2005, J MOL ENDOCRINOL, V35, P305, DOI 10.1677/jme.1.01853; Mitchell RT, 2015, ENDOCRINOLOGY, V156, P24, DOI 10.1210/en.2014-1534; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; O'Hara L, 2015, FASEB J, V29, P894, DOI 10.1096/fj.14-255729; O'Hara L, 2011, ENDOCRINOLOGY, V152, P718, DOI 10.1210/en.2010-0928; O'Shaughnessy PJ, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000002; O'Shaughnessy PJ, 2000, ENDOCRINOLOGY, V141, P2631, DOI 10.1210/en.141.7.2631; O'Shaughnessy PJ, 2002, J CELL SCI, V115, P3491; Ogawa N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092073; Rantakari P, 2010, ENDOCRINOLOGY, V151, P1893, DOI 10.1210/en.2009-0929; Rebourcet D, 2016, ENDOCRINOLOGY, V157, P2479, DOI 10.1210/en.2016-1156; Rebourcet D, 2014, DEVELOPMENT, V141, P2139, DOI 10.1242/dev.107029; Sakurai N, 2006, J STEROID BIOCHEM, V99, P174, DOI 10.1016/j.jsbmb.2006.01.010; Saloniemi T, 2009, MOL CELL ENDOCRINOL, V301, P163, DOI 10.1016/j.mce.2008.10.047; Sha J, 1996, BIOCHEM BIOPH RES CO, V222, P90, DOI 10.1006/bbrc.1996.0702; SHARPE RM, 1980, J REPROD FERTIL, V60, P359; SHARPE RM, 1983, MOL CELL ENDOCRINOL, V33, P131, DOI 10.1016/0303-7207(83)90162-4; Shima Y, 2013, MOL ENDOCRINOL, V27, P63, DOI 10.1210/me.2012-1256; Shores Molly M, 2014, Curr Sex Health Rep, V6, P235; Smith JT, 2005, ENDOCRINOLOGY, V146, P2976, DOI 10.1210/en.2005-0323; Soeborg T, 2017, CLIN CHIM ACTA, V468, P180, DOI 10.1016/j.cca.2017.03.002; Spitzer M, 2013, NAT REV ENDOCRINOL, V9, DOI [10.1038/nrendo.2013.73-c2, 10.1038/nrendo.2013.73]; Tajar A, 2010, J CLIN ENDOCR METAB, V95, P1810, DOI 10.1210/jc.2009-1796; Wei YH, 2019, MOL CELL PROTEOMICS, V18, P216, DOI 10.1074/mcp.RA117.000479; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Welsh M, 2009, ENDOCRINOLOGY, V150, P2472, DOI 10.1210/en.2008-0529; Willems A, 2015, MOL REPROD DEV, V82, P626, DOI 10.1002/mrd.22506	48	21	23	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10373	10386		10.1096/fj.202000361R	http://dx.doi.org/10.1096/fj.202000361R		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32557858	Green Published, hybrid			2022-12-26	WOS:000544279700001
J	Wong, MYW; Saad, S; Wong, MG; Stangenberg, S; Jarolimek, W; Schilter, H; Zaky, A; Gill, A; Pollock, C				Wong, May Y. W.; Saad, Sonia; Wong, Muh Geot; Stangenberg, Stefanie; Jarolimek, Wolfgang; Schilter, Heidi; Zaky, Amgad; Gill, Anthony; Pollock, Carol			Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy	PLOS ONE			English	Article							VASCULAR ADHESION PROTEIN-1; CELL-SURFACE; RENAL FIBROSIS; KNOCKOUT MICE; INFLAMMATION; DEFICIENCY; MORTALITY; INJURY	Semicarbazide-sensitive amine oxidase (SSAO) is an enzyme with a unique dual function in controlling inflammation as well as reactive oxygen species (ROS) generation. We have demonstrated benefit of SSAO inhibition in acute kidney fibrosis. However the function of SSAO in chronic kidney disease (CKD) and diabetic kidney disease (DKD) is yet to be determined. We aimed to assess the effectiveness of a SSAO inhibitor (SSAOi; PXS-4728A) as an antifibrotic agent using a diabetic model of CKD. Diabetic mice were treated with SSAOi for 24 weeks and outcomes compared with untreated diabetic mice and telmisartan treated animals as a standard of care comparator. Extracellular matrix markers, fibronectin and oxidative stress, were downregulated in diabetic mice treated with SSAOi compared with untreated diabetic mice. Expression of the pan-leukocyte marker CD45 was also supressed by SSAOi. SSAO inhibition in diabetic mice resulted in a significant reduction in glomerulosclerosis and associated albuminuria compared to untreated diabetic mice. However, the effect of SSAO inhibition was less obvious in the tubulointerstitial compartment than in the glomeruli. Therefore, SSAO may be a potential target for diabetic glomerulosclerosis.	[Wong, May Y. W.; Zaky, Amgad] Royal North Shore Hosp, Dept Gastroenterol, Sydney, NSW, Australia; [Wong, May Y. W.; Saad, Sonia; Wong, Muh Geot; Stangenberg, Stefanie; Pollock, Carol] Univ Sydney, Royal North Shore Hosp, Kolling Inst Med Res, Sydney, NSW, Australia; [Jarolimek, Wolfgang; Schilter, Heidi] Pharmaxis Ltd, Sydney, NSW, Australia; [Gill, Anthony] Royal North Shore Hosp, Dept Anat Pathol, Sydney, NSW, Australia; [Gill, Anthony] Univ Sydney, Sydney, NSW, Australia	Royal North Shore Hospital; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Pharmaxis; Royal North Shore Hospital; University of Sydney	Pollock, C (corresponding author), Univ Sydney, Royal North Shore Hosp, Kolling Inst Med Res, Sydney, NSW, Australia.	carol.pollock@sydney.edu.au	Gill, Anthony/D-4215-2015; Zaky, Amgad/D-8367-2015	Gill, Anthony/0000-0002-9447-1967; Zaky, Amgad/0000-0001-7738-5330; Wong, May/0000-0003-2856-7327; Saad, Sonia/0000-0001-8067-8046	Pharmaxis	Pharmaxis	Pharmaxis (http://www.pharmaxis.com.au) supported the study in addition to a successful peer reviewed application to the Australian Research Council. WJ provided critical scientific review in the preparation of the manuscript but the content of the manuscript was at all times decided by the academic investigators. They approved the study design but were not directly involved. They were not directly involved with data collection or analysis. HS provided support with the SSAO activity assay. Both WJ and HS reviewed the manuscript prior to publication but were not involved in the decision to publish nor were they involved in the preparation of the manuscript.	Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; Alexakis C, 2006, NEPHRON EXP NEPHROL, V102, pE71, DOI 10.1159/000089684; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; Berl Tomas, 2009, J Renin Angiotensin Aldosterone Syst, V10, P1, DOI 10.1177/1470320309102747; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Carpene C, 2005, J PHYSIOL BIOCHEM, V61, P405, DOI 10.1007/BF03167058; de Zeeuw D, 2018, LANCET DIABETES ENDO, V6, P925, DOI 10.1016/S2213-8587(18)30289-4; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Enrique-Tarancon G, 1998, J BIOL CHEM, V273, P8025, DOI 10.1074/jbc.273.14.8025; Jalkanen S, 2008, ARTERIOSCL THROM VAS, V28, P18, DOI 10.1161/ATVBAHA.107.153130; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Komala MG, 2016, NEPHROLOGY, V21, P423, DOI 10.1111/nep.12618; Kosugi T, 2010, AM J PATHOL, V176, P619, DOI 10.2353/ajpath.2010.090578; Lin MS, 2008, CLIN BIOCHEM, V41, P1362, DOI 10.1016/j.clinbiochem.2008.06.019; Lv WS, 2018, EUR J PHARMACOL, V820, P65, DOI 10.1016/j.ejphar.2017.12.016; Maric C, 2004, J AM SOC NEPHROL, V15, P1546, DOI 10.1097/01.ASN.0000128219.65330.EA; MCEWEN CM, 1963, J LAB CLIN MED, V62, P766; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Meshkani R, 2016, CLIN CHIM ACTA, V462, P77, DOI 10.1016/j.cca.2016.08.015; Morin N, 2001, J PHARMACOL EXP THER, V297; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Pershadsingh HA, 2004, DIABETES CARE, V27, P1015, DOI 10.2337/diacare.27.4.1015; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Shinohara M, 2018, NEPHROL DIAL TRANSPL, V33, pi173; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; Sterzel RB, 2000, KIDNEY INT, V58, P1588, DOI 10.1046/j.1523-1755.2000.00320.x; Stolen CM, 2005, IMMUNITY, V22, P105, DOI 10.1016/j.immuni.2004.12.006; Stolen CM, 2004, FASEB J, V18, P702, DOI 10.1096/fj.03-0562fje; Suksomboon N, 2012, J CLIN PHARM THER, V37, P319, DOI 10.1111/j.1365-2710.2011.01295.x; Tanaka S, 2017, KIDNEY INT, V92, P154, DOI 10.1016/j.kint.2017.01.014; Wang EY, 2006, J MED CHEM, V49, P2166, DOI 10.1021/jm050538l; Wong M, 2014, AM J PHYSIOL-RENAL, V307, pF908, DOI 10.1152/ajprenal.00698.2013; Yong R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073428; Yu CD, 2002, AM J PATHOL, V161, P2003, DOI 10.1016/S0002-9440(10)64478-1; Yuen DA, 2012, J AM SOC NEPHROL, V23, P1810, DOI 10.1681/ASN.2011121170; Yung S, 2006, NEPHROL DIAL TRANSPL, V21, P1504, DOI 10.1093/ndt/gfl017; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7; Zorzano A, 2003, BBA-PROTEINS PROTEOM, V1647, P3, DOI 10.1016/S1570-9639(03)00039-6	40	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234617	10.1371/journal.pone.0234617	http://dx.doi.org/10.1371/journal.pone.0234617			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555665	Green Published, gold			2022-12-26	WOS:000543273200054
J	Iqbal, MS; Muthanna, FMS; Kassab, YW; Hassali, MA; Al-Saikhan, FI; Iqba, MZ; Haseeb, A; Ahmed, M; Khan, SUD; Naqvi, AA; Islam, MA; Ali, M				Iqbal, Muhammad Shahid; Muthanna, Fares M. S.; Kassab, Yaman Walid; Hassali, Mohamed Azmi; Al-Saikhan, Fahad, I; Iqba, Muhammad Zahid; Haseeb, Abdul; Ahmed, Muhammad; Khan, Salah-Ud-Din; Naqvi, Atta Abbas; Islam, Md Ashraful; Ali, Majid			Determinants of health-related quality of life among warfarin patients in Pakistan	PLOS ONE			English	Article							ORAL ANTICOAGULANT-THERAPY; PERITONEAL-DIALYSIS; LIVER-DISEASE; GLOBAL BURDEN; HEMODIALYSIS; TRANSPLANTATION; QUESTIONNAIRE; ASSOCIATION; PREVENTION; MANAGEMENT	Introduction The effect of anticoagulation control on overall Health-Related Quality of Life (HRQoL) in patients taking warfarin in Pakistan has not been explored yet. Therefore, this study aimed to evaluate HRQoL among warfarin patients in Pakistan. Methods This cross-sectional study was conducted among patients on warfarin in Pakistan. By purposive sampling, data were collected using demographic data collection form and the World Health Organization Quality of Life: Brief Version (WHOQOL-BREF). The WHOQOL-BREF is comprised of four domains; physical, psychological, social relationships, and environment. Descriptive and inferential statistical analysis was done using SPSS version 22. Results Out of 295 warfarin patients, more females than males (<0.001) were observed (n = 184, 62.4%, and n = 111, 37.6% respectively). One hundred and eighteen (40.0%) patients were less than 30-years of age, whereas one hundred and seventy-seven (60.0%) patients were above 30-years of age. Mean scores for the physical (62.44 +/- 15.36), psychological (67.84 +/- 15.54), social (64.27 +/- 26.28) and environment domains (63.45 +/- 17.66) were observed. Conclusion Patients had overall lower to moderate but satisfactory HRQoL scores in all four domains. Age, gender, employment status, education level, the indication of use and duration of warfarin therapy was associated with one or more domains of HRQoL among warfarin patients. The findings of this study would serve as a primary database for future studies. This study highlights how non-clinical factors could impact HRQoL in studied patients.	[Iqbal, Muhammad Shahid; Al-Saikhan, Fahad, I] Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Clin Pharm, Al Kharj, Saudi Arabia; [Muthanna, Fares M. S.] Univ Teknol MARA UiTM, Fac Pharm, Selangor Darul Ehsan, Malaysia; [Kassab, Yaman Walid] Cyberjaya Univ, Dept Hosp & Clin Pharm, Fac Pharm, Coll Med Sci, Cyberjaya, Selangor, Malaysia; [Hassali, Mohamed Azmi] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Social & Adm Pharm, George Town, Malaysia; [Iqba, Muhammad Zahid] AIMST Univ, Fac Pharm, Dept Clin Pharm & Pharm Practice, Kedah Darul Aman, Malaysia; [Haseeb, Abdul; Ali, Majid] Umm Al Qura Univ, Coll Pharm, Dept Clin Pharm, Al Abdia Campus, Mecca, Saudi Arabia; [Ahmed, Muhammad] Umm Al Qura Univ, Coll Pharm, Dept Pharmacol & Toxicol, Al Abdia Campus, Mecca, Saudi Arabia; [Khan, Salah-Ud-Din] Al Imam Mohammad Ibn Saud Univ, Coll Med, Dept Biochem, Riyadh, Saudi Arabia; [Naqvi, Atta Abbas; Islam, Md Ashraful] Imam Abdul Rehman Bin Faisal Univ, Coll Clin Pharm, Dept Pharm Practice, Dammam, Saudi Arabia	Prince Sattam Bin Abdulaziz University; Universiti Sains Malaysia; AIMST University; Umm Al Qura University; Umm Al Qura University; Imam Mohammad Ibn Saud Islamic University (IMSIU); Imam Abdulrahman Bin Faisal University	Iqbal, MS (corresponding author), Prince Sattam bin Abdulaziz Univ, Coll Pharm, Dept Clin Pharm, Al Kharj, Saudi Arabia.	drmmsiqbal@gmail.com	SIDDIQUI, MUHAMMAD AHMED/ABB-8610-2020; Khan, Shahab/GSO-1694-2022; Haseeb, Abdul/T-7419-2017; Al-Saikhan, Fahad I./H-2265-2016; Khan, Salah Ud-Din/ABC-5995-2020; Muthanna, Fares M.S/C-1575-2018; Iqbal, Prof Dr Muhammad Shahid/AIB-1390-2022; Muthanna, Fares/C-1575-2018; Islam, Md. Ashraful/B-8887-2015; , Muhammad Ahmed/Q-6464-2016	SIDDIQUI, MUHAMMAD AHMED/0000-0003-1191-9189; Haseeb, Abdul/0000-0003-2455-5054; Al-Saikhan, Fahad I./0000-0002-4149-3978; Muthanna, Fares M.S/0000-0002-7722-9466; Iqbal, Prof Dr Muhammad Shahid/0000-0003-0245-5976; Kassab, Yaman/0000-0003-2560-5092; Muthanna, Fares/0000-0002-6191-4653; Islam, Md. Ashraful/0000-0001-8777-6183; , Muhammad Ahmed/0000-0002-5518-413X	Deanship of Scientific Research at Prince Sattam bin Abdulaziz University, Alkharj, Saudi Arabia	Deanship of Scientific Research at Prince Sattam bin Abdulaziz University, Alkharj, Saudi Arabia	The authors would like to thank the Deanship of Scientific Research at Prince Sattam bin Abdulaziz University, Alkharj, Saudi Arabia for the support in the publication of this manuscript. The authors would also like to expresstheir sincere gratitude to all of the participants involved in this study in any capacity.	Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; Corbi ISA, 2011, REV LAT-AM ENFERM, V19, P865, DOI 10.1590/S0104-11692011000400003; Almeida GD, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-91; Anees M, 2014, PAK J MED SCI, V30, P1123, DOI 10.12669/pjms.305.5239; Barcellona D, 2000, THROMB HAEMOSTASIS, V83, P49; Bayoumi Magda, 2013, Saudi J Kidney Dis Transpl, V24, P254; BORN D, 1992, AM HEART J, V124, P413, DOI 10.1016/0002-8703(92)90606-V; Casais P, 2005, CURR MED RES OPIN, V21, P1085, DOI 10.1185/030079905X50624; Daher AM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-407; Elbur A., 2015, INT J PHARM SCI REV, V31, P274; Eltayeb TYM, 2017, J SAUDI HEART ASSOC, V29, P169, DOI 10.1016/j.jsha.2016.10.007; Fukuoka Y, 2007, QUAL LIFE RES, V16, P1655, DOI 10.1007/s11136-007-9272-7; Gadisseur APA, 2004, J THROMB HAEMOST, V2, P584, DOI 10.1111/j.1538-7836.2004.00659.x; Gemmell LA, 2016, J PAIN SYMPTOM MANAG, V52, P806, DOI 10.1016/j.jpainsymman.2016.05.029; Gerasimoula Kousoula, 2015, Mater Sociomed, V27, P305, DOI 10.5455/msm.2015.27.305-309; Goretti B, 2010, NEUROL SCI, V31, P227, DOI 10.1007/s10072-010-0372-8; Haitjema S., 2014, IJC HEART VESSEL, V4, P53, DOI 10.1016/j.ijchv.2014.07.001; Hakem H, 2018, J PAK MED ASSOC, V68, P1339; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Harrison M B, 1996, Can J Nurs Res, V28, P49; Heo M, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0070-6; Jafar TH, 2008, HEART, V94, P408, DOI 10.1136/hrt.2007.120774; Joshi U, 2017, INT J NEPHROL RENOV, V10, P195, DOI 10.2147/IJNRD.S136522; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kimmel SE, 2008, EXPERT OPIN PHARMACO, V9, P677, DOI 10.1517/14656566.9.5.677; Kuruvilla M, 2001, Proc (Bayl Univ Med Cent), V14, P305; Lam ETP, 2009, WORLD J GASTROENTERO, V15, P3288, DOI 10.3748/wjg.15.3288; Lemos CF, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0390-6; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Megari K, 2013, HEALTH PSYCHOL RES, V1, P141, DOI [10.4081/hpr.2013.e27, 10.4082/hpr.2013.e27]; Meschengieser SS, 1999, HEART, V82, P23, DOI 10.1136/hrt.82.1.23; Misra A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1420; National Bioethics Committee (NBC) Pakistan, 2004, ETH RES COMM GUID 20; Nedjat S, 2006, IRAN J HLTH SCH, V4, P1; Nedjat S, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-61; Ogutmen B, 2006, TRANSPLANT P, V38, P419, DOI 10.1016/j.transproceed.2006.01.016; Peterson S., 2019, MIDDLE RANGE THEORIE; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Poljicanin T, 2010, J MED SCI, V10, P12, DOI [10.3923/jms.2011.84.89, DOI 10.3923/JMS.2011.84.89]; Saad MM, 2015, INT J NEPHROL RENOV, V8, P119, DOI 10.2147/IJNRD.S84929; Sakpal Tushar Vijay, 2010, Perspect Clin Res, V1, P67; Saleem F, 2014, HEALTH EXPECT, V17, P388, DOI 10.1111/j.1369-7625.2012.00765.x; Sathvik B S, 2008, Indian J Nephrol, V18, P141, DOI 10.4103/0971-4065.45288; Sayin A, 2007, TRANSPL P, V39, P3047, DOI 10.1016/j.transproceed.2007.09.030; Sobhonslidsuk A, 2006, WORLD J GASTROENTERO, V12, P7786, DOI 10.3748/wjg.v12.i48.7786; Svirtlih N, 2008, J GASTROINTEST LIVER, V17, P405; The World Bank, 2016, WORLD BANK DAT WORLD; ul Haq N, 2014, TROP J PHARM RES, V13, P1163, DOI 10.4314/tjpr.v13i7.22; Wang HM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-246; Wigle P, 2013, AM FAM PHYSICIAN, V87, P556; World Health Organization, 2017, CARDIOVASC DIS; Yang SC, 2005, AM J KIDNEY DIS, V46, P635, DOI 10.1053/j.ajkd.2005.06.015; Yasmeen F, 2015, J THROMB THROMBOLYS, V40, P218, DOI 10.1007/s11239-015-1215-5; Yurdakok M, 2012, TURKISH J PEDIATR, V54, P207; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	55	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234734	10.1371/journal.pone.0234734	http://dx.doi.org/10.1371/journal.pone.0234734			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB7DG	32555595	Green Published, gold			2022-12-26	WOS:000542759600034
J	Kim, E; Watanabe, A; Duffy, CDP; Ruban, AV; Minagawa, J				Kim, Eunchul; Watanabe, Akimasa; Duffy, Christopher D. P.; Ruban, Alexander V.; Minagawa, Jun			Multimeric and monomeric photosystem II supercomplexes represent structural adaptations to low- and high-light conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photosystem II; light-harvesting complex II; photosynthesis; antenna complex; supramolecular complex; thylakoid; light adaptation; semicrystalline photosystem II array; nonphotochemical quenching (NPQ); thermal dissipation; plant physiology; fluorescence; plant; nonphotochemical quenching; photoprotection; supramolecular organization	PSBS PROTEIN CONTROLS; STATE TRANSITIONS; HARVESTING COMPLEX; ENERGY-DISSIPATION; ANTENNA; IDENTIFICATION; MEMBRANES; PLANTS; PHOTOPROTECTION; MEGACOMPLEXES	An intriguing molecular architecture called the "semi-crystalline photosystem II (PSII) array" has been observed in the thylakoid membranes in vascular plants. It is an array of PSII-light-harvesting complex II (LHCII) supercomplexes that only appears in low light, but its functional role has not been clarified. Here, we identified PSII-LHCII supercomplexes in their monomeric and multimeric forms in low light-acclimated spinach leaves and prepared them using sucrose-density gradient ultracentrifugation in the presence of amphipol A8-35. When the leaves were acclimated to high light, only the monomeric forms were present, suggesting that the multimeric forms represent a structural adaptation to low light and that disaggregation of the PSII-LHCII supercomplex represents an adaptation to high light. Single-particle EM revealed that the multimeric PSII-LHCII supercomplexes are composed of two ("megacomplex") or three ("arraycomplex") units of PSII-LHCII supercomplexes, which likely constitute a fraction of the semi-crystalline PSII array. Further characterization with fluorescence analysis revealed that multimeric forms have a higher light-harvesting capability but a lower thermal dissipation capability than the monomeric form. These findings suggest that the configurational conversion of PSII-LHCII supercomplexes may serve as a structural basis for acclimation of plants to environmental light.	[Kim, Eunchul; Watanabe, Akimasa; Minagawa, Jun] Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi, Japan; [Kim, Eunchul] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi, Japan; [Watanabe, Akimasa; Minagawa, Jun] SOKENDAI Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan; [Duffy, Christopher D. P.; Ruban, Alexander V.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Nagoya University; Graduate University for Advanced Studies - Japan; University of London; Queen Mary University London	Minagawa, J (corresponding author), Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi, Japan.; Minagawa, J (corresponding author), SOKENDAI Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan.	minagawa@nibb.ac.jp	Kim, Eunchul/E-9565-2013	Kim, Eunchul/0000-0003-3380-3953; Minagawa, Jun/0000-0002-3028-3203; Watanabe, Akimasa/0000-0001-6068-1328	Japan Society for the Promotion of Science KAKENHI [16H06553]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant-in-Aid 16H06553 (to J. M.).	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Albanese P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15184-1; Albanese P, 2016, PHOTOSYNTH RES, V130, P19, DOI 10.1007/s11120-016-0216-3; Avenson TJ, 2009, J BIOL CHEM, V284, P2830, DOI 10.1074/jbc.M807192200; Ballottari M, 2010, J BIOL CHEM, V285, P28309, DOI 10.1074/jbc.M110.124115; Belgio E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5433; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Boekema EJ, 2000, J MOL BIOL, V301, P1123, DOI 10.1006/jmbi.2000.4037; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; Burton-Smith RN, 2019, J BIOL CHEM, V294, P15003, DOI 10.1074/jbc.RA119.009341; Correa-Galvis V, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.225, 10.1038/nplants.2015.225]; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Goral TK, 2012, PLANT J, V69, P289, DOI 10.1111/j.1365-313X.2011.04790.x; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; Kereiche S, 2010, FEBS LETT, V584, P759, DOI 10.1016/j.febslet.2009.12.031; Kim E, 2019, J PHYS CHEM LETT, V10, P3615, DOI 10.1021/acs.jpclett.9b01208; Kirchhoff H, 2007, BIOCHEMISTRY-US, V46, P11169, DOI 10.1021/bi700748y; Kiss AZ, 2008, J BIOL CHEM, V283, P3972, DOI 10.1074/jbc.M707410200; Kosuge K, 2018, P NATL ACAD SCI USA, V115, P3722, DOI 10.1073/pnas.1720574115; Kromdijk J, 2016, SCIENCE, V354, P857, DOI 10.1126/science.aai8878; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; MALKIN S, 1981, PLANT PHYSIOL, V67, P570, DOI 10.1104/pp.67.3.570; Muller MG, 2010, CHEMPHYSCHEM, V11, P1289, DOI 10.1002/cphc.200900852; Nosek L, 2017, PLANT J, V89, P104, DOI 10.1111/tpj.13325; Papageorgiou GC., 2007, CHLOROPHYLL FLUORESC; Popot JL, 2018, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-319-73148-3; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Sheng X, 2019, NAT PLANTS, V5, P1320, DOI 10.1038/s41477-019-0543-4; SIMPSON DJ, 1978, CARLSBERG RES COMMUN, V43, P365, DOI 10.1007/BF02906109; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; Tietz S, 2015, J BIOL CHEM, V290, P14091, DOI 10.1074/jbc.M114.619841; Tokutsu R, 2013, P NATL ACAD SCI USA, V110, P10016, DOI 10.1073/pnas.1222606110; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Wada M, 2003, ANNU REV PLANT BIOL, V54, P455, DOI 10.1016/j.plantsci.2013.05.016; Walters RG, 2005, J EXP BOT, V56, P435, DOI 10.1093/jxb/eri060; Watanabe A, 2019, FEBS LETT, V593, P1072, DOI 10.1002/1873-3468.13394; Wei XP, 2016, NATURE, V534, P69, DOI 10.1038/nature18020; YAMAMOTO HY, 1979, PURE APPL CHEM, V51, P639, DOI 10.1351/pac197951030639	44	10	10	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2020	295	43					14537	14545		10.1074/jbc.RA120.014198	http://dx.doi.org/10.1074/jbc.RA120.014198			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OP9LU	32561642	Green Published, hybrid			2022-12-26	WOS:000588412800001
J	Coles, CH; McMurran, C; Lloyd, A; Hock, M; Hibbert, L; Raman, MCC; Hayes, C; Lupardus, P; Cole, DK; Harper, S				Coles, Charlotte H.; McMurran, Catriona; Lloyd, Angharad; Hock, Miriam; Hibbert, Linda; Raman, Marine C. C.; Hayes, Conor; Lupardus, Patrick; Cole, David K.; Harper, Stephen			T cell receptor interactions with human leukocyte antigen govern indirect peptide selectivity for the cancer testis antigen MAGE-A4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer-associated antigen; melanoma antigen-A4 (MAGE-A4); immuno-oncology; crystal structure; peptide-human leukocyte antigen (pHLA); surface plasmon resonance (SPR); T cell receptor (TCR); adaptive immunity; antigen recognition; cancer therapy; immunotherapy; antigen presentation; antigen recognition; cancer-associated antigen; MAGE-A4; peptide-human leukocyte antigen; T cell receptor	CROSS-REACTIVITY; STRUCTURAL BASIS; TCR-BINDING; DIRECTED EVOLUTION; AFFINITY; COMPLEX; MHC; FLEXIBILITY; SPECIFICITY; RECOGNITION	T cell-mediated immunity is governed primarily by T cell receptor (TCR) recognition of peptide-human leukocyte antigen (pHLA) complexes and is essential for immunosurveillance and disease control. This interaction is generally stabilized by interactions between the HLA surface and TCR germline-encoded complementarity-determining region (CDR) loops 1 and 2, whereas peptide selectivity is guided by direct interactions with the TCR CDR3 loops. Here, we solved the structure of a newly identified TCR in complex with a clinically relevant peptide derived from the cancer testis antigen melanoma antigen-A4 (MAGE-A4). The TCR bound pHLA in a position shifted toward the peptide's N terminus. This enabled the TCR to achieve peptide selectivity via an indirect mechanism, whereby the TCR sensed the first residue of the peptide through HLA residue Trp-167, which acted as a tunable gateway. Amino acid substitutions at peptide position 1 predicted to alter the HLA Trp-167 side-chain conformation abrogated TCR binding, indicating that this indirect binding mechanism is essential for peptide recognition. These findings extend our understanding of the molecular rules that underpin antigen recognition by TCRs and have important implications for the development of TCR-based therapies.	[Coles, Charlotte H.; McMurran, Catriona; Lloyd, Angharad; Hock, Miriam; Hibbert, Linda; Raman, Marine C. C.; Hayes, Conor; Cole, David K.; Harper, Stephen] Immunocore Ltd, Milton Pk, Abingdon, Oxon, England; [Lupardus, Patrick] Genentech Inc, San Francisco, CA 94080 USA; [Cole, David K.] Cardiff Univ, Sch Med, Heath Pk, Cardiff, Wales	Roche Holding; Genentech; Cardiff University	Cole, DK; Harper, S (corresponding author), Immunocore Ltd, Milton Pk, Abingdon, Oxon, England.; Cole, DK (corresponding author), Cardiff Univ, Sch Med, Heath Pk, Cardiff, Wales.	david.cole@immunocore.com; stephen.harper@immunocore.com		Harper, Stephen/0000-0002-6029-8668; Coles, Charlotte/0000-0003-4525-7144				Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Archbold JK, 2006, J BIOL CHEM, V281, P34324, DOI 10.1074/jbc.M606755200; Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Ayres CM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00966; Ayres CM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00935; Ayres CM, 2016, SCI REP-UK, V6, DOI 10.1038/srep25070; Beringer DX, 2015, NAT IMMUNOL, V16, P1153, DOI 10.1038/ni.3271; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bianchi V, 2016, J BIOL CHEM, V291, P8951, DOI 10.1074/jbc.M115.707414; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cole DK, 2007, PROTEINS, V67, P65, DOI 10.1002/prot.21176; Cole DK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01503; Cole DK, 2017, J BIOL CHEM, V292, P802, DOI 10.1074/jbc.M116.741603; Cole DK, 2016, J CLIN INVEST, V126, P2191, DOI 10.1172/JCI85679; Cole DK, 2014, J BIOL CHEM, V289, P628, DOI 10.1074/jbc.M113.522110; Cole DK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00168; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; DeLano W. L., PYMOL MOL GRAPICS SY; Dunn SM, 2006, PROTEIN SCI, V15, P710, DOI 10.1110/ps.051936406; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Harndahl M, 2012, EUR J IMMUNOL, V42, P1405, DOI 10.1002/eji.201141774; Hawse WF, 2014, J IMMUNOL, V192, P2885, DOI 10.4049/jimmunol.1302953; Hawse WF, 2013, J BIOL CHEM, V288, P24372, DOI 10.1074/jbc.M113.490664; Hillig RC, 2001, J MOL BIOL, V310, P1167, DOI 10.1006/jmbi.2001.4816; Holland CJ, 2020, J CLIN INVEST, V130, P2673, DOI 10.1172/JCI130562; Holland CJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00674; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kirksey TJ, 1999, J BIOL CHEM, V274, P37259, DOI 10.1074/jbc.274.52.37259; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Knapp B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003748; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Liang RY, 2018, J VIROL, V92, DOI 10.1128/JVI.01631-17; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Madura F, 2019, EUR J IMMUNOL, V49, P1052, DOI 10.1002/eji.201948085; Madura F, 2015, EUR J IMMUNOL, V45, P584, DOI 10.1002/eji.201445114; Madura F, 2013, J BIOL CHEM, V288, P18766, DOI 10.1074/jbc.M113.464560; Marchand M, 1999, INT J CANCER, V80, P219, DOI 10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miles JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001198; Motozono C, 2015, J BIOL CHEM, V290, P18924, DOI 10.1074/jbc.M114.622522; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Raman MCC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18851; Rapoport AP, 2015, NAT MED, V21, P914, DOI 10.1038/nm.3910; Reboul CF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002404; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Sami M, 2007, PROTEIN ENG DES SEL, V20, P397, DOI 10.1093/protein/gzm033; Schmid DA, 2010, J IMMUNOL, V184, P4936, DOI 10.4049/jimmunol.1000173; Scott DR, 2012, BIOPHYS J, V103, P2532, DOI 10.1016/j.bpj.2012.10.037; Scott DR, 2011, J MOL BIOL, V414, P385, DOI 10.1016/j.jmb.2011.10.006; Sethi DK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3623; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7	69	9	9	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11486	11494		10.1074/jbc.RA120.014016	http://dx.doi.org/10.1074/jbc.RA120.014016			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32532817	hybrid, Green Published			2022-12-26	WOS:000563922500011
J	Cascarina, SM; Ross, ED				Cascarina, Sean M.; Ross, Eric D.			A proposed role for the SARS-CoV-2 nucleocapsid protein in the formation and regulation of biomolecular condensates	FASEB JOURNAL			English	Article						enveloped viruses; liquid-liquid phase separation; low-complexity domain; stress granule; viral capsid	LIQUID-PHASE-SEPARATION; HOST GENE-EXPRESSION; SARS-CORONAVIRUS; STRESS GRANULES; VIRUS-REPLICATION; INNATE IMMUNITY; NSP1; INTERFERON; INHIBITOR; PATHWAY	To date, the recently discovered SARS-CoV-2 virus has afflicted >6.9 million people worldwide and disrupted the global economy. Development of effective vaccines or treatments for SARS-CoV-2 infection will be aided by a molecular-level understanding of SARS-CoV-2 proteins and their interactions with host cell proteins. The SARS-CoV-2 nucleocapsid (N) protein is highly homologous to the N protein of SARS-CoV, which is essential for viral RNA replication and packaging into new virions. Emerging models indicate that nucleocapsid proteins of other viruses can form biomolecular condensates to spatiotemporally regulate N protein localization and function. Our bioinformatic analyses, in combination with pre-existing experimental evidence, suggest that the SARS-CoV-2 N protein is capable of forming or regulating biomolecular condensates in vivo by interaction with RNA and key host cell proteins. We discuss multiple models, whereby the N protein of SARS-CoV-2 may harness this activity to regulate viral life cycle and host cell response to viral infection.	[Cascarina, Sean M.; Ross, Eric D.] Colorado State Univ, Dept Biochem & Mol Biol, 1870 Campus Delivery, Ft Collins, CO 80523 USA	Colorado State University	Ross, ED (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, 1870 Campus Delivery, Ft Collins, CO 80523 USA.	Eric.Ross@colostate.edu		Cascarina, Sean/0000-0002-3054-2332	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [R35GM130352]	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS)	HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R35GM130352	Alberti S, 2019, ANNU REV GENET, V53, P171, DOI 10.1146/annurev-genet-112618-043527; Alenquer M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09549-4; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bolognesi B, 2016, CELL REP, V16, P222, DOI 10.1016/j.celrep.2016.05.076; Brocard M, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008250; Burke JM, 2020, J BIOL CHEM, V295, P1426, DOI 10.1074/jbc.RA119.011638; Cascarina SM, 2020, PLOS COMPUT BIOL, V16, DOI [10.1371/journal.pcbi.1007487, 10.1371/journal.pcbi.1007487.r001, 10.1371/journal.pcbi.1007487.r002, 10.1371/journal.pcbi.1007487.r003, 10.1371/journal.pcbi.1007487.r004]; Cascarina SM, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006256; Case LB, 2019, SCIENCE, V363, P1093, DOI 10.1126/science.aau6313; Chan CP, 2006, J VIROL, V80, P9279, DOI 10.1128/JVI.00659-06; Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902; Chang CN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061196, 10.1371/journal.pone.0065045]; Chen CY, 2007, J MOL BIOL, V368, P1075, DOI 10.1016/j.jmb.2007.02.069; Cid-Samper F, 2018, CELL REP, V25, P3422, DOI 10.1016/j.celrep.2018.11.076; Cui L, 2015, J VIROL, V89, P9029, DOI 10.1128/JVI.01331-15; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Gaete-Argel A, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00336; Goldstein SA, 2017, J VIROL, V91, DOI 10.1128/JVI.02201-16; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002; Guillen-Boixet J, 2020, CELL, V181, P346, DOI 10.1016/j.cell.2020.03.049; Guseva S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz7095; Hackbart M, 2020, P NATL ACAD SCI USA, V117, P8094, DOI 10.1073/pnas.1921485117; Hatcher JM, 2018, CELL CHEM BIOL, V25, P460, DOI 10.1016/j.chembiol.2018.01.013; Heger-Stevic J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007488; Heinrich BS, 2018, MBIO, V9, DOI 10.1128/mBio.02290-17; Hernandez-Vega A, 2017, CELL REP, V20, P2304, DOI 10.1016/j.celrep.2017.08.042; Hosmillo M, 2019, ELIFE, V8, DOI 10.7554/eLife.46681; Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17; Hu Y, 2017, J VIROL, V91, DOI 10.1128/JVI.02143-16; Huang C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002433; Hur S, 2019, ANNU REV IMMUNOL, V37, P349, DOI 10.1146/annurev-immunol-042718-041356; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Kamitani W, 2009, NAT STRUCT MOL BIOL, V16, P1134, DOI 10.1038/nsmb.1680; Kang SS, 2020, ACTA PHARM SIN B, V10, P1228, DOI 10.1016/j.apsb.2020.04.009; Karakama Y, 2010, ANTIMICROB AGENTS CH, V54, P3179, DOI 10.1128/AAC.00113-10; Khaperskyy DA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004217; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kim SSY, 2019, J BIOL CHEM, V294, P6430, DOI 10.1074/jbc.RA118.005868; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Krahling V, 2009, J VIROL, V83, P2298, DOI 10.1128/JVI.01245-08; Law LMJ, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007798; Li D, 2020, APPL COMPOS MATER, V27, P1, DOI 10.1007/s10443-019-09791-5; Liu GQ, 2019, J VIROL, V93, DOI 10.1128/JVI.02299-18; Lokugamage KG, 2012, J VIROL, V86, P13598, DOI 10.1128/JVI.01958-12; Luo HB, 2005, FEBS LETT, V579, P2623, DOI 10.1016/j.febslet.2005.03.080; Manivannan P, 2020, J VIROL, V94, DOI 10.1128/JVI.00205-20; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991; McSwiggen DT, 2019, ELIFE, V8, DOI 10.7554/eLife.47098; Monette A, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.084; Mu JF, 2020, SCI CHINA LIFE SCI, V63, P1413, DOI 10.1007/s11427-020-1692-1; Nakagawa K, 2018, J VIROL, V92, DOI 10.1128/JVI.00902-18; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Neuman BW, 2006, J VIROL, V80, P7918, DOI 10.1128/JVI.00645-06; Ng CS, 2013, J VIROL, V87, P9511, DOI 10.1128/JVI.03248-12; Nikolic J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00102-9; Oh SW, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005444; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Peng TY, 2008, FEBS J, V275, P4152, DOI 10.1111/j.1742-4658.2008.06564.x; Piotrowska J, 2010, J VIROL, V84, P3654, DOI 10.1128/JVI.01320-09; Prescott EL, 2014, J VIROL, V88, P12599, DOI 10.1128/JVI.02029-14; Raaben M, 2007, CELL MICROBIOL, V9, P2218, DOI 10.1111/j.1462-5822.2007.00951.x; Rabouw HH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005982; Reineke LC, 2015, MBIO, V6, DOI 10.1128/mBio.02486-14; Reineke LC, 2015, J VIROL, V89, P2575, DOI 10.1128/JVI.02791-14; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Rozelle DK, 2014, MOL CELL BIOL, V34, P2003, DOI 10.1128/MCB.01630-13; Sanders DW, 2020, CELL, V181, P306, DOI 10.1016/j.cell.2020.03.050; Scholte FEM, 2015, J VIROL, V89, P4457, DOI 10.1128/JVI.03612-14; Shattuck JE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11550-w; Simpson-Holley M, 2011, J VIROL, V85, P1581, DOI 10.1128/JVI.02247-10; Slaine PD, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120388; Sola I, 2011, J VIROL, V85, P5136, DOI 10.1128/JVI.00195-11; Spiegel M, 2005, J VIROL, V79, P2079, DOI 10.1128/JVI.79.4.2079-2086.2005; Takamatsu Y, 2020, MBIO, V11, DOI 10.1128/mBio.02565-19; Tauber D, 2020, CELL, V180, P411, DOI 10.1016/j.cell.2019.12.031; Vernon RM, 2018, ELIFE, V7, DOI 10.7554/eLife.31486; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07; Weirich KL, 2017, P NATL ACAD SCI USA, V114, P2131, DOI 10.1073/pnas.1616133114; Wong HH, 2018, VIROLOGY, V515, P165, DOI 10.1016/j.virol.2017.12.028; Wu CH, 2009, J BIOL CHEM, V284, P5229, DOI 10.1074/jbc.M805747200; Yang PG, 2020, CELL, V181, P325, DOI 10.1016/j.cell.2020.03.046; Yoo JS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004012; Zhao L, 2012, CELL HOST MICROBE, V11, P607, DOI 10.1016/j.chom.2012.04.011; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	92	58	59	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9832	9842		10.1096/fj.202001351	http://dx.doi.org/10.1096/fj.202001351		JUN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32562316	Green Published			2022-12-26	WOS:000541814300001
J	Ben Kayale, L; Ling, J; Henderson, E; Carter, N				Ben Kayale, Lilahom; Ling, Jonathan; Henderson, Emily; Carter, Noel			The influence of cultural attitudes to nut exposure on reported nut allergy: A pilot cross sectional study	PLOS ONE			English	Article							PEANUT ALLERGY; FOOD ALLERGY; CHILDREN; PREVALENCE; RISK; EPIDEMIOLOGY; PATHOGENESIS; CONSUMPTION; PREVENTION; DIAGNOSIS	Food allergies in children have become a common management and diagnostic concern and have a significant influence on general health-related quality of life. We investigated the prevalence of reported nut allergy between populations with different cultural attitudes to nuts during pregnancy and infancy. We conducted a survey to investigate the relationship between cultural differences in the consumption of nuts during pregnancy, breastfeeding and exposure to nuts in early childhood against the reported prevalence of nut allergy between three populations: Libyan, UK Libyan and a general UK population. The survey was administered to a representative sample of UK and Libyan parents with children aged between 3 and 16 years who were asked to report prevalence of nut allergy and to describe the factors that might affect this such as cultural behaviours and diet. A total of 1,123 parents responded. Nut allergy was defined as an allergic reaction that required medical treatment. The reported rates of nut allergy showed a significant difference in nut allergy between the Libyan populations and the general UK population with an increased odds ratio of nut allergy of similar to 10 when comparing the Native Libyan population to the UK population. The UK Libyan population reported the same low rate of allergic reactions as the Libyan population which were both significantly lower than the UK population (p < .0001). The Libyan populations showed significant differences from the UK population in exposure to nuts during pregnancy, breastfeeding and early infancy. The development of peanut and almond allergy through tolerance induction could be prevented by frequent and early ingestion of a moderate quantity of nuts during infancy and by maternal ingestion during pregnancy or lactation.	[Ben Kayale, Lilahom; Ling, Jonathan; Carter, Noel] Univ Sunderland, Fac Hlth Sci & Wellbeing, Sunderland, Tyne & Wear, England; [Henderson, Emily] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England	University of Sunderland; Newcastle University - UK	Carter, N (corresponding author), Univ Sunderland, Fac Hlth Sci & Wellbeing, Sunderland, Tyne & Wear, England.	noel.carter@sunderland.ac.uk	Ling, Jonathan/AAY-4098-2020	Ling, Jonathan/0000-0003-2932-4474; Carter, Noel/0000-0002-6888-3829	Fuse, the Centre for Translational Research in Public Health	Fuse, the Centre for Translational Research in Public Health	The work was all conducted as part of a self funded MPhil research project by the lead author, as such the student had a primary role in the study design, data collection, data analysis, decision to publish and preparation of the manuscript. JL received funding for this study from Fuse, the Centre for Translational Research in Public Health (www.fuse.ac.uk).The views expressed in this paper do not necessarily represent those of the funders or UKCRC and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostou K, 2014, LANCET, V383, P1297, DOI 10.1016/S0140-6736(13)62301-6; Bowling A., 2014, RES METHODS HLTH INV, Vfourth; Boye Joyce Irene, 2012, Clin Transl Allergy, V2, P25, DOI 10.1186/2045-7022-2-25; Chatzi L, 2007, THORAX, V62, P677, DOI 10.1136/thx.2006.069419; Cummings AJ, 2010, PEDIAT ALLERG IMM-UK, V21, P586, DOI 10.1111/j.1399-3038.2009.00975.x; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; Enrique E, 2005, J ALLERGY CLIN IMMUN, V116, P1073, DOI 10.1016/j.jaci.2005.08.027; Food standards Agency, 1998, COT REP PEAN ALL; Hofmann AM, 2009, J ALLERGY CLIN IMMUN, V124, P286, DOI 10.1016/j.jaci.2009.03.045; Hourihane JO, 2007, J ALLERGY CLIN IMMUN, V119, P1197, DOI 10.1016/j.jaci.2006.12.670; Katz Y, 2010, J ALLERGY CLIN IMMUN, V126, P77, DOI 10.1016/j.jaci.2010.04.020; Koplin JJ, 2010, J ALLERGY CLIN IMMUN, V126, P807, DOI 10.1016/j.jaci.2010.07.028; Kull I, 2006, ALLERGY, V61, P1009, DOI 10.1111/j.1398-9995.2006.01115.x; Lack G, 2012, J ALLERGY CLIN IMMUN, V129, P1187, DOI 10.1016/j.jaci.2012.02.036; Longo G, 2008, J ALLERGY CLIN IMMUN, V121, P343, DOI 10.1016/j.jaci.2007.10.029; Lopez-Exposito I, 2009, J ALLERGY CLIN IMMUN, V124, P1039, DOI 10.1016/j.jaci.2009.08.024; McWilliam V, 2019, J ALLERGY CLIN IMMUN, V143, P644, DOI 10.1016/j.jaci.2018.07.038; Panjari M, 2016, CLIN EXP ALLERGY, V46, P602, DOI 10.1111/cea.12699; Poole JA, 2006, PEDIATRICS, V117, P2175, DOI 10.1542/peds.2005-1803; R Core Team, 2021, R LANGUAGE ENV STAT; R Studio Team, 2016, RSTUDIO INT DEV ENV; Sahyoun N. R., 2016, Mediterranean diet: dietary guidelines and impact on health and disease, P43; Schoonjans F, MEDCALC STAT SOFTWAR; Sicherer SH, 2007, J ALLERGY CLIN IMMUN, V120, P491, DOI 10.1016/j.jaci.2007.07.015; Sicherer SH, 2018, J ALLERGY CLIN IMMUN, V141, P41, DOI 10.1016/j.jaci.2017.11.003; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V126, P1191, DOI 10.1016/j.jaci.2010.08.036; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Togias A, 2017, ANN ALLERG ASTHMA IM, V118, P166, DOI 10.1016/j.anai.2016.10.004	29	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234846	10.1371/journal.pone.0234846	http://dx.doi.org/10.1371/journal.pone.0234846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559218	Green Published, gold, Green Accepted			2022-12-26	WOS:000543261600029
J	Lin, DM; Chen, XJ				Lin, Dongming; Chen, Xinjun			Top predator reveals the stability of prey community in the western subarctic Pacific	PLOS ONE			English	Article							NEON FLYING SQUID; FATTY-ACID-COMPOSITION; 2 OMMASTREPHID SQUIDS; NORTH PACIFIC; FEEDING-HABITS; STOMACH CONTENTS; STABLE-ISOTOPES; LIFE-HISTORIES; MOROTEUTHIS-INGENS; TROPHIC POSITION	The stability of the ecosystems depends on the dynamics of the prey community, but changes in the composition and abundance of prey species are poorly understood, especially in open ocean ecosystems. We used neon flying squidOmmastrephes bartramii, an active top predator, as a biological sampler to investigate the dynamics of the prey community in the southwestern part of the Western Subarctic Gyre in the northwestern Pacific Ocean. Squid were collected monthly from July to November 2016. There were no significant differences among months in stable isotopes (delta C-13 and delta N-15) in the digestive gland, a fast turnover organ reflecting recent dietary information. Similar findings were obtained from analyses of isotopic niche width and fatty acid profiles. The potential influence of the environment (monthly mean sea surface temperature, SST, and chlorophyll-a, Chl-a) on the prey community was examined with SST and Chl-aboth varying significantly among sampling months. We found little evidence for significant effects of SST and Chl-aon the isotopic values, nor on the fatty acid profiles except for 20:4n6 and 24:1n9. These lines of evidence indicate that the prey community in the southwestern part of the gyre remains stable, with little evidence for systematic changes at the community level. This study provides a novel understanding of the dynamics of the prey community and highlights the use of top predators to study the trophic dynamics of an oceanic system where a long-term scientific survey is unavailable.	[Lin, Dongming; Chen, Xinjun] Shanghai Ocean Univ, Coll Marine Sci, Shanghai, Peoples R China; [Lin, Dongming; Chen, Xinjun] Minist Educ, Key Lab Sustainable Exploitat Ocean Fishery Resou, Shanghai, Peoples R China; [Lin, Dongming; Chen, Xinjun] Natl Distant Water Fisheries Engn Res Ctr, Shanghai, Peoples R China; [Lin, Dongming; Chen, Xinjun] Minist Agr & Rural Affairs, Key Lab Ocean Fisheries Explorat, Shanghai, Peoples R China; [Chen, Xinjun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China	Shanghai Ocean University; Ministry of Agriculture & Rural Affairs; Qingdao National Laboratory for Marine Science & Technology	Chen, XJ (corresponding author), Shanghai Ocean Univ, Coll Marine Sci, Shanghai, Peoples R China.; Chen, XJ (corresponding author), Minist Educ, Key Lab Sustainable Exploitat Ocean Fishery Resou, Shanghai, Peoples R China.; Chen, XJ (corresponding author), Natl Distant Water Fisheries Engn Res Ctr, Shanghai, Peoples R China.; Chen, XJ (corresponding author), Minist Agr & Rural Affairs, Key Lab Ocean Fisheries Explorat, Shanghai, Peoples R China.; Chen, XJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China.	xjchen@shou.edu.cn		Lin, Dongming/0000-0002-6826-0306	National Key Research and Development Project [2019YFD0901404]; National Natural Science Foundation of China [41876144, 41876141]; Natural Science Foundation of Shanghai [16ZR1415400]; Shanghai Science and Technology Innovation Program [19DZ1207502]	National Key Research and Development Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Science and Technology Innovation Program	This work was supported by National Key Research and Development Project (2019YFD0901404), National Natural Science Foundation of China (41876144, 41876141), Natural Science Foundation of Shanghai (16ZR1415400) and Shanghai Science and Technology Innovation Program (19DZ1207502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J, 2017, STAT REFERENCE ONLIN, P1, DOI [10.1002/9781118445112.stat07841, DOI 10.1002/9781118445112.STAT07841]; Arkhipkin AI, 2013, DEEP-SEA RES PT II, V95, P7, DOI 10.1016/j.dsr2.2012.07.003; BALLANTYNE JS, 1981, MAR BIOL LETT, V2, P75; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bell G, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1463; Boyle P, 2005, CEPHALOPODS: ECOLOGY AND FISHERIES, P1, DOI 10.1002/9780470995310; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chen XJ, 2008, FISH RES, V92, P221, DOI 10.1016/j.fishres.2008.01.011; Cherel Y, 2005, P ROY SOC B-BIOL SCI, V272, P1601, DOI 10.1098/rspb.2005.3115; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P979, DOI 10.1098/rstb.1996.0088; Cline TJ, 2019, NAT ECOL EVOL, V3, P935, DOI 10.1038/s41559-019-0901-7; Coll M, 2013, DEEP-SEA RES PT II, V95, P21, DOI 10.1016/j.dsr2.2012.08.020; de la Chesnais T, 2019, REV FISH BIOL FISHER, V29, P313, DOI 10.1007/s11160-019-09554-2; Dee LE, 2019, TRENDS ECOL EVOL, V34, P746, DOI 10.1016/j.tree.2019.03.010; Espinoza P, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3119-8; Fang Z, 2016, FISH RES, V177, P153, DOI 10.1016/j.fishres.2016.01.011; Fluckiger M, 2008, MAR BIOL, V154, P363, DOI 10.1007/s00227-008-0932-0; Fujinami Y, 2018, PAC SCI, V72, P21, DOI 10.2984/72.1.2; GAQSIQ, 2008, DET TOT FAT SAT FAT; Goetsch C, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00430; Gong Y, 2018, MAR ECOL PROG SER, V607, P99, DOI 10.3354/meps12768; Gould P, 1997, CAN J ZOOL, V75, P549, DOI 10.1139/z97-068; Graeve M, 2002, MAR ECOL PROG SER, V231, P67, DOI 10.3354/meps231067; Griffith GP, 2018, GLOBAL CHANGE BIOL, V24, pE90, DOI 10.1111/gcb.13891; Guerreiro M, 2015, MAR ECOL PROG SER, V530, P119, DOI 10.3354/meps11266; Harrison PJ, 2004, J OCEANOGR, V60, P93, DOI 10.1023/B:JOCE.0000038321.57391.2a; Harrison PJ, 1999, PROG OCEANOGR, V43, P205, DOI 10.1016/S0079-6611(99)00015-4; ICES, 2010, WORKSH SEX MAT STAG; Imai K, 2002, DEEP-SEA RES PT II, V49, P5395, DOI 10.1016/S0967-0645(02)00198-4; Iverson SJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P281, DOI 10.1007/978-0-387-89366-2_12; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jereb P., 2010, MYOPSID OEGOPSID SQU, V2, P605; Kato Y, 2016, FISH RES, V173, P169, DOI 10.1016/j.fishres.2015.09.016; Kefi S, 2019, ECOL LETT, V22, P1349, DOI 10.1111/ele.13340; Kuhnen VV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181188; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; LIPINSKI MR, 1988, S AFR J MARINE SCI, V6, P43, DOI 10.2989/025776188784480573; Lourenco S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00467; Mackas DL, 1999, PROG OCEANOGR, V43, P335, DOI 10.1016/S0079-6611(99)00012-9; Magurran Anne E, 2018, Proc Natl Acad Sci U S A, V115, P1843, DOI 10.1073/pnas.1712594115; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Meyer L, 2019, FUNCT ECOL, V33, P1243, DOI 10.1111/1365-2435.13328; MOMMSEN TP, 1981, EUR J BIOCHEM, V120, P345, DOI 10.1111/j.1432-1033.1981.tb05710.x; Murase H, 2012, FISHERIES SCI, V78, P761, DOI 10.1007/s12562-012-0508-2; Navarro J, 2013, DEEP-SEA RES PT II, V95, P93, DOI 10.1016/j.dsr2.2013.01.031; Ohshimo S, 2019, PROG OCEANOGR, V175, P124, DOI 10.1016/j.pocean.2019.04.003; Ohshimo S, 2018, MAR FRESHWATER RES, V69, P585, DOI 10.1071/MF17058; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Okuda T, 2017, DEEP-SEA RES PT II, V140, P45, DOI 10.1016/j.dsr2.2016.11.013; Parrish CC, 2000, HANDB ENVIRON CHEM, V5, P193; Parry M, 2008, MAR BIOL, V153, P249, DOI 10.1007/s00227-007-0800-3; Parry M, 2006, MAR ECOL PROG SER, V318, P229, DOI 10.3354/meps318229; Parry MP, 2003, TROPHIC ECOLOGY 2 OM; Pecl GT, 2004, OECOLOGIA, V139, P515, DOI 10.1007/s00442-004-1537-z; Pethybridge HR, 2013, DEEP-SEA RES PT II, V95, P119, DOI 10.1016/j.dsr2.2012.07.025; Phillips KL, 2003, POLAR BIOL, V26, P474, DOI 10.1007/s00300-003-0509-9; Phillips KL, 2001, MAR ECOL PROG SER, V215, P179, DOI 10.3354/meps215179; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Qiu B., 2001, ENCY OCEAN SCI, P1413, DOI DOI 10.1006/RWOS.2001.0350; R Core Team, 2021, R LANGUAGE ENV STAT; Rodhouse PG, 1996, PHILOS T ROY SOC B, V351, P1003, DOI 10.1098/rstb.1996.0090; Roo J, 2017, AQUAC RES, V48, P633, DOI 10.1111/are.12910; Rosas-Luis R, 2017, REG STUD MAR SCI, V11, P17, DOI 10.1016/j.rsma.2017.02.003; Sanchez-Hernandez J, 2018, FISH FISH, V19, P1003, DOI 10.1111/faf.12308; Sogawa S, 2017, J CRUSTACEAN BIOL, V37, P29, DOI 10.1093/jcbiol/ruw014; Stowasser G, 2006, J EXP MAR BIOL ECOL, V333, P97, DOI 10.1016/j.jembe.2005.12.008; Sunday JM, 2015, ECOL LETT, V18, P944, DOI 10.1111/ele.12474; Tsuda A, 2004, FISH OCEANOGR, V13, P10, DOI 10.1111/j.1365-2419.2004.00315.x; Watanabe H, 2004, MAR ECOL PROG SER, V266, P173, DOI 10.3354/meps266173; Watanabe H, 2008, J MAR BIOL ASSOC UK, V88, P381, DOI 10.1017/S0025315408000635; Yamaguchi A, 2017, PROG OCEANOGR, V150, P13, DOI 10.1016/j.pocean.2015.04.011; Yeakel JD, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00001; Yuan XJ, 1996, J GEOPHYS RES-OCEANS, V101, P16491, DOI 10.1029/96JC01249; Zar J.H., 2010, BIOSTAT ANAL; Zhao QH, 2019, ECOL LETT, V22, P1152, DOI 10.1111/ele.13282; Zuur A, 2009, MIXED EFFECTS MODELS; Zuur AF, 2007, STAT BIOL HEALTH, P1	80	0	0	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234905	10.1371/journal.pone.0234905	http://dx.doi.org/10.1371/journal.pone.0234905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559216	Green Published, gold			2022-12-26	WOS:000543261600001
J	Baudry, AS; Christophe, V; Constant, E; Piessen, G; Anota, A				Baudry, Anne-Sophie; Christophe, Veronique; Constant, Emilie; Piessen, Guillaume; Anota, Amelie		FREGAT Working Grp	The Profile of Emotional Competence (PEC): A French short version for cancer patients	PLOS ONE			English	Article							ITEM RESPONSE THEORY; SAMPLE-SIZE; INTELLIGENCE; QLQ-C30; ANXIETY; HEALTH; POWER; LIFE	Background Intrapersonal and interpersonal Emotional Competence (EC) predicts better health and disease adjustment. This study aimed to validate a short version of the Profile of Emotional Competence (PEC) scale for cancer patients. Methods Five hundred and thirty-five patients with cancer completed a self-reported questionnaire assessing their intra- and interpersonal EC (PEC), their anxiety and depression symptoms (HADS), and their health-related quality of life (QLQ-C30). Confirmatory factor analyses and Item Response Theory models with the Partial Credit Model were performed to validate and reduce the scale. Findings The Short-PEC (13 items), composed of 2 sub-scores of intra- (6 items) and interpersonal (7 items) EC, showed an improved factorial structure (Root Mean Square Error of Approximation (RMSEA) = 0.075 (90% confidence interval 0.066-0.085), comparative fit index = 0.915) with good psychometric properties. Discussion Future studies should use the Short-PEC to explain and predict the adjustment of cancer patients. The short-PEC could be also used in clinical routine to assess the level of EC of patients and to adapt psychosocial intervention.	[Baudry, Anne-Sophie] Ctr Hosp Valenciennes, Pole Cancerol & Specialites Med, Valenciennes, France; [Baudry, Anne-Sophie; Christophe, Veronique; Constant, Emilie] Univ Lille, CNRS, CHU Lille, UMR 9193,SCALab,Sci Cognit & Sci Affect, Lille, France; [Christophe, Veronique; Anota, Amelie] French Natl Platform Qual Life & Canc, Lille, France; [Christophe, Veronique] Ctr Leon Berard, Human & Social Sci Dept, Lyon, France; [Piessen, Guillaume] Univ Lille, Claude Huriez Univ Hosp, Dept Digest & Oncol Surg, Lille, France; [Anota, Amelie] Univ Hosp Besancon, UMR 1098, NSERM, Methodol & Qual Life Oncol Unit, Besancon, France	CH de Valenciennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; CHU Lille; Universite de Lille; UNICANCER; Centre Leon Berard; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon	Baudry, AS (corresponding author), Ctr Hosp Valenciennes, Pole Cancerol & Specialites Med, Valenciennes, France.; Baudry, AS; Christophe, V (corresponding author), Univ Lille, CNRS, CHU Lille, UMR 9193,SCALab,Sci Cognit & Sci Affect, Lille, France.; Christophe, V (corresponding author), French Natl Platform Qual Life & Canc, Lille, France.; Christophe, V (corresponding author), Ctr Leon Berard, Human & Social Sci Dept, Lyon, France.	anne-sophie.baudry@univ-lille.fr; veronique.christophe@univ-lille.fr		Christophe, Veronique/0000-0002-0000-0663	SIRIC ONCOLille [INCa-DGOS Inserm 6041]; Region Hauts-de-France; French National Cancer Institute (INCa); CHU de Lille	SIRIC ONCOLille; Region Hauts-de-France(Region Hauts-de-France); French National Cancer Institute (INCa)(Institut National du Cancer (INCA) France); CHU de Lille	This work was supported by the SIRIC ONCOLille (Grant INCa-DGOS Inserm 6041) to VC and the "Region Hauts-de-France." FREGAT was funded with support from the French National Cancer Institute (INCa) and the CHU de Lille is the sponsor of the FREGAT study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Austin EJ, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00974; Baudry AS, 2018, SUPPORT CARE CANCER, V26, P223, DOI 10.1007/s00520-017-3838-x; Baudry AS, 2019, PSYCHO-ONCOLOGY, V28, P799, DOI 10.1002/pon.5023; Baudry AS, 2018, SCAND J PSYCHOL, V59, P206, DOI 10.1111/sjop.12424; Brasseur S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062635; Coccaro EF, 2016, PRIM CARE DIABETES, V10, P334, DOI 10.1016/j.pcd.2016.05.006; Edelen MO, 2007, QUAL LIFE RES, V16, P5, DOI 10.1007/s11136-007-9198-0; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; Liu M, 2012, CORROS SCI, V54, P139, DOI 10.1016/j.corsci.2011.09.004; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Malouff JM, 2014, AM J FAM THER, V42, P53, DOI 10.1080/01926187.2012.748549; Mariette C, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-3991-8; Martins A, 2010, PERS INDIV DIFFER, V49, P554, DOI 10.1016/j.paid.2010.05.029; Mikolajczak M, 2015, EMOTION, V15, P653, DOI 10.1037/emo0000034; Naz R., 2016, PAFMJ, V66, P903; O'Boyle EH, 2011, J ORGAN BEHAV, V32, P788, DOI 10.1002/job.714; Teques AP, 2016, PSYCHO-ONCOLOGY, V25, P324, DOI 10.1002/pon.3921; Petersen MA, 2006, J CLIN EPIDEMIOL, V59, P36, DOI 10.1016/j.jclinepi.2005.04.010; RAZAVI D, 1989, REV PSYCHOL APPL, V39, P295; Sanchez-Alvarez N, 2016, J POSIT PSYCHOL, V11, P276, DOI 10.1080/17439760.2015.1058968; Schinckus L, 2018, PERS INDIV DIFFER, V131, P124, DOI 10.1016/j.paid.2018.03.028; Schmidt JE, 2004, HEALTH PSYCHOL, V23, P259, DOI 10.1037/0278-6133.23.3.259; Smith SG, 2012, SUPPORT CARE CANCER, V20, P2933, DOI 10.1007/s00520-012-1423-x; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Wolf EJ, 2013, EDUC PSYCHOL MEAS, V73, P913, DOI 10.1177/0013164413495237; Zeidner M, 2012, APPL PSYCHOL-HLTH WE, V4, P1, DOI 10.1111/j.1758-0854.2011.01062.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0232706	10.1371/journal.pone.0232706	http://dx.doi.org/10.1371/journal.pone.0232706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555672	Green Published, gold			2022-12-26	WOS:000543273200045
J	Kitagawa, K; So, R; Nomura, N; Mizuno, Y; Misawa, F; Kodama, M; Uchida, H; Mimura, M; Takeuchi, H				Kitagawa, Kohei; So, Ryuhei; Nomura, Nobuyuki; Mizuno, Yuya; Misawa, Fuminari; Kodama, Masafumi; Uchida, Hiroyuki; Mimura, Masaru; Takeuchi, Hiroyoshi			Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J)	PLOS ONE			English	Article							TREATMENT-RESISTANT SCHIZOPHRENIA; RATING-SCALE; MANAGEMENT; EFFICACY; BLIND; RISPERIDONE; OLANZAPINE	The purpose of this study was to develop the Glasgow Antipsychotic Side effects Scale for Clozapine Japanese version (GASS-C-J) and examine its reliability to assess clozapine-related side effects. We developed the GASS-C-J using forward and backward translation. Semantic equivalence of the GASS-C-J to the GASS-C was confirmed by the original author. We then administered the GASS-C-J twice to 109 patients on clozapine treatment at two psychiatric hospitals in Japan. We assessed the internal consistency and test-retest reliability of the GASS-C-J using Cronbach's alpha and weighted kappa coefficient, respectively. We also examined if discrepancies in each GASS-C-J item score between the first and second rating were correlated with items of the Brief Evaluation of Psychosis Symptom Domains (BE-PSD). The Cronbach's alpha coefficient of the GASS-C-J at the first and second rating was 0.78 (95% CI: 0.72 to 0.84) and 0.82 (95% CI: 0.76 to 0.88), respectively. The weighted kappa coefficient of individual and total GASS-C-J item scores ranged from 0.45 to 0.88. Some symptom domains were correlated with discrepancies in specific items of the GASS-C-J: psychotic symptoms and nausea/vomiting (r(s)= 0.27), thirst (r(s)= 0.31), and appetite/weight gain (r(s)= 0.27); disorganized thinking and urinary incontinence (r(s)= 0.26); depression/anxiety and myoclonus (r(s)= 0.25), hypersalivation (r(s)= -0.27), and blurred vision (r(s)= -0.22). These findings demonstrate that the GASS-C-J can be used in clinical and research settings as a reliable scale to assess clozapine-related side effects.	[Kitagawa, Kohei; So, Ryuhei; Kodama, Masafumi] Okayama Psychiat Med Ctr, Dept Neuropsychiat, Okayama, Japan; [Nomura, Nobuyuki; Misawa, Fuminari; Takeuchi, Hiroyoshi] Yamanashi Prefectural Kita Hosp, Dept Neuropsychiat, Kofu, Yamanashi, Japan; [Nomura, Nobuyuki; Mizuno, Yuya; Uchida, Hiroyuki; Mimura, Masaru; Takeuchi, Hiroyoshi] Keio Univ, Dept Neuropsychiat, Sch Med, Tokyo, Japan; [Mizuno, Yuya] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London, England	Keio University; University of London; King's College London	Takeuchi, H (corresponding author), Yamanashi Prefectural Kita Hosp, Dept Neuropsychiat, Kofu, Yamanashi, Japan.; Takeuchi, H (corresponding author), Keio Univ, Dept Neuropsychiat, Sch Med, Tokyo, Japan.	hirotak@dk9.so-net.ne.jp	Nomura, Nobuyuki/AAX-2283-2021; Uchida, Hiroyuki/I-4867-2015	Nomura, Nobuyuki/0000-0001-6516-4573; Uchida, Hiroyuki/0000-0002-0628-7036; Takeuchi, Hiroyoshi/0000-0002-8844-4786	Kobayashi Magobe Memorial Medical Foundation; Inokashira Hospital	Kobayashi Magobe Memorial Medical Foundation; Inokashira Hospital	This research was supported by a grant from Kobayashi Magobe Memorial Medical Foundation to RS and Inokashira Hospital to NN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azorin JM, 2001, AM J PSYCHIAT, V158, P1305, DOI 10.1176/appi.ajp.158.8.1305; Bachmann CJ, 2017, ACTA PSYCHIAT SCAND, V136, P37, DOI 10.1111/acps.12742; Chakos M, 2001, AM J PSYCHIAT, V158, P518, DOI 10.1176/appi.ajp.158.4.518; GROHMANN R, 1989, PSYCHOPHARMACOLOGY, V99, pS101, DOI 10.1007/BF00442571; Hynes C, 2015, SCHIZOPHR RES, V168, P505, DOI 10.1016/j.schres.2015.07.052; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Legge SE, 2016, SCHIZOPHR RES, V174, P113, DOI 10.1016/j.schres.2016.05.002; LEPPIG M, 1989, PSYCHOPHARMACOLOGY, V99, pS77, DOI 10.1007/BF00442565; Lewis SW, 2006, SCHIZOPHRENIA BULL, V32, P715, DOI 10.1093/schbul/sbj067; Lin CC, 2013, J CLIN PSYCHOPHARM, V33, P211, DOI 10.1097/JCP.0b013e31828700c7; MARINKOVIC D, 1994, PROG NEURO-PSYCHOPH, V18, P537, DOI 10.1016/0278-5846(94)90010-8; McEvoy JP, 2006, AM J PSYCHIAT, V163, P600, DOI 10.1176/appi.ajp.163.4.600; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Mustafa FA, 2013, J CLIN PSYCHOPHARM, V33, P63, DOI 10.1097/JCP.0b013e31827a813b; NABER D, 1989, PSYCHOPHARMACOLOGY, V99, pS73, DOI 10.1007/BF00442564; NABER D, 1992, BRIT J PSYCHIAT, V160, P54, DOI 10.1192/S0007125000296931; Souza JS, 2013, CNS SPECTRUMS, V18, P82, DOI 10.1017/S1092852912000806; Still DJ, 1996, PSYCHIATR SERV, V47, P1382; Takeuchi H, 2016, PSYCHIAT RES, V244, P415, DOI 10.1016/j.psychres.2016.07.055; Takeuchi H, 2016, J PSYCHIATR RES, V80, P87, DOI 10.1016/j.jpsychires.2016.06.005; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Waddell L, 2008, J PSYCHOPHARMACOL, V22, P238, DOI 10.1177/0269881107087976; Warnez S, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-102; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Young CR, 1998, SCHIZOPHRENIA BULL, V24, P381, DOI 10.1093/oxfordjournals.schbul.a033333	26	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234864	10.1371/journal.pone.0234864	http://dx.doi.org/10.1371/journal.pone.0234864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555706	Green Published, gold			2022-12-26	WOS:000543273200075
J	Tolu, LB; Ararso, R; Abdulkadir, A; Feyissa, GT; Worku, Y				Tolu, Lemi Belay; Ararso, Roba; Abdulkadir, Abdulfetah; Feyissa, Garumma Tolu; Worku, Yoseph			Perinatal outcome of growth restricted fetuses with abnormal umbilical artery Doppler waveforms compared to growth restricted fetuses with normal umbilical artery Doppler waveforms at a tertiary referral hospital in urban Ethiopia	PLOS ONE			English	Article							VELOCIMETRY	Background Intrauterine growth restriction is defined as a fetal weight below the 10th percentile for a given gestational age and can be identified using umbilical artery Doppler velocimetry which is a non-invasive technique. The objective of this study was to determine the perinatal outcome of growth-restricted fetuses with abnormal umbilical artery Doppler study compared to those with normal umbilical artery Doppler waveforms at a tertiary referral hospital in Ethiopia. Methods A prospective cohort study was conducted among pregnant mothers with fetal growth restriction admitted for labour and delivery from September 2018-February 2019. The data were entered and analyzed using SPSS version 23. After conducting descriptive analysis, exploring the entire data, and checking for, statistical associations between abnormal umbilical artery Doppler and outcome variables, multiple logistic regression was conducted to control for confounders. Results A total of 170 pregnant mothers complicated with growth-restricted fetuses were included in the study, among which 133 were with normal umbilical artery Doppler studies and 37 were with abnormal umbilical artery Doppler studies. Four (3%) of normal and 9(24.3%) of abnormal umbilical artery Doppler studies ended in perinatal death-value = 0.001. Twenty (15%) of normal and 24(64.9%) of abnormal umbilical artery Doppler study neonates required neonatal intensive care admission-value = 0.002. Growth restricted fetuses complicated with abnormal Doppler were two times more likely to require neonatal intensive care unit admissions compared to growth-restricted fetuses with normal umbilical artery Doppler flow, P-value 0.002, (OR = 2.059,95%CI 1.449-2.926). Growth restricted fetuses complicated with abnormal Doppler were four times more likely to end in early neonatal death compared to growth-restricted fetuses with normal umbilical artery Doppler flow, P-value 0.001, (OR = 4.136, 95%CI 3.423-4.998). However, the study is unmatched and there is a possibility of gestational age confounding the result and should be seen with the context of preterm morbidity and mortality. Conclusion The abnormal umbilical artery Doppler waveform is associated with cesarean section delivery, neonatal intensive care unit admission, respiratory distress syndrome, neonatal sepsis, neonatal hyperbilirubinemia, and early neonatal death compared to normal umbilical artery Doppler flow.	[Tolu, Lemi Belay; Ararso, Roba; Abdulkadir, Abdulfetah; Worku, Yoseph] St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia; [Feyissa, Garumma Tolu] Jimma Univ, Dept Hlth Behav & Soc, Jimma, Ethiopia	Jimma University	Tolu, LB (corresponding author), St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia.	lemi.belay@gmail.com	Feyissa, Garumma/AAP-9097-2020; Worku, Yoseph/AAX-3398-2021	Feyissa, Garumma/0000-0001-6179-0024; Worku, Yoseph/0000-0002-6885-0437; Tolu, Lemi Belay/0000-0001-6703-828X				Alfirevic Z, 2017, COCHRANE DATABASE SY; Ali Azmat, 2014, J Ayub Med Coll Abbottabad, V26, P344; Ananth CV, 2007, OBSTET GYNECOL, V110, P128, DOI 10.1097/01.AOG.0000266983.77458.71; [Anonymous], 2016, ETH DEM HLTH SURV 20; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Arora D, 2005, J OBSTETGYNAECOL IND, V55, P138; Berkley E, 2012, AM J OBSTET GYNECOL, V206, P300, DOI 10.1016/j.ajog.2012.01.022; Cappell MS, 2017, OBSTET NORMAL PROBLE, P824; Chauhan SP, 2014, AM J PERINAT, V31, P187, DOI 10.1055/s-0033-1343771; Doctor BA, 2001, AM J OBSTET GYNECOL, V185, P652, DOI 10.1067/mob.2001.116749; Figueras F, 2008, BJOG-INT J OBSTET GY, V115, P590, DOI 10.1111/j.1471-0528.2008.01670.x; GILES WB, 1985, BRIT J OBSTET GYNAEC, V92, P31, DOI 10.1111/j.1471-0528.1985.tb01045.x; Khawar N, 2013, ANN KING EDWARD MED, V19, P216; Kolobo HA, 2019, J CLIN NEONATOL, V8, P232, DOI 10.4103/jcn.JCN_23_19; Lancet Global Health, 2019, LANCET GLOB HEALTH, V7, pe1; Malhotra Neena, 2006, Indian J Med Sci, V60, P311; Oros D, 2011, ULTRASOUND OBST GYN, V37, P191, DOI 10.1002/uog.7738; Rana MJ, 2005, BIOMEDICA, V21, P4; Rekha BR, 2017, INT J REPROD CONTRAC, V6, P955, DOI DOI 10.18203/2320-1770.IJRCOG20170563; Seyam YS, 2002, INT J GYNECOL OBSTET, V77, P131, DOI 10.1016/S0020-7292(02)00027-9; Soregaroli M, 2002, J Matern Fetal Neonatal Med, V11, P199	21	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234810	10.1371/journal.pone.0234810	http://dx.doi.org/10.1371/journal.pone.0234810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555633	Green Published, gold			2022-12-26	WOS:000543273200049
J	Krishnagopal, S; von Coelln, R; Shulman, LM; Girvan, M				Krishnagopal, Sanjukta; von Coelln, Rainer; Shulman, Lisa M.; Girvan, Michelle			Identifying and predicting Parkinson's disease subtypes through trajectory clustering via bipartite networks	PLOS ONE			English	Article							CLINICAL SUBTYPES; HETEROGENEITY; MOTOR; IDENTIFICATION; PROGRESSION; MEDICINE; COHORT	Chronic medical conditions show substantial heterogeneity in their clinical features and progression. We develop the novel data-driven, network-based Trajectory Profile Clustering (TPC) algorithm for 1) identification of disease subtypes and 2) early prediction of subtype/disease progression patterns. TPC is an easily generalizable method that identifies subtypes by clustering patients with similar disease trajectory profiles, based not only on Parkinson's Disease (PD) variable severity, but also on their complex patterns of evolution. TPC is derived from bipartite networks that connect patients to disease variables. Applying our TPC algorithm to a PD clinical dataset, we identify 3 distinct subtypes/patient clusters, each with a characteristic progression profile. We show that TPC predicts the patient's disease subtype 4 years in advance with 72% accuracy for a longitudinal test cohort. Furthermore, we demonstrate that other types of data such as genetic data can be integrated seamlessly in the TPC algorithm. In summary, using PD as an example, we present an effective method for subtype identification in multidimensional longitudinal datasets, and early prediction of subtypes in individual patients.	[Krishnagopal, Sanjukta; Girvan, Michelle] Univ Maryland, College Pk, MD 20742 USA; [von Coelln, Rainer; Shulman, Lisa M.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Girvan, Michelle] Santa Fe Inst, Santa Fe, NM 87501 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore; The Santa Fe Institute	Krishnagopal, S (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	sanju33@gmail.com		Girvan, Michelle/0000-0001-7519-2842	UMB-UMD Research and Innovation Seed Grant Program; NSF [DGE-1632976]	UMB-UMD Research and Innovation Seed Grant Program; NSF(National Science Foundation (NSF))	This work was supported in part by the UMB-UMD Research and Innovation Seed Grant Program. S.K. and M.G. also received support for their contributions through NSF award DGE-1632976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Braun P, 2008, P NATL ACAD SCI USA, V105, P9849, DOI 10.1073/pnas.0805644105; Castaldi PJ, 2014, THORAX, V69, P415, DOI 10.1136/thoraxjnl-2013-203601; Chan SY, 2012, CIRC RES, V111, P359, DOI 10.1161/CIRCRESAHA.111.258541; Cooper CA, 2017, ANN CLIN TRANSL NEUR, V4, P15, DOI 10.1002/acn3.371; Davis AA, 2016, NEUROBIOL AGING, V37, DOI 10.1016/j.neurobiolaging.2015.09.014; Fereshtehnejad SM, 2017, BRAIN, V140, P1959, DOI 10.1093/brain/awx118; Fereshtehnejad SM, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0738-x; Fereshtehnejad SM, 2015, JAMA NEUROL, V72, P863, DOI 10.1001/jamaneurol.2015.0703; Foltynie T, 2002, J NEUROL, V249, P138, DOI 10.1007/PL00007856; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Ivanov PC, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/10/100201; Iwaki H, 2019, MOVEMENT DISORD, V34, P1839, DOI 10.1002/mds.27845; Iwaki H, 2019, NEUROL-GENET, V5, DOI 10.1212/NXG.0000000000000348; Javed MA, 2018, J NETW COMPUT APPL, V108, P87, DOI 10.1016/j.jnca.2018.02.011; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Latourelle JC, 2017, LANCET NEUROL, V16, P908, DOI 10.1016/S1474-4422(17)30328-9; Lawton M, 2018, J NEUROL NEUROSUR PS, V89, P1279, DOI 10.1136/jnnp-2018-318337; Lees AJ, 2009, LANCET, V374, P684; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; Marras C, 2013, J NEUROL NEUROSUR PS, V84, P409, DOI 10.1136/jnnp-2012-303455; Nalls MA, 2019, LANCET NEUROL, V18, P1091, DOI 10.1016/S1474-4422(19)30320-5; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Rajput AH, 2017, NEUROLOGY, V89, P138, DOI 10.1212/WNL.0000000000004078; Santiago JA, 2014, TRENDS MOL MED, V20, P694, DOI 10.1016/j.molmed.2014.10.002; Thenganatt MA, 2014, JAMA NEUROL, V71, P499, DOI 10.1001/jamaneurol.2013.6233; Vinayagam A, 2016, P NATL ACAD SCI USA, V113, P4976, DOI 10.1073/pnas.1603992113; von Coelln R, 2016, CURR OPIN NEUROL, V29, P727, DOI 10.1097/WCO.0000000000000384	31	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0233296	10.1371/journal.pone.0233296	http://dx.doi.org/10.1371/journal.pone.0233296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555729	Green Published, gold, Green Submitted			2022-12-26	WOS:000542759600059
J	Xiong, ZQ; Yu, QZ; Sun, T; Chen, W; Wu, YH; Yin, J				Xiong, ZhengQiang; Yu, Qiuze; Sun, Tao; Chen, Wen; Wu, Yuhao; Yin, Jie			Super-resolution reconstruction of real infrared images acquired with unmanned aerial vehicle	PLOS ONE			English	Article							HIGH-RESOLUTION IMAGE; DISCRETE; SEQUENCE; FRAMES	Super-resolution (SR) technology provides a far promising computational imaging approach in obtaining a high-resolution (HR) image (or image sequences) from observed multiple low-resolution (LR) images by incorporating complementary information. In this paper, a three-stage SR method is proposed to generate a HR image from infrared (IR) LR Images acquired with Unmanned Aerial Vehicle (UAV). The proposed method integrates a high-level image capturing process and a low-level SR process. In this integrated process, we incorporate UAV path optimization, sub-pixel image registration, and sparseness constraint into a computational imaging framework of a region of interest (ROI). To refine ROI complementary feathers, we design an optimal flight control scheme to acquire adequate image sequences from multi-angles. In particular, a phase correlation approach achieving reliable sub-pixel image feature matching is adapted, on the basis of which an effective sparseness regularization model is built to enhance the fine structures of the IR image. Unlike most traditional multiple-frame SR algorithms that mainly focus on signal processing and achieve good performances when using standard test datasets, the performed experiments with real-life IR sequences indicate the three-stage SR method can also deal with practical LR IR image sequences collected by UAVs. The experimental results demonstrate that the proposed method is capable of generating HR images with good performance in terms of edge preservation and detail enhancement.	[Xiong, ZhengQiang; Yu, Qiuze; Sun, Tao; Wu, Yuhao; Yin, Jie] Wuhan Univ, Elect Informat Sch, Wuhan, Peoples R China; [Chen, Wen] Shanghai Inst Spaceflight Control Technol, Shanghai Key Lab Aerosp Intelligent Control Techn, Shanghai, Peoples R China	Wuhan University	Sun, T (corresponding author), Wuhan Univ, Elect Informat Sch, Wuhan, Peoples R China.	suntao@whu.edu.cn		Sun, Tao/0000-0001-6006-2762	Science and Technology on Near-Surface Detection Laboratory Foundation of China [614241409041317]; National Key R&D Program of China [2018YFB10046]; Innovation Fund of Shanghai Academy of Spaceflight Technology [SAST2017-080]	Science and Technology on Near-Surface Detection Laboratory Foundation of China; National Key R&D Program of China; Innovation Fund of Shanghai Academy of Spaceflight Technology	This work was supported in part by the Science and Technology on Near-Surface Detection Laboratory Foundation of China (614241409041317) to TS, the National Key R&D Program of China (2018YFB10046) to ZQX, and the Innovation Fund of Shanghai Academy of Spaceflight Technology (SAST2017-080) to WC.	[Anonymous], 2007, PLOS ONE, V2, pe779; Aziz SA, 2009, T ASABE, V52, P1057, DOI 10.13031/2013.27775; Bose NK, 2001, INT S CIRC SYST; Chainais P, 2011, J MATH IMAGING VIS, V39, P28, DOI 10.1007/s10851-010-0222-6; Chan TF, 2007, APPL COMPUT HARMON A, V23, P3, DOI 10.1016/j.acha.2006.09.005; Chappalli MB, 2005, IEEE SIGNAL PROC LET, V12, P772, DOI 10.1109/LSP.2005.856875; CLARK JJ, 1985, IEEE T ACOUST SPEECH, V33, P1151, DOI 10.1109/TASSP.1985.1164714; Demirel H, 2011, IEEE T IMAGE PROCESS, V20, P1458, DOI 10.1109/TIP.2010.2087767; Dong C, 2016, IEEE T PATTERN ANAL, V38, P295, DOI 10.1109/TPAMI.2015.2439281; Evgeniou T, 2000, ADV COMPUT MATH, V13, P1, DOI 10.1023/A:1018946025316; Hardie RC, 1998, OPT ENG, V37, P247, DOI 10.1117/1.601623; Hennings-Yeomans P. H., 2008, COMPUTER VISION PATT; Hong M, 1997, INT C IM PROC; Hu Y, 2011, IEEE T IMAGE PROCESS, V20, P433, DOI 10.1109/TIP.2010.2063437; Kang MG, 1998, OPT ENG, V37, P2953, DOI 10.1117/1.601883; Kim SP, 1993, IEEE T IMAGE PROCESS, V2, P534, DOI 10.1109/83.242363; KIM SP, 1990, IEEE T ACOUST SPEECH, V38, P1013, DOI 10.1109/29.56062; KIM SP, 1990, IEE PROC-F, V137, P197, DOI 10.1049/ip-f-2.1990.0030; Lin ZC, 2004, IEEE T PATTERN ANAL, V26, P83, DOI 10.1109/TPAMI.2004.1261081; Luo H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194690; Obuchi T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188012; Schultz RR, 1996, IEEE T IMAGE PROCESS, V5, P996, DOI 10.1109/83.503915; Shen HF, 2007, IEEE T IMAGE PROCESS, V16, P479, DOI 10.1109/TIP.2006.888334; Shi XY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212735; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Solomon O, 2018, OPT EXPRESS, V26, P18238, DOI 10.1364/OE.26.018238; Sroubek F, 2007, IEEE T IMAGE PROCESS, V16, P2322, DOI 10.1109/TIP.2007.903256; Sun T, 2013, OPT LETT, V38, P3471, DOI [10.1364/OL.38.083471, 10.1364/OL.38.003471]; Tian J, 2010, J VIS COMMUN IMAGE R, V21, P232, DOI 10.1016/j.jvcir.2010.01.001; Tsai R.Y., 1984, ADV COMPUTER VISION, V1, P317; Wang X, 2018, 2018 IEEE CVF C COMP; Zhao S, 2003, P IEEE INT C IMAGE P, V2, P983	35	2	2	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234775	10.1371/journal.pone.0234775	http://dx.doi.org/10.1371/journal.pone.0234775			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555724	Green Published, gold			2022-12-26	WOS:000542759600036
J	Wu, RY; Zhang, G; Feng, J; Zhang, L; Yang, ZM				Wu, RuiYang; Zhang, Gang; Feng, Jiao; Zhang, Liang; Yang, ZhiMing			Proposal of the optimal numbers of examined and positive lymph nodes to the 8th edition of American Joint Committee on Cancer (AJCC) staging for 758 patients with distal cholangiocarcinoma	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; PANCREATICODUODENECTOMY; IMPACT	Introduction The American Joint Committee on Cancer (AJCC) recommended retrieval of at least 12 lymph nodes and firstly classified N category by the number of positive lymph nodes (PLNs) for Distal Cholangiocarcinoma (DCC). Objective The end of this cohort study was to explore the optimal cut-off values of the number of examined lymph nodes (ELNs) and PLNs to better stratify patients by utilizing a population-based database. Methods A number of 758 patients with DCC from the Surveillance, Epidemiology, and End Results (SEER) database were enrolled in the study and comparing by the survival analysis. Results Survival analysis found that patients with ELNs < 5 had a lower 3-year disease-specific survival rate than ELNs >= 5 in N0M0 cohort (35.3% vs. 53.0%, P = 0.001) and in M0 cohort (42.7% vs. 32.8%, P = 0.006); survival curves between patients with ELNs < 12 and ELNs >= 12 were overlapped in N0M0 cohort (P = 0.256) and in M0 cohort (P = 0.233). Among patients with ELNs >= 5, using the optimal cut-off value of the number of PLNs (0, 2) could accurately stratify patients, but the recommendation of the number of PLNs (0, 3) by the AJCC could not. Conclusions This study recommended examining at least 5 lymph nodes and defining PLNs = 1-2 as the N1 category and PLNs >= 3 as the N2 category, which may better stratify distal cholangiocarcinoma patients and improve the accuracy of the eighth edition AJCC staging.	[Wu, RuiYang; Feng, Jiao; Zhang, Liang; Yang, ZhiMing] Chengdu Med Coll, Dept Vasc Surg, Affiliated Hosp 1, Chengdu, Peoples R China; [Zhang, Gang] Sichuan Prov Hosp Women & Children, Dept Gen Surg, Chengdu, Peoples R China	Chengdu Medical College	Yang, ZM (corresponding author), Chengdu Med Coll, Dept Vasc Surg, Affiliated Hosp 1, Chengdu, Peoples R China.	yangzmmd@163.com						Bolm L, 2019, HPB, V21, P1513, DOI 10.1016/j.hpb.2019.03.363; Buyyounouski M, 2017, AJCC CANC STAGING MA, P317; DeOliveira ML, 2007, ANN SURG, V245, P755, DOI 10.1097/01.sla.0000251366.62632.d3; Hoshimoto S, 2019, ONCOLOGY-BASEL, V96, P290, DOI 10.1159/000499050; Im JH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41622-2; Ito K, 2010, ANN SURG, V251, P675, DOI 10.1097/SLA.0b013e3181d3d2b2; Kang JS, 2020, J HEPATO-BIL-PAN SCI, V27, P75, DOI 10.1002/jhbp.690; Kang JS, 2018, J HEPATO-BIL-PAN SCI, V25, P124, DOI 10.1002/jhbp.520; Kawai M, 2010, AM J SURG, V199, P447, DOI 10.1016/j.amjsurg.2009.01.019; Kiriyama M, 2015, BRIT J SURG, V102, P399, DOI 10.1002/bjs.9752; Lee RM, 2019, SURG ONCOL CLIN N AM, V28, P631, DOI 10.1016/j.soc.2019.06.014; Li XC, 2019, J SURG RES, V236, P2, DOI 10.1016/j.jss.2018.10.044; Lin HP, 2018, WORLD J GASTROENTERO, V24, P1022, DOI 10.3748/wjg.v24.i9.1022; Murakami Y, 2007, WORLD J SURG, V31, P337, DOI 10.1007/s00268-006-0224-0; Murakami Y, 2011, ANN SURG ONCOL, V18, P651, DOI 10.1245/s10434-010-1325-4; Oshiro Y, 2011, EJSO-EUR J SURG ONC, V37, P60, DOI 10.1016/j.ejso.2010.10.011; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Roos E, 2020, HPB, V22, P405, DOI 10.1016/j.hpb.2019.07.011; Sasaki R, 2001, SURGERY, V129, P677, DOI 10.1067/msy.2001.114555; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Strijker M, 2019, ACTA ONCOL, V58, P1048, DOI 10.1080/0284186X.2019.1590634; Suzuki S, 2019, CLIN EXP GASTROENTER, V12, P255, DOI 10.2147/CEG.S207333; Valle JW, 2016, ANN ONCOL, V27, pv28, DOI 10.1093/annonc/mdw324; Zhao YY, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017903	24	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234464	10.1371/journal.pone.0234464	http://dx.doi.org/10.1371/journal.pone.0234464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544187	Green Published, gold			2022-12-26	WOS:000542957200052
J	De Lestrange-Anginieur, E; Kee, CS				De Lestrange-Anginieur, Elie; Kee, Chea-su			Investigation of the impact of blur under mobile attentional orientation using a vision simulator	PLOS ONE			English	Article							RESOLUTION ACUITY; NEURAL COMPENSATION; VISUAL PERFORMANCE; SPATIAL-FREQUENCY; OPTICAL DEFOCUS; ABERRATIONS; QUALITY; UNCERTAINTY; POSITION; DESIGN	It is well-known that correction of blur can improve visual perception. However, it is unclear how the beneficial effect of correction is affected by the regions of correction and the spatial uncertainty introduced by the retinal stimulation. The purpose of this study was two-fold: first, to compare the impacts of blur correction between isoeccentric locations of the visual field; and second, to evaluate the effect of spatial cueing in each corrected location on performing a simple task. Five subjects were asked to complete a simple detection task of a small dark spot stimulus presented randomly at four cardinal retinal locations (eccentricity: 5 degrees) under manipulation of attention via an exogenous cue. Both clear and blurred targets were randomly displayed across the visual field and viewed monocularly through a vision simulator, used to minimize peripheral ocular aberrations. Results confirmed the advantage of clear vs/ blurred images under spatial uncertainty. It was also found that the visual benefit from blur correction is unequal at isoeccentric locations, even for a simple detection task. While manipulation of attention in the presence of spatial uncertainty significantly modulated response time (RT) performance, no differential effect was observed for clear and blurred stimuli, suggesting that attention has only a small effect on the optical benefit for a simple detection task when the display is depleted (no distractor). Those observations highlight the importance of field performance asymmetries in optical interventions and may offer useful implications for the design of extrafoveal refractive correction. Further studies are needed to elucidate how the focus of attention interacts with the perceived gain of vision correction.	[De Lestrange-Anginieur, Elie; Kee, Chea-su] Hong Kong Polytech Univ, Sch Optometry, Hong Kong, Peoples R China; [Kee, Chea-su] Hong Kong Polytech Univ, Interdisciplinary Div Biomed Engn, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University	De Lestrange-Anginieur, E (corresponding author), Hong Kong Polytech Univ, Sch Optometry, Hong Kong, Peoples R China.	elie.delestrange@hotmail.com		Kee, Chea-Su/0000-0002-5177-129X; de Lestrange-Anginieur, Elie/0000-0002-4940-2057	Shenzhen Fundamental Research fund [JCYJ20160331185006518]	Shenzhen Fundamental Research fund	This work was supported by Shenzhen Fundamental Research fund (JCYJ20160331185006518).	Anderson RS, 1996, CURR EYE RES, V15, P351, DOI 10.3109/02713689609007632; Artal P, 2004, J VISION, V4, P281, DOI 10.1167/4.4.4; Barbero S, 2011, OPT EXPRESS, V19, P6215, DOI 10.1364/OE.19.006215; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carrasco M, 2001, SPATIAL VISION, V15, P61, DOI 10.1163/15685680152692015; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; CHARMAN WN, 1988, OPHTHAL PHYSL OPT, V8, P153, DOI 10.1111/j.1475-1313.1988.tb01031.x; Chen L, 2007, J VISION, V7, DOI 10.1167/7.10.9; Cheng X, 2004, J VISION, V4, P310, DOI 10.1167/4.4.7; COHN TE, 1974, J OPT SOC AM, V64, P1715, DOI 10.1364/JOSA.64.001715; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Dalimier E, 2008, J OPT SOC AM A, V25, P2078, DOI 10.1364/JOSAA.25.002078; Foley JM, 1998, J OPT SOC AM A, V15, P1036, DOI 10.1364/JOSAA.15.001036; GEORGESON MA, 1975, J PHYSIOL-LONDON, V252, P627, DOI 10.1113/jphysiol.1975.sp011162; Goodman J. W., 1996, INTRO FOURIER OPTICS; Huang DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep20502; Lee J, 2010, J NEUROPHYSIOL, V104, P960, DOI 10.1152/jn.01019.2009; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Lundstrom L, 2007, OPT EXPRESS, V15, P12654, DOI 10.1364/OE.15.012654; Maringelli F, 1998, EUR J COGN PSYCHOL, V10, P225; Marsack JD, 2004, J VISION, V4, P322, DOI 10.1167/4.4.8; Meister DJ, 2008, CLIN EXP OPTOM, V91, P240, DOI 10.1111/j.1444-0938.2007.00245.x; O'Regan J. K., 1987, EYE MOVEMENTS PHYSL, P37; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Ravikumar A, 2012, J VISION, V12, DOI 10.1167/12.10.11; RIJSDIJK JP, 1980, VISION RES, V20, P235, DOI 10.1016/0042-6989(80)90108-X; Rosen R, 2011, INVEST OPHTH VIS SCI, V52, P318, DOI 10.1167/iovs.10-5623; Rossi EA, 2010, J VISION, V10, DOI 10.1167/10.12.11; ROVAMO J, 1979, EXP BRAIN RES, V37, P495, DOI 10.1007/bf00236819; Sabesan R, 2010, INVEST OPHTH VIS SCI, V51, P3835, DOI 10.1167/iovs.09-4558; Sabesan R, 2009, J VISION, V9, DOI 10.1167/9.5.6; SAGI D, 1986, NATURE, V321, P693, DOI 10.1038/321693a0; Sawides L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070856; Sawides L, 2011, J VISION, V11, DOI 10.1167/11.7.21; Turatto M, 2000, PERCEPT PSYCHOPHYS, V62, P935, DOI 10.3758/BF03212079; Villegas EA, 2008, INVEST OPHTH VIS SCI, V49, P4688, DOI 10.1167/iovs.08-2316; Wang YZ, 1997, INVEST OPHTH VIS SCI, V38, P2134; Wilkinson MO, 2016, J VISION, V16, DOI 10.1167/16.2.1; Zheleznyak L, 2016, J VISION, V16, DOI 10.1167/16.5.1	41	4	4	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234380	10.1371/journal.pone.0234380	http://dx.doi.org/10.1371/journal.pone.0234380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB6AZ	32542032	Green Published, gold			2022-12-26	WOS:000542685100017
J	Wang, R; Wang, YF; Edrington, TC; Liu, ZJ; Lee, TC; Silvanovich, A; Moon, HS; Liu, ZL; Li, B				Wang, Rong; Wang, Yanfei; Edrington, Thomas C.; Liu, Zhenjiu; Lee, Thomas C.; Silvanovich, Andre; Moon, Hong S.; Liu, Zi L.; Li, Bin			Presence of small resistant peptides from newin vitrodigestion assays detected by liquid chromatography tandem mass spectrometry: An implication of allergenicity prediction of novel proteins?	PLOS ONE			English	Article							BOVINE BETA-LACTOGLOBULIN; FOOD ALLERGENS; ALPHA-LACTALBUMIN; BINDING EPITOPES; IMMUNOGLOBULIN-E; PEPSIN; DIGESTION; PH; STABILITY; KINETICS	The susceptibility of newly expressed proteins to digestion by gastrointestinal proteases (e.g., pepsin) has long been regarded as one of the important endpoints in the weight-of-evidence (WOE) approach to assess the allergenic risk of genetically modified (GM) crops. The European Food Safety Authority (EFSA) has suggested that current digestion study protocols used for this assessment should be modified to more accurately reflect the diverse physiological conditions encountered in human populations and that the post-digestion analysis should include analytical methods to detect small peptide digestion products.The susceptibility of two allergens (beta-lactoglobin (beta-Lg) and alpha-lactalbumin (alpha-La)) and two non-allergens (hemoglobin (Hb) and phosphofructokinase (PFK)) to proteolytic degradation was investigated under two pepsin digestion conditions (optimal pepsin digestion condition: pH 1.2, 10 U pepsin/mu g test protein; sub-optimal pepsin digestion condition: pH 5.0, 1 U pepsin/10 mg test protein), followed by 34.5 U trypsin/mg test protein and 0.4 U chymotrypsin/mg test protein digestion in the absence or presence of bile salts. All samples were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in conjunction with Coomassie Blue staining and, in parallel, liquid chromatography tandem mass spectrometry (LC-MS) detection. The results provide following insights: 1) LC-MS methodology does provide the detection of small peptides; 2) Peptides are detected in both allergens and non-allergens from all digestion conditions; 3) No clear differences among the peptides detected from allergen and non-allergens; 4) The differences observed in SDS-PAGE between the optimal and sub-optimal pepsin digestion conditions are expected and align with kinetics and properties of the specific enzymes; 5) The new methodology with new digestion conditions and LC-MS detection does not provide any differentiating information for prediction whether a protein is an allergen. The classic pepsin resistance assay remains the most useful assessment of the potential exposure of an intact newly expressed protein as part of product safety assessment within a WOE approach.	[Wang, Rong; Wang, Yanfei; Edrington, Thomas C.; Liu, Zhenjiu; Lee, Thomas C.; Silvanovich, Andre; Moon, Hong S.; Liu, Zi L.; Li, Bin] Bayer CropSci, Chesterfield, MO 63017 USA	Bayer AG; Bayer CropScience	Wang, R (corresponding author), Bayer CropSci, Chesterfield, MO 63017 USA.	rong.wang@bayer.com	Wang, Yin/HCI-9352-2022; Wang, Yanbo/HFZ-8018-2022; wangwangwang, yuanyaun/HHN-6432-2022; wang, yan/GSE-6489-2022; Wang, Yuan/HHC-1520-2022; Wang, Yu/GZL-9655-2022	Silvanovich, Andre/0000-0002-4932-7448; Wang, Rong/0000-0002-7198-7784				Ahn J, 2013, BBA-PROTEINS PROTEOM, V1834, P1222, DOI 10.1016/j.bbapap.2012.10.003; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; [Anonymous], 2017, CLIN GENITOURIN CANC; ANTONOV VK, 1974, FEBS LETT, V46, P29, DOI 10.1016/0014-5793(74)80327-3; Astwood JD, 1996, NAT BIOTECHNOL, V14, P1269, DOI 10.1038/nbt1096-1269; BALL G, 1994, CLIN EXP ALLERGY, V24, P758, DOI 10.1111/j.1365-2222.1994.tb00987.x; Bogh KL, 2016, CRIT REV FOOD SCI, V56, P1545, DOI 10.1080/10408398.2013.779569; Bougle D, 2017, CRIT REV FOOD SCI, V57, P335, DOI 10.1080/10408398.2013.873766; Boyer JL, 2013, COMPR PHYSIOL, V3, P1035, DOI 10.1002/cphy.c120027; Boys BL, 2007, BIOCHEMISTRY-US, V46, P10675, DOI 10.1021/bi701076q; Brockmeyer J, 2018, J AOAC INT, V101, P124, DOI 10.5740/jaoacint.17-0402; Caminero A, 2016, GASTROENTEROLOGY, V151, P670, DOI 10.1053/j.gastro.2016.06.041; Cocco RR, 2007, CLIN EXP ALLERGY, V37, P831, DOI 10.1111/j.1365-2222.2007.02712.x; Codex Alimentarius Commission, 2003, COD AL COMM 25 SESS, P47; Cong YJ, 2012, J DAIRY SCI, V95, P6307, DOI 10.3168/jds.2012-5543; Cong YJ, 2016, J FOOD SCI, V81, pT2597, DOI 10.1111/1750-3841.13425; Deglaire, 2019, EFSA SUPP PUBL, V16, p1765E; Delaney B, 2008, FOOD CHEM TOXICOL, V46, pS71, DOI 10.1016/j.fct.2008.01.045; FAO/WHO, 2001, REPORT JOINT FAOWHO, P22; Fatien P, 2013, DARK SIDE 2: CRITICAL CASES ON THE DOWNSIDE OF BUSINESS, P1; Fernandez A, 2019, TRENDS BIOTECHNOL; Fu TT, 2002, J AGR FOOD CHEM, V50, P7154, DOI 10.1021/jf020599h; Gundry Rebekah L, 2009, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1025s88; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Herman RA, 2018, REGUL TOXICOL PHARM, V94, P283, DOI 10.1016/j.yrtph.2018.02.016; Hustoft HK, 2012, CRITICAL REV TRYPSIN; Jarvinen KM, 2001, INT ARCH ALLERGY IMM, V126, P111, DOI 10.1159/000049501; KASSERRA HP, 1969, CAN J CHEMISTRY, V47, P4021, DOI 10.1139/v69-668; LEBRAS G, 1991, EUR J BIOCHEM, V198, P683, DOI 10.1111/j.1432-1033.1991.tb16067.x; Luo Q, 2018, FOOD CHEM, V268, P94, DOI 10.1016/j.foodchem.2018.06.042; Macierzanka A, 2012, FOOD CHEM, V134, P2156, DOI 10.1016/j.foodchem.2012.04.018; Mamone G, 2009, J CHROMATOGR A, V1216, P7130, DOI 10.1016/j.chroma.2009.07.052; Mandalari G, 2009, MOL NUTR FOOD RES, V53, pS131, DOI 10.1002/mnfr.200800321; Minekus M, 2014, FOOD FUNCT, V5, P1113, DOI 10.1039/c3fo60702j; Moreno FJ, 2005, J AGR FOOD CHEM, V53, P9810, DOI 10.1021/jf0515227; PIPER DW, 1965, GUT, V6, P506, DOI 10.1136/gut.6.5.506; Rahaman T, 2017, FOOD CHEM, V217, P517, DOI 10.1016/j.foodchem.2016.08.129; Robic S, 2011, PROTEIN J, V30, P539, DOI 10.1007/s10930-011-9360-y; Robinson PK, 2015, ESSAYS BIOCHEM, V59, P1, DOI [10.1042/bse0590001, 10.1042/BSE0590001]; Rodriguez J, 2008, J PROTEOME RES, V7, P300, DOI 10.1021/pr0705035; Sanchez A, 2017, FOOD QUAL SAF-OXFORD, V1, P29, DOI 10.1093/fqsafe/fyx006; SCHMIDT DG, 1995, CLIN EXP ALLERGY, V25, P1007, DOI 10.1111/j.1365-2222.1995.tb00404.x; Schnell Santiago, 2009, Clin Mol Allergy, V7, P1, DOI 10.1186/1476-7961-7-1; Slechtova T, 2015, ANAL CHEM, V87, P7636, DOI 10.1021/acs.analchem.5b00866; Taulier N, 2001, J MOL BIOL, V314, P873, DOI 10.1006/jmbi.2001.5188; Thomas K, 2004, REGUL TOXICOL PHARM, V39, P87, DOI 10.1016/j.yrtph.2003.11.003; Thompson T, 2015, EUR J CLIN NUTR, V69, P143, DOI 10.1038/ejcn.2014.211; TOMPKINS RK, 1980, AM J SURG, V139, P237, DOI 10.1016/0002-9610(80)90262-7; Velusamy V, 2016, EFFECT PH GLUCOSE ST; Verhoeckx K, 2019, FOOD CHEM TOXICOL, V129, P405, DOI 10.1016/j.fct.2019.04.052; Walters D.E., 2002, J MED CHEM, V45, P5607, DOI [10.1021/jm020467f, DOI 10.1021/JM020467F]; Wang R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171926; 2018, REVISTA80DIAS   0202, V8, P30	53	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0233745	10.1371/journal.pone.0233745	http://dx.doi.org/10.1371/journal.pone.0233745			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542029	Green Published, gold			2022-12-26	WOS:000542685100007
J	Hyslop, SR; Alexander, M; Thai, AA; Kersbergen, A; Kueh, AJ; Herold, MJ; Corbin, J; Gangatirkar, P; Ng, AP; Solomon, BJ; Alexander, WS; Sutherland, KD; Josefsson, EC				Hyslop, Stephanie R.; Alexander, Marliese; Thai, Alesha A.; Kersbergen, Ariena; Kueh, Andrew J.; Herold, Marco J.; Corbin, Jason; Gangatirkar, Pradnya; Ng, Ashley P.; Solomon, Benjamin J.; Alexander, Warren S.; Sutherland, Kate D.; Josefsson, Emma C.			Targeting platelets for improved outcome inKRAS-driven lung adenocarcinoma	ONCOGENE			English	Article							CANCER; METASTASIS; THROMBOCYTOSIS; SUPPRESSION; PROGRESSION; TUMORS; CELLS	Elevated platelet count is associated with poor survival in certain solid cancers, including lung cancer. In addition, experimental transplantation of cancer cell lines has uncovered a role for platelets in blood-borne metastasis. These studies, however, do not account for heterogeneity between lung cancer subtypes. Subsequently, the role of platelets in the major subtypes of non-small cell lung cancer (adenocarcinoma (ADC) and squamous cell carcinoma (SqCC)) is not fully understood. We utilised an autochthonousKras(LSL-G12D/+);p53(flox/flox)mouse model of lung ADC together with genetic models of thrombocytopenia to interrogate the role of platelets in lung cancer growth and progression. While thrombocytopenia failed to impact primary tumour growth, in experimental metastatic models however, thrombocytopenic mice displayed significantly extended survival. Utilising a novel thrombocytopenic immunocompromised mouse, the importance of platelets in metastatic dissemination was confirmed with humanKRAS-mutant ADC cell lines. Finally, retrospective analysis of a NSCLC patient cohort revealed thrombocytosis was predictive of poor survival in ADC patients with metastatic disease. Interestingly, this association was not apparent in SqCC patients. Overall, these data highlight the possibility of patient stratification using thrombocytosis as a biomarker, and indicates opportunities for potential novel treatment strategies that combine anti-platelet and lung cancer therapies.	[Hyslop, Stephanie R.; Kersbergen, Ariena; Corbin, Jason; Gangatirkar, Pradnya; Sutherland, Kate D.; Josefsson, Emma C.] Walter & Eliza Hall Inst Med Res, ACRF Canc Biol & Stem Cells Div, Melbourne, Vic, Australia; [Hyslop, Stephanie R.; Kueh, Andrew J.; Herold, Marco J.; Ng, Ashley P.; Alexander, Warren S.; Josefsson, Emma C.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Alexander, Marliese] Univ Melbourne, Peter MacCallum Canc Ctr, Pharm Dept, Parkville, Vic, Australia; [Alexander, Marliese; Solomon, Benjamin J.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia; [Thai, Alesha A.; Solomon, Benjamin J.] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia; [Kueh, Andrew J.; Herold, Marco J.; Ng, Ashley P.; Alexander, Warren S.] Walter & Eliza Hall Inst Med Res, Blood Cells & Blood Canc Div, Melbourne, Vic, Australia	University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center	Josefsson, EC (corresponding author), Walter & Eliza Hall Inst Med Res, ACRF Canc Biol & Stem Cells Div, Melbourne, Vic, Australia.; Josefsson, EC (corresponding author), Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia.	josefsson@wehi.edu.au	Ng, Ashley/D-3842-2011; Josefsson, Emma/CAF-4970-2022; Herold, Marco J/C-8039-2013	Ng, Ashley/0000-0001-9690-0879; Herold, Marco J/0000-0001-7539-7581; Alexander, Marliese/0000-0001-5782-7912; Solomon, Benjamin/0000-0003-3059-5730; Hyslop, Stephanie Rose/0000-0001-5006-1627; Josefsson, Emma/0000-0001-6478-5204	Australian National Health and Medical Research Council [1079250, 1113577, 1122783, 1159658, 1058344, 1156095]; Independent Research Institutes Infrastructure Support Scheme Grant [9000220]; Victorian State Government Operational Infrastructure Support Grant; Lorenzo and Pamela Galli Charitable Trust; Australian Postgraduate Award from the University of Melbourne; Victorian Cancer Agency Mid-Career Fellowship [MCRF18003]; Peter and Julie Alston Centenary Fellowship; Australian Phenomics Network; Leukemia and Lymphoma Society [LLS SCOR 7001-13 MJH]; Australian Government through the National Collaborative Research Infrastructure Strategy program	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Independent Research Institutes Infrastructure Support Scheme Grant; Victorian State Government Operational Infrastructure Support Grant; Lorenzo and Pamela Galli Charitable Trust; Australian Postgraduate Award from the University of Melbourne; Victorian Cancer Agency Mid-Career Fellowship; Peter and Julie Alston Centenary Fellowship; Australian Phenomics Network; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Australian Government through the National Collaborative Research Infrastructure Strategy program(Australian GovernmentDepartment of Industry, Innovation and Science)	We thank Prof Benjamin Kile for generously providing Bcl-x<SUP>Plt20</SUP> mice and A/Prof Marie-Liesse Asselin-Labat for kindly sharing cell lines. We thank Janelle Lochland, Dr Amanda Au, Nicole Lynch, Stephanie Bound, Keti Stoev, Rebekah Meeny and Shannon Oliver for outstanding assistance and Prof Doug Hilton for helpful discussions. Ann Officer facilitated data collection for the Thoracic Malignancies Cohort Study and Him Ahmad assisted with patient pathology data collation. This work was supported by Australian National Health and Medical Research Council Project, Ideas, and Program Grants (1079250 ECJ, 1113577, 1122783 APN, 1186575 MJH, 1159658 MJH), Fellowships (1058344 WSA, 1156095 MJH), an Independent Research Institutes Infrastructure Support Scheme Grant (9000220), and a Victorian State Government Operational Infrastructure Support Grant. ECJ is the recipient of a fellowship from the Lorenzo and Pamela Galli Charitable Trust. SRH is the recipient of an Australian Postgraduate Award from the University of Melbourne. KDS is supported by a Victorian Cancer Agency Mid-Career Fellowship (MCRF18003) and the Peter and Julie Alston Centenary Fellowship. The generation of the NSG Mpl-/-mice was supported by the Australian Phenomics Network, the Leukemia and Lymphoma Society (LLS SCOR 7001-13 MJH), and the Australian Government through the National Collaborative Research Infrastructure Strategy program.	Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Cho MS, 2012, BLOOD, V120, P4869, DOI 10.1182/blood-2012-06-438598; Coenen DM, 2017, BLOOD, V130, P2819, DOI 10.1182/blood-2017-04-780825; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Gay LJ, 2011, CANCER CELL, V20, P553, DOI 10.1016/j.ccr.2011.11.001; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Han R, 2020, MOL ONCOL, V14, P1152, DOI 10.1002/1878-0261.12682; Hu X, 2018, ONCOL LETT, V16, P2715, DOI 10.3892/ol.2018.8956; Hyslop SR, 2017, TRENDS CANCER, V3, P235, DOI 10.1016/j.trecan.2017.01.006; Izaguirre-Avila R, 2002, CLIN APPL THROMB-HEM, V8, P169, DOI 10.1177/107602960200800214; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; JAIN R, 1983, SOUTHERN MED J, V76, P1380, DOI 10.1097/00007611-198311000-00013; Kopp HG, 2009, CANCER RES, V69, P7775, DOI 10.1158/0008-5472.CAN-09-2123; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lebois M, 2016, J THROMB HAEMOST, V14, P1882, DOI 10.1111/jth.13397; LEVIN J, 1964, ARCH INTERN MED, V114, P497, DOI 10.1001/archinte.1964.03860100079008; Lucotti S, 2019, J CLIN INVEST, V129, P1845, DOI 10.1172/JCI121985; Malhotra J, 2017, TRANSL LUNG CANCER R, V6, P196, DOI 10.21037/tlcr.2017.03.01; Mammadova-Bach E, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88245; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; McNeil JJ, 2018, NEW ENGL J MED, V379, P1519, DOI 10.1056/NEJMoa1803955; Michael JV, 2017, BLOOD, V130, P567, DOI 10.1182/blood-2016-11-751099; Miyata K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04324-1; Niki M, 2017, LUNG CANCER-TARGETS, V8, P91, DOI 10.2147/LCTT.S138887; Osmani L, 2018, SEMIN CANCER BIOL, V52, P103, DOI 10.1016/j.semcancer.2017.11.019; Pedersen LM, 1996, EUR RESPIR J, V9, P1826; Plantureux L, 2020, CANCER RES, V80, P291, DOI 10.1158/0008-5472.CAN-19-1181; Pucci F, 2016, CELL REP, V17, P1764, DOI 10.1016/j.celrep.2016.10.031; Rachidi S, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai7911; Riesenberg BP, 2019, J IMMUNOL, V203, P1105, DOI 10.4049/jimmunol.1900594; Roselli M, 2004, CLIN CANCER RES, V10, P610, DOI 10.1158/1078-0432.CCR-0348-03; Roselli M, 2002, INT J BIOL MARKER, V17, P56, DOI 10.1177/172460080201700107; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Schumacher D, 2013, CANCER CELL, V24, P130, DOI 10.1016/j.ccr.2013.05.008; Spiro SG, 2005, CURR OPIN PULM MED, V11, P287, DOI 10.1097/01.mcp.0000166590.03042.56; Takagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073609; Tomita Masaki, 2008, Interact Cardiovasc Thorac Surg, V7, P613, DOI 10.1510/icvts.2007.174391; Wang JJ, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819837261; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Yu LX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6256; Zhang H, 2015, AM J SURG, V210, P526, DOI 10.1016/j.amjsurg.2015.03.022; Zhang X, 2015, INT J CLIN EXP MED, V8, P5379	44	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 16	2020	39	29					5177	5186		10.1038/s41388-020-1357-6	http://dx.doi.org/10.1038/s41388-020-1357-6		JUN 2020	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ML6WO	32535617				2022-12-26	WOS:000539953300001
J	Weldearegay, HG; Kahsay, AB; Medhanyie, AA; Godefay, H; Petrucka, P				Weldearegay, Haftom Gebrehiwot; Kahsay, Alemayehu Bayray; Medhanyie, Araya Abrha; Godefay, Hagos; Petrucka, Pammla			Quality of and barriers to routine childbirth care signal functions in primary level facilities of Tigray, Northern Ethiopia: Mixed method study	PLOS ONE			English	Article							HEALTH; READINESS	Background Efforts to expand access to institutional delivery alone without quality of care do not guarantee better survival. However, little evidence documents the quality of childbirth care in Ethiopia, which limits our ability to improve quality. Therefore, this study assessed the quality of and barriers to routine childbirth care signal functions during intra-partum and immediate postpartum period. Methods A sequential explanatory mixed method study was conducted among 225 skilled birth attendants who attended 876 recently delivered women in primary level facilities. A multi stage sampling procedure was used for the quantitative phase whilst purposive sampling was used for the qualitative phase. The quantitative survey recruitment occurred in July to August 2018 and in April 2019 for the qualitative key informant interview and Focus Group Discussions (FGD). A validated quantitative tool from a previous validated measurement study was used to collect quantitative data, whereas an interview guide, informed by the literature and quantitative findings, was used to collect the qualitative data. Principal component analysis and a series of univariate and multivariate linear regression analysis were used to analyze the quantitative data. For the qualitative data, verbatim review of the data was iteratively followed by content analysis and triangulation with the quantitative results. Results This study showed that one out of five (20.7%, n = 181) mothers received high quality of care in primary level facilities. Primary hospitals (beta = 1.27, 95% CI:0.80,1.84, p = 0.001), facilities which had staff rotation policies (beta = 2.19, 95% CI:0.01,4.31, p = 0.019), maternal involvement in care decisions (beta = 0.92, 95% CI:0.38,1.47, p = 0.001), facilities with maternal and newborn health quality improvement initiatives (beta = 1.58, 95% CI:0.26, 3.43, p = 0.001), compassionate respectful maternity care training (beta = 0.08, 95% CI: 0.07,0.88, p = 0.021), client flow for delivery (beta = 0.19, 95% CI:-0.34, -0.04, p = 0.012), mentorship (beta = 0.02, 95% CI:0.01, 0.78, p = 0.049), and providers' satisfaction (beta = 0.16, 95% CI:0.03, 0.29, p = 0.013) were predictors of quality of care. This is complemented by qualitative research findings that poor quality of care during delivery and immediate postpartum related to: work related burnout, gap between providers' skill and knowledge, lack of enabling working environment, poor motivation scheme and issues related to retention, poor providers caring behavior, unable translate training into practice, mismatch between number of provider and facility client flow for delivery, and in availability of essential medicine and supplies. Conclusions There is poor quality of childbirth care in primary level facilities of Tigray. Primary hospitals, facilities with staff rotation, maternal and newborn health quality improvement initiatives, maternal involvement in care decisions, training on compassionate respectful maternity care, mentorship, and high provider satisfaction were found to have significantly increased quality of care. However, client flow for delivery service is negatively associated with quality of care. Efforts must be made to improve the quality of care through catchment-based mentorship to increase providers' level of adherence to good practices and standards. More attention and thoughtful strategies are required to minimize providers' work-related burnout.	[Weldearegay, Haftom Gebrehiwot; Kahsay, Alemayehu Bayray; Medhanyie, Araya Abrha] Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia; [Godefay, Hagos] Tigray Reg Hlth Bur, Tigray, Ethiopia; [Petrucka, Pammla] Univ Saskatchewan, Coll Nursing, Saskatoon, SK, Canada; [Petrucka, Pammla] Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania	Mekelle University; University of Saskatchewan; Nelson Mandela African Institution of Science & Technology	Weldearegay, HG (corresponding author), Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia.	haftom1224@gmail.com		Petrucka, Pammla/0000-0003-3174-3328; Weldearegay, Haftom/0000-0003-1909-7853	Bill and Melinda Gates foundation; World Health Organization [201526690]	Bill and Melinda Gates foundation(Bill & Melinda Gates Foundation); World Health Organization(World Health Organization)	This study was financially supported by "Tigray KMC Project" which is funded by Bill and Melinda Gates foundation and World Health Organization; Grant Number: 201526690."The funders had no role in study design, data collection 548 and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000907; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2012, LANCET, V379, pP1851; [Anonymous], 2017, J PROSTHET DENT, V11, pe1; [Anonymous], 2018, RECOMMENDATIONS INTR; Baldisserotto ML, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0233-x; Bradley S, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0492-5; Central Statistics Agency Ethiopia, 2016, TD PROGR ICF U ROCKV; Delaney MM, 2017, GLOB HEALTH-SCI PRAC, V5, P217, DOI 10.9745/GHSP-D-16-00410; Delvaux Therese, 2007, Afr J Reprod Health, V11, P22, DOI 10.2307/30032485; Dettrick Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157110; Dewana Z., 2017, J GYNECOL OBSTET, V5, P31, DOI [10.11648/j.jgo.20170502.12, DOI 10.11648/J.JGO.20170502.12, DOI 10.11648/j.jgo.20170502.12]; Dolea C, 2010, B WORLD HEALTH ORGAN, V88, P379, DOI 10.2471/BLT.09.070607; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Enweronu-Laryea C, 2009, RESUSCITATION, V80, P1308, DOI 10.1016/j.resuscitation.2009.08.005; FDRE: Ministry of health, 2015, HLTH SECT TRANSF PLA; Fisseha G, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2184-z; Fogarty L, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-11; Freedman LP, 2014, LANCET, V384, pE42, DOI 10.1016/S0140-6736(14)60859-X; GiftCO AO, 2018, J MIDWIFERY REPROD H, V6, P1356; Haftom G, BMC REPROD HLTH; Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013; Hole MK, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/408689; Kifle MM, 2017, OBSTET GYNECOL INT, V2017, DOI 10.1155/2017/3717408; Kigenyi O, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-162; Larson E, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-483; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Leslie HH, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002464; Leslie HH, 2017, B WORLD HEALTH ORGAN, V95, P738, DOI 10.2471/BLT.17.191916; Leslie HH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002151; Marchant T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126840; Nesbitt RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081089; O'Neill K, 2013, B WORLD HEALTH ORGAN, V91, P923, DOI 10.2471/BLT.12.116798; Owili PO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177756; Peet ED, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211500; Randive B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067452; Saima T, 2018, OPEN PUBLIC HLTH J, V11, P17, DOI [10.2174/1874944501811010017, DOI 10.2174/1874944501811010017]; Sharma J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171236; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Strand H, ACTA P DIATRICA; The Lancet Global Health, 2016, LANCET GLOB HEALTH, V4, pe427; The Lancet Global Health, 2018, LANCET GLOB HEALTH, V6, pE593; Tigray Region, 2017, PLAN FIN BUR ANN REP; Tripathi V, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2281-z; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; WHO, 2010, IT TAK WORKF DENS DO; WHO (World Health Organization), 2015, STRAT END PREV MAT M; Wilunda C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127827; World Health Organization, 2015, SERV PROV ASS SERV A	49	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234318	10.1371/journal.pone.0234318	http://dx.doi.org/10.1371/journal.pone.0234318			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530944	Green Published, gold			2022-12-26	WOS:000542037200005
J	Suarez, P; Ferro, JM; Nagamachi, CY; Cardozo, DE; Blasco-Zuniga, A; Silva, JB; Marciano, E; Costa, MA; Orrico, VGD; Sole, M; Roberto, IJ; Rivera, M; Wiley, JE; Faivovich, J; Baldo, D; Pieczarka, JC				Suarez, Pablo; Ferro, Juan M.; Nagamachi, Cleusa Y.; Cardozo, Dario E.; Blasco-Zuniga, Ailin; Silva, Jessica B.; Marciano-JR, Euvaldo; Costa, Marco A.; Orrico, Victor G. D.; Sole, Mirco; Roberto, Igor J.; Rivera, Miryan; Wiley, John E.; Faivovich, Julian; Baldo, Diego; Pieczarka, Julio C.			Chromosome evolution in Lophyohylini (Amphibia, Anura, Hylinae)	PLOS ONE			English	Article							NUCLEOLUS ORGANIZER REGIONS; REPLICATION BANDING-PATTERNS; TREEFROGS HYLA-CHRYSOSCELIS; CYTOGENETIC ANALYSIS; TELOMERIC SEQUENCE; TREE FROG; HYLIDAE; POLYMORPHISM; LEPTODACTYLIDAE; KARYOTYPES	The hyline tribe Lophyohylini includes 87 species of treefrogs, of which cytogenetics aspects have been studied in less than 20% of them. In order to evaluate the evolution of some of its chromosome characters (NOR position, C-bands, and DAPI/CMA(3)bands), we studied the karyotypes of 21 lophyohylines, 16 of them for the first time, and analyzed them in a phylogenetic context. Most species showed similar karyotypes regarding chromosome number (2n = 24) and morphology (FN = 48), exceptingPhyllodytes edelmoiandOsteocephalus buckleyiwith 2n = 22 (FN = 44) and 2n = 28 (FN = 50), respectively. The NOR location was variable among species and provided valuable phylogenetic information. This marker was located in pair 11 in all species ofTrachycephalus,Itapotihyla langsdorffii, andNyctimantis arapapa, representing the plesiomorphic condition of Lophyohylini. Besides, other apomorphic states were recovered for the clades comprisingN.rugicepsandN.siemersi(NOR in pair 5), andDryaderces pearsoni,Osteocephalus, andOsteopilus(NOR in pair 9).Phyllodytespresented variation for NORs position; they were in pair 2 inP.edelmoi, pair 7 inP.melanomystax, and pair 8 inP.gyrinaethesandP.praeceptor. Polymorphisms in size, number, and activity of this marker were observed forN.siemersi,Osteocephalus fuscifacies, and some species ofTrachycephalus. Remarkably, inN.siemersiNORs were detected on a single chromosome in the two specimens studied by this technique, raising the question of how this complex polymorphism is maintained. Interstitial telomeric sequences were found inP.edelmoi,P.melanomystax, andOsteocephalus buckleyi, and their presence seems to be not related to the chromosome reorganization events. Finally, some species showed spontaneous rearrangements, possibly as a consequence of an uncommon phenomenon in anuran cytogenetics: the presence of fragile sites or secondary constrictions not associated with NORs. We propose that this rare feature would have played an important role in the evolution of this group of frogs. From the evidence obtained in this and previous studies, we conclude that Lophyohylini presents a complex chromosome evolution.	[Suarez, Pablo] UNaM, Inst Biol Subtrop, CONICET, Puerto Iguazu, Misiones, Argentina; [Ferro, Juan M.; Cardozo, Dario E.; Baldo, Diego] Univ Nacl Misiones, Fac Ciencias Exactas Quim & Nat, UNAM, Inst Biol Subtrop,CONICET,Lab Genet Evolut Claudi, Posadas, Misiones, Argentina; [Nagamachi, Cleusa Y.; Silva, Jessica B.; Pieczarka, Julio C.] Univ Fed Para, Inst Ciencias Biol, Lab Citogenet, Ctr Estudos Avancados Biodiversidade, Belem, Para, Brazil; [Blasco-Zuniga, Ailin; Rivera, Miryan] Pontificia Univ Catolica Ecuador, Lab Invest Citogenet & Biomol Anfibios LICBA, Ctr Invest Salud Amer Latina CISeAL, Fac Ciencias Exactas & Nat, Quito, Ecuador; [Marciano-JR, Euvaldo; Costa, Marco A.; Orrico, Victor G. D.; Sole, Mirco] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil; [Marciano-JR, Euvaldo] Ctr Conservacao & Manejo Fauna Caatinga, Petrolina, PE, Brazil; [Roberto, Igor J.] Univ Fed Amazonas, Dept Ciencias Biol, Posgrad Zool, Manaus, Amazonas, Brazil; [Wiley, John E.] East Carolina Univ, Dept Pediat Med Genet, Greenville, NC 27858 USA; [Faivovich, Julian] Consejo Nacl Invest Cient & Tecn, Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Herpetol, Buenos Aires, DF, Argentina; [Faivovich, Julian] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade Federal do Para; Pontificia Universidad Catolica del Ecuador; Universidade Estadual de Santa Cruz; Universidade Federal de Amazonas; University of North Carolina; East Carolina University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); University of Buenos Aires	Ferro, JM; Baldo, D (corresponding author), Univ Nacl Misiones, Fac Ciencias Exactas Quim & Nat, UNAM, Inst Biol Subtrop,CONICET,Lab Genet Evolut Claudi, Posadas, Misiones, Argentina.	ferrojm@gmail.com; diegobaldo@gmail.com	Pieczarka, Julio C/E-7585-2016; Marciano, Euvaldo/O-4817-2019; Costa, Marco A/H-8035-2015; Solé, Mirco/A-9722-2008; Nagamachi, Cleusa/AAV-8985-2021; Roberto, Igor Joventino/M-2785-2013; Orrico, Victor/G-9796-2012	Pieczarka, Julio C/0000-0003-2951-8877; Marciano, Euvaldo/0000-0002-7647-2480; Solé, Mirco/0000-0001-7881-6227; Cardozo, Dario/0000-0003-0612-2458; RIVERA, MIRYAN/0000-0002-9944-7130; Orrico, Victor/0000-0002-4560-4006; Blasco, Ailin/0000-0002-7318-2795	Universidad Nacional de Misiones [16Q001-TI]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICTs 2013-404, 2015-820, 20152381, PICT 2018-3349]; Banco Nacional de Desenvolvimento Economico e Social -BNDES [Operacao 2.318.697.0001]; Research Directory of the Pontificia Universidad Catolica del Ecuador project [QINV0046 -IINV529010100]; Fundacao de Amparo a Pesquisa da Bahia FAPESB [8952/2014]; Fundacao de Amparo a Pesquisa e Inovacao do Espirito Santo -FAPES [78252482]; Rede Baiana de Pesquisas sobre Anfibios; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [001, 88882.156872/2016-01]	Universidad Nacional de Misiones; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Banco Nacional de Desenvolvimento Economico e Social -BNDES; Research Directory of the Pontificia Universidad Catolica del Ecuador project; Fundacao de Amparo a Pesquisa da Bahia FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Fundacao de Amparo a Pesquisa e Inovacao do Espirito Santo -FAPES; Rede Baiana de Pesquisas sobre Anfibios; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	JMF is grateful to the Universidad Nacional de Misiones (16Q001-TI). DB and JF thanks Agencia Nacional de Promocion Cientifica y Tecnologica (PICTs 2013-404, 2015-820, 20152381, PICT 2018-3349). CYN and JCP aknowledge Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Fundacao Amazonia Paraense de Amparo a Pesquisa (FAPESPA) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) on projects coordinated by CY Nagamachi (Edital BIONORTE-CNPq, Proc 552032/2010-7; Edital BIONORTE-FAPESPA, ICAAF 007/2011; Edital Pro-Amazonia Proc 047/2012); the FAPESPA (Edital Vale -Proc 2010/110447) and Banco Nacional de Desenvolvimento Economico e Social -BNDES (Operacao 2.318.697.0001) on a project coordinated by JC Pieczarka. ABZ y MR appreciate the partial financing of this research by Research Directory of the Pontificia Universidad Catolica del Ecuador project code QINV0046 -IINV529010100. EMJ thanks Fundacao de Amparo a Pesquisa da Bahia FAPESB (#8952/2014) for the doctoral grant, Fundacao de Amparo a Pesquisa e Inovacao do Espirito Santo -FAPES (Processo 78252482) for post doctoral Grant and Rede Baiana de Pesquisas sobre Anfibios for partially funding this project. IJR thanks Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)Finance code 001 doctoral fellowship (88882.156872/2016-01). VGDO was supported with a CNPq fellow (#310467/2017-9)	Anderson Karen, 1996, Contributions to Herpetology, V12, P157; Silva AEBE, 2010, BIOTECH HISTOCHEM, V85, P115, DOI [10.3109/10520290903149596, 10.1080/10520290903149596]; Barth A, 2009, J HERPETOL, V43, P676, DOI 10.1670/08-210.1; Berneck BVM, 2016, MOL PHYLOGENET EVOL, V97, P213, DOI 10.1016/j.ympev.2015.11.014; Blotto BL, 2021, CLADISTICS, V37, P36, DOI 10.1111/cla.12409; Bogart JP, 1973, EVOLUTIONARY BIOL AN, P337; Busin CS, 2006, MICRON, V37, P355, DOI 10.1016/j.micron.2005.11.009; Cardozo DE, 2011, COPEIA, P251, DOI 10.1643/CH-09-105; Carvalho KA, 2009, CYTOGENET GENOME RES, V126, P359, DOI 10.1159/000264179; Catroli GF, 2011, J HERPETOL, V45, P120, DOI 10.1670/09-249.1; Cesar C, 2008, CARYOLOGIA, V61, P10, DOI 10.1080/00087114.2008.10589605; Cole C.J., 1974, American Museum Novitates, VNo. 2541, P1; Duellman WE, 2016, ZOOTAXA, V4104, P1, DOI 10.11646/zootaxa.4104.1.1; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Faivovich J, 2005, B AM MUSEUM NAT HIST, P294; Faivovich J, 2018, S AM J HERPETOL, V13, P1, DOI 10.2994/SAJH-D-17-00115.1; FEITOSA VLC, 1995, REV BRAS GENET, V18, P191; Ferro JM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192861; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Frost DR., 2019, AMPHIBIAN SPECIES WO; Gazoni T, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-109; Goloboff P, 2008, CLADISTICS, V24, P91; Green D. M, 1991, AMPHIBIAN CYTOGENETI, P431, DOI [DOI 10.1016/B978-0-12-297880-7.50021-4, 10.1016/B978-0-12-297880-7.50021-4]; Gruber SL, 2007, GENETICA, V130, P281, DOI 10.1007/s10709-006-9105-6; Gruber SL, 2017, COMP CYTOGENET, V11, P267, DOI 10.3897/CompCytogen.v11i2.11524; Gruber SL, 2012, COMP CYTOGENET, V6, P409, DOI 10.3897/CompCytogen.v6i4.3945; Gruber SL, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-28; Gruber SL, 2005, FOLIA BIOL-PRAGUE, V51, P68; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; Jetz W, 2018, NAT ECOL EVOL, V2, P850, DOI 10.1038/s41559-018-0515-5; Jowers MJ, 2008, STUD NEOTROP FAUNA E, V43, P181, DOI 10.1080/01650520801965490; Jungfer KH, 2013, ZOOL SCR, V42, P351, DOI 10.1111/zsc.12015; Kasahara S, 2003, CYTOGENET GENOME RES, V103, P155, DOI 10.1159/000076304; Kasahara S, 1998, GENET MOL BIOL, V21, P471, DOI 10.1590/S1415-47571998000400011; Lourenco LB, 2000, HEREDITAS, V133, P201, DOI 10.1111/j.1601-5223.2000.00201.x; Lourenco LB, 1998, CHROMOSOME RES, V6, P621, DOI 10.1023/A:1009253410553; Medeiros LR, 2003, J HERED, V94, P149, DOI 10.1093/jhered/esg019; MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283; MILANI M, 2011, ANIM BIOL, V2, P21; MIURA I, 1995, CHROMOSOMA, V103, P567, DOI 10.1007/BF00355322; Moen DS, 2009, EVOLUTION, V63, P195, DOI 10.1111/j.1558-5646.2008.00538.x; Morand M., 1996, FACENA, V12, P141; Nunes Rosana R.A., 2008, Boletim do Museu de Biologia Mello Leitao, V23, P21; Peixoto MAA, 2016, COMP CYTOGENET, V10, P505, DOI 10.3897/CompCytogen.v10i4.9176; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Pyron RA, 2014, SYST BIOL, V63, P779, DOI 10.1093/sysbio/syu042; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Reeves A, 2000, MICROMEASURE VERSION; Rovatsos MT, 2011, CHROMOSOME RES, V19, P869, DOI 10.1007/s10577-011-9242-3; SCHEMPP W, 1981, CHROMOSOMA, V83, P697, DOI 10.1007/BF00328528; Schmid M., 2012, Cytogenetic and Genome Research, V138, P69, DOI 10.1159/000343460; Schmid M., 2010, Cytogenetic and Genome Research, V130-131, P1, DOI 10.1159/000301339; SCHMID M, 1995, CYTOGENET CELL GENET, V69, P18, DOI 10.1159/000133929; SCHMID M, 1978, CHROMOSOMA, V66, P361, DOI 10.1007/BF00328536; SCHMID M, 1982, CHROMOSOMA, V87, P327, DOI 10.1007/BF00327634; Schmid Michael, 2018, Cytogenetic and Genome Research, V155, P1; Schmid M, 2016, CYTOGENET GENOME RES, V148, P211, DOI 10.1159/000446298; Schweizer D, 1994, Methods Mol Biol, V29, P97; Silva APZ, 1999, HEREDITAS, V131, P135, DOI 10.1111/j.1601-5223.1999.00135.x; Suarez P, 2013, CYTOGENET GENOME RES, V141, P295, DOI 10.1159/000354997; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Veiga-Menoncello ACP, 2003, HEREDITAS, V139, P189; White MJD, 1954, ANIMAL CYTOLOGY EVOL; Wiens JJ, 2010, MOL PHYLOGENET EVOL, V55, P871, DOI 10.1016/j.ympev.2010.03.013; Wiley JE, 2003, CYTOGENET GENOME RES, V101, P80, DOI 10.1159/000073422; WILEY JE, 1989, CHROMOSOMA, V97, P481, DOI 10.1007/BF00295033; Wiley JE, 2000, CYTOGENET CELL GENET, V88, P11, DOI 10.1159/000015475; Silva APZ, 2006, GENETICA, V127, P35, DOI 10.1007/s10709-005-2450-z	68	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234331	10.1371/journal.pone.0234331	http://dx.doi.org/10.1371/journal.pone.0234331			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525943	gold, Green Published			2022-12-26	WOS:000542036800065
J	McQuail, J; Switzer, A; Burchell, L; Wigneshweraraj, S				McQuail, Josh; Switzer, Amy; Burchell, Lynn; Wigneshweraraj, Sivaramesh			The RNA-binding protein Hfq assembles into foci-like structures in nitrogen starvedEscherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hfq protein; Escherichia coli (E; coli); photoactivatable localization microscopy (PALM); nitrogen starvation; T7 phage; environmental adaptation; RNA chaperone; gene expression; small regulatory RNA (sRNA); stress response; bacteriophage; gene regulation	ESCHERICHIA-COLI; STRESS-RESPONSE; DEGRADATION; RPOS; ORGANIZATION; POLYMERASE; STARVATION; MOLECULES; INSIGHTS; REVEALS	The initial adaptive responses to nutrient depletion in bacteria often occur at the level of gene expression. Hfq is an RNA-binding protein present in diverse bacterial lineages that contributes to many different aspects of RNA metabolism during gene expression. Using photoactivated localization microscopy and single-molecule tracking, we demonstrate that Hfq forms a distinct and reversible focus-like structure inEscherichia colispecifically experiencing long-term nitrogen starvation. Using the ability of T7 phage to replicate in nitrogen-starved bacteria as a biological probe ofE. colicell function during nitrogen starvation, we demonstrate that Hfq foci have a role in the adaptive response ofE. colito long-term nitrogen starvation. We further show that Hfq foci formation does not depend on gene expression once nitrogen starvation has set in and occurs indepen-dently of the transcription factor N-regulatory protein C, which activates the initial adaptive response to N starvation inE. coli. These results serve as a paradigm to demonstrate that bacterial adaptation to long-term nutrient starvation can be spatiotemporally coordinated and can occur independently ofde novogene expression during starvation.	[McQuail, Josh; Switzer, Amy; Burchell, Lynn; Wigneshweraraj, Sivaramesh] Imperial Coll London, MRC, Ctr Mol Bacteriol & Infect, London, England	Imperial College London	Wigneshweraraj, S (corresponding author), Imperial Coll London, MRC, Ctr Mol Bacteriol & Infect, London, England.	s.r.wig@imperial.ac.uk	Switzer, Amy/AEP-0843-2022	Wigneshweraraj, Sivaramesh/0000-0002-1418-4029; McQuail, Josh/0000-0003-1327-5495	Wellcome Trust Investigator Award [100958]; Medical Research Council Ph.D. studentship; MRC [MR/P028225/1] Funding Source: UKRI	Wellcome Trust Investigator Award(Wellcome Trust); Medical Research Council Ph.D. studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Investigator Award 100958 (to S. W.) and a Medical Research Council Ph.D. studentship (to J. M.).	Al-Husini N, 2020, MOL CELL, V78, P670, DOI 10.1016/j.molcel.2020.04.001; Al-Husini N, 2018, MOL CELL, V71, P1027, DOI 10.1016/j.molcel.2018.08.003; Amin SV, 2016, RNA BIOL, V13, P331, DOI 10.1080/15476286.2016.1144010; Andrade JM, 2018, EMBO J, V37, DOI 10.15252/embj.201797631; Andrade JM, 2012, RNA, V18, P844, DOI 10.1261/rna.029413.111; [Anonymous], 2010, HDB MICROBIOLOGICAL, DOI DOI 10.1201/EBK1439804063; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Balasubramanian D, 2013, RNA BIOL, V10, P337, DOI 10.4161/rna.23696; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Bren A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24834; Brown DR, 2014, MICROB CELL, V1, P315, DOI 10.15698/mic2014.09.168; Brown DR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5115; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Desnoyers G, 2013, TRENDS GENET, V29, P92, DOI 10.1016/j.tig.2012.10.004; Endesfelder U, 2013, BIOPHYS J, V105, P172, DOI 10.1016/j.bpj.2013.05.048; Figueira R, 2015, SCI REP-UK, V5, DOI 10.1038/srep17524; Fortas E, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140128; Gerrick ER, 2018, P NATL ACAD SCI USA, V115, P6464, DOI 10.1073/pnas.1718003115; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Gyaneshwar P, 2005, J BACTERIOL, V187, P1074, DOI 10.1128/JB.187.3.1074-1090.2005; Holmqvist E, 2018, MOL CELL, V70, P971, DOI 10.1016/j.molcel.2018.04.017; Holmqvist E, 2017, BIOCHEM SOC T, V45, P1203, DOI 10.1042/BST20160363; Iyer S, 2018, NAT MICROBIOL, V3, P741, DOI 10.1038/s41564-018-0161-3; Kannaiah S, 2019, MOL CELL, V76, P574, DOI 10.1016/j.molcel.2019.08.013; Kwenda S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2376-0; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Le Derout J, 2003, NUCLEIC ACIDS RES, V31, P4017, DOI 10.1093/nar/gkg456; Lee T, 2008, RNA, V14, P514, DOI 10.1261/rna.531408; Luo Y, 2018, BIOCHEMISTRY-US, V57, P2424, DOI 10.1021/acs.biochem.7b01162; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Majdalani N, 2001, MOL MICROBIOL, V39, P1382, DOI 10.1111/j.1365-2958.2001.02329.x; Mohanty BK, 2004, MOL MICROBIOL, V54, P905, DOI 10.1111/j.1365-2958.2004.04337.x; Mohd-Padil H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17356-4; Moll I, 2003, EMBO REP, V4, P284, DOI 10.1038/sj.embor.embor772; Panja S, 2015, J MOL BIOL, V427, P3491, DOI 10.1016/j.jmb.2015.07.010; Park S., 2020, DYNAMIC INTERACTIONS, DOI [10.1101/2020.01.13.903641, DOI 10.1101/2020.01.13.903641]; Persson F, 2013, NAT METHODS, V10, P265, DOI [10.1038/NMETH.2367, 10.1038/nmeth.2367]; Robledo M, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8030384; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schumacher J, 2013, MBIO, V4, DOI 10.1128/mBio.00881-13; Smirnov A, 2016, P NATL ACAD SCI USA, V113, P11591, DOI 10.1073/pnas.1609981113; Sonnleitner E, 2004, BIOCHEM BIOPH RES CO, V323, P1017, DOI 10.1016/j.bbrc.2004.08.190; Soper T, 2010, P NATL ACAD SCI USA, V107, P9602, DOI 10.1073/pnas.1004435107; Standart N, 2018, TRENDS GENET, V34, P612, DOI 10.1016/j.tig.2018.05.005; Stracy M, 2015, P NATL ACAD SCI USA, V112, pE4390, DOI 10.1073/pnas.1507592112; Switzer A, 2018, BIOCHEM SOC T, V46, P1721, DOI 10.1042/BST20180502; Tabib-Salazar A, 2018, P NATL ACAD SCI USA, V115, pE5353, DOI 10.1073/pnas.1800429115; Taghbalout A, 2014, BIOCHEM J, V458, P11, DOI 10.1042/BJ20131287; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; van Leeuwen W, 2019, TRAFFIC, V20, P623, DOI 10.1111/tra.12669; Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Westermann AJ, 2019, MBIO, V10, DOI 10.1128/mBio.02504-18; YIN J, 1993, J BACTERIOL, V175, P1272, DOI 10.1128/JB.175.5.1272-1277.1993; Zhang AX, 2013, J MOL BIOL, V425, P3678, DOI 10.1016/j.jmb.2013.01.006; Zimmer DP, 2000, P NATL ACAD SCI USA, V97, P14674, DOI 10.1073/pnas.97.26.14674	57	11	11	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2020	295	35					12355	12367		10.1074/jbc.RA120.014107	http://dx.doi.org/10.1074/jbc.RA120.014107			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NL7DH	32532816	hybrid, Green Published			2022-12-26	WOS:000567571100004
J	Abdisalaam, S; Bhattacharya, S; Mukherjee, S; Sinha, D; Srinivasan, K; Zhu, MR; Akbay, EA; Sadek, HA; Shay, JW; Asaithamby, A				Abdisalaam, Salim; Bhattacharya, Souparno; Mukherjee, Shibani; Sinha, Debapriya; Srinivasan, Kalayarasan; Zhu, Mingrui; Akbay, Esra A.; Sadek, Hesham A.; Shay, Jerry W.; Asaithamby, Aroumougame			Dysfunctional telomeres trigger cellular senescence mediated by cyclic GMP-AMP synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic GMP-AMP synthase (cGAS); micronuclei; genome maintenance; DNA damage; senescence; telomere; CRISPR; Cas; DNA damage response; chromatin; cyclic GMP-AMP synthase (cGAS); genome maintenance; micronuclei	DNA-DAMAGE; CHROMOSOME BREAKAGE; MOLECULAR-DYNAMICS; HUMAN-CELLS; CGAS; INFLAMMATION; REVEALS; CANCER	Defective DNA damage response (DDR) signaling is a common mechanism that initiates and maintains the cellular senescence phenotype. Dysfunctional telomeres activate DDR signaling, genomic instability, and cellular senescence, but the links among these events remains unclear. Here, using an array of biochemical and imaging techniques, including a highly regulatable CRISPR/Cas9 strategy to induce DNA double strand breaks specifically in the telomeres, ChIP, telomere immunofluorescence, fluorescencein situhybridization (FISH), micronuclei imaging, and the telomere shortest length assay (TeSLA), we show that chromosome mis-segregation due to imperfect DDR signaling in response to dysfunctional telomeres creates a preponderance of chromatin fragments in the cytosol, which leads to a premature senescence phenotype. We found that this phenomenon is caused not by telomere shortening, but by cyclic GMP-AMP synthase (cGAS) recognizing cytosolic chromatin fragments and then activating the stimulator of interferon genes (STING) cytosolic DNA-sensing pathway and downstream interferon signaling. Significantly, genetic and pharmacological manipulation of cGAS not only attenuated immune signaling, but also prevented premature cellular senescence in response to dysfunctional telomeres. The findings of our study uncover a cellular intrinsic mechanism involving the cGAS-mediated cytosolic self-DNA-sensing pathway that initiates premature senescence independently of telomere shortening.	[Abdisalaam, Salim; Bhattacharya, Souparno; Mukherjee, Shibani; Sinha, Debapriya; Srinivasan, Kalayarasan; Asaithamby, Aroumougame] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Zhu, Mingrui; Akbay, Esra A.] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Sadek, Hesham A.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Shay, Jerry W.] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Asaithamby, A (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	Asaithamby.Aroumougame@UTSouthwestern.edu		Akbay, Esra/0000-0002-4149-2529; Aroumougame, Asaithamby/0000-0001-5195-4224; bhattacharya, souparno/0000-0002-8681-6363; Shay, Jerry W./0000-0001-5052-0627	National Institutes of Health [R01AG053341, R01HL115275]; Cancer Prevention and Research Institute of Texas Grants [RP190435]; NCI SPORE [P50CA70907]; NIH [C06RR30414]; NCI [P30CA142543]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas Grants; NCI SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01AG053341 (to A. A.) and R01HL115275 (to H. A. S.) and Cancer Prevention and Research Institute of Texas Grants RP190435 (to A. A. and H. A. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. J. W. S. is supported by NCI SPORE P50CA70907, NIH grant C06RR30414, and NCI P30CA142543. J.W.S. holds the Southland Financial Corporation Distinguished Chair in Geriatrics Research.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Asaithamby A, 2011, P NATL ACAD SCI USA, V108, P8293, DOI 10.1073/pnas.1016045108; Asaithamby A, 2009, NUCLEIC ACIDS RES, V37, P3912, DOI 10.1093/nar/gkp237; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bartsch K, 2017, HUM MOL GENET, V26, P3960, DOI 10.1093/hmg/ddx283; Brooke S, 2004, EXP CELL RES, V298, P549, DOI 10.1016/j.yexcr.2004.04.035; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen YA, 2017, NAT STRUCT MOL BIOL, V24, P1124, DOI 10.1038/nsmb.3498; Cho NW, 2014, CELL, V159, P108, DOI 10.1016/j.cell.2014.08.030; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Csaszar K, 2001, J MOL BIOL, V313, P1073, DOI 10.1006/jmbi.2001.5100; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Denchi EL, 2009, DNA REPAIR, V8, P1118, DOI 10.1016/j.dnarep.2009.04.013; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Fumagalli M, 2009, NAT CELL BIOL, V11, P921, DOI 10.1038/ncb0809-921; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kranzusch PJ, 2013, IMMUNITY, V39, P992, DOI 10.1016/j.immuni.2013.11.012; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kwon Munjin, 2013, Methods Mol Biol, V1018, P107, DOI 10.1007/978-1-62703-444-9_10; Lai TP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01291-z; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Mehta A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016428; Mender I, 2018, NEOPLASIA, V20, P826, DOI 10.1016/j.neo.2018.06.002; Mender I, 2015, CANCER DISCOV, V5, P82, DOI 10.1158/2159-8290.CD-14-0609; Miller D, 2011, DNA REPAIR, V10, P536, DOI 10.1016/j.dnarep.2011.03.001; Millrine D, 2016, P NATL ACAD SCI USA, V113, P10625, DOI 10.1073/pnas.1611751113; Nassour J, 2019, NATURE, V565, P659, DOI 10.1038/s41586-019-0885-0; Sengupta S, 2018, MOL CANCER THER, V17, P1504, DOI 10.1158/1535-7163.MCT-17-0792; SHERWOOD SW, 1988, P NATL ACAD SCI USA, V85, P9086, DOI 10.1073/pnas.85.23.9086; Silva BA, 2014, J BIOL CHEM, V289, P22771, DOI 10.1074/jbc.M113.535955; Stefl R, 2001, BIOPHYS J, V80, P455, DOI 10.1016/S0006-3495(01)76028-6; Su FT, 2014, CELL REP, V9, P1387, DOI 10.1016/j.celrep.2014.10.025; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun LX, 2015, NUCLEIC ACIDS RES, V43, P6334, DOI 10.1093/nar/gkv598; Terzoudi GI, 2005, CANCER RES, V65, P11292, DOI 10.1158/0008-5472.CAN-05-2148; Umbreit NT, 2017, NATURE, V550, P340, DOI 10.1038/nature24146; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vincent J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01770-3; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003	54	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11144	11160		10.1074/jbc.RA120.012962	http://dx.doi.org/10.1074/jbc.RA120.012962			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32540968	Green Published, hybrid			2022-12-26	WOS:000562757100019
J	Sevillano, V; Holt, K; Aznarte, JL				Sevillano, Victor; Holt, Katherine; Aznarte, Jose L.			Precise automatic classification of 46 different pollen types with convolutional neural networks	PLOS ONE			English	Article							PALYNOLOGY; SYSTEM; DISCRIMINATION; IDENTIFICATION	In palynology, the visual classification of pollen grains from different species is a hard task which is usually tackled by human operators using microscopes. Many industries, including medical and pharmaceutical, rely on the accuracy of this manual classification process, which is reported to be around 67%. In this paper, we propose a new method to automatically classify pollen grains using deep learning techniques that improve the correct classification rates in images not previously seen by the models. Our proposal manages to properly classify up to 98% of the examples from a dataset with 46 different classes of pollen grains, produced by the Classifynder classification system. This is an unprecedented result which surpasses all previous attempts both in accuracy and number and difficulty of taxa under consideration, which include types previously considered as indistinguishable.	[Sevillano, Victor; Aznarte, Jose L.] Univ Nacl Educ Distancia, Dept Artificial Intelligence, Madrid, Spain; [Holt, Katherine] Massey Univ, Inst Nat Resources, Palmerston North, New Zealand	Universidad Nacional de Educacion a Distancia (UNED); Massey University	Aznarte, JL (corresponding author), Univ Nacl Educ Distancia, Dept Artificial Intelligence, Madrid, Spain.	jlaznarte@dia.uned.es	Aznarte, Jose L./B-3372-2015	Aznarte, Jose L./0000-0002-1636-244X				[Anonymous], 2014, PEERJ, V2, pe447; [Anonymous], 2004, DVM NEWSMAGAZINE VET, V35, p16S; Bogota-A RG, 2011, QUATERNARY SCI REV, V30, P3321, DOI 10.1016/j.quascirev.2011.08.003; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; Daood Amar, 2016, Advances in Visual Computing. 12th International Symposium, ISVC 2016. Proceedings: LNCS 10072, P321, DOI 10.1007/978-3-319-50835-1_30; Daood A., 2018, 31 INT FLAIRS C; Daood A, 2016, INT C PATT RECOG, P3091, DOI 10.1109/ICPR.2016.7900109; Dell'Anna R, 2009, ANAL BIOANAL CHEM, V394, P1443, DOI 10.1007/s00216-009-2794-9; Dhawale VR, 2013, 2013 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P79, DOI 10.1109/ICACCI.2013.6637150; ERDTMAN G., 1960, SVENSK BOT TIDSKR, V54, P561; Flantua SGA, 2016, CLIM PAST, V12, P483, DOI 10.5194/cp-12-483-2016; Flenley J. R., 1968, PROBLEMS PICTURE INT, P141; Goncalves AB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157044; Holt K, 2011, REV PALAEOBOT PALYNO, V167, P175, DOI 10.1016/j.revpalbo.2011.08.006; Holt KA, 2014, NEW PHYTOL, V203, P735, DOI 10.1111/nph.12848; Ivleva NP, 2005, ANAL BIOANAL CHEM, V381, P261, DOI 10.1007/s00216-004-2942-1; Kaya Y, 2013, REV PALAEOBOT PALYNO, V189, P50, DOI 10.1016/j.revpalbo.2012.11.004; Khanzhina N, 2018, ESANN; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Lagerstrom R, 2015, ADV EXP MED BIOL, V823, P207, DOI 10.1007/978-3-319-10984-8_12; Lagerstrom R, 2013, AIP CONF PROC, V1559, P250, DOI 10.1063/1.4825017; Li P, 2004, J QUATERNARY SCI, V19, P755, DOI 10.1002/jqs.874; Menad Hanane, 2019, JOURNEE ETUDE RECHER; Mildenhall DC, 2006, FORENSIC SCI INT, V163, P163, DOI 10.1016/j.forsciint.2006.07.012; Mitsumoto K, 2009, J BIOSCI BIOENG, V107, P90, DOI 10.1016/j.jbiosc.2008.10.001; Moar N.T., 1994, POLLEN GRAINS NZ DIC; Odgaard BV, 1999, J BIOGEOGR, V26, P7, DOI 10.1046/j.1365-2699.1999.00280.x; Sevillano V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201807; Stillman EC, 1996, QUATERNARY SCI REV, V15, P1, DOI 10.1016/0277-3791(95)00076-3; Ticay-Rivas JR, 2011, IFIP ADV INF COMM TE, V364, P342; Treloar WJ, 2004, J QUATERNARY SCI, V19, P745, DOI 10.1002/jqs.871; Marcos JV, 2015, MICRON, V68, P36, DOI 10.1016/j.micron.2014.09.002; 2017, COLORECTAL DIS, V19, pE152	33	31	33	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0229751	10.1371/journal.pone.0229751	http://dx.doi.org/10.1371/journal.pone.0229751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574174	Green Submitted, Green Published, gold			2022-12-26	WOS:000544972400004
J	Tarrahimofrad, H; Meimandipour, A; Arjmand, S; Nassiri, MB; Jahangirian, E; Tavana, H; Zamani, J; Rahimnahal, S; Aminzadeh, S				Tarrahimofrad, Hossein; Meimandipour, Amir; Arjmand, Sareh; Beigi Nassiri, Mohammadtaghi; Jahangirian, Ehsan; Tavana, Hossein; Zamani, Javad; Rahimnahal, Somayyeh; Aminzadeh, Saeed			Structural and biochemical characterization of a novel thermophilic Coh01147 protease	PLOS ONE			English	Article							ALKALINE PROTEASE; BACILLUS-STEAROTHERMOPHILUS; THERMODYNAMIC PROPERTIES; CYSTEINE PROTEASE; STEP PURIFICATION; ESCHERICHIA-COLI; STABLE PROTEASE; SERINE-PROTEASE; FLUORESCENCE; STABILITY	Proteases play an essential role in living organisms and represent one of the largest groups of industrial enzymes. The aim of this work was recombinant production and characterization of a newly identified thermostable protease 1147 from thermophilum indigenous Cohnella sp. A01. Phylogenetic tree analysis showed that protease 1147 is closely related to the cysteine proteases from DJ-1/ThiJ/PfpI superfamily, with the conserved catalytic tetrad. Structural prediction using MODELLER 9v7 indicated that protease 1147 has an overall alpha/beta sandwich tertiary structure. The gene of protease 1147 was cloned and expressed in Escherichia coli (E. coli) BL21. The recombinant protease 1147 appeared as a homogenous band of 18 kDa in SDS-PAGE, which was verified by western blot and zymography. The recombinant protein was purified with a yield of approximately 88% in a single step using Ni-NTA affinity chromatography. Furthermore, a rapid one-step thermal shock procedure was successfully implemented to purify the protein with a yield of 73%. Using casein as the substrate, K-m, and k(cat), k(ca)t/K(m)values of 13.72 mM, 3.143 x 10(-3)(s(-1)), and 0.381 (M-1S-1) were obtained, respectively. The maximum protease activity was detected at pH = 7 and 60 degrees C with the inactivation rate constant (kin) of 2.10 x 10-3 (m(-1)), and half-life (t(1/2)) of 330.07 min. Protease 1147 exhibited excellent stability to organic solvent, metal ions, and 1% SDS. The protease activity was significantly enhanced by Tween 20 and Tween 80 and suppressed by cysteine protease specific inhibitors. Docking results and molecular dynamics (MD) simulation revealed that Tween 20 interacted with protease 1147 via hydrogen bonds and made the structure more stable. CD and fluorescence spectra indicated structural changes taking place at 100 degrees C, very basic and acidic pH, and in the presence of Tween 20. These properties make this newly characterized protease a potential candidate for various biotechnological applications.	[Tarrahimofrad, Hossein; Meimandipour, Amir; Jahangirian, Ehsan; Zamani, Javad; Rahimnahal, Somayyeh; Aminzadeh, Saeed] Natl Inst Genet Engn & Biotechnol NIGEB, Inst Ind & Environm Biotechnol, Bioproc Engn Grp, Tehran, Iran; [Tarrahimofrad, Hossein; Beigi Nassiri, Mohammadtaghi; Rahimnahal, Somayyeh] Agr Sci & Nat Resources Univ Khouzestan, Dept Anim Sci & Food Technol, Ahvaz, Iran; [Arjmand, Sareh] Shahid Beheshti Univ, Prot Res Ctr, GC, Tehran, Iran; [Tavana, Hossein] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA	Shahid Beheshti University; University System of Ohio; University of Akron	Aminzadeh, S (corresponding author), Natl Inst Genet Engn & Biotechnol NIGEB, Inst Ind & Environm Biotechnol, Bioproc Engn Grp, Tehran, Iran.	aminzade@nigeb.ac.ir	Jahangirian, Ehsan/AAV-5954-2021	Jahangirian, Ehsan/0000-0002-9982-7846	National Institute of Genetic Engineering and Biotechnology (NIGEB) [971215-I-712]	National Institute of Genetic Engineering and Biotechnology (NIGEB)	Yes Saeed Aminzadeh, National Institute of Genetic Engineering and Biotechnology (NIGEB) grant number 971215-I-712; The authors would like to thank the National Institute of Genetic Engineering and Biotechnology (NIGEB) for providing the research facility by grant number 971215-I-712.	Abdel-Naby MA, 2017, INT J BIOL MACROMOL, V96, P265, DOI 10.1016/j.ijbiomac.2016.11.094; Ahmed SA, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01674; Aliabadi N, 2016, BRAZ J MICROBIOL, V47, P931, DOI 10.1016/j.bjm.2016.07.009; Amid M, 2014, BIOMED RES INT, P2014; [Anonymous], 2008, AM J TRANSPLANT, V8, P57; [Anonymous], 2017, CRIT CARE NURSE, V37, pe19; Benmrad MO, 2016, INT J BIOL MACROMOL, V91, P961, DOI 10.1016/j.ijbiomac.2016.06.025; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Lopez-Rodriguez JC, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101256; Chittoor JT, 2016, IRAN J BIOTECHNOL, V14, P23, DOI 10.15171/ijb.1269; Correcirc DH, 2009, J BIOCH, V3, P164, DOI DOI 10.1038/NPR0T.2006.204; D'Amico S, 2003, J BIOL CHEM, V278, P7891, DOI 10.1074/jbc.M212508200; Dhanavade MJ, 2013, COMPUT BIOL MED, V43, P2063, DOI 10.1016/j.compbiomed.2013.09.021; Doddapaneni KK, 2009, MICROBIOL RES, V164, P383, DOI 10.1016/j.micres.2007.04.005; Aguilar JGD, 2018, FOOD RES INT, V103, P253, DOI 10.1016/j.foodres.2017.10.044; Foukis A, 2012, BIORESOURCE TECHNOL, V123, P214, DOI 10.1016/j.biortech.2012.06.090; Fu ZB, 2003, PROTEIN EXPRES PURIF, V28, P63, DOI 10.1016/S1046-5928(02)00637-X; GARCIACARRENO FL, 1993, ANAL BIOCHEM, V214, P65, DOI 10.1006/abio.1993.1457; Garidel P, 2009, BIOPHYS CHEM, V143, P70, DOI 10.1016/j.bpc.2009.04.004; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gohel SD, 2015, INT J BIOL MACROMOL, V72, P421, DOI 10.1016/j.ijbiomac.2014.08.008; Gohel SD, 2013, INT J BIOL MACROMOL, V56, P20, DOI 10.1016/j.ijbiomac.2013.01.028; Golaki BP, 2015, PROTEIN J, V34, P267, DOI 10.1007/s10930-015-9622-1; Guleria S, 2016, J BASIC MICROB, V56, P138, DOI 10.1002/jobm.201500341; Gulmez C, 2018, INT J BIOL MACROMOL, V108, P436, DOI 10.1016/j.ijbiomac.2017.11.133; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; Hamza TA., 2017, INT J CHEM BIOMOL SC, V3, P1; Hernandez-Martinez R, 2011, PROCESS BIOCHEM, V46, P2001, DOI 10.1016/j.procbio.2011.07.013; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Jalkute CB, 2017, BIOCATAL AGR BIOTECH, V10, P91, DOI 10.1016/j.bcab.2017.02.012; Jamir K, 2018, INT J BIOL MACROMOL, V106, P277, DOI 10.1016/j.ijbiomac.2017.08.019; Joshi S, 2013, BIORESOURCE TECHNOL, V131, P76, DOI 10.1016/j.biortech.2012.12.124; Kandasamy S, 2018, BIOCATAL AGR BIOTECH, V13, P95, DOI 10.1016/j.bcab.2017.11.016; Kerwin BA, 2008, J PHARM SCI-US, V97, P2924, DOI 10.1002/jps.21190; Kikani BA, 2020, STARCH-STARKE, V72, DOI 10.1002/star.201900105; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Koma D, 2007, EXTREMOPHILES, V11, P769, DOI 10.1007/s00792-007-0103-0; Kumar D, 2008, MICROBIAL PROTEASES; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li Q, 2013, FEBS LETT, V587, P1155, DOI 10.1016/j.febslet.2012.12.019; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Ma XJ, 2016, PROTEIN EXPRES PURIF, V128, P52, DOI 10.1016/j.pep.2016.08.008; Madsen JK, 2019, COLLOID INTERFAC, V3, DOI 10.3390/colloids3010042; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Margrethe Oxenboll K, 2011, USE PROTEASE POULTRY; Monsellier E, 2005, PROTEIN ENG DES SEL, V18, P445, DOI 10.1093/protein/gzi046; Nigam PS, 2013, BIOMOLECULES, V3, DOI 10.3390/biom3030597; OKA M, 1989, BIOTECHNOL APPL BIOC, V11, P307; Papamichael E. M., 2019, ADV ENZYME TECHNOLOG, P71, DOI [10.1016/B978-0-444-64114-4.00003-0, DOI 10.1016/B978-0-444-64114-4.00003-0]; Qadeer A, 2014, BIOCHEMISTRY-MOSCOW+, V79, P785, DOI 10.1134/S0006297914080069; Randolph Theodore W, 2002, Pharm Biotechnol, V13, P159; Reed CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089452; Ruiz-Pena M, 2010, COLLOID SURFACE B, V75, P282, DOI 10.1016/j.colsurfb.2009.08.046; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shaikh I. K., 2018, Journal of Genetic Engineering and Biotechnology, V16, P273, DOI 10.1016/j.jgeb.2018.07.003; Sharma AK, 2020, INT J BIOL MACROMOL, V153, P680, DOI 10.1016/j.ijbiomac.2020.03.006; Sharma Kanupriya Miglani, 2017, Journal of Genetic Engineering and Biotechnology, V15, P115, DOI 10.1016/j.jgeb.2017.02.001; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Tcherkasskaya O, 2000, J BIOL CHEM, V275, P36285, DOI 10.1074/jbc.M003008200; Toymentseva AA, 2016, RUSS J BIOORG CHEM+, V42, P53, DOI 10.1134/S1068162015060175; Tripathi P, 2011, FOOD CHEM, V125, P1005, DOI 10.1016/j.foodchem.2010.09.108; Udatha DBRKG, 2015, J STRUCT BIOL, V190, P314, DOI 10.1016/j.jsb.2015.04.009; Wehaidy HR, 2018, INT J BIOL MACROMOL, V111, P296, DOI 10.1016/j.ijbiomac.2017.12.125; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; Zhan DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103902	67	6	7	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234958	10.1371/journal.pone.0234958	http://dx.doi.org/10.1371/journal.pone.0234958			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574185	Green Published, gold			2022-12-26	WOS:000544972400012
J	Yen, FS; Hsu, CC; Li, HL; Wei, JCC; Hwu, CM				Yen, Fu-Shun; Hsu, Chih-Cheng; Li, Hsin-Lun; Wei, James Cheng-Chung; Hwu, Chii-Min			Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout	PLOS ONE			English	Article							SERUM URIC-ACID; CORONARY-HEART-DISEASE; ALLOPURINOL USE; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; HYPERURICEMIA; FAILURE; HEALTH; LIPIDS; IMPACT	Objectives Although studies have demonstrated the association of hyperuricemia with cardiovascular (CV) diseases, few have explored the effect of urate-lowering therapy (ULT) on the incidence of CV diseases. Therefore, we compared the risks of hospitalized coronary artery disease (CAD), stroke, heart failure (HF), and all-cause mortality between ULT users and nonusers among patients with gout. Methods We performed this retrospective cohort study using Taiwan's population-based National Health Insurance Research Database. In total, 5218 patients with gout were included from 2000 to 2012. We compared the incidence rates (IRs) of hospitalized CAD, stroke, HF, and all-cause mortality between ULT users and matched nonusers. Results The IRs of hospitalized stroke were 0.6 and 1.0 per 100 person-years for ULT users and nonusers, respectively, after adjusting for age, sex, residence, comorbidities, and medications. ULT users showed lower adjusted hazard ratios (aHR) for hospitalized stroke (aHR: 0.52,p< 0.001) and all-cause mortality (aHR: 0.6,p= 0.02) than nonusers. Subgroup analyses revealed that uricosuric agents and xanthine oxidase inhibitors were significantly associated with lower risks of hospitalized stroke and all-cause mortality, respectively. The effect of uricosuric agents on the decrease in hospitalized stroke risk indicated a dose-response relationship. Conclusions Our study showed lower risks of hospitalized stroke and all-cause mortality in ULT users than in nonusers among patients with gout. Therefore, patients with gout may receive ULT to mitigate the risks of hospitalized stroke and mortality.	[Yen, Fu-Shun] Dr Yens Clin, Taoyuan, Taiwan; [Hsu, Chih-Cheng] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Miaoli County, Taiwan; [Hsu, Chih-Cheng] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Hsu, Chih-Cheng] Min Sheng Gen Hosp, Dept Family Med, Taoyuan, Taiwan; [Li, Hsin-Lun] China Med Univ, Management Off Hlth Data, Taichung, Taiwan; [Li, Hsin-Lun] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wei, James Cheng-Chung] Chung Shan Med Univ Hosp, Dept Med, Taichung, Taiwan; [Wei, James Cheng-Chung] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Hwu, Chii-Min] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan; [Hwu, Chii-Min] Taipei Vet Gen Hosp, Sect Endocrinol & Metab, Dept Med, Taipei, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Wei, JCC (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Wei, JCC (corresponding author), Chung Shan Med Univ Hosp, Dept Med, Taichung, Taiwan.; Wei, JCC (corresponding author), China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan.; Hwu, CM (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan.; Hwu, CM (corresponding author), Taipei Vet Gen Hosp, Sect Endocrinol & Metab, Dept Med, Taipei, Taiwan.	wei3228@gmail.com; chhwu@vghtpe.gov.tw	Hwu, Chii-Min/AAZ-7384-2021	Li, Hsin-Lun/0000-0003-1497-1599	Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW108-TDU-B-212-133004]; China Medical University Hospital, Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 107-2321-B-039 -004-]; Tseng-Lien Lin Foundation (Taichung, Taiwan); Katsuzo and Kiyo Aoshima Memorial Funds (Japan)	Taiwan Ministry of Health and Welfare Clinical Trial Center; China Medical University Hospital, Academia Sinica Stroke Biosignature Project; MOST Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation (Taichung, Taiwan); Katsuzo and Kiyo Aoshima Memorial Funds (Japan)	This work was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW108-TDU-B-212-133004), China Medical University Hospital, Academia Sinica Stroke Biosignature Project (BM10701010021), MOST Clinical Trial Consortium for Stroke (MOST 107-2321-B-039 -004-), Tseng-Lien Lin Foundation (Taichung, Taiwan), and Katsuzo and Kiyo Aoshima Memorial Funds (Japan), The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; de Abajo FJ, 2015, HEART, V101, P679, DOI 10.1136/heartjnl-2014-306670; Doehner W, 2005, HEART, V91, P707, DOI 10.1136/hrt.2004.057190; Doehner W, 2007, INT J CARDIOL, V115, P156, DOI 10.1016/j.ijcard.2006.05.003; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; GERTLER MM, 1951, ANN INTERN MED, V34, P1421, DOI 10.7326/0003-4819-34-6-1421; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Grimaldi-Bensouda L, 2015, ANN RHEUM DIS, V74, P836, DOI 10.1136/annrheumdis-2012-202972; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; Huang H, 2014, EUR J HEART FAIL, V16, P15, DOI 10.1093/eurjhf/hft132; Jin M, 2012, FRONT BIOSCI-LANDMRK, V17, P656, DOI 10.2741/3950; Khan F, 2008, CARDIOVASC THER, V26, P247, DOI 10.1111/j.1755-5922.2008.00057.x; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Kojima S, 2019, EUR HEART J, V40, P1778, DOI 10.1093/eurheartj/ehz119; Krca M, 2016, J RECEPT SIG TRANSD, V12, P1; Krishnan E, 2010, RHEUMATOLOGY, V49, P1229, DOI 10.1093/rheumatology/keq037; Luk AJ, 2009, RHEUMATOLOGY, V48, P804, DOI 10.1093/rheumatology/kep069; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Muir SW, 2008, STROKE, V39, P3303, DOI 10.1161/STROKEAHA.108.519793; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; SIMONS LA, 1991, AUST NZ J MED, V21, P701, DOI 10.1111/j.1445-5994.1991.tb01373.x; Singh JA, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0513-6; Struthers AD, 2002, HEART, V87, P229, DOI 10.1136/heart.87.3.229; VIGNA GB, 1992, CIRCULATION, V85, P2205, DOI 10.1161/01.CIR.85.6.2205; Wei L, 2011, BRIT J CLIN PHARMACO, V71, P600, DOI 10.1111/j.1365-2125.2010.03887.x; Weisman A, 2019, DIABETES OBES METAB, V21, P1322, DOI 10.1111/dom.13656; Wen CP, 2010, AM J KIDNEY DIS, V56, P273, DOI 10.1053/j.ajkd.2010.01.024; Wheeler JG, 2005, PLOS MED, V2, P236, DOI 10.1371/journal.pmed.0020076; Zhao G, 2013, ATHEROSCLEROSIS, V231, P61, DOI 10.1016/j.atherosclerosis.2013.08.023	34	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234909	10.1371/journal.pone.0234909	http://dx.doi.org/10.1371/journal.pone.0234909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574194	gold, Green Published			2022-12-26	WOS:000544972400005
J	Zhang, XM; Yang, L; Szeto, P; Abali, GK; Zhang, YF; Kulkarni, A; Amarasinghe, K; Li, JS; Vergara, IA; Molania, R; Papenfuss, AT; McLean, C; Shackleton, M; Harvey, KF				Zhang, Xiaomeng; Yang, Lie; Szeto, Pacman; Abali, Gamze Kuser; Zhang, Youfang; Kulkarni, Aishwarya; Amarasinghe, Kaushalya; Li, Jason; Vergara, Ismael A.; Molania, Ramyar; Papenfuss, Anthony T.; McLean, Catriona; Shackleton, Mark; Harvey, Kieran F.			The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis	ONCOGENE			English	Article							SIGNALING PATHWAY; VEMURAFENIB; EXPRESSION; DROSOPHILA; TAZ; DIFFERENTIATION; CLASSIFICATION; FOLLISTATIN; RESISTANCE; PHENOTYPE	Melanoma is a deadly form of skin cancer that accounts for a disproportionally large proportion of cancer-related deaths in younger people. Compared with most other skin cancers, a feature of melanoma is its high metastatic capacity, although the mechanisms that confer this are not well understood. The Hippo pathway is a key regulator of organ growth and cell fate that is deregulated in many cancers. To analyse the Hippo pathway in cutaneous melanoma, we generated a transcriptional signature of melanoma cells that overexpressed YAP, the key downstream Hippo pathway oncoprotein. YAP-mediated transcriptional activity varied in melanoma cell lines but did not cluster with known genetic drivers of melanomagenesis such asBRAFandNRASmutations. Instead, it correlated strongly with published gene expression profiles linked to melanoma cell invasiveness and varied throughout the metastatic cascade in melanoma patient tumours. Consistent with this, YAP was both necessary and sufficient for melanoma cell invasion in vitro. In vivo, YAP promoted spontaneous melanoma metastasis, whilst the growth of YAP-expressing primary tumours was impeded. Finally, we identified the YAP target genesAXL,THBS1andCYR61as key mediators of YAP-induced melanoma cell invasion. These data suggest that YAP is a critical regulator of melanoma metastasis.	[Zhang, Xiaomeng; Yang, Lie; Kulkarni, Aishwarya; Amarasinghe, Kaushalya; Li, Jason; Vergara, Ismael A.; Papenfuss, Anthony T.; Harvey, Kieran F.] Peter MacCallum Canc Ctr, 305 Grattan St, Melbourne, Vic 3000, Australia; [Yang, Lie] Tsinghua Univ, Sch Med, 1 Tsinghua Yuan, Beijing 100084, Peoples R China; [Szeto, Pacman; Abali, Gamze Kuser; Zhang, Youfang; McLean, Catriona; Shackleton, Mark] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Szeto, Pacman; Abali, Gamze Kuser; Zhang, Youfang; Shackleton, Mark] Alfred Hlth, Melbourne, Vic, Australia; [Kulkarni, Aishwarya; Papenfuss, Anthony T.; Harvey, Kieran F.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia; [Vergara, Ismael A.; Molania, Ramyar; Papenfuss, Anthony T.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Papenfuss, Anthony T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Harvey, Kieran F.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Harvey, Kieran F.] Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia	Peter Maccallum Cancer Center; Tsinghua University; Monash University; Peter Maccallum Cancer Center; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Monash University; Monash University	Harvey, KF (corresponding author), Peter MacCallum Canc Ctr, 305 Grattan St, Melbourne, Vic 3000, Australia.; Harvey, KF (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia.; Harvey, KF (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia.; Harvey, KF (corresponding author), Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia.	kieran.harvey@petermac.org	Papenfuss, Anthony T/C-6297-2008; Harvey, Kieran/AAD-5268-2022	Papenfuss, Anthony T/0000-0002-1102-8506; Amarasinghe, Kaushalya C./0000-0001-6024-657X; Vergara, Ismael/0000-0002-2960-2967; Kuser Abali, Gamze/0000-0002-4590-0577; Szeto, Pacman/0000-0002-6159-9913; Yang, Lie/0000-0001-7563-3214; Kulkarni, Aishwarya/0000-0001-5365-214X	Australian Cancer Research Foundation; National Health and Medical Research Council (NHMRC) Senior Research Fellowship [APP1078220, APP1116955]; Pfizer Australia; NHMRC [APP1145166]; veski; VCA Fellowships; Cancer Council of Victoria [APP1080255]; Peter MacCallum Cancer Foundation; Lorenzo and Pamela Galli Charitable Trust; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institute Infrastructure Support; China Scholarship Council; Australian Government Research Training Programme Scholarship; Rosie Lew Peter MacCallum Cancer Foundation Postgraduate Award	Australian Cancer Research Foundation; National Health and Medical Research Council (NHMRC) Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Pfizer Australia(PfizerPfizer Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); veski; VCA Fellowships; Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Peter MacCallum Cancer Foundation; Lorenzo and Pamela Galli Charitable Trust; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institute Infrastructure Support(National Health and Medical Research Council (NHMRC) of Australia); China Scholarship Council(China Scholarship Council); Australian Government Research Training Programme Scholarship(Australian Government); Rosie Lew Peter MacCallum Cancer Foundation Postgraduate Award	We thank the following Peter MacCallum Cancer Centre core facilities: Molecular Genomics, Bioinformatics, Flow Cytometry and the Centre for Advanced Histology and Microscopy, which were in part supported by the Australian Cancer Research Foundation. KFH was supported by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship (APP1078220). MS was supported by Pfizer Australia, NHMRC, veski, and VCA Fellowships. This research was supported by grants from the Cancer Council of Victoria (APP1080255) and NHMRC (APP1145166), and by the Peter MacCallum Cancer Foundation. ATP was supported by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship (APP1116955) and by the Lorenzo and Pamela Galli Charitable Trust. The research benefitted by support from the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support. LY was supported by the China Scholarship Council. AK was supported by an Australian Government Research Training Programme Scholarship and a Rosie Lew Peter MacCallum Cancer Foundation Postgraduate Award.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Brastianos PK, 2013, NAT GENET, V45, P285, DOI 10.1038/ng.2526; Bueno R, 2016, NAT GENET; Calses PC, 2019, TRENDS CANCER, V5, P297, DOI 10.1016/j.trecan.2019.04.001; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chen Q, 2014, GENE DEV, V28, P432, DOI 10.1101/gad.233676.113; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Cox AG, 2016, NAT CELL BIOL, V18, P886, DOI 10.1038/ncb3389; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ege N, 2018, CELL SYST, V6, P692, DOI 10.1016/j.cels.2018.05.006; Elosegui-Artola A, 2017, CELL, V171, P1397, DOI 10.1016/j.cell.2017.10.008; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jayachandran A, 2014, ONCOTARGET, V5, P5782, DOI 10.18632/oncotarget.2164; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Larkin J, 2014, LANCET ONCOL, V15, P436, DOI 10.1016/S1470-2045(14)70051-8; Lee CK, 2019, SCIENCE, V363, P644, DOI 10.1126/science.aav0173; Lin LP, 2015, NAT GENET, V47, P250, DOI 10.1038/ng.3218; Manning SA, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.179069; Manning SA, 2018, CURR BIOL, V28, P1651, DOI 10.1016/j.cub.2018.04.018; McArthur GA, 2014, LANCET ONCOL, V15, P323, DOI 10.1016/S1470-2045(14)70012-9; Moroishi T, 2016, CELL, V167, P1525, DOI 10.1016/j.cell.2016.11.005; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Nallet-Staub F, 2014, J INVEST DERMATOL, V134, P123, DOI 10.1038/jid.2013.319; Ogasawara N, 2018, BIOL PHARM BULL, V41, P604, DOI 10.1248/bpb.b17-00990; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Ramsdale R, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1111; Seachrist DD, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0857-y; Sensi M, 2011, J INVEST DERMATOL, V131, P2448, DOI 10.1038/jid.2011.218; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Titz B, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.28; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Widmer DS, 2012, PIGM CELL MELANOMA R, V25, P343, DOI 10.1111/j.1755-148X.2012.00986.x; Xu MZ, 2011, ONCOGENE, V30, P1229, DOI 10.1038/onc.2010.504; Yu FX, 2014, CANCER CELL, V25, P822, DOI 10.1016/j.ccr.2014.04.017; Zabkiewicz C, 2017, CANCER GENOM PROTEOM, V14, P241, DOI 10.21873/cgp.20035; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zeng H, 2015, GROWTH FACTORS, V33, P384, DOI 10.3109/08977194.2015.1119132; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhang XM, 2019, MOL CANCER RES, V17, P1435, DOI 10.1158/1541-7786.MCR-18-0407; Zhang XM, 2009, CANCER RES, V69, P6033, DOI 10.1158/0008-5472.CAN-08-4592; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111	58	29	30	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 23	2020	39	30					5267	5281		10.1038/s41388-020-1362-9	http://dx.doi.org/10.1038/s41388-020-1362-9		JUN 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MO5BV	32561850	Green Submitted			2022-12-26	WOS:000541308400001
J	Cowan, AE; Higgins, KA; Fisher, JO; Tripicchio, GL; Mattes, RD; Zou, PS; Bailey, RL				Cowan, Alexandra E.; Higgins, Kelly A.; Fisher, Jennifer O.; Tripicchio, Gina L.; Mattes, Richard D.; Zou, Peishan; Bailey, Regan L.			Examination of different definitions of snacking frequency and associations with weight status among US adults	PLOS ONE			English	Article							ENERGY-INTAKE; FOOD-INTAKE; UNITED-STATES; DIET QUALITY; NATIONAL-HEALTH; EATING PATTERNS; NUTRITION; CHILDREN; OBESITY; TRENDS	Snacks, while widely consumed in the United States (U.S.), do not have a standard definition, complicating research to understand associations, if any, with weight status. Therefore, the purpose of this study was to examine the association between snacking frequency and weight status using various snacking definitions that exist in the scientific literature among U.S. adults (NHANES 2013-2016; >= 20y n = 9,711). Four event-based snacking definitions were operationalized including participant-defined snacks, eating events outside of meals, and operationally defined snacks based on absolute thresholds of energy consumed (>50 kcal). Weight status was examined using body mass index (BMI), waist circumference, and sagittal abdominal diameter risk. Logistic regression models examined snacking frequency and associations with weight status. Outcomes varied by the definition of a snack employed, but the majority of findings were null. Mean energy from snacks was significantly higher among women with obesity compared to women with normal weight when a snack was defined as any event outside of a typical mealtime (i.e. other than breakfast, lunch, dinner, super, brunch), regardless of whether or not it contributed >= 50 kcal. Further investigation into ingestive behaviors that may influence the relationship between snacking frequency and weight status is needed.	[Cowan, Alexandra E.; Higgins, Kelly A.; Mattes, Richard D.; Zou, Peishan; Bailey, Regan L.] Purdue Univ, Coll Hlth & Human Sci, Dept Nutr Sci, W Lafayette, IN 47907 USA; [Higgins, Kelly A.] Exponent Inc, Ctr Chem Regulat & Food Safety, Washington, DC 20036 USA; [Fisher, Jennifer O.; Tripicchio, Gina L.] Temple Univ, Coll Publ Hlth, Ctr Obes Res & Educ, Philadelphia, PA 19122 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Exponent; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Higgins, KA (corresponding author), Purdue Univ, Coll Hlth & Human Sci, Dept Nutr Sci, W Lafayette, IN 47907 USA.; Higgins, KA (corresponding author), Exponent Inc, Ctr Chem Regulat & Food Safety, Washington, DC 20036 USA.	khiggins@exponent.com		Tripicchio, Gina/0000-0003-2820-5756; Higgins, Kelly/0000-0002-0663-8975				Ahluwalia N, 2016, ADV NUTR, V7, P121, DOI 10.3945/an.115.009258; Almoosawi S, 2016, P NUTR SOC, V75, P487, DOI 10.1017/S0029665116000306; [Anonymous], 2019, KOREAN NATL HLTH NUT; [Anonymous], 2018, BREAKF PERC SEL NUTR; [Anonymous], 2000, WHO TECHN REP SER; Appleton KM, 2011, APPETITE, V56, P602, DOI 10.1016/j.appet.2011.01.032; Bailey RL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010102; Bailey RL, 2017, J NUTR EDUC BEHAV, V49, P639, DOI 10.1016/j.jneb.2016.11.008; Belcher BR, 2010, MED SCI SPORT EXER, V42, P2211, DOI 10.1249/MSS.0b013e3181e1fba9; Bellisle F, 2014, PHYSIOL BEHAV, V134, P38, DOI 10.1016/j.physbeh.2014.03.010; BIRCH LL, 1986, APPETITE, V7, P323, DOI 10.1016/S0195-6663(86)80001-0; Blanton CA, 2006, J NUTR, V136, P2594, DOI 10.1093/jn/136.10.2594; Cecil JE, 2005, AM J CLIN NUTR, V82, P302, DOI 10.1093/ajcn/82.2.302; Center for Disease Control and Prevention, 2016, NAT HLTH NUTR EX SUR; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Cowan AE, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081114; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Duffey KJ, 2014, J NUTR, V144, P1843, DOI 10.3945/jn.114.198192; Garriguet Didier, 2007, Health Rep, V18, P17; Goodwin S, 2002, CLIN NURSE SPEC, V16, P164, DOI [10.1097/00002800-200205000-00016, DOI 10.1097/00002800-200205000-00016]; Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016; Han TS, 1995, BMJ-BRIT MED J, V311; Hess JM, 2018, PHYSIOL BEHAV, V193, P284, DOI 10.1016/j.physbeh.2018.04.019; Hess JM, 2016, ADV NUTR, V7, P466, DOI 10.3945/an.115.009571; Hill RJ, 2001, BRIT J NUTR, V85, P415, DOI 10.1079/BJN2000281; Hunter CD, 2019, INT J INCLUSIVE EDUC, V23, P950, DOI 10.1080/13603116.2019.1602363; *I MED, 2006, DIET REF INT ESS GUI; Johnson GH, 2010, CRIT REV FOOD SCI, V50, P848, DOI 10.1080/10408390903572479; Kachurak A, 2018, OBESITY, V26, P1034, DOI 10.1002/oby.22172; Kahn HS, 2018, DIABETES RES CLIN PR, V136, P7, DOI 10.1016/j.diabres.2017.11.019; Kahn HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108707; Kant AK, 2007, PUBLIC HEALTH NUTR, V10, P158, DOI 10.1017/S1368980007246749; Kant AK, 2015, J ACAD NUTR DIET, V115, P50, DOI 10.1016/j.jand.2014.06.354; Kant AK, 2012, AM J CLIN NUTR, V96, P1369, DOI 10.3945/ajcn.112.044974; Leech RM, 2015, AM J CLIN NUTR, V102, P1229, DOI 10.3945/ajcn.115.114660; Luke A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-387; Ma YS, 2003, AM J EPIDEMIOL, V158, P85, DOI 10.1093/aje/kwg117; Macdiarmid J, 2009, EUR J CLIN NUTR, V63, P1297, DOI 10.1038/ejcn.2009.87; MacLean RR, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5248-5; Masters MA, 2014, J ACAD NUTR DIET, V114, P1533, DOI 10.1016/j.jand.2014.04.023; Mattes R, 2013, CHAPTER 27 SNACKING, P501; Mattes RD, 2001, PHYSIOL BEHAV, V74, P551, DOI 10.1016/S0031-9384(01)00597-2; Mattes RD, 2018, PHYSIOL BEHAV, V193, P279, DOI 10.1016/j.physbeh.2018.02.010; Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585; Murakami K, 2016, BRIT J NUTR, V116, P1633, DOI 10.1017/S0007114516003731; Murakami K, 2016, J ACAD NUTR DIET, V116, P1101, DOI 10.1016/j.jand.2015.12.012; Murakami K, 2015, J NUTR, V145, P2715, DOI 10.3945/jn.115.219808; Murakami K, 2015, BRIT J NUTR, V114, P1294, DOI 10.1017/S0007114515002706; Musialik K, 2017, EUR REV MED PHARMACO, V21, P4379; Ng SW, 2011, EUR J CLIN NUTR, V65, P1328, DOI 10.1038/ejcn.2011.135; OGDEN CL, 2015, NCHS DATA BRIEF, V219, P1, DOI DOI 10.1017/S1368980017000088; Ovaskainen ML, 2010, APPETITE, V54, P623, DOI 10.1016/j.appet.2010.03.012; Piernas C, 2010, J NUTR, V140, P325, DOI 10.3945/jn.109.112763; Poppitt SD, 1998, INT J OBESITY, V22, P303, DOI 10.1038/sj.ijo.0800584; Ritchie LD, 2012, AM J CLIN NUTR, V95, P290, DOI 10.3945/ajcn.111.016881; Skrypnik D, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020469; Skrypnik D, 2019, POL ARCH INTERN MED, V129, P267, DOI 10.20452/pamw.4426; Subar AF, 2015, J NUTR, V145, P2639, DOI 10.3945/jn.115.219634; Tooze JA, 2004, AM J CLIN NUTR, V79, P795; Tripicchio GL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071486; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; U.S. Department of Agriculture Agricultural Research Service, 2018, SNACKS PERC SEL NUTR; U.S. Department of Agriculture ARS Beltsville Human Nutrition Research Center Food Surveys Research Group, 2011, SNACK PATT US AD NHA; US Department of Agriculture, 2018, FOOD NUTRIENT DATABA; VanderWeele TJ, 2019, EUR J EPIDEMIOL, V34, pCP3, DOI 10.1007/s10654-019-00494-6; Veldheer S, 2015, INT J OBESITY, V39, P1727, DOI 10.1038/ijo.2015.127; Wang ZH, 2012, ASIA PAC J CLIN NUTR, V21, P253; Wardle J, 2004, ANN BEHAV MED, V27, P107, DOI 10.1207/s15324796abm2702_5; Woteki CE., 1993, CLIN NUTR INSIGHT, DOI [10.17226/1365, DOI 10.17226/1365]; Zandstra EH, 2000, EUR J CLIN NUTR, V54, P239, DOI 10.1038/sj.ejcn.1600927; Zipf George, 2013, Vital Health Stat 1, P1	71	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234355	10.1371/journal.pone.0234355	http://dx.doi.org/10.1371/journal.pone.0234355			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555712	Green Published, gold			2022-12-26	WOS:000542759600011
J	Oreel, TH; Nieuwkerk, PT; Hartog, ID; Netjes, JE; Vonk, ABA; Lemkes, J; van Laarhoven, HWM; Scherer-Rath, M; Sprangers, MAG; Henriques, JPS				Oreel, Tom H.; Nieuwkerk, Pythia T.; Hartog, Iris D.; Netjes, Justine E.; Vonk, Alexander B. A.; Lemkes, Jorrit; van Laarhoven, Hanneke W. M.; Scherer-Rath, Michael; Sprangers, Mirjam A. G.; Henriques, Jose P. S.			Gender differences in quality of life in coronary artery disease patients with comorbidities undergoing coronary revascularization	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; BYPASS GRAFT; SEX; WOMEN; INTERVENTION; OUTCOMES; MEN	In comparison to male patients with coronary artery disease, female patients suffer from more comorbidities, experience symptoms of coronary artery disease differently and report poorer health-related quality of life (HRQoL) after coronary revascularization. However, there is limited data on the impact of comorbidity burden on the recovery in HRQoL in female and male patients. We investigated the impact of comorbidity burden on the change in HRQoL following coronary revascularization in female patients versus male patients. 230 patients (60 female) with coronary artery disease were assessed before, and two weeks, three months and six months after coronary revascularization. Disease-specific HRQoL was measured with the Short-Form Seattle Angina Questionnaire. Physical and mental health was measured with the Short-Form Health Survey. Comorbidity burden was assessed by the total number of identified comorbidity conditions and by the Charlson comorbidity score. Linear mixed models were used to estimate the effects of time, gender and comorbidity burden on HRQoL. Whereas HRQoL improved after coronary revascularization in all patients, female patients reported poorer physical health and disease-specific HRQoL and their physical health improved more slowly than male patients. A higher comorbidity burden was related with poorer physical health and disease-specific HRQoL in male patients, but not in female patients. A higher comorbidity burden was associated with slower improvement in HRQoL for both female and male patients. Female patients reported poorer HRQoL and their physical health improved more slowly after coronary revascularization, irrespective of comorbidity burden. Higher comorbidity burden was associated with poorer physical health and disease-specific HRQoL in male patients only. Our results indicate that female and male patients recover differently after coronary revascularization. These findings highlight the importance of comorbidity- and gender-specific approaches for evaluating coronary artery disease and coronary revascularization procedures.	[Oreel, Tom H.; Nieuwkerk, Pythia T.; Hartog, Iris D.; Netjes, Justine E.; Sprangers, Mirjam A. G.] Univ Amsterdam, Amsterdam Univ Med Ctr, Locat Acad Med Ctr, Amsterdam Publ Hlth Res Inst,Dept Med Psychol, Amsterdam, Netherlands; [Hartog, Iris D.; Scherer-Rath, Michael] Radboud Univ Nijmegen, Fac Philosophy Theol & Religious Studies, Nijmegen, Netherlands; [Vonk, Alexander B. A.] Locat Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Cardiothorac Surg, Amsterdam, Netherlands; [Lemkes, Jorrit] Locat Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [van Laarhoven, Hanneke W. M.] Univ Amsterdam, Amsterdam Univ Med Ctr, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam, Netherlands; [Henriques, Jose P. S.] Univ Amsterdam, Amsterdam Univ Med Ctr, Locat Acad Med Ctr, Dept Cardiol, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam	Oreel, TH (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr, Locat Acad Med Ctr, Amsterdam Publ Hlth Res Inst,Dept Med Psychol, Amsterdam, Netherlands.	t.h.oreel@amsterdamumc.nl	van Laarhoven, Hanneke/AAW-3464-2021; Scherer-Rath, Michael/AGE-2943-2022	Scherer-Rath, Michael/0000-0001-7652-8213; van Laarhoven, Hanneke/0000-0003-3546-9709; van Laarhoven, H.W.M./0000-0003-1274-5643; Henriques, Jose PS/0000-0002-8969-7929	Netherlands Organisation for Scientific Research (NWO) [NWO319-20-003]; Merck Sharp Dohme (MSD)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Merck Sharp Dohme (MSD)(Merck & Company)	Mirjam A.G. Sprangers. This study was funded by the Netherlands Organisation for Scientific Research (NWO; grant number NWO319-20-003) and Merck Sharp & Dohme (MSD). https://www.nwo.nl/en and http://www.msd.com/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INTRO STAT ANAL; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benzer W, 2003, HERZ, V28, P421, DOI 10.1007/s00059-003-2388-9; Blankenship JC, 2013, CATHETER CARDIO INTE, V81, P243, DOI 10.1002/ccd.24376; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; Brink E., 2002, PSYCHOL HEALTH MED, V7, P5, DOI DOI 10.1080/13548500120101522; Chan PS, 2014, CIRC-CARDIOVASC QUAL, V7, P640, DOI 10.1161/CIRCOUTCOMES.114.000967; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Herlitz J, 2001, CLIN CARDIOL, V24, P385, DOI 10.1002/clc.4960240508; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Kulik A, 2017, CURR OPIN CARDIOL, V32, P707, DOI 10.1097/HCO.0000000000000458; lijn NZe, 2018, PREVALENTIE DIABETES; Loponen P, 2009, SCAND CARDIOVASC J, V43, P94, DOI 10.1080/14017430802395450; Maas AHEM, 2010, NETH HEART J, V18, P598, DOI 10.1007/s12471-010-0841-y; Mattioli AV, 2019, J CARDIOVASC MED, V20, P575, DOI 10.2459/JCM.0000000000000831; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Mehilli J, 2000, JAMA-J AM MED ASSOC, V284, P1799, DOI 10.1001/jama.284.14.1799; Norris Colleen M, 2004, Health Qual Life Outcomes, V2, P21, DOI 10.1186/1477-7525-2-21; Norris CM, 2008, CIRC-CARDIOVASC QUAL, V1, P123, DOI 10.1161/CIRCOUTCOMES.108.793448; OBRIEN R, 1993, APPL ANAL VARIANCE B; Pettersen KI, 2008, INT J CARDIOL, V130, P449, DOI 10.1016/j.ijcard.2007.10.016; RAP JLFSR, 2018, REV LATINOAM ENFERMA, V26, pe3100; Sajobi TT, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.003661; Say Lale, 2014, Lancet Glob Health, V2, pe323, DOI 10.1016/S2214-109X(14)70227-X; Unsar S, 2007, J CARDIOVASC NURS, V22, P501, DOI 10.1097/01.JCN.0000297382.91131.8d; Vaccarino V, 2003, J AM COLL CARDIOL, V41, P307, DOI 10.1016/S0735-1097(02)02698-0; Westin L, 2005, SCAND CARDIOVASC J, V39, P50, DOI 10.1080/14017430410003903; Wiklund I, 1996, METHOD FIND EXP CLIN, V18, P37; Xie JP, 2008, CIRCULATION, V118, P491, DOI 10.1161/CIRCULATIONAHA.107.752006	31	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234543	10.1371/journal.pone.0234543	http://dx.doi.org/10.1371/journal.pone.0234543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555617	gold, Green Published			2022-12-26	WOS:000542759600063
J	Eggers, R; de Winter, F; Smit, L; Luimens, M; Muir, EM; Bradbury, EJ; Tannemaat, MR; Verhaagen, J				Eggers, Ruben; de Winter, Fred; Smit, Lotte; Luimens, Maruelle; Muir, Elizabeth M.; Bradbury, Elizabeth J.; Tannemaat, Martijn R.; Verhaagen, Joost			Combining timed GDNF and ChABC gene therapy to promote long-distance regeneration following ventral root avulsion and repair	FASEB JOURNAL			English	Article						axonal regeneration; chronic denervation; nerve damage; peripheral nerve	CHONDROITIN SULFATE PROTEOGLYCAN; IMPROVES FUNCTIONAL RECOVERY; PERIPHERAL-NERVE; NEUROTROPHIC FACTOR; SPINAL-CORD; AXONAL REGENERATION; MOTONEURON SURVIVAL; SCIATIC-NERVE; EXTRACELLULAR-MATRIX; VIRAL VECTOR	Ventral root avulsion leads to severe motoneuron degeneration and prolonged distal nerve denervation. After a critical period, a state of chronic denervation develops as repair Schwann cells lose their pro-regenerative properties and inhibitory factors such as CSPGs accumulate in the denervated nerve. In rats with ventral root avulsion injuries, we combined timed GDNF gene therapy delivered to the proximal nerve roots with the digestion of inhibitory CSPGs in the distal denervated nerve using sustained lentiviral-mediated chondroitinase ABC (ChABC) enzyme expression. Following reimplantation of lumbar ventral roots, timed GDNF-gene therapy enhanced motoneuron survival up to 45 weeks and improved axonal outgrowth, electrophysiological recovery, and muscle reinnervation. Despite a timed GDNF expression period, a subset of animals displayed axonal coils. Lentiviral delivery of ChABC enabled digestion of inhibitory CSPGs for up to 45 weeks in the chronically denervated nerve. ChABC gene therapy alone did not enhance motoneuron survival, but led to improved muscle reinnervation and modest electrophysiological recovery during later stages of the regeneration process. Combining GDNF treatment with digestion of inhibitory CSPGs did not have a significant synergistic effect. This study suggests a delicate balance exists between treatment duration and concentration in order to achieve therapeutic effects.	[Eggers, Ruben; de Winter, Fred; Smit, Lotte; Luimens, Maruelle; Tannemaat, Martijn R.; Verhaagen, Joost] Royal Acad Arts & Sci, Lab Neuroregenerat, Netherlands Inst Neurosci, An Inst, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands; [Muir, Elizabeth M.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Bradbury, Elizabeth J.] Kings Coll London, Regenerat Grp, Inst Psychiat Psychol & Neurosci IoPPN, Wolfson Ctr Age Related Dis, London, England; [Tannemaat, Martijn R.] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands; [Verhaagen, Joost] Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Cambridge; University of London; King's College London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Eggers, R (corresponding author), Royal Acad Arts & Sci, Lab Neuroregenerat, Netherlands Inst Neurosci, An Inst, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.	r.eggers@nin.knaw.nl	eggers, ruben/B-8937-2008; De Winter, Fred/AAZ-8671-2020; Tannemaat, Martijn/S-3445-2016	eggers, ruben/0000-0001-7017-0791; De Winter, Fred/0000-0002-3042-2429; Bradbury, Elizabeth/0000-0003-4252-0234; Tannemaat, Martijn/0000-0003-2929-0390	Wings for Life (Wings for Life International) [WFLNL17-16]; International Spinal Research Trust (Spinal Research) [TRI004_3]	Wings for Life (Wings for Life International); International Spinal Research Trust (Spinal Research)	Wings for Life (Wings for Life International), Grant/Award Number: WFLNL17-16; International Spinal Research Trust (Spinal Research), Grant/Award Number: TRI004_3	Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014; Bergerot A, 2004, EXP NEUROL, V187, P359, DOI 10.1016/j.expneurol.2004.02.003; Blits B, 2004, EXP NEUROL, V189, P303, DOI 10.1016/j.expneurol.2004.05.014; Boyer RB, 2015, J SURG RES, V193, P969, DOI 10.1016/j.jss.2014.09.023; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BRAUNEWELL KH, 1995, EUR J NEUROSCI, V7, P792, DOI 10.1111/j.1460-9568.1995.tb00682.x; Burnside ER, 2018, BRAIN, V141, P2362, DOI 10.1093/brain/awy158; Chu TH, 2009, J NEUROPATH EXP NEUR, V68, P94, DOI 10.1097/NEN.0b013e31819344a9; Ee XP, 2017, BIOTECHNOL BIOENG, V114, P2121, DOI 10.1002/bit.26335; Eggers R, 2010, EXP NEUROL, V223, P207, DOI 10.1016/j.expneurol.2009.07.021; Eggers R, 2008, MOL CELL NEUROSCI, V39, P105, DOI 10.1016/j.mcn.2008.05.018; Eggers R, 2019, EXP NEUROL, V321, DOI 10.1016/j.expneurol.2019.113037; Eggers R, 2019, BRAIN, V142, P295, DOI 10.1093/brain/awy340; Eggers R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071076; FU SY, 1995, J NEUROSCI, V15, P3886; FUNAKOSHI H, 1993, J CELL BIOL, V123, P455, DOI 10.1083/jcb.123.2.455; Galtrey CM, 2007, BRAIN, V130, P926, DOI 10.1093/brain/awl372; GIANNINI C, 1990, J NEUROPATH EXP NEUR, V49, P550, DOI 10.1097/00005072-199011000-00002; Graham JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155981; Grimpe B, 2005, MOL CELL NEUROSCI, V28, P18, DOI 10.1016/j.mcn.2004.06.010; Groves ML, 2005, EXP NEUROL, V195, P278, DOI 10.1016/j.expneurol.2005.04.007; Gu HY, 2005, EXP NEUROL, V192, P89, DOI 10.1016/j.expneurol.2004.10.019; Gu YM, 1997, DEV NEUROSCI-BASEL, V19, P255, DOI 10.1159/000111214; Guo WL, 2019, NEURAL REGEN RES, V14, P328, DOI 10.4103/1673-5374.244796; Hallin RG, 1999, EXP BRAIN RES, V124, P304, DOI 10.1007/s002210050627; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Hoke A, 2006, NAT CLIN PRACT NEURO, V2, P448, DOI 10.1038/ncpneuro0262; Hoyng SA, 2014, GENE THER, V21, P549, DOI 10.1038/gt.2014.22; Hoyng SA, 2014, EXP NEUROL, V261, P578, DOI 10.1016/j.expneurol.2014.08.002; Jessen KR, 2019, GLIA, V67, P421, DOI 10.1002/glia.23532; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; Krekoski CA, 2001, J NEUROSCI, V21, P6206, DOI 10.1523/JNEUROSCI.21-16-06206.2001; Li H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14923; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Marquardt LM, 2015, TISSUE ENG PT A, V21, P2852, DOI [10.1089/ten.tea.2015.0311, 10.1089/ten.TEA.2015.0311]; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pajenda G, 2014, EXP NEUROL, V261, P367, DOI 10.1016/j.expneurol.2014.05.019; RISLING M, 1992, BRAIN RES, V570, P27, DOI 10.1016/0006-8993(92)90559-R; Ronchi G, 2017, J NEUROSURG, V127, P843, DOI 10.3171/2016.9.JNS16140; Roney IJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27697; Ruven C, 2018, J NEUROPATH EXP NEUR, V77, P325, DOI 10.1093/jnen/nly009; Sabatier MJ, 2012, J NEUROPHYSIOL, V107, P747, DOI 10.1152/jn.00887.2011; Santos D, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4969523; Santosa KB, 2013, MUSCLE NERVE, V47, P213, DOI 10.1002/mus.23490; Sarhane KA, 2019, NEUROTHERAPEUTICS, V16, P1283, DOI 10.1007/s13311-019-00745-0; Shakhbazau A, 2013, J CONTROL RELEASE, V172, P841, DOI 10.1016/j.jconrel.2013.10.004; Sivak WN, 2017, J TISSUE ENG REGEN M, V11, P733, DOI 10.1002/term.1970; Sulaiman OAR, 2009, NEUROSURGERY, V65, pA105, DOI 10.1227/01.NEU.0000358537.30354.63; Sulaiman W, 2013, OCHSNER J, V13, P100; Tannemaat MR, 2008, EUR J NEUROSCI, V28, P1467, DOI 10.1111/j.1460-9568.2008.06452.x; Tom VJ, 2009, J NEUROSCI, V29, P14881, DOI 10.1523/JNEUROSCI.3641-09.2009; TONA A, 1993, J HISTOCHEM CYTOCHEM, V41, P593, DOI 10.1177/41.4.8450198; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Tsui CC, 2010, J NEUROSCI, V30, P5149, DOI 10.1523/JNEUROSCI.5246-09.2010; Udina E, 2010, EXP NEUROL, V223, P143, DOI 10.1016/j.expneurol.2009.08.026; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Wang ZZ, 2018, J NEUROSCI METH, V308, P183, DOI 10.1016/j.jneumeth.2018.08.002; Wu WT, 2003, J NEUROTRAUM, V20, P603, DOI 10.1089/089771503767168528; WU WT, 1993, NEUROSCI LETT, V153, P121, DOI 10.1016/0304-3940(93)90303-3; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Yang LJS, 2006, P NATL ACAD SCI USA, V103, P11057, DOI 10.1073/pnas.0604613103; Yuan QJ, 2000, NEUROREPORT, V11, P2237, DOI 10.1097/00001756-200007140-00035; Zahavi EE, 2015, J CELL SCI, V128, P1241, DOI 10.1242/jcs.167544; Zhang Y, 2013, J CRANIOFAC SURG, V24, P2153, DOI 10.1097/01.SCS.0000436700.65891.3b; Zhou LH, 2006, J NEUROTRAUM, V23, P920, DOI 10.1089/neu.2006.23.920; Zuo J, 2002, EXP NEUROL, V176, P221, DOI 10.1006/exnr.2002.7922; Zuo J, 1998, J NEUROBIOL, V34, P41, DOI 10.1002/(SICI)1097-4695(199801)34:1<41::AID-NEU4>3.3.CO;2-4	69	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10605	10622		10.1096/fj.202000559R	http://dx.doi.org/10.1096/fj.202000559R		JUN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32543730	Green Published, hybrid			2022-12-26	WOS:000541638800001
J	Jaen, RI; Fernandez-Velasco, M; Terron, V; Sanchez-Garcia, S; Zaragoza, C; Canales-Bueno, N; Val-Blasco, A; Vallejo-Cremades, MT; Bosca, L; Prieto, P				Jaen, Rafael I.; Fernandez-Velasco, Maria; Terron, Veronica; Sanchez-Garcia, Sergio; Zaragoza, Carlos; Canales-Bueno, Natalia; Val-Blasco, Almudena; Vallejo-Cremades, Maria Teresa; Bosca, Lisardo; Prieto, Patricia			BML-111 treatment prevents cardiac apoptosis and oxidative stress in a mouse model of autoimmune myocarditis	FASEB JOURNAL			English	Article						inflammation; lipoxin; myocarditis; oxidative stress; resolution	ISCHEMIA-REPERFUSION INJURY; PRO-RESOLVING MEDIATORS; ACUTE LUNG INJURY; RECEPTOR AGONIST; SIGNALING PATHWAY; DOWN-REGULATION; HEART-FAILURE; A(4) RECEPTOR; LIPOXIN; PEPTIDE	Myocarditis is an inflammation of the myocardium that can progress to a more severe phenotype of dilated cardiomyopathy (DCM). Three main harmful factors determine this progression: inflammation, cell death, and oxidative stress. Lipoxins and their derivatives are endogenous proresolving mediators that induce the resolution of the inflammatory process. This study aims to determine whether these mediators play a protective role in a murine model of experimental autoimmune myocarditis (EAM) by treating with the lipoxin A(4)analog BML-111. We observed that EAM mice presented extensive infiltration areas that correlated with higher levels of inflammatory and cardiac damage markers. Both parameters were significantly reduced in BML-treated EAM mice. Consistently, cardiac dysfunction, hypertrophy, and emerging fibrosis detected in EAM mice was prevented by BML-111 treatment. At the molecular level, we demonstrated that treatment with BML-111 hampered apoptosis and oxidative stress induction by EAM. Moreover, both in vivo and in vitro studies revealed that these beneficial effects were mediated by activation of Nrf2 pathway through CaMKK2-AMPK alpha kinase pathway. Altogether, our data indicate that treatment with the lipoxin derivative BML-111 effectively alleviates EAM outcome and prevents cardiac dysfunction, thus, underscoring the therapeutic potential of lipoxins and their derivatives to treat myocarditis and other inflammatory cardiovascular diseases.	[Jaen, Rafael I.; Terron, Veronica; Sanchez-Garcia, Sergio; Bosca, Lisardo; Prieto, Patricia] Ctr Mixto CSIC UAM, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain; [Jaen, Rafael I.; Fernandez-Velasco, Maria; Zaragoza, Carlos; Bosca, Lisardo; Prieto, Patricia] Inst Salud Carlos III ISCIII, CIBER Enfermedades Cardiovasc CIBER CV, Madrid, Spain; [Fernandez-Velasco, Maria; Terron, Veronica; Canales-Bueno, Natalia; Val-Blasco, Almudena; Vallejo-Cremades, Maria Teresa] Hosp Univ La Paz IdiPAZ, Inst Invest, Madrid, Spain; [Zaragoza, Carlos] Univ Francisco de Vitoria, Serv Cardiol, Hosp Univ Ramon y Cajal, Inst Ramon y Cajal Invest Sanitaria IRYCIS, Madrid, Spain; [Vallejo-Cremades, Maria Teresa] Hosp Univ La Paz, Unidad Imagen & Inmunohistoquim, Fdn Invest Biomed, Madrid, Spain; [Prieto, Patricia] Univ Complutense Madrid, Dept Farmacol Farmacognosia & Bot, Fac Farm, Plaza Ramon y Cajal S-N, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Hospital Universitario La Paz; Hospital Universitario Ramon y Cajal; Universidad Francisco de Vitoria; Hospital Universitario La Paz; Complutense University of Madrid	Bosca, L (corresponding author), Ctr Mixto CSIC UAM, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.; Prieto, P (corresponding author), Univ Complutense Madrid, Dept Farmacol Farmacognosia & Bot, Fac Farm, Plaza Ramon y Cajal S-N, Madrid 28040, Spain.	lbosca@iib.uam.es; patriciaprieto@ucm.es	velasco, maria fernandez/AAO-5062-2021; Zaragoza, Carlos/AAH-9275-2019; Prieto, Patricia/ABG-8343-2020	Prieto, Patricia/0000-0001-6943-7663; Zaragoza, Carlos/0000-0002-1706-8592; Inigo Jaen, Rafael/0000-0002-7298-2125; VAL BLASCO, ALMUDENA/0000-0001-7029-2895; Sanchez-Garcia, Sergio/0000-0002-3332-7603	Ministerio de Economia y Competitividad (MINECO) [SAF2017-82436R]; Comunidad de Madrid [S2017/BMD-3686]; Fundacion Ramon Areces (Ramon Areces Foundation) [CIVP18A3864]; MINECO \ Instituto de Salud Carlos III (ISCIII) [CIBER CV-CB11/00222]	Ministerio de Economia y Competitividad (MINECO); Comunidad de Madrid(Comunidad de Madrid); Fundacion Ramon Areces (Ramon Areces Foundation); MINECO \ Instituto de Salud Carlos III (ISCIII)	Ministerio de Economia y Competitividad (MINECO), Grant/Award Number: SAF2017-82436R; Comunidad de Madrid, Grant/Award Number: S2017/BMD-3686; Fundacion Ramon Areces (Ramon Areces Foundation), Grant/Award Number: CIVP18A3864; MINECO vertical bar Instituto de Salud Carlos III (ISCIII), Grant/Award Number: CIBER CV-CB11/00222	ARETZ HT, 1987, HUM PATHOL, V18, P619; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Blyszczuk P, 2016, EUR HEART J, V38; Carreno JE, 2006, REV ESP CARDIOL, V59, P473, DOI 10.1016/S1885-5857(06)60796-2; Chandrasekharan JA, 2015, J INFLAMM RES, V8, P181, DOI 10.2147/JIR.S90380; Chen HM, 2014, INFLAMMATION, V37, P1078, DOI 10.1007/s10753-014-9831-3; Chen XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067120; Cheng X, 2016, FREE RADICAL BIO MED, V93, P52, DOI 10.1016/j.freeradbiomed.2016.01.026; da Costa RM, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00382; El Kebir D, 2008, J LEUKOCYTE BIOL, V84, P600, DOI 10.1189/jlb.1107765; Fairweather D.L., 2017, HDB SYSTEMIC AUTOIMM, V14, P1; Fontes JA, 2015, CYTOKINE, V74, P62, DOI 10.1016/j.cyto.2014.12.024; Fung G, 2016, CIRC RES, V118, P496, DOI 10.1161/CIRCRESAHA.115.306573; Garcia RA, 2019, JACC-BASIC TRANSL SC, V4, P905, DOI 10.1016/j.jacbts.2019.07.005; Gehlken C, 2018, HEART FAIL CLIN, V14, P75, DOI 10.1016/j.hfc.2017.08.009; Han X, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9303606; Hirakawa H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119360; Joo MS, 2016, MOL CELL BIOL, V36, P1931, DOI 10.1128/MCB.00118-16; Kania G, 2009, CIRC RES, V105, P462, DOI 10.1161/CIRCRESAHA.109.196287; Kong X, 2017, EXP THER MED, V14, P2284, DOI 10.3892/etm.2017.4787; Liu HZ, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0937-2; Liu XC, 2017, INFORMATION SCIENCE AND ELECTRONIC ENGINEERING, P1; Liu YF, 2012, INT IMMUNOL, V24, P605, DOI 10.1093/intimm/dxs056; Long C S, 2001, Heart Fail Rev, V6, P81; Mason JW, 2003, CARDIOVASC RES, V60, P5, DOI 10.1016/S0008-6363(03)00437-1; Matzinger M, 2020, REDOX BIOL, V29, DOI 10.1016/j.redox.2019.101393; McArthur S, 2020, J CLIN INVEST, V130, P1156, DOI 10.1172/JCI124635; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Parkinson John F., 2006, Inflammation & Allergy Drug Targets, V5, P91, DOI 10.2174/187152806776383125; Patriki D, 2018, JACC-HEART FAIL, V6, P573, DOI 10.1016/j.jchf.2018.03.002; Posso SV, 2018, INT IMMUNOPHARMACOL, V56, P330, DOI 10.1016/j.intimp.2018.01.045; Prieto P, 2010, CELL DEATH DIFFER, V17, P1179, DOI 10.1038/cdd.2009.220; Qi D, 2015, TRENDS ENDOCRIN MET, V26, P422, DOI 10.1016/j.tem.2015.05.010; Qin CX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14232; Reina-Couto M, 2014, EUR J CLIN INVEST, V44, P527, DOI 10.1111/eci.12265; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sergeeva IA, 2013, BBA-MOL BASIS DIS, V1832, P2403, DOI 10.1016/j.bbadis.2013.07.003; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sevigny MB, 2006, FEBS LETT, V580, P6533, DOI 10.1016/j.febslet.2006.10.073; Shi Y, 2017, EUR REV MED PHARMACO, V21, P1850; SHIVERICK KT, 1975, BIOCHIM BIOPHYS ACTA, V393, P124, DOI 10.1016/0005-2795(75)90222-6; Tada Y, 2016, CURR PHARM DESIGN, V22, P450, DOI 10.2174/1381612822666151222160559; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Tojkander S, 2018, CELL REP, V24, P11, DOI 10.1016/j.celrep.2018.06.011; Tonelli C, 2018, ANTIOXID REDOX SIGN, V29, P1727, DOI 10.1089/ars.2017.7342; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Tu WJ, 2019, AGING DIS, V10, P637, DOI 10.14336/AD.2018.0513; Val-Blasco A, 2017, J AM COLL CARDIOL, V69, P423, DOI 10.1016/j.jacc.2016.10.073; Wang Y, 2018, BIOCHEM BIOPH RES CO, V506, P130, DOI 10.1016/j.bbrc.2018.09.092; Watanabe Kenichi, 2011, Inflammation & Allergy Drug Targets, V10, P218; Wu SH, 2017, MOL MED REP, V15, P1682, DOI 10.3892/mmr.2017.6195; Wu SH, 2016, INFLAMMATION, V39, P611, DOI 10.1007/s10753-015-0286-y; Yang SB, 2019, CELL SIGNAL, V60, P146, DOI 10.1016/j.cellsig.2019.05.002; Zhang L, 2008, INFLAMM RES, V57, P157, DOI 10.1007/s00011-007-7141-z; Zhang L, 2018, CURR MED SCI, V38, P997, DOI 10.1007/s11596-018-1975-1; Zhao QF, 2014, HEART VESSELS, V29, P667, DOI 10.1007/s00380-013-0418-y	57	10	10	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10531	10546		10.1096/fj.202000611R	http://dx.doi.org/10.1096/fj.202000611R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32543747	Green Submitted, Bronze			2022-12-26	WOS:000541639100001
J	Anuarbek, S; Abugalieva, S; Pecchioni, N; Laido, G; Maccaferri, M; Tuberosa, R; Turuspekov, Y				Anuarbek, Shynar; Abugalieva, Saule; Pecchioni, Nicola; Laido, Giovanni; Maccaferri, Marco; Tuberosa, Roberto; Turuspekov, Yerlan			Quantitative trait loci for agronomic traits in tetraploid wheat for enhancing grain yield in Kazakhstan environments	PLOS ONE			English	Article							TRITICUM-DURUM DESF.; HIGH-DENSITY; GENETIC-ANALYSIS; ASSOCIATION; POPULATION; SOFTWARE; QTL; DOMESTICATION; DIVERSITY; CLIMATE	Durum wheat (Triticum turgidumL. ssp.durum) is one of the top crops in Kazakhstan, where it is cultivated in different ecological niches, mainly at higher latitudes in the steppe zone of the northern region. Therefore, local breeding programs for durum wheat are primarily focused on selection for high productivity in Northern Kazakhstan based on the introduction of promising foreign germplasm and the adoption of marker-assisted selection. In this study, a world tetraploid wheat collection consisted of 184 primitive and domesticated accessions, which were previously genotyped using 16,425 polymorphic SNP markers, was field-tested in Northern and South-eastern Kazakhstan. The field tests have allowed the identification of 80 durum wheat promising lines in Northern Kazakhstan in comparison with a local standard cultivar. Also, GGE (Genotype and Genotype by Environment) biplot analyses for yield performance revealed that accessions ofT.dicoccum,T.carthlicum, andT.turanicumalso have potential to improve durum wheat yield in the region. The genome-wide association study (GWAS) has allowed the identification of 83 MTAs (marker-trait associations) for heading date, seed maturation time, plant height, spike length, number of fertile spikes, number of kernels per spike, and thousand kernel weight. The comparison of the 83 identified MTAs with those previously reported in GWAS for durum wheat suggests that 38 MTAs are presumably novel, while the co-localization of a large number of MTAs with those previously published confirms the validity of the results of this study. The MTAs reported herewith will provide the opportunity to implement marker-assisted selection in ongoing durum wheat breeding projects targeting higher productivity in the region.	[Anuarbek, Shynar; Abugalieva, Saule; Turuspekov, Yerlan] Inst Plant Biol & Biotechnol, Alma Ata, Kazakhstan; [Anuarbek, Shynar; Turuspekov, Yerlan] al Farabi Kazakh Natl Univ, Alma Ata, Kazakhstan; [Abugalieva, Saule] Kazakh Natl Agr Univ, Alma Ata, Kazakhstan; [Pecchioni, Nicola; Laido, Giovanni] CREA, Res Cereal & Ind Crops, Foggia, Italy; [Maccaferri, Marco; Tuberosa, Roberto] Univ Bologna, Dept Agr & Food Sci, Bologna, Italy	Institute of Plant Biology & Biotechnology in Kazakhstan; Al-Farabi Kazakh National University; Kazakh National Agrarian University; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Bologna	Turuspekov, Y (corresponding author), Inst Plant Biol & Biotechnol, Alma Ata, Kazakhstan.; Turuspekov, Y (corresponding author), al Farabi Kazakh Natl Univ, Alma Ata, Kazakhstan.	yerlant@yahoo.com	Anuarbek, Shynar/AAO-1161-2020; Turuspekov, Yerlan/C-3458-2011; Abugalieva, Saule/M-6690-2015	Turuspekov, Yerlan/0000-0001-8590-1745; Abugalieva, Saule/0000-0002-9748-507X; Anuarbek, Shynar/0000-0002-8673-9820	Ministry of Education and Sciences of the Republic of Kazakhstan [AP05131328]	Ministry of Education and Sciences of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	YT has received the grant for the research purpose. The grant number: AP05131328. Duration of the project: 2018-2020. The funder name: Ministry of Education and Sciences of the Republic of Kazakhstan (https://www.gov.kz/memleket/entities/edu?lang=en).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Fedorenko from "North Kazakhstan Agricultural Experimental Station" for providing phenotypic data.	Acquaah G., 2012, PRINCIPLES PLANT GEN; Almerekova S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221064; [Anonymous], 2018, NAT REV GENET, V19, P1, DOI 10.1038/nrg.2017.141; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; Anuarbek SN, 2019, EURASIAN J ECOLOGY, V59, P39; Bassi FM, 2019, 1 INT EXP WORKSH PRE, P49; BHIVA/ BASHH, 2019, HIV MED S2, V20, ps2; Blanco A, 2012, MOL BREEDING, V30, P79, DOI 10.1007/s11032-011-9600-z; Boden SA, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2014.16, 10.1038/nplants.2014.16]; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chourghal N, 2016, REG ENVIRON CHANGE, V16, P1623, DOI 10.1007/s10113-015-0889-8; Cristina D., 2016, Scientific Bulletin. Series F. Biotechnologies, V20, P27; Ellis MH, 2005, THEOR APPL GENET, V111, P423, DOI 10.1007/s00122-005-2008-6; Genievskaya Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205421; Golabadi M, 2011, EUPHYTICA, V177, P207, DOI 10.1007/s10681-010-0242-8; Graziani M, 2014, CROP PASTURE SCI, V65, P80, DOI 10.1071/CP13349; Iannucci A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02124; Kidane YG, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01230; Laido G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067280; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Maccaferri M, 2016, J EXP BOT, V67, P1161, DOI 10.1093/jxb/erw039; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; Maccaferri M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-873; Maccaferri M, 2011, J EXP BOT, V62, P409, DOI 10.1093/jxb/erq287; Mal'chikov PN, 2018, VAVILOVSKII ZH GENET, V22, P939, DOI 10.18699/VJ18.436; Mangini G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190162; Mengistu DK, 2016, PLANT BIOTECHNOL J, V14, P1800, DOI 10.1111/pbi.12538; Milner SG, 2016, PLANT BIOTECHNOL J, V14, P735, DOI 10.1111/pbi.12424; Morgounov A, 2008, INT S WHEAT YIELD PO, P161; Pauli D, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.11.0037; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Pritchard JK, 2000, GENETICS, V155, P945; Pyrzynska K, 2019, SEP PURIF REV, V48, P65, DOI 10.1080/15422119.2018.1430589; Roncallo PF, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-2058-2; Royo C, 2014, GENET RESOUR CROP EV, V61, P1345, DOI 10.1007/s10722-014-0116-3; Sall AT, 2018, AGRICULTURE-BASEL, V8, DOI 10.3390/agriculture8070099; Salvi S, 2015, CURR OPIN BIOTECH, V32, P179, DOI 10.1016/j.copbio.2015.01.001; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Soriano JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178290; Sukumaran S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00081; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Turuspekov Y, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1131-2; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wolde GM, 2019, THEOR APPL GENET, V132, P1661, DOI 10.1007/s00122-019-03305-4; Wurschum T, 2017, PLANT J, V92, P892, DOI 10.1111/tpj.13726; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; Zhai HJ, 2018, THEOR APPL GENET, V131, P539, DOI 10.1007/s00122-017-3017-y; 2014, REG ANESTH PAIN MED, V9	55	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234863	10.1371/journal.pone.0234863	http://dx.doi.org/10.1371/journal.pone.0234863			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574201	gold, Green Published			2022-12-26	WOS:000544972400052
J	Engelke, E; Pfarrer, C; Radelof, K; Fehr, M; Mathes, KA				Engelke, Elisabeth; Pfarrer, Christiane; Radelof, Katharina; Fehr, Michael; Mathes, Karina A.			Gross anatomy, histology and blood vessel topography of the alimentary canal of the Inland Bearded Dragon (Pogona vitticeps)	PLOS ONE			English	Article								Imaging techniques have proved to be crucial for diagnosis in reptile species. The topography of the internal organs of bearded dragons has been described in recent studies as meeting the small animal practitioners ' demand for knowledge concerning their anatomy. However, the nomenclature in the respective literature is not uniform, which could lead to misunderstandings concerning the respective and/or affected parts of the alimentary canal. Therefore, the aim of this study was to provide clear information on anatomy and histology of the alimentary canal of bearded dragons including supplying blood vessels. For the dissection of the alimentary canal, 11 Inland Bearded Dragons (Pogona vitticeps) were used (five males, six females), which had been euthanised for clinical reasons other than those concerning the digestive tract or had died spontaneously. The supplying arteries were demonstrated by injecting red latex into the aorta, while the intestinal veins were filled with blue latex via the portal vein. Microscopic examination was carried out on specimens of seven additional bearded dragons using routine histologic procedures. Macroscopically, the sections of the alimentary canal from oral to aboral were distinguished into oesophagus, stomach, small intestine, colic ampulla, colic isthmus, rectum and cloaca. Differentiation of the duodenum, jejunum and ileum was only possible when considering the bile duct, the vasculature and the histology of the organ wall. Arteries supplying the oesophagus and the final straight part of the large intestine originated from the aorta in a segmental manner. Between these, three unpaired arteries arose from the aorta. Their branches supplied stomach and intestine excluding its last part. Based on the findings of the present study, a nomenclature for the different parts of the alimentary canal and the supplying blood vessels of bearded dragons is suggested which is well understandable for veterinary practitioners and is based on zoological knowledge of reptiles.	[Engelke, Elisabeth; Pfarrer, Christiane] Univ Vet Med Hannover, Inst Anat, Hannover, Germany; [Radelof, Katharina; Fehr, Michael; Mathes, Karina A.] Univ Vet Med Hannover, Clin Small Mammals Reptiles & Birds, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Engelke, E (corresponding author), Univ Vet Med Hannover, Inst Anat, Hannover, Germany.	elisabeth.engelke@tiho-hannover.de		Mathes, Karina/0000-0003-2320-4578	Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover, Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation	This publication was supported by Deutsche Forschungsgemeinschaft (https://www.dfg.de) and University of Veterinary Medicine Hannover, Foundation (https://www.tiho-hannover.de) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, JSCOTT, V2, P103; [Anonymous], 1992, ESPACIO TIEMPO FORMA, VV, P283; Banzato T, 2013, ANAT HISTOL EMBRYOL, V42, P453, DOI 10.1111/ahe.12037; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P407; Bucy DS, 2015, JAVMA-J AM VET MED A, V246, P868, DOI 10.2460/javma.246.8.868; Evans H.E..C..J., 1993, HDB AVIAN ANATOMY NO, V23, P301; Evans HE, 1979, MILLERS ANATOMY DOG; Gegenbaur C., 1901, VERGLEICHENDE ANATOM; Grosset C, 2014, VET RADIOL ULTRASOUN, V55, P241, DOI 10.1111/vru.12128; Hertwig O., 1906, HDB VERGLEICHENDEN E; Hochstetter F, 1898, GEGENBAURS MORPHOLOG, V26, P213; International Committee on Veterinary Histological Nomenclature, 2017, NOM HIST VET; Jacobshagen E., 1937, HDB VERGLEICHENDEN A, V3, P563; Johnson Jay D., 2006, Exotic DVM, V8, P38; Liebich H.-G., 1990, FUNKTIONELLE HISTOLO; Lippert H, 2000, LEHRBUCH ANATOMIE; Luppa H., 1977, P225; Mathes KA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221050; Moeller H, 1985, LEHRBUCH ZOOLOGIE, P411; Nomina Anatomica Veterinaria, 2017, NOMINA ANATOMICA VET, V6th; Ottaviani G., 1977, P315; Parsons T.S., 1977, P159; Pernkopf E., 1937, HDB VERGLEICHENDEN A, P349; Radelof K, 2016, GASTROINTESTINALTRAK; Remane A, 1986, SYSTEMATISCHE ZOOLOG; Sinn AD, 2004, THESIS; Sisson S, 1975, ANATOMY DOMESTIC ANI, V1, P104; Smith D, 2001, VET RADIOL ULTRASOUN, V42, P515, DOI 10.1111/j.1740-8261.2001.tb00979.x; Vollmerhaus B., 1992, LEHRBUCH ANATOMIE HA, V5, P176; Wachsmann S, 2010, THESIS; Welsch U, 2010, LEHRBUCH HISTOLOGIE; [No title captured]	32	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234736	10.1371/journal.pone.0234736	http://dx.doi.org/10.1371/journal.pone.0234736			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574166	gold, Green Published			2022-12-26	WOS:000544972400042
J	Luo, G; McHenry, ML; Letterio, JJ				Luo, George; McHenry, Michael L.; Letterio, John J.			Estimating the prevalence and risk of COVID-19 among international travelers and evacuees of Wuhan through modeling and case reports	PLOS ONE			English	Article							CHINA	Coronavirus disease 2019 (COVID-19) started in Wuhan, China and has spread through other provinces and countries through infected travelers. On January 23(rd), 2020, China issued a quarantine and travel ban on Wuhan because travelers from Wuhan were thought to account for the majority of exported COVID-19 cases to other countries. Additionally, countries evacuated their citizens from Wuhan after institution of the travel ban. Together, these two populations account for the vast majority of the "total cases with travel history to China" as designated by the World Health Organization (WHO). The current study aims to assess the prevalence and risk of COVID-19 among international travelers and evacuees of Wuhan. We first used case reports from Japan, Singapore, and Korea to investigate the date of flights of infected travelers. We then used airline traveler data and the number of infected exported cases to correlate the cases with the number of travelers for multiple countries. Our findings suggest that the risk of COVID-19 infection is highest among Wuhan travelers between January 19(th)and 22(nd), 2020, with an approximate infection rate of up to 1.3% among international travelers. We also observed that evacuee infection rates varied heavily between countries and propose that the timing of the evacuation and COVID-19 testing of asymptomatic evacuees played significant roles in the infection rates among evacuees. These findings suggest COVID-19 cases and infectivity are much higher than previous estimates, including numbers from the WHO and the literature, and that some estimates of the infectivity of COVID-19 may need re-assessment.	[Luo, George; Letterio, John J.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [McHenry, Michael L.] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Letterio, John J.] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Letterio, John J.] Univ Hosp, Rainbow Babies & Childrens Hosp, Angie Fowler Adolescent & Young Adult Canc Inst, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Luo, G (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	gxl263@case.edu		Luo, George/0000-0002-0566-2025				Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Chowell G, 2016, PHYS LIFE REV, V18, P66, DOI 10.1016/j.plrev.2016.07.005; Hoehl S, 2020, NEW ENGL J MED, V382, P1278, DOI 10.1056/NEJMc2001899; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Imai N, 2020, 2 IMP COLL LOND; Japan Minister of Health, 2020, PRES SIT NEW COR INF; Japan Ministry of Health, 2020, COR INF 2020; Jung S- M, 2020, J CLIN MED, V9; Korea Ministry of Health, 2020, COR INF 19 DOM OUTBR; Lai Shengjie, 2020, medRxiv, DOI 10.1101/2020.02.04.20020479; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058; Ma J, 2020, 5000000 LEFT WUHAN L; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Ng OT, 2020, NEW ENGL J MED, V382, P1476, DOI 10.1056/NEJMc2003100; Read J. M., 2020, MEDRXIV, DOI 10.1101/2020.01.23.20018549; Rothe C, N ENGL J MED, V3822020, P970; Singapore Ministry of Health, 2020, UPD COVID 19 COR DIS; Thailand Ministry of Public Health, 2020, THAIL REP JAN 24 202; Wang H, 2021, COMPLEX INTELL SYST, V7, P1139, DOI 10.1007/s40747-020-00171-2; WHO, 2020, COR DIS COVID 19 PAN; Winn P, 2020, CORONAVIRUS FEARS SP; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9	25	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234955	10.1371/journal.pone.0234955	http://dx.doi.org/10.1371/journal.pone.0234955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574177	Green Published, gold			2022-12-26	WOS:000544972400014
J	Seale, H; Heywood, AE; Leask, J; Sheel, M; Thomas, S; Durrheim, DN; Bolsewicz, K; Kaur, R				Seale, Holly; Heywood, Anita E.; Leask, Julie; Sheel, Meru; Thomas, Susan; Durrheim, David N.; Bolsewicz, Katarzyna; Kaur, Rajneesh			COVID-19 is rapidly changing: Examining public perceptions and behaviors in response to this evolving pandemic	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; RISK PERCEPTION; HONG-KONG; SWINE FLU; INFLUENZA; OUTBREAK; KNOWLEDGE; EFFICACY; ATTITUDE	Background Since the emergence of SARS-CoV-2, the virus that causes coronavirus disease (COVID-19) in late 2019, communities have been required to rapidly adopt community mitigation strategies rarely used before, or only in limited settings. This study aimed to examine the attitudes and beliefs of Australian adults towards the COVID-19 pandemic, and willingness and capacity to engage with these mitigation measures. In addition, we aimed to explore the psychosocial and demographic factors that are associated with adoption of recommended hygiene-related and avoidance-related behaviors. Methods A national cross-sectional online survey of 1420 Australian adults (18 years and older) was undertaken between the 18 and 24 March 2020. The statistical analysis of the data included univariate and multivariate logistic regression analysis. Findings The survey of 1420 respondents found 50% (710) of respondents felt COVID-19 would 'somewhat' affect their health if infected and 19% perceived their level of risk as high or very high. 84 center dot 9% had performed >= 1 of the three recommended hygiene-related behaviors and 93 center dot 4% performed >= 1 of six avoidance-related behaviors over the last one month. Adopting avoidance behaviors was associated with trust in government/authorities (aOR: 6.0, 95% CI 2.6-11 center dot 0), higher perceived rating of effectiveness of behaviors (aOR: 4 center dot 0, 95% CI: 1 center dot 8-8 center dot 7), higher levels of perceived ability to adopt social distancing strategies (aOR: 5.0, 95% CI: 1 center dot 5-9.3), higher trust in government (aOR: 6.0, 95% CI: 2.6-11.0) and higher level of concern if self-isolated (aOR: 1.8, 95% CI: 1.1-3.0). Interpretation In the last two months, members of the public have been inundated with messages about hygiene and social (physical) distancing. However, our results indicate that a continued focus on supporting community understanding of the rationale for these strategies, as well as instilling community confidence in their ability to adopt or sustain the recommendations is needed.	[Seale, Holly; Heywood, Anita E.] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Leask, Julie; Kaur, Rajneesh] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia; [Leask, Julie] Sydney Childrens Hosp Network, Natl Ctr Immunisat Res & Surveillance, Kids Res, Westmead, NSW, Australia; [Sheel, Meru] Australian Natl Univ, ANU Coll Hlth & Med, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Acton, ACT, Australia; [Thomas, Susan; Durrheim, David N.; Bolsewicz, Katarzyna] Univ Newcastle, Sch Med & Publ Hlth, Wallsend, NSW, Australia; [Kaur, Rajneesh] Univ New South Wales, Fac Med, Off Med Educ, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney; Australian National University; University of Newcastle; University of New South Wales Sydney	Seale, H (corresponding author), Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia.	h.seale@unsw.edu.au	Leask, Julie/ABE-2077-2020; Seale, Holly/D-4200-2011	Leask, Julie/0000-0001-5095-1443; Seale, Holly/0000-0002-1877-5395; sheel, meru/0000-0001-5453-070X	Westpac Scholars Trust	Westpac Scholars Trust	No funding was received for this specific study. MS is supported by a fellowship from the Westpac Scholars Trust.	Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, PUBLIC DIVIDED WHETH; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Bandura A, 1994, SOCIAL COGNITIVE THE, P25, DOI DOI 10.1007/978-1-4899-1193-3_3; Bardsley N, 2005, J ECON PSYCHOL, V26, P664, DOI 10.1016/j.joep.2005.02.001; Betsch C., 2020, NATURE HUMAN BEHAV; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Blake KD, 2010, EMERG INFECT DIS, V16, P212, DOI 10.3201/eid1602.090638; Blendon RJ, 2004, CLIN INFECT DIS, V38, P925, DOI 10.1086/382355; Brekke KA, 2003, J PUBLIC ECON, V87, P1967, DOI 10.1016/S0047-2727(01)00222-5; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Brewer NT, 2017, PSYCHOL SCI PUBL INT, V18, P149, DOI 10.1177/1529100618760521; Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283; Brug J, 2009, INT J BEHAV MED, V16, P3, DOI 10.1007/s12529-008-9000-x; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; Eastwood K, 2009, B WORLD HEALTH ORGAN, V87, P588, DOI 10.2471/BLT.08.060772; Faasse K, 2020, PUBLIC PERCEPTIONS C, DOI [10.1101/2020.04.25.20079996, DOI 10.1101/2020.04.25.20079996]; Geldsetzer P, 2020, J MED INTERNET RES, V22, DOI 10.2196/18790; Grow JA, 2008, QUAL HEALTH RES, V18, P1401, DOI 10.1177/1049732308322603; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; HERSHEY JC, 1994, ORGAN BEHAV HUM DEC, V59, P177, DOI 10.1006/obhd.1994.1055; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; Lau JTF, 2010, AM J INFECT CONTROL, V38, P374, DOI 10.1016/j.ajic.2010.03.002; Lau JTF, 2004, EPIDEMIOL INFECT, V132, P727, DOI 10.1017/S0950268804002225; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Leask J., 2020, SYDNEY MORNING HERAL; Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857; Marshall H, 2009, AM J PUBLIC HEALTH, V99, pS365, DOI 10.2105/AJPH.2008.153056; McFadden SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231808; Pereira A, 2011, USING EMPATHY IMPROV; Pfattheicher S., 2020, EMOTIONAL PATH ACTIO, DOI 10.31234/osf.io/y2cg5; Rimal RN, 2003, HUM COMMUN RES, V29, P370, DOI 10.1111/j.1468-2958.2003.tb00844.x; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; SCHUNK DH, 2001, SELF REGULATED LEARN, P125; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Seale H, 2009, MED J AUSTRALIA, V191, P267, DOI 10.5694/j.1326-5377.2009.tb02781.x; Sharot T, 2011, CURR BIOL, V21, pR941, DOI 10.1016/j.cub.2011.10.030; Tang CSK, 2003, AM J PUBLIC HEALTH, V93, P1887, DOI 10.2105/AJPH.93.11.1887; Ward H., 2020, PERCEPTIONS BEHAV RE, DOI 10.1101/2020.04.01.20050039	40	119	120	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235112	10.1371/journal.pone.0235112	http://dx.doi.org/10.1371/journal.pone.0235112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ME9KK	32574184	Green Published, gold, Green Submitted			2022-12-26	WOS:000544972400059
J	Aguayo, GA; Schritz, A; Ruiz-Castell, M; Villarroel, L; Valdivia, G; Fagherazzi, G; Witte, DR; Lawson, A				Aguayo, Gloria A.; Schritz, Anna; Ruiz-Castell, Maria; Villarroel, Luis; Valdivia, Gonzalo; Fagherazzi, Guy; Witte, Daniel R.; Lawson, Andrew			Identifying hotspots of cardiometabolic outcomes based on a Bayesian approach: The example of Chile	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; CARDIOVASCULAR-DISEASE; RISK-FACTORS; PREVALENCE; HEALTH; HYPERTENSION; INEQUALITIES	Background There is a need to identify priority zones for cardiometabolic prevention. Disease mapping in countries with high heterogeneity in the geographic distribution of the population is challenging. Our goal was to map the cardiometabolic health and identify hotspots of disease using data from a national health survey. Methods Using Chile as a case study, we applied a Bayesian hierarchical modelling. We performed a cross-sectional analysis of the 2009-2010 Chilean Health Survey. Outcomes were diabetes (all types), obesity, hypertension, and high LDL cholesterol. To estimate prevalence, we used individual and aggregated data by province. We identified hotspots defined as prevalence in provinces significantly greater than the national prevalence. Models were adjusted for age, sex, their interaction, and sampling weight. We imputed missing data. We applied a joint outcome modelling approach to capture the association between the four outcomes. Results We analysed data from 4,780 participants (mean age (SD) 46 (19) years; 60% women). The national prevalence (percentage (95% credible intervals) for diabetes, obesity, hypertension and high LDL cholesterol were 10.9 (4.5, 19.2), 30.0 (17.7, 45.3), 36.4 (16.4, 57.6), and 13.7 (3.4, 32.2) respectively. Prevalence of diabetes was lower in the far south. Prevalence of obesity and hypertension increased from north to far south. Prevalence of high LDL cholesterol was higher in the north and south. A hotspot for diabetes was located in the centre. Hotspots for obesity were mainly situated in the south and far south, for hypertension in the centre, south and far south and for high LDL cholesterol in the far south. Conclusions The distribution of cardiometabolic risk factors in Chile has a characteristic pattern with a general trend to a north-south gradient. Our approach is reproducible and demonstrates that the Bayesian approach enables the accurate identification of hotspots and mapping of disease, allowing the identification of areas for cardiometabolic prevention.	[Aguayo, Gloria A.; Ruiz-Castell, Maria; Fagherazzi, Guy] Luxembourg Inst Hlth, Populat Hlth Dept, Strassen, Luxembourg; [Schritz, Anna] Luxembourg Inst Hlth, Competence Ctr Methodol & Stat, Strassen, Luxembourg; [Villarroel, Luis; Valdivia, Gonzalo] Pontificia Univ Catolica Chile, Sch Med, Dept Publ Hlth, Santiago, Chile; [Witte, Daniel R.] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Witte, Daniel R.] Danish Diabet Acad, Odense, Denmark; [Lawson, Andrew] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA	Luxembourg Institute of Health; Luxembourg Institute of Health; Pontificia Universidad Catolica de Chile; Aarhus University; Medical University of South Carolina	Aguayo, GA (corresponding author), Luxembourg Inst Hlth, Populat Hlth Dept, Strassen, Luxembourg.	gloria.aguayo@lih.lu	Fagherazzi, Guy/ABB-2555-2020; Fagherazzi, Guy/P-3534-2017; Schritz, Anna/K-8887-2019; Aguayo, Gloria/W-2580-2019; Witte, Daniel/C-1722-2008	Fagherazzi, Guy/0000-0001-5033-5966; Fagherazzi, Guy/0000-0001-5033-5966; Schritz, Anna/0000-0002-8478-8055; Aguayo, Gloria/0000-0002-5625-1664; Ruiz-Castell, Maria/0000-0001-9741-7491; Valdivia, Gonzalo/0000-0001-5368-6745; Witte, Daniel/0000-0002-0769-2922				Albala C, 2002, PUBLIC HEALTH NUTR, V5, P123, DOI 10.1079/PHN2001283; Albers C, COBERTURAS SIG CHILE; [Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; Ardern CI, 2005, CIRCULATION, V112, P1478, DOI 10.1161/CIRCULATIONAHA.105.548198; Aregay M, 2015, STAT METHODS MED RES; Black HR, 1997, ARCH INTERN MED, V157, P2413; Cabieses B, 2015, INT MIGR, V53, P303, DOI 10.1111/imig.12077; Clark-Nunez X, 2017, COMPENDIO ESTADISTIC; Connolly V, 2000, J EPIDEMIOL COMMUN H, V54, P173, DOI 10.1136/jech.54.3.173; de Groot R, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001017; Di Cesare M, 2015, LANCET GLOB HEALTH, V3, pE229, DOI 10.1016/S2214-109X(15)70001-X; Dintrans PV, 2018, HEALTH POLICY, V122, P184, DOI 10.1016/j.healthpol.2017.11.007; Expert Panel on Neurologic Imaging, 2017, J AM COLL RADIOL, V14, pS550; Ferreccio C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-015-2454-2; Gaglioti AH, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.170220; Gavin JR, 1999, DIABETES CARE, V22, pS5; Jaacks LM, 2019, LANCET DIABETEENDO; Kirby RS, 2017, ANN EPIDEMIOL, V27, P1, DOI 10.1016/j.annepidem.2016.12.001; Kuklina Elena V, 2013, NCHS Data Brief, P1; Lawson A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051682; Lawson AB, 2014, STAT PUBLIC POLICY, V1, P99, DOI 10.1080/2330443X.2014.970247; Leng B, 2015, J HYPERTENS, V33, P221, DOI 10.1097/HJH.0000000000000428; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Matute I, 2017, MEDICC REV, V19, P51, DOI 10.37757/MR2017.V19.N2-3.9; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Mindell JS, 2017, AM J EPIDEMIOL, pkwx045; Ministerio de Salud DdPS Departamento de Epidemiologia, 2003, ENC SAL CHIL 2003; Ministerio de Salud DdPS Departamento de Epidemiologia, 2011, ENC NAC SAL CHIL 200; Ministerio de Salud DdPS Departamento de Epidemiologia, 2017, ENCU NAC SAL 2016 20; Misra A, 2018, J DIABETES COMPLICAT, V32, P1068, DOI 10.1016/j.jdiacomp.2018.08.001; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Popkin BM, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0631-4; Pringle DG, 1996, ECON SOC REV, V27, P341; Ramachandran A, 2008, DIABETES CARE, V31, P893, DOI 10.2337/dc07-1207; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Ruiz-Castell M, 2015, AM J PUBLIC HEALTH, V105, pE122, DOI 10.2105/AJPH.2014.302290; Solimano G, 2007, REV MED CHILE, V135, P932; Sturtz S., 2005, R2WINBUGS PACKAGE RU; Subramanian SV, 2003, J EPIDEMIOL COMMUN H, V57, P844, DOI 10.1136/jech.57.11.844; TANNER MA, 1987, J AM STAT ASSOC, V82, P528, DOI 10.2307/2289457; Tennekes M, 2018, J STAT SOFTW, V84, P1, DOI 10.18637/jss.v084.i06; Thornton LE, 2011, J EPIDEMIOL COMMUN H, V65, P873, DOI 10.1136/jech.2009.099614; Timonin S, 2018, INT J EPIDEMIOL, V47, P1594, DOI 10.1093/ije/dyy146; Vandendijck Y, 2016, SPAT STAT-NETH, V18, P455, DOI 10.1016/j.spasta.2016.09.004; Venables WN., 2002, MODERN APPL STAT S 4; Watjou K, 2017, STAT MED, V36, P3708, DOI 10.1002/sim.7369; WHO. World Health Organization, 1995, TECHNICAL REPORT SER, V854; Yeates K, 2015, CAN J CARDIOL, V31, P1081, DOI 10.1016/j.cjca.2015.06.035; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	51	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235009	10.1371/journal.pone.0235009	http://dx.doi.org/10.1371/journal.pone.0235009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569307	gold, Green Published			2022-12-26	WOS:000543547900003
J	Norden, PR; Sun, ZY; Davis, GE				Norden, Pieter R.; Sun, Zheying; Davis, George E.			Control of endothelial tubulogenesis by Rab and Ral GTPases, and apical targeting of caveolin-1-labeled vacuoles	PLOS ONE			English	Article							CAPILLARY LUMEN FORMATION; IN-VITRO; CELL MORPHOGENESIS; MOLECULAR-BASIS; COLLAGEN; MECHANISMS; REQUIRES; CDC42; VASCULOGENESIS; EXOCYTOSIS	Here, we examine known GTPase regulators of vesicle trafficking events to assess whether they affect endothelial cell (EC) lumen and tube formation. We identify novel roles for the small GTPases Rab3A, Rab3B, Rab8A, Rab11A, Rab27A, RalA, RalB and caveolin-1 in co-regulating membrane trafficking events that control EC lumen and tube formation. siRNA suppression of individual GTPases such as Rab3A, Rab8A, and RalB markedly inhibit tubulogenesis, while greater blockade is observed with combinations of siRNAs such as Rab3A and Rab3B, Rab8A and Rab11A, and RalA and RalB. These combinations of siRNAs also disrupt very early events in lumen formation including the formation of intracellular vacuoles. In contrast, knockdown of the endocytosis regulator, Rab5A, fails to inhibit EC tube formation. Confocal microscopy and real-time videos reveal that caveolin-1 strongly labels intracellular vacuoles and localizes to the EC apical surface as they fuse to form the luminal membrane. In contrast, Cdc42 and Rab11A localize to a perinuclear, subapical region where intracellular vacuoles accumulate and fuse during lumen formation. Our new data demonstrates that EC tubulogenesis is coordinated by a series of small GTPases to control polarized membrane trafficking events to generate, deliver, and fuse caveolin-1-labeled vacuoles to create the apical membrane surface.	[Norden, Pieter R.; Sun, Zheying; Davis, George E.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Davis, GE (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	gedavis@usf.edu		Norden, Pieter/0000-0002-5960-5245	National Institutes of Health [HL126518, HL128584]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (www.nih.gov) grants HL126518 and HL128584 to GED. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2011, ETHNIC DIS, V21, p[S1, S1]; Ariotti N, 2015, J BIOL CHEM, V290, P24875, DOI 10.1074/jbc.M115.644336; Balasubramanian N, 2010, CURR BIOL, V20, P75, DOI 10.1016/j.cub.2009.11.016; Barry DM, 2015, DEVELOPMENT, V142, P3058, DOI 10.1242/dev.125260; Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Bayless KJ, 2004, J BIOL CHEM, V279, P11686, DOI 10.1074/jbc.M308373200; Bayless KJ, 2002, J CELL SCI, V115, P1123; Bhuin T, 2014, EXP CELL RES, V328, P1, DOI 10.1016/j.yexcr.2014.07.027; Bierings R, 2012, BLOOD, V120, P2757, DOI 10.1182/blood-2012-05-429936; Biesemann A, 2017, J BIOL CHEM, V292, P11631, DOI 10.1074/jbc.M116.773333; Bryant DM, 2014, DEV CELL, V31, P171, DOI 10.1016/j.devcel.2014.08.027; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Conte IL, 2016, J CELL SCI, V129, P592, DOI 10.1242/jcs.178285; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis GE, 2003, MICROCIRCULATION, V10, P27, DOI 10.1038/sj.mn.7800175; Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159; Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107; Davis GE, 2015, CELL POLARITY 1: BIOLOGICAL ROLE AND BASIC MECHANISMS, P205, DOI 10.1007/978-3-319-14463-4_9; Davis GE, 2014, DEV CELL, V31, P140, DOI 10.1016/j.devcel.2014.10.011; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Griffoni C, 2000, BIOCHEM BIOPH RES CO, V276, P756, DOI 10.1006/bbrc.2000.3484; Huebner H, 2018, PLACENTA, V62, P58, DOI 10.1016/j.placenta.2017.12.019; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Jiang Y, 2016, J BIOL CHEM, V291, P20729, DOI 10.1074/jbc.M116.752485; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kim DJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184461; Kim DJ, 2013, BLOOD, V121, P3521, DOI 10.1182/blood-2012-11-470179; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Koh W, 2009, J CELL SCI, V122, P1812, DOI 10.1242/jcs.045799; Koller GM, 2020, ARTERIOSCL THROM VAS, V40, P365, DOI 10.1161/ATVBAHA.119.313536; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Norden PR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147758; Parker Sara S, 2018, Small GTPases, V9, P116, DOI 10.1080/21541248.2016.1277840; PARTON RG, 2019, TRAFFIC 0909, DOI DOI 10.1111/TRA.12689; Pfeffer SR, 2017, MOL BIOL CELL, V28, P712, DOI 10.1091/mbc.E16-10-0737; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108; Rondaij MG, 2008, BLOOD, V112, P56, DOI 10.1182/blood-2007-07-099309; Sandvig K, 2018, HISTOCHEM CELL BIOL, V150, P107, DOI 10.1007/s00418-018-1678-5; Shirakawa R, 2015, J BIOCHEM, V157, P285, DOI 10.1093/jb/mvv029; Sigurbjornsdottir S, 2014, NAT REV MOL CELL BIO, V15, P665, DOI 10.1038/nrm3871; Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785; Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010; Yu JXA, 2015, DEVELOPMENT, V142, P2951, DOI 10.1242/dev.123174; Zimnicka AM, 2016, MOL BIOL CELL, V27, P2090, DOI 10.1091/mbc.E15-11-0756; Zografou S, 2012, J CELL SCI, V125, P4780, DOI 10.1242/jcs.104174	52	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235116	10.1371/journal.pone.0235116	http://dx.doi.org/10.1371/journal.pone.0235116			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569321	Green Published, gold			2022-12-26	WOS:000543547900047
J	Purtlebaugh, CH; Martin, CW; Allen, MS				Purtlebaugh, Caleb H.; Martin, Charles W.; Allen, Micheal S.			Poleward expansion of common snookCentropomus undecimalisin the northeastern Gulf of Mexico and future research needs	PLOS ONE			English	Article							SNOOK CENTROPOMUS-UNDECIMALIS; SUWANNEE RIVER-BASIN; CLIMATE-CHANGE; AVICENNIA-GERMINANS; MANGROVE EXPANSION; GROWING-SEASON; SALT-MARSHES; LIFE-HISTORY; HABITAT USE; RED DRUM	Globally, rising temperatures have resulted in numerous examples of poleward shifts in species distribution patterns with accompanying changes in community structure and ecosystem processes. In the Gulf of Mexico, higher mean temperatures and less frequent winter freezes have led to the expansion of tropics-associated marine organisms. Our objectives were to quantify changing environmental conditions and the poleward expansion of the common snookCentropomus undecimalisinto the Cedar Keys area of Florida, USA (29 deg N). The snook is an economically and recreationally important sport fish found from southern Brazil to south Florida. Cedar Key and the Lower Suwannee River are north of the snook's historically documented range, likely due to lethal water temperatures during winter. Using data from a long-term monitoring program, we report an increase in catches of snook in this area since 2007. The spatial and temporal expansion of the species began with adult fish in 2007. By 2018, snook of all sizes were found in the region, and we found strong evidence of local reproduction during 2016-2018. The locations of nursery habitat and winter thermal refuges (e.g., freshwater springs) need to be identified and have implications for land-use policy and minimum-flow regulations for rivers. The arrival of the snook in the northern Gulf of Mexico could affect food web ecology and habitat interactions among estuarine predators, and future studies should evaluate snook's food habits and competitive interactions with resident fishes in this expanded range. Our study provides an example of how species range expansions due to changing temperatures should result in new research priorities to evaluate impacts of climate change on coastal systems.	[Purtlebaugh, Caleb H.] Florida Fish & Wildlife Conservat Commiss, Senator George Kirkpatrick Marine Lab, Fish & Wildlife Res Inst, Cedar Key, FL 32625 USA; [Martin, Charles W.; Allen, Micheal S.] Univ Florida, Fisheries & Aquat Sci Program, Inst Food & Agr Sci, Nat Coast Biol Stn, Cedar Key, FL USA	Florida Fish & Wildlife Conservation Commission; State University System of Florida; University of Florida	Purtlebaugh, CH (corresponding author), Florida Fish & Wildlife Conservat Commiss, Senator George Kirkpatrick Marine Lab, Fish & Wildlife Res Inst, Cedar Key, FL 32625 USA.	Caleb.Purtlebaugh@myFWC.com		Martin, Charles/0000-0001-9240-3824	State of Florida saltwater recreational fishing licenses; U.S. Department of the Interior, U.S. Fish and Wildlife Service, Federal Aid for Sportfish Restoration Project	State of Florida saltwater recreational fishing licenses; U.S. Department of the Interior, U.S. Fish and Wildlife Service, Federal Aid for Sportfish Restoration Project	This project was supported by proceeds from State of Florida saltwater recreational fishing licenses, and by funding from the U.S. Department of the Interior, U.S. Fish and Wildlife Service, Federal Aid for Sportfish Restoration Project. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2015, AM FISH S S, V83, P43; Adams Aaron J., 2012, Gulf and Caribbean Research, V24, P13; Aliaume C., 1997, GULF MEX SCI, V2, P77, DOI [10.18785/goms.1502.03, DOI 10.18785/GOMS.1502.03]; Anderson D. R., 2008, MODEL BASED INFERENC; Anderson J, 2020, N AM J FISH MANAGE, V40, P190, DOI 10.1002/nafm.10394; [Anonymous], 2007, HORISONT, V1, P15; [Anonymous], 2014, J ORTHOP RES S1, V32, pS158; Aven A, 2016, W INDIAN MANATEE MOV, DOI [10.7287/peerj.preprints.2072, DOI 10.7287/PEERJ.PREPRINTS.2072]; Avens L, 2012, MAR ECOL PROG SER, V458, P213, DOI 10.3354/meps09720; Barbour AB, 2014, MAR ECOL PROG SER, V507, P263, DOI 10.3354/meps10837; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Beck MW, 2001, AQUAT CONSERV, V11, P235, DOI 10.1002/aqc.449; Berge J, 2005, MAR ECOL PROG SER, V303, P167, DOI 10.3354/meps303167; Bianchi TS, 2013, ESTUAR COAST SHELF S, V119, P7, DOI 10.1016/j.ecss.2012.12.007; Boucek RE, 2017, GLOBAL CHANGE BIOL, V23, P4045, DOI 10.1111/gcb.13761; Brame AB, 2014, MAR ECOL PROG SER, V509, P255, DOI 10.3354/meps10902; Brodeur RD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026614; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; CONOVER DO, 1990, OECOLOGIA, V83, P316, DOI 10.1007/BF00317554; CONOVER DO, 1990, T AM FISH SOC, V119, P416, DOI 10.1577/1548-8659(1990)119<0416:TRBCFG>2.3.CO;2; Crandall CA, 1999, HYDROGEOL J, V7, P454, DOI 10.1007/s100400050218; Fertl D, 2004, J MAMMAL, V85, P816; Fish and Wildlife Research Institute, 2018, FISH IND MON PROGR 2; Florida Fish and Wildlife Conservation Commission, 2019, SPRINGS COAST FISH C; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; Foster John M., 2004, Gulf and Caribbean Research, V16, P161; Francis JA, 2017, WIRES CLIM CHANGE, V8, DOI 10.1002/wcc.474; Holbrook SJ, 1997, ECOL APPL, V7, P1299; Hollebone AL, 2007, MAR ECOL PROG SER, V336, P211, DOI 10.3354/meps336211; HOWELLS R G, 1990, Northeast Gulf Science, V11, P155; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Katz BG, 1997, J AM WATER RESOUR AS, V33, P1237, DOI 10.1111/j.1752-1688.1997.tb03549.x; Ley JA, 2013, FISH RES, V144, P60, DOI 10.1016/j.fishres.2012.10.008; Ley JA, 2018, MAR ECOL PROG SER, V606, P151, DOI 10.3354/meps12765; Lima FP, 2007, GLOBAL CHANGE BIOL, V13, P2592, DOI 10.1111/j.1365-2486.2007.01451.x; Llanso RJ, 1998, ESTUARIES, V21, P294, DOI 10.2307/1352476; Macy A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210144; Malinowski C, 2019, ESTUAR COAST, V42, P842, DOI 10.1007/s12237-018-00512-y; Marshak AR, 2017, J FISH BIOL, V91, P1139, DOI 10.1111/jfb.13406; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; MCMILLAN C, 1986, CONTRIB MAR SCI, V29, P9; Mieszkowska N, 2005, MARINE BIOL ASS OCCA, V20, P43; Muller RG, 2015, 2015004 WILDL RES I; Nehring S, 1998, ICES J MAR SCI, V55, P818, DOI 10.1006/jmsc.1998.0389; Osland MJ, 2019, ESTUAR COAST, V42, P1084, DOI 10.1007/s12237-019-00533-1; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PAULY D, 1980, J CONSEIL, V39, P175; Perera-Garcia MA, 2011, REV BIOL TROP, V59, P669; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Perry CL, 2009, WETLANDS, V29, P396, DOI 10.1672/08-100.1; Peters KM, 1998, B MAR SCI, V62, P509; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Precht WF, 2006, CONSERV BIOL SER, P40; Raabe EA, 2010, THERMAL IMAGING WACC, DOI [10.3133/ofr20101120, DOI 10.3133/OFR20101120]; Saintilan N, 2014, GLOBAL CHANGE BIOL, V20, P147, DOI 10.1111/gcb.12341; Santos RO, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1335; Scheffers BR, 2019, NAT CLIM CHANGE, V9, P581, DOI 10.1038/s41558-019-0526-5; Schulz K, 2019, THESIS; SHAFLAND P L, 1983, Northeast Gulf Science, V6, P175; Solomon S., 2007, CLIMATE CHANGE 2007; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Spivak ED, 2005, P BIOL SOC WASH, V118, P551, DOI 10.2988/0006-324X(2005)118[551:SREOTW]2.0.CO;2; Stevens PW, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1400; Stevens Philip W., 2006, Wetlands Ecology and Management, V14, P435, DOI 10.1007/s11273-006-0006-3; Stevens PW, 2007, B MAR SCI, V80, P93; Stevens PW, 2020, ESTUAR COAST, V43, P438, DOI 10.1007/s12237-019-00674-3; Taylor RG, 1998, J FISH BIOL, V53, P502, DOI 10.1006/jfbi.1998.0721; TUCKER J W JR, 1988, Florida Scientist, V51, P1; Winner BL, 2010, T AM FISH SOC, V139, P62, DOI 10.1577/T08-215.1; Young JM, 2014, MAR ECOL PROG SER, V505, P227, DOI 10.3354/meps10774; Zomlefer WB, 2006, CASTANEA, V71, P239, DOI 10.2179/05-33.1	72	21	21	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234083	10.1371/journal.pone.0234083	http://dx.doi.org/10.1371/journal.pone.0234083			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569296	Green Published, gold			2022-12-26	WOS:000543547900015
J	Kumar, SH; Athimoolam, K; Suraj, M; Das, MSDC; Muralidharan, A; Jeyam, D; Ashokan, J; Karthikeyan, P; Krishna, R; Khanna-Gupta, A; Bremadesam, RL				Kumar, Shalini H.; Athimoolam, Kalpana; Suraj, Manikandan; Das, Mary Shoba Das Christu; Muralidharan, Aparna; Jeyam, Divya; Ashokan, Jaicy; Karthikeyan, Priya; Krishna, Ragav; Khanna-Gupta, Arati; Bremadesam Raman, Lakshmi			Comprehensive genetic analysis of 961 unrelated Duchenne Muscular Dystrophy patients: Focus on diagnosis, prevention and therapeutic possibilities	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; PHENOTYPE; DELETIONS; EXPERIENCE; MUTATIONS; STRATEGY; DATABASE; TOOL	Recently DNA sequencing analysis has played a vital role in the unambiguous diagnosis of clinically suspected patients with Duchenne Muscular Dystrophy (DMD). DMD is a monogenic, X-linked, recessive, degenerative pediatric neuromuscular disorder affecting males, invariably leading to fatal cardiopulmonary failure. Early and precise diagnosis of the disease is an essential part of an effective disease management strategy as care guidelines and prevention through counseling need to be initiated at the earliest particularly since therapies are now available for a subset of patients. In this manuscript we report theDMDgene mutational profiles of 961 clinically suspected male DMD patients, 99% of whom were unrelated. We utilized a molecular diagnostic approach which is cost-effective for most patients and follows a systematic process that sequentially involves identification of hotspot deletions using mPCR, large deletions and duplications using MLPA and small insertions/ deletions and point mutations using an NGS muscular dystrophy gene panel. PathogenicDMDgene mutations were identified in 84% of patients. Our data compared well with the frequencies and distribution of deletions and duplications reported in theDMDgene in other published studies. We also describe a number of rare in-frame mutations, which appeared to be enriched in the 5' proximal hotspot region of theDMDgene. Furthermore, we identified a family with a rare non-contiguous deletion mutation in theDMDgene where three males were affected and two females were deemed carriers. A subset of patients with mutations in theDMDgene who are likely to benefit therapeutically from new FDA and EMA approved drugs were found in our cohort. Given that the burden of care for DMD patients invariably falls on the mothers, particularly in rural India, effective genetic counseling followed by carrier screening is crucial for prevention of this disorder. We analyzed the carrier status of consented female relatives of 463 probands to gauge the percentage of patients with familial disease. Our analysis revealed 43.7% of mothers withDMDgene mutations. Our comprehensive efforts, involving complete genetic testing coupled with compassionate genetic counseling provided to DMD patients and their families, are intended to improve the quality of life of DMD patients and to empower carrier females to make informed reproductive choices to impede the propagation of this deadly disease.	[Kumar, Shalini H.; Athimoolam, Kalpana; Suraj, Manikandan; Das, Mary Shoba Das Christu; Muralidharan, Aparna; Jeyam, Divya; Ashokan, Jaicy; Karthikeyan, Priya; Krishna, Ragav; Khanna-Gupta, Arati; Bremadesam Raman, Lakshmi] Royal CareSuper Special Hosp, Mol Diagnost Counseling Care & Res Ctr MDCRC, Coimbatore, Tamil Nadu, India		Bremadesam, RL (corresponding author), Royal CareSuper Special Hosp, Mol Diagnost Counseling Care & Res Ctr MDCRC, Coimbatore, Tamil Nadu, India.	drlakshmi@mdcrcindia.org		/0000-0002-5305-1309; Khanna-Gupta, Arati/0000-0002-0965-1737; BREMADESAM, LAKSHMI/0000-0001-5447-9473				Aartsma-Rus A, 2019, HUM MUTAT, V40, P1630, DOI 10.1002/humu.23850; Abbs Stephen, 2010, Neuromuscul Disord, V20, P422, DOI 10.1016/j.nmd.2010.04.005; Aravind S, 2019, INDIAN J MED RES, V150, P282, DOI 10.4103/ijmr.IJMR_290_18; Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758; Buzin CH, 2005, HUM MUTAT, V25, P177, DOI 10.1002/humu.20132; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Conklin LS, 2018, PHARMACOL RES, V136, P140, DOI 10.1016/j.phrs.2018.09.007; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Echigoya Y, 2018, J PERS MED, V8, DOI 10.3390/jpm8040041; Fraser HG, 2018, J GENET COUNS, V27, P1349, DOI 10.1007/s10897-018-0266-0; Guiraud S, 2017, CURR OPIN PHARMACOL, V34, P36, DOI 10.1016/j.coph.2017.04.002; Gurvich OL, 2009, HUM MUTAT, V30, P633, DOI 10.1002/humu.20913; Haas M, 2015, NEUROMUSCULAR DISORD, V25, P5, DOI 10.1016/j.nmd.2014.11.011; Hawkins AK, 2011, CLIN GENET, V80, P424, DOI 10.1111/j.1399-0004.2011.01769.x; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoffman EP, 2011, AM J PATHOL, V179, P12, DOI 10.1016/j.ajpath.2011.03.050; Juan-Mateu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135189; Lee T, 2014, J HUM GENET, V59, P46, DOI 10.1038/jhg.2013.119; Lim KRQ, 2017, DRUG DES DEV THER, V11, P533, DOI 10.2147/DDDT.S97635; Malik V, 2010, ANN NEUROL, V67, P771, DOI 10.1002/ana.22024; Manjunath M, 2015, NEUROL INDIA, V63, P58, DOI 10.4103/0028-3886.152635; McDonald CM, 2018, LANCET, V391, P451, DOI 10.1016/S0140-6736(17)32160-8; Miller S.A., 1988, NUCLEIC ACIDS RES, V16, P3, DOI [10.1093/nar/16.3.1215, DOI 10.1093/NAR/16.3.1215]; Moat SJ, 2013, EUR J HUM GENET, V21, P1049, DOI 10.1038/ejhg.2012.301; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Moxley RT, 2010, J CHILD NEUROL, V25, P1116, DOI 10.1177/0883073810371004; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Nakamura A, 2017, J HUM GENET, V62, P459, DOI 10.1038/jhg.2016.152; Niks EH, 2017, EXPERT OPIN BIOL TH, V17, P225, DOI 10.1080/14712598.2017.1271872; Prior TW, 2005, J MOL DIAGN, V7, P317, DOI 10.1016/S1525-1578(10)60560-0; Rao MV, 2014, ANN INDIAN ACAD NEUR, V17, P303, DOI 10.4103/0972-2327.138508; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rosenberg AS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7322; Sakthivel Murugan SM, 2013, INDIAN J MED RES, DOI [10.1111/j.1399-0004.1985.tb02281.x, DOI 10.1111/J.1399-0004.1985.TB02281.X]; Sakthivel Murugan SM, 2010, INDIAN J MED RES; Salian S, 2016, GENET COUNSEL, V27, P449; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Taglia A, 2015, ACTA MYOL; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; Vengalil S, 2017, J CLIN NEUROL, V13, P91, DOI 10.3988/jcn.2017.13.1.91; Verhaart IEC, 2019, NEUROMUSCULAR DISORD, V29, P576, DOI 10.1016/j.nmd.2019.06.004; WINNARD AV, 1995, AM J HUM GENET, V56, P158; Zampatti S, 2018, PRENATAL DIAG, V38, P1096, DOI 10.1002/pd.5369	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0232654	10.1371/journal.pone.0232654	http://dx.doi.org/10.1371/journal.pone.0232654			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559196	Green Published, gold			2022-12-26	WOS:000543261600006
J	Basson, AE; Charalambous, S; Hoffmann, CJ; Morris, L				Basson, Adriaan E.; Charalambous, Salome; Hoffmann, Christopher J.; Morris, Lynn			HIV-1 re-suppression on a first-line regimen despite the presence of phenotypic drug resistance	PLOS ONE			English	Article							2ND-LINE ANTIRETROVIRAL THERAPY; SUB-SAHARAN AFRICA; REVERSE-TRANSCRIPTASE; VIROLOGICAL FAILURE; VIRAL FAILURE; SUBTYPE-C; ADHERENCE; RESUPPRESSION; SWITCH; SUSCEPTIBILITY	We have previously reported on HIV-1 infected patients who fail anti-retroviral therapy but manage to re-suppress without a regimen change despite harbouring major drug resistance mutations. Here we explore phenotypic drug resistance in such patients in order to better understand this phenomenon. Patients (n = 71) failing a non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimen, but who subsequently re-suppressed on the same regimen, were assessed for HIV-1 genotypic drug resistance through Sanger sequencing. A subset (n = 23) of these samples, as well as genotypically matched samples from patients who did not re-suppress (n = 19), were further assessed for phenotypic drug resistance in anin vitrosingle cycle assay. Half of the patients (n = 36/71, 51%) harboured genotypic drug resistance, with M184V (n = 18/36, 50%) and K103N (n = 16/36, 44%) being the most prevalent mutations. No significant difference in the median time to re-suppression (31-39 weeks) were observed for either group (p = 0.41). However, re-suppressors with mutant virus rebounded significantly earlier than those with wild-type virus (16 vs. 33 weeks; p = 0.014). Similar phenotypic drug resistance profiles were observed between patients who re-suppressed and patients who failed to re-suppress. While most remained susceptible to stavudine (d4T) and zidovudine (AZT), both groups showed a reduced susceptibility to 3TC and NNRTIs. HIV- 1 infected patients on an NNRTI-based regimen can achieve viral re-suppression on the same regimen despite harbouring viruses with genotypic and phenotypic drug resistance. However, re-suppression was less durable in those with resistance, reinforcing the importance of appropriate regimen choices, ongoing viral load monitoring and adherence counselling.	[Basson, Adriaan E.; Morris, Lynn] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, Gauteng, South Africa; [Basson, Adriaan E.; Morris, Lynn] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, Gauteng, South Africa; [Charalambous, Salome; Hoffmann, Christopher J.] Aurum Inst, Johannesburg, Gauteng, South Africa; [Charalambous, Salome] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, Gauteng, South Africa; [Hoffmann, Christopher J.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; Johns Hopkins University	Basson, AE (corresponding author), Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, Gauteng, South Africa.; Basson, AE (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, Gauteng, South Africa.	adriaan.basson@wits.ac.za	; , Lynn/V-3941-2018	Hoffmann, Christopher/0000-0002-9422-0519; , Lynn/0000-0003-3961-7828; Basson, Adriaan/0000-0002-7541-8132; Charalambous, Salome/0000-0001-7143-1009	National Health Laboratory Service (NHLS); Poliomyelitis Research Foundation (PRF)	National Health Laboratory Service (NHLS); Poliomyelitis Research Foundation (PRF)	AEB and LM received research grants from the National Health Laboratory Service (NHLS) and the Poliomyelitis Research Foundation (PRF) to fund this study.	[Anonymous], 2013, ENDOKRYNOL POL, V64, P74; [Anonymous], 2016, LANCET INFECT DIS, V16, P565, DOI [10.1016/S1473-3099(15)00536-8, DOI 10.1016/S1473-3099(15)00536-8]; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Barth RE, 2012, ANTIVIR THER, V17, P377, DOI 10.3851/IMP2010; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Basson AE, 2015, ANTIMICROB AGENTS CH, V59, P960, DOI 10.1128/AAC.04215-14; Ceccherini-Silberstein F, 2018, J ANTIMICROB CHEMOTH, V73, P3460, DOI 10.1093/jac/dky350; Charalambous S, 2007, AIDS CARE, V19, P34, DOI 10.1080/09500340600677872; Chen Y, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/5283706; El-Khatib Z., 2011, Journal of AIDS and Clinical Research, V2, P117; Eron JJ, 2004, JAIDS-J ACQ IMM DEF, V37, P1581, DOI 10.1097/00126334-200412150-00009; Fatti G, 2020, CLIN INFECT DIS, V70, P395, DOI 10.1093/cid/ciz214; Ford N, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25415; Fox MP, 2018, TROP MED INT HEALTH, V23, P1314, DOI 10.1111/tmi.13152; Fox Z, 2008, AIDS, V22, P2279, DOI 10.1097/QAD.0b013e328311d16f; Georgette N, 2016, AIDS BEHAV, V20, P2629, DOI 10.1007/s10461-016-1287-z; Gerber JG, 2003, J CLIN VIROL, V27, P117, DOI 10.1016/S1386-6532(03)00033-7; Gupta RK, 2014, CLIN INFECT DIS, V58, P1023, DOI 10.1093/cid/cit933; Haberer JE, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21371; Hoffmann CJ, 2016, TROP MED INT HEALTH, V21, P219, DOI 10.1111/tmi.12639; Hoffmann CJ, 2014, TROP MED INT HEALTH, V19, P236, DOI 10.1111/tmi.12237; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Huang A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv158; Iacob SA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00831; Jobanputra K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116144; Johnston V, 2012, JAIDS-J ACQ IMM DEF, V61, P370, DOI 10.1097/QAI.0b013e318266ee3f; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lucas GM, 2005, J ANTIMICROB CHEMOTH, V55, P413, DOI 10.1093/jac/dki042; McCluskey SM, 2017, JAIDS-J ACQ IMM DEF, V76, P183, DOI 10.1097/QAI.0000000000001479; McCormick AL, 2011, ANTIMICROB AGENTS CH, V55, P1806, DOI 10.1128/AAC.01197-10; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Mukherjee JS, 2016, CURR HIV-AIDS REP, V13, P359, DOI 10.1007/s11904-016-0335-7; Murphy RA, 2017, AIDS RES HUM RETROV, V33, P1181, DOI [10.1089/aid.2017.0134, 10.1089/AID.2017.0134]; Nachega JB, 2016, CURR HIV-AIDS REP, V13, P241, DOI 10.1007/s11904-016-0325-9; NDoH, 2015, NAT CONS GUID PREV M; Orrell C, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/469127; Parry CM, 2009, J VIROL, V83, P9094, DOI 10.1128/JVI.02356-08; Petersen ML, 2014, AIDS, V28, P2097, DOI 10.1097/QAD.0000000000000349; Pretorius E, 2011, THER DRUG MONIT, V33, P265, DOI 10.1097/FTD.0b013e31821b42d1; Rhead R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167852; Rhee SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145772; Rosenbloom DIS, 2012, NAT MED, V18, P1378, DOI 10.1038/nm.2892; Rutstein SE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1611-2; Shet A, 2015, TROP MED INT HEALTH, V20, P1462, DOI 10.1111/tmi.12563; Shubber Z, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002183; Skhosana L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118145; Ssempijja V, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2680-6; Steegen K, 2017, J ANTIMICROB CHEMOTH, V72, P210, DOI 10.1093/jac/dkw358; Sutton SS, 2016, JAAPA-J AM ACAD PHYS, V29, P16, DOI 10.1097/01.JAA.0000502870.89587.b6; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Turner D, 2004, MICROBIOLOGICA, V27, P31; UNAIDS, 2018, UNAIDSJC2929E; Villa G, 2020, ECLINICALMEDICINE, V18, DOI 10.1016/j.eclinm.2019.12.001; von Wyl V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077691; Wainberg MA, 1996, AIDS, V10, pS3, DOI 10.1097/00002030-199612005-00002; Wainberg Mark A., 1997, Leukemia (Basingstoke), V11, P85	56	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234937	10.1371/journal.pone.0234937	http://dx.doi.org/10.1371/journal.pone.0234937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555643	gold, Green Published			2022-12-26	WOS:000543273200071
J	Hollandsworth, HM; Amirfakhri, S; Filemoni, F; Molnar, J; Hoffman, RM; Yazaki, P; Bouvet, M				Hollandsworth, Hannah M.; Amirfakhri, Siamak; Filemoni, Filemoni; Molnar, Justin; Hoffman, Robert M.; Yazaki, Paul; Bouvet, Michael			Near-infrared photoimmunotherapy is effective treatment for colorectal cancer in orthotopic nude-mouse models	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN	Background Photoimmunotherapy (PIT) employs the use of a near-infrared (NIR) laser to activate an antibody conjugated to a NIR-activatable dye to induce cancer cell death. PIT has shown to be effective in a number of studies, however, there are no data on its use in colorectal cancer in an orthotopic model. Methods Humanized anti-CEA antibody (M5A) was conjugated to NIR-activatable IRDye700DX (M5A-700). PIT was validated in vitro with a colon cancer cell-line, using a laser intensity of either 4 J/cm(2), 8 J/cm(2), or 16 J/cm(2). Orthotopic colon cancer mouse models were established by surgical implantation of LS174T tumor fragments onto the cecum. M5A-700 was administered and PIT was performed 24 hours later using a 690 nm laser. Repeat PIT was performed after 7 days in one group. Control mice received laser treatment only. Results In vitro PIT demonstrated tumor cell death in a laser intensity dose-dependent fashion. In orthotopic models, control mice demonstrated persistent tumor growth. Mice that underwent PIT one time had tumor growth arrested for one week, after which re-growth occurred. The group that received repeated PIT exposure had persistent inhibition of tumor growth. Conclusion PIT arrests tumor growth in colon cancer orthotopic nude-mouse models. Repeated PIT arrests colon cancer growth for a longer period of time. PIT may be a useful therapy in the future as an adjunct to surgical resection or as primary therapy to suppress tumor progression.	[Hollandsworth, Hannah M.; Amirfakhri, Siamak; Filemoni, Filemoni; Hoffman, Robert M.; Bouvet, Michael] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hollandsworth, Hannah M.; Amirfakhri, Siamak; Filemoni, Filemoni; Hoffman, Robert M.; Bouvet, Michael] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA; [Hollandsworth, Hannah M.; Amirfakhri, Siamak; Filemoni, Filemoni; Bouvet, Michael] VA San Diego Healthcare Syst, Dept Surg, San Diego, CA 92161 USA; [Molnar, Justin; Yazaki, Paul] Beckman Res Inst City Hope, Dept Mol Imaging & Therapy, Los Angeles, CA USA; [Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; City of Hope; Beckman Research Institute of City of Hope; Anti Cancer Inc	Bouvet, M (corresponding author), Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA.; Bouvet, M (corresponding author), Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA.; Bouvet, M (corresponding author), VA San Diego Healthcare Syst, Dept Surg, San Diego, CA 92161 USA.	mbouvet@uscd.edu		Hollandsworth, Hannah/0000-0002-8867-6835	VA [1 I01 BX003856-01A1, 1 I01 BX004494-01]; NIH/NCI [T32CA121938]	VA(US Department of Veterans Affairs); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was supported by VA Merit Review grant numbers 1 I01 BX003856-01A1 and 1 I01 BX004494-01 (MB), and NIH/NCI grant number T32CA121938 (HH). The funder provided support in the form of salaries for authors [HH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Hoffman is affiliated with the commercial company AntiCancer Inc. This commercial affiliation did not provide salaries for any authors and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Amri R, 2015, JAMA SURG, V150, P890, DOI 10.1001/jamasurg.2015.1525; Boudreau V, 2009, PAC REV, V22, P233, DOI 10.1080/09512740902815359; DeLong JC, 2017, J SURG RES, V218, P139, DOI 10.1016/j.jss.2017.05.069; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hiroshima Y, 2015, ANN SURG ONCOL, V22, pS1469, DOI 10.1245/s10434-015-4553-9; Hoffman RM, 2017, MEMORIAM J RYGAARD 1, P16; Jang Eun Jung, 2011, J Korean Soc Coloproctol, V27, P194, DOI 10.3393/jksc.2011.27.4.194; Kobayashi H, 2020, BIOCONJUGATE CHEM, V31, P28, DOI 10.1021/acs.bioconjchem.9b00546; Kobayashi H, 2019, ACCOUNTS CHEM RES, V52, P2332, DOI 10.1021/acs.accounts.9b00273; Maawy AA, 2015, J SURG RES, V197, P5, DOI 10.1016/j.jss.2015.02.037; Maawy AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121989; Ogata F, 2017, ONCOTARGET, V8, P35069, DOI 10.18632/oncotarget.17047; Ogawa M, 2017, ONCOTARGET, V8, P10425, DOI 10.18632/oncotarget.14425; Sato K, 2015, ONCOTARGET, V6, P19747, DOI 10.18632/oncotarget.3850; Sato K, 2015, MOL CANCER THER, V14, P141, DOI 10.1158/1535-7163.MCT-14-0658; Tiernan JP, 2013, BRIT J CANCER, V108, P662, DOI 10.1038/bjc.2012.605; Yazaki PJ, 2004, PROTEIN ENG DES SEL, V17, P481, DOI 10.1093/protein/gzh056; Zare-Bandamiri Mohammad, 2017, Asian Pac J Cancer Prev, V18, P2465	18	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234643	10.1371/journal.pone.0234643	http://dx.doi.org/10.1371/journal.pone.0234643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555717	Green Published, gold			2022-12-26	WOS:000543273200028
J	Bordehore, C; Fonfria, ES; Alonso, C; Rubio-Tortosa, B; Acevedo, MJ; Canepa, A; Falco, S; Rodilla, M; Fuentes, V				Bordehore, Cesar; Fonfria, Eva S.; Alonso, Cristina; Rubio-Tortosa, Beatriz; Acevedo, Melissa J.; Canepa, Antonio; Falco, Silvia; Rodilla, Miguel; Fuentes, Veronica			Effects of environmental variables on the distribution of juvenile cubomedusaeCarybdea marsupialisin the coastal Western Mediterranean	PLOS ONE			English	Article							LIFE-CYCLE; CNIDARIA; CUBOZOA; MORPHOLOGY; ECOLOGY; GULF	Relationships between environmental factors and oscillations in jellyfish abundance, especially in the early life stages, could help to interpret past increases and also predict scenarios in a changing future. For the first time, we present cubozoan spatial and temporal distributions in the earliest stages and their relationships with different factors. Abundances ofCarybdea marsupialismedusae showed high interannual variability from 2008 to 2014 along the Denia coast (SE Spain, W Mediterranean). During 2015, samples were collected from 11 beaches along 17 km of coastline, 8 times from January to November in order to determine the effects of environmental factors on the distribution of juvenileC.marsupialis. Juveniles (<= 15 mm diagonal bell width) were present from May to July, with more sampled near shore (0-15 m). Most of them occurred in June when their numbers were unequal among beaches (average 0.05 ind m(-3), maximum 6.71 ind m(-3)). We tested distributions of juveniles over time and space versus temperature, salinity, nutrients (N, P and Si), chlorophyll-a(Chl-a), and zooplankton abundance. Temperature and cladocerans (zooplankton group) were significantly positively correlated with juvenile distribution, whereas Chl-aconcentration was weakly negative. By contrast, in 2014, high productivity areas (Chl-aand zooplankton) overlapped the maximum adult abundance (5.2 ind m(-3)). The distribution of juveniles during 2015 did not spatially coincide with the areas where ripe adults were located the previous year, suggesting that juveniles drift with the currents upon release from the cubopolyps. Our results yield important insights into the complexity of cubozoan distributions.	[Bordehore, Cesar; Fonfria, Eva S.; Alonso, Cristina; Rubio-Tortosa, Beatriz] Univ Alicante, Ramon Margalef Environm Res Inst IMEM, San Vicente Del Raspeig, Spain; [Bordehore, Cesar] Univ Alicante, Dept Ecol, San Vicente Del Raspeig, Spain; [Acevedo, Melissa J.; Fuentes, Veronica] CSIC, Inst Marine Sci, Barcelona, Spain; [Canepa, Antonio] Univ Burgos, Polytech Sch, Burgos, Spain; [Falco, Silvia; Rodilla, Miguel] Univ Politecn Valencia, Res Inst Integrated Management Coastal Areas, Gandia, Spain	Universitat d'Alacant; Universitat d'Alacant; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Universidad de Burgos; Universitat Politecnica de Valencia	Bordehore, C (corresponding author), Univ Alicante, Ramon Margalef Environm Res Inst IMEM, San Vicente Del Raspeig, Spain.; Bordehore, C (corresponding author), Univ Alicante, Dept Ecol, San Vicente Del Raspeig, Spain.	cesar.bordehore@ua.es	Falco, Silvia/L-8050-2014; Rodilla, Miguel/J-4814-2012; Bordehore, Cesar/H-2773-2014; Canepa Oneto, Antonio Jesus/R-5260-2018	Falco, Silvia/0000-0002-8679-9153; Rodilla, Miguel/0000-0001-6767-5676; Bordehore, Cesar/0000-0002-2816-0538; FONFRIA, EVA/0000-0001-5593-8838; Canepa Oneto, Antonio Jesus/0000-0002-0608-2743	European Commission's LIFE programme [Alicante University] [LIFE08 NAT ES64]; European Commission's LIFE programme [Institute of Marine Science, CSIC, Spain] [LIFE08 NAT ES64]; D.G Sostenibilidad de la Costa y el Mar from the Spanish Ministry of Agriculture, Food and the Environment; Fundacion Biodiversidad; D.G. Agua -Generalitat Valenciana; Parques Nacionales; Ajuntament de Denia	European Commission's LIFE programme [Alicante University]; European Commission's LIFE programme [Institute of Marine Science, CSIC, Spain]; D.G Sostenibilidad de la Costa y el Mar from the Spanish Ministry of Agriculture, Food and the Environment; Fundacion Biodiversidad(European Commission); D.G. Agua -Generalitat Valenciana; Parques Nacionales; Ajuntament de Denia	This study has received funding through European Commission's LIFE programme [LIFE08 NAT ES64 CUBOMED.eu to C.B. from the Alicante University and V.L.F. from the Institute of Marine Science, CSIC, Spain], and from the D.G Sostenibilidad de la Costa y el Mar from the Spanish Ministry of Agriculture, Food and the Environment, the Fundacion Biodiversidad, and the D.G. Agua -Generalitat Valenciana. It has also received support from Parques Nacionales and Ajuntament de Denia.	Acevedo M, 2016, THESIS; Acevedo MJ, 2019, ZOOTAXA, V4543, P515, DOI 10.11646/zootaxa.4543.4.3; American Public Health Association (APHA), 2012, STANDARD METHODS EXA, DOI [10.2105/SMWW.2882?gclid=CjwKCAiA25v_BRBNEiwAZb4-ZRdKz6ceq6, DOI 10.2105/SMWW.2882?GCLID=CJWKCAIA25V_BRBNEIWAZB4-ZRDKZ6CEQ6]; Aminot A., 1983, MANUEL ANAL CHIMIQUE; Bettoso N, 2002, PERIOD BIOL, V104, P233; Boero F., 1986, Bollettino del Museo Civico di Storia Naturale di Venezia, V35, P179; Boero F., 2013, MAR BIOL RES, V92, DOI [10.1080/17451000.2014.880790, DOI 10.1080/17451000.2014.880790]; Bordehore C, 2014, THESIS; Bordehore C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137272; Bordehore Cesar, 2011, Marine Biodiversity Records, V4; Canepa A, 2014, THESIS; Canepa A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181611; Canepa A, 2014, J PLANKTON RES, V36, P585, DOI 10.1093/plankt/fbt124; Cegolon L, 2013, MAR DRUGS, V11, P523, DOI 10.3390/md11020523; Chiaverano LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077039; Coates MM, 2003, INTEGR COMP BIOL, V43, P542, DOI 10.1093/icb/43.4.542; Colin SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056393; Gadea I, 2013, THALASSAS, V29, P35; Garm A, 2007, J EXP BIOL, V210, P3616, DOI 10.1242/jeb.004044; Gershwin Lisa-Ann, 2005, Beagle, V21, P27; Gordon MR, 2009, HYDROBIOLOGIA, V616, P87, DOI 10.1007/s10750-008-9594-7; Gordon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031277; Graham WM, 2014, FRONT ECOL ENVIRON, V12, P515, DOI 10.1890/130298; HAMNER WM, 1982, LIMNOL OCEANOGR, V27, P896, DOI 10.4319/lo.1982.27.5.0896; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P181, DOI 10.1007/BF00026460; Kingsford M, 2014, JELLYFISH BLOOMS; Kingsford MJ, 2012, HYDROBIOLOGIA, V690, P257, DOI 10.1007/s10750-012-1041-0; LEWIN R, 1986, SCIENCE, V234, P25, DOI 10.1126/science.234.4772.25; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Marcus NH, 1998, LIMNOL OCEANOGR, V43, P763, DOI 10.4319/lo.1998.43.5.0763; Mooney CJ, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2867-1; Pulis K., 2015, THESIS; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Satterlie RA, 2001, J EXP BIOL, V204, P1413; Straehler-Pohl I, 2005, MAR BIOL, V147, P1271, DOI 10.1007/s00227-005-0031-4; Straehler-Pohl I, 2011, ZOOTAXA, P36; Yang C, 2004, BUS WEEK, P78; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur Alain F., 2009, P1	39	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0230768	10.1371/journal.pone.0230768	http://dx.doi.org/10.1371/journal.pone.0230768			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555581	Green Published, Green Submitted, gold			2022-12-26	WOS:000542759600028
J	Childs, RD; Nakao, H; Isogai, N; Murthy, A; Landis, WJ				Childs, Robin DiFeo; Nakao, Hitomi; Isogai, Noritaka; Murthy, Ananth; Landis, William J.			An analytical study of neocartilage from microtia and otoplasty surgical remnants: A possible application for BMP7 in microtia development and regeneration	PLOS ONE			English	Article							AURICULAR RECONSTRUCTION; STEM-CELL; GENE-EXPRESSION; IN-VITRO; EAR RECONSTRUCTION; CONTROLLED-RELEASE; DONOR SOURCE; CARTILAGE; TISSUE; CHONDROCYTES	To investigate auricular reconstruction by tissue engineering means, this study compared cartilage regenerated from human chondrocytes obtained from either microtia or normal (conchal) tissues discarded from otoplasties. Isolated cells were expanded in vitro, seeded onto nanopolyglycolic acid (nanoPGA) sheets with or without addition of bone morphogenetic protein-7 (BMP7), and implanted in nude mice for 10 weeks. On specimen harvest, cartilage development was assessed by gross morphology, histology, and RT-qPCR and microarray analyses. Neocartilages from normal and microtia surgical tissues were found equivalent in their dimensions, qualitative degree of proteoglycan and elastic fiber staining, and quantitative gene expression levels of types II and III collagen, elastin, and SOX5. Microarray analysis, applied for the first time for normal and microtia neocartilage comparison, yielded no genes that were statistically significantly different in expression between these two sample groups. These results support use of microtia tissue as a cell source for normal auricular reconstruction. Comparison of normal and microtia cells, each seeded on nanoPGA and supplemented with BMP7 in a slow-release hydrogel, showed statistically significant differences in certain genes identified by microarray analysis. Such differences were also noted in several analyses comparing counterpart seeded cells without BMP7. Summary data suggest a possible application for BMP7 in microtia cartilage regeneration and encourage further studies to elucidate whether such genotypic differences translate to phenotypic characteristics of the human microtic ear. The present work advances understanding relevant to the potential clinical use of microtia surgical remnants as a suitable cell source for tissue engineering of the pinna.	[Childs, Robin DiFeo; Landis, William J.] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA; [Childs, Robin DiFeo; Murthy, Ananth] Childrens Hosp Med Ctr, Div Plast & Reconstruct Surg, Akron, OH USA; [Nakao, Hitomi; Isogai, Noritaka] Kindai Univ, Dept Plast & Reconstruct Surg, Med Sch, Osakasayama, Osaka, Japan	University System of Ohio; University of Akron	Landis, WJ (corresponding author), Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.	wlandis@uakron.edu			Children's Hospital Medical Center of Akron, OH	Children's Hospital Medical Center of Akron, OH	Foundation grant from Children's Hospital Medical Center of Akron, OH, (Research grant to A. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasti F, 2009, J MED GENET, V46, P361, DOI 10.1136/jmg.2008.062158; Ali K, 2017, SEMIN PLAST SURG, V31, DOI 10.1055/s-0037-1604261; Bichara DA, 2012, TISSUE ENG PART B-RE, V18, P51, DOI [10.1089/ten.teb.2011.0326, 10.1089/ten.TEB.2011.0326]; bin Ishak MF, 2015, INT J PEDIATR OTORHI, V79, P1634, DOI 10.1016/j.ijporl.2015.06.034; Brent B, 2002, CLIN PLAST SURG, V29, P257, DOI 10.1016/S0094-1298(01)00013-X; Brown KK, 2013, HUM MUTAT, V34, P1347, DOI 10.1002/humu.22367; Cabin JA, 2014, FACIAL PLAST SURG CL, V22, P623, DOI 10.1016/j.fsc.2014.07.004; Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001; Cohen BP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202356; Cox TC, 2014, EUR J MED GENET, V57, P394, DOI 10.1016/j.ejmg.2014.05.003; Dexheimer V, 2016, SCI REP-UK, V6, DOI 10.1038/srep36655; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Flechtenmacher J, 1996, ARTHRITIS RHEUM-US, V39, P1896, DOI 10.1002/art.1780391117; Groves AK, 2000, DEVELOPMENT, V127, P3489; Haisch A, 2010, ADV OTO-RHINO-LARYNG, V68, P108, DOI 10.1159/000314566; Ishak MF, 2011, INT J PEDIATR OTORHI, V75, P835, DOI 10.1016/j.ijporl.2011.03.021; Jessop ZM, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0273-0; Johnson JS, 2015, J BONE JOINT SURG AM, V97A, P71, DOI 10.2106/JBJS.N.00246; Kamil SH, 2004, LARYNGOSCOPE, V114, P2187, DOI 10.1097/01.mlg.0000149455.68135.de; Kim HY, 2019, LARYNGOSCOPE, V129, P351, DOI 10.1002/lary.27344; Klagsbrun M, 1979, Methods Enzymol, V58, P560; Kobayashi S, 2011, P NATL ACAD SCI USA, V108, P14479, DOI 10.1073/pnas.1109767108; Kolios G, 2013, RESPIRATION, V85, P3, DOI 10.1159/000345615; Krause HM, 2018, TRENDS GENET, V34, P736, DOI 10.1016/j.tig.2018.06.005; Kusuhara H, 2009, WOUND REPAIR REGEN, V17, P136, DOI 10.1111/j.1524-475X.2008.00451.x; Landis WJ, 2017, J TISSUE ENG REGEN M, V11, P2373, DOI 10.1002/term.2137; Lewin S, 2015, FACIAL PLAST SURG, V31, P617, DOI 10.1055/s-0035-1567890; Luquetti DV, 2012, AM J MED GENET A, V158A, P124, DOI 10.1002/ajmg.a.34352; Luquetti DV, 2011, BIRTH DEFECTS RES A, V91, P813, DOI 10.1002/bdra.20836; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708; Melgarejo-Ramirez Y, 2016, CELL TISSUE BANK, V17, P481, DOI 10.1007/s10561-016-9574-5; Miao Y, 2017, ONCOTARGET, V8, P83114, DOI 10.18632/oncotarget.20851; Minoux M, 2013, DEVELOPMENT, V140, P4386, DOI 10.1242/dev.098046; Mussi E, 2019, BIOENGINEERING-BASEL, V6, DOI 10.3390/bioengineering6010014; Nakao H, 2017, PLAST RECONSTR SURG, V139, DOI 10.1097/PRS.0000000000003201; Nayyer L, 2012, PLAST RECONSTR SURG, V129, P1123, DOI 10.1097/PRS.0b013e31824a2c1c; Odabas S, 2013, J TISSUE ENG REGEN M, V7, P831, DOI 10.1002/term.1634; Otto IA, 2018, EUR CELLS MATER, V35, P132, DOI 10.22203/eCM.v035a10; OZKAYNAK E, 1990, EMBO J, V9, P2085, DOI 10.1002/j.1460-2075.1990.tb07376.x; Park C, 2010, CURR OPIN OTOLARYNGO, V18, P544, DOI 10.1097/MOO.0b013e32833fecb9; Patel KH, 2013, J TISSUE ENG, V4, DOI 10.1177/2041731413516782; Qiao RM, 2015, DIS MODEL MECH, V8, P611, DOI 10.1242/dmm.018291; Rafiee A, 2018, BIOTECHNOL GENET ENG, V34, P153, DOI 10.1080/02648725.2018.1471566; Reighard Chelsea L, 2018, J 3D Print Med, V2, P35, DOI 10.2217/3dp-2017-0017; Sabbagh W, 2011, J PLAST RECONSTR AES, V64, P452, DOI 10.1016/j.bjps.2010.07.027; Santo VE, 2013, TISSUE ENG PART B-RE, V19, P308, DOI [10.1089/ten.teb.2012.0138, 10.1089/ten.TEB.2012.0138]; Scarfi S, 2016, WORLD J STEM CELLS, V8, P1, DOI 10.4252/wjsc.v8.i1.1; Schiavi J, 2015, NANOMEDICINE-UK, V10, P753, DOI [10.2217/NNM.14.228, 10.2217/nnm.14.228]; Seifert A, 2015, WORLD J STEM CELLS, V7, P583, DOI 10.4252/wjsc.v7.i3.583; Shah CA, 2012, J BIOL CHEM, V287, P18230, DOI 10.1074/jbc.M111.328401; Shasti M, 2014, INT J PEDIATR OTORHI, V78, P416, DOI 10.1016/j.ijporl.2013.11.028; Siegert R, 2009, FACIAL PLAST SURG, V25, P149, DOI 10.1055/s-0029-1239451; Sivayoham E, 2012, CURR OPIN OTOLARYNGO, V20, P287, DOI 10.1097/MOO.0b013e328355b1d9; Sterodimas A, 2009, J PLAST RECONSTR AES, V62, P447, DOI 10.1016/j.bjps.2008.11.046; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Wang H, 2016, EUR SPINE J, V25, P2691, DOI 10.1007/s00586-016-4522-4; Wilkes GH, 2014, PLAST RECONSTR SURG, V134, p464E, DOI 10.1097/PRS.0000000000000526; Xue K, 2016, AM J TRANSL RES, V8, P732; Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5; Yanaga H, 2012, TISSUE ENG PT A, V18, P2020, DOI [10.1089/ten.tea.2011.0370, 10.1089/ten.TEA.2011.0370]; Zhang Q, 2009, PLAST RECONSTR SURG, V123, P849, DOI 10.1097/PRS.0b013e318199f057; Zhou GD, 2018, EBIOMEDICINE, V28, P287, DOI 10.1016/j.ebiom.2018.01.011	63	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234650	10.1371/journal.pone.0234650	http://dx.doi.org/10.1371/journal.pone.0234650			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555733	Green Published, gold			2022-12-26	WOS:000542759600048
J	Lopez-Duran, D; Plesiat, E; Krompiec, M; Artacho, E				Lopez-Duran, D.; Plesiat, Etienne; Krompiec, Michal; Artacho, Emilio			Gap variability upon packing in organic photovoltaics	PLOS ONE			English	Article							ELECTRON-ACCEPTOR; SOLAR-CELLS; DESIGN	The variation of the HOMO-LUMO band gap is explored for varying packing arrangements of the 4modBT-4TIC donor-acceptor molecule pair, by means of a high-throughput ab-initio random structure search of packing possibilities. 350 arrangements of the dimer have been relaxed from initial random dispositions, using non-local density-functional theory. We find that the electronic band gap varies within 0.3 eV, and that this magnitude, the binding energy, and the geometry are not significantly correlated. A clearly favoured structure is found with a binding energy of 1.75 +/- 0.07 eV, with all but three other arrangements displaying values of less than one third of this highest binding one, which involves the aliphatic chain of 4TIC.	[Lopez-Duran, D.; Artacho, Emilio] CIC Nanogune BRTA, San Sebastian, Spain; [Plesiat, Etienne] Univ Autonoma Madrid, Dept Quim, Modulo 13, Madrid, Spain; [Krompiec, Michal] Merck Chem Ltd, Chilworth Tech Ctr, Univ Pkwy, Southampton, Hants, England; [Krompiec, Michal] Univ Southampton, Sch Chem, Southampton, Hants, England; [Artacho, Emilio] Univ Cambridge, Theory Condensed Matter, Cavendish Lab, Cambridge, England; [Artacho, Emilio] Donostia Int Phys Ctr DIPC, San Sebastian, Spain; [Artacho, Emilio] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Lopez-Duran, D.] Univ Cordoba, Dept Fis, Campus Rabanales, Cordoba, Spain	Autonomous University of Madrid; University of Southampton; University of Cambridge; Basque Foundation for Science; Universidad de Cordoba	Lopez-Duran, D (corresponding author), CIC Nanogune BRTA, San Sebastian, Spain.; Lopez-Duran, D (corresponding author), Univ Cordoba, Dept Fis, Campus Rabanales, Cordoba, Spain.	dlduran@uco.es	López-Durán, David/L-9474-2014; Artacho, Emilio/G-2616-2015	López-Durán, David/0000-0003-2250-101X; Artacho, Emilio/0000-0001-9357-1547	Spain's MINECO [RTC-2016-5681-7, FIS2015-64886-C5-1-P]; European Union [676531]; Merck	Spain's MINECO; European Union(European Commission); Merck(Merck & Company)	Financial support was provided by Spain's MINECO project RTC-2016-5681-7, Spain's MINECO project FIS2015-64886-C5-1-P, and the European Union Horizon 2020 research and innovation program under the grant agreement No. 676531 (project E-CAM). Merck provided funding in the form of salary for Michal Krompiec The funder provided support in the form of salary for M.K., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2010, RESUSCITATION, V81, pe1; [Anonymous], 2018, CLIN BIOCH REV, V39, pS1; Artacho E, 1999, PHYS STATUS SOLIDI B, V215, P809, DOI 10.1002/(SICI)1521-3951(199909)215:1<809::AID-PSSB809>3.0.CO;2-0; Berland K, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.035412; Bitzek E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.170201; Blum V, 2009, COMPUT PHYS COMMUN, V180, P2175, DOI 10.1016/j.cpc.2009.06.022; Boschetto G, 2017, J PHYS CHEM C, V121, P2529, DOI 10.1021/acs.jpcc.6b10851; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Brabec C, 2014, ORGANIC PHOTOVOLTAICS: MATERIALS, DEVICE PHYSICS, AND MANUFACTURING TECHNOLOGIES, 2ND EDITION, P1, DOI 10.1002/9783527656912; ChemAxon, MARVINSKETCH MARVINV; Corsetti F, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/43/435504; Dar A. M., J ANAL BIOANAL TECH, DOI [10.4172/2155-9872.1000356, DOI 10.4172/2155-9872.1000356]; Dion M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.246401; Dou LT, 2013, ADV MATER, V25, P6642, DOI 10.1002/adma.201302563; El-Shehawy A.A., 2018, J MAT SCI NANOMATER, V2, P103; Halls MD, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/10/105029; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Junquera J, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.235111; KLEINMAN L, 1982, PHYS REV LETT, V48, P1425, DOI 10.1103/PhysRevLett.48.1425; Klimes J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/2/022201; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kokalj A, 1999, J MOL GRAPH MODEL, V17, P176, DOI 10.1016/S1093-3263(99)00028-5; Lee K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.245310; Lin YZ, 2015, ADV MATER, V27, P1170, DOI 10.1002/adma.201404317; Liu Y, 2018, ACS ENERGY LETT, V3, P2396, DOI 10.1021/acsenergylett.8b01416; Lopez SA, 2017, JOULE, V1, P857, DOI 10.1016/j.joule.2017.10.006; LOUIE SG, 1982, PHYS REV B, V26, P1738, DOI 10.1103/PhysRevB.26.1738; Lu LY, 2015, CHEM REV, V115, P12666, DOI 10.1021/acs.chemrev.5b00098; Oroya J, PSEUDOPOTENTIAL NUME; Paul J, TURNER GRACE DEV TEA; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pickard CJ, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/5/053201; PULAY P, 1980, CHEM PHYS LETT, V73, P393, DOI 10.1016/0009-2614(80)80396-4; Roman-Perez G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.096102; Rwenyagila ER, 2017, INT J PHOTOENERGY, V2017, DOI 10.1155/2017/1656512; Sagdullina DK, 2019, SYNTHETIC MET, V250, P7, DOI 10.1016/j.synthmet.2019.01.019; Saikia S, 2019, CURR DRUG TARGETS, V20, P501, DOI 10.2174/1389450119666181022153016; SHAM LJ, 1983, PHYS REV LETT, V51, P1888, DOI 10.1103/PhysRevLett.51.1888; Sharma A, 2014, J OPTOELECTRON ADV M, V16, P1257; Shi XL, 2017, CHEM MATER, V29, P8369, DOI 10.1021/acs.chemmater.7b02853; Sledz P, 2018, CURR OPIN STRUC BIOL, V48, P93, DOI 10.1016/j.sbi.2017.10.010; Soler JM, 2002, J PHYS-CONDENS MAT, V14, P2745, DOI 10.1088/0953-8984/14/11/302; The Lancet HIV, 2016, LANCET HIV, V3, pe191; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Vydrov OA, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3521275; YIJIE T, 2016, J POLYM SCI A, V54, P2239, DOI DOI 10.1002/pola.28097; Yuan J, 2019, JOULE, V3, P1140, DOI 10.1016/j.joule.2019.01.004; Zhang SQ, 2018, ADV MATER, V30, DOI 10.1002/adma.201800868; Zuo LJ, 2018, ADV MATER, V30, DOI 10.1002/adma.201706816	50	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234115	10.1371/journal.pone.0234115	http://dx.doi.org/10.1371/journal.pone.0234115			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544157	Green Published, gold			2022-12-26	WOS:000542957200003
J	Otaki, Y; Honda, H; Ueda, K				Otaki, Yurina; Honda, Hidehito; Ueda, Kazuhiro			Water demand management: Visualising a public good	PLOS ONE			English	Article							FIELD EXPERIMENT; INFORMATION; STRATEGIES; FEEDBACK; NORMS	Recent studies on water demand management show that providing visual information on water usage along with social comparisons with neighbouring households resulted in more efficient water usage. However, social comparisons can be discomforting for participants, especially in the case of downward or negative evaluations. To avoid this, some studies promote the use of social identity, a social norm approach that avoids comparisons. Past studies using social comparison used infographics, whereas other study types have used only textual (non-graphic) information. Therefore, in this study, we created a visualisation of water usage to highlight the importance of water as a shared resource, that is, as a public good, and feedback over six months according to the participants' water usage. A difference-in-difference analysis indicated that the feedback was marginally significant in decreasing water consumption immediately and continuously, especially for the middle and low use households, during the summer months, which is a period of perceived water shortage. From the questionnaire survey, we found that households felt that they determined their water usage based on their preference and were satisfied with the outcome.	[Otaki, Yurina] Hitotsubashi Univ, Kunitachi, Tokyo, Japan; [Honda, Hidehito] Yasuda Womens Univ, Hiroshima Asaminami Ku, Hiroshima, Japan; [Ueda, Kazuhiro] Univ Tokyo, Meguro Ku, Tokyo, Japan	Hitotsubashi University; University of Tokyo	Otaki, Y (corresponding author), Hitotsubashi Univ, Kunitachi, Tokyo, Japan.	yurina.otaki@r.hit-u.ac.jp	Honda, Hidehito/ABD-6043-2020		JSPS: Japan Society for the Promotion of Science [JP18H04324]; LIXIL Jyukankyo Foundation [17-42]; SECOM Science and Technology Foundation [2018]	JSPS: Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); LIXIL Jyukankyo Foundation; SECOM Science and Technology Foundation	This research was funded by JSPS: Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (b), grant number JP18H04324 to YO, LIXIL Jyukankyo Foundation grant number 17-42 to YO, and SECOM Science and Technology Foundation grant number 2018 to KU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DE., 1990, SOCIAL IDENTITY THEO; Allcott H, 2011, J PUBLIC ECON, V95, P1082, DOI 10.1016/j.jpubeco.2011.03.003; Ayres I, 2013, J LAW ECON ORGAN, V29, P992, DOI 10.1093/jleo/ews020; Beshears J, 2015, J FINANC, V70, P1161, DOI 10.1111/jofi.12258; Bhanot SP, 2017, J ECON PSYCHOL, V62, P155, DOI 10.1016/j.joep.2017.06.011; Brent DA, 2015, J ASSOC ENVIRON RESO, V2, P597, DOI 10.1086/683427; Costa DL, 2013, J EUR ECON ASSOC, V11, P680, DOI 10.1111/jeea.12011; Davies K, 2014, WATER RESOUR RES, V50, P7348, DOI 10.1002/2014WR015812; Erickson T, 2012, P SIGCHI C HUM FACT; Ferraro PJ, 2013, REV ECON STAT, V95, P64, DOI 10.1162/REST_a_00344; Ferraro PJ, 2011, AM ECON REV, V101, P318, DOI 10.1257/aer.101.3.318; Gallier C, 2019, J ECON BEHAV ORGAN, V164, P500, DOI 10.1016/j.jebo.2019.05.028; Goette L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211891; Hussien WA, 2018, J CLEAN PROD, V171, P1275, DOI 10.1016/j.jclepro.2017.10.094; Islan S, 2005, WATER RESOUR MANAG, V19, P423; Torres MMJ, 2018, J ENVIRON ECON MANAG, V92, P222, DOI 10.1016/j.jeem.2018.08.005; John LK, 2013, HEALTH PSYCHOL, V32, P1023, DOI 10.1037/a0033849; Landon AC, 2018, J CLEAN PROD, V195, P56, DOI 10.1016/j.jclepro.2018.05.196; Lehmann Sandra, 2007, STUDIA PHAENOMENOLOG, VVII, P15; Otaki Y, 2019, WATER-SUI, V11, DOI 10.3390/w11040844; Otaki Y, 2017, J CLEAN PROD, V143, P719, DOI 10.1016/j.jclepro.2016.12.051; Russell S, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008408; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Schultz PW, 2016, ENVIRON BEHAV, V48, P686, DOI 10.1177/0013916514553835; Seyranian V, 2015, J ENVIRON PSYCHOL, V41, P81, DOI 10.1016/j.jenvp.2014.11.009; Sonderlund AL, 2014, PROCEDIA ENGINEER, V89, P990, DOI 10.1016/j.proeng.2014.11.216; Stewart RA, 2013, BEHAV INFORM TECHNOL, V32, P695, DOI 10.1080/0144929X.2011.577195; Syme GJ, 2000, EVALUATION REV, V24, P539, DOI 10.1177/0193841X0002400601; Tajfel H., 1981, HUMAN GROUPS SOCIAL, DOI DOI 10.1002/EJSP.2420120209; TAYLOR SE, 1989, PSYCHOL REV, V96, P569, DOI 10.1037/0033-295X.96.4.569; Tiefenbeck V, 2018, MANAGE SCI, V64, P1458, DOI 10.1287/mnsc.2016.2646; Tom G., 2011, APPL ENV ED COMMUN, V10, P80, DOI [10.1080/1533015X.2011.575632, DOI 10.1080/1533015X.2011.575632]; Tortajada C, 2019, SUSTAIN CITIES SOC, V45, P649, DOI 10.1016/j.scs.2018.11.044; Willis RM, 2010, RESOUR CONSERV RECY, V54, P1117, DOI 10.1016/j.resconrec.2010.03.004	34	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234621	10.1371/journal.pone.0234621	http://dx.doi.org/10.1371/journal.pone.0234621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB9ZQ	32544207	Green Published, gold			2022-12-26	WOS:000542957200039
J	Rieck, LO; Sullivan, SMP				Rieck, Leslie O.; Sullivan, S. Mazeika P.			Coupled fish-hydrogeomorphic responses to urbanization in streams of Columbus, Ohio, USA	PLOS ONE			English	Article							INSECTIVOROUS BIRD ABUNDANCE; SCALE ENVIRONMENTAL-FACTORS; CHANNEL EVOLUTION MODEL; LAND-USE; ASSEMBLAGES EVIDENCE; HABITAT STRUCTURE; PHYSICAL HABITAT; PROCESS DOMAINS; RIVER-BASIN; URBAN LAND	Despite a developing literature on urban streams, few studies have addressed the timing and mechanisms of urban-induced stream hydrogeomorphic adjustment on biotic assemblages. Here, we investigated the relationships between urbanization-driven annual changes in fluvial geomorphic characteristics and fish assemblages in 12 headwater streams in the Columbus Metropolitan Area (CMA), Ohio (USA) over 3-5 years. Multiple stream hydrogeomorphic characteristics changed over time including slope (0.1% decrease on average), discharge (39% decrease), and shear stress (29% decrease), some in concert with one another (e.g., slope and shear stress). Species-specific fish associations with hydrogeomorphic associations varied in nature and strength by year and thus were somewhat equivocal. At the assemblage level, we observed a negative relationship between D-50(median sediment particle size) and % tolerant individuals as well as a positive trend between incision ratio and % generalists over study years. Study reaches with higher total catchment imperviousness were associated with both finer median sediment size (R-2= 0.19) and lower assemblage diversity (R-2= 0.55). These results contribute to current understanding of the drivers of fish assemblages in urbanizing catchments, and point to urban-induced hydrogeomorphic alterations as one mechanism through which land-use changes influence in-channel characteristics important to aquatic biota.	[Rieck, Leslie O.; Sullivan, S. Mazeika P.] Ohio State Univ, Sch Environm & Nat Resources, Wilma H Schiermeier Olentangy River Wetland Res P, Columbus, OH 43210 USA; [Rieck, Leslie O.] Lycoming Coll, Dept Biol, 1 Coll Pl, Williamsport, PA 17701 USA	University System of Ohio; Ohio State University	Rieck, LO (corresponding author), Ohio State Univ, Sch Environm & Nat Resources, Wilma H Schiermeier Olentangy River Wetland Res P, Columbus, OH 43210 USA.; Rieck, LO (corresponding author), Lycoming Coll, Dept Biol, 1 Coll Pl, Williamsport, PA 17701 USA.	rieck@lycoming.edu	Sulliván, Mažeika Patricio/C-8261-2012	Sulliván, Mažeika Patricio/0000-0003-2341-5316; Rieck, Leslie/0000-0003-0378-5256	Ohio Department of Natural Resources, Division of Wildlife through the USFWS State Wildlife Grant Program; Ohio Biodiversity Conservation Partnership (SMPS)	Ohio Department of Natural Resources, Division of Wildlife through the USFWS State Wildlife Grant Program; Ohio Biodiversity Conservation Partnership (SMPS)	Research support was provided by state and federal funds appropriated to The Ohio State University, Ohio Agricultural Research and Development Center (https://oardc.osu.edu/) and by the Ohio Department of Natural Resources, Division of Wildlife (http://wildlife.ohiodnr.gov/) through the USFWS State Wildlife Grant Program and the Ohio Biodiversity Conservation Partnership (https://obcp.osu.edu/) (SMPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Angermeier PL, 1999, ECOL APPL, V9, P335, DOI 10.2307/2641189; Annable WK, 2012, RIVER RES APPL, V28, P302, DOI 10.1002/rra.1457; [Anonymous], 2000, Am J Audiol, V9, P9; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2014, J APPL ECOL, DOI [DOI 10.1111/1365-2664.12306, DOI 10.1016/S0167-8809(99)00024-9]; Arnold CL, 1996, J AM PLANN ASSOC, V62, P243, DOI 10.1080/01944369608975688; ARNOLD CL, 1982, J GEOL, V90, P155, DOI 10.1086/628660; Baxter CV, 2005, FRESHWATER BIOL, V50, P201, DOI 10.1111/j.1365-2427.2004.01328.x; Bey CR, 2015, AQUAT CONSERV, V25, P555, DOI 10.1002/aqc.2539; Booth DB, 1997, J AM WATER RESOUR AS, V33, P1077, DOI 10.1111/j.1752-1688.1997.tb04126.x; BOOTH DB, 1990, WATER RESOUR BULL, V26, P407; Booth DB, 2015, AREA, V47, P408, DOI 10.1111/area.12180; Buffington JM, 1997, WATER RESOUR RES, V33, P1993, DOI 10.1029/96WR03190; Burcher CL, 2007, ECOLOGY, V88, P228, DOI 10.1890/0012-9658(2007)88[228:TLCRCL]2.0.CO;2; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chin A, 1998, J GEOL, V106, P59, DOI 10.1086/516007; Chin A, 2006, GEOMORPHOLOGY, V79, P460, DOI 10.1016/j.geomorph.2006.06.033; Chone G, 2016, RIVER RES APPL, V32, P528, DOI 10.1002/rra.2896; Cianfrani CM, 2006, J AM WATER RESOUR AS, V42, P941, DOI 10.1111/j.1752-1688.2006.tb04506.x; Colosimo MF, 2007, J AM WATER RESOUR AS, V43, P499, DOI 10.1111/j.1752-1688.2007.00039.x; Cunico AM, 2012, LANDSCAPE URBAN PLAN, V105, P336, DOI 10.1016/j.landurbplan.2012.01.002; D'Ambrosio JL, 2009, ENVIRON MONIT ASSESS, V148, P325, DOI 10.1007/s10661-008-0163-3; Daitsa G, DELAWARE COUNTY AUDI; de Carvalho Debora Reis, 2015, Acta Scientiarum Biological Sciences, V37, P439, DOI 10.4025/actascibiolsci.v37i4.28063; DeBoer JA, 2019, J GEOPHYS RES-BIOGEO, V124, P384, DOI 10.1029/2018JG004930; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; Ebrahimian A, 2016, J HYDROL, V536, P109, DOI 10.1016/j.jhydrol.2016.02.023; Engman AC, 2012, HYDROBIOLOGIA, V693, P141, DOI 10.1007/s10750-012-1100-6; Feld CK, 2016, SCI TOTAL ENVIRON, V573, P1320, DOI 10.1016/j.scitotenv.2016.06.243; Fitzpatrick FA, 2005, AM FISH S S, V47, P87; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Fusillo TV, 1977, P INT S URBAN HYDROL; GORMAN OT, 1978, ECOLOGY, V59, P507, DOI 10.2307/1936581; Gregory KJ, 2006, GEOMORPHOLOGY, V79, P172, DOI 10.1016/j.geomorph.2006.06.018; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Gross J., 2003, R NEWS, V3, P13; HAMMER TR, 1972, WATER RESOUR RES, V8, P1530, DOI 10.1029/WR008i006p01530; Harrelson C. C., 1994, GEN TECHNICAL REPORT; Hassett BA, 2018, FRESHW SCI, V37, P653, DOI 10.1086/699387; Hawley RJ, 2013, J HYDROL, V496, P17, DOI 10.1016/j.jhydrol.2013.05.010; Hawley RJ, 2012, J AM WATER RESOUR AS, V48, P722, DOI 10.1111/j.1752-1688.2012.00645.x; Henshaw PC, 2000, J AM WATER RESOUR AS, V36, P1219, DOI 10.1111/j.1752-1688.2000.tb05722.x; Hession WC, 2003, GEOLOGY, V31, P147, DOI 10.1130/0091-7613(2003)031<0147:IOBVOC>2.0.CO;2; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hogan DM, 2014, J AM WATER RESOUR AS, V50, P163, DOI 10.1111/jawr.12123; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Hunt K, 2013, PROF GEOGR, V65, P296, DOI 10.1080/00330124.2012.681517; Iwata T, 2003, ECOGRAPHY, V26, P325, DOI 10.1034/j.1600-0587.2003.03355.x; Iwata T, 2010, CONSERV BIOL, V24, P1278, DOI 10.1111/j.1523-1739.2010.01493.x; Jeje LK, 2002, SINGAPORE J TROP GEO, V23, P37, DOI 10.1111/1467-9493.00117; Jordan BA, 2010, RIVER RES APPL, V26, P1281, DOI 10.1002/rra.1333; Kang RS, 2006, GEOMORPHOLOGY, V79, P488, DOI 10.1016/j.geomorph.2006.06.034; Kang RS, 2010, PHYS GEOGR, V31, P186, DOI 10.2747/0272-3646.31.2.186; Kautza A, 2015, FRESHWATER BIOL, V60, P2156, DOI 10.1111/fwb.12642; Kautza A, 2012, FUND APPL LIMNOL, V180, P259, DOI 10.1127/1863-9135/2012/0282; KONDOLF GM, 1995, ENVIRON MANAGE, V19, P1, DOI 10.1007/BF02471999; KONDOLF GM, 1995, AQUAT CONSERV, V5, P127, DOI 10.1002/aqc.3270050205; Kuik Cheng-Chwee, 2018, E ASIA FORUM Q JAN, P22; Latli A, 2019, FRESHWATER BIOL, V00, P1; LEMMON PAUL E., 1957, JOUR FOREST, V55, P667; LENAT DR, 1994, HYDROBIOLOGIA, V294, P185, DOI 10.1007/BF00021291; Leopold L.B., 1968, GEOL SURV CIRCULAR, VUSG, pS554; Leopold LB, 2005, P AM PHILOS SOC, V149, P349; LEOPOLD LB, 1973, GEOL SOC AM BULL, V84, P1845, DOI 10.1130/0016-7606(1973)84<1845:RCCWTA>2.0.CO;2; MacFarland MF, 2012, THESIS; Meyer JL, 2005, J N AM BENTHOL SOC, V24, P602, DOI 10.1899/04-021.1; Mingo CE, FRANKLIN COUNTY AUDI; Montgomery DR, 1999, J AM WATER RESOUR AS, V35, P397, DOI 10.1111/j.1752-1688.1999.tb03598.x; Morgan RP, 2005, J N AM BENTHOL SOC, V24, P643, DOI 10.1899/0887-3593(2005)024\\[0643:UEOSFA\\]2.0.CO;2; National Weather Service, 2019, COL CLIM GRAPHS; Navratil O, 2013, J HYDROL, V485, P24, DOI 10.1016/j.jhydrol.2012.01.036; Nelson AC, 2014, COLUMBUS OHIO METROP, P3; Nelson PA, 2006, EARTH SURF PROC LAND, V31, P1063, DOI 10.1002/esp.1308; O'Driscoll M, 2010, WATER-SUI, V2, P605, DOI 10.3390/w2030605; Ohio Environmental Protection Agency, 1987, US MAN BIOL FIELD AS, VII; Parks TP, 2016, RIVER RES APPL, V32, P66, DOI 10.1002/rra.2844; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Pease AA, 2015, HYDROBIOLOGIA, V753, P265, DOI 10.1007/s10750-015-2235-z; Peressin A, 2014, URBAN ECOSYST, V17, P675, DOI 10.1007/s11252-014-0352-5; Peterson JT, 2015, RIVER RES APPL, V31, P1227, DOI 10.1002/rra.2835; Pizzuto JE, 2000, GEOLOGY, V28, P79, DOI 10.1130/0091-7613(2000)028<0079:CGRIPU>2.0.CO;2; POFF NL, 1995, ECOLOGY, V76, P606, DOI 10.2307/1941217; Poole GC, 2002, FRESHWATER BIOL, V47, P641, DOI 10.1046/j.1365-2427.2002.00922.x; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Powell GE, SPREADSHEET TOOLS RI; POWER ME, 1984, J ANIM ECOL, V53, P357, DOI 10.2307/4521; Rencher A.C., 1995, METHODS MULTIVARIATE; Roberts C.R., 1989, FLOODS HYDROLOGICAL, P57; Rowe DC, 2009, N AM J FISH MANAGE, V29, P1333, DOI 10.1577/M08-193.1; Russell KL, 2018, ANTHROPOCENE, V23, P53, DOI 10.1016/j.ancene.2018.09.001; Russell KL, 2017, EARTH-SCI REV, V168, P73, DOI 10.1016/j.earscirev.2017.04.001; SCHLOSSER IJ, 1991, BIOSCIENCE, V41, P704, DOI 10.2307/1311765; Schumm S.A., 1984, FLUVIAL SYSTEM; Schwartz JS, 2015, ECOL ENG, V78, P112, DOI 10.1016/j.ecoleng.2014.06.002; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shepherd SL, 2011, RIVER RES APPL, V27, P857, DOI 10.1002/rra.1401; Shields FD, 2010, ECOL ENG, V36, P78, DOI 10.1016/j.ecoleng.2009.09.014; Smith M, LICKING COUNTY AUDIT; Stein ED, 2013, J AM WATER RESOUR AS, V49, P780, DOI 10.1111/jawr.12035; Strahler AN, 1957, AM GEOPHYS UNION T, V8, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; Sullivan SMP, 2006, FRESHWATER BIOL, V51, P1811, DOI 10.1111/j.1365-2427.2006.01616.x; Sullivan SMP, 2013, FRESHW SCI, V32, P606, DOI 10.1899/12-101.1; Sullivan SMP, 2012, ENVIRON TOXICOL CHEM, V31, P1175, DOI 10.1002/etc.1842; Sullivan SMP, 2008, CAN J FISH AQUAT SCI, V65, P2667, DOI 10.1139/F08-165; Sullivan SMP, 2004, ENVIRON MANAGE, V34, P669, DOI 10.1007/s00267-004-4032-8; Tagwireyi P, 2016, MAR FRESHWATER RES, V67, P309, DOI 10.1071/MF14335; Thorp JH, 2006, RIVER RES APPL, V22, P123, DOI 10.1002/rra.901; Trautman M. B, 1981, FISHES OHIO ILLUSTRA; Troia MJ, 2015, ECOL ENG, V75, P484, DOI 10.1016/j.ecoleng.2014.12.016; United States Geological Survey, NAT WAT INF SYST; Vaughan IP, 2009, AQUAT CONSERV, V19, P113, DOI 10.1002/aqc.895; Vietz GJ, 2016, PROG PHYS GEOG, V40, P480, DOI 10.1177/0309133315605048; Walsh CJ, 2016, PROG PHYS GEOG, V40, P714, DOI 10.1177/0309133316671626; Walsh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045814; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Walters DM, 2009, ECOL INDIC, V9, P1222, DOI 10.1016/j.ecolind.2009.02.011; Walters DM, 2003, FRESHWATER BIOL, V48, P1950, DOI 10.1046/j.1365-2427.2003.01137.x; Ward A.D., 2004, ENV HYDROLOGY; Wenger SJ, 2009, J N AM BENTHOL SOC, V28, P1080, DOI 10.1899/08-186.1; Whitney JE, 2019, T AM FISH SOC, V148, P191, DOI 10.1002/tafs.10130; Wohl E, 2005, WATER RESOUR RES, V41, DOI 10.1029/2005WR003985; Wolman M. G., 1954, T AM GEOPHYS UNION, V35, P951, DOI DOI 10.1029/TR035I006P00951	124	6	6	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234303	10.1371/journal.pone.0234303	http://dx.doi.org/10.1371/journal.pone.0234303			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB6AZ	32542035	Green Published, gold			2022-12-26	WOS:000542685100028
J	Nies, F; Mielke, M; Pochert, J; Lamparter, T				Nies, Fabian; Mielke, Marion; Pochert, Janko; Lamparter, Tilman			Natural transformation of the filamentous cyanobacteriumPhormidium lacuna	PLOS ONE			English	Article							GENETIC-TRANSFORMATION; GROOVE-BINDING; PCC 6803; MOTILITY; DNA; COMPETENCE; MECHANISMS; DAPI; INTERCALATION; CYANOBACTERIA	Research for biotechnological applications of cyanobacteria focuses on synthetic pathways and bioreactor design, while little effort is devoted to introduce new, promising organisms in the field. Applications are most often based on recombinant work, and the establishment of transformation can be a risky, time-consuming procedure. In this work we demonstrate the natural transformation of the filamentous cyanobacteriumPhormidium lacunaand insertion of a selection marker into the genome by homologous recombination. This is the first example for natural transformation filamentous non-heterocystous cyanobacterium. We found thatPhormidium lacunais polyploid, each cell has about 20-90 chromosomes. Transformed filaments were resistant against up to 14 mg/ml of kanamycin. Formerly, natural transformation in cyanobacteria has been considered a rare and exclusive feature of a few unicellular species. Our finding suggests that natural competence is more distributed among cyanobacteria than previously thought. This is supported by bioinformatic analyses which show that all protein factors for natural transformation are present in the majority of the analyzed cyanobacteria.	[Nies, Fabian; Mielke, Marion; Pochert, Janko; Lamparter, Tilman] Karlsruhe Inst Technol, Inst Bot, Karlsruhe, Germany; [Nies, Fabian] Univ Kiel, Inst Gen Microbiol, Kiel, Germany	Helmholtz Association; Karlsruhe Institute of Technology; University of Kiel	Lamparter, T (corresponding author), Karlsruhe Inst Technol, Inst Bot, Karlsruhe, Germany.	tilman.lamparter@kit.edu	Lamparter, Tilman/E-4421-2013	Lamparter, Tilman/0000-0003-4327-9737	Nagelschneider Foundation	Nagelschneider Foundation	This work was supported by the PhD fellowship of the Nagelschneider Foundation to Fabian Nies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermayr SA, 2015, TRENDS BIOTECHNOL, V33, P352, DOI 10.1016/j.tibtech.2015.03.009; [Anonymous], 2015, Z INTERKULTURELLE GE, V6, P9; [Anonymous], 2016, CANC DISCOV; Bhaya D, 2000, MOL MICROBIOL, V37, P941, DOI 10.1046/j.1365-2958.2000.02068.x; Brendel V, 1997, J MOL EVOL, V44, P528, DOI 10.1007/PL00006177; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cassier-Chauvat C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01809; Chazotte B., 2011, COLD SPRING HARBOR P, V6, P80, DOI [10.1101/pdb.prot5556, DOI 10.1101/PDB.PROT5556]; Chen AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047837; Dada AC, 2013, ENVIRON MONIT ASSESS, V185, P7427, DOI 10.1007/s10661-013-3110-x; DEVILLY CI, 1977, J GEN MICROBIOL, V98, P277, DOI 10.1099/00221287-98-1-277; Dexter J, 2015, J APPL MICROBIOL, V119, P11, DOI 10.1111/jam.12821; Dittmann E, 1997, MOL MICROBIOL, V26, P779, DOI 10.1046/j.1365-2958.1997.6131982.x; Dubnau D, 2019, ANNU REV GENET, V53, P217, DOI 10.1146/annurev-genet-112618-043641; ElhaI J, 1997, J BACTERIOL, V179, P1998, DOI 10.1128/jb.179.6.1998-2005.1997; FUJITA Y, 1992, PLANT CELL PHYSIOL, V33, P81; Griese M, 2011, FEMS MICROBIOL LETT, V323, P124, DOI 10.1111/j.1574-6968.2011.02368.x; GRIGORIEVA G, 1982, FEMS MICROBIOL LETT, V13, P367, DOI 10.1111/j.1574-6968.1982.tb08289.x; Gupta S, 2006, FOLIA MICROBIOL, V51, P565, DOI 10.1007/BF02931621; Ishida K, 2007, CHEM BIOL, V14, P565, DOI 10.1016/j.chembiol.2007.04.006; Jeamton W, 2017, PLANT CELL PHYSIOL, V58, P822, DOI 10.1093/pcp/pcx016; Johnsborg O, 2007, RES MICROBIOL, V158, P767, DOI 10.1016/j.resmic.2007.09.004; Johnson TJ, 2018, BIOTECHNOL PROGR, V34, P811, DOI 10.1002/btpr.2628; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Khayatan B, 2015, MOL MICROBIOL, V98, P1021, DOI 10.1111/mmi.13205; Khetkorn W, 2017, BIORESOURCE TECHNOL, V243, P1194, DOI 10.1016/j.biortech.2017.07.085; Knoot CJ, 2020, ACS SYNTH BIOL, V9, P132, DOI 10.1021/acssynbio.9b00417; Koksharova OA, 2002, APPL MICROBIOL BIOT, V58, P123, DOI 10.1007/s00253-001-0864-9; Kufryk GI, 2002, FEMS MICROBIOL LETT, V206, P215; LEE LS, 1993, J BIOCHEM BIOPH METH, V26, P249, DOI 10.1016/0165-022X(93)90026-K; Matthey N, 2016, TRENDS MICROBIOL, V24, P98, DOI 10.1016/j.tim.2015.10.008; Mell JC, 2014, J BACTERIOL, V196, P1471, DOI 10.1128/JB.01293-13; Nakasugi K, 2006, MICROBIOL-SGM, V152, P3623, DOI 10.1099/mic.0.29189-0; Nies F, 2017, PROCESS BIOCHEM, V59, P194, DOI 10.1016/j.procbio.2017.05.015; Okamoto S, 2002, PLANT CELL PHYSIOL, V43, P1127, DOI 10.1093/pcp/pcf128; Onai K, 2004, MOL GENET GENOMICS, V271, P50, DOI 10.1007/s00438-003-0953-9; Ravindran CRM, 2006, J MICROBIOL METH, V66, P174, DOI 10.1016/j.mimet.2005.11.011; Roca AI, 1990, CRIT REV BIOCHEM MOL, V25, P11996; Sargent EC, 2016, FEMS MICROBIOLOGY LE, V363, P7; Sarnaik A, 2018, ALGAL RES, V36, P139, DOI 10.1016/j.algal.2018.10.021; SCHAEFER MR, 1993, J BACTERIOL, V175, P5701, DOI 10.1128/JB.175.17.5701-5705.1993; SHESTAKOV SV, 1970, MOL GEN GENET, V107, P372, DOI 10.1007/BF00441199; Soppa J, 2014, J MOL MICROB BIOTECH, V24, P409, DOI 10.1159/000368855; STEVENS SE, 1980, P NATL ACAD SCI-BIOL, V77, P6052, DOI 10.1073/pnas.77.10.6052; Stucken K, 2013, BIOL RES, V46, P373, DOI 10.4067/S0716-97602013000400009; Sukenik A, 2012, ISME J, V6, P670, DOI 10.1038/ismej.2011.128; TANIOUS FA, 1992, BIOCHEMISTRY-US, V31, P3103, DOI 10.1021/bi00127a010; Taton A, 2020, NAT COMM, V11; Toyomizu M, 2001, J APPL PHYCOL, V13, P209, DOI 10.1023/A:1011182613761; TREHAN K, 1982, AUST J BIOL SCI, V35, P573, DOI 10.1071/BI9820573; Ungerer J, 2016, SCI REP-UK, V6, DOI 10.1038/srep39681; Vermaas W, 1996, J APPL PHYCOL, V8, P263, DOI 10.1007/BF02178569; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Vijayakumar S, 2015, J ACUTE MED, V5, P15, DOI 10.1016/j.jacme.2015.02.004; Vioque A, 2007, ADV EXP MED BIOL, V616, P12; Watanabe S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136800; Wendt KE, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01259; Wendt KE, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0514-7; Wilde A, 2002, MOL MICROBIOL, V44, P981, DOI 10.1046/j.1365-2958.2002.02923.x; WILSON WD, 1989, J AM CHEM SOC, V111, P5008, DOI 10.1021/ja00195a080; Yoshihara S, 2001, PLANT CELL PHYSIOL, V42, P63, DOI 10.1093/pcp/pce007; Zang XN, 2007, J MICROBIOL, V45, P241; Zerulla K, 2016, MICROBIOL-SGM, V162, P730, DOI 10.1099/mic.0.000264	63	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234440	10.1371/journal.pone.0234440	http://dx.doi.org/10.1371/journal.pone.0234440			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530971	Green Submitted, gold, Green Published			2022-12-26	WOS:000542037200025
J	Sager, R; Gusewell, S; Ruhli, F; Bender, N; Staub, K				Sager, Roman; Guesewell, Sabine; Ruehli, Frank; Bender, Nicole; Staub, Kaspar			Multiple measures derived from 3D photonic body scans improve predictions of fat and muscle mass in young Swiss men	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; WAIST CIRCUMFERENCE; WHOLE-BODY; SKELETAL-MUSCLE; MEASUREMENT ERROR; OBESITY; MORTALITY; SHAPE; RISK; BMI	Introduction Digital tools like 3D laser-based photonic scanners, which can assess external anthropometric measurements for population based studies, and predict body composition, are gaining in importance. Here we focus on a) systematic deviation between manually determined and scanned standard measurements, b) differences regarding the strength of association between these standard measurements and body composition, and c) improving these predictions of body composition by considering additional scan measurements. Methods We analysed 104 men aged 19-23. Bioelectrical Impedance Analysis was used to estimate whole body fat mass, visceral fat mass and skeletal muscle mass (SMM). For the 3D body scans, an Anthroscan VITUSbodyscan was used to automatically obtain 90 body shape measurements. Manual anthropometric measurements (height, weight, waist circumference) were also taken. Results Scanned and manually measured height, waist circumference, waist-to-height-ratio, and BMI were strongly correlated (Spearman Rho>0.96), however we also found systematic differences. When these variables were used to predict body fat or muscle mass, explained variation and prediction standard errors were similar between scanned and manual measurements. The univariable predictions performed well for both visceral fat (r(2)up to 0.92) and absolute fat mass (AFM, r(2)up to 0.87) but not for SMM (r(2)up to 0.54). Of the 90 body scanner measures used in the multivariable prediction models, belly circumference and middle hip circumference were the most important predictors of body fat content. Stepwise forward model selection using the AIC criterion showed that the best predictive power (r(2)up to 0.99) was achieved with models including 49 scanner measurements. Conclusion The use of a 3D full body scanner produced results that strongly correlate to manually measured anthropometric measures. Predictions were improved substantially by including multiple measurements, which can only be obtained with a 3D body scanner, in the models.	[Sager, Roman] Univ Zurich, Med Fac, Zurich, Switzerland; [Guesewell, Sabine; Ruehli, Frank; Bender, Nicole; Staub, Kaspar] Univ Zurich, Inst Evolutionary Med, Zurich, Switzerland; [Guesewell, Sabine] Kantonsspital St Gallen, Clin Trials Unit, St Gallen, Switzerland; [Ruehli, Frank; Staub, Kaspar] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland	University of Zurich; University of Zurich; Kantonsspital St. Gallen; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Staub, K (corresponding author), Univ Zurich, Inst Evolutionary Med, Zurich, Switzerland.; Staub, K (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland.	kaspar.staub@iem.uzh.ch		Bender, Nicole/0000-0002-3838-587X; Staub, Kaspar/0000-0002-3951-1807; Eppenberger, Patrick/0000-0002-9526-8709	Maxi Foundation, Zurich	Maxi Foundation, Zurich	Maxi Foundation, Zurich (Grantee Frank Ruhli). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180201; Anderson LJ, 2012, NUTR RES, V32, P479, DOI 10.1016/j.nutres.2012.05.009; Atish S, 2002, N ENGL J MED; Beckmann C, 2019, PEERJ, V7, DOI 10.7717/peerj.8095; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bosy-Westphal A, 2017, EUR J CLIN NUTR, V71, P1061, DOI 10.1038/ejcn.2017.27; Bosy-Westphal A, 2013, EUR J CLIN NUTR, V67, pS14, DOI 10.1038/ejcn.2012.160; Burini R. C., 2012, HDB ANTHROPOMETRY, P1747, DOI DOI 10.1007/978.1.4419.1788.1.107; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cui Zhaohui, 2013, Int J Body Compos Res, V11, P85; Dalgleish T, 2007, J EXP PSYCHOL GEN, V136, P23, DOI 10.1037/0096-3445.136.1.23; Day K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101469; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; Dhana K, 2016, J EPIDEMIOL COMMUN H, V70, P90, DOI 10.1136/jech-2014-205257; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Duren Dana L, 2008, J Diabetes Sci Technol, V2, P1139; Eckel RH, 1998, AM HEART ASS CALL AC; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; HAARBO J, 1991, CLIN PHYSIOL, V11, P331, DOI 10.1111/j.1475-097X.1991.tb00662.x; Harbin MM, 2018, EUR J CLIN NUTR, V72, P1191, DOI 10.1038/s41430-017-0046-1; Heitmann BL, 2000, INT J OBESITY, V24, P33, DOI 10.1038/sj.ijo.0801082; Heymsfield SB, 2018, EUR J CLIN NUTR, V72, P680, DOI 10.1038/s41430-018-0145-7; Jaeschke L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119430; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kahlhofer J, 2016, OBESITY, V24, P335, DOI 10.1002/oby.21326; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kit B.K., 2014, HDB EPIDEMIOLOGY, P2229, DOI DOI 10.1007/978-0-387-09834-0; Koepke N, 2017, PEERJ, V5, DOI 10.7717/peerj.2980; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kuehnapfel A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26672; Lee CG, 2011, J AM GERIATR SOC, V59, P233, DOI 10.1111/j.1532-5415.2010.03245.x; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lee JJ, 2015, AM J HUM BIOL, V27, P445, DOI 10.1002/ajhb.22663; Lee SY, 2008, CURR OPIN CLIN NUTR, V11, P566, DOI 10.1097/MCO.0b013e32830b5f23; Lim JS, 2009, PEDIATR INT, V51, P263, DOI 10.1111/j.1442-200X.2008.02698.x; Lin JD, 2004, CLIN NUTR, V23, P1313, DOI 10.1016/j.clnu.2004.04.005; Loeffler-Wirth H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186881; Loffler-Wirth H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159887; Lu Y, 2020, IEEE J BIOMED HEALTH, V24, P205, DOI 10.1109/JBHI.2019.2903190; Lu Y, 2019, PROC SPIE, V10949, DOI 10.1117/12.2505896; Lu Yao, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P3999, DOI 10.1109/EMBC.2018.8513261; Navarro P, 2020, AM J HUM BIOL, V32, DOI 10.1002/ajhb.23323; Ng BK, 2016, EUR J CLIN NUTR, V70, P1265, DOI 10.1038/ejcn.2016.109; Ng BK, 2019, AM J CLIN NUTR, V110, P1316, DOI 10.1093/ajcn/nqz218; Nuttall FQ, 2015, NUTR TODAY, V50, P117, DOI [10.1097/NT.0000000000000092, DOI 10.1097/NT.0000000000000092]; Olds T, 2013, J SPORT SCI, V31, P936, DOI 10.1080/02640414.2012.759660; Olivares Josefina, 2007, J Diabetes Sci Technol, V1, P921; Peyer KE, 2015, PEERJ, V3, DOI 10.7717/peerj.831; Pleuss JD, 2019, EUR J CLIN NUTR, V73, P200, DOI 10.1038/s41430-018-0337-1; Schweitzer L, 2015, AM J CLIN NUTR, V102, P58, DOI 10.3945/ajcn.115.111203; Staub K, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018664; Staub K, 2016, OBESITY FACTS, V9, P259, DOI 10.1159/000446966; Thurlow S, 2018, EUR J CLIN NUTR, V72, P148, DOI 10.1038/ejcn.2017.110; Treleaven P, 2007, COMPUTER, V40, P28, DOI 10.1109/MC.2007.225; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; Verweij LM, 2013, PUBLIC HEALTH NUTR, V16, P281, DOI 10.1017/S1368980012002741; Wang J, 2006, AM J CLIN NUTR, V83, P3; Wang J, 2007, OBESITY, V15, P2688, DOI 10.1038/oby.2007.321; Wannamethee SG, 2007, AM J CLIN NUTR, V86, P1339, DOI 10.1093/ajcn/86.5.1339; Wells JCK, 2008, INT J OBESITY, V32, P152, DOI 10.1038/sj.ijo.0803685; Wells JCK, 2008, INT J OBESITY, V32, P232, DOI 10.1038/sj.ijo.0803727; Wells JCK, 2012, INT J OBESITY, V36, P148, DOI 10.1038/ijo.2011.51; Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522; Wells JCK, 2019, AM J CLIN NUTR, V110, P1272, DOI 10.1093/ajcn/nqz258; Wells JCK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124193; Wong MC, 2019, OBESITY, V27, P1738, DOI 10.1002/oby.22637; World Health Organization, 2008, WAIST CIRCUMFERENCE; 2012, BIOS ENV HLTH, P1	71	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234552	10.1371/journal.pone.0234552	http://dx.doi.org/10.1371/journal.pone.0234552			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QL	32525949	Green Published, Green Accepted, gold			2022-12-26	WOS:000542036800030
J	Haizel, SA; Bhardwaj, U; Gonzalez, RL; Mitra, S; Goss, DJ				Haizel, Solomon A.; Bhardwaj, Usha; Gonzalez, Ruben L., Jr.; Mitra, Somdeb; Goss, Dixie J.			5 '-UTR recruitment of the translation initiation factor eIF4GI or DAP5 drives cap-independent translation of a subset of human mRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						5 ' cap-independent translation enhancer (CITE); internal ribosome entry site (IRES); eukaryotic translation initiation factor 4 GI (eIF4GI); death-associated protein 5 (DAP5); fluorescence anisotropy; protein synthesis; gene expression; cell stress; hypoxia-inducible factor 1 alpha (HIF-1 alpha); eukaryotic translation initiation factor 4G (eIF4G); protein-nucleic acid interaction; gene regulation; mRNA; hypoxia-inducible factor (HIF); cap-independent translation	RIBOSOMAL ENTRY SITE; FACTOR 4G EIF4G; EUKARYOTIC TRANSLATION; MEDIATED TRANSLATION; CELL-PROLIFERATION; GENE-EXPRESSION; CORE DOMAIN; BINDING; ELEMENT; VIRUS	During unfavorable conditions (e.g.tumor hypoxia or viral infection), canonical, cap-dependent mRNA translation is suppressed in human cells. Nonetheless, a subset of physiologically important mRNAs (e.g.hypoxia-inducible factor 1 alpha [HIF-1 alpha], fibroblast growth factor 9 [FGF-9], and p53) is still translated by an unknown, cap-independent mechanism. Additionally, expression levels of eukaryotic translation initiation factor 4GI (eIF4GI) and of its homolog, death-associated protein 5 (DAP5), are elevated. By examining the 5 ' UTRs of HIF-1 alpha, FGF-9, and p53 mRNAs and using fluorescence anisotropy binding studies, luciferase reporter-basedin vitrotranslation assays, and mutational analyses, we demonstrate here that eIF4GI and DAP5 specifically bind to the 5 ' UTRs of these cap-independently translated mRNAs. Surprisingly, we found that the eIF4E-binding domain of eIF4GI increases not only the binding affinity but also the selectivity among these mRNAs. We further demonstrate that the affinities of eIF4GI and DAP5 binding to these 5 ' UTRs correlate with the efficiency with which these factors drive cap-independent translation of these mRNAs. Integrating the results of our binding and translation assays, we conclude that eIF4GI or DAP5 is critical for recruitment of a specific subset of mRNAs to the ribosome, providing mechanistic insight into their cap-independent translation.	[Haizel, Solomon A.; Goss, Dixie J.] CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10010 USA; [Haizel, Solomon A.; Bhardwaj, Usha; Goss, Dixie J.] Hunter Coll, Dept Chem, New York, NY 10065 USA; [Gonzalez, Ruben L., Jr.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Mitra, Somdeb] NYU, Dept Chem, New York, NY USA; [Goss, Dixie J.] CUNY, Grad Ctr, PhD Program Chem, New York, NY 10010 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); Columbia University; New York University; City University of New York (CUNY) System	Goss, DJ (corresponding author), CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10010 USA.; Goss, DJ (corresponding author), Hunter Coll, Dept Chem, New York, NY 10065 USA.; Goss, DJ (corresponding author), CUNY, Grad Ctr, PhD Program Chem, New York, NY 10010 USA.	dgoss@hunter.cuny.edu		Gonzalez, Ruben/0000-0002-1344-5581; Goss, Dixie/0000-0002-8500-0629; Bhardwaj, Usha/0000-0003-1830-5059	Susan G. Komen Foundation for the Cure Postdoctoral Fellowship [PDF12231199]; National Institute of General Medical Science of the National Institutes of Health [GM R01 084288, GM R01 128239]; National Center for Advancing Translational Sciences [1UL1TR002384-01]	Susan G. Komen Foundation for the Cure Postdoctoral Fellowship; National Institute of General Medical Science of the National Institutes of Health; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The research reported in this publication was supported by the Susan G. Komen Foundation for the Cure Postdoctoral Fellowship PDF12231199 (to S. M.), the National Institute of General Medical Science of the National Institutes of Health under award numbers GM R01 084288 (to R. L. G.) and GM R01 128239 (to D. J. G.), and the National Center for Advancing Translational Sciences 1UL1TR002384-01 Seed Project (to D. J. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alard A, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00254; Alard A, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-2262; Babendure JR, 2006, RNA, V12, P851, DOI 10.1261/rna.2309906; Banerjee B, 2014, J BIOL CHEM, V289, P4286, DOI 10.1074/jbc.M113.530329; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Chen TM, 2014, NUCLEIC ACIDS RES, V42, P2932, DOI 10.1093/nar/gkt1286; CHU LY, 1978, BIOCHEMISTRY-US, V17, P2450, DOI 10.1021/bi00605a032; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; de la Parra C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05539-0; Dennis MD, 2013, DIABETES, V62, P2204, DOI 10.2337/db12-1453; Dhungel N, 2015, NEURON, V85, P76, DOI 10.1016/j.neuron.2014.11.027; Dmitriev SE, 2003, MOL CELL BIOL, V23, P8925, DOI 10.1128/MCB.23.24.8925-8933.2003; Dyer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074085; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Graber TE, 2007, MOL BIOSYST, V3, P825, DOI 10.1039/b708867a; Grover R, 2011, RNA BIOL, V8, P132, DOI 10.4161/rna.8.1.14260; Gruner S, 2016, MOL CELL, V64, P467, DOI 10.1016/j.molcel.2016.09.020; Guo L, 2001, MOL CELL, V7, P1103, DOI 10.1016/S1097-2765(01)00252-0; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Johnson AG, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0177; Khan MA, 2014, NUCLEIC ACIDS RES, V42, P6567, DOI 10.1093/nar/gku248; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Lacerda R, 2017, CELL MOL LIFE SCI, V74, P1659, DOI 10.1007/s00018-016-2428-2; Lee ASY, 2016, NATURE, V536, P96, DOI 10.1038/nature18954; Lee ASY, 2015, NATURE, V522, P111, DOI 10.1038/nature14267; Lee KM, 2017, TRENDS MICROBIOL, V25, P547, DOI 10.1016/j.tim.2017.01.010; Lee SH, 2006, EMBO J, V25, P4008, DOI 10.1038/sj.emboj.7601268; Leppek K, 2018, NAT REV MOL CELL BIO, V19, P158, DOI 10.1038/nrm.2017.103; Liberman N, 2015, NUCLEIC ACIDS RES, V43, P3764, DOI 10.1093/nar/gkv205; Lomakin IB, 2000, MOL CELL BIOL, V20, P6019, DOI 10.1128/MCB.20.16.6019-6029.2000; Ma J, 2012, P NATL ACAD SCI USA, V109, P8417, DOI 10.1073/pnas.1120045109; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Morino S, 2000, MOL CELL BIOL, V20, P468, DOI 10.1128/MCB.20.2.468-477.2000; Nevins TA, 2003, J BIOL CHEM, V278, P3572, DOI 10.1074/jbc.M206781200; Ozes AR, 2011, J MOL BIOL, V412, P674, DOI 10.1016/j.jmb.2011.08.004; Olszewska DA, 2016, FRONT NEUROSCI-SWITZ, V10, DOI [10.3389/fnins.7016.00162, 10.3389/fnins.2016.00162]; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; Pestova TV, 1996, MOL CELL BIOL, V16, P6870; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Plank TDM, 2012, WIRES RNA, V3, P195, DOI 10.1002/wrna.1105; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Schrufer TL, 2010, DIABETES, V59, P2107, DOI 10.2337/db10-0148; Sekiyama N, 2015, P NATL ACAD SCI USA, V112, pE4036, DOI 10.1073/pnas.1512118112; Sharathchandra A, 2014, WIRES RNA, V5, P131, DOI 10.1002/wrna.1202; Sharma Sohani Das, 2015, J Biol Chem, V290, P11268, DOI 10.1074/jbc.M115.645002; Shatsky IN, 2018, TRENDS BIOCHEM SCI, V43, P882, DOI 10.1016/j.tibs.2018.04.011; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Terenin IM, 2017, CELL MOL LIFE SCI, V74, P1431, DOI 10.1007/s00018-016-2409-5; Terenin IM, 2013, NUCLEIC ACIDS RES, V41, P1807, DOI 10.1093/nar/gks1282; Thakur A, 2019, NUCLEIC ACIDS RES, V47, P2574, DOI 10.1093/nar/gky1274; Treder K, 2008, RNA, V14, P134, DOI 10.1261/rna.777308; Virgili G, 2013, STRUCTURE, V21, P517, DOI 10.1016/j.str.2013.01.015; Weingarten-Gabbay S, 2014, ONCOGENE, V33, P611, DOI 10.1038/onc.2012.626; Xia XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004136; Yasuda M, 2014, BIOCHEM BIOPH RES CO, V447, P638, DOI 10.1016/j.bbrc.2014.04.058; Zhao P, 2017, J BIOL CHEM, V292, P5921, DOI [10.1074/jbc.M116.764902, 10.1074/jbc.m116.764902]; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377	63	10	10	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11693	11706		10.1074/jbc.RA120.013678	http://dx.doi.org/10.1074/jbc.RA120.013678			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32571876	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000563922500026
J	Hayashi, C; Miyazaki, E; Ozaki, S; Abe, Y; Katayama, T				Hayashi, Chihiro; Miyazaki, Erika; Ozaki, Shogo; Abe, Yoshito; Katayama, Tsutomu			DnaB helicase is recruited to the replication initiation complex via binding of DnaA domain I to the lateral surface of the DnaB N-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; DNA replication; protein complex; protein dynamics; protein-protein interaction; oriC; origin DNA; DnaA; DnaB; DNA helicase	STRUCTURAL BASIS; PROTEIN; ORIGIN; RING; OLIGOMERIZATION; DIRECTS; REGION; RECOGNITION; MECHANISMS; SEQUENCES	The DNA replication protein DnaA inEscherichia coliconstructs higher-order complexes on the origin,oriC, to unwind this region. DnaB helicase is loaded onto unwoundoriCvia interactions with the DnaC loader and the DnaA complex. The DnaB-DnaC complex is recruited to the DnaA complex via stable binding of DnaB to DnaA domain I. The DnaB-DnaC complex is then directed to unwoundoriCvia a weak interaction between DnaB and DnaA domain III. Previously, we showed that Phe(46)in DnaA domain I binds to DnaB. Here, we searched for the DnaA domain I-binding site in DnaB. The DnaB L160A variant was impaired in binding to DnaA complex onoriCbut retained its DnaC-binding and helicase activities. DnaC binding moderately stimulated DnaA binding of DnaB L160A, and loading of DnaB L160A ontooriCwas consistently and moderately inhibited. In a helicase assay with partly single-stranded DNA bearing a DnaA-binding site, DnaA stimulated DnaB loading, which was strongly inhibited in DnaB L160A even in the presence of DnaC. DnaB L160A was functionally impairedin vivo. On the basis of these findings, we propose that DnaB Leu(160)interacts with DnaA domain I Phe(46). DnaB Leu(160)is exposed on the lateral surface of the N-terminal domain, which can explain unobstructed interactions of DnaA domain I-bound DnaB with DnaC, DnaG primase, and DnaA domain III. We propose a probable structure for the DnaA-DnaB-DnaC complex, which could be relevant to the process of DnaB loading ontooriC.	[Hayashi, Chihiro; Miyazaki, Erika; Ozaki, Shogo; Katayama, Tsutomu] Kyushu Univ, Dept Mol Biol, Grad Sch Pharmaceut Sci, Fukuoka, Japan; [Abe, Yoshito] Kyushu Univ, Dept Prot Struct Funct & Design, Grad Sch Pharmaceut Sci, Fukuoka, Japan; [Abe, Yoshito] Int Univ Hlth & Welf, Dept Pharmaceut Sci, Okawa, Japan	Kyushu University; Kyushu University; International University of Health & Welfare	Katayama, T (corresponding author), Kyushu Univ, Dept Mol Biol, Grad Sch Pharmaceut Sci, Fukuoka, Japan.	katayama@phar.kyushu-u.ac.jp	Abe, Yoshito/D-8370-2012; Abe, Yoshito/AAH-6141-2021	Abe, Yoshito/0000-0002-0016-8490; Abe, Yoshito/0000-0002-0016-8490; Ozaki, Shogo/0000-0002-4384-1366; Katayama, Tsutomu/0000-0001-9994-1684	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP17H03656, JP20H03212]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants JP17H03656 and JP20H03212.	Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Arias-Palomo E, 2019, MOL CELL, V74, P173, DOI 10.1016/j.molcel.2019.01.023; Arias-Palomo E, 2013, CELL, V153, P438, DOI 10.1016/j.cell.2013.03.006; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bell SP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010124; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Carney SM, 2017, J BIOL CHEM, V292, P19001, DOI 10.1074/jbc.M117.814178; Chang P, 2000, J BIOL CHEM, V275, P26187, DOI 10.1074/jbc.M001800200; Chodavarapu S, 2016, NUCLEIC ACIDS RES, V44, P210, DOI 10.1093/nar/gkv961; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Felczak MM, 2017, J BIOL CHEM, V292, P20871, DOI 10.1074/jbc.M117.807644; Felczak MM, 2005, J BIOL CHEM, V280, P24627, DOI 10.1074/jbc.M503684200; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kaguni JM, 2011, CURR OPIN CHEM BIOL, V15, P606, DOI 10.1016/j.cbpa.2011.07.016; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Katayama T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02496; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Keyamura K, 2009, J BIOL CHEM, V284, P25038, DOI 10.1074/jbc.M109.002717; Leonard AC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00545; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; Nagata K, 2020, J BIOCHEM, V167, P1, DOI 10.1093/jb/mvz087; Noguchi Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00239; Noguchi Y, 2015, J BIOL CHEM, V290, P20295, DOI 10.1074/jbc.M115.662601; Nozaki S, 2008, MICROBIOL-SGM, V154, P3379, DOI 10.1099/mic.0.2008/019745-0; O'Donnell ME, 2018, NAT STRUCT MOL BIOL, V25, P122, DOI 10.1038/s41594-018-0024-x; Oakley AJ, 2019, PROTEIN SCI, V28, P990, DOI 10.1002/pro.3615; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Ozaki S, 2012, J BIOL CHEM, V287, P37458, DOI 10.1074/jbc.M112.372052; Ozaki S, 2012, NUCLEIC ACIDS RES, V40, P1648, DOI 10.1093/nar/gkr832; Rozgaja TA, 2011, MOL MICROBIOL, V82, P475, DOI 10.1111/j.1365-2958.2011.07827.x; Sakiyama Y, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02017; Sakiyama Y, 2017, NUCLEIC ACIDS RES, V45, P12354, DOI 10.1093/nar/gkx914; SALUJA D, 1995, J BACTERIOL, V177, P1104, DOI 10.1128/jb.177.4.1104-1111.1995; Saxena R, 2020, NUCLEIC ACIDS RES, V48, P200, DOI 10.1093/nar/gkz939; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; Shimizu M, 2016, P NATL ACAD SCI USA, V113, pE8021, DOI 10.1073/pnas.1609649113; Soultanas P, 2012, MOL MICROBIOL, V84, P6, DOI 10.1111/j.1365-2958.2012.08012.x; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Thirlway J, 2004, NUCLEIC ACIDS RES, V32, P2977, DOI 10.1093/nar/gkh628; Weigel C, 2002, MOL MICROBIOL, V46, P1149, DOI 10.1046/j.1365-2958.2002.03232.x	49	7	7	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11131	11143		10.1074/jbc.RA120.014235	http://dx.doi.org/10.1074/jbc.RA120.014235			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32540966	hybrid, Green Published			2022-12-26	WOS:000562757100018
J	Sugiyama, A; Matsuoka, T; Sakamune, K; Akita, T; Makita, R; Kimura, S; Kuroiwa, Y; Nagao, M; Tanaka, J				Sugiyama, Aya; Matsuoka, Toshihiko; Sakamune, Kazuaki; Akita, Tomoyuki; Makita, Ryosuke; Kimura, Shinsuke; Kuroiwa, Yukio; Nagao, Masataka; Tanaka, Junko			The Tokyo subway sarin attack has long-term effects on survivors: A 10-year study started 5 years after the terrorist incident	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; EVENT SCALE; VICTIMS; SYMPTOMS; PREVALENCE; EXPOSURE; IMPACT; JAPAN	Objectives The Tokyo subway sarin attack in 1995 was an unprecedented act of terrorism that killed 13 people and sickened more than 6,000. The long-term somatic and psychological effects on its victims remain unknown. Methods We conducted analyses on the self-rating questionnaire collected annually by the Recovery Support Center (RSC) during the period from 2000 to 2009. The RSC is the only organization that has large-scale follow-up data about sarin attack victims. The prevalence of self-reported symptoms was calculated over 10 years. We also evaluated the prevalence of posttraumatic stress response (PTSR), defined as a score >= 25 on the Japanese-language version of the Impact of Event Scale-Revised. The multivariate Poisson regression model was applied to estimate the risk ratios of age, gender, and year factor on the prevalence of PTSR. Results Subjects were 747 survivors (12% of the total) who responded to the annual questionnaire once or more during the study period. The prevalence of somatic symptoms, especially eye symptoms, was 60-80% and has not decreased. PTSR prevalence was 35.1%, and again there was no change with time. The multivariate Poisson regression model results revealed "old age" and "female" as independent risk factors, but the passage of time did not decrease the risk of PTSR. Conclusions Although symptoms in most victims of the Tokyo subway sarin were transient, this large-scale follow-up data analysis revealed that survivors have been suffering from somatic and psychological long-term effects.	[Sugiyama, Aya; Matsuoka, Toshihiko; Sakamune, Kazuaki; Akita, Tomoyuki; Tanaka, Junko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima, Japan; [Makita, Ryosuke; Nagao, Masataka] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Forens Med, Hiroshima, Japan; [Kimura, Shinsuke; Kuroiwa, Yukio] Nonprofit Org NPO Recovery Support Ctr, Tokyo, Japan	Hiroshima University; Hiroshima University	Tanaka, J (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima, Japan.	jun-tanaka@hiroshima-u.ac.jp	Tanaka, Junko/G-6166-2019	Tanaka, Junko/0000-0002-5669-4051				[Anonymous], 2016, AIPJ, V27, P88; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Himuro K, 1998, NEUROLOGY, V51, P1195, DOI 10.1212/WNL.51.4.1195; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Iwasa M, 2012, J EYE, V29, P1435; Kadokura M, 2000, JAPANESE J CLIN PSYC, V29, P677; Kato T, 1996, AM J OPHTHALMOL, V121, P209, DOI 10.1016/S0002-9394(14)70587-2; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kawakami N, 2004, PSYCHIAT RES, V121, P293, DOI 10.1016/S0165-1781(03)00239-7; Kawakami N, 2014, J PSYCHIATR RES, V53, P157, DOI 10.1016/j.jpsychires.2014.01.015; Kawana N, 2005, TRAUMATOLOGY, V11, P87, DOI [10.1177/153476560501100204, DOI 10.1177/153476560501100204]; Kinoshita H, 2012, JAPANESE J CLIN PSYC, V41, P1293; Maekawa K, 1996, IGAKU NO AYUMI, V177, P731; Ministry of Health Labour and Welfare Japan, 2011, COMPR SURV LIV COND; MORITA H, 1995, LANCET, V346, P290; Murata K, 1997, J NEUROL, V244, P601, DOI 10.1007/s004150050153; Nakamine S, 2018, J SOC CLIN PSYCHOL, V37, P794; Naoi K, 2009, JPN B SOCIAL PSYCHIA, V18, P52; National Research Institute of Police Science, 1995, KEIJIJIHOU, V54, P22; Ohbu S, 1997, SOUTHERN MED J, V90, P587, DOI 10.1097/00007611-199706000-00002; Ohtani T, 2004, PSYCHIAT CLIN NEUROS, V58, P624, DOI 10.1111/j.1440-1819.2004.01313.x; Okumura T, 2005, ENVIRON TOXICOL PHAR, V19, P447, DOI 10.1016/j.etap.2004.12.005; Okumura T, 1996, ANN EMERG MED, V28, P129, DOI 10.1016/S0196-0644(96)70052-5; Sharp D, 2006, LANCET, V367, P95, DOI 10.1016/S0140-6736(06)67942-7; Shigemura J, 2012, JAMA-J AM MED ASSOC, V308, P667, DOI 10.1001/jama.2012.9699; Shimizu A, 2002, JAPANESE J CLIN PSYC, V31, P549; St. Luke's International Hospital, 1997, JAPAN MED J, V3828, P42; Tochigi M, 2002, NEUROSCI RES, V44, P267, DOI 10.1016/S0168-0102(02)00146-3; Weiss DS, 2004, IMPACT EVENT SCALE R; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; World Health Organization, 2005, Biosecur Bioterror, V3, P268; World Health Organization, FACT SHEETS DEPR; Yokoyama K, 1998, ARCH ENVIRON HEALTH, V53, P249, DOI 10.1080/00039899809605705	33	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234967	10.1371/journal.pone.0234967	http://dx.doi.org/10.1371/journal.pone.0234967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ME9KK	32574198	Green Published, gold			2022-12-26	WOS:000544972400030
J	Bouguetoch, A; Grospretre, S; Martin, A				Bouguetoch, Amandine; Grospretre, Sidney; Martin, Alain			Optimal stimulation parameters for spinal and corticospinal excitabilities during contraction, motor imagery and rest: A pilot study	PLOS ONE			English	Article							FACILITATION; REFLEX; REPRESENTATIONS; PERFORMANCE; SIMULATION; MOVEMENTS	Objectives It is commonly accepted that motor imagery (MI), i.e. the mental simulation of a movement, leads to an increased size of cortical motor evoked potentials (MEPs), although the magnitude of this effect differs between studies. Its impact on the spinal level is even more variable in the literature. Such discrepancies may be explained by many different experimental approaches. Therefore, the question of the optimal stimulation parameters to assess both spinal and corticospinal excitabilities remains open. Methods H-reflexes and MEPs of the triceps surae were evoked in 11 healthy subjects during MI, weak voluntary contraction (CON) and rest (REST). In each condition, the full recruitment curve from the response threshold to maximal potential was investigated. Results At stimulation intensities close to the maximal response, MEP amplitude was increased by CON compared to REST on the triceps surae. No effect of the different conditions was found on the H-reflex recruitment curve, except a small variation beyond maximal H-reflex in the soleus muscle. Conclusion Based on our results, we recommend to assess corticospinal excitability between 70% and 100% of maximal MEP intensity instead of the classical use of a percentage of the motor threshold and to elicit H-reflexes on the ascending part of the recruitment curve.	[Bouguetoch, Amandine; Martin, Alain] Univ Bourgogne Franche Comte, Cognit Act & Sensorimotor Plast CAPS, INSERM, Dijon, France; [Grospretre, Sidney] Univ Bourgogne Franche Comte, EA 4660 C3S Culture Sport Hlth Soc, Besancon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Franche-Comte	Bouguetoch, A (corresponding author), Univ Bourgogne Franche Comte, Cognit Act & Sensorimotor Plast CAPS, INSERM, Dijon, France.	amandine.bouguetoch@free.fr		Grospretre, Sidney/0000-0003-1023-5842				Abbruzzese G, 1996, EXP BRAIN RES, V111, P465; ANNETT J, 1995, NEUROPSYCHOLOGIA, V33, P1395, DOI 10.1016/0028-3932(95)00072-B; [Anonymous], 2017, LANCET ONCOL, V18, P1, DOI 10.1016/S1470-2045(16)30642-8; [Anonymous], 1994, BRIT J 18 CENTURY ST, V17, P1, DOI DOI 10.1007/BF02724515; Bonnet M, 1997, COGNITIVE BRAIN RES, V5, P221, DOI 10.1016/S0926-6410(96)00072-9; Crammond DJ, 1997, TRENDS NEUROSCI, V20, P54, DOI 10.1016/S0166-2236(96)30019-2; CRONE C, 1990, EXP BRAIN RES, V81, P35; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Decety J., 1990, PSYCHOL RES, P39, DOI [10.1007/BF00867210, DOI 10.1007/BF00867210]; Ehrsson HH, 2000, EUR J NEUROSCI, V12, P3385, DOI 10.1046/j.1460-9568.2000.00209.x; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25, DOI 10.1123/jsp.5.1.25; Gandevia SC, 1997, J PHYSIOL-LONDON, V505, P259, DOI 10.1111/j.1469-7793.1997.259bc.x; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Grospretre S, 2019, J PHYSIOL-LONDON, V597, P921, DOI 10.1113/JP276694; Grospretre S, 2016, EUR J SPORT SCI, V16, P317, DOI 10.1080/17461391.2015.1024756; Grospretre S, 2012, J NEUROPHYSIOL, V107, P1649, DOI 10.1152/jn.00611.2011; Hale BS, 2003, BEHAV BRAIN RES, V142, P81, DOI 10.1016/S0166-4328(02)00397-2; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Hashimoto R, 1999, DYNAMIC CHANGES CORT, P75; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Jeannerod M., 2004, INT J SPORT EXERC PS, V2, P376, DOI [10.1080/1612197X.2004.9671752, DOI 10.1080/1612197X.2004.9671752]; Jeannerod M., 2006, MOTOR COGNITION WHAT, DOI [10.1093/acprof:oso/9780198569657.001.0001, DOI 10.1093/ACPROF:OSO/9780198569657.001.0001]; Kasai T, 1997, BRAIN RES, V744, P147, DOI 10.1016/S0006-8993(96)01101-8; Kiers L, 1997, ELECTROMYOGR MOTOR C, V105, P262, DOI 10.1016/S0921-884X(97)00027-1; Kukke SN, 2014, J CLIN NEUROPHYSIOL, V31, P246, DOI 10.1097/WNP.0000000000000057; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P7113, DOI 10.1073/pnas.1002462107; Oku K, 2011, PERCEPT MOTOR SKILL, V113, P982, DOI 10.2466/05.23.25.PMS.113.6.982-994; Park WH, 2011, NEUROSCI LETT, V494, P255, DOI 10.1016/j.neulet.2011.03.027; Pierrot-Deseilligny E, 2012, CIRCUITRY OF THE HUMAN SPINAL CORD: SPINAL AND CORTICOSPINAL MECHANISMS OF MOVEMENT, P292; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; Porro CA, 1996, J NEUROSCI, V16, P7688; Roth R, 1996, NEUROREPORT, V7, P1280, DOI 10.1097/00001756-199605170-00012; Rupp T, 2012, J NEUROPHYSIOL, V108, P1270, DOI 10.1152/jn.01162.2011; Stephan KM, 1996, NEUROCHEM RES, V21, P1105, DOI 10.1007/BF02532421; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Temesi J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-40; Temesi J, 2013, MED SCI SPORT EXER, V45, P2243, DOI 10.1249/MSS.0b013e31829ce379; Yahagi S, 1996, PERCEPT MOTOR SKILL, V83, P288, DOI 10.2466/pms.1996.83.1.288	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235074	10.1371/journal.pone.0235074	http://dx.doi.org/10.1371/journal.pone.0235074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569326	Green Published, gold			2022-12-26	WOS:000543547900042
J	Grayson, JM; Perez, MD; Blevins, R; Coe, BN; Detty, MR; McIver, ZA				Grayson, Jason M.; Perez, Mildred D.; Blevins, Rebecca; Coe, Benjamin N.; Detty, Michael R.; McIver, Zachariah A.			Photodepletion with 2-Se-Cl prevents lethal graft-versus-host disease while preserving antitumor immunity	PLOS ONE			English	Article							T-CELL EXHAUSTION; BONE-MARROW-TRANSPLANTATION; PERSISTENCE; CD8	Acute graft-versus-host-disease (GVHD), limits the use of hematopoietic cell transplant (HCT) to treat a variety of malignancies. Any new therapeutic approach must satisfy three requirements: 1) Prevent GVHD, 2) Maintain anti-pathogen immunity, and 3) Maintain anti-tumor immunity. In prior studies we have shown that the selective photosensitizer 2-Se-Cl eliminates highly alloreactive lymphocytes from the graft prior to HCT preventing GVHD and that antiviral immune responses were preserved following incubation with 2-Se-Cl. In this report, we investigated whether 2-Se-Cl treatment preserves antitumor immunity, and then used high dimensional flow cytometry to identify the determinants of successful immune reconstitution. Donor C57BL/6 splenocytes were cocultured for 4 days with irradiated BALB/c splenocytes and then exposed to 2-Se-Cl. Photodepletion (PD)-treated splenocytes were then infused into lethally irradiated BALB/c mice inoculated with A20 leukemia/lymphoma cells. Recipient mice that received PD-treated splenocytes survived > 100 days without evidence of GVHD or leukemia. In contrast, mice that did not receive PD-treated cells at time of HCT died of leukemia progression. Multiparameter flow cytometry of cytokines and surface markers on peripheral blood samples 15 days after HCT demonstrated unique patterns of immune reconstitution. We found that before clinical disease onset GVHD was marked by functionally exhausted T cells, while tumor clearance and long-term survival were associated with an expansion of polyfunctional T cells, monocytes, and DCs early after transplantation. Taken together these results demonstrate that 2-Se-Cl photodepletion is a new treatment that can facilitate HCT by preventing GVHD while preserving antiviral and anti-tumor immunity.	[Grayson, Jason M.; Perez, Mildred D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27103 USA; [Blevins, Rebecca; Coe, Benjamin N.; McIver, Zachariah A.] Wake Forest Univ, Bowman Gray Sch Med, Dept Hematol & Oncol, Winston Salem, NC 27109 USA; [Detty, Michael R.] SUNY Buffalo, Dept Chem, Buffalo, NY USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Grayson, JM (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27103 USA.; McIver, ZA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Hematol & Oncol, Winston Salem, NC 27109 USA.	jgrayson@wakehealth.edu; zmciver@wakehealth.edu		Perez, Mildred/0000-0002-8918-6600	Comprehensive Cancer Center of Wake Forest University [NCI CCSG P30CA012197]; Wake Forest Clinical and Translational Science Award [5KL2TR001421-03]	Comprehensive Cancer Center of Wake Forest University; Wake Forest Clinical and Translational Science Award	This work was supported in part by the Comprehensive Cancer Center of Wake Forest University NCI CCSG P30CA012197 grant, and in part by the Wake Forest Clinical and Translational Science Award 5KL2TR001421-03 to Z.A.M.	Bashey ZA, 2018, BONE MARROW TRANSPL, V53, P756, DOI 10.1038/s41409-018-0126-4; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bleakley M, 2015, J CLIN INVEST, V125, P2677, DOI 10.1172/JCI81229; Chen BJ, 2002, BLOOD, V99, P3083, DOI 10.1182/blood.V99.9.3083; Chung DJ, 2016, CANCER IMMUNOL RES, V4, P61, DOI 10.1158/2326-6066.CIR-15-0055; Finak G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-546; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Gatza E, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001975; Halpert M, 2018, J IMMUNOL, V200; Hartwell MJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89798; Hill L, 2018, THER ADV HEMATOL, V9, P21, DOI 10.1177/2040620717741860; Hossein MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184254; Kohonen T, 2013, NEURAL NETWORKS, V37, P52, DOI 10.1016/j.neunet.2012.09.018; Kong Y, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.58; Laurent S, 2010, HUM IMMUNOL, V71, P934, DOI 10.1016/j.humimm.2010.07.007; Liu L, 2018, CLIN IMMUNOL, V190, P32, DOI 10.1016/j.clim.2018.02.009; Luznik L, 2008, BIOL BLOOD MARROW TR, V14, P641, DOI 10.1016/j.bbmt.2008.03.005; Martin PJ, 2004, BIOL BLOOD MARROW TR, V10, P552, DOI 10.1016/j.bbmt.2004.04.002; McIver ZA, 2016, J IMMUNOL, V197, P1631, DOI 10.4049/jimmunol.1402445; O'Donnell PV, 2002, BIOL BLOOD MARROW TR, V8, P377, DOI 10.1053/bbmt.2002.v8.pm12171484; Paczesny S, 2018, BLOOD, V131, P2193, DOI 10.1182/blood-2018-02-791509; Pasquini MC, 2008, BEST PRACT RES CL HA, V21, P193, DOI 10.1016/j.beha.2008.02.011; Reddy P, 2008, BIOL BLOOD MARROW TR, V14, P129, DOI 10.1016/j.bbmt.2007.10.021; Sega EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086551; Solomon SR, 2014, BIOL BLOOD MARROW TR, V20, P1828, DOI 10.1016/j.bbmt.2014.07.020; Sugita J., 2018, BONE MARROW TRANSPLA; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Van Gassen S, 2018, FLOWSOM USING SELF O; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Wahl DR, 2012, IMMUNOL REV, V249, P104, DOI 10.1111/j.1600-065X.2012.01148.x; Wang XB, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-21; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wilson J, 2009, J EXP MED, V206, P1203, DOI 10.1084/jem.20070723041509c; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zarour HM, 2016, CLIN CANCER RES, V22, P1856, DOI 10.1158/1078-0432.CCR-15-1849	36	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234778	10.1371/journal.pone.0234778	http://dx.doi.org/10.1371/journal.pone.0234778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569289	Green Published, gold			2022-12-26	WOS:000543547900031
J	Wan, SS; Pan, YM; Yang, WJ; Rao, ZQ; Yang, YN				Wan, Shan-Shan; Pan, Yu-Miao; Yang, Wan-Ju; Rao, Zhuo-Qun; Yang, Yan-Ning			Inhibition of EZH2 alleviates angiogenesis in a model of corneal neovascularization by blocking FoxO3a-mediated oxidative stress	FASEB JOURNAL			English	Article						angiogenesis; cornea; enhancer of zeste homolog 2; oxidative stress	NF-KAPPA-B; CELLS; MAINTENANCE	Enhancer of zeste homolog 2 (EZH2), a well-known methyltransferase, mediates histone H3 lysine 27 trimethylation (H3K27me3) and plays a vital role in ophthalmological disease. However, its role in corneal neovascularization (CoNV) remains unclear. In vitro and in vivo models were assessed in hypoxia-stimulated angiogenesis and in a mouse model of alkali burn-induced CoNV. Human umbilical vein endothelial cells (HUVECs) were cultured under hypoxic conditions and different reoxygenation times to identify the molecular mechanisms involved in this process. In this study, we found that EZH2 was positively related to corneal alkali burn-induced injury. Inhibition of EZH2 with 3-Deazaneplanocin A (DZNeP) alleviated corneal injury, including oxidative stress and neovascularization in vivo. Similarly, inhibition of EZH2 with either DZNeP or small interfering RNA (siRNA) exerted an inhibitory effect on hypoxia/reoxygenation (H/R)-induced oxidative stress and angiogenesis in HUVECs. Moreover, our study revealed that ablation of reactive oxygen species (ROS) with N-acetyl-cysteine suppressed angiogenesis in HUVECs exposed to H/R stimulation. Furthermore, Forkhead-box protein O3a (FoxO3a), which was positively associated with ROS production and angiogenesis, was elevated during H/R. This effect could be reversed through the suppression of the transcription activity of EZH2 with DZNeP or siRNA. In addition, the PI3K/Akt pathway, which is the upstream of FoxO3a, was activated in both DZNeP-treated mice and EZH2-inhibited HUVECs. Collectively, our results demonstrated that the inhibition of EZH2 alleviated corneal angiogenesis by inhibiting FoxO3a-dependent ROS production through the PI3K/Akt signaling pathway. These findings indicate that EZH2 may be a valuable therapeutic target for CoNV.	[Wan, Shan-Shan; Pan, Yu-Miao; Yang, Wan-Ju; Rao, Zhuo-Qun; Yang, Yan-Ning] Wuhan Univ, Dept Ophthalmol, Renmin Hosp, Wuhan 430060, Peoples R China	Wuhan University	Yang, YN (corresponding author), Wuhan Univ, Dept Ophthalmol, Renmin Hosp, Wuhan 430060, Peoples R China.	ophyyn@163.com		Yang, Wanju/0000-0002-3071-2805	National Natural Science Foundation of China (NSFC) [81370986, 81770899, 81070708]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81370986, 81770899 and 81070708	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Anderson C, 2014, JOVE-J VIS EXP, DOI 10.3791/51159; Aurora AB, 2010, BLOOD, V116, P475, DOI 10.1182/blood-2009-07-232132; Avedschmidt SE, 2016, INVEST OPHTH VIS SCI, V57, P6242, DOI 10.1167/iovs.16-20463; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050165; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fu YC, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20180552; Fujimura N, 2018, DEV BIOL, V433, P47, DOI 10.1016/j.ydbio.2017.11.004; Gao M, 2016, FREE RADICAL BIO MED, V92, P39, DOI 10.1016/j.freeradbiomed.2016.01.005; Iida A, 2015, DEV NEUROBIOL, V75, P947, DOI 10.1002/dneu.22261; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kubota M, 2011, INVEST OPHTH VIS SCI, V52, P427, DOI 10.1167/iovs.10-6167; Liu H, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101195; Liu W, 2020, CELL MOL LIFE SCI, V77, P651, DOI 10.1007/s00018-019-03297-w; Mitic T, 2015, MOL THER, V23, P32, DOI 10.1038/mt.2014.163; Mukwaya A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32137; Nakao S, 2018, FASEB J, V32, P143, DOI 10.1096/fj.201601229R; Qazi Y, 2010, BRAIN RES BULL, V81, P198, DOI 10.1016/j.brainresbull.2009.05.019; Raju I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067126; Rogers MS, 2007, NAT PROTOC, V2, P2545, DOI 10.1038/nprot.2007.368; Saika S, 2005, AM J PATHOL, V166, P1405, DOI 10.1016/S0002-9440(10)62358-9; Shi WZ, 2019, BIOCHEM BIOPH RES CO, V516, P285, DOI 10.1016/j.bbrc.2019.05.181; Shoham A, 2008, FREE RADICAL BIO MED, V45, P1047, DOI 10.1016/j.freeradbiomed.2008.07.021; Tsou PS, 2019, P NATL ACAD SCI USA, V116, P3695, DOI 10.1073/pnas.1813006116; Wen Q, 2012, NEUROGENETICS, V13, P105, DOI 10.1007/s10048-012-0320-2; Wing MR, 2013, SEMIN NEPHROL, V33, P363, DOI 10.1016/j.semnephrol.2013.05.008; Zhang XP, 2018, FASEB J, V32, P3782, DOI 10.1096/fj.201701074RR; Zheng SJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0349-8	31	9	9	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10168	10181		10.1096/fj.201902814RRR	http://dx.doi.org/10.1096/fj.201902814RRR		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32562311				2022-12-26	WOS:000541813700001
J	Wietkamp, S; Krock, B; Clarke, D; Voss, D; Salas, R; Kilcoyne, J; Tillmann, U				Wietkamp, Stephan; Krock, Bernd; Clarke, Dave; Voss, Daniela; Salas, Rafael; Kilcoyne, Jane; Tillmann, Urban			Distribution and abundance of azaspiracid-producing dinophyte species and their toxins in North Atlantic and North Sea waters in summer 2018	PLOS ONE			English	Article							DINOFLAGELLATE GENUS AZADINIUM; SP-NOV; QPCR ASSAY; AMPHIDOMATACEAE DINOPHYCEAE; KARLODINIUM-VENEFICUM; MOLECULAR-DETECTION; MEDITERRANEAN SEA; COASTAL WATERS; SHELF WATERS; ALGAL BLOOM	Representatives of the marine dinophyte family Amphidomataceae produce lipophilic phycotoxins called azaspiracids (AZA) which may cause azaspiracid shellfish poisoning (AZP) in humans after consumption of contaminated seafood. Three of the four known toxigenic species are observed frequently in the eastern North Atlantic. In 2018, a research survey was performed to strengthen knowledge on the distribution and abundance of toxigenic Amphidomataceae and their respective toxins in Irish coastal waters and in the North Sea. Species-specific quantification of the three toxigenic species (Azadinium spinosum,Azadinium poporumandAmphidoma languida) was based on recently developed qPCR assays, whose performance was successfully validated and tested with specificity tests and spike experiments. The multi-method approach of on-board live microscopy, qPCR assays and chemical AZA-analysis revealed the presence of Amphidomataceae in the North Atlantic including the three targeted toxigenic species and their respective AZA analogues (AZA-1, -2, -33, -38, -39).Azadinium spinosumwas detected at the majority of Irish stations with a peak density of 8.3 x 10(4)cells L(-1)and AZA (AZA-1, -2, -33) abundances up to 1,274 pg L-1.Amphidoma languidawas also present at most Irish stations but appeared in highest abundance in a bloom at a central North Sea station with a density of 1.2 x 10(5)cells L(-1)and an AZA (AZA-38, -39) abundances of 618 pg L-1.Azadinium poporumwas detected sporadically at the Irish south coast and North Sea and was rather low in abundance during this study. The results confirmed the wide distribution and frequent occurrence of the target species in the North Atlantic area and revealed, for the first time, bloom abundances of toxigenic Amphidomataceae in this area. This emphasizes the importance of future studies and monitoring of amphidomatacean species and their respective AZA analogues in the North Atlantic.	[Wietkamp, Stephan; Krock, Bernd; Tillmann, Urban] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Clarke, Dave; Salas, Rafael; Kilcoyne, Jane] Marine Inst, Galway, Ireland; [Voss, Daniela] Carl vn Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Wilhelmshaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Marine Institute Ireland	Tillmann, U (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany.	urban.tillmann@awi.de	Krock, Bernd/ABB-7541-2020	Wietkamp, Stephan/0000-0001-7516-9861; Salas, Rafael/0000-0003-4688-0579; Clarke, Dave/0000-0002-8122-5193	German Ministry for Education and Research [03F0763A]; PACES II research program of the Alfred-Wegener-Institute as part of the Helmholtz Foundation initiative in Earth and Environment	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); PACES II research program of the Alfred-Wegener-Institute as part of the Helmholtz Foundation initiative in Earth and Environment	This work was supported by funding of the German Ministry for Education and Research (project RIPAZA, 03F0763A) and by the PACES II research program of the Alfred-Wegener-Institute as part of the Helmholtz Foundation initiative in Earth and Environment.	Aasen J, 2006, P 5 INT C MOLL SHELL, P162; Akselman R, 2012, HARMFUL ALGAE, V19, P30, DOI 10.1016/j.hal.2012.05.004; Anderson DM, 2012, HARMFUL ALGAE, V14, P10, DOI 10.1016/j.hal.2011.10.012; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Antonella P, 2013, ENVIRON SCI POLLUT R, V20, P6851, DOI 10.1007/s11356-012-1377-z; Araujo AJ de, 2004, J BRAS PNEUMOL, V30, pS1, DOI [10.1590/S1806-37132004000800002, DOI 10.1590/S1806-37132004000800002]; Battocchi C, 2010, MAR POLLUT BULL, V60, P1074, DOI 10.1016/j.marpolbul.2010.01.017; Berdalet E, 2014, DEEP-SEA RES PT II, V101, P4, DOI 10.1016/j.dsr2.2013.09.042; Berdalet E, 2017, OCEANOGRAPHY, V30, P36, DOI 10.5670/oceanog.2017.108; Botana L.M., 2014, SEAFOOD FRESHWATER T; Brown J, 2003, CONT SHELF RES, V23, P533, DOI 10.1016/S0278-4343(03)00008-6; Busch JA, 2016, HARMFUL ALGAE, V55, P191, DOI 10.1016/j.hal.2016.02.012; Cardiovascular Disease and Risk Management, 2019, DIABETES CARE, V2, pS103, DOI 10.2337/dc19-S010; Casabianca S, 2013, ENVIRON SCI TECHNOL, V47, P3788, DOI 10.1021/es305018s; Charnock H, 1994, UNDERSTANDING N SEA; Clarke D, 2018, P 18 C HARMF ALG BLO; Dai XF, 2019, HARMFUL ALGAE, V89, DOI 10.1016/j.hal.2019.101665; Ebenezer V, 2012, MAR BIOTECHNOL, V14, P129, DOI 10.1007/s10126-011-9427-y; Eckford-Soper LK, 2015, HARMFUL ALGAE, V48, P37, DOI 10.1016/j.hal.2015.06.009; Engesmo A, 2018, HARMFUL ALGAE, V75, P105, DOI 10.1016/j.hal.2018.04.007; Forootan Amin, 2017, Biomol Detect Quantif, V12, P1, DOI 10.1016/j.bdq.2017.04.001; Fu MQ, 2019, HARMFUL ALGAE, V84, P1, DOI 10.1016/j.hal.2019.01.011; Galluzzi L, 2010, J APPL PHYCOL, V22, P1, DOI 10.1007/s10811-009-9411-3; Hill AE, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033459; Hinder SL, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-54; Huang HL, 2019, HARMFUL ALGAE, V81, P65, DOI 10.1016/j.hal.2018.12.001; Husson B, 2016, HARMFUL ALGAE, V51, P26, DOI 10.1016/j.hal.2015.10.017; James K., 1998, HARMFUL ALGAE, P468; Jauffrais T, 2013, HARMFUL ALGAE, V27, P138, DOI 10.1016/j.hal.2013.05.009; JOINT I, 1993, MAR ECOL PROG SER, V99, P169, DOI 10.3354/meps099169; Kilcoyne J, 2019, MAR DRUGS, V17, DOI 10.3390/md17090489; Krock B, 2018, PHYS OCEANOGRAPHY HE, DOI [10.1594/PANGAEA.896405, DOI 10.1594/PANGAEA.896405]; Krock B, 2019, HARMFUL ALGAE, V82, P1, DOI 10.1016/j.hal.2018.12.005; Krock B, 2015, MAR DRUGS, V13, P6687, DOI 10.3390/md13116687; Krock B, 2012, TOXICON, V60, P830, DOI 10.1016/j.toxicon.2012.05.007; Krock B, 2009, HARMFUL ALGAE, V8, P254, DOI 10.1016/j.hal.2008.06.003; Luo ZH, 2018, HARMFUL ALGAE, V78, P75, DOI 10.1016/j.hal.2018.08.003; Luo ZH, 2017, HARMFUL ALGAE, V66, P65, DOI 10.1016/j.hal.2017.05.001; Massoud EAS, 2020, AM J OTOLARYNG, V41, DOI 10.1016/j.amjoto.2020.102417; Nielsen LT, 2016, TOXICON, V117, P84, DOI 10.1016/j.toxicon.2016.03.021; PEDERSEN F, 1994, ESTUAR COAST SHELF S, V38, P249, DOI 10.1006/ecss.1994.1017; Percopo I, 2013, J PHYCOL, V49, P950, DOI 10.1111/jpy.12104; Perini F., 2018, MAR POLLUT B; Perini F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017699; PRESTONTHOMAS H, 1990, METROLOGIA, V27, P3, DOI 10.1088/0026-1394/27/1/002; RAINE R, 1990, ESTUAR COAST SHELF S, V30, P579, DOI 10.1016/0272-7714(90)90094-8; Raine R, 1998, CONT SHELF RES, V18, P883, DOI 10.1016/S0278-4343(98)00017-X; Raine R, 2014, DEEP-SEA RES PT II, V101, P21, DOI 10.1016/j.dsr2.2013.06.021; Richardson K, 2000, J PLANKTON RES, V22, P1663, DOI 10.1093/plankt/22.9.1663; Rossi R, 2017, ANAL BIOANAL CHEM, V409, P1121, DOI 10.1007/s00216-016-0037-4; Ruvindy R, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03153; Salas R, 2011, HARMFUL ALGAE, V10, P774, DOI 10.1016/j.hal.2011.06.010; Satake Masayuki, 1997, Natural Toxins, V5, P164; Schlitzer R., 2018, OCEAN DATA VIEW; Smith KF, 2016, J APPL PHYCOL, V28, P1125, DOI 10.1007/s10811-015-0667-5; Tillmann U., 2018, HARMFUL ALGAE BLOOMS, P575; Tillmann U., 2014, SEAFOOD FRESHWATER T, P773; Tillmann U, 2020, PHYCOLOGIA, V59, P63, DOI 10.1080/00318884.2019.1670013; Tillmann U, 2019, HARMFUL ALGAE, V84, P244, DOI 10.1016/j.hal.2019.01.008; Tillmann U, 2018, HARMFUL ALGAE, V80, P15, DOI 10.1016/j.hal.2018.08.011; Tillmann U, 2017, REV BIOL MAR OCEANOG, V52, P591, DOI 10.4067/S0718-19572017000300015; Tillmann U, 2017, HARMFUL ALGAE, V62, P113, DOI 10.1016/j.hal.2016.12.001; Tillmann U, 2016, PHYCOL RES, V64, P160, DOI 10.1111/pre.12133; Tillmann Urban, 2015, Marine Biodiversity Records, V8, pe142, DOI 10.1017/S1755267215001128; Tillmann U, 2012, HARMFUL ALGAE, V20, P142, DOI 10.1016/j.hal.2012.10.001; Tillmann U, 2012, PROTIST, V163, P701, DOI 10.1016/j.protis.2011.10.005; Tillmann U, 2011, EUR J PHYCOL, V46, P74, DOI 10.1080/09670262.2011.556753; Tillmann U, 2009, EUR J PHYCOL, V44, P63, DOI 10.1080/09670260802578534; Toebe K, 2013, J PLANKTON RES, V35, P225, DOI 10.1093/plankt/fbs077; Toldra A, 2018, ANAL CHIM ACTA, V1039, P140, DOI 10.1016/j.aca.2018.07.057; Trainer VL, 2020, HARMFUL ALGAE, V91, DOI 10.1016/j.hal.2019.03.009; Twiner M., 2014, SEAFOOD FRESHWATER T, P823; Wells ML, 2018, ECOL STUD-ANAL SYNTH, V232, P77, DOI 10.1007/978-3-319-70069-4_5; Wietkamp S, 2019, HARMFUL ALGAE, V88, DOI 10.1016/j.hal.2019.101637; Wietkamp S, 2019, J PLANKTON RES, V41, P101, DOI 10.1093/plankt/fby052; Zamyadi A, 2019, WATER RES, V152, P96, DOI 10.1016/j.watres.2019.01.002	76	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0235015	10.1371/journal.pone.0235015	http://dx.doi.org/10.1371/journal.pone.0235015			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559229	Green Published, gold			2022-12-26	WOS:000543261600034
J	Vanani, FR; Shabani, L; Sabzalian, MR; Dehghanian, F; Winner, L				Vanani, Fatemeh Raeisi; Shabani, Leila; Sabzalian, Mohammad R.; Dehghanian, Fariba; Winner, Lisa			Comparative physiological and proteomic analysis indicates lower shock response to drought stress conditions in a self-pollinating perennial ryegrass	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; PHOSPHOLIPASE-D; WATER DEFICITS; NITROGEN-METABOLISM; HORMONE METABOLISM; GENE-EXPRESSION; TOLERANCE; DEHYDRATION; PROTEINS; BARLEY	We investigated the physiological and proteomic changes in the leaves of threeLolium perennegenotypes, one Iranian putative self-pollinating genotype named S10 and two commercial genotypes of Vigor and Speedy, subjected to drought stress conditions. The results of this study indeed showed higher RWC (relative water content), SDW (shoot dry weight), proline, ABA (abscisic acid), nitrogen and amino acid contents, and antioxidant enzymes activities of S10 under drought stress in comparison with the two other genotypes. A total of 915 proteins were identified using liquid chromatography-mass spectrometry (LC/MS) analysis, and the number of differentially abundant proteins between normal and stress conditions was 467, 456, and 99 in Vigor, Speedy, and S10, respectively. Proteins involved in carbon and energy metabolism, photosynthesis, TCA cycle, redox, and transport categories were up-regulated in the two commercial genotypes. We also found that some protein inductions, including those involved in amino acid and ABA metabolisms, aquaporin, HSPs, photorespiration, and increases in the abundance of antioxidant enzymes, are essential responses of the two commercial genotypes to drought stress. In contrast, we observed only slight changes in the protein profile of the S10 genotype under drought stress. Higher homozygosity due to self-pollination in the genetic background of the S10 genotype may have led to a lower variation in response to drought stress conditions.	[Vanani, Fatemeh Raeisi; Shabani, Leila] Shahrekord Univ, Fac Sci, Dept Plant Sci, Shahrekord, Iran; [Shabani, Leila] Shahrekord Univ, Res Inst Biotechnol, Shahrekord, Iran; [Sabzalian, Mohammad R.] Isfahan Univ Technol, Coll Agr, Dept Agron & Plant Breeding, Esfahan, Iran; [Dehghanian, Fariba] Univ Isfahan, Fac Biol Sci & Technol, Dept Cell & Mol Biol & Microbiol, Esfahan, Iran; [Winner, Lisa] Univ Freiburg, Ctr Biol Syst Anal ZBSA, Core Facil Prote, Freiburg, Germany	Shahrekord University; Shahrekord University; Isfahan University of Technology; University of Isfahan; University of Freiburg	Shabani, L (corresponding author), Shahrekord Univ, Fac Sci, Dept Plant Sci, Shahrekord, Iran.; Shabani, L (corresponding author), Shahrekord Univ, Res Inst Biotechnol, Shahrekord, Iran.	shabani-l@sku.ac.ir	Dehghanian, Fariba/GLU-7428-2022; Shabani, Leila/ABA-2527-2021; Sabzalian, Mohammad R./E-6279-2013	Shabani, Leila/0000-0001-6194-4708; Dehghanian, Fariba/0000-0003-3357-5903; Sabzalian, Mohammad R./0000-0002-7315-9990	University of Shahrekord, SKU [98GRD30M1032]	University of Shahrekord, SKU	We acknowledge the University of Shahrekord, SKU, for supporting this research (grant number: 98GRD30M1032).	Akinci S, 2011, WATER STRESS, P15; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Aroca R, 2006, ANN BOT-LONDON, V98, P1301, DOI 10.1093/aob/mcl219; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Bargmann BOR, 2009, PLANT CELL PHYSIOL, V50, P78, DOI 10.1093/pcp/pcn173; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bellon MR, 2006, WORLD DEV, V34, P113, DOI 10.1016/j.worlddev.2005.05.012; Ceccarelli S, 2010, J AGR SCI-CAMBRIDGE, V148, P627, DOI 10.1017/S0021859610000651; CHAVES MM, 1991, J EXP BOT, V42, P1, DOI 10.1093/jxb/42.1.1; Cheng LX, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0871-8; Chmielewska K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01108; Choudhary MK, 2009, MOL CELL PROTEOMICS, V8, P1579, DOI 10.1074/mcp.M800601-MCP200; Coleman HD, 2009, P NATL ACAD SCI USA, V106, P13118, DOI 10.1073/pnas.0900188106; CONNOR HE, 1979, NEW ZEAL J BOT, V17, P547, DOI 10.1080/0028825X.1979.10432571; CORNISH MA, 1979, HEREDITY, V43, P95, DOI 10.1038/hdy.1979.63; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deng X, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00425; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; El Maarouf H, 1999, PLANT MOL BIOL, V39, P1257, DOI 10.1023/A:1006165919928; Falloon P, 2010, SCI TOTAL ENVIRON, V408, P5667, DOI 10.1016/j.scitotenv.2009.05.002; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Fulda S, 2011, PLANT BIOLOGY, V13, P632, DOI 10.1111/j.1438-8677.2010.00426.x; Furet PM, 2012, PLANT PHYSIOL BIOCH, V61, P88, DOI 10.1016/j.plaphy.2012.09.011; Garg BK, 2001, BIOL PLANTARUM, V44, P289, DOI 10.1023/A:1010215812791; Ghaffari MR, 2019, ENVIRON EXP BOT, V157, P197, DOI 10.1016/j.envexpbot.2018.10.002; Ghotbi-Ravandi AA, 2014, J AGRON CROP SCI, V200, P403, DOI 10.1111/jac.12062; Grigorova B, 2011, BIOL PLANTARUM, V55, P105, DOI 10.1007/s10535-011-0014-x; Guo BZ, 2006, PLANTA, V223, P512, DOI 10.1007/s00425-005-0112-0; Guo QF, 2008, J PLANT PHYSIOL, V165, P1745, DOI 10.1016/j.jplph.2007.10.002; Hong YY, 2008, MOL PLANT, V1, P262, DOI 10.1093/mp/ssm025; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P385; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Kaldenhoff R, 2008, PLANT CELL ENVIRON, V31, P658, DOI 10.1111/j.1365-3040.2008.01792.x; Kausar R, 2013, AMINO ACIDS, V44, P345, DOI 10.1007/s00726-012-1338-3; Kelen M, 2004, TURK J CHEM, V28, P603; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; Kramer P.J., 1983, WATER RELATIONS PLAN; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; LEE JC, 1981, J BIOL CHEM, V256, P7193; Lisiewska Z, 2008, FOOD CHEM, V108, P642, DOI 10.1016/j.foodchem.2007.11.030; Loka D, 2019, FOOD ENERGY SECUR, V8, DOI 10.1002/fes3.152; Man D, 2011, HORTSCIENCE, V46, P1027, DOI 10.21273/HORTSCI.46.7.1027; May MJ, 1993, PLANT PHYSIOL, V103, P157, DOI DOI 10.1104/PP.103.1.157; Miazek A, 2008, BIOL PLANTARUM, V52, P687, DOI 10.1007/s10535-008-0133-1; Mirzaei M, 2012, J PROTEOME RES, V11, P348, DOI 10.1021/pr2008779; Mirzahosseini Z, 2014, EUR J SOIL BIOL, V63, P33, DOI 10.1016/j.ejsobi.2014.05.004; Moon KB, 2018, MOL CELLS, V41, P979, DOI 10.14348/molcells.2018.0312; Nagabhyru P, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-127; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ng LM, 2014, ACTA PHARMACOL SIN, V35, P567, DOI 10.1038/aps.2014.5; Nguema-Ona E, 2013, TRENDS PLANT SCI, V18, P445, DOI 10.1016/j.tplants.2013.03.006; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; NORRIS IB, 1985, GRASS FORAGE SCI, V40, P151, DOI 10.1111/j.1365-2494.1985.tb01732.x; Norton MR, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0362-1; Olmos E, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01092; Pandey V, 2016, PLANTA, V243, P1251, DOI 10.1007/s00425-016-2482-x; Patro L, 2014, J PHOTOCH PHOTOBIO B, V137, P49, DOI 10.1016/j.jphotobiol.2014.03.018; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; Raorane ML, 2016, METHODS MOL BIOL, V1385, P139, DOI 10.1007/978-1-4939-3289-4_10; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; SAS, 1999, SAS COMP PROGR; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Shanker AK, 2014, FUNCT INTEGR GENOMIC, V14, P11, DOI 10.1007/s10142-013-0356-x; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Sinclair TR, 2000, AGR ECOSYST ENVIRON, V79, P53, DOI 10.1016/S0167-8809(99)00146-2; Singh NB, 2015, PHYSIOL MOL BIOL PLA, V21, P207, DOI 10.1007/s12298-015-0291-5; Skirycz A, 2010, CURR OPIN BIOTECH, V21, P197, DOI 10.1016/j.copbio.2010.03.002; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Torkian M, 2019, GRASS FORAGE SCI, V74, P559, DOI 10.1111/gfs.12437; TROLL W, 1955, J BIOL CHEM, V215, P655; Turgeon A.J., 2002, TURFGRASS MANAGEMENT; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Volaire F, 2006, ANN BOT-LONDON, V98, P927, DOI 10.1093/aob/mcl195; Wang JB, 2014, PLANTA, V240, P103, DOI 10.1007/s00425-014-2066-6; Wang NB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1657-3; Wang XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101706; Wang YJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112621; Xu CP, 2010, J PLANT PHYSIOL, V167, P1477, DOI 10.1016/j.jplph.2010.05.006; Xu ZZ, 2006, J PLANT GROWTH REGUL, V25, P252, DOI 10.1007/s00344-006-0043-4; Yang YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117475; Ye JX, 2013, PLANT OMICS, V6, P286; Ye TT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01694; Yue C, 2014, PLANT PHYSIOL BIOCH, V83, P65, DOI 10.1016/j.plaphy.2014.07.011; Zang LN, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01140; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zhang XZ, 2009, CROP SCI, V49, P1893, DOI 10.2135/cropsci2008.09.0521; Zhou SS, 2015, PLANT SCI, V236, P44, DOI 10.1016/j.plantsci.2015.03.017	93	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234317	10.1371/journal.pone.0234317	http://dx.doi.org/10.1371/journal.pone.0234317			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555744	Green Published, gold			2022-12-26	WOS:000543273200009
J	Adamovicz, L; Baker, SJ; Kessler, E; Kelly, M; Johnson, S; Winter, J; Phillips, CA; Allender, MC				Adamovicz, Laura; Baker, Sarah J.; Kessler, Ethan; Kelly, Marta; Johnson, Samantha; Winter, John; Phillips, Christopher A.; Allender, Matthew C.			Erythrocyte sedimentation rate and hemoglobin-binding protein in free-living box turtles (Terrapene spp.)	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; C-REACTIVE PROTEIN; PLASMA ELECTROPHORETIC PROFILES; LINEAR-REGRESSION PROCEDURES; REFERENCE INTERVALS; CAROLINA-CAROLINA; HAPTOGLOBIN CONCENTRATIONS; HEMATOLOGICAL PARAMETERS; INFLAMMATORY MARKERS; BIOCHEMICAL VALUES	The acute phase response is a highly conserved reaction to infection, inflammation, trauma, stress, and neoplasia. Acute phase assays are useful for wildlife health assessment, however, they are infrequently utilized in reptiles. This study evaluated erythrocyte sedimentation rate (ESR) in eastern (Terrapene carolina carolina) and ornate box turtles (Terrapene ornata ornata) and hemoglobin-binding protein (HBP) inT.ornata. Erythrocyte sedimentation rate in 90T.carolinaand 105T.ornatawas negatively associated with packed cell volume and was greater in unhealthy turtles (p < 0.05). FemaleT.ornatahad higher ESR values than males (p < 0.05). Measurement of ESR with a microhematocrit tube proportionally overestimated values from a commercial kit (Winpette), though both methods may retain utility with separate reference intervals. Hemoglobin-binding protein concentration in 184T.ornatawas significantly increased in adults and unhealthy turtles (p < 0.05). Erythrocyte sedimentation rate values were similar between seasons and populations, and HBP values were consistent between years, indicating that these analytes may have more stable baseline values than traditional health metrics in reptiles. This study demonstrates that ESR and HBP are promising diagnostics for health assessment in wild box turtles. Incorporating these tests into wild herptile health assessment protocols may support conservation efforts and improve ecosystem health monitoring.	[Adamovicz, Laura; Baker, Sarah J.; Kessler, Ethan; Kelly, Marta; Johnson, Samantha; Winter, John; Allender, Matthew C.] Univ Illinois, Wildlife Epidemiol Lab, Urbana, IL 61801 USA; [Baker, Sarah J.] Arizona Game & Fish Dept, Phoenix, AZ USA; [Kessler, Ethan; Phillips, Christopher A.] Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; Illinois Natural History Survey	Adamovicz, L (corresponding author), Univ Illinois, Wildlife Epidemiol Lab, Urbana, IL 61801 USA.	adamovi2@illinois.edu		Winter, John/0000-0002-4262-5450; Adamovicz, Laura/0000-0002-5696-2327	Illinois Department of Natural Resources [T104-R-1]; Friends of Nachusa	Illinois Department of Natural Resources; Friends of Nachusa	Our research was partially funded by the Illinois Department of Natural Resources (State Wildlife Grant T104-R-1; MCA, LA), which supported field work and sampling supplies. Website: https://www.dnr.illinois.gov/conservation/IWAP/Pages/StateWildlifeGrants.aspx We were also partially funded by the Friends of Nachusa, which supported ornate box turtle erythrocyte sedimentation rates and hemoglobin binding protein kits (MCA, LA). Website: https://www.nachusagrasslands.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAIGAR T, 1993, J ZOO WILDLIFE MED, V24, P177; Adamovicz L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195617; Ajadi R. A., 2013, Bulgarian Journal of Veterinary Medicine, V16, P37; Allender MC, 2015, J ZOO WILDLIFE MED, V46, P767, DOI 10.1638/2015-0034.1; Allender MC, 2015, ECOTOXICOLOGY, V24, P1269, DOI 10.1007/s10646-015-1498-5; Anderson NL, 1997, J ZOO WILDLIFE MED, V28, P394; Archer GA, 2017, J ZOO WILDLIFE MED, V48, P1127, DOI 10.1638/2017-0148r.1; BABLOK W, 1988, J CLIN CHEM CLIN BIO, V26, P783; Babu Ram, 2008, Journal of Experimental Zoology India, V11, P63; BANERJEE V, 1981, Journal of the Zoological Society of India, V33, P89; Beechler BR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006122; BERESFORD WA, 1981, B ENVIRON CONTAM TOX, V27, P349, DOI 10.1007/BF01611031; Bernal L, 2011, J WILDLIFE DIS, V47, P829, DOI 10.7589/0090-3558-47.4.829; Bertelsen MF, 2009, J ZOO WILDLIFE MED, V40, P199, DOI 10.1638/2007-0125.1; Boers K, 2017, HERPETOL REV, V48, P300; Bondo KJ, 2019, J WILDLIFE DIS, V55, P544, DOI 10.7589/2018-01-018; CAGLE FRED R., 1939, COPEIA, V1939, P170, DOI 10.2307/1436818; Cai J. J., 2011, HUBEI SPORTS SCI TEC, V20, P74; CALLE PP, 1993, ZOO BIOL, V12, P483, DOI 10.1002/zoo.1430120510; Castellanos R., 1979, Zoologische Garten, V49, P69; Cha CH, 2010, CLIN CHEM LAB MED, V48, P1043, DOI 10.1515/CCLM.2010.162; Christopher MM, 1999, J WILDLIFE DIS, V35, P212, DOI 10.7589/0090-3558-35.2.212; Clayton LA, 2012, J ZOO WILDLIFE MED, V43, P961, DOI 10.1638/2012-0110R.1; Cray C, 2013, J ZOO WILDLIFE MED, V44, P1107, DOI 10.1638/2013-0033R.1; Cray C, 2012, PROG MOL BIOL TRANSL, V105, P113, DOI 10.1016/B978-0-12-394596-9.00005-6; Cray C, 2009, COMPARATIVE MED, V59, P517; Delk KW, 2015, J ZOO WILDLIFE MED, V46, P929, DOI 10.1638/2014-0191.1; Depauw S, 2014, J ZOO WILDLIFE MED, V45, P497, DOI 10.1638/2013-0111R1.1; Dickey M, 2014, J ZOO WILDLIFE MED, V45, P700, DOI 10.1638/2013-0262R1.1; Dodd C.K., 2002, N AM BOX TURTLES NAT; Dolka B, 2014, VET RES COMMUN, V38, P93, DOI 10.1007/s11259-014-9589-y; DUFFY LK, 1993, J WILDLIFE DIS, V29, P353, DOI 10.7589/0090-3558-29.2.353; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; Fair Patricia A., 2006, Aquatic Mammals, V32, P182, DOI 10.1578/AM.32.2.2006.182; Farkas SL, 2009, VET MICROBIOL, V138, P169, DOI 10.1016/j.vetmic.2009.03.016; Feldman SH, 2006, J WILDLIFE DIS, V42, P279, DOI 10.7589/0090-3558-42.2.279; Finnegan D, 2014, REFERENCEINTERVALS R; Flower JE, 2014, J ZOO WILDLIFE MED, V45, P836, DOI 10.1638/2014-0035.1; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; Ganheim C, 2007, VET J, V173, P645, DOI 10.1016/j.tvjl.2006.01.011; Glidden CK, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01944; Greunz EM, 2018, J ZOO WILDLIFE MED, V49, P361, DOI 10.1638/2017-0221.1; Heatley JJ, 2010, J EXOT PET MED, V19, P160, DOI 10.1053/j.jepm.2010.06.002; Hernandez-Divers Sonia M., 2002, Journal of Herpetological Medicine and Surgery, V12, P32; HOLCOMB CM, 1979, B ENVIRON CONTAM TOX, V23, P369, DOI 10.1007/BF01769972; Horadagoda NU, 1999, VET REC, V144, P437, DOI 10.1136/vr.144.16.437; Horn PS, 2001, CLIN CHEM, V47, P2137; Hyatt MW, 2016, J ZOO WILDLIFE MED, V47, P984, DOI 10.1638/2016-0048.1; Johnson AJ, 2008, J WILDLIFE DIS, V44, P851, DOI 10.7589/0090-3558-44.4.851; Jou JM, 2011, INT J LAB HEMATOL, V33, P125, DOI 10.1111/j.1751-553X.2011.01302.x; Kane LP, 2017, J WILDLIFE DIS, V53, P285, DOI 10.7589/2016-06-138; Kennedy SN, 2019, J WILDLIFE DIS, V55, P91, DOI 10.7589/2017-10-257; Khan MZ, 1997, VET RES COMMUN, V21, P265, DOI 10.1023/A:1005838809787; Krafft BA, 2006, J WILDLIFE DIS, V42, P442, DOI 10.7589/0090-3558-42.2.442; Kratz A, 2017, INT J LAB HEMATOL, V39, P448, DOI 10.1111/ijlh.12693; Krogh AKH, 2014, J ZOO WILDLIFE MED, V45, P306, DOI 10.1638/2013-0153R.1; Krol L, 2014, J ZOO WILDLIFE MED, V45, P782, DOI 10.1638/2013-0303.1; Kusak J, 2005, J WILDLIFE DIS, V41, P843, DOI 10.7589/0090-3558-41.4.843; Le Boedec K, 2016, VET CLIN PATH, V45, P648, DOI 10.1111/vcp.12390; Lee KA, 2015, J WILDLIFE DIS, V51, P860, DOI 10.7589/2014-04-093; Lehnert B., 2015, BLANDALTMANLEH PLOTS; LEVI A, 1989, AVIAN PATHOL, V18, P321, DOI 10.1080/03079458908418605; Lloyd TC, 2016, ECOHEALTH, V13, P467, DOI 10.1007/s10393-016-1142-8; Mahlangu JN, 2008, J CLIN LAB ANAL, V22, P346, DOI 10.1002/jcla.20267; Mahmood A, 2013, J ANIM PLANT SCI-PAK, V23, P364; Manire CA, 2018, J WILDLIFE DIS, V54, P1, DOI 10.7589/2016-07-152; Mazerolle MJ, 2015, AICCMODAVG MODEL SEL; Mellish JA, 2007, WILDLIFE RES, V34, P43, DOI 10.1071/WR06073; Mishra B, 1988, UTTAR PRADESH J ZOOL, V8, P27; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Muro J, 1998, J ZOO WILDLIFE MED, V29, P40; Nakamura M, 2008, J VET MED SCI, V70, P127, DOI 10.1292/jvms.70.127; Nollens HH, 2019, VET CLIN PATH, V48, P100, DOI 10.1111/vcp.12697; Ohno K, 2006, J VET MED SCI, V68, P1275, DOI 10.1292/jvms.68.1275; Orro T, 2004, COMP IMMUNOL MICROB, V27, P413, DOI 10.1016/j.cimid.2004.01.005; Parkinson L, 2016, J ZOO WILDLIFE MED, V47, P754; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002; Preet K., 2018, INT J RES MED SCI, V6, P628; R Core Team, 2013, R LANG ENV STAT COMP; Rahman MM, 2010, VET PARASITOL, V168, P293, DOI 10.1016/j.vetpar.2009.12.001; Rose Brittany M. Way, 2011, Journal of Herpetological Medicine and Surgery, V21, P107, DOI 10.5818/1529-9651-21.4.107; Rosenberg JF, 2018, J ZOO WILDLIFE MED, V49, P765, DOI 10.1638/2017-0211.1; Rosenberg JF, 2018, J ZOO WILDLIFE MED, V49, P520, DOI 10.1638/2017-0183.1; Rosenberg JF, 2017, J ZOO WILDLIFE MED, V48, P581, DOI 10.1638/2016-228R1.1; Ryser-Degiorgis MP, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-223; Saadeh C, 1998, SOUTHERN MED J, V91, P220; Schuetzenmeister EMA, 2014, METHOD COMP REGRESSI; Shah Y, 1982, J NATL MED ASSOC, V74, P887; Siemons L, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-368; Sim RR, 2015, VET MICROBIOL, V175, P218, DOI 10.1016/j.vetmic.2014.11.029; SKINNER JG, 1994, VET REC, V134, P33, DOI 10.1136/vr.134.2.33; Smitka P, 2015, ACTA VET BRNO, V84, P25, DOI 10.2754/avb201584010025; SOLTER PF, 1991, AM J VET RES, V52, P1738; Stallknecht DE, 2007, CURR TOP MICROBIOL, V315, P445; Stay NI, 2011, CLIN LAB MED, V31, P87, DOI 10.1016/j.cll.2010.10.006; Sykes John M., 2015, Veterinary Clinics of North America Exotic Animal Practice, V18, P63, DOI 10.1016/j.cvex.2014.09.011; Tamukai K, 2011, VET CLIN PATH, V40, P368, DOI 10.1111/j.1939-165X.2011.00329.x; Tangredi BP, 1997, J ZOO WILDLIFE MED, V28, P97; Tecles F, 2007, VET RES COMMUN, V31, P23, DOI 10.1007/s11259-006-3397-y; Thomton JD, 2007, J WILDLIFE DIS, V43, P258, DOI 10.7589/0090-3558-43.2.258; Tsai YL, 2016, AQUAT MAMM, V42, P494, DOI 10.1578/AM.42.4.2016.494; Tvarijonaviciute A, 2017, J WILDLIFE DIS, V53, P718, DOI 10.7589/2016-06-126; van Dijk, 2011, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2011-1.RLTS.T21641A9303747.en, DOI 10.2305/IUCN.UK.2011-1.RLTS.T21641A9303747.EN, 10.2305/IUCN.UK.2011-1.RLTS.T163444A5606651.en]; Varela M de LL, 2009, ENFERMEDADES INFECC, V29, P66; Venn-Watson S, 2008, J WILDLIFE DIS, V44, P318, DOI 10.7589/0090-3558-44.2.318; Venn-Watson Stephanie, 2014, Comparative Clinical Pathology, V23, P1031, DOI 10.1007/s00580-013-1738-0; Venn-Watson S, 2011, J COMP PHYSIOL B, V181, P667, DOI 10.1007/s00360-011-0549-3; VERMA G K, 1981, Annals of Zoology (Agra), V18, P135; Wells RS, 2013, MAR MAMMAL SCI, V29, pE463, DOI 10.1111/mms.12007; Wicher KB, 2006, P NATL ACAD SCI USA, V103, P4168, DOI 10.1073/pnas.0508723103; WOJTASZEK JS, 1991, COMP BIOCHEM PHYS A, V100, P805, DOI 10.1016/0300-9629(91)90296-O; Yonkers SB, 2015, J VET DIAGN INVEST, V27, P408, DOI 10.1177/1040638715589612; ZentenoSavin T, 1997, J WILDLIFE DIS, V33, P64, DOI 10.7589/0090-3558-33.1.64	114	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234805	10.1371/journal.pone.0234805	http://dx.doi.org/10.1371/journal.pone.0234805			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555669	Green Published, gold			2022-12-26	WOS:000542759600030
J	Husaini, DC; Kishan, UJV; Wu, CY; Guerra, EN; Bush, CJ; Perez, AW; Coc, I				Husaini, Danladi Chiroma; Kishan, Uppala Jyana Venkata; Wu, Chen-Yi; Guerra, Elsbeth Nerissa; Bush, Cindy J.; Perez, Ayleen Walewska; Coc, Israel			Field-based screening of selected oral antibiotics in Belize	PLOS ONE			English	Article								Introduction The presence of poor quality antibiotics on the market has contributed to the antibiotics resistance and global threat to public health. Antibiotic resistance is now a global concern. One area to address this issue is by evaluating the quality of antibiotics accessible to the public. The purpose of this study was to test and compare (with corresponding pharmacopeia) the quality of common oral antibiotics available in the country of Belize with a view to providing base-line data on the testing of medications imported to the country for public consumption. The study focused only on level 2 field-based screening quality assurance on three Key Access Antibiotics from the World Health Organization (WHO) Model List of Essential Medicines. Methods Five brands of antibiotic tablets/capsules with denoted pharmacopeia imported into the country of Belize were tested for quality at The University of Belize pharmacy laboratory. A sample of 30 tablets/capsules each of the selected antibiotic brand were used for study. Visual inspection and weight variation were done for each sample while Monsanto type tablet hardness tester, Roche(@)Tablet Friability Test Apparatus (single drum), and Ajanta(@)Tablet Disintegration Test Apparatus (double basket) were conducted on selected antibiotics. Results were recorded and compared with corresponding pharmacopoeia references. Results Most of the samples collected passed performed tests. Only a few samples from both BP and USP antibiotics failed in visual inspection and weight variation tests. All antibiotics tested conformed to their corresponding pharmacopeia reference in terms of friability and disintegration time. Conclusion Most of the selected antibiotics passed performed tests when compared with their pharmacopeia. Only a few samples from both BP and USP antibiotics failed the tests conducted. There is need for regular quality assurance tests on all medications imported to Belize especially antibiotics.	[Husaini, Danladi Chiroma; Kishan, Uppala Jyana Venkata] Univ Belize, Fac Hlth Sci, Pharm Program, Belmopan City, Cayo District, Belize; [Wu, Chen-Yi] La Sante Pharm, San Ignacio Town, Cayo District, Belize; [Guerra, Elsbeth Nerissa] Friendly Pharm, Belmopan City, Cayo District, Belize; [Bush, Cindy J.] CJS Pharm, Benque Viejo Del Carmen, Cayo District, Belize; [Perez, Ayleen Walewska] Genesis Med Clin, Orange Walk Town, Orange Walk Dis, Belize; [Coc, Israel] Codds Pharm, Belmopan City, Cayo District, Belize		Husaini, DC (corresponding author), Univ Belize, Fac Hlth Sci, Pharm Program, Belmopan City, Cayo District, Belize.	hchiroma@ub.edu.bz	Husaini, Danladi/AAP-7793-2020	Husaini, Danladi/0000-0003-1655-2873				Addae-Mensah I, 2005, WHO TECH REP SER, V929, P1; [Anonymous], 2013, NATURE, V495, P141, DOI 10.1038/495141a; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2014, J CLIN DIAGN RES, V8; [Anonymous], 2014, DIABETES CARE, V38, pS1; [Anonymous], 2013, CAN J DIABETES S3, V37, pS357; [Anonymous], 2009, KIDNEY INT, V6, pS1; Bartlett JG, 2013, CLIN INFECT DIS, V56, P1445, DOI 10.1093/cid/cit070; British Pharmacopoeia, 2016, FRIAB, pV; British Pharmacopoeia, 2016, DIS, pV; British Pharmacopoeia, 2016, CONS FORM PREP, pV; British Pharmacopoeia, 2016, RES CRUSH TABL, pV; Centers for Disease Control and Prevention, 2018, BIGG THREATS DAT; Dall C, 2018, CIDRAP NEWS     1106; Gross M, ANTIBIOTICS CRISIS; Heyman ML, 2011, J PHARM SCI-US, V100, P1280, DOI 10.1002/jps.22391; IBM Corp. Released, 2017, IBM SPSS STAT WIND V; International Pharmaceutical Federation, 2009, FIP FRAM EST NAT GUI, P16; Kumar DD, 2017, INT J EDUC MATH SCI, V5, P53, DOI 10.18404/ijemst.69590; Michael CA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00145; Microsoft Corporation, 2007, MICR OFF EXC 2007 SO; Nkansah P, 2017, GUIDANCE IMPLEMENTIN; Nwokike J, 2018, B WORLD HEALTH ORGAN, V96, P135, DOI 10.2471/BLT.17.199562; Pharmapporach, 2019, PHARM QUAL CONTR TES; Pisani E, 2015, REV ANTIMICROBIAL RE; ReAct, 2014, PROBL REL QUAL ANT; Sumpradit N, 2017, BMJ-BRIT MED J, V358, P20, DOI 10.1136/bmj.j2423; United States Pharmacopeia, 2011, TABL BREAK FORC; United States Pharmacopeia, 2011, TABL FRIAB; United States Pharmacopeia, 2008, DIS; United States Pharmacopeia, 2011, UN DOS UN; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Ventola C Lee, 2015, P T, V40, P344; WHO (WorldHealthOrganization), 2018, WHO FACT SHEETS; World Health Organization, 1994, BAS TESTS PHARM DOS; World Health Organization, 1996, GUID STAB TEST PHARM; Zaid AN, 2013, SAUDI PHARM J, V21, P71, DOI 10.1016/j.jsps.2011.12.009	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234814	10.1371/journal.pone.0234814	http://dx.doi.org/10.1371/journal.pone.0234814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555711	gold, Green Published			2022-12-26	WOS:000542759600041
J	Playford, RJ; Cattell, M; Marchbank, T				Playford, Raymond J.; Cattell, Meg; Marchbank, Tania			Marked variability in bioactivity between commercially available bovine colostrum for human use; implications for clinical trials	PLOS ONE			English	Article							SECRETORY TRYPSIN-INHIBITOR; HEALTH FOOD SUPPLEMENT; GROWTH-FACTORS; INCREASE; PEPTIDE; MUCOSA; SYSTEM; DAMAGE; MODEL; MILK	Background Colostrum, the milk produced during first few days after birth, is rich in immunoglobulins, antimicrobial peptides & growth factors. Multiple clinical trials using bovine colostrum are ongoing but with no assessment of test product bioactivity. Objectives To examine variability of bioactivity between 20 commercial colostrum products, contribution of TGF beta and EGFR in mediating effects, heat sensitivity of bioactivity and changes in bioactivity of colostrum milkings in the days following calving. Design In vitro bioactivity used AGS, RIE-1 and Caco-2 cell proliferation (Alamar blue) and migration (wounded monolayers) assays. Changes in colostrum bioactivity determined following addition of TGF beta-neutralising antibody, EGFR blocker (Typhostin) and after heating (40-60 degrees C, 60 min). In vivo bioassay assessed ability of colostrum gavage (2ml, 7mg/ml) to reduce gastric damage (NSAID + restraint) in rats. Milkings from 6 cows, days 0-3 post calving were assessed for bioactivity and growth factor concentrations. Result Six-fold differences in pro-proliferative and migratory activity were seen comparing commercial products. Comparison of most- and least-active samples from in vitro studies showed two- to three-fold differences in ability to reduce gastric injury (86% reduction using most-active vs 48% using least-active, p<0.01). Tyrphostin reduced pro-migratory and proliferative activity by 23% and 55%. TGF beta neutralisation reduced migratory activity by 83% but did not affect proliferation Heating colostrum powder to 50 degrees C did not affect immunoactivity of haptoglobin, EGF, TGF beta, IgG, IGF-1 or betacellulin but decreased bioactivity by >40%. Milking studies showed high bioactivity during first and second milkings on day 0 but 77% reduction by day 3. Changes in total protein, haptoglobin, EGF, TGF beta, IgG and IGF-1 paralleled falls in bioactivity. Conclusion Commercial colostrum products possess widely different bioactivity. Variation in heat exposure and/or proportion of day 0 colostrum content may contribute to this. Assessment of colostrum bioactivity has advantages to growth factor quantitation for quality control.	[Playford, Raymond J.; Marchbank, Tania] Queen Mary Univ London, Ctr Immunobiol, Barts & London Sch Med, Blizard Inst, London, England; [Playford, Raymond J.] Univ Plymouth, Peninsula Med Sch, Plymouth, Devon, England; [Playford, Raymond J.; Cattell, Meg] Pantheryx Inc, Dept Res & Dev, Boulder, CO USA	University of London; Queen Mary University London; University of Plymouth	Marchbank, T (corresponding author), Queen Mary Univ London, Ctr Immunobiol, Barts & London Sch Med, Blizard Inst, London, England.	t.marchbank@qmul.ac.uk		Playford, Raymond/0000-0003-1235-8504	Pantheryx Inc.	Pantheryx Inc.	Partially funded by Pantheryx Inc. The funder provided support in the form of salaries for authors (RJP, MC) and provided partial funding for TM in her role as an external consultant. Pantheryx did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	BARRANCO SC, 1983, CANCER RES, V43, P1703; BLAY J, 1984, CELL BIOL INT REP, V8, P551, DOI 10.1016/0309-1651(84)90054-7; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; Fiske WH, 2009, EXP CELL RES, V315, P583, DOI 10.1016/j.yexcr.2008.10.043; FitzGerald AJ, 2004, PEPTIDES, V25, P793, DOI 10.1016/j.peptides.2003.12.022; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Gauthier SF, 2006, LAIT, V86, P99, DOI 10.1051/lait:2005048; Jones AW, 2016, BMC SPORTS SCI MED R, V8, DOI 10.1186/s13102-016-0047-8; Khan Z, 2002, ALIMENT PHARM THER, V16, P1917, DOI 10.1046/j.1365-2036.2002.01354.x; Kotsis Y, 2018, EUR J NUTR, V57, P1181, DOI 10.1007/s00394-017-1401-7; LEVI S, 1994, BRIT J RHEUMATOL, V33, P605; M'Rabet L, 2008, J NUTR, V138, p1782S, DOI 10.1093/jn/138.9.1782S; Marchbank T, 1996, AM J PATHOL, V148, P715; Marchbank T, 2007, AM J PATHOL, V171, P1462, DOI 10.2353/ajpath.2007.070192; Marchbank T, 2011, AM J PHYSIOL-GASTR L, V300, pG477, DOI 10.1152/ajpgi.00281.2010; Marchbank T, 2009, AM J PHYSIOL-GASTR L, V296, pG697, DOI 10.1152/ajpgi.90565.2008; McGrath BA, 2016, DAIRY SCI TECHNOL, V96, P133, DOI 10.1007/s13594-015-0258-x; Mihic T, 2016, J EVID-BASED INTEGR, V21, pNP110, DOI 10.1177/2156587216658846; Playford RJ, 2020, J NUTR, V150, P1434, DOI 10.1093/jn/nxaa083; PLAYFORD RJ, 1991, DIGESTION, V49, P198, DOI 10.1159/000200722; Playford RJ, 2001, CLIN SCI, V100, P627, DOI 10.1042/CS20010015; Playford RJ, 2000, AM J CLIN NUTR, V72, P5; Playford RJ, 1999, GUT, V44, P653, DOI 10.1136/gut.44.5.653; Rathe M, 2014, NUTR REV, V72, P237, DOI 10.1111/nure.12089; Sobczuk-Szul G, 2003, TURK J VET ANIM SCI, V37, P43; SVANES K, 1982, GASTROENTEROLOGY, V82, P1409	26	15	16	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234719	10.1371/journal.pone.0234719	http://dx.doi.org/10.1371/journal.pone.0234719			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555629	gold, Green Published			2022-12-26	WOS:000542759600017
J	Kong, J; Kim, S				Kong, Jiwon; Kim, Sunghoon			Cell-based analysis of pairwise interactions between the components of the multi-tRNA synthetase complex	FASEB JOURNAL			English	Article						aminoacyl-tRNA synthetase; macromolecular complex; mammalian multi-tRNA synthetase complex; ribosome; tRNA	AMINOACYL-TRANSFER-RNA; PROTEIN INTERACTIONS; TRANSLATION; ELONGATION; REVEALS; ASSOCIATION; RIBOSOMES; REPORTER; DOMAIN; FORMS	Cytoplasmic aminoacyl-tRNA synthetases (ARSs) are organized into multi-tRNA synthetase complexes (MSCs), from Archaea to mammals. An evolutionary conserved role of the MSCs is enhancement of aminoacylation by forming stable associations of the ARSs and tRNAs. In mammals, a single macromolecular MSC exists, which is composed of eight cytoplasmic ARSs, for nine amino acids, and three scaffold proteins. Consequently, nearly half of aminoacyl-tRNA efflux becomes concentrated at the MSC. Stable supply of aminoacyl-tRNA to the ribosome is, therefore, considered to be a major role of the mammalian MSC. Furthermore, the mammalian MSC also serves as a reservoir for releasable components with noncanonical functions. In this study, a split-luciferase complementation system was applied to investigate the configuration of the MSC in live mammalian cells. Multiplex interconnections between the components were simplified into binary protein-protein interactions, and pairwise comparison of the interactions reconstituted a framework consistent with previousin vitrostudies. Reversibility of the split-luciferase reporter binding demonstrated convertible organization of the mammalian MSC, including interferon gamma (IFN gamma)-stimulated glutamyl-prolyl-tRNA synthetase 1 (EPRS1) release, as well as the cooperation with the ribosome bridged by the tRNAs. The cell-based analysis provided an improved understanding of the flexible framework of the mammalian MSC in physiological conditions.	[Kong, Jiwon; Kim, Sunghoon] Seoul Natl Univ, Coll Pharm, Med Bioconvergence Res Ctr, Seoul 08826, South Korea; [Kim, Sunghoon] Yonsei Univ, Gangnam Severance Hosp, Coll Pharm, Med Bioconvergence Res Ctr, Incheon 21983, South Korea; [Kim, Sunghoon] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Incheon 21983, South Korea; [Kong, Jiwon] Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea	Seoul National University (SNU); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU)	Kim, S (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Coll Pharm, Med Bioconvergence Res Ctr, Incheon 21983, South Korea.; Kim, S (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Coll Med, Incheon 21983, South Korea.	sunghoonkim@yonsei.ac.kr	Kong, Jiwon/GXH-5761-2022	Kong, Jiwon/0000-0003-3990-5619	National Research Foundation - Ministry of Science and ICT (MSIT) of Korea [NRF-M3A6A4-2010-0029785]	National Research Foundation - Ministry of Science and ICT (MSIT) of Korea	This work was supported by the Global Frontier Project grant (NRF-M3A6A4-2010-0029785) of National Research Foundation funded by the Ministry of Science and ICT (MSIT) of Korea.	Azad T, 2014, ANAL BIOANAL CHEM, V406, P5541, DOI 10.1007/s00216-014-7980-8; AZZAM ME, 1973, P NATL ACAD SCI USA, V70, P3866, DOI 10.1073/pnas.70.12.3866; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P11288, DOI 10.1073/pnas.96.20.11288; Cho HY, 2015, J BIOL CHEM, V290, P29313, DOI 10.1074/jbc.M115.690867; Choi JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001351; David A, 2011, J BIOL CHEM, V286, P20688, DOI 10.1074/jbc.M110.209452; Dias J, 2013, J BIOL CHEM, V288, P23979, DOI 10.1074/jbc.M113.489922; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Fang PF, 2011, P NATL ACAD SCI USA, V108, P8239, DOI 10.1073/pnas.1100224108; Fu YY, 2014, P NATL ACAD SCI USA, V111, P15084, DOI 10.1073/pnas.1408836111; Godinic V, 2007, FEBS J, V274, P2788, DOI 10.1111/j.1742-4658.2007.05812.x; Godinic-Mikulcic V, 2011, J BIOL CHEM, V286, P3396, DOI 10.1074/jbc.M110.168526; Guo M, 2008, P NATL ACAD SCI USA, V105, P2331, DOI 10.1073/pnas.0712072105; GUPTA RS, 1977, CELL, V10, P61, DOI 10.1016/0092-8674(77)90140-4; Hahn H, 2019, IUCRJ, V6, P958, DOI 10.1107/S2052252519010790; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hausmann CD, 2007, NUCLEIC ACIDS RES, V35, P6094, DOI 10.1093/nar/gkm534; Hei ZF, 2019, J BIOL CHEM, V294, P4775, DOI 10.1074/jbc.RA118.006356; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kaminska M, 2009, J BIOL CHEM, V284, P13746, DOI 10.1074/jbc.M900480200; Kang T, 2012, J MOL BIOL, V423, P475, DOI 10.1016/j.jmb.2012.07.020; Kim DG, 2014, NAT CHEM BIOL, V10, P29, DOI [10.1038/nchembio.1381, 10.1038/NCHEMBIO.1381]; Kwon NH, 2011, P NATL ACAD SCI USA, V108, P19635, DOI 10.1073/pnas.1103922108; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Laschet C, 2019, J BIOL CHEM, V294, P4079, DOI 10.1074/jbc.RA118.006231; MartinNieto J, 1997, J CELL SCI, V110, P955; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Moulinier L, 2001, EMBO J, V20, P5290, DOI 10.1093/emboj/20.18.5290; Negrutskii BS, 1999, J BIOL CHEM, V274, P4545, DOI 10.1074/jbc.274.8.4545; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Praetorius-Ibba M, 2007, J BIOL CHEM, V282, P3680, DOI 10.1074/jbc.M609988200; Raina M, 2012, FEBS LETT, V586, P2232, DOI 10.1016/j.febslet.2012.05.039; Ray PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098493; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Simos G, 1998, MOL CELL, V1, P235, DOI 10.1016/S1097-2765(00)80024-6; SIVARAM P, 1990, P NATL ACAD SCI USA, V87, P3665, DOI 10.1073/pnas.87.10.3665; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Yaremchuk A, 2000, ACTA CRYSTALLOGR D, V56, P197, DOI 10.1107/S0907444999015504; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774	44	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10476	10488		10.1096/fj.202000418R	http://dx.doi.org/10.1096/fj.202000418R		JUN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32539228	hybrid			2022-12-26	WOS:000541800100001
J	Nishi, RA; Badner, A; Hooshmand, MJ; Creasman, DA; Liu, HL; Anderson, AJ				Nishi, Rebecca A.; Badner, Anna; Hooshmand, Mitra J.; Creasman, Dana A.; Liu, Hongli; Anderson, Aileen J.			The effects of mouse strain and age on a model of unilateral cervical contusion spinal cord injury	PLOS ONE			English	Article							LOCOMOTION; RECOVERY; OUTCOMES; PAIN	There are approximately 1.2 million people currently living with spinal cord injury (SCI), with a majority of cases at the cervical level and half involving incomplete injuries. Yet, as most preclinical research has been focused on bilateral thoracic models, there remains a disconnect between bench and bedside that limits translational success. Here, we profile a clinically relevant model of unilateral cervical contusion injury in the mouse (30kD with 0, 2, 5, or 10 second dwell time). We demonstrate sustained behavioral deficits in performance on grip strength, cylinder reaching, horizontal ladderbeam and CatWalk automated gait analysis tasks. Beyond highlighting reliable parameters for injury assessment, we also explored the effect of mouse strain and age on injury outcome, including evaluation of constitutively immunodeficient mice relevant for neurotransplantation and cellular therapy testing. Comparison of C57Bl/6 and immunodeficient Rag2gamma(c)-/- as well as Agouti SCIDxRag2Gamma(c)-/- hybrid mouse strains revealed fine differences in post-injury ipsilateral grip strength as well as total number of rearings on the cylinder task. Differences in post-SCI contralateral forepaw duty cycle and regularity index as measured by CatWalk gait analysis between the two immunodeficient strains were also observed. Further, assessment of young (3-4 months old) and aging (16-17 months old) Rag2gamma(c)-/- mice identified age-related pre-injury differences in strength and rearing that were largely masked following cervical contusion injury; observations that may help interpret previous results in aged rodents as well as human clinical trials. Collectively, the work provides useful insight for experimental design and analysis of future pre-clinical studies in a translational unilateral cervical contusion injury model.	[Nishi, Rebecca A.; Badner, Anna; Hooshmand, Mitra J.; Liu, Hongli; Anderson, Aileen J.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Ctr, Irvine, CA 92717 USA; [Nishi, Rebecca A.; Hooshmand, Mitra J.; Liu, Hongli; Anderson, Aileen J.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorder, Irvine, CA 92717 USA; [Creasman, Dana A.; Anderson, Aileen J.] Univ Calif Irvine, Anat & Neurobiol, Irvine, CA USA; [Anderson, Aileen J.] Univ Calif Irvine, Phys & Med Rehabil, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Nishi, RA (corresponding author), Univ Calif Irvine, Sue & Bill Gross Stem Cell Ctr, Irvine, CA 92717 USA.; Nishi, RA (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorder, Irvine, CA 92717 USA.	rnishi@uci.edu	Badner, Anna/N-8035-2019	Badner, Anna/0000-0002-5244-6165	NIH U01 GRANT (Aileen J. Anderson) [U01-NS079420]; Christopher & Dana Reeve Foundation	NIH U01 GRANT (Aileen J. Anderson); Christopher & Dana Reeve Foundation	This study was supported by NIH U01 GRANT (Aileen J. Anderson) U01-NS079420 (Aileen J. Anderson) and the Christopher & Dana Reeve Foundation (Aileen J. Anderson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; Badhiwala JH, 2019, LANCET NEUROL, V18, P24, DOI 10.1016/S1474-4422(18)30444-7; Badner A, 2017, EXPERT OPIN BIOL TH, V17, P529, DOI 10.1080/14712598.2017.1308481; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BEM T, 1995, EXP BRAIN RES, V104, P70, DOI 10.1007/BF00229856; Cummings BJ, 2007, BEHAV BRAIN RES, V177, P232, DOI 10.1016/j.bbr.2006.11.042; Detloff MR, 2013, J NEUROTRAUM, V30, P884, DOI 10.1089/neu.2012.2632; Dunham KA, 2010, J NEUROTRAUM, V27, P2091, DOI 10.1089/neu.2010.1424; Dunnett SB, 1998, NEUROSCI LETT, V246, P1, DOI 10.1016/S0304-3940(98)00194-3; Ferguson AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059712; Frontera JE, 2017, PHYS MED REH CLIN N, V28, P821, DOI 10.1016/j.pmr.2017.06.013; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Hong J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082167; Hooshmand MJ, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-15; Hooshmand MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005871; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Kerr BJ, 2007, EXP NEUROL, V206, P240, DOI 10.1016/j.expneurol.2007.04.014; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Ma MH, 2001, EXP NEUROL, V169, P239, DOI 10.1006/exnr.2001.7679; Mills CD, 2001, J NEUROTRAUM, V18, P743, DOI 10.1089/089771501316919111; Nishi RA, 2007, J NEUROTRAUM, V24, P674, DOI 10.1089/neu.2006.0204; Noristani HN, 2018, J NEUROTRAUM, V35, P2924, DOI 10.1089/neu.2017.5613; Noristani HN, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00173; Siegenthaler MM, 2008, EXP NEUROL, V213, P363, DOI 10.1016/j.expneurol.2008.06.015; Streijger F, 2013, J NEUROTRAUM, V30, P869, DOI 10.1089/neu.2012.2405; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Ulndreaj Antigona, 2017, F1000Res, V6, P1907, DOI 10.12688/f1000research.11633.1; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; Zhang B, 2016, NEUROBIOL AGING, V47, P157, DOI 10.1016/j.neurobiolaging.2016.07.029	29	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234245	10.1371/journal.pone.0234245	http://dx.doi.org/10.1371/journal.pone.0234245			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542053	Green Published, gold			2022-12-26	WOS:000542685100041
J	Wittenborn, AK; Schmale, O; Thiel, V				Wittenborn, Anna K.; Schmale, Oliver; Thiel, Volker			Zooplankton impact on lipid biomarkers in water column vs. surface sediments of the stratified Eastern Gotland Basin (Central Baltic Sea)	PLOS ONE			English	Article							FATTY-ACIDS; PARTICULATE MATTER; ORGANIC-MATTER; WAX ESTERS; COPEPODS; MARINE; TROPHODYNAMICS; DEGRADATION; DIAGENESIS; MARKERS	Sediments from stratified marine environments often show an enhanced preservation of organic matter (OM) which is attributed to the limitation, or absence, of oxygen in the bottom waters and surface sediments. Yet there is still a limited knowledge about the changes that the associated biomarker signals undergo in the different parts of a stratified environment, and as to which extent the situation in the productive upper parts of the water column is eventually reflected in the sedimentary record. To better understand these processes we studied particulate matter samples from the stratified, partly anoxic Eastern Gotland Basin (EGB, Central Baltic Sea) during a strong cyanobacterial bloom in August 2016. Endmember samples representing the main biomass producers within the phytoplankton (cyanobacteria) and mesozooplankton (copepods) were obtained from different levels of the water column. Major extractable lipids (fatty acids, n-alcohols, sterols, and selected hydrocarbons) were analysed from the same materials and compared to samples cored from the underlying surface sediments (0-12 cm). Given the annually recurring phenomenon of cyanobacterial blooms we anticipated to find a considerable lipid footprint of the major primary producers in the sedimentary record of the EGB. Unexpectedly, however, lipids in the surface sediments largely derived from the storage lipids (mainly wax esters) of the copepodPseudocalanusspp. which thrived in deeper, more saline and oxygen-depleted waters. Carbon number and unsaturation patterns suggest that the component n-alcohols of these wax esters are transformed into the corresponding n-fatty acids prior to further degradation in the sediment. In the EGB deposits, most of the plankton-derived lipids studied appear to be degraded on a time scale of decades. In terms of relative abundances, long-chain n-alkyl lipids and C(29)sterols from terrestrial plant sources instead become predominant in the deeper sediment layers. Likewise, higher stanol/sterol ratios of C-27-sterols vs. C-29-sterols indicate a more intense biodegradation of planktonic OM as compared to terrestrial OM. Our observations indicate that primary produced particulate OM is heavily modified by mesozooplankton grazing. This overprint adds on the influence of heterotrophic microorganisms and, in the sediment, preferential preservation of terrestrial biomarkers. Taken together, these factors result in a major decoupling of the biomarker signals between the productive upper mixed layer and the oxygen-depleted bottom waters and sediments of the EGB.	[Wittenborn, Anna K.; Thiel, Volker] Georg August Univ Gottingen, Geosci Ctr, Gottingen, Germany; [Schmale, Oliver] Leibniz Inst Balt Sea Res Warnemunde, Marine Chem, Rostock, Germany; [Wittenborn, Anna K.] Leibniz Inst Balt Sea Res Warnemunde, Marine Geol, Rostock, Germany	University of Gottingen; Leibniz Institut fur Ostseeforschung Warnemunde; Leibniz Institut fur Ostseeforschung Warnemunde	Wittenborn, AK (corresponding author), Georg August Univ Gottingen, Geosci Ctr, Gottingen, Germany.; Wittenborn, AK (corresponding author), Leibniz Inst Balt Sea Res Warnemunde, Marine Geol, Rostock, Germany.	anna.wittenborn@io-warnemuende.de		Thiel, Volker/0000-0003-4758-2784; Wittenborn, Anna/0000-0003-1857-4144	German Research Foundation [SCHM 2530/5-1, TH713/12-1]; Open Access Fund of the Leibniz Association	German Research Foundation(German Research Foundation (DFG)); Open Access Fund of the Leibniz Association	The work was funded by the grants of the German Research Foundation (SCHM 2530/5-1) awarded to OS and grant TH713/12-1 awarded to VT. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Berndmeyer C, 2014, BIOGEOSCIENCES, V11, P7009, DOI 10.5194/bg-11-7009-2014; Berndmeyer C, 2013, ORG GEOCHEM, V55, P103, DOI 10.1016/j.orggeochem.2012.11.010; Blumenberg M, 2013, BIOGEOSCIENCES, V10, P2725, DOI 10.5194/bg-10-2725-2013; Blumenberg M, 2012, BIOGEOSCIENCES, V9, P4139, DOI 10.5194/bg-9-4139-2012; Brocks JJ, 2017, NATURE, V548, P578, DOI 10.1038/nature23457; Coates RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085140; Dargahi B, 2017, J MAR SCI ENG, V5, DOI 10.3390/jmse5010002; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; Moller EF, 2007, LIMNOL OCEANOGR, V52, P79, DOI 10.4319/lo.2007.52.1.0079; Grote J, 2007, APPL ENVIRON MICROB, V73, P7155, DOI 10.1128/AEM.00466-07; Gugger M, 2002, INT J SYST EVOL MICR, V52, P1007, DOI 10.1099/00207713-52-3-1007; HADDAD RI, 1992, ORG GEOCHEM, V19, P205, DOI 10.1016/0146-6380(92)90037-X; Harvey HR, 1997, J EUKARYOT MICROBIOL, V44, P189, DOI 10.1111/j.1550-7408.1997.tb05698.x; Jenkyns HC, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002788; Kaiser J, 2019, BIOGEOSCIENCES; KATTNER G, 1994, MAR BIOL, V118, P637, DOI 10.1007/BF00347511; KATTNER G, 1989, MAR CHEM, V26, P261, DOI 10.1016/0304-4203(89)90007-8; Los Dmitry A., 2015, Life-Basel, V5, P554, DOI 10.3390/life5010554; MEYERS PA, 1993, ORG GEOCHEM, V20, P867, DOI 10.1016/0146-6380(93)90100-P; Mohrholz V, 2015, J MARINE SYST, V148, P152, DOI 10.1016/j.jmarsys.2015.03.005; Moros M, 2017, BOREAS, V46, P129, DOI 10.1111/bor.12193; Nazzaro A, 2011, HUMAN REPROD, V26, pi227; oberg J., 2017, HELCOM BALTIC SEA EN; Omstedt A, 2004, PROG OCEANOGR, V63, P1, DOI 10.1016/j.pocean.2004.09.001; Peters J, 2006, MAR BIOL, V149, P1417, DOI 10.1007/s00227-006-0290-8; Peters J, 2013, J PLANKTON RES, V35, P595, DOI 10.1093/plankt/fbt004; Pond DW, 2011, LIMNOL OCEANOGR, V56, P1310, DOI 10.4319/lo.2011.56.4.1310; PRAHL FG, 1985, J MAR BIOL ASSOC UK, V65, P547, DOI 10.1017/S0025315400050591; Ratnayake NP, 2005, ORG GEOCHEM, V36, P531, DOI 10.1016/j.orggeochem.2004.11.004; Reuss N, 2002, MAR BIOL, V141, P423, DOI 10.1007/s00227-002-0841-6; Rohl HJ, 2001, PALAEOGEOGR PALAEOCL, V165, P27, DOI 10.1016/S0031-0182(00)00152-8; Rontani JF, 2012, BIOGEOSCIENCES, V9, P3513, DOI 10.5194/bg-9-3513-2012; Sargent J.R., 1986, P59; Schmale O, 2018, LIMNOL OCEANOGR, V63, P412, DOI 10.1002/lno.10640; Schmale O, 2016, GEOPHYS RES LETT, V43, P5225, DOI 10.1002/2016GL069032; Seifert T, BALTIC SEA SCI C; SHIEA J, 1990, ORG GEOCHEM, V15, P223, DOI 10.1016/0146-6380(90)90001-G; SIMONEIT BRT, 1991, CHEMOSPHERE, V23, P447, DOI 10.1016/0045-6535(91)90196-K; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Stawiarski B, 2019, BIOGEOSCIENCES, V16, P1, DOI 10.5194/bg-16-1-2019; Sun MY, 2000, ORG GEOCHEM, V31, P889, DOI 10.1016/S0146-6380(00)00051-6; Taipale S, 2016, FRONT PLANT SCI, P7, DOI [10.3389/fpls.2016.00007, DOI 10.3389/FPLS.2016.00007]; Vargas MA, 1998, J PHYCOL, V34, P812, DOI 10.1046/j.1529-8817.1998.340812.x; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; Volkman J. K., 1980, C INT CNRS, V293, P185; Volkman JK, 2003, APPL MICROBIOL BIOT, V60, P495, DOI 10.1007/s00253-002-1172-8; VOLKMAN JK, 1986, ORG GEOCHEM, V9, P83, DOI 10.1016/0146-6380(86)90089-6; WAKEHAM SG, 1989, NATURE, V342, P787, DOI 10.1038/342787a0; Wakeham SG, 1997, DEEP-SEA RES PT II, V44, P2131, DOI 10.1016/S0967-0645(97)00035-0; Wasmund N, 1997, INT REV GES HYDROBIO, V82, P169, DOI 10.1002/iroh.19970820205; Wasmund N, 2017, MAR SCI REPORTS, P98	53	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234110	10.1371/journal.pone.0234110	http://dx.doi.org/10.1371/journal.pone.0234110			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530916	Green Published, gold			2022-12-26	WOS:000542037200007
J	Miller-Ensminger, T; Mormando, R; Maskeri, L; Shapiro, JW; Wolfe, AJ; Putonti, C				Miller-Ensminger, Taylor; Mormando, Rita; Maskeri, Laura; Shapiro, Jason W.; Wolfe, Alan J.; Putonti, Catherine			Introducing Lu-1, a NovelLactobacillus jenseniiPhage Abundant in the Urogenital Tract	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; LACTOBACILLUS PHAGES; BACTERIOPHAGES; INDUCTION; WOMEN; IDENTIFICATION; SELECTION; PROPHAGE; URINE; FLORA	Bacteriophages (phages) play a key role in shaping microbial communities, including those of the human body. Phages are abundant members of the urogenital tract, most often persisting through the lysogenic life cycle as prophages integrated within the genomes of their bacterial hosts. While numerous studies of the urogenital microbiota have focused on the most abundant bacterial member of this niche-Lactobacillusspecies-very little is known aboutLactobacillusphages. Focusing onLactobacillus jenseniistrains from the urinary tract, we identified numerous prophages related to the previously characterized Lv-1 phage from a vaginalL.jenseniistrain. Furthermore, we identified a newL.jenseniiphage, Lu-1. Evidence suggests that both phages are abundant within the urogenital tract. CRISPR spacer sequences matching to Lv-1 and Lu-1 prophages were identified. While first detected in urinary isolates, the Lu-1 phage was also discovered inL.jenseniiisolates from vaginal and perineal swabs, and both phages were found in metagenomic data sets. The prevalence of these phages in the isolates suggests that both phages are active members of the urogenital microbiota.	[Miller-Ensminger, Taylor; Mormando, Rita; Maskeri, Laura; Putonti, Catherine] Loyola Univ, Bioinformat Program, Chicago, IL 60611 USA; [Shapiro, Jason W.; Putonti, Catherine] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Wolfe, Alan J.; Putonti, Catherine] Loyola Univ, Stritch Sch Med, Dept Microbiol & Immunol, 2160 S 1st Ave, Maywood, IL 60153 USA; [Putonti, Catherine] Loyola Univ, Dept Comp Sci, Chicago, IL 60611 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Putonti, C (corresponding author), Loyola Univ, Bioinformat Program, Chicago, IL 60611 USA.; Putonti, C (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.; Putonti, C (corresponding author), Loyola Univ, Stritch Sch Med, Dept Microbiol & Immunol, 2160 S 1st Ave, Maywood, IL 60153 USA.; Putonti, C (corresponding author), Loyola Univ, Dept Comp Sci, Chicago, IL 60611 USA.	cputonti@luc.edu			Loyola University Chicago's Carbon Research Fellowship; Loyola University Chicago's Mulcahy Research Fellowship; National Science Foundation [1661357]	Loyola University Chicago's Carbon Research Fellowship; Loyola University Chicago's Mulcahy Research Fellowship; National Science Foundation(National Science Foundation (NSF))	TME is supported by Loyola University Chicago's Carbon Research Fellowship. RM and LM are supported by Loyola University Chicago's Mulcahy Research Fellowship. CP is supported by the National Science Foundation (Grant no. 1661357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmaksoud AA, 2016, MICROBIOL-SGM, V162, P466, DOI 10.1099/mic.0.000238; Amabebe E, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00181; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; [Anonymous], 2017, LANCET GLOB HEALTH, V5, pe428; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Aroutcheva A, 2001, AM J OBSTET GYNECOL, V185, P375, DOI 10.1067/mob.2001.115867; Atassi F, 2006, FEMS MICROBIOL LETT, V257, P132, DOI 10.1111/j.1574-6968.2006.00163.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barr JJ, 2017, IMMUNOL REV, V279, P106, DOI 10.1111/imr.12565; Blackwell AL, 1999, SEX TRANSM INFECT, V75, P352, DOI 10.1136/sti.75.5.352; Crawley AB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29746-3; Damelin LH, 2011, J MED MICROBIOL, V60, P180, DOI 10.1099/jmm.0.024463-0; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Eckert Linda O, 2003, Infect Dis Obstet Gynecol, V11, P11, DOI 10.1155/S1064744903000024; Fok C, 2018, INT UROGYNECOL J, V29, P1765, DOI 10.1007/s00192-018-3732-1; Garretto A, 2019, NAT REV UROL, V16, P422, DOI 10.1038/s41585-019-0192-4; Gervasi T, 2014, LETT APPL MICROBIOL, V59, P355, DOI 10.1111/lam.12298; Ghartey JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096659; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; HILLIER SL, 1992, OBSTET GYNECOL, V79, P369, DOI 10.1097/00006250-199203000-00008; Hilt EE, 2014, J CLIN MICROBIOL, V52, P871, DOI 10.1128/JCM.02876-13; Jacobs KM, 2017, AJP REP, V7, pe188, DOI 10.1055/s-0037-1606860; Jang SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44579-4; Kaewsrichan J, 2006, FEMS IMMUNOL MED MIC, V48, P75, DOI 10.1111/j.1574-695X.2006.00124.x; Kalyoussef S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049506; Karstens L, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00078; Kilic AO, 1996, APPL ENVIRON MICROB, V62, P2111; Kilic AO, 2001, CLIN DIAGN LAB IMMUN, V8, P31, DOI 10.1128/CDLI.8.1.31-39.2001; KLEBANOFF SJ, 1991, J INFECT DIS, V164, P94, DOI 10.1093/infdis/164.1.94; Komesu YM, 2019, AM J OBSTET GYNECOL, VS0002-9378, P31010; Komesu Y, 2018, INT UROGYNECOL J, V29, P1785, DOI 10.1007/s00192-018-3683-6; Lawrence D, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070587; Ly M, 2014, MBIO, V5, DOI 10.1128/mBio.01133-14; Ma YF, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0410-y; Manrique P, 2016, P NATL ACAD SCI USA, V113, P10400, DOI 10.1073/pnas.1601060113; Martin R, 2010, INT MICROBIOL, V13, P113, DOI 10.2436/20.1501.01.116; Martin R, 2009, INT MICROBIOL, V12, P131, DOI 10.2436/20.1501.01.90; Meriwether KV, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00092; Miller-Ensminger T, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00738-17; Nanda AM, 2015, J BACTERIOL, V197, P410, DOI 10.1128/JB.02230-14; Nasioudis D, 2017, BJOG-INT J OBSTET GY, V124, P61, DOI 10.1111/1471-0528.14209; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nunn KL, 2015, MBIO, V6, DOI 10.1128/mBio.01084-15; Ojala T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1070; Oliveira H, 2013, J VIROL, V87, P4558, DOI 10.1128/JVI.03277-12; Pavlova S I, 1997, Infect Dis Obstet Gynecol, V5, P36; Pearce MM, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.009; Pearce MM, 2014, MBIO, V5, DOI 10.1128/mBio.01283-14; Price TK, 2020, BJOG-INT J OBSTET GY, V127, P193, DOI 10.1111/1471-0528.15920; Price TK, 2016, J CLIN MICROBIOL, V54, P1216, DOI 10.1128/JCM.00044-16; Putonti C, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.00970-19; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Raya Raul R., 2009, V501, P23, DOI 10.1007/978-1-60327-164-6_3; Szafranski SP, 2017, J BIOTECHNOL, V250, P29, DOI 10.1016/j.jbiotec.2017.01.002; Tamarelle J, 2019, CLIN MICROBIOL INFEC, V25, P35, DOI 10.1016/j.cmi.2018.04.019; Tao L, 1998, Infect Dis Obstet Gynecol, V6, P236; Thomas-White K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03968-5; Thomas-White K, 2018, INT UROGYNECOL J, V29, P1797, DOI 10.1007/s00192-018-3767-3; Thomas-White KJ, 2016, INT UROGYNECOL J, V27, P723, DOI 10.1007/s00192-015-2847-x; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Voravuthikunchai SP, 2006, ANAEROBE, V12, P221, DOI 10.1016/j.anaerobe.2006.06.003; Wagner J, 2013, INFLAMM BOWEL DIS, V19, P1598, DOI 10.1097/MIB.0b013e318292477c; Wylie KM, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0071-7; Zhou X, 2010, FEMS IMMUNOL MED MIC, V58, P169, DOI 10.1111/j.1574-695X.2009.00618.x	65	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234159	10.1371/journal.pone.0234159	http://dx.doi.org/10.1371/journal.pone.0234159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525961	Green Published, gold			2022-12-26	WOS:000542036800012
J	Trisrivirat, D; Lawan, N; Chenprakhon, P; Matsui, D; Asano, Y; Chaiyen, P				Trisrivirat, Duangthip; Lawan, Narin; Chenprakhon, Pirom; Matsui, Daisuke; Asano, Yasuhisa; Chaiyen, Pimchai			Mechanistic insights into the dual activities of the single active site ofl-lysine oxidase/monooxygenase from Pseudomonas sp. AIU 813	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						l-amino acid monooxygenase; l-amino acid oxidase; 5-aminopentanamide; flavin-dependent monooxygenase; flavin-dependent oxidase; decarboxylation; imino acid; keto acid; dual activity enzyme; flavin enzyme mechanism; oxidase; flavin adenine dinucleotide (FAD); flavoprotein; monooxygenase	AMINO-ACID OXIDASE; FLAVOPROTEIN TRYPTOPHAN 2-MONOOXYGENASE; L-PHENYLALANINE OXIDASE; FLAVIN-DEPENDENT MONOOXYGENASE; MOLECULAR-DYNAMICS; KINETIC MECHANISM; LIGAND COMPLEX; PURIFICATION; ENZYME; OXIDATION	l-Lysine oxidase/monooxygenase (l-LOX/MOG) fromPseudomonassp. AIU 813 catalyzes the mixed bioconversion ofl-amino acids, particularlyl-lysine, yielding an amide and carbon dioxide by an oxidative decarboxylation (i.e.apparent monooxygenation), as well as oxidative deamination (hydrolysis of oxidized product), resulting in alpha-keto acid, hydrogen peroxide (H2O2), and ammonia. Here, using high-resolution MS and monitoring transient reaction kinetics with stopped-flow spectrophotometry, we identified the products from the reactions ofl-lysine andl-ornithine, indicating that besides decarboxylating imino acids (i.e.5-aminopentanamide froml-lysine),l-LOX/MOG also decarboxylates keto acids (5-aminopentanoic acid froml-lysine and 4-aminobutanoic acid froml-ornithine). The reaction of reduced enzyme and oxygen generated an imino acid and H2O2, with no detectable C4a-hydroperoxyflavin. Single-turnover reactions in whichl-LOX/MOG was first reduced byl-lysine to form imino acid before mixing with various compounds revealed that under anaerobic conditions, only hydrolysis products are present. Similar results were obtained upon H(2)O(2)addition after enzyme denaturation. H(2)O(2)addition to activel-LOX/MOG resulted in formation of more 5-aminopentanoic acid, but not 5-aminopentamide, suggesting that H(2)O(2)generated froml-LOX/MOGin situcan result in decarboxylation of the imino acid, yielding an amide product, and extra H(2)O(2)resulted in decarboxylation only of keto acids. Molecular dynamics simulations and detection of charge transfer species suggested that interactions between the substrate and its binding site onl-LOX/MOG are important for imino acid decarboxylation. Structural analysis indicated that the flavoenzyme oxidases catalyzing decarboxylation of an imino acid all share a common plug loop configuration that may facilitate this decarboxylation.	[Trisrivirat, Duangthip; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok, Thailand; [Trisrivirat, Duangthip; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Ctr Excellence Prot & Enzyme Technol, Bangkok, Thailand; [Trisrivirat, Duangthip; Chaiyen, Pimchai] Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, Rayong, Thailand; [Lawan, Narin] Chiang Mai Univ, Fac Sci, Dept Chem, Chiang Mai, Thailand; [Chenprakhon, Pirom] Mahidol Univ, Inst Innovat Learning, Salaya, Nakhon Pathom, Thailand; [Matsui, Daisuke; Asano, Yasuhisa] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama, Japan; [Matsui, Daisuke; Asano, Yasuhisa] Toyama Prefectural Univ, Dept Biotechnol, Imizu, Toyama, Japan; [Matsui, Daisuke] Ritsumeikan Univ, Coll Life Sci, Dept Biotechnol, Kyoto, Japan	Mahidol University; Mahidol University; Vidyasirimedhi Institute of Science & Technology; Chiang Mai University; Mahidol University; Toyama Prefectural University; Toyama Prefectural University; Ritsumeikan University	Chaiyen, P (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Bangkok, Thailand.; Chaiyen, P (corresponding author), Mahidol Univ, Fac Sci, Ctr Excellence Prot & Enzyme Technol, Bangkok, Thailand.; Chaiyen, P (corresponding author), Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, Rayong, Thailand.	pimchai.chaiyen@vistec.ac.th	Matsui, Daisuke/H-7125-2019; Asano, Yasuhisa/K-5898-2016	Matsui, Daisuke/0000-0002-2832-5769; Lawan, Narin/0000-0003-0940-9278; Trisrivirat, Duangthip/0000-0003-0079-4739; Asano, Yasuhisa/0000-0003-3645-3952; Chenprakhon, Pirom/0000-0002-5927-6920	Development and Promotion of Science and Technology Talents Project (DPST); Thailand Research Fund [RTA5980001]; Thailand Science Research and Innovation and Program Management Unit-B Global Partnership program; Chiang Mai University; ERATO Asano Active Enzyme Molecule Project of Japan Science and Technology Agency Grant [JPMJER1102]	Development and Promotion of Science and Technology Talents Project (DPST); Thailand Research Fund(Thailand Research Fund (TRF)); Thailand Science Research and Innovation and Program Management Unit-B Global Partnership program; Chiang Mai University; ERATO Asano Active Enzyme Molecule Project of Japan Science and Technology Agency Grant	This work was supported by the Development and Promotion of Science and Technology Talents Project (DPST) (to D. T.) and Thailand Research Fund Grant RTA5980001 and the Thailand Science Research and Innovation and Program Management Unit-B Global Partnership program (to P. Chaiyen). This research work was also supported in part by Chiang Mai University (to N. L.) and ERATO Asano Active Enzyme Molecule Project of Japan Science and Technology Agency Grant JPMJER1102 (to Y. N. and D. M.).	Adkins J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00313; Anandarajah K, 2000, BIOCHEMISTRY-US, V39, P5303, DOI 10.1021/bi9923813; Asano Y., 2015, Patent, Patent No. [US20140335553, 20140335553]; Asano Y., 2013, International Patent, Patent No. [WO/2013/115180, 2013115180]; Binda C, 2002, NAT STRUCT BIOL, V9, P22, DOI 10.1038/nsb732; Blank LM, 2010, ANTIOXID REDOX SIGN, V13, P349, DOI 10.1089/ars.2009.2931; BOHMER A, 1989, EUR J BIOCHEM, V182, P327, DOI 10.1111/j.1432-1033.1989.tb14834.x; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; Burton F, 1999, ACAD INT BUSINESS, P1; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Chauhan N, 2013, ENZYME MICROB TECH, V52, P265, DOI 10.1016/j.enzmictec.2013.01.006; Chuaboon L, 2019, ANGEW CHEM INT EDIT, V58, P2428, DOI 10.1002/anie.201814219; CIVITELLI R, 1992, NUTRITION, V8, P400; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Copley SD, 2017, CURR OPIN STRUC BIOL, V47, P167, DOI 10.1016/j.sbi.2017.11.001; Copley SD, 2015, TRENDS BIOCHEM SCI, V40, P72, DOI 10.1016/j.tibs.2014.12.004; Dijkman WP, 2013, APPL MICROBIOL BIOT, V97, P5177, DOI 10.1007/s00253-013-4925-7; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; EMANUELE JJ, 1995, BIOCHEMISTRY-US, V34, P3716, DOI 10.1021/bi00011a029; EMANUELE JJ, 1995, ARCH BIOCHEM BIOPHYS, V316, P241, DOI 10.1006/abbi.1995.1034; Eram Mohammad S, 2016, Biochem Biophys Rep, V7, P394, DOI 10.1016/j.bbrep.2016.07.008; Fitzpatrick PF, 2010, ARCH BIOCHEM BIOPHYS, V493, P13, DOI 10.1016/j.abb.2009.07.019; FLASHNER MI, 1974, J BIOL CHEM, V249, P2579; Fuller JJ, 2016, J BIOL CHEM, V291, P20068, DOI 10.1074/jbc.M116.741561; Gaweska HM, 2013, BIOCHEMISTRY-US, V52, P2620, DOI 10.1021/bi4001563; GHISLA S, 1980, J BIOL CHEM, V255, P5688; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Ida K, 2008, J BIOL CHEM, V283, P16584, DOI 10.1074/jbc.M800366200; Ida K, 2011, J BIOCHEM, V150, P659, DOI 10.1093/jb/mvr103; Im D, 2018, FEBS OPEN BIO, V8, P314, DOI 10.1002/2211-5463.12387; Isgro T., 2017, NAMD TUTORIAL; Isgro T., 2012, NAMD TUTORIAL; Isobe K, 2012, J BIOSCI BIOENG, V114, P257, DOI 10.1016/j.jbiosc.2012.04.020; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; Kean KM, 2019, PROTEIN SCI, V28, P135, DOI 10.1002/pro.3506; Kelly SC, 2000, ANAL CHIM ACTA, V412, P111, DOI 10.1016/S0003-2670(00)00767-4; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Kingston NL, 2017, BBA-PROTEINS PROTEOM, V1865, P99, DOI 10.1016/j.bbapap.2016.09.018; KOYAMA H, 1982, J BIOCHEM-TOKYO, V92, P1235, DOI 10.1093/oxfordjournals.jbchem.a134041; Lee ML, 2014, BASIC CLIN PHARMACOL, V114, P336, DOI 10.1111/bcpt.12155; Leese C, 2013, J MOL CATAL B-ENZYM, V85-86, P17, DOI 10.1016/j.molcatb.2012.07.008; LOCKRIDGE O, 1972, J BIOL CHEM, V247, P8097; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Matsui D, 2014, FEBS OPEN BIO, V4, P220, DOI 10.1016/j.fob.2014.02.002; Matthews A, 2020, NAT CHEM BIOL, V16, P556, DOI 10.1038/s41589-020-0476-2; Mora MF, 2009, ANAL CHEM, V81, P1016, DOI 10.1021/ac802068n; Moustafa IM, 2006, J MOL BIOL, V364, P991, DOI 10.1016/j.jmb.2006.09.032; NAKAZAWA T, 1972, J BIOL CHEM, V247, P3439; Olschewski H, 2000, ENZYME MICROB TECH, V26, P537, DOI 10.1016/S0141-0229(99)00192-1; Phillips A. T., 1986, BACTERIA, P385; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pimviriyakul P, 2018, J BIOL CHEM, V293, P18525, DOI 10.1074/jbc.RA118.005538; Pimviriyakul P, 2017, J BIOL CHEM, V292, P4818, DOI 10.1074/jbc.M116.774448; Pollegioni L, 1997, J BIOL CHEM, V272, P4924, DOI 10.1074/jbc.272.8.4924; POLLEGIONI L, 1994, J BIOL CHEM, V269, P31666; Pollegioni L, 2011, TRENDS BIOTECHNOL, V29, P276, DOI 10.1016/j.tibtech.2011.01.010; Pongpamorn P, 2019, CHEMBIOCHEM, V20, P3020, DOI 10.1002/cbic.201900413; Romero E, 2018, CHEM REV, V118, P1742, DOI 10.1021/acs.chemrev.7b00650; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; Sanders SA, 1999, J BIOL CHEM, V274, P22289, DOI 10.1074/jbc.274.32.22289; Sobrado P, 2003, BIOCHEMISTRY-US, V42, P13833, DOI 10.1021/bi035300i; Sobrado P, 2003, BIOCHEMISTRY-US, V42, P13826, DOI 10.1021/bi035299n; Su D, 2019, CHEMBIOCHEM, V20, P1646, DOI 10.1002/cbic.201900016; Suadee C, 2007, J BIOCHEM, V142, P539, DOI 10.1093/jb/mvm155; Sucharitakul J, 2008, BIOCHEMISTRY-US, V47, P8485, DOI 10.1021/bi801039d; SUTTON WB, 1957, J BIOL CHEM, V226, P395; TAKEDA H, 1969, J BIOL CHEM, V244, P2935; Teufel R, 2013, NATURE, V503, P552, DOI 10.1038/nature12643; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; Turpin F, 2012, METHODS MOL BIOL, V794, P299, DOI 10.1007/978-1-61779-331-8_20; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; YAMAMOTO S, 1972, P NATL ACAD SCI USA, V69, P3723, DOI 10.1073/pnas.69.12.3723; YAMAUCHI T, 1975, J BIOL CHEM, V250, P7127; Yang HC, 2005, J EXP BIOL, V208, P3609, DOI 10.1242/jeb.01795	75	7	7	7	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11246	11261		10.1074/jbc.RA120.014055	http://dx.doi.org/10.1074/jbc.RA120.014055			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32527725	hybrid, Green Published			2022-12-26	WOS:000562757100026
J	Perez-Rial, S; Barreiro, E; Fernandez-Acenero, MJ; Fernandez-Valle, ME; Gonzalez-Mangado, N; Peces-Barba, G				Perez-Rial, Sandra; Barreiro, Esther; Fernandez-Acenero, Maria Jesus; Fernandez-Valle, Maria Encarnacion; Gonzalez-Mangado, Nicolas; Peces-Barba, German			Early detection of skeletal muscle bioenergetic deficit by magnetic resonance spectroscopy in cigarette smoke-exposed mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MITOCHONDRIAL DYSFUNCTION; FIBER TYPES; IN-VIVO; MODEL; COPD; MANIFESTATIONS; MORTALITY	Skeletal muscle dysfunction is a common complication and an important prognostic factor in patients with chronic obstructive pulmonary disease (COPD). It is associated with intrinsic muscular abnormalities of the lower extremities, but it is not known whether there is an easy way to predict its presence. Using a mouse model of chronic cigarette smoke exposure, we tested the hypothesis that magnetic resonance spectroscopy allows us to detect muscle bioenergetic deficit in early stages of lung disease. We employed this technique to evaluate the synthesis rate of adenosine triphosphate (ATP) and characterize concomitant mitochondrial dynamics patterns in the gastrocnemius muscle of emphysematous mice. The fibers type composition and citrate synthase (CtS) and cytochrome c oxidase subunit IV (COX4) enzymatic activities were evaluated. We found that the rate of ATP synthesis was reduced in the distal skeletal muscle of mice exposed to cigarette smoke. Emphysematous mice showed a significant reduction in body weight gain, in the cross-sectional area of the total fiber and in the COX4 to CtS activity ratio, due to a significant increase in CtS activity of the gastrocnemius muscle. Taken together, these data support the hypothesis that in the early stage of lung disease, we can detect a decrease in ATP synthesis in skeletal muscle, partly caused by high oxidative mitochondrial enzyme activity. These findings may be relevant to predict the presence of skeletal bioenergetic deficit in the early stage of lung disease besides placing the mitochondria as a potential therapeutic target for the treatment of COPD comorbidities.	[Perez-Rial, Sandra; Gonzalez-Mangado, Nicolas; Peces-Barba, German] Fdn Jimenaz Diaz, Biomed Res Inst, Resp Res Unit, Madrid, Spain; [Perez-Rial, Sandra; Barreiro, Esther; Gonzalez-Mangado, Nicolas; Peces-Barba, German] Inst Salud Carlos III, Consorcio Ctr Invest Biomed Red Enfermedades Resp, MP CIBERES, Madrid, Spain; [Barreiro, Esther] Hosp del Mar, Inst Med Res, Resp Med Dept, Muscle Wasting & Cachexia Chron Resp Dis & Lung C, Barcelona Biomed Res Pk, Barcelona, Spain; [Fernandez-Acenero, Maria Jesus] Hosp Clin Univ San Carlos, Dept Pathol, Madrid, Spain; [Fernandez-Valle, Maria Encarnacion] Univ Complutense Madrid, Bioimaging Res Support Ctr, Nucl Magnet Resonance Unit, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Complutense University of Madrid	Perez-Rial, S (corresponding author), Fdn Jimenaz Diaz, Biomed Res Inst, Resp Res Unit, Madrid, Spain.; Perez-Rial, S (corresponding author), Inst Salud Carlos III, Consorcio Ctr Invest Biomed Red Enfermedades Resp, MP CIBERES, Madrid, Spain.	sperezr@fjd.es	; Perez Rial, Sandra/C-6809-2019	Fernandez-Acenero/0000-0002-2439-3553; Perez Rial, Sandra/0000-0002-7349-7682; Fernandez-Valle, Maria Encarnacion/0000-0002-7433-5976	Spanish Society of Pulmonology and Thoracic Surgery Grant (SEPAR 2014); Instituto de Salud Carlos III - Accion Estrategica en Salud [AES 13/01909, 16/01783, 18/00075]; Fundacion Catalana de Pneumologia (FUCAP); Fondazione Internazionale Menarini (Spain); Spanish Society of Pulmonology and Thoracic Surgery Grant (SEPAR 2018)	Spanish Society of Pulmonology and Thoracic Surgery Grant (SEPAR 2014); Instituto de Salud Carlos III - Accion Estrategica en Salud(Instituto de Salud Carlos III); Fundacion Catalana de Pneumologia (FUCAP); Fondazione Internazionale Menarini (Spain); Spanish Society of Pulmonology and Thoracic Surgery Grant (SEPAR 2018)	This study was supported in part by a Spanish Society of Pulmonology and Thoracic Surgery Grant (SPR - SEPAR 2014 and EB SEPAR 2018); Instituto de Salud Carlos III - Accion Estrategica en Salud (GPB -AES 13/01909, GBP - 16/01783, EB - 18/00075); Fundacion Catalana de Pneumologia (EB -FUCAP) 2016 and EB - Unrestricted grant from Fondazione Internazionale Menarini 2018 (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Barreiro E, 2018, J THORAC DIS, V10, pS1415, DOI 10.21037/jtd.2018.04.168; Barreiro E, 2012, RESP PHYSIOL NEUROBI, V182, P9, DOI 10.1016/j.resp.2012.02.001; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Boesch C, 2007, J MAGN RESON IMAGING, V25, P321, DOI 10.1002/jmri.20806; Ceco E, 2017, AM J RESP CELL MOL, V57, P28, DOI 10.1165/rcmb.2016-0355TR; Charles AL, 2011, BRIT J SURG, V98, P511, DOI 10.1002/bjs.7384; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Constantinou C, 2011, INT J MOL MED, V27, P15, DOI 10.3892/ijmm.2010.557; Fermoselle C, 2011, ARCH BRONCONEUMOL, V47, P590, DOI 10.1016/j.arbres.2011.07.008; Gea JG, 2001, EUR RESPIR J, V17, P939, DOI 10.1183/09031936.01.17509390; Gea J, 2015, J THORAC DIS, V7, pE418, DOI 10.3978/j.issn.2072-1439.2015.08.04; Gosker HR, 2007, EUR RESPIR J, V30, P73, DOI 10.1183/09031936.00146906; Gosker HR, 2009, AM J RESP CELL MOL, V40, P710, DOI 10.1165/rcmb.2008-0312OC; Gosker HR, 2002, EUR RESPIR J, V19, P617, DOI 10.1183/09031936.02.00762001; Hamaoka T, 2005, RESPIROLOGY, V10, P164, DOI 10.1111/j.1440-1843.2005.00696.x; Harris RS, 2000, AM J RESP CRIT CARE, V161, P432; Hayasaki H, 2001, ACTA HISTOCHEM, V103, P355, DOI 10.1078/0065-1281-00605; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Jucker BM, 2000, P NATL ACAD SCI USA, V97, P6880, DOI 10.1073/pnas.120131997; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; Koopman R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00032; Larsen RG, 2009, J APPL PHYSIOL, V107, P873, DOI 10.1152/japplphysiol.00260.2009; Levine S, 2003, AM J RESP CRIT CARE, V168, P706, DOI 10.1164/rccm.200209-1070OC; Maltais F, 2014, AM J RESP CRIT CARE, V189, P1121, DOI 10.1164/rccrn.201402-0373ST; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Meyer A, 2013, EXP PHYSIOL, V98, P1063, DOI 10.1113/expphysiol.2012.069468; Naimi AI, 2011, CLIN PHYSIOL FUNCT I, V31, P124, DOI 10.1111/j.1475-097X.2010.00988.x; Perez-Rial S, 2014, AM J PHYSIOL-LUNG C, V307, pL718, DOI 10.1152/ajplung.00293.2013; Pouw EM, 2000, EUR RESPIR J, V16, P247, DOI 10.1034/j.1399-3003.2000.16b11.x; Puente-Maestu L, 2009, EUR RESPIR J, V33, P1045, DOI 10.1183/09031936.00112408; Puente-Maestu L, 2009, AM J RESP CELL MOL, V40, P746, DOI 10.1165/rcmb.2008-0289OC; Salazar-Degracia A, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1003-9; Sato Y, 1997, EUR NEUROL, V37, P116, DOI 10.1159/000117421; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Seymour JM, 2010, EUR RESPIR J, V36, P81, DOI 10.1183/09031936.00104909; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; ten Hove M, 2007, HEART FAIL REV, V12, P48, DOI 10.1007/s10741-007-9003-8; Tzika AA, 2013, INT J ONCOL, V43, P886, DOI 10.3892/ijo.2013.1998; van den Borst B, 1985, J APPL PHYSIOL, V114, P1319; VanderVeen BN, 2017, OXID MED CELL LONGEV, V2017, P1, DOI 10.1155/2017/3292087; Venegas JG, 1998, J APPL PHYSIOL, V84, P389, DOI 10.1152/jappl.1998.84.1.389	44	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234606	10.1371/journal.pone.0234606	http://dx.doi.org/10.1371/journal.pone.0234606			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569331	Green Published, gold			2022-12-26	WOS:000543547900020
J	Wang, YC; Fang, QL; Dissanayake, STM; Onal, H				Wang, Yicheng; Fang, Qiaoling; Dissanayake, Sahan T. M.; Onal, Hayri			Optimizing conservation planning for multiple cohabiting species	PLOS ONE			English	Article							RESERVE DESIGN MODELS; PROGRAMMING-MODEL; SELECTION; COMPACT; CONNECTIVITY; ALGORITHMS; EXAMPLE; VALUES	Conservation planning often involves multiple species occupying large areas including habitat sites with varying characteristics. For a given amount of financial resources, designing a spatially coherent nature reserve system that provides the best possible protection to targeted species is an important ecological and economic problem. In this paper, we address this problem using optimization methods. Incorporating spatial criteria in an optimization framework considering spatial habitat needs of multiple species poses serious challenges because of modeling and computational complexities. We present a novel linear integer programming model to address this issue considering spatial contiguity and compactness of the reserved area. The model uses the concept of path in graph theory to ensure contiguity and minimizes the sum of distances between selected sites and a central site in individual reserves to promote compactness. We test the computational efficiency of the model using randomly generated data sets. The results show that the model can be solved quite efficiently in most cases. We also present an empirical application of the model to simultaneous protection of two cohabiting species, Gopher Tortoise and Gopher Frogs, in a military installation in Georgia, USA.	[Wang, Yicheng] Qingdao Agr Univ, Coll Resources & Environm, Qingdao, Peoples R China; [Fang, Qiaoling] Ocean Univ China, Coll Management, Qingdao, Peoples R China; [Dissanayake, Sahan T. M.] Portland State Univ, Dept Econ, Portland, OR 97207 USA; [Onal, Hayri] Univ Illinois, Dept Agr & Consumer Econ, Urbana, IL 61801 USA	Qingdao Agricultural University; Ocean University of China; Portland State University; University of Illinois System; University of Illinois Urbana-Champaign	Onal, H (corresponding author), Univ Illinois, Dept Agr & Consumer Econ, Urbana, IL 61801 USA.	h-onal@illinois.edu		Onal, Hayri/0000-0002-0307-1731	National Natural Science Foundation of China [71202096]; Natural Science Foundation of Shandong Province [ZR2019MG011]; Illinois CREES Project [ILLU 05-0361]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Illinois CREES Project	YW and QF received financial support from National Natural Science Foundation of China (71202096) and Natural Science Foundation of Shandong Province (ZR2019MG011), HO received financial support from the Illinois CREES Project (ILLU 05-0361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; Bazaraa M. S., 2009, LINEAR PROGRAMMING N; Billionnet A, 2016, ENVIRON MODEL ASSESS, V21, P211, DOI 10.1007/s10666-015-9465-3; Billionnet A, 2013, EUR J OPER RES, V231, P514, DOI 10.1016/j.ejor.2013.03.025; Billionnet A, 2012, APPL MATH MODEL, V36, P2213, DOI 10.1016/j.apm.2011.08.002; Camm JD, 1996, BIOL CONSERV, V78, P353, DOI 10.1016/0006-3207(95)00132-8; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Carwardine J, 2010, CONSERV BIOL, V24, P1529, DOI 10.1111/j.1523-1739.2010.01535.x; Cerdeira JO, 2010, BIOL CONSERV, V143, P408, DOI 10.1016/j.biocon.2009.11.005; Church RL, 1996, BIOL CONSERV, V76, P105, DOI 10.1016/0006-3207(95)00102-6; COCKS KD, 1989, BIOL CONSERV, V49, P113, DOI 10.1016/0006-3207(89)90083-9; Conrad JM, 2012, J ENVIRON ECON MANAG, V63, P1, DOI 10.1016/j.jeem.2011.08.001; Csuti B, 1997, BIOL CONSERV, V80, P83, DOI 10.1016/S0006-3207(96)00068-7; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; Dilkina B, 2017, CONSERV BIOL, V31, P192, DOI 10.1111/cobi.12814; Dissanayake STM, 2012, ECOL MODEL, V224, P65, DOI 10.1016/j.ecolmodel.2011.07.016; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ellner SP, 2002, CONSERV BIOL, V16, P258, DOI 10.1046/j.1523-1739.2002.00553.x; Gupta A, 2019, CONSERV BIOL, V33, P1023, DOI 10.1111/cobi.13369; Jafari N, 2017, COMPUT OPER RES, V81, P119, DOI 10.1016/j.cor.2016.12.017; Jafari N, 2013, EUR J OPER RES, V231, P202, DOI 10.1016/j.ejor.2013.05.015; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marianov V, 2008, COMPUT OPER RES, V35, P475, DOI 10.1016/j.cor.2006.03.011; Matisziw TC, 2009, LANDSCAPE ECOL, V24, P89, DOI 10.1007/s10980-008-9282-z; McCarthy MA, 2006, AM NAT, V167, P717, DOI 10.1086/503058; Moilanen A., 2009, SPATIAL CONSERVATION; Nicholson E, 2006, ECOL LETT, V9, P1049, DOI 10.1111/j.1461-0248.2006.00956.x; Onal H, 2016, EUR J OPER RES, V251, P957, DOI 10.1016/j.ejor.2015.12.005; Onal H, 2006, OPER RES, V54, P379, DOI 10.1287/opre.1060.0272; St John R, 2018, OPER RES, V66, P1471, DOI 10.1287/opre.2018.1758; UNDERHILL LG, 1994, BIOL CONSERV, V70, P85, DOI 10.1016/0006-3207(94)90302-6; Wang YC, 2016, CONSERV BIOL, V30, P413, DOI 10.1111/cobi.12629; Williams J., 1998, ENVIRON MODEL ASSESS, V3, P77, DOI DOI 10.1023/A:1019006721277; Williams JC, 2005, ENVIRON MODEL ASSESS, V10, P163, DOI 10.1007/s10666-005-9007-5; Williams JC, 2002, GEOGR ANAL, V34, P330, DOI 10.1353/geo.2002.0024; WRIGHT J, 1983, REG SCI URBAN ECON, V13, P31, DOI 10.1016/0166-0462(83)90004-2; Zentelis R, 2015, CONSERV LETT, V8, P299, DOI 10.1111/conl.12155; ZOLTNERS AA, 1983, MANAGE SCI, V29, P1237, DOI 10.1287/mnsc.29.11.1237	39	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234968	10.1371/journal.pone.0234968	http://dx.doi.org/10.1371/journal.pone.0234968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569315	Green Published, gold			2022-12-26	WOS:000543547900019
J	Al-Sawalha, NA; Almahmmod, Y; Awawdeh, MS; Alzoubi, KH; Khabour, OF				Al-Sawalha, Nour A.; Almahmmod, Yehya; Awawdeh, Mofleh S.; Alzoubi, Karem H.; Khabour, Omar F.			Effect of waterpipe tobacco smoke exposure on the development of metabolic syndrome in adult male rats	PLOS ONE			English	Article							INSULIN-RESISTANCE; OXIDATIVE STRESS; ADIPONECTIN; LEPTIN; GHRELIN	The prevalence of metabolic syndrome is increased worldwide. Tobacco smoking increases the risk of developing metabolic syndrome. Waterpipe tobacco smoking has become a global trend of tobacco consumption and is as common as cigarette smoking. In this study, the effect of waterpipe tobacco smoke (WTS) on the development of metabolic syndrome in rats was evaluated. Adult Wistar rats were exposed for 19 weeks to either fresh air (control) or WTS for 1 hour daily/ 5 days per week (WTS). Central obesity, systolic blood pressure, lipid profile, glucose hemostasis and levels of leptin and adiponectin were evaluated. The WTS exposure increased body weight, abdominal circumference, systolic blood pressure and fasting glucose compared to control animals (P<0.05), consistent with inducing metabolic syndrome. The retroperitoneal fat, lipid profile and levels of insulin, leptin and adiponectin were not affected by WTS exposure (P>0.05). In conclusion, exposure to WTS has detrimental health effects leading to the development of metabolic syndrome in experimental animals.	[Al-Sawalha, Nour A.; Almahmmod, Yehya; Alzoubi, Karem H.] Jordan Univ Sci & Technol, Fac Pharm, Dept Clin Pharm, Irbid, Jordan; [Awawdeh, Mofleh S.] Jordan Univ Sci & Technol, Fac Vet Med, Dept Vet Pathol & Publ Hlth, Irbid, Jordan; [Khabour, Omar F.] Jordan Univ Sci & Technol, Fac Appl Med Sci, Dept Med Lab Sci, Irbid, Jordan	Jordan University of Science & Technology; Jordan University of Science & Technology; Jordan University of Science & Technology	Al-Sawalha, NA (corresponding author), Jordan Univ Sci & Technol, Fac Pharm, Dept Clin Pharm, Irbid, Jordan.	nasawalha@just.edu.jo		Khabour, Omar/0000-0002-3006-3104; Al-Sawalha, Nour/0000-0002-7401-8065	Jordan University of Science and Technology, Irbid, Jordan [118/2017]	Jordan University of Science and Technology, Irbid, Jordan	This study was supported by the deanship of research (grant number 118/2017, NAS, MA, KHA) at Jordan University of Science and Technology, Irbid, Jordan, http://www.just.edu.jo/Deanships/DeanshipofResearch/Pages/Default.aspx.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; Akl EA, 2010, INT J EPIDEMIOL, V39, P834, DOI 10.1093/ije/dyq002; Al-Sawalha N, 2018, NICOTINE TOB RES, V20, P508, DOI 10.1093/ntr/ntx142; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; de Artinano AA, 2009, BRIT J NUTR, V102, P1246, DOI 10.1017/S0007114509990729; Ansarimoghaddam A, 2018, DIABETES METAB SYND, V12, P195, DOI 10.1016/j.dsx.2017.11.004; Azar RR, 2016, INHAL TOXICOL, V28, P339, DOI 10.3109/08958378.2016.1171934; Ballantyne CM, 2008, INT J OBESITY, V32, pS21, DOI 10.1038/ijo.2008.31; Baratta Mario, 2002, Med Sci Monit, V8, pRA282; Bhatnagar A, 2019, CIRCULATION, V139, pE917, DOI 10.1161/CIR.0000000000000671; Calo William A, 2014, Int J Prev Med, V5, P849; Chwyeed SH, 2018, MED J BABYLON, V15, P39, DOI [10.4103/MJBL.MJBL_11_18, DOI 10.4103/MJBL.MJBL_11_18]; Cobb C, 2010, AM J HEALTH BEHAV, V34, P275, DOI 10.5993/AJHB.34.3.3; Despres JP, 2006, EUR HEART J SUPPL, V8, pB4, DOI 10.1093/eurheartj/sul002; Faraj M, 2003, J CLIN ENDOCR METAB, V88, P1594, DOI 10.1210/jc.2002-021309; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Golbidi S, 2018, ANTIOXID REDOX SIGN, V28, P741, DOI 10.1089/ars.2017.7257; Jawad M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192191; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Khabour OF, 2012, INHAL TOXICOL, V24, P667, DOI 10.3109/08958378.2012.710918; Knopfholz J, 2014, CHOLESTEROL, DOI 10.1155/2014/261878; Kotani K, 2012, J ATHEROSCLER THROMB, V19, P787, DOI 10.5551/jat.11833; Mahjoub S, 2012, CASP J INTERN MED, V3, P386; Maziak W, 2011, ADDICT BEHAV, V36, P1, DOI 10.1016/j.addbeh.2010.08.030; Meier U, 2004, CLIN CHEM, V50, P1511, DOI 10.1373/clinchem.2004.032482; Moehlecke M, 2016, ARCH ENDOCRIN METAB, V60, P152, DOI 10.1590/2359-3997000000129; Nemmar A, 2017, AM J PHYSIOL-HEART C, V312, pH329, DOI 10.1152/ajpheart.00450.2016; Nolan Paul B, 2017, Prev Med Rep, V7, P211, DOI 10.1016/j.pmedr.2017.07.004; Perkins Kenneth A, 2002, Nicotine Tob Res, V4, P459, DOI 10.1080/1462220021000018434; Pierozan P, 2017, BASIC CLIN PHARMACOL, V121, P113, DOI 10.1111/bcpt.12774; Shafique K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039734; Shi H, 2009, PHYSIOL BEHAV, V97, P199, DOI 10.1016/j.physbeh.2009.02.017; Shihadeh A, 2003, FOOD CHEM TOXICOL, V41, P143, DOI 10.1016/S0278-6915(02)00220-X; Soflaei SS, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0335-4; Speakman JR, 2002, P NUTR SOC, V61, P473, DOI 10.1079/PNS2002194; Toste FP, 2006, BRIT J NUTR, V95, P830, DOI 10.1079/BJN20061726; Ward KD, 2015, NICOTINE TOB RES, V17, P34, DOI 10.1093/ntr/ntu121; Weitzman M, 2005, CIRCULATION, V112, P862, DOI 10.1161/CIRCULATIONAHA.104.520650; Zimmet P, 1999, ANN NY ACAD SCI, V892, P25, DOI 10.1111/j.1749-6632.1999.tb07783.x	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234516	10.1371/journal.pone.0234516	http://dx.doi.org/10.1371/journal.pone.0234516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559253	Green Published, gold			2022-12-26	WOS:000543261600009
J	Veit, T; Munker, D; Leuschner, G; Mummler, C; Sisic, A; Kauke, T; Schneider, C; Irlbeck, M; Michel, S; Eser-Valerie, D; Huber, M; Barton, J; Milger, K; Meiser, B; Behr, J; Kneidinger, N				Veit, Tobias; Munker, Dieter; Leuschner, Gabriela; Muemmler, Carlo; Sisic, Alma; Kauke, Teresa; Schneider, Christian; Irlbeck, Michael; Michel, Sebastian; Eser-Valerie, Daniela; Huber, Maximilian; Barton, Juergen; Milger, Katrin; Meiser, Bruno; Behr, Juergen; Kneidinger, Nikolaus			High prevalence of falsely declaring nicotine abstinence in lung transplant candidates	PLOS ONE			English	Article							SMOKING RESUMPTION; CARBON-MONOXIDE; RECIPIENTS; SMOKERS; HEART	Tobacco use after lung transplantation is associated with adverse outcome. Therefore, active smoking is regarded as a contraindication for lung transplantation and should be excluded prior to placement on the waiting list. The aim of the study was to compare self-reporting with a systematic cotinine based screening approach to identify patients with active nicotine abuse. Nicotine use was systematically assessed by interviews and cotinine test in all lung transplant candidates at every visit in our center. Patients were classified according to the stage prior to transplantation and cotinine test results were compared to self-reports and retrospectively analyzed until June 2019. Of 620 lung transplant candidates, 92 patients (14.8%) had at least one positive cotinine test. COPD as underlying disease (OR 2.102, CI 1.110-3.981; p = 0.023), number of pack years (OR 1.014, CI 1.000-1.028; p = 0.047) and a time of cessation less than one year (OR 2.413, CI 1.410-4.128; p = 0.001) were associated with a positive cotinine test in multivariable regression analysis. The majority of non-COPD patients (n = 13, 72.2%) with a positive test had a cessation time of less than one year. 78 patients (84.7%) falsely declared not consuming any nicotine-based products prior to the test. Finally, all never smokers were test negative. In conclusion, our data demonstrate that active nicotine use is prevalent in transplant candidates with a high prevalence of falsely declaring nicotine abstinence. COPD was the main diagnosis in affected patients. Short cessation time and a high number of pack years are risk factors for continued nicotine abuse.	[Veit, Tobias; Munker, Dieter; Leuschner, Gabriela; Muemmler, Carlo; Barton, Juergen; Milger, Katrin; Behr, Juergen; Kneidinger, Nikolaus] Univ Munich, German Ctr Lung Res DZL, Dept Internal Med 5, Comprehens Pneumol Ctr CPC M, Munich, Germany; [Sisic, Alma; Meiser, Bruno] Univ Munich, Transplant Ctr, Munich, Germany; [Kauke, Teresa; Schneider, Christian] Univ Munich, Dept Thorac Surg, Munich, Germany; [Irlbeck, Michael] Univ Munich, Dept Anaesthesiol, LMU, Munich, Germany; [Michel, Sebastian] Univ Munich, LMU, Clin Cardiac Surg, Munich, Germany; [Eser-Valerie, Daniela; Huber, Maximilian] Univ Munich, Dept Psychiat & Psychotherapy, LMU, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich; University of Munich	Kneidinger, N (corresponding author), Univ Munich, German Ctr Lung Res DZL, Dept Internal Med 5, Comprehens Pneumol Ctr CPC M, Munich, Germany.	nikolaus.kneidinger@med.uni-muenchen.de	Milger, Katrin/AFI-3881-2022	Milger, Katrin/0000-0003-2914-8773; Schneider, Christian/0000-0003-4501-3094	German Center for Lung Research (Deutsches Zentrum fur Lungenforschung, DZL)	German Center for Lung Research (Deutsches Zentrum fur Lungenforschung, DZL)	The study was supported by the German Center for Lung Research (Deutsches Zentrum fur Lungenforschung, DZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anis KH, 2019, AM J MED, V132, P413, DOI 10.1016/j.amjmed.2018.11.005; [Anonymous], 2016, PREV CHRONIC DIS, V13, pE40; [Anonymous], 2016, STUDIES ROMANTICISM, V55, P29; Bauldoff GS, 2015, J CARDIOPULM REHABIL, V35, P147, DOI 10.1097/HCR.0000000000000096; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Berastegui C, 2017, TRANSPL P, V49, P2285, DOI 10.1016/j.transproceed.2017.09.043; Chambers DC, 2019, J HEART LUNG TRANSPL, V38, P1042, DOI 10.1016/j.healun.2019.08.001; Chang CM, 2017, CANCER EPIDEM BIOMAR, V26, P291, DOI 10.1158/1055-9965.EPI-16-0675; Duerinckx N, 2016, TRANSPLANTATION, V100, P2252, DOI 10.1097/TP.0000000000001335; Hellemons ME, 2011, AM J TRANSPLANT, V11, P2490, DOI 10.1111/j.1600-6143.2011.03701.x; Hofmann P, 2019, TRANSPLANTATION, V103, P1260, DOI 10.1097/TP.0000000000002576; Hofmann P, 2018, J THORAC DIS, V10, P4609, DOI 10.21037/jtd.2018.07.16; JAFFE JH, 1981, ADDICT BEHAV, V6, P337, DOI 10.1016/0306-4603(81)90049-6; JARVIS MJ, 1987, AM J PUBLIC HEALTH, V77, P1435, DOI 10.2105/AJPH.77.11.1435; Le Cook B, 2014, JAMA-J AM MED ASSOC, V311, P172, DOI 10.1001/jama.2013.284985; Maurer J R, 1998, Transplantation, V66, P951; Ruttens D, 2014, EUR RESPIR J, V43, P300, DOI 10.1183/09031936.00141113; Sozen F, 2016, EXP CLIN TRANSPLANT, V14, P95, DOI 10.6002/ect.tondtdtd2016.P35; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Stelmach R, 2015, J BRAS PNEUMOL, V41, P124, DOI 10.1590/S1806-37132015000004526; STITZER ML, 1982, ADDICT BEHAV, V7, P403, DOI 10.1016/0306-4603(82)90010-7; Triplette M, 2019, AM J TRANSPLANT, V19, P1478, DOI 10.1111/ajt.15181; Weig T, 2016, ANN THORAC SURG, V101, P1318, DOI 10.1016/j.athoracsur.2015.10.041; Weill D, 2018, J THORAC DIS, V10, P4574, DOI 10.21037/jtd.2018.06.141; WOODWARD M, 1992, EUR HEART J, V13, P160, DOI 10.1093/oxfordjournals.eurheartj.a060140	25	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234808	10.1371/journal.pone.0234808	http://dx.doi.org/10.1371/journal.pone.0234808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555678	Green Published, gold			2022-12-26	WOS:000543273200043
J	Roudnicky, P; Patesil, D; Zdrahal, Z; Gelnar, M; Kasny, M				Roudnicky, Pavel; Patesil, David; Zdrahal, Zbynek; Gelnar, Milan; Kasny, Martin			Laser capture microdissection in combination with mass spectrometry: Approach to characterization of tissue-specific proteomes ofEudiplozoon nipponicum(Monogenea, Polyopisthocotylea)	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; FLATWORMS PLATYHELMINTHES; MONOGENEA; PARASITE; ULTRASTRUCTURE; SCHISTOSOMES; MICROSCOPY	Eudiplozoon nipponicum(Goto, 1891) is a hematophagous monogenean ectoparasite which inhabits the gills of the common carp (Cyprinus carpio). Heavy infestation can lead to anemia and in conjunction with secondary bacterial infections cause poor health and eventual death of the host. This study is based on an innovative approach to protein localization which has never been used in parasitology before. Using laser capture microdissection, we dissected particular areas of the parasite body without contaminating the samples by surrounding tissue and in combination with analysis by mass spectrometry obtained tissue-specific proteomes of tegument, intestine, and parenchyma of our model organism,E.nipponicum. We successfully verified the presence of certain functional proteins (e.g. cathepsin L) in tissues where their presence was expected (intestine) and confirmed that there were no traces of these proteins in other tissues (tegument and parenchyma). Additionally, we identified a total of 2,059 proteins, including 72 peptidases and 33 peptidase inhibitors. As expected, the greatest variety was found in the intestine and the lowest variety in the parenchyma. Our results are significant on two levels. Firstly, we demonstrated that one can localize all proteins in one analysis and without using laboratory animals (antibodies for immunolocalization of single proteins). Secondly, this study offers the first complex proteomic data on not only theE.nipponicumbut within the whole class of Monogenea, which was from this point of view until recently neglected.	[Roudnicky, Pavel; Gelnar, Milan; Kasny, Martin] Masaryk Univ, Fac Sci, Dept Bot & Zool, Brno, Czech Republic; [Patesil, David; Zdrahal, Zbynek] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Zdrahal, Zbynek] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno; Masaryk University Brno	Roudnicky, P (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, Brno, Czech Republic.	p.roudnicky@mail.muni.cz	Potesil, David/D-9696-2012	Potesil, David/0000-0003-0390-0904; Zdrahal, Zbynek/0000-0003-3044-5548; Roudnicky, Pavel/0000-0002-6904-7646	Czech Science Foundation [GBP505/12/G112, GAP506/12/1258]; Grant Agency of Masaryk University [MUNI/A/0918/2018]; NCMG research infrastructure (MEYS CR) [LM2018132]; MEYS CR [LM2018127]; project CEITEC 2020, MEYS CR [LQ1601]; project "e-Infrastruktura CZ" [e-INFRA LM2018140]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Masaryk University; NCMG research infrastructure (MEYS CR); MEYS CR; project CEITEC 2020, MEYS CR; project "e-Infrastruktura CZ"	This work was supported by the Czech Science Foundation (GBP505/12/G112, GAP506/12/1258) and Grant Agency of Masaryk University (MUNI/A/0918/2018). We acknowledge the CF Genomics CEITEC MU supported by the NCMG research infrastructure (LM2018132 funded by MEYS CR) for their support with obtaining scientific data presented in this paper. CIISB research infrastructure project LM2018127 funded by MEYS CR is gratefully acknowledged for their financial support of LC-MS/MS measurements at the Proteomics Core Facility. The work was supported by the project CEITEC 2020 (LQ1601), MEYS CR. Computational resources were supplied by the project "e-Infrastruktura CZ" (e-INFRA LM2018140) provided within the program Projects of Large Research, Development, and Innovations Infrastructures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, FARSOTTAFRETTIR, V11, P1, DOI DOI 10.1186/s13071-017-2573-y; [Anonymous], 2006, EUROPEAN CONSTITUTIO, V2, P268; Baeza JA, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3711-5; BERNS MW, 1981, SCIENCE, V213, P505, DOI 10.1126/science.7017933; Bohm M, 1997, AM J PATHOL, V151, P63; Brennan GP, 1996, PARASITOL RES, V82, P638, DOI 10.1007/s004360050178; Clement-Sengewald A, 2000, PATHOBIOLOGY, V68, P232, DOI 10.1159/000055929; Cohen SC, 2001, MEM I OSWALDO CRUZ, V96, P555, DOI 10.1590/S0074-02762001000400019; CONN DB, 1993, T AM MICROSC SOC, V112, P241, DOI 10.2307/3226561; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crecelius AC, 2015, ANALYST, V140, P5806, DOI 10.1039/c5an00990a; CREMER C, 1974, Microscopica Acta, V75, P331; Cubi R, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12735; Datta S, 2015, HISTOL HISTOPATHOL, V30, P1255, DOI 10.14670/HH-11-622; Dilillo M, 2017, J PROTEOME RES, V16, P2993, DOI 10.1021/acs.jproteome.7b00284; Dinguirard N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02773; Dvorak J, 2018, INT J PARASITOL, V48, P333, DOI 10.1016/j.ijpara.2018.01.001; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Fajtova P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003827; Ferreira MS, 2014, J MASS SPECTROM, V49, P86, DOI 10.1002/jms.3308; Glerup S, 2005, J BIOL CHEM, V280, P9823, DOI 10.1074/jbc.M413228200; Gobert GN, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000469; Hahn C, 2014, GENOME BIOL EVOL, V6, P1105, DOI 10.1093/gbe/evu078; Horn M, 2009, CHEM BIOL, V16, P1053, DOI 10.1016/j.chembiol.2009.09.009; Hsu CC, 2015, ANAL CHEM, V87, P11171, DOI 10.1021/acs.analchem.5b03389; Huyse T, 2007, PARASITOLOGY, V134, P739, DOI 10.1017/S0031182006002010; Ilgova J, 2020, MOL BIOCHEM PARASIT, V235, DOI 10.1016/j.molbiopara.2019.111248; Ilgova J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17598-2; Jedlickova L, 2019, INT J PARASITOL, V49, P337, DOI 10.1016/j.ijpara.2018.11.010; Jedlickova L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2666-2; Jedlickova L, 2016, PARASITOLOGY, V143, P494, DOI 10.1017/S0031182015001808; Johann DJ, 2009, J PROTEOME RES, V8, P2310, DOI 10.1021/pr8009403; Jones MK, 2007, EXP PARASITOL, V117, P259, DOI 10.1016/j.exppara.2007.06.004; Jones MK, 2007, INT J BIOCHEM CELL B, V39, P1646, DOI 10.1016/j.biocel.2007.04.017; Kadesch P, 2019, ANAL CHEM, V91, P4520, DOI 10.1021/acs.analchem.8b05440; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kang S, 2012, MITOCHONDR DNA, V23, P176, DOI 10.3109/19401736.2012.668900; Konstanzova V, 2015, PARASITOL RES, V114, P1485, DOI 10.1007/s00436-015-4331-4; Konstanzova V, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2203-8; Lutz HL, 2016, PARASITOL RES, V115, P4503, DOI 10.1007/s00436-016-5237-5; Lyons K.M., 1973, Advances Parasit, V11, P193, DOI 10.1016/S0065-308X(08)60187-6; MONAJEMBASHI S, 1986, EXP CELL RES, V167, P262, DOI 10.1016/0014-4827(86)90223-5; Nawaratna SSK, 2014, MOL BIOCHEM PARASIT, V196, P82, DOI 10.1016/j.molbiopara.2014.08.002; Nawaratna SSK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001043; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Plaisance L, 2007, MOL BIOCHEM PARASIT, V154, P190, DOI 10.1016/j.molbiopara.2007.04.012; Protasio AV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001455; Pshezhetsky AV, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P3413, DOI 10.1016/B978-0-12-382219-2.00754-7; Roche L, 1999, MOL BIOCHEM PARASIT, V98, P271, DOI 10.1016/S0166-6851(98)00164-9; Roudnicky P, 2018, PARASITE, V25, DOI 10.1051/parasite/2018062; Roy S, 2007, P NATL ACAD SCI USA, V104, P14472, DOI 10.1073/pnas.0706793104; Salmon CR, 2017, BONE, V101, P219, DOI 10.1016/j.bone.2017.05.014; Schutze K, 2007, METHOD CELL BIOL, V82, P649, DOI 10.1016/S0091-679X(06)82023-6; Shapiro JP, 2012, J PROTEOMICS, V77, P433, DOI 10.1016/j.jprot.2012.09.019; Shawky M, 2007, TRANSPORT RES REC, P11, DOI 10.3141/2012-02; Stilwell JM, 2019, PARASITOL RES, V118, P1639, DOI 10.1007/s00436-019-06295-w; Taverna D, 2015, BONE, V74, P83, DOI 10.1016/j.bone.2015.01.004; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhang D, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174214; Zhang D, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2404-1; Zhang J, 2014, MOL BIOL REP, V41, P6583, DOI 10.1007/s11033-014-3542-6; Zhang J, 2012, MOL BIOL REP, V39, P8115, DOI 10.1007/s11033-012-1659-z; Zhang SS, 2018, METHODS MOL BIOL, V1676, P153, DOI 10.1007/978-1-4939-7315-6_9	64	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0231681	10.1371/journal.pone.0231681	http://dx.doi.org/10.1371/journal.pone.0231681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555742	gold, Green Published, Green Submitted			2022-12-26	WOS:000542759600012
J	Santos, MCD; Gabani, FL; Dias, DF; de Andrade, SM; Gonzalez, AD; Loch, MR; Mesas, AE				Santos, Mayara Cristina da Silva; Gabani, Flavia Lopes; Dias, Douglas Fernando; de Andrade, Selma Maffei; Gonzalez, Alberto Duran; Loch, Mathias Roberto; Mesas, Arthur Eumann			Longitudinal associations of changes in physical activity and TV viewing with chronic musculoskeletal pain in Brazilian schoolteachers	PLOS ONE			English	Article							RISK; EXERCISE	This study analyzed the longitudinal association of changes in leisure-time physical activity (LTPA) practice and television viewing (TV viewing) with chronic musculoskeletal pain (CMP). The data about LTPA, TV viewing, and CMP were obtained in 2012 and after 24 months through individual interviews with schoolteachers from elementary and secondary education public schools in a large city in the southern region of Brazil. The statistical analysis was performed using generalized estimating equation regression models adjusted for sex, age, body mass index and depression. A total of 527 schoolteachers were studied, among which 66.6% were women, and the median age was 42 years (interquartile range: 34 to 49). A total of 170 (32.3%) participants reported CMP at baseline and 130 (24.7%) at follow-up. Both LTPA and TV viewing were independently and significantly associated with CMP regardless of all adjustment variables. Concretely, increasing LTPA by 60 minutes/week was associated with a 6.2% lower likelihood of CMP, and increasing TV viewing by 30 minutes/day was associated with a 5.1% higher likelihood of having CMP among the participants. In summary, this study showed that LTPA and TV viewing have independent and opposite relationships with the longitudinal risk of CMP, which suggests that the potential benefits obtained from practicing more LTPA are insufficient to compensate for the potential detrimental effect of viewing TV for longer with respect to the CMP.	[Santos, Mayara Cristina da Silva; Gabani, Flavia Lopes; Dias, Douglas Fernando; de Andrade, Selma Maffei; Gonzalez, Alberto Duran; Loch, Mathias Roberto; Mesas, Arthur Eumann] Univ Estadual Londrina, Dept Publ Hlth, Londrina, Parana, Brazil; [Mesas, Arthur Eumann] Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain	Universidade Estadual de Londrina; Universidad de Castilla-La Mancha	Mesas, AE (corresponding author), Univ Estadual Londrina, Dept Publ Hlth, Londrina, Parana, Brazil.; Mesas, AE (corresponding author), Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain.	arthur.emesas@uclm.es	Mesas, Arthur/AAK-3361-2021; De Andrade, Selma M/B-2822-2008; Gabani, Flavia Lopes/AAW-9258-2020	Mesas, Arthur/0000-0002-0088-8607; De Andrade, Selma M/0000-0001-6843-8330; Gabani, Flavia Lopes/0000-0002-9442-4896; Cristina da Silva Santos, Mayara/0000-0003-1250-0873	CAPES (Coordination for the Improvement of Higher Level Personnel, Ministry of Education, Brazil); Brazilian National Research Council (CNPq)	CAPES (Coordination for the Improvement of Higher Level Personnel, Ministry of Education, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	M.C.S.S. is the recipient of a scholarship from CAPES (Coordination for the Improvement of Higher Level Personnel, Ministry of Education, Brazil) as part of the funding for her dissertation. S. M.A. and A.E.M. are the recipients of research productivity scholarships from the Brazilian National Research Council (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebaw T.-A., 2018, BIOMED J SCI TECH RE, V10, P1, DOI [10.26717/BJSTR.2018.10.001886, DOI 10.26717/BJSTR.2018.10.001886]; Ambrose KR, 2015, BEST PRACT RES CL RH, V29, P120, DOI 10.1016/j.berh.2015.04.022; [Anonymous], 2019, NAT METHODS, V16, P1, DOI 10.1038/s41592-018-0292-8; [Anonymous], 2018, NAT SUSTAIN, V1, P151, DOI 10.1038/s41893-018-0060-x; [Anonymous], 2017, Hosp Case Manag, V25, P1; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2012, AM J TRANSPLANT, V12, P1, DOI 10.1111/j.1600-6143.2011.03886.x; [Anonymous], 2016, CLADISTICS, V32, P1, DOI [10.1111/cla.12, DOI 10.1111/CLA.12]; [Anonymous], 2017, JAP CLASS ES CANC, V14, P1, DOI [DOI 10.1007/s10388-016-0551-7, DOI 10.1093/GERONT/GNY014]; [Anonymous], 2018, U TORONTO LAW J S1, V68, P1, DOI DOI 10.1007/S11881-018-0158-X; [Anonymous], 2016, J GERIATR CARDIOL; Cimas M, 2018, EUR J PAIN, V22, P333, DOI 10.1002/ejp.1123; Cooper L, 2018, OBES REV, V19, P989, DOI 10.1111/obr.12686; de Farias JC, 2010, CAD SAUDE PUBLICA, V26, P1669, DOI 10.1590/S0102-311X2010000900002; Durmus D, 2012, J BACK MUSCULOSKELET, V25, P5, DOI 10.3233/BMR-2012-0304; Gibbs BB, 2018, OCCUP ENVIRON MED, V75, P321, DOI 10.1136/oemed-2017-104732; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Korkmaz NC, 2011, SCI RES ESSAYS, V6, P649; Lee LFR, 2019, MED ENG PHYS, V74, P82, DOI 10.1016/j.medengphy.2019.09.018; Lima LV, 2017, PAIN, V158, P1697, DOI 10.1097/j.pain.0000000000000967; Lima LV, 2017, J PHYSIOL-LONDON, V595, P4141, DOI 10.1113/JP273355; Marchant S., 2012, PHENOMENON PAIN; Mekary RA, 2013, AM J EPIDEMIOL, V178, P474, DOI 10.1093/aje/kws590; Page MG, 2018, J PAIN RES, V11, P237, DOI 10.2147/JPR.S149262; Patterson J, 2017, ENVIRON INNOV SOC TR, V24, P1, DOI 10.1016/j.eist.2016.09.001; Pinto RZ, 2014, EUR J PAIN, V18, P1190, DOI 10.1002/j.1532-2149.2014.00468.x; Polaski AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210418; Santos MCS, 2018, BEHAV MED, V44, P335, DOI 10.1080/08964289.2017.1384358; Shiri R, 2017, BRIT J SPORT MED, V51, P1410, DOI 10.1136/bjsports-2016-097352; Siebra Maiara Mota Rocha, 2017, Rev. dor, V18, P43, DOI 10.5935/1806-0013.20170010; Stamatakis E, 2012, PREV MED, V54, P82, DOI 10.1016/j.ypmed.2011.10.009; van Hecke O, 2013, BRIT J ANAESTH, V111, P13, DOI 10.1093/bja/aet123; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wong JJ, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-1192-4; Zhang YE, 2018, CURR OPIN CELL BIOL, V51, P1, DOI 10.1016/j.ceb.2017.10.001	35	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234609	10.1371/journal.pone.0234609	http://dx.doi.org/10.1371/journal.pone.0234609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555745	Green Published, gold			2022-12-26	WOS:000542759600027
J	Vigliotti , V; Taggart, T; Walker, M; Kusmastuti, S; Ransome, Y				Vigliotti, Vivian; Taggart, Tamara; Walker, Mahaya; Kusmastuti, Sasmita; Ransome, Yusuf			Religion, faith, and spirituality influences on HIV prevention activities: A scoping review	PLOS ONE			English	Review							CONDOM USE; INTERVENTION; HIV/AIDS; STIGMA; BARRIERS; FACILITATORS; INVOLVEMENT; DIMENSIONS; PREDICTORS; REDUCTION	Introduction Strategies to increase uptake of next-generation biomedical prevention technologies (e.g., long-acting injectable pre-exposure prophylaxis (PrEP)) can benefit from understanding associations between religion, faith, and spirituality (RFS) and current primary HIV prevention activities (e.g., condoms and oral PrEP) along with the mechanisms which underlie these associations. Methods We searched PubMed, Embase, Academic Search Premier, Web of Science, and Sociological Abstracts for empirical articles that investigated and quantified relationships between RFS and primary HIV prevention activities outlined by the United States (U.S.) Department of Health and Human Services: condom use, HIV and STI testing, number of sexual partners, injection drug use treatment, medical male circumcision, and PrEP. We included articles in English language published between 2000 and 2020. We coded and analyzed studies based on a conceptual model. We then developed summary tables to describe the relation between RFS variables and the HIV prevention activities and any underlying mechanisms. We used CiteNetExplorer to analyze citation patterns. Results We identified 2881 unique manuscripts and reviewed 29. The earliest eligible study was published in 2001, 41% were from Africa and 48% were from the U.S. RFS measures included attendance at religious services or interventions in religious settings; religious and/or spirituality scales, and measures that represent the influence of religion on behaviors. Twelve studies included multiple RFS measures. Twenty-one studies examined RFS in association with condom use, ten with HIV testing, nine with number of sexual partners, and one with PrEP. Fourteen (48%) documented a positive or protective association between all RFS factors examined and one or more HIV prevention activities. Among studies reporting a positive association, beliefs and values related to sexuality was the most frequently observed mechanism. Among studies reporting negative associations, behavioral norms, social influence, and beliefs and values related to sexuality were observed equally. Studies infrequently cited each other. Conclusion More than half of the studies in this review reported a positive/protective association between RFS and HIV prevention activities, with condom use being the most frequently studied, and all having some protective association with HIV testing behaviors. Beliefs and values related to sexuality are possible mechanisms that could underpin RFS-related HIV prevention interventions. More studies are needed on PrEP and spirituality/subjective religiosity.	[Vigliotti, Vivian] Baylor Univ, Robbins Inst Hlth Policy & Leadership, Waco, TX 76798 USA; [Taggart, Tamara; Walker, Mahaya; Ransome, Yusuf] Yale Sch Publ Hlth, Dept Social & Behav Sci, New Haven, CT 06510 USA; [Taggart, Tamara] George Washington Univ, Prevent & Community Hlth, Sch Publ Hlth, Washington, DC USA; [Kusmastuti, Sasmita] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Kobenhavns, Denmark	Baylor University; Yale University; George Washington University; University of Copenhagen	Ransome, Y (corresponding author), Yale Sch Publ Hlth, Dept Social & Behav Sci, New Haven, CT 06510 USA.	Yusuf.ransome@yale.edu		Kusumastuti, Sasmita/0000-0002-7748-1514; Ransome, Yusuf/0000-0003-4170-2001	National Institute of Mental Health of the National institutes of Health [K01MH111374, R25MH083620, P30MH062294]	National Institute of Mental Health of the National institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Y. Ransome's research was supported by the National Institute of Mental Health of the National institutes of Health under award number (s) K01MH111374, R25MH083620, and P30MH062294. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Y. Ransome's research was supported by the National Institute of Mental Health of the National institutes of Health under award number (s) K01MH111374, R25MH083620, and P30MH062294.	Abara W, 2015, J RELIG HEALTH, V54, P122, DOI 10.1007/s10943-013-9789-8; Ackah W., 2018, RELIG CULTURE SPIRIT; Adong J, 2018, AIDS BEHAV, V22, P1802, DOI 10.1007/s10461-017-1805-7; Agadjanian V, 2005, SOC SCI MED, V61, P1529, DOI 10.1016/j.socscimed.2005.03.012; Agardh A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-527; Agardh A, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5432; Agha S, 2006, J ADOLESCENT HEALTH, V38, P550, DOI 10.1016/j.jadohealth.2005.04.012; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Ansari DA, 2010, CULT HEALTH SEX, V12, P633, DOI 10.1080/13691051003736253; Archer M. S., 2003, STRUCTURE AGENCY INT, DOI [10.1017/cbo9781139087315.001, DOI 10.1017/CBO9781139087315.001]; Auerbach JD, 2011, GLOB PUBLIC HEALTH, V6, pS293, DOI 10.1080/17441692.2011.594451; Avants SK, 2001, J PSYCHOACTIVE DRUGS, V33, P39, DOI 10.1080/02791072.2001.10400467; Baral S, 2019, LANCET HIV, pS2352; Bekker LG, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007435; Berkley-Patton J, 2010, AIDS EDUC PREV, V22, P218, DOI 10.1521/aeap.2010.22.3.218; Berkley-Patton JY, 2019, AIDS BEHAV, V23, P76, DOI 10.1007/s10461-018-2240-0; Berkley-Patton JY, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18644; Bluthenthal RN, 2012, SOC SCI MED, V74, P1520, DOI 10.1016/j.socscimed.2012.01.020; Cahill S, 2017, AIDS CARE, V29, P1351, DOI 10.1080/09540121.2017.1300633; Cerqueira-Santos E, 2008, SPAN J PSYCHOL, V11, P94, DOI 10.1017/S1138741600004157; CHATTERS LM, 1992, J GERONTOL, V47, pS269, DOI 10.1093/geronj/47.6.S269; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Coleman CL, 2009, WESTERN J NURS RES, V31, P889, DOI 10.1177/0193945909339895; Dalmida SG, 2014, RELIG SOCIAL DETERMI, P364; Derose KP, 2016, AIDS BEHAV, V20, P1692, DOI 10.1007/s10461-015-1280-y; Doolittle BR, 2018, AIDS BEHAV, V22, P1792, DOI 10.1007/s10461-016-1651-z; Downs JA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002802; Durkheim E., 1975, DURKHEIM RELIG SELEC; Eakle R, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25306; Eisinger RW, 2019, JAMA; Ellison CG, 1998, HEALTH EDUC BEHAV, V25, P700, DOI 10.1177/109019819802500603; Eriksson E, 2014, J RELIG HEALTH, V53, P1662, DOI 10.1007/s10943-013-9753-7; Ezeanolue EE, 2015, LANCET GLOB HEALTH, V3, pE692, DOI 10.1016/S2214-109X(15)00195-3; Farmer Paul, 2006, AIDS ACCUSATION HAIT; Geertz Clifford, 2002, READER ANTHR RELIG, P57; Golub SA, 2018, CURR HIV-AIDS REP, V15, P190, DOI 10.1007/s11904-018-0385-0; Gunthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hill PC, 2000, J THEOR SOC BEHAV, V30, P51, DOI 10.1111/1468-5914.00119; Idler E.L., 2014, RELIG SOCIAL DETERMI, DOI 10.1093/acprof:oso/9780199362202.001.0001/acprof-9780199362202; Idler EL, 2003, RES AGING, V25, P327, DOI 10.1177/0164027503025004001; Jemmott LS, 2020, J ADOLESCENT HEALTH, V66, P107, DOI 10.1016/j.jadohealth.2019.07.021; Kagimu M, 2013, J RELIG HEALTH, V52, P1211, DOI 10.1007/s10943-011-9563-8; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kendrick HM, 2017, AIDS CARE, V29, P1, DOI 10.1080/09540121.2016.1201196; Kesson K, 2002, COUNTERPOINTS, V38, P46; Kippax S, 2013, AM J PUBLIC HEALTH, V103, P1367, DOI 10.2105/AJPH.2013.301301; Koenig H., 2011, SPIRITUALITY HLTH RE; Koenig H. G, 2001, HDB RELIG HLTH; Koenig HG, 2010, RELIGIONS, V1, P78, DOI 10.3390/rel1010078; Lanzi RG, 2019, AIDS BEHAV, V23, P2936, DOI 10.1007/s10461-019-02604-7; Latkin CA, 2005, AIDS CARE, V17, pS102, DOI 10.1080/09540120500121185; Lipka M, 2017, MORE ERICANS NOW SAY; Mannell J, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19073; Margolin A, 2006, AIDS EDUC PREV, V18, P311, DOI 10.1521/aeap.2006.18.4.311; Mash R, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000638; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; McCree DH, 2003, J ADOLESCENT HEALTH, V33, P2, DOI 10.1016/S1054-139X(02)00460-3; Mendel P, 2020, SOC SCI MED, V246, DOI 10.1016/j.socscimed.2019.112718; Muula Adamson S, 2011, World Health Popul, V12, P35; Nelson JM, 2009, PSYCHOL RELIG SPIRIT, P233; Nelson LE, 2017, AM J MENS HEALTH, V11, P1309, DOI 10.1177/1557988315626264; Oman D, 2018, RELIG SPIRITUALITY H; Payne-Foster P, 2018, AIDS CARE, V30, P232, DOI 10.1080/09540121.2017.1371664; Perez-Jimenez D, 2009, CULT DIVERS ETHN MIN, V15, P11, DOI 10.1037/a0013872; Pew Research Center, 2018, AG GAP REL WORLD; Pew Research Center, 2012, GLOB REL LANDSC; Pew Research Centre, 2017, CHANG GLOB REL LANDS; Powell LH, 2003, AM PSYCHOL, V58, P36, DOI 10.1037/0003-066X.58.1.36; Ransome Y, 2020, AM J EPIDEMIOL, V189, P755, DOI 10.1093/aje/kwaa022; Ransome Y, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6301-0; Ransome Y, 2019, AIDS BEHAV, V23, P459, DOI 10.1007/s10461-018-2206-2; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Shaw SA, 2014, AIDS BEHAV, V18, P1569, DOI 10.1007/s10461-014-0714-2; Stewart JM, 2016, WESTERN J NURS RES, V38, P819, DOI 10.1177/0193945916629621; Szaflarski M, 2013, AIDS BEHAV, V17, P1839, DOI 10.1007/s10461-013-0455-7; Taylor MarkC., 2007, GOD; TAYLOR RJ, 1999, J BLACK PSYCHOL, V0025; Trinitapoli J, 2011, GLOB PUBLIC HEALTH, V6, P41, DOI 10.1080/17441692.2010.486764; Trinitapoli J, 2009, SOC SCI MED, V69, P199, DOI 10.1016/j.socscimed.2009.04.018; UNAIDS, 2010, COMB HIV PREV TAIL C; UNAIDS, GLOB HIV AIDS STAT 2; United States (US) Department of Health and Human Services, 2017, HIV PREV ACT; Vermund SH, 2013, JAIDS-J ACQ IMM DEF, V63, pS12, DOI 10.1097/QAI.0b013e31829202a2; Weber M., 1958, PROTESTANT ETHICS SP; Williams MV, 2018, J HIV-AIDS SOC SERV, V17, P290, DOI 10.1080/15381501.2018.1477641; Wingood GM, 2013, AM J PUBLIC HEALTH, V103, P2226, DOI 10.2105/AJPH.2013.301386; Witzel TC, 2019, SEX TRANSM INFECT, V95, P262, DOI 10.1136/sextrans-2018-053773; World Values Survey, 2019, A098 ACT IN MEMB CHU; Wu F, 2010, CHINESE MED J-PEKING, V123, P1011, DOI 10.3760/cma.j.issn.0366-6999.2010.08.007; Zinnbauer BJ, 1997, J SCI STUD RELIG, V36, P549, DOI 10.2307/1387689	92	15	15	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234720	10.1371/journal.pone.0234720	http://dx.doi.org/10.1371/journal.pone.0234720			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB9ZQ	32544212	Green Published, gold			2022-12-26	WOS:000542957200010
J	De Faoite, D; Ries, C; Foster, M; Boese, CK				De Faoite, Diarmuid; Ries, Christian; Foster, Michelle; Boese, Christoph Kolja			Indications for bi-cruciate retaining total knee replacement: An international survey of 346 knee surgeons	PLOS ONE			English	Article							ARTHROPLASTY; LIGAMENTS; RETENTION	There is limited evidence on total knee arthroplasty (TKA) that retains the anterior and the posterior cruciate ligaments. Bi-cruciate retaining (BCR) TKA is considered to show improved clinical function and kinematics. This survey aimed to (1) identify interest in and acceptance of BCR TKA surgery and (2) to capture the range of indications for BCR in the opinion of practicing knee surgeons. 346 surgeons with experience in TKA surgery completed a bi-lingual online survey. Demographics, arthroplasty experience as well as acceptance of and indications for BCR TKA were collected. 53 surgeons were experienced in BCR TKA and 225 would consider implanting it. A mean of 19.5% of TKA patients were considered eligible for BCR TKA. 56.3% were thought to have intact ACL at the time of TKA surgery. Surgeons were not likely to perform BCR TKA in patients with inflammatory arthritis, aged over 80, BMI above 34.9 kg/m(2), a varus or valgus deformity of more than 10 degrees and flexion contractures of more than 10 degrees. There is strong interest among orthopedic surgeons to perform BCR TKA and the percentage of potentially eligible patients is high. Significant joint deformity is a limitation of BCR TKA, while age and high BMI are less relevant. BCR TKA experienced surgeons are less restrictive.	[De Faoite, Diarmuid] Smith Nephew, Baar, Switzerland; [Ries, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Orthoped, Hamburg, Germany; [Foster, Michelle] Smith Nephew, Kingston Upon Hull, N Humberside, England; [Boese, Christoph Kolja] Univ Hosp Cologne, Dept Orthopaed & Trauma Surg, Cologne, Germany; [Boese, Christoph Kolja] Smith Nephew GmbH, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Smith & Nephew; University of Cologne	De Faoite, D (corresponding author), Smith Nephew, Baar, Switzerland.	diarmuid.defaoite@smith.nephew.com			Smith + Nephew [IIS 585]	Smith + Nephew	The study was funded by Smith + Nephew as an investigator initiated study (IIS 585). The funder provided support in the form of coverage of costs associated with the survey (fee for online services by SurveyMonkey), coverage of publication fees (if applicable) and salaries for authors CKB, DDF and MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abdelbadie A, 2018, SICOT-J, V4, DOI 10.1051/sicotj/2017042; Alnachoukati OK, 2018, J ARTHROPLASTY; Alnachoukati OK, 2018, J ARTHROPLASTY, V33, P2485, DOI 10.1016/j.arth.2018.03.026; Baumann F, 2018, ARCH ORTHOP TRAUM SU, V138, P273, DOI 10.1007/s00402-017-2839-z; Baumann F, 2017, KNEE SURG SPORT TR A, V25, P1697, DOI 10.1007/s00167-016-4121-2; Cherian JJ, 2014, J KNEE SURG, V27, P199, DOI 10.1055/s-0034-1374812; Christensen JC, 2017, CLIN ORTHOP RELAT R, V475, P62, DOI 10.1007/s11999-016-4812-5; Cloutier JM, 1999, J BONE JOINT SURG AM, V81A, P697, DOI 10.2106/00004623-199905000-00011; CLOUTIER JM, 1991, CLIN ORTHOP RELAT R, P63; Geifman N, 2013, AGE, V35, P2357, DOI 10.1007/s11357-013-9510-6; Jenny JY, 1998, ARCH ORTHOP TRAUM SU, V118, P145, DOI 10.1007/s004020050335; Johnson AJ, 2013, CLIN ORTHOP RELAT R, V471, P181, DOI 10.1007/s11999-012-2505-2; Komistek RD, 2002, CLIN ORTHOP RELAT R, P315, DOI 10.1097/01.blo.0000026562.55792.90; Lutzner J, 2018, ORTHOPADE, V47, P777, DOI 10.1007/s00132-018-3612-x; McElroy MJ, 2013, J KNEE SURG, V26, P83, DOI 10.1055/s-0033-1341407; Parcells Bertrand W, 2016, Am J Orthop (Belle Mead NJ), V45, pE153; Pelt CE, 2019, J ARTHROPLASTY, V34, P1957, DOI 10.1016/j.arth.2019.04.030; Pritchett JW, 2015, CLIN ORTHOP RELAT R, V473, P2327, DOI 10.1007/s11999-015-4219-8; Pritchett JW, 2004, J BONE JOINT SURG BR, V86B, P979, DOI 10.1302/0301-620X.86B7.14991; Roussi K, 2019, 32 ANN C INT SOC TEC; Sabouret P, 2013, BONE JOINT J, V95B, P917, DOI 10.1302/0301-620X.95B7.30904	21	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234616	10.1371/journal.pone.0234616	http://dx.doi.org/10.1371/journal.pone.0234616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542002	gold, Green Published			2022-12-26	WOS:000542685100005
J	Wang, XF; Zhu, JQ; Li, ZH; Wei, T				Wang, Xiaofei; Zhu, Jingqiang; Li, Zhihui; Wei, Tao			The benefits of radioactive iodine ablation for patients with intermediate-risk papillary thyroid cancer	PLOS ONE			English	Article							END-RESULTS PROGRAM; PROGNOSTIC-FACTORS; REMNANT ABLATION; SCORING SYSTEM; LYMPH-NODES; THERAPY; CARCINOMA; RECURRENCE; ASSOCIATION; EPIDEMIOLOGY	Background The beneficial effects of radioactive iodine (RAI) ablation for intermediate-risk papillary thyroid cancer (PTC) patients are still controversial. Materials and methods To determine the impact of RAI therapy on disease-specific survival (DSS) in patients with intermediate-risk PTC, we retrospectively analyzed the data of 23107 intermediate-risk PTC patients who underwent primary thyroidectomy with or without RAI in the Surveillance, Epidemiology, and End Results (SEER) database. Results RAI therapy was significantly associated with improved DSS (adjusted HR = 0.65,P= 0.017) in intermediate-risk PTC patients after multivariate adjusting for clinicopathological characteristics. However, subgroup analyses demonstrated that RAI ablation was only associated with improved DSS in patients with male gender (adjusted HR = 0.47,P= 0.005), age >= 45 years (adjusted HR = 0.34,P< 0.001) and tumor size > 20 mm (adjusted HR = 0.58,P= 0.007). Conclusion RAI decision-making should be considered on an individual basis rather than "one size fits all" in intermediate-risk PTC patients; only patients with male gender, age >= 45 years, and tumor size > 20 mm may benefit from RAI therapy.	[Wang, Xiaofei; Zhu, Jingqiang; Li, Zhihui; Wei, Tao] Sichuan Univ, West China Hosp, Dept Thyroid & Parathyroid Surg, Chengdu, Peoples R China	Sichuan University	Wei, T (corresponding author), Sichuan Univ, West China Hosp, Dept Thyroid & Parathyroid Surg, Chengdu, Peoples R China.	docweitao@sina.com			Project of Sichuan Provincial Education Department [17ZA0170]; Project of Sichuan Province Science & Technology Department [20ZDYF2669]	Project of Sichuan Provincial Education Department; Project of Sichuan Province Science & Technology Department	Yes. X.W received the Project of Sichuan Provincial Education Department (17ZA0170) and Project of Sichuan Province Science & Technology Department (20ZDYF2669). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MB, 2016, AJCC CANC STAGINGMAN; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; Aschebrook-Kilfoy B, 2011, THYROID, V21, P125, DOI 10.1089/thy.2010.0021; Brierley J, 2005, CLIN ENDOCRINOL, V63, P418, DOI 10.1111/j.1365-2265.2005.02358.x; Buffet C, 2012, EUR J ENDOCRINOL, V167, P267, DOI 10.1530/EJE-12-0105; CADY B, 1988, SURGERY, V104, P947; Carhill AA, 2015, J CLIN ENDOCR METAB, V100, P3270, DOI 10.1210/JC.2015-1346; Chow SM, 2006, ENDOCR-RELAT CANCER, V13, P1159, DOI 10.1677/erc.1.01320; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Glikson E, 2017, ISR MED ASSOC J, V19, P114; Hankey BF, 1999, CANCER EPIDEM BIOMAR, V8, P1117; Harlan LC, 2003, J CLIN ONCOL, V21, P2232, DOI 10.1200/JCO.2003.94.023; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; HAY ID, 1993, SURGERY, V114, P1050; Haymart MR, 2011, JAMA-J AM MED ASSOC, V306, P721, DOI 10.1001/jama.2011.1139; Ito Y, 2012, ENDOCR J, V59, P399; Iyer NG, 2011, CANCER-AM CANCER SOC, V117, P4439, DOI 10.1002/cncr.26070; Jinno H, 2016, BREAST CANCER-TOKYO, V23, P367, DOI 10.1007/s12282-016-0671-x; Kim HJ, 2013, CLIN ENDOCRINOL, V78, P614, DOI 10.1111/cen.12034; Kloos RT, 2002, J CLIN ENDOCR METAB, V87, P5817, DOI 10.1210/jc.2002-020210; Klubo-Gwiezdzinska J, 2010, THYROID, V20, P647, DOI 10.1089/thy.2009.0466; Lamartina L, 2015, J CLIN ENDOCR METAB, V100, P1748, DOI 10.1210/jc.2014-3882; Lee J, 2014, WORLD J SURG, V38, P858, DOI 10.1007/s00268-013-2345-6; Lee SL, 2010, J NATL COMPR CANC NE, V8, P1277, DOI 10.6004/jnccn.2010.0094; Liu FH, 2015, J SURG ONCOL, V112, P149, DOI 10.1002/jso.23967; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Moon HJ, 2011, ANN SURG ONCOL, V18, P1916, DOI 10.1245/s10434-011-1556-z; Pitoia F, 2013, THYROID, V23, P1401, DOI 10.1089/thy.2013.0011; Ruel E, 2015, J CLIN ENDOCR METAB, V100, P1529, DOI 10.1210/jc.2014-4332; Sacks W, 2010, THYROID, V20, P1235, DOI 10.1089/thy.2009.0455; SUGINO K, 1995, SURG TODAY, V25, P324, DOI 10.1007/BF00311254; Tsang TW, 1998, CANCER-AM CANCER SOC, V82, P375; Tuttle RM, 2010, THYROID, V20, P1341, DOI 10.1089/thy.2010.0178; 2015, XENOTRANSPLANTATION, V22, pS728	34	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234843	10.1371/journal.pone.0234843	http://dx.doi.org/10.1371/journal.pone.0234843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542018	gold, Green Published			2022-12-26	WOS:000542685100020
J	Thompson, MJ; Domville, JA; Baenziger, JE				Thompson, Mackenzie J.; Domville, Jaimee A.; Baenziger, John E.			The functional role of the alpha M4 transmembrane helix in the muscle nicotinic acetylcholine receptor probed through mutagenesis and coevolutionary analyses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nicotinic acetylcholine receptor (nAChR); pentameric ligand-gated ion channel (pLGIC); lipid-protein interactions; M4 transmembrane helix; transmembrane domain; channel gating; GLIC; ELIC; lipid sensing; membrane protein; coevolutionary analysis; Cys-loop receptor; mutagenesis; protein evolution; M4	X-RAY-STRUCTURE; ALLOSTERIC MODULATION; CYS-LOOP; TRYPTOPHAN SUBSTITUTIONS; MOLECULAR-DYNAMICS; AROMATIC RESIDUES; LIPID-COMPOSITION; ION-CHANNEL; C-TERMINUS; M4	The activity of the muscle-typeTorpedonicotinic acetylcholine receptor (nAChR) is highly sensitive to lipids, but the underlying mechanisms remain poorly understood. The nAChR transmembrane alpha-helix, M4, is positioned at the perimeter of each subunit in direct contact with lipids and likely plays a central role in lipid sensing. To gain insight into the mechanisms underlying nAChR lipid sensing, we used homology modeling, coevolutionary analyses, site-directed mutagenesis, and electrophysiology to examine the role of the alpha-subunit M4 (alpha M4) in the function of the adult muscle nAChR. Ala substitutions for most alpha M4 residues, including those in clusters of polar residues at both the N and C termini, and deletion of up to 11 C-terminal residues had little impact on the agonist-induced response. Even Ala substitutions for coevolved pairs of residues at the interface between alpha M4 and the adjacent helices, alpha M1 and alpha M3, had little effect, although some impaired nAChR expression. On the other hand, Ala substitutions for Thr422 and Arg429 caused relatively large losses of function, suggesting functional roles for these specific residues. Ala substitutions for aromatic residues at the alpha M4-alpha M1/alpha M3 interface generally led to gains of function, as previously reported for the prokaryotic homolog, theErwinia chrysanthemiligand-gated ion channel (ELIC). The functional effects of individual Ala substitutions in alpha M4 were found to be additive, although not in a completely independent manner. Our results provide insight into the structural features of alpha M4 that are important. They also suggest how lipid-dependent changes in alpha M4 structure ultimately modify nAChR function.	[Thompson, Mackenzie J.; Domville, Jaimee A.; Baenziger, John E.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa	Baenziger, JE (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	John.Baenziger@uottawa.ca		Thompson, Mackenzie/0000-0001-8421-4222; Baenziger, John/0000-0002-2888-5328	National Sciences and Engineering Research Council of Canada [113312]	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the National Sciences and Engineering Research Council of Canada (113312) to J. E. B.	Alcaino C, 2017, J BIOL CHEM, V292, P551, DOI 10.1074/jbc.M116.751206; Antollini SS, 2005, MOL MEMBR BIOL, V22, P471, DOI 10.1080/09687860500367915; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; Baenziger JE, 2008, MOL PHARMACOL, V73, P880, DOI 10.1124/mol.107.039008; Baenziger JE, 2015, BBA-BIOMEMBRANES, V1848, P1806, DOI 10.1016/j.bbamem.2015.03.010; Barrantes FJ, 2015, BBA-BIOMEMBRANES, V1848, P1796, DOI 10.1016/j.bbamem.2015.03.028; BLANTON MP, 1992, BIOCHEMISTRY-US, V31, P3738, DOI 10.1021/bi00130a003; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2000, J GEN PHYSIOL, V115, P663, DOI 10.1085/jgp.115.5.663; Bouzat C, 1998, MOL PHARMACOL, V54, P146, DOI 10.1124/mol.54.1.146; Butler AS, 2009, NEUROPHARMACOLOGY, V56, P292, DOI 10.1016/j.neuropharm.2008.08.017; Carswell CL, 2015, STRUCTURE, V23, P1655, DOI 10.1016/j.str.2015.06.020; Carswell CL, 2015, J BIOL CHEM, V290, P2496, DOI 10.1074/jbc.M114.624395; Carswell CL, 2013, BIOPHYS J, V104, p219A, DOI 10.1016/j.bpj.2012.11.1235; Cory-Wright J, 2018, ACS CHEM NEUROSCI, V9, P284, DOI 10.1021/acschemneuro.7b00315; CRIADO M, 1982, BIOCHEMISTRY-US, V21, P3622, DOI 10.1021/bi00258a015; CRIADO M, 1984, J BIOL CHEM, V259, P9188; Couto ARGMD, 2020, ACS CHEM NEUROSCI, V11, P1406, DOI 10.1021/acschemneuro.0c00027; daCosta CJB, 2002, J BIOL CHEM, V277, P201, DOI 10.1074/jbc.M108341200; Dacosta CJB, 2013, NAT CHEM BIOL, V9, P701, DOI [10.1038/NCHEMBIO.1338, 10.1038/nchembio.1338]; daCosta CJB, 2009, J BIOL CHEM, V284, P33841, DOI 10.1074/jbc.M109.048280; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; Daeffler KNM, 2012, J AM CHEM SOC, V134, P14890, DOI 10.1021/ja304560x; Domville JA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22150-x; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Forman SA, 2015, NEUROPHARMACOLOGY, V96, P169, DOI 10.1016/j.neuropharm.2014.10.002; Gharpure A, 2019, NEURON, V104, P501, DOI 10.1016/j.neuron.2019.07.030; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; Henault CM, 2019, NAT CHEM BIOL, V15, P1156, DOI 10.1038/s41589-019-0369-4; Henault CM, 2015, J BIOL CHEM, V290, P25118, DOI 10.1074/jbc.M115.676833; Henault CM, 2015, NEUROPHARMACOLOGY, V96, P157, DOI 10.1016/j.neuropharm.2014.11.011; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Lasalde JA, 1996, BIOCHEMISTRY-US, V35, P14139, DOI 10.1021/bi961583l; Laverty D, 2019, NATURE, V565, P516, DOI 10.1038/s41586-018-0833-4; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; LEE YH, 1994, BIOPHYS J, V66, P646, DOI 10.1016/S0006-3495(94)80838-0; LI L, 1990, BIOCHEMISTRY-US, V29, P5428, DOI 10.1021/bi00475a003; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Mesoy S, 2019, ACS CHEM NEUROSCI, V10, P3167, DOI 10.1021/acschemneuro.8b00603; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Mnatsakanyan N, 2013, J NEUROCHEM, V125, P843, DOI 10.1111/jnc.12260; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Newcombe J, 2018, MOL PHARMACOL, V93, P128, DOI 10.1124/mol.117.110551; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Paradiso K, 2001, J NEUROSCI, V21, P6561, DOI 10.1523/JNEUROSCI.21-17-06561.2001; Pons S, 2004, EUR J NEUROSCI, V20, P2022, DOI 10.1111/j.1460-9568.2004.03673.x; Rahman MM, 2020, NEURON, V106, P952, DOI 10.1016/j.neuron.2020.03.012; Shen XM, 2006, ANN NEUROL, V60, P128, DOI 10.1002/ana.20861; Tamamizu S, 2000, BIOCHEMISTRY-US, V39, P4666, DOI 10.1021/bi992835w; Tang BJ, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0454-8; Therien JPD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00573-2; Thompson MJ, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183304; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Walsh RM, 2018, NATURE, V557, P261, DOI 10.1038/s41586-018-0081-7; Williamson PTF, 2005, MOL MEMBR BIOL, V22, P485, DOI 10.1080/09687860500370653; Xu YC, 2005, J AM CHEM SOC, V127, P1291, DOI 10.1021/ja044577i	61	7	7	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11056	11067		10.1074/jbc.RA120.013751	http://dx.doi.org/10.1074/jbc.RA120.013751			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32527728	Green Published, hybrid			2022-12-26	WOS:000562757100013
J	Anderson, KJ; Osvaldsdottir, AB; Atzinger, B; Traustadottir, GA; Jensen, KN; Larusdottir, AE; Bergthorsson, JT; Hardardottir, I; Magnusdottir, E				Anderson, Kimberley Jade; Osvaldsdottir, Arny Bjorg; Atzinger, Birgit; Traustadottir, Gunnhildur Asta; Jensen, Kirstine Nolling; Larusdottir, Adalheidur Elin; Bergthorsson, Jon Thor; Hardardottir, Ingibjorg; Magnusdottir, Erna			The BLIMP1-EZH2 nexus in a non-Hodgkin lymphoma	ONCOGENE			English	Article							PLASMA-CELL DIFFERENTIATION; CLASS-II TRANSACTIVATOR; WALDENSTROM MACROGLOBULINEMIA; B-CELLS; TRANSCRIPTIONAL REPRESSION; METHYLTRANSFERASE ACTIVITY; SOMATIC MUTATIONS; MYD88 L265P; BLIMP-1; EXPRESSION	Waldenstrom's macroglobulinemia (WM) is a non-Hodgkin lymphoma, resulting in antibody-secreting lymphoplasmacytic cells in the bone marrow and pathologies resulting from high levels of monoclonal immunoglobulin M (IgM) in the blood. Despite the key role for BLIMP1 in plasma cell maturation and antibody secretion, its potential effect on WM cell biology has not yet been explored. Here we provide evidence of a crucial role for BLIMP1 in the survival of cells from WM cell line models and further demonstrate that BLIMP1 is necessary for the expression of the histone methyltransferase EZH2 in both WM and multiple myeloma cell lines. The effect of BLIMP1 on EZH2 levels is post-translational, at least partially through the regulation of proteasomal targeting of EZH2. Chromatin immunoprecipitation analysis and transcriptome profiling suggest that the two factors co-operate in regulating genes involved in cancer cell immune evasion. Co-cultures of natural killer cells and cells from a WM cell line further suggest that both factors participate in immune evasion by promoting escape from natural killer cell-mediated cytotoxicity. Together, the interplay of BLIMP1 and EZH2 plays a vital role in promoting the survival of WM cell lines, suggesting a role for the two factors in Waldenstrom's macroglobulinaemia.	[Anderson, Kimberley Jade; Osvaldsdottir, Arny Bjorg; Atzinger, Birgit; Traustadottir, Gunnhildur Asta; Larusdottir, Adalheidur Elin; Magnusdottir, Erna] Univ Iceland, Fac Med, Dept Anat, Vatnsmyrarvegur 16, IS-101 Reykjavik, Iceland; [Anderson, Kimberley Jade; Osvaldsdottir, Arny Bjorg; Atzinger, Birgit; Larusdottir, Adalheidur Elin; Bergthorsson, Jon Thor; Magnusdottir, Erna] Univ Iceland, Fac Med, Dept Biomed Sci, Vatnsmyrarvegur 16, IS-101 Reykjavik, Iceland; [Anderson, Kimberley Jade; Osvaldsdottir, Arny Bjorg; Atzinger, Birgit; Traustadottir, Gunnhildur Asta; Jensen, Kirstine Nolling; Larusdottir, Adalheidur Elin; Bergthorsson, Jon Thor; Hardardottir, Ingibjorg; Magnusdottir, Erna] Univ Iceland, Biomed Ctr, Vatnsmyrarvegur 16, IS-101 Reykjavik, Iceland; [Jensen, Kirstine Nolling; Hardardottir, Ingibjorg] Univ Iceland, Fac Med, Dept Biochem & Mol Biol, Vatnsmyrarvegur 16, IS-101 Reykjavik, Iceland; [Jensen, Kirstine Nolling; Hardardottir, Ingibjorg] Landspitali Natl Univ Hosp Iceland, Dept Immunol, IS-101 Reykjavik, Iceland; [Bergthorsson, Jon Thor] Landspitali Natl Univ Hosp Iceland, Dept Lab Haematol, IS-101 Reykjavik, Iceland	University of Iceland; University of Iceland; University of Iceland; University of Iceland	Magnusdottir, E (corresponding author), Univ Iceland, Fac Med, Dept Anat, Vatnsmyrarvegur 16, IS-101 Reykjavik, Iceland.; Magnusdottir, E (corresponding author), Univ Iceland, Fac Med, Dept Biomed Sci, Vatnsmyrarvegur 16, IS-101 Reykjavik, Iceland.; Magnusdottir, E (corresponding author), Univ Iceland, Biomed Ctr, Vatnsmyrarvegur 16, IS-101 Reykjavik, Iceland.	erna@hi.is	Magnusdottir, Erna/H-5181-2013	Magnusdottir, Erna/0000-0002-3369-4390; Hardardottir, Ingibjorg/0000-0003-0178-7047; Anderson, Kimberley/0000-0003-0629-6343; Nolling Jensen, Kirstine/0000-0002-7625-7529; Traustadottir, Gunnhildur Asta/0000-0001-6044-0989; Bergthorsson, Jon Thor/0000-0002-0560-2639				Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Barakat FH, 2011, AM J CLIN PATHOL, V135, P365, DOI 10.1309/AJCP15YFULCZHZVH; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Calado DP, 2010, CANCER CELL, V18, P580, DOI 10.1016/j.ccr.2010.11.024; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Chen H, 2007, MOL IMMUNOL, V44, P1461, DOI 10.1016/j.molimm.2006.04.026; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; de Charette M, 2018, HAEMATOLOGICA, V103, P1256, DOI 10.3324/haematol.2017.184192; de Tute RM, 2013, CL LYMPH MYELOM LEUK, V13, P211, DOI 10.1016/j.clml.2013.02.018; Doody GM, 2007, J IMMUNOL, V179, P7614, DOI 10.4049/jimmunol.179.11.7614; El-Ayoubi A, 2017, PATHOLOGY, V49, P337, DOI 10.1016/j.pathol.2017.02.004; Elias S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18652-9; Garcia JF, 2006, HAEMATOLOGICA, V91, P467; Gavriatopoulou M, 2018, LEUKEMIA, V32, P1883, DOI 10.1038/s41375-018-0209-7; Ghobrial IM, 2004, CANCER-AM CANCER SOC, V101, P2593, DOI 10.1002/cncr.20658; Guo M, 2018, J IMMUNOL, V200, P1039, DOI 10.4049/jimmunol.1701470; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hernando H, 2016, MOL CANCER THER, V15, P287, DOI 10.1158/1535-7163.MCT-15-0486; Herviou L, 2019, LEUKEMIA, V33, P2047, DOI 10.1038/s41375-019-0392-1; Hung KH, 2016, CELL DEATH DIFFER, V23, P1175, DOI 10.1038/cdd.2015.167; Hunter ZR, 2016, BLOOD, V128, P827, DOI 10.1182/blood-2016-03-708263; Iwanaga M, 2014, INT J CANCER, V134, P174, DOI 10.1002/ijc.28343; Jalali S, 2018, BLOOD ADV, V2, P1985, DOI 10.1182/bloodadvances.2018021113; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Kriangkum J, 2004, BLOOD, V104, P2134, DOI 10.1182/blood-2003-11-4024; Kuo TC, 2004, J IMMUNOL, V173, P5556, DOI 10.4049/jimmunol.173.9.5556; Kurimoto K, 2015, CELL STEM CELL, V16, P517, DOI 10.1016/j.stem.2015.03.002; Kyle RA, 2018, MAYO CLIN PROC, V93, P739, DOI 10.1016/j.mayocp.2018.02.011; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lin FR, 2007, CANCER RES, V67, P11914, DOI 10.1158/0008-5472.CAN-07-1868; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lozano E, 2018, J IMMUNOL, V200, P2581, DOI 10.4049/jimmunol.1701622; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; Magnusdottir E, 2013, NAT CELL BIOL, V15, P905, DOI 10.1038/ncb2798; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; Minnich M, 2016, NAT IMMUNOL, V17, P331, DOI 10.1038/ni.3349; Morgan MAJ, 2009, MOL CELL BIOL, V29, P5813, DOI 10.1128/MCB.00670-09; Morice WG, 2009, MODERN PATHOL, V22, P807, DOI 10.1038/modpathol.2009.34; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mould AW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005375; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Murakami K, 2016, NATURE, V529, P403, DOI 10.1038/nature16480; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Pasricha SR, 2011, J CLIN PATHOL, V64, P520, DOI 10.1136/jcp.2010.088591; Paulus A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122338; Pawlyn C, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.27; Petermann F, 2019, MOL CELL, V75, P1229, DOI 10.1016/j.molcel.2019.06.025; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Roberts MJ, 2013, AM J CLIN PATHOL, V139, P210, DOI 10.1309/AJCP0YGM8BLFYHJY; Roccaro AM, 2010, BLOOD; Savitsky D, 2006, J EXP MED, V203, P2305, DOI 10.1084/jem.20060411; Schop RFJ, 2002, BLOOD, V100, P2996, DOI 10.1182/blood.V100.8.2996; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Steinberg MW, 2011, IMMUNOL REV, V244, P169, DOI 10.1111/j.1600-065X.2011.01064.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tellier J, 2016, NAT IMMUNOL, V17, P323, DOI 10.1038/ni.3348; Tooze RM, 2006, J IMMUNOL, V177, P4584, DOI 10.4049/jimmunol.177.7.4584; Treon SP, 2014, BLOOD, V123, P2791, DOI 10.1182/blood-2014-01-550905; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Treon SP, 2009, BLOOD, V114, P2375, DOI 10.1182/blood-2009-05-174359; Varghese AM, 2009, CLIN LYMPHOMA MYELOM, V9, P53, DOI 10.3816/CLM.2009.n.013; Vijay A, 2007, BLOOD, V109, P5096, DOI 10.1182/blood-2006-11-055012; Wang HJ, 2012, CANCER-AM CANCER SOC, V118, P3793, DOI 10.1002/cncr.26627; Xu L, 2014, LEUKEMIA, V28, P1698, DOI 10.1038/leu.2014.65; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000; Yu XF, 2018, CANCER RES, V78, P2457, DOI 10.1158/0008-5472.CAN-18-0215; Zhou YS, 2014, BRIT J HAEMATOL, V166, P677, DOI 10.1111/bjh.12936; Zingg D, 2017, CELL REP, V20, P854, DOI 10.1016/j.celrep.2017.07.007	77	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 9	2020	39	28					5138	5151		10.1038/s41388-020-1347-8	http://dx.doi.org/10.1038/s41388-020-1347-8			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MH4RK	32533097	Green Submitted, Green Published			2022-12-26	WOS:000546718100005
J	Lin, CC; Yao, CY; Hsu, YW; Hou, HA; Yuan, CS; Li, YH; Kao, HJ; Chuang, PH; Chiu, YC; Chen, YD; Chou, WC; Tien, WF				Lin, Chien-Chin; Yao, Chi-Yuan; Hsu, Yueh-Chwen; Hou, Hsin-An; Yuan, Chang-Tsu; Li, Yi-Hung; Kao, Chein-Jun; Chuang, Po-Han; Chiu, Yu-Chiao; Chen, Yidong; Chou, Wen-Chien; Tien, Hwei-Fang			Knock-out ofHopxdisrupts stemness and quiescence of hematopoietic stem cells in mice	ONCOGENE			English	Article							LABEL-RETAINING CELLS; HOMEOBOX GENE; HOPX EXPRESSION; CXCR4; PROLIFERATION; METHYLATION; POPULATION; SUBSET; CANCER	HOPX is a stem cell marker in hair follicles and intestines. It was shown critical for primitive hematopoiesis. We previously showed an association between higherHOPXexpression and clinical characteristics related to stemness and quiescence of leukemic cells in acute myeloid leukemia (AML) patients. To further explore its physiologic functions in hematopoietic system, we generated a mouse model with hematopoietic cell-specific knockout ofHopx(Hopx(-/-)). In youngHopx(-/-)mice, the hematopoietic stem cells (HSC) showed decreased reconstitution ability after serial transplantation. Further transcriptomic study revealed decreased HSC signatures in long-term HSCs from theHopx(-/-)mice. At 18 months of age, half of theHopx(-/-)mice developed cytopenia and splenomegaly. Bone marrow (BM) from the sick mice showed myeloid hyperplasia with predominant mature neutrophils, and decreased progenitor cells and lymphocytes. These phenotypes suggested critical functions of Hopx in maintaining HSC quiescence. Transcriptomic study of theHopx(-/-)marrow cells showed significant downregulation of theCxcl12-Cxcr4axis, which is critical for maintenance of HSC quiescence. We next examined the role of Hopx in AML by using theMN1overexpression murine leukemia model. Mice transplanted withMN1-overexpressedHopx(-/-)BM cells developed AML with more aggressive phenotypes compared with those transplanted withMN1-overexpressedHopx-wild cells.Hopx(-/-)MN1-overexpressed leukemia cells showed higher proliferation rate and downregulation ofCxcl12andCxcr4. Furthermore, in human AML, BM plasma CXCL12 levels were lower in patients with lowerHOPXexpression. In conclusion, our study highlights the roles of Hopx in maintenance of quiescence of the hematopoietic stem cells through CXCL12 pathway in vivo and provides implication of this protein in normal and malignant hematopoiesis.	[Lin, Chien-Chin; Yao, Chi-Yuan; Hsu, Yueh-Chwen; Chou, Wen-Chien] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Lin, Chien-Chin; Yao, Chi-Yuan; Hou, Hsin-An; Kao, Chein-Jun; Chuang, Po-Han; Chou, Wen-Chien; Tien, Hwei-Fang] Natl Taiwan Univ Hosp, Dept Internal Med, Div Hematol, Taipei, Taiwan; [Lin, Chien-Chin; Yuan, Chang-Tsu] Natl Taiwan Univ, Grad Inst Clin Med, Taipei, Taiwan; [Yuan, Chang-Tsu] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Dept Pathol, Taipei, Taiwan; [Li, Yi-Hung] Chinese Culture Univ, Dept Anim Sci, Taipei, Taiwan; [Chiu, Yu-Chiao; Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Chinese Culture University; University of Texas System; University of Texas Health San Antonio	Chou, WC (corresponding author), Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan.; Chou, WC; Tien, WF (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Hematol, Taipei, Taiwan.	wchou@ntu.edu.tw; hftien@ntu.edu.tw		HOU, HSIN-AN/0000-0003-2780-4845; Yuan, Chang-Tsu/0000-0003-1438-9187; Chiu, Yu-Chiao/0000-0003-1647-8634; LIN, CHIEN-CHIN/0000-0001-7160-2285; Yao, Chi-Yuan/0000-0001-5052-9445; TIEN, HWEI-FANG/0000-0002-1384-5593; CHOU, WEN-CHIEN/0000-0003-2967-698X				Agarwal P, 2019, CELL STEM CELL, V24, P769, DOI 10.1016/j.stem.2019.02.018; Basak O, 2017, CELL STEM CELL, V20, P177, DOI 10.1016/j.stem.2016.11.001; Beck TC, 2014, J EXP MED, V211, P2567, DOI 10.1084/jem.20140457; Berg DA, 2019, CELL, V177, P654, DOI 10.1016/j.cell.2019.02.010; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Chen Y, 2007, INT J CANCER, V121, P1021, DOI 10.1002/ijc.22753; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Harada Y, 2011, ANTICANCER RES, V31, P2889; Heuser M, 2011, CANCER CELL, V20, P39, DOI 10.1016/j.ccr.2011.06.020; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hsu YC, 2019, BLOOD ADV, V3, P2355, DOI 10.1182/bloodadvances.2019000391; Jain R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7727; Katoh H, 2012, NEOPLASIA, V14, P559, DOI 10.1593/neo.12330; Kook H, 2006, BIOCHEMISTRY-US, V45, P10584, DOI 10.1021/bi060641s; Lin CC, 2017, HAEMATOLOGICA, V102, P1044, DOI 10.3324/haematol.2016.161257; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Ni F, 2019, CELL STEM CELL, V24, P608, DOI 10.1016/j.stem.2019.02.009; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Ooki A, 2010, ONCOGENE, V29, P3263, DOI 10.1038/onc.2010.76; Palpant NJ, 2017, CELL REP, V20, P1597, DOI 10.1016/j.celrep.2017.07.067; Pitt LA, 2015, CANCER CELL, V27, P755, DOI 10.1016/j.ccell.2015.05.002; Ren XY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14053; Scadden DT, 2014, CELL, V157, P41, DOI 10.1016/j.cell.2014.02.013; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Takeda N, 2013, DEVELOPMENT, V140, P1655, DOI 10.1242/dev.093005; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tumpel S, 2019, TRENDS CELL BIOL, V29, P672, DOI 10.1016/j.tcb.2019.05.002; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Waraya M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-397; Yamaguchi S, 2009, INT J CANCER, V124, P2577, DOI 10.1002/ijc.24217; Yamashita K, 2008, MOL CANCER RES, V6, P31, DOI 10.1158/1541-7786.MCR-07-0213; Zhou XY, 2015, STEM CELL REP, V5, P125, DOI 10.1016/j.stemcr.2015.05.008	41	8	8	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 9	2020	39	28					5112	5123		10.1038/s41388-020-1340-2	http://dx.doi.org/10.1038/s41388-020-1340-2			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MH4RK	32533098				2022-12-26	WOS:000546718100003
J	Yamazaki, A; Nakamura, T; Miyabe-Nishiwaki, T; Hirata, A; Inoue, R; Kobayashi, K; Miyazaki, Y; Hamasaki, Y; Ishigami, A; Nagata, N; Kaneko, A; Koizumi, M; Ohta, H; Okano, HJ; Murata, T				Yamazaki, Arisa; Nakamura, Tatsuro; Miyabe-Nishiwaki, Takako; Hirata, Akihiro; Inoue, Rikako; Kobayashi, Koji; Miyazaki, Yusuke; Hamasaki, Yuta; Ishigami, Akiyo; Nagata, Nanae; Kaneko, Akihisa; Koizumi, Makoto; Ohta, Hiroki; Okano, Hirotaka James; Murata, Takahisa			The profile of lipid metabolites in urine of marmoset wasting syndrome	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ISOPROSTANE PATHWAY; PROSTAGLANDINS; INFLAMMATION; RESOLVINS; COLITIS; WEIGHT	Marmoset wasting syndrome (MWS) is clinically characterized by progressive weight loss. Although morbidity and mortality of MWS are relatively high in captive marmosets, its causes remain unknown. Lipid mediators are bioactive metabolites which are produced from polyunsaturated fatty acids, such as arachidonic acid (AA) and eicosapentaenoic acid. These lipid metabolites regulate a wide range of inflammatory responses and they are excreted into the urine. As urinary lipid profiles reflect systemic inflammatory conditions, we comprehensively measured the levels of 141 types of lipid metabolites in the urines obtained from healthy common marmoset (Callithrix jacchus) (N = 7) or marmosets with MWS (N = 7). We found that 41 types of metabolites were detected in all urine samples of both groups. Among them, AA-derived metabolites accounted for 63% (26/41 types) of all detected metabolites. Notably, the levels of AA-derived prostaglandin (PG) E-2, PGF(2 alpha), thromboxane (TX) B(2)and F-2-isoprostanes significantly increased in the urine samples of marmosets with MWS. In this study, we found some urinary lipid metabolites which may be involved in the development of MWS. Although the cause of MWS remains unclear, our findings may provide some insight into understanding the mechanisms of development of MWS.	[Yamazaki, Arisa; Nakamura, Tatsuro; Inoue, Rikako; Kobayashi, Koji; Miyazaki, Yusuke; Hamasaki, Yuta; Nagata, Nanae; Murata, Takahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan; [Miyabe-Nishiwaki, Takako; Ishigami, Akiyo; Kaneko, Akihisa] Kyoto Univ, Dept Primate Res Inst, Inuyama, Aichi, Japan; [Hirata, Akihiro] Gifu Univ, Dept Anim Expt, Life Sci Res Ctr, Gifu, Japan; [Koizumi, Makoto] Jikei Univ, Dept Lab Anim Facil, Sch Med, Tokyo, Japan; [Ohta, Hiroki; Okano, Hirotaka James] Jikei Univ, Dept Regenerat Med, Sch Med, Tokyo, Japan	University of Tokyo; Kyoto University; Gifu University; Jikei University; Jikei University	Murata, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan.	amurata@mail.ecc.u-tokyo.ac.jp		Murata, Takahisa/0000-0002-3328-0796; Koizumi, Makoto/0000-0002-4662-0382; Okano, Hirotaka James/0000-0003-4611-7098	Cooperative Research Program of Primate Research Institute, Kyoto University; Japan Society for the Promotion of Science; Takeda Science Foundation; Nipponham Foundation; Hoyu Science Foundation; Futaba Foundation	Cooperative Research Program of Primate Research Institute, Kyoto University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Nipponham Foundation; Hoyu Science Foundation; Futaba Foundation	This work was supported by the Cooperative Research Program of Primate Research Institute, Kyoto University, the Japan Society for the Promotion of Science, the Takeda Science Foundation, the Nipponham Foundation, Hoyu Science Foundation, and the Futaba Foundation to T.M.	Arai Y, 2016, DIGESTION, V93, P32, DOI 10.1159/000441665; Araujo A, 2000, INT J PRIMATOL, V21, P317, DOI 10.1023/A:1005433722475; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Bennett M, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0035-2016; BRACK M, 1981, VET PATHOL, V18, P45, DOI 10.1177/0300985881018s0605; BUSSE WW, 1998, AM J RESP CRIT CAR S, V157, pS21; Cabana F, 2018, ZOO BIOL, V37, P98, DOI 10.1002/zoo.21398; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; CHALIFOUX LV, 1982, VET PATHOL, V19, P141, DOI 10.1177/030098588201907s11; Chiabrando C, 1999, J BIOL CHEM, V274, P1313, DOI 10.1074/jbc.274.3.1313; Collins D, 2009, BRIT J PHARMACOL, V158, P1771, DOI 10.1111/j.1476-5381.2009.00464.x; Sousa MBC, 2008, PRIMATES, V49, P283, DOI 10.1007/s10329-008-0105-2; Cracowski JL, 2002, AM J GASTROENTEROL, V97, P99; Duvall MG, 2016, EUR J PHARMACOL, V785, P144, DOI 10.1016/j.ejphar.2015.11.001; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Fu JZ, 2016, ANAL BIOANAL CHEM, V408, P6307, DOI 10.1007/s00216-016-9742-2; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gao L, 2003, J BIOL CHEM, V278, P28479, DOI 10.1074/jbc.M303984200; Hirota Y, 2005, J PHARMACOL SCI, V98, P430, DOI 10.1254/jphs.FP0050453; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Logan AC, 1996, TOXICOL PATHOL, V24, P707, DOI 10.1177/019262339602400605; Maeda S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17798-w; Michalak A, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00459; Miles EA, 2012, BRIT J NUTR, V107, pS171, DOI 10.1017/S0007114512001560; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Nakashima E, 2013, J VET MED SCI, V75, P1633, DOI 10.1292/jvms.13-0257; Otovic P, 2015, J MED PRIMATOL, V44, P53, DOI 10.1111/jmp.12159; Prossomariti A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07992-1; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; Schwanke RC, 2016, EUR J PHARMACOL, V785, P156, DOI 10.1016/j.ejphar.2015.08.050; Yin HY, 2007, J BIOL CHEM, V282, P329, DOI 10.1074/jbc.M608975200; Yoshimoto T, 2016, COMPARATIVE MED, V66, P468	32	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234634	10.1371/journal.pone.0234634	http://dx.doi.org/10.1371/journal.pone.0234634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574169	Green Published, gold			2022-12-26	WOS:000544972400007
J	El-Khoury, M; Cabagnols, X; Mosca, M; Vertenoeil, G; Marzac, C; Favale, F; Bluteau, O; Lorre, F; Tisserand, A; Moraes, GR; Ugo, V; Ianotto, JC; Rey, J; Solary, E; Roy, L; Rameau, P; Debili, N; Pasquier, F; Casadevall, N; Marty, C; Constantinescu, SN; Raslova, H; Vainchenker, W; Plo, I				El-Khoury, Mira; Cabagnols, Xenia; Mosca, Matthieu; Vertenoeil, Gaelle; Marzac, Christophe; Favale, Fabrizia; Bluteau, Olivier; Lorre, Florence; Tisserand, Amandine; Moraes, Graciela Rabadan; Ugo, Valerie; Ianotto, Jean-Christophe; Rey, Jerome; Solary, Eric; Roy, Lydia; Rameau, Philippe; Debili, Najet; Pasquier, Florence; Casadevall, Nicole; Marty, Caroline; Constantinescu, Stefan N.; Raslova, Hana; Vainchenker, William; Plo, Isabelle			Different impact of calreticulin mutations on human hematopoiesis in myeloproliferative neoplasms	ONCOGENE			English	Article							ESSENTIAL THROMBOCYTHEMIA; THROMBOPOIETIN RECEPTOR; MUTANT CALRETICULIN; POLYCYTHEMIA-VERA; CALR MUTATIONS; SOMATIC MUTATIONS; JAK2 MUTATION; STEM-CELLS; MPL; MYELOFIBROSIS	Mutations of calreticulin (CALRm) define a subtype of myeloproliferative neoplasms (MPN). We studied the biological and genetic features ofCALR-mutated essential thrombocythemia and myelofibrosis patients. In most cases,CALRmwere found in granulocytes, monocytes, B and NK cells, but also in T cells. However, the type 1CALRmspreads more easily than the type 2CALRmin lymphoid cells. TheCALRmwere also associated with an early clonal dominance at the level of hematopoietic stem and progenitor cells (HSPC) with no significant increase during granulo/monocytic differentiation in most cases. Moreover, we found that half of type 2CALRmpatients harbors some homozygous progenitors. Those patients were associated with a higher clonal dominance during granulo/monocytic differentiation than patients with only heterozygous type 2CALRmprogenitors. When associated mutations were present,CALRmwere the first genetic event suggesting that they are both the initiating and phenotypic event. In blood, type 1CALRmled to a greater increased number of all types of progenitors compared with the type 2CALRm. However, both types ofCALRminduced an increase in megakaryocytic progenitors associated with a ruxolitinib-sensitive independent growth and with a mild constitutive signaling in megakaryocytes. At the transcriptional level, type 1CALRmseems to deregulate more pathways than the type 2CALRmin megakaryocytes. Altogether, our results show thatCALRmmodify both the HSPC and megakaryocyte biology with a stronger effect for type 1 than for type 2CALRm.	[El-Khoury, Mira; Cabagnols, Xenia; Mosca, Matthieu; Bluteau, Olivier; Tisserand, Amandine; Moraes, Graciela Rabadan; Solary, Eric; Debili, Najet; Pasquier, Florence; Casadevall, Nicole; Marty, Caroline; Raslova, Hana; Vainchenker, William; Plo, Isabelle] INSERM, UMR1287, Villejuif, France; [El-Khoury, Mira; Cabagnols, Xenia; Mosca, Matthieu; Bluteau, Olivier; Tisserand, Amandine; Moraes, Graciela Rabadan; Solary, Eric; Rameau, Philippe; Debili, Najet; Pasquier, Florence; Casadevall, Nicole; Marty, Caroline; Raslova, Hana; Vainchenker, William; Plo, Isabelle] Gustave Roussy, Villejuif, France; [El-Khoury, Mira; Cabagnols, Xenia; Tisserand, Amandine; Moraes, Graciela Rabadan] Univ Paris Diderot Paris 7, Gustave Roussy, UMR1287, Villejuif, France; [Mosca, Matthieu; Bluteau, Olivier; Solary, Eric; Debili, Najet; Pasquier, Florence; Marty, Caroline; Raslova, Hana; Vainchenker, William; Plo, Isabelle] Univ Paris XI, UMR1287, Gustave Roussy, Villejuif, France; [Vertenoeil, Gaelle; Constantinescu, Stefan N.] Ludwig Inst Canc Res Brussels, Brussels, Belgium; [Vertenoeil, Gaelle; Constantinescu, Stefan N.] Catholic Univ Louvain, Brussels, Belgium; [Vertenoeil, Gaelle; Constantinescu, Stefan N.] Duve Inst, Brussels, Belgium; [Marzac, Christophe; Solary, Eric; Pasquier, Florence] Gustave Roussy, Dept Hematol, Villejuif, France; [Favale, Fabrizia; Lorre, Florence] Sorbonne Univ, INSERM, Ctr Rech St Antoine, CRSA,UMR S 938, Paris, France; [Ugo, Valerie] CHU Angers, Lab Hematol, Angers, France; [Ianotto, Jean-Christophe] CHRU Brest, Serv Hematol, Brest, France; [Rey, Jerome] Inst Paoli Calmettes, Dept Hematol, Serv Hematol, Marseille, France; [Roy, Lydia] CHU Henri Mondor, Assistance Publ Hop Paris, Serv Hematol, Creteil, France; [Casadevall, Nicole] Hop St Antoine, Assistance Publ Hop Paris, Lab Hematol, Paris, France; [Constantinescu, Stefan N.] WELBIO Walloon Excellence Life Sci & Biotechnol, Brussels, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Universite Catholique Louvain; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Brest; Universite de Bretagne Occidentale; UNICANCER; Institut Paoli-Calmette (IPC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; WELBIO	Vainchenker, W; Plo, I (corresponding author), INSERM, UMR1287, Villejuif, France.; Vainchenker, W; Plo, I (corresponding author), Gustave Roussy, Villejuif, France.; Vainchenker, W; Plo, I (corresponding author), Univ Paris XI, UMR1287, Gustave Roussy, Villejuif, France.	william.vainchenker@gustaveroussy.fr; isabelle.plo@gustaveroussy.fr	Plo, Isabelle/AAT-6742-2021; Plo, Isabelle/C-9056-2017; Raslova, Hana/N-3562-2018	Plo, Isabelle/0000-0002-5915-6910; Raslova, Hana/0000-0001-8846-5299; Bluteau, Olivier/0000-0002-6943-8858; Ugo, Valerie/0000-0002-4678-2138; Solary, Eric/0000-0002-8629-1341; Ianotto, Jean-Christophe/0000-0001-9074-7287	Agence Nationale pour la Recherche; Ligue Nationale contre le Cancer; Fondation Laurette Fugain; INCA PLBIO 2016; grant "Taxe d'apprentissage" Gustave Roussy-2016; INSERM; program "Investissements d'avenir"; Salus Sanguinis Action de recherche concertee (ARC) [16/21-073]; WelBio [F 44/8/5-MCF/UIG-10955]; SFH (Societe francaise d'hematologie); university Paris-Diderot (MENRT grant); Gustave Roussy Foundation; SFH; Fonds Nationals de la Recherche Scientifique, Belgium; Fondation contre le cancer; la Ligue Nationale contre le Cancer	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Fondation Laurette Fugain; INCA PLBIO 2016; grant "Taxe d'apprentissage" Gustave Roussy-2016; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); program "Investissements d'avenir"(French National Research Agency (ANR)); Salus Sanguinis Action de recherche concertee (ARC); WelBio(WELBIO); SFH (Societe francaise d'hematologie); university Paris-Diderot (MENRT grant); Gustave Roussy Foundation; SFH; Fonds Nationals de la Recherche Scientifique, Belgium; Fondation contre le cancer; la Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	This work was funded by grants from the Agence Nationale pour la Recherche (Thrombocytosis, WV), the Ligue Nationale contre le Cancer (equipe labellelisee HR 2016, 2019), the Fondation Laurette Fugain (WV, IP), INCA PLBIO 2016 (IP), by grant "Taxe d'apprentissage" Gustave Roussy-2016 (LS and MEK) and from the INSERM. Labex GR-Ex (IP, WV) is funded by the program "Investissements d'avenir." Support to SNC was from Fondation contre le cancer, Salus Sanguinis Action de recherche concertee (ARC) 16/21-073 and WelBio F 44/8/5-MCF/UIG-10955. MEK was supported by the SFH (Societe francaise d'hematologie), XC and AT were supported by the university Paris-Diderot (MENRT grant), MM by la Ligue Nationale contre le Cancer, Gustave Roussy Foundation and SFH. GRM was a recipient from allocations doctorales sur domaines cibles (ARDoc, Ile-de-France region). GV was supported by a PhD aspirant fellowship of the Fonds Nationals de la Recherche Scientifique, Belgium. We want to thank the platforms of bioinformatic (Khadija M Diop, Guillaume Meurice and Marc Deloger) and flow cytometry and Edwige Leclercq, Marie-Helene Courtier for CALR sizing analysis.	Allen C, 2014, BLOOD, V124, P2091, DOI 10.1182/blood-2014-06-580183; Anand S, 2011, BLOOD, V118, P177, DOI 10.1182/blood-2010-12-327593; Andrikovics H, 2014, HAEMATOLOGICA, V99, P1184, DOI 10.3324/haematol.2014.107482; Araki M, 2016, BLOOD, V127, P1307, DOI 10.1182/blood-2015-09-671172; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Balligand T, 2020, LEUKEMIA, V34, P510, DOI 10.1038/s41375-019-0538-1; Barosi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035631; Cabagnols X, 2015, LEUKEMIA, V29, P249, DOI 10.1038/leu.2014.270; Cabagnols X, 2016, BLOOD, V127, P333, DOI 10.1182/blood-2015-07-661983; Campbell PJ, 2005, LANCET, V366, P1945, DOI 10.1016/S0140-6736(05)67785-9; Chachoua I, 2016, BLOOD, V127, P1325, DOI 10.1182/blood-2015-11-681932; Chagraoui H, 2002, BLOOD, V100, P3495, DOI 10.1182/blood-2002-04-1133; Debili N, 1996, BLOOD, V88, P1284, DOI 10.1182/blood.V88.4.1284.bloodjournal8841284; Delhommeau F, 2007, BLOOD, V109, P71, DOI 10.1182/blood-2006-03-007146; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Di Buduo CA, 2020, BLOOD, V135, P133, DOI 10.1182/blood.2019001103; Dupont S, 2007, BLOOD, V110, P1013, DOI 10.1182/blood-2006-10-054940; Eder-Azanza L, 2014, LEUKEMIA, V28, P2106, DOI 10.1038/leu.2014.190; Elf S, 2018, BLOOD, V131, P782, DOI 10.1182/blood-2017-08-800896; Elf S, 2016, CANCER DISCOV, V6, P368, DOI 10.1158/2159-8290.CD-15-1434; Feenstra JDM, 2016, BLOOD, V127, P325, DOI 10.1182/blood-2015-07-661835; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; James C, 2008, BLOOD, V112, P2429, DOI 10.1182/blood-2008-02-137877; Kent DG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001576; Kjaer L, 2018, LEUKEMIA LYMPHOMA, V59, P973, DOI 10.1080/10428194.2017.1359743; Kjaer L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165336; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Kollmann K, 2017, LEUKEMIA, V31, P934, DOI 10.1038/leu.2016.280; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lau WWY, 2015, BLOOD, V125, P1679, DOI 10.1182/blood-2014-12-618074; Li J, 2018, BLOOD, V131, P649, DOI 10.1182/blood-2017-09-806356; Lundberg P, 2014, BLOOD, V123, P2220, DOI 10.1182/blood-2013-11-537167; Marty C, 2016, BLOOD, V127, P1317, DOI 10.1182/blood-2015-11-679571; Mondet J, 2015, HAEMATOLOGICA, V100, DOI 10.3324/haematol.2014.118927; Nam AS, 2019, NATURE, V571, P355, DOI 10.1038/s41586-019-1367-0; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Ortmann CA, 2015, NEW ENGL J MED, V372, P601, DOI 10.1056/NEJMoa1412098; Passamonti F, 2010, LEUKEMIA, V24, P1574, DOI 10.1038/leu.2010.148; Pietra D, 2016, LEUKEMIA, V30, P431, DOI 10.1038/leu.2015.277; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Pronier E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122703; Rodriguez-Meira A, 2019, MOL CELL, V73, P1292, DOI 10.1016/j.molcel.2019.01.009; Rotunno G, 2014, BLOOD, V123, P1552, DOI 10.1182/blood-2013-11-538983; Rumi E, 2014, BLOOD, V123, P1544, DOI 10.1182/blood-2013-11-539098; Rumi E, 2013, BLOOD, V121, P4388, DOI 10.1182/blood-2013-02-486050; Saint-Martin C, 2009, BLOOD, V114, P1628, DOI 10.1182/blood-2009-01-197525; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Scott LM, 2006, BLOOD, V108, P2435, DOI 10.1182/blood-2006-04-018259; Shide K, 2017, LEUKEMIA, V31, P1136, DOI 10.1038/leu.2016.308; Tefferi A, 2014, LEUKEMIA, V28, P1568, DOI 10.1038/leu.2014.83; Tefferi A, 2014, LEUKEMIA, V28, P1407, DOI 10.1038/leu.2014.35; Tefferi A, 2014, AM J HEMATOL, V89, pE121, DOI 10.1002/ajh.23743; Vainchenker W, 2011, BLOOD, V118, P1723, DOI 10.1182/blood-2011-02-292102	54	6	6	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 30	2020	39	31					5323	5337		10.1038/s41388-020-1368-3	http://dx.doi.org/10.1038/s41388-020-1368-3		JUN 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MT1TS	32572159	Green Published			2022-12-26	WOS:000542723000001
J	Algredo-Badillo, I; Conde-Mones, JJ; Hernandez-Gracidas, CA; Morin-Castillo, MM; Oliveros-Oliveros, JJ; Feregrino-Uribe, C				Algredo-Badillo, Ignacio; Julio Conde-Mones, Jose; Arturo Hernandez-Gracidas, Carlos; Monserrat Morin-Castillo, Maria; Jacobo Oliveros-Oliveros, Jose; Feregrino-Uribe, Claudia			An FPGA-based analysis of trade-offs in the presence of ill-conditioning and different precision levels in computations	PLOS ONE			English	Article								Several areas, such as physical and health sciences, require the use of matrices as fundamental tools for solving various problems. Matrices are used in real-life contexts, such as control, automation, and optimization, wherein results are expected to improve with increase of computational precision. However, special attention should be paid to ill-conditioned matrices, which can produce unstable systems; an inadequate handling of precision might worsen results since the solution found for data with errors might be too far from the one for data without errors besides increasing other costs in hardware resources and critical paths. In this paper, we make a wake-up call, using 2 x 2 matrices to show how ill-conditioning and precision can affect system design (resources, cost, etc.). We first demonstrate some examples of real-life problems where ill-conditioning is present in matrices obtained from the discretization of the operational equations (ill-posed in the sense of Hadamard) that model these problems. If these matrices are not handled appropriately (i.e., if ill-conditioning is not considered), large errors can result in the computed solutions to the systems of equations in the presence of errors. Furthermore, we illustrate the generated effect in the calculation of the inverse of an ill-conditioned matrix when its elements are approximated by truncation. We present two case studies to illustrate the effects on calculation errors caused by increasing or reducing precision tosdigits. To illustrate the costs, we implemented the adjoint matrix inversion algorithm on different field-programmable gate arrays (FPGAs), namely,Spartan-7,Artix-7,Kintex-7, andVirtex-7, using the full-unrolling hardware technique. The implemented architecture is useful for analyzing trade-offs when precision is increased; this also helps analyze performance, efficiency, and energy consumption. By means of a detailed description of the trade-offs among these metrics, concerning precision and ill-conditioning, we conclude that the need for resources seems to grow not linearly when precision is increased. We also conclude that, if error is to be reduced below a certain threshold, it is necessary to determine an optimal precision point. Otherwise, the system becomes more sensitive to measurement errors and a better alternative would be to choose precision carefully, and/or to apply regularization or preconditioning methods, which would also reduce the resources required.	[Algredo-Badillo, Ignacio] CONACYT INAOE, Comp Sci Dept, Puebla, Mexico; [Julio Conde-Mones, Jose; Jacobo Oliveros-Oliveros, Jose] BUAP, Phys Math Sci Fac, Puebla, Mexico; [Arturo Hernandez-Gracidas, Carlos] CONACYT BUAP, Phys Math Sci Fac, Puebla, Mexico; [Monserrat Morin-Castillo, Maria] BUAP, Elect Sci Fac, Puebla, Mexico; [Feregrino-Uribe, Claudia] INAOE, Comp Sci Dept, Puebla, Mexico	Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla; Instituto Nacional de Astrofisica, Optica y Electronica	Conde-Mones, JJ (corresponding author), BUAP, Phys Math Sci Fac, Puebla, Mexico.; Hernandez-Gracidas, CA (corresponding author), CONACYT BUAP, Phys Math Sci Fac, Puebla, Mexico.; Morin-Castillo, MM (corresponding author), BUAP, Elect Sci Fac, Puebla, Mexico.	juliocondem@hotmail.com; carloshg@fcfm.buap.mx; maria.morin@correo.buap.mx	Algredo-Badillo, Ignacio/HDN-8875-2022; Feregrino, Claudia/AAW-2607-2021	Oliveros Oliveros, Jacobo/0000-0002-1715-3631; Algredo Badillo, Ignacio/0000-0002-4748-3500; Hernandez-Gracidas, Carlos/0000-0003-0267-6306; Conde Mones, Jose Julio/0000-0002-3686-7031	Meritorious Autonomous University of Puebla (BUAP) [VIEP-00174]; National Council of Science and Technology (CONACYT) [882, 278]	Meritorious Autonomous University of Puebla (BUAP); National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	J.J.O. received financial support from the Meritorious Autonomous University of Puebla (BUAP), through project VIEP-00174 (Web page: https://www.buap.mx/).I.A.and C.A.H. are commissioned to their respective institutions through the National Council of Science and Technology (CONACYT) Research Fellows program, by means of projects 882 and 278, respectively (Web page: https://www.conacyt.gob.mx/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A F, 2001, REV MEX FIS, V77, P162; [Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; [Anonymous], 2002, FRONTIERS APPL MATH; [Anonymous], 2012, P 8 SO C PROGR LOG, P1; [Anonymous], 2002, SPRINGER SERIES OPTI; [Anonymous], 2014, PLOS ONE, V9, P1, DOI [10.1371/journal.pone.0109970, DOI 10.1371/JOURNAL.PONE.0109970, DOI 10.1371/J0URNAL.P0NE.0109970]; beda A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0127296; Defense P. M., 1992, US GAO REPORTS; DIRAC PAM, 1953, PHYSICA, V19, P888, DOI 10.1016/S0031-8914(53)80099-6; Dmytro F, 2008, KARLSRUHE T BIOMEDIC, V4; FEYNMAN RP, 1963, ANN PHYS-NEW YORK, V24, P118, DOI 10.1016/0003-4916(63)90068-X; GUSTAFSSON P., 2012, PLOS ONE, V7, P1; Irturk A, 2009, TECHNICAL REPORT; Kalinin A, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00058; Karkooti M, 2005, 2005 39TH ASILOMAR CONFERENCE ON SIGNALS, SYSTEMS AND COMPUTERS, VOLS 1 AND 2, P1625; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171394; Kirsch A, 2011, INTRO MATH THEORY IN; Kumar GA, 2014, 2014 INTERNATIONAL CONFERENCE ON CONTROL, INSTRUMENTATION, COMMUNICATION AND COMPUTATIONAL TECHNOLOGIES (ICCICCT), P87, DOI 10.1109/ICCICCT.2014.6992935; Kushida N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122331; Mones JJC, 2017, NUMERICAL METHODS PA; Castillo MMM, 2019, ADV DIFFER EQU CONTR, V20, P53, DOI 10.17654/DE020010053; Morin-Castillo M., 2019, REV MEX ING BIOMED, V40, P1; Oliveros J., 2013, FAR E J APPL MATH, V77, P1; Ruan M, 2017, SCALABLE FLOATING PO; Tayyib M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0225397	25	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234293	10.1371/journal.pone.0234293	http://dx.doi.org/10.1371/journal.pone.0234293			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559235	Green Published, gold			2022-12-26	WOS:000543261600039
J	Chien, LC				Chien, Li-Chu			A rank-based normalization method with the fully adjusted full-stage procedure in genetic association studies	PLOS ONE			English	Article							BODY-MASS INDEX; RARE; LOCI; TRANSFORMATIONS; METAANALYSIS; FAMILY	In the area of genetic epidemiology, studies of the genotype-phenotype associations have made significant contributions to human complicated trait genetics. These studies depend on specialized statistical methods for uncover the association between traits and genetic variants, both common and rare variants. Often, in analyzing such studies, potentially confounding factors, such as social and environmental conditions, are required to be involved. Multiple linear regression is the most widely used type of regression analysis when the outcome of interest is quantitative traits. Many statistical tests for identifying genotype-phenotype associations using linear regression rely on the assumption that the traits (or the residuals) of the regression follow a normal distribution. In genomic research, the rank-based inverse normal transformation (INT) is one of the most popular approaches to reach normally distributed traits (or normally distributed residuals). Many researchers believe that applying the INT to the non-normality of the traits (or the non-normality of the residuals) is required for valid inference, because the phenotypic (or residual) outliers and non-normality have the significant influence on both the type I error rate control and statistical power, especially under the situation in rare-variant association testing procedures. Here we propose a test for exploring the association of the rare variant with the quantitative trait by using a fully adjusted full-stage INT. Using simulations we show that the fully adjusted full-stage INT is more appropriate than the existing INT methods, such as the fully adjusted two-stage INT and the INT-based omnibus test, in testing genotype-phenotype associations with rare variants, especially when genotypes are uncorrelated with covariates. The fully adjusted full-stage INT retains the advantages of the fully adjusted two-stage INT and ameliorates the problems of the fully adjusted two-stage INT for analysis of rare variants under non-normality of the trait. We also present theoretical results on these desirable properties. In addition, the two available methods with non-normal traits, the quantile/median regression method and the Yeo-Johnson power transformation, are also included in simulations for comparison with these desirable properties.	[Chien, Li-Chu] Kaohsiung Med Univ, Ctr Fundamental Sci, Kaohsiung, Taiwan	Kaohsiung Medical University	Chien, LC (corresponding author), Kaohsiung Med Univ, Ctr Fundamental Sci, Kaohsiung, Taiwan.	lcchien@kmu.edu.tw			Ministry of Science and Technology, Taiwan, R.O.C [MOST 107-2118-M-037-002, MOST 108-2118-M-037-001-MY2]	Ministry of Science and Technology, Taiwan, R.O.C(Ministry of Science and Technology, Taiwan)	This work is supported by grants MOST 107-2118-M-037-002 and MOST 108-2118-M-037-001-MY2 of Ministry of Science and Technology, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, DTBI S, V1, P1, DOI DOI 10.36811/RJCSE.2019.110001; [Anonymous], 2018, CANC DISCOV, V8, pOF6; ASHTON GC, 1987, BEHAV GENET, V17, P243, DOI 10.1007/BF01065504; Auer PL, 2016, EUR J HUM GENET, V24, P1188, DOI 10.1038/ejhg.2015.270; Beasley TM, 2009, BEHAV GENET, V39, P580, DOI 10.1007/s10519-009-9281-0; Beyerlein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019057; Bliss CI, 1967, STAT BIOL; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Buzkova P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056976; Che RL, 2012, GENET EPIDEMIOL, V36, P890, DOI 10.1002/gepi.21671; Demissie S, 2011, GENET EPIDEMIOL, V35, P592, DOI 10.1002/gepi.20607; Fox J., 2019, R COMPANION APPL REG, V3; Hoffmann TJ, 2017, NAT GENET, V49, P54, DOI 10.1038/ng.3715; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Koenker R., 2019, QUANTILE REGRESSION; Kozlitina J, 2015, STAT APPL GENET MOL, V14, P443, DOI 10.1515/sagmb-2014-0050; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Lee SS, 2017, SNP SET SEQUENCE KER, DOI [10.1002/gepi.22016, DOI 10.1002/GEPI.22016]; McCaw ZR, 2019, RANK NORMAL TRANSFOR; Nascimento M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190303; Pain O, 2018, EUR J HUM GENET, V26, P1194, DOI 10.1038/s41431-018-0159-6; Peng Bo, 2007, BMC Proc, V1 Suppl 1, pS156; Quinn TP, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz107; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Sofer T, 2019, GENET EPIDEMIOL, V43, P263, DOI 10.1002/gepi.22188; Tajuddin SM, 2016, AM J HUM GENET, V99, P22, DOI 10.1016/j.ajhg.2016.05.003; Tang ZZ, 2015, AM J HUM GENET, V97, P35, DOI 10.1016/j.ajhg.2015.05.001; Wang K, 2002, AM J HUM GENET, V70, P412, DOI 10.1086/338659; Weisberg S, 2001, WORKING PAPER; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu XD, 2002, AM J HUM GENET, V70, P1247, DOI 10.1086/340362; Yeo IK, 2000, BIOMETRIKA, V87, P954, DOI 10.1093/biomet/87.4.954	33	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0233847	10.1371/journal.pone.0233847	http://dx.doi.org/10.1371/journal.pone.0233847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559184	Green Published, gold			2022-12-26	WOS:000543261600049
J	Haider, N; Dutt, P; van de Kooij, B; Ho, JS; Palomero, L; Pujana, MA; Yaffe, M; Stambolic, V				Haider, Nasir; Dutt, Previn; van de Kooij, Bert; Ho, Jason; Palomero, Luis; Pujana, Miquel Angel; Yaffe, Michael; Stambolic, Vuk			NEK10tyrosine phosphorylates p53 and controls its transcriptional activity	ONCOGENE			English	Article							DNA-DAMAGE RESPONSE; CELL-CYCLE ARREST; REPLICATION; STRESS; MULTIPLE; ACETYLATION; SENSITIVITY; EXPRESSION; MORTALITY; PATTERNS	In response to genotoxic stress, multiple kinase signaling cascades are activated, many of them directed towards the tumor suppressor p53, which coordinates the DNA damage response (DDR). Defects in DDR pathways lead to an accumulation of mutations that can promote tumorigenesis. Emerging evidence implicates multiple members of the NimA-related kinase (NEK) family (NEK1,NEK10, andNEK11) in the DDR. Here, we describe a function forNEK10in the regulation of p53 transcriptional activity through tyrosine phosphorylation.NEK10loss increases cellular proliferation by modulating the p53-dependent transcriptional output.NEK10directly phosphorylates p53 on Y327, revealingNEK10'sunexpected substrate specificity. A p53 mutant at this site (Y327F) acts as a hypomorph, causing an attenuated p53-mediated transcriptional response. Consistently,NEK10-deficient cells display heightened sensitivity to DNA-damaging agents. Further, a combinatorial score ofNEK10andTP53-target gene expression is an independent predictor of a favorable outcome in breast cancers.	[Haider, Nasir; Stambolic, Vuk] Univ Toronto, Dept Med Biophys, Princess Margaret Canc Res Tower, Toronto, ON M5G 1L7, Canada; [Haider, Nasir; Dutt, Previn; Ho, Jason; Stambolic, Vuk] Univ Hlth Network, Princess Margaret Canc Ctr, Princess Margaret Canc Res Tower, Toronto, ON M5G 1L7, Canada; [van de Kooij, Bert; Yaffe, Michael] MIT, David H Koch Inst Integrat Canc Res, Ctr Precis Canc Med, Cambridge, MA 02142 USA; [Palomero, Luis; Pujana, Miquel Angel] Bellvitge Inst Biomed Res IDIBELL, Catalan Inst Oncol, ProCURE, Gran Via 199, Barcelona 08908, Spain; [Yaffe, Michael] MIT, Dept Biol & Biol Engn, Cambridge, MA 02142 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Massachusetts Institute of Technology (MIT); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Massachusetts Institute of Technology (MIT)	Stambolic, V (corresponding author), Univ Toronto, Dept Med Biophys, Princess Margaret Canc Res Tower, Toronto, ON M5G 1L7, Canada.; Stambolic, V (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Princess Margaret Canc Res Tower, Toronto, ON M5G 1L7, Canada.	vuks@uhnresearch.ca	Pujana, Miquel Angel/N-3127-2014; Pujana, Miguel Angel/ABF-9055-2021; Palomero, Luis/K-1058-2017	Pujana, Miquel Angel/0000-0003-3222-4044; Pujana, Miguel Angel/0000-0003-3222-4044; Stambolic, Vuk/0000-0001-8853-3239; Palomero, Luis/0000-0002-9144-1017; Yaffe, Michael/0000-0002-9547-3251	Princess Margaret Hospital Foundation; CIHR strategic training fellowship of the EIRR 21st Program	Princess Margaret Hospital Foundation; CIHR strategic training fellowship of the EIRR 21st Program(Canadian Institutes of Health Research (CIHR))	We thank Ryan Dowling and members of the Stambolic group (Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada) for their helpful discussion and advice. We thank Anne van Vlimmeren for technical assistance. This work was supported by the Princess Margaret Hospital Foundation and by the CIHR strategic training fellowship of the EIRR 21st Program (Awarded to NH). The results published here are in whole or part based upon data generated by the TCGA Research Network: https://www.cancer.gov/tcga.	Abeyta A, 2017, CELL CYCLE, V16, P335, DOI 10.1080/15384101.2016.1259038; Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Bai Y, 2012, CANCER RES, V72, P2501, DOI 10.1158/0008-5472.CAN-11-3015; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Burstein MD, 2015, CLIN CANCER RES, V21, P1688, DOI 10.1158/1078-0432.CCR-14-0432; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chao C, 2006, MOL CELL BIOL, V26, P6859, DOI 10.1128/MCB.00062-06; Chen YM, 2008, CELL CYCLE, V7, P3194, DOI 10.4161/cc.7.20.6815; Chen YM, 2011, CELL CYCLE, V10, P655, DOI 10.4161/cc.10.4.14814; Choi HJC, 2013, MOL CELL, V51, P423, DOI 10.1016/j.molcel.2013.08.006; Chong LT, 2006, J MOL BIOL, V357, P1039, DOI 10.1016/j.jmb.2005.12.083; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; DEFFIE A, 1993, MOL CELL BIOL, V13, P3415, DOI 10.1128/MCB.13.6.3415; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502; Fletcher L, 2004, RADIAT RES, V162, P128, DOI 10.1667/RR3211; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; GAO J, 2013, SCI SIGNAL, V6, ppp11; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hafner A, 2019, NAT REV MOL CELL BIO, V20, P199, DOI 10.1038/s41580-019-0110-x; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Huang YF, 2014, ONCOTARGET, V5, P5808, DOI 10.18632/oncotarget.2199; HUDSON JM, 1995, DNA CELL BIOL, V14, P759, DOI 10.1089/dna.1995.14.759; Jee HJ, 2010, CELL CYCLE, V9, P4703, DOI 10.4161/cc.9.23.14059; Jin SQ, 2002, ONCOGENE, V21, P8696, DOI 10.1038/sj.onc.1206034; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; Kawaguchi T, 2005, ONCOGENE, V24, P6976, DOI 10.1038/sj.onc.1208839; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Kumari R, 2014, MOL CELL ONCOL, V1; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lee MY, 2008, CELL CYCLE, V7, P2705, DOI 10.4161/cc.7.17.6551; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Liu L, 1999, MOL CELL BIOL, V19, P1202; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Malkin D., 2011, GENES CANC, V2, P475, DOI DOI 10.1177/1947601911413466; McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Melixetian M, 2009, NAT CELL BIOL, V11, P1247, DOI 10.1038/ncb1969; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Mi J, 2007, CANCER RES, V67, P1082, DOI 10.1158/0008-5472.CAN-06-3071; Moniz L, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-18; Moniz LS, 2011, MOL CELL BIOL, V31, P30, DOI 10.1128/MCB.00648-10; Moniz LS, 2010, CHARACTERIZATION NIM; Noguchi K, 2002, J BIOL CHEM, V277, P39655, DOI 10.1074/jbc.M204599200; Pappas K, 2017, MOL CANCER RES, V15, P1051, DOI 10.1158/1541-7786.MCR-17-0089; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sabir SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140975; Salem H, 2010, ONCOGENE, V29, P4046, DOI 10.1038/onc.2010.162; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Smith SC, 2014, NUCLEIC ACIDS RES, V42, P11517, DOI 10.1093/nar/gku840; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tsai CF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7622; Tutt A, 2018, NAT MED, V24, P628, DOI 10.1038/s41591-018-0009-7; van de Kooij B, 2019, ELIFE, V8, DOI 10.7554/eLife.44635; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Yakovlev VA, 2010, BIOCHEMISTRY-US, V49, P5331, DOI 10.1021/bi100564w	70	7	8	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 23	2020	39	30					5252	5266		10.1038/s41388-020-1361-x	http://dx.doi.org/10.1038/s41388-020-1361-x		JUN 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MO5BV	32561851	Green Submitted			2022-12-26	WOS:000541308400003
J	Toda, Y; Wakatsuki, H; Aoike, T; Kajiya-Kanegae, H; Yamasaki, M; Yoshioka, T; Ebana, K; Hayashi, T; Nakagawa, H; Hasegawa, T; Iwata, H				Toda, Yusuke; Wakatsuki, Hitomi; Aoike, Toru; Kajiya-Kanegae, Hiromi; Yamasaki, Masanori; Yoshioka, Takuma; Ebana, Kaworu; Hayashi, Takeshi; Nakagawa, Hiroshi; Hasegawa, Toshihiro; Iwata, Hiroyoshi			Predicting biomass of rice with intermediate traits: Modeling method combining crop growth models and genomic prediction models	PLOS ONE			English	Article							LEAF-AREA INDEX; GENETIC DISSECTION; PHOTOPERIOD SENSITIVITY; SELECTION METHODS; NATURAL VARIATION; WIDE PREDICTION; FLOWERING TIME; PEDIGREE; YIELD; TEMPERATURE	Genomic prediction (GP) is expected to become a powerful technology for accelerating the genetic improvement of complex crop traits. Several GP models have been proposed to enhance their applications in plant breeding, including environmental effects and genotype-by-environment interactions (GxE). In this study, we proposed a two-step model for plant biomass prediction wherein environmental information and growth-related traits were considered. First, the growth-related traits were predicted by GP. Second, the biomass was predicted from the GP-predicted values and environmental data using machine learning or crop growth modeling. We applied the model to a 2-year-old field trial dataset of recombinant inbred lines of japonica rice and evaluated the prediction accuracy with training and testing data by cross-validation performed over two years. Therefore, the proposed model achieved an equivalent or a higher correlation between the observed and predicted values (0.53 and 0.65 for each year, respectively) than the model in which biomass was directly predicted by GP (0.40 and 0.65 for each year, respectively). This result indicated that including growth-related traits enhanced accuracy of biomass prediction. Our findings are expected to contribute to the spread of the use of GP in crop breeding by enabling more precise prediction of environmental effects on crop traits.	[Toda, Yusuke; Aoike, Toru; Iwata, Hiroyoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan; [Wakatsuki, Hitomi] Natl Agr & Food Res Org NARO, Inst Agroenvironm Sci, Ibaraki, Japan; [Kajiya-Kanegae, Hiromi; Nakagawa, Hiroshi] NARO, Res Ctr Agr Informat Technol, Ibaraki, Japan; [Yamasaki, Masanori; Yoshioka, Takuma] Kobe Univ, Food Resources Educ & Res Ctr, Grad Sch Agr Sci, Kobe, Hyogo, Japan; [Ebana, Kaworu] NARO, Genet Resources Ctr, Ibaraki, Japan; [Hayashi, Takeshi] NARO, Inst Crop Sci, Ibaraki, Japan; [Hasegawa, Toshihiro] NARO, Tohoku Agr Res Ctr, Morioka, Iwate, Japan	University of Tokyo; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; Kobe University; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Iwata, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan.	aiwata@mail.ecc.u-tokyo.ac.jp	Kanegae, Hiromi/AFS-0023-2022	Kanegae, Hiromi/0000-0002-5719-7559; Toda, Yusuke/0000-0002-9462-6412; Wakatsuki, Hitomi/0000-0002-9861-5921	Japan Society for the Promotion of Science, KAKENHI [JP25252002, JP16H0458]; Japan Science and Technology Agency, CREST [JPMJCR16O2]	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	Author HI received funding from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/index.html), KAKENHI, grants JP25252002 and JP16H0458. Author HI received funding from the Japan Science and Technology Agency (https://www.jst.go.jp), CREST, grant JPMJCR16O2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asoro FG, 2013, CROP SCI, V53, P1894, DOI 10.2135/cropsci2012.09.0526; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Burgueno J, 2012, CROP SCI, V52, P707, DOI 10.2135/cropsci2011.06.0299; Bustos-Korts D., 2017, CROP SYSTEMS BIOL, P55; Cabrera-Bosquet L, 2012, J INTEGR PLANT BIOL, V54, P312, DOI 10.1111/j.1744-7909.2012.01116.x; Calus MPL, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-26; Cooper M, 2016, CROP SCI, V56, P2141, DOI 10.2135/cropsci2015.08.0512; Corcoles JI, 2013, BIOSYST ENG, V115, P31, DOI 10.1016/j.biosystemseng.2013.02.002; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; Duan SB, 2014, INT J APPL EARTH OBS, V26, P12, DOI 10.1016/j.jag.2013.05.007; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garcia-Ruiz A, 2016, P NATL ACAD SCI USA, V113, pE3995, DOI 10.1073/pnas.1519061113; Gonzalez-Recio O, 2014, LIVEST SCI, V166, P217, DOI 10.1016/j.livsci.2014.05.036; Grenier C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136594; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Heslot N, 2014, THEOR APPL GENET, V127, P463, DOI 10.1007/s00122-013-2231-5; Holzworth DP, 2014, ENVIRON MODELL SOFTW, V62, P327, DOI 10.1016/j.envsoft.2014.07.009; Hori K, 2013, PLANT J, V76, P36, DOI 10.1111/tpj.12268; Horie T., 1987, Southeast Asian Studies, V25, P62; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Iizumi T, 2009, AGR FOREST METEOROL, V149, P333, DOI 10.1016/j.agrformet.2008.08.015; Jahn CE, 2011, PLANT PHYSIOL, V155, P157, DOI 10.1104/pp.110.165654; Jarquin D, 2014, THEOR APPL GENET, V127, P595, DOI 10.1007/s00122-013-2243-1; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Kang Manjit S., 2002, P221, DOI 10.1079/9780851996011.0221; Khush GS, 2013, PLANT BREEDING, V132, P433, DOI 10.1111/pbr.1991; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Matsubara K, 2012, PLANT CELL PHYSIOL, V53, P709, DOI 10.1093/pcp/pcs028; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-2; Montes JM, 2011, FIELD CROP RES, V121, P268, DOI 10.1016/j.fcr.2010.12.017; Moser G, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-56; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagasaki H, 2010, BREEDING SCI, V60, P648, DOI 10.1270/jsbbs.60.648; Nakagawa H, 2005, THEOR APPL GENET, V110, P778, DOI 10.1007/s00122-004-1905-4; Okada S, 2017, THEOR APPL GENET, V130, P2567, DOI 10.1007/s00122-017-2977-2; Onogi A, 2016, THEOR APPL GENET, V129, P805, DOI 10.1007/s00122-016-2667-5; Onogi A, 2015, THEOR APPL GENET, V128, P41, DOI 10.1007/s00122-014-2411-y; Oraby H, 2007, TRANSGENIC RES, V16, P739, DOI 10.1007/s11248-006-9064-9; PINNSCHMIDT HO, 1995, AGR SYST, V48, P193, DOI 10.1016/0308-521X(94)00012-G; R Core Team, R LANG ENV STAT COMP; Ramirez-Villegas J, 2015, J EXP BOT, V66, P3451, DOI 10.1093/jxb/erv014; Rutkoski J, 2015, PLANT GENOME-US, V8, DOI [10.3835/plantgenome2014.09.0046, 10.3835/plantgenome2014.10.0074]; Rutkoski J, 2016, G3-GENES GENOM GENET, V6, P2799, DOI 10.1534/g3.116.032888; Schulz-Streeck T, 2013, PLANT BREEDING, V132, P532, DOI 10.1111/pbr.12105; Singh U., 1993, USERS GUIDE CERES RI; Soltani A, 2002, MODELING PHYSL CROP; Spindel JE, 2016, HEREDITY, V116, P395, DOI 10.1038/hdy.2015.113; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Sun J, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2016.11.0111; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Technow F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130855; Timsina J, 2006, AGR SYST, V90, P5, DOI 10.1016/j.agsy.2005.11.007; Wang P, 2016, SCI REP, V6, P1, DOI DOI 10.1038/s41598-016-0001-8; Wang X, 2017, HEREDITY, V118, P302, DOI 10.1038/hdy.2016.87; Watanabe K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00421; Xavier A, 2016, THEOR APPL GENET, V129, P1933, DOI 10.1007/s00122-016-2750-y; Xu SH, 2014, P NATL ACAD SCI USA, V111, P12456, DOI 10.1073/pnas.1413750111; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yabe S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00276; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yin XY, 1997, FIELD CROP RES, V51, P189, DOI 10.1016/S0378-4290(96)03456-9; Zhang ZH, 2004, PLANT SCI, V167, P1, DOI 10.1016/j.plantsci.2004.01.007; Zhou Y, 2001, THEOR APPL GENET, V102, P1236, DOI 10.1007/s001220100539	68	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0233951	10.1371/journal.pone.0233951	http://dx.doi.org/10.1371/journal.pone.0233951			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559220	Green Published, gold			2022-12-26	WOS:000543261600022
J	Apidechkul, T; Chomchoei, C; Wongnuch, P; Tamornpark, R; Upala, P; Yeemard, F; Poomiphak, M; Nongkhai, N; Nachaiwieng, W; Sunsern, R				Apidechkul, Tawatchai; Chomchoei, Chalitar; Wongnuch, Pilasinee; Tamornpark, Ratipark; Upala, Panupong; Yeemard, Fartima; Poomiphak, Marisa; Nongkhai, Na; Nachaiwieng, Woottichai; Sunsern, Rachanee			Associations of childhood experiences and methamphetamine use among Akha and Lahu hill tribe youths in northern Thailand: A cross-sectional study	PLOS ONE			English	Article							AMPHETAMINE USE; INITIATION	Background Methamphetamine (MA) is a commonly used substance among youths, particularly those who are living in poor economic conditions with low levels of education and who have had bad childhood experiences. The Akha and Lahu hill tribe youths living on the Thailand-Myanmar-Laos border are identified as the group most vulnerable to MA use in Thailand. The study aimed to estimate the prevalence of MA use and determine its associations with childhood experiences among Akha and Lahu youths aged 15-24 years in northern Thailand. Methods A cross-sectional study was performed. Validated and sealed questionnaires were used to gather information from participants after obtaining the informed consent form. Questionnaires were completed by participants and their parents at home. Logistic regression was used to identify the associations between variables at the alpha = 0.05 level. Results A total of 710 participants participated in the study: 54.2% were Akha, 52.5% were females, 50.6% were aged 15-17 years, and 11.4% did not have Thai identification card (ID) cards. The overall prevalence of MA use at least once among Akha and Lahu youths was 14.5%. After controlling for all potential confounding factors, 8 variables were found to be associated with MA use. Males had a greater chance of MA use than females (AOR = 4.75; 95% CI = 2.27-9.95). Participants aged 21-24 years had a greater chance of MA use than those aged 15-17 years (AOR = 2.51; 95% CI = 1.11-5.71). Those who had a family member who used MA had a greater chance of MA use than those who did not (AOR = 5.04; 95% CI = 1.66-15.32). Those who had been physically assaulted by a family member while aged 0-5 years had a greater chance of MA use than those who had not (AOR = 2.29; 95% CI = 1.02-5.12). Those who had been physically assaulted by a family member while aged 6-14 years had a greater chance of MA use than those who had not (AOR = 3.15; 95% CI = 1.32-7.54). Those who had a close friend who used alcohol had a greater chance of MA use than those who did not (AOR = 2.24; 95% CI = 1.24-4.72). Those who had a highly confident personality had a greater chance of MA use than those who did not (AOR = 2.35; 95% CI = 1.17-4.69), and those who smoked had a greater chance of MA use than those who did not (AOR = 8.27; 95% CI = 4.42-15.46). Conclusions All relevant government and nongovernment agencies together with the Ministry of Public Health Thailand should address MA use among Akha and Lahu youths by properly developing a community health intervention that lowers risk of MA use by addressing family relationships, male youth behaviors, and focused on those individuals with a highly confident personality.	[Apidechkul, Tawatchai; Tamornpark, Ratipark; Upala, Panupong; Yeemard, Fartima] Mae Fah Luang Univ, Ctr Excellence Hill Tribe Hlth Res, Chiang Rai, Thailand; [Apidechkul, Tawatchai; Wongnuch, Pilasinee; Nongkhai, Na; Nachaiwieng, Woottichai; Sunsern, Rachanee] Mae Fah Luang Univ, Sch Hlth Sci, Chiang Rai, Thailand; [Chomchoei, Chalitar] Chulabhorn Royal Acad, Bangkok, Thailand	Mae Fah Luang University; Mae Fah Luang University; Chulabhorn Royal Academy	Apidechkul, T (corresponding author), Mae Fah Luang Univ, Ctr Excellence Hill Tribe Hlth Res, Chiang Rai, Thailand.; Apidechkul, T (corresponding author), Mae Fah Luang Univ, Sch Hlth Sci, Chiang Rai, Thailand.	Tawatchai.api@mfu.ac.th		Apidechkul, Tawatchai/0000-0001-8301-2055	National Research Council of Thailand (NRCT) [29/2561]; Center of Excellence for the Hill Tribe Health Research	National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Center of Excellence for the Hill Tribe Health Research	Funding was provided by the National Research Council of Thailand (NRCT) (Grant No.29/2561). NRCT has no role and involving any step of conducting this research.; We would like to thank the National Research Council of Thailand (NRCT), Mae Fah Luang University (MFU), and The Center of Excellence for the Hill Tribe Health Research in support grant for doing this project. We also would like to extend our thank to community leaders and participants in their cooperation along the process of data collection.	Alcohol and Drug Abuse Institute (ADAI) University of Washington United State, 2018, METH WASH; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; Apidechkul T., 2016, J PUBLIC HLTH DEV, V14, P53; Arya R, 2012, INDIAN J PEDIATR, V79, P1482, DOI 10.1007/s12098-012-0763-3; ASEAN Narcotics Cooperation Center, 2017, ASEAN DRUG MON REP; Bethell C, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2019.3007; Branstetter SA, 2011, J SUBST USE, V16, P150, DOI 10.3109/14659891.2010.519421; Brecht ML, 2013, J DRUG ISSUES, V43, P468, DOI 10.1177/0022042613491098; Cacia R, 2019, METHAMPHETAMINE USE; Chan GCK, 2019, DRUG ALCOHOL DEPEN, V194, P121, DOI 10.1016/j.drugalcdep.2018.08.042; Chomchoei C, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7226-y; Chomsri P, 2017, NURSING J, V44, P172; Chooi WT, 2017, J PSYCHOACTIVE DRUGS, V49, P326, DOI 10.1080/02791072.2017.1342152; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; Department of Mental Health Ministry of Public Health, 2019, BEH YOUTHS THAIL; DiMiceli LE, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2851-1; Ding YY, 2014, DRUG ALCOHOL DEPEN, V142, P295, DOI 10.1016/j.drugalcdep.2014.06.042; Dluzen DE, 2008, GENDER MED, V5, P24, DOI 10.1016/S1550-8579(08)80005-8; Drug Policy Research Center, 2005, EC COST METHAMPHETAM; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Galbraith N, 2015, BJPSYCH BULL, V39, P218, DOI 10.1192/pb.bp.115.050930; Guyll M, 2011, J STUD ALCOHOL DRUGS, V72, P577, DOI 10.15288/jsad.2011.72.577; Lukas H, SE ASIAN HILL TRIBES, P2017; Ma CH, 2020, J FORMOS MED ASSOC, V119, P735, DOI 10.1016/j.jfma.2019.08.026; Mburu G, 2019, INT J DRUG POLICY, V74, P136, DOI 10.1016/j.drugpo.2019.09.010; Nacotics Control Management Center Ministry of Public Health, METH TREATM PROJ; Pedersen W, 2015, DEVIANT BEHAV, V36, P146, DOI 10.1080/01639625.2014.923272; Peltzer K, 2017, CENT ASIAN J GLOB HE, V6, DOI 10.5195/cajgh.2017.288; Princess Maha Chakri Siridhorn Anthropology center, HILL TRIB; Rungnirundorn T, 2017, J ADDICT MED, V11, P19, DOI 10.1097/ADM.0000000000000262; Russell K, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-48; Saw YM, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0147-0; Sege RD, 2017, ACAD PEDIATR, V17, pS79, DOI 10.1016/j.acap.2017.03.007; Sherman SG, 2008, J ADOLESCENT HEALTH, V42, P36, DOI 10.1016/j.jadohealth.2007.07.002; Stoneberg DM, 2018, INT CRIM JUSTICE REV, V28, P136, DOI 10.1177/1057567717730104; Substance Abuse and Mental Health Services Administration, 2015, NAT SURV DRUG US HLT; The Hill Tribe Welfare and Development Center, 2018, HILL TRIB POP HILL T, P23; The Narcotic Control Management Center Ministry of Public Health, TRENDS DRUGS 2019; The Transnational Institute, METH MYANM THAIL SO; Toeam A, 2016, THAI RED CROSS NURSI, V9, P88; UCL Institute of Health Equality, IMP ADV EXP HOM HLTH; United Nations, DEF YOUTH; United Nations Country Team in Thailand, THAIL COMM COUNTR AS; United Nations Office on Drugs and Crime, 2018, WORLD DRUG REP; Watt MH, 2014, INT J DRUG POLICY, V25, P219, DOI 10.1016/j.drugpo.2013.10.007; Weinberger AH, 2016, PREV MED, V92, P148, DOI 10.1016/j.ypmed.2016.05.011; World Health Organization (WHO), THAIL 2015 GLOB SCH; Zarrouq B, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3143-5; 2012, SURG OBES RELAT DIS, V8	49	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234923	10.1371/journal.pone.0234923	http://dx.doi.org/10.1371/journal.pone.0234923			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555604	Green Published, gold			2022-12-26	WOS:000543273200035
J	Kyaw, KWY; Kyaw, NTT; Kyi, MS; Aye, S; Harries, AD; Kumar, AMV; Oo, NL; Satyanarayana, S; Aung, ST				Kyaw, Khine Wut Yee; Nang Thu Thu Kyaw; Kyi, Myo Su; Aye, Sandar; Harries, Anthony D.; Kumar, Ajay M., V; Oo, Nay Lynn; Satyanarayana, Srinath; Si Thu Aung			HIV testing uptake and HIV positivity among presumptive tuberculosis patients in Mandalay, Myanmar, 2014-2017	PLOS ONE			English	Article							SUSPECTS; TB; CARE	Introduction The World Health Organization's framework for TB/HIV collaborative activities recommends provider-initiated HIV testing and counselling (PITC) of patients with presumptive TB. In Myanmar, PITC among presumptive TB patients was started at the TB outpatient department (TB OPD) in Mandalay in 2014. In this study, we assessed the uptake of PITC among presumptive TB patients and the number needed to screen to find one additional HIV positive case, stratified by demographic and clinical characteristics. Method This was a cross-sectional study using routinely collected data of presumptive TB patients who registered for PITC services at the TB OPD between August 2014 and December 2017 in Mandalay. Result Among 21,989 presumptive TB patients registered, 9,796 (44.5%) had known HIV status at registration and 2,763 (28.2%) were people already living with HIV (PLHIV). Of the remainder, 85.3% (10,401/12,193) were newly tested for HIV. Patients <55 years old, those registered in 2014, 2015 and 2017, those employed and those having a history of TB contact had higher uptakes of HIV testing. Among 10,401 patients tested for HIV, 213 (2.1%) patients were newly diagnosed with HIV and this included 147 (69.0%) who were not diagnosed as having TB. The overall prevalence of HIV (previously known and newly diagnosed) among presumptive TB patients was 14.8% (2,976/20,119). The number needed to screen to find one additional HIV case was 48: this number was lower (i.e., a higher yield) among patients aged 35-44 years and among those who were divorced or separated. Conclusion Uptake of HIV testing among eligible presumptive TB patients was high with four out of five presumptive TB patients being tested for HIV. This strategy detected many additional HIV-positive persons, and this included those who were not diagnosed with TB. We strongly recommend that this strategy be implemented nationwide in Myanmar.	[Kyaw, Khine Wut Yee; Nang Thu Thu Kyaw; Aye, Sandar; Oo, Nay Lynn] Int Union TB & Lung Dis Union, Mandalay, Myanmar; [Kyaw, Khine Wut Yee; Nang Thu Thu Kyaw; Harries, Anthony D.; Kumar, Ajay M., V; Satyanarayana, Srinath] Int Union TB & Lung Dis Union, Paris, France; [Kyi, Myo Su] Natl TB Programme, Dept Publ Hlth, Nay Pyi Taw, Myanmar; [Harries, Anthony D.] London Sch Hyg & Trop Med, London, England; [Kumar, Ajay M., V] Union South East Asia Off, Int Union TB & Lung Dis, New Delhi, India; [Kumar, Ajay M., V] Yenepoya Deemed Be Univ, Yenepoya Med Coll, Mangaluru, India; [Si Thu Aung] Dept Publ Hlth, Dis Control Div, Nay Pyi Taw, Myanmar	University of London; London School of Hygiene & Tropical Medicine; Yenepoya (Deemed to be University)	Kyaw, KWY (corresponding author), Int Union TB & Lung Dis Union, Mandalay, Myanmar.; Kyaw, KWY (corresponding author), Int Union TB & Lung Dis Union, Paris, France.	dr.khinewutyeekyaw2015@gmail.com	Kyaw, Khine Wut Yee/K-4130-2019	Kyaw, Khine Wut Yee/0000-0003-0709-484X; Kyi, Myo Su/0000-0001-6968-5456; Satyanarayana, Srinath/0000-0002-5420-2551	Department of International Development (DFD), UK; National TB Programme (NTP), TB unit (The Union)	Department of International Development (DFD), UK; National TB Programme (NTP), TB unit (The Union)	We gratefully acknowledge the support of Department of International Development (DFD), UK, National TB Programme (NTP), TB unit (The Union) and all the presumptive TB patients participated in this study.	Achanta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041378; Adjei A A, 2006, West Afr J Med, V25, P38; Ayenew A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009702; Department of Population Ministry of Immigration and Population Republic of the Union of Myanmar, 2015, 2014 MYANM POP HOUS; Deribew A, 2010, INT J TUBERC LUNG D, V14, P1442; Dimairo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011849; Dlodlo RA, 2015, PUBLIC HEALTH ACTION, V5, P217, DOI 10.5588/pha.15.0036; Kayigamba FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095459; Kennedy CE, 2013, AIDS BEHAV, V17, P1571, DOI 10.1007/s10461-012-0241-y; Kumar AMV, 2017, J EPIDEMIOL GLOB HEA, V7, P11, DOI 10.1016/j.jegh.2015.12.002; Kumar AMV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156487; MacPherson P, 2011, INT J TUBERC LUNG D, V15, P1390, DOI 10.5588/ijtld.11.0056; Montoy JCC, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6895; Munthali L, 2006, INT J TUBERC LUNG D, V10, P199; Nagai S, 2014, T ROY SOC TROP MED H, V108, P173, DOI 10.1093/trstmh/trt116; Naik B, 2012, J ACQ IMMUN DEF SYND, V59, P72, DOI [10.1097/QAI.0b013e318236bd6f, DOI 10.1097/QAI.0B013E318236BD6F]; National AIDS Programme, 2017, NAT STRAT PLAN HIV A; National AIDS Programme, 2011, GUID CLIN MAN HIV IN; National AIDS Programme, 2014, CLIN MANAGEMENT HIV; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Opollo VS, 2018, INT J TUBERC LUNG D, V22, P1443, DOI 10.5588/ijtld.18.0108; Palanivel C, 2013, PUBLIC HEALTH ACTION, V3, P220, DOI 10.5588/pha.13.0045; Porskrog A, 2011, INT J TUBERC LUNG D, V15, P459, DOI 10.5588/ijtld.10.0353; Rajaram M, 2018, ADV RESPIR MED, V86, P211, DOI 10.5603/ARM.2018.0033; Schatz E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196158; Srikantiah P, 2007, INT J TUBERC LUNG D, V11, P168; Thomas BE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008389; UNAIDS, 2019, GLOB HIV STAT 2018; van Lettow M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141414; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; WHO, 2019, GLOB TUB REP; WHO, 2019, TOB KEY FACTS, P1; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization and Joint United Nations Programme on HIV and AIDS, 2007, GUID PROV IN HIV TES; Yadeta D, 2013, J INFECT PUBLIC HEAL, V6, P222, DOI 10.1016/j.jiph.2013.01.002; Yotebieng Marcel, 2016, Pan Afr Med J, V25, P161, DOI 10.11604/pamj.2016.25.161.8125; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234429	10.1371/journal.pone.0234429	http://dx.doi.org/10.1371/journal.pone.0234429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555731	Green Published, gold			2022-12-26	WOS:000543273200076
J	Langmann, C				Langmann, Caillin			Effect of firearms legislation on suicide and homicide in Canada from 1981 to 2016	PLOS ONE			English	Article							BILL C-17; IMPACT; VIOLENCE; RATES; PREVENTION; CRIME	Canada implemented a series of laws regulating firearms including background and psychological screening, licensing, and training in the years 1991, 1994, and 2001. The effects of this legislation on suicide and homicide rates were examined over the years 1981 to 2016. Models were constructed using difference-in-difference analysis of firearms and non firearms death rates from 1981 to 2016. In addition, negative binomial regression was used to test for an association between rates of suicide by Canadian Province and firearms prevalence, using licensing rates as a proxy for prevalence. No associated benefit from firearms legislation on aggregate rates of male suicide was found. In men aged 45 to 59 an associated shift from firearms suicide after 1991 and 1994 to an increase in hanging resulted in overall rate ratios of 0.994 (95%CI, 0.978,1.010) and 0.993 (95%CI, 0.980,1.005) respectively. In men 60 and older a similar effect was seen after 1991, 1994, and 2001, that resulted in rate ratios of 0.989 (95%CI, 0.971,1.008), 0.994 (95%CI, 0.979,1.010), and 1.010 (95%CI, 0.998,1.022) respectively. In females a similar effect was only seen after 1991, rate ratio 0.983 (95%CI, 0.956,1.010). No beneficial association was found between legislation and female or male homicide rates. There was no association found with firearm prevalence rates per province and provincial suicide rates, but an increased association with suicide rates was found with rates of low income, increased unemployment, and the percentage of aboriginals in the population. In conclusion, firearms legislation had no associated beneficial effect on overall suicide and homicide rates. Prevalence of firearms ownership was not associated with suicide rates. Multifaceted strategies to reduce mortality associated with firearms may be required such as steps to reduce youth gang membership and violence, community-based suicide prevention programs, and outreach to groups for which access to care may be a particular issue, such as Aboriginals.	[Langmann, Caillin] McMaster Univ, Dept Med, Div Emergency Med, Hamilton, ON, Canada	McMaster University	Langmann, C (corresponding author), McMaster Univ, Dept Med, Div Emergency Med, Hamilton, ON, Canada.	caillin.langmann@medportal.ca		Langmann, Caillin/0000-0003-2358-2958				Beattie Sara, 2018, HOMICIDES CANADA 201; Beautrais AL, 1996, AUST NZ J PSYCHIAT, V30, P741, DOI 10.3109/00048679609065040; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bridges FS, 2004, PSYCHOL REP, V94, P819; Caron J, 2008, SUICIDE LIFE-THREAT, V38, P195, DOI 10.1521/suli.2008.38.2.195; Caron Jean, 2004, Arch Suicide Res, V8, P361, DOI 10.1080/13811110490476752; Cheung AH, 2005, CAN J PUBLIC HEALTH, V96, P131, DOI 10.1007/BF03403676; Department of Justice Canada, 2015, FIR ACC DEATHS SUIC; Gagne M, 2010, INJURY PREV, V16, P247, DOI 10.1136/ip.2009.022491; Gilmour S, 2018, AM J PUBLIC HEALTH, V108, P1511, DOI 10.2105/AJPH.2018.304640; Hajizadeh M, 2019, CAN MED ASSOC J, V191, pE325, DOI 10.1503/cmaj.181374; Karp A., 2018, SMALL ARMS SURVEY; Kerr WC, 2017, AM J PREV MED, V52, P469, DOI 10.1016/j.amepre.2016.09.021; Kleck G, 2004, J RES CRIME DELINQ, V41, P3, DOI 10.1177/0022427803256229; Kleck G, 2015, J CRIM JUST, V43, P40, DOI 10.1016/j.jcrimjus.2014.12.002; Knopov A, 2019, AM J PREV MED, V56, P335, DOI 10.1016/j.amepre.2018.10.027; Kral MJ, 2016, CAN J PSYCHIAT, V61, P688, DOI 10.1177/0706743716661329; Langmann C, 2012, J INTERPERS VIOLENCE, V27, P2303, DOI 10.1177/0886260511433515; Lee MJ, 2016, SOCIOL METHOD RES, V45, P134, DOI 10.1177/0049124114566717; Leenaars AA, 2001, J CRIM JUST, V29, P287, DOI 10.1016/S0047-2352(01)00094-0; LESTER D, 1994, PERCEPT MOTOR SKILL, V79, P962, DOI 10.2466/pms.1994.79.2.962; MAUSER GA, 1992, EVALUATION REV, V16, P603, DOI 10.1177/0193841X9201600602; McPhedran S, 2013, VIOLENCE VICTIMS, V28, P875, DOI 10.1891/0886-6708.VV-D-12-00145; Navaneelan T., 2012, HLTH GLANCE SUICIDE; Office of the Auditor General of Canada. Department of Justice-Chapter 10, 2002, DEC 2002 REP AUD GEN, P101, DOI DOI 10.1-10.21; Ohsfeldt R L, 1992, Adv Health Econ Health Serv Res, V13, P65; Owens B, 2019, CAN MED ASSOC J, V191, pE59, DOI 10.1503/cmaj.109-5700; Phillips CD, 2018, AM J PUBLIC HEALTH, V108, P868, DOI 10.2105/AJPH.2018.304462; Santaella-Tenorio J, 2016, EPIDEMIOL REV, V38, P140, DOI 10.1093/epirev/mxv012; Smith-Moncrieffe D, 2013, YOUTH GANG PREVENTIO; Vasiliadis HM, 2015, J MENT HEALTH POLICY, V18, P147	31	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234457	10.1371/journal.pone.0234457	http://dx.doi.org/10.1371/journal.pone.0234457			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555647	Green Published, gold			2022-12-26	WOS:000543273200052
J	Muhlberger, D; Wenkel, M; Papapostolou, G; Mumme, A; Stucker, M; Reich-Schupke, S; Hummel, T				Muehlberger, Dominic; Wenkel, Martin; Papapostolou, Georg; Mumme, Achim; Stuecker, Markus; Reich-Schupke, Stefanie; Hummel, Thomas			Surgical thrombectomy for iliofemoral deep vein thrombosis: Patient outcomes at 8.5 years	PLOS ONE			English	Article							CLINICAL-PRACTICE-GUIDELINES; POSTTHROMBOTIC SYNDROME; VENOUS THROMBOSIS; VASCULAR-SURGERY; HEMODYNAMICS; SOCIETY; LEG	Introduction Deep vein thrombosis (DVT) is a frequent burden and a post-thrombotic syndrome (PTS) can be a serious long-term consequence. Iliofemoral DVT should be associated with severe forms of PTS. Therefore an early thrombus removal has been recommended in specific conditions. The aim of this study was to find out both, the long-term results after surgical thrombectomy of iliofemoral DVT in respect of the development of PTS as well as the venous hemodynamics after surgery concerning venous reflux and venous obstruction. Methods Sixty-seven patients who underwent surgical thrombectomy between the years 2000 and 2014 were included in this study; iliofemoral DVT was present in 52 of these patients. 35 patients could be reinvestigated after a mean follow-up of 8.5 years. CEAP (Clinical-Etiological-Anatomical-Pathophysiological) and Villalta scores were recorded in order to describe and assess PTS. Follow-up examinations included a detailed duplex mapping. Venous hemodynamics were measured by digital photoplethysmography and venous occlusion plethysmography. Results The primary patency rate of the iliofemoral segment was 88% after 8.5 years. 48% of all patients showed reflux in deep vein segments. Mild or moderate PTS occurred in 57% of all patients. Notably, there was no patient with an active ulcer or severe PTS. The mean venous outflow volume of all patients in the treated legs was 66.1 ml/100ml/min and significantly less than in the controlled contralateral non-treated legs (p<0.05). The mean venous refilling time was 16.3 seconds, while the mean value of the non-treated contralateral legs was 25.6 seconds and therefore significantly higher (p<0.05). Conclusion Even though venous hemodynamics are significantly inferior in the treated legs, this study demonstrates excellent patency rates and good clinical outcome after surgical thrombectomy of iliofemoral veins.	[Muehlberger, Dominic; Wenkel, Martin; Papapostolou, Georg; Mumme, Achim; Hummel, Thomas] Ruhr Univ Bochum, St Josef Hosp Bochum, Dept Vasc Surg, Kathol Klinikum Bochum, Bochum, Germany; [Muehlberger, Dominic; Papapostolou, Georg; Mumme, Achim; Stuecker, Markus; Reich-Schupke, Stefanie; Hummel, Thomas] Kathol Klinikum Bochum, Dept Dermatol & Vasc Surg, Vein Ctr, Bochum, Germany; [Stuecker, Markus; Reich-Schupke, Stefanie] Ruhr Univ Bochum, St Josef Hosp Bochum, Dept Dermatol, Kathol Klinikum Bochum, Bochum, Germany; [Wenkel, Martin] Johannes Gutenberg Univ Mainz, Dept Heart Thorac & Vasc Surg, Mainz, Germany; [Reich-Schupke, Stefanie] Privatpraxis Haut & Gefassmed, Recklinghausen, Germany	Ruhr University Bochum; Ruhr University Bochum; Johannes Gutenberg University of Mainz	Muhlberger, D (corresponding author), Ruhr Univ Bochum, St Josef Hosp Bochum, Dept Vasc Surg, Kathol Klinikum Bochum, Bochum, Germany.; Muhlberger, D (corresponding author), Kathol Klinikum Bochum, Dept Dermatol & Vasc Surg, Vein Ctr, Bochum, Germany.	dominic.muehlberger@gmail.com	Mühlberger, Dominic/AAQ-9390-2021; Reich-Schupke, Stefanie/AAJ-2152-2021	Mühlberger, Dominic/0000-0001-9636-5108; Wenkel, Martin/0000-0002-8569-4288				Attigah N, 2012, ZBL CHIR, V137, P83, DOI 10.1055/s-0030-1247421; Baekgaard N, 2019, EUR J VASC ENDOVASC, V57, P755, DOI 10.1016/j.ejvs.2019.03.017; Broholm R, 2011, J VASC SURG, V54, p18S, DOI 10.1016/j.jvs.2011.06.021; Casey ET, 2012, J VASC SURG, V55, P1463, DOI 10.1016/j.jvs.2011.12.082; Comerota AJ, 2019, CIRCULATION, V139, P1162, DOI 10.1161/CIRCULATIONAHA.118.037425; Delis KT, 2004, ANN SURG, V239, P118, DOI 10.1097/01.sla.0000103067.10695.74; Gohel MS, 2007, EUR J VASC ENDOVASC, V33, P742, DOI 10.1016/j.ejvs.2006.11.039; Haenen JH, 1999, J VASC SURG, V29, P1071, DOI 10.1016/S0741-5214(99)70248-X; Holper P, 2010, EUR J VASC ENDOVASC, V39, P349, DOI 10.1016/j.ejvs.2009.09.028; Kahn SR, 2009, J THROMB HAEMOST, V7, P879, DOI 10.1111/j.1538-7836.2009.03294.x; Kamphausen M, 2005, ZBL CHIR, V130, P454, DOI 10.1055/s-2005-836874; Lindow C, 2010, EUR J VASC ENDOVASC, V40, P134, DOI 10.1016/j.ejvs.2010.02.023; Meissner MH, 2012, J VASC SURG, V55, P1449, DOI 10.1016/j.jvs.2011.12.081; Muhlberger D, 2018, VASOMED, P2; Neglen P, 2003, J VASC SURG, V38, P879, DOI 10.1016/S0741-5214(03)01020-6; Ockert S, 2018, ANN VASC SURG, V46, P314, DOI 10.1016/j.avsg.2017.07.003; Plate G, 1997, EUR J VASC ENDOVASC, V14, P367, DOI 10.1016/S1078-5884(97)80286-9; Rosfors S, 2014, EUR J VASC ENDOVASC, V47, P81, DOI 10.1016/j.ejvs.2013.10.021; Vedantham S, 2017, NEW ENGL J MED, V377, P2240, DOI 10.1056/NEJMoa1615066; Wagenhauser MU, 2018, PHLEBOLOGY, V33, P600, DOI 10.1177/0268355517736437; Wittens C, 2015, EUR J VASC ENDOVASC, V49, P678, DOI 10.1016/j.ejvs.2015.02.007	21	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0235003	10.1371/journal.pone.0235003	http://dx.doi.org/10.1371/journal.pone.0235003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555683	Green Published, gold			2022-12-26	WOS:000543273200017
J	Silva, AAO; de Oliveira, UD; Vasconcelos, LDM; Foti, L; Leony, LM; Daltro, RT; Leitolis, A; Lima, FWD; Krieger, MA; Zanchin, NIT; Santos, FLN				Oliveira Silva, Angelo Antonio; de Oliveira, Ueriton Dias; Medrado Vasconcelos, Larissa de Carvalho; Foti, Leonardo; Leony, Leonardo Maia; Daltro, Ramona Tavares; Leitolis, Amanda; de Mendonca Lima, Fernanda Washington; Krieger, Marco Aurlio; Tonin Zanchin, Nilson Ivo; Neves Santos, Fred Luciano			Performance ofTreponema pallidumrecombinant proteins in the serological diagnosis of syphilis	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; ANTIGEN ENZYME-IMMUNOASSAY; TREPONEMA-PALLIDUM; RECOMBINANT ANTIGENS; REVERSE ALGORITHM; SERODIAGNOSIS; ANTIBODY; REACTIVITY; INFECTION; TP	Syphilis serodiagnosis is challenging because distinct clinical forms of the infection may influence serological performance and discordant results between tests make clinical decisions difficult. Several recombinantTreponema pallidum-proteins have already been tested for syphilis diagnosis and they are critical to achieve high accuracy in serological testing. Our aim was to assess the varied from performance ofT.pallidum-recombinant proteins TmpA, TpN17 and TpN47 for syphilis serodiagnosis. The proteins were evaluated using sera of 338T.pallidum-negative, 173T.pallidum-positive individuals and 209 sera from individuals infected with unrelated diseases. The diagnostic potential was validated by analysis of ROC curves. In the liquid microarray analyses, the ROC curve varied from 99.0% for TmpA and TpN17 to 100% for TpN47. The sensitivity score yielded values of up to 90% for TpN17, 100% for TpN47 and 80.0% for TmpA. The lowest and highest specificity values were presented by TpN47 (91.9%) and TmpA antigens (100%), respectively. TpN47 showed the highest accuracy score (95.5%) among all the recombinant proteins assayed. For the ELISA, the ROC curve was 97.2%, 91.8% and 81.6% for TpN17, TmpA and TpN47, respectively. TpN17 and TmpA yielded a sensitivity of 69.9%, while TpN47 obtained a value of 53.8%. Specificity was almost 100% for all three proteins. No cross-reaction was observed for TpN17 in the serum samples from non-bacterial infections. Regarding leptospirosis-positive samples, cross-reactivity score was varied from 8.6 to 34.6%. This is most probably due to conservation of the epitopes in these proteins across bacteria. The use of recombinant proteins in immunoassays for syphilis diagnosis was showed provide greater reliability to results of the treponemal assays. Despite the low sensitivity, the proteins showed high diagnostic capacity due to the AUC values found. However, an improvement in sensitivity could be achieved when antigenic mixtures are evaluated.	[Oliveira Silva, Angelo Antonio; Medrado Vasconcelos, Larissa de Carvalho; Leony, Leonardo Maia; Daltro, Ramona Tavares; Neves Santos, Fred Luciano] Oswaldo Cruz Fdn Fiocruz BA, Goncalo Moniz Inst, Salvador, BA, Brazil; [de Oliveira, Ueriton Dias; Leitolis, Amanda] Univ Fed Parana, Curitiba, Parana, Brazil; [Foti, Leonardo; Krieger, Marco Aurlio; Tonin Zanchin, Nilson Ivo] Oswaldo Cruz Fdn Fiocruz PR, Carlos Chagas Inst, Curitiba, Parana, Brazil; [de Mendonca Lima, Fernanda Washington] Univ Fed Bahia, Salvador, BA, Brazil; [Krieger, Marco Aurlio] Mol Biol Inst Parana, Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal da Bahia	Santos, FLN (corresponding author), Oswaldo Cruz Fdn Fiocruz BA, Goncalo Moniz Inst, Salvador, BA, Brazil.	fred.santos@fiocruz.br	SANTOS, Fred/S-2954-2019	SANTOS, Fred/0000-0002-3944-0818; Leony, Leonardo/0000-0003-0681-8332; Leitolis, Amanda/0000-0001-9782-2366; Vasconcelos, Larissa/0000-0003-4818-6732; Krieger, Marco Aurelio/0000-0003-0030-3952; Oliveira, Ueriton/0000-0002-2852-9526; Zanchin, Nilson/0000-0002-1153-0694				[Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2010, MITTELALTER, VXV, P66; Backhouse JL, 2001, DIAGN MICR INFEC DIS, V39, P9, DOI 10.1016/S0732-8893(00)00213-3; Baiao AM, 2014, TRANSFUSION MED, V24, P64, DOI 10.1111/tme.12095; Binnicker MJ, 2012, CURR OPIN INFECT DIS, V25, P79, DOI 10.1097/QCO.0b013e32834e9a3c; Christenson RH, 2018, J APPL LAB MED, V3, P89, DOI 10.1373/jalm.2017.024943; Cooley GM, 2016, J CLIN MICROBIOL, V54, P1321, DOI 10.1128/JCM.02572-15; Dunseth CD, 2017, PRACT LAB MED, V8, P52, DOI 10.1016/j.plabm.2017.04.007; EPSTEIN E, 1952, Calif Med, V77, P149; Fakile YF, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01165-17; Fleury MK, 2017, BIOCHEM MEDICA, V27, P93, DOI 10.11613/BM.2017.012; Fujimura K, 1997, J CLIN LAB ANAL, V11, P315; Gerber A, 1997, IMMUNOBIOLOGY, V196, P535, DOI 10.1016/S0171-2985(97)80070-8; Giacani L, 2014, CLIN MICROBIOL REV, V27, P89, DOI 10.1128/CMR.00070-13; Golkocheva-Markova E, 2008, CLIN MICROBIOL INFEC, V14, P873, DOI 10.1111/j.1469-0691.2008.02051.x; Gomez E, 2010, CLIN VACCINE IMMUNOL, V17, P966, DOI 10.1128/CVI.00086-10; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hoare R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159155; Hook EW, 2017, LANCET, V389, P1550, DOI 10.1016/S0140-6736(16)32411-4; IJSSELMUIDEN OE, 1989, J CLIN MICROBIOL, V27, P152, DOI 10.1128/JCM.27.1.152-157.1989; IJSSELMUIDEN OE, 1989, EUR J CLIN MICROBIOL, V8, P716, DOI 10.1007/BF01963758; Jacobson RH, 1998, REV SCI TECH OIE, V17, P469, DOI 10.20506/rst.17.2.1119; Jiang CH, 2013, CLIN VACCINE IMMUNOL, V20, P1563, DOI 10.1128/CVI.00122-13; Keasey SL, 2009, MOL CELL PROTEOMICS, V8, P924, DOI 10.1074/mcp.M800213-MCP200; Kuller L, 2005, DIAGN MICR INFEC DIS, V53, P185, DOI 10.1016/j.diagmicrobio.2005.05.012; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1; Liu W, 2019, CLIN CHIM ACTA, V488, P13, DOI 10.1016/j.cca.2018.10.017; Marangoni A, 2013, CLIN VACCINE IMMUNOL, V20, P1084, DOI 10.1128/CVI.00316-13; Mikalova L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015713; Santos FLN, 2017, J CLIN MICROBIOL, V55, P2934, DOI 10.1128/JCM.00851-17; Oh Y, 2008, INT J DERMATOL, V47, P978, DOI 10.1111/j.1365-4632.2008.03617.x; Park IU, 2019, CLIN INFECT DIS, V68, P913, DOI 10.1093/cid/ciy558; Peng J, 2018, CLIN INFECT DIS, V67, P947, DOI 10.1093/cid/ciy198; Rodriguez I, 2002, MEM I OSWALDO CRUZ, V97, P347, DOI 10.1590/S0074-02762002000300012; Rostopira N, 2003, FOLIA MICROBIOL, V48, P549, DOI 10.1007/BF02931339; Rourk AR, 2016, AM J CLIN PATHOL, V146, P572, DOI [10.1093/AJCP/AQW182, 10.1093/ajcp/aqw182]; Sambri V, 2001, CLIN MICROBIOL INFEC, V7, P200, DOI 10.1046/j.1469-0691.2001.00232.x; Sambri V, 2001, CLIN DIAGN LAB IMMUN, V8, P534, DOI 10.1128/CDLI.8.3.534-539.2001; Sanfilippo AM, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00215-18; Sato Neuza Satomi, 1999, Revista do Instituto de Medicina Tropical de Sao Paulo, V41, P115, DOI 10.1590/S0036-46651999000200009; Smith BC, 2013, J CLIN MICROBIOL, V51, P105, DOI 10.1128/JCM.01390-12; Sun AH, 2009, CLIN CHEM LAB MED, V47, P321, DOI 10.1515/CCLM.2009.071; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Totten YR, 2019, ANN LAB MED, V39, P396, DOI 10.3343/alm.2019.39.4.396; Van Voorhis WC, 2003, J CLIN MICROBIOL, V41, P3668, DOI 10.1128/JCM.41.8.3668-3674.2003; WHO, 2012, GLOB INC PREV SEL CU; Xie Y, 2016, LETT APPL MICROBIOL, V62, P336, DOI 10.1111/lam.12554; Xu M, 2016, INT J INFECT DIS, V43, P51, DOI 10.1016/j.ijid.2015.12.013; Young H, 1998, J CLIN MICROBIOL, V36, P913, DOI 10.1128/JCM.36.4.913-917.1998; Yu X, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003303; Zajkowska J., 2014, ANTIB TECHNOL J, V4, P33; Zhou PY, 2009, SEX TRANSM DIS, V36, P216, DOI 10.1097/OLQ.0b013e3181901c79	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234043	10.1371/journal.pone.0234043	http://dx.doi.org/10.1371/journal.pone.0234043			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555593	Green Published, gold			2022-12-26	WOS:000543273200036
J	Shamsaddini, A; Dadkhah, K; Gillevet, PM				Shamsaddini, Amirhossein; Dadkhah, Kimia; Gillevet, Patrick M.			BiomMiner: An advanced exploratory microbiome analysis and visualization pipeline	PLOS ONE			English	Article							STATISTICAL-ANALYSIS; GUT MICROBIOME; DIVERSITY	Current microbiome applications require substantial bioinformatics expertise to execute. As microbiome clinical diagnostics are being developed, there is a critical need to implement computational tools and applications that are user-friendly for the medical community to understand microbiome correlation with the health. To address this need, we have developed BiomMiner (pronounced as "biominer"), an automated pipeline that provides a comprehensive analysis of microbiome data. The pipeline finds taxonomic signatures of microbiome data and compiles actionable clinical report that allows clinicians and biomedical scientists to efficiently perform statistical analysis and data mining on the large microbiome datasets. BiomMiner generates web-enabled visualization of the analysis results and is specifically designed to facilitate the use of microbiome datasets in clinical applications.	[Shamsaddini, Amirhossein; Dadkhah, Kimia; Gillevet, Patrick M.] George Mason Univ, Microbiome Anal Ctr, Manassas, VA 20110 USA	George Mason University	Shamsaddini, A (corresponding author), George Mason Univ, Microbiome Anal Ctr, Manassas, VA 20110 USA.	ashamsad@gmu.edu		Shamsaddini, Amirhossein/0000-0002-7830-304X	Microbiome Analysis Center	Microbiome Analysis Center	This research was supported by Dr. Gillevet's indirect funds at the Microbiome Analysis Center. The funders played no role in the study design, analysis, decision to publish, or preparation of the manuscript. There is no competing interest for any of the authors.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; BERGER WH, 1970, SCIENCE, V168, P1345, DOI 10.1126/science.168.3937.1345; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Buttigieg PL, 2014, FEMS MICROBIOL ECOL, V90, P543, DOI 10.1111/1574-6941.12437; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dadkhah E, 2019, BMJ OPEN GASTROENTER, V6, DOI 10.1136/bmjgast-2019-000297; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; EXCOFFIER L, 1992, GENETICS, V131, P479; Gruning B, 2018, NAT METHODS, V15, P475, DOI 10.1038/s41592-018-0046-7; Jaccard P, 1901, B SOC VAUD SCI NAT, V37, P547, DOI [10.5169/seals.266450, DOI 10.5169/SEALS.266450, DOI 10.5169/SEALS-266450]; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Komanduri S, 2007, CLIN GASTROENTEROL H, V5, P352, DOI 10.1016/j.cgh.2007.01.001; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; LARSEN N, 1993, NUCLEIC ACIDS RES, V21, P3021, DOI 10.1093/nar/21.13.3021; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Meirmans PG, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00066; Nilakanta Haema, 2014, BMC Res Notes, V7, P830, DOI 10.1186/1756-0500-7-830; Plummer E., 2015, J PROTEOM BIOINFORM, V8, P283, DOI [10.4172/jpb.1000381, DOI 10.4172/JPB.1000381]; Schloss PD, 2012, GUT MICROBES, V3, P383, DOI 10.4161/gmic.21008; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; Stewart CN, 1996, J EVOLUTION BIOL, V9, P153, DOI 10.1046/j.1420-9101.1996.9020153.x; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xia YL, 2017, GENES DIS, V4, P138, DOI 10.1016/j.gendis.2017.06.001	35	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234860	10.1371/journal.pone.0234860	http://dx.doi.org/10.1371/journal.pone.0234860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555605	Green Published, gold			2022-12-26	WOS:000543273200083
J	Li, QL; Karim, RM; Cheng, M; Das, M; Chen, LH; Zhang, C; Lawrence, HR; Daughdrill, GW; Schonbrunn, E; Ji, HT; Chen, JD				Li, Qingliang; Karim, Rezaul M.; Cheng, Mo; Das, Mousumi; Chen, Lihong; Zhang, Chen; Lawrence, Harshani R.; Daughdrill, Gary W.; Schonbrunn, Ernst; Ji, Haitao; Chen, Jiandong			Inhibition of p53 DNA binding by a small molecule protects mice from radiation toxicity	ONCOGENE			English	Article							PARADOXICAL ACTIVATION; PROLIFERATING CELLS; INVOLVEMENT; EXPRESSION; STABILITY; PROMOTES; DAMAGE; ALPHA; RAF	Transcription factors are attractive therapeutic targets that are considered non-druggable because they do not have binding sites for small drug-like ligands. We established a cell-free high-throughput screening assay to search for small molecule inhibitors of DNA binding by transcription factors. A screen was performed using p53 as a target, resulting in the identification of NSC194598 that inhibits p53 sequence-specific DNA binding in vitro (IC50 = 180 nm) and in vivo. NSC194598 selectively inhibited DNA binding by p53 and homologs p63/p73, but did not affect E2F1, TCF1, and c-Myc. Treatment of cells with NSC194598 alone paradoxically led to p53 accumulation and modest increase of transcriptional output owing to disruption of the MDM2-negative feedback loop. When p53 was stabilized and activated by irradiation or chemotherapy drug treatment, NSC194598 inhibited p53 DNA binding and induction of target genes. A single dose of NSC194598 increased the survival of mice after irradiation. The results suggest DNA binding by p53 can be targeted using small molecules to reduce acute toxicity to normal tissues by radiation and chemotherapy.	[Li, Qingliang; Das, Mousumi; Chen, Lihong; Chen, Jiandong] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Karim, Rezaul M.; Cheng, Mo; Lawrence, Harshani R.; Schonbrunn, Ernst; Ji, Haitao] H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL USA; [Karim, Rezaul M.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA; [Zhang, Chen] Univ Illinois, High Throughput Screening Facil, Urbana, IL USA; [Daughdrill, Gary W.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Illinois System; University of Illinois Urbana-Champaign; State University System of Florida; University of South Florida	Chen, JD (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA.	Jiandong.chen@moffitt.org	Karim, Rezaul M./H-7930-2016; Ji, Haitao/P-6441-2015	Karim, Rezaul M./0000-0002-0424-127X; Ji, Haitao/0000-0001-5526-4503; Schonbrunn, Ernst/0000-0002-3589-3510	National Institutes of Health [CA141244, CA186917, CA208363, GM115556, R50CA211447]; H. Lee Moffitt Cancer Center & Research Institute [P30-CA076292]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); H. Lee Moffitt Cancer Center & Research Institute	The authors wish to thank the National Cancer Institute Developmental Therapeutics Program for providing key compounds. This work is supported in part by grants from the National Institutes of Health (CA141244, CA186917, CA208363 to J.C. GM115556 to D.G. R50CA211447 to H. R. L.). H. Lee Moffitt Cancer Center & Research Institute is an NCI designated Comprehensive Cancer Center (P30-CA076292).	Berg T, 2011, CURR TOP MICROBIOL, V348, P139, DOI 10.1007/82_2010_90; Bushweller JH, 2019, NAT REV CANCER, V19, P611, DOI 10.1038/s41568-019-0196-7; Carvajal D, 2005, CANCER RES, V65, P1918, DOI 10.1158/0008-5472.CAN-04-3576; Checler F, 2014, PHARMACOL THERAPEUT, V142, P99, DOI 10.1016/j.pharmthera.2013.11.009; CRUMRINE RC, 1994, J CEREBR BLOOD F MET, V14, P887, DOI 10.1038/jcbfm.1994.119; Goh AM, 2015, ONCOTARGET, V6, P17968, DOI 10.18632/oncotarget.4956; Gudkov AV, 2005, BIOCHEM BIOPH RES CO, V331, P726, DOI 10.1016/j.bbrc.2005.03.153; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; He F, 2019, P NATL ACAD SCI USA, V116, P8859, DOI 10.1073/pnas.1903077116; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Hoggard LR, 2015, J AM CHEM SOC, V137, P12249, DOI 10.1021/jacs.5b04988; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Khoo KH, 2009, J MOL BIOL, V393, P161, DOI 10.1016/j.jmb.2009.08.013; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Komarova EA, 2003, J BIOL CHEM, V278, P15465, DOI 10.1074/jbc.C300011200; Lilyestrom W, 2006, GENE DEV, V20, P2373, DOI 10.1101/gad.1456306; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Midgley CA, 1997, ONCOGENE, V15, P1179, DOI 10.1038/sj.onc.1201459; Pant V, 2013, GENE DEV, V27, P1857, DOI 10.1101/gad.227249.113; Pochampally R, 2000, BIOCHEM BIOPH RES CO, V279, P1001, DOI 10.1006/bbrc.2000.4056; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Retzlaff M, 2013, J MOL BIOL, V425, P144, DOI 10.1016/j.jmb.2012.10.015; Ross FA, 2017, CELL CHEM BIOL, V24, P813, DOI 10.1016/j.chembiol.2017.05.021; Segal DJ, 2006, J MOL BIOL, V363, P405, DOI 10.1016/j.jmb.2006.08.016; Shin YJ, 2015, ONCOGENE, V34, P1292, DOI 10.1038/onc.2014.65; Tisato V, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0500-5; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Walton MI, 2005, MOL CANCER THER, V4, P1369, DOI 10.1158/1535-7163.MCT-04-0341; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wassman CD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2361; Wei QQ, 2007, AM J PHYSIOL-RENAL, V293, pF1282, DOI 10.1152/ajprenal.00230.2007; Westphal CH, 1998, CANCER RES, V58, P5637; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zhu JW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58051-1	41	6	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 16	2020	39	29					5187	5200		10.1038/s41388-020-1344-y	http://dx.doi.org/10.1038/s41388-020-1344-y		JUN 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ML6WO	32555331	Green Accepted			2022-12-26	WOS:000545371000002
J	Du, ZW; Holme, P				Du, Zhanwei; Holme, Petter			Coupling the circadian rhythms of population movement and the immune system in infectious disease modeling	PLOS ONE			English	Article								The dynamics of infectious diseases propagating in populations depends both on human interaction patterns, the contagion process and the pathogenesis within hosts. The immune system follows a circadian rhythm and, consequently, the chance of getting infected varies with the time of day an individual is exposed to the pathogen. The movement and interaction of people also follow 24-hour cycles, which couples these two phenomena. We use a stochastic metapopulation model informed by hourly mobility data for two medium-sized Chinese cities. By this setup, we investigate how the epidemic risk depends on the difference of the clocks governing the population movement and the immune systems. In most of the scenarios we test, we observe circadian rhythms would constrain the pace and extent of disease emergence. The three measures (strength, outward transmission and introduction speeds) are highly correlated with each other. For example of the Yushu City, outward transmission speed and introduction speed are correlated with a Pearson's correlation coefficient of 0.83, and the speeds correlate to strength with coefficients of -0.85 and -0.75, respectively (all havep< 0.05), in simulations with no circadian effect andR(0)= 1.5. The relation between the circadian rhythms of the immune system and daily routines in human mobility can affect the pace and extent of infectious disease spreading. Shifting commuting times could mitigate the emergence of outbreaks.	[Du, Zhanwei] Minist Nat Resources, Key Lab Urban Land Resources Monitoring & Simulat, Shenzhen, Peoples R China; [Du, Zhanwei] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Holme, Petter] Tokyo Inst Technol, Inst Innovat Res, Tokyo Tech World Res Hub Initiat WRHI, Yokohama, Kanagawa, Japan	Ministry of Natural Resources of the People's Republic of China; University of Texas System; University of Texas Austin; Tokyo Institute of Technology	Holme, P (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Tokyo Tech World Res Hub Initiat WRHI, Yokohama, Kanagawa, Japan.	holme@cns.pi.titech.ac.jp	Holme, Petter/A-7646-2008; Du, Zhanwei/HGF-3197-2022	Holme, Petter/0000-0003-2156-1096; 	Open Fund of Key Laboratory of Urban Land Resources Monitoring and Simulation, Ministry of Natural Resources [KF-2019-04-034]; NIH [U01 GM087719]; Natural Science Foundation of Jilin Provincial Science and Technology Department [20180101332JC]; National Society Science Foundation of China [16BGL180]; JSPS KAKENHI [JP18H01655]; Sumitomo Foundation	Open Fund of Key Laboratory of Urban Land Resources Monitoring and Simulation, Ministry of Natural Resources; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of Jilin Provincial Science and Technology Department; National Society Science Foundation of China; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sumitomo Foundation	ZD acknowledges the Open Fund of Key Laboratory of Urban Land Resources Monitoring and Simulation, Ministry of Natural Resources (KF-2019-04-034) and the financial support from NIH (U01 GM087719), Natural Science Foundation of Jilin Provincial Science and Technology Department (Grant No. 20180101332JC), and National Society Science Foundation of China (Grant No. 16BGL180). PH was supported by JSPS KAKENHI Grant Number JP18H01655 and by the Grant for Basic Science Research Projects by the Sumitomo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aledavood T, 2018, EPJ DATA SCI, V7, DOI 10.1140/epjds/s13688-018-0174-4; Amini A, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds31; [Anonymous], 2017, J ONCOL PRACT, V13, pe353; Atkinson J, 2009, NATURAL VENTILATION FOR INFECTION CONTROL IN HEALTH-CARE SETTINGS, P1; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Ball F, 2008, MATH BIOSCI, V212, P69, DOI 10.1016/j.mbs.2008.01.001; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bass J, 2016, SCIENCE, V354, P994, DOI 10.1126/science.aah4965; Chaitow L, 2009, J BODYW MOV THER, V13, P295, DOI 10.1016/j.jbmt.2009.07.002; Chuangchun Bureau of Statistics, 2017, CHANGCH STAT YB 2017; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; Cooley P, 2011, J URBAN HEALTH, V88, P982, DOI 10.1007/s11524-011-9603-4; Dalziel BD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0763; Du ZW, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0070-1; Edgar RS, 2016, P NATL ACAD SCI USA, V113, P10085, DOI 10.1073/pnas.1601895113; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Fernstrom A, 2013, J PATHOG, V2013, DOI [10.1155/013/493960, 10.1155/2013/493960]; Fox SJ, 2018, ARXIV180905203; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Geng L, 2009, CITY PLANNING REV, V3, P17; Hanski I, 1999, METAPOPULATION ECOLO; Herrera JL, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004928; Hoen AG, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3720; Jacobs J., 1961, DEATH LIFE GREAT AM; Man K, 2016, SCIENCE, V354, P999, DOI 10.1126/science.aah4966; Mei S, 2015, COMPUT ENVIRON URBAN, V51, P97, DOI 10.1016/j.compenvurbsys.2014.12.002; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; OP026, 2016, J CROHNS COLITIS, V10, pS21; Papa E., 2008, RAILWAY DEV, P337; Scheiermann C, 2018, NAT REV IMMUNOL, V18, P423, DOI 10.1038/s41577-018-0008-4; [王腾 WANG Teng], 2006, [城市规划学刊, Urban Planning Forum], V0, P76; Wesolowski A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02064-4; Yang B, 2016, IEEE T PATTERN ANAL; Zhong C, 2015, J COMPUT SCI-NETH, V9, P125, DOI 10.1016/j.jocs.2015.04.021	34	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234619	10.1371/journal.pone.0234619	http://dx.doi.org/10.1371/journal.pone.0234619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544167	Green Published, Green Submitted, gold			2022-12-26	WOS:000542957200034
J	Herbert, E; Stewart, M; Hutchison, M; Flenniken, AM; Qu, DW; Nutter, LMJ; McKerlie, C; Hobson, L; Kick, B; Lyons, B; Wiegand, JP; Doty, R; Aguilar-Pimentel, JA; Angelis, MHD; Dickinson, M; Seavitt, J; White, JK; Scudamore, CL; Wells, S				Herbert, Eleanor; Stewart, Michelle; Hutchison, Marie; Flenniken, Ann M.; Qu, Dawei; Nutter, Lauryl M. J.; McKerlie, Colin; Hobson, Liane; Kick, Brenda; Lyons, Bonnie; Wiegand, Jean-Paul; Doty, Rosalinda; Aguilar-Pimentel, Juan Antonio; Angelis, Martin Hrabe de; Dickinson, Mary; Seavitt, John; White, Jacqueline K.; Scudamore, Cheryl L.; Wells, Sara			The occurrence of tarsal injuries in male mice of C57BL/6N substrains in multiple international mouse facilities	PLOS ONE			English	Article								Dislocation in hindlimb tarsals are being observed at a low, but persistent frequency in group-housed adult male mice from C57BL/6N substrains. Clinical signs included a sudden onset of mild to severe unilateral or bilateral tarsal abduction, swelling, abnormal hindlimb morphology and lameness. Contraction of digits and gait abnormalities were noted in multiple cases. Radiographical and histological examination revealed caudal dislocation of the calcaneus and partial dislocation of the calcaneoquartal (calcaneus-tarsal bone IV) joint. The detection, frequency, and cause of this pathology in five large mouse production and phenotyping centres (MRC Harwell, UK; The Jackson Laboratory, USA; The Centre for Phenogenomics, Canada; German Mouse Clinic, Germany; Baylor College of Medicine, USA) are discussed.	[Herbert, Eleanor] Royal Vet Coll, Dept Pathobiol & Populat Sci, Hatfield, Herts, England; [Stewart, Michelle; Hutchison, Marie; Hobson, Liane; Scudamore, Cheryl L.; Wells, Sara] MRC Harwell Inst, Mary Lyon Ctr, Didcot, Oxon, England; [Flenniken, Ann M.; Qu, Dawei; Nutter, Lauryl M. J.; McKerlie, Colin; White, Jacqueline K.] Ctr Phenogen, Toronto, ON, Canada; [Flenniken, Ann M.; Qu, Dawei] Sinai Hlth, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Nutter, Lauryl M. J.; McKerlie, Colin] Hosp Sick Children, Toronto, ON, Canada; [Kick, Brenda; Lyons, Bonnie; Wiegand, Jean-Paul; Doty, Rosalinda] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Aguilar-Pimentel, Juan Antonio; Angelis, Martin Hrabe de] Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, Neuherberg, Germany; [Angelis, Martin Hrabe de] Tech Univ Munich, Sch Life Sci Weihenstephan, Freising Weihenstephan, Germany; [Angelis, Martin Hrabe de] German Ctr Diabet Res DZD, Neuherberg, Germany; [Dickinson, Mary; Seavitt, John] Baylor Coll Med, Houston, TX 77030 USA	University of London; University of London Royal Veterinary College; MRC Harwell; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Jackson Laboratory; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Baylor College of Medicine	Wells, S (corresponding author), MRC Harwell Inst, Mary Lyon Ctr, Didcot, Oxon, England.	s.wells@har.mrc.ac.uk	de Angelis, Martin Hrabe/F-5531-2012	de Angelis, Martin Hrabe/0000-0002-7898-2353; Nutter, Lauryl/0000-0001-9619-146X; Herbert, Eleanor/0000-0002-2216-7771; Hobson, Liane/0000-0002-4784-5436	National Institute of Health (USA) [UM1 OD0232221OD023222, UM1HG006348-07S2, UM1 OD023221]; Medical Research Council (UK) [A410]; Federal Ministry of Education and Research (BMBF-Germany) [01KX1012]; European Union [653961]; MRC [MC_UP_1502/1] Funding Source: UKRI	National Institute of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Federal Ministry of Education and Research (BMBF-Germany)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for the IMPC studies at each centre is provided by: National Institute of Health (USA), https://commonfund.nih.gov/, grant UM1HG006348-07S2 (MRC Harwell and Baylor College of Medicine)-JS, MD. Medical Research Council (UK), https://mrc.ukri.org, grant A410 (MRC Harwell)-EH, MS, MH, LH, CLS, SW. National Institute of Health (USA), https://commonfund.nih.gov/, grant UM1 OD023221 (The Centre for Phenogenomics, Toronto)-AMF, DQ, LMJN, CM. National Institute of Health (USA), https://commonfund.nih.gov/, UM1 OD0232221OD023222 (The Jackson Laboratory)-BK, BL, J-PW, RD, JKW. The Federal Ministry of Education and Research (BMBF-Germany), https://www.bmbf.de/en/researchfunding, Infrafrontier grant 01KX1012 (GMC) and European Union Horizon2020: IPAD-MD funding 653961 (German Mouse Clinic), https://ec.europa.eu/programmes/horizon2020/en -JAA-P, MHA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adissu HA, 2015, VET PATHOL, V52, P967, DOI 10.1177/0300985814552108; [Anonymous], INT LAB ANIM RES J; Huang HJ, 2011, BRAIN RES, V1371, P150, DOI 10.1016/j.brainres.2010.11.043; Johnson KR, 1997, HEARING RES, V114, P83, DOI 10.1016/S0378-5955(97)00155-X; Lidster K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51674-z; Mason RM, 2001, OSTEOARTHR CARTILAGE, V9, P85, DOI 10.1053/joca.2000.0363; Meakin LB, 2013, BONE, V54, P113, DOI 10.1016/j.bone.2013.01.029; Miczek KA, 2001, BEHAV BRAIN RES, V125, P167, DOI 10.1016/S0166-4328(01)00298-4; Rogers DC, 2001, NEUROSCI LETT, V306, P89, DOI 10.1016/S0304-3940(01)01885-7; SCHMIDT SY, 1973, J CELL BIOL, V57, P117, DOI 10.1083/jcb.57.1.117; Staines KA, 2017, J CELL PHYSIOL, V232, P3006, DOI 10.1002/jcp.25999; Sundberg JP, 2004, J INVEST DERMATOL, V123, P294, DOI 10.1111/j.0022-202X.2004.23222.x; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4	13	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0230162	10.1371/journal.pone.0230162	http://dx.doi.org/10.1371/journal.pone.0230162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542000	gold, Green Submitted, Green Published			2022-12-26	WOS:000542685100042
J	Xue, YL; Razafsky, D; Hodzic, D; Kefalov, VJ				Xue, Yunlu; Razafsky, David; Hodzic, Didier; Kefalov, Vladimir J.			Mislocalization of cone nuclei impairs cone function in mice	FASEB JOURNAL			English	Article						cone photoreceptor; dark adaptation; LINC complex; nucleus migration; retinal degeneration; retina electrophysiology	RETINAL VISUAL CYCLE; PHOTORECEPTORS; PHOTOTRANSDUCTION; BINDING; ROD; EVOLUTION; PROTEINS; SEGMENTS; CELLS	The nuclei of cone photoreceptors are located on the apical side of the outer nuclear layer (ONL) in vertebrate retinas. However, the functional role of this evolutionarily conserved localization of cone nuclei is unknown. We previously showed that Linkers of the Nucleoskeleton to the Cytoskeleton (LINC complexes) are essential for the apical migration of cone nuclei during development. Here, we developed an efficient genetic strategy to disrupt cone LINC complexes in mice. Experiments with animals from both sexes revealed that disrupting cone LINC complexes resulted in mislocalization of cone nuclei to the basal side of ONL in mouse retina. This, in turn, disrupted cone pedicle morphology, and appeared to reduce the efficiency of synaptic transmission from cones to bipolar cells. Although we did not observe other developmental or phototransduction defects in cones with mislocalized nuclei, their dark adaptation was impaired, consistent with a deficiency in chromophore recycling. These findings demonstrate that the apical localization of cone nuclei in the ONL is required for the timely dark adaptation and efficient synaptic transmission in cone photoreceptors.	[Xue, Yunlu] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Xue, Yunlu] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA; [Razafsky, David; Hodzic, Didier; Kefalov, Vladimir J.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Washington University (WUSTL)	Xue, YL (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	yunlu_xue@hms.harvard.edu	Xue, Yunlu/AAJ-8433-2021	Xue, Yunlu/0000-0002-2088-9826	HHS \ NIH \ National Eye Institute (NEI) [K99EY030951, EY025696, EY027387, EY022632]	HHS \ NIH \ National Eye Institute (NEI)	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: K99EY030951, EY025696, EY027387 and EY022632	Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; Bringmann A, 2019, ANAT HISTOL EMBRYOL, V48, P177, DOI 10.1111/ahe.12432; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Cuenca N, 2002, J NEUROCYTOL, V31, P649, DOI 10.1023/A:1025791512555; DICKSON DH, 1979, EXP EYE RES, V29, P45, DOI 10.1016/0014-4835(79)90165-9; Fain GL, 2010, CURR BIOL, V20, pR114, DOI 10.1016/j.cub.2009.12.006; Hoang QV, 2002, VISUAL NEUROSCI, V19, P395, DOI 10.1017/S0952523802194028; ISHIKAWA M, 1987, CELL TISSUE RES, V249, P241; Kolb H., 1995, WEBVISION ORG RETINA; Kolesnikov AV, 2012, JOVE-J VIS EXP, DOI 10.3791/3424; Kolesnikov AV, 2011, J NEUROSCI, V31, P7900, DOI 10.1523/JNEUROSCI.0438-11.2011; Lagman D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121330; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283; Le YZ, 2006, MOL VIS, V12, P389; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Lombardi ML, 2011, JOVE-J VIS EXP, DOI 10.3791/3087; Lopez-Lopez R, 2008, CELL TISSUE RES, V332, P13, DOI 10.1007/s00441-007-0572-6; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Morshedian A, 2015, CURR BIOL, V25, P484, DOI 10.1016/j.cub.2014.12.031; Rajgor D, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.6; Razafsky D, 2015, JOVE-J VIS EXP, DOI 10.3791/53318; Razafsky D, 2014, GENESIS, V52, P359, DOI 10.1002/dvg.22755; Razafsky D, 2014, ADV EXP MED BIOL, V773, P471, DOI 10.1007/978-1-4899-8032-8_21; Razafsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047180; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rich KA, 1997, J COMP NEUROL, V388, P47; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Sato S, 2017, VISUAL NEUROSCI, V34, DOI 10.1017/S0952523817000013; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; Vinberg F, 2014, VISION RES, V101, P108, DOI 10.1016/j.visres.2014.06.003; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Wang JS, 2014, J NEUROSCI, V34, P11212, DOI 10.1523/JNEUROSCI.1245-14.2014; Wang JS, 2009, NAT NEUROSCI, V12, P295, DOI 10.1038/nn.2258; Xue YL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02549-8; Xue YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep17616; Xue YL, 2015, J CLIN INVEST, V125, P727, DOI 10.1172/JCI79651; Yang SH, 2011, HUM MOL GENET, V20, P3537, DOI 10.1093/hmg/ddr266; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Zhou ZC, 2012, J BIOL CHEM, V287, P5317, DOI 10.1074/jbc.M111.304543	44	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10242	10249		10.1096/fj.202000568R	http://dx.doi.org/10.1096/fj.202000568R		JUN 2020	8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32539195	Bronze, Green Accepted			2022-12-26	WOS:000541801100001
J	Abidin, N; Ismail, SI; Vadamalai, G; Yusof, MT; Hakiman, M; Karam, DS; Ismail-Suhaimy, NW; Ibrahim, R; Zulperi, D				Abidin, Nuraizat; Ismail, Siti Izera; Vadamalai, Ganesan; Yusof, Mohd Termizi; Hakiman, Mansor; Karam, Daljit Singh; Ismail-Suhaimy, Noor Wahida; Ibrahim, Rohaya; Zulperi, Dzarifah			Genetic diversity of Pantoea stewartii subspecies stewartii causing jackfruit-bronzing disease in Malaysia	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; 1ST REPORT; ZEA-MAYS; IDENTIFICATION; MAIZE; DIFFERENTIATION; PHYLOGENY; PLANTS; WTSE; WILT	Jackfruit-bronzing is caused by bacteriaPantoea stewartiisubspeciesstewartii(P.stewartiisubsp.stewartii), showing symptoms of yellowish-orange to reddish discolouration and rusty specks on pulps and rags of jackfruit. Twenty-eight pure bacterial strains were collected from four different jackfruit outbreak collection areas in Peninsular Malaysia (Jenderam, Maran, Muadzam Shah and Ipoh). PositiveP.stewartiisubsp.stewartiiverification obtained in the study was based on the phenotypic, hypersensitivity, pathogenicity and molecular tests. Multilocus sequence analysis (MLSA) was performed using four housekeeping genes (gyrB,rpoB,atpD andinfB) on all 28 bacterial strains. SinglegyrB,rpoB,atpD and infB phylogenetic trees analyses revealed the bootstrap value of 99-100% between our bacterial strains withP.stewartiisubsp.stewartiireference strains andP.stewartiisubsp.indologenesreference strains. On the other hand, phylogenetic tree of the concatenated sequences of the four housekeeping genes revealed that our 28 bacterial strains were more closely relatedto P.stewartiisubsp.stewartii(99% similarities) compared to its close relativeP.stewartiisubsp.indologenes, although sequence similarity between these two subspecies were up to 100%. All the strains collected from the four collection areas clustered together, pointing to no variation among the bacterial strains. This study improves our understanding and provided new insight on the genetic diversity ofP.stewartiisubsp.stewartiiassociated with jackfruit-bronzing in Malaysia.	[Abidin, Nuraizat; Ismail, Siti Izera; Vadamalai, Ganesan; Ismail-Suhaimy, Noor Wahida; Ibrahim, Rohaya; Zulperi, Dzarifah] Univ Putra Malaysia, Fac Agr, Dept Plant Protect, Serdang, Selangor, Malaysia; [Yusof, Mohd Termizi] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Microbiol, Serdang, Selangor, Malaysia; [Hakiman, Mansor] Univ Putra Malaysia, Fac Agr, Dept Crop Sci, Serdang, Selangor, Malaysia; [Karam, Daljit Singh] Univ Putra Malaysia, Fac Agr, Dept Land Management, Serdang, Selangor, Malaysia; [Zulperi, Dzarifah] Univ Putra Malaysia, Inst Trop Forestry & Forest Prod, Lab Sustainable Resources Management, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Zulperi, D (corresponding author), Univ Putra Malaysia, Fac Agr, Dept Plant Protect, Serdang, Selangor, Malaysia.	dzarifah@upm.edu.my			IPM-UPM [9494600]; FRGS [5540090]; SEAMEO SEARCA; UPM-SEAMEO SEARCA scholarship	IPM-UPM; FRGS; SEAMEO SEARCA; UPM-SEAMEO SEARCA scholarship	This work was supported by IPM-UPM (Grant number: 9494600), FRGS (Grant number: 5540090) and SEAMEO SEARCA (https://www.searca.org/). Nuraizat Abidin was the recipient of UPM-SEAMEO SEARCA scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Orio AGA, 2012, PLANT DIS, V96, P1819, DOI 10.1094/PDIS-07-12-0668-PDN; [Anonymous], 2016, B OEPP EPPO B, V46, P226; Brady C, 2008, SYST APPL MICROBIOL, V31, P447, DOI 10.1016/j.syapm.2008.09.004; Brady CL, 2010, INT J SYST EVOL MICR, V60, P2430, DOI 10.1099/ijs.0.017301-0; Castagno LN, 2011, J APPL MICROBIOL, V110, P1151, DOI 10.1111/j.1365-2672.2011.04968.x; Chen CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41564; Coplin DL, 2002, PLANT DIS, V86, P304, DOI 10.1094/PDIS.2002.86.3.304; Correa VR, 2012, APPL ENVIRON MICROB, V78, P6327, DOI 10.1128/AEM.00892-12; De Vos P, 2011, METHOD MICROBIOL, V38, P385, DOI 10.1016/B978-0-12-387730-7.00017-6; Deletoile A, 2009, J CLIN MICROBIOL, V47, P300, DOI 10.1128/JCM.01916-08; Duron O, 2016, ENV MICROBIOL REP, V8, P715, DOI 10.1111/1758-2229.12432; EPPO (European Mediterranean Plant Protection Organization), 2006, BULL OEPP, V36, P111, DOI [10.1111/j.1365-2338.2006.00920.x, DOI 10.1111/J.1365-2338.2006.00920.X]; Frederick RD, 2001, MOL PLANT MICROBE IN, V14, P1213, DOI 10.1094/MPMI.2001.14.10.1213; Gapasin R. M., 2014, Annals of Tropical Research, V36, P17; Gehring I, 2014, J APPL MICROBIOL, V116, P1553, DOI 10.1111/jam.12467; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Glaeser SP, 2015, SYST APPL MICROBIOL, V38, P237, DOI 10.1016/j.syapm.2015.03.007; Goszczynska T, 2007, PLANT DIS, V91, P711, DOI 10.1094/PDIS-91-6-0711; Goszczynska T, 1999, INTRO PRACTICAL PHYT; Guo YP, 2008, INT J SYST EVOL MICR, V58, P149, DOI 10.1099/ijs.0.65224-0; Gutierrez CMH, 2008, THESIS; Gutierrez-Barranquero JA, 2019, PHYTOPATHOLOGY, V109, P17, DOI 10.1094/PHYTO-06-18-0186-R; Haliatur Rahma, 2014, Journal of ISSAAS (International Society for Southeast Asian Agricultural Sciences), V20, P131; Halim NA, 2016, FFTC AGR POLICY ARTI; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Ham JH, 2008, MOL PLANT PATHOL, V9, P633, DOI 10.1111/J.1364-3703.2008.00489.X; Hernandez-Morales A, 2017, J PLANT PATHOL, V99, P807; ITFN, 2012, ITFN TROP FRUIT NEWS, P16; Janse JD, 2005, PHYTOBACTERIOLOGY: PRINCIPLES AND PRACTICE, P1, DOI 10.1079/9781845930257.0000; Jeger M, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5356; KADA, 2018, VAR REG NAT CROP LIS; Kini K, 2018, DIAGNOSTIC MULTIPLEX, DOI [10.1101/456806, DOI 10.1101/456806]; Kuhnert P, 2009, INT J FOOD MICROBIOL, V136, P152, DOI 10.1016/j.ijfoodmicro.2009.02.022; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Martens M, 2008, INT J SYST EVOL MICR, V58, P200, DOI 10.1099/ijs.0.65392-0; Moretti C, 2017, PLANT PATHOL, V66, P595, DOI 10.1111/ppa.12614; Mulaw T., 2018, American Journal of Plant Sciences, V9, P667, DOI 10.4236/ajps.2018.94053; Naum M, 2008, J MOL EVOL, V66, P630, DOI 10.1007/s00239-008-9115-3; Nechwatal J., 2018, Bulletin OEPP, V48, P78, DOI 10.1111/epp.12448; Palmer M, 2017, ANTON LEEUW INT J G, V110, P1287, DOI 10.1007/s10482-017-0852-4; Performance Management and Delivery Unit (PEMANDU), 2012, EC TRANSF PROGR ANN; Popp A, 2010, INT J SYST EVOL MICR, V60, P2786, DOI 10.1099/ijs.0.019430-0; Roper MC, 2011, MOL PLANT PATHOL, V12, P628, DOI [10.1111/j.1364-3703.2010.00698.x, 10.1111/J.1364-3703.2010.00698.X]; Stumpf S, 2018, PLANT DIS, V102, P727, DOI 10.1094/PDIS-08-17-1321-RE; Sundarraj A. A., 2018, Vegetos, V31, P67, DOI 10.5958/2229-4473.2018.00009.5; Suryani L, 2012, AGRIVITA, V34, P286, DOI 10.17503/Agrivita-2012-34-3-p286-295; Vinuesa P., 2010, MOL PHYLOGENY MICROO; Wang LY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00471; Xu R, 2010, LETT APPL MICROBIOL, V50, P216, DOI 10.1111/j.1472-765X.2009.02780.x; Yazdani R, 2018, EUR J PLANT PATHOL, V150, P167, DOI 10.1007/s10658-017-1264-z; Young JM, 2007, SYST APPL MICROBIOL, V30, P343, DOI 10.1016/j.syapm.2007.03.002; Zhang YC, 2015, ANTON LEEUW INT J G, V108, P1037, DOI 10.1007/s10482-015-0556-6; Zulperi D, 2017, PLANT DIS, V101, P831, DOI 10.1094/PDIS-11-16-1689-PDN	53	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234350	10.1371/journal.pone.0234350	http://dx.doi.org/10.1371/journal.pone.0234350			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530926	gold, Green Accepted, Green Published			2022-12-26	WOS:000542037200009
J	Shimizu, T; Nakamura, T; Inaba, H; Iwasa, H; Maruyama, J; Arimoto-Matsuzaki, K; Nakata, T; Nishina, H; Hata, Y				Shimizu, Takanobu; Nakamura, Takeshi; Inaba, Hironori; Iwasa, Hiroaki; Maruyama, Junichi; Arimoto-Matsuzaki, Kyoko; Nakata, Takao; Nishina, Hiroshi; Hata, Yutaka			The RAS-interacting chaperone UNC119 drives the RASSF6-MDM2-p53 axis and antagonizes RAS-mediated malignant transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; KRAS; TP53; tumor suppressor; Ras association domain family member 6 (RASSF6); human retina gene 4 (HRG4); cancer; cell signaling; cell proliferation; GTPase; tumor suppressor gene; p53	BOVINE BRAIN CYTOSOL; SUBCELLULAR-LOCALIZATION; SUBSEQUENT BINDING; STRUCTURAL BASIS; NUCLEAR EXPORT; PROTEIN UNC119; DOMAIN; ASSOCIATION; FAMILY; P53	The gene encoding the proto-oncogene GTPase RAS is frequently mutated in human cancers. Mutated RAS proteins trigger antiapoptotic and cell-proliferative signals and lead to oncogenesis. However, RAS also induces apoptosis and senescence, which may contribute to the eradication of cells with RAS mutations. We previously reported that Ras association domain family member 6 (RASSF6) binds MDM2 and stabilizes the tumor suppressor p53 and that the active form of KRAS promotes the interaction between RASSF6 and MDM2. We also reported that Unc-119 lipid-binding chaperone (UNC119A), a chaperone of myristoylated proteins, interacts with RASSF6 and regulates RASSF6-mediated apoptosis. In this study, using several human cancer cell lines, quantitative RT-PCR, RNAi-based gene silencing, and immunoprecipitation/-fluorescence and cell biology assays, we report that UNC119A interacts with the active form of KRAS and that the C-terminal modification of KRAS is required for this interaction. We also noted that the hydrophobic pocket of UNC119A, which binds the myristoylated peptides, is not involved in the interaction. We observed that UNC119A promotes the binding of KRAS to RASSF6, enhances the interaction between RASSF6 and MDM2, and induces apoptosis. Conversely,UNC119Asilencing promoted soft-agar colony formation, migration, and invasiveness in KRAS-mutated cancer cells. We conclude that UNC119A promotes KRAS-mediated p53-dependent apoptosis via RASSF6 and may play a tumor-suppressive role in cells with KRAS mutations.	[Shimizu, Takanobu; Nakamura, Takeshi; Iwasa, Hiroaki; Maruyama, Junichi; Arimoto-Matsuzaki, Kyoko; Hata, Yutaka] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Med Biochem, Tokyo, Japan; [Inaba, Hironori; Nakata, Takao] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Biol, Tokyo, Japan; [Nakata, Takao; Hata, Yutaka] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo, Japan; [Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Iwasa, H; Hata, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Med Biochem, Tokyo, Japan.; Hata, Y (corresponding author), Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo, Japan.	hiwammch@tmd.ac.jp; yuhammch@tmd.ac.jp	Iwasa, Hiroaki/ABG-9082-2021; Inaba, Hironori/C-7794-2016	Inaba, Hironori/0000-0002-9622-6017; Nakata, Takao/0000-0002-0629-0518; MARUYAMA, Junichi/0000-0002-3665-2700; Shimizu, Takanobu/0000-0003-1186-0703; /0000-0003-1304-5286	Japan Society for the Promotion of Science (JSPS) [26460359, 26293061, 17K08624, 19H03414]; Mitsubishi Foundation [26138]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Foundation	This work was funded by the Japan Society for the Promotion of Science (JSPS) (26460359, 26293061, 17K08624, and 19H03414) and the Mitsubishi Foundation (26138).	Allen NPC, 2007, ONCOGENE, V26, P6203, DOI 10.1038/sj.onc.1210440; Alpadi K, 2008, J BIOL CHEM, V283, P26461, DOI 10.1074/jbc.M801625200; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; Cen O, 2003, J BIOL CHEM, V278, P8837, DOI 10.1074/jbc.M208261200; Constantine R, 2012, VISION RES, V75, P26, DOI 10.1016/j.visres.2012.08.012; Dharmaiah S, 2016, P NATL ACAD SCI USA, V113, pE6766, DOI 10.1073/pnas.1615316113; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Garivet G, 2019, CELL CHEM BIOL, V26, P842, DOI 10.1016/j.chembiol.2019.02.019; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Gopalakrishna KN, 2011, J BIOL CHEM, V286, P28954, DOI 10.1074/jbc.M111.268821; Gorska MM, 2010, J IMMUNOL, V184, P4488, DOI 10.4049/jimmunol.0903115; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; HANCOCK JF, 1991, EMBO J, V10, P641, DOI 10.1002/j.1460-2075.1991.tb07992.x; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Higashide T, 1996, J BIOL CHEM, V271, P1797, DOI 10.1074/jbc.271.3.1797; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Ikeda M, 2007, EXP CELL RES, V313, P1484, DOI 10.1016/j.yexcr.2007.02.013; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Iwasa H, 2018, CANCER SCI, V109, P2767, DOI 10.1111/cas.13706; KAPLAN JB, 1991, CANCER COMMUN, V3, P383, DOI 10.3727/095535491820873704; Karim Z, 2010, CELL SIGNAL, V22, P128, DOI 10.1016/j.cellsig.2009.09.022; Kobayashi A, 2000, INVEST OPHTH VIS SCI, V41, P3268; Kobayashi A, 2003, FEBS LETT, V534, P26, DOI 10.1016/S0014-5793(02)03766-3; Lee Y, 2013, CELL CYCLE, V12, P1303, DOI 10.4161/cc.24404; Lei B, 2015, AM J CANCER RES, V5, P3123; Mejuch T, 2015, CHEMBIOCHEM, V16, P2460, DOI 10.1002/cbic.201500355; Nancy V, 2002, J BIOL CHEM, V277, P15076, DOI 10.1074/jbc.M109983200; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Park HS, 2014, INT J CLIN ONCOL, V19, P842, DOI 10.1007/s10147-013-0639-1; PRIVE GG, 1992, P NATL ACAD SCI USA, V89, P3649, DOI 10.1073/pnas.89.8.3649; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarkar A, 2017, FEBS LETT, V591, P260, DOI 10.1002/1873-3468.12551; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Swanson DA, 1998, INVEST OPHTH VIS SCI, V39, P2085; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; UEDA T, 1990, J BIOL CHEM, V265, P9373; Vepachedu R, 2007, J IMMUNOL, V179, P682, DOI 10.4049/jimmunol.179.1.682; Vepachedu R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005211; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111; Yang ZY, 2014, MOL CELL BIOL, V34, P1607, DOI 10.1128/MCB.01346-13; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835	48	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11214	11230		10.1074/jbc.RA120.012649	http://dx.doi.org/10.1074/jbc.RA120.012649			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32554467	Green Published, hybrid			2022-12-26	WOS:000562757100024
J	Stammers, M; Niewczas, IS; Segonds-Pichon, A; Clark, J				Stammers, Melanie; Niewczas, Izabella S.; Segonds-Pichon, Anne; Clark, Jonathan			Mechanical stretching changes crosslinking and glycation levels in the collagen of mouse tail tendon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Tendon; collagen; crosslinks; glycation; physical strain; chemistry; mechanical stress; imine bond; connective tissue; protein crosslinking; stress	FIBRILS	Collagen I is a major tendon protein whose polypeptide chains are linked by covalent crosslinks. It is unknown how the crosslinking contributes to the mechanical properties of tendon or whether crosslinking changes in response to stretching or relaxation. Since their discovery, imine bonds within collagen have been recognized as being important in both crosslink formation and collagen structure. They are often described as acidic or thermally labile, but no evidence is available from direct measurements of crosslink levels whether these bonds contribute to the mechanical properties of collagen. Here, we used MS to analyze these imine bonds after reduction with sodium borohydride while under tension and found that their levels are altered in stretched tendon. We studied the changes in crosslink bonding in tail tendon from 11-week-old C57Bl/6 mice at 4% physical strain, at 10% strain, and at breaking point. The crosslinks hydroxy-lysino-norleucine (HLNL), dihydroxy-lysino-norleucine (DHLNL), and lysino-norleucine (LNL) in-creased or decreased depending on the specific crosslink and amount of mechanical strain. We also noted a decrease in glycated lysine residues in collagen, indicating that the imine formed between circulating glucose and lysine is also stress labile. We also carried out mechanical testing, including cyclic testing at 4% strain, stress relaxation tests, and stress-strain profiles taken at breaking point, both with and without sodium borohydride reduction. The results from both the MS studies and mechanical testing provide insights into the chemical changes during tendon stretching and directly link these chemical changes to functional collagen properties.	[Stammers, Melanie; Niewczas, Izabella S.; Segonds-Pichon, Anne; Clark, Jonathan] Babraham Inst, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Clark, J (corresponding author), Babraham Inst, Cambridge, England.	jonathan.clark@babraham.ac.uk			SENS Research Foundation	SENS Research Foundation	This work was supported by SENS Research Foundation (to J. C. and M. S.).	BERNSTEIN PH, 1980, J BIOL CHEM, V255, P414; DAVISON PF, 1989, CONNECT TISSUE RES, V18, P293, DOI 10.3109/03008208909019078; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; Eyre DR, 2019, J BIOL CHEM, V294, P6578, DOI 10.1074/jbc.RA118.007202; FOLKHARD W, 1987, INT J BIOL MACROMOL, V9, P169, DOI 10.1016/0141-8130(87)90047-X; Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966; Fratzl P, 2008, COLLAGEN STRUCTURE M; Misof K, 1997, BIOPHYS J, V72, P1376, DOI 10.1016/S0006-3495(97)78783-6; MOSLER E, 1985, J MOL BIOL, V182, P589, DOI 10.1016/0022-2836(85)90244-X; OTSUBO K, 1992, BIOCHEMISTRY-US, V31, P396, DOI 10.1021/bi00117a013; Stammers M, 2020, J BIOL CHEM, V295, P10562, DOI 10.1074/jbc.RA119.011031; Svensson RB, 2013, BIOPHYS J, V104, P2476, DOI 10.1016/j.bpj.2013.04.033; TANZER ML, 1973, J BIOL CHEM, V248, P393; Terajima M, 2016, J BIOL CHEM, V291, P9501, DOI 10.1074/jbc.M115.699470; Veres SP, 2013, J ORTHOP RES, V31, P1907, DOI 10.1002/jor.22460	15	6	7	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10572	10580		10.1074/jbc.RA119.012067	http://dx.doi.org/10.1074/jbc.RA119.012067			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32546479	Green Published, hybrid			2022-12-26	WOS:000560405600006
J	Kigozi, G; Liu, CM; Park, D; Packman, ZR; Gray, RH; Kaul, R; Tobian, AAR; Abraham, AG; Ssekasanvu, J; Kagaayi, J; Prodger, JL				Kigozi, Godfrey; Liu, Cindy M.; Park, Daniel; Packman, Zoe R.; Gray, Ronald H.; Kaul, Rupert; Tobian, Aaron A. R.; Abraham, Alison G.; Ssekasanvu, Joseph; Kagaayi, Joseph; Prodger, Jessica L.			Foreskin surface area is not associated with sub-preputial microbiome composition or penile cytokines	PLOS ONE			English	Article							RISK HUMAN-PAPILLOMAVIRUS; MALE CIRCUMCISION; HIV ACQUISITION; YOUNG MEN; ORANGE FARM; RAKAI; PREVENTION; PREVALENCE; EXPRESSION; UGANDA	Objective Male circumcision (MC) reduces acquisition of HIV-1 in heterosexual men by at least 60%, but the biological mechanism for this protection is incompletely understood. Previous studies have shown that a larger foreskin size, increased abundance of anaerobic bacteria in the sub-preputial space, and higher levels of pro-inflammatory cytokines on the penis are all prospectively associated with risk of HIV-1 acquisition. Since coverage of the glans on the non-erect penis is dependent on foreskin size, a larger foreskin could result in a less aerobic environment that might preferentially support anaerobic bacterial growth and induce inflammation. We therefore assessed the relationship between foreskin size, penile microbiome composition and local inflammation. Methods This is a retrospective, cross-sectional analysis of 82 HIV-uninfected men who participated in a randomized trial of MC for HIV-1 prevention in Rakai, Uganda between 2003-2006. Sub-preputial swabs were collected prior to MC and assessed for cytokines (multiplexed immunosorbent assay) and bacterial load (qPCR) and taxon abundance (sequencing). Foreskin size was measured immediately after MC. Results Foreskin surface area did not correlate with total bacterial load (rho = 0.05) nor the abundance of key taxa of bacteria previously associated with HIV-1 risk (rho = 0.04-0.25). Foreskin surface area also did not correlate with sub-preputial cytokine concentrations previously associated with HIV-1 risk (IL-8 rho = 0.05). Conclusions Larger foreskin size is not associated with either increased penile anaerobes or pro-inflammatory cytokines. These data suggest that foreskin size does not increase HIV-1 risk through changes in penile microbiome composition or penile inflammation.	[Kigozi, Godfrey; Gray, Ronald H.; Tobian, Aaron A. R.; Ssekasanvu, Joseph; Kagaayi, Joseph] Rakai Hlth Sci Program, Kalisizo, Uganda; [Liu, Cindy M.; Park, Daniel] George Washington Univ, Dept Environm & Occupat Hlth, Milken Inst Sch Publ Hlth, Washington, DC USA; [Packman, Zoe R.; Tobian, Aaron A. R.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Gray, Ronald H.; Abraham, Alison G.; Ssekasanvu, Joseph] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Kaul, Rupert] Univ Toronto, Dept Med, Toronto, ON, Canada; [Abraham, Alison G.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Prodger, Jessica L.] Western Univ, Schulich Sch Med & Dent, Dept Microbiol & Immunol, London, ON, Canada; [Prodger, Jessica L.] Western Univ, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada; [Prodger, Jessica L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Rakai Health Sciences Program; George Washington University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Toronto; Johns Hopkins University; Western University (University of Western Ontario); Western University (University of Western Ontario); Johns Hopkins University	Prodger, JL (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Microbiol & Immunol, London, ON, Canada.; Prodger, JL (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada.; Prodger, JL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	jprodge@uwo.ca	Liu, Cindy/ABF-7427-2020	Kaul, Rupert/0000-0002-1586-4093; Prodger, Jessica/0000-0003-0805-4196	National Institutes of Health [R01AI128779, R01AI123002]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health (www.nih.gov), grant numbers R01AI128779 (AT) and R01AI123002 (CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CLIN TRANSL GASTROEN, V4, pe39; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 2009, EUROPEAN J ENDOVASCU, V37, pS1; Arnold KB, 2016, MUCOSAL IMMUNOL, V9, P194, DOI 10.1038/mi.2015.51; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Backes DM, 2012, INT J CANCER, V130, P1888, DOI 10.1002/ijc.26196; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Borgdorff H, 2016, MUCOSAL IMMUNOL, V9, P621, DOI 10.1038/mi.2015.86; Carias AM, 2013, J VIROL, V87, P11388, DOI 10.1128/JVI.01377-13; Fahrbach KM, 2010, MUCOSAL IMMUNOL, V3, P410, DOI 10.1038/mi.2010.18; Gosmann C, 2017, IMMUNITY, V46, P29, DOI 10.1016/j.immuni.2016.12.013; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2010, J INFECT DIS, V201, P1455, DOI 10.1086/652184; Gray RH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000187; Kigozi G, 2009, AIDS, V23, P2209, DOI 10.1097/QAD.0b013e328330eda8; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; McClelland RS, 2018, LANCET INFECT DIS, V18, P554, DOI 10.1016/S1473-3099(18)30058-6; McKinnon LR, 2012, CURR OPIN HIV AIDS, V7, P195, DOI 10.1097/COH.0b013e3283504941; Prodger JL, 2014, MUCOSAL IMMUNOL, V7, P634, DOI 10.1038/mi.2013.83; Prodger JL, 2012, MUCOSAL IMMUNOL, V5, P121, DOI 10.1038/mi.2011.56; Prodger JL, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0167-6; Prodger JL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006025; Sobngwi-Tambekou J, 2009, J INFECT DIS, V199, P958, DOI 10.1086/597208; Stieh DJ, 2016, CELL HOST MICROBE, V19, P529, DOI 10.1016/j.chom.2016.03.005; Tobian AAR, 2011, JAMA-J AM MED ASSOC, V306, P1479, DOI 10.1001/jama.2011.1431; 2015, CORSALUD, V6	29	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234256	10.1371/journal.pone.0234256	http://dx.doi.org/10.1371/journal.pone.0234256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574173	Green Published, gold			2022-12-26	WOS:000544972400045
J	Wang, YH; Zhen, C; Zhang, Z; Tao, ZC				Wang, Yanhua; Zhen, Cheng; Zhang, Zhan; Tao, Zhencheng			Corrosion behavior of an AZ91D magnesium alloy under a heterogeneous electrolyte layer	PLOS ONE			English	Article							ATMOSPHERIC CORROSION; MICROSTRUCTURE	The corrosion behavior of an AZ91D magnesium alloy was investigated under a heterogeneous electrolyte layer by using electrochemical methods and surface analysis techniques. Dynamic polarization curves and morphological characterization were obtained at the center and near the edge zones under the electrolyte layer. The influence of the gas/liquid/solid three-phase boundary zone (TPB) on the corrosion behavior of the AZ91D magnesium alloy was discussed. The corrosion rate changed more significantly near the TPB zone than that at the other zones. The AZ91D alloy exhibited the characteristics of filiform corrosion together with shallow pitting corrosion. Different from the randomly distributed shallow pits, the filiform corrosion preferred to initiate near the TPB region and then progressively expanded adjacent to the edge of the electrolyte layer. The TPB zone played a vital role in determining the corrosion location, the corrosion morphologies and the corrosion rate of the magnesium alloy by influencing the mass transport process of carbon dioxide.	[Wang, Yanhua; Zhen, Cheng; Zhang, Zhan] Ocean Univ China, Coll Chem & Chem Engn, Minist Educ, Key Lab Marine Chem Theory & Technol, Qingdao, Peoples R China; [Zhang, Zhan] Ocean Univ China, Lib, Qingdao, Peoples R China; [Tao, Zhencheng] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Tao, Zhencheng] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Tao, Zhencheng] Chinese Acad Sci, Ctr Ocean Mega Sci, Qingdao, Peoples R China	Ocean University of China; Ocean University of China; Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences	Wang, YH (corresponding author), Ocean Univ China, Coll Chem & Chem Engn, Minist Educ, Key Lab Marine Chem Theory & Technol, Qingdao, Peoples R China.; Tao, ZC (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.; Tao, ZC (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.; Tao, ZC (corresponding author), Chinese Acad Sci, Ctr Ocean Mega Sci, Qingdao, Peoples R China.	wyhazz@163.com; taozc@qdio.ac.cn	Wang, Yu/GZL-9655-2022; wang, yan/GSE-6489-2022; Wang, Yuan/HHC-1520-2022; Wang, Yanbo/HFZ-8018-2022; wang, yi/GVT-8516-2022; wangwangwang, yuanyaun/HHN-6432-2022; Wang, Yin/HCI-9352-2022	Zhencheng, TAO/0000-0002-5948-0171	National Natural Science Foundation of China (NSFC) [51131005]; National Key R&D Program of China [2017YFC1404402]; Science & Technology Basic Resources Investigation Program of China [2017FY100803]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Science & Technology Basic Resources Investigation Program of China	This research is supported by the National Natural Science Foundation of China (NSFC) (No. 51131005), the National Key R&D Program of China (No. 2017YFC1404402), and the Science & Technology Basic Resources Investigation Program of China (No. 2017FY100803).	[Anonymous], 2012, J ELECTROCHEM SOC, V159, pA1135; [Anonymous], 2014, J ELECTROCHEM SOC, V161, pF263; Cao FY, 2016, CORROS SCI, V111, P835, DOI 10.1016/j.corsci.2016.05.041; Chen C, 2010, MATER CORROS, V61, P388, DOI 10.1002/maco.200905330; Ding ZY, 2018, J MATER SCI TECHNOL, V34, P1550, DOI 10.1016/j.jmst.2018.05.014; Esmaily M, 2017, PROG MATER SCI, V89, P92, DOI 10.1016/j.pmatsci.2017.04.011; [高璐璐 Gao Lulu], 2013, [材料导报, Materials Review], V27, P31; Jiang J, 2009, ELECTROCHIM ACTA, V54, P1426, DOI 10.1016/j.electacta.2008.09.017; Jonsson M, 2007, CORROS SCI, V49, P1540, DOI 10.1016/j.corsci.2006.08.004; Jonsson M, 2006, CORROS SCI, V48, P1193, DOI 10.1016/j.corsci.2005.05.008; Lindstrom R, 2004, CORROS SCI, V46, P1141, DOI 10.1016/j.corsci.2003.09.010; Lindstrom R, 2002, J ELECTROCHEM SOC, V149, pB103, DOI 10.1149/1.1452115; Liu WJ, 2010, CORROS SCI, V52, P627, DOI 10.1016/j.corsci.2009.10.031; Mordike BL, 2001, MAT SCI ENG A-STRUCT, V302, P37, DOI 10.1016/S0921-5093(00)01351-4; Moulder J. F., 1992, HDB XRAY PHOTOELECTR, P261; Nie LL, 2019, INT J ELECTROCHEM SC, V14, P3095, DOI 10.20964/2019.03.07; Pardo A, 2008, ELECTROCHIM ACTA, V53, P7890, DOI 10.1016/j.electacta.2008.06.001; Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013; Wang YH, 2013, MATER CORROS, V64, P309, DOI 10.1002/maco.201106423; Xiong YL, 2008, APPL GEOCHEM, V23, P1634, DOI 10.1016/j.apgeochem.2007.12.035; Zhang RF, 2009, CORROS SCI, V51, P2820, DOI 10.1016/j.corsci.2009.08.009; Zhang T, 2008, ELECTROCHIM ACTA, V53, P7921, DOI 10.1016/j.electacta.2008.05.074; 2015, APPL SURF SCI, V347, P736	23	1	1	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234981	10.1371/journal.pone.0234981	http://dx.doi.org/10.1371/journal.pone.0234981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574186	Green Published, gold			2022-12-26	WOS:000544972400060
J	Monroy-Perez, E; Ceron, AB; Cortes, LRG; Alonso, NN; Dominguez-Trejo, P; Hernandez-Jaimes, T; Bustos-Martinez, J; Hamdan-Partida, A; Jimenez, EAR; Vaca, S; Vaca-Paniagua, F; Paniagua-Contreras, GL				Monroy-Perez, Eric; Ceron, Areli Bautista; Garcia Cortes, Luis Rey; Alonso, Nancy Nolasco; Dominguez-Trejo, Pablo; Hernandez-Jaimes, Tania; Bustos-Martinez, Jaime; Hamdan-Partida, Aida; Rojas Jimenez, Ernesto Arturo; Vaca, Sergio; Vaca-Paniagua, Felipe; Paniagua-Contreras, Gloria Luz			Virulence gene transcription, phylogroups, and antibiotic resistance of cervico-vaginal pathogenicE.coliin Mexico	PLOS ONE			English	Article							ESCHERICHIA-COLI STRAINS; MECHANISMS; EXPRESSION; WOMEN	The pathogenicity ofEscherichia colistrains that cause cervico-vaginal infections (CVI) is due to the presence of several virulence genes. The objective of this study was to define the variability regarding the genotype of antibiotic resistance, the transcription profiles of virulence genes after in vitro infection of the vaginal cell line A431 and the phylogroup composition of a group of cervico-vaginalE.colistrains (CVEC). A total of 200E.colistrains isolated from Mexican women with CVI from two medical units of the Mexican Institute of Social Security were analysed.E.colistrains and antibiotic resistance genes were identified using conventional polymerase chain reaction (PCR), and phylogroups were identified using multiplex PCR. Virulence gene transcription was measured through reverse-transcriptase real-time PCR after infection of the vaginal cell line A431. The most common antibiotic resistance genes among the CVEC strains wereaac(3)II, TEM,dfrA1,sul1, andqnrA. The predominant phylogroup was B2. The genes most frequently transcribed in these strains werefimH,papC,irp2,iroN,kpsMTII,cnf1, andompT, mainly in CVEC strains isolated from chronic and occasional vaginal infections. The strains showed a large diversity of transcription of the virulence genes phenotype and antibiotic resistance genotype, especially in the strains of phylogroups, B2, A, and D. The strains formed 2 large clusters, which contained several subclusters. The genetic diversity of CVEC strains was high. These strains have a large number of transcription patterns of virulence genes, and one-third of them carry three to seven antibiotic resistance genes.	[Monroy-Perez, Eric; Ceron, Areli Bautista; Hernandez-Jaimes, Tania; Vaca, Sergio; Paniagua-Contreras, Gloria Luz] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Tlalnepantla, Estado De Mexic, Mexico; [Garcia Cortes, Luis Rey; Alonso, Nancy Nolasco; Dominguez-Trejo, Pablo] Inst Mexicano Seguro Social, Mexico City, DF, Mexico; [Bustos-Martinez, Jaime; Hamdan-Partida, Aida] Univ Autonoma Metropolitana Xochimilco, Dept Atenc Salud, Mexico City, DF, Mexico; [Rojas Jimenez, Ernesto Arturo; Vaca-Paniagua, Felipe] Univ Nacl Autonoma Mexico, Fa Estudios Super Iztacala, Lab Nacl Salud Diagnost Mol & Efecto Ambiental En, Mexico City, DF, Mexico; [Rojas Jimenez, Ernesto Arturo; Vaca-Paniagua, Felipe] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Unidad Biomed, Mexico City, DF, Mexico; [Vaca-Paniagua, Felipe] Inst Nacl Cancerol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Mexicano del Seguro Social; Universidad Autonoma Metropolitana - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Cancerologia (INCAN)	Paniagua-Contreras, GL (corresponding author), Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Tlalnepantla, Estado De Mexic, Mexico.; Vaca-Paniagua, F (corresponding author), Univ Nacl Autonoma Mexico, Fa Estudios Super Iztacala, Lab Nacl Salud Diagnost Mol & Efecto Ambiental En, Mexico City, DF, Mexico.; Vaca-Paniagua, F (corresponding author), Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Unidad Biomed, Mexico City, DF, Mexico.; Vaca-Paniagua, F (corresponding author), Inst Nacl Cancerol, Mexico City, DF, Mexico.	felipe.vaca@gmail.com; mya@unam.mx	Bustos-Martínez, Jaime/AAN-8472-2020; Alonso, Nivaldo/D-2711-2012; Alonso, Nivaldo/AAB-4570-2021	Bustos-Martínez, Jaime/0000-0001-9763-754X; Alonso, Nivaldo/0000-0003-1532-9610; Alonso, Nivaldo/0000-0003-1532-9610; Nolasco-Alonso, Nancy/0000-0002-0175-6235; Rojas-Jimenez, Ernesto/0000-0003-2311-0205; HAMDAN-PARTIDA, AIDA/0000-0002-5827-3576	Universidad Nacional Autonoma de Mexico-Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [IN216517 (UNAM-DGAPA-PAPIIT IN216517)]; Facultad de Estudios Superiores Iztacala-DIP-Programa de Apoyo a Profesores de Carrera-2016-5 [FESI-DIPPAPCA-2016-5]	Universidad Nacional Autonoma de Mexico-Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica; Facultad de Estudios Superiores Iztacala-DIP-Programa de Apoyo a Profesores de Carrera-2016-5	This investigation was funded by Universidad Nacional Autonoma de Mexico-Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica IN216517 (UNAM-DGAPA-PAPIIT IN216517) and Facultad de Estudios Superiores Iztacala-DIP-Programa de Apoyo a Profesores de Carrera-2016-5 (FESI-DIPPAPCA-2016-5).	Abreu AG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00452; Adamus-Bialek W, 2018, MOL BIOL REP, V45, P1055, DOI 10.1007/s11033-018-4254-0; Al-Agamy MH, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-4; Ali ASM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10445-4; [Anonymous], 2017, CATHOLIC HIST REV, V103, P1, DOI 10.1353/cat.2017.0000; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Bubpamala J, 2018, INFECT DRUG RESIST, V11, P2151, DOI 10.2147/IDR.S174506; Cheng G, 2005, INFECT IMMUN, V73, P1656, DOI 10.1128/IAI.73.3.1656-1663.2005; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Comstock LE, 2006, CELL, V126, P847, DOI 10.1016/j.cell.2006.08.021; Cyoia PS, 2015, J INFECT DEV COUNTR, V9, P1068, DOI 10.3855/jidc.6683; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Domingues Sara, 2012, Mob Genet Elements, V2, P211; Floyd KA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004697; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Blancarte-Lagunas MI, 2020, J INFECT DEV COUNTR, V14, P48, DOI 10.3855/jidc.11940; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Kaczmarek A, 2014, FOLIA MICROBIOL, V59, P419, DOI 10.1007/s12223-014-0315-5; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Paniagua-Contreras GL, 2019, J INFECT CHEMOTHER, V25, P494, DOI 10.1016/j.jiac.2019.02.004; Paniagua-Contreras GL, 2018, PATHOG GLOB HEALTH, V112, P415, DOI 10.1080/20477724.2018.1547542; Molina L, 2011, J INFECT DEV COUNTR, V5, P840; Momtaz H, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-8; Morales-Espinosa R, 2016, J INFECT DEV COUNTR, V10, P317, DOI 10.3855/jidc.6652; Naglik JR, 2008, MICROBIOL-SGM, V154, P3266, DOI 10.1099/mic.0.2008/022293-0; Ngonzi J, 2018, INT J MICROBIOL, V2018, DOI 10.1155/2018/6579139; Norinder BS, 2011, INFECTION, V39, P571, DOI 10.1007/s15010-011-0199-0; Paniagua-Contreras GL, 2017, J MICROBIOL IMMUNOL, V50, P478, DOI 10.1016/j.jmii.2015.08.005; Raeispour M, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0411-4; Ramirez-Castillo FY, 2018, ANN CLIN MICROB ANTI, V17, DOI 10.1186/s12941-018-0286-5; Ranjit E, 2018, INT J MICROBIOL, V2018, DOI 10.1155/2018/8349601; Rashki A, 2014, MICROB PATHOGENESIS, V75, P29, DOI 10.1016/j.micpath.2014.08.004; Saenz Y, 2004, ANTIMICROB AGENTS CH, V48, P3996, DOI 10.1128/AAC.48.10.3996-4001.2004; Saghafi N, 2018, INT J REPROD BIOMED, V16, P341; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Song Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00949; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Van TTH, 2008, INT J FOOD MICROBIOL, V124, P217, DOI 10.1016/j.ijfoodmicro.2008.03.029; Wang C, 2020, DIAGN MICR INFEC DIS, V96, DOI 10.1016/j.diagmicrobio.2019.114981; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	40	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234730	10.1371/journal.pone.0234730	http://dx.doi.org/10.1371/journal.pone.0234730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569308	Green Published, gold			2022-12-26	WOS:000543547900039
J	Yazdani, A; Hohne, GWH; Misture, ST; Graeve, OA				Yazdani, Arash; Hoehne, Guenther W. H.; Misture, Scott T.; Graeve, Olivia A.			A method to quantify crystallinity in amorphous metal alloys: A differential scanning calorimetry study	PLOS ONE			English	Article							ELECTRON BACKSCATTER DIFFRACTION; STRUCTURAL RELAXATION; GLASS-TRANSITION; CRYSTALLIZATION KINETICS; INITIAL CRYSTALLINITY; SPECIMEN PREPARATION; MICROSTRUCTURE; BEHAVIORS; POLYMERS; LIQUID	We developed and describe a differential scanning calorimetry method for calculating the initial crystallinity, change of crystallinity and crystallinity percentage of amorphous metal alloys as a function of temperature. Using thermodynamic enthalpies of amorphous, crystalline and partially devitrified specimens, our methodology is capable of determining crystallinity percentages as low as a few percent. Moreover, the linear relationship between the set (pre-determined) and calculated crystallinities of experimental samples indicates that there is no need to prepare calibration samples before measuring the crystallinity percentage of target samples. This technique also eliminates the need for expensivein situaccessories, such as those required in electron microscopy. Thus, the technique is highly relevant as a primary technique for characterization of devitrification behavior in amorphous materials.	[Yazdani, Arash; Graeve, Olivia A.] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Hoehne, Guenther W. H.] Univ Ulm, Ulm, Germany; [Misture, Scott T.] Alfred Univ, Kazuo Inamori Sch Engn, Alfred, NY 14802 USA	University of California System; University of California San Diego; Ulm University; State University of New York (SUNY) System; Alfred University	Graeve, OA (corresponding author), Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA.	ograeve@ucsd.edu		Graeve, Olivia/0000-0003-3599-0502	Defense Threat Reduction Agency [HDTRA1-11-1-0067]; TA Instruments, Inc.	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); TA Instruments, Inc.	This work was funded by project HDTRA1-11-1-0067 from the Defense Threat Reduction Agency (https://www.dtra.mil/) awarded to OAG. TA Instruments, Inc. provided technical support. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthanarayanan A, 2011, CRIT REV SOLID STATE, V36, P229, DOI 10.1080/10408436.2011.593643; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380; Axinte E, 2011, MATER DESIGN, V32, P1717, DOI 10.1016/j.matdes.2010.11.057; Bennett TD, 2018, NAT REV MATER, V3, P431, DOI 10.1038/s41578-018-0054-3; Biswas D, 2019, J NON-CRYST SOLIDS, V510, P101, DOI 10.1016/j.jnoncrysol.2019.01.013; Bouvard JL, 2009, J ENG MATER-T ASME, V131, DOI 10.1115/1.3183779; Brittain H.G, 1995, PHYS CHARACTERIZATIO, P187; CHEN HS, 1978, J APPL PHYS, V49, P3289, DOI 10.1063/1.325279; Chen YM, 2019, CRYST GROWTH DES, V19, P1103, DOI 10.1021/acs.cgd.8b01608; Cheng IC, 2018, ADV ENG MATER, V20, DOI 10.1002/adem.201800023; Dittmer M, 2012, J BIOMED MATER RES B, V100B, P463, DOI 10.1002/jbm.b.31972; EGAMI T, 1978, MATER RES BULL, V13, P557, DOI 10.1016/0025-5408(78)90178-2; Eggleton BJ, 2011, NAT PHOTONICS, V5, P141, DOI [10.1038/nphoton.2011.309, 10.1038/NPHOTON.2011.309]; European Union, 2016, OFFICIAL J EUROPEAN, DOI DOI 10.2873/84730; Ferrer G, 2017, J ENERGY STORAGE, V11, P1, DOI 10.1016/j.est.2017.02.002; Frankel GS, 2018, MAT DEGRAD, V2, P1, DOI [10.1038/s41529-017-0021-2, DOI 10.1038/s41529-018-0037-2]; Graeve OA, 2008, MATER LETT, V62, P2988, DOI 10.1016/j.matlet.2008.01.092; Greer AL, 1993, STRUCTURAL RELAXATIO; HANCOCK BC, 1995, PHARMACEUT RES, V12, P799, DOI 10.1023/A:1016292416526; Hasegawa R, 2001, J NON-CRYST SOLIDS, V287, P405, DOI 10.1016/S0022-3093(01)00633-0; Hegedus J, 2008, NAT MATER, V7, P399, DOI 10.1038/nmat2157; HERMANS PH, 1950, J POLYM SCI, V5, P269, DOI 10.1002/pol.1950.120050301; HERMANS PH, 1948, J APPL PHYS, V19, P491, DOI 10.1063/1.1698162; Hohne GWH, 2003, DIFFERENTIAL SCANNIN; Hua NB, 2018, J ALLOY COMPD, V745, P111, DOI 10.1016/j.jallcom.2018.02.138; Huang L, 2015, ACTA BIOMATER, V25, P356, DOI 10.1016/j.actbio.2015.07.012; Huang YJ, 2009, J ALLOY COMPD, V479, P121, DOI 10.1016/j.jallcom.2008.12.074; Inoue A, 2005, P JPN ACAD B-PHYS, V81, P172, DOI 10.2183/pjab.81.172; Irifune T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13753; Jafary-Zadeh M, 2018, J FUNCT BIOMATER, V9, DOI 10.3390/jfb9010019; JCGM, 2008, EV MEAS DAT GUID EXP; Johnson WA, 1939, T AM I MIN MET ENG, V135, P416; Johnson WL, 2002, JOM-J MIN MET MAT S, V54, P40, DOI 10.1007/BF02822619; Katrakova D, 2002, PRAKT METALLOGR-PR M, V39, P644; Katrakova D, 2001, PRAKT METALLOGR-PR M, V38, P547; Kelly JP, 2015, JOM-US, V67, P29, DOI 10.1007/s11837-014-1202-x; Lei C, 2013, MICROSYST TECHNOL, V19, P167, DOI 10.1007/s00542-012-1523-z; Leshchyns'ka I, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6427537; Lewandowski JJ, 2005, PHIL MAG LETT, V85, P77, DOI 10.1080/09500830500080474; Li JY, 2019, ADV MATER, V31, DOI 10.1002/adma.201802120; Lin CG, 2018, PROG MATER SCI, V93, P1, DOI 10.1016/j.pmatsci.2017.11.001; Loke D, 2012, SCIENCE, V336, P1566, DOI 10.1126/science.1221561; Meagher P, 2016, ADV MATER, V28, P5755, DOI 10.1002/adma.201505347; Novitskaya E, 2018, MAT SCI ENG A-STRUCT, V717, P62, DOI 10.1016/j.msea.2018.01.076; Nowell MM, 2015, MICROSC MICROANAL, V11, P504, DOI [10.1017/s1431927698980485, DOI 10.1017/S1431927698980485]; Nunes C, 2005, PHARM RES-DORDR, V22, P1942, DOI 10.1007/s11095-005-7626-9; Paul T, 2018, J ALLOY COMPD, V753, P679, DOI 10.1016/j.jallcom.2018.04.133; RAY CS, 1991, J AM CERAM SOC, V74, P60, DOI 10.1111/j.1151-2916.1991.tb07297.x; Roura P, 2011, THERMOCHIM ACTA, V522, P161, DOI 10.1016/j.tca.2011.02.014; SALEKIGERHARDT A, 1994, INT J PHARM, V101, P237, DOI 10.1016/0378-5173(94)90219-4; SAUERBRUNN S, 1995, AM LAB, V27, P19; Schawe JEK, 2002, J THERM ANAL CALORIM, V68, P741, DOI 10.1023/A:1016033012403; Schawe JEK, 2017, THERMOCHIM ACTA, V657, P151, DOI 10.1016/j.tca.2017.09.006; Shamblin SL, 1998, PHARMACEUT RES, V15, P1828, DOI 10.1023/A:1011997721086; Sharma E, 2019, PHYSICA B, V562, P100, DOI 10.1016/j.physb.2019.03.019; Slipenyuk A, 2004, SCRIPTA MATER, V50, P39, DOI 10.1016/j.scriptamat.2003.09.038; Smith DS, 2017, NUCL ENG DES, V322, P331, DOI 10.1016/j.nucengdes.2017.07.016; Sreekanth KV, 2019, ADV OPT MATER, V7, DOI 10.1002/adom.201900081; Stephenson GA, 2001, ADV DRUG DELIVER REV, V48, P67, DOI 10.1016/S0169-409X(01)00099-0; Surana R, 2004, PHARM RES-DORDR, V21, P1167, DOI 10.1023/B:PHAM.0000033003.17251.c3; Trexler MM, 2010, PROG MATER SCI, V55, P759, DOI 10.1016/j.pmatsci.2010.04.002; VANDENBEUKEL A, 1990, ACTA METALL MATER, V38, P383, DOI 10.1016/0956-7151(90)90142-4; VANDENBEUKEL A, 1983, ACTA METALL MATER, V31, P419, DOI 10.1016/0001-6160(83)90219-5; Vasic MM, 2018, J NON-CRYST SOLIDS, V500, P326, DOI 10.1016/j.jnoncrysol.2018.08.017; Wang DJ, 2013, MAT SCI ENG A-STRUCT, V560, P841, DOI 10.1016/j.msea.2012.10.067; Wang P, 2016, SCI REP, V6, P1, DOI DOI 10.1038/s41598-016-0001-8; Wuttig M, 2007, NAT MATER, V6, P824, DOI 10.1038/nmat2009; Xu YB, 2019, J MATER RES TECHNOL, V8, P2486, DOI 10.1016/j.jmrt.2019.02.007; Yodoshi N, 2014, J ALLOY COMPD, V615, pS61, DOI 10.1016/j.jallcom.2013.12.256; Zhou X, 2013, CORROSION-US, V69, P781, DOI 10.5006/0870; Zhou X, 2018, SOLID EARTH SCI, V3, P16, DOI 10.1016/j.sesci.2017.12.002; Zhukova V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21356-3	73	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234774	10.1371/journal.pone.0234774	http://dx.doi.org/10.1371/journal.pone.0234774			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569283	Green Published, gold			2022-12-26	WOS:000543547900040
J	Hayashi, H; Yamashita, Y; Okabe, H; Imai, K; Higashi, T; Yamamura, K; Chikamoto, A; Beppu, T; Takamori, H; Baba, H				Hayashi, Hiromitsu; Yamashita, Yo-ichi; Okabe, Hirohisa; Imai, Katsunori; Higashi, Takaaki; Yamamura, Kensuke; Chikamoto, Akira; Beppu, Toru; Takamori, Hiroshi; Baba, Hideo			Varied application of intercostal trans-diaphragmatic ports for laparoscopic hepatectomy	PLOS ONE			English	Article							RESECTION; TROCARS	Background The ribcage and diaphragm are mechanical barriers for laparoscopic access during hepatectomy. Here, we introduce the varied application of intercostal trans-diaphragmatic ports during laparoscopic hepatectomy, and describe the management of intercostal ports with key technical points. Methods From January 2013 to December 2017, 180 patients underwent laparoscopic hepatectomy. In 32 of these patients (17.8%), intercostal ports (31 right and one left) were applied, and we analyzed the feasibility and safety of intercostal ports during laparoscopic hepatectomy. Results The main tumor location was segment VII and VIII (78%). The major type of laparoscopic hepatectomy was partial hepatectomy (91%). In the majority of cases (66%) the number and size of intercostal trocars was a single 5-mm port. The median operative time and blood loss were 232 min and 50 mL, respectively. A chest drain was placed via the hole of the intercostal port on the chest wall in two cases (6.3%). The median duration of the post-operative hospital stay was 6 days. There was no conversion, and a pure laparoscopic hepatectomy was achieved in all cases. There was no mortality. As for complications due to the application of intercostal ports, an asymptomatic pneumothorax was detected in only one case, and it was cured by conservative treatment. Conclusions The ribcage and diaphragm could be overcome as barriers to laparoscopic access by the placement of intercostal ports with minimal access during laparoscopic hepatectomy. The use of an intercostal port and proper management allows for a feasible approach and safe resection during laparoscopic hepatectomy.	[Hayashi, Hiromitsu; Yamashita, Yo-ichi; Okabe, Hirohisa; Imai, Katsunori; Higashi, Takaaki; Yamamura, Kensuke; Chikamoto, Akira; Baba, Hideo] Kumamoto Univ, Dept Gastroenterol Surg, Kumamoto, Japan; [Beppu, Toru] Yamaga City Hosp, Dept Surg, Kumamoto, Japan; [Takamori, Hiroshi] Saiseikai Kumamoto Hosp, Imperial Gift Fdn, Dept Surg, Kumamoto, Japan	Kumamoto University; Saiseikai Kumamoto Hospital	Hayashi, H (corresponding author), Kumamoto Univ, Dept Gastroenterol Surg, Kumamoto, Japan.	hhayasi@kumamoto-u.ac.jp		Hayashi, Hiromitsu/0000-0002-1832-4287				[Anonymous], 2015, NICOTINE TOB RES, V17, P299, DOI [10.1093/ntr/ntu144, DOI 10.1093/NTR/NTU144]; [Anonymous], 2014, NYU ENVTL LJ, V21; Ban D, 2014, J HEPATO-BIL-PAN SCI, V21, P745, DOI 10.1002/jhbp.166; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Hirokawa F, 2017, WORLD J SURG, V41, P1340, DOI 10.1007/s00268-016-3867-5; Ichida H, 2017, SURG ENDOSC, V31, P1280, DOI 10.1007/s00464-016-5107-3; Xiao L, 2015, SURG ENDOSC, V29, P2994, DOI 10.1007/s00464-015-4214-x	7	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234919	10.1371/journal.pone.0234919	http://dx.doi.org/10.1371/journal.pone.0234919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559223	Green Published, gold			2022-12-26	WOS:000543261600018
J	Kataria, J; Garner, LJ; Monu, EA; Wang, YF; Morey, A				Kataria, Jasmine; Garner, Laura J.; Monu, Emefa A.; Wang, Yifen; Morey, Amit			Investigating the effects of Functional Ice (FICE) onSalmonella-food safety, microbial spoilage and quality of raw poultry thigh meat during refrigerated storage	PLOS ONE			English	Article							SODIUM LACTATE; LISTERIA-MONOCYTOGENES; SHELF-LIFE; LACTIC-ACID; OBJECTIVE CHARACTERISTICS; BINDING-PROPERTIES; BREAST FILLETS; PERACETIC-ACID; TRIPOLYPHOSPHATE; SALMONELLA	In meat processing, antimicrobial treatment applied during slaughter and deboning may not control pathogens and spoilage organisms during subsequent transportation and storage. "Functional Ice" (FICE), an innovation over traditional ice, was investigated for its effects on food safety, shelf life, and quality of raw poultry thigh meat during refrigerated storage. FICE was prepared by freezing aqueous solutions of sodium tripolyphosphate (STPP) (2.5% and 5% w/v) and sodium lactate-sodium diacetate (SL-SD) (1% and 2.5% v/v). Potable water was used to prepare ice for the control treatment. Thigh meat inoculated withSalmonellaTyphimurium (10(8)CFU/sample) was placed in FICE treatments, stored at 4 degrees C and sampled at 0, 12, 24, 36 and 48 h (n = 375). Weight pick-up was recorded for the uninoculated thighs. Additionally, shelf life and quality were evaluated for 8 days on tray-packed thighs that were stored in FICE treatments for 48 h (STPP 5%, and SL-SD 2.5%). Differences among treatments were determined using ANOVA with LSMeans (p <= 0.05). Results indicated that inoculated thighs stored in individual STPP 5%, and SL-SD 2.5% treatments lead to a significant reduction inSalmonellaTyphimurium compared to the control (p <= 0.05) after 48 h of storage. FICE treated thighs showed higher yields, lower cook loss, and an extended shelf life of 1-2 days, without any color changes. FICE has the potential to improve food safety and shelf life while improving the yields and quality during storage and transportation of raw poultry meat.	[Kataria, Jasmine; Garner, Laura J.; Monu, Emefa A.; Morey, Amit] Auburn Univ, Dept Poultry Sci, Auburn, AL 36849 USA; [Wang, Yifen] Auburn Univ, Dept Biosyst Engn, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Morey, A (corresponding author), Auburn Univ, Dept Poultry Sci, Auburn, AL 36849 USA.	azm0011@auburn.edu		Morey, Amit/0000-0003-4726-8322	Alabama Agricultural Experiment Station (AAES); Hatch program of the National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture	Alabama Agricultural Experiment Station (AAES); Hatch program of the National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture	The research was supported through a grant award to Dr. Amit Morey from the Alabama Agricultural Experiment Station (AAES) and the Hatch program of the National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture. The funding agency did not make any decision or influence any decision on the experiment, experiment design, data collection, and where we can publish the manuscript.; This research was supported by Alabama Agricultural Experiment Station (AAES) and the Hatch program of the National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture.	Alvarado C, 2007, J APPL POULTRY RES, V16, P113, DOI 10.1093/japr/16.1.113; Baptista RC, 2020, FOOD RES INT, V127, DOI 10.1016/j.foodres.2019.108762; Bauermeister LJ, 2008, POULTRY SCI, V87, P2390, DOI 10.3382/ps.2008-00087; Bragg RJ, 2003, SAN ANTONIO EXPRESS, P1; Bunkova L., 2008, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V56, P19; Carroll CD, 2007, POULTRY SCI, V86, P150, DOI 10.1093/ps/86.1.150; Centers for Disease Control and Prevention, 2018, OUTBR SALM INF LINK; Cheng Q, 2008, CRIT REV FOOD SCI, V48, P137, DOI 10.1080/10408390601177647; DICKSON JS, 1992, J FOOD PROTECT, V55, P133, DOI 10.4315/0362-028X-55.2.133; Dominguez SA, 2009, J FOOD PROTECT, V72, P2088, DOI 10.4315/0362-028X-72.10.2088; ELLIOTT RP, 1964, APPL MICROBIOL, V12, P517, DOI 10.1128/AEM.12.6.517-522.1964; Fletcher DL, 2002, WORLD POULTRY SCI J, V58, P131, DOI 10.1079/WPS20020013; FOSTER RD, 1976, J APPL BACTERIOL, V41, P505, DOI 10.1111/j.1365-2672.1976.tb00663.x; Fratamico PM, 2012, J FOOD SCI, V77, pM285, DOI 10.1111/j.1750-3841.2012.02682.x; FRONING GW, 1965, POULTRY SCI, V44, P1104, DOI 10.3382/ps.0441104; Graham J, 1992, ICE FISHERIES; Harvey MS, 2007, United States Patent Application Publication, Patent No. [US 2007/0184155 A1, 20070184155]; Hill J. C., 1988, U.S. Patent, Patent No. [4,770,884., 4770884]; Jeyasekaran G., 2004, Innovative Food Science & Emerging Technologies, V5, P485, DOI 10.1016/j.ifset.2004.06.003; Kin S, 2011, J FOOD SCI, V76, pS242, DOI 10.1111/j.1750-3841.2011.02122.x; LAMBERT AD, 1991, FOOD MICROBIOL, V8, P267, DOI 10.1016/S0740-0020(05)80002-4; Lee N, 2015, POULTRY SCI, V94, P302, DOI 10.3382/ps/peu063; LEE RM, 1994, J FOOD PROTECT, V57, P289, DOI 10.4315/0362-028X-57.4.289; LEE RM, 1994, J FOOD PROTECT, V57, P276, DOI 10.4315/0362-028X-57.4.276; Li B, 2018, IEEE T RELIAB, V67, P1, DOI DOI 10.15585/MMWR.SS6706A1; Mbandi E, 2001, J FOOD PROTECT, V64, P640, DOI 10.4315/0362-028X-64.5.640; Morey A, 2014, J NUTR HLTH FOOD ENG, V1, P25, DOI [10.15406/jnhfe.2014.01.00005, DOI 10.15406/JNHFE.2014.01.00005]; Morey A, 2014, J FOOD SCI, V79, pM54, DOI 10.1111/1750-3841.12220; Nagel GM, 2013, INT J FOOD MICROBIOL, V165, P281, DOI 10.1016/j.ijfoodmicro.2013.05.016; PALUMBO SA, 1986, J FOOD PROTECT, V49, P1003, DOI 10.4315/0362-028X-49.12.1003; PAPADOPOULOS LS, 1991, J FOOD SCI, V56, P341, DOI 10.1111/j.1365-2621.1991.tb05276.x; Pechacek N, 2015, TOXICOL LETT, V233, P45, DOI 10.1016/j.toxlet.2014.12.014; Pintar K, 2007, J FOOD PROTECT, V70, P739, DOI 10.4315/0362-028X-70.3.739; RATHGEBER BM, 1995, J FOOD PROTECT, V58, P530, DOI 10.4315/0362-028X-58.5.530; Rouger A, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5030050; Saha A, 2009, POULTRY SCI, V88, P1250, DOI 10.3382/ps.2008-00236; SALMOND CV, 1984, J GEN MICROBIOL, V130, P2845; Shafit HM, 2010, POULTRY SCI, V89, P594, DOI 10.3382/ps.2009-00412; Shekarforoush SS, 2015, INT J BIOL MACROMOL, V76, P303, DOI 10.1016/j.ijbiomac.2015.02.033; SHELEF LA, 1994, J FOOD PROTECT, V57, P445, DOI 10.4315/0362-028X-57.5.445; Smaoui S, 2011, AFR J BIOTECHNOL, V10, P11317; Smith DP, 2007, POULTRY SCI, V86, P2666, DOI 10.3382/ps.2007-00144; Vareltzis K, 1997, FOOD SCI TECHNOL-LEB, V30, P665; Williams SK, 1998, POULTRY SCI, V77, P765, DOI 10.1093/ps/77.5.765; WILLIAMS SK, 1995, J FOOD SCI, V60, P636, DOI 10.1111/j.1365-2621.1995.tb09845.x; Wynveen EJ, 2001, J FOOD SCI, V66, P886, DOI 10.1111/j.1365-2621.2001.tb15191.x; Young LL, 1997, POULTRY SCI, V76, P1587, DOI 10.1093/ps/76.11.1587; YOUNG LL, 1987, J FOOD SCI, V52, P571, DOI 10.1111/j.1365-2621.1987.tb06677.x; ZEITOUN AAM, 1992, INT J FOOD MICROBIOL, V16, P89, DOI 10.1016/0168-1605(92)90001-J; 2000, FED REG, V65, P3121	50	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234781	10.1371/journal.pone.0234781	http://dx.doi.org/10.1371/journal.pone.0234781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559209	gold, Green Published			2022-12-26	WOS:000543261600061
J	Soos, J; Resch, MD; Berko, S; Kovacs, A; Katona, G; Facsko, A; Csanyi, E; Budai-Szucs, M				Soos, Judit; Resch, Miklos D.; Berko, Szilvia; Kovacs, Anita; Katona, Gabor; Facsko, Andrea; Csanyi, Erzsebet; Budai-Szucs, Maria			Comparison of hydrophilic ophthalmic media on silicone oil emulsification	PLOS ONE			English	Article							INTRAOCULAR SILICONE; COMPLICATIONS; REPLACEMENT; EYES	The aim of this study was to investigate whether and how the biological media which are in contact with silicone oil play a role in the silicone emulsification process. Commercially available Oxane 1300 silicone oil and potential hydrophilic phases of the emulsions in the eye (porcine aqueous humor, porcine vitreous and balanced salt solution) were investigated separately and in a mixture or emulsions by means of surface tension, rheological, zeta potential measurements and microscopic investigation. The surface tension of biological media (vitreous and aqueous humor) was significantly lower than that of non-biological media, especially in the case of aqueous humor, which indicates a remarkable emulsification tendency with these phases. The biological media are able to form both oil-in-water and water-in-oil emulsions, which can be observed in the clinical practice as well. It was established that the vitreous has a more expressed emulsification ability compared with the aqueous humor because smaller and more stable droplets can form with silicon oil when the vitreous is still there. It can be concluded that the vitreous has a higher impact on emulsification than the aqueous medium, which can predict that the vitreous remaining after vitrectomy has a key role in emulsion formation in the eye with silicone oil endotamponade.	[Soos, Judit; Facsko, Andrea] Univ Szeged, Dept Ophthalmol, Szeged, Hungary; [Soos, Judit] Univ Szeged, Doctoral Sch Clin Med, Szeged, Hungary; [Resch, Miklos D.] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary; [Berko, Szilvia; Kovacs, Anita; Katona, Gabor; Csanyi, Erzsebet; Budai-Szucs, Maria] Univ Szeged, Dept Pharmaceut Technol & Regulatory Affairs, Szeged, Hungary	Szeged University; Szeged University; Semmelweis University; Szeged University	Csanyi, E (corresponding author), Univ Szeged, Dept Pharmaceut Technol & Regulatory Affairs, Szeged, Hungary.	csanyi@pharm.u-szeged.hu	Berkó, Szilvia/AFM-7458-2022; Katona, Gabor/AFE-0796-2022	Berkó, Szilvia/0000-0002-3842-8876; Katona, Gabor/0000-0003-1564-4813	University of Szeged Open Access Fund [4520]	University of Szeged Open Access Fund	The publication was supported by The University of Szeged Open Access Fund (Fund Ref, Grant No. 4520) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMALY MF, 1962, ARCH OPHTHALMOL-CHIC, V68, P390, DOI 10.1001/archopht.1962.00960030394013; Azen SP, 1998, OPHTHALMOLOGY, V105, P1587, DOI 10.1016/S0161-6420(98)99023-6; Brunner S, 2011, GRAEF ARCH CLIN EXP, V249, P29, DOI 10.1007/s00417-010-1464-0; Chan YK, 2017, ACTA OPHTHALMOL, V95, pE385, DOI 10.1111/aos.13258; Chan YK, 2011, INVEST OPHTH VIS SCI, V52, P9721, DOI 10.1167/iovs.11-8586; CIBIS PA, 1962, ARCH OPHTHALMOL-CHIC, V68, P590; de Silva DJ, 2005, BRIT J OPHTHALMOL, V89, P1348, DOI 10.1136/bjo.2004.063768; FEDERMAN JL, 1988, OPHTHALMOLOGY, V95, P870, DOI 10.1016/s0161-6420(88)33080-0; Halberstadt M, 2006, KLIN MONATSBL AUGENH, V223, P361, DOI 10.1055/s-2006-926594; Hanaor D, 2012, J EUR CERAM SOC, V32, P235, DOI 10.1016/j.jeurceramsoc.2011.08.015; Heidenkummer H-P, 1992, RETINA, V12, P28; HEIDENKUMMER HP, 1991, GRAEF ARCH CLIN EXP, V229, P88, DOI 10.1007/BF00172269; Ichhpujani P, 2009, GRAEF ARCH CLIN EXP, V247, P1585, DOI 10.1007/s00417-009-1155-x; Jonas JB, 2001, J GLAUCOMA, V10, P102, DOI 10.1097/00061198-200104000-00006; Kruglyakov P. M., 2000, HYDROPHILE LIPOPHILE; Lakits A, 1999, OPHTHALMOLOGY, V106, P1091, DOI 10.1016/S0161-6420(99)90261-0; Lu YJ, 2019, ACTA OPHTHALMOL, V97, P313, DOI 10.1111/aos.13982; Mezger TG, 2006, RHEOLOGY HDB, P2; Miller JB, 2014, SEMIN OPHTHALMOL, V29, P312, DOI 10.3109/08820538.2014.962181; NAKAMURA K, 1990, INVEST OPHTH VIS SCI, V31, P647; Partenhauser A, 2017, J BIOMED MATER RES B, V105, P551, DOI 10.1002/jbm.b.33575; REFOJO MF, 1988, OPHTHALMOLOGY, V95, P614; RIEDEL KG, 1990, GRAEF ARCH CLIN EXP, V228, P19, DOI 10.1007/BF02764284; Toklu Y, 2012, RETINA-J RET VIT DIS, V32, P2039, DOI 10.1097/IAE.0b013e3182561f98	24	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0235067	10.1371/journal.pone.0235067	http://dx.doi.org/10.1371/journal.pone.0235067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559226	Green Accepted, gold, Green Published			2022-12-26	WOS:000543261600051
J	Chen, X; Wang, QC; Luo, C; Yang, Y; Jiang, H; Guo, XM; Chen, XP; Yang, JZ; Xu, KJ				Chen, Xi; Wang, Quanchuan; Luo, Cheng; Yang, Yong; Jiang, Hao; Guo, Xiangmei; Chen, Xipeng; Yang, Jiazhong; Xu, Kaijun			Increased functional dynamics in civil aviation pilots: Evidence from a neuroimaging study	PLOS ONE			English	Article							SCALE BRAIN NETWORKS; RISK PERCEPTION; AIRLINE PILOTS; CONNECTIVITY; EXPERIENCE; PATTERNS; STATES	Civil aviation is a distinctive career. Pilots need to monitor the entire system in real time. However, the psychophysiological mechanism of flying is largely unknown. The human brain is a large-scale interconnected organization, and many stable intrinsic large-scale brain networks have been identified. Among them are three core neurocognitive networks: default mode network (DMN), central executive network (CEN), and salience network (SN). These three networks play a critical role in human cognition. This study aims to examine the dynamic properties of the three large-scale brain networks in civil aviation pilots. We collected resting-state functional magnetic resonance imaging data from pilots. Independent component analysis, which is a data-driven approach, was combined with sliding window dynamic functional connectivity analysis to detect the dynamic properties of large-scale brain networks. Our results revealed that pilots exhibit an increased interaction of the CEN with the DMN and the SN along with a decreased interaction within the CEN. In addition, the temporal properties of functional dynamics (number of transitions) increased in pilots compared to healthy controls. In general, pilots exhibited increased between-network functional connectivity, decreased within-network functional connectivity, and a higher number of transitions. These findings suggest that pilots might have better functional dynamics and cognitive flexibility.	[Chen, Xi; Wang, Quanchuan; Yang, Yong; Jiang, Hao; Guo, Xiangmei; Chen, Xipeng; Yang, Jiazhong; Xu, Kaijun] Civil Aviat Flight Univ China, Inst Flight Technol, Guanghan, Peoples R China; [Luo, Cheng] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu, Peoples R China	Civil Aviation Flight University of China; University of Electronic Science & Technology of China	Yang, JZ; Xu, KJ (corresponding author), Civil Aviat Flight Univ China, Inst Flight Technol, Guanghan, Peoples R China.	Jiazhongyang@msn.com; k_j_xu@163.com	Luo, Cheng/A-4647-2015	Luo, Cheng/0000-0003-0524-5886; Jiang, Hao/0000-0002-4520-0394	National Nature Science Foundation of China [U1833130]; Foundation of General Program in Civil Aviation Flight University of China [XM3802]; Foundation of "Research Institute of Flight Training Safety Control and Service" Scientific research innovation team in Civil Aviation Flight University of China	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of General Program in Civil Aviation Flight University of China; Foundation of "Research Institute of Flight Training Safety Control and Service" Scientific research innovation team in Civil Aviation Flight University of China	This study was supported by the National Nature Science Foundation of China (No. U1833130) to Xi Chen, Foundation of General Program in Civil Aviation Flight University of China (XM3802), and Foundation of "Research Institute of Flight Training Safety Control and Service" Scientific research innovation team in Civil Aviation Flight University of China (Grant No. JG2019-15).	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Buckner RL, 2019, NAT REV NEUROSCI, V20, P593, DOI 10.1038/s41583-019-0212-7; Cao WF, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00070; Chen F, 2019, TUNN UNDERGR SP TECH, V92, DOI 10.1016/j.tust.2019.103034; Chen P, 2018, TRANS RES BOARD 97 A; Chen X, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01406; Chen X, 2016, PSYCHIAT RES-NEUROIM, V256, P26, DOI 10.1016/j.pscychresns.2016.09.006; Damaraju E, 2014, NEUROIMAGE-CLIN, V5, P298, DOI 10.1016/j.nicl.2014.07.003; Du YH, 2018, NEUROIMAGE, V180, P632, DOI 10.1016/j.neuroimage.2017.10.022; Fiorenzato E, 2019, BRAIN, V142, P2860, DOI 10.1093/brain/awz192; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gu S, 2015, P NATL ACAD SCI USA, V112, P13681, DOI 10.1073/pnas.1502829112; Jenkins JC, 2008, AVIAT SPACE ENVIR MD, V79, P397, DOI 10.3357/ASEM.2195.2008; Ji M, 2018, J SAFETY RES, V66, P161, DOI 10.1016/j.jsr.2018.07.005; Jiang YC, 2017, PROG NEURO-PSYCHOPH, V79, P302, DOI 10.1016/j.pnpbp.2017.07.007; Kearney P, 2019, ERGONOMICS, V62, P305, DOI 10.1080/00140139.2018.1493151; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Laboratoire de Microbiologie d'Actalia Cecalait, 2015, NEW FOOD MAGAZINE, V16, P55; Lee WH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16789-1; Manoliu A, 2014, SCHIZOPHRENIA BULL, V40, P428, DOI 10.1093/schbul/sbt037; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Navarro J, 2018, NEUROSCI BIOBEHAV R, V95, P464, DOI 10.1016/j.neubiorev.2018.10.016; Nomi JS, 2017, NEUROIMAGE, V147, P861, DOI 10.1016/j.neuroimage.2016.10.026; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Ryali S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005138; Satterthwaite TD, 2015, CEREB CORTEX, V25, P2383, DOI 10.1093/cercor/bhu036; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; You XQ, 2013, ACCIDENT ANAL PREV, V57, P131, DOI 10.1016/j.aap.2013.03.036; Zalesky A, 2015, NEUROIMAGE, V114, P466, DOI 10.1016/j.neuroimage.2015.03.047	36	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234790	10.1371/journal.pone.0234790	http://dx.doi.org/10.1371/journal.pone.0234790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555721	Green Published, gold			2022-12-26	WOS:000543273200013
J	Boissinot, M; King, H; Adams, M; Higgins, J; Shaw, G; Ward, TA; Steele, LP; Tams, D; Morton, R; Polson, E; da Silva, B; Droop, A; Hayes, JL; Martin, H; Laslo, P; Morrison, E; Tomlinson, DC; Wurdak, H; Bond, J; Lawler, SE; Short, SC				Boissinot, M.; King, H.; Adams, M.; Higgins, J.; Shaw, G.; Ward, T. A.; Steele, L. P.; Tams, D.; Morton, R.; Polson, E.; da Silva, B.; Droop, A.; Hayes, J. L.; Martin, H.; Laslo, P.; Morrison, E.; Tomlinson, D. C.; Wurdak, H.; Bond, J.; Lawler, S. E.; Short, S. C.			Profiling cytotoxic microRNAs in pediatric and adult glioblastoma cells by high-content screening, identification, and validation of miR-1300	ONCOGENE			English	Article							CLEAVAGE FURROW FORMATION; EXCHANGE FACTORS; ECT2; TARGETS; POLYPLOIDIZATION; PATHWAYS; MIRBASE; MEDIATE; TRIO	MicroRNAs play an important role in the regulation of mRNA translation and have therapeutic potential in cancer and other diseases. To profile the landscape of microRNAs with significant cytotoxicity in the context of glioblastoma (GBM), we performed a high-throughput screen in adult and pediatric GBM cells using a synthetic oligonucleotide library representing all known human microRNAs. Bioinformatics analysis was used to refine this list and the top seven microRNAs were validated in a larger panel of GBM cells using state-of-the-art in vitro assays. The cytotoxic effect of our most relevant candidate was assessed in a preclinical model. Our screen identified similar to 100 significantly cytotoxic microRNAs with 70% concordance between cell lines. MicroRNA-1300 (miR-1300) was the most potent and robust candidate. We observed a striking binucleated phenotype in miR-1300 transfected cells due to cytokinesis failure followed by apoptosis. This was also observed in two stem-like patient-derived cultures. We identified the physiological role of miR-1300 as a regulator of endomitosis in megakaryocyte differentiation where blockade of cytokinesis is an essential step. In GBM cells, where miR-1300 is normally not expressed, the oncogene Epithelial Cell Transforming 2 (ECT2) was validated as a direct key target. ECT2 siRNA phenocopied the effects of miR-1300, and ECT2 overexpression led to rescue of miR-1300 induced binucleation. We showed that ectopic expression of miR-1300 led to decreased tumor growth in an orthotopic GBM model. Our screen provides a resource for the neuro-oncology community and identified miR-1300 as a novel regulator of endomitosis with translatable potential for therapeutic application.	[Boissinot, M.; Higgins, J.; Shaw, G.; Ward, T. A.; Steele, L. P.; Tams, D.; Hayes, J. L.; Lawler, S. E.; Short, S. C.] Univ Leeds, St Jamess Hosp, Leeds Inst Med Res, Radiat Biol & Therapy Grp, Leeds LS9 7TF, W Yorkshire, England; [King, H.; Adams, M.; Tomlinson, D. C.; Bond, J.] Univ Leeds, St Jamess Hosp, BioScreening Technol Grp, Leeds LS9 7TF, W Yorkshire, England; [Tams, D.] Babraham, Roslin Cell Sci, Cambridge CB22 3AT, England; [Morton, R.; Polson, E.; da Silva, B.; Wurdak, H.] Univ Leeds, St Jamess Hosp, Leeds Inst Med Res, Stem Cells & Brain Tumour Res Grp, Leeds LS9 7TF, W Yorkshire, England; [Droop, A.] Univ Leeds, MRC Med Bioinformat Ctr, Clarendon Way, Leeds LS2 9NL, W Yorkshire, England; [Hayes, J. L.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Martin, H.; Tomlinson, D. C.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Laslo, P.] Univ Leeds, St Jamess Hosp, Leeds Inst Med Res, Myeloid Differentiat Grp, Leeds LS9 7TF, W Yorkshire, England; [Morrison, E.] Univ Leeds, St Jamess Hosp, Leeds Inst Med Res, Cell Biol Res Grp, Leeds LS9 7TF, W Yorkshire, England; [Bond, J.] Univ Leeds, St Jamess Hosp, Leeds Inst Med Res, Microcephaly & Neurogenesis Res Grp, Leeds LS9 7TF, W Yorkshire, England; [Lawler, S. E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Harvey Cushing Neurooncol Labs, Boston, MA 02115 USA; [Short, S. C.] Univ Leeds, St Jamess Hosp, St Jamess Inst Oncol, Leeds LS9 7TF, W Yorkshire, England; [Short, S. C.] Univ Leeds, St Jamess Hosp, Leeds Inst Med Res, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Saint James's University Hospital; University of Leeds; University of Leeds; University of California System; University of California Berkeley; University of Leeds; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds	Lawler, SE; Short, SC (corresponding author), Univ Leeds, St Jamess Hosp, Leeds Inst Med Res, Radiat Biol & Therapy Grp, Leeds LS9 7TF, W Yorkshire, England.; Lawler, SE (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Harvey Cushing Neurooncol Labs, Boston, MA 02115 USA.; Short, SC (corresponding author), Univ Leeds, St Jamess Hosp, St Jamess Inst Oncol, Leeds LS9 7TF, W Yorkshire, England.; Short, SC (corresponding author), Univ Leeds, St Jamess Hosp, Leeds Inst Med Res, Leeds LS9 7TF, W Yorkshire, England.	SLAWLER@bwh.harvard.edu; S.C.Short@leeds.ac.uk		Ward, Thomas/0000-0003-0937-4554; Boissinot, Marjorie/0000-0002-5241-2520; Wurdak, Heiko/0000-0003-4385-4324; Martin, Heather/0000-0002-5455-4434; Short, Susan/0000-0003-4423-7256	UK-based charities Yorkshire Cancer Research [L369]; Brain Tumor Charity [13/192]; Brain Tumor Research and Support Yorkshire; Candle-lighters; MRC [MR/J001171/1] Funding Source: UKRI	UK-based charities Yorkshire Cancer Research; Brain Tumor Charity; Brain Tumor Research and Support Yorkshire; Candle-lighters; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was supported by the UK-based charities Yorkshire Cancer Research (award L369 SEL, DCT), The Brain Tumor Charity (Program reference number 13/192 SCS), Candle-lighters and Brain Tumor Research and Support Yorkshire (SEL).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ahir BK, 2017, CRIT REV ONCOL HEMAT, V120, P22, DOI 10.1016/j.critrevonc.2017.10.003; Alexander BM, 2017, J CLIN ONCOL, V35, P2402, DOI 10.1200/JCO.2017.73.0119; Banelli B, 2017, INT J GENOMICS, V2017, DOI 10.1155/2017/7639084; Bastos RN, 2012, J CELL BIOL, V198, P865, DOI 10.1083/jcb.201204107; Bhaskaran V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08390-z; Brower JV, 2014, NEUROCHEM INT, V77, P68, DOI 10.1016/j.neuint.2014.06.002; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Castoreno AB, 2010, NAT CHEM BIOL, V6, P457, DOI 10.1038/nchembio.363; Chalamalasetty RB, 2006, J CELL SCI, V119, P3008, DOI 10.1242/jcs.03032; Chen LY, 2015, ONCOTARGET, V6, P38628, DOI 10.18632/oncotarget.5926; Eulalio A, 2015, J BIOMOL SCREEN, V20, P1003, DOI 10.1177/1087057115578837; Fields AP, 2010, ADV ENZYME REGUL, V50, P190, DOI 10.1016/j.advenzreg.2009.10.010; Fortin SP, 2012, MOL CANCER RES, V10, P958, DOI 10.1158/1541-7786.MCR-11-0616; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao Y, 2012, DEV CELL, V22, P573, DOI 10.1016/j.devcel.2011.12.019; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Godlewski J, 2010, CELL DEATH DIFFER, V17, P221, DOI 10.1038/cdd.2009.71; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Katsushima K, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00014; King HO, 2017, STEM CELL REP, V8, P125, DOI 10.1016/j.stemcr.2016.12.005; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krichevsky AM, 2019, NEUROTHERAPEUTICS, V16, P319, DOI 10.1007/s13311-018-00702-3; Lannutti BJ, 2005, BLOOD, V105, P3875, DOI 10.1182/blood-2004-10-3934; LeBlanc VC, 2015, J CLIN MED, V4, P1612, DOI 10.3390/jcm4081612; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Mercatelli N, 2017, INT REV CEL MOL BIO, V333, P269, DOI 10.1016/bs.ircmb.2017.03.002; Moskwa P, 2014, MOL CANCER RES, V12, P1767, DOI 10.1158/1541-7786.MCR-14-0268; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Nam JW, 2014, MOL CELL, V53, P1031, DOI 10.1016/j.molcel.2014.02.013; Normand G, 2010, ADV EXP MED BIOL, V676, P27; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Polson ES, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2718; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Sana J, 2011, J CELL MOL MED, V15, P1636, DOI 10.1111/j.1582-4934.2011.01317.x; Sano M, 2006, ONCOL REP, V16, P1093; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Su KC, 2011, DEV CELL, V21, P1104, DOI 10.1016/j.devcel.2011.11.003; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Wen Q, 2012, CELL, V150, P575, DOI 10.1016/j.cell.2012.06.032; Westphal M, 2015, NAT REV NEUROL, V11, P556, DOI 10.1038/nrneurol.2015.171; Wurdak H, 2010, CELL STEM CELL, V6, P37, DOI 10.1016/j.stem.2009.11.002	48	2	2	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 23	2020	39	30					5292	5306		10.1038/s41388-020-1360-y	http://dx.doi.org/10.1038/s41388-020-1360-y		JUN 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MO5BV	32555332	Green Published, hybrid			2022-12-26	WOS:000545371000004
J	Shalizi, A; Wiegers, TN; Maamar, H				Shalizi, Aryaman; Wiegers, Toni N.; Maamar, Hedia			Click-to-Capture: A method for enriching viableStaphylococcus aureus using bio-orthogonal labeling of surface proteins	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; EPIDEMIOLOGY; CHEMISTRY; SEPSIS	Staphylococcus aureusis one of the principal causative agents of bacteremia which can progress to sepsis. Rapid diagnostic tests for identification and antibiotic resistance profiling ofS.aureuswould improve patient outcomes and antibiotic stewardship, but existing methods require a lengthy culture step to obtain enough material for testing. Complexity of the host matrix, where pathogenic microbes are often present, also interferes with many diagnostic methods. Here, we describe a straightforward and rapid method for enriching viableS.aureususing bio-orthogonal, or "click," chemistry methods. Bacteria labeled in this manner can potentially be cultured, interrogated using molecular methods for pathogen identification, or used to test antibiotic susceptibility.	[Shalizi, Aryaman; Wiegers, Toni N.; Maamar, Hedia] Talis Biomed Corp, Dept Assay Dev, Menlo Pk, CA 94025 USA		Maamar, H (corresponding author), Talis Biomed Corp, Dept Assay Dev, Menlo Pk, CA 94025 USA.	hmaamar@talisbio.com		Shalizi, Aryaman/0000-0001-9226-0800	National Institute Of Allergy And Infectious Diseases of the National Institutes of Health [R01AI139005]; Talis Biomedical corporation; Talis Biomedical Corporation	National Institute Of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Talis Biomedical corporation; Talis Biomedical Corporation	Research reported in this publication was supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number R01AI139005. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. It was also supported by Talis Biomedical corporation. Talis Biomedical Corporation provided support in the form of salaries for authors [AS, TW and HM] and therefor was involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section'.	[Anonymous], 2017, LANCET HIV, V2, pe115; Baboo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099346; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Cartwright M, 2016, EBIOMEDICINE, V9, P217, DOI 10.1016/j.ebiom.2016.06.014; de Sousa MA, 2004, FEMS IMMUNOL MED MIC, V40, P101, DOI 10.1016/S0928-8244(03)00370-5; Fratila RM, 2017, NEW J CHEM, V41, P10835, DOI 10.1039/c7nj01822c; Fugier E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127700; Gerlach D, 2018, NATURE, V563, P705, DOI 10.1038/s41586-018-0730-x; Hilmi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096416; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Khanna S, 2016, EXPERT REV GASTROENT, V10, P1145, DOI 10.1586/17474124.2016.1158097; Kopp BJ, 2004, ANN PHARMACOTHER, V38, P1377, DOI 10.1345/aph.1E028; Lallana E, 2011, ANGEW CHEM INT EDIT, V50, P8794, DOI 10.1002/anie.201101019; Lamy B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00697; Mahla RS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00248; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; Metan G, 2005, J HOSP INFECT, V61, P93, DOI 10.1016/j.jhin.2005.02.020; Monaco M, 2017, CURR TOP MICROBIOL, V409, P21, DOI 10.1007/82_2016_3; O'Neill J, 2015, RAPID DIAGNOSTICS ST; ONeill J., 2016, TACKLING DRUG RESIST; Opota O, 2015, CLIN MICROBIOL INFEC, V21, P323, DOI 10.1016/j.cmi.2015.02.005; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Reddy Prakash Narayana, 2017, Infect Dis (Auckl), V10, p1179916117703999, DOI 10.1177/1179916117703999; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Shorr AF, 2007, PHARMACOECONOMICS, V25, P751, DOI 10.2165/00019053-200725090-00004; van Belkum A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01437; Wang MC, 2015, J MICROBIOL IMMUNOL, V48, P419, DOI 10.1016/j.jmii.2013.10.006; Wypych TP, 2018, TRENDS IMMUNOL, V39, P697, DOI 10.1016/j.it.2018.02.008; YAGUPSKY P, 1990, CLIN MICROBIOL REV, V3, P269, DOI 10.1128/CMR.3.3.269-279.1990; Zhang SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136082	32	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234542	10.1371/journal.pone.0234542	http://dx.doi.org/10.1371/journal.pone.0234542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555702	Green Published, gold			2022-12-26	WOS:000542759600061
J	Bhanbhro, S; Kamal, T; Diyo, RW; Lipoeto, NI; Soltani, H				Bhanbhro, Sadiq; Kamal, Tahira; Diyo, Ratno W.; Lipoeto, Nur Indrawaty; Soltani, Hora			Factors affecting maternal nutrition and health: A qualitative study in a matrilineal community in Indonesia	PLOS ONE			English	Article							PREGNANCY; IRON; ANEMIA; WOMEN	The Minangkabau people of West Sumatra in Indonesia are renowned for their matrilineal culture with property and land passing down from mother to daughter. Despite there being a fairly balanced social status for women in the community, the impact of health inequalities is uneven. This study was therefore carried out to explore the relationship between the social, cultural and economic contexts in such a distinctive community with maternal nutrition and pregnancy-related health outcomes, from the perspectives of the mothers, fathers and care providers. Qualitative methods were used to undertake this study in collaboration with partners from the University of Andalas in a suburban area of Padang district. The data collection method was qualitative, semi-structured interviews (n = 19) with women, men, midwives and community health workers. The data were recorded with informed consent, transcribed in the local language and then translated into English prior to being thematically analysed. The major themes which emerged from the data included 'Minangkabau matrilineality and role of women'; 'culture and supportive attitude towards pregnant women'; 'dietary patterns, attitude and access to food'; and 'limited access to information about food and nutrition'. The findings showed healthy dietary patterns such as regular consumption of vegetables and fruit among the participants. However, the issues of poverty, access to food, dietary taboos and inadequate nutritional information remained major challenges for the mothers and the families who participated in the study. The evidence from this study suggests that the matrilineal culture of the Minangkabau promotes the empowerment of women and offers an encouraging environment for enhancing reproductive health. This lends itself to co-developing locally sensitive and sustainable complex interventions incorporating professional support and building on family and community back-up, enhancing knowledge and demystifying dietary misinformation to improve maternal health and nutrition.	[Bhanbhro, Sadiq; Soltani, Hora] Sheffield Hallam Univ, Coll Hlth & Wellbeing & Life Sci, Sheffield, S Yorkshire, England; [Kamal, Tahira] Bolan Univ Med & Hlth Sci, Dept Community Med, Quetta, Balochistan, Pakistan; [Diyo, Ratno W.; Lipoeto, Nur Indrawaty] Andalas Univ, Fac Publ Hlth, Padang, West Sumatra, Indonesia	Sheffield Hallam University; Universitas Andalas	Bhanbhro, S (corresponding author), Sheffield Hallam Univ, Coll Hlth & Wellbeing & Life Sci, Sheffield, S Yorkshire, England.	S.bhanbhro@shu.ac.uk	Bhanbhro, Sadiq/I-3038-2014	Bhanbhro, Sadiq/0000-0003-0771-8130; Widoyo, Ratno/0000-0001-7606-7680; lipoeto, nurindrawaty/0000-0003-4119-3593	British Council under Researcher Links travel grant scheme [127406428]; British Council; Faculty of Public Health Andalas University	British Council under Researcher Links travel grant scheme; British Council(The British Council in India); Faculty of Public Health Andalas University	SB received the funding for this work. The grant number awarded was 127406428. The funding was awarded by the British Council under Researcher Links travel grant scheme. URL of the funder https://www.britishcouncil.org/education/science/researcher-links.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Therefore, the opinions expressed are the authors' own.; We would like to thank our funders the British Council and the Dean and staff of Faculty of Public Health Andalas University for their support for the study. We would also like to thank Widari Iqbal (WI) and Jihan Faradisha (JF) for the data collection. Thanks to all the participants for their time and cooperation.	Abbaspour N, 2014, J RES MED SCI, V19, P164; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; [Anonymous], 2016, J LARGE SCALE RES FA, V2, pA49; [Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; [Anonymous], 2011, HEART ADVIS, V14, P5; Blackwood E., 2000, WEBS POWER WOMEN KIN; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Braveman P, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/00333549141291S206; Chakrabarti S, 2019, J FAM MED PRIM CARE, V8, P86, DOI 10.4103/jfmpc.jfmpc_53_17; Colwell J, 2004, 3 INT C AGR STAT ICA; Diana R., 2018, Journal of Ethnic Foods, V5, P246, DOI 10.1016/j.jef.2018.10.006; Frith H., 2004, PSYCHOL MEN MASCULIN, V5, P40, DOI [10.1037/1524-9220.5.1.40, DOI 10.1037/1524-9220.5.1.40]; Hartini TNS, 2005, SOC SCI MED, V61, P199, DOI 10.1016/j.socscimed.2004.11.043; Higginbottom GMA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0370-6; Lau Y, 2013, J NURS MEAS, V21, P120, DOI 10.1891/1061-3749.21.1.120; Lipoeto NI, 2001, ASIA PAC J CLIN NUTR, V10, P10, DOI 10.1046/j.1440-6047.2001.00201.x; Meyer-Rochow VB, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-18; ONU, 2015, TRANSF OUR WORLD 203; Patton MQ., 2002, QUALITATIVE RES EVAL, V3rd; Sanday PR, 2002, WOMEN CTR LIFE MODER; Santos-Torres MI, 2003, J HEALTH POPUL NUTR, V21, P142; Singer M, 2018, CRITICAL MED ANTHR; Soltani H, 2005, BR J MIDWIFERY, V13, P633, DOI [DOI 10.12968/BJOM.2005.13.10.19838, DOI 10.12968/bjom.2005.13.10.19838]; Soltani H, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0455-2; Suryadarma D, 2006, ACCESS INCOME REGION; Szwajcer EM, 2005, EUR J CLIN NUTR, V59, pS57, DOI 10.1038/sj.ejcn.1602175; The Lancet HIV, 2016, LANCET HIV, V3, pe191; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Trisnantoro L., 2017, REPUBLIC INDONESIA H, V7; Unicef Indonesia Country Office, 2012, UNICEF ANN REP 2012; van Dillen SME, 2003, AM J CLIN NUTR, V77, p1065S, DOI 10.1093/ajcn/77.4.1065S; Wijaya-Erhardt M, 2011, PUBLIC HEALTH NUTR, V14, P2185, DOI 10.1017/S1368980011000954; World Bank Group, 2018, LIF EXP BIRTH TOT YE; World Health Organisation, 2018, MAT MORT KEY FACTS; Wulandari LPL, 2011, MIDWIFERY, V27, P867, DOI 10.1016/j.midw.2010.09.005; Xiong X, 2000, AM J PERINAT, V17, P137, DOI 10.1055/s-2000-9508; 2003, METABOLIZMUS SA, V6	37	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234545	10.1371/journal.pone.0234545	http://dx.doi.org/10.1371/journal.pone.0234545			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB9ZQ	32544180	Green Published, gold, Green Accepted			2022-12-26	WOS:000542957200041
J	Moon, HR; Ospina-Munoz, N; Noe-Kim, V; Yang, Y; Elzey, BD; Konieczny, SF; Han, B				Moon, Hye-ran; Ospina-Munoz, Natalia; Noe-Kim, Victoria; Yang, Yi; Elzey, Bennett D.; Konieczny, Stephen F.; Han, Bumsoo			Subtype-specific characterization of breast cancer invasion using a microfluidic tumor platform	PLOS ONE			English	Article							CARCINOMA IN-SITU; DUCTAL CARCINOMA; CELL-MIGRATION; GENOME EVOLUTION; CD24 EXPRESSION; VITRO MODEL; PROGRESSION; IDENTIFICATION; HETEROGENEITY; METASTASIS	Understanding progression of breast cancers to invasive ductal carcinoma (IDC) can significantly improve breast cancer treatments. However, it is still difficult to identify genetic signatures and the role of tumor microenvironment to distinguish pathological stages of pre-invasive lesion and IDC. Presence of multiple subtypes of breast cancers makes the assessment more challenging. In this study, anin-vitromicrofluidic assay was developed to quantitatively assess the subtype-specific invasion potential of breast cancers. The developed assay is a microfluidic platform in which a ductal structure of epithelial cancer cells is surrounded with a three-dimensional (3D) collagen matrix. In the developed platform, two triple negative cancer subtypes (MDA-MB-231 and SUM-159PT) invaded into the surrounding matrix but the luminal A subtype, MCF-7, did not. Among invasive subtypes, SUM-159PT cells showed significantly higher invasion and degradation of the surrounding matrix than MDA-MB-231. Interestingly, the cells cultured on the platform expressed higher levels of CD24 than in their conventional 2D cultures. This microfluidic platform may be a useful tool to characterize and predict invasive potential of breast cancer subtypes or patient-derived cells.	[Moon, Hye-ran; Ospina-Munoz, Natalia; Noe-Kim, Victoria; Han, Bumsoo] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Ospina-Munoz, Natalia] Univ Nacl Colombia, Sch Med, Cellular & Mol Physiol Grp, Bogota, DC, Colombia; [Yang, Yi; Konieczny, Stephen F.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Elzey, Bennett D.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Elzey, Bennett D.; Konieczny, Stephen F.; Han, Bumsoo] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA; [Han, Bumsoo] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universidad Nacional de Colombia; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Han, B (corresponding author), Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA.; Han, B (corresponding author), Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA.; Han, B (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	bumsoo@purdue.edu	Moon, Hye-ran/AAL-8678-2021; Ospina-Muñoz, Natalia/AAV-7645-2020	Moon, Hye-ran/0000-0001-7456-6398; 	NIH [HHSN261201400021C]; CTR Award from Indiana CTSI - NIH [UL1 TR000006]; Phase I grant from the Purdue University Center for Cancer Research; Walther Cancer Foundation; Purdue University Center for Cancer Research, NIH grant [P30 CA023168]; COLCIENCIAS	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTR Award from Indiana CTSI - NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Phase I grant from the Purdue University Center for Cancer Research; Walther Cancer Foundation; Purdue University Center for Cancer Research, NIH grant; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was partially supported by NIH HHSN261201400021C, a CTR Award from Indiana CTSI funded in part by UL1 TR000006 from NIH, a Phase I grant from the Purdue University Center for Cancer Research, and a grant from Walther Cancer Foundation. The confocal microscopy was by a Shared Resource Award from the Purdue University Center for Cancer Research, NIH grant P30 CA023168. Natalia Ospina-Munoz was partially supported by COLCIENCIAS. National PhD, Call 647 Year 2015.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Albanese A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3718; American Cancer S, 2016, GLOB BURD CANC WOM C; [Anonymous], 2015, J OPER OCEANOGR, V8, ps80, DOI 10.1080/1755876X.2015.1022329; [Anonymous], 2009, TANZAN J HLTH RES, V11, piii; Badve S, 2011, MODERN PATHOL, V24, P157, DOI 10.1038/modpathol.2010.200; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barrio AV, 2017, ANNU REV MED, V68, P197, DOI 10.1146/annurev-med-050715-104920; Barton VN, 2015, MOL CANCER THER, V14, P769, DOI 10.1158/1535-7163.MCT-14-0926; Bersini S, 2014, BIOMATERIALS, V35, P2454, DOI 10.1016/j.biomaterials.2013.11.050; Bircan S, 2006, PATHOL RES PRACT, V202, P569, DOI 10.1016/j.prp.2006.05.004; Bischel LL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1007-5; Bischel LL, 2013, BIOMATERIALS, V34, P1471, DOI 10.1016/j.biomaterials.2012.11.005; Casasent AK, 2017, J PATHOL, V241, P208, DOI 10.1002/path.4840; Chavez Kathryn J, 2010, Breast Dis, V32, P35, DOI 10.3233/BD-2010-0307; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Choi Y, 2015, LAB CHIP, V15, P3350, DOI 10.1039/c5lc00514k; Clark SE, 2011, BRIT J CANCER, V104, P120, DOI 10.1038/sj.bjc.6606021; Cowell CF, 2013, MOL ONCOL, V7, P859, DOI 10.1016/j.molonc.2013.07.005; De Donatis A, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-20; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gorringe KL, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00248; Hernandez L, 2012, J PATHOL, V227, P42, DOI 10.1002/path.3990; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Hua M, 2009, P NATL ACAD SCI USA, V106, P3372, DOI 10.1073/pnas.0813306106; Kim SY, 2015, ONCOTARGET, V6, P7597, DOI 10.18632/oncotarget.3162; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Kroigard AB, 2015, ONCOTARGET, V6, P5634, DOI 10.18632/oncotarget.3111; Kwak B, 2014, J CONTROL RELEASE, V194, P157, DOI 10.1016/j.jconrel.2014.08.027; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Meyer MJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2449; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Onega T, 2017, EUR J CANCER, V80, P39, DOI 10.1016/j.ejca.2017.04.013; Ozcelikkale A, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0287; Ozcelikkale A, 2017, J CONTROL RELEASE, V266, P129, DOI 10.1016/j.jconrel.2017.09.024; Ozcelikkale A, 2017, WIRES NANOMED NANOBI, V9, DOI 10.1002/wnan.1460; Prat A, 2013, BREAST CANCER RES TR, V142, P237, DOI 10.1007/s10549-013-2743-3; Semenza GL, 2012, TRENDS MOL MED, V18, P534, DOI 10.1016/j.molmed.2012.08.001; Shih WT, 2012, J CELL SCI, V125, P3661, DOI 10.1242/jcs.103861; Shin K, 2016, MOL PHARMACEUT, V13, P2214, DOI 10.1021/acs.molpharmaceut.6b00131; Sung KE, 2011, INTEGR BIOL-UK, V3, P439, DOI 10.1039/c0ib00063a; Sung KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076373; Tsai HF, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0137; Valdez KE, 2011, J PATHOL, V225, P565, DOI 10.1002/path.2969; Van Bockstal Mieke, 2014, Oncoscience, V1, P634; Vargas AC, 2012, BREAST CANCER RES TR, V135, P153, DOI 10.1007/s10549-012-2123-4; Wang H, 2017, ONCOL LETT, V14, P5890, DOI 10.3892/ol.2017.6959	51	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234012	10.1371/journal.pone.0234012	http://dx.doi.org/10.1371/journal.pone.0234012			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544183	Green Published, gold			2022-12-26	WOS:000542957200031
J	Cabezas, C; Trujillo, O; Gonzales-Vivanco, A; Villafane, CMB; Balbuena, J; Borda-Olivas, AO; Suarez-Jara, MA; Peceros, FD; Ramirez-Soto, MC				Cabezas, Cesar; Trujillo, Omar; Gonzales-Vivanco, Angel; Benites Villafane, Carlos Manuel; Balbuena, Johanna; Oswaldo Borda-Olivas, Alfredo; Aurora Suarez-Jara, Magna; de Maria Peceros, Flor; Carlos Ramirez-Soto, Max			Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study	PLOS ONE			English	Article							PREVALENCE; SEROPREVALENCE; ANTIBODIES	Background Viral hepatitis (hepatitis A, B, C, D and E) remains a public health problem in Peru, with a high disease burden. There are limited data on the prevalence of viral hepatitis at a national level, and none reported for over two decades. In this study, the prevalence rates of hepatitis A (HAV), B (HBV), C (HCV), D (HDV) and E virus (HEV) infections in the Peruvian population were determined to provide updated baseline data that would help guide the development of strategies aimed at reducing the transmission of viral hepatitis in Peru. Methods We conducted a cross-sectional, population-based study in the 25 regions of Peru. The study included participants of both sexes, aged 15-69 years, who had lived for >6 months in a specific region of Peru. Serum samples were analyzed by ELISA for anti-HAV (IgG), anti-HBs >= 10 mUI/ml, anti-HCV, anti-HDV and anti-HEV (IgG) antibodies, and by chemiluminescence for the HBV surface antigen (HBsAg) and antibodies against the core HBV antigen (anti-HBc IgM and IgG). Results In a total of 5183 study participants, the prevalence rates of anti-HAV (IgG), HBsAg, total anti-HBc IgG, anti-HBs >= 10 mUI/ml, anti-HCV and anti-HEV (IgG) were 98.4% [95% confidence interval (CI) 98.0-98.7), 0.4% (95% CI 0.21-0.55), 10.1% (95% CI 9.4-11.0), 60% (95% CI 58.5-61.2), 0.1% (95% CI 0.02-0.25), and 14% (95% CI 13.1-15.0%), respectively. The prevalence of anti-HDV among HBsAg carriers was 15% (3/20). Conclusions The prevalence of HAV and HEV in the population aged 15-69 years in Peru is high, while the prevalence of HBV and HDV has changed from intermediate to low endemicity level and the prevalence of HCV is low. These findings would prove useful in the development of new strategies aimed at reducing the transmission of viral hepatitis in Peru, with a view to ultimately eliminating these infections in the future.	[Cabezas, Cesar; Balbuena, Johanna; Aurora Suarez-Jara, Magna; de Maria Peceros, Flor; Carlos Ramirez-Soto, Max] Inst Nacl Salud, Ctr Nacl Salud Publ, Lima, Peru; [Trujillo, Omar] Inst Nacl Salud, Ctr Nacl Salud Intercultural, Lima, Peru; [Gonzales-Vivanco, Angel; Benites Villafane, Carlos Manuel] Minist Salud, VIH SIDA & Hepatitis B, Estrategia Sanitaria Prevenc & Control Infecc Tra, Lima, Peru; [Oswaldo Borda-Olivas, Alfredo] Inst Nacl Salud Nino San Borja, Lima, Peru; [Cabezas, Cesar] Univ Nacl Mayor San Marcos, Fac Med, Lima, Peru	Instituto Nacional de Salud - Peru; Instituto Nacional de Salud - Peru; Instituto Nacional de Salud del Nino - San Borja; Universidad Nacional Mayor de San Marcos	Cabezas, C (corresponding author), Inst Nacl Salud, Ctr Nacl Salud Publ, Lima, Peru.; Cabezas, C (corresponding author), Univ Nacl Mayor San Marcos, Fac Med, Lima, Peru.	ccabezas@ins.gob.pe	Ramírez-Soto, Max Carlos BSc, MPH, FRSPH, MACE/O-7824-2018	Ramírez-Soto, Max Carlos BSc, MPH, FRSPH, MACE/0000-0003-0471-6746; CABEZAS, CESAR/0000-0001-5120-0713; Balbuena Torres, Johanna Nery/0000-0003-4830-6933	Instituto Nacional de Salud, Peru [OI-082-13]	Instituto Nacional de Salud, Peru	This study was funded by the Instituto Nacional de Salud, Peru (project OI-082-13).	[Anonymous], 2002, KARUNUNGAN, V19, P5; Assis Sandra Breder, 2002, Rev. Soc. Bras. Med. Trop., V35, P155, DOI 10.1590/S0037-86822002000200005; Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Betancur Carlos Alberto, 2013, Acta Med Colomb, V38, P68; Bricks G, 2018, BRAZ J INFECT DIS, V22, P85, DOI 10.1016/j.bjid.2018.02.001; Butler EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30078-5; Cabezas C, 1994, Rev Gastroenterol Peru, V14, P123; Cabezas Cesar, 2000, Rev Gastroenterol Peru, V20, P201; Cabezas Cesar, 1997, Rev Gastroenterol Peru, V17, P128; Cabezas César, 2007, Rev. perú. med. exp. salud publica, V24, P378; Cabezas S César, 2006, Rev. perú. med. exp. salud publica, V23, P114; Cabezas-Sánchez César, 2014, Rev. perú. med. exp. salud publica, V31, P204; Campolmi I, 2018, AM J TROP MED HYG, V98, P1275, DOI 10.4269/ajtmh.17-0747; Villa DD, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0402-5; Farfán Gustavo, 2003, Rev. gastroenterol. Perú, V23, P171; Fix AD, 2002, AM J TROP MED HYG, V66, P628, DOI 10.4269/ajtmh.2002.66.628; Gomez-Gutierrez C, 2015, ANN HEPATOL, V14, P807, DOI 10.5604/16652681.1171751; Han K, 2012, HUM VACC IMMUNOTHER, V8, P1845, DOI 10.4161/hv.21818; Hernández Roger, 2015, Rev. perú. med. exp. salud publica, V32, P499; Hyams KC, 1996, CLIN INFECT DIS, V22, P719, DOI 10.1093/clinids/22.4.719; Indacochea S, 1991, REV MED HERED, V2, P168; KILPATRICK ME, 1986, AM J EPIDEMIOL, V124, P111, DOI 10.1093/oxfordjournals.aje.a114354; Laguna-Torres V A, 2005, J Clin Virol, V34 Suppl 2, pS61, DOI 10.1016/S1386-6532(05)80036-8; Loza Munarriz C, 2005, REV GASTROENTEROL PE, V25, P320; Organizacion Mundial de la Salud, 2016, OBJ DES SOST MET; Organizacion Mundial de la Salud, 2016, EST MUND SECT SAL CO; Pando MA, 2006, SEX TRANSM DIS, V33, P307, DOI 10.1097/01.olq.0000194578.06795.2d; Pinto Valdivia José Luis, 2003, Rev. gastroenterol. Perú, V23, P22; PUJOL FH, 1994, J MED VIROL, V42, P234, DOI 10.1002/jmv.1890420305; Ramirez-Soto MC, 2017, VACCINE, V35, P3808, DOI 10.1016/j.vaccine.2017.05.086; Rivero Jorge David Machicado, 2010, Rev Gastroenterol Peru, V30, P357; Rizzetto M, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021576; Suguitan Jr AL, 2011, PLOS ONE, V6; Trinta KS, 2001, MEM I OSWALDO CRUZ, V96, P25, DOI 10.1590/S0074-02762001000100004; Valdespino JL, 2007, SALUD PUBLICA MEXICO, V49, pS395, DOI 10.1590/S0036-36342007000900011; Vildosola H, 1990, Rev Gastroenterol Peru, V10, P96; Vildosola Herman, 2000, Rev Gastroenterol Peru, V20, P111; Vildosola Herman, 2000, Rev Gastroenterol Peru, V20, P141; Whitford K, 2018, B WORLD HEALTH ORGAN, V96, P484, DOI 10.2471/BLT.17.205153; zu Siederdissen CH, 2016, VISC MED, V32, P86, DOI 10.1159/000445518	40	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234273	10.1371/journal.pone.0234273	http://dx.doi.org/10.1371/journal.pone.0234273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542052	gold, Green Published			2022-12-26	WOS:000542685100011
J	Koirala, R; Soegaard, EGI; Ojha, SP; Thapa, SB; Hauff, E				Koirala, Rishav; Soegaard, Erik Ganesh Iyer; Ojha, Saroj Prasad; Thapa, Suraj B.; Hauff, Edvard			Trauma related psychiatric disorders and their correlates in a clinical sample: A cross-sectional study in trauma affected patients visiting a psychiatric clinic in Nepal	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSIVE DISORDER; MENTAL-HEALTH; BHUTANESE REFUGEES; PTSD; PREVALENCE; CONFLICT; TORTURE; EVENTS; WORLD	Background Nepal, like many other low-income countries, has a great burden of mental health issues but few resources to meet them. In addition, Nepal has endured several traumatic events in recent decades but the impact on mental health has not been studied in clinical settings. This study explores trauma-related psychiatric disorders and their correlates. Methods 100 patients with a history of trauma who visited the outpatient psychiatry clinic at a University hospital in Kathmandu were assessed. The Composite International Diagnostic Interview 2.1 (CIDI) was used to evaluate lifetime and current depressive disorder, generalized anxiety disorder (GAD) and lifetime post-traumatic stress disorder (PTSD). Current PTSD was evaluated using PSTD Checklist-Civilian Version (PCL-C). Results The median number of lifetime traumatic events was two. Natural disaster was the most common trauma type (84%) compared to other types of trauma. Rape was reported as the most traumatizing. Current PTSD was found in 15%, depression in 33% and GAD in 38% of the patients. The lifetime rates were PTSD 83%, depression 45% and GAD 40%. There was high comorbidity between the disorders. The 31 to 45 years age group, above high school education level and trauma types other than earthquake were independently associated with current PTSD. Marital status and upper socioeconomic status (SES) compared to upper-middle SES were independently associated with lifetime PTSD. Both lifetime and current depression rates were independently associated with the upper SES compared to upper-middle SES. Place of living, education above high school and lower-middle SES were significantly associated with lifetime and current GAD. Conclusion PTSD, depression and GAD were prevalent in a trauma exposed patient population visiting a psychiatric clinic in Nepal. High rates of comorbidities and several risk factors were identified. Our findings highlight the need for addressing trauma related disorders in clinical settings in developing countries.	[Koirala, Rishav; Soegaard, Erik Ganesh Iyer; Thapa, Suraj B.; Hauff, Edvard] Univ Oslo, Inst Clin Med, Div Mental Hlth & Addict, Oslo, Norway; [Koirala, Rishav] Brain & Neurosci Ctr, Kathmandu, Nepal; [Soegaard, Erik Ganesh Iyer; Thapa, Suraj B.; Hauff, Edvard] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Ojha, Saroj Prasad; Thapa, Suraj B.] Tribhuvan Univ, Inst Med, Dept Psychiat & Mental Hlth, Teaching Hosp, Kathmandu, Nepal	University of Oslo; University of Oslo; Tribhuvan University; Institute of Medicine (IoM) - Nepal	Koirala, R (corresponding author), Univ Oslo, Inst Clin Med, Div Mental Hlth & Addict, Oslo, Norway.; Koirala, R (corresponding author), Brain & Neurosci Ctr, Kathmandu, Nepal.	rishavk@gmail.com		Soegaard, Erik Ganesh Iyer/0000-0003-2380-4995; Koirala, Rishav/0000-0002-9721-2952	QUOTA scholarship through the Lanakassen, Norwegian Government [15/1488575-4, F4R4C2T7]	QUOTA scholarship through the Lanakassen, Norwegian Government	The scholarship to conduct this research was provided to Rishav Koirala by QUOTA scholarship for PhD program through the Lanakassen, Norwegian Government (case no. 15/1488575-4, reference no. F4R4C2T7). URL: https://www.lanekassen.no/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saffar S, 2003, SOC PSYCH PSYCH EPID, V38, P456, DOI 10.1007/s00127-003-0659-7; Alisic E, 2014, BRIT J PSYCHIAT, V204, P335, DOI 10.1192/bjp.bp.113.131227; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 2016, EJ INSIGHT      1108; [Anonymous], 2019, POPULATION TOTAL; [Anonymous], 2009, FORUM NOVEISHEI VOST, V6, P5; [Anonymous], 2018, J NEUROTRAUMA, V35, pA2; [Anonymous], 2007, KIRK OTHMER ENCY CHE, V6, P12; APA, 2013, DIAGNOSTIC STAT MANU, Vxliv, P947; Atwoli L, 2015, CURR OPIN PSYCHIATR, V28, P307, DOI 10.1097/YCO.0000000000000167; Atwoli L, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-182; awahar A, 2005, NEUROSURG FOCUS, V18, pE8; Ayazi T, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-6; Banks LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189996; Breslau N, 1999, AM J PSYCHIAT, V156, P902, DOI 10.1176/ajp.156.6.902; C. E, 2012, LIES J MAT FEMINISM, V1, P15; C IBM, 2017, IBM SPSS STAT WINDOW; Carmassi C, 2014, J PSYCHIATR RES, V59, P77, DOI 10.1016/j.jpsychires.2014.09.006; Charlson F, 2019, LANCET, V394, P240, DOI 10.1016/S0140-6736(19)30934-1; da Silva HC, 2019, BRAZ J PSYCHIAT, V41, P213, DOI 10.1590/1516-4446-2017-0025; Darves-Bornoz JM, 2008, J TRAUMA STRESS, V21, P455, DOI 10.1002/jts.20357; Facer-Irwin E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222407; Ferry F, 2014, SOC PSYCH PSYCH EPID, V49, P435, DOI 10.1007/s00127-013-0757-0; Ghosh A, 2009, INDIAN PEDIATR, V46, P1104; Guo J, 2017, J AFFECT DISORDERS, V210, P27, DOI 10.1016/j.jad.2016.12.009; Kafle BBY, 2018, DEVDAHA MED J, V1, P6; Kane JC, 2018, EPIDEMIOL PSYCH SCI, V27, P301, DOI 10.1017/S2045796016001104; Kawakami N, 2014, J PSYCHIATR RES, V53, P157, DOI 10.1016/j.jpsychires.2014.01.015; Kazlauskas E, 2017, J TRAUMA STRESS, V30, P99, DOI 10.1002/jts.22152; Keane TM, 1997, ANN NY ACAD SCI, V821, P24, DOI 10.1111/j.1749-6632.1997.tb48266.x; Koenen KC, 2017, PSYCHOL MED, V47, P2260, DOI 10.1017/S0033291717000708; Kohrt BA, 2010, CULT MED PSYCHIAT, V34, P322, DOI 10.1007/s11013-010-9170-2; Kvestad I, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00734; Lazar Susan G, 2014, Psychodyn Psychiatry, V42, P459, DOI 10.1521/pdps.2014.42.3.459; Liebschutz J, 2007, J GEN INTERN MED, V22, P719, DOI 10.1007/s11606-007-0161-0; Luitel NP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183223; Luitel NP, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-014-0030-5; Luitel NP, 2013, SOC PSYCH PSYCH EPID, V48, P183, DOI 10.1007/s00127-012-0539-0; Neupane D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158113; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Pietrzak RH, 2012, AM J GERIAT PSYCHIAT, V20, P380, DOI 10.1097/JGP.0b013e31820d92e7; Puri M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-29; Risal A, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0810-0; Rytwinski NK, 2013, J TRAUMA STRESS, V26, P299, DOI 10.1002/jts.21814; Sharma RK, 2017, IET CIRC DEVICE SYST, V11, P10, DOI 10.1049/iet-cds.2016.0210; Sheeran T, 2002, J CONSULT CLIN PSYCH, V70, P961, DOI 10.1037//0022-006X.70.4.000; Shrestha NM, 1998, JAMA-J AM MED ASSOC, V280, P443, DOI 10.1001/jama.280.5.443; Soegaard EGI, 2020, NORD J PSYCHIAT, V74, P390, DOI 10.1080/08039488.2020.1714724; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Thapa Prakash, 2018, J Nepal Health Res Counc, V16, P53; Thapa SB, 2005, SOC PSYCH PSYCH EPID, V40, P672, DOI 10.1007/s00127-005-0943-9; Thapa SB, 2003, AM J PSYCHIAT, V160, P2032, DOI 10.1176/appi.ajp.160.11.2032; Thornicroft G, 2017, BRIT J PSYCHIAT, V210, P119, DOI 10.1192/bjp.bp.116.188078; Tol WA, 2007, J NERV MENT DIS, V195, P463, DOI 10.1097/NMD.0b013e31802f5dac; Tol WA, 2010, SOC SCI MED, V70, P35, DOI 10.1016/j.socscimed.2009.09.037; Ulak N, 2016, GAZE, V7, P58, DOI [10.3126/gaze.v7i0.15120, DOI 10.3126/GAZE.V7I0.15120]; UNHCR W, 2012, ASYLUM TRENDS 2012, V18; UNOHCHR, 2012, HCHR NEP CONFL REP E; Upadhaya N, 2017, INT J MENT HEALTH SY, V11, DOI 10.1186/s13033-017-0145-3; Upadhyaya K, 2017, J PSYCHIAT ASS NEPAL, V4, P60, DOI DOI 10.3126/JPAN.V4I1.16746; van Ameringen M, 2008, CNS NEUROSCI THER, V14, P171, DOI 10.1111/j.1755-5949.2008.00049.x; van Ommeren M., 1999, TRANSCULT PSYCHIATRY, V36, P285, DOI [10.1177/136346159903600304, DOI 10.1177/136346159903600304]; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Weinmann S, 2016, CURR OPIN PSYCHIATR, V29, P270, DOI 10.1097/YCO.0000000000000256; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; World Health Organization, 1992, ICD 10 CLASS MENT BE, Vxii, P362; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941	67	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234203	10.1371/journal.pone.0234203	http://dx.doi.org/10.1371/journal.pone.0234203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB6AZ	32541999	Green Published, gold			2022-12-26	WOS:000542685100025
J	Drummond, C; Gebhardt, ME; Robles, MTS; Carpi, G; Hoyer, I; Pastusiak, A; Reddy, MR; Norris, DE; Pipes, JM; Jackson, EK				Drummond, Coyne; Gebhardt, Mary E.; Robles, Maria Teresa Sienz; Carpi, Giovanna; Hoyer, Isaiah; Pastusiak, Andrzej; Reddy, Michael R.; Norris, Douglas E.; Pipes, James M.; Jackson, Ethan K.			Stability and detection of nucleic acid from viruses and hosts in controlled mosquito blood feeds	PLOS ONE			English	Article							BURDEN	Monitoring the presence and spread of pathogens in the environment is of critical importance. Rapid detection of infectious disease outbreaks and prediction of their spread can facilitate early responses of health agencies and reduce the severity of outbreaks. Current sampling methods are sorely limited by available personnel and throughput. For instance, xenosurveillance utilizes captured arthropod vectors, such as mosquitoes, as sampling tools to access blood from a wide variety of vertebrate hosts. Next generation sequencing (NGS) of nucleic acid from individual blooded mosquitoes can be used to identify mosquito and host species, and microorganisms including pathogens circulating within either host. However, there are practical challenges to collecting and processing mosquitoes for xenosurveillance, such as the rapid metabolization or decay of microorganisms within the mosquito midgut. This particularly affects pathogens that do not replicate in mosquitoes, preventing their detection by NGS or other methods. Accordingly, we performed a series of experiments to establish the windows of detection for DNA or RNA from human blood and/or viruses present in mosquito blood meals. Our results will contribute to the development of xenosurveillance techniques with respect to optimal timing of sample collection and NGS processing and will also aid trap design by demonstrating the stabilizing effect of temperature control on viral genome recovery from blood-fed mosquitoes.	[Drummond, Coyne; Robles, Maria Teresa Sienz; Pipes, James M.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Gebhardt, Mary E.; Norris, Douglas E.] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Carpi, Giovanna] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Hoyer, Isaiah; Pastusiak, Andrzej; Reddy, Michael R.; Jackson, Ethan K.] Microsoft Res, Hlth Futures, Redmond, WA 98052 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Microsoft	Reddy, MR (corresponding author), Microsoft Res, Hlth Futures, Redmond, WA 98052 USA.	michael.reddy@microsoft.com	Norris, Doug/GXV-3397-2022; Carpi, Giovanna/HHM-5942-2022	Reddy, Michael/0000-0001-8371-8306; Norris, Douglas/0000-0002-4631-2777	Hopkins Malaria Research Institute; Bloomberg Philanthropies; NIH [5T32AI007417]; Microsoft	Hopkins Malaria Research Institute; Bloomberg Philanthropies; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microsoft(Microsoft)	DEN and MEG were supported in part by the Hopkins Malaria Research Institute and Bloomberg Philanthropies, and MEG also received support from NIH 5T32AI007417. Commercial funder Microsoft Research provided financial support in the form of a gift to authors, James M. Pipas (JMP; University of Pittsburgh) and Douglas E. Norris (DEN; Johns Hopkins University). This gift was intended to support in the form of salaries for JMP and DEN. Authors Isaiah Hoyer, Andrzej Pastusiak, Michael R Reddy and Ethan K Jackson are paid employees of Microsoft Research. The funder provided support in the form of salaries for authors [IH, AP, MRR, EKJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Agha SB, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2598-2; Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743; Barrett ADT, 2014, AM J TROP MED HYG, V90, P389, DOI 10.4269/ajtmh.14-0009; Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15; Brinkmann A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101743; Brugman VA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1034-8; Buggele WA, 2013, J VIROL, V87, P9260, DOI 10.1128/JVI.01064-13; Camp JV, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3417-8; Cantalupo PG, 2019, CURR OPIN VIROL, V39, P41, DOI 10.1016/j.coviro.2019.07.010; Castro Marcia C, 2017, Lancet Infect Dis, V17, pe70, DOI 10.1016/S1473-3099(16)30545-X; Deviatkin AA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10342-w; Falzon LC, 2019, FRONTIERS VET SCI, V6; Fauver JR, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006348; Fauver JR, 2017, AM J TROP MED HYG, V97, P324, DOI 10.4269/ajtmh.17-0063; Grubaugh ND, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003628; Halliday J, 2011, SURVEILLANCE MONITOR; Kading RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099342; Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531; Metsky HC, 2019, NAT BIOTECHNOL, V37, P160, DOI 10.1038/s41587-018-0006-x; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Ogunrinade A, 1980, Afr J Med Med Sci, V9, P69; Ramirez AL, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2901-x; Reeves LE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1791-z; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Taylor LH, 2017, ACTA TROP, V165, P133, DOI 10.1016/j.actatropica.2015.12.007; Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115; Zimmermann M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090508	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0231061	10.1371/journal.pone.0231061	http://dx.doi.org/10.1371/journal.pone.0231061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525960	Green Published, gold			2022-12-26	WOS:000542036800057
J	Perwaiz, U; Younas, I; Anwar, AA				Perwaiz, Uzman; Younas, Irfan; Anwar, Adeem Ali			Many-objective BAT algorithm	PLOS ONE			English	Article							OPTIMIZATION ALGORITHM; RANKING	In many objective optimization problems (MaOPs), more than three distinct objectives are optimized. The challenging part in MaOPs is to get the Pareto approximation (PA) with high diversity and good convergence. In Literature, in order to solve the issue of diversity and convergence in MaOPs, many approaches are proposed using different multi objective evolutionary algorithms (MOEAs). Moreover, to get better results, the researchers use the sets of reference points to differentiate the solutions and to model the search process, it further evaluates and selects the non-dominating solutions by using the reference set of solutions. Furthermore, this technique is used in some of the swarm-based evolutionary algorithms. In this paper, we have used some effective adaptations of bat algorithm with the previous mentioned approach to effectively handle the many objective problems. Moreover, we have called this algorithm as many objective bat algorithm (MaOBAT). This algorithm is a biologically inspired algorithm, which uses echolocation power of micro bats. Each bat represents a complete solution, which can be evaluated based on the problem specific fitness function and then based on the dominance relationship, non-dominated solutions are selected. In proposed MaOBAT, dominance rank is used as dominance relationship (dominance rank of a solution means by how many other solutions a solution dominated). In our proposed strategy, dynamically allocated set of reference points are used, allowing the algorithm to have good convergence and high diversity pareto fronts (PF). The experimental results show that the proposed algorithm has significant advantages over several state-of-the-art algorithms in terms of the quality of the solution.	[Perwaiz, Uzman; Younas, Irfan; Anwar, Adeem Ali] Natl Univ Comp & Emerging Sci, Dept Comp Sci, Lahore, Pakistan		Younas, I; Anwar, AA (corresponding author), Natl Univ Comp & Emerging Sci, Dept Comp Sci, Lahore, Pakistan.	irfan.younas@nu.edu.pk; l155003@lhr.nu.edu.pk		Anwar, Adeem Ali/0000-0002-6474-3810; Younas, Irfan/0000-0002-2756-9980				Anonymous, 2004, Bulletin OEPP, V34, P315, DOI 10.1111/j.1365-2338.2004.00735.x; [Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2015, ACCOUNTS CHEM RES, V48, P1, DOI DOI 10.1016/J.WOCN.2014.11.001; [Anonymous], 2011, ARCHITECT FUNCT GLAS, V1, P32; [Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1; Apornak A, 2020, INT J HEALTHCARE MAN, V4, P1; Asafuddoula M, 2015, IEEE T EVOLUT COMPUT, V19, P445, DOI 10.1109/TEVC.2014.2339823; Cai L, 2015, APPL SOFT COMPUT, V35, P681, DOI 10.1016/j.asoc.2015.06.020; Cheng JX, 2015, IEEE T EVOLUT COMPUT, V19, P592, DOI 10.1109/TEVC.2015.2424921; Cui ZH, 2019, SWARM EVOL COMPUT, V49, P23, DOI 10.1016/j.swevo.2019.05.011; Deb K, 2004, ADV INFO KNOW PROC, P105; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K, 2014, IEEE T EVOLUT COMPUT, V18, P577, DOI 10.1109/TEVC.2013.2281535; Figueiredo EMN, 2016, INFORM SCIENCES, V374, P115, DOI 10.1016/j.ins.2016.09.026; Fister I, 2014, SCI WORLD J, V2014; Geem ZW, 2001, SIMULATION, V76, P60, DOI 10.1177/003754970107600201; GriYn DR, 1960, ANIM BEHAV, V8, P3; Ishibuchi H., 2008, PROC 10 ANN C GENET, P649, DOI DOI 10.1145/1389095.1389225; Ishibuchi H, 2010, GECCO 10, DOI DOI 10.1145/1830483.1830577; Ishibuchi H, 2009, IEEE SYS MAN CYBERN, P1758, DOI 10.1109/ICSMC.2009.5346628; Ishibuchi H, 2008, IEEE C EVOL COMPUTAT, P2419, DOI 10.1109/CEC.2008.4631121; Jaddi NS, 2015, APPL SOFT COMPUT, V37, P71, DOI 10.1016/j.asoc.2015.08.002; Jaddi NS, 2015, INFORM SCIENCES, V294, P628, DOI 10.1016/j.ins.2014.08.050; JPL Publication 10-6, 2011, JPL PUBL, V17, P474; Kaveh A, 2010, ACTA MECH, V213, P267, DOI 10.1007/s00707-009-0270-4; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Khan K, 2012, INT J INTELL SYST, V4, P23, DOI [DOI 10.5815/IJISA.2012.07.03, 10.5815/ijisa10.5815/ijisa:2012.0710.5815/ijisa:2012.07.03]; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KUNG HT, 1975, J ACM, V22, P469, DOI 10.1145/321906.321910; Li J, 2016, IEEE T SYST MAN CYB, V47, P1007; Liu T.-Y., 2009, FOUND TRENDS INF RET, V3, P225, DOI [DOI 10.1561/1500000016, DOI 10.1007/978-3-642-14267-3]; Mostaahim S, 2008, LECT NOTES COMPUT SC, V5199, P753, DOI 10.1007/978-3-540-87700-4_75; Nebro AJ, 2009, MCDM: 2009 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN MULTI-CRITERIA DECISION-MAKING, P66; Purshouse RC, 2007, IEEE T EVOLUT COMPUT, V11, P770, DOI 10.1109/TEVC.2007.910138; Rao S.S., 2019, ENG OPTIMIZATION THE, DOI DOI 10.1002/9781119454816; Raychaudhuri, 2020, NATURE INSPIRED COMP, P279, DOI [10.1007/978-981-15-2125-6_12, DOI 10.1007/978-981-15-2125-6_12]; Reyes-Sierra M., 2006, INT J COMPUTATIONAL, V2, P287, DOI DOI 10.5019/J.IJCIR.2006.68; Talal R, 2014, INT J COMPUT APPL, V92, P16, DOI DOI 10.5120/16004-4998; Van Veldhuizen D. A., 2007, EVOLUTIONARY ALGORIT, V5; Wagner T, 2007, LECT NOTES COMPUT SC, V4403, P742; Yang SX, 2013, IEEE T EVOLUT COMPUT, V17, P721, DOI 10.1109/TEVC.2012.2227145; Yang X., 2008, NATURE INSPIRED META, V2nd; Yang X.-S., 2012, ARXIV12036571; Younas I, 2018, NEUROCOMPUTING, V314, P409, DOI 10.1016/j.neucom.2018.07.008; Zhu HH, 2019, IEEE ACCESS, V7, P97974, DOI 10.1109/ACCESS.2019.2927846; Zitzler E., 2001, 103 TIK REP, V103	46	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234625	10.1371/journal.pone.0234625	http://dx.doi.org/10.1371/journal.pone.0234625			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525939	Green Published, gold			2022-12-26	WOS:000542036800082
J	Reddy, VRP; Aski, MS; Mishra, GP; Dikshit, HK; Singh, A; Pandey, R; Singh, MP; Gayacharan; Ramtekey, V; Priti; Rai, N; Nair, RM				Reddy, Venkata Ravi Prakash; Aski, Muraleedhar S.; Mishra, Gyan Prakash; Dikshit, Harsh Kumar; Singh, Akanksha; Pandey, Renu; Singh, Madan Pal; Gayacharan; Ramtekey, Vinita; Priti; Rai, Neha; Nair, Ramakrishnan M.			Genetic variation for root architectural traits in response to phosphorus deficiency in mungbean at the seedling stage	PLOS ONE			English	Article							GENOTYPIC VARIATION; BRASSICA CULTIVARS; EFFICIENCY; TOLERANCE; STRESS; AVAILABILITY; ACQUISITION; GROWTH; PLANT; YIELD	Roots enable the plant to survive in the natural environment by providing anchorage and acquisition of water and nutrients. In this study, root architectural traits of 153 mungbean genotypes were compared under optimum and low phosphorus (P) conditions. Significant variations and medium to high heritability were observed for the root traits. Total root length was positively and significantly correlated with total root surface area, total root volume, total root tips and root forks under both optimum P (r = 0.95, r = 0.85, r = 0.68 and r = 0.82 respectively) and low P (r = 0.95, r = 0.82, r = 0.71 and r = 0.81 respectively). The magnitudes of the coefficient of variations were relatively higher for root forks, total root tips and total root volume. Total root length, total root surface area and total root volume were major contributors of variation and can be utilized for screening of P efficiency at the seedling stage. Released Indian mungbean varieties were found to be superior for root traits than other genotypic groups. Based on comprehensive P efficiency measurement, IPM-288, TM 96-25, TM 96-2, M 1477, PUSA 1342 were found to be the best highly efficient genotypes, whereas M 1131, PS-16, Pusa Vishal, M 831, IC 325828 were highly inefficient. Highly efficient genotypes identified would be valuable genetic resources for P efficiency for utilizing in the mungbean breeding programme.	[Reddy, Venkata Ravi Prakash; Aski, Muraleedhar S.; Mishra, Gyan Prakash; Dikshit, Harsh Kumar; Singh, Akanksha; Ramtekey, Vinita; Priti; Rai, Neha] ICAR Indian Agr Res Inst, Div Genet, New Delhi, India; [Singh, Akanksha] Amity Univ, Amity Inst Organ Agr, Noida, India; [Pandey, Renu; Singh, Madan Pal] ICAR Indian Agr Res Inst, Div Plant Physiol, New Delhi, India; [Gayacharan] ICAR Natl Bur Plant Genet Resources, Germplasm Evaluat Div, New Delhi, India; [Nair, Ramakrishnan M.] South Asia Cent Asia, World Vegetable Ctr, Hyderabad, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Amity University Noida; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources	Dikshit, HK (corresponding author), ICAR Indian Agr Res Inst, Div Genet, New Delhi, India.	harshgeneticsiari@gmail.com	Prakash Reddy, Bana Venkata Ravi/GRX-6782-2022; Mishra, Gyan P./E-5980-2010; Aski, Muraleedhar S/GNM-7254-2022; Pandey, Renu/AES-7797-2022	Prakash Reddy, Bana Venkata Ravi/0000-0003-2601-5350; Mishra, Gyan P./0000-0002-7023-2638; Aski, Muraleedhar S/0000-0002-9021-2650; Pandey, Renu/0000-0002-9244-8579; Ramtekey, Vinita/0000-0002-8059-4640; Singh, Akanksha/0000-0001-6480-2641; RAI, NEHA/0000-0002-4058-0076; , Gayacharan/0000-0002-3582-6422	Department of Science and Technology, Ministry of Science and Technology, Government of India [CRG/2018/002642]	Department of Science and Technology, Ministry of Science and Technology, Government of India(Department of Science & Technology (India))	The funds for this study were provided by Department of Science and Technology, Ministry of Science and Technology, Government of India vide grant number CRG/2018/002642 to Dr. Harsh Kumar Dikshit.	Abdel-Ghani AH, 2013, EUPHYTICA, V189, P123, DOI 10.1007/s10681-012-0759-0; Adler PR, 2004, ENCY LIFE SUPPORT SY, VI; Adu MO, 2019, FIELD CROP RES, V232, P106, DOI 10.1016/j.fcr.2018.12.015; Akhtar MS, 2008, J AGRON CROP SCI, V194, P380, DOI 10.1111/j.1439-037X.2008.00326.x; Ao JH, 2010, FUNCT PLANT BIOL, V37, P304, DOI 10.1071/FP09215; Arif MR, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8070192; Asaduzzaman M., 2008, American-Eurasian Journal of Scientific Research, V3, P40; Aziz T, 2011, J PLANT NUTR, V34, P522, DOI 10.1080/01904167.2011.538114; Borch K, 1999, PLANT CELL ENVIRON, V22, P425, DOI 10.1046/j.1365-3040.1999.00405.x; Bouma TJ, 2000, PLANT SOIL, V218, P185, DOI 10.1023/A:1014905104017; Carstensen A, 2018, PLANT PHYSIOL, V177, P271, DOI 10.1104/pp.17.01624; Chen LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113200; Chen XJ, 2012, FIELD CROP RES, V137, P195, DOI 10.1016/j.fcr.2012.09.008; Chen YL, 2013, CROP PASTURE SCI, V64, P588, DOI 10.1071/CP13012; da Silva DA, 2016, BRAGANTIA, V75, P152, DOI 10.1590/1678-4499.454; Dai XY, 2012, PLANT PHYSIOL, V159, P169, DOI 10.1104/pp.112.194217; de la Cruz M, 2008, ECOGRAPHY, V31, P720, DOI 10.1111/j.0906-7590.2008.05299.x; De la Riva LM, 2010, THESIS; Fageria NK, 2008, J PLANT NUTR, V31, P1121, DOI 10.1080/01904160802116068; FAI, 2011, FERT STAT; FAO, 2017, WORLD FERT TRENDS OU; Franco JA, 2011, J HORTIC SCI BIOTECH, V86, P543, DOI 10.1080/14620316.2011.11512802; Gill HS., 2004, ARCH AGRON SOIL SCI, V50, P563, DOI DOI 10.1080/03650340410001729708; Gong YM, 2011, J PLANT NUTR, V34, P1290, DOI 10.1080/01904167.2011.580816; Gorim LY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01632; GPRI, 2009, DECL GLOB PHOSPH SEC; Gulles AA., 2014, PHILIPP J CROP SCI, V39, P137; He J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01499; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Heuer S, 2017, PLANT J, V90, P868, DOI 10.1111/tpj.13423; Himmelbauer ML, 2004, PLANT SOIL, V260, P111, DOI 10.1023/B:PLSO.0000030171.28821.55; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Hodge A, 2009, PLANT SOIL, V321, P153, DOI 10.1007/s11104-009-9929-9; HUTCHESON K, 1970, J THEOR BIOL, V29, P151, DOI 10.1016/0022-5193(70)90124-4; Imada S, 2008, FUNCT ECOL, V22, P1018, DOI 10.1111/j.1365-2435.2008.01454.x; Jakkeral S. A., 2009, Karnataka Journal of Agricultural Sciences, V22, P946; Kitajima K., 2000, Seeds: the ecology of regeneration in plant communities, P331, DOI 10.1079/9780851994321.0331; Kumar B, 2012, PLANT BREEDING, V131, P465, DOI 10.1111/j.1439-0523.2012.01980.x; Leslie M, 2018, CANCER DISCOV, V8, P131, DOI 10.1158/2159-8290.CD-NB2017-179; Li RY, 2015, BREEDING SCI, V65, P298, DOI 10.1270/jsbbs.65.298; Lin Y, 2019, PLANT GENOME-US, V12, DOI 10.3835/plantgenome2019.03.0025; Liu CY, 2018, J PLANT NUTR, V41, P2470, DOI 10.1080/01904167.2018.1476539; Liu LP, 2010, CROP SCI, V50, P222, DOI 10.2135/cropsci2009.03.0156; Liu YX, 2015, THEOR APPL GENET, V128, P2203, DOI 10.1007/s00122-015-2578-x; Liu Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21248-6; Liu YX, 2017, AGRONOMY-BASEL, V7, DOI 10.3390/agronomy7030051; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Lynch JP, 2011, PLANT PHYSIOL, V156, P1041, DOI 10.1104/pp.111.175414; Lyu Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01939; Maharajan T, 2018, PLANT BREEDING, V137, P10, DOI 10.1111/pbr.12537; Malamy JE, 1997, DEVELOPMENT, V124, P33; McCormack ML, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00205; Meeks M, 2013, AGRONOMY-BASEL, V3, P135, DOI 10.3390/agronomy3010135; Nadeem M. A., 2004, Journal of Agronomy, V3, P40; Nair RM, 2013, J SCI FOOD AGR, V93, P1805, DOI 10.1002/jsfa.6110; Nielsen KL, 2001, J EXP BOT, V52, P329, DOI 10.1093/jexbot/52.355.329; Niu YF, 2013, ANN BOT-LONDON, V112, P391, DOI 10.1093/aob/mcs285; Ochigbo AE, 2014, AGR BIOL J N AM, V5, P2151, DOI [10.5251/abjna.2014.5.2.68.77, DOI 10.5251/ABJNA.2014.5.2.68.77]; Pandey JC, 2015, C ELECT INSUL DIEL P, P499, DOI 10.1109/CEIDP.2015.7352064; Pandey R, 2014, PLANT CELL REP, V33, P919, DOI 10.1007/s00299-014-1570-2; Panigrahy M, 2009, BIOTECHNOL ADV, V27, P389, DOI 10.1016/j.biotechadv.2009.02.006; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Postma JA, 2011, ANN BOT-LONDON, V107, P829, DOI 10.1093/aob/mcq199; Qiu HB, 2013, MOL BREEDING, V32, P629, DOI 10.1007/s11032-013-9895-z; Rajkumar S., 2014, American-Eurasian Journal of Agricultural & Environmental Sciences, V14, P396; Raju BR, 2014, FUNCT PLANT BIOL, V41, P930, DOI 10.1071/FP13291; Ramaekers L, 2010, FIELD CROP RES, V117, P169, DOI 10.1016/j.fcr.2010.03.001; Rathinavel K., 2017, INT J CURRENT MICROB, V6, P2407, DOI DOI 10.20546/IJCMAS.2017.608.285; Sandhu N, 2016, PLANT PHYSIOL, V171, P2562, DOI 10.1104/pp.16.00705; Sarker BC, 2009, BANGL J BOT, V38, P215; Schafleitner R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1556-7; Shannon C.E., 1963, MATH THEORY COMMUNIC; Shen Q, 2018, AOB PLANTS, V10, DOI 10.1093/aobpla/ply054; Sivasakthi K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01663; SWINNEN J, 1994, AGR ECOSYST ENVIRON, V51, P115, DOI 10.1016/0167-8809(94)90038-8; Thiyagarajan T. M., 2003, Agricultural Reviews, V24, P40; Vairam N., 2016, International Journal of Plant Sciences (Muzaffarnagar), V11, P265, DOI 10.15740/HAS/IJPS/11.2/265-269; van de Wiel CCM, 2016, EUPHYTICA, V207, P1, DOI 10.1007/s10681-015-1572-3; Vejchasarn P, 2016, RICE, V9, DOI 10.1186/s12284-016-0102-9; Wang J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01709; Wang QJ, 2019, PLANT GENOME-US, V12, DOI 10.3835/plantgenome2019.06.0039; Wang YS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00865; Wasaya A, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8110241; Wu H, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00530; Xie Q, 2017, ANN BOT-LONDON, V119, P1115, DOI 10.1093/aob/mcx001; [许桂芳 XU Gui-fang], 2009, [西北林学院学报, Journal of Northwest Forestry College], V24, P24; Yadav R. K., 2018, Agriculture and Food Security, V7, DOI 10.1186/s40066-018-0238-5; Yun SJ, 2001, PLANT SOIL, V237, P109, DOI 10.1023/A:1013329430212; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zar J.H., 2010, BIOSTAT ANAL, Vfifth, P944; Zhang LT, 2014, EUPHYTICA, V197, P435, DOI 10.1007/s10681-014-1079-3; Zheng HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep24778; Zhu JM, 2005, FUNCT PLANT BIOL, V32, P749, DOI 10.1071/FP05005; Zobel RW, 2010, PLANT BIOSYST, V144, P507, DOI 10.1080/11263501003764483; Zobel RW, 2007, PLANT SOIL, V297, P243, DOI 10.1007/s11104-007-9341-2	95	19	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0221008	10.1371/journal.pone.0221008	http://dx.doi.org/10.1371/journal.pone.0221008			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525951	gold, Green Submitted, Green Published			2022-12-26	WOS:000542036800070
J	Chernov, AV; Hullugundi, SK; Eddinger, KA; Dolkas, J; Remacle, AG; Angert, M; James, BP; Yaksh, TL; Strongin, AY; Shubayev, VI				Chernov, Andrei V.; Hullugundi, Swathi K.; Eddinger, Kelly A.; Dolkas, Jennifer; Remacle, Albert G.; Angert, Mila; James, Brian P.; Yaksh, Tony L.; Strongin, Alex Y.; Shubayev, Veronica I.			A myelin basic protein fragment induces sexually dimorphic transcriptome signatures of neuropathic pain in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sexual dimorphism; chronic pain; myelin basic protein; neuropathic pain; mechanical allodynia; myelin; RNA-seq; MBP(84-104); transcriptomics; systems biology; pain; neuroinflammation; myelin; dorsal root ganglia; analgesia; chronic pain; mechanical allodynia	T-CELL INFILTRATION; SEX-DIFFERENCES; XESTOSPONGIN-C; IMMUNE CELLS; SPINAL-CORD; GENDER; NERVE; HYPERSENSITIVITY; QUANTIFICATION; EXPRESSION	In the peripheral nerve, mechanosensitive axons are insulated by myelin, a multilamellar membrane formed by Schwann cells. Here, we offer first evidence that a myelin degradation product induces mechanical hypersensitivity and global transcriptomics changes in a sex-specific manner. Focusing on downstream signaling events of the functionally active 84-104 myelin basic protein (MBP(84-104)) fragment released after nerve injury, we demonstrate that exposing the sciatic nerve to MBP(84-104) via endoneurial injection produces robust mechanical hypersensitivity in female, but not in male, mice. RNA-seq and systems biology analysis revealed a striking sexual dimorphism in molecular signatures of the dorsal root ganglia (DRG) and spinal cord response, not observed at the nerve injection site. Mechanistically, intra-sciatic MBP(84-104) induced phospholipase C (PLC)-driven (females) and phosphoinositide 3-kinase-driven (males) phospholipid metabolism (tier 1). PLC/inositol trisphosphate receptor (IP3R) and estrogen receptor co-regulation in spinal cord yielded Ca2+-dependent nociceptive signaling induction in females that was suppressed in males (tier 2). IP3R inactivation by intrathecal xestospongin C attenuated the female-specific hypersensitivity induced by MBP(84-104). According to sustained sensitization in tiers 1 and 2, T cell-related signaling spreads to the DRG and spinal cord in females, but remains localized to the sciatic nerve in males (tier 3). These results are consistent with our previous finding that MBP(84-104)-induced pain is T cell-dependent. In summary, an autoantigenic peptide endogenously released in nerve injury triggers multisite, sex-specific transcriptome changes, leading to neuropathic pain only in female mice. MBP(84-104) acts through sustained co-activation of metabolic, estrogen receptor-mediated nociceptive, and autoimmune signaling programs.	[Chernov, Andrei V.; Hullugundi, Swathi K.; Eddinger, Kelly A.; Dolkas, Jennifer; Angert, Mila; Yaksh, Tony L.; Shubayev, Veronica I.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Chernov, Andrei V.; Remacle, Albert G.; James, Brian P.; Strongin, Alex Y.] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Hullugundi, Swathi K.; Dolkas, Jennifer; Angert, Mila; Shubayev, Veronica I.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA USA	University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Chernov, AV; Shubayev, VI (corresponding author), Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA.; Chernov, AV (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA.; Shubayev, VI (corresponding author), Vet Affairs San Diego Healthcare Syst, La Jolla, CA USA.	achernov@ucsd.edu; vshubayev@ucsd.edu	Chernov, Andrei/I-1623-2019	Chernov, Andrei/0000-0002-3294-5418; Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [R01 DE022757]; National Institutes of Health Office of Research on Women's Health Administrative Supplement for Research on Sex/Gender Differences; University of California Academic Senate Research Grant [RS283B]; Department of Veterans Affairs Merit Award [5I01BX000638]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Office of Research on Women's Health Administrative Supplement for Research on Sex/Gender Differences; University of California Academic Senate Research Grant; Department of Veterans Affairs Merit Award(US Department of Veterans Affairs)	This work was supported by the National Institutes of Health Grant R01 DE022757 and National Institutes of Health Office of Research on Women's Health Administrative Supplement for Research on Sex/Gender Differences (to V. I. S., A. Y. S., and T. L. Y.), Department of Veterans Affairs Merit Award 5I01BX000638 (to V. I. S.), and University of California Academic Senate Research Grant RS283B (to V. I. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Barbazuk WB, 2008, GENOME RES, V18, P1381, DOI 10.1101/gr.053678.106; Blackburn-Munro G, 2005, CURR PHARM DESIGN, V11, P2961, DOI 10.2174/1381612054865000; Boerner KE, 2018, PAIN, V159, P2137, DOI 10.1097/j.pain.0000000000001275; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Castonguay A, 2002, CELL CALCIUM, V32, P39, DOI 10.1016/S0143-4160(02)00093-3; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen Yunshun, 2016, F1000Res, V5, P1438, DOI 10.12688/f1000research.8987.2; Chernov AV, 2018, FEBS J, V285, P3485, DOI 10.1111/febs.14623; Chernov AV, 2015, J BIOL CHEM, V290, P11771, DOI 10.1074/jbc.M114.622316; Cobos EJ, 2018, CELL REP, V22, P1301, DOI 10.1016/j.celrep.2018.01.006; Corona JC, 2016, FREE RADICAL BIO MED, V100, P153, DOI 10.1016/j.freeradbiomed.2016.06.023; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Demarest TG, 2015, J BIOENERG BIOMEMBR, V47, P173, DOI 10.1007/s10863-014-9583-7; Devor M, 1999, PAIN, pS27, DOI 10.1016/S0304-3959(99)00135-9; Devor M, 2009, EXP BRAIN RES, V196, P115, DOI 10.1007/s00221-009-1724-6; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Draleau K, 2014, J PAIN RELIEF, V3; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; Hammer P, 2010, GENOME RES, V20, P847, DOI 10.1101/gr.101204.109; Harauz G, 2009, BIOCHEMISTRY-US, V48, P8094, DOI 10.1021/bi901005f; Held RG, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.170258; Henry MA, 2009, J PAIN, V10, P750, DOI 10.1016/j.jpain.2009.01.264; Hirai T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03390-9; Hong S, 2017, BRAIN BEHAV IMMUN, V60, P282, DOI 10.1016/j.bbi.2016.11.003; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; KADLUBOWSKI M, 1979, NATURE, V277, P140, DOI 10.1038/277140a0; Khomula EV, 2017, J NEUROSCI, V37, P2032, DOI 10.1523/JNEUROSCI.2911-16.2017; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033664; Kleinschnitz C, 2006, EXP NEUROL, V200, P480, DOI 10.1016/j.expneurol.2006.03.014; Ko JS, 2016, BRAIN BEHAV IMMUN, V56, P378, DOI 10.1016/j.bbi.2016.03.003; Kobayashi H, 2008, MOL CELL NEUROSCI, V39, P619, DOI 10.1016/j.mcn.2008.08.008; Liu HQ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-119; Lopes DM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16664-z; Love Michael I, 2015, F1000Res, V4, P1070, DOI 10.12688/f1000research.7035.1; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Moalem G, 2004, NEUROSCIENCE, V129, P767, DOI 10.1016/j.neuroscience.2004.08.035; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Myers RR, 2006, DRUG DISCOV TODAY, V11, P8, DOI 10.1016/S1359-6446(05)03637-8; Nahin RL, 2015, J PAIN, V16, P769, DOI 10.1016/j.jpain.2015.05.002; Nawaz S, 2009, J NEUROSCI, V29, P4794, DOI 10.1523/JNEUROSCI.3955-08.2009; Oka T, 2002, BRIT J PHARMACOL, V135, P1959, DOI 10.1038/sj.bjp.0704662; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Perera CJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0253-4; Prato V, 2017, CELL REP, V21, P3102, DOI 10.1016/j.celrep.2017.11.066; Price TJ, 2018, NAT REV NEUROSCI, V19, P383, DOI 10.1038/s41583-018-0012-5; Raju HB, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00168; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Remacle AG, 2018, BIOCHEM J, V475, P2355, DOI 10.1042/BCJ20180137; Remacle AG, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1123-7; Remacle AG, 2018, J IMMUNOL METHODS, V455, P80, DOI 10.1016/j.jim.2018.02.002; Rosen SF, 2017, J NEUROSCI, V37, P9819, DOI 10.1523/JNEUROSCI.2053-17.2017; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Shubayev VI, 2018, MOL PAIN, V14, DOI 10.1177/1744806918815005; Shubayev VI, 2016, NEURAL REGEN RES, V11, P890, DOI 10.4103/1673-5374.184452; Solovyova N, 2002, CELL CALCIUM, V32, P49, DOI 10.1016/S0143-4160(02)00094-5; Sorge RE, 2017, J NEUROSCI RES, V95, P1271, DOI 10.1002/jnr.23841; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; Sorge RE, 2011, J NEUROSCI, V31, P15450, DOI 10.1523/JNEUROSCI.3859-11.2011; Stephens KE, 2018, MOL PAIN, V14, DOI 10.1177/1744806918817429; Stokes JA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-148; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6; Voskuhl Rhonda, 2011, Biol Sex Differ, V2, P1, DOI 10.1186/2042-6410-2-1; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; Wu SG, 2016, MOL PAIN, V12, DOI 10.1177/1744806916629048; Zagni Emanuela, 2016, Neurosci J, V2016, P2827090, DOI 10.1155/2016/2827090	73	9	9	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10807	10821		10.1074/jbc.RA120.013696	http://dx.doi.org/10.1074/jbc.RA120.013696			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32532796	Green Published, hybrid			2022-12-26	WOS:000560405600023
J	Schmitt, CA; Bergey, CM; Jasinska, AJ; Ramensky, V; Burt, F; Svardal, H; Jorgensen, MJ; Freimer, NB; Grobler, JP; Turner, TR				Schmitt, Christopher A.; Bergey, Christina M.; Jasinska, Anna J.; Ramensky, Vasily; Burt, Felicity; Svardal, Hannes; Jorgensen, Matthew J.; Freimer, Nelson B.; Grobler, J. Paul; Turner, Trudy R.			ACE2 and TMPRSS2 variation in savanna monkeys (Chlorocebus spp.): Potential risk for zoonotic/anthroponotic transmission of SARS-CoV-2 and a potential model for functional studies	PLOS ONE			English	Article							CORONAVIRUS SPIKE PROTEIN; SARS-CORONAVIRUS; VERVET MONKEYS; COVID-19; REHABILITATION; CONSERVATION; ACTIVATION; HUMANS; GENOME; GREEN	The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, has devastated health infrastructure around the world. Both ACE2 (an entry receptor) and TMPRSS2 (used by the virus for spike protein priming) are key proteins to SARS-CoV-2 cell entry, enabling progression to COVID-19 in humans. Comparative genomic research into critical ACE2 binding sites, associated with the spike receptor binding domain, has suggested that African and Asian primates may also be susceptible to disease from SARS-CoV-2 infection. Savanna monkeys (Chlorocebusspp.) are a widespread non-human primate with well-established potential as a bi-directional zoonotic/anthroponotic agent due to high levels of human interaction throughout their range in sub-Saharan Africa and the Caribbean. To characterize potential functional variation in savanna monkeyACE2andTMPRSS2, we inspected recently published genomic data from 245 savanna monkeys, including 163 wild monkeys from Africa and the Caribbean and 82 captive monkeys from the Vervet Research Colony (VRC). We found several missense variants. One missense variant inACE2(X:14,077,550; Asp30Gly), common inCh.sabaeus, causes a change in amino acid residue that has been inferred to reduce binding efficiency of SARS-CoV-2, suggesting potentially reduced susceptibility. The remaining populations appear as susceptible as humans, based on these criteria for receptor usage. All missense variants observed in wildCh.sabaeuspopulations are also present in the VRC, along with two splice acceptor variants (at X:14,065,076) not observed in the wild sample that are potentially disruptive to ACE2 function. The presence of these variants in the VRC suggests a promising model for SARS-CoV-2 infection and vaccine and therapy development. In keeping with a One Health approach, characterizing actual susceptibility and potential for bi-directional zoonotic/anthroponotic transfer in savanna monkey populations may be an important consideration for controlling COVID-19 epidemics in communities with frequent human/non-human primate interactions that, in many cases, may have limited health infrastructure.	[Schmitt, Christopher A.] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Bergey, Christina M.] Rutgers State Univ, Dept Genet, New Brunswick, NJ USA; [Jasinska, Anna J.; Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Jasinska, Anna J.] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Jasinska, Anna J.] Eye Primates, Los Angeles, CA USA; [Ramensky, Vasily] Minist Healthcare Russian Federat, Fed State Inst Natl Med Res Ctr Therapy & Prevent, Moscow, Russia; [Burt, Felicity] Natl Hlth Lab Serv, Div Med Virol, Bloemfontein, Free State, South Africa; [Burt, Felicity] Univ Free State, Div Virol, Fac Hlth Sci, Bloemfontein, Free State, South Africa; [Svardal, Hannes] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Svardal, Hannes] Nat Biodivers Ctr, Leiden, Netherlands; [Jorgensen, Matthew J.] Wake Forest Sch Med, Dept Pathol, Comparat Med Sect, Winston Salem, NC 27101 USA; [Grobler, J. Paul; Turner, Trudy R.] Univ Free State, Dept Genet, Bloemfontein, Free State, South Africa; [Turner, Trudy R.] Univ Wisconsin, Dept Anthropol, Milwaukee, WI 53201 USA	Boston University; Rutgers State University New Brunswick; University of California System; University of California Los Angeles; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; National Medical Research Center for Therapy & Preventive Medicine; University of the Free State; University of Antwerp; Naturalis Biodiversity Center; Wake Forest University; University of the Free State; University of Wisconsin System; University of Wisconsin Milwaukee	Schmitt, CA (corresponding author), Boston Univ, Dept Anthropol, Boston, MA 02215 USA.	caschmit@bu.edu	Burt, Felicity/AAB-6993-2020; Bergey, Christina/ADV-1840-2022	Burt, Felicity/0000-0002-7238-7799; Bergey, Christina/0000-0001-8336-8078; Jasinska, Anna/0000-0002-1897-4570; Svardal, Hannes/0000-0001-7866-7313; Grobler, Paul/0000-0002-5913-7031; Turner, Trudy/0000-0001-8615-442X	Boston University; NSF [SOC 74-24166, BNS 770-3322, BCS 0938969]; NIH [R01RR0163009, R01RR016300, R01OD010980]; University of WisconsinMilwaukee; University of the Free State, South Africa; University of Limpopo, South Africa; Coriell Institute; Austrian Ministry of Science and Research; National Institute of Neurological Disorders and Stroke (NINDS) Informatics Center for Neurogenetics and Neurogenomics [P30 NS062691]	Boston University; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of WisconsinMilwaukee; University of the Free State, South Africa; University of Limpopo, South Africa; Coriell Institute; Austrian Ministry of Science and Research; National Institute of Neurological Disorders and Stroke (NINDS) Informatics Center for Neurogenetics and Neurogenomics	This work was supported by funding from Boston University, to C.A.S., http://www.bu.edu.There was no additional external funding received for this study. Original data collection was supported by funding from NSF (SOC 74-24166, BNS 770-3322, BCS 0938969) to T.R.T., http://www.nsf.gov; NIH (R01RR0163009) to N.B.F., and to N.B.F. for the UCLA Systems Biology Sample Repository (R01RR016300 and R01OD010980), http://www.nih.gov; the University of WisconsinMilwaukee to T.R.T., http://www.uwm.edu; The University of the Free State, South Africa, to J.P.G., http://www.ufs.ac.za; the University of Limpopo, South Africa, to J.P.G., http://www.ul.ac.za; Coriell Institute, to T.R.T., http://www.coriell.org; the Austrian Ministry of Science and Research, to H.S, https://www.bmbwf.gv.at/.We acknowledge the support of the National Institute of Neurological Disorders and Stroke (NINDS) Informatics Center for Neurogenetics and Neurogenomics (P30 NS062691), to N.B.F., http://www.ninds.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r For the generation of this data, the authors gratefully acknowledge assistance in the field by Jennifer Danzy Cramer, Oliver "Pess" Morton, Yoon Jung, Stephanie Groman, David Jentsch, Eugene Redmond and the St. Kitts Biomedical Research Foundation in St. Kitts; veterinarians Lizanne Meiring, Murray Stokoe and numerous field assistants in South Africa including especially Gabriel Coetzer, Magali Jacquier, Helene DeNys, JD Pampush, Elzet Answegen, Tegan Gaetano, Dewald DuPlessis, Micah Beller, David Beller and Pess Morton; the University of Limpopo and the University of the Free State; and Mamkumba Sanneh, Katie Camfield, Michel Dione, Martin Antonio and the Medical Research Council in the Gambia. Collections of these data were conducted under permits and permissions issued by the following: Ethiopian Wildlife Conservation Authority; Gambia Department of Parks and Wildlife Management; Ministry of Tourism and Wildlife, Kenya; in South Africa the Department of Economic Development and Environmental Affairs, Eastern Cape; Department of Tourism, Environmental and Economic Affairs, Free State Province; Ezemvelo KZN Wildlife; Department of Economic Development, Environment and Tourism, Limpopo; the Department of Agriculture, Conservation and Environment, Mpumalanga and the Department of Environment and Nature Conservation, Northern Cape, as well as the South African National Department of Environmental Affairs.	Afar DEH, 2001, CANCER RES, V61, P1686; American Veterinary Medical Association, COVID 19 FAQS PET OW; Anderson CJ, 2017, SOUTHEAST NAT, V16, P19, DOI 10.1656/058.016.0103; Benavides J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031290; Blaszczyk MB, 2017, ANIM BEHAV, V123, P91, DOI 10.1016/j.anbehav.2016.10.017; Cao YN, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0147-1; Centers for Disease Control and Prevention, YOU HAV AN; Clark NL, 2005, PLOS GENET, V1, P335, DOI 10.1371/journal.pgen.0010035; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Denham WW, 1982, J BARBADOS MUSEUM HI, V36, P211; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dore KM, 2018, FOLIA PRIMATOL, V89, P63, DOI 10.1159/000479064; Gaetano TJ, 2014, S AFR J WILDL RES, V44, P56, DOI 10.3957/056.044.0105; Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6; Gillespie TR, 2008, YEARB PHYS ANTHROPOL, V51, P53, DOI 10.1002/ajpa.20949; GROBLER P., 2006, ECOLOGICAL ENV ANTHR, V2, P12; Groves C.P., 2001, PRIMATE TAXONOMY; Healy A, 2014, ANIM WELFARE, V23, P353, DOI 10.7120/09627286.23.3.353; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hopman J, 2020, JAMA-J AM MED ASSOC, V323, P1549, DOI 10.1001/jama.2020.4169; Huang X, 2019, BIOINFORMATICS, DOI [10.1093/bioinformatics/btz926.36, DOI 10.1093/BIOINFORMATICS/BTZ926.36]; Jasinska AJ, 2013, ILAR J, V54, P122, DOI 10.1093/ilar/ilt049; Jia HP, 2006, ADV EXP MED BIOL, V581, P479; Karczewski K.J., 2019, GENOMICS, DOI [10.1101/531210, DOI 10.1101/531210]; Kelly TR, 2020, ONE HEALTH OUTLOOK, V2, DOI 10.1186/s42522-019-0007-9; Leendertz SAJ, 2017, MAMMAL REV, V47, P98, DOI 10.1111/mam.12082; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li R, 2020, J INFECTION, V80, P469, DOI 10.1016/j.jinf.2020.02.013; Liu ZX, 2020, J MED VIROL, V92, P595, DOI 10.1002/jmv.25726; Matsuyama S, 2020, P NATL ACAD SCI USA, V117, P7001, DOI 10.1073/pnas.2002589117; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; McAuliffe J, 2004, VIROLOGY, V330, P8, DOI 10.1016/j.virol.2004.09.030; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Melin Amanda D, 2020, bioRxiv, DOI 10.1101/2020.04.09.034967; Mikula P, 2018, BEHAV PROCESS, V147, P21, DOI 10.1016/j.beproc.2017.12.011; Nasiri MJ, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00459; Ramensky V, 2019, BIORXIV, DOI [10.1101/784132, DOI 10.1101/784132]; Saj TL, 2001, AFR J ECOL, V39, P195, DOI 10.1046/j.0141-6707.2000.00299.x; Schmitt C.A., 2020, ANTHROPOGENIC FOOD E, DOI [10.1101/2020.04.18.048314, DOI 10.1101/2020.04.18.048314]; Senghore M, 2016, APPL ENVIRON MICROB, V82, P5910, DOI 10.1128/AEM.01496-16; Shan C, 2020, RES SQUARE, DOI [10.21203/rs.2.25200/v1, DOI 10.21203/RS.2.25200/V1]; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Simmons G, 2013, ANTIVIR RES, V100, P605, DOI 10.1016/j.antiviral.2013.09.028; South African Government, REG GUID COR COV 19; Svardal H, 2017, NAT GENET, V49, P1705, DOI 10.1038/ng.3980; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HEALTH, V8, pe545; Turner TR, 2019, SAVANNA MONKEYS: THE GENUS CHLOROCEBUS, P1, DOI 10.1017/9781139019941; Turner TR, 2018, AM J PHYS ANTHROPOL, V166, P682, DOI 10.1002/ajpa.23459; Warren WC, 2015, GENOME RES, V25, P1921, DOI 10.1101/gr.192922.115; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Wimberger K, 2010, ANIM WELFARE, V19, P481; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; Wu C., 2020, SILICO ANAL INTERMED, DOI [10.26434/chemrxiv.12057996.v1, DOI 10.26434/CHEMRXIV.12057996.V1]; Xue J, 2020, REINFECTION COULD NO, DOI [10.1101/2020.03.13.990226v2, DOI 10.1101/2020.03.13.990226V1, 10.1101/2020.03.13.990226]; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yu P, 2020, ANIM MODEL EXP MED, V3, P93, DOI 10.1002/ame2.12108; Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9; Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022	61	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235106	10.1371/journal.pone.0235106	http://dx.doi.org/10.1371/journal.pone.0235106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574196	Green Published, Green Submitted, gold			2022-12-26	WOS:000544972400038
J	von der Esch, E; Kohles, AJ; Anger, PM; Hoppe, R; Niessner, R; Elsner, M; Ivleva, NP				von der Esch, Elisabeth; Kohles, Alexander J.; Anger, Philipp M.; Hoppe, Roland; Niessner, Reinhard; Elsner, Martin; Ivleva, Natalia P.			TUM-ParticleTyper: A detection and quantification tool for automated analysis of (Microplastic) particles and fibers	PLOS ONE			English	Article							NILE RED; FILTER SUBSTRATE; IDENTIFICATION; FTIR; MICROSPECTROSCOPY; MICROSCOPY; FALLOUT; WATER; MP	TUM-ParticleTyperis a novel program for the automated detection, quantification and morphological characterization of fragments, including particles and fibers, in images from optical, fluorescence and electron microscopy (SEM). It can be used to automatically select targets for subsequent chemical analysis, e.g., Raman microscopy, or any other single particle identification method. The program was specifically developed and validated for the analysis of microplastic particles on gold coated polycarbonate filters. Our method development was supported by the design of a filter holder that minimizes filter roughness and facilitates enhanced focusing for better images and Raman measurements. TheTUM-ParticleTypersoftware is tunable to the user's specific sample demands and can extract the morphological characteristics of detected objects (coordinates, Feret's diameter min / max, area and shape). Results are saved in csv-format and contours of detected objects are displayed as an overlay on the original image. Additionally, the program can stitch a set of images to create a full image out of several smaller ones. An additional useful feature is the inclusion of a statistical process to calculate the minimum number of particles that must be chemically identified to be representative of all particles localized on the substrate. The program performance was evaluated on genuine microplastic samples. TheTUM-ParticleTypersoftware localizes particles using an adaptive threshold with results comparable to the "gold standard" method (manual localization by an expert) and surpasses the commonly usedOtsuthresholding by doubling the rate of true positive localizations. This enables the analysis of a statistically significant number of particles on the filter selected by random sampling, measured via single point approach. This extreme reduction in measurement points was validated by comparison to chemical imaging, applying both procedures to the same area at comparable processing times. The single point approach was both faster and more accurate proving the applicability of the presented program.	[von der Esch, Elisabeth; Kohles, Alexander J.; Anger, Philipp M.; Hoppe, Roland; Niessner, Reinhard; Elsner, Martin; Ivleva, Natalia P.] Tech Univ Munich, Inst Hydrochem, Chair Analyt Chem & Water Chem, Munich, Germany	Technical University of Munich	Ivleva, NP (corresponding author), Tech Univ Munich, Inst Hydrochem, Chair Analyt Chem & Water Chem, Munich, Germany.	natalia.ivleva@tum.de	Elsner, Martin/J-4637-2012; Ivleva, Natalia/AAQ-9987-2020	Elsner, Martin/0000-0003-4746-9052; Ivleva, Natalia/0000-0002-7685-5166	Bayerische Forschungsstiftung [AZ-1258-16]; German Federal Ministry of Education and Research [02WRS1378C]; German Research Foundation (DFG); Technical University of Munich, within the funding program Open Access Publishing	Bayerische Forschungsstiftung; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich, within the funding program Open Access Publishing	Funding by the Bayerische Forschungsstiftung (https://www.forschungsstiftung.de/) for the Project MiPaq "Microparticles in the aquatic environment and in foodstuffs" are biodegradable polymers a conceivable solution to the "microplastic problem"?, AZ-1258-16 is gratefully acknowledged. Funding by the German Federal Ministry of Education and Research https://www.bmbf.de/for the Project MiWa -Microplastic in the water cycle, 02WRS1378C is gratefully acknowledged. Furthermore, this work was supported by the German Research Foundation (DFG, https://www.dfg.de/) and the Technical University of Munich, within the funding program Open Ac-cess Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Anger PM, 2018, TRAC-TREND ANAL CHEM, V109, P214, DOI 10.1016/j.trac.2018.10.010; Anger PM, 2019, ANAL METHODS; [Anonymous], 2006, AM J KIDNEY DIS, V2006, pS176; [Anonymous], 2016, IM THRESH; Bassan P, 2010, ANALYST, V135, P268, DOI 10.1039/b921056c; Bittrich L., 2018, GEPARD GEPARD ENABLE; Cabernard L, 2018, ENVIRON SCI TECHNOL, V52, P13279, DOI 10.1021/acs.est.8b03438; Catarino AI, 2018, ENVIRON POLLUT, V237, P675, DOI 10.1016/j.envpol.2018.02.069; Chae Y, 2018, ENVIRON POLLUT, V240, P387, DOI 10.1016/j.envpol.2018.05.008; Dris R, 2016, MAR POLLUT BULL, V104, P290, DOI 10.1016/j.marpolbul.2016.01.006; Eerkes-Medrano D, 2015, WATER RES, V75, P63, DOI 10.1016/j.watres.2015.02.012; Erni-Cassola G, 2017, ENVIRON SCI TECHNOL, V51, P13641, DOI 10.1021/acs.est.7b04512; Huppertsberg S, 2018, ANAL BIOANAL CHEM, V410, P6343, DOI 10.1007/s00216-018-1210-8; Imhof HK, 2016, WATER RES, V98, P64, DOI 10.1016/j.watres.2016.03.015; Ivleva NP, 2017, ANGEW CHEM INT EDIT, V56, P1720, DOI 10.1002/anie.201606957; Kappler A, 2016, ANAL BIOANAL CHEM, V408, P8377, DOI 10.1007/s00216-016-9956-3; Kappler A, 2015, ANAL BIOANAL CHEM, V407, P6791, DOI 10.1007/s00216-015-8850-8; Kohles A.J., 2020, TUM PARTICLETYPER SO; Maes T, 2017, SCI REP-UK, V7, DOI 10.1038/srep44501; Ossmann BE, 2018, WATER RES, V141, P307, DOI 10.1016/j.watres.2018.05.027; Ossmann BE, 2017, ANAL BIOANAL CHEM, V409, P4099, DOI 10.1007/s00216-017-0358-y; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Prata JC, 2019, SCI TOTAL ENVIRON, V690, P1277, DOI 10.1016/j.scitotenv.2019.07.060; Primpke S, 2019, ANAL METHODS-UK, V11, P2138, DOI 10.1039/c9ay00126c; Primpke S, 2017, ANAL METHODS-UK, V9, P1499, DOI 10.1039/c6ay02476a; Renner Gerrit, 2018, Current Opinion in Environmental Science & Health, V1, P55, DOI 10.1016/j.coesh.2017.11.001; Schymanski D, 2018, WATER RES, V129, P154, DOI 10.1016/j.watres.2017.11.011; Shim WJ, 2016, MAR POLLUT BULL, V113, P469, DOI 10.1016/j.marpolbul.2016.10.049; Simon M, 2018, WATER RES, V142, P1, DOI 10.1016/j.watres.2018.05.019; Tagg AS, 2015, ANAL CHEM, V87, P6032, DOI 10.1021/acs.analchem.5b00495; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; Udupa JK, 2006, COMPUT MED IMAG GRAP, V30, P75, DOI 10.1016/j.compmedimag.2005.12.001; von der Esch E, 2020, FRONT CHEM, V8, DOI 10.3389/fchem.2020.00169	33	12	12	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234766	10.1371/journal.pone.0234766	http://dx.doi.org/10.1371/journal.pone.0234766			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574195	Green Published, gold			2022-12-26	WOS:000544972400022
J	Huang, J; Cui, Z; Gu, QH; Zhang, YM; Qu, Z; Wang, X; Wang, F; Cheng, XY; Meng, LQ; Liu, G; Zhao, MH				Huang, Jing; Cui, Zhao; Gu, Qiu-hua; Zhang, Yi-miao; Qu, Zhen; Wang, Xin; Wang, Fang; Cheng, Xu-yang; Meng, Li-qiang; Liu, Gang; Zhao, Ming-hui			Complement activation profile of patients with primary focal segmental glomerulosclerosis	PLOS ONE			English	Article							UROKINASE RECEPTOR; MICE; IGM; CONTRIBUTES; INJURY; DAMAGE; ROLES	Background Studies on adriamycin mice model suggest complement system is activated and together with IgM contributes to the glomerular injury of primary focal segmental glomerulosclerosis (FSGS). We recently reported primary FSGS patients with IgM and C3 deposition showed unfavorable therapeutic responses and worse renal outcomes. Here we examined the plasma and urinary complement profile of patients with primary FSGS, aiming to investigate the complement participation in FSGS pathogenesis. Methods Seventy patients with biopsy-proven primary FSGS were enrolled. The plasma and urinary levels of C3a, C5a, soluble C5b-9, C4d, C1q, MBL, and Bb were determined by commercial ELISA kits. Results The levels of C3a, C5a and C5b-9 in plasma and urine of FSGS patients were significantly higher than those in normal controls. The plasma and urinary levels of C5b-9 were positively correlated with urinary protein, renal dysfunction and interstitial fibrosis. The plasma C5a levels were positively correlated with the proportion of segmental sclerotic glomeruli. The urinary levels of Bb were elevated, positively correlated with C3a and C5b-9 levels, renal dysfunction, and interstitial fibrosis. The plasma C1q level was significantly decreased, and negatively correlated with urinary protein excretion. Urinary Bb level was a risk factor for no remission (HR = 3.348, 95% CI 1.264-8.870, P = 0.015) and ESRD (HR = 2.323, 95% CI 1.222-4.418, P = 0.010). Conclusion In conclusion, our results identified the systemic activation of complement in human primary FSGS, possibly via the classical and alternative pathway. The activation of complement system was partly associated with the clinical manifestations, kidney pathological damage, and renal outcomes.	[Huang, Jing; Cui, Zhao; Gu, Qiu-hua; Zhang, Yi-miao; Qu, Zhen; Wang, Xin; Wang, Fang; Cheng, Xu-yang; Meng, Li-qiang; Liu, Gang; Zhao, Ming-hui] Peking Univ, Div Renal, Hosp 1, Beijing, Peoples R China; [Huang, Jing; Cui, Zhao; Gu, Qiu-hua; Zhang, Yi-miao; Qu, Zhen; Wang, Xin; Wang, Fang; Cheng, Xu-yang; Meng, Li-qiang; Liu, Gang; Zhao, Ming-hui] Peking Univ, Inst Nephrol, Beijing, Peoples R China; [Huang, Jing; Cui, Zhao; Gu, Qiu-hua; Zhang, Yi-miao; Qu, Zhen; Wang, Xin; Wang, Fang; Cheng, Xu-yang; Meng, Li-qiang; Liu, Gang; Zhao, Ming-hui] Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China; [Huang, Jing; Cui, Zhao; Gu, Qiu-hua; Zhang, Yi-miao; Qu, Zhen; Wang, Xin; Wang, Fang; Cheng, Xu-yang; Meng, Li-qiang; Liu, Gang; Zhao, Ming-hui] Minist Educ China, Key Lab CKD Prevent & Treatment, Beijing, Peoples R China; [Zhao, Ming-hui] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Peking University; Ministry of Education, China	Cui, Z (corresponding author), Peking Univ, Div Renal, Hosp 1, Beijing, Peoples R China.; Cui, Z (corresponding author), Peking Univ, Inst Nephrol, Beijing, Peoples R China.; Cui, Z (corresponding author), Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China.; Cui, Z (corresponding author), Minist Educ China, Key Lab CKD Prevent & Treatment, Beijing, Peoples R China.	cuizhao@bjmu.edu.cn	Cui, Zhao/ABZ-9262-2022	Cui, Zhao/0000-0002-5837-1926	National Natural Science Foundation of China (NSFC) [81621092, 81330020, 81500542, 81622009]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (NSFC) to the Innovation Research Group (81621092) and other NSFC programs (81330020, 81500542, 81622009).	Addis-Lieser E, 2005, J IMMUNOL, V175, P1894, DOI 10.4049/jimmunol.175.3.1894; Cofiell R, 2015, BLOOD, V125, P3253, DOI 10.1182/blood-2014-09-600411; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; EMBER JA, 1998, HUMAN COMPLEMENT SYS, P241; Hillebrandt S, 2005, NAT GENET, V37, P835, DOI 10.1038/ng1599; Huang J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-81; Huang J, 2013, KIDNEY INT, V84, P366, DOI 10.1038/ki.2013.55; Lenderink AM, 2007, AM J PHYSIOL-RENAL, V293, pF555, DOI 10.1152/ajprenal.00403.2006; Mastellos D, 2001, J IMMUNOL, V166, P2479, DOI 10.4049/jimmunol.166.4.2479; Morita Y, 2000, J AM SOC NEPHROL, V11, P700, DOI 10.1681/ASN.V114700; Panzer SE, 2015, KIDNEY INT, V88, P528, DOI 10.1038/ki.2015.120; Rangan GK, 2004, KIDNEY INT, V66, P1838, DOI 10.1111/j.1523-1755.2004.00957.x; SCHWARTZ MM, 1995, AM J KIDNEY DIS, V25, P845, DOI 10.1016/0272-6386(95)90566-9; Schwartz MM, 2007, HEPINSTALLS PATHOLOG, V2, P156; Sorman A, 2014, MOL IMMUNOL, V61, P79, DOI 10.1016/j.molimm.2014.06.010; Strassheim D, 2013, J AM SOC NEPHROL, V24, P393, DOI 10.1681/ASN.2012020187; Thurman JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136558; Turnberg D, 2006, J IMMUNOL, V177, P4094, DOI 10.4049/jimmunol.177.6.4094; Vivarelli M, 2014, SEMIN THROMB HEMOST, V40, P472, DOI 10.1055/s-0034-1375299; Wada T, 2013, KIDNEY INT, V84, P441, DOI 10.1038/ki.2013.134; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; YAMAMOTO T, 1993, LUPUS, V2, P261, DOI 10.1177/096120339300200410; Yu F, 2010, KIDNEY INT, V77, P820, DOI 10.1038/ki.2010.13; Zhang YM, 2016, CLIN J AM SOC NEPHRO, V11, P1582, DOI 10.2215/CJN.01190216; 2003, SEMICOND SCI TECHNOL, V18, pVI45	26	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234934	10.1371/journal.pone.0234934	http://dx.doi.org/10.1371/journal.pone.0234934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569286	Green Published, gold			2022-12-26	WOS:000543547900035
J	Ananthapavan, J; Sacks, G; Brown, V; Moodie, M; Nguyen, P; Veerman, L; Herrera, AMM; Lal, A; Peeters, A; Carter, R				Ananthapavan, Jaithri; Sacks, Gary; Brown, Vicki; Moodie, Marj; Nguyen, Phuong; Veerman, Lennert; Herrera, Ana Maria Mantilla; Lal, Anita; Peeters, Anna; Carter, Rob			Priority-setting for obesity prevention-The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study	PLOS ONE			English	Article							INTERVENTIONS; ADOLESCENTS; CHILDREN; LIFE	The aim of the ACE-Obesity Policy study was to assess the economic credentials of a suite of obesity prevention policies across multiple sectors and areas of governance for the Australian setting. The study aimed to place the cost-effectiveness results within a broad decision-making context by providing an assessment of the key considerations for policy implementation. The Assessing Cost-Effectiveness (ACE) approach to priority-setting was used. Systematic literature reviews were undertaken to assess the evidence of intervention effectiveness on body mass index and/or physical activity for selected interventions. A standardised evaluation framework was used to assess the cost-effectiveness of each intervention compared to a 'no intervention' comparator, from a limited societal perspective. A multi-state life table Markov cohort model was used to estimate the long-term health impacts (quantified as health adjusted life years (HALYs)) and health care cost-savings resulting from each intervention. In addition to the technical cost-effectiveness results, qualitative assessments of implementation considerations were undertaken. All 16 interventions evaluated were found to be cost-effective (using a willingness-to-pay threshold of AUD50,000 per HALY gained). Eleven interventions were dominant (health promoting and cost-saving). The incremental cost-effectiveness ratio for the non-dominant interventions ranged from AUD1,728 to 28,703 per HALY gained. Regulatory interventions tended to rank higher on their cost-effectiveness results, driven by lower implementation costs. However, the program-based policy interventions were generally based on higher quality evidence of intervention effectiveness. This comparative analysis of the economic credentials of obesity prevention policies for Australia indicates that there are a broad range of policies that are likely to be cost-effective, although policy options vary in strength of evidence for effectiveness, affordability, feasibility, acceptability to stakeholders, equity impact and sustainability. Implementation of these policies will require sustained co-ordination across jurisdictions and multiple government sectors in order to generate the predicted health benefits for the Australian population.	[Ananthapavan, Jaithri; Brown, Vicki; Moodie, Marj; Nguyen, Phuong; Lal, Anita; Carter, Rob] Deakin Univ, Sch Hlth & Social Dev, Inst Hlth Transformat, Deakin Hlth Econ, Geelong, Vic, Australia; [Ananthapavan, Jaithri; Sacks, Gary; Brown, Vicki; Moodie, Marj; Nguyen, Phuong; Lal, Anita; Peeters, Anna] Deakin Univ, Global Obes Ctr, Sch Hlth & Social Dev, Inst Hlth Transformat, Geelong, Vic, Australia; [Veerman, Lennert] Griffith Univ, Sch Med, Gold Coast, Australia; [Herrera, Ana Maria Mantilla] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Herrera, Ana Maria Mantilla] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Herrera, Ana Maria Mantilla] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Deakin University; Deakin University; Griffith University; Queensland Centre for Mental Health Research; University of Queensland; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Ananthapavan, J (corresponding author), Deakin Univ, Sch Hlth & Social Dev, Inst Hlth Transformat, Deakin Hlth Econ, Geelong, Vic, Australia.; Ananthapavan, J (corresponding author), Deakin Univ, Global Obes Ctr, Sch Hlth & Social Dev, Inst Hlth Transformat, Geelong, Vic, Australia.	jaithri.ananthapavan@deakin.edu.au	; Veerman, Lennert/A-9973-2011	Carter, Rob/0000-0002-1586-5619; PEETERS, ANNA/0000-0003-4340-9132; Veerman, Lennert/0000-0002-3206-8232; Ananthapavan, Jaithri/0000-0002-5957-6931	National Health and Medical Research Council (NHMRC) [APP1041020]; Australian Research Council [DE160100307]; National Heart Foundation of Australia [102035]; Deakin University	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); National Heart Foundation of Australia(National Heart Foundation of Australia); Deakin University	This research activity was supported by the National Health and Medical Research Council (NHMRC) funded Centre of Research Excellence in Obesity Policy and Food Systems (APP1041020). GS was supported by an Australian Research Council Discovery Early Career Researcher Award (DE160100307) and a National Heart Foundation of Australia Future Leader Fellowship (102035). VB and AL were supported by a Deakin University Postgraduate Research Scholarship. AL was supported by a Deakin University Dean's Postdoctoral Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ananthapavan J, 2019, INT J OBESITY, V43, P1102, DOI 10.1038/s41366-019-0341-0; Ananthapavan J, 2014, INT J ENV RES PUB HE, V11, P4007, DOI 10.3390/ijerph110404007; [Anonymous], 2014, CHOICES CHILDH OB IN; Australian Bureau of Statistics, 2011, 3101 0 AUSTR DEM STA; Australian Bureau of Statistics, 2015, AUSTR HLTH SURV 2011; Australian Bureau of Statistics, 2015, 63060DO011 201405 EM; Australian Government Department of Health, 2019, OV OB CAMB; Australian Institute of Health and Welfare, 2016, HLTH EXP AUSTR 2014; Australian Institute of Health and Welfare, 2017, PICTURE OVERWEIGHT O; Barendregt JJ, 2010, J EPIDEMIOL COMMUN H, V64, P209, DOI 10.1136/jech.2009.090274; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Brown V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4271-2; Brown V, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050622; Carter R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-419; Carter Rob, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P593, DOI 10.1586/14737167.8.6.593; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chen G, 2014, PEDIATRICS, V133, pE868, DOI 10.1542/peds.2013-0622; Clarke B, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3639-z; Cobiac L, 2010, AUST NZ J PUBL HEAL, V34, P240, DOI 10.1111/j.1753-6405.2010.00520.x; Crino M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090983; Dunford E, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3230; Epigear International, 2016, ERS BRISB; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Food Standards Australia and New Zealand, 2016, NUTR TABL US AUSTR N; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Gao L, 2018, SCAND J WORK ENV HEA, V44, P503, DOI 10.5271/sjweh.3740; George B, 2001, PHARMACOECONOMICS, V19, P1103, DOI 10.2165/00019053-200119110-00004; Haby MM, 2006, INT J OBESITY, V30, P1463, DOI 10.1038/sj.ijo.0803469; Hall KD, 2013, LANCET DIABETES ENDO, V1, P97, DOI 10.1016/S2213-8587(13)70051-2; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Huse O, 2020, INT J OBESITY, V44, P1011, DOI 10.1038/s41366-019-0495-9; Husereau D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1049; Institute for Physcial Activity and Nutrition, 2019, TRANSF US; Kumanyika SK, 2010, BRIDGING THE EVIDENCE GAP IN OBESITY PREVENTION: A FRAMEWORK TO INFORM DECISION MAKING, P1; Lal A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002326; Metrics IfH Evaluation. Global Burden of Disease Collaborative Network, 2017, GLOBAL BURDEN DIS ST; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; New South Wales Government, 2018, PREM PRIOR 2015 2019; North Caucasus Analysis, 2005, N CAUCASUS ANAL, V6, P23; Obesity Policy Coalition GLOBE, 2017, TIPP SCAL; Organisation for Economic Co- operation and Development, 2017, OB UPD; Price Waterhouse Coopers (PwC), 2015, WEIGH COST OB CAS AC; Ridley K, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-45; Robinson E, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030603; Sacks G, 2009, OBES REV, V10, P76, DOI 10.1111/j.1467-789X.2008.00524.x; Sacks G., 2019, POLICIES TACKLING OB; Sacks G, 2020, CURR OBES REP, V9, P150, DOI 10.1007/s13679-020-00376-z; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Shiell A, 2018, HEALTH PROMOT J AUST, V29, P7, DOI 10.1002/hpja.165; Snowdon W, 2011, FOOD POLICY, V36, P597, DOI 10.1016/j.foodpol.2011.06.001; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Veerman L., 2010, ASSESSING COST EFFEC; WHO, 1997, GLOB DAT CHILD GROWT; World Health Organisation, 2018, OB OV KEY FACTS; World Health Organization, 2019, WHO EUR APPR OB; World Health Organization, 2017, REP COMM END CHILDH; Zapata-Diomedi B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184799; 2018, CURR OPIN TOXICOL, V10	59	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234804	10.1371/journal.pone.0234804	http://dx.doi.org/10.1371/journal.pone.0234804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559212	Green Published, gold			2022-12-26	WOS:000543261600027
J	Barros-Santos, T; Silva, KSO; Libarino-Santos, M; Cata-Preta, EG; Reis, HS; Tamura, EK; de Oliveira-Lima, AJ; Berro, LF; Uetanabaro, APT; Marinho, EAV				Barros-Santos, Thaisa; Oliveira Silva, Kallyane Santos; Libarino-Santos, Matheus; Cata-Preta, Elisangela Gouveia; Reis, Henrique Sousa; Tamura, Eduardo Koji; de Oliveira-Lima, Alexandre Justo; Berro, Lais Fernanda; Trovatti Uetanabaro, Ana Paula; Villela Marinho, Eduardo Ary			Effects of chronic treatment with new strains of Lactobacillus plantarumon cognitive, anxiety- and depressive-like behaviors in male mice	PLOS ONE			English	Article							KYNURENINE PATHWAY; BACTERIA; FERMENTATION; MOUSE	Psychobiotics correspond to a class of probiotics, mainly of the genusLactobacillusandBifidobacterium, capable of producing neuroactive substances, such as gamma-aminobutyric acid (GABA) and serotonin, which exert effects on the brain-gut axis. Evidence suggests that psychobiotics can have a beneficial effect on mood, anxiety and cognition. The present study evaluated the effects of chronic administration of two new strains ofLactobacillus plantarum,L.plantarum286 (Lp 286) andL.plantarum81 (Lp 81) isolated from the fermentation of cocoa (Theobroma cacaoL.) and cupuacu (Theobroma grandiflorum), respectively, on cognitive, anxiety- and depressive-like behaviors in male Swiss mice. Different groups of animals were administered (oral gavage) solutions of vehicle (0.85% saline plus 15% skim milk), Lp 286 (10(9)/0.1 ml CFU) or Lp 81 (10(9)/0.1 ml CFU) for 30 days, and animals were tested for general locomotor activity, depressive-like behavior in the forced swim test, and learning/memory and anxiety-like behavior in the plus-maze discriminative avoidance task. Treatment with the strains Lp 286 and Lp 81 did not interfere with locomotor activity or learning and memory. The Lp 286 strain exerted anti-depressant- and anxiolytic-like effects under our experimental conditions. Our findings add to the current body of evidence suggesting that probiotics from the genusLactobacillusmay exert psychobiotic potential and introduce a new strain, Lp 286, as a potential candidate in the prevention or as therapeutic adjuvant in the treatment of mental disorders.	[Barros-Santos, Thaisa; Oliveira Silva, Kallyane Santos; Libarino-Santos, Matheus; Trovatti Uetanabaro, Ana Paula] Univ Estadual Santa Cruz, Dept Biol Sci, Ilheus, BA, Brazil; [Cata-Preta, Elisangela Gouveia; Reis, Henrique Sousa; Tamura, Eduardo Koji; de Oliveira-Lima, Alexandre Justo; Berro, Lais Fernanda; Villela Marinho, Eduardo Ary] Univ Estadual Santa Cruz, Dept Hlth Sci, Ilheus, BA, Brazil; [Berro, Lais Fernanda] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA	Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz; University of Mississippi; University of Mississippi Medical Center	Berro, LF; Marinho, EAV (corresponding author), Univ Estadual Santa Cruz, Dept Hlth Sci, Ilheus, BA, Brazil.; Berro, LF (corresponding author), Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA.	lberro@umc.edu; eavmarinho@uesc.br	Tamura, Eduardo Koji/F-7068-2012; Avaliação, PPGCS/ABF-2467-2020; Berro, Laís F/D-9710-2014; Marinho, Eduardo Ary Villela/D-7223-2013; Marinho, Eduardo/AGK-8589-2022; Lima, Alexandre Justo Oliveira-/AAU-4084-2020	Tamura, Eduardo Koji/0000-0002-6105-7452; Berro, Laís F/0000-0003-4841-4117; Marinho, Eduardo Ary Villela/0000-0002-3179-2819; Lima, Alexandre Justo Oliveira-/0000-0003-1414-4761; Uetanabaro, Ana Paula/0000-0003-3992-8474	Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) [DTE 0034/2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES) [407278/2013-3]; Universidade Estadual de Santa Cruz	Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Universidade Estadual de Santa Cruz	Funding for this study was provided by grants from Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB), grant DTE 0034/2013; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES), grant 407278/2013-3; and by intramural funding from Universidade Estadual de Santa Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, J PROSTHET DENT, V11, pe1; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2009, OXFORD CRITICAL CULT, V1, P6; Barrett E, 2012, J APPL MICROBIOL, V113, P411, DOI 10.1111/j.1365-2672.2012.05344.x; Benton D, 2007, EUR J CLIN NUTR, V61, P355, DOI 10.1038/sj.ejcn.1602546; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Claes S, 2011, PSYCHIAT RES, V188, P355, DOI 10.1016/j.psychres.2011.03.012; Dinan TG, 2013, BIOL PSYCHIAT, V74, P720, DOI 10.1016/j.biopsych.2013.05.001; FAO/WHO, 2002, GUIDELINES EVALUATIO; Gibney SM, 2013, BRAIN BEHAV IMMUN, V28, P170, DOI 10.1016/j.bbi.2012.11.010; Holmes A, 2000, PHYSIOL BEHAV, V71, P509, DOI 10.1016/S0031-9384(00)00373-5; Kopp MV, 2008, CLIN EXP ALLERGY, V38, P602, DOI 10.1111/j.1365-2222.2007.02911.x; Kubera N, 2001, J CLIN PSYCHOPHARM, V21, P199, DOI 10.1097/00004714-200104000-00012; Liang S, 2015, NEUROSCIENCE, V310, P561, DOI 10.1016/j.neuroscience.2015.09.033; Liu WH, 2016, BEHAV BRAIN RES, V298, P202, DOI 10.1016/j.bbr.2015.10.046; Lyte M, 2011, BIOESSAYS, V33, P574, DOI 10.1002/bies.201100024; Marin IA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43859; Marinho EAV, 2015, PROG NEURO-PSYCHOPH, V58, P22, DOI 10.1016/j.pnpbp.2014.11.010; Marschalek J, 2017, BREAST CARE, V12, P335, DOI 10.1159/000478994; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Navarro-Lopez V, 2018, JAMA DERMATOL, V154, P37, DOI 10.1001/jamadermatol.2017.3647; Porsolt RD, 1977, NATURE, V21, P266; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Saarela M, 2000, J BIOTECHNOL, V84, P197, DOI 10.1016/S0168-1656(00)00375-8; Ornellas RMS, 2017, ADV EXP MED BIOL, V973, P1, DOI 10.1007/5584_2017_5; Santos TT, 2016, LWT-FOOD SCI TECHNOL, V73, P259, DOI 10.1016/j.lwt.2016.06.003; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Silva RH, 2000, J NEUROSCI METH, V102, P117, DOI 10.1016/S0165-0270(00)00289-2; Singh PK, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01861.x; Vecsei L, 2013, NAT REV DRUG DISCOV, V12, P64, DOI 10.1038/nrd3793; Wei CL, 2019, BRAIN RES, V1711, P202, DOI 10.1016/j.brainres.2019.01.025	32	18	19	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234037	10.1371/journal.pone.0234037	http://dx.doi.org/10.1371/journal.pone.0234037			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559185	Green Published, gold			2022-12-26	WOS:000543261600014
J	Cole, CL; Beck, CA; Robinson, D; Ye, J; Mills, B; Gerber, SA; Schwarz, EM; Linehan, D				Cole, Calvin L.; Beck, Christopher A.; Robinson, Deja; Ye, Jian; Mills, Bradley; Gerber, Scott A.; Schwarz, Edward M.; Linehan, David			Dual Energy X-ray Absorptiometry (DEXA) as a longitudinal outcome measure of cancer-related muscle wasting in mice	PLOS ONE			English	Article							PANCREATIC-CANCER; TREATMENT OPTIONS; ECHOMRI-AH; SARCOPENIA; CACHEXIA; OBESITY; DXA	Introduction Pancreatic ductal adenocarcinoma (PDAC) is notorious for its associated skeletal muscle wasting (SMW) and mortality. Currently, the relationships between PDAC, SMW, and survival are poorly understood. Thus, there is great need for a faithful small animal model with quantitative longitudinal outcome measures that recapitulate clinical PDAC, to define SMW onset and assess progression. Therefore, we aimed to validate dual energy X-ray absorptiometry (DEXA) as a longitudinal measure of lean mass, and demonstrate its utility to quantify SMW in the KCKO murine model of PDAC. Methods In vivo body composition of: 1) untreated mice at 5, 8, 12, 18, and 22 weeks of age (n = 4) and 2) a cohort of mice with (n = 5) and without PDAC (n = 5), was determined via DEXA and lean mass of the lower hind limbs was predicted via a region of interest analysis by two-independent observers. Total body weight was determined. Tibialis anterior (TA) muscles were weighed and processed for histomorphometry immediately post-mortem. Statistical differences between groups were assessed using ANOVA and Student's t-tests. Linear regression models and correlation analysis were used to measure the association between TA and DEXA mass, and reproducibility of DEXA was quantified via the intraclass correlation coefficient (ICC). Results Lean mass in growing untreated mice determined by DEXA correlated with TA mass (r(2)= 0.94; p <0.0001) and body weight (r(2)= 0.89; p <0.0001). DEXA measurements were highly reproducible between observers (ICC = 0.95; 95% CI: 0.89-0.98). DEXA and TA mass also correlated in the PDAC cohort (r(2)= 0.76; p <0.0001). Significant SMW in tumor-bearing mice was detected within 38 days of implantation, by DEXA, TA mass, and histomorphometry. Conclusions DEXA is a longitudinal outcome measure of lean mass in mice. The KCKO syngeneic model is abona fidemodel of PDAC associated SMW that can be quantified with longitudinal DEXA.	[Cole, Calvin L.; Robinson, Deja; Schwarz, Edward M.] Univ Rochester, Med Ctr, Dept Orthopaed, Rochester, NY 14642 USA; [Cole, Calvin L.; Robinson, Deja; Schwarz, Edward M.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Cole, Calvin L.; Ye, Jian; Mills, Bradley; Gerber, Scott A.; Linehan, David] Univ Rochester, Med Ctr, Dept Surg, Rochester, NY 14642 USA; [Cole, Calvin L.] Univ Rochester, Med Ctr, Canc Control, Rochester, NY 14642 USA; [Beck, Christopher A.] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Beck, Christopher A.] Univ Rochester, Med Ctr, Dept Orthpaed, Rochester, NY 14642 USA; [Gerber, Scott A.] Univ Rochester, Med Ctr, Dept Microbiol, Rochester, NY 14642 USA; [Gerber, Scott A.] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA; [Schwarz, Edward M.; Linehan, David] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Cole, CL (corresponding author), Univ Rochester, Med Ctr, Dept Orthopaed, Rochester, NY 14642 USA.; Cole, CL (corresponding author), Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA.; Cole, CL (corresponding author), Univ Rochester, Med Ctr, Dept Surg, Rochester, NY 14642 USA.; Cole, CL (corresponding author), Univ Rochester, Med Ctr, Canc Control, Rochester, NY 14642 USA.	Calvin_Cole@urmc.rochester.edu		Schwarz, Edward/0000-0002-4854-9698	National Institutes of Health [P30 AR069955]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the National Institutes of Health (P30 AR069955) (CLC) www.nih.gov The funders had no role in study design, data collection and analysis, decisition to publish, or preparation of the manuscript.	Bachman JF, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.167197; Bergqvist J, 2017, ACTA ONCOL, V56, P1168, DOI 10.1080/0284186X.2017.1327719; Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Bozzetti F, 2017, ANN ONCOL, V28, P2107, DOI 10.1093/annonc/mdx271; Bredella MA, 2010, OBESITY, V18, P2227, DOI 10.1038/oby.2010.5; Cole C., 2018, J CACHEXIA SARCOPENI, V3, P19; Costamagna D, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/805172; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, DOI 10.1093/ageing/afz046; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2010, HPB, V12, P323, DOI 10.1111/j.1477-2574.2010.00178.x; Galgani JE, 2011, INT J OBESITY, V35, P1241, DOI 10.1038/ijo.2010.268; Gargiulo S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/253067; Guglielmi G, 2016, AGING CLIN EXP RES, V28, P1047, DOI 10.1007/s40520-016-0589-3; Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254; Lee SJ, 2017, CANCER NURS, V40, P479, DOI 10.1097/NCC.0000000000000454; Marlatt KL, 2017, EUR J CLIN NUTR, V71, P558, DOI 10.1038/ejcn.2016.236; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Michaelis KA, 2017, J CACHEXIA SARCOPENI, V8, P824, DOI 10.1002/jcsm.12225; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Ninomiya G., PANCREATOLOGY, V16, pS91; Nywening TM, 2018, GUT, V67, P1112, DOI 10.1136/gutjnl-2017-313738; Pasetto L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198089; Peng P, 2012, J GASTROINTEST SURG, V16, P1478, DOI 10.1007/s11605-012-1923-5; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Romanick M, 2013, BBA-MOL BASIS DIS, V1832, P1410, DOI 10.1016/j.bbadis.2013.03.011; Ryan AM, 2016, P NUTR SOC, V75, P199, DOI 10.1017/S002966511500419X; Sandini M, 2018, JAMA SURG, V153, P809, DOI 10.1001/jamasurg.2018.0979; Shukla SK, 2015, ONCOTARGET, V6, P41146, DOI 10.18632/oncotarget.5843; Shukla SK, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-18; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Takagi K, 2017, INT J SURG OPEN, V6, P12, DOI 10.1016/j.ijso.2016.12.002; Wang SL, 2016, ANN SURG ONCOL, V23, P556, DOI 10.1245/s10434-015-4887-3; Zhang XM, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-6645-6	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0230695	10.1371/journal.pone.0230695	http://dx.doi.org/10.1371/journal.pone.0230695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559188	gold, Green Published, Green Submitted			2022-12-26	WOS:000543261600045
J	Lawless, SP; Cohen, ND; Lawhon, SD; Chamoun-Emanuelli, AM; Wu, J; Rivera-Velez, A; Weeks, BR; Whitfield-Cargile, CM				Lawless, Shauna P.; Cohen, Noah D.; Lawhon, Sara D.; Chamoun-Emanuelli, Ana M.; Wu, Jing; Rivera-Velez, Andres; Weeks, Brad R.; Whitfield-Cargile, Canaan M.			Effect of gallium maltolate on a model of chronic, infected equine distal limb wounds	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL ACTIVITY; NITRIC-OXIDE; IFN-GAMMA; IN-VIVO; HORSES; NITRATE; SUPPRESSION; EXPRESSION; EFFICACY	Distal limb wounds are common injuries sustained by horses and their healing is fraught with complications due to equine anatomy, prevalence of infection, and challenges associated with wound management. Gallium is a semi-metallic element that has been shown to possess antimicrobial properties and aid in wound healing in various preclinical models. The effects of Gallium have not been studied in equine wound healing. Therefore, the objective of this study was to compare healing rates between gallium-treated and untreated wounds of equine distal limbs and to demonstrate the antimicrobial effects of gallium on wounds inoculated withS.aureus. Using an established model of equine wound healing we demonstrated beneficial effects of 0.5% topical gallium maltolate on equine wound healing. Specifically we documented reduced healing times, reduced bioburden, and reduced formation of exuberant granulation tissue in wounds treated with gallium maltolate as compared with untreated wounds. Gallium appeared to exert its beneficial effects via its well-described antimicrobial actions as well as by altering the expression of specific genes known to be involved in wound healing of horses and other animals. Specifically, gallium maltolate appeared to increase expression of transforming growth factor-beta in both infected and un-infected wounds. Further work is needed to document the effects of gallium on naturally occurring equine wounds and to compare the effects of gallium with other wound treatment options. These data, however, suggest that gallium may be an attractive and novel means of improving equine distal limb wound healing.	[Lawless, Shauna P.; Cohen, Noah D.; Chamoun-Emanuelli, Ana M.; Rivera-Velez, Andres; Whitfield-Cargile, Canaan M.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA; [Lawhon, Sara D.; Weeks, Brad R.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX USA; [Wu, Jing] Texas A&M Univ, Vet Med Teaching Hosp, Coll Vet Med & Biomed Sci, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Whitfield-Cargile, CM (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA.	cwhitfield@cvm.tamu.edu	Lawhon, Sara D./G-5147-2011	Lawhon, Sara D./0000-0001-9154-8909; Chamoun-Emanuelli, Ana/0000-0001-5314-7266; Weeks, Brad/0000-0002-5509-5719; Whitfield-Cargile, Canaan/0000-0002-9743-8783; Cohen, Noah/0000-0002-0384-2903	Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Texas AM University; Link Equine Research Endowment, College of Veterinary Medicine, Texas AM University	Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Texas AM University; Link Equine Research Endowment, College of Veterinary Medicine, Texas AM University	SPL, CMW, NDC: Research and Graduate Studies Trainee Grant, Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University. NDC: Link Equine Research Endowment, College of Veterinary Medicine, Texas A&M University	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2019, INTEL 64 IA 32 ARCHI, V3; [Anonymous], 2003, REV ETUD ITAL, V49, P1; [Anonymous], 2008, TS, V69, P144, DOI [10.1177/004056390806900108, DOI 10.1177/004056390806900108]; Arnold CE, 2012, VET MICROBIOL, V155, P389, DOI 10.1016/j.vetmic.2011.09.009; Baldoni D, 2010, ANTIMICROB AGENTS CH, V54, P157, DOI 10.1128/AAC.00700-09; Bill T J, 2001, Ostomy Wound Manage, V47, P34; Bischofberger AS, 2011, VET SURG, V40, P898, DOI 10.1111/j.1532-950X.2011.00886.x; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; Carricajo A, 2001, J CLIN MICROBIOL, V39, P2581, DOI 10.1128/JCM.39.7.2581-2583.2001; Caston SS, 2012, VET CLIN N AM-EQUINE, V28, P83, DOI 10.1016/j.cveq.2012.01.001; Celeste CJ, 2013, VET SURG, V42, P147, DOI 10.1111/j.1532-950X.2012.00966.x; Chaffin MK, 2011, AM J VET RES, V72, P945, DOI 10.2460/ajvr.72.7.945; Cirioni O, 2013, J MED MICROBIOL, V62, P1552, DOI 10.1099/jmm.0.057414-0; CLARK RAF, 1993, AM J MED SCI, V306, P42, DOI 10.1097/00000441-199307000-00011; Collery P, 2002, CRIT REV ONCOL HEMAT, V42, P283, DOI 10.1016/S1040-8428(01)00225-6; Dart AJ, 2009, AUST VET J, V87, P215, DOI 10.1111/j.1751-0813.2009.00428.x; Dart AJ, 2002, VET SURG, V31, P309, DOI 10.1053/jvet.2002.33585; Dart AJ, 2002, VET SURG, V31, P314, DOI 10.1053/jvet.2002.33589; Davis SC, 2008, WOUND REPAIR REGEN, V16, P23, DOI 10.1111/j.1524-475X.2007.00303.x; DeLeon K, 2009, ANTIMICROB AGENTS CH, V53, P1331, DOI 10.1128/AAC.01330-08; ENONEN, 1995, FALL SCH ANAL, V68, P1; Fecteau ME, 2011, AM J VET RES, V72, P1243, DOI 10.2460/ajvr.72.9.1243; Freeman K, 2009, CAN J MICROBIOL, V55, P197, DOI [10.1139/w08-115, 10.1139/W08-115]; Goncalves J, 2002, J SURG RES, V103, P134, DOI 10.1006/jsre.2001.6347; GREENE SA, 1986, AM J VET RES, V47, P2364; Greenlee-Wacker MC, 2017, J LEUKOCYTE BIOL, V101, P751, DOI 10.1189/jlb.4A1215-565RR; Hanson RR, 2008, VET CLIN N AM-EQUINE, V24, P663, DOI 10.1016/j.cveq.2008.10.005; Harrington JR, 2006, J VET PHARMACOL THER, V29, P121, DOI 10.1111/j.1365-2885.2006.00723.x; Ishida Y, 2004, J IMMUNOL, V172, P1848, DOI 10.4049/jimmunol.172.3.1848; JACOBS KA, 1984, VET SURG, V13, P83, DOI 10.1111/j.1532-950X.1984.tb00765.x; Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783; Kelson AB, 2013, CURR OPIN PHARMACOL, V13, P707, DOI 10.1016/j.coph.2013.07.001; KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X; Krecic-Shepard ME, 1999, LIFE SCI, V65, P1359, DOI 10.1016/S0024-3205(99)00375-6; Laato M, 2001, ANN CHIR GYNAECOL, V90, P19; Lazaro JL, 2016, J WOUND CARE, V25, P277, DOI 10.12968/jowc.2016.25.5.277; Lefebvre-Lavoie J, 2005, PHYSIOL GENOMICS, V22, P157, DOI 10.1152/physiolgenomics.00018.2005; Lepault E, 2005, WOUND REPAIR REGEN, V13, P520, DOI 10.1111/j.1067-1927.2005.00073.x; Makkonen N, 1995, INFLAMM RES, V44, P523, DOI 10.1007/BF01757356; Nijhuis RHT, 2014, J CLIN MICROBIOL, V52, P2861, DOI 10.1128/JCM.00808-14; Olakanmi O, 2010, ANTIMICROB AGENTS CH, V54, P244, DOI 10.1128/AAC.00655-09; Olczak T, 2012, ARCH MICROBIOL, V194, P719, DOI 10.1007/s00203-012-0804-3; Panagakos FS, 2000, BIOCHIMIE, V82, P147, DOI 10.1016/S0300-9084(00)00384-9; Pierezan F, 2016, VET DERMATOL, V27, P332, DOI 10.1111/vde.12366; Samra Z, 2004, DIAGN MICR INFEC DIS, V49, P243, DOI 10.1016/j.diagmicrobio.2004.02.009; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Stick, 2012, EQUINE SURG, P47; Theoret C., 2008, EQUINE WOUND MANAGEM; Theoret CL, 2013, WOUND REPAIR REGEN, V21, P365, DOI 10.1111/wrr.12018; Theoret CL, 2002, VET SURG, V31, P266, DOI 10.1053/jvet.2002.32394; Toth T, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-45; Van den Boom R, 2002, WOUND REPAIR REGEN, V10, P188, DOI 10.1046/j.1524-475X.2002.10608.x; Van den Eede A, 2009, VET MICROBIOL, V133, P138, DOI 10.1016/j.vetmic.2008.06.021; Weese JS, 2005, JAVMA-J AM VET MED A, V226, P580, DOI 10.2460/javma.2005.226.580; Westgate SJ, 2011, VET MICROBIOL, V150, P152, DOI 10.1016/j.vetmic.2011.01.003; WHITACRE C, 1992, J NEUROIMMUNOL, V39, P175, DOI 10.1016/0165-5728(92)90186-O; Wilmink JM, 2003, EQUINE VET J, V35, P561, DOI 10.2746/042516403775467234; Wilmink JM, 2002, EQUINE VET J, V34, P270, DOI 10.2746/042516402776186047; Wilmink JM, 1999, EQUINE VET J, V31, P61, DOI 10.1111/j.2042-3306.1999.tb03792.x; Wilmink JM, 1999, EQUINE VET J, V31, P53, DOI 10.1111/j.2042-3306.1999.tb03791.x; Xu ZR, 2017, RSC ADV, V7, P52266, DOI 10.1039/c7ra10265h	64	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0235006	10.1371/journal.pone.0235006	http://dx.doi.org/10.1371/journal.pone.0235006			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559258	Green Published, gold			2022-12-26	WOS:000543261600007
J	Kendrick, N; Powers, G; Johansen, J; Hoelter, M; Koll, A; Carlson, S; Channaveerappa, D; Darie, CC				Kendrick, Nancy; Powers, Ginny; Johansen, Jon; Hoelter, Matt; Koll, Andrew; Carlson, Sofia; Channaveerappa, Devika; Darie, Costel C.			Preparation of a phosphotyrosine-protein standard for use in semiquantitative western blotting with enhanced chemiluminescence	PLOS ONE			English	Article							RESOLUTION 2-DIMENSIONAL ELECTROPHORESIS; LYMPHOMA KINASE ALK; SPECIFICITY	Protein tyrosine phosphorylation is key to activation of receptor tyrosine kinases (RTK) that drive development of some cancers. One challenge of RTK-targeted therapy is identification of those tumors that express non-mutated but activated RTKs. Phosphotyrosine (pTyr) RTK levels should be more predictive of the latter than expressed total protein. Western blotting (WB) with a pTyr antibody and enhanced chemiluminescence (ECL) detection is sufficiently sensitive to detect pTyr-RTKs in human tumor homogenates. Presentation of results by comparing WB images, however, is wanting. Here we describe the preparation of a new pTyr-protein standard, pTyr-ALK48-SB (pA), derived from a commercial anaplastic lymphoma kinase (ALK) recombinant fragment, and its use to quantify pTyr-epidermal growth factor receptor (pTyr-EGFR) in commercial A431 cell lysates. Linearity of one-dimensional (1D) WB plots of pA band density versus load as well as its lower level of detection (0.1 ng, 2 fmole) were determined for standardized conditions. Adding pA to two lots of A431 cell lysates with high and low pTyr-EGFR allowed normalization and quantification of the latter by expressing results as density ratios for both 1D and 2D WB. This approach is semi-quantitative because unknown RTKs may be outside the linear range of detection. Semiquantitative ratios are an improvement over comparisons of images without a reference standard and facilitate comparisons between samples.	[Kendrick, Nancy; Powers, Ginny; Johansen, Jon; Hoelter, Matt; Koll, Andrew; Carlson, Sofia] Kendrick Labs Inc, Madison, WI 53713 USA; [Channaveerappa, Devika; Darie, Costel C.] Clarkson Univ, Dept Chem & Biomol Sci, Biochem & Prote Grp, Potsdam, NY 13699 USA	Clarkson University	Kendrick, N (corresponding author), Kendrick Labs Inc, Madison, WI 53713 USA.; Darie, CC (corresponding author), Clarkson Univ, Dept Chem & Biomol Sci, Biochem & Prote Grp, Potsdam, NY 13699 USA.	nancy@kendricklabs.com; cdarie@clarkson.edu		Carlson, Sofia/0000-0002-3959-768X; Darie, Costel C./0000-0001-6402-2311; Kendrick, Nancy/0000-0002-0282-4906	Kendrick Labs, Inc.	Kendrick Labs, Inc.	Funding for this research was provided by Kendrick Labs, Inc. NK and JJ are officers, board members, and stockholders of Kendrick Labs. Kendrick Labs provided support in the form of salaries for employees NK, JJ, GP, MH, AD and SC. The specific roles of these authors are articulated in the 'author contributions' section. All studies were conceived and performed by Kendrick Labs employees except for mass spectrometry studies which were conceived and performed by CCD and DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria-Schaffer A, 2009, METHOD ENZYMOL, V463, P573, DOI 10.1016/S0076-6879(09)63033-0; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; ANDERSON L, 1977, P NATL ACAD SCI USA, V74, P5421, DOI 10.1073/pnas.74.12.5421; Awasthi S, 2018, J PROTEOMICS; Awasthi S, 2018, DATA BRIEF, V19, P424, DOI 10.1016/j.dib.2018.04.086; Bainor A, 2011, ANAL BIOCHEM, V410, P310, DOI 10.1016/j.ab.2010.11.015; Boersema PJ, 2009, J MASS SPECTROM, V44, P861, DOI 10.1002/jms.1599; BURGESSCASSLER A, 1989, CLIN CHEM, V35, P2297; Chang YC, 2018, PEERJ, V6, DOI 10.7717/peerj.4719; Channaveerappa D, 2017, J CELL MOL MED, V21, P2223, DOI 10.1111/jcmm.13145; Degasperi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087293; Donella-Deana A, 2005, BIOCHEMISTRY-US, V44, P8533, DOI 10.1021/bi0472954; Du ZF, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0782-4; Finotello F, 2018, CANCER IMMUNOL IMMUN, V67, P1031, DOI 10.1007/s00262-018-2150-z; Fosang AJ, 2015, J BIOL CHEM, V290, P29692, DOI 10.1074/jbc.E115.000002; Gajiwala KS, 2013, PROTEIN SCI, V22, P995, DOI 10.1002/pro.2283; Genova C, 2016, ONCOTARGETS THER, V9, P5427, DOI 10.2147/OTT.S114039; Gorg A, 2009, ELECTROPHORESIS, V30, pS122, DOI 10.1002/elps.200900051; Johnson H, 2012, SEMIN CELL DEV BIOL, V23, P854, DOI 10.1016/j.semcdb.2012.05.008; Kendrick N, 2019, ADV EXP MED BIOL, V1140, P563, DOI 10.1007/978-3-030-15950-4_33; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lopez-Coral A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31426-1; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Rabilloud T, 2009, ELECTROPHORESIS, V30, pS174, DOI 10.1002/elps.200900050; Rodrigues JG, 2018, CELL IMMUNOL, V333, P46, DOI 10.1016/j.cellimm.2018.03.007; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sattu K, 2013, FEBS J, V280, P5269, DOI 10.1111/febs.12453; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Tinti M, 2012, NEW BIOTECHNOL, V29, P571, DOI 10.1016/j.nbt.2011.12.001; Trivedi MV, 2009, CURR PROTEIN PEPT SC, V10, P614, DOI 10.2174/138920309789630534; Weinberg RA, 2014, BIOLOGY OF CANCER, SECOND EDITION, P1; Zhen YJ, 2003, BIOCHEMISTRY-US, V42, P5478, DOI 10.1021/bi027101p	32	2	2	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234645	10.1371/journal.pone.0234645	http://dx.doi.org/10.1371/journal.pone.0234645			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555693	gold, Green Published			2022-12-26	WOS:000543273200023
J	Wulczyn, E; Steiner, DF; Xu, ZY; Sadhwani, A; Wang, HW; Flament-Auvigne, I; Mermel, CH; Chen, PHC; Liu, Y; Stumpe, MC				Wulczyn, Ellery; Steiner, David F.; Xu, Zhaoyang; Sadhwani, Apaar; Wang, Hongwu; Flament-Auvigne, Isabelle; Mermel, Craig H.; Chen, Po-Hsuan Cameron; Liu, Yun; Stumpe, Martin C.			Deep learning-based survival prediction for multiple cancer types using histopathology images	PLOS ONE			English	Article								Providing prognostic information at the time of cancer diagnosis has important implications for treatment and monitoring. Although cancer staging, histopathological assessment, molecular features, and clinical variables can provide useful prognostic insights, improving risk stratification remains an active research area. We developed a deep learning system (DLS) to predict disease specific survival across 10 cancer types from The Cancer Genome Atlas (TCGA). We used a weakly-supervised approach without pixel-level annotations, and tested three different survival loss functions. The DLS was developed using 9,086 slides from 3,664 cases and evaluated using 3,009 slides from 1,216 cases. In multivariable Cox regression analysis of the combined cohort including all 10 cancers, the DLS was significantly associated with disease specific survival (hazard ratio of 1.58, 95% CI 1.28-1.70, p<0.0001) after adjusting for cancer type, stage, age, and sex. In a per-cancer adjusted subanalysis, the DLS remained a significant predictor of survival in 5 of 10 cancer types. Compared to a baseline model including stage, age, and sex, the c-index of the model demonstrated an absolute 3.7% improvement (95% CI 1.0-6.5) in the combined cohort. Additionally, our models stratified patients within individual cancer stages, particularly stage II (p = 0.025) and stage III (p<0.001). By developing and evaluating prognostic models across multiple cancer types, this work represents one of the most comprehensive studies exploring the direct prediction of clinical outcomes using deep learning and histopathology images. Our analysis demonstrates the potential for this approach to provide significant prognostic information in multiple cancer types, and even within specific pathologic stages. However, given the relatively small number of cases and observed clinical events for a deep learning task of this type, we observed wide confidence intervals for model performance, thus highlighting that future work will benefit from larger datasets assembled for the purposes for survival modeling.	[Wulczyn, Ellery; Steiner, David F.; Xu, Zhaoyang; Sadhwani, Apaar; Wang, Hongwu; Mermel, Craig H.; Chen, Po-Hsuan Cameron; Liu, Yun; Stumpe, Martin C.] Google LLC, Google Hlth, Palo Alto, CA USA; [Flament-Auvigne, Isabelle] Adv Clin, Chicago, IL USA; [Stumpe, Martin C.] Tempus Labs Inc, Chicago, IL USA		Liu, Y (corresponding author), Google LLC, Google Hlth, Palo Alto, CA USA.	liuyun@google.com	Mermel, Craig/AAZ-7322-2020	Mermel, Craig/0000-0002-0816-3395; Sadhwani, Apaar/0000-0002-9272-2574; Liu, Yun/0000-0003-4079-8275	Google LLC	Google LLC(Google Incorporated)	This study was funded by Google LLC. All authors contributed to this work while employed at or performing work at Google. Most authors own Alphabet stock. Google did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of each author is articulated in the `author contributions' section.	Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; BRESLOW N, 1974, BIOMETRICS, V30, P89, DOI 10.2307/2529620; Bychkov D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21758-3; Cooper LAD, 2018, J PATHOL, V244, P512, DOI 10.1002/path.5028; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; COX DR, 1975, BIOMETRIKA, V62, P269, DOI 10.2307/2335362; COX DR, 1972, J R STAT SOC B, V34, P187; Davidson-Pilon C, 2019, CAMDAVIDSONPILON LIF, DOI [10.5281/zenodo.3240536, DOI 10.5281/ZENODO.3240536]; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Howard A.G., 2017, MOBILENETS EFFICIENT; Kather JN, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002730; LeCun Y., 2015, NATURE, V521, P436, DOI [10.1038/nature14539, DOI 10.1038/nmeth.3707, DOI 10.1038/nature14539, DOI 10.1038/NATURE14539]; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Liu Y, 2019, ARCH PATHOL LAB MED, V143, P859, DOI 10.5858/arpa.2018-0147-OA; Mobadersany P, 2018, P NATL ACAD SCI USA, V115, pE2970, DOI 10.1073/pnas.1717139115; Nagpal K, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0112-2; Rakha EA, 2008, J CLIN ONCOL, V26, P3153, DOI 10.1200/JCO.2007.15.5986; Saltz J, 2018, CELL REP, V23, P181, DOI 10.1016/j.celrep.2018.03.086; Sparano JA, 2018, NEW ENGL J MED, V379, P111, DOI 10.1056/NEJMoa1804710; Sparano JA, 2019, NEW ENGL J MED, V380, P2395, DOI 10.1056/NEJMoa1904819; Steck H., 2008, ADV NEURAL INFORM PR, V20, P1209; The Cancer Genome Atlas Network, 2015, CELL, V161, P1681, DOI [10.1016/j.cell.2015.05.044, DOI 10.1016/J.CELL.2015.05.044]; Tieleman T, 2012, COURSERA NEURAL NETW, V4, P26; Wang C, 2013, J AM MED INFORM ASSN, V20, P680, DOI 10.1136/amiajnl-2012-001538; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Weiser MR, 2011, J CLIN ONCOL, V29, P4796, DOI 10.1200/JCO.2011.36.5080; Yu KH, 2017, CELL SYST, V5, P620, DOI 10.1016/j.cels.2017.10.014; Yu KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12474; Zhu XL, 2017, PROC CVPR IEEE, P6855, DOI 10.1109/CVPR.2017.725	32	72	73	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0233678	10.1371/journal.pone.0233678	http://dx.doi.org/10.1371/journal.pone.0233678			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555646	Green Published, Green Submitted, gold			2022-12-26	WOS:000542759600019
J	Chavan, VV; Dalal, A; Nagaraja, S; Thekkur, P; Mansoor, H; Meneguim, A; Paryani, R; Singh, P; Kalon, S; Das, M; Ferlazzo, G; Isaakidis, P				Chavan, Vijay Vinayak; Dalal, Alpa; Nagaraja, Sharath; Thekkur, Pruthu; Mansoor, Homa; Meneguim, Augusto; Paryani, Roma; Singh, Pramila; Kalon, Stobdan; Das, Mrinalini; Ferlazzo, Gabriella; Isaakidis, Petros			Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; IMIPENEM/CLAVULANATE; REGIMENS; SAFETY	Background Imipenem, an intravenous antibiotic is recommended for use in drug resistant tuberculosis (DR-TB) when an effective regimen with combination of other second line drugs is not possible. Though the treatment success rates with carbapenems are promising, the twice daily injection of Imipenem usually requires patients to be hospitalized. The Medecins Sans Frontieres independent clinic in Mumbai, India implemented ambulatory and home based management of patients receiving Imipenem through the use of port-a-cath. Objective We aimed to describe the adverse events and treatment outcomes of ambulatory pre- and XDR-TB patients initiated on imipenem through port-a-cath between January 2015 and June 2018 and to explore the challenges with this regimen as perceived by healthcare providers and patients. Methods A convergent mixed methods study with quantitative (longitudinal descriptive study using the routine data) and qualitative (descriptive study) part conducted concurrently. For the quantitative component, all XDR-TB and pre-XDR-TB initiated on imipenem containing regimen during January 2015-June 2018 were included. For qualitative component, interviews were carried out including patients who initiated on imipenem (n = 5) and healthcare providers (n = 7) involved in providing treatment. Treatment outcomes, culture conversion and adverse events during treatment were described. Thematic analysis was carried out for qualitative component. Results Of the 70 patients included, the mean age was 28.1 (standard deviation: 11.2) years and 36 (51.4%) were females. Fifty one (72.9%) had XDR-TB. All patients were resistant to fluoroquinilone, levofloxacin. Vomiting was reported by 55 (78.6%) patients and at least one episode of QTC prolongation (more than 500 msec by Fredrecia method) was detected in 25 (35.7%). Port-a-cath block and infection was seen in 11 (15.7%) and 20 (28.6%) patients respectively. Favourable outcomes were seen in 43 (61.4%) patients. Mortality was seen in 22 (31.4%) patients, 2 (2.9%) were lost-to-follow-up and 3 (4.3%) were declared as treatment failure. The overarching theme of the qualitative analysis was: Challenges in delivering Imipenem via port-a-cath device in ambulatory care. Major challenges identified were difficulties in adhering to drug dose timelines, vomiting, restricted mobility due to port-a-cath, paucity of infection control and space constraints at patients' home for optimal care. Conclusion Administration of imipenem was feasible through port-a-cath. Though outcomes with ambulatory based imipenem containing regimens were promising, there were several challenges in providing care. The feasibility of infusion at day care facilities needs to explored to overcome challenges in infusion at patients home.	[Chavan, Vijay Vinayak; Mansoor, Homa; Meneguim, Augusto; Paryani, Roma; Singh, Pramila; Kalon, Stobdan; Das, Mrinalini] Medecins Sans Frontieres Doctors Borders, Mumbai, Maharashtra, India; [Dalal, Alpa] Jupiter Hosp, Mumbai, Maharashtra, India; [Nagaraja, Sharath] ESIC Med Coll & PGIMSR, Bengaluru, India; [Thekkur, Pruthu] Int Union TB & Lung Dis, Paris, France; [Thekkur, Pruthu] Union South East Asia Off, New Delhi, India; [Ferlazzo, Gabriella; Isaakidis, Petros] Medecins Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa		Chavan, VV (corresponding author), Medecins Sans Frontieres Doctors Borders, Mumbai, Maharashtra, India.	dr.vijayvchavan@gmail.com	Nagaraja, Sharath Burugina/ABD-7748-2021; Nagaraja, Sharath Burugina/ABD-7238-2021	Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Chavan, Vijay/0000-0003-3563-6896; Das, Mrinalini/0000-0002-1354-4299; Isaakidis, Petros/0000-0002-7881-1554				Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Alkindi Salam, 2012, J Infect Public Health, V5, P57, DOI 10.1016/j.jiph.2011.10.004; [Anonymous], 2014, GUIDE USE BEDAQUILIN; [Anonymous], 2017, REV AVAILABLE EVIDEN; Arbex MA, 2016, REV PORT PNEUMOL, V22, P337, DOI 10.1016/j.rppnen.2016.06.006; Attride-Stirling J, 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307; Brigden G, 2015, INFECT DRUG RESIST, V8, P367, DOI 10.2147/IDR.S68351; Brigden G, 2014, B WORLD HEALTH ORGAN, V92, P68, DOI 10.2471/BLT.13.122028; Central TB Division, 2019, IND TB REP 2019; Creswell J.W., 2018, RES DESIGN, V5th; Dooley KE, 2013, J INFECT DIS, V207, P1352, DOI 10.1093/infdis/jis460; India [Internet]. Ministry of Health & Family Welfare Government of India, 2016, REV NAT TB CONTR PRO; Kulkarni S, 2014, CARDIOVASC INTER RAD, V37, P990, DOI 10.1007/s00270-013-0771-3; Laxmeshwar C, 2019, INT J TUBERC LUNG D, V23, P73, DOI 10.5588/ijtld.18.0149; Madabhavi I, 2017, CLIN MED INSIGHTS-ON, V11, DOI 10.1177/1179554917691031; Migliori GB, 2008, EUR RESPIR J, V31, P1155, DOI 10.1183/09031936.00028708; Ng F, 2007, CLIN ONCOL-UK, V19, P551, DOI 10.1016/j.clon.2007.04.003; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Pontali E, 2019, EUR RESPIR REV, V28, DOI 10.1183/16000617.0035-2019; Sotgiu G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030373; TB-Alliance, 2019, NIX TB TB ALL; Tiberi S, 2016, EUR RESPIR J, V47, P333, DOI 10.1183/13993003.01278-2015; WHO, 2019, GLOB TUB REP; WHO, 2019, WHO CONS GUID DRUG R, DOI DOI 10.30978/TB2021-2-86; WHO, 2015, WORLD HEAL ORGAN, V58, P7250; World Health Organization, 2018, PREM NCD DEATHS; World Health Organization, 2016, AMBIENT AIR POLLUTIO, DOI DOI 10.1017/CBO9781107415324.004; World Health Organization, 2014, MOD DEL MDR TB TREAT	28	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234651	10.1371/journal.pone.0234651	http://dx.doi.org/10.1371/journal.pone.0234651			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544174	Green Published, gold			2022-12-26	WOS:000542957200032
J	Chen, Y; Laotaweerungsawat, S; Zhao, T; Haq, Z; Liu, XY; Psaras, C; Yang, DN; Stewart, JM				Chen, Yi; Laotaweerungsawat, Sawarin; Zhao, Tong; Haq, Zeeshan; Liu, Xiuyun; Psaras, Catherine; Yang, Daphne; Stewart, Jay M.			Discordant vascular parameter measurements in diabetic and non-diabetic eyes detected by different optical coherence tomography angiography devices	PLOS ONE			English	Article							VESSEL DENSITY; RETINOPATHY	Purpose To compare quantitative changes in macular parameters in diabetic patients detected by two optical coherence tomography angiography (OCTA) instruments. Methods 80 phakic eyes were classified as no diabetes, diabetes without diabetic retinopathy (DR), mild non-proliferative diabetic retinopathy (NPDR), and severe NPDR or proliferative DR (PDR). OCTA was performed using devices from two manufacturers (Zeiss and Heidelberg). Superficial and deeper vascular skeleton density (SVSD, DVSD), superficial and deeper vessel area density (SVAD, DVAD), choriocapillaris flow voids (CCFV), and choroidal flow voids (CFV) were calculated. Inter-device comparisons were performed using the size comparison index (SCI) and the discrepancy index (DI). Results The two devices were inconsistent in SVSD, DVSD, DVAD, CCFV and CFV parameters (allP< 0.05). In addition, the SCI was positive for DVAD (all P < 0.001) and negative for SVSD, DVSD, CCFV and CFV in all groups (allP<0.001), except for DVSD in severe NPDR or PDR. The discrepancy index was not significantly different among groups for SVD, SPD, DVD, DPD and CFV (allP>0.05). The mean DI of CCFV was statistically different between the four groups (P< 0.001). Conclusions The two instruments were largely inconsistent in the measurement of macular parameters relevant to DR. The choice of imaging device can impact OCTA analytics and should be taken into account when drawing conclusions about DR-related changes.	[Chen, Yi; Laotaweerungsawat, Sawarin; Zhao, Tong; Haq, Zeeshan; Psaras, Catherine; Yang, Daphne; Stewart, Jay M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Chen, Yi; Laotaweerungsawat, Sawarin; Zhao, Tong; Haq, Zeeshan; Psaras, Catherine; Yang, Daphne; Stewart, Jay M.] Zuckerberg San Francisco Gen Hosp & Trauma Ctr, Dept Ophthalmol, San Francisco, CA 94110 USA; [Chen, Yi] Jinan Univ, Shenzhen Eye Hosp, Shenzhen Key Lab Ophthalmol, Affiliated Shenzhen Eye Hosp, Shenzhen, Peoples R China; [Laotaweerungsawat, Sawarin] Charoenkrung Pracharak Hosp, Dept Ophthalmol, Bangkok, Thailand; [Zhao, Tong] China Japan Friendship Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Liu, Xiuyun] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA USA	University of California System; University of California San Francisco; Jinan University; China-Japan Friendship Hospital; University of California System; University of California San Francisco	Stewart, JM (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.; Stewart, JM (corresponding author), Zuckerberg San Francisco Gen Hosp & Trauma Ctr, Dept Ophthalmol, San Francisco, CA 94110 USA.	jay.stewart@ucsf.edu	Liu, Xiuyun/V-4427-2017	Liu, Xiuyun/0000-0001-9540-4865	That Man May See, Inc.; Research to Prevent Blindness; National Eye Institute, Core Grant for Vision Research [EY002162]; National Eye Institute [1R01EY024004]	That Man May See, Inc.; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Eye Institute, Core Grant for Vision Research; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	1. JMS: That Man May See, Inc. 2. JMS: Research to Prevent Blindness 3. JMS: National Eye Institute, Core Grant for Vision Research EY002162 4. JMS: National Eye Institute, 1R01EY024004 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agemy SA, 2015, RETINA-J RET VIT DIS, V35, P2353, DOI 10.1097/IAE.0000000000000862; [Anonymous], 1991, OPHTHALMOLOGY, V98, P807; [Anonymous], 2017, CURRENT ANTHR S16, V58, pS303; [Anonymous], 2016, BALKAN J GEOM APPL, V21, piii; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Campbell JP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42201; Conti FF, 2019, BRIT J OPHTHALMOL, V103, P452, DOI 10.1136/bjophthalmol-2018-311903; Corvi F, 2018, AM J OPHTHALMOL, V186, P25, DOI 10.1016/j.ajo.2017.11.011; Coscas G, 2018, OPHTHALMOLOGICA, V239, P61, DOI 10.1159/000485323; Delori F, 2011, INVEST OPHTH VIS SCI, V52, P9379, DOI 10.1167/iovs.11-8319; Diaz J Daniel, 2018, J Vitreoretin Dis, V2, P146, DOI 10.1177/2474126418771805; Durbin MK, 2017, JAMA OPHTHALMOL, V135, P370, DOI 10.1001/jamaophthalmol.2017.0080; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Ishibazawa A, 2015, AM J OPHTHALMOL, V160, P35, DOI 10.1016/j.ajo.2015.04.021; Lauermann JL, 2018, OPHTHALMOLOGICA, V239, P74, DOI 10.1159/000485261; Lauermann JL, 2017, OPHTHALMOLOGICA, V237, P238, DOI 10.1159/000464355; Leung CKS, 2007, INVEST OPHTH VIS SCI, V48, P3178, DOI 10.1167/iovs.06-1315; Melancia D, 2016, GRAEF ARCH CLIN EXP, V254, P1453, DOI 10.1007/s00417-016-3360-8; Mihailovic N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206045; Munk MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177059; Reif R, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/509783; Rochepeau C, 2018, AM J OPHTHALMOL, V194, P26, DOI 10.1016/j.ajo.2018.07.004; Rocholz Roland, SPECTRALIS OPTICAL C; Sampson DM, 2017, INVEST OPHTH VIS SCI, V58, P3065, DOI 10.1167/iovs.17-21551; SNMMI Newsline, 2016, J NUCL MED, V57, p19N, DOI DOI 10.1167/iovs.15-18904; Spaide RF, 2016, AM J OPHTHALMOL, V170, P58, DOI 10.1016/j.ajo.2016.07.023; Spaide RF, 2015, RETINA-J RET VIT DIS, V35, P2161, DOI 10.1097/IAE.0000000000000881; Stitt AW, 2016, PROG RETIN EYE RES, V51, P156, DOI 10.1016/j.preteyeres.2015.08.001; Ting DSW, 2017, JAMA OPHTHALMOL, V135, P306, DOI 10.1001/jamaophthalmol.2016.5877; Vujosevic S, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/2547216; Yasukura S, 2018, INVEST OPHTH VIS SCI, V59, P5893, DOI 10.1167/iovs.18-25108; Zhang Q, 2015, J BIOMEDICAL OPTICS, V20, DOI [10.1117/1.JBO.20.10.100901, DOI 10.1117/1.JB0.20.10.100901]; Zhang QQ, 2018, INVEST OPHTH VIS SCI, V59, P203, DOI 10.1167/iovs.17-22953	33	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234664	10.1371/journal.pone.0234664	http://dx.doi.org/10.1371/journal.pone.0234664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544179	gold, Green Published			2022-12-26	WOS:000542957200048
J	Szopa, A; Domagalska-Szopa, M; Siwiec, A; Kwiecien-Czerwieniec, I				Szopa, Andrzej; Domagalska-Szopa, Malgorzata; Siwiec, Andrzej; Kwiecien-Czerwieniec, Ilona			Canonical correlation between body-posture deviations and gait disorders in children with cerebral palsy	PLOS ONE			English	Article							SPASTIC HEMIPLEGIA; PATTERNS; BALANCE; INDEX; CLASSIFICATION; SCOLIOSIS; DIPLEGIA	Children with Cerebral Palsy (CP) show the postural constraints while standing, and gait disorders, resulting from both primary and secondary impairments of brain injury. In our previous studies, several characteristic postural and gait patterns in children with unilateral as well as with bilateral CP were defined, and the relationship between these patterns was demonstrated. The purpose of present study was to identify which features of body posture deviation during standing were strongly related to gait deviations in independently ambulatory children with CP. For this aim we explored the cross-relationship between features of body posture while standing examined by surface topography and the selected gait parameters from three-dimensional instrumented gait analysis in one hundred twenty children with cerebral palsy, aged between 7 and 13 years, who were able to walk independently. First, our study documented that that sagittal misalignment of the spine curvature was significantly related to kinematic deviations such as deviations of pelvic tilt, inadequate swing phase and knee flexion, and peak dorsiflexion in stance. Second, the study shows that the static asymmetry of pelvis and trunk was significantly associated with kinematic deviations during gait cycle such as pelvic rotation, hip abduction in swing, ROM of knee flexion, peak dorsiflexion in stance. Based on obtained results and referring to our previous findings it can be assumed that the first model of the relationship between postural deviation and gait disturbances, called 'postural and gait complex of disorders in sagittal plane', is related to children with bilateral CP, whereas the second model 'postural and gait complex of disorders in coronal plane' to children with unilateral CP. The clinical applications of this study relate to the early recognition of particular features of postural deviation using surface topography, instead of more difficult and demanding expensive tools 3-D gait analysis.	[Szopa, Andrzej] Med Univ Silesia, Sch Hlth Sci Katowice, Dept Physiotherapy, Katowice, Poland; [Domagalska-Szopa, Malgorzata] Med Univ Silesia, Sch Hlth Sci Katowice, Dept Med Rehabil, Katowice, Poland; [Siwiec, Andrzej; Kwiecien-Czerwieniec, Ilona] Pediat Ctr John Paul II Sosnowiec, Sosnowiec, Poland	Medical University Silesia; Medical University Silesia	Szopa, A (corresponding author), Med Univ Silesia, Sch Hlth Sci Katowice, Dept Physiotherapy, Katowice, Poland.	aszopa@sum.edu.pl		Domagalska-Szopa, Malgorzata/0000-0001-9086-9970; Szopa, Andrzej/0000-0002-1765-1622				[Anonymous], 2016, J CHIROPR MED, V15, P155, DOI DOI 10.1016/J.JCM.2016.02.012; [Anonymous], 2019, FRONTIERS PLANT SCI; [Anonymous], 2012, J NEUROINFLAMM, V7, P9; Benoni G, 1983, MOIRE FRINGE TOPOGRA, P93; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; DENTON TE, 1992, SPINE, V17, P509, DOI 10.1097/00007632-199205000-00007; Domagalska-Szopa M, 2017, CLIN BIOMECH, V49, P22, DOI 10.1016/j.clinbiomech.2017.08.005; Domagalska-Szopa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103095; Domagalska-Szopa M, 2014, THER CLIN RISK MANAG, V10, P113, DOI 10.2147/TCRM.S58186; Gage JR, 2004, TREATMENT GAIT PROBL; Iosa M, 2012, RES DEV DISABIL, V33, P129, DOI 10.1016/j.ridd.2011.08.031; Liao HF, 2003, PERCEPT MOTOR SKILL, V96, P1173, DOI 10.2466/PMS.96.3.1173-1184; Lin CJ, 2000, GAIT POSTURE, V11, P224, DOI 10.1016/S0966-6362(00)00049-7; Moreno-De-Luca A, 2012, LANCET NEUROL, V11, P283, DOI 10.1016/S1474-4422(11)70287-3; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Patias P, 2010, SCOLIOSIS SPINAL DIS, V5, DOI 10.1186/1748-7161-5-12; Pavao SL, 2014, BRAZ J PHYS THER, V18, P300, DOI 10.1590/bjpt-rbf.2014.0056; Releford Jodi Stevens, 2009, Atoll Research Bulletin, P1; Rodda J, 2001, EUR J NEUROL, V8, P98, DOI 10.1046/j.1468-1331.2001.00042.x; Rodda JM, 2004, J BONE JOINT SURG BR, V86B, P251, DOI 10.1302/0301-620X.86B2.13878; Romei M, 2004, GAIT POSTURE, V19, P85, DOI 10.1016/S0966-6362(03)00017-1; Rose J, 2002, DEV MED CHILD NEUROL, V44, P58, DOI 10.1017/S0012162201001669; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; RUGGERONE M, 1986, PHYS THER, V66, P1072, DOI 10.1093/ptj/66.7.1072; Russell Debra, 2002, CLIN DEV MED; Schutte LM, 2000, GAIT POSTURE, V11, P25, DOI 10.1016/S0966-6362(99)00047-8; Schwartz MH, 2008, GAIT POSTURE, V28, P351, DOI 10.1016/j.gaitpost.2008.05.001; Sherry A, 2005, J PERS ASSESS, V84, P37, DOI 10.1207/s15327752jpa8401_09; Wallard L, 2014, GAIT POSTURE, V40, P43, DOI 10.1016/j.gaitpost.2014.02.009; WINTERS TF, 1987, J BONE JOINT SURG AM, V69A, P437; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Woollacott Marjorie Hines, 2005, Neural Plasticity, V12, P211, DOI 10.1155/NP.2005.211	32	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234654	10.1371/journal.pone.0234654	http://dx.doi.org/10.1371/journal.pone.0234654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544177	Green Published, gold			2022-12-26	WOS:000542957200025
J	Westerhausen, R; Samuelsen, F				Westerhausen, Rene; Samuelsen, Fredrik			An optimal dichotic-listening paradigm for the assessment of hemispheric dominance for speech processing	PLOS ONE			English	Article							RIGHT-EAR ADVANTAGE; CORPUS-CALLOSUM; BRAIN ASYMMETRY; ATTENTION; FMRI; RELIABILITY; PERCEPTION; INFERENCES; HANDEDNESS; RESPONSES	Dichotic-listening paradigms are widely accepted as non-invasive tests of hemispheric dominance for language processing and represent a standard diagnostic tool for the assessment of developmental auditory and language disorders. Despite its popularity in research and clinical settings, dichotic paradigms show comparatively low reliability, significantly threatening the validity of conclusions drawn from the results. Thus, the aim of the present work was to design and evaluate a novel, highly reliable dichotic-listening paradigm for the assessment of hemispheric differences. Based on an extensive literature review, the paradigm was optimized to account for the main experimental variables which are known to systematically bias task performance or affect random error variance. The main design principle was to minimize the relevance of higher cognitive functions on task performance in order to obtain stimulus-driven laterality estimates. To this end, the key design features of the paradigm were the use of stop-consonant vowel (CV) syllables as stimulus material, a single stimulus pair per trial presentation mode, and a free recall (single) response instruction. Evaluating a verbal and manual response-format version of the paradigm in a sample of N = 50 healthy participants, we yielded test-retest intra-class correlations ofr(ICC)= .91 and .93 for the two response format versions. These excellent reliability estimates suggest that the optimal paradigm may offer an effective and efficient alternative to currently used paradigms both in research and diagnostic.	[Westerhausen, Rene] Univ Oslo, Dept Psychol, Oslo, Norway; [Westerhausen, Rene; Samuelsen, Fredrik] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway	University of Oslo; University of Bergen	Westerhausen, R (corresponding author), Univ Oslo, Dept Psychol, Oslo, Norway.; Westerhausen, R (corresponding author), Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.	rene.westerhausen@psykologi.uio.no	Westerhausen, René/D-2441-2013	Westerhausen, René/0000-0001-7107-2712	Department of Psychology, University of Oslo	Department of Psychology, University of Oslo	The "Department of Psychology, University of Oslo" has supported the work with funds.	Aase I, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00608; [Anonymous], 2016, J CHIROPR MED, V15, P155, DOI DOI 10.1016/J.JCM.2016.02.012; BROADBENT DE, 1956, Q J EXP PSYCHOL, V8, P145, DOI 10.1080/17470215608416814; Bryden M.P., 1988, HDB DICHOTIC LISTENI, P1, DOI DOI 10.1002/ACP.2350040307; BRYDEN MP, 1964, CAN J PSYCHOLOGY, V18, P126, DOI 10.1037/h0083290; Carey DP, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01128; Carter A S, 2001, J Am Acad Audiol, V12, P86; D'Anselmo A, 2016, HEARING RES, V342, P144, DOI 10.1016/j.heares.2016.10.012; de Bode S, 2007, NEUROPSYCHOLOGIA, V45, P2461, DOI 10.1016/j.neuropsychologia.2007.03.026; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Gootjes L, 2004, J CLIN EXP NEUROPSYC, V26, P826, DOI 10.1080/13803390490509448; GREEN MF, 1994, AM J PSYCHIAT, V151, P357; Helland T, 2018, DYSLEXIA, V24, P336, DOI 10.1002/dys.1600; Hiscock M, 1999, NEUROPSYCHOLOGY, V13, P404, DOI 10.1037/0894-4105.13.3.404; Hiscock M, 2000, J INT NEUROPSYCH SOC, V6, P539, DOI 10.1017/S1355617700655030; Hiscock M, 2011, BRAIN COGNITION, V76, P263, DOI 10.1016/j.bandc.2011.03.016; Hugdahl K, 1997, ARCH NEUROL-CHICAGO, V54, P1494, DOI 10.1001/archneur.1997.00550240046011; Hugdahl K, 2016, NEUROPSYCHOLOGIA, V93, P466, DOI 10.1016/j.neuropsychologia.2015.12.011; Hugdahl K, 2009, SCAND J PSYCHOL, V50, P11, DOI 10.1111/j.1467-9450.2008.00676.x; Keith R W, 1995, J Am Acad Audiol, V6, P286; Kelley KS, 2019, J SPEECH LANG HEAR R, V62, P169, DOI 10.1044/2018_JSLHR-H-17-0158; KIMURA D, 1961, CAN J PSYCHOLOGY, V15, P166, DOI 10.1037/h0083219; Kimura D., 1967, CORTEX, V3, P163, DOI DOI 10.1016/S0010-9452(67)80010-8; Kompus K, 2012, BRAIN LANG, V121, P240, DOI 10.1016/j.bandl.2012.03.004; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Moncrieff D, 2018, J SPEECH LANG HEAR R, V61, P924, DOI 10.1044/2017_JSLHR-H-17-0098; MUSIEK FE, 1983, EAR HEARING, V4, P79, DOI 10.1097/00003446-198303000-00002; Musiek FE, 2011, BRAIN COGNITION, V76, P225, DOI 10.1016/j.bandc.2011.03.011; Ocklenburg S., 2018, LATERALIZED BRAIN NE; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Passow S, 2012, PSYCHOL AGING, V27, P99, DOI 10.1037/a0025667; Pedhazur E. J., 2013, MEASUREMENT DESIGN A; Penner IK, 2009, J CLIN EXP NEUROPSYC, V31, P959, DOI 10.1080/13803390902766895; Saetrevik B, 2007, NEUROPSYCHOLOGIA, V45, P282, DOI 10.1016/j.neuropsychologia.2006.07.005; Shinn-Cunningham BG, 2008, TRENDS COGN SCI, V12, P182, DOI 10.1016/j.tics.2008.02.003; SPEAKS C, 1982, J ACOUST SOC AM, V72, P1185, DOI 10.1121/1.388327; Steinmann S, 2014, NEUROIMAGE, V100, P435, DOI 10.1016/j.neuroimage.2014.06.012; Techentin C, 2011, LATERALITY, V16, P313, DOI 10.1080/13576501003623349; Tervaniemi M, 2003, BRAIN RES REV, V43, P231, DOI 10.1016/j.brainresrev.2003.08.004; van den Noort M, 2008, NEUROIMAGE, V40, P902, DOI 10.1016/j.neuroimage.2007.11.051; Van der Haegen L, 2013, NEUROPSYCHOLOGIA, V51, P91, DOI 10.1016/j.neuropsychologia.2012.11.002; Voyer D, 1998, BRAIN COGNITION, V36, P209, DOI 10.1006/brcg.1997.0953; Westerhausen R, 2019, LATERALITY ASYMMETRI, P1; Westerhausen R, 2008, NEUROSCI BIOBEHAV R, V32, P1044, DOI 10.1016/j.neubiorev.2008.04.005; Westerhausen R, 2018, SCAND J PSYCHOL, V59, P66, DOI 10.1111/sjop.12408; Westerhausen R, 2013, BRAIN COGNITION, V83, P288, DOI 10.1016/j.bandc.2013.09.006; Westerhausen R, 2010, DEV NEUROPSYCHOL, V35, P752, DOI 10.1080/87565641.2010.508551; WEXLER BE, 1990, NEUROPSYCHOLOGIA, V28, P71, DOI 10.1016/0028-3932(90)90087-5; WEXLER BE, 1981, BRAIN LANG, V13, P13, DOI 10.1016/0093-934X(81)90125-5	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234665	10.1371/journal.pone.0234665	http://dx.doi.org/10.1371/journal.pone.0234665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB9ZQ	32544204	gold, Green Published, Green Submitted			2022-12-26	WOS:000542957200040
J	Garritson, J; Krynski, L; Haverbeck, L; Haughian, JM; Pullen, NA; Hayward, R				Garritson, Jacob; Krynski, Luke; Haverbeck, Lea; Haughian, James M.; Pullen, Nicholas A.; Hayward, Reid			Physical activity delays accumulation of immunosuppressive myeloid-derived suppressor cells	PLOS ONE			English	Article							BREAST-CANCER PROGRESSION; BLOCKADE THERAPY; RUNNING-WHEEL; EXERCISE; INFLAMMATION; MICE; INHIBITION; INDUCTION; SUBSETS; SITES	Background Myeloid-derived suppressor cells (MDSCs) are potent suppressors of immune function and may play a key role in the development and progression of metastatic cancers. Aerobic exercise has been shown to have anticancer effects, yet the mechanisms behind this protection are largely unknown. Therefore, we examined the effects of physical activity on MDSC accumulation and function. Methods Female BALB/c mice were assigned to one of two primary groups: sedentary tumor (SED+TUM) or wheel run tumor (WR+TUM). After 6 weeks of voluntary wheel running, all animals were randomly subdivided into 4 different timepoint groups; 16, 20, 24, and 28 days post-tumor injection. All mice were inoculated with 4T1 mammary carcinoma cells in the mammary fat pad and WR groups continued to run for the specified time post-injection. Spleen, blood, and tumor samples were analyzed using flow cytometry to assess proportions of MDSCs. Results Cells expressing MDSC biomarkers were detected in the spleen, blood, and tumor beginning at d16. However, since there was no evidence of immunosuppressive function until d28, we refer to them as immature myeloid cells (IMCs). Compared to SED+TUM, levels of IMCs in the spleen were significantly lower (p< 0.05) in WR+TUM at day 16 (33.0 +/- 5.2%; 23.1 +/- 10.2% of total cells, respectively) and day 20 (33.9 +/- 8.1%; 24.3 +/- 5.1% of total cells, respectively). Additionally, there were fewer circulating IMCs in WR+TUM at day 16 and MDSC levels were significantly lower (p< 0.05) in the tumor at day 28 in WR+TUM. Additionally, a non-significant 62% and 26% reduction in metastatic lung nodules was observed at days 24 and 28, respectively. At day 28, MDSCs harvested from SED+TUM significantly suppressed CD3(+)CD4(+)T cell proliferation (3.2 +/- 1.3 proliferation index) while proliferation in WR+TUM MDSC co-cultures (5.1 +/- 1.7 proliferation index) was not different from controls. Conclusions These findings suggest that physical activity may delay the accumulation of immunosuppressive MDSCs providing a broader window of opportunity for interventions with immunotherapies.	[Garritson, Jacob; Krynski, Luke; Haverbeck, Lea; Hayward, Reid] Univ Northern Colorado, Sch Sport & Exercise Sci, Greeley, CO 80639 USA; [Garritson, Jacob; Krynski, Luke; Haverbeck, Lea; Hayward, Reid] Univ Northern Colorado, Canc Rehabil Inst, Greeley, CO 80639 USA; [Haughian, James M.; Pullen, Nicholas A.] Univ Northern Colorado, Sch Biol Sci, Greeley, CO USA	University of Northern Colorado; University of Northern Colorado; University of Northern Colorado	Hayward, R (corresponding author), Univ Northern Colorado, Sch Sport & Exercise Sci, Greeley, CO 80639 USA.; Hayward, R (corresponding author), Univ Northern Colorado, Canc Rehabil Inst, Greeley, CO 80639 USA.	reid.hayward@unco.edu		Pullen, Nicholas/0000-0002-4014-9278; Garritson, Jacob/0000-0002-7125-8768				Betof AS, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv040; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Buss LA, 2018, J APPL PHYSIOL, V124, P938, DOI 10.1152/japplphysiol.00738.2017; Davis RJ, 2017, CANCER RES, V77, P2607, DOI 10.1158/0008-5472.CAN-16-2534; De Henau O, 2016, NATURE, V539, P443, DOI 10.1038/nature20554; Dethlefsen C, 2017, BREAST CANCER RES TR, V162, P399, DOI 10.1007/s10549-017-4129-4; Dethlefsen C, 2016, BREAST CANCER RES TR, V159, P469, DOI 10.1007/s10549-016-3970-1; DEXTER DL, 1978, CANCER RES, V38, P3174; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gabrilovich DI, 2017, CANCER IMMUNOL RES, V5, P3, DOI 10.1158/2326-6066.CIR-16-0297; Goh J, 2014, AM J CANCER RES, V4, P378; Goh J, 2012, EXERC IMMUNOL REV, V18, P158; Golzari Z, 2010, INT IMMUNOPHARMACOL, V10, P1415, DOI 10.1016/j.intimp.2010.08.008; Hagar A, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5745-7; Hardman AE, 2001, P NUTR SOC, V60, P107, DOI 10.1079/PNS200076; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Hojman P, 2017, BIOCHEM SOC T, V45, P905, DOI 10.1042/BST20160466; Huang Y, 2015, ONCOTARGET, V6, P17462, DOI 10.18632/oncotarget.3958; Iida Y, 2017, CANCER SCI, V108, P1974, DOI 10.1111/cas.13337; Jones LW, 2012, J APPL PHYSIOL, V113, P263, DOI 10.1152/japplphysiol.01575.2011; Jones LW, 2010, J APPL PHYSIOL, V108, P343, DOI 10.1152/japplphysiol.00424.2009; Krohn TC, 2006, ANIM WELFARE, V15, P343; Kumar V, 2016, IMMUNITY, V44, P303, DOI 10.1016/j.immuni.2016.01.014; Mao YM, 2014, CLIN CANCER RES, V20, P4096, DOI 10.1158/1078-0432.CCR-14-0635; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Martens A, 2016, CLIN CANCER RES, V22, P2908, DOI 10.1158/1078-0432.CCR-15-2412; Morales JK, 2010, BREAST CANCER RES TR, V123, P39, DOI 10.1007/s10549-009-0622-8; Murphy EA, 2011, CYTOKINE, V55, P274, DOI 10.1016/j.cyto.2011.04.007; Nagaraj S, 2008, CANCER RES, V68, P2561, DOI 10.1158/0008-5472.CAN-07-6229; Ostrand-Rosenberg S, 2018, J IMMUNOL, V200, P422, DOI 10.4049/jimmunol.1701019; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Paschall AV, 2016, JOVE-J VIS EXP, DOI 10.3791/54040; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; Pedersen L, 2016, CELL METAB, V23, P554, DOI 10.1016/j.cmet.2016.01.011; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Qian X, 2019, AM J CANCER RES, V9, P529; Smeda M, 2017, AM J CANCER RES, V7, P1926; Solito Samantha, 2019, Curr Protoc Immunol, V124, pe61, DOI 10.1002/cpim.61; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Thune I, 2001, MED SCI SPORT EXER, V33, pS530, DOI 10.1097/00005768-200106001-00025; Turbitt WJ, 2019, CANCER PREV RES, V12, P493, DOI 10.1158/1940-6207.CAPR-17-0233; Turner MJ, 2005, PHYSIOL GENOMICS, V22, P76, DOI 10.1152/physiolgenomics.00243.2004; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Veltman JD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-464; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	48	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234548	10.1371/journal.pone.0234548	http://dx.doi.org/10.1371/journal.pone.0234548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542046	gold, Green Published			2022-12-26	WOS:000542685100033
J	Ji, H; Godsland, I; Oliver, NS; Hill, NE				Ji, HaEun; Godsland, Ian; Oliver, Nick S.; Hill, Neil E.			Loss of association between HbA1c and vascular disease in older adults with type 1 diabetes	PLOS ONE			English	Article							COMPLICATIONS	Aims Robust evidence supports intensive glucose control in those with recently diagnosed type 1 diabetes to reduce the risk of developing micro- and macrovascular complications. Data to support longitudinal glycaemic targets is lacking. We aimed to explore if longer duration of diabetes and greater age might reduce the impact of glycaemia on the risk of vascular complications. Research and design methods Data for adults age 20 years or more, was extracted from a clinical database of people with type 1 diabetes cared for at a London teaching hospital. The presence or absence of micro- and macro-vascular complications was recorded. Multivariable logistic regression analysis was performed using HbA1c as independent variable, diabetes duration and age as continuous variable and obesity, hypertension, hypercholesterolaemia, low HDL cholesterol and hypertriglyceridaemia as categorical variables. Results Data from 495 patients was used. HbA1c above 60 mmol/mol (7.6%) was associated with increased microvascular complications in patients aged 20-44 years, independent of age and duration of diabetes. In older people with T1DM duration of diabetes was the major risk factor. Conclusions Our study suggests that increased age and greater duration of diabetes reduce the impact of glycaemia on the risk of vascular complications. Intensive blood glucose management in patients aged >= 45 years may have limited benefits in terms of reducing the risk of complications although this does not dismiss the benefits of good glycaemic control in older people with T1DM.	[Ji, HaEun; Oliver, Nick S.; Hill, Neil E.] Imperial Coll Healthcare NHS Trust, London, England; [Godsland, Ian; Oliver, Nick S.] Imperial Coll London, Dept Metab Endocrinol & Metab Digest & Reprod, Fac Med, London, England	Imperial College London; Imperial College London	Hill, NE (corresponding author), Imperial Coll Healthcare NHS Trust, London, England.	neil.hill@nhs.net	Oliver, Nick/G-9109-2016	Oliver, Nick/0000-0003-3525-3633				American Diabetes Association, 2018, Diabetes Care, V41, pS119, DOI 10.2337/dc18-S011; Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008; Ceriello A, 2010, DIABETIC MED, V27, P862, DOI 10.1111/j.1464-5491.2010.02967.x; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Forbes A, 2018, LANCET DIABETES ENDO, V6, P476, DOI 10.1016/S2213-8587(18)30048-2; Fullerton B, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009122.pub2; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Lachin JM, 2014, DIABETES CARE, V37, P39, DOI 10.2337/dc13-2116; Lawes T, 2014, PEDIATR DIABETES, V15, P372, DOI 10.1111/pedi.12100; Matuleviciene-Anangen V, 2017, HEART, V103, P1687, DOI 10.1136/heartjnl-2016-311050; Melvin A, 2019, IRISH J MED SCI, V188, P129, DOI 10.1007/s11845-018-1827-9; National Institute for Health and Care Excellence (NICE), 2015, TYP 2 DIAB AD MAN NG; National Institute for Health and Care Excellence (NICE), 2015, TYP 1 DIAB AD DIAGN; Nirantharakumar K, 2018, DIABETOLOGIA, V61, P1064, DOI 10.1007/s00125-018-4574-6	14	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234319	10.1371/journal.pone.0234319	http://dx.doi.org/10.1371/journal.pone.0234319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542057	gold, Green Published			2022-12-26	WOS:000542685100006
J	Sahin, HB; Sayin, S; Holder, M; Bugra, K; Celik, A				Sahin, H. Bahar; Sayin, Sercan; Holder, Maxine; Bugra, Kuyas; Celik, Arzu			Salt inducible kinases as novel Notch interactors in the developing Drosophila retina	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ADHERENS JUNCTIONS; BINDING PROTEIN; GENE-EXPRESSION; GLUCOSE-UPTAKE; SIK2; POLARITY; GROWTH; EYE; PHOSPHORYLATION	Developmental processes require strict regulation of proliferation, differentiation and patterning for the generation of final organ size. Aberrations in these fundamental events are critically important in tumorigenesis and cancer progression.Salt inducible kinases(Siks) are evolutionarily conserved genes involved in diverse biological processes, including salt sensing, metabolism, muscle, cartilage and bone formation, but their role in development remains largely unknown. Recent findings implicate Siks in mitotic control, and in both tumor suppression and progression. Using a tumor model in theDrosophilaeye, we show that perturbation of Sik function exacerbates tumor-like tissue overgrowth and metastasis. Furthermore, we show that bothDrosophila Sikgenes,Sik2andSik3, function in eye development processes. We propose that an important target of Siks may be the Notch signaling pathway, as we demonstrate genetic interaction between Siks and Notch pathway members. Finally, we investigate Sik expression in the developing retina and show that Sik2 is expressed in all photoreceptors, basal to cell junctions, while Sik3 appears to be expressed specifically in R3/R4 cells in the developing eye. Combined, our data suggest thatSikgenes are important for eye tissue specification and growth, and that their dysregulation may contribute to tumor formation.	[Sahin, H. Bahar; Sayin, Sercan; Bugra, Kuyas; Celik, Arzu] Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Holder, Maxine] Francis Crick Inst, Apoptosis & Proliferat Control Lab, London, England; [Bugra, Kuyas; Celik, Arzu] Bogazici Univ, Ctr Life Sci & Technol, Istanbul, Turkey; [Sahin, H. Bahar] Kadir Has Univ, Dept Bioinformat & Genet, Istanbul, Turkey; [Sayin, Sercan] Ctr Adv Study Collect Behav, Neurobiol, Constance, Germany	Bogazici University; Francis Crick Institute; Bogazici University; Kadir Has University	Celik, A (corresponding author), Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey.; Celik, A (corresponding author), Bogazici Univ, Ctr Life Sci & Technol, Istanbul, Turkey.	arzu.celik@boun.edu.tr	Sahin, H Bahar/HHC-7573-2022	Sahin, H Bahar/0000-0002-5221-7637; Celik Fuss, ARZU/0000-0001-9889-6957; Holder, Maxine/0000-0002-4613-2194	EMBO installation grant [1656]; Bogazici University Research Fund [BAP10B01P12, BAP5682]; TUBITAK BIDEB 2218 postdoctoral fellowship	EMBO installation grant; Bogazici University Research Fund(Bogazici University); TUBITAK BIDEB 2218 postdoctoral fellowship(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This study was funded by an EMBO installation grant (Grant number 1656), and Bogazici University Research Fund Grant Numbers BAP10B01P12 and BAP5682 to AC, as well as a TUBITAK BIDEB 2218 postdoctoral fellowship to HBS. EMBO: http://www.embo.org/funding-awards Bogazici BAP: https://arastirma.boun.edu.tr/tr/bap TUBITAK BIDEB: https://e-bideb.tubitak.gov.tr/giris.htm?language=en The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2010, CANCER CELL, V18, P109, DOI 10.1016/j.ccr.2010.06.018; Amara S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180097; Amin N, 2009, P NATL ACAD SCI USA, V106, P8941, DOI 10.1073/pnas.0812469106; [Anonymous], 2018, J ORTHOP TRAUMA, V32, pS141; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Aster JC, 2017, ANNU REV PATHOL-MECH, V12, P245, DOI 10.1146/annurev-pathol-052016-100127; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baonza A, 2001, DEVELOPMENT, V128, P3889; Bennett D, 2015, OCUL ONCOL PATHOL, V1, P190, DOI 10.1159/000370155; Berggreen C, 2012, CELL SIGNAL, V24, P1863, DOI 10.1016/j.cellsig.2012.05.001; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bon H, 2015, MOL CANCER RES, V13, P620, DOI 10.1158/1541-7786.MCR-13-0182-T; Bossuyt W, 2009, PLOS BIOL, V7, P301, DOI 10.1371/journal.pbio.1000040; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Brown NP, 1998, BIOINFORMATICS, V14, P380, DOI 10.1093/bioinformatics/14.4.380; Charoenfuprasert S, 2011, ONCOGENE; Chen H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.154; Cheng HL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000369; Chern JJ, 2002, DEVELOPMENT, V129, P4005; Choi S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005263; Choi S, 2011, J BIOL CHEM, V286, P2658, DOI 10.1074/jbc.C110.119222; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Domingos PM, 2004, DEV BIOL, V273, P121, DOI 10.1016/j.ydbio.2004.05.026; Dominguez M, 2004, NAT GENET, V36, P31, DOI 10.1038/ng1281; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Du J, 2008, OBESITY, V16, P531, DOI 10.1038/oby.2007.98; Du WQ, 2016, EXPERT OPIN THER TAR, V20, P477, DOI 10.1517/14728222.2016.1101452; Fan SC, 2019, NPJ GENOM MED, V4, DOI 10.1038/s41525-019-0077-8; Fanto M, 1998, MECH DEVELOP, V74, P51, DOI 10.1016/S0925-4773(98)00063-X; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; Funato H, 2016, NATURE, V539, P378, DOI 10.1038/nature20142; Goodwin JM, 2014, MOL CELL, V55, P436, DOI 10.1016/j.molcel.2014.06.021; Henriksson E., 2012, BIOCH J; Henriksson E, 2015, J CELL SCI, V128, P472, DOI 10.1242/jcs.153932; Hirabayashi S, 2015, ELIFE, V4, DOI [10.7554/eLife.08501.001, 10.7554/eLife.08501]; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Gutierrez-Avino FJ, 2009, EMBO REP, V10, P1051, DOI 10.1038/embor.2009.140; Jukam D, 2011, DEV CELL, V21, P874, DOI 10.1016/j.devcel.2011.10.004; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Kuser-Abali G, 2013, INVEST OPHTH VIS SCI, V54, P3526, DOI 10.1167/iovs.12-10729; Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(01)00265-3; Lee G, 2011, DEV BIOL, V356, P588, DOI 10.1016/j.ydbio.2011.06.024; Lee HJ, 2015, BMB REP, V48, P431, DOI 10.5483/BMBRep.2015.48.8.107; Liu YY, 2016, TUMOR BIOL, V37, P12231, DOI 10.1007/s13277-016-5066-2; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; Maduzia LL, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-8; Miranda F, 2016, CANCER CELL, V30, P273, DOI 10.1016/j.ccell.2016.06.020; Mirkovic I, 2006, DEVELOPMENT, V133, P3283, DOI 10.1242/dev.02468; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Nowell CS, 2017, NAT REV CANCER, V17, P145, DOI 10.1038/nrc.2016.145; Parsons LM, 2017, G3-GENES GENOM GENET, V7, P2497, DOI 10.1534/g3.117.043513; Patel K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5535; Proschel C, 2017, EUR J HUM GENET, V25, P216, DOI 10.1038/ejhg.2016.145; Qu C, 2016, J HEPATOL, V64, P1076, DOI 10.1016/j.jhep.2016.01.005; Sahin HB, 2013, DROSOPHILA EYE DEV P; Sakamaki JI, 2014, NAT CELL BIOL, V16, P234, DOI 10.1038/ncb2919; Sakamoto K, 2018, TRENDS ENDOCRIN MET, V29, P828, DOI 10.1016/j.tem.2018.09.007; Sall J, 2017, DIABETOLOGIA, V60, P314, DOI 10.1007/s00125-016-4141-y; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Sato A, 2007, DEVELOPMENT, V134, P659, DOI 10.1242/dev.02786; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Singh A, 2012, DEV DYNAM, V241, P69, DOI 10.1002/dvdy.22764; Takemori H, 2009, ENDOCR J, V56, P121, DOI 10.1507/endocrj.K08E-173; Teesalu M, 2017, CURR BIOL, V27, P458, DOI 10.1016/j.cub.2016.12.032; Tepass U, 2007, TRENDS CELL BIOL, V17, P26, DOI 10.1016/j.tcb.2006.11.006; Uebi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037803; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wehr MC, 2012, NAT CELL BIOL; Wein MN, 2018, TRENDS ENDOCRIN MET, V29, P723, DOI 10.1016/j.tem.2018.08.004; Yahara Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10959; Yang S, 2013, J NONLINEAR FUNCT AN; Yao YH, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0113-3; Yoshida H, 2012, J NEUROCHEM, V120, P165, DOI 10.1111/j.1471-4159.2011.07523.x; Zhang Y, 2018, CELL PHYSIOL BIOCHEM, V47, P1411, DOI 10.1159/000490831; Zohrap Neslihan, 2018, Oncotarget, V9, P21876, DOI 10.18632/oncotarget.25082	83	1	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234744	10.1371/journal.pone.0234744	http://dx.doi.org/10.1371/journal.pone.0234744			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542037	Green Published, gold, Green Submitted			2022-12-26	WOS:000542685100021
J	Agizew, T; Boyd, R; Mathebula, U; Mathoma, A; Basotli, J; Serumola, C; Pals, S; Finlay, A; Lekone, P; Rankgoane-Pono, G; Tlhakanelo, T; Chihota, V; Auld, AF				Agizew, Tefera; Boyd, Rosanna; Mathebula, Unami; Mathoma, Anikie; Basotli, Joyce; Serumola, Christipher; Pals, Sherri; Finlay, Alyssa; Lekone, Phenyo; Rankgoane-Pono, Goabaone; Tlhakanelo, Thato; Chihota, Violet; Auld, Andrew F.			Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria	PLOS ONE			English	Article								Background Patients with non-tuberculous mycobacteria (NTM) orMycobacterium tuberculosis(MTB) pulmonary disease may have similar clinical presentation. The potential for misdiagnosis and inappropriate treatment exists in settings with limited testing capacity for Xpert(R)MTB/RIF (Xpert), phenotypic culture and NTM speciation. We describe treatment outcomes among people living with HIV (PLHIV) who received anti-tuberculosis treatment and were found to have NTM or MTB positive sputum cultures. Methods PLHIV attending one of the 22 participating HIV clinics, who screened positive for >= 1 tuberculosis (TB) symptoms (cough, fever, night sweats, or weight loss) were asked to submit sputa for culture and speciation from August 2012 to November 2014. The national intensified TB case finding algorithms were followed: initially symptomatic patients were evaluated by testing sputum samples using a smear (smear-based TB diagnostic algorithm) and, after GeneXpert instruments were installed, by testing with Xpert (Xpert-based TB diagnostic algorithm). Within the study period, TB diagnostic algorithms used for MTB did not include screening, diagnosis, and management of NTM. Despite MTB negative culture, some symptomatic patients, including those with NTM positive culture, received empirical anti-TB treatment at the discretion of treating clinicians. Per the World Health Organization treatment outcomes classification: died, treatment failure or loss-to-follow-up were classified as unfavorable (unsuccessful) outcome; cured and treatment completed were classified as favorable (successful) outcome. Empiric treatment was defined as initiating treatment without or before receiving a test result indicating MTB. We compare treatment outcomes and characteristics among patients with NTM or MTB positive culture who received anti-TB treatment. Results Among 314 PLHIV, who were found co-infected with TB, 146 cases had microbiological evidence; and for 131/146 MTB positive cultures were reported. One-hundred fifty-two of the 314 were clinically diagnosed with TB and treated empirically. Among those empirically treated for TB, 36/152 had culture results positive for NTM, and another 43/152 had culture results positive for MTB, reported after patients received empirical anti-TB treatment. Overall, MTB positive culture results were reported for 174 (131 plus 43) patients. Treatment outcomes were available for 32/36 NTM and 139/174 MTB; unfavorable outcomes were 12.5% and 8.7% for NTM and MTB, respectively,p = 0.514, respectively. For 34/36 tested NTM patients, all Xpert results indicated 'no MTB'. Among patients who initially received empiric anti-TB treatment and ultimately were found to have MTB positive culture, the unfavorable outcome was 11.8% (4/34), compared to 12.5% (4/32) of patients with NTM positive culture, Fisher's exact testp = 1.00. Conclusions While the higher unfavorable outcome was non statistically significant, the impact of inappropriate treatment among NTM patients should not be overlooked. Our findings suggest that Xpert has the potential to rapidly rule-out NTM and avoid sub-optimal treatment; further research is needed to evaluate such potential.	[Agizew, Tefera; Boyd, Rosanna; Mathebula, Unami; Mathoma, Anikie; Basotli, Joyce; Serumola, Christipher; Finlay, Alyssa; Lekone, Phenyo] US Ctr Dis Control & Prevent CDC, Gaborone, Botswana; [Agizew, Tefera; Tlhakanelo, Thato] Univ Botswana, Fac Med, Dept Family Med & Publ Hlth, Gaborone, Botswana; [Agizew, Tefera; Chihota, Violet] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Boyd, Rosanna; Finlay, Alyssa] CDC, Div TB Eliminat, Atlanta, GA 30333 USA; [Pals, Sherri; Auld, Andrew F.] CDC, Div Global HIV AIDS & TB, Atlanta, GA 30333 USA; [Rankgoane-Pono, Goabaone] Minist Hlth & Wellness, Natl TB Control Programme, Gaborone, Botswana; [Chihota, Violet] Aurum Inst, Johannesburg, South Africa	University of Botswana; University of Witwatersrand; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Agizew, T (corresponding author), US Ctr Dis Control & Prevent CDC, Gaborone, Botswana.; Agizew, T (corresponding author), Univ Botswana, Fac Med, Dept Family Med & Publ Hlth, Gaborone, Botswana.; Agizew, T (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.	tagizew@cdc.gov	Chihota, Violet/DWH-9372-2022	Auld, Andrew/0000-0001-5089-9163; Tlhakanelo, John Thato/0000-0001-7365-1603; Chihota, Violet/0000-0003-1444-9266; Agizew, Tefera/0000-0003-1848-7307	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adikaram CP, 2018, INTECHOPEN, P257, DOI DOI 10.5772/INTECHOPEN.73542; Agizew T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189981; [Anonymous], 2015, STAT STAT SOFTW REL; [Anonymous], GUID INT TUB CAS FIN; Antonenka U, 2013, BMC INF DIS; Auld AF, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1905-4; BNTP, 2011, NAT TUB PROGR MAN; Brode S.K, 2014, INT J TUBERC LUNG DI; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Helb D, 2010, J CLIN MICROB; Maiga M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036902; Nyamogoba HDN, 2012, AFR HEALTH SCI, V12, P305, DOI 10.4314/ahs.v12i3.9; Rachow A, 2011, PLOSONE; Ryu YJ, 2016, TUBERC RESPIR DIS, V79, P74, DOI 10.4046/trd.2016.79.2.74; Steingart R, 2014, COCHRANE DATABASE SY; Theron G, 2014, LANCET INFECT DIS, V14, P527, DOI 10.1016/S1473-3099(13)70360-8; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2013, DEFINITIONS REPORTIN	18	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234646	10.1371/journal.pone.0234646	http://dx.doi.org/10.1371/journal.pone.0234646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530972	Green Published, gold			2022-12-26	WOS:000542037200021
J	Fang, YW; Wang, WB; He, MX; Xu, XJ; Gao, F; Liu, J; Yang, TW; Cao, Y; Yang, T; Wang, Y; Zhang, CX				Fang, Yi-Wei; Wang, Wen-Bing; He, Ming-Xia; Xu, Xin-Jing; Gao, Feng; Liu, Jing; Yang, Tian-Wei; Cao, Yang; Yang, Tao; Wang, Yun; Zhang, Chun-Xia			Relationship between the honeydew of mealy bugs and the growth ofPhlebopus portentosus	PLOS ONE			English	Article							BOLETE; ANTS	Background Phlebopus portentosusand mealy bugs form a fungus-insect gall on the roots of host plants. The fungus and mealy bugs benefit mutually through the gall, which is the key link in the nutritional mechanism ofP.portentosus. The cavity of the fungus-insect gall provides an ideal shelter for mealy bugs survival and reproduction, but how doesP.portentosusbenefit from this symbiotic relationship? Methodology and results Anatomical examination of fungus-insect galls revealed that one or more mealy bugs of different generations were living inside the galls. The mealy bug's mouthpart could penetrate through the mycelium layer of the inside of the gall and suck plant juice from the host plant root. Mealy bugs excreted honeydew inside or outside the galls. The results of both honeydew agar medium and quartz tests showed that the honeydew can attract and promote the mycelial growth ofP.portentosus. A test of the relationship between the honeydew and the formation of the fungus-insect gall showed that honeydew promoted gall formation. Conclusions All experimental results in this study show that the honeydew secreted by mealy bugs can attract and promote the mycelial growth ofP.portentosus, forming a fungus-insect gall, because mealy bugs' honeydew is rich in amino acids and sugars.	[Fang, Yi-Wei; Wang, Wen-Bing; He, Ming-Xia; Xu, Xin-Jing; Gao, Feng; Liu, Jing; Yang, Tian-Wei; Cao, Yang; Yang, Tao; Wang, Yun; Zhang, Chun-Xia] Yunnan Inst Trop Crops, Jinghong, Yunnan, Peoples R China		Wang, Y; Zhang, CX (corresponding author), Yunnan Inst Trop Crops, Jinghong, Yunnan, Peoples R China.	zhangchunxia7084@163.com; wangy10melrose@hotmail.com			Key Project of Applied Basic Research of Yunnan Province [2017FA017]; Youth Project of Applied Basic Research of Yunnan Province [2018FD157]; National Natural Science Foundation of China [31560008]; Sci-Tech Innovation System Construction for Tropical Crops of Yunnan Province [RF2019-12]; project of Sci-Tech Talents and the Platform of Yunnan Province [2019HB069]	Key Project of Applied Basic Research of Yunnan Province; Youth Project of Applied Basic Research of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sci-Tech Innovation System Construction for Tropical Crops of Yunnan Province; project of Sci-Tech Talents and the Platform of Yunnan Province	This study was supported by: the Key Project of Applied Basic Research of Yunnan Province (No. 2017FA017), Youth Project of Applied Basic Research of Yunnan Province (No. 2018FD157), National Natural Science Foundation of China (No. 31560008), Funds of Sci-Tech Innovation System Construction for Tropical Crops of Yunnan Province (No. RF2019-12),and the project of Sci-Tech Talents and the Platform of Yunnan Province (No. 2019HB069).	BRUNDRETT MC, 1987, SYMBIOSIS, V3, P315; GONCALVES CINCINATO R., 1940, RODRIGUESIA [RIO DE JANEIRO], V4, P179; GRAY HE, 1954, PHYSIOL ZOOL, V27, P56, DOI 10.1086/physzool.27.1.30152279; He MingXia, 2009, Acta Edulis Fungi, V16, P41; Hur Onsook, 2011, [Korean Journal of Plant Reources., 한국자원식물학회지], V24, P688; Ji KP, 2011, MYCOL PROG, V10, P293, DOI 10.1007/s11557-010-0700-7; Kumla J, 2016, MYCORRHIZA, V26, P333, DOI 10.1007/s00572-015-0672-1; Lumyong S., 2007, OPERA MYCOLOGICA, V1, P34; SALAMA HS, 1969, J INSECT PHYSIOL, V15, P1873, DOI 10.1016/0022-1910(69)90017-1; Sanmee R, 2003, FOOD CHEM, V82, P527, DOI 10.1016/S0308-8146(02)00595-2; Sanmee R, 2010, MYCOSCIENCE, V51, P15, DOI 10.1007/s10267-009-0010-6; Singer R, 1975, AGARICALES MODERN TA; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Watling Roy, 2006, Mycoscience, V47, P18, DOI 10.1007/s10267-005-0267-3; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; Zhang C., 2017, J AGR SCI TECHNOLOGY, V7, P386, DOI DOI 10.17265/2161-6264/2017.06.003; Zhang CX, 2015, MYCOLOGIA, V107, P12, DOI 10.3852/13-267; Zhang ChunXia, 2012, Southwest China Journal of Agricultural Sciences, V25, P614; Zhang CX, 2018, MAGICAL DELICIOUS BL	19	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0233710	10.1371/journal.pone.0233710	http://dx.doi.org/10.1371/journal.pone.0233710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530963	Green Published, gold			2022-12-26	WOS:000542037200019
J	Kang, D; Jung, SH; Lee, GH; Lee, S; Park, HJ; Ko, YG; Kim, YN; Lee, JS				Kang, Donghee; Jung, Seung Hee; Lee, Gun-Hee; Lee, Seongju; Park, Heon Joo; Ko, Young-Gyu; Kim, Yong-Nyun; Lee, Jae-Seon			Sulfated syndecan 1 is critical to preventing cellular senescence by modulating fibroblast growth factor receptor endocytosis	FASEB JOURNAL			English	Article						cellular senescence; endocytosis; heparan sulfation; SDC1; FGFR1	HEPARAN-SULFATE; MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; PROTEOGLYCANS; APOPTOSIS; BINDING; REQUIREMENTS; REGULATORS; INTEGRIN; TARGET	Cellular senescence can be triggered by various intrinsic and extrinsic stimuli. We previously reported that silencing of 3 '-phosphoadenosine 5 '-phosphosulfate synthetase 2 (PAPSS2) induces cellular senescence through augmented fibroblast growth factor receptor 1 (FGFR1) signaling. However, the exact molecular mechanism connecting heparan sulfation and cellular senescence remains unclear. Here, we investigated the potential involvement of heparan sulfate proteoglycans (HSPGs) in augmented FGFR1 signaling and cellular senescence. Depletion of several types of HSPGs revealed that cells depleted of syndecan 1 (SDC1) exhibited typical senescence phenotypes, and those depleted of PAPSS2-, SDC1-, or heparan sulfate 2-O sulfotransferase 1 (HS2ST1) showed decreased FGFR1 internalization along with hyperresponsiveness to and prolonged activation of fibroblast growth factor 2 (FGF2)-stimulated FGFR1- v-akt murine thymoma viral oncogene homolog (AKT) signaling. Clathrin- and caveolin-mediated FGFR1 endocytosis contributed to cellular senescence through the FGFR1-AKT-p53-p21 signaling pathway. Dynasore treatment triggered senescence phenotypes, augmented FGFR1-AKT-p53-p21 signaling, and decreased SDC1 expression. Finally, the replicatively and prematurely senescent cells were characterized by decreases of SDC1 expression and FGFR1 internalization, and an increase in FGFR1-AKT-p53-p21 signaling. Together, our results demonstrate that properly sulfated SDC1 plays a critical role in preventing cellular senescence through the regulation of FGFR1 endocytosis.	[Kang, Donghee; Jung, Seung Hee; Lee, Gun-Hee; Lee, Jae-Seon] Inha Univ, Coll Med, Dept Mol Med, Incheon 22212, South Korea; [Kang, Donghee; Jung, Seung Hee; Lee, Gun-Hee; Lee, Seongju; Park, Heon Joo; Lee, Jae-Seon] Inha Univ, Coll Med, Med Res Ctr, Incheon, South Korea; [Lee, Seongju] Inha Univ, Coll Med, Dept Anat, Incheon, South Korea; [Park, Heon Joo] Inha Univ, Coll Med, Dept Microbiol, Incheon, South Korea; [Ko, Young-Gyu] Korea Univ, Div Life Sci, Seoul, South Korea; [Kim, Yong-Nyun] Natl Canc Ctr, Div Translat Sci, Goyang, South Korea	Inha University; Inha University; Inha University; Inha University; Korea University; National Cancer Center - Korea (NCC)	Lee, JS (corresponding author), Inha Univ, Coll Med, Dept Mol Med, Incheon 22212, South Korea.	jaeslee@inha.ac.kr	Lee, Seongju/AHE-8571-2022		National Research Foundation [2014R1A5A2009392, 2020R1A2B5B02002375]	National Research Foundation	National Research Foundation, Grant/Award Number: 2014R1A5A2009392 and 2020R1A2B5B02002375	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Akl MR, 2016, ONCOTARGET, V7, P44735, DOI 10.18632/oncotarget.8203; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Auciello G, 2013, J CELL SCI, V126, P613, DOI 10.1242/jcs.116228; AVIEZER D, 1994, J BIOL CHEM, V269, P114; Axelsson J, 2012, BLOOD, V120, P1742, DOI 10.1182/blood-2012-03-417139; Belleudi F, 2007, TRAFFIC, V8, P1854, DOI 10.1111/j.1600-0854.2007.00651.x; Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chen LL, 2018, MOL CELLS, V41, P853, DOI 10.14348/molcells.2018.0103; Citores L, 1999, MOL BIOL CELL, V10, P3835, DOI 10.1091/mbc.10.11.3835; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Deguchi Y, 2002, J NEUROCHEM, V83, P381, DOI 10.1046/j.1471-4159.2002.01129.x; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Echtermeyer F, 2011, CARDIOVASC RES, V92, P123, DOI 10.1093/cvr/cvr149; Elfenbein A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002495; Feng L, 2012, J CELL PHYSIOL, V227, P2480, DOI 10.1002/jcp.22984; Ferreras C, 2012, J BIOL CHEM, V287, P36132, DOI 10.1074/jbc.M112.384875; Gleizes PE, 1996, EUR J CELL BIOL, V71, P144; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Harada E, 2017, ONCOTARGET, V8, P24741, DOI 10.18632/oncotarget.15799; Hassan H, 2013, FEBS J, V280, P2216, DOI 10.1111/febs.12111; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001; Hinze C, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216804; Ishikawa T, 2010, EXP CELL RES, V316, P951, DOI 10.1016/j.yexcr.2009.12.013; Jung SH, 2016, CELL DEATH DIFFER, V23, P417, DOI 10.1038/cdd.2015.107; Kwak IH, 2004, CANCER RES, V64, P572, DOI 10.1158/0008-5472.CAN-03-1856; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lecot P, 2016, BRIT J CANCER, V114, P1180, DOI 10.1038/bjc.2016.115; Liu SY, 2012, BIOCHEM BIOPH RES CO, V419, P656, DOI 10.1016/j.bbrc.2012.02.069; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; MALI M, 1993, J BIOL CHEM, V268, P24215; Marchese C, 1998, J CELL SCI, V111, P3517; Matsuo I, 2013, CURR OPIN GENET DEV, V23, P399, DOI 10.1016/j.gde.2013.02.004; Miaczynska M, 2008, J CELL BIOL, V180, P7, DOI 10.1083/jcb.200711073; Mundhenke C, 2002, AM J PATHOL, V160, P185, DOI 10.1016/S0002-9440(10)64362-3; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Park JS, 2001, FASEB J, V15, P1625, DOI 10.1096/fj.00-0723fje; Pye DA, 2000, GLYCOBIOLOGY, V10, P1183, DOI 10.1093/glycob/10.11.1183; Rajarajacholan UK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001502; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rapraeger AC, 2013, FEBS J, V280, P2194, DOI 10.1111/febs.12134; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Steinfeld R, 1996, J CELL BIOL, V133, P405, DOI 10.1083/jcb.133.2.405; Stephen JR, 2006, CELL MOL LIFE SCI, V63, P1823; Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Zhang Z, 2001, J BIOL CHEM, V276, P41921, DOI 10.1074/jbc.M106608200; Zwick E, 2001, ENDOCR-RELAT CANCER, V8, P161, DOI 10.1677/erc.0.0080161	58	12	12	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10316	10328		10.1096/fj.201902714R	http://dx.doi.org/10.1096/fj.201902714R		JUN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32530114	Bronze			2022-12-26	WOS:000541523700001
J	Olszewski, M; Dilliott, M; Garcia-Ruiz, I; Bendarvandi, B; Costea, M				Olszewski, Magdalena; Dilliott, Meghan; Garcia-Ruiz, Ignacio; Bendarvandi, Behrang; Costea, Mihai			Cuscutaseeds: Diversity and evolution, value for systematics/identification and exploration of allometric relationships	PLOS ONE			English	Article							EPITHYMUM L. L.; SEED SIZE; COMPLEX CONVOLVULACEAE; SUBGENUS GRAMMICA; WATER-GAP; PHYLOGENETIC-RELATIONSHIPS; GERMINATION ECOLOGY; PHYSICAL DORMANCY; POLLEN LIMITATION; PARASITIC PLANTS	Cuscuta(dodders) is a group of parasitic plants with tremendous economic and ecological significance. Their seeds are often described as "simple" or "unspecialized" because they do not exhibit any classical dispersal syndrome traits. Previous studies of seed morphology and/or anatomy were conducted on relatively few species. We expanded research to 101 species; reconstructed ancestral character states; investigated correlations among seed characters and explored allometric relationships with breeding systems, the size of geographical distribution of species in North America, as well as the survival of seedlings. Seed morphological and anatomical characters permit the separation of subgenera, but not of sections. Identification ofCuscutaspecies using seed characteristics is difficult but not impossible if their geographical origin is known. Seeds of subg.Monogynellaspecies, exhibit the likely ancestral epidermis type consisting of elongated and interlocked cells, which are morphologically invariant, uninfluenced by dryness/wetness. SubgeneraCuscuta,PachystigmaandGrammicahave evolved a seed epidermis with isodiametric cells that can alternate their morphology between two states: pitted when seeds are dry, and papillose after seed imbibition. A seed coat with double palisade architecture throughout the entire seed has also apparently evolved in subgeneraCuscuta,PachystigmaandGrammica, but several species in two clades of the latter subgenus reverted to a single palisade layer outside the hilum area. The same latter species also evolved a peculiar, globose embryo, likely having a storage role, in contrast to the ancestral filiform and coiled embryo present throughout the remainder of the genus. Autogamous species had on average the highest number of seeds per capsule, whereas fully xenogamous taxa had the lowest. No correlation was revealed between the size of the seeds and the size of their geographical distribution in North America, but seedlings of species with larger seeds survived significantly longer than seedlings resulted from smaller seeds. Diversity and evolution of seed traits was discussed in relationship with their putative roles in dormancy, germination and dispersal.	[Olszewski, Magdalena; Dilliott, Meghan; Bendarvandi, Behrang; Costea, Mihai] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON, Canada; [Garcia-Ruiz, Ignacio] Inst Politecn Nacl CIIDIR IPN Michoacan, Jiquilpan, Michoacan, Mexico	Wilfrid Laurier University	Costea, M (corresponding author), Wilfrid Laurier Univ, Dept Biol, Waterloo, ON, Canada.	mcostea@wlu.ca		Costea, Mihai/0000-0003-3049-1763; Dilliott, Meghan/0000-0002-6833-5750	NSERC Discovery Canada [213918]	NSERC Discovery Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	MC lab was funded by NSERC Discovery Canada (213918): https://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_ eng.asp The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLRED KEITH R., 1964, WEEDS, V12, P45, DOI 10.2307/4040639; [Anonymous], 2000, OJEU, V43, P22; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; BAKER HG, 1972, ECOLOGY, V53, P997, DOI 10.2307/1935413; Barton LV, 1965, DORMANCY SEEDS IMPOS, P2374; Baskin Jerry M., 2000, Plant Species Biology, V15, P139, DOI 10.1046/j.1442-1984.2000.00034.x; Behdarvandi B, 2015, MYCORRHIZA, V25, P573, DOI 10.1007/s00572-015-0632-9; Bekker RM, 1998, FUNCT ECOL, V12, P834, DOI 10.1046/j.1365-2435.1998.00252.x; Benvenuti S, 2005, WEED RES, V45, P270, DOI 10.1111/j.1365-3180.2005.00460.x; Benvenuti S, 2003, AGRON J, V95, P191, DOI 10.2134/agronj2003.0191; Casley-Smith JR, 1963, J ROY MICROSC SOC, V81, P235; CHUANG T, 1972, AM J BOT, V59, P258, DOI 10.2307/2441426; Clayson C, 2014, PERSPECT PLANT ECOL, V16, P310, DOI 10.1016/j.ppees.2014.08.004; Corner E. J. H., 1976, SEEDS DICOTYLEDONS; Costea M, 2005, BRITTONIA, V57, P264, DOI 10.1663/0007-196X(2005)057[0264:TSOCNA]2.0.CO;2; COSTEA M., 2006, SIDA, V22, P176; Costea M, 2008, BOTANY, V86, P670, DOI 10.1139/B08-030; Costea Mihai, 2006, SIDA Contributions to Botany, V22, P209; Costea Mihai, 2006, SIDA Contributions to Botany, V22, P151; Costea M, 2006, CAN J PLANT SCI, V86, P293, DOI 10.4141/P04-077; Costea M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226551; Costea M, 2016, AM J BOT, V103, P957, DOI 10.3732/ajb.1500507; Costea M, 2015, TAXON, V64, P1225, DOI 10.12705/646.7; Costea M, 2015, SYST BOT, V40, P269, DOI 10.1600/036364415X686567; Costea M, 2013, SYST BOT, V38, P1160, DOI 10.1600/036364413X674887; Costea M, 2011, ORG DIVERS EVOL, V11, P373, DOI 10.1007/s13127-011-0061-3; Costea M, 2011, BOTANY, V89, P715, DOI 10.1139/b11-049; Costea M, 2010, TAXON, V59, P1783, DOI 10.1002/tax.596011; Costea M, 2009, SYST BOT, V34, P787, DOI 10.1600/036364409790139583; Costea M, 2009, SYST BOT, V34, P570, DOI 10.1600/036364409789271317; Costea M, 2009, AM J BOT, V96, P1744, DOI 10.3732/ajb.0800425; CRUDEN RW, 1977, EVOLUTION, V31, P32, DOI 10.1111/j.1558-5646.1977.tb00979.x; Dawson Jean H., 1994, Reviews of Weed Science, V6, P265; Dean HL, 1955, P ACAD IOWA SCI, V61, P99; ELISENS WJ, 1983, PLANT SYST EVOL, V142, P23, DOI 10.1007/BF00989601; ENGELMANN G., 1859, ACAD SCI ST LOUIS, V1, P453; Eriksson O, 2011, PERSPECT PLANT ECOL, V13, P73, DOI 10.1016/j.ppees.2011.02.002; FRANKLAND B, 1961, NATURE, V192, P678, DOI 10.1038/192678a0; Gaertner E.E., 1950, MEM CORNELL AGR EXP, V294, P1; Garcia MA, 2018, ORG DIVERS EVOL, V18, P383, DOI 10.1007/s13127-018-0383-5; Garcia MA, 2014, AM J BOT, V101, P670, DOI 10.3732/ajb.1300449; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Geneve RL, 2018, SEED SCI RES, V28, P186, DOI 10.1017/S0960258518000089; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; GOVIL CM, 1980, P INDIAN AS-PLANT SC, V89, P219; GRAUMANN S, 1988, Lagascalia, V15, P673; GRUBERT M, 1982, PLANT SYST EVOL, V141, P7, DOI 10.1007/BF01006475; Guo QF, 2000, ECOLOGY, V81, P2149, DOI 10.1890/0012-9658(2000)081[2149:COSSOP]2.0.CO;2; Guo QF, 2002, J VEG SCI, V13, P575, DOI 10.1111/j.1654-1103.2002.tb02084.x; HAIG D, 1988, AM NAT, V131, P757, DOI 10.1086/284817; Hamed K. A., 2005, International Journal of Agriculture and Biology, V7, P325; Hamed Karima A., 1994, Egyptian Journal of Botany, V34, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARPER JL, 1966, J ECOL, V54, P151, DOI 10.2307/2257664; Herrero A, 2011, IAU SYMP P SERIES, P292, DOI 10.1017/S1743921311010623; HICKEY LJ, 1973, AM J BOT, V60, P17, DOI 10.2307/2441319; Ho A, 2018, PERSPECT PLANT ECOL, V32, P1, DOI 10.1016/j.ppees.2018.02.001; Holm L., 1997, WORLD WEEDS NATURAL; Hooker HE, 1889, BOT GAZ, V14, P31; Hunziker AT, 1950, REV FACULTAD CIENCIA, V13, P177; HUTCHISON JM, 1979, AM J BOT, V66, P40, DOI 10.2307/2442623; Isselstein J, 2002, RESTOR ECOL, V10, P173, DOI 10.1046/j.1526-100X.2002.00045.x; Jayasuriya KMGG, 2008, ANN BOT-LONDON, V102, P39, DOI 10.1093/aob/mcn064; Jayasuriya KMGG, 2007, ANN BOT-LONDON, V100, P13, DOI 10.1093/aob/mcm070; JOHRI BM, 1952, PHYTOMORPHOLOGY, V2, P162; KELLY KM, 1992, PLANT GROWTH REGUL, V11, P201, DOI 10.1007/BF00024559; Ketjarun K, 2016, BOT STUD, V57, DOI 10.1186/s40529-016-0141-y; Khalik K. N. Abdel, 2006, Feddes Repertorium, V117, P217, DOI 10.1002/fedr.200511100; Kidson R, 2000, OECOLOGIA, V125, P11, DOI 10.1007/PL00008882; KNEPPER DA, 1990, SEED SCI TECHNOL, V18, P731; Koch L, 1880, CARL WINTERS UNIVERS; KUIJT J., 1969, The biology of parasitic flowering plants. University of California Press, Berkeley.; Larson BMH, 2000, BIOL J LINN SOC, V69, P503, DOI 10.1111/j.1095-8312.2000.tb01221.x; LOPEZCURTO L, 1990, PHYTON-INT J EXP BOT, V51, P17; LYSHEDE O B, 1990, Micron and Microscopica Acta, V21, P163, DOI 10.1016/0739-6260(90)90051-G; LYSHEDE OB, 1984, NORD J BOT, V4, P669, DOI 10.1111/j.1756-1051.1984.tb01992.x; LYSHEDE OB, 1992, ANN BOT-LONDON, V69, P365, DOI 10.1093/oxfordjournals.aob.a088353; Macpherson GE, 1921, BOT GAZ, V71, P392, DOI 10.1086/332850; Maddison WP., 2019, CHROMASEQ MESQUITE P; Maestre FT, 2003, ECOSYSTEMS, V6, P630, DOI 10.1007/s10021-002-0222-5; Martincova M, 2019, FLORA, V256, P61, DOI 10.1016/j.flora.2019.04.010; MAUN MA, 1994, VEGETATIO, V111, P59; McCullagh P, 1989, MONOGRAPHS STAT APPL, V37, P1, DOI DOI 10.1007/978-1-4899-3242-6; Meulebrouck K, 2008, SEED SCI RES, V18, P25, DOI 10.1017/S0960258508871139; Meulebrouck K, 2009, FLORA, V204, P306, DOI 10.1016/j.flora.2008.03.005; Michaels HJ, 1988, EVOL ECOL, V2, P157, DOI 10.1007/BF02067274; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; MULLIGAN GA, 1972, CAN J BOTANY, V50, P1767, DOI 10.1139/b72-219; MUSSELMAN LJ, 1986, P ROY SOC EDINB B, V89, P283, DOI 10.1017/S0269727000009106; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Parker C, 1993, BIOL CONTROL; Peterson R.L., 2008, TEACHING PLANT ANATO; Press MC, 2005, NEW PHYTOL, V166, P737, DOI 10.1111/j.1469-8137.2005.01358.x; PRIMACK RB, 1979, AM NAT, V114, P51, DOI 10.1086/283453; Rao LN, 1938, NEW PHYTOL, V37, P474; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Rodriguez-Pontes M, 2009, FLORA, V204, P228, DOI 10.1016/j.flora.2008.02.005; ROLSTON MP, 1978, BOT REV, V44, P365, DOI 10.1007/BF02957854; Sandler Hilary A., 2010, Sustainability, V2, P660, DOI 10.3390/su2020660; Spisar K, 1910, BER DEUT BOT GES, V28, P329; SRIPLENG A, 1960, AM J BOT, V47, P386, DOI 10.2307/2439227; Stefanovic S, 2004, SYST BIOL, V53, P384, DOI 10.1080/10635150490445896; Stefanovic S, 2007, AM J BOT, V94, P568, DOI 10.3732/ajb.94.4.568; Stewart FC, 1909, TORREYA, V9, P28; THOMPSON K, 1979, J ECOL, V67, P893, DOI 10.2307/2259220; TRUSCOTT FH, 1966, AM J BOT, V53, P739, DOI 10.2307/2439752; VENABLE DL, 1988, AM NAT, V131, P360, DOI 10.1086/284795; VERDCOURT B, 1948, J ECOL, V36, P356, DOI 10.2307/2256682; Vogler DW, 2001, EVOLUTION, V55, P202, DOI 10.1111/j.0014-3820.2001.tb01285.x; WERKER E, 1981, ISRAEL J BOT, V29, P22; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114; WESTOBY M, 1990, ECOLOGY, V71, P1307, DOI 10.2307/1938268; Wright MAR, 2012, PLANT SYST EVOL, V298, P369, DOI 10.1007/s00606-011-0550-z; Wright MAR, 2011, PLANT SYST EVOL, V296, P51, DOI 10.1007/s00606-011-0476-5; Yuncker T. G, 1932, MEM TORREY BOT CLUB, V18, P113	115	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234627	10.1371/journal.pone.0234627	http://dx.doi.org/10.1371/journal.pone.0234627			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530960	Green Published, gold			2022-12-26	WOS:000542037200049
J	Ojala, VK; Knittle, AM; Kirjalainen, P; Merilahti, JAM; Kortesoja, M; Tvorogov, D; Vaparanta, K; Lin, SJ; Kast, J; Pulliainen, AT; Kurppa, KJ; Elenius, K				Ojala, Veera K.; Knittle, Anna M.; Kirjalainen, Peppi; Merilahti, Johannes A. M.; Kortesoja, Maarit; Tvorogov, Denis; Vaparanta, Katri; Lin, Shujun; Kast, Jurgen; Pulliainen, Arto T.; Kurppa, Kari J.; Elenius, Klaus			The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; cancer; cell migration; ERBB4; guanine nucleotide exchange factor (GEF); HER4; phosphotyrosine signaling; protein-protein interaction; receptor tyrosine kinase; Vav guanine nucleotide exchange factor 3 (VAV3)	ERBB4 ISOFORM; GROWTH-FACTOR; INTRACELLULAR DOMAIN; NUCLEAR-LOCALIZATION; PHOSPHORYLATION; FAMILY; CLEAVAGE; IDENTIFICATION; PROTEINS; SURVIVAL	ERBB4 is a member of the epidermal growth factor receptor (EGFR)/ERBB subfamily of receptor tyrosine kinases that regulates cellular processes including proliferation, migration, and survival. ERBB4 signaling is involved in embryogenesis and homeostasis of healthy adult tissues, but also in human pathologies such as cancer, neurological disorders, and cardiovascular diseases. Here, an MS-based analysis revealed the Vav guanine nucleotide exchange factor 3 (VAV3), an activator of Rho family GTPases, as a critical ERBB4-interacting protein in breast cancer cells. We confirmed the ERBB4-VAV3 interaction by targeted MS and coimmunoprecipitation experiments and further defined it by demonstrating that kinase activity and Tyr-1022 and Tyr-1162 of ERBB4, as well as the intact phosphotyrosine-interacting SH2 domain of VAV3, are necessary for this interaction. We found that ERBB4 stimulates tyrosine phosphorylation of the VAV3 activation domain, known to be required for guanine nucleotide exchange factor (GEF) activity of VAV proteins. In addition to VAV3, the other members of the VAV family, VAV1 and VAV2, also coprecipitated with ERBB4. Analyses of the effects of overexpression of dominant-negative VAV3 constructs or shRNA-mediated down-regulation of VAV3 expression in breast cancer cells indicated that active VAV3 is involved in ERBB4-stimulated cell migration. These results define the VAV GEFs as effectors of ERBB4 activity in a signaling pathway relevant for cancer cell migration.	[Ojala, Veera K.; Knittle, Anna M.; Kirjalainen, Peppi; Merilahti, Johannes A. M.; Kortesoja, Maarit; Tvorogov, Denis; Vaparanta, Katri; Pulliainen, Arto T.; Kurppa, Kari J.; Elenius, Klaus] Univ Turku, Inst Biomed, Turku, Finland; [Ojala, Veera K.; Knittle, Anna M.; Kirjalainen, Peppi; Merilahti, Johannes A. M.; Kortesoja, Maarit; Tvorogov, Denis; Vaparanta, Katri; Pulliainen, Arto T.; Kurppa, Kari J.; Elenius, Klaus] Univ Turku, Med Res Labs, Turku, Finland; [Ojala, Veera K.; Merilahti, Johannes A. M.; Vaparanta, Katri] Univ Turku, Turku Doctoral Programme Mol Med, Turku, Finland; [Ojala, Veera K.; Kirjalainen, Peppi; Merilahti, Johannes A. M.; Vaparanta, Katri; Elenius, Klaus] Univ Turku, Turku Biosci Ctr, Turku, Finland; [Ojala, Veera K.; Kirjalainen, Peppi; Merilahti, Johannes A. M.; Vaparanta, Katri; Elenius, Klaus] Abo Akad Univ, Turku, Finland; [Lin, Shujun; Kast, Jurgen] Univ British Columbia, Dept Chem, Biomed Res Ctr, Vancouver, BC, Canada; [Lin, Shujun; Kast, Jurgen] Univ British Columbia, Ctr Blood Res, Vancouver, BC, Canada; [Elenius, Klaus] Turku Univ Hosp, Dept Oncol & Radiotherapy, Turku, Finland; [Kortesoja, Maarit] Univ Helsinki, Fac Pharm, Div Pharmaceut Biosci, Drug Res Program, Helsinki, Finland; [Tvorogov, Denis] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Tvorogov, Denis] Univ South Australia, Adelaide, SA, Australia; [Kast, Jurgen] Protagen Prot Serv GmbH, Heilbronn, Germany	University of Turku; University of Turku; University of Turku; University of Turku; Abo Akademi University; University of British Columbia; University of British Columbia; University of Turku; University of Helsinki; Centre for Cancer Biology; SA Pathology; University of South Australia; Protagen Protein Services (PPS)	Elenius, K (corresponding author), Univ Turku, Inst Biomed, Turku, Finland.; Elenius, K (corresponding author), Univ Turku, Med Res Labs, Turku, Finland.; Elenius, K (corresponding author), Univ Turku, Turku Biosci Ctr, Turku, Finland.; Elenius, K (corresponding author), Abo Akad Univ, Turku, Finland.; Elenius, K (corresponding author), Turku Univ Hosp, Dept Oncol & Radiotherapy, Turku, Finland.	klaus.elenius@utu.fi	Elenius, Klaus/AAI-7594-2021; Pulliainen, Arto/AAX-2052-2021	Elenius, Klaus/0000-0001-5700-0827; Ojala, Veera/0000-0001-5204-8899; Pulliainen, Arto Tapio/0000-0002-9361-8963; Kortesoja, Maarit/0000-0002-1552-5956; Kurppa, Kari/0000-0001-8286-2429; Tvorogov, Denis/0000-0002-2009-1347; Merilahti, Johannes/0000-0002-9113-5175	Academy of Finland [274728, 316796]; Cancer Foundation of Finland; Turku University Central Hospital	Academy of Finland(Academy of Finland); Cancer Foundation of Finland; Turku University Central Hospital	This study has been supported by Academy of Finland (274728, 316796), the Cancer Foundation of Finland, and the Turku University Central Hospital.	Aguilar H, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3664; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; [Anonymous], 2019, ONCOGENE, DOI DOI 10.1038/S41388-018-0465-Z; Bustelo XR, 2018, BIOCHEM SOC T, V46, P741, DOI 10.1042/BST20170531; Bustelo Xose R, 2014, Small GTPases, V5, P9, DOI 10.4161/21541248.2014.973757; Charvet C, 2005, J BIOL CHEM, V280, P15289, DOI 10.1074/jbc.M500275200; Chen X, 2015, ONCOL LETT, V9, P2143, DOI 10.3892/ol.2015.3004; Citterio C, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002962; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Elenius K, 1999, ONCOGENE, V18, P2607, DOI 10.1038/sj.onc.1202612; Gessulat S, 2019, NAT METHODS, V16, P509, DOI 10.1038/s41592-019-0426-7; Gilmore-Hebert M, 2010, MOL CANCER RES, V8, P1388, DOI 10.1158/1541-7786.MCR-10-0042; Haskins JW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005770; Hause RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044471; Hollmen M, 2010, FUTURE ONCOL, V6, P37, DOI 10.2217/fon.09.144; Hughes CS, 2019, NAT PROTOC, V14, P68, DOI 10.1038/s41596-018-0082-x; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; Kaushansky A, 2008, CHEM BIOL, V15, P808, DOI 10.1016/j.chembiol.2008.07.006; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kiuchi T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005157; Lee KW, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-158; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Linggi B, 2006, J BIOL CHEM, V281, P25373, DOI 10.1074/jbc.M603998200; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mill Christopher P, 2011, Genes Cancer, V2, P792, DOI 10.1177/1947601911431080; Modjtahedi H, 2014, N-S ARCH PHARMACOL, V387, P505, DOI 10.1007/s00210-014-0967-3; Moores SL, 2000, MOL CELL BIOL, V20, P6364, DOI 10.1128/MCB.20.17.6364-6373.2000; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Omerovic J, 2007, FASEB J, V21, P2849, DOI 10.1096/fj.06-7925com; Pandey A, 2000, P NATL ACAD SCI USA, V97, P179, DOI 10.1073/pnas.97.1.179; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Solca F, 2012, J PHARMACOL EXP THER, V343, P342, DOI 10.1124/jpet.112.197756; Sundvall M, 2007, ONCOGENE, V26, P6905, DOI 10.1038/sj.onc.1210501; Sundvall M, 2008, J MAMMARY GLAND BIOL, V13, P259, DOI 10.1007/s10911-008-9079-3; Sundvall M, 2008, P NATL ACAD SCI USA, V105, P4162, DOI 10.1073/pnas.0708333105; Sundvall M, 2012, J BIOL CHEM, V287, P23216, DOI 10.1074/jbc.M111.335927; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Tvorogov D, 2009, J BIOL CHEM, V284, P5582, DOI 10.1074/jbc.M805438200; Veikkolainen V, 2011, CELL CYCLE, V10, P2647, DOI 10.4161/cc.10.16.17194; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zauber H, 2018, NAT METHODS, V15, P156, DOI 10.1038/nmeth.4607; Zhang K, 1996, J BIOL CHEM, V271, P3884	51	5	5	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11559	11571		10.1074/jbc.RA119.010925	http://dx.doi.org/10.1074/jbc.RA119.010925			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32561640	hybrid, Green Published			2022-12-26	WOS:000563922500016
J	Kumar, M; Haghighi, K; Kranias, EG; Sadayappan, S				Kumar, Mohit; Haghighi, Kobra; Kranias, Evangelia G.; Sadayappan, Sakthivel			Phosphorylation of cardiac myosin-binding protein-C contributes to calcium homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac arrhythmia; cMyBP-C; HFpEF; MYBPC3; protein phosphorylation; myofilament; sarcomere; calcium homeostasis; posttranslational modification calcium; cardiomyocyte; heart failure; phosphorylation; cardiomyopathy; arrhythmia; hypertrophic cardiomyopathy; omecamtiv mecarbil	HEART-FAILURE; SARCOMERE MECHANICS; CA2+ WAVES; MYBP-C; CONTRACTILITY; ACTIVATION; MUTATION; GENE; DYSFUNCTION; PROGRESSION	Cardiac myosin-binding protein-C (cMyBP-C) is highly phosphorylated under basal conditions. However, its phosphorylation level is decreased in individuals with heart failure. The necessity of cMyBP-C phosphorylation for proper contractile function is well-established, but the physiological and pathological consequences of decreased cMyBP-C phosphorylation in the heart are not clear. Herein, using intact adult cardiomyocytes from mouse models expressing phospho-ablated (AAA) and phosphomimetic (DDD) cMyBP-C as well as controls, we found that cMyBP-C dephosphorylation is sufficient to reduce contractile parameters and calcium kinetics associated with prolonged decay time of the calcium transient and increased diastolic calcium levels. Isoproterenol stimulation reversed the depressive contractile and Ca2+-kinetic parameters. Moreover, caffeine-induced calcium release yielded no difference between AAA/DDD and controls in calcium content of the sarcoplasmic reticulum. On the other hand, sodium-calcium exchanger function and phosphorylation levels of calcium-handling proteins were significantly decreased in AAA hearts compared with controls. Stress conditions caused increases in both spontaneous aftercontractions in AAA cardiomyocytes and the incidence of arrhythmiasin vivocompared with the controls. Treatment with omecamtiv mecarbil, a positive cardiac inotropic drug, rescued the contractile deficit in AAA cardiomyocytes, but not the calcium-handling abnormalities. These findings indicate a cascade effect whereby cMyBP-C dephosphorylation causes contractile defects, which then lead to calcium-cycling abnormalities, resulting in aftercontractions and increased incidence of cardiac arrhythmias under stress conditions. We conclude that improvement of contractile deficits alone without improving calcium handling may be insufficient for effective management of heart failure.	[Kumar, Mohit; Sadayappan, Sakthivel] Univ Cincinnati, Heart Lung & Vasc Inst, Dept Internal Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45221 USA; [Kumar, Mohit; Haghighi, Kobra; Kranias, Evangelia G.; Sadayappan, Sakthivel] Univ Cincinnati, Dept Pharmacol & Syst Physiol, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Sadayappan, S (corresponding author), Univ Cincinnati, Heart Lung & Vasc Inst, Dept Internal Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45221 USA.; Sadayappan, S (corresponding author), Univ Cincinnati, Dept Pharmacol & Syst Physiol, Cincinnati, OH 45221 USA.	sadayasl@ucmail.uc.edu	Kumar, Mohit/AAM-6405-2021	Kumar, Mohit/0000-0002-3554-0563; Sadayappan, Sakthivel/0000-0003-2006-7678; Haghighi, Kobra/0000-0002-3122-3894; KRANIAS, EVANGELIA/0000-0002-4621-6179	American Heart Association Predoctoral Fellowship [17PRE33630192]; National Institutes of Health [R01 HL130356, R56 HL139680, R01 AR067279, R01 HL105826, R01 HL143490]; American Heart Association [19UFEL34380251, 19TPA34830084]; PLN Foundation (PLN Crazy Idea); Leducq Foundation [18CVD01]	American Heart Association Predoctoral Fellowship(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); PLN Foundation (PLN Crazy Idea); Leducq Foundation(Leducq Foundation)	This work was supported by American Heart Association Predoctoral Fellowship 17PRE33630192 (to M. K.). S. S. has received support from National Institutes of Health Grants R01 HL130356, R56 HL139680, R01 AR067279, R01 HL105826, and R01 HL143490. This work was further supported by the American Heart Association 2019 Institutional Undergraduate Student (19UFEL34380251) and Transformation (19TPA34830084) awards, the PLN Foundation (PLN Crazy Idea), and the Leducq Foundation (Transatlantic Network 18CVD01, PLN-CURE). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Azevedo PS, 2016, ARQ BRAS CARDIOL, V106, P62, DOI 10.5935/abc.20160005; Barefield D, 2014, AM J PHYSIOL-HEART C, V306, pH807, DOI 10.1152/ajpheart.00913.2013; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Barefield DY, 2019, J MOL CELL CARDIOL, V129, P236, DOI 10.1016/j.yjmcc.2019.03.006; Bennett PM, 1999, REV PHYSIOL BIOCH P, V138, P203, DOI 10.1007/BF02346664; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Berul CI, 2001, CIRCULATION, V104, P2734, DOI 10.1161/hc4701.099582; Bidwell PA, 2018, J BIOL CHEM, V293, P359, DOI 10.1074/jbc.RA117.000128; BONNE G, 1995, NAT GENET, V11, P438, DOI 10.1038/ng1295-438; Bristow M, 2000, LANCET, V356, P1621, DOI 10.1016/S0140-6736(00)03149-4; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; Cheng Y, 2013, AM J PHYSIOL-HEART C, V305, pH52, DOI 10.1152/ajpheart.00929.2012; Coats AJS, 2002, PROG CARDIOVASC DIS, V44, P231, DOI 10.1053/pcad.2002.31585; Colucci WS, 1996, CIRCULATION, V94, P2800, DOI 10.1161/01.CIR.94.11.2800; Copeland O, 2010, J MOL CELL CARDIOL, V49, P1003, DOI 10.1016/j.yjmcc.2010.09.007; Curran J, 2007, CIRC RES, V100, P391, DOI 10.1161/01.RES.0000258172.74570.e6; DANIELS MCG, 1990, J GEN PHYSIOL, V95, P1123, DOI 10.1085/jgp.95.6.1123; Dobrev D, 2014, CIRC RES, V114, P1311, DOI 10.1161/CIRCRESAHA.114.300568; Eisner DA, 2017, CIRC RES, V121, P181, DOI 10.1161/CIRCRESAHA.117.310230; El-Armouche A, 2006, CIRCULATION, V114, P670, DOI 10.1161/CIRCULATIONAHA.106.636845; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P223, DOI 10.1016/j.yjmcc.2007.05.003; From A H, 1998, J Card Fail, V4, P127, DOI 10.1016/S1071-9164(98)90253-6; Gradman AH, 2006, PROG CARDIOVASC DIS, V48, P326, DOI 10.1016/j.pcad.2006.02.001; Haghighi K, 2015, J MOL CELL CARDIOL, V89, P349, DOI 10.1016/j.yjmcc.2015.10.004; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; Helms AS, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133782; Houser SR, 2000, J MOL CELL CARDIOL, V32, P1595, DOI 10.1006/jmcc.2000.1206; HOUSMANS PR, 1983, SCIENCE, V221, P159, DOI 10.1126/science.6857274; Jacques AM, 2008, J MOL CELL CARDIOL, V45, P209, DOI 10.1016/j.yjmcc.2008.05.020; Kensler RW, 2017, P NATL ACAD SCI USA, V114, pE1355, DOI 10.1073/pnas.1614020114; Kulikovskaya I, 2003, J GEN PHYSIOL, V122, P761, DOI 10.1085/jgp.200308941; Kumar M, 2015, J BIOL CHEM, V290, P29241, DOI 10.1074/jbc.M115.686790; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; Kuster DWD, 2019, CARDIOVASC RES, V115, P1986, DOI 10.1093/cvr/cvz111; Landstrom AP, 2017, CIRC RES, V120, P1969, DOI 10.1161/CIRCRESAHA.117.310083; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Liu GS, 2015, CARDIOVASC RES, V107, P164, DOI 10.1093/cvr/cvv127; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Masarone D, 2017, J CARDIOVASC DEV DIS, V4, DOI 10.3390/jcdd4010003; Mattiazzi A, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00005; McNamara JW, 2019, P NATL ACAD SCI USA, V116, P11731, DOI 10.1073/pnas.1821660116; McNamara JW, 2016, J MOL CELL CARDIOL, V94, P65, DOI 10.1016/j.yjmcc.2016.03.009; Mollova MY, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00178; Mun JY, 2014, P NATL ACAD SCI USA, V111, P2170, DOI 10.1073/pnas.1316001111; Ponnam S, 2019, P NATL ACAD SCI USA, V116, P15485, DOI 10.1073/pnas.1903033116; Port JD, 2001, J MOL CELL CARDIOL, V33, P887, DOI 10.1006/jmcc.2001.1358; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; Previs MJ, 2016, P NATL ACAD SCI USA, V113, P3239, DOI 10.1073/pnas.1522236113; Previs MJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400205; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Rosas PC, 2019, JACC-BASIC TRANSL SC, V4, P817, DOI 10.1016/j.jacbts.2019.06.003; Rosas PC, 2015, CIRC-HEART FAIL, V8, P582, DOI 10.1161/CIRCHEARTFAILURE.114.001550; Sabbah HN, 2002, EUR J HEART FAIL, V4, P3, DOI 10.1016/S1388-9842(01)00183-0; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Shannon TR, 2000, BIOPHYS J, V78, P322, DOI 10.1016/S0006-3495(00)76595-7; Singh VP, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000460; Squire JM, 2003, J MOL BIOL, V331, P713, DOI 10.1016/S0022-2836(03)00781-2; Stanczyk PJ, 2018, J CELL SCI, V131, DOI 10.1242/jcs.210443; Stelzer JE, 2006, CIRC RES, V98, P1212, DOI 10.1161/01.RES.0000219863.94390.ce; Tang WW, 2003, EXPERT OPIN INV DRUG, V12, P1791, DOI 10.1517/13543784.12.11.1791; Taylor EN, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002836; Teerlink JR, 2016, LANCET, V388, P2895, DOI 10.1016/S0140-6736(16)32049-9; ter Keurs HEDJ, 2006, PROG BIOPHYS MOL BIO, V90, P151, DOI 10.1016/j.pbiomolbio.2005.07.002; ter Keurs HEDJ, 2012, AM J PHYSIOL-HEART C, V302, pH38, DOI 10.1152/ajpheart.00219.2011; ter Keurs HEDJ, 2008, PROG BIOPHYS MOL BIO, V97, P312, DOI 10.1016/j.pbiomolbio.2008.02.013; Ter Keurs HEDJ, 2006, ANN NY ACAD SCI, V1080, P248, DOI 10.1196/annals.1380.020; Timmermann V, 2019, BIOPHYS J, V117, P2471, DOI 10.1016/j.bpj.2019.11.009; Toepfer CN, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat1199; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; Tong CW, 2015, CIRC-HEART FAIL, V8, P595, DOI 10.1161/CIRCHEARTFAILURE.114.001585; Wakayama Y, 2005, CIRC RES, V96, P1266, DOI 10.1161/01.RES.0000172544.56818.54; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Woody MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06193-2	78	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11275	11291		10.1074/jbc.RA120.013296	http://dx.doi.org/10.1074/jbc.RA120.013296			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32554466	Green Published, hybrid			2022-12-26	WOS:000562757100028
J	Furfaro, LL; Payne, MS; Chang, BJ				Furfaro, Lucy L.; Payne, Matthew S.; Chang, Barbara J.			Host range, morphological and genomic characterisation of bacteriophages with activity against clinicalStreptococcus agalactiaeisolates	PLOS ONE			English	Article							GROUP-B STREPTOCOCCI; MULTIPLEX PCR ASSAY; MOLECULAR CHARACTERIZATION; IDENTIFICATION; ENUMERATION; RESISTANCE; PHAGE; IA	Streptococcus agalactiaeor Group B Streptococcus (GBS) is a leading cause of sepsis in neonates. As a preventative measure prophylactic antibiotic administration is common in pregnant women colonised with GBS, but antibiotic-resistance and adverse effects on neonatal microbiomes may result. Use of bacteriophages (phages) is one option for targeted therapy. To this end, four phages (LF1 -LF4) were isolated from wastewater. They displayed lytic activityin vitroagainstS.agalactiaeisolates collected from pregnant women and neonates, with 190/246 isolates (77.2%) and 10/10 (100%) isolates susceptible to at least one phage, respectively. Phage genomes ranged from 32,205-44,768 bp and all phages were members of theSiphoviridaefamily. High nucleotide identity (99.9%) was observed between LF1 and LF4, which were closely related to a putative prophage ofS.agalactiae. The genome organisation of LF2 differed, and it showed similarity to a differentS.agalactiaeprophage, while LF3 was more closely related to aStreptococcus pyogenesphage. Lysogenic gene presence (integrase, repressor and regulatory modules), was suggestive of temperate phages. In a therapeutic context, temperate phages are not ideal candidates, however, the broad host range activity of these phages observed on clinical isolatesin vitrois promising for future therapeutic approaches including bioengineered phage or lysin applications.	[Furfaro, Lucy L.; Payne, Matthew S.] Univ Western Australia, Sch Med, Div Obstet & Gynaecol, Crawley, Australia; [Chang, Barbara J.] Univ Western Australia, Sch Biomed Sci, Marshall Ctr Infect Dis Res & Training, Crawley, Australia	University of Western Australia; University of Western Australia	Furfaro, LL (corresponding author), Univ Western Australia, Sch Med, Div Obstet & Gynaecol, Crawley, Australia.	lucy.furfaro@uwa.edu.au	; Furfaro, Lucy/H-5569-2018	Chang, Barbara/0000-0002-6077-1646; Furfaro, Lucy/0000-0001-7652-0713	Channel 7 Telethon Trust Fund; Australian Government Research Training Program Scholarship; Professor Gordon King Postgraduate Scholarship by the Women's and Infants' Research Foundation; NHMRC [1144040]	Channel 7 Telethon Trust Fund; Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Professor Gordon King Postgraduate Scholarship by the Women's and Infants' Research Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the Channel 7 Telethon Trust Fund to MSP. LLF is supported by the Australian Government Research Training Program Scholarship and the Professor Gordon King Postgraduate Scholarship provided by the Women's and Infants' Research Foundation. MSP is also supported by an NHMRC Project Grant [1144040].	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Aloisio I, 2016, APPL MICROBIOL BIOT, V100, P5537, DOI 10.1007/s00253-016-7410-2; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Back EE, 2012, ANTIMICROB AGENTS CH, V56, P739, DOI 10.1128/AAC.05794-11; Bai Qinqin, 2016, Weishengwu Xuebao, V56, P317; Bai QQ, 2013, ARCH VIROL, V158, P1733, DOI 10.1007/s00705-013-1667-x; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BETRIU C, 1994, ANTIMICROB AGENTS CH, V38, P2183, DOI 10.1128/AAC.38.9.2183; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Cheng Q, 2005, ANTIMICROB AGENTS CH, V49, P111, DOI 10.1128/AAC.49.1.111-117.2005; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Domelier AS, 2009, J BACTERIOL, V191, P4776, DOI 10.1128/JB.00426-09; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Furfaro LL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223256; Furfaro LL, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02660; Furfaro LL, 2017, DIAGN MICR INFEC DIS, V89, P7, DOI 10.1016/j.diagmicrobio.2017.06.003; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Imperi M, 2010, J MICROBIOL METH, V80, P212, DOI 10.1016/j.mimet.2009.11.010; Jacobs-Sera D, 2012, VIROLOGY, V434, P187, DOI 10.1016/j.virol.2012.09.026; Kimura K, 2008, ANTIMICROB AGENTS CH, V52, P2890, DOI 10.1128/AAC.00185-08; Kropinski Andrew M., 2009, V501, P69, DOI 10.1007/978-1-60327-164-6_7; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Mazzocco Amanda, 2009, V501, P81, DOI 10.1007/978-1-60327-164-6_9; Mcshan WM, 1997, MOL MICROBIOL, V23, P719, DOI 10.1046/j.1365-2958.1997.2591616.x; Nale JY, 2018, ANTIBIOTICS-BASEL, V7, DOI 10.3390/antibiotics7010013; NCBI Resource Coordinators, 2018, NUCLEIC ACIDS RES, V46, pD8; Nobrega FL, 2015, TRENDS MICROBIOL, V23, P185, DOI 10.1016/j.tim.2015.01.006; Russell NJ, 2017, CLIN INFECT DIS, V65, pS100, DOI 10.1093/cid/cix658; Salloum M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020256; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seki T, 2015, J ANTIMICROB CHEMOTH, V70, P2725, DOI 10.1093/jac/dkv203; Simioni J, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0724-5; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595; Wommack K. Eric, 2009, V501, P3, DOI 10.1007/978-1-60327-164-6_1; 2016, CANC DISCOV, V6	37	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235002	10.1371/journal.pone.0235002	http://dx.doi.org/10.1371/journal.pone.0235002			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574197	Green Published, gold			2022-12-26	WOS:000544972400020
J	Kadler, S; Vural, O; Rosowski, J; Reiners-Schramm, L; Lauster, R; Rosowski, M				Kadler, Shirin; Vural, Oezlem; Rosowski, Jennifer; Reiners-Schramm, Luzia; Lauster, Roland; Rosowski, Mark			Effects of 5-aza-2 '-deoxycytidine on primary human chondrocytes from osteoarthritic patients	PLOS ONE			English	Article							MESENCHYMAL STEM-CELL; DNA METHYLATION; PROGENITOR CELLS; CARTILAGE; TISSUE; DEDIFFERENTIATION; EXPRESSION; DIFFERENTIATION; DEMETHYLATION; 5-AZACYTIDINE	Chondrocytes, comparable to many cells from the connective tissue, dedifferentiate and end up in a similar fibroblastoid cell type, marked by the loss of the specific expression pattern. Here, chondrocytes isolated from osteoarthritic (OA) patients were investigated. The OA chondrocytes used in this work were not affected by the loss of specific gene expression upon cell culture. The mRNA levels of known cartilage markers, such as SOX5, SOX6, SOX9, aggrecan and proteoglycan 4, remained unchanged. Since chondrocytes from OA and healthy tissue show different DNA methylation patterns, the underlying mechanisms of cartilage marker maintenance were investigated with a focus on the epigenetic modification by DNA methylation. The treatment of dedifferentiated chondrocytes with the DNA methyltransferase inhibitor 5-aza-2 '-deoxycytidine (5-aza-dC) displayed no considerable impact on the maintenance of marker gene expression observed in the dedifferentiated state, while the chondrogenic differentiation capacity was compromised. On the other hand, the pre-cultivation with 5-aza-dC improved the osteogenesis and adipogenesis of OA chondrocytes. Contradictory to these effects, the DNA methylation levels were not reduced after treatment for four weeks with 1 mu M 5-aza-dC. In conclusion, 5-aza-dC affects the differentiation capacity of OA chondrocytes, while the global DNA methylation level remains stable. Furthermore, dedifferentiated chondrocytes isolated from late-stage OA patients represent a reliable cell source forin vitrostudies and disease models without the need for additional alterations.	[Kadler, Shirin; Vural, Oezlem; Rosowski, Jennifer; Reiners-Schramm, Luzia; Lauster, Roland; Rosowski, Mark] Tech Univ Berlin, Inst Biotechnol, Dept Med Biotechnol, Berlin, Germany	Technical University of Berlin	Kadler, S (corresponding author), Tech Univ Berlin, Inst Biotechnol, Dept Med Biotechnol, Berlin, Germany.	shirin.kadler@tu-berlin.de		Kadler, Shirin/0000-0001-9281-4770	German Research Foundation; Open Access Publication Fund of TU Berlin	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Fund of TU Berlin	We acknowledge support by the German Research Foundation and the Open Access Publication Fund of TU Berlin.	Ahmed TAE, 2014, HISTOL HISTOPATHOL, V29, P669, DOI 10.14670/HH-29.669; Alvarez-Garcia O, 2016, ARTHRITIS RHEUMATOL, V68, P1876, DOI 10.1002/art.39643; Avgustinova A, 2016, NAT REV MOL CELL BIO, V17, P643, DOI 10.1038/nrm.2016.76; Barter MJ, 2012, OSTEOARTHR CARTILAGE, V20, P339, DOI 10.1016/j.joca.2011.12.012; Bonin CA, 2016, GENE, V576, P312, DOI 10.1016/j.gene.2015.10.037; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Decker RS, 2014, MATRIX BIOL, V39, P5, DOI 10.1016/j.matbio.2014.08.006; Demoor M, 2014, BBA-GEN SUBJECTS, V1840, P2414, DOI 10.1016/j.bbagen.2014.02.030; Doran PM, 2015, METHODS MOL BIOL, V1340, P3, DOI 10.1007/978-1-4939-2938-2_1; Duan L, 2017, J CELL PHYSIOL, V232, P1708, DOI 10.1002/jcp.25486; Duan L, 2015, AM J TRANSL RES, V7, P194; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; Goldring SR, 2016, NAT REV RHEUMATOL, V12, P632, DOI 10.1038/nrrheum.2016.148; Hagemann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017388; Hashimoto K, 2009, ARTHRITIS RHEUM-US, V60, P3303, DOI 10.1002/art.24882; Ikegami K, 2009, INT J DEV BIOL, V53, P203, DOI 10.1387/ijdb.082741ki; Im GI, 2013, EXPERT OPIN BIOL TH, V13, P713, DOI 10.1517/14712598.2013.764410; Jiang YZ, 2015, NAT REV RHEUMATOL, V11, P206, DOI 10.1038/nrrheum.2014.200; Khan IM, 2009, CELL STEM CELL, V4, P282, DOI 10.1016/j.stem.2009.03.007; Kim HJ, 2016, BIOTECHNOL LETT, V38, P167, DOI 10.1007/s10529-015-1949-3; Koelling S, 2009, CELL STEM CELL, V4, P324, DOI 10.1016/j.stem.2009.01.015; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Komashko Vitalina M, 2010, Epigenetics, V5, P229; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; La Noce M, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0978-x; Liang X, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/7028901; Lin Z, 2008, J ORTHOP RES, V26, P1230, DOI 10.1002/jor.20523; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Ma B, 2013, OSTEOARTHR CARTILAGE, V21, P599, DOI 10.1016/j.joca.2013.01.014; Momparler RL, 2005, SEMIN HEMATOL, V42, pS9, DOI 10.1053/j.seminhematol.2005.05.002; Oda T, 2016, BIOCHEM BIOPH RES CO, V479, P469, DOI 10.1016/j.bbrc.2016.09.085; Pohlig F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150020; Rosowski M, 2006, ARTIF ORGANS, V30, P775, DOI 10.1111/j.1525-1594.2006.00300.x; Stellavato A, 2016, J CELL BIOCHEM, V117, P2158, DOI 10.1002/jcb.25556; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Unterberger A, 2006, MOL CELL BIOL, V26, P7575, DOI 10.1128/MCB.01887-05; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Yamada Y, 2014, STEM CELL TRANSL MED, V3, P1182, DOI 10.5966/sctm.2014-0090; Zhang W, 2016, BONE RES, V4, DOI 10.1038/boneres.2015.40	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234641	10.1371/journal.pone.0234641	http://dx.doi.org/10.1371/journal.pone.0234641			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574164	Green Published, gold			2022-12-26	WOS:000544972400033
J	Lin, LT; Chen, JT; Lu, DW; Tai, MC; Liang, CM; Chen, CL; Pao, SI; Hsu, CK; Chen, YH				Lin, Le-Tien; Chen, Jiann-Torng; Lu, Da-Wen; Tai, Ming-Cheng; Liang, Chang-Min; Chen, Ching-Long; Pao, Shu-, I; Hsu, Chih-Kang; Chen, Yi-Hao			Antifibrotic role of low-dose mitomycin-c-induced cellular senescence in trabeculectomy models	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; INDUCED PREMATURE SENESCENCE; REPLICATIVE SENESCENCE; RISK-FACTORS; TGF-BETA; FIBROSIS; FIBROBLASTS; MECHANISMS; CELLS; DIFFERENTIATION	Purpose We assessed whether mitomycin-C (MMC) has different antifibrotic mechanisms in trabeculectomy wound healing. Methods We identified 2 concentrations of MMC as "low-dose" by using WST-1 assay, Lactic dehydrogenase assay, and fluorescence-activated cell sorting flow cytometry. Senescence-associated beta-galactosidase (SA-beta-gal) and fibrotic gene expression was examined through immunocytochemistry, flow cytometry, real-time quantitative reverse transcription polymerase chain reaction, Western blotting, zymography, and modified scratch assay in vitro. In vivo, 0.1 mL of MMC or normal saline was injected to Tenon's capsule before trabeculectomy in a rabbit model. SA-beta-gal expression, apoptotic cell death, and collagen deposition in sites treated and not treated with MMC were evaluated using terminal dUTP nick end labeling assay and histochemical staining. Bleb function and intraocular pressure (IOP) levels were examined 3, 7, 14, 21, 28, and 35 days after trabeculectomy. Results In vitro, human Tenon's fibroblast (HTF) senescence was confirmed by observing cell morphologic change, SA-beta-gal accumulation, formation of senescence-associated heterochromatin, increased p16(INK4a)and p21(CIP1/WAF1)expression, lower percentage of Ki-67-positive cells, and decreased COL1A1 release. Increased expression of alpha-SMA,COL1A1, and Smad2 signaling in TGF-beta 1-induced stress fibers were passivated in senescent HTFs. In addition, cellular migration enhanced by TGF-beta 1was inactivated. In vivo, histological examination indicated increased SA-beta-gal accumulation, lower apoptosis ratios, and looser collagen deposition in sites treated with 0.2 mu M MMC. Low-dose MMC-induced cellular senescence prolonged trabeculectomy bleb survival and reduced IOP levels in a rabbit model. Conclusion Low-dose MMC-induced cellular senescence is involved in the antifibrotic mechanism of trabeculectomy wound healing.	[Lin, Le-Tien; Hsu, Chih-Kang] Tri Serv Gen Hosp, Dept Ophthalmol, Natl Def Med Ctr, Songshan Branch, Taipei, Taiwan; [Lin, Le-Tien; Chen, Jiann-Torng; Lu, Da-Wen; Tai, Ming-Cheng; Liang, Chang-Min; Chen, Ching-Long; Chen, Yi-Hao] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Le-Tien; Chen, Jiann-Torng; Lu, Da-Wen; Tai, Ming-Cheng; Liang, Chang-Min; Chen, Ching-Long; Pao, Shu-, I; Hsu, Chih-Kang; Chen, Yi-Hao] Tri Serv Gen Hosp, Dept Ophthalmol, Natl Def Med Ctr, Taipei, Taiwan; [Liang, Chang-Min] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Chen, YH (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Chen, YH (corresponding author), Tri Serv Gen Hosp, Dept Ophthalmol, Natl Def Med Ctr, Taipei, Taiwan.	doc30879@mail.ndmctsgh.edu.tw			Ministry of Science and Technology, Taiwan [107-2314-B-016-032]; National Defense Medical Center, Tri-Service General Hospital, Taiwan [C108-124]; National Defense Medical Center, Tri-Service General Hospital Songshan Branch, Taiwan [108-23, 108-38]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Defense Medical Center, Tri-Service General Hospital, Taiwan; National Defense Medical Center, Tri-Service General Hospital Songshan Branch, Taiwan	This study was funded by the Ministry of Science and Technology, Taiwan to YHC (grant no. 107-2314-B-016-032), National Defense Medical Center, Tri-Service General Hospital, Taiwan to YHC (grant no. C108-124), and National Defense Medical Center, Tri-Service General Hospital Songshan Branch, Taiwan to LTL and CKH (grant no. 108-23 and 108-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Broadway DC, 2001, J GLAUCOMA, V10, P237, DOI 10.1097/00061198-200106000-00017; Bruno CA, 2007, EXPERT REV OPHTHALMO, V2, P79, DOI 10.1586/17469899.2.1.79; CAIRNS JE, 1968, AM J OPHTHALMOL, V66, P673, DOI 10.1016/0002-9394(68)91288-9; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Caprioli J, 2011, AM J OPHTHALMOL, V152, P340, DOI 10.1016/j.ajo.2011.05.029; Chen CZC, 2009, FIBROGENESIS TISSUE, V2, DOI 10.1186/1755-1536-2-7; Chen YH, 2013, ACTA OPHTHALMOL, V91, pE506, DOI 10.1111/aos.12160; Cicinnati VR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-350; Classen L, 1996, AM J OPHTHALMOL, V122, P205, DOI 10.1016/S0002-9394(14)72011-2; Cordeiro M F, 2000, Curr Opin Ophthalmol, V11, P121, DOI 10.1097/00055735-200004000-00010; Cordeiro MF, 2003, CLIN SCI, V104, P181, DOI 10.1042/CS20020150; Crowston JG, 1998, INVEST OPHTH VIS SCI, V39, P449; Daniels JT, 2003, INVEST OPHTH VIS SCI, V44, P1104, DOI 10.1167/iovs.02-0412; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DESMOULIERE A, 1995, J HEPATOL, V22, P61; Deva NC, 2012, INFLAMMATION, V35, P1276, DOI 10.1007/s10753-012-9439-4; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Ederer F, 2004, OPHTHALMOLOGY, V111, P651, DOI 10.1016/j.ophtha.2003.09.025; Ekinci M, 2014, J GLAUCOMA, V23, P372, DOI 10.1097/IJG.0000000000000052; Esson DW, 2004, INVEST OPHTH VIS SCI, V45, P4450, DOI 10.1167/iovs.04-0375; Fontana H, 2006, OPHTHALMOLOGY, V113, P930, DOI 10.1016/j.ophtha.2006.01.062; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Giannandrea M, 2014, DIS MODEL MECH, V7, P193, DOI 10.1242/dmm.012062; Gossrau R, 1991, GLYCOSIDASE HISTOCHE, P241; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hackbarth H, 2000, LAB ANIM-UK, V34, P91, DOI 10.1258/002367700780578055; Hata A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022061; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hoyles RK, 2008, ARTHRITIS RHEUM-US, V58, P1175, DOI 10.1002/art.23379; Huang WT, 2015, EXP GERONTOL, V61, P62, DOI 10.1016/j.exger.2014.11.018; Ihn H, 2002, CURR OPIN RHEUMATOL, V14, P681, DOI 10.1097/00002281-200211000-00009; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Jurikova M, 2016, ACTA HISTOCHEM, V118, P544, DOI 10.1016/j.acthis.2016.05.002; KARSENTY G, 1991, BIOCHEM BIOPH RES CO, V177, P538, DOI 10.1016/0006-291X(91)92017-E; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Krieg T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2188; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leask A, 2008, J CELL COMMUN SIGNAL, V2, P49, DOI 10.1007/s12079-008-0029-z; Leng F, 2011, CURR EYE RES, V36, P301, DOI 10.3109/02713683.2010.547648; Liang CM, 2011, ACTA OPHTHALMOL, V89, pE505, DOI 10.1111/j.1755-3768.2011.02147.x; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin XC, 2009, INVEST OPHTH VIS SCI, V50, P3763, DOI 10.1167/iovs.08-2815; Maier AB, 2007, ANN NY ACAD SCI, V1100, P323, DOI 10.1196/annals.1395.035; Mawal-Dewan M, 2002, J BIOL CHEM, V277, P7857, DOI 10.1074/jbc.M104515200; McKenna E, 2012, CELL CYCLE, V11, P3132, DOI 10.4161/cc.21506; Mellone M, 2017, AGING-US, V9, P128, DOI 10.18632/aging.101127; Mietz H, 1996, GRAEF ARCH CLIN EXP, V234, P364, DOI 10.1007/BF00190712; Mohan R, 2002, J BIOL CHEM, V277, P2065, DOI 10.1074/jbc.M107611200; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Perkins TW, 2002, ARCH OPHTHALMOL-CHIC, V120, P941, DOI 10.1001/archopht.120.7.941; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Pinilla I, 1998, OPHTHALMOLOGICA, V212, P306, DOI 10.1159/000027313; Pratt WB, 1994, THE ANTICANCER DRUGS, P124; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Razeghinejad MR, 2012, SURV OPHTHALMOL, V57, P1, DOI 10.1016/j.survophthal.2011.07.005; SAPPINO AP, 1990, LAB INVEST, V63, P144; Sarrazy V, 2011, WOUND REPAIR REGEN, V19, pS10, DOI 10.1111/j.1524-475X.2011.00708.x; Sethi A, 2011, INVEST OPHTH VIS SCI, V52, P5240, DOI 10.1167/iovs.11-7287; Shi SR, 2008, AM J CLIN PATHOL, V129, P358, DOI 10.1309/7CXUYXT23E5AL8KQ; Shin DM, 2004, PLAST RECONSTR SURG, V113, P633, DOI 10.1097/01.PRS.0000101530.33096.5B; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7; Toussaint O, 2002, BIOCHEM PHARMACOL, V64, P1007, DOI 10.1016/S0006-2952(02)01170-X; Verhaegen PDHM, 2009, WOUND REPAIR REGEN, V17, P649, DOI 10.1111/j.1524-475X.2009.00533.x; Walton KL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00461; Wang L, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9365950; Wong TTL, 2003, INVEST OPHTH VIS SCI, V44, P1097, DOI 10.1167/iovs.02-0366; Yanai H, 2015, AGING-US, V7, P664, DOI 10.18632/aging.100807; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	74	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234706	10.1371/journal.pone.0234706	http://dx.doi.org/10.1371/journal.pone.0234706			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574191	Green Published, gold			2022-12-26	WOS:000544972400003
J	Oka, S; Sabry, AD; Horiuchi, AK; Cawley, KM; O'Very, SA; Zaitsev, MA; Shankar, TS; Byun, J; Mukai, R; Xu, XY; Torres, NS; Kumar, A; Yazawa, M; Ling, J; Taleb, I; Saijoh, Y; Drakos, SG; Sadoshima, J; Warren, JS				Oka, Shin-ichi; Sabry, Amira D.; Horiuchi, Amanda K.; Cawley, Keiko M.; O'Very, Sean A.; Zaitsev, Maria A.; Shankar, Thirupura S.; Byun, Jaemin; Mukai, Risa; Xu, Xiaoyong; Torres, Natalia S.; Kumar, Anil; Yazawa, Masayuki; Ling, Jing; Taleb, Iosif; Saijoh, Yukio; Drakos, Stavros G.; Sadoshima, Junichi; Warren, Junco S.			Perm1 regulates cardiac energetics as a downstream target of the histone methyltransferase Smyd1	PLOS ONE			English	Article							RECEPTOR-GAMMA COACTIVATOR-1-ALPHA; ACTIVATED PROTEIN-KINASE; MITOCHONDRIAL BIOGENESIS; OXIDATIVE CAPACITY; GENE-EXPRESSION; ERR-ALPHA; TRANSCRIPTION; HYPERTROPHY; FAMILY; STIMULATION	The transcriptional regulatory machinery in mitochondrial bioenergetics is complex and is still not completely understood. We previously demonstrated that the histone methyltransferase Smyd1 regulates mitochondrial energetics. Here, we identifiedPerm1(PPARGC-1 andESRR-inducedregulator,muscle specific1) as a downstream target of Smyd1 through RNA-seq. Chromatin immunoprecipitation assay showed that Smyd1 directly interacts with the promoter of Perm1 in the mouse heart, and this interaction was significantly reduced in mouse hearts failing due to pressure overload for 4 weeks, where Perm1 was downregulated (24.4 +/- 5.9% of sham, p<0.05). Similarly, the Perm1 protein level was significantly decreased in patients with advanced heart failure (55.2 +/- 13.1% of donors, p<0.05). Phenylephrine (PE)-induced hypertrophic stress in cardiomyocytes also led to downregulation of Perm1 (55.7 +/- 5.7% of control, p<0.05), and adenovirus-mediated overexpression of Perm1 rescued PE-induced downregulation of estrogen-related receptor alpha (ERR alpha), a key transcriptional regulator of mitochondrial energetics, and its target gene,Ndufv1(Complex I). Pathway enrichment analysis of cardiomyocytes in whichPerm1was knocked-down by siRNA (siPerm1), revealed that the most downregulated pathway was metabolism. Cell stress tests using the Seahorse XF analyzer showed that basal respiration and ATP production were significantly reduced in siPerm1 cardiomyocytes (40.7% and 23.6% of scrambled-siRNA, respectively, both p<0.05). Luciferase reporter gene assay further revealed that Perm1 dose-dependently increased the promoter activity of theERR alpha gene and known target of ERR alpha, Ndufv1 (Complex I). Overall, our study demonstrates that Perm1 is an essential regulator of cardiac energetics through ERR alpha, as part of the Smyd1 regulatory network.	[Oka, Shin-ichi; Byun, Jaemin; Mukai, Risa; Xu, Xiaoyong; Sadoshima, Junichi] Rutgers New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ USA; [Sabry, Amira D.; Horiuchi, Amanda K.; Cawley, Keiko M.; O'Very, Sean A.; Zaitsev, Maria A.; Shankar, Thirupura S.; Torres, Natalia S.; Ling, Jing; Taleb, Iosif; Drakos, Stavros G.; Warren, Junco S.] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA; [Xu, Xiaoyong] Lihuili Hosp, Dept Cardiol, Ningbo Med Ctr, Ningbo, Zhejiang, Peoples R China; [Kumar, Anil] Univ Utah, Metab Phenotyping Core Facil, Salt Lake City, UT USA; [Yazawa, Masayuki] Columbia Univ, Columbia Stem Cell Initiat Rehabil & Regenerat Me, New York, NY USA; [Yazawa, Masayuki] Columbia Univ, Pharmacol, New York, NY USA; [Taleb, Iosif; Drakos, Stavros G.; Warren, Junco S.] Univ Utah, Sch Med, Dept Internal Med, Div Cardiovasc Med, Salt Lake City, UT 84112 USA; [Saijoh, Yukio] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Warren, Junco S.] Kumamoto Univ, Inst Resource Dev & Anal, Kumamoto, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Columbia University; Columbia University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Kumamoto University	Warren, JS (corresponding author), Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA.; Warren, JS (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Div Cardiovasc Med, Salt Lake City, UT 84112 USA.; Warren, JS (corresponding author), Kumamoto Univ, Inst Resource Dev & Anal, Kumamoto, Japan.	junco.warren@utah.edu		Mukai, Risa/0000-0003-4669-4100; O'Very, Sean/0000-0003-2885-6962; Torres, Natalia/0000-0002-8192-2562	Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research [51005911]; University of Utah Research Initiative Seed Grant Program; Nora Eccles Treadwell Foundation; American Heart Association [17GRNT33440031]; American Heart Association Transformational Project Award [19TPA34850170]; New Jersey Health Foundation (NJHF) [PC56-16 PC80-17]; University of Utah Undergraduate Research Opportunity Program; American Heart Association Heart Failure Strategically Focused Research Network [16SFRN290200000]; NHLBI [R01 HL132067-01A1, R01 HL135121-01]; National Cancer Institute of the National Institutes of Health [P30CA042014]	Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research; University of Utah Research Initiative Seed Grant Program; Nora Eccles Treadwell Foundation; American Heart Association(American Heart Association); American Heart Association Transformational Project Award(American Heart Association); New Jersey Health Foundation (NJHF); University of Utah Undergraduate Research Opportunity Program; American Heart Association Heart Failure Strategically Focused Research Network; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research #51005911 (J.S. W.)(https://hria.org/tmf/geneen/), University of Utah Research Initiative Seed Grant Program (J.S. W)(https://research.utah.edu/funding/1U4U-targeted-research-seed-grant.php), the Nora Eccles Treadwell Foundation (J.S.W., S.D.)(https://www.tides.org/project/tenant/nora-eccles-treadwell-foundation/), American Heart Association Grant in Aid 17GRNT33440031 (S.O.)(URL n/a), American Heart Association Transformational Project Award 19TPA34850170 (S.O.) (https://professional.heart.org/professional/ResearchPrograms/UCM_ 497208_Transformational-Project-Award.jsp), New Jersey Health Foundation (NJHF) research grants PC56-16 PC80-17 (S.O.)(https://www.njhealthfoundation.org/research-grant-program), University of Utah Undergraduate Research Opportunity Program (A.H.)(https://our.utah.edu/urop/), American Heart Association Heart Failure Strategically Focused Research Network 16SFRN290200000 (S. D.)(https://professional.heart.org/professional/ResearchPrograms/StrategicallyFocusedResearchPrograms/UCM_ 454438_Strategically-Focused-ResearchNetworks.jsp), NHLBI R01 HL135121-01 (S.D.), NHLBI R01 HL132067-01A1 (S.D.)(https://www.nhlbi.nih.gov/grants-and-training/fundingopportunities-and-contacts), and the National Cancer Institute of the National Institutes of Health under Award Number P30CA042014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, AM J PHYSIOL-RENAL, V307, pF891; Berkholz J, 2015, EXP CELL RES, V336, P182, DOI 10.1016/j.yexcr.2015.06.019; Bhat S, 2019, CIRC-HEART FAIL, V12, DOI 10.1161/CIRCHEARTFAILURE.118.005529; Bugger H, 2010, CARDIOVASC RES, V85, P376, DOI 10.1093/cvr/cvp344; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cho Y, 2019, MOL METAB, V23, P88, DOI 10.1016/j.molmet.2019.02.009; Cho Y, 2016, FASEB J, V30, P674, DOI 10.1096/fj.15-276360; Cho Y, 2013, J BIOL CHEM, V288, P25207, DOI 10.1074/jbc.M113.489674; Diakos Nikolaos A, 2016, JACC Basic Transl Sci, V1, P432, DOI 10.1016/j.jacbts.2016.06.009; Diakos NA, 2014, J AM COLL CARDIOL, V64, P1602, DOI 10.1016/j.jacc.2014.05.073; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Franklin S, 2016, AM J PHYSIOL-HEART C, V311, pH1234, DOI 10.1152/ajpheart.00235.2016; Hu XL, 2011, HYPERTENSION, V58, P696, DOI 10.1161/HYPERTENSIONAHA.111.174128; Hur B, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3302-7; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Kam Y JN, 2017, NORMALIZATION AGILEN; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Karkkainen O, 2019, CARDIOVASC RES, V115, P107, DOI 10.1093/cvr/cvy155; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Liu D, 2005, J MOL ENDOCRINOL, V34, P473, DOI 10.1677/jme.1.01586; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Oka S, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00002; Oka SI, 2020, CARDIOVASC RES, V116, P1742, DOI 10.1093/cvr/cvz251; Oka S, 2011, CELL METAB, V14, P598, DOI 10.1016/j.cmet.2011.10.001; Pereira RO, 2014, FASEB J, V28, P3691, DOI 10.1096/fj.14-253823; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; SIMPSON P, 1985, CIRC RES, V56, P884, DOI 10.1161/01.RES.56.6.884; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Tracy CM, 2018, CURR OPIN PHYSIOL, V1, P140, DOI 10.1016/j.cophys.2017.10.001; Warren JS, 2018, P NATL ACAD SCI USA, V115, pE7871, DOI 10.1073/pnas.1800680115; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Zhao M, 1999, MOL CELL BIOL, V19, P21	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234913	10.1371/journal.pone.0234913	http://dx.doi.org/10.1371/journal.pone.0234913			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574189	Green Published, gold			2022-12-26	WOS:000544972400011
J	Murcia, H; Diaz, GJ				Murcia, Hansen; Diaz, Gonzalo J.			Dealing with aflatoxin B(1)dihydrodiol acute effects: Impact of aflatoxin B-1-aldehyde reductase enzyme activity in poultry species tolerant to AFB(1)toxic effects	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; ALDEHYDE REDUCTASE; RAT-LIVER; METABOLISM; KEGG; HYDROLYSIS; ETHOXYQUIN; DIALDEHYDE; MECHANISM; OXIDATION	Aflatoxin B(1)aldehyde reductase (AFAR) enzyme activity has been associated to a higher resistance to the aflatoxin B-1(AFB(1)) toxicity in ethoxyquin-fed rats. However, no studies about AFAR activity and its relationship with tolerance to AFB(1)have been conducted in poultry. To determine the role of AFAR in poultry tolerance, the hepaticin vitroenzymatic activity of AFAR was investigated in liver cytosol from four commercial poultry species (chicken, quail, turkey and duck). Specifically, the kinetic parameters V-max, K(m)and intrinsic clearance (CLint) were determined for AFB(1)dialdehyde reductase (AFB(1)-monoalcohol production) and AFB(1)monoalcohol reductase (AFB(1)-dialcohol production). In all cases, AFB(1)monoalcohol reductase activity saturated at the highest aflatoxin B(1)dialdehyde concentration tested (66.4 mu M), whereas AFB(1)dialdehyde reductase did not. Both activities were highly and significantly correlated and therefore are most likely catalyzed by the same AFAR enzyme. However, it appears that production of the AFB(1)monoalcohol is favored over the AFB(1)dialcohol. The production of alcohols from aflatoxin dialdehyde showed the highest enzymatic efficiency (highest CL(int)value) in chickens, a species resistant to AFB(1); however, it was also high in the turkey, a species with intermediate sensitivity; further, CL(int)values were lowest in another tolerant species (quail) and in the most sensitive poultry species (the duck). These results suggest that AFAR activity is related to resistance to the acute toxic effects of AFB(1)only in chickens and ducks. Genetic selection of ducks for high AFAR activity could be a means to control aflatoxin sensitivity in this poultry species.	[Murcia, Hansen; Diaz, Gonzalo J.] Univ Nacl Colombia, Fac Med Vet & Zootecnia, Lab Toxicol, Bogota, Colombia	Universidad Nacional de Colombia	Murcia, H (corresponding author), Univ Nacl Colombia, Fac Med Vet & Zootecnia, Lab Toxicol, Bogota, Colombia.	hwmurciag@unal.edu.co		Diaz, Gonzalo/0000-0002-9858-0845; Murcia, Hansen/0000-0003-0545-9307	Departamento Administrativo de Ciencia, Tecnologia e Innovacion, COLCIENCIAS; Departamento de Salud Animal, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional de Colombia, Bogota D.C., Colombia	Departamento Administrativo de Ciencia, Tecnologia e Innovacion, COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Departamento de Salud Animal, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional de Colombia, Bogota D.C., Colombia	HM, Convocatoria 647, Departamento Administrativo de Ciencia, Tecnologia e Innovacion, COLCIENCIAS, https://www.colciencias.gov.co/convocatorias/2014/doctorados-nacionales-2014, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GD, Departamento de Salud Animal, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional de Colombia, Bogota D.C., Colombia, http://medicinaveterinariaydezootecnia.bogota.unal.edu.co/la-facultad/departamentos/, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; BAERTSCHI SW, 1989, CHEM RES TOXICOL, V2, P114, DOI 10.1021/tx00008a008; Budavari S, 1996, THE MERK INDEX; Diaz GJ., 2020, TOXICOLOGIA MICOTOXI; Diaz GJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44515-6; EATON DL, 1994, ANNU REV PHARMACOL, V34, P135, DOI 10.1146/annurev.pa.34.040194.001031; Ellis EM, 2003, CARCINOGENESIS, V24, P727, DOI 10.1093/carcin/bgg016; ELLIS EM, 1993, P NATL ACAD SCI USA, V90, P10350, DOI 10.1073/pnas.90.21.10350; FRINGUELLI F, 1989, SYNTHETIC COMMUN, V19, P1939, DOI 10.1080/00397918908052586; Guengerich FP, 2002, CHEM RES TOXICOL, V15, P780, DOI 10.1021/tx010156s; Guengerich FP, 1998, MUTAT RES-FUND MOL M, V402, P121, DOI 10.1016/S0027-5107(97)00289-3; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P727, DOI 10.1021/tx010005p; Hetzel D. J. S., 1984, Singapore Veterinary Journal, V8, P6; Johnson WW, 1996, J AM CHEM SOC, V118, P8213, DOI 10.1021/ja960525k; JUDAH DJ, 1993, BIOCHEM J, V292, P13, DOI 10.1042/bj2920013; Kakkar T, 1999, DRUG METAB DISPOS, V27, P756; Kakkar T, 2000, J PHARMACOL EXP THER, V293, P861; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kelly VP, 2002, BIOCHEM J, V366, P847, DOI 10.1042/BJ20020342; Kelly VP, 2000, BIOCHEM J, V348, P389, DOI 10.1042/0264-6021:3480389; KENSLER TW, 1986, CANCER RES, V46, P3924; Klein PJ, 2002, COMP BIOCHEM PHYS C, V132, P193, DOI 10.1016/S1532-0456(02)00065-0; Marangoni AG, 2003, ENZYME KINETICS MODE; MCLELLAN LI, 1994, BIOCHEM J, V300, P117, DOI 10.1042/bj3000117; NEAL GE, 1981, TOXICOL APPL PHARM, V58, P431, DOI 10.1016/0041-008X(81)90095-8; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; REDINBAUGH MG, 1986, ANAL BIOCHEM, V153, P267, DOI 10.1016/0003-2697(86)90091-6; SAS Institute Inc, 2013, BAS SAS 9 4 PROC GUI; Seibert E, 2014, ENZYME KINETICS DRUG; SIU GM, 1982, LIPIDS, V17, P349, DOI 10.1007/BF02535193; SWENSON DH, 1973, BIOCHEM BIOPH RES CO, V53, P1260, DOI 10.1016/0006-291X(73)90601-3; Tulayakul P, 2005, TOXICON, V46, P204, DOI 10.1016/j.toxicon.2005.03.023	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235061	10.1371/journal.pone.0235061	http://dx.doi.org/10.1371/journal.pone.0235061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569334	gold, Green Published			2022-12-26	WOS:000543547900027
J	Simon, N; Guichard, N; Odou, P; Decaudin, B; Bonnabry, P; Fleury-Souverain, S				Simon, Nicolas; Guichard, Nicolas; Odou, Pascal; Decaudin, Bertrand; Bonnabry, Pascal; Fleury-Souverain, Sandrine			Efficiency of four solutions in removing 23 conventional antineoplastic drugs from contaminated surfaces	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; CLEANING SOLUTIONS; DECONTAMINATION EFFICACY; GUIDELINES; NURSES	Background Residual contamination by intravenous conventional antineoplastic drugs (ICAD) is still a daily issue in hospital facilities. This study aimed to compare the efficiency (Eff(Q)) of 4 different solutions to remove 23 widely used ICADs from surfaces. Method and findings A solution containing 23 ICADs (4 alkylating agents, 8 antimetabolites, 2 topo-I inhibitors, 6 topo-II inhibitors and 3 spindle poisons) was spread over 100 cm(2)stainless steel. After drying, decontamination was carried out using 10x10 cm wipes moistened with 300 mu L of one of the following solutions: 70% isopropanol (S1); ethanol-hydrogen peroxide 91.6-50.0 mg/g (S2); 10(-2)M sodium dodecyl sulphate/isopropanol 80/20 (S3) or 0.5% sodium hypochlorite (S4). Six tests were performed for each decontamination solution. Two modalities were tested: a single wipe motion from top to bottom or vigorous wiping (n = 6 for each modality). Residual contamination was measured with a validated liquid chromatography with tandem mass spectrometry detection method. Solution efficiency (in %) was computed as follows: Eff(Q)= 1-(quantity after decontamination/quantity before decontamination), as median (min-max) for the 23 ICADs. The overall decontamination efficiency (Eff(Q)) of the 4 solutions was compared by a Kruskall-Wallis test. Decontamination modalities were compared for each solution and per ICAD with a Mann-Whitney test (p<0.05). Eff(Q)were significantly different from one solution to the next for single wipe motion decontamination: 79.9% (69.3-100), 86.5% (13.0-100), 85.4% (56.5-100) and 100% (52.9-100) for S1, S2, S3 and S4 (p<0.0001), respectively. Differences were also significant for vigorous decontamination: Eff(Q)of 84.3% (66.0-100), 92.3% (68.7-100), 99.6% (84.8-100) and 100% (82.9-100) for S1, S2, S3 and S4, respectively (p<0.0001). Generally, vigorous decontamination increased Eff(Q)for all tested solutions and more significantly for the surfactant. Conclusion Decontamination efficiency depended on the solution used but also on the application modality. An SDS admixture seems to be a good alternative to sodium hypochlorite, notably after vigorous chemical decontamination with no hazard either to materials or workers.	[Simon, Nicolas; Guichard, Nicolas; Bonnabry, Pascal; Fleury-Souverain, Sandrine] Geneva Univ Hosp, Pharm, Geneva, Switzerland; [Simon, Nicolas; Guichard, Nicolas; Bonnabry, Pascal; Fleury-Souverain, Sandrine] Univ Geneva, Inst Pharmaceut Sci Western Switzerland, Geneva, Switzerland; [Simon, Nicolas; Odou, Pascal; Decaudin, Bertrand] Univ Lille, CHU Lille, ULR 7365, GRITA, Lille, France	University of Geneva; University of Geneva; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Simon, N (corresponding author), Geneva Univ Hosp, Pharm, Geneva, Switzerland.; Simon, N (corresponding author), Univ Geneva, Inst Pharmaceut Sci Western Switzerland, Geneva, Switzerland.; Simon, N (corresponding author), Univ Lille, CHU Lille, ULR 7365, GRITA, Lille, France.	nicolas.simon@univ-lille.fr	Decaudin, Bertrand/E-5828-2010; SIMON, Nicolas/G-4328-2016; GUICHARD, Nicolas/K-4504-2016	Decaudin, Bertrand/0000-0001-8267-5594; SIMON, Nicolas/0000-0001-5257-440X; GUICHARD, Nicolas/0000-0002-6228-2379	French Society of Clinical Pharmacy; Fondation pour la Recherche en Pharmacie Hospitaliere; AstraZeneca laboratories	French Society of Clinical Pharmacy; Fondation pour la Recherche en Pharmacie Hospitaliere; AstraZeneca laboratories(AstraZeneca)	NS received a grant from French Society of Clinical Pharmacy, by la Fondation pour la Recherche en Pharmacie Hospitaliere, AstraZeneca laboratories for his post-doctoral position in the University Hospital of Geneva. The specific roles of this author is articulated in the 'author contributions' section. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade A, 2017, CAN J HOSP PHARM, V70, P407; Alexander K, 2018, VET COMP ONCOL, V16, P385, DOI 10.1111/vco.12390; American Society of Health-System Pharmacists, 2006, AM J HEALTH-SYST PH, V63, P1172, DOI DOI 10.2146/AJHP050529; Anastasi M, 2015, ANN OCCUP HYG, V59, P895, DOI 10.1093/annhyg/mev031; [Anonymous], 2007, J ONCOL PHARM PRACT, V13, P1; Berthod F, 2020, J ONCOL PHARM PRACT, V26, P853, DOI 10.1177/1078155219875504; Bohlandt A, 2017, INT J HYG ENVIR HEAL, V220, P757, DOI 10.1016/j.ijheh.2017.03.005; Bohlandt Antje, 2015, J Occup Environ Hyg, V12, P384, DOI 10.1080/15459624.2015.1009985; Boiano JM, 2015, J OCCUP ENVIRON HYG, V12, P588, DOI 10.1080/15459624.2015.1029610; Centers for Disease Control and Prevention, NAT I OCC SAF HLTH H; Connor TH, 2014, J OCCUP ENVIRON MED, V56, P901, DOI 10.1097/JOM.0000000000000249; European parliament, PREV OCC EXP CYT OTH; European Pharmacopeia, 2019, MON PAR; FALCK K, 1979, LANCET, V1, P1250; GERPAC-Europharmat Workgroup, 2007, PREP ADM DRUGS RISK; Guichard N, 2019, EUR J HOSP PHARM; Guichard N, 2019, J PHARMACEUT BIOMED, V172, P139, DOI 10.1016/j.jpba.2019.04.042; Guichard N, 2019, J PHARMACEUT BIOMED, V164, P395, DOI 10.1016/j.jpba.2018.11.014; HARRISON BR, 1981, AM J HOSP PHARM, V38, P1686, DOI 10.1093/ajhp/38.11.1686; Hedmer M, 2008, INT ARCH OCC ENV HEA, V81, P899, DOI 10.1007/s00420-007-0284-y; Hon CY, 2014, J ONCOL PHARM PRACT, V20, P210, DOI 10.1177/1078155213497070; Lamerie TQ, 2013, ANN OCCUP HYG, V57, P456, DOI 10.1093/annhyg/mes087; Lee Su-Gil, 2009, Journal of Pharmacy Practice and Research, V39, P181; Le LMM, 2013, INT ARCH OCC ENV HEA, V86, P333, DOI 10.1007/s00420-012-0769-1; Martin Susan, 2003, Oncol Nurs Forum, V30, P575, DOI 10.1188/03.ONF.575-581; McDiarmid M, 1998, J OCCUP MED, V30, P984; Occupational Safety and Health Administration, 1996, AM J HEALTH-SYST PH, V53, P1669, DOI DOI 10.1093/AJHP/53.14.1669; Power Luci A, 2018, Am J Health Syst Pharm, V75, P1996, DOI 10.2146/ajhp180564; Sessink Paul J M, 2013, Hosp Pharm, V48, P204, DOI 10.1310/hpj4803-204; SESSINK PJM, 1994, INT ARCH OCC ENV HEA, V65, P401, DOI 10.1007/BF00383251; Simon N, 2020, ANN WORK EXPOS HEAL, V64, P114, DOI 10.1093/annweh/wxz093; Simon N, 2019, J ONCOL PHARM PRACT, V25, P929, DOI 10.1177/1078155219831427; Simon N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159052; Touzin K, 2010, ANN OCCUP HYG, V54, P351, DOI 10.1093/annhyg/meq004; United States Pharmacopeia, USP GEN HAZ DRUGS HA; VALANIS BG, 1993, CANCER NURS, V16, P288; VALANIS BG, 1993, AM J HOSP PHARM, V50, P455, DOI 10.1093/ajhp/50.3.455; Vasseur M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201335; Villarini M, 2016, MUTAT RES-REV MUTAT, V770, P35, DOI 10.1016/j.mrrev.2016.05.001; ZELLMER WA, 1981, AM J HOSP PHARM, V38, P1679, DOI 10.1093/ajhp/38.11.1679; ZIMMERMAN PF, 1981, AM J HOSP PHARM, V38, P1693, DOI 10.1093/ajhp/38.11.1693; 1986, AM J HOSP PHARM, V43, P1193	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235131	10.1371/journal.pone.0235131	http://dx.doi.org/10.1371/journal.pone.0235131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569333	gold, Green Published			2022-12-26	WOS:000543547900025
J	Lynch, EE; Meier, HCS				Lynch, Emily E.; Meier, Helen C. S.			The intersectional effect of poverty, home ownership, and racial/ethnic composition on mean childhood blood lead levels in Milwaukee County neighborhoods	PLOS ONE			English	Article							GEOGRAPHIC ANALYSIS; HEALTH DISPARITIES; CHILDREN BORN; BIRTH-WEIGHT; CONSEQUENCES; DIVERSITY; EXPOSURE; SEPARATE	Environmental conditions that contribute to childhood lead exposure are spatially patterned. Socioeconomic and racial inequities in childhood lead exposure have been well documented, however childhood lead exposure in Milwaukee is understudied. As a segregated rustbelt metropolitan area with childhood lead exposure concerns, Milwaukee is uniquely positioned to evaluate the synergistic effects of racial and economic drivers of childhood lead exposure. Using surveillance data from the Wisconsin Department of Health Services, Division of Public Health and the US Census Bureau, this cross-sectional study determined the intersectional effect of poverty, home ownership, and racial/ethnic composition on childhood lead exposure in Milwaukee County neighborhoods using linear regression adjusting for average census tract housing age and number of children. The final analytical sample consisted of 48,393 individual childhood blood lead levels aggregated to 215 Milwaukee County census tracts. Census tracts with mean childhood blood lead levels greater than or equal to 5 mu g/dL were predominantly low home ownership, high poverty, and majority non-White census tracts. The effects of low home ownership, high poverty, and majority non-White census tracts were synergistic, producing 1.78 (95% CI: 1.44, 2.11) mu g/dL higher mean childhood blood lead level than high home ownership, low poverty, and majority White census tracts (referent). This research reveals that social determinants at the neighborhood level co-occur and interact to produce inequities in childhood lead exposure. Lead prevention efforts should align with equity-focused housing and economic policies that target primary prevention in neighborhoods disproportionately burdened by childhood lead exposure.	[Lynch, Emily E.; Meier, Helen C. S.] Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Meier, HCS (corresponding author), Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA.	meierh2@uwm.edu	Meier, Helen/AAD-3381-2020	Meier, Helen/0000-0003-4400-0216	Shaw Scientist Award; Greater Milwaukee Foundation	Shaw Scientist Award; Greater Milwaukee Foundation	This work was supported by the Shaw Scientist Award to HM from the Greater Milwaukee Foundation https://www.greatermilwaukeefoundation.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Garcia D, 2008, HEALTH AFFAIR, V27, P321, DOI 10.1377/hlthaff.27.2.321; Acevedo-Garcia D, 2008, AM J EPIDEMIOL, V168, P1255, DOI 10.1093/aje/kwn290; Advisory Committee on Childhood Lead Poisoning Prevention of the Centers for Disease Control and Prevention, 2012, LOW LEV LEAD EXP HAR; [Anonymous], 2016, PEDIATRICS, V138; Ayoob M, 2008, EVALUATION CITY ROCH; Brink LA, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/8791686; Cantor AG, 2019, SCREENING ELEVATED B; Centers for Disease Control and Prevention, 2009, 4 CDCP; Christensen K, 2017, P0120216 WISC DEP HL; City of Milwaukee Health Department, 2007, CHILDH LEAD POIS DAS; City of Milwaukee Health Department, 2018, CHILDH LEAD POIS PRE; Farrell CR, 2011, SOC SCI RES, V40, P1108, DOI 10.1016/j.ssresearch.2011.04.003; Greene SK, 2015, AM J PUBLIC HEALTH, V105, pE27, DOI 10.2105/AJPH.2015.302741; Haley VB, 2004, ENVIRON HEALTH PERSP, V112, P1577, DOI 10.1289/ehp.7053; Handler P, 2012, INT J ENV RES PUB HE, V9, P3934, DOI 10.3390/ijerph9113934; Jacobs DE, 2002, ENVIRON HEALTH PERSP, V110, pA599, DOI 10.1289/ehp.021100599; Korfmacher KS, 2012, ENVIRON HEALTH PERSP, V120, P309, DOI 10.1289/ehp.1103606; Krieger N, 2006, J URBAN HEALTH, V83, P355, DOI 10.1007/s11524-006-9040-y; Krieger N, 2003, J EPIDEMIOL COMMUN H, V57, P186, DOI 10.1136/jech.57.3.186; Langhoff KK, 2001, LANDLORDS NEED HELP, P84; Lanphear BP, 1998, PEDIATRICS, V101, P264, DOI 10.1542/peds.101.2.264; Lanphear BP, 2005, PUBLIC HEALTH REP, V120, P305, DOI 10.1177/003335490512000315; Miranda ML, 2011, ENVIRON HEALTH PERSP, V119, P1513, DOI 10.1289/ehp.1003231; Moody H, 2016, SOCIOL RACE ETHNIC, V2, P200, DOI 10.1177/2332649215608873; Moody HA, 2016, J URBAN HEALTH, V93, P820, DOI 10.1007/s11524-016-0071-8; Muller C, 2018, ANNU REV SOCIOL, V44, P263, DOI 10.1146/annurev-soc-073117-041222; National Toxicology Program, 2012, NTP MON HLTH EFF LOW; NORC at the University of Chicago, 2012, WISC PROM PRACT COOR; Ohri-Vachaspati P, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16132354; Osypuk TL, 2009, URBAN AFF REV, V45, P25, DOI 10.1177/1078087408331119; Oyana TJ, 2007, ARCH ENVIRON OCCUP H, V62, P93, DOI 10.3200/AEOH.62.2.93-104; Oyana TJ, 2010, PROF GEOGR, V62, P46, DOI 10.1080/00330120903375894; President's Task Force on Environmental Health Risks and Safety Risks to Children, 2016, KEY FED PROGR RED CH; Stults B, 2011, PERSISTENCE SEGREGAT; Taggert E, 2019, J ENVIRON HEALTH, V82, P18; Thornton, 2018, POVERTY INCOMES RACE; Toprani A, 2013, SELECTING APPL STAND; U. S. Census Bureau, 2012 2016 AM COMM SU; U.S. Census Bureau, DEC CENS 2010 TABL P; United States Environmental Protection Agency, 2018, INT SCI ASS ISA LEAD; US Census Bureau, 2014, CENSUS BUREAU REPORT; Vaidyanathan A, 2009, J PEDIATR-US, V154, P409, DOI 10.1016/j.jpeds.2008.09.027; Vang ZM, 2013, SOC SCI MED, V97, P56, DOI 10.1016/j.socscimed.2013.07.013; Wisconsin Department of Health Services, 2019, WISC LOC HLTH DEP MI; Wisconsin Department of Health Services, 2010, P44535B WISC DEP HLT	45	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234995	10.1371/journal.pone.0234995	http://dx.doi.org/10.1371/journal.pone.0234995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559243	Green Published, gold			2022-12-26	WOS:000543261600005
J	Jacobs-Sera, D; Abad, LA; Alvey, RM; Anders, KR; Aull, HG; Bhalla, SS; Blumer, LS; Bollivar, DW; Bonilla, JA; Butela, KA; Coomans, RJ; Cresawn, SG; D'Elia, T; Diaz, A; Divens, AM; Edgington, NP; Frederick, GD; Gainey, MD; Garlena, RA; Grant, KW; Gurney, SMR; Hendrickson, HL; Hughes, LE; Kenna, MA; Klyczek, KK; Kotturi, H; Mavrich, TN; McKinney, AL; Merkhofer, EC; Parker, JM; Molloy, SD; Monti, DL; Pape-Zambito, DA; Pollenz, RS; Pope, WH; Reyna, NS; Rinehart, CA; Russell, DA; Shaffer, CD; Sivanathan, V; Stoner, TH; Stukey, J; Sunnen, CN; Tolsma, SS; Tsourkas, PK; Wallen, JR; Ware, VC; Warner, MH; Washington, JM; Westover, KM; Whitefleet-Smith, JL; Wiersma-Koch, HI; Williams, DC; Zack, KM; Hatfull, GF				Jacobs-Sera, Deborah; Abad, Lawrence A.; Alvey, Richard M.; Anders, Kirk R.; Aull, Haley G.; Bhalla, Suparna S.; Blumer, Lawrence S.; Bollivar, David W.; Bonilla, J. Alfred; Butela, Kristen A.; Coomans, Roy J.; Cresawn, Steven G.; D'Elia, Tom; Diaz, Arturo; Divens, Ashley M.; Edgington, Nicholas P.; Frederick, Gregory D.; Gainey, Maria D.; Garlena, Rebecca A.; Grant, Kenneth W.; Gurney, Susan M. R.; Hendrickson, Heather L.; Hughes, Lee E.; Kenna, Margaret A.; Klyczek, Karen K.; Kotturi, Hari; Mavrich, Travis N.; McKinney, Angela L.; Merkhofer, Evan C.; Parker, Jordan Moberg; Molloy, Sally D.; Monti, Denise L.; Pape-Zambito, Dana A.; Pollenz, Richard S.; Pope, Welkin H.; Reyna, Nathan S.; Rinehart, Claire A.; Russell, Daniel A.; Shaffer, Christopher D.; Sivanathan, Viknesh; Stoner, Ty H.; Stukey, Joseph; Sunnen, C. Nicole; Tolsma, Sara S.; Tsourkas, Philippos K.; Wallen, Jamie R.; Ware, Vassie C.; Warner, Marcie H.; Washington, Jacqueline M.; Westover, Kristi M.; Whitefleet-Smith, JoAnn L.; Wiersma-Koch, Helen, I; Williams, Daniel C.; Zack, Kira M.; Hatfull, Graham F.			Genomic diversity of bacteriophages infecting Microbacterium spp	PLOS ONE			English	Article							TRANSFER-RNA GENES; SP-NOV.; PERITONEAL-DIALYSIS; 1ST REPORT; BACTERIUM; SEQUENCE; PROGRAM; AMMONIAPHILUM; SYSTEM; PHAGE	The bacteriophage population is vast, dynamic, old, and genetically diverse. The genomics of phages that infect bacterial hosts in the phylum Actinobacteria show them to not only be diverse but also pervasively mosaic, and replete with genes of unknown function. To further explore this broad group of bacteriophages, we describe here the isolation and genomic characterization of 116 phages that infectMicrobacteriumspp. Most of the phages are lytic, and can be grouped into twelve clusters according to their overall relatedness; seven of the phages are singletons with no close relatives. Genome sizes vary from 17.3 kbp to 97.7 kbp, and their G+C% content ranges from 51.4% to 71.4%, compared to similar to 67% for theirMicrobacteriumhosts. The phages were isolated on five differentMicrobacteriumspecies, but typically do not efficiently infect strains beyond the one on which they were isolated. TheseMicrobacteriumphages contain many novel features, including very large viral genes (13.5 kbp) and unusual fusions of structural proteins, including a fusion of VIP2 toxin and a MuF-like protein into a single gene. These phages and their genetic components such as integration systems, recombineering tools, and phage-mediated delivery systems, will be useful resources for advancingMicrobacteriumgenetics.	[Jacobs-Sera, Deborah; Abad, Lawrence A.; Aull, Haley G.; Butela, Kristen A.; Divens, Ashley M.; Garlena, Rebecca A.; Mavrich, Travis N.; Pope, Welkin H.; Russell, Daniel A.; Stoner, Ty H.; Warner, Marcie H.; Zack, Kira M.; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Alvey, Richard M.; Bollivar, David W.] Illinois Wesleyan Univ, Dept Biol, Bloomington, IL 61701 USA; [Anders, Kirk R.] Gonzaga Univ, Dept Biol, Spokane, WA 99258 USA; [Bhalla, Suparna S.; Merkhofer, Evan C.] Mt St Mary Coll, Dept Nat Sci, Newburgh, NY USA; [Blumer, Lawrence S.] Morehouse Coll, Dept Biol, Atlanta, GA USA; [Bonilla, J. Alfred; Klyczek, Karen K.] Univ Wisconsin, Dept Biol, River Falls, WI 54022 USA; [Coomans, Roy J.] North Carolina A&T State Univ, Dept Biol, Greensboro, NC USA; [Cresawn, Steven G.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA; [D'Elia, Tom; Wiersma-Koch, Helen, I] Indian River State Coll, Dept Biol Sci, Ft Pierce, FL USA; [Diaz, Arturo] La Sierra Univ, Dept Biol, Riverside, CA USA; [Edgington, Nicholas P.] Southern Connecticut State Univ, Dept Biol, New Haven, CT USA; [Frederick, Gregory D.] LeTourneau Univ, Dept Biol & Kinesiol, Longview, TX USA; [Gainey, Maria D.; Wallen, Jamie R.] Western Carolina Univ, Dept Chem & Phys, Cullowhee, NC 28723 USA; [Grant, Kenneth W.] Wake Forest Baptist Hlth, Dept Pathol, Winston Salem, NC USA; [Gurney, Susan M. R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Hendrickson, Heather L.] Massey Univ, Sch Nat & Computat Sci, Auckland, New Zealand; [Hughes, Lee E.] Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA; [Kenna, Margaret A.; Ware, Vassie C.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Kotturi, Hari] Univ Cent Oklahoma, Dept Biol, Edmond, OK USA; [McKinney, Angela L.] Nebraska Wesleyan Univ, Dept Biol, Lincoln, NE USA; [Parker, Jordan Moberg] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Molloy, Sally D.] Univ Maine, Dept Mol & Biomed Sci, Orono, ME USA; [Monti, Denise L.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Pape-Zambito, Dana A.] Univ Sci Philadelphia, Dept Biol Sci, Philadelphia, PA USA; [Pollenz, Richard S.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Reyna, Nathan S.] Ouachita Baptist Univ, Dept Biol, Arkadelphia, AR USA; [Rinehart, Claire A.] Western Kentucky Univ, Dept Biol, Bowling Green, KY 42101 USA; [Shaffer, Christopher D.] Univ Washington St Louis, Dept Biol, St Louis, MO USA; [Sivanathan, Viknesh] Howard Hughes Med Inst, Chevy Chase, MD USA; [Stukey, Joseph] Hope Coll, Biol Dept, Holland, MI 49423 USA; [Sunnen, C. Nicole] Univ Sci, Dept Biol Sci, Philadelphia, PA USA; [Tolsma, Sara S.] Northwestern Coll, Biol Dept, Orange City, IA USA; [Tsourkas, Philippos K.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Washington, Jacqueline M.] Nyack Coll, Dept Nat Sci, Nyack, NY USA; [Westover, Kristi M.] Winthrop Univ, Dept Biol, Rock Hill, SC 29733 USA; [Whitefleet-Smith, JoAnn L.] Worcester Polytech Inst, Dept Biol & Biotechnol, Worcester, MA 01609 USA; [Williams, Daniel C.] Coastal Carolina Univ, Dept Biol, Conway, SC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Illinois Wesleyan University; Gonzaga University; Morehouse College; University of Wisconsin System; University of North Carolina; North Carolina A&T State University; James Madison University; Connecticut State University System; Southern Connecticut State University; University of North Carolina; Western Carolina University; Wake Forest University; Wake Forest Baptist Medical Center; Drexel University; Massey University; University of North Texas System; University of North Texas Denton; Lehigh University; University of Central Oklahoma; University of California System; University of California Los Angeles; University of Maine System; University of Maine Orono; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of South Florida; Western Kentucky University; Howard Hughes Medical Institute; Hope College; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Worcester Polytechnic Institute; Coastal Carolina University	Hatfull, GF (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	gfh@pitt.edu		Bollivar, David/0000-0002-9378-3408; Moberg Parker, Jordan/0000-0003-1445-9587; Reyna, Nathan/0000-0003-3430-0282; Butela, Kristen/0000-0003-1463-5288; Divens, Ashley/0000-0003-4793-4129	National Institutes of Health [GM116884, GM131729]; Howard Hughes Medical Institute [54308198, GT12053]; Provost Internal Support grant from Western Carolina University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Provost Internal Support grant from Western Carolina University	This work was supported by grants from the National Institutes of Health (GM116884 and GM131729; https://www.nih.gov/) and Howard Hughes Medical Institute (54308198 and GT12053; https://www.hhmi.org) to GFH. Work performed by M.D.G and J.R.W was supported by a Provost Internal Support grant from Western Carolina University. HHMI supported the SEA-PHAGES program that generated the data and analyses (data collection and analysis), and supported a workshop where genomic data was analyzed for manuscript preparation.	Akimkina T, 2007, RES MICROBIOL, V158, P582, DOI 10.1016/j.resmic.2007.06.005; Ali N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57224-x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amano J, 2019, J INFECT CHEMOTHER, V25, P806, DOI 10.1016/j.jiac.2019.03.013; [Anonymous], 2004, HUMAN RIGHTS WATCH, V16, P11; [Anonymous], 2005, NUCLEIC ACIDS RES, V33, pe80; [Anonymous], 2017, J PEDIAT REHAB MED, V10, ps1; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Behrendt U, 2001, INT J SYST EVOL MICR, V51, P1267, DOI 10.1099/00207713-51-4-1267; Borodovsky Mark, 2011, Curr Protoc Bioinformatics, VChapter 4, DOI [10.1002/0471250953.bi0406s35, 10.1002/0471250953.bi0405s35]; Cheng L, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1159-y; Cresawn SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118725; Cresawn SG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-395; Davydova EK, 2003, METHOD ENZYMOL, V370, P83; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hanauer DI, 2017, P NATL ACAD SCI USA, V114, P13531, DOI 10.1073/pnas.1718188115; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hatfull GF, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.GPP3-0026-2018; Hatfull GF, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0032-2013; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jacobs-Sera D, 2012, VIROLOGY, V434, P187, DOI 10.1016/j.virol.2012.09.026; Kageyama A, 2007, INT J SYST EVOL MICR, V57, P2355, DOI 10.1099/ijs.0.65038-0; Kageyama A, 2007, J GEN APPL MICROBIOL, V53, P1, DOI 10.2323/jgam.53.1; Kageyama A, 2006, INT J SYST EVOL MICR, V56, P2113, DOI 10.1099/ijs.0.64236-0; Klyczek KK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180517; Knowles B, 2016, NATURE, V531, P466, DOI 10.1038/nature17193; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Laffineur K, 2003, J CLIN MICROBIOL, V41, P2242, DOI 10.1128/JCM.41.5.2242-2246.2003; Lam PW, 2018, PERITON DIALYSIS INT, V38, P9, DOI 10.3747/pdi.2017.00121; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lassmann T, 2020, BIOINFORMATICS, V36, P1928, DOI 10.1093/bioinformatics/btz795; Liu J, 2005, INT J SYST EVOL MICR, V55, P661, DOI 10.1099/ijs.0.63265-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marinelli LJ, 2012, MBIO, V3, DOI 10.1128/mBio.00279-12; Mavrich TN, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.112; MCLEAN RA, 1953, J BACTERIOL, V65, P428, DOI 10.1128/JB.65.4.428-433.1953; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Petrovski S, 2012, J VIROL, V86, P358, DOI 10.1128/JVI.05460-11; Pope WH, 2015, ELIFE, V4, DOI 10.7554/eLife.06416; Pope WH, 2018, METHODS MOL BIOL, V1681, P217, DOI 10.1007/978-1-4939-7343-9_16; Pope WH, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.01143-16; Pope WH, 2017, MBIO, V8, DOI 10.1128/mBio.01069-17; Pope WH, 2014, MBIO, V5, DOI 10.1128/mBio.02145-14; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026750; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Russell DA, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.01467-18; Russell DA, 2018, METHODS MOL BIOL, V1681, P109, DOI 10.1007/978-1-4939-7343-9_9; Russell DA, 2017, BIOINFORMATICS, V33, P784, DOI 10.1093/bioinformatics/btw711; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkis GJ, 1998, METH MOL B, V101, P145, DOI 10.1385/0-89603-471-2:145; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma P, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-97; Sharma P, 2012, J BACTERIOL, V194, P4785, DOI 10.1128/JB.01088-12; STRIEBEL HM, 1990, GENE, V91, P95, DOI 10.1016/0378-1119(90)90167-P; Striebel HM, 1996, GENE, V172, P41, DOI 10.1016/0378-1119(96)00189-8; Sun WH, 2019, J HAZARD MATER, V370, P225, DOI 10.1016/j.jhazmat.2018.02.003; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tanaka N, 2011, J BIOL CHEM, V286, P7727, DOI 10.1074/jbc.C111.219022; The Lancet Haematology, 2018, LANCET HAEMATOL, V5, pe127; Yusuf E, 2016, J MICROBIOL IMMUNOL, V49, P464, DOI 10.1016/j.jmii.2014.03.008; Zakhia F, 2006, MICROB ECOL, V51, P375, DOI 10.1007/s00248-006-9025-0; Zamani I, 2014, ARCH VIROL, V159, P2537, DOI 10.1007/s00705-014-2092-5; Zlamala C, 2002, INT J SYST EVOL MICR, V52, P1229, DOI [10.1099/ijs.0.02013-0, 10.1099/00207713-52-4-1229]	68	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234636	10.1371/journal.pone.0234636	http://dx.doi.org/10.1371/journal.pone.0234636			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555720	gold, Green Published			2022-12-26	WOS:000543273200010
J	Cheng, YS; Lin, SH; Chang, CJ				Cheng, Yuan-Shao; Lin, Shih-Huan; Chang, Chia-Jen			Combined Endoscope assisted Procedures (CEaP) as a complete treatment for neovascular glaucoma	PLOS ONE			English	Article							AHMED GLAUCOMA; CILIARY BODY; CYCLOPHOTOCOAGULATION; PHOTOCOAGULATION; MANAGEMENT; IMPLANT; VALVE	Purpose To investigate the effect and complications of Combined Endoscope assisted Procedures (CEaP): endoscopic cyclophotocoagulation and pars plana ablation (ECP-plus), along with endoscopic panretinal photocoagulation (PRP). Patients and methods The study design is a retrospective and noncomparative interventional case series from a tertiary referral center in Taiwan. Patients experiencing vessel growth at the iris and anterior chamber angle, along with an IOP > 21 mmHg were included. Results Twenty-five eyes from 23 patients were included over a 24-month period. After the procedures, all of them had a lower IOP value than their preoperative value. The mean IOP was 38.2 +/- 7.1 mm Hg preoperatively, and 10.2 +/- 4.7 mmHg (1 day), 13.8 +/- 4.6 mmHg (1 week), 15.0 +/- 5.3 mmHg (2 weeks), 17.4 +/- 4.7 mmHg (1 month), 16.6 +/- 4.1 mmHg (3 months), 16.0 +/- 5.0 mmHg (6 months), and 15.7 +/- 5.5 mmHg (12 months) postoperatively. At the 6th and 12th months, the IOP stabilized rate was 84% and 75%, respectively. Complications in the initial postoperative period (< 3 months) included uveitis (24%), and hyphema (16%), which were both resolved in the early postoperative period. Complications beyond 6 months included hypotony and phthisis bulbi in two patients (8%) in our study. There was no subject who suffered from retinal detachment, endophthalmitis or any other severe complications. Conclusions The results of this study show that CEaP offers positive results in IOP lowering and NV regression. Additionally, CEaP is a complete treatment for NVG in controlling IOP and NV growth. The IOP lowering effects can be sustained upon completion of the treatment.	[Cheng, Yuan-Shao; Chang, Chia-Jen] Taichung Vet Gen Hosp, Dept Ophthalmol, Taichung, Taiwan; [Lin, Shih-Huan] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung, Taiwan; [Chang, Chia-Jen] Cent Taiwan Univ Sci & Technol, Dept Optometry, Taichung, Taiwan	Taichung Veterans General Hospital; National Chung Hsing University; Central Taiwan University Science & Technology	Chang, CJ (corresponding author), Taichung Vet Gen Hosp, Dept Ophthalmol, Taichung, Taiwan.; Chang, CJ (corresponding author), Cent Taiwan Univ Sci & Technol, Dept Optometry, Taichung, Taiwan.	capmchangcj@gmail.com		CHENG, YUANSHAO/0000-0002-0717-9678				Barkana Y, 2002, AM J OPHTHALMOL, V133, P405, DOI 10.1016/S0002-9394(01)01359-9; BROWN GC, 1984, OPHTHALMOLOGY, V91, P315; CAPRIOLI J, 1985, OPHTHALMOLOGY, V92, P947; Chen J, 1997, AM J OPHTHALMOL, V124, P787, DOI 10.1016/S0002-9394(14)71696-4; Chen S, 2015, TRANSL STROKE RES, V6, P4, DOI 10.1007/s12975-014-0384-4; Cohen A, 2017, SURV OPHTHALMOL, V62, P357, DOI 10.1016/j.survophthal.2016.09.004; Feinstein MA, 2019, CLIN EXP OPHTHALMOL, V47, P766, DOI 10.1111/ceo.13501; Francis BA, 2011, J GLAUCOMA, V20, P523, DOI 10.1097/IJG.0b013e3181f46337; HAWKINS TA, 1993, ARCH OPHTHALMOL-CHIC, V111, P488, DOI 10.1001/archopht.1993.01090040080035; Hayreh SS, 2012, RETINA-J RET VIT DIS, V32, P1553, DOI 10.1097/IAE.0b013e318246912c; Ho H, 2019, J GLAUCOMA, V28, P563, DOI 10.1097/IJG.0000000000001245; Kokubun T, 2018, OCUL IMMUNOL INFLAMM, V26, P1177, DOI 10.1080/09273948.2017.1327605; Landrine H, 2016, TOB CONTROL, V25, pe142; Lima FE, 2004, J GLAUCOMA, V13, P233, DOI 10.1097/00061198-200406000-00011; Lin S, 2002, BRIT J OPHTHALMOL, V86, P1434, DOI 10.1136/bjo.86.12.1434; Marra KV, 2015, RETINA-J RET VIT DIS, V35, P1072, DOI 10.1097/IAE.0000000000000449; Murthy GJ, 2009, INDIAN J OPHTHALMOL, V57, P127, DOI 10.4103/0301-4738.45502; Nakatake S, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-55; Ohira S, 2015, INVEST OPHTH VIS SCI, V56, P3541, DOI 10.1167/iovs.14-15918; Olmos LC, 2016, EYE, V30, P463, DOI 10.1038/eye.2015.259; Olmos Lisa C, 2011, Int Ophthalmol Clin, V51, P27, DOI 10.1097/IIO.0b013e31821e5960; Rodrigues Gustavo B, 2016, Int J Retina Vitreous, V2, P26; Shen CC, 2011, CLIN OPHTHALMOL, V5, P281, DOI 10.2147/OPTH.S16976; SooHoo JR, 2014, CURR OPIN OPHTHALMOL, V25, P127, DOI 10.1097/ICU.0000000000000036; Sun YY, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0327-9; Takihara Y, 2009, AM J OPHTHALMOL, V147, P912, DOI 10.1016/j.ajo.2008.11.015; URAM M, 1992, OPHTHALMOLOGY, V99, P1823; Wang JW, 2015, CLIN EXP OPHTHALMOL, V43, P415, DOI 10.1111/ceo.12477; Yalvac IS, 2007, EYE, V21, P65, DOI 10.1038/sj.eye.6702125	29	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234798	10.1371/journal.pone.0234798	http://dx.doi.org/10.1371/journal.pone.0234798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555597	Green Published, gold			2022-12-26	WOS:000542759600005
J	Huff, A; Reed, MD; Iceman, KE; Howland, DR; Pitts, T				Huff, Alyssa; Reed, Mitchell D.; Iceman, Kimberly E.; Howland, Dena R.; Pitts, Teresa			Sex-specific vagal and spinal modulation of breathing with chest compression	PLOS ONE			English	Article							INTERCOSTAL TENDON ORGANS; MEDULLARY INSPIRATORY NEURONS; RESPIRATORY PATTERN; PULMONARY STRETCH; MUSCLE-ACTIVITY; AIRWAY ANESTHESIA; NERVE BLOCK; RESPONSES; REFLEXES; MOTONEURONS	Lung volume is modulated by sensory afferent feedback via vagal and spinal pathways. The purpose of this study was to systematically alter afferent feedback with and without a mechanical challenge (chest compression). We hypothesized that manipulation of afferent feedback by nebulization of lidocaine, extra-thoracic vagotomy, or lidocaine administration to the pleural space would produce differential effects on the motor pattern of breathing during chest compression in sodium pentobarbital anesthetized rats (N= 43). Our results suggest that: 1) pulmonary stretch receptors are not the sole contributor to breathing feedback in adult male and female rats; 2) of our manipulations, chest compression had the largest effect on early expiratory diaphragm activity ("yield"); 3) reduction of spinally-mediated afferent feedback modulates breathing patterns most likely via inhibition; and 4) breathing parameters demonstrate large sex differences. Compared to males, female animals had lower respiratory rates (RR), which were further depressed by vagotomy, while chest compression increased RR in males, and decreased yield in females without changing RR. Collectively, our results suggest that balance between tonic vagal inhibition and spinal afferent feedback maintains breathing characteristics, and that it is important to specifically evaluate sex differences when studying control of breathing.	[Huff, Alyssa] Univ Louisville, Dept Physiol, Louisville, KY 40292 USA; [Huff, Alyssa; Reed, Mitchell D.; Iceman, Kimberly E.; Howland, Dena R.; Pitts, Teresa] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Dept Neurol Surg, Louisville, KY 40292 USA; [Howland, Dena R.] Robley Rex Vet Affairs Med Ctr, Res Serv, Louisville, KY USA; [Huff, Alyssa] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA	University of Louisville; University of Louisville; Seattle Children's Hospital	Pitts, T (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Dept Neurol Surg, Louisville, KY 40292 USA.	t.pitts@louisville.edu		Huff, Alyssa/0000-0003-2817-251X; Iceman, Kimberly/0000-0002-9004-3893	NIH [HL 111215, HL 103415, OT2OD023854]; Craig F. Neilson Foundation Pilot Research Grant [546714]; Kentucky Spinal Cord and Head Injury Trust; Commonwealth of Kentucky Challenge for Excellence; Rebecca F Hammond Endowment	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Craig F. Neilson Foundation Pilot Research Grant; Kentucky Spinal Cord and Head Injury Trust; Commonwealth of Kentucky Challenge for Excellence; Rebecca F Hammond Endowment	NIH HL 111215, HL 103415 and OT2OD023854: TP Craig F. Neilson Foundation Pilot Research Grant 546714: TP The Kentucky Spinal Cord and Head Injury Trust: TP The Commonwealth of Kentucky Challenge for Excellence: TP Rebecca F Hammond Endowment: DH The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1933, J PHYSIOL-LONDON, V79, P332, DOI 10.1113/jphysiol.1933.sp003053; AGOSTONI E, 1977, RESP PHYSIOL, V30, P153, DOI 10.1016/0034-5687(77)90028-7; AITKEN ML, 1986, J APPL PHYSIOL, V60, P1894, DOI 10.1152/jappl.1986.60.6.1894; Anderson TM, 2016, NATURE, V536, P76, DOI 10.1038/nature18944; Baertsch NA, 2019, P NATL ACAD SCI USA, V116, P7493, DOI 10.1073/pnas.1900523116; Baertsch NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03223-x; BARTLETT D, 1973, RESP PHYSIOL, V18, P197, DOI 10.1016/0034-5687(73)90050-9; BARTLETT D, 1989, PHYSIOL REV, V69, P33, DOI 10.1152/physrev.1989.69.1.33; BASMAJIAN JV, 1962, J APPL PHYSIOL, V17, P849, DOI 10.1152/jappl.1962.17.5.849; Baum DM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00788; Bautista TG, 2014, PROG BRAIN RES, V212, P253, DOI 10.1016/B978-0-444-63488-7.00013-6; Bellemare F, 2003, AM J RESP CRIT CARE, V168, P305, DOI 10.1164/rccm.200208-876OC; BERGER AJ, 1977, BRAIN RES, V135, P231, DOI 10.1016/0006-8993(77)91028-9; BLAND S, 1967, RESP PHYSIOL, V3, P47, DOI 10.1016/0034-5687(67)90023-0; Bolser D, 1983, SOC NEUR ABSTR; Bolser D, 1984, FEDERATION P, P20814; BOLSER DC, 1989, J NEUROPHYSIOL, V61, P918, DOI 10.1152/jn.1989.61.5.918; BOLSER DC, 1988, J APPL PHYSIOL, V64, P2458, DOI 10.1152/jappl.1988.64.6.2458; BOLSER DC, 1987, J APPL PHYSIOL, V62, P1046, DOI 10.1152/jappl.1987.62.3.1046; Campbell E, 1962, CIBA F S PULMONARY S, P29; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; CROSS BA, 1976, CLIN SCI MOL MED, V50, P439, DOI 10.1042/cs0500439; DANGELO E, 1982, RESP PHYSIOL, V47, P193, DOI 10.1016/0034-5687(82)90111-6; DANGELO E, 1976, RESP PHYSIOL, V28, P161, DOI 10.1016/0034-5687(76)90036-0; DAVENPORT PW, 1986, J APPL PHYSIOL, V61, P1857, DOI 10.1152/jappl.1986.61.5.1857; De Troyer A, 2005, PHYSIOL REV, V85, P717, DOI 10.1152/physrev.00007.2004; DeTroyer A, 1997, J PHYSIOL-LONDON, V503, P445, DOI 10.1111/j.1469-7793.1997.445bh.x; Dhingra RR, 2011, J APPL PHYSIOL, V111, P272, DOI 10.1152/japplphysiol.91196.2008; Dick TE, 2008, J PHYSIOL-LONDON, V586, P4265, DOI 10.1113/jphysiol.2008.152108; DURON B, 1980, Z MIKROSK ANAT FORSC, V94, P257; Dutschmann M, 2014, PROG BRAIN RES, V212, P113, DOI 10.1016/B978-0-444-63488-7.00007-0; ECCLES RM, 1962, NATURE, V193, P844, DOI 10.1038/193844a0; FAHIM M, 1979, J PHYSIOL-LONDON, V288, P367; Feldman J.L., 1986, HDB PHYSL 1, V1, P463; FORD DJ, 1984, ANESTHESIOLOGY, V60, P28, DOI 10.1097/00000542-198401000-00007; GARCIA RAMOS J, 1959, Acta Physiol Lat Am, V9, P246; Gargaglioni LH, 2019, COMP BIOCHEM PHYS A, V238, DOI 10.1016/j.cbpa.2019.110543; Gasser HS, 1929, AM J PHYSIOL, V88, P581, DOI 10.1152/ajplegacy.1929.88.4.581; GAUTIER H, 1973, RESP PHYSIOL, V17, P238, DOI 10.1016/0034-5687(73)90065-0; Gokin AP, 2001, ANESTHESIOLOGY, V95, P1441, DOI 10.1097/00000542-200112000-00025; GOSLOW GE, 1973, J MORPHOL, V141, P1, DOI 10.1002/jmor.1051410102; Hammouda M, 1932, J PHYSIOL-LONDON, V74, P81, DOI 10.1113/jphysiol.1932.sp002831; HARDING R, 1984, ANNU REV PHYSIOL, V46, P645, DOI 10.1146/annurev.ph.46.030184.003241; Hudeorand M., 1959, Journal of Mammalogy, V40, P481; Huff ARM, 2020, PLOS ONE; Hutchinson J, 1846, Med Chir Trans, V29, P137; INSALACO G, 1991, J APPL PHYSIOL, V70, P2410, DOI 10.1152/jappl.1991.70.6.2410; Jaiswal PB, 2016, J APPL PHYSIOL, V120, P792, DOI 10.1152/japplphysiol.00436.2015; Joseph V, 2013, RESP PHYSIOL NEUROBI, V185, P75, DOI 10.1016/j.resp.2012.07.001; Krishnan BS, 1997, AM J RESP CRIT CARE, V155, P459, DOI 10.1164/ajrccm.155.2.9032179; Kubin L, 2006, J APPL PHYSIOL, V101, P618, DOI 10.1152/japplphysiol.00252.2006; LARRABEE MG, 1946, AM J PHYSIOL, V147, P90, DOI 10.1152/ajplegacy.1946.147.1.90; Lee LY, 2011, COMPREHENSIVE PHYSL, V4, P287; Li HF, 2009, AM J PHYSIOL-REG I, V297, pR853, DOI 10.1152/ajpregu.00013.2009; Loeppky JA, 2001, RESP PHYSIOL, V125, P225, DOI 10.1016/S0034-5687(00)00221-8; LoMauro A, 2018, BREATHE, V14, P131, DOI 10.1183/20734735.000318; Lust RM, 2007, CONTROL RESPIRATION; Mantilla CB, 2009, J NEUROSCI METH, V182, P244, DOI 10.1016/j.jneumeth.2009.06.016; Massaro D, 2006, AM J PHYSIOL-LUNG C, V290, pL866, DOI 10.1152/ajplung.00396.2005; MASSARO GD, 1995, P NATL ACAD SCI USA, V92, P1105, DOI 10.1073/pnas.92.4.1105; Mondal P, 2016, LANCET GLOB HEALTH, V4, pe12668; Morris KF, 2010, J APPL PHYSIOL, V109, P189, DOI 10.1152/japplphysiol.01324.2009; Mutoh T, 2001, VET SURG, V30, P87, DOI 10.1053/jvet.2001.20329; Pitts T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199903; Pitts T, 2015, LUNG, V193, P129, DOI 10.1007/s00408-014-9662-x; REMMERS JE, 1970, RESP PHYSIOL, V10, P358, DOI 10.1016/0034-5687(70)90055-1; Richter DW, 2014, PHYSIOLOGY, V29, P58, DOI 10.1152/physiol.00035.2013; SANDERS MH, 1989, AM REV RESPIR DIS, V140, P45, DOI 10.1164/ajrccm/140.1.45; Sant'Ambrogio G, 2001, RESP PHYSIOL, V125, P33, DOI 10.1016/S0034-5687(00)00203-6; SAVOY J, 1982, RESP PHYSIOL, V50, P41, DOI 10.1016/0034-5687(82)90005-6; Schelegle ES, 2001, RESP PHYSIOL, V125, P17, DOI 10.1016/S0034-5687(00)00202-4; SHANNON R, 1979, RESP PHYSIOL, V36, P65, DOI 10.1016/0034-5687(79)90015-X; SHANNON R, 1980, RESP PHYSIOL, V39, P73, DOI 10.1016/0034-5687(80)90015-8; SHANNON R, 1975, RESP PHYSIOL, V23, P11, DOI 10.1016/0034-5687(75)90067-5; SHANNON R, 1987, J APPL PHYSIOL, V62, P1057, DOI 10.1152/jappl.1987.62.3.1057; SHANNON R, 1985, RESP PHYSIOL, V60, P193, DOI 10.1016/0034-5687(85)90103-3; SHANNON R, 1977, J APPL PHYSIOL, V43, P20, DOI 10.1152/jappl.1977.43.1.20; SHANNON R, 1972, RESP PHYSIOL, V16, P70, DOI 10.1016/0034-5687(72)90089-8; Shannon R, 1986, HDB PHYSL 3, P431; SHEA SA, 1988, RESP PHYSIOL, V72, P131, DOI 10.1016/0034-5687(88)90001-1; SHERREY JH, 1974, EXP NEUROL, V43, P487, DOI 10.1016/0014-4886(74)90189-7; VONEULER C, 1966, J PHYSIOL-LONDON, V187, P501, DOI 10.1113/jphysiol.1966.sp008106; Wenninger JM, 2009, J APPL PHYSIOL, V106, P1522, DOI 10.1152/japplphysiol.90802.2008; WHITEHEAD RW, 1947, ANESTHESIOLOGY, V8, P159; Widdicome J, 2003, ANAT REC PART A, V270A, P2, DOI 10.1002/ar.a.10003; WINNING AJ, 1985, CLIN SCI, V68, P215, DOI 10.1042/cs0680215; Zabka AG, 2001, J PHYSIOL-LONDON, V531, P509, DOI 10.1111/j.1469-7793.2001.0509i.x; Zechman Jr FW, 2011, COMPREHENSIVE PHYSL, P449	88	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234193	10.1371/journal.pone.0234193	http://dx.doi.org/10.1371/journal.pone.0234193			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555612	gold, Green Published			2022-12-26	WOS:000542759600002
J	Moss, RB; Pryor, MM; Baillie, R; Kudrycki, K; Friedrich, C; Reed, M; Carlo, DJ				Moss, Ronald B.; Pryor, Meghan McCabe; Baillie, Rebecca; Kudrycki, Katherine; Friedrich, Christina; Reed, Mike; Carlo, Dennis J.			Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level	PLOS ONE			English	Article							HIGH-DOSE FENTANYL; RESPIRATORY DEPRESSION; RADIORECEPTOR ASSAY; NITROUS-OXIDE; BINDING; PHARMACOKINETICS; MORPHINE; POSTMORTEM; AFFINITY; PROPOFOL	Rapid resuscitation of an opioid overdose with naloxone, an opioid antagonist, is critical. We developed an opioid receptor quantitative systems pharmacology (QSP) model for evaluation of naloxone dosing. In this model we examined three opioid exposure levels that have been reported in the literature (25 ng/ml, 50 ng/ml, and 75 ng/ml of fentanyl). The model predicted naloxone-fentanyl interaction at the mu opioid receptor over a range of three naloxone doses. For a 2 mg intramuscular (IM) dose of naloxone at lower fentanyl exposure levels (25 ng/ml and 50 ng/ml), the time to decreasing mu receptor occupancy by fentanyl to 50% was 3 and 10 minutes, respectively. However, at a higher fentanyl exposure level (75 ng/ml), a dose of 2 mg IM of the naloxone failed to reduce mu receptor occupancy by fentanyl to 50%. In contrast, naloxone doses of 5 mg and 10 mg IM reduced mu receptor occupancy by fentanyl to 50% in 5.5 and 4 minutes respectively. These results suggest that the current doses of naloxone (2 mg IM or 4 mg intranasal (IN)) may be inadequate for rapid reversal of toxicity due to fentanyl exposure and that increasing the dose of naloxone is likely to improve outcomes.	[Moss, Ronald B.; Carlo, Dennis J.] Adamis Pharmaceut Corp, San Diego, CA 92130 USA; [Pryor, Meghan McCabe; Baillie, Rebecca; Kudrycki, Katherine; Friedrich, Christina; Reed, Mike] Rosa & Co LLC, San Carlos, CA USA		Moss, RB (corresponding author), Adamis Pharmaceut Corp, San Diego, CA 92130 USA.	rmoss@adamispharma.com	baillie, rebecca/AAQ-3400-2020	baillie, rebecca/0000-0003-3966-6320; Moss, Ron/0000-0001-8662-3599	Adamis Pharmaceuticals	Adamis Pharmaceuticals	This study was funded by Adamis Pharmaceuticals. RBM and DJC are employees of Adamis Pharmaceuticals and have equity in the company. MMP, RB, KK,CF, and MR are employees of Rosa & Co and have equity in the company. The funder provided support in the form of salaries for authors RBM and DJC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Afify EA, 2002, MOL BRAIN RES, V106, P83, DOI 10.1016/S0169-328X(02)00414-X; Ahmad F.B., 2022, PROVISIONAL DRUG OVE; ALBURGES ME, 1992, J ANAL TOXICOL, V16, P36, DOI 10.1093/jat/16.1.36; Allouche S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00280; ANDERSEN HB, 1986, ACTA ANAESTH SCAND, V30, P393, DOI 10.1111/j.1399-6576.1986.tb02437.x; Anderson DT, 2000, J ANAL TOXICOL, V24, P627, DOI 10.1093/jat/24.7.627; Andresen H, 2012, J ANAL TOXICOL, V36, P182, DOI 10.1093/jat/bks005; Avedschmidt S, 2019, J FORENSIC SCI, V64, P149, DOI 10.1111/1556-4029.13840; BJORKMAN S, 1990, ANESTHESIOLOGY, V72, P865, DOI 10.1097/00000542-199005000-00017; Blanco ME, 2015, DRUG TEST ANAL, V7, P804, DOI 10.1002/dta.1778; BOVILL JG, 1980, BRIT J ANAESTH, V52, P795, DOI 10.1093/bja/52.8.795; Brasel CM, 2008, EUR J PHARMACOL, V599, P36, DOI 10.1016/j.ejphar.2008.09.043; Burns SM, 2018, ACS CHEM NEUROSCI, V9, P2428, DOI 10.1021/acschemneuro.8b00174; Busardo FP, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00184; CARROLL JA, 1988, BRIT J PHARMACOL, V94, P625, DOI 10.1111/j.1476-5381.1988.tb11569.x; Chan K, 1995, EUR J PHARMACOL, V287, P135, DOI 10.1016/0014-2999(95)00488-2; CHEN JC, 1993, LIFE SCI, V52, P389, DOI 10.1016/0024-3205(93)90152-S; CHILDERS SR, 1979, EUR J PHARMACOL, V55, P11, DOI 10.1016/0014-2999(79)90142-0; Corli O, 2014, MINERVA ANESTESIOL, V80, P1123; Dahan A, 2010, ANESTHESIOLOGY, V112, P226, DOI 10.1097/ALN.0b013e3181c38c25; de Jong LAA, 2005, J PHARMACEUT BIOMED, V39, P964, DOI 10.1016/j.jpba.2005.04.049; Del Gaudio A, 2006, MINERVA ANESTESIOL, V72, P309; Deschamps JY, 2012, VET ANAESTH ANALG, V39, P653, DOI 10.1111/j.1467-2995.2012.00749.x; Dowling J, 2008, THER DRUG MONIT, V30, P490, DOI 10.1097/FTD.0b013e3181816214; DRUMMOND GB, 1983, BRIT J ANAESTH, V55, P825, DOI 10.1093/bja/55.9.825; Dwyer JB, 2018, J FORENSIC SCI, V63, P195, DOI 10.1111/1556-4029.13517; Ellis CR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197734; Emmerson PJ, 1996, J PHARMACOL EXP THER, V278, P1121; Eriksson O, 2015, MOL IMAGING, V14, P476, DOI 10.2310/7290.2015.00019; Fairbairn N, 2017, INT J DRUG POLICY, V46, P172, DOI 10.1016/j.drugpo.2017.06.005; Fallows Z., 2012, DRUG CHART MIT CTR H; FDA, 2015, 3848912 FDA; Fogarty MF, 2018, J ANAL TOXICOL, V42, P592, DOI 10.1093/jat/bky035; General S, 2018, US SURG GEN ADV NAL; Gill JR, 2013, J MED TOXICOL, V9, P34, DOI 10.1007/s13181-012-0253-z; HANDAL KA, 1983, ANN EMERG MED, V12, P438, DOI 10.1016/S0196-0644(83)80343-6; HARPER MH, 1976, J PHARMACOL EXP THER, V199, P464; HENDERSON GL, 1991, J FORENSIC SCI, V36, P422; ILIEN B, 1988, BIOCHEM PHARMACOL, V37, P3843, DOI 10.1016/0006-2952(88)90065-2; Inserro A., 2018, FENTANYL DRIVING OVE; Johansson J, 2019, NEUROPSYCHOPHARMACOL, V44, P1667, DOI 10.1038/s41386-019-0368-x; JUSTINS DM, 1983, ANAESTHESIA, V38, P937, DOI 10.1111/j.1365-2044.1983.tb12022.x; Kalvass JC, 2007, J PHARMACOL EXP THER, V323, P346, DOI 10.1124/jpet.107.119560; Kazama T, 1998, ANESTHESIOLOGY, V89, P894, DOI 10.1097/00000542-199810000-00014; Kelly HE, 2016, ANAESTHESIA, V71, P529, DOI 10.1111/anae.13410; Kodaka M, 2004, BRIT J ANAESTH, V92, P238, DOI 10.1093/bja/aeh033; Kuhlman JJ, 2003, J ANAL TOXICOL, V27, P499, DOI 10.1093/jat/27.7.499; Lee D, 2016, J ANAL TOXICOL, V40, P588, DOI 10.1093/jat/bkw087; Levoye A, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00167; Li F, 2016, MOL NEUROBIOL, V53, P4918, DOI 10.1007/s12035-015-9417-6; Lilleng PK, 2004, J FORENSIC SCI, V49, P1364; Lipinski PFJ, 2019, MOL BASEL SWITZERLAN, V24; LUNN JK, 1979, ANESTH ANALG, V58, P390; Lynn RR, 2018, THER ADV DRUG SAF, V9, P63, DOI 10.1177/2042098617744161; MAGUIRE P, 1992, EUR J PHARMACOL, V213, P219, DOI 10.1016/0014-2999(92)90685-W; Maillet EL, 2015, NEUROPHARMACOLOGY, V99, P675, DOI 10.1016/j.neuropharm.2015.08.032; Matsuda C, 2014, OPEN J ANESTHESIOLOG, V04, P177; Melichar JK, 2003, EUR J PHARMACOL, V459, P217, DOI 10.1016/S0014-2999(02)02872-8; Metz C, 2000, ANESTHESIOLOGY, V92, P1559, DOI 10.1097/00000542-200006000-00012; Moss RB, 2019, SUBST ABUSE TREAT PR, V14, DOI 10.1186/s13011-019-0195-4; MOSTERT JW, 1971, BRIT J ANAESTH, V43, P1053, DOI 10.1093/bja/43.11.1053; NGAI SH, 1976, ANESTHESIOLOGY, V44, P398, DOI 10.1097/00000542-197605000-00008; NIH, 2019, CER HYP INF PAG WHAT; Paronis CA, 1997, EUR J PHARMACOL, V337, P27, DOI 10.1016/S0014-2999(97)01296-X; Pattinson KTS, 2008, BRIT J ANAESTH, V100, P747, DOI 10.1093/bja/aen094; Peng PWH, 1999, ANESTHESIOLOGY, V90, P576, DOI 10.1097/00000542-199902000-00034; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; REILLY CS, 1985, ANAESTHESIA, V40, P837, DOI 10.1111/j.1365-2044.1985.tb11043.x; Saccone PA, 2016, J PHARMACOL EXP THER, V359, P366, DOI 10.1124/jpet.116.235192; Schaefer CP, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-017-0080-3; SCHLEIMER R, 1978, CLIN PHARMACOL THER, V23, P188; SCOTT JC, 1985, ANESTHESIOLOGY, V62, P234, DOI 10.1097/00000542-198503000-00005; Seith RW, 2012, ACAD EMERG MED, V19, P31, DOI 10.1111/j.1553-2712.2011.01241.x; Selley DE, 1998, J PHARMACOL EXP THER, V285, P496; Sianati S., 2015, OPIOID RECEPTOR SIGN; SMITH C, 1994, ANESTHESIOLOGY, V81, P820, DOI 10.1097/00000542-199410000-00008; SOLIS E, 2017, ENEURO, V4; Somerville NJ, 2017, MMWR-MORBID MORTAL W, V66, P382, DOI 10.15585/mmwr.mm6614a2; STANSKI DR, 1982, ANESTHESIOLOGY, V57, P435, DOI 10.1097/00000542-198212000-00001; STREISAND JB, 1993, ANESTHESIOLOGY, V78, P629, DOI 10.1097/00000542-199304000-00003; Sutter ME, 2017, ACAD EMERG MED, V24, P106, DOI 10.1111/acem.13034; Toll L, 1998, NIDA Res Monogr, V178, P440; Tomassoni AJ, 2017, MMWR-MORBID MORTAL W, V66, P107, DOI 10.15585/mm6604a4; TRAYNOR JR, 1995, MOL PHARMACOL, V47, P848; Vardanyan RS, 2014, FUTURE MED CHEM, V6, P385, DOI 10.4155/fmc.13.215; Volpe DA, 2011, REGUL TOXICOL PHARM, V59, P385, DOI 10.1016/j.yrtph.2010.12.007; Vukojevic V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004008; WELCHEW EA, 1983, ANAESTHESIA, V38, P1037, DOI 10.1111/j.1365-2044.1983.tb12476.x; White JM, 1999, ADDICTION, V94, P961, DOI 10.1046/j.1360-0443.1999.9479612.x; XU H, 1991, NEUROPHARMACOLOGY, V30, P455, DOI 10.1016/0028-3908(91)90006-W; Yassen A, 2005, J PHARMACOL EXP THER, V313, P1136, DOI 10.1124/jpet.104.082560; Yassen A, 2007, CLIN PHARMACOKINET, V46, P965, DOI 10.2165/00003088-200746110-00004; YEADON M, 1988, NEUROPHARMACOLOGY, V27, P345, DOI 10.1016/0028-3908(88)90141-4; YOBURN BC, 1993, J PHARMACOL EXP THER, V265, P314; Yoo JH, 2017, NEUROSCI LETT, V643, P16, DOI 10.1016/j.neulet.2017.02.002	95	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234683	10.1371/journal.pone.0234683	http://dx.doi.org/10.1371/journal.pone.0234683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544184	Green Published, gold			2022-12-26	WOS:000542957200019
J	Colucci, S; Colaianni, G; Brunetti, G; Ferranti, F; Mascetti, G; Mori, G; Grano, M				Colucci, Silvia; Colaianni, Graziana; Brunetti, Giacomina; Ferranti, Francesca; Mascetti, Gabriele; Mori, Giorgio; Grano, Maria			Irisin prevents microgravity-induced impairment of osteoblast differentiation in vitro during the space flight CRS-14 mission	FASEB JOURNAL			English	Article						irisin; ISS; microgravity; osteoblasts	BONE; EXERCISE; SPACEFLIGHT; MYOKINE; MUSCLE	Understanding molecular mechanisms responsible for bone cells unbalance in microgravity would allow the development of better countermeasures for astronauts, and eventually advancing terrestrial osteoporosis treatments. We conduct a unique investigation by using a controlled 3D in vitro cell model to mimic the bone microenvironment in microgravity aboard the SpaceX Dragon cargo ferry to the ISS. Osteoblasts (OBs), osteoclasts (OCs), and endothelial cells (ECs), seeded on Skelite discs, were cultured w/ or w/o rec-Irisin and exposed to 14 days of microgravity in the eOSTEO hardware. Gene expression analysis was assessed, and results were compared to ground controls treated within identical payloads. Our results show that the microgravity-induced downregulation of mRNA levels of genes encoding for OB key transcription factors (Atf4-75%,P RunX2-87%,P < .001,Osterix-95%,P < .05 vs ground) and proteins (Collagen I-84%,P Osteoprotegerin-94%,P < .05) were prevented by irisin. Despite it was not effective in preventing Trap and Cathepsin K mRNA increase, irisin induced a 2.8-fold increase of Osteoprotegerin (P < .05) that might act for reducing osteoclastogenesis in microgravity. Our results provide evidence that irisin supports OB differentiation and activity in microgravity and it might represent a countermeasure to prevent bone loss in astronauts.	[Colucci, Silvia; Brunetti, Giacomina] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Colaianni, Graziana; Grano, Maria] Univ Bari, Dept Emergency & Organ Transplantat, Piazza Giulio Cesare 11, I-70124 Bari, Italy; [Ferranti, Francesca; Mascetti, Gabriele] Italian Space Agcy ASI, Rome, Italy; [Mori, Giorgio] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Agenzia Spaziale Italiana (ASI); University of Foggia	Grano, M (corresponding author), Univ Bari, Dept Emergency & Organ Transplantat, Piazza Giulio Cesare 11, I-70124 Bari, Italy.	maria.grano@uniba.it	Mori, Giorgio/P-1370-2014	Mori, Giorgio/0000-0001-6731-0247	ERISTO by ESA; ASI	ERISTO by ESA; ASI(Agenzia Spaziale Italiana (ASI))	ERISTO by ESA; ASI	Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cazzaniga A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/857934; Chim SM, 2013, CYTOKINE GROWTH F R, V24, P297, DOI 10.1016/j.cytogfr.2013.03.008; Colaianni G, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/902186; Colaianni G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02557-8; Colaianni G, 2015, P NATL ACAD SCI USA, V112, P12157, DOI 10.1073/pnas.1516622112; Drake MT, 2017, ENDOCR REV, V38, P325, DOI 10.1210/er.2015-1114; Guignandon A, 2014, FASEB J, V28, P4077, DOI 10.1096/fj.14-249714; Halleen JM, 2006, CLIN LAB, V52, P499; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Hofbauer LC, 1999, EUR J ENDOCRINOL, V141, P195, DOI 10.1530/eje.0.1410195; HughesFulford M, 1996, EXP CELL RES, V224, P103, DOI 10.1006/excr.1996.0116; Lang TF, 2006, J BONE MINER RES, V21, P1224, DOI 10.1359/JBMR.060509; LeBlanc A, 2013, OSTEOPOROSIS INT, V24, P2105, DOI 10.1007/s00198-012-2243-z; LittlewoodEvans A, 1997, BONE, V20, P81, DOI 10.1016/S8756-3282(96)00351-1; Lu JL, 2016, ONCOTARGET, V7, P37471, DOI 10.18632/oncotarget.9650; McCarthy EF, 2011, SKELETAL RADIOL, V40, P661, DOI 10.1007/s00256-011-1100-z; Nabavi N, 2011, BONE, V49, P965, DOI 10.1016/j.bone.2011.07.036; Pang H, 2013, BIOCHEM BIOPH RES CO, V430, P729, DOI 10.1016/j.bbrc.2012.11.081; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Shackelford LC, 2004, J APPL PHYSIOL, V97, P119, DOI 10.1152/japplphysiol.00741.2003; Storlino G, 2020, J BONE MINER RES, V35, P766, DOI 10.1002/jbmr.3944; Tamma R, 2009, FASEB J, V23, P2549, DOI 10.1096/fj.08-127951; Tesch PA, 2005, EUR J APPL PHYSIOL, V93, P463, DOI 10.1007/s00421-004-1236-9; Veeriah V, 2019, CALCIFIED TISSUE INT, V104, P344, DOI 10.1007/s00223-018-0496-z; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Xu HJ, 2017, BIOCHIMIE, V138, P184, DOI 10.1016/j.biochi.2017.04.015; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yu SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007583	30	21	23	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10096	10106		10.1096/fj.202000216R	http://dx.doi.org/10.1096/fj.202000216R		JUN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32539174	Bronze			2022-12-26	WOS:000543403200001
J	Narayanan, CS				Narayanan, Charit Samyak			A novel cohort analysis approach to determining the case fatality rate of COVID-19 and other infectious diseases	PLOS ONE			English	Article								As the Coronavirus contagion develops, it is increasingly important to understand the dynamics of the disease. Its severity is best described by two parameters: its ability to spread and its lethality. Here, we combine a mathematical model with a cohort analysis approach to determine the range of case fatality rates (CFR). We use a logistical function to describe the exponential growth and subsequent flattening of COVID-19 CFR that depends on three parameters: the final CFR (L), the CFR growth rate (k), and the onset-to-death interval (t(0)). Using the logistic model with specific parameters (L, k and t(0)), we calculate the number of deaths each day for each cohort. We build an objective function that minimizes the root mean square error between the actual and predicted values of cumulative deaths and run multiple simulations by altering the three parameters. Using all of these values, we find out which set of parameters returns the lowest error when compared to the number of actual deaths. We were able to predict the CFR much closer to reality at all stages of the viral outbreak compared to traditional methods. This model can be used far more effectively than current models to estimate the CFR during an outbreak, allowing for better planning. The model can also help us better understand the impact of individual interventions on the CFR. With much better data collection and labeling, we should be able to improve our predictive power even further.	[Narayanan, Charit Samyak] Mission San Jose High Sch, Fremont, CT 94539 USA		Narayanan, CS (corresponding author), Mission San Jose High Sch, Fremont, CT 94539 USA.	charitsn28@gmail.com		Narayanan, Charit/0000-0003-0998-6745				[Anonymous], 2020, SITUATION REPORT 68; Cuffe J, RETENTION; Delamater PL, 2019, EMERG INFECT DIS, V25, P1, DOI 10.3201/eid2501.171901; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Oh MD, 2018, KOREAN J INTERN MED, V33, P233, DOI 10.3904/kjim.2018.031; Qui F, 2017, ONCOTARGET, V8, P268, DOI DOI 10.18632/ONCOTARGET.13613; Werker AR, 1997, ANN BOT-LONDON, V79, P657, DOI 10.1006/anbo.1997.0387; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	11	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0233146	10.1371/journal.pone.0233146	http://dx.doi.org/10.1371/journal.pone.0233146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542041	Green Published, gold, Green Submitted			2022-12-26	WOS:000542685100014
J	Jha, S; Taschler, U; Domenig, O; Poglitsch, M; Bourgeois, B; Pollheimer, M; Pusch, LM; Malovan, G; Frank, S; Madl, T; Gruber, K; Zimmermann, R; Macheroux, P				Jha, Shalinee; Taschler, Ulrike; Domenig, Oliver; Poglitsch, Marko; Bourgeois, Benjamin; Pollheimer, Marion; Pusch, Lisa M.; Malovan, Grazia; Frank, Sasa; Madl, Tobias; Gruber, Karl; Zimmermann, Robert; Macheroux, Peter			Dipeptidyl peptidase 3 modulates the renin-angiotensin system in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiotensin II; dipeptidyl peptidase 3 (DPP3); metalloprotease; mouse; oxidative stress; peptidase; renal physiology; renin angiotensin system; kidney function; sex-specific difference; reactive oxygen species (ROS)	II-INDUCED HYPERTENSION; OXIDATIVE STRESS; SEX-DIFFERENCES; PROTECTION; PATHWAY; DISEASE; WATER; ACE	Dipeptidyl peptidase 3 (DPP3) is a zinc-dependent hydrolase involved in degrading oligopeptides with 4-12 amino acid residues. It has been associated with several pathophysiological processes, including blood pressure regulation, pain signaling, and cancer cell defense against oxidative stress. However, the physiological substrates and the cellular pathways that are potentially targeted by DPP3 to mediate these effects remain unknown. Here, we show that global DPP3 deficiency in mice (DPP3(-/-)) affects the renin-angiotensin system (RAS). LC-MS-based profiling of circulating angiotensin peptides revealed elevated levels of angiotensin II, III, IV, and 1-5 in DPP3(-/-)mice, whereas blood pressure, renin activity, and aldosterone levels remained unchanged. Activity assays using the purified enzyme confirmed that angiotensin peptides are substrates for DPP3. Aberrant angiotensin signaling was associated with substantially higher water intake and increased renal reactive oxygen species formation in the kidneys of DPP3(-/-)mice. The metabolic changes and altered angiotensin levels observed in male DPP3(-/-)mice were either absent or attenuated in female DPP3(-/-)mice, indicating sex-specific differences. Taken together, our observations suggest that DPP3 regulates the RAS pathway and water homeostasis by degrading circulating angiotensin peptides.	[Jha, Shalinee; Malovan, Grazia; Macheroux, Peter] Graz Univ Technol, Inst Biochem, NAWI Graz, Graz, Austria; [Taschler, Ulrike; Pusch, Lisa M.; Gruber, Karl; Zimmermann, Robert] Karl Franzens Univ Graz, NAWI Graz, Inst Mol Biosci, Graz, Austria; [Domenig, Oliver; Poglitsch, Marko] Attoquant Diagnost GmbH, Vienna, Austria; [Bourgeois, Benjamin; Frank, Sasa; Madl, Tobias] Gottfried Schatz Res Ctr, Div Mol Biol & Biochem, Graz, Austria; [Pollheimer, Marion] Med Univ Graz, Diagnost & Res Inst Pathol, Graz, Austria; [Madl, Tobias; Zimmermann, Robert] BioTechMed Graz, Graz, Austria	Graz University of Technology; University of Graz; Medical University of Graz	Macheroux, P (corresponding author), Graz Univ Technol, Inst Biochem, NAWI Graz, Graz, Austria.	peter.macheroux@tugraz.at	Bourgeois, Benjamin/U-2482-2019; Gruber, Karl/GPP-6706-2022; Macheroux, Peter/AAB-5157-2019	Gruber, Karl/0000-0002-3485-9740; Macheroux, Peter/0000-0002-0242-454X; Jha, Shalinee/0000-0002-6421-3529; Domenig, Oliver/0000-0002-5995-8753; Zimmermann, Robert/0000-0002-7354-870X; Taschler, Ulrike/0000-0001-9000-1602	Austrian Science Foundation [W901]; Interuniversity Program in Natural Sciences	Austrian Science Foundation(Austrian Science Fund (FWF)); Interuniversity Program in Natural Sciences	This work was supported by Austrian Science Foundation Grant W901 (Doctoral Program "Molecular Enzymology"; to K. G., R. Z., and P. M.) and by the Interuniversity Program in Natural Sciences (to NAWI Graz).	Baral PK, 2008, J BIOL CHEM, V283, P22316, DOI 10.1074/jbc.M803522200; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Bezerra GA, 2012, P NATL ACAD SCI USA, V109, P6525, DOI 10.1073/pnas.1118005109; Brewster UC, 2003, AM J MED SCI, V326, P15, DOI 10.1097/00000441-200307000-00003; Cat AND, 2013, ANTIOXID REDOX SIGN, V19, P1110, DOI 10.1089/ars.2012.4641; Chiba T, 2003, PEPTIDES, V24, P773, DOI 10.1016/S0196-9781(03)00119-0; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Cruz-Diaz N., 2017, ENZYM INHIB ACT INTE, DOI [10.5772/65949, DOI 10.5772/65949]; Cruz-Diaz N, 2016, PEPTIDES, V83, P29, DOI 10.1016/j.peptides.2016.06.005; Daniels D, 2009, EXP PHYSIOL, V94, P130, DOI 10.1113/expphysiol.2008.044446; de Cavanagh EMV, 2007, AM J NEPHROL, V27, P545, DOI 10.1159/000107757; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; Deniau B, 2020, EUR J HEART FAIL, V22, P290, DOI 10.1002/ejhf.1601; Depret F, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02888-5; Deshmukh Prashant, 2017, Biophys Rev, V9, P41, DOI 10.1007/s12551-016-0244-4; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Fitzsimons JT, 1998, PHYSIOL REV, V78, P583, DOI 10.1152/physrev.1998.78.3.583; Gupte M, 2012, ARTERIOSCL THROM VAS, V32, P1392, DOI 10.1161/ATVBAHA.112.248559; Hast BE, 2013, CANCER RES, V73, P2199, DOI 10.1158/0008-5472.CAN-12-4400; Hitomi H, 2007, CURR OPIN CARDIOL, V22, P311, DOI 10.1097/HCO.0b013e3281532b53; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Kihara M, 1998, KIDNEY INT, V53, P548, DOI 10.1046/j.1523-1755.1998.00801.x; Kim SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039739; Klein JD, 2002, AM J PHYSIOL-RENAL, V283, pF517, DOI 10.1152/ajprenal.00326.2001; Komukai K, 2010, FUND CLIN PHARMACOL, V24, P687, DOI 10.1111/j.1472-8206.2010.00854.x; Kumar P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23787; Lazartigues E, 2008, AM J PHYSIOL-REG I, V295, pR1539, DOI 10.1152/ajpregu.00751.2007; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; Lu K, 2017, CANCER RES, V77, P2881, DOI 10.1158/0008-5472.CAN-16-2204; Menale C, 2019, J BONE MINER RES, V34, P2133, DOI 10.1002/jbmr.3829; Pang XL, 2016, HYPERTENSION, V68, P630, DOI 10.1161/HYPERTENSIONAHA.116.07357; Pavelescu L A, 2015, J Med Life, V8 Spec Issue, P38; Perazella MA, 2003, J NUCL CARDIOL, V10, P184, DOI 10.1067/mnc.2003.392; Prajapati SC, 2011, FEBS J, V278, P3256, DOI 10.1111/j.1742-4658.2011.08275.x; Rehfeld L, 2019, J APPL LAB MED, V3, P943, DOI 10.1373/jalm.2018.027995; Sabljic I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187295; Sachse A, 2007, J AM SOC NEPHROL, V18, P2439, DOI 10.1681/ASN.2007020149; Safranko ZM, 2015, J ENDOCRINOL INVEST, V38, P471, DOI 10.1007/s40618-014-0217-z; Sato Hiroshi, 2003, Masui, V52, P257; Sharp S, 2015, J RENIN-ANGIO-ALDO S, V16, P1149, DOI 10.1177/1470320314568438; Shono M, 2007, CIRC J, V71, P1040, DOI 10.1253/circj.71.1040; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Sobocanec S, 2016, REDOX BIOL, V8, P149, DOI 10.1016/j.redox.2016.01.003; Takagi K, 2020, EUR J HEART FAIL, V22, P279, DOI 10.1002/ejhf.1600; Tatchum-Talom R, 2005, CAN J PHYSIOL PHARM, V83, P413, DOI 10.1139/Y05-012; Toering TJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12434; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Wen Hairuo, 2012, World J Hypertens, V2, P34; Wilde E, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005204; Xue BJ, 2007, AM J PHYSIOL-HEART C, V292, pH1770, DOI 10.1152/ajpheart.01011.2005; Xue BJ, 2005, AM J PHYSIOL-HEART C, V288, pH2177, DOI 10.1152/ajpheart.00969.2004; Yu L, 2016, PEPTIDES, V86, P33, DOI 10.1016/j.peptides.2016.09.009; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974	54	21	21	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2020	295	40					13711	13723		10.1074/jbc.RA120.014183	http://dx.doi.org/10.1074/jbc.RA120.014183			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OB4MB	32546481	hybrid, Green Published			2022-12-26	WOS:000578444100002
J	Gray, SM; Xin, YR; Ross, EC; Chazotte, BM; Capozzi, ME; El, K; Svendsen, B; Ravn, P; Sloop, KW; Tong, J; Gromada, J; Campbell, JE; D'Alessio, DA				Gray, Sarah M.; Xin, Yurong; Ross, Elizabeth C.; Chazotte, Bryanna M.; Capozzi, Megan E.; El, Kimberley; Svendsen, Berit; Ravn, Peter; Sloop, Kyle W.; Tong, Jenny; Gromada, Jesper; Campbell, Jonathan E.; D'Alessio, David A.			Discordance between GLP-1R gene and protein expression in mouse pancreatic islet cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell sorting; flow cytometry; G protein-coupled receptor (GPCR); glucagon-like peptide 1 receptor (GLP-1R); GLP-1R antibody; glucose-dependent insulinotropic polypeptide receptor (GIPR); heterogeneity; incretin; islet; metabolism	GLUCAGON-LIKE PEPTIDE-1; GASTRIC-INHIBITORY POLYPEPTIDE; RECEPTOR AGONIST; DELTA CELLS; BETA; TYPE-2; SOMATOSTATIN; RAT; SECRETION; HYPERGLYCEMIA	The insulinotropic actions of glucagon-like peptide 1 receptor (GLP-1R) in beta-cells have made it a useful target to manage type 2 diabetes. Metabolic stress reduces beta-cell sensitivity to GLP-1, yet the underlying mechanisms are unknown. We hypothesized thatGlp1rexpression is heterogeneous among beta-cells and that metabolic stress decreases the number of GLP-1R-positive beta-cells. Here, analyses of publicly available single-cell RNA-Seq sequencing (scRNASeq) data from mouse and human beta-cells indicated that significant populations of beta-cells do not express theGlp1rgene, supporting heterogeneous GLP-1R expression. To check these results, we used complementary approaches employing FACS coupled with quantitative RT-PCR, a validated GLP-1R antibody, and flow cytometry to quantify GLP-1R promoter activity, gene expression, and protein expression in mouse alpha-, beta-, and delta-cells. Experiments withGlp1rreporter mice and a validated GLP-1R antibody indicated that >90% of the beta-cells are GLP-1R positive, contradicting the findings with the scRNASeq data. alpha-cells did not expressGlp1rmRNA and delta-cells expressedGlp1rmRNA but not protein. We also examined the expression patterns of GLP-1R in mouse models of metabolic stress. Multiparous female mice had significantly decreased beta-cellGlp1rexpression, but no reduction in GLP-1R protein levels or GLP-1R-mediated insulin secretion. These findings suggest caution in interpreting the results of scRNASeq for low-abundance transcripts such as the incretin receptors and indicate that GLP-1R is widely expressed in beta-cells, absent in alpha-cells, and expressed at the mRNA, but not protein, level in delta-cells.	[Gray, Sarah M.; Ross, Elizabeth C.; Chazotte, Bryanna M.; Capozzi, Megan E.; El, Kimberley; Svendsen, Berit; Campbell, Jonathan E.; D'Alessio, David A.] Duke Univ, Duke Mol Physiol Inst, Durham, NC 27706 USA; [Xin, Yurong; Gromada, Jesper] Regeneron Pharmaceut, Tarrytown, NY USA; [Ravn, Peter] AstraZeneca, BioPharmaceut R&D, Antibody Discovery & Prot Engn, Cambridge, England; [Sloop, Kyle W.] Eli Lilly & Co, Lilly Res Labs, Diabet & Complicat, Indianapolis, IN 46285 USA; [Tong, Jenny] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA; [Campbell, Jonathan E.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Campbell, Jonathan E.; D'Alessio, David A.] Duke Univ, Dept Med, Div Endocrinol, Durham, NC 27706 USA; [Xin, Yurong; Gromada, Jesper] Vertex Pharmaceut, Watertown, MA USA; [Svendsen, Berit] Univ Copenhagen, Novo Nordisk Fdn Basic Metab Res, Copenhagen, Denmark	Duke University; Regeneron; AstraZeneca; Eli Lilly; University of Washington; University of Washington Seattle; Duke University; Duke University; Vertex Pharmaceuticals; University of Copenhagen	D'Alessio, DA (corresponding author), Duke Univ, Duke Mol Physiol Inst, Durham, NC 27706 USA.; D'Alessio, DA (corresponding author), Duke Univ, Dept Med, Div Endocrinol, Durham, NC 27706 USA.			Svendsen, Berit/0000-0002-3604-000X; Gray, Sarah/0000-0003-2370-7968	NIDDK, National Institutes of Health [T32-DK007012, F32-DK121420, F32-DK-116542, R01 DK123075, R01 DK101991]; Carlsberg Foundation Grant [CF16-0996]; Lundbeck Foundation [2016-2394]; career development award from the American Diabetes Association Grant [1-18-JDF-017]; Eli Lilly and Company through the Lilly Research Award Program (LRAP)	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Carlsberg Foundation Grant; Lundbeck Foundation(Lundbeckfonden); career development award from the American Diabetes Association Grant; Eli Lilly and Company through the Lilly Research Award Program (LRAP)	This work was supported by NIDDK, National Institutes of Health Grants T32-DK007012 and F32-DK121420 (to S. M. G), F32-DK-116542 (to M. E. C.), T32-DK007012 (to K. E.), R01 DK123075 (to J. E. C.), and R01 DK101991 (to D. A. D.); Carlsberg Foundation Grant CF16-0996 and Lundbeck Foundation Grant 2016-2394 (to B. S.). This work was also supported by career development award from the American Diabetes Association Grant 1-18-JDF-017 (to J. E. C.). J. E. C. is a Borden Scholar. A portion of this work was supported by Eli Lilly and Company through the Lilly Research Award Program (LRAP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adriaenssens AE, 2016, DIABETOLOGIA, V59, P2156, DOI 10.1007/s00125-016-4033-1; [Anonymous], 2019, JCI INSIGHT; Ast J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14309-w; Aulinger BA, 2015, J CLIN ENDOCR METAB, V100, P2489, DOI 10.1210/jc.2014-4009; Baeyens L, 2016, DIABETES OBES METAB, V18, P63, DOI 10.1111/dom.12716; Baron M, 2016, CELL SYST, V3, P346, DOI 10.1016/j.cels.2016.08.011; Biggs EK, 2018, DIABETOLOGIA, V61, P711, DOI 10.1007/s00125-017-4491-0; Bonde L, 2013, DIABETES OBES METAB, V15, P713, DOI 10.1111/dom.12082; Buenaventura T, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000097; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Capozzi ME, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126742; Capozzi ME, 2018, ENDOCR REV, V39, P719, DOI 10.1210/er.2018-00117; Coskun T, 2018, MOL METAB, V18, P3, DOI 10.1016/j.molmet.2018.09.009; de Heer J, 2008, DIABETOLOGIA, V51, P2263, DOI 10.1007/s00125-008-1149-y; DiGruccio MR, 2016, MOL METAB, V5, P449, DOI 10.1016/j.molmet.2016.04.007; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Finan B, 2015, NAT MED, V21, P27, DOI 10.1038/nm.3761; Frias JP, 2017, CELL METAB, V26, P343, DOI 10.1016/j.cmet.2017.07.011; Grun D, 2016, CELL STEM CELL, V19, P266, DOI 10.1016/j.stem.2016.05.010; Kjems LL, 2003, DIABETES, V52, P380, DOI 10.2337/diabetes.52.2.380; Lawlor N, 2017, GENOME RES, V27, P208, DOI 10.1101/gr.212720.116; Mawla AM, 2019, DIABETES, V68, P1380, DOI 10.2337/dbi18-0019; Moffett RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096863; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; NAUCK MA, 1993, J CLIN ENDOCR METAB, V76, P912, DOI 10.1210/jcem.76.4.8473405; Orgaard A, 2017, DIABETOLOGIA, V60, P1731, DOI 10.1007/s00125-017-4315-2; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; PIPELEERS DG, 1981, DIABETOLOGIA, V20, P654; Rajan S, 2015, MOL METAB, V4, P265, DOI 10.1016/j.molmet.2015.01.010; Ramracheya R, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13852; Rebholz SL, 2012, AM J PHYSIOL-ENDOC M, V302, pE449, DOI 10.1152/ajpendo.00487.2011; Richards P, 2014, DIABETES, V63, P1224, DOI 10.2337/db13-1440; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Saponaro C, 2019, CELL REP, V28, P1447, DOI 10.1016/j.celrep.2019.07.009; SCAGLIA L, 1995, ENDOCRINOLOGY, V136, P5461, DOI 10.1210/en.136.12.5461; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tornehave D, 2008, J HISTOCHEM CYTOCHEM, V56, P841, DOI 10.1369/jhc.2008.951319; VANDEWINKEL M, 1982, BIOCHEM BIOPH RES CO, V107, P525, DOI 10.1016/0006-291X(82)91523-6; Wang YJ, 2019, CELL METAB, V29, P539, DOI 10.1016/j.cmet.2018.11.016; Williams EK, 2016, CELL, V166, P209, DOI 10.1016/j.cell.2016.05.011; Xin Y, 2018, DIABETES, V67, P1783, DOI 10.2337/db18-0365; Xin YR, 2016, CELL METAB, V24, P608, DOI 10.1016/j.cmet.2016.08.018; Xu G, 2007, DIABETES, V56, P1551, DOI 10.2337/db06-1033; Xue Y, 2010, ENDOCRINE, V37, P83, DOI 10.1007/s12020-009-9273-0; Zhang YQ, 2019, DIABETES, V68, P34, DOI 10.2337/db18-0317	54	18	18	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11529	11541		10.1074/jbc.RA120.014368	http://dx.doi.org/10.1074/jbc.RA120.014368			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32554468	Green Published, hybrid			2022-12-26	WOS:000563922500014
J	Adu-Oppong, B; Mangan, SA; Stein, C; Catano, CP; Myers, JA; Dantas, G				Adu-Oppong, Boahemaa; Mangan, Scott A.; Stein, Claudia; Catano, Christopher P.; Myers, Jonathan A.; Dantas, Gautam			Prairie plants harbor distinct and beneficial root-endophytic bacterial communities	PLOS ONE			English	Article							SOIL FEEDBACK; RHIZOSPHERE MICROBIOME; DIVERSITY; POPULATION; DYNAMICS; BIOTA; ANTIBIOTICS; PRODUCTIVITY; BIODIVERSITY; BIOGEOGRAPHY	Plant-soil feedback studies attempt to understand the interplay between composition of plant and soil microbial communities. A growing body of literature suggests that plant species can coexist when they interact with a subset of the soil microbial community that impacts plant performance. Most studies focus on the microbial community in the soil rhizosphere; therefore, the degree to which the bacterial community within plant roots (root-endophytic compartment) influences plant-microbe interactions remains relatively unknown. To determine if there is an interaction between conspecific vs heterospecific soil microbes and plant performance, we sequenced root-endophytic bacterial communities of five tallgrass-prairie plant species, each reciprocally grown with soil microbes from each hosts' soil rhizosphere. We found evidence of plant-soil feedbacks for some pairs of plant hosts; however, the strength and direction of feedbacks varied substantially across plant species pairs-from positive to negative feedbacks. Additionally, each plant species harbored a unique subset of root-endophytic bacteria. Conspecifics that hosted similar bacterial communities were more similar in biomass than individuals that hosted different bacterial communities, suggesting an important functional link between root-endophytic bacterial community composition and plant fitness. Our findings suggest a connection between an understudied component of the root-endophytic microbiome and plant performance, which may have important implications in understanding plant community composition and coexistence.	[Adu-Oppong, Boahemaa; Dantas, Gautam] Washington Univ, Sch Med, Edison Family Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA; [Mangan, Scott A.; Catano, Christopher P.; Myers, Jonathan A.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Mangan, Scott A.; Catano, Christopher P.; Myers, Jonathan A.] Washington Univ, Tyson Res Ctr, St Louis, MO 63110 USA; [Stein, Claudia] Auburn Univ, Dept Biol & Environm Sci, Montgomery, AL 36117 USA; [Catano, Christopher P.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Dantas, Gautam] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Dantas, Gautam] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Dantas, Gautam] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Auburn University System; Auburn University; Michigan State University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Dantas, G (corresponding author), Washington Univ, Sch Med, Edison Family Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA.; Dantas, G (corresponding author), Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Dantas, G (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Dantas, G (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA.	dantas@wustl.edu	Stein, Claudia/AAV-8970-2020	Adu-Oppong, Boahemaa/0000-0002-1185-6598	NIH Director's New Innovator Award; National Institute of Diabetes and Digestive and Kidney Diseases [DP2DK098089]; National Institute of General Medical Sciences [R01GM099538]; National Science Foundation [DGE1143945]	NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF))	G.D. from the NIH Director's New Innovator Award, the National Institute of Diabetes and Digestive and Kidney Diseases (DP2DK098089) and the National Institute of General Medical Sciences (R01GM099538). B.A. was supported by National Science Foundation graduate research fellow (award number DGE1143945). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank Mike Dryer, Darlene Branson, Khadine Gomez, Max Herzog, Kevin Stiles, and the undergraduates of the Mangan Lab for their assistance in the greenhouse, Jessica Hoisington-Lopez, Eric Martin, and Brian Koebbe for next-generation sequencing and high-throughput computing support at the Edison Family Center for Genome Sciences and Systems Biology at Washington University in St Louis School of Medicine, and members of the Dantas lab for insightful discussions of the results and conclusions.	[Anonymous], 2015, ANN ONCOL S5, V26, pv174; [Anonymous], 2019, CANC DISCOV, V10, pOF5; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 1996, PRAIRIE CONSERVATION; [Anonymous], 2013, PSYCHIAT SERV, V64, pe10; Batten KM, 2008, MICROB ECOL, V55, P220, DOI 10.1007/s00248-007-9269-3; Bennett JA, 2017, SCIENCE, V355, P181, DOI 10.1126/science.aai8212; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bever JD, 2015, ANNU REV ECOL EVOL S, V46, P305, DOI 10.1146/annurev-ecolsys-112414-054306; Bever JD, 2013, ECOL LETT, V16, P167, DOI 10.1111/ele.12024; Bever JD, 2012, ANNU REV MICROBIOL, V66, P265, DOI 10.1146/annurev-micro-092611-150107; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Bonanomi G, 2005, OIKOS, V111, P311, DOI 10.1111/j.0030-1299.2005.13975.x; Brinkman EP, 2010, J ECOL, V98, P1063, DOI 10.1111/j.1365-2745.2010.01695.x; Brun S, 2001, EUR J CLIN MICROBIOL, V20, P718, DOI 10.1007/s100960100577; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Burns JH, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv030; Callaway RM, 2004, ECOLOGY, V85, P1062, DOI 10.1890/02-0775; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaparro JM, 2014, ISME J, V8, P790, DOI 10.1038/ismej.2013.196; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; Coleman-Derr D, 2016, NEW PHYTOL, V209, P798, DOI 10.1111/nph.13697; Cumming JR, 2007, J TORREY BOT SOC, V134, P63, DOI 10.3159/1095-5674(2007)134[63:PVIISA]2.0.CO;2; Du L, 2012, AGRON SUSTAIN DEV, V32, P309, DOI DOI 10.1007/s13593-011-0062-9; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Eppinga MB, 2018, NAT ECOL EVOL, V2, P1403, DOI 10.1038/s41559-018-0622-3; Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459; Faisal M, 2006, LETT APPL MICROBIOL, V43, P461, DOI 10.1111/j.1472-765X.2006.01977.x; Fitzpatrick CR, 2018, P NATL ACAD SCI; Gornish ES, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163930; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Gustafson DJ, 2004, PLANT SOIL, V259, P9, DOI 10.1023/B:PLSO.0000020936.56786.a4; Hacquard S, 2016, NEW PHYTOL, V209, P454, DOI 10.1111/nph.13760; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Hammesfahr U, 2008, SOIL BIOL BIOCHEM, V40, P1583, DOI 10.1016/j.soilbio.2008.01.010; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hartnett DC, 2002, PLANT SOIL, V244, P319, DOI 10.1023/A:1020287726382; Hervu M., 2015, RVAIDEMEMOIRE DIVERS; Hu LF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05122-7; Kaisermann A, 2017, NEW PHYTOL, V215, P1413, DOI 10.1111/nph.14661; Keymer DP, 2017, J ECOL, V105, P816, DOI 10.1111/1365-2745.12716; Kim H, 1998, J APPL MICROBIOL, V85, P731, DOI 10.1111/j.1365-2672.1998.00586.x; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kourtev PS, 2003, SOIL BIOL BIOCHEM, V35, P895, DOI 10.1016/S0038-0717(03)00120-2; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Larsson DGJ, 2014, UPSALA J MED SCI, V119, P108, DOI 10.3109/03009734.2014.896438; Lebeis SL, 2015, SCIENCE, V349, P860, DOI 10.1126/science.aaa8764; Leebens-Mack Y., 2012, GENOME BIOL, V13, pR3; Leff JW, 2017, NEW PHYTOL, V214, P412, DOI 10.1111/nph.14323; Lesk C, 2016, NATURE, V529, P84, DOI 10.1038/nature16467; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luby E, 2016, J ENVIRON QUAL, V45, P441, DOI 10.2134/jeq2015.07.0367; Martinez JL, 2009, ENVIRON POLLUT, V157, P2893, DOI 10.1016/j.envpol.2009.05.051; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Majeed A, 2018, PLANT CELL REP, V37, P1599, DOI 10.1007/s00299-018-2341-2; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Mayak S, 2004, PLANT SCI, V166, P525, DOI 10.1016/j.plantsci.2003.10.025; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meisner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031596; Naylor D, 2017, ISME J, V11, P2691, DOI 10.1038/ismej.2017.118; Oksanen J, 2013, R PACKAGE, V2, P9; Paredes SH, 2016, FUNCT ECOL, V30, P1043, DOI 10.1111/1365-2435.12684; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Prober SM, 2015, ECOL LETT, V18, P85, DOI 10.1111/ele.12381; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Reinhart KO, 2004, ECOL APPL, V14, P1737, DOI 10.1890/03-5204; Reinhart KO, 2003, ECOL LETT, V6, P1046, DOI 10.1046/j.1461-0248.2003.00539.x; Reinhart KO, 2010, NEW PHYTOL, V186, P484, DOI 10.1111/j.1469-8137.2009.03159.x; Reinhold-Hurek B, 2015, ANNU REV PHYTOPATHOL, V53, P403, DOI 10.1146/annurev-phyto-082712-102342; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Semedo M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02121; Shakya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076382; Shannon S, 2012, OECOLOGIA, V169, P235, DOI 10.1007/s00442-011-2195-6; Stockwell VO, 2012, REV SCI TECH OIE, V31, P199; Stringlis IA, 2018, P NATL ACAD SCI USA, V115, pE5213, DOI 10.1073/pnas.1722335115; Suding KN, 2013, J ECOL, V101, P298, DOI 10.1111/1365-2745.12057; Thiele-Bruhn S, 2005, CHEMOSPHERE, V59, P457, DOI 10.1016/j.chemosphere.2005.01.023; Timmusk S, 1999, MOL PLANT MICROBE IN, V12, P951, DOI 10.1094/MPMI.1999.12.11.951; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; van der Heijden MGA, 2006, FEMS MICROBIOL ECOL, V56, P178, DOI 10.1111/j.1574-6941.2006.00086.x; van Grunsven RHA, 2007, J ECOL, V95, P1050, DOI 10.1111/j.1365-2745.2007.01282.x; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wagner MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12151; Walters WA, 2018, P NATL ACAD SCI USA, V115, P7368, DOI 10.1073/pnas.1800918115; Wassermann B, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0723-5; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Whitaker BK, 2017, ECOL LETT, V20, P1064, DOI 10.1111/ele.12805; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wohlwend MR, 2019, RESTOR ECOL, V27, P1307, DOI 10.1111/rec.13006; Wolfe BE, 2005, BIOSCIENCE, V55, P477, DOI 10.1641/0006-3568(2005)055[0477:BNGSCA]2.0.CO;2; Zhalnina K, 2018, NAT MICROBIOL, V3, P470, DOI 10.1038/s41564-018-0129-3; Zuppinger-Dingley D, 2014, NATURE, V515, P108, DOI 10.1038/nature13869	102	0	0	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0234537	10.1371/journal.pone.0234537	http://dx.doi.org/10.1371/journal.pone.0234537			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574172	Green Published, gold			2022-12-26	WOS:000544972400040
J	Ihmig, FR; Gogeascoechea, HA; Neurohr-Parakenings, F; Schafer, SK; Lass-Hennemann, J; Michael, T				Ihmig, Frank R.; Gogeascoechea, Antonio H.; Neurohr-Parakenings, Frank; Schaefer, Sarah K.; Lass-Hennemann, Johanna; Michael, Tanja			On-line anxiety level detection from biosignals: Machine learning based on a randomized controlled trial with spider-fearful individuals	PLOS ONE			English	Article							REALITY EXPOSURE THERAPY; STRESS; METAANALYSIS; AGREEMENT; PHOBIA	We present performance results concerning the validation for anxiety level detection based on trained mathematical models using supervised machine learning techniques. The model training is based on biosignals acquired in a randomized controlled trial. Wearable sensors were used to collect electrocardiogram, electrodermal activity, and respiration from spider-fearful individuals. We designed and applied ten approaches for data labeling considering individual biosignals as well as subjective ratings. Performance results revealed a selection of trained models adapted for two-level (low and high) and three-level (low, medium and high) classification of anxiety using a minimal set of six features. We obtained a remarkable accuracy of 89.8% for the two-level classification and of 74.4% for the three-level classification using a short time window length of ten seconds when applying the approach that uses subjective ratings for data labeling.Bagged Treesproved to be the most suitable classifier type among the classification models studied. The trained models will have a practical impact on the feasibility study of an augmented reality exposure therapy based on a therapeutic game for the treatment of arachnophobia.	[Ihmig, Frank R.; Neurohr-Parakenings, Frank] Fraunhofer Inst Biomed Tech IBMT, Dept Biomed Microsyst, Sulzbach, Germany; [Gogeascoechea, Antonio H.] Univ Twente, Fac Elect Engn Math & Comp Sci, Enschede, Netherlands; [Schaefer, Sarah K.; Lass-Hennemann, Johanna; Michael, Tanja] Saarland Univ, Dept Psychol, Div Clin Psychol & Psychotherapy, Saarbrucken, Germany	Fraunhofer Gesellschaft; University of Twente; Saarland University	Ihmig, FR (corresponding author), Fraunhofer Inst Biomed Tech IBMT, Dept Biomed Microsyst, Sulzbach, Germany.	frank.ihmig@ibmt.fraunhofer.de			German Federal Ministry of Education and Research through an applied research grant [13GW0158B, 13GW0158C]	German Federal Ministry of Education and Research through an applied research grant	This research is funded by the German Federal Ministry of Education and Research through an applied research grant (contract numbers 13GW0158B and 13GW0158C) within the program "Medical technology solutions for the digital healthcare". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alom MZ, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8030292; [Anonymous], 2015, DIABET CARE S1, V38, pS4, DOI DOI https://doi.org/10.2337/dc15-S005; Barua S, 2015, STUD HEALTH TECHNOL, V211, P241, DOI 10.3233/978-1-61499-516-6-241; Ben-David A, 2008, EXPERT SYST APPL, V34, P825, DOI 10.1016/j.eswa.2006.10.022; Bishop C. M., 2006, SPRINGER; Braithwaite Watson, 2013, TECHNICAL REPORT; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CACIOPPO JT, 1980, AM J PSYCHOL, V93, P173, DOI 10.2307/1422117; Camm AJ, 1996, CIRCULATION, V93, P1043; Cardos RAI, 2017, COMPUT HUM BEHAV, V72, P371, DOI 10.1016/j.chb.2017.03.007; Carl E, 2019, J ANXIETY DISORD, V61, P27, DOI 10.1016/j.janxdis.2018.08.003; Chen LL, 2017, EXPERT SYST APPL, V85, P279, DOI 10.1016/j.eswa.2017.01.040; Choi J, 2010, IEEE SENSOR, P150, DOI 10.1109/ICSENS.2010.5690677; Christy T, 2014, GSTF J COMPUT, V3, P29; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Deterding S., 2011, P 15 INT ACAD MINDTR, P9; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; El Khayat GA, 2012, 2012 17TH INTERNATIONAL CONFERENCE ON COMPUTER GAMES (CGAMES), P30, DOI 10.1109/CGames.2012.6314547; Emmelkamp PMG, 2005, PSYCHOTHER PSYCHOSOM, V74, P336, DOI 10.1159/000087780; Fodor LA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28113-6; Fu WJJ, 2005, BIOINFORMATICS, V21, P1979, DOI 10.1093/bioinformatics/bti294; Gevirtz R., 2013, BIOFEEDBACK, V41, P110, DOI [10.5298/1081-5937-41.3.01, DOI 10.5298/1081-5937-41.3.01]; Giannakakis G, 2019, IEEE T AFFECTIVE COM, P1; GROSSMAN P, 1983, PSYCHOPHYSIOLOGY, V20, P284, DOI 10.1111/j.1469-8986.1983.tb02156.x; Hammad M, 2019, FUTURE GENER COMP SY, V101, P180, DOI 10.1016/j.future.2019.06.008; Hammad M, 2018, MEASUREMENT, V125, P634, DOI 10.1016/j.measurement.2018.05.033; Handouzi W, 2013, IEEE SYS MAN CYBERN, P3145, DOI 10.1109/SMC.2013.536; Healey JA, 2005, IEEE T INTELL TRANSP, V6, P156, DOI 10.1109/TITS.2005.848368; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Kampmann IL, 2016, BEHAV RES THER, V77, P147, DOI 10.1016/j.brat.2015.12.016; Keshan N, 2015, PROCEEDINGS 2015 IEEE INTERNATIONAL CONFERENCE ON BIG DATA, P2661, DOI 10.1109/BigData.2015.7364066; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liu Y, 2018, BEHAV BRAIN RES, V341, P50, DOI 10.1016/j.bbr.2017.12.021; LYKKEN DT, 1966, PSYCHOL BULL, V66, P481, DOI 10.1037/h0023922; McDuff D, 2014, IEEE ENG MED BIO, P2957, DOI 10.1109/EMBC.2014.6944243; Mclay RN, 2017, CYBERPSYCH BEH SOC N, V20, P218, DOI 10.1089/cyber.2016.0554; Morina N, 2015, BEHAV RES THER, V74, P18, DOI 10.1016/j.brat.2015.08.010; Nemcova A, 2016, C PAPER EEICT, P543; Newman MG, 2011, CLIN PSYCHOL REV, V31, P89, DOI 10.1016/j.cpr.2010.09.008; Olatunji BO, 2009, COGN BEHAV PRACT, V16, P172, DOI 10.1016/j.cbpra.2008.07.003; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Picard RW, 2001, IEEE T PATTERN ANAL, V23, P1175, DOI 10.1109/34.954607; Rothbaum BO, 2000, J CONSULT CLIN PSYCH, V68, P1020, DOI 10.1037/0022-006X.68.6.1020; Rothbaurn BO, 2010, ANN NY ACAD SCI, V1208, P126, DOI 10.1111/j.1749-6632.2010.05691.x; Schafer SK, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2554-2; Sedghamiz H., 2014, MATLAB IMPLEMENTATIO; Shiban Y, 2015, BEHAV RES THER, V71, P45, DOI 10.1016/j.brat.2015.05.014; Siegel EH, 2018, PSYCHOL BULL, V144, P343, DOI 10.1037/bul0000128; SPITZER L, 1989, ANNU REV ASTRON ASTR, V27, P1; Wardenaar KJ, 2017, PSYCHOL MED, V47, P1744, DOI [10.1017/S0033291717000174, 10.1017/s0033291717000174]; Wolitzky-Taylor KB, 2008, CLIN PSYCHOL REV, V28, P1021, DOI 10.1016/j.cpr.2008.02.007	51	17	18	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0231517	10.1371/journal.pone.0231517	http://dx.doi.org/10.1371/journal.pone.0231517			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ME9KK	32574167	Green Published, gold			2022-12-26	WOS:000544972400002
J	Roland, MCP; Lekva, T; Godang, K; Bollerslev, J; Henriksen, T				Roland, Marie Cecilie Paasche; Lekva, Tove; Godang, Kristin; Bollerslev, Jens; Henriksen, Tore			Changes in maternal blood glucose and lipid concentrations during pregnancy differ by maternal body mass index and are related to birthweight: A prospective, longitudinal study of healthy pregnancies	PLOS ONE			English	Article							MODIFIABLE DETERMINANTS; OVERWEIGHT; OBESITY; GAIN	Background Maternal obesity is increasing worldwide but the consequences for maternal physiology and fetal growth are not fully understood. Objective To study whether changes in glucose and lipid metabolism during pregnancy differ between women with normal weight and overweight/obesity, and investigate which of these metabolic factors are associated with birthweight. Design Prospective, longitudinal study. Setting Department of Obstetrics, Oslo University Hospital, Rikshospitalet. Population 1031 healthy pregnant women with singleton pregnancies. Methods Blood samples from early and late pregnancy were analyzed for fasting glucose, insulin and lipids (total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides). Associations between metabolic factors and birthweight (z-scores) were explored by linear regression models. Main Outcome Measures: Group-dependent longitudinal changes in glucose and lipids and their association with birthweight (z-scores). Results Compared to women with normal weight (BMI < 25), women with overweight (BMI 25-29.9) and obesity (BMI > 30) had significantly higher fasting glucose (4.54, 4.68 and 4.84 mmol/l), insulin (23, 33 and 50 pmol/l), total cholesterol (4.85, 4.99 and 5.14 mmol/l), LDL-C (2.49, 2.66 and 2.88 mmol/l) and triglycerides (1.10, 1.28 and 1.57 mmol/l), but lower HDL-C (1.86, 1.75 and 1.55 mmol/l). BMI (B 0.05, 95% CI 0.03-0.06, p<0.001), gestational weight gain (GWG) (B 0.06, 0.05-0.08, p<0.001) and an increase in fasting glucose (B 0.30, 0.16-0.43, p<0.001) were positively associated with birthweight, whereas a decrease in HDL-C (B -0.72, -0.96- -0.53, p<0.001) had a negative association with birthweight. Conclusions Overweight/obesity was associated with an unfavorable metabolic profile in early pregnancy which was associated with increased birthweight. However, modifiable factors like gestational weight gain and an increase in fasting glucose were identified and can be targeted for interventions.	[Roland, Marie Cecilie Paasche] Oslo Univ Hosp, Dept Obstet, Oslo, Norway; [Roland, Marie Cecilie Paasche] Oslo Univ Hosp, Natl Advisory Unit Womens Hlth, Oslo, Norway; [Lekva, Tove] Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway; [Godang, Kristin; Bollerslev, Jens] Oslo Univ Hosp, Dept Endocrinol, Oslo, Norway; [Bollerslev, Jens; Henriksen, Tore] Univ Oslo, Dept Clin Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Roland, MCP (corresponding author), Oslo Univ Hosp, Dept Obstet, Oslo, Norway.; Roland, MCP (corresponding author), Oslo Univ Hosp, Natl Advisory Unit Womens Hlth, Oslo, Norway.	mcpaasche@hotmail.com		Lekva, Tove/0000-0002-7962-4726	National Advisory Unit for Women's Health after external peer review for scientific quality	National Advisory Unit for Women's Health after external peer review for scientific quality	MCPR was awarded a 3 years postdoctoral grant from the National Advisory Unit for Women's Health after external peer review for scientific quality. The funding body has played no role in conducting the research or writing the paper.	Barbour LA, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1008-2; Barker DJP, 2013, CLIN OBSTET GYNECOL, V56, P511, DOI 10.1097/GRF.0b013e31829cb9ca; Bozkurt L, 2016, SCI REP-UK, V6, DOI 10.1038/srep29971; Bringhenti I, 2016, NUTRITION, V32, P1138, DOI 10.1016/j.nut.2016.03.001; CATALANO PM, 1992, AM J OBSTET GYNECOL, V167, P913, DOI 10.1016/S0002-9378(12)80011-1; CATALANO PM, 1991, AM J OBSTET GYNECOL, V165, P1667, DOI 10.1016/0002-9378(91)90012-G; Farias D, 2015, BJOG; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Friedman JE, 1999, DIABETES, V48, P1807, DOI 10.2337/diabetes.48.9.1807; Friis CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057467; Geraghty AA, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1543-x; Langer O, 2015, J MATERN-FETAL NEO M, P1, DOI DOI 10.3109/14767058; McIntyre HD, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0098-8; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Metzger Be Fau-Lowe LP, HYPERGLYCEMIA ADVERS, P1533; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; Poston L, 2012, CURR OPIN CLIN NUTR, V15, P252, DOI 10.1097/MCO.0b013e3283527cf2; Qvigstad E, 2010, EUR J ENDOCRINOL, V162, P67, DOI 10.1530/EJE-09-0416; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Roland MCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087303; Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324; Schaefer-Graf UM, 2008, DIABETES CARE, V31, P1858, DOI 10.2337/dc08-0039; Scifres CM, 2014, OBESITY, V22, P932, DOI 10.1002/oby.20576; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Sommer C, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0512-5; Voldner N, 2008, ACTA OBSTET GYN SCAN, V87, P423, DOI 10.1080/00016340801989825; Voldner N, 2009, ACTA OBSTET GYN SCAN, V88, P550, DOI 10.1080/00016340902818162	28	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0232749	10.1371/journal.pone.0232749	http://dx.doi.org/10.1371/journal.pone.0232749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574162	gold, Green Published			2022-12-26	WOS:000544972400037
J	Bhargava, M; Bhargava, A; Ghate, SD; Rao, RSP				Bhargava, Madhavi; Bhargava, Anurag; Ghate, Sudeep D.; Rao, R. Shyama Prasad			Nutritional status of Indian adolescents (15-19 years) from National Family Health Surveys 3 and 4: Revised estimates using WHO 2007 Growth reference	PLOS ONE			English	Article							ACTION GROUP EAG; THINNESS; CHILDREN; GIRLS; PREVALENCE; TRANSITION; OVERWEIGHT	Background The National Family Health Surveys (NFHS) in India apply adult cutoffs of nutritional status for the estimation of undernutrition/overweight in the 15-19 age group. The prevalence of thinness in boys and girls thus estimated is 58.1% and 46.8% in NFHS-3, and 45% and 42% in NFHS-4 respectively. But the WHO recommends using age and sex-specific reference for adolescents. We reanalyzed the nutritional status of the adolescents using the WHO 2007 Growth Reference to obtain revised estimates of thinness, overweight and stunting across states, rural-urban residence, and wealth quintiles. Methods and findings Demographic information, anthropometric data, and wealth index were accessed from the Demographic and Health Survey (DHS) database. We re-analyzed the anthropometric data using WHO AnthroPlus software which uses the WHO 2007 Growth reference. The revised estimates of thinness assessed by BMI-for-age z-scores in boys and girls was 22.3% (95%CI: 21.6, 23.0) and 9.9% (95%CI: 9.5, 10.3) in NFHS-3 and 16.5% (95%CI: 16.0,17.0) and 9% (95%CI: 8.9, 9.2) in NFHS-4 respectively. Stunting was found to be 32.2% (95% CI: 31.6, 32.9) in boys and 34.4% (95% CI: 34.2, 34.7) in girls in NFHS-4. This was higher than that in NFHS-3; 25.2% (95% CI: 24.4, 26) in boys and 31.2 (95% CI: 30.6, 31.8) in girls. There was a clear socioeconomic gradient as there were higher thinness and stunting in rural areas. There was wide variation among the states with pockets of a double burden of malnutrition. Conclusion Using the adult cutoffs significantly overestimates thinness in adolescents in the age group of 15-19 years old in India. Stunting, which is an indicator of long term nutrition is also widely prevalent in them. Future editions of DHS and NFHS should consider adolescents as a separate age group for nutritional assessment for a better understanding of nutritional transition in the population.	[Bhargava, Madhavi] Yenepoya Med Coll, Dept Community Med, Mangalore, Karnataka, India; [Bhargava, Madhavi; Bhargava, Anurag] Yenepoya Deemed Be Univ, Ctr Nutr Studies, Mangalore, Karnataka, India; [Ghate, Sudeep D.] Yenepoya Med Coll, Dept Gen Med, Mangalore, Karnataka, India; [Rao, R. Shyama Prasad] Yenepoya Deemed Be Univ, Yenepoya Res Ctr, Mangalore, Karnataka, India	Yenepoya (Deemed to be University); Yenepoya (Deemed to be University); Yenepoya (Deemed to be University); Yenepoya (Deemed to be University)	Bhargava, M (corresponding author), Yenepoya Med Coll, Dept Community Med, Mangalore, Karnataka, India.; Bhargava, M (corresponding author), Yenepoya Deemed Be Univ, Ctr Nutr Studies, Mangalore, Karnataka, India.	madhavibhargava4@gmail.com	Ghate, Sudeep/GPX-0141-2022; Rao, R Shyama Prasad/E-5434-2011	Rao, R Shyama Prasad/0000-0002-2285-6788; Bhargava, Madhavi/0000-0001-7480-566X	United Nations Children's Fund (UNICEF) [SSFA/2019/07]	United Nations Children's Fund (UNICEF)	MB received grant from The United Nations Children's Fund (UNICEF) SSFA/2019/07. URL of the website available at: https://unicef.in/Karnataka.The funders did not play any role in the design, analysis and preparation of the manuscript.	[Anonymous], 2006, Prescrire Int, V15, P64; [Anonymous], 2016, J AM SOC ECHOCARDIOG, V29, pA19; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2015, 201516 DHS; [Anonymous], 2017, POLICY BRIEF; [Anonymous], 2017, INT J SCI REIJSR, V6, P513, DOI [10.21275/art20178761, DOI 10.21275/ART20178761]; Arokiasamy P, 2013, J BIOSOC SCI, V45, P167, DOI 10.1017/S0021932012000211; Auslander P, 2006, PAJ, P1; Bhargava M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156283; Bulbul T, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-86; Bundy DAP, 2018, LANCET, V391, P687, DOI 10.1016/S0140-6736(17)32417-0; Caleyachetty R, 2018, AM J CLIN NUTR, V108, P414, DOI 10.1093/ajcn/nqy105; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Corsi DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025120; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; Department of Health and Human Services, CDC GROWTH CHARTS US; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Engidaw MT, 2019, CONFL HEALTH, V13, DOI 10.1186/s13031-019-0203-3; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fanzo J., 2019, 2018 GLOBAL NUTR REP; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Ghosh Ayan, 2015, J Family Med Prim Care, V4, P84, DOI 10.4103/2249-4863.152261; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; International Obesity Task Force, 1998, OB PREV MAN GLOB EP; Kapoor SK, 2002, J EPIDEMIOL COMMUN H, V56, P804, DOI 10.1136/jech.56.11.804; Khadilkar VV, 2007, INDIAN PEDIATR, V44, P187; Kumar V, 2016, NATL MED J INDIA, V29, P267; Laxmaiah A, 2007, OBESITY, V15, P1384, DOI 10.1038/oby.2007.165; Lukito Widjaja, 2006, Asia Pac J Clin Nutr, V15 Suppl, P21; Maehara M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221273; Mamidi RS, 2016, FOOD NUTR BULL, V37, P425, DOI 10.1177/0379572116647579; Mansur D I, 2015, Kathmandu Univ Med J (KUMJ), V13, P146; Melaku YA, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0093-9; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Office of Registrar General and Census Commissioner India, 2015, POP EN DAT FIN POP; Partap U, 2019, GLOB HEALTH EPIDEM G, V4, DOI 10.1017/gheg.2019.1; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Popkin BM, 2020, LANCET, V395, P65, DOI 10.1016/S0140-6736(19)32497-3; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Prendergast AJ, 2014, PAEDIATR INT CHILD H, V34, P250, DOI 10.1179/2046905514Y.0000000158; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Rah JH, 2009, PUBLIC HEALTH NUTR, V12, P2400, DOI 10.1017/S1368980009005345; Rohilla Ravi, 2014, J Family Med Prim Care, V3, P404, DOI 10.4103/2249-4863.148127; Sethi V, 2019, PUBLIC HEALTH NUTR, V22, P2189, DOI 10.1017/S1368980019000594; Shahabuddin A.K.M., 2000, Indian Journal of Pediatrics, V67, P93, DOI 10.1007/BF02726173; Soliman Ashraf, 2014, Indian J Endocrinol Metab, V18, pS39, DOI 10.4103/2230-8210.145073; Spears D, 2012, ECON HUM BIOL, V10, P210, DOI 10.1016/j.ehb.2011.08.005; Story M., 1992, TXB ADOLESCENT MED, P75; Suguitan Jr AL, 2011, PLOS ONE, V6; Tanner J M, 1987, Acta Paediatr Jpn, V29, P96; Tumilowicz A, 2019, ADV NUTR, V10, P563, DOI 10.1093/advances/nmy133; UNICEF, 2019, AD DEM UNICEF DATA; United Nations Department of Economic and Social Affairs, 2019, WORLD POP PROSP 2019; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO, 2009, WHO ANTHR PER COMP S; World Health Organization, 2001, 2 DEC IMPR AD HLTH D	58	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234570	10.1371/journal.pone.0234570	http://dx.doi.org/10.1371/journal.pone.0234570			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569312	Green Published, gold			2022-12-26	WOS:000543547900037
J	Kotanska, M; Dziubina, A; Szafarz, M; Mika, K; Regula, K; Bednarski, M; Zygmunt, M; Drabczynska, A; Sapa, J; Kiec-Kononowicz, K				Kotanska, Magdalena; Dziubina, Anna; Szafarz, Malgorzata; Mika, Kamil; Regula, Karolina; Bednarski, Marek; Zygmunt, Malgorzata; Drabczynska, Anna; Sapa, Jacek; Kiec-Kononowicz, Katarzyna			KD-64-A new selective A(2A)adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist-Caffeine does not reduce diet-induced obesity in mice	PLOS ONE			English	Article							ADENOSINE A(2A) RECEPTORS; ADIPOSE-TISSUE; ENERGY-INTAKE; INFLAMMATION; MECHANISMS; HYPERGLYCEMIA; CONSUMPTION; ACTIVATION; EXPRESSION; ADIPOKINES	The A(2)adenosine receptors play an important role, among others, in the regulation of inflammatory process and glucose homeostasis in diabetes and obesity. Thus, the presented project evaluated of influence of the selective antagonist of A(2A)adenosine receptor-KD-64 as compared to the known non-selective antagonist-caffeine on these two particular processes. Two different inflammation models were induced namely local and systemic inflammation. Obesity was induced in mice by high-fat diet and the tested compounds (KD-64 and caffeine) were administrated for 21 days. KD-64 showed anti-inflammatory effect in both tested inflammation models and administered at the same dose as ketoprofen exerted stronger effect than this reference compound. Elevated levels of IL-6 and TNF-alpha observed in obese control mice were significantly lowered by the administration of KD-64 and were similar to the values observed in control non-obese mice. Interestingly, caffeine increased the levels of these parameters. In contrast to caffeine which had no influence on AlaT activity, KD-64 administration significantly lowered AlaT activity in the obese mice. Although, contrary to caffeine, KD-64 did not reduce diet-induced obesity in mice, it improved glucose tolerance. Thus, the activity of the selective adenosine A(2A)receptor antagonist was quite different from that of the non-selective.	[Kotanska, Magdalena; Mika, Kamil; Regula, Karolina; Bednarski, Marek; Zygmunt, Malgorzata; Sapa, Jacek] Jagiellonian Univ Med Coll, Dept Pharmacol Screening, Krakow, Poland; [Dziubina, Anna] Jagiellonian Univ Med Coll, Dept Pharmacodynam, Krakow, Poland; [Szafarz, Malgorzata] Jagiellonian Univ Med Coll, Dept Pharmacokinet & Phys Pharm, Krakow, Poland; [Drabczynska, Anna; Kiec-Kononowicz, Katarzyna] Jagiellonian Univ Med Coll, Fac Pharm, Dept Technol & Biotechnol Drugs, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Kotanska, M (corresponding author), Jagiellonian Univ Med Coll, Dept Pharmacol Screening, Krakow, Poland.	magda.dudek@uj.edu.pl	Kotańska, Magdalena/AAX-5140-2021; Mika, Kamil/ABB-5630-2020	Kotańska, Magdalena/0000-0002-3946-1192; SAPA, JACEK/0000-0003-4670-1665	Faculty of Pharmacy Jagiellonian University Medical College, Krakow, Poland [N42/DBS/000039]	Faculty of Pharmacy Jagiellonian University Medical College, Krakow, Poland	KK-K received each award. This work was supported by statutory funds N42/DBS/000039 from the Faculty of Pharmacy Jagiellonian University Medical College, Krakow, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro TM, 2017, PULM PHARMACOL THER, V45, P90, DOI 10.1016/j.pupt.2017.04.009; [Anonymous], 1999, FRANCISCAN STUDIES, V57, P79; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Azizian M, 2016, ANN CLIN BIOCHEM, V53, P663, DOI 10.1177/0004563216629997; Badescu S V, 2016, J Med Life, V9, P275; Bakuradze T, 2014, FOOD RES INT, V63, P420, DOI 10.1016/j.foodres.2014.05.032; Bilkei-Gorzo A, 2008, N-S ARCH PHARMACOL, V377, P65, DOI 10.1007/s00210-007-0252-9; Bina KG, 2000, NEUROENDOCRINOLOGY, V71, P68, DOI 10.1159/000054522; Bynoe MS, 2015, FLUIDS BARRIERS CNS, V2, P12; Carrageta DF, 2018, J FUNCT FOODS, V43, P84, DOI 10.1016/j.jff.2018.02.001; Chavez-Valdez R, 2009, PEDIATR RES, V65, P203, DOI 10.1203/PDR.0b013e31818d66b1; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Cincotta AH, 1997, LIFE SCI, V61, P951, DOI 10.1016/S0024-3205(97)00599-7; Csoka B, 2017, FASEB J, V31, P4985, DOI 10.1096/fj.201700398R; Cully M, 2014, NAT REV DRUG DISCOV, V13, P886, DOI 10.1038/nrd4490; Davis CA, 2009, OBESITY, V17, P1220, DOI 10.1038/oby.2009.52; Davoodi SH, 2014, IRAN J PHARM RES, V13, P707; Di Bonaventura MVM, 2019, J PSYCHOPHARMACOL, V33, P1550, DOI 10.1177/0269881119845798; Drabczynska A, 2011, EUR J MED CHEM, V46, P3590, DOI 10.1016/j.ejmech.2011.05.023; Drabczynska A, 2011, ARCH PHARM, V344, P20, DOI 10.1002/ardp.201000124; Dudek M, 2016, METAB BRAIN DIS, V31, P1023, DOI 10.1007/s11011-016-9840-z; Dudek M, 2015, METAB BRAIN DIS, V30, P1487, DOI 10.1007/s11011-015-9736-3; Dulloo AG, 2011, OBES REV, V12, P866, DOI 10.1111/j.1467-789X.2011.00909.x; El Yacoubi M, 2000, BRIT J PHARMACOL, V129, P1465, DOI 10.1038/sj.bjp.0703170; Ellulu MS, 2017, ARCH MED SCI, V13, P851, DOI 10.5114/aoms.2016.58928; Fang CY, 2019, BBA-MOL CELL BIOL L, V1864, P271, DOI 10.1016/j.bbalip.2018.12.003; Fenu S, 1997, EUR J PHARMACOL, V321, P143, DOI 10.1016/S0014-2999(96)00944-2; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; FINK JS, 1992, MOL BRAIN RES, V14, P186, DOI 10.1016/0169-328X(92)90173-9; Giri B, 2018, BIOMED PHARMACOTHER, V107, P306, DOI 10.1016/j.biopha.2018.07.157; Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hong F, 2004, HEPATOLOGY, V40, P933, DOI 10.1002/hep.20400; Iris M, 2018, CLIN IMMUNOL, V192, P68, DOI 10.1016/j.clim.2018.04.008; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Knowles A, 2015, PHILOSOPHIA-J CONT F, V5, P1; Kolaczkowska E, 2008, INFLAMM RES, V57, P272, DOI 10.1007/s00011-007-7131-1; Kotanska M, 2019, BIOCHEM PHARMACOL, V168, P193, DOI 10.1016/j.bcp.2019.07.006; Kotanska M, 2018, N-S ARCH PHARMACOL, V391, P875, DOI 10.1007/s00210-018-1516-2; Kwiecien B, 2013, POSTEP HIG MED DOSW, V67, P331, DOI 10.5604/17322693.1046290; Lee EB, 2014, ACTA NEUROPATHOL, V127, P3, DOI 10.1007/s00401-013-1190-x; Leon-Cabrera S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/493409; Li L, 2010, NEUROSCIENCE, V170, P923, DOI 10.1016/j.neuroscience.2010.07.045; Liu AG, 2013, OBESITY, V314, P433; Liu AG, 2015, OBESITY, V23, P1830, DOI 10.1002/oby.21163; Liu CW, 2018, AM J PHYSIOL-ENDOC M, V314, pE433, DOI 10.1152/ajpendo.00094.2017; Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674; Lv XW, 2010, INFLAMM RES, V59, P635, DOI 10.1007/s00011-010-0176-6; Mingote S, 2008, PHARMACOL BIOCHEM BE, V89, P345, DOI 10.1016/j.pbb.2008.01.006; Nathan C, 2008, MOL MED, V14, P485, DOI 10.2119/2008-00038.Nathan; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pardo F, 2017, MOL ASPECTS MED, V55, P90, DOI 10.1016/j.mam.2017.01.003; Reece TB, 2005, J THORAC CARDIOV SUR, V129, P1137, DOI 10.1016/j.jtcvs.2004.11.042; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Sawynok J, 1999, EUR J PHARMACOL, V386, P253, DOI 10.1016/S0014-2999(99)00752-9; Schubert MM, 2014, J APPL PHYSIOL, V117, P745, DOI 10.1152/japplphysiol.00570.2014; Scislowski PWD, 1999, INT J OBESITY, V23, P425, DOI 10.1038/sj.ijo.0800893; Sharma AK, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-58; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Sitaraman SV, 2001, J CLIN INVEST, V107, P861, DOI 10.1172/JCI11783; Stenberg D, 2007, CELL MOL LIFE SCI, V64, P1187, DOI 10.1007/s00018-007-6530-3; Tauler P, 2013, MED SCI SPORT EXER, V45, P1269, DOI 10.1249/MSS.0b013e3182857c8a; Trayhurn P, 2005, ENDOCRINOLOGY, V146, P1003, DOI 10.1210/en.2004-1597; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Umapathy NS, 2010, VASC PHARMACOL, V52, P199, DOI 10.1016/j.vph.2009.12.008; Villar-Menendez I, 2014, J PSYCHIATR RES, V51, P49, DOI 10.1016/j.jpsychires.2013.12.013; Villar-Menendez I, 2013, NEUROMOL MED, V15, P295, DOI 10.1007/s12017-013-8219-0; von Loeffelholz C, 2017, HEPATOLOGY, V66, P616, DOI 10.1002/hep.29089; Walker GJ, 2007, MED SCI SPORT EXER, V39, P1554, DOI 10.1249/mss.0b013e3180a74228; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; Yaar R, 2005, J CELL PHYSIOL, V202, P9, DOI 10.1002/jcp.20138; Yao ZY, 2019, INFLAMM RES, V68, P815, DOI 10.1007/s00011-019-01269-1; Yazawa K, 2011, J NUTR SCI VITAMINOL, V57, P104, DOI 10.3177/jnsv.57.104; Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6; Zheng ZF, 2018, CLIN HEMORHEOL MICRO, V68, P5, DOI 10.3233/CH-160214; Zygmunt M, 2015, PHARMACOL BIOCHEM BE, V132, P71, DOI 10.1016/j.pbb.2015.02.020	79	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0229806	10.1371/journal.pone.0229806	http://dx.doi.org/10.1371/journal.pone.0229806			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555600	Green Published, Green Submitted, gold			2022-12-26	WOS:000543273200068
J	Ito, A; Wang, TS; Nakahara, R; Kawai, H; Nishitani, K; Aoyama, T; Kuroki, H				Ito, Akira; Wang, Tianshu; Nakahara, Ryo; Kawai, Hideki; Nishitani, Kohei; Aoyama, Tomoki; Kuroki, Hiroshi			Ultrasound therapy with optimal intensity facilitates peripheral nerve regeneration in rats through suppression of pro-inflammatory and nerve growth inhibitor gene expression	PLOS ONE			English	Article							SCIATIC-NERVE; PULSED ULTRASOUND; FUNCTIONAL RECOVERY; ELECTRICAL-STIMULATION; NEUROTROPHINS; NEURONS; CELLS; DIFFERENTIATION; PARAMETERS; GSK-3-BETA	Background Therapeutic ultrasound (US) is a promising physical therapy modality for peripheral nerve regeneration. However, it is necessary to identify the most effective US parameters and clarify the underlying mechanisms before its clinical application. The intensity of US is one of the most important parameters. However, the optimum intensity for the promotion of peripheral nerve regeneration has yet to be determined. Objectives To identify the optimum intensity of US necessary for the promotion of peripheral nerve regeneration after crush injuries in rats and to clarify the underlying mechanisms of US by mRNA expression analysis. Methods We inflicted sciatic nerve crush injuries on adult Lewis rats and performed ultrasound irradiation using 4 different US intensities: 0 (sham stimulation), 30, 140, and 250 mW/cm(2)with frequency (5 days/week) and duration (5 min/day). We evaluated peripheral nerve regeneration by quantitative real-time PCR one week after injury. Histomorphometric analyses and motor function analysis were evaluated 3 weeks after injury. Results US stimulation enhanced re-myelination as well as sprouting of axons, especially at an intensity of 140 mW/cm(2). mRNA expression revealed that US suppressed the expression of the inflammatory cytokines TNF and IL-6 and the axonal growth inhibitors SEMA3A and GSK3 beta. Conclusions An intensity of 140 mW/cm(2)was optimal to support regeneration of the sciatic nerve after a crush injury in rats by, in part, the suppression of pro-inflammatory and nerve growth inhibitor gene expression.	[Ito, Akira; Nakahara, Ryo; Kawai, Hideki; Kuroki, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Motor Funct Anal, Human Hlth Sci, Kyoto, Japan; [Wang, Tianshu; Aoyama, Tomoki] Kyoto Univ, Grad Sch Med, Dept Dev & Rehabil Motor Funct, Human Hlth Sci, Kyoto, Japan; [Nishitani, Kohei] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University	Kuroki, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Motor Funct Anal, Human Hlth Sci, Kyoto, Japan.	hiroshi.kuroki.6s@kyoto-u.ac.jp	Ito, Akira/AAA-4872-2021; Nishitani, Kohei/ABB-1788-2021	Ito, Akira/0000-0002-9645-9777; Nishitani, Kohei/0000-0002-8327-3826	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP19K19793, JP18H03129, JP18K19739]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/index.html) KAKENHI Grant, Number JP19K19793 to AI, and Number JP18H03129 and JP18K19739 to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhlaghi Zhamak, 2012, Iranian Biomedical Journal, V16, P107, DOI 10.6091/IBJ.942.2012; Altland OD, 2004, J THROMB HAEMOST, V2, P637, DOI 10.1111/j.1538-7836.2004.00655.x; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arslantunali D, 2014, MED DEVICES-EVID RES, V7, P405, DOI 10.2147/MDER.S59124; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Bosse F, 2012, CELL TISSUE RES, V349, P5, DOI 10.1007/s00441-012-1389-5; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Chen WZ, 2010, ULTRASOUND MED BIOL, V36, P1109, DOI 10.1016/j.ultrasmedbio.2010.04.014; Chung JI, 2012, OSTEOARTHR CARTILAGE, V20, P314, DOI 10.1016/j.joca.2012.01.005; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Crisci AR, 2002, ULTRASOUND MED BIOL, V28, P1335, DOI 10.1016/S0301-5629(02)00576-8; Daeschler SC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01057; Daeschler SC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21540-5; DINNO MA, 1989, ULTRASOUND MED BIOL, V15, P461, DOI 10.1016/0301-5629(89)90099-9; FUNAKOSHI H, 1993, J CELL BIOL, V123, P455, DOI 10.1083/jcb.123.2.455; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; HONG CZ, 1988, ARCH PHYS MED REHAB, V69, P410; Huang JH, 2010, NEUROREHAB NEURAL RE, V24, P736, DOI 10.1177/1545968310368686; Ito A, 2019, NEURAL REGEN RES, V14, P2077, DOI 10.4103/1673-5374.262581; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jiang WL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22773; Kato K, 2010, J NEUROSCI RES, V88, P360, DOI 10.1002/jnr.22202; Khanna A, 2009, BRIT MED BULL, V89, P169, DOI 10.1093/bmb/ldn040; Kim JR, 2013, TISSUE ENG PT A, V19, P2674, DOI [10.1089/ten.tea.2012.0735, 10.1089/ten.TEA.2012.0735]; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Lv YG, 2015, BIOTECHNOL LETT, V37, P2497, DOI 10.1007/s10529-015-1939-5; Lv YG, 2013, BIOTECHNOL LETT, V35, P2201, DOI 10.1007/s10529-013-1313-4; MORTIMER AJ, 1988, ULTRASOUND MED BIOL, V14, P499, DOI 10.1016/0301-5629(88)90111-1; Mourad PD, 2001, NEUROSURGERY, V48, P1136, DOI 10.1097/00006123-200105000-00035; Munoz-Montano Juan Ramon, 1999, J Alzheimers Dis, V1, P361; Nadeau S, 2011, J NEUROSCI, V31, P12533, DOI 10.1523/JNEUROSCI.2840-11.2011; Nakayama T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19834-9; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Ni XJ, 2017, ULTRASOUND MED BIOL, V43, P461, DOI 10.1016/j.ultrasmedbio.2016.09.017; Omoto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047716; Raso VVM, 2005, J NEUROSCI METH, V142, P185, DOI 10.1016/j.jneumeth.2004.08.016; Ren C, 2010, BIOMED ENVIRON SCI, V23, P244, DOI 10.1016/S0895-3988(10)60059-1; SCHNEIDERSCHAULIES J, 1991, NEURON, V7, P995, DOI 10.1016/0896-6273(91)90344-Y; Syed YA, 2011, J NEUROSCI, V31, P3719, DOI 10.1523/JNEUROSCI.4930-10.2011; VENTIMIGLIA R, 1995, EUR J NEUROSCI, V7, P213, DOI 10.1111/j.1460-9568.1995.tb01057.x; Wang TS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208985; Watanabe Y, 2010, J ORTHOP TRAUMA, V24, pS56, DOI 10.1097/BOT.0b013e3181d2efaf; Willand MP, 2016, NEUROREHAB NEURAL RE, V30, P490, DOI 10.1177/1545968315604399; Yang M, 2011, J RECONSTR MICROSURG, V27, P451, DOI 10.1055/s-0031-1281526; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yurie H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171448; Zhang H, 2009, MICROSURG, V29, P479, DOI 10.1002/micr.20644	47	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234691	10.1371/journal.pone.0234691	http://dx.doi.org/10.1371/journal.pone.0234691			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555658	gold, Green Published			2022-12-26	WOS:000542759600045
J	Song, LR; Lu, HC; Yin, JD				Song, Lirong; Lu, Hecheng; Yin, Jiandong			Preliminary study on discriminating HER2 2+amplification status of breast cancers based on texture features semi-automatically derived from pre-, post-contrast, and subtraction images of DCE-MRI	PLOS ONE			English	Article							MOLECULAR SUBTYPES; NEOADJUVANT CHEMOTHERAPY; TUMOR HETEROGENEITY; ENHANCED MRI; PREDICTION; RECEPTOR; WOMEN; CLASSIFICATION; EXPRESSION; RADIOMICS	Objective To investigate whether texture features extracted from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) are associated with human epidermal growth factor receptor type 2 (HER2) 2+ status of breast cancer. Materials and methods 92 MRI cases including 52 HER2 2+ positive and 40 negative patients confirmed by fluorescencein situhybridization were retrospectively selected. The lesion area was semi-automatically delineated, and a total of 488 texture features were respectively extracted from precontrast, postcontrast, and subtraction images. The Student'st-test or Mann-WhitneyUtest was performed to identify statistically significant features between different HER2 2+ amplification groups. Least absolute shrinkage and selection operator (LASSO) was used to search for the optimal feature subsets. Three machine learning classifiers, logistic regression analysis (LRA), quadratic discriminant analysis (QDA), and support vector machine (SVM), were used with a leave-one-out cross validation method to establish the classification models of HER2 2+ status. Classification performance was evaluated by receiver operating characteristic (ROC) analysis. Results Based on the texture analysis with SVM model, the areas under the ROC curve (AUCs) were 0.890 for subtraction images, 0.736 for postcontrast images, and 0.672 for precontrast images, respectively. For LRA model, the AUCs were 0.884, 0.733, and 0.623, respectively. For QDA model, the AUCs were 0.831, 0.726, and 0.568, respectively. LRA and the SVM model with subtraction images reached significantly better performance than the QDA model (P= 0.0227 andP= 0.0088, respectively). Conclusion Texture features of breast cancer extracted from DCE-MRI are associated with HER2 2+ status. Additional studies are necessary to confirm the present preliminary findings.	[Song, Lirong; Yin, Jiandong] China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Liaoning, Peoples R China; [Lu, Hecheng] Northeastern Univ, Coll Med & Biol Informat Engn, Shenyang, Liaoning, Peoples R China	China Medical University; Northeastern University - China	Yin, JD (corresponding author), China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Liaoning, Peoples R China.	jiandongyin@sina.com			Research and development (R&D) foundation for major Science and Technology from Shenyang [19-112-4105]; Big data foundation for health care from China Medical University [HMB201902105]; Natural Fund Guidance Plan [2019-ZD0743]	Research and development (R&D) foundation for major Science and Technology from Shenyang; Big data foundation for health care from China Medical University; Natural Fund Guidance Plan	this study is supported by Research and development (R&D) foundation for major Science and Technology from Shenyang (No. 19-112-4105), Big data foundation for health care from China Medical University (No. HMB201902105) and Natural Fund Guidance Plan (No. 2019-ZD0743).	Berg WA, 2012, JAMA-J AM MED ASSOC, V307, P1394, DOI 10.1001/jama.2012.388; Blaschke E, 2015, J MAGN RESON IMAGING, V42, P920, DOI 10.1002/jmri.24884; Braman N, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.2561; Chamming's F, 2018, RADIOLOGY, V286, P412, DOI 10.1148/radiol.2017170143; Chang RF, 2016, MAGN RESON IMAGING, V34, P809, DOI 10.1016/j.mri.2016.03.001; Chaudhury B, 2015, J MAGN RESON IMAGING, V42, P1421, DOI 10.1002/jmri.24921; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; Fan M, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1199-8; Fan M, 2017, EUR J RADIOL, V94, P140, DOI 10.1016/j.ejrad.2017.06.019; Field A., 2013, DISCOVERING STAT USI; Fleeman N, 2011, HEALTH TECHNOL ASSES, V15, pXIII, DOI 10.3310/hta15330; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Grimm LJ, 2017, BREAST J, V23, P579, DOI 10.1111/tbj.12799; Hatt M, 2019, J NUCL MED, V60, p38S, DOI 10.2967/jnumed.118.220582; Herlidou-Meme S, 2003, MAGN RESON IMAGING, V21, P989, DOI 10.1016/S0730-725X(03)00212-1; Holli-Helenius K, 2017, BMC MED IMAGING, V17, DOI 10.1186/s12880-017-0239-z; Imbriaco M, 2018, RADIOLOGY, V286, P421, DOI 10.1148/radiol.2017172454; Jeong JH, 2017, CLIN COLORECTAL CANC, V16, pE147, DOI 10.1016/j.clcc.2017.01.005; Karahaliou A, 2010, BRIT J RADIOL, V83, P296, DOI 10.1259/bjr/50743919; Kim JH, 2017, RADIOLOGY, V282, P665, DOI 10.1148/radiol.2016160261; Kuhl CK, 2007, LANCET, V370, P485, DOI 10.1016/S0140-6736(07)61232-X; Lambin P, 2017, NAT REV CLIN ONCOL, V14, P749, DOI 10.1038/nrclinonc.2017.141; Lehman Constance D., 2010, Journal of the National Cancer Institute Monographs, P150, DOI 10.1093/jncimonographs/lgq030; Li H, 2016, NPJ BREAST CANCER, V2, DOI 10.1038/npjbcancer.2016.12; Liu ZH, 2019, BREAST CANCER RES TR, V175, P51, DOI 10.1007/s10549-019-05148-5; Loibl S, 2017, LANCET, V389, P2415, DOI 10.1016/S0140-6736(16)32417-5; Ma W, 2018, CLIN RADIOL, V73, DOI 10.1016/j.crad.2018.05.027; Mao N, 2019, J COMPUT ASSIST TOMO, V43, P93, DOI 10.1097/RCT.0000000000000793; Nam KJ, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015871; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ozturk M, 2017, J BREAST HEALTH, V13, P27, DOI 10.5152/tjbh.2016.3247; Park JE, 2020, EUR RADIOL, V30, P523, DOI 10.1007/s00330-019-06360-z; Press MF, 2016, J CLIN ONCOL, V34, P3518, DOI 10.1200/JCO.2016.66.6693; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Sardanelli F, 2007, RADIOLOGY, V242, P698, DOI 10.1148/radiol.2423051965; Schick U, 2019, BRIT J RADIOL, V92, DOI 10.1259/bjr.20190105; Srivastava S, 2007, J MACH LEARN RES, V8, P1277; Sun XR, 2018, J COMPUT ASSIST TOMO, V42, P531, DOI 10.1097/RCT.0000000000000738; Sutton EJ, 2015, J MAGN RESON IMAGING, V42, P1398, DOI 10.1002/jmri.24890; Teruel JR, 2014, NMR BIOMED, V27, P887, DOI 10.1002/nbm.3132; Thibault G, 2017, TOMOGRAPHY, V3, P23, DOI 10.18383/j.tom.2016.00241; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; van der Velden BHM, 2019, EUR J RADIOL, V121, DOI 10.1016/j.ejrad.2019.108705; Wang LJ, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-018-1537-9; Wong TT, 2015, PATTERN RECOGN, V48, P2839, DOI 10.1016/j.patcog.2015.03.009; Wu MX, 2019, EUR J RADIOL, V114, P175, DOI 10.1016/j.ejrad.2019.03.015; Yeh AC, 2019, CANCER IMAGING, V19, DOI 10.1186/s40644-019-0233-5; Yin JD, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0140-y; Yoon HH, 2012, CLIN CANCER RES, V18, P546, DOI 10.1158/1078-0432.CCR-11-2272; Yuan CR, 2019, J MED SYST, V43, DOI 10.1007/s10916-019-1197-5; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147	52	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234800	10.1371/journal.pone.0234800	http://dx.doi.org/10.1371/journal.pone.0234800			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555662	Green Published, gold			2022-12-26	WOS:000542759600018
J	Murni, IK; Duke, T; Kinney, S; Daley, AJ; Laksanawati, IS; Nurnaningsih; Rusmawatiningtyas, D; Wirawan, MT; Soenarto, Y				Murni, Indah K.; Duke, Trevor; Kinney, Sharon; Daley, Andrew J.; Laksanawati, Ida S.; Nurnaningsih; Rusmawatiningtyas, Desy; Wirawan, M. Taufik; Soenarto, Yati			Multifaceted interventions for healthcare-associated infections and rational use of antibiotics in a low-to-middle-income country: Can they be sustained?	PLOS ONE			English	Article							HAND HYGIENE; NOSOCOMIAL INFECTIONS; HOSPITAL-WIDE	Background Transmission of infection between patients by health workers, and the irrational use of antibiotics are preventable causes for healthcare-associated infections (HAI) and multi-resistant organisms. A previous study implementing a hand hygiene campaign and antibiotic stewardship program significantly reduced these infections. Sustaining such interventions can be challenging. Aims To evaluate whether there was a sustained effect of a multifaceted infection control and antibiotic stewardship program on HAI and antibiotic use 5 years after it began. Methods A prospective evaluation study was conducted over 26 months (from February 2016 to April 2018) in a teaching hospital in Indonesia, 5 years after the implementation of an antibiotic stewardship and infection control program, which was successful when initially evaluated. All children admitted to the pediatric ICU and pediatric wards were observed daily. Assessment of HAI was made based on the criteria from the Centers for Disease Control and Prevention. Assessment of rational antibiotic use was based on the WHO Pocket Book of Hospital Care for Children. Multivariable logistic regression analysis was used to quantify the relationship between the HAI and the multifaceted intervention. Results We observed an increase in HAIs, from 8.6% (123/1419 patients) in the initial post-intervention period in 2011-2013 to 16.9% (314/1855) in the evaluation study (relative risk (RR) (95% CI) 1.95 (1.60 to 2.37)). After adjusting for potential confounders, we found that an increase in HAI in the evaluation period with adjusted OR 1.94 (95% CI 1.53 to 2.45). Inappropriate antibiotic use also increased, from 20.6% (182 of 882 patients who were prescribed antibiotics) to 48.6% (545/1855) (RR 2.35 (2.04 to 2.71)). Hand hygiene compliance also declined from 62.9% (1125/1789) observed moments requiring hand hygiene to 51% (1526/2993) (RR 3.33 (2.99 to 3.70)). Conclusions Healthcare-associated infections and irrational use of antibiotics remain significant even after the implementation of a multifaceted infection control intervention and antibiotic stewardship program. There is a need for continuous input, ongoing surveillance and long-term monitoring of these interventions to sustain compliance and effectiveness and address problems as they emerge.	[Murni, Indah K.; Laksanawati, Ida S.; Nurnaningsih; Rusmawatiningtyas, Desy; Wirawan, M. Taufik; Soenarto, Yati] Univ Gadjah Mada, Dept Pediat, Fac Med Publ Hlth & Nursing, DR Sardjito Hosp, Yogyakarta, Indonesia; [Murni, Indah K.; Laksanawati, Ida S.; Soenarto, Yati] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Pediat Res Off, Yogyakarta, Indonesia; [Duke, Trevor] Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Hlth, MCRI,Dept Pediat, Melbourne, Vic, Australia; [Duke, Trevor] Pediat Intens Care Unit, Melbourne, Vic, Australia; [Duke, Trevor; Daley, Andrew J.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Kinney, Sharon] Univ Melbourne, Royal Childrens Hosp, Dept Pediat & Nursing, Melbourne, Vic, Australia; [Daley, Andrew J.] Royal Childrens Hosp, Infect Prevent & Control, Melbourne, Vic, Australia	Central General Hospital Dr. Sardjito; Gadjah Mada University; Gadjah Mada University; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne	Murni, IK (corresponding author), Univ Gadjah Mada, Dept Pediat, Fac Med Publ Hlth & Nursing, DR Sardjito Hosp, Yogyakarta, Indonesia.; Murni, IK (corresponding author), Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Pediat Res Off, Yogyakarta, Indonesia.	indah.kartika.m@ugm.ac.id	Murni, Indah Kartika/AEH-6887-2022	Murni, Indah Kartika/0000-0001-9174-8425; Daley, Andrew/0000-0001-8470-6438				Al-Tawfiq JA, 2013, AM J INFECT CONTROL, V41, P482, DOI 10.1016/j.ajic.2012.08.009; Archibald LK, 1997, PEDIATR INFECT DIS J, V16, P1045, DOI 10.1097/00006454-199711000-00008; Boyles TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079747; Charani E, 2010, J ANTIMICROB CHEMOTH, V65, P2275, DOI 10.1093/jac/dkq357; Clinical and Laboratory Standards Institute (CLSI), 2015, M07A10 CLIN LAB STAN, V10th; Dye C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0426; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Levison ME, 2009, INFECT DIS CLIN N AM, V23, P791, DOI 10.1016/j.idc.2009.06.008; Mayer J, 2011, INFECT CONT HOSP EP, V32, P59, DOI 10.1086/657666; Murni I, 2013, PAEDIATR INT CHILD H, V33, P61, DOI 10.1179/2046905513Y.0000000054; Murni IK, 2018, J TROP PEDIATRICS, V64, P389, DOI 10.1093/tropej/fmx081; Murni IK, 2016, SE ASIAN J TROP MED, V47, P983; Murni IK, 2015, ARCH DIS CHILD, V100, P454, DOI 10.1136/archdischild-2014-307297; Pronovost PJ, 2016, AM J MED QUAL, V31, P197, DOI 10.1177/1062860614568647; Rodrigues AT, 2013, INT J ANTIMICROB AG, V41, P203, DOI 10.1016/j.ijantimicag.2012.09.003; Sax H, 2007, J HOSP INFECT, V67, P9, DOI 10.1016/j.jhin.2007.06.004; Sax H, 2009, AM J INFECT CONTROL, V37, P827, DOI 10.1016/j.ajic.2009.07.003; Valencia C, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0139-y; World Health Organization, 2009, WHO GUID HAND HYG HL; World Health Organization, 2016, GUID COR COMP INF PR; World Health Organization, 2013, POCK BOOK HOSP CAR C	22	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234233	10.1371/journal.pone.0234233	http://dx.doi.org/10.1371/journal.pone.0234233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544154	Green Published, gold			2022-12-26	WOS:000542957200007
J	Butler, TL; Anderson, K; Condon, JR; Garvey, G; Brotherton, JML; Cunningham, J; Tong, A; Moore, SP; Maher, CM; Mein, JK; Warren, EF; Whop, LJ				Butler, Tamara L.; Anderson, Kate; Condon, John R.; Garvey, Gail; Brotherton, Julia M. L.; Cunningham, Joan; Tong, Allison; Moore, Suzanne P.; Maher, Clare M.; Mein, Jacqueline K.; Warren, Eloise F.; Whop, Lisa J.			Indigenous Australian women's experiences of participation in cervical screening	PLOS ONE			English	Article							CANCER; BARRIERS	Aboriginal and Torres Strait Islander (collectively, Indigenous Australian) women experience a higher burden of cervical cancer than other women. The National Cervical Screening Program (NCSP) is failing to meet the needs of Indigenous Australian women, resulting in many women not regularly participating in cervical screening. However, one third of Indigenous Australian women do participate in cervical screening. The reasons that some women in this population commence and continue to screen remain unheard but could provide insights to support women who currently do not participate. We aimed to describe Indigenous Australian women's experiences and views of participation in cervical screening by yarning (a culturally-appropriate interview technique) with 50 Indigenous Australian women aged 25-70 years who had completed cervical screening in the past five years, recruited via Primary Health Care Centres (PHCCs) from three jurisdictions. Aboriginal or Torres Strait Islander women researchers conducted the interviews. Thematic analysis identified six themes: screening as a means of staying strong and in control; overcoming fears, shame, and negative experiences of screening; needing to talk openly about screening; the value of trusting relationships with screening providers; logistical barriers; and overcoming privacy concerns for women employed at PHCCs. Despite describing screening as shameful, invasive, and uncomfortable, women perceived it as a way of staying healthy and exerting control over their health. This ultimately supported their participation and a sense of empowerment. Women valued open discussion about screening and strong relationships with health providers. We identified logistical barriers and specific barriers faced by women employed at PHCCs. This study is strengthened by a research approach that centred Indigenous Australian women's voices. Understanding the experiences of Indigenous Australian women who participate in screening will help screening providers support women to start and continue to screen regularly. Recommendations for practice are provided.	[Butler, Tamara L.; Anderson, Kate; Condon, John R.; Garvey, Gail; Cunningham, Joan; Moore, Suzanne P.; Whop, Lisa J.] Charles Darwin Univ, Menzies Sch Hlth Res, Wellbeing & Preventable Chron Dis Div, Darwin, NT, Australia; [Brotherton, Julia M. L.] VCS Fdn, VCS Populat Hlth, Melbourne, Vic, Australia; [Tong, Allison] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Maher, Clare M.] Southern Queensland Ctr Excellence Aboriginal & T, Brisbane, Qld, Australia; [Mein, Jacqueline K.] Wuchopperen Hlth Serv Pty Ltd, Manoora, Qld, Australia; [Warren, Eloise F.] Yerin Eleanor Duncan Aboriginal Hlth Ctr, Wyong, NSW, Australia	Charles Darwin University; Menzies School of Health Research; University of Sydney	Butler, TL (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Wellbeing & Preventable Chron Dis Div, Darwin, NT, Australia.	tamara.butler@menzies.edu.au	Moore, Suzanne/AAC-3801-2021; Anderson, Kate/AAR-4006-2020; Butler, Tamara/B-3579-2014	Anderson, Kate/0000-0002-1214-2001; Whop, Lisa/0000-0003-4816-2933; Garvey, Gail/0000-0001-5065-5716; Moore, Suzanne/0000-0002-8045-0305; Butler, Tamara/0000-0001-6507-8157	National Health and Medical Research Council (NHMRC) [1153027]; NHMRC [1041111, 1105399, 1142035, 1058244, 1106716]; Cancer Council NSW Strategic Research Partnership to improve cancer control for Indigenous Australians (STREP Ca-CIndA) (Cancer Council WA) [SRP 1301]; Australian Research Council Discovery Australian Aboriginal and Torres Strait Islander Award - Australian Government [IN190100050]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW Strategic Research Partnership to improve cancer control for Indigenous Australians (STREP Ca-CIndA) (Cancer Council WA); Australian Research Council Discovery Australian Aboriginal and Torres Strait Islander Award - Australian Government(Australian Research Council)	This study was supported by the National Health and Medical Research Council (NHMRC) funded Centre of Research Excellence (CRE) in Targeted Approaches To Improve Cancer Services for Aboriginal and Torres Strait Islander Australians (TACTICS; #1153027), the NHMRC-funded CRE in Discovering Indigenous Strategies to improve Cancer Outcomes Via Engagement, Research Translation and Training (DISCOVER-TT; #1041111), and the Cancer Council NSW Strategic Research Partnership to improve cancer control for Indigenous Australians (STREP Ca-CIndA; SRP 1301, with supplementary funding from Cancer Council WA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this publication are those of the authors and do not necessarily reflect the views of the funder. TB was supported by an Australian Research Council Discovery Australian Aboriginal and Torres Strait Islander Award (#IN190100050) funded by the Australian Government. KA, JCo, JB, SM, JM, EW, and CM received no specific funding for this work. GG and LJW were funded by NHMRC Early Career Fellowships (#1105399 and #1142035, respectively). JCu was funded by an NHMRC Research Fellowship (#1058244). AT was supported by a NHMRC Career Development Fellowship (#1106716).	Adcock A, 2019, AUST NZ J OBSTET GYN, V59, P301, DOI 10.1111/ajo.12933; [Anonymous], 1999, NEPHROL DIAL TRAN S4, V14, pS1; [Anonymous], 2010, GLOBAL COMPETITION L, V3, pR; Australian Bureau of Statistics, 2018, 1270 0 55 005 AUSTR; Australian Bureau of Statistics, 2016, ABORIGINAL TORRES ST; Australian Bureau of Statistics, 2016, AB TORR STRAIT ISL P; Australian Government Department of Health, 2018, CANC SCREEN NAT CERV; Australian Government Department of Health, 2018, CANC SCREEN POL TRAN; Australian Institute of Health and Welfare, 2019, CERV SCREEN AUSTR 20; Australian Institute of Health and Welfare, 2018, AB TORR STRAIT ISL S; Australian Institute of Health and Welfare, 2018, CANC AB TORR STRAIT; Becker SA, 2006, PUBLIC HEALTH NURS, V23, P27, DOI 10.1111/j.0737-1209.2006.230105.x; Binns PL, 2006, MED J AUSTRALIA, V185, P490, DOI 10.5694/j.1326-5377.2006.tb00663.x; Bishop R., 1999, MAORI PSYCHOL RES PR; Brown RF, 2019, SOC SCI MED, V220, P396, DOI 10.1016/j.socscimed.2018.11.038; Butler TL, 2019, SOC SCI MED, V233, P138, DOI 10.1016/j.socscimed.2019.06.004; Chorley AJ, 2017, PSYCHO-ONCOLOGY, V26, P161, DOI 10.1002/pon.4126; Coory MD, 2002, MED J AUSTRALIA, V177, P544, DOI 10.5694/j.1326-5377.2002.tb04949.x; Durie M., 1995, HE PUKENGA KORERO, V1, P44; Faulkhead S, 2006, INT OR HIST ASS C; Ferlay J, 2018, GLOBAL CANC OBSERVAT; Gibbs A., 2006, INT J SOC RES METHOD, V9, P331, DOI [DOI 10.1080/13645570600916049, 10.1080/13645570600916049]; Hall MT, 2019, LANCET PUBLIC HEALTH, V4, pE19, DOI 10.1016/S2468-2667(18)30183-X; Kelaher MA, 2014, MED J AUSTRALIA, V201, P44, DOI 10.5694/mja13.10503; Kirk M., 1998, BARRIERS APPROPRIATE; Kirk M., 1998, ABORIG ISL HLTH WORK, V22, P3; Kolahdooz F, 2014, LANCET ONCOL, V15, pE504, DOI 10.1016/S1470-2045(14)70508-X; Maar M, 2013, WOMEN HEALTH ISS, V23, pE319, DOI 10.1016/j.whi.2013.06.005; Manderson L, 2006, WOMEN HEALTH, V43, P69, DOI 10.1300/J013v43n04_05; Nagendiram A, 2020, HEALTH PROMOT J AUST, V31, P343, DOI 10.1002/hpja.280; QSR International, NVIVO QUAL DAT AN SO; Shahid S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-132; Shahid S, 2009, AUST NZ J PUBL HEAL, V33, P109, DOI 10.1111/j.1753-6405.2009.00355.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Whop LJ, 2019, LANCET ONCOL, V20, pE238, DOI 10.1016/S1470-2045(19)30237-2; Whop LJ, 2016, CANCER-AM CANCER SOC, V122, P1560, DOI 10.1002/cncr.29954; World Health Organization, 2019, DRAFT GLOB STRAT EL; 2013, OFFICIAL GAZETTE REP, V46, P13	38	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234536	10.1371/journal.pone.0234536	http://dx.doi.org/10.1371/journal.pone.0234536			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB6AZ	32542004	gold, Green Published			2022-12-26	WOS:000542685100002
J	Shin, D; Shim, SR; Kim, CH				Shin, Dongseong; Shim, Sung Ryul; Kim, Chang Hee			Changes in Beck Depression Inventory scores in prostate cancer patients undergoing androgen deprivation therapy or prostatectomy	PLOS ONE			English	Article							QUALITY-OF-LIFE; MEN; ASSOCIATION; PREVALENCE; IMPACT; RISK; MASS; FAT	Objectives Androgen deprivation therapy (ADT) has seen increasing use as a prostate cancer treatment in recent years and has proven medically effective in numerous contexts. The treatment, however, is associated with a host of side effects including depression. Managing the psychological wellbeing of prostate cancer patients is important for maximizing their survival outcomes. Thus, this study aimed to evaluate depressive symptomatology in patients with androgen deprivation therapy (ADT) compared with that in patients who underwent prostatectomy and to explore the factors that affect depressive symptoms, which might occur during ADT. Methods One hundred and seven patients undergoing ADT (ADT group) and prostatectomy (Operation group) were enrolled. Adjustments were made for differences in characteristics between groups using a propensity score model with stabilized weights before treatment. Depressive symptoms between groups were compared using the Beck Depression Inventory (BDI) before treatment and six months after treatment initiation. To identify factors affecting depressive symptoms during ADT, multivariate regression analysis was performed on the mean change in BDI score, age, body mass index, testosterone level, prostate-specific antigen level, the international index of erectile function (IIEF), and the Gleason score. Results The BDI score significantly increased in the ADT group compared to the operation group six months after treatment initiation (p< 0.001). Multivariate regression analysis revealed that before ADT, the BDI score was higher by 0.446 according to the IIEF. During ADT, the BDI score increased by 1.579 according to changes in BMI (p= 0.021) and decreased by 0.01 according to changes in testosterone levels (p= 0.034). Conclusion Depressive symptoms can be exacerbated in prostate cancer patients undergoing ADT. Efforts are needed to diagnose and treat depression appropriately, especially if depressive symptoms change in ADT patients with a high IIEF score before ADT, or reduced testosterone levels or increased BMI during ADT.	[Shin, Dongseong] Gachon Univ, Dept Pharmacol, Coll Med, Incheon, South Korea; [Shin, Dongseong] Gachon Univ, Clin Trials Ctr, Gil Med Ctr, Incheon, South Korea; [Shim, Sung Ryul] Korea Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Kim, Chang Hee] Gachon Univ, Gil Med Ctr, Dept Urol, Coll Med, Incheon, South Korea	Gachon University; Gachon University; Korea University; Korea University Medicine (KU Medicine); Gachon University	Kim, CH (corresponding author), Gachon Univ, Gil Med Ctr, Dept Urol, Coll Med, Incheon, South Korea.	budee@gilhospital.com	shim, sungryul/D-3792-2016	shim, sungryul/0000-0003-4143-7383	Gachon University Gil Medical Center [FRD2019-11]	Gachon University Gil Medical Center	This work was supported by the Gachon University Gil Medical Center (Grant number: FRD2019-11) to DS. The funder had no role in our study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amore M, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/280724; Aragon-Ching JB, 2007, FRONT BIOSCI-LANDMRK, V12, P4957, DOI 10.2741/2441; Bennett G, 2005, ONCOL NURS FORUM, V32, P545, DOI 10.1188/05.ONF.545-556; Casey RG, 2012, ASIAN J ANDROL, V14, P226, DOI 10.1038/aja.2011.108; de Moor JS, 2013, CANCER EPIDEM BIOMAR, V22, P561, DOI 10.1158/1055-9965.EPI-12-1356; Galvao DA, 2008, BJU INT, V102, P44, DOI 10.1111/j.1464-410X.2008.07539.x; Hagedoorn M, 2008, PSYCHOL BULL, V134, P1, DOI 10.1037/0033-2909.134.1.1; Initiative NCS, 2009, PRIOR RES CANC SURV; Kim CH, 2018, UROL J, V15, P104, DOI 10.22037/uj.v0i0.4138; Kim HS, 2011, BJU INT, V107, P924, DOI 10.1111/j.1464-410X.2010.09679.x; Lee M, 2015, PSYCHO-ONCOLOGY, V24, P472, DOI 10.1002/pon.3608; Lev EL, 2009, SUPPORT CARE CANCER, V17, P509, DOI 10.1007/s00520-008-0493-2; Loblaw DA, 2007, J CLIN ONCOL, V25, P1596, DOI 10.1200/JCO.2006.10.1949; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Meyers B, 2010, NEUROSCIENCE, V165, P850, DOI 10.1016/j.neuroscience.2009.11.013; Pasquini Massimo, 2007, Clin Pract Epidemiol Ment Health, V3, P2, DOI 10.1186/1745-0179-3-2; Pop-Jordanova Nada, 2017, Pril (Makedon Akad Nauk Umet Odd Med Nauki), V38, P103, DOI 10.1515/prilozi-2017-0014; Rosenblatt D E, 1995, J Am Board Fam Pract, V8, P317; Savard J, 2013, SLEEP MED CLIN, V8, P373, DOI 10.1016/j.jsmc.2013.04.006; Shahinian VB, 2005, CANCER-AM CANCER SOC, V103, P1615, DOI 10.1002/cncr.20955; Shin MS, 2016, INT UROL NEPHROL, V48, P517, DOI 10.1007/s11255-015-1200-0; Smith MR, 2004, UROLOGY, V63, P742, DOI 10.1016/j.urology.2003.10.063; Soloway CT, 2005, BJU INT, V95, P780, DOI 10.1111/j.1464-410X.2005.05400.x; Soyupek F, 2008, UROL ONCOL-SEMIN ORI, V26, P141, DOI 10.1016/j.urolonc.2006.12.014; Tavlarides AM, 2013, PSYCHO-ONCOLOGY, V22, P1328, DOI 10.1002/pon.3138; Timilshina N, 2012, CANCER-AM CANCER SOC, V118, P1940, DOI 10.1002/cncr.26477; Watts S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007618; Xu S, 2010, VALUE HEALTH, V13, P273, DOI 10.1111/j.1524-4733.2009.00671.x	28	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234264	10.1371/journal.pone.0234264	http://dx.doi.org/10.1371/journal.pone.0234264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542009	Green Published, gold			2022-12-26	WOS:000542685100039
J	Tehrani, MHH; Soltani, M; Kashkooli, FM; Raahemifar, K				Tehrani, Masoud H. H.; Soltani, M.; Kashkooli, Farshad Moradi; Raahemifar, Kaamran			Use of microwave ablation for thermal treatment of solid tumors with different shapes and sizes-A computational approach	PLOS ONE			English	Article							EX-VIVO BOVINE; IN-VIVO; DIELECTRIC-PROPERTIES; THEORETICAL EVALUATION; HEAT-TRANSFER; POROUS LIVER; TISSUE; CELL; RADIOFREQUENCY; CARCINOMA	Microwave Ablation (MWA) is one of the most recent developments in the field of thermal therapy. This approach is an effective method for thermal tumor ablation by increasing the temperature above the normal physiological threshold to kill cancer cells with minimum side effects to surrounding organs due to rapid heat dispersive tissues. In the present study, the effects of the shape and size of the tumor on MWA are investigated. To obtain the temperature gradient, coupled bio-heat and electromagnetic equations are solved using a three-dimensional finite element method (FEM). To extract cellular response at different temperatures and times, the three-state mathematical model was employed to achieve the ablation zone size. Results show that treatment of larger tumors is more difficult than that of smaller ones. By doubling the diameter of the tumor, the percentage of dead cancer cells is reduced by 20%. For a spherical tumor smaller than 2 cm, applying 50 W input power compared to 25 W has no significant effects on treatment efficiency and only increases the risk of damage to adjacent tissues. However, for tumors larger than 2 cm, it can increase the ablation zone up to 21%. In the spherical and oblate tumors, the mean percentage of dead cells at 6 GHz is nearly 30% higher than that at 2.45GHz, but for prolate tumors, treatment efficacy is reduced by 10% at a higher frequency. Moreover, the distance between two slots in the coaxial double slot antenna is modified based on the best treatment of prolate tumors. The findings of this study can be used to choose the optimum frequency and the best antenna design according to the shape and size of the tumor.	[Tehrani, Masoud H. H.; Soltani, M.; Kashkooli, Farshad Moradi] KN Toosi Univ Techno, Dept Mech Engn, Tehran, Iran; [Soltani, M.] KN Toosi Univ Techno, Computat Med Ctr, Adv Bioengn Initiat Ctr, Tehran, Iran; [Soltani, M.] Univ Waterloo, Dept Elect & Comp Engn, Waterloo, ON, Canada; [Soltani, M.] Univ Waterloo, Ctr Biotechnol & Bioengn CBB, Waterloo, ON, Canada; [Soltani, M.] Univ Tehran Med Sci, Canc Biol Res Ctr, Canc Inst Iran, Tehran, Iran; [Raahemifar, Kaamran] Sultan Qaboos Univ, Elect & Comp Engn Dept, Muscat, Oman; [Raahemifar, Kaamran] Univ Waterloo, Chem Engn Dept, Waterloo, ON, Canada; [Raahemifar, Kaamran] Penn State Univ, Coll Informat Sci & Technol IST, Data Sci & Artificial Intelligence Program, State Coll, PA USA	University of Waterloo; University of Waterloo; Tehran University of Medical Sciences; Sultan Qaboos University; University of Waterloo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Soltani, M (corresponding author), KN Toosi Univ Techno, Dept Mech Engn, Tehran, Iran.; Soltani, M (corresponding author), KN Toosi Univ Techno, Computat Med Ctr, Adv Bioengn Initiat Ctr, Tehran, Iran.; Soltani, M (corresponding author), Univ Waterloo, Dept Elect & Comp Engn, Waterloo, ON, Canada.; Soltani, M (corresponding author), Univ Waterloo, Ctr Biotechnol & Bioengn CBB, Waterloo, ON, Canada.; Soltani, M (corresponding author), Univ Tehran Med Sci, Canc Biol Res Ctr, Canc Inst Iran, Tehran, Iran.	msoltani@uwaterloo.ca	Moradi Kashkooli, Farshad/ABD-7574-2021; Moradi Kashkooli, Farshad/GXW-0169-2022	Moradi Kashkooli, Farshad/0000-0003-4338-8538; Soltani, Madjid/0000-0003-0878-6274				[Anonymous], 2014, NUCL ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Brace CL, 2009, CURR PROBL DIAGN RAD, V38, P135, DOI 10.1067/j.cpradiol.2007.10.001; Cheng ZG, 2011, EUR J RADIOL, V79, P131, DOI 10.1016/j.ejrad.2009.12.013; Cho J, 2006, INT J CANCER, V119, P593, DOI 10.1002/ijc.21896; Deshazer G, 2017, INT J HYPERTHER, V33, P74, DOI 10.1080/02656736.2016.1206630; Dewey WC, 2009, INT J HYPERTHER, V25, P3, DOI 10.1080/02656730902747919; Etoz S, 2018, INT J RF MICROW C E, V28, DOI 10.1002/mmce.21224; Facciorusso A, 2016, INT J HYPERTHER, V32, P339, DOI 10.3109/02656736.2015.1127434; Farina L, 2018, TISSUE SHRINKAGE MIC; Farina L, 2014, INT J HYPERTHER, V30, P419, DOI 10.3109/02656736.2014.957250; Hall SK, 2015, INT J HYPERTHER, V31, P538, DOI 10.3109/02656736.2015.1032370; He XM, 2005, ANN BIOMED ENG, V33, P502, DOI 10.1007/s10439-005-2508-1; He XM, 2004, ANN BIOMED ENG, V32, P1384, DOI 10.1114/B:ABME.0000042226.97347.de; HENRIQUES FC, 1947, ARCH PATHOL, V43, P489; Hines-Peralta AU, 2006, RADIOLOGY, V239, P94, DOI 10.1148/radiol.2383050262; Hoffmann R, 2013, RADIOLOGY, V268, P89, DOI 10.1148/radiol.13121127; Hossan MR, 2012, INT J HEAT MASS TRAN, V55, P3412, DOI 10.1016/j.ijheatmasstransfer.2012.02.072; Huang HC, 2010, ACS NANO, V4, P2892, DOI 10.1021/nn901884d; Iizuka MN, 2000, PHYS MED BIOL, V45, P1335, DOI 10.1088/0031-9155/45/5/317; Jamil M, 2013, J THERM BIOL, V38, P272, DOI 10.1016/j.jtherbio.2013.03.007; Ji Z, 2011, PHYS MED BIOL, V56, P5249, DOI 10.1088/0031-9155/56/16/011; Jones RP, 2012, INT J HYPERTHER, V28, P43, DOI 10.3109/02656736.2011.610428; Kabiri A, 2019, THEORETICAL INVESTIG; Karampatzakis A, 2013, PHYS MED BIOL, V58, P3191, DOI 10.1088/0031-9155/58/10/3191; Keangin P, 2011, INT COMMUN HEAT MASS, V38, P757, DOI 10.1016/j.icheatmasstransfer.2011.03.027; Keangin P, 2013, INT J HEAT MASS TRAN, V67, P46, DOI 10.1016/j.ijheatmasstransfer.2013.07.064; Keangin R, 2011, APPL THERM ENG, V31, P3243, DOI 10.1016/j.applthermaleng.2011.06.005; Liewei S, 2002, P IEEE SOUTHEASTCON, P5; Liljemalm R, 2014, ANN BIOMED ENG, V42, P822, DOI 10.1007/s10439-013-0940-1; Lin FC, 2018, INT J NANOMED, V13, P3529, DOI 10.2147/IJN.S166000; Liu D, 2017, PHYS MED BIOL, V62, P2070, DOI 10.1088/1361-6560/aa5de4; Lopresto V, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aaaf07; Lopresto V, 2014, INT J HYPERTHER, V30, P110, DOI 10.3109/02656736.2013.879744; Lubner MG, 2014, J VASC INTERV RADIOL, V25, P1633, DOI 10.1016/j.jvir.2014.06.032; Mehmeti A, 2018, ENVIRONMENTS, V5, DOI 10.3390/environments5020024; O'Neill DP, 2011, ANN BIOMED ENG, V39, P570, DOI 10.1007/s10439-010-0177-1; O'Rourke AP, 2007, PHYS MED BIOL, V52, P4707, DOI 10.1088/0031-9155/52/15/022; Peng T, 2011, INT J HEAT MASS TRAN, V54, P2100, DOI 10.1016/j.ijheatmasstransfer.2010.12.019; Pennes HH, 1998, J APPL PHYSIOL, V85, P5, DOI 10.1152/jappl.1998.85.1.5; Rattanadecho P, 2013, INT J HEAT MASS TRAN, V58, P457, DOI 10.1016/j.ijheatmasstransfer.2012.10.043; Saccomandi P, 2015, EJSO-EUR J SURG ONC, V41, P1699, DOI 10.1016/j.ejso.2015.08.171; Sefidgar M, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-12; Simanovskii DM, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011915; Simon CJ, 2005, RADIOGRAPHICS, V25, pS69, DOI 10.1148/rg.25si055501; Singh S, 2016, J THERM BIOL, V58, P80, DOI 10.1016/j.jtherbio.2016.04.002; Soltani M, 2019, MED BIOL ENG COMPUT, V57, P1497, DOI 10.1007/s11517-019-01961-8; Soltani M, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-4; Soltani M., 2013, THESIS U WATERLOO; Steuperaert M, 2017, DRUG DELIV, V24, P491, DOI 10.1080/10717544.2016.1269848; Sun YY, 2012, EUR J RADIOL, V81, P553, DOI 10.1016/j.ejrad.2011.02.013; Trujillo M, 2013, INT J HYPERTHER, V29, P590, DOI 10.3109/02656736.2013.807438; Vaz RH, 2014, APPL THERM ENG, V70, P1025, DOI 10.1016/j.applthermaleng.2014.06.005; Wang T, 2015, INT J HEAT MASS TRAN, V90, P81, DOI 10.1016/j.ijheatmasstransfer.2015.06.030; Wu X, 2016, APPL THERM ENG, V107, P501, DOI 10.1016/j.applthermaleng.2016.07.010; Yang DS, 2007, IEEE T BIO-MED ENG, V54, P1382, DOI 10.1109/TBME.2007.890740; Yoon J, 2011, INT J CANCER, V129, P1970, DOI 10.1002/ijc.25845	56	26	26	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0233219	10.1371/journal.pone.0233219	http://dx.doi.org/10.1371/journal.pone.0233219			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542034	Green Published, gold			2022-12-26	WOS:000542685100031
J	Liu, HC; Lin, WC; Chiu, MJ; Lu, CH; Lin, CY; Yang, SY				Liu, Huei-Chun; Lin, Wei-Che; Chiu, Ming-Jang; Lu, Cheng-Hsien; Lin, Chin-Yi; Yang, Shieh-Yueh			Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology	PLOS ONE			English	Article							DIFFERENTIAL-DIAGNOSIS; CSF; DISEASE; ASSOCIATION; BLOOD; IMMUNOASSAY; BIOMARKER; PROTEINS	Axonal damage leads to the release of neurofilament light chain (NFL), which enters the CSF or blood. In this work, an assay kit for plasma NFL utilizing immunomagnetic reduction (IMR) was developed. Antibodies against NFL were immobilized on magnetic nanoparticles to develop an IMR NFL kit. The preclinical properties, such as the standard curve, limit of detection (LoD), and dynamic range, were characterized. Thirty-one normal controls (NC), fifty-two patients with Parkinson's disease (PD) or PD dementia (PDD) and thirty-one patients with Alzheimer's disease (AD) were enrolled in the study evaluating the plasma NFL assay using an IMR kit. T-tests and receiver operating characteristic (ROC) curve analysis were performed to investigate the capability for discrimination among the clinical groups according to plasma NFL levels. The LoD of the NFL assay using the IMR kit was found to be 0.18 fg/ml. The dynamic range of the NFL assay reached 1000 pg/ml. The NC group showed a plasma NFL level of 7.70 +/- 4.00 pg/ml, which is significantly lower than that of the PD/PDD (15.85 +/- 7.82 pg/ml,p< 0.001) and AD (19.24 +/- 8.99 pg/ml,p< 0.001) groups. A significant difference in plasma NFL levels was determined between the PD and AD groups (p< 0.01). Through ROC curve analysis, the cut-off value of the plasma NFL concentration for differentiating NCs from dementia patients (AD and PD/PDD) was found to be 12.71 pg/ml, with a clinical sensitivity and specificity of 73.5% and 90.3%, respectively. The AUC was 0.868. Furthermore, the cut-off value of the plasma NFL concentration for discriminating AD from PD/PDD was found to be 18.02 pg/ml, with a clinical sensitivity and specificity of 61.3% and 65.4%, respectively. The AUC was 0.630. An ultrasensitive assay for measuring plasma NFL utilizing IMR technology was developed. Clear differences in plasma NFL concentrations were observed among NCs and PD and AD patients. These results imply that the determination of plasma NFL is promising not only for screening dementia but also for differential diagnosis.	[Liu, Huei-Chun; Lin, Chin-Yi; Yang, Shieh-Yueh] MagQu Co Ltd, New Taipei, Taiwan; [Lin, Wei-Che] Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung, Taiwan; [Lin, Wei-Che; Lu, Cheng-Hsien] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lu, Cheng-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Neurol, Kaohsiung, Taiwan; [Yang, Shieh-Yueh] MagQu LLC, Surprise, AZ 85378 USA	Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital	Yang, SY (corresponding author), MagQu Co Ltd, New Taipei, Taiwan.; Yang, SY (corresponding author), MagQu LLC, Surprise, AZ 85378 USA.	syyang@magqu.com		Chiu, Ming-Jang/0000-0002-4158-4423; Yang, Shieh-Yueh/0000-0002-7850-4597	MagQu Co., Ltd	MagQu Co., Ltd	MagQu Co., Ltd provided funding for this study in the form of salaries for Huei-Chun Liu, Chin-Yi Lin and Shieh-Yueh Yang. MagQu Co., Ltd did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Author contributions' section.	Abu-Rumeileh S, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-017-0331-1; Chieh JJ, 2008, J APPL PHYS, V103, DOI 10.1063/1.2827359; Christensen JR, 2013, MULT SCLER J, V19, P877, DOI 10.1177/1352458512466929; de Jong D, 2007, J NEUROL NEUROSUR PS, V78, P936, DOI 10.1136/jnnp.2006.107326; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Hall S, 2012, ARCH NEUROL-CHICAGO, V69, P1445, DOI 10.1001/archneurol.2012.1654; Hansson O, 2017, NEUROLOGY, V88, P930, DOI 10.1212/WNL.0000000000003680; Hong CY, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2536127; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Lewczuk P, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0404-9; Lin CH, 2019, NEUROLOGY, V93, pe1; Lin YS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35766-w; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Meeter LH, 2016, ANN CLIN TRANSL NEUR, V3, P623, DOI 10.1002/acn3.325; Meeter LHH, 2019, J NEUROL NEUROSUR PS, V90, P997, DOI 10.1136/jnnp-2018-319784; Merisson E, 2016, NEUROCHEM INT, V93, P1, DOI 10.1016/j.neuint.2015.12.003; Mielke MM, 2019, NEUROLOGY, V93, P1; Oosterveld LP, 2020, MOVEMENT DISORD, V35, P288, DOI 10.1002/mds.27897; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Teunissen CE, 2005, LANCET NEUROL, V4, P32, DOI 10.1016/S1474-4422(04)00964-0; van Eijk JJJ, 2010, J ALZHEIMERS DIS, V21, P569, DOI 10.3233/JAD-2010-090649; Van Geel WJA, 2005, J IMMUNOL METHODS, V296, P179, DOI 10.1016/j.jim.2004.11.015; Waldo ML, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-54; Yang CC, 2013, J NANOMATER, V2013, DOI 10.1155/2013/695276; Yang CC, 2012, J APPL PHYS, V112, DOI 10.1063/1.4739735; Yang CC, 2011, ACS CHEM NEUROSCI, V2, P500, DOI 10.1021/cn200028j; Yang SY, 2008, J MAGN MAGN MATER, V320, P2688, DOI 10.1016/j.jmmm.2008.05.048; Yang SY, 2010, J VIROL METHODS, V164, P14, DOI 10.1016/j.jviromet.2009.11.016; Zetterberg H, 2016, JAMA NEUROL, V73, P60, DOI 10.1001/jamaneurol.2015.3037; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163	35	9	8	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234519	10.1371/journal.pone.0234519	http://dx.doi.org/10.1371/journal.pone.0234519			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530970	gold, Green Published			2022-12-26	WOS:000542037200017
J	Olgun, T; Everhart, SE; Anderson, T; Wu-Smart, J				Olgun, Tugce; Everhart, Sydney E.; Anderson, Troy; Wu-Smart, Judy			Comparative analysis of viruses in four bee species collected from agricultural, urban, and natural landscapes	PLOS ONE			English	Article							DEFORMED WING VIRUS; HONEY-BEE; BUMBLE-BEES; DISSIMILARITIES; INFECTIONS; IMPACT; BOMBUS	Managed honey bees (Apis melliferaL.) and wild bees provide critical ecological services that shape and sustain natural, agricultural, and urban landscapes. In recent years, declines in bee populations have highlighted the importance of the pollination services they provide and the need for more research into the reasons for global bee losses. Several stressors cause declining populations of managed and wild bee species such as habitat degradation, pesticide exposure, and pathogens. Viruses, which have been implicated as a key stressor, are able to infect a wide range of species and can be transmitted both intra- and inter-specifically from infected bee species to uninfected bee species via vertical (from parent to offspring) and/or horizontal (between individuals via direct or indirect contact) transmission. To explore how viruses spread both intra- and inter-specifically within a community, we examined the impact of management, landscape type, and bee species on the transmission of four common viruses in Nebraska: Deformed wing virus (DWV), Israeli acute paralysis virus (IAPV), Black queen cell virus (BQCV), and Sacbrood virus (SBV). Results indicated the prevalence of viruses is significantly affected (P< 0.005) by bee species, virus type, and season, but not by landscape or year (P= 0.290 and 0.065 respectively). The higher prevalence of DWV detected across bee species (10.4% onApis mellifera, 5.3% onBombus impatiens, 6.1% onBombus griseocollis, and 22.44% onHalictus ligatus) and seasons (10.8% in early-mid summer and 11.4% in late summer) may indicate a higher risk of interspecific transmission of DWV. However, IAPV was predominately detected inHalictus ligatus(20.7%) and in late season collections (28.1%), which may suggest species-specific susceptibility and seasonal trends in infection rates associated with different virus types. However, there were limited detections of SBV and BQCV in bees collected during both sampling periods, indicating SBV and BQCV may be less prevalent among bee communities in this area.	[Olgun, Tugce; Anderson, Troy; Wu-Smart, Judy] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA; [Everhart, Sydney E.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Wu-Smart, J (corresponding author), Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA.	jwu-smart@unl.edu		Anderson, Troy/0000-0002-9403-2833; OLGUN, TUGCE/0000-0003-2386-1244				Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Aparicio F, 1999, EUR J PLANT PATHOL, V105, P623, DOI 10.1023/A:1008783705183; Arduser M, 2018, IDENTIFICATION ECOLO; Ascher J. S., 2018, DISCOVER LIFE BEE SP; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Boncristiani H, 2011, APIDOLOGIE, V42, P457, DOI 10.1007/s13592-011-0009-9; Brutscher LM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005757; Cameron DG, 1988, QUEENSLAND AGR J, V114, P110; Canestri J, 2001, CHALLENGES OF PSYCHOANALYSIS IN THE 21ST CENTURY, P1; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; de Miranda JR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.22; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Dinno A, 2015, STATA J, V15, P292, DOI 10.1177/1536867X1501500117; Dolezal AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166190; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Fujiyuki T, 2004, J VIROL, V78, P1093, DOI 10.1128/JVI.78.3.1093-1100.2004; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Glenny W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182814; HARDER LD, 1983, OECOLOGIA, V57, P274, DOI 10.1007/BF00379591; HARDER LD, 1982, CAN J ZOOL, V60, P1073, DOI 10.1139/z82-148; Hatfield R, 2012, CONSERVING BUMBLE BE, P2; Kevill JL, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11050426; Kevill JL, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110314; Klein S, 2017, TRENDS ECOL EVOL, V32, P268, DOI 10.1016/j.tree.2016.12.009; Krischik V, 2018, USDA NCIPM CONSUMER; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Levitt AL, 2013, VIRUS RES, V176, P232, DOI 10.1016/j.virusres.2013.06.013; Li JL, 2011, J ECON ENTOMOL, V104, P732, DOI 10.1603/EC10355; Locke B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099998; MACFARLANE RP, 1992, NEW ZEAL J CROP HORT, V20, P91, DOI 10.1080/01140671.1992.10422331; MACKENZIE KE, 1994, APIDOLOGIE, V25, P375, DOI 10.1051/apido:19940404; Manley R, 2015, J APPL ECOL, V52, P331, DOI 10.1111/1365-2664.12385; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mazzei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113448; McMenamin AJ, 2018, VIRUSES-BASEL, V10, DOI [10.3390/v10080395, 10.3390/v10]; McMenamin AJ, 2018, CURR OPIN INSECT SCI, V26, P120, DOI 10.1016/j.cois.2018.02.009; Meisels S, 1996, ACTA HORTIC, V437, P425; Mineau P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057457; Mordecai GJ, 2016, ISME J, V10, P1182, DOI 10.1038/ismej.2015.186; Mordecai GJ, 2016, ISME J, V10, P1264, DOI 10.1038/ismej.2015.178; National Research Council Committee (NRCC), 2007, NATL RES COUNCIL COM; Nebraska crop reports-2016, 2016, NEBR CROP REP 2016; Nordstrom S, 1999, APIDOLOGIE, V30, P475, DOI 10.1051/apido:19990602; Nordstrom S, 2000, VIRUS INFECTIONS VAR, V209, P32; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Palma G, 2008, J APPL ENTOMOL, V132, P79, DOI 10.1111/j.1439-0418.2007.01246.x; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Pierce RA, 2008, FIELD BORDERS AGRONO; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Sauer John R., 2013, North American Fauna, V79, P2, DOI 10.3996/nafa.79.0001; Schneider R., 2005, NEBRASKA NATURAL LEG; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Tehel A, 2016, CURR OPIN VIROL, V19, P16, DOI 10.1016/j.coviro.2016.06.006; Urbanek S.R, 2018, R 3 5 1 BINARY MAC O; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Waldbauer G, 2017, INSECT, V52, P66; Williams PH, 2014, BUMBLE BEES N AM IDE; Youngsteadt E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142031	64	8	8	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234431	10.1371/journal.pone.0234431	http://dx.doi.org/10.1371/journal.pone.0234431			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530936	Green Published, gold			2022-12-26	WOS:000542037200014
J	Meng, QY; Moinuddin, SGA; Kim, SJ; Bedgar, DL; Costa, MA; Thomas, DG; Young, RP; Smith, CA; Cort, JR; Davin, LB; Lewis, NG				Meng, Qingyan; Moinuddin, Syed G. A.; Kim, Sung-Jin; Bedgar, Diana L.; Costa, Michael A.; Thomas, Dennis G.; Young, Robert P.; Smith, Clyde A.; Cort, John R.; Davin, Laurence B.; Lewis, Norman G.			Pterocarpan synthase (PTS) structures suggest a common quinone methide-stabilizing function in dirigent proteins and proteins with dirigent-like domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystallography; dimerization; docking; plant biochemistry; plant defense; dirigent protein; lignans; lignins; pterocarpans; quinone methides	GENE-EXPRESSION; CASPARIAN STRIP; BIOSYNTHESIS; ARABIDOPSIS; GENERATION; PREDICTION; EVOLUTION; OPPOSITE; INSIGHTS; LIGNIN	The biochemical activities of dirigent proteins (DPs) give rise to distinct complex classes of plant phenolics. DPs apparently began to emerge during the aquatic-to-land transition, with phylogenetic analyses revealing the presence of numerous DP subfamilies in the plant kingdom. The vast majority (>95%) of DPs in these large multigene families still await discovery of their biochemical functions. Here, we elucidated the 3D structures of two pterocarpan-forming proteins with dirigent-like domains. Both proteins stereospecifically convert distinct diastereomeric chiral isoflavonoid precursors to the chiral pterocarpans, (-)- and (+)-medicarpin, respectively. Their 3D structures enabled comparisons with stereoselective lignan- and aromatic terpenoid-forming DP orthologs. Each protein provides entry into diverse plant natural products classes, and our experiments suggest a common biochemical mechanism in binding and stabilizing distinct plant phenol-derived mono- and bis-quinone methide intermediates during different C-C and C-O bond-forming processes. These observations provide key insights into both their appearance and functional diversification of DPs during land plant evolution/adaptation. The proposed biochemical mechanisms based on our findings provide important clues to how additional physiological roles for DPs and proteins harboring dirigent-like domains can now be rationally and systematically identified.	[Meng, Qingyan; Moinuddin, Syed G. A.; Kim, Sung-Jin; Bedgar, Diana L.; Costa, Michael A.; Cort, John R.; Davin, Laurence B.; Lewis, Norman G.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Thomas, Dennis G.; Young, Robert P.; Cort, John R.] Pacific Northwest Natl Lab, Earth & Biol Sci Directorate, Richland, WA 99352 USA; [Smith, Clyde A.] Stanford Univ, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA	Washington State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Stanford University	Lewis, NG (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	lewisn@wsu.edu		Lewis, Norman/0000-0001-5742-032X; Meng, Qingyan/0000-0003-3523-8628; Davin, Laurence/0000-0002-3248-6485	Office of Biological and Environmental Research; Department of Energy, Office of Science, Basic Energy Sciences (BES) [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research (BER); NIGMS, National Institutes of Health [P41GM103393]	Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Energy, Office of Science, Basic Energy Sciences (BES)(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research (BER)(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This paper is dedicated to Professor W. David Nes (Texas Tech) on the occasion of his 65th birthday and to Emeritus Professor Robert Verpoorte for his scientific contributions dedicated to the plant sciences. A portion of the research was performed using EMSL (grid.436923.9), a United States Department of Energy Office of Science User Facility sponsored by the Office of Biological and Environmental Research. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, was supported by the Department of Energy, Office of Science, Basic Energy Sciences (BES), under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research (BER) and by NIGMS, National Institutes of Health, Grant P41GM103393.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alves-Carvalho S, 2015, PLANT J, V84, P1, DOI 10.1111/tpj.12967; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Bowman JL, 2017, CELL, V171, P287, DOI 10.1016/j.cell.2017.09.030; Celoy R. M., 2013, THESIS; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiang Y, 2002, J AM CHEM SOC, V124, P6349, DOI 10.1021/ja020020w; Corbin C, 2018, PLANT MOL BIOL, V97, P73, DOI 10.1007/s11103-018-0725-x; Dalisay DS, 2015, J NAT PROD, V78, P1231, DOI 10.1021/acs.jnatprod.5b00023; Davin L. B., 2020, LIGNAN HDB CD ROM; Davin LB, 1997, SCIENCE, V275, P362, DOI 10.1126/science.275.5298.362; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Effenberger I, 2015, ANGEW CHEM INT EDIT, V54, P14660, DOI 10.1002/anie.201507543; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gang DR, 1999, CHEM BIOL, V6, P143, DOI 10.1016/S1074-5521(99)89006-1; Gasper R, 2016, PLANT PHYSIOL, V172, P2165, DOI 10.1104/pp.16.01281; Hosmani PS, 2013, P NATL ACAD SCI USA, V110, P14498, DOI 10.1073/pnas.1308412110; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaimoyo E, 2008, PHYTOCHEMISTRY, V69, P76, DOI 10.1016/j.phytochem.2007.06.013; Kamiya T, 2015, P NATL ACAD SCI USA, V112, P10533, DOI 10.1073/pnas.1507691112; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim KW, 2015, J BIOL CHEM, V290, P1308, DOI 10.1074/jbc.M114.611780; Kim KW, 2012, J BIOL CHEM, V287, P33957, DOI 10.1074/jbc.M112.387423; Kim MK, 2002, PHYTOCHEMISTRY, V61, P311, DOI 10.1016/S0031-9422(02)00261-3; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lang D, 2018, PLANT J, V93, P515, DOI 10.1111/tpj.13801; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liu JG, 2008, PHYTOCHEMISTRY, V69, P3038, DOI 10.1016/j.phytochem.2008.06.007; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pickel B, 2010, ANGEW CHEM INT EDIT, V49, P202, DOI 10.1002/anie.200904622; Ralph SG, 2007, PHYTOCHEMISTRY, V68, P1975, DOI 10.1016/j.phytochem.2007.04.042; Seneviratne HK, 2015, PHYTOCHEMISTRY, V113, P140, DOI 10.1016/j.phytochem.2014.10.013; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Toteva MM, 2011, ADV PHYS ORG CHEM, V45, P39, DOI 10.1016/B978-0-12-386047-7.00002-3; Toteva MM, 2003, J AM CHEM SOC, V125, P8814, DOI 10.1021/ja029588v; Uchida K, 2017, PLANT CELL PHYSIOL, V58, P398, DOI 10.1093/pcp/pcw213; Vassao DG, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P815; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xia ZQ, 2000, PHYTOCHEMISTRY, V55, P537, DOI 10.1016/S0031-9422(00)00242-9	47	10	10	3	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11584	11601		10.1074/jbc.RA120.012444	http://dx.doi.org/10.1074/jbc.RA120.012444			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32565424	Green Published, hybrid			2022-12-26	WOS:000563922500018
J	Valentino, H; Campbell, AC; Schuermann, JP; Sultana, N; Nam, HG; LeBlanc, S; Tanner, JJ; Sobrado, P				Valentino, Hannah; Campbell, Ashley C.; Schuermann, Jonathan P.; Sultana, Nazneen; Nam, Han G.; LeBlanc, Sophie; Tanner, John J.; Sobrado, Pablo			Structure and function of a flavin-dependent S-monooxygenase from garlic (Allium sativum)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavin-dependent monooxygenases; sulfenic acid; S-oxygenation; allicin; class B monooxygenases; allyl mercaptan; hydroxylation; garlic (Allium sativum); natural product biosynthesis; structure-function; flavin; FAD; natural product; plant biochemistry; oxidation-reduction (redox); C4a-hydroperoxyflavin	BIOSYNTHESIS; MECHANISM; IDENTIFICATION; ONION; VALIDATION; CHEMISTRY; OXIDATION; ENZYME	Allicin is a component of the characteristic smell and flavor of garlic (Allium sativum). A flavin-containing monooxygenase (FMO) produced byA. sativum(AsFMO) was previously proposed to oxidizeS-allyl-l-cysteine (SAC) to alliin, an allicin precursor. Here, we present a kinetic and structural characterization of AsFMO that suggests a possible contradiction to this proposal. Results of steady-state kinetic analyses revealed that AsFMO exhibited negligible activity with SAC; however, the enzyme was highly active withl-cysteine,N-acetyl-l-cysteine, and allyl mercaptan. We found that allyl mercaptan with NADPH was the preferred substrate-cofactor combination. Rapid-reaction kinetic analyses showed that NADPH binds tightly (K(D)of similar to 2 mu m) to AsFMO and that the hydride transfer occurs with pro-Rstereospecificity. We detected the formation of a long-wavelength band when AsFMO was reduced by NADPH, probably representing the formation of a charge-transfer complex. In the absence of substrate, the reduced enzyme, in complex with NADP(+), reacted with oxygen and formed an intermediate with a spectrum characteristic of C4a-hydroperoxyflavin, which decays several orders of magnitude more slowly than thek(cat). The presence of substrate enhanced C4a-hydroperoxyflavin formation and, upon hydroxylation, oxidation occurred with a rate constant similar to thek(cat). The structure of AsFMO complexed with FAD at 2.08-angstrom resolution features two domains for binding of FAD and NADPH, representative of class B flavin monooxygenases. These biochemical and structural results are consistent with AsFMO being an S-monooxygenase involved in allicin biosynthesis through direct formation of sulfenic acid and not SAC oxidation.	[Valentino, Hannah; Sultana, Nazneen; Nam, Han G.; LeBlanc, Sophie; Sobrado, Pablo] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Valentino, Hannah; Sobrado, Pablo] Virginia Tech, Ctr Drug Discovery, Blacksburg, VA 24061 USA; [Campbell, Ashley C.; Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65201 USA; [Schuermann, Jonathan P.] Cornell Univ, Northeastern Collaborat Access Team, Dept Chem & Chem Biol, Ithaca, NY USA; [Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Missouri System; University of Missouri Columbia; Cornell University; University of Missouri System; University of Missouri Columbia	Sobrado, P (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.; Sobrado, P (corresponding author), Virginia Tech, Ctr Drug Discovery, Blacksburg, VA 24061 USA.; Tanner, JJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65201 USA.; Tanner, JJ (corresponding author), Univ Missouri, Dept Chem, Columbia, MO 65211 USA.	tannerjj@missouri.edu; psobrado@vt.edu		Sultana, Nazneen/0000-0001-9866-4443; Tanner, John/0000-0001-8314-113X	National Science Foundation [CHE 2003658, CHE-2003986]; Virginia Tech Institute of Critical Technology and Applied Science Doctoral Scholars Fellowship; Fulbright Science and Innovation Graduate Award	National Science Foundation(National Science Foundation (NSF)); Virginia Tech Institute of Critical Technology and Applied Science Doctoral Scholars Fellowship; Fulbright Science and Innovation Graduate Award	Research reported in this publication was supported by National Science Foundation Grants CHE 2003658 (to P. S.) and CHE-2003986 (to J. J. T.). H. V. was supported by the Virginia Tech Institute of Critical Technology and Applied Science Doctoral Scholars Fellowship. A. C. C. was funded in part by a Fulbright Science and Innovation Graduate Award.	Abdelwahab H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162578; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alcock LJ, 2019, ACS CHEM BIOL, V14, P594, DOI 10.1021/acschembio.8b01104; Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; Ballou DP, 2013, HANDBOOK OF FLAVOPROTEINS: COMPLEX FLAVOPROTEINS, DEHYDROGENASES AND PHYSICAL METHODS, VOL 2, P1; Binda C, 2015, J BIOL CHEM, V290, P12676, DOI 10.1074/jbc.M114.629485; BLOCK E, 1993, PURE APPL CHEM, V65, P625, DOI 10.1351/pac199365040625; Blumenthal M., 2000, HERBAL MED EXPANDED, P130; Borlinghaus J, 2014, MOLECULES, V19, P12591, DOI 10.3390/molecules190812591; Catucci G, 2017, REND LINCEI-SCI FIS, V28, P195, DOI 10.1007/s12210-016-0583-x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chhabria S, 2014, HELIX, V3, P541; Cho HJ, 2011, J STRUCT BIOL, V175, P39, DOI 10.1016/j.jsb.2011.04.007; Chocklett SW, 2010, BIOCHEMISTRY-US, V49, P6777, DOI 10.1021/bi100291n; Dai XH, 2013, J BIOL CHEM, V288, P1448, DOI 10.1074/jbc.M112.424077; Dhatwalia R, 2012, J AM CHEM SOC, V134, P18132, DOI 10.1021/ja308188z; Dhatwalia R, 2012, J BIOL CHEM, V287, P9041, DOI 10.1074/jbc.M111.327536; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fabiani A, 2002, J CHROMATOGR SCI, V40, P14, DOI 10.1093/chromsci/40.1.14; Franceschini S, 2012, BIOCHEMISTRY-US, V51, P7043, DOI 10.1021/bi301072w; Gonzalez-Morales S, 2017, MOLECULES, V22, DOI 10.3390/molecules22040558; Gore S, 2017, STRUCTURE, V25, P1916, DOI 10.1016/j.str.2017.10.009; Granroth B., 1970, ANN ACAD SCI FENN CH, V154, P4; Hann G., 1996, HIST FOLK MED LEGEND, P37; Hansen BG, 2007, PLANT J, V50, P902, DOI 10.1111/j.1365-313X.2007.03101.x; Harris JC, 2001, APPL MICROBIOL BIOT, V57, P282, DOI 10.1007/s002530100722; Hartmann M, 2018, CELL, V173, P456, DOI 10.1016/j.cell.2018.02.049; HILL JW, 1990, J CHEM EDUC, V67, P172, DOI 10.1021/ed067p172; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Jones MG, 2004, J EXP BOT, V55, P1903, DOI 10.1093/jxb/erh138; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaschula CH, 2010, BIOFACTORS, V36, P78, DOI 10.1002/biof.76; Keusgen M, 2008, PLANTA MED, V74, P73, DOI 10.1055/s-2007-993777; Kim NY, 2011, FOOD SCI BIOTECHNOL, V20, P775, DOI 10.1007/s10068-011-0108-4; Kong WW, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.01202, 10.3389/fpls.2016.01292]; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kubitza C, 2018, ACTA CRYSTALLOGR D, V74, P422, DOI 10.1107/S2059798318003510; Kumar MR, 2017, ACS CHEM BIOL, V12, P474, DOI 10.1021/acschembio.6b00980; Lanzotti V, 2006, J CHROMATOGR A, V1112, P3, DOI 10.1016/j.chroma.2005.12.016; Li CY, 2017, MOL MICROBIOL, V103, P992, DOI 10.1111/mmi.13605; Li J, 2008, PLANT PHYSIOL, V148, P1721, DOI 10.1104/pp.108.125757; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Mansor N., 2016, J MED BIOENG, V5, P24, DOI [DOI 10.12720/JOMB.5.1.24-27, 10.12720/jomb.5.1.24-27]; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Molina-Calle M, 2017, LWT-FOOD SCI TECHNOL, V80, P98, DOI 10.1016/j.lwt.2017.02.010; Noji M, 2003, SULPHUR IN PLANTS, P135; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Petrovska Biljana Bauer, 2010, Pharmacogn Rev, V4, P106, DOI 10.4103/0973-7847.65321; Robinson R, 2013, BIOCHEMISTRY-US, V52, P9089, DOI 10.1021/bi4014903; Robinson RM, 2013, HANDBOOK OF FLAVOPROTEINS: COMPLEX FLAVOPROTEINS, DEHYDROGENASES AND PHYSICAL METHODS, VOL 2, P29; Robinson RM, 2014, ARCH BIOCHEM BIOPHYS, V550, P58, DOI 10.1016/j.abb.2014.04.006; Romero E, 2012, BBA-PROTEINS PROTEOM, V1824, P850, DOI 10.1016/j.bbapap.2012.03.004; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shang A, 2019, FOODS, V8, DOI 10.3390/foods8070246; Shih WL, 2018, ONCOL LETT, V16, P2046, DOI 10.3892/ol.2018.8864; Siddens LK, 2014, BIOCHEM PHARMACOL, V89, P141, DOI 10.1016/j.bcp.2014.02.006; Slusarenko A., 2020, SUSTAINABLE DIS MANA, P313; Sobolewska D, 2015, PHYTOCHEM REV, V14, P81, DOI 10.1007/s11101-013-9334-0; Thodberg S, 2020, CATALYSTS, V10, DOI 10.3390/catal10030329; Valentino H, 2019, METHOD ENZYMOL, V620, P51, DOI 10.1016/bs.mie.2019.03.006; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Wijker RS, 2015, ENVIRON SCI TECH LET, V2, P329, DOI 10.1021/acs.estlett.5b00254; Wojcieszynska D, 2012, INT J MOL SCI, V13, P16751, DOI 10.3390/ijms131216751; Yamaguchi Y, 2020, EXP THER MED, V19, P1528, DOI 10.3892/etm.2019.8385; Yoshimoto N, 2019, J EXP BOT, V70, P4123, DOI 10.1093/jxb/erz243; Yoshimoto N, 2015, PLANT J, V83, P941, DOI 10.1111/tpj.12954; Zhou W., 2018, NATURAL SMALL MOL DR, P569; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	72	6	6	5	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11042	11055		10.1074/jbc.RA120.014484	http://dx.doi.org/10.1074/jbc.RA120.014484			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32527723	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000562757100012
J	Salian, SR; Uppangala, S; Cheredath, A; D'Souza, F; Kalthur, G; Nayak, VC; Anderson, RA; Adiga, SK				Salian, Sujith Raj; Uppangala, Shubhashree; Cheredath, Aswathi; D'Souza, Fiona; Kalthur, Guruprasad; Nayak, Vinod C.; Anderson, Richard A.; Adiga, Satish Kumar			Early prepubertal cyclophosphamide exposure in mice results in long-term loss of ovarian reserve, and impaired embryonic development and blastocyst quality	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; CHILDHOOD-CANCER; FEMALE SURVIVORS; YOUNG-WOMEN; MOUSE; FAILURE; CHEMOTHERAPY; CHECKPOINT; FERTILITY; TOXICITY	Background Due to improved treatment, there is an increasing focus on the reproductive potential of survivors of childhood cancer. Cytotoxic chemotherapy accelerates the decline in the number of primordial follicles within the mammalian ovary at all ages, but effects on the developmental potential of remaining oocytes following prepubertal cancer treatment are unclear. Objectives To investigate whether cyclophosphamide (CY) exposure in the prepubertal period in female mice influences ovarian function and the functional competence of oocytes in adulthood. Methods This study used Swiss albino mice as the experimental model. Female mice were treated with 200 mg/kg CY on either postnatal day 14 (CY14), 21 (CY21) or 28 (CY28) i.e at a prepubertal and 2 young postpubertal ages. At 14 weeks of life, ovarian function, functional competence of oocytes, and embryo quality were assessed. Results The number of primordial follicles decreased significantly in CY14 and CY21 groups compared to control (p < 0.01). The number of oocytes from superovulated was 8.5 +/- 1.4, 24.1 +/- 2.9 and 26.8 +/- 2.1 in CY14, CY21 and CY28 respectively which was significantly lower than control (50.2 +/- 3.2; p < 0.001).In vitroculture of CY14 embryos demonstrated only 55.4% blastocyst formation (p < 0.0001) and reduced ability of inner cell mass (ICM) to proliferatein vitro(p < 0.05) at 120 and 216 h post insemination respectively. On the other hand, ICM proliferation was unaltered in 2 young postpubertal ages. Conclusion Our results indicate long-term effects on the developmental competence of oocytes exposed to CY in early but not adult life. These data provide a mechanism whereby long-term fertility can be impaired after chemotherapy exposure, despite the continuing presence of follicles within the ovary, and support the need for fertility preservation in prepubertal girls before alkylating agent exposure.	[Salian, Sujith Raj; Uppangala, Shubhashree; Cheredath, Aswathi; D'Souza, Fiona; Kalthur, Guruprasad; Adiga, Satish Kumar] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Clin Embryol, Manipal, India; [Nayak, Vinod C.] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Forens Med, Manipal, India; [Anderson, Richard A.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; University of Edinburgh	Adiga, SK (corresponding author), Manipal Acad Higher Educ, Kasturba Med Coll, Dept Clin Embryol, Manipal, India.	satish.adiga@manipal.edu	Adiga, Satish Kumar/AAU-4386-2020; Uppangala, Shubhashree/AAA-4965-2021	Adiga, Satish Kumar/0000-0002-2897-4697; Nayak, Vinod/0000-0002-4614-235X	Manipal Academy of Higher Education; MRC [MR/N022556/1, G1100357] Funding Source: UKRI	Manipal Academy of Higher Education; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was partly funded by Manipal Academy of Higher Education intramural support to SRS towards integrated PhD course fellowship. This funder did not play a role in study design, data collection, analysis, or decision to publish the manuscript.	Adiga SK, 2007, ONCOGENE, V26, P6141, DOI 10.1038/sj.onc.1210444; Adiga SK, 2010, FERTIL STERIL, V93, P2486, DOI 10.1016/j.fertnstert.2009.06.015; Anderson RA, 2014, HUM REPROD, V29, P97, DOI 10.1093/humrep/det388; [Anonymous], 2013, J THORAC DIS S2, V5, pS168; Barton SE, 2013, LANCET ONCOL, V14, P873, DOI 10.1016/S1470-2045(13)70251-1; Bath LE, 2003, HUM REPROD, V18, P2368, DOI 10.1093/humrep/deg473; Brougham MFH, 2012, J CLIN ENDOCR METAB, V97, P2059, DOI 10.1210/jc.2011-3180; Chang EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144245; Comish PB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093311; Connors T., 1975, ANTINEOPLASTIC IMM 2, P18; Cui W, 2016, SCI REP-UK, V6, DOI 10.1038/srep37396; D'Souza F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35342-2; D'Souza F, 2016, SCI REP-UK, V6, DOI 10.1038/srep37291; Fong SL, 2009, HUM REPROD, V24, P982, DOI 10.1093/humrep/den487; Gada RP, 2012, FERTIL STERIL, V98, P863, DOI 10.1016/j.fertnstert.2012.06.012; Green DM, 2009, J CLIN ONCOL, V27, P2374, DOI 10.1200/JCO.2008.21.1839; Green DM, 2009, J CLIN ONCOL, V27, P2677, DOI 10.1200/JCO.2008.20.1541; HIMELSTEINBRAW R, 1978, BRIT J CANCER, V38, P82, DOI 10.1038/bjc.1978.166; Jaroudi S, 2007, MUTAT RES-REV MUTAT, V635, P53, DOI 10.1016/j.mrrev.2006.09.002; KOYAMA H, 1977, CANCER, V39, P1403, DOI 10.1002/1097-0142(197704)39:4<1403::AID-CNCR2820390408>3.0.CO;2-8; Letourneau JM, 2012, CANCER-AM CANCER SOC, V118, P1933, DOI 10.1002/cncr.26403; Luan Y, 2019, J ENDOCRINOL, V240, P243, DOI 10.1530/JOE-18-0370; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; MILLER JJ, 1971, AM J MED, V50, P530, DOI 10.1016/0002-9343(71)90341-X; Nguyen QN, 2019, MOL HUM REPROD, V25, P433, DOI 10.1093/molehr/gaz020; PETERS H, 1969, ACTA ENDOCRINOL-COP, V62, P98, DOI 10.1530/acta.0.0620098; PLOWCHALK DR, 1992, REPROD TOXICOL, V6, P411, DOI 10.1016/0890-6238(92)90004-D; Salian SR, 2019, J ASSIST REPROD GEN, V36, P255, DOI 10.1007/s10815-018-1323-1; Shimura T, 2002, MOL CELL BIOL, V22, P2220, DOI 10.1128/MCB.22.7.2220-2228.2002; Shimura T, 2002, RADIAT RES, V158, P735, DOI 10.1667/0033-7587(2002)158[0735:TNSMOT]2.0.CO;2; Spears N, 2019, HUM REPROD UPDATE, V25, P673, DOI 10.1093/humupd/dmz027; Uppangala S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119735; van Dorp W, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2017.76.3441; Wallace WHB, 2005, LANCET ONCOL, V6, P209, DOI 10.1016/S1470-2045(05)70092-9; Winship AL, 2018, HUM REPROD UPDATE, V24, P119, DOI 10.1093/humupd/dmy002	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235140	10.1371/journal.pone.0235140	http://dx.doi.org/10.1371/journal.pone.0235140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574203	Green Published, Green Submitted, gold			2022-12-26	WOS:000544972400036
J	Chai, TF; Manu, KA; Casey, PJ; Wang, M				Chai, Tin Fan; Manu, Kanjoormana Aryan; Casey, Patrick J.; Wang, Mei			Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal	ONCOGENE			English	Article							SMALL-MOLECULE INHIBITOR; STEM-CELLS; K-RAS; HIPPO PATHWAY; CARBOXYL METHYLTRANSFERASE; CONDITIONAL EXPRESSION; TUMOR-GROWTH; YAP; PROMOTES; RESISTANCE	Cancer stem cells possess the capacity for self-renewal and resistance to chemotherapy. It is therefore crucial to understand the molecular regulators of stemness in the quest to develop effective cancer therapies. TAZ is a transcription activator that promotes stem cell functions in post-development mammalian cells; suppression of TAZ activity reduces or eliminates cancer stemness in select cancers. Isoprenylcysteine carboxylmethyltransferase (ICMT) is the unique enzyme of the last step of posttranslational prenylation processing pathway that modifies several oncogenic proteins, including RAS. We found that suppression of ICMT results in reduced self-renewal/stemness in KRAS-driven pancreatic and breast cancer cells. Silencing of ICMT led to significant reduction of TAZ protein levels and loss of self-renewal ability, which could be reversed by overexpressing mutant KRAS, demonstrating the functional impact of ICMT modification on the ability of KRAS to control TAZ stability and function. Contrary to expectation, YAP protein levels appear to be much less susceptible than TAZ to the regulation by ICMT and KRAS, and YAP is less consequential in regulating stemness characteristics in these cells. Further, we found that the ICMT-dependent KRAS regulation of TAZ was mediated through RAF, but not PI3K, signaling. Functionally, we demonstrate that a signaling cascade from ICMT modification of KRAS to TAZ protein stability supports cancer cell self-renewal abilities in both in vitro and in vivo settings. In addition, studies using the proof-of-concept small molecule inhibitors of ICMT confirmed its role in regulating TAZ and self-renewal, demonstrating the potential utility of targeting ICMT to control aggressive KRAS-driven cancers.	[Chai, Tin Fan; Manu, Kanjoormana Aryan; Casey, Patrick J.; Wang, Mei] Duke NUS Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore; [Chai, Tin Fan; Wang, Mei] Natl Univ Singapore, Dept Biochem, Singapore 117596, Singapore; [Casey, Patrick J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	National University of Singapore; National University of Singapore; Duke University	Wang, M (corresponding author), Duke NUS Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore.; Wang, M (corresponding author), Natl Univ Singapore, Dept Biochem, Singapore 117596, Singapore.	mei.wang@duke-nus.edu.sg		Casey, Patrick/0000-0002-7366-9309; Kanjoormana Aryan, Manu/0000-0002-4437-6486; Wang, Mei/0000-0001-6887-6840	Ministry of Education [MOE2017-T2-1-039]; National Medical Research Council [NMRC/CIRG/1486/2018]	Ministry of Education; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work is supported by Ministry of Education (MOE2017-T2-1-039) and National Medical Research Council (NMRC/CIRG/1486/2018) Singapore.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Awasthi N, 2013, CARCINOGENESIS, V34, P2361, DOI 10.1093/carcin/bgt227; Bahmad HF, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00347; Bartucci M, 2015, ONCOGENE, V34, P681, DOI 10.1038/onc.2014.5; Bender RHF, 2015, STEM CELLS, V33, P1998, DOI 10.1002/stem.1990; Bergo MO, 2000, J BIOL CHEM, V275, P17605, DOI 10.1074/jbc.C000079200; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; Caruso C, 2019, CANCER DISCOV, V9, P988, DOI 10.1158/2159-8290.CD-NB2019-073; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Cushman I, 2009, J BIOL CHEM, V284, P27964, DOI 10.1074/jbc.M109.025296; Do MT, 2017, ONCOGENE, V36, P5757, DOI 10.1038/onc.2017.183; Garcia-Rendueles MER, 2015, CANCER DISCOV, V5, P1178, DOI 10.1158/2159-8290.CD-15-0330; Gierut JJ, 2015, STEM CELL RES, V15, P165, DOI 10.1016/j.scr.2015.06.003; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hong X, 2014, EMBO J, V33, P2447, DOI 10.15252/embj.201489385; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Janes MR, 2018, CELL, V172, P578, DOI 10.1016/j.cell.2018.01.006; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lau HY, 2017, ONCOGENE, V36, P3934, DOI 10.1038/onc.2016.508; Lau HY, 2014, CANCER BIOL THER, V15, P1280, DOI 10.4161/cbt.29692; Lau HK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06477-7; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lin LP, 2015, NAT GENET, V47, P250, DOI 10.1038/ng.3218; Manu KA, 2017, MOL CANCER THER, V16, P914, DOI 10.1158/1535-7163.MCT-16-0703; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Moon BS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt373; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Pichot CS, 2009, BRIT J CANCER, V101, P38, DOI 10.1038/sj.bjc.6605101; Plouffe SW, 2018, J BIOL CHEM, V293, P11230, DOI 10.1074/jbc.RA118.002715; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Prieto-Vila M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122574; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Shaheen S, 2016, STEM CELL REV REP, V12, P492, DOI 10.1007/s12015-016-9664-6; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; Teh JT, 2015, ONCOGENE, V34, P3296, DOI 10.1038/onc.2014.260; Teh JT, 2019, MOL CANCER THER, V18, P693, DOI 10.1158/1535-7163.MCT-18-0766; Touil Y, 2014, CLIN CANCER RES, V20, P837, DOI 10.1158/1078-0432.CCR-13-1854; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Van den Broeck A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-354; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623; Wang M, 2010, ONCOGENE, V29, P4959, DOI 10.1038/onc.2010.247; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Winter-Vann AM, 2005, P NATL ACAD SCI USA, V102, P4336, DOI 10.1073/pnas.0408107102; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Yuan YL, 2016, MOL MED REP, V13, P237, DOI 10.3892/mmr.2015.4550; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zanconato F, 2016, EMBO J, V35, P459, DOI 10.15252/embj.201593584; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; Zhang ZK, 2019, MOL CELL, V73, P7, DOI 10.1016/j.molcel.2018.10.030; Zhao X, 2017, CANCER LETT, V402, P61, DOI 10.1016/j.canlet.2017.05.015; Zhao YL, 2018, MOL CANCER RES, V16, P1046, DOI 10.1158/1541-7786.MCR-17-0593; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606; Zhu WL, 2011, J BIOL CHEM, V286, P35291, DOI 10.1074/jbc.M111.280990	78	7	7	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 30	2020	39	31					5373	5389		10.1038/s41388-020-1364-7	http://dx.doi.org/10.1038/s41388-020-1364-7		JUN 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MT1TS	32561852	hybrid, Green Published			2022-12-26	WOS:000541308400004
J	Jones, A; Bronskill, SE; Seow, H; Junek, M; Feeny, D; Costa, AP				Jones, Aaron; Bronskill, Susan E.; Seow, Hsien; Junek, Mats; Feeny, David; Costa, Andrew P.			Associations between continuity of primary and specialty physician care and use of hospital-based care among community-dwelling older adults with complex care needs	PLOS ONE			English	Article							MINIMUM DATA SET; INTERPERSONAL CONTINUITY; VALIDATION; MULTIMORBIDITY; WORKFORCE; OUTCOMES; DISEASE; BURDEN; SCALE; RISK	Objective While research suggests that higher continuity of primary and specialty physician care can improve patient outcomes, their effects have rarely been examined and compared concurrently. We investigated associations between continuity of primary and specialty physician care and emergency department visits and hospital admissions among community-dwelling older adults with complex care needs. Methods We conducted a retrospective cohort study of home care patients in Ontario, Canada, from October 2014 to September 2016. We measured continuity of primary and specialty physician care over the two years prior to a home care assessment and categorized them into low, medium, and high groups using terciles of the distribution. We used Cox regression models to concurrently test the associations between continuity of primary and specialty care and risk of an emergency department visit and hospital admission within six months of assessment, controlling for potential confounders. We examined interactions between continuity of care and count of chronic conditions, count of physician specialties seen, functional impairment, and cognitive impairment. Results Of 178,686 participants, 49% had an emergency department visit during follow-up and 27% had a hospital admission. High vs. low continuity of primary care was associated with a reduced risk of an emergency department visit (HR = 0.90 (0.89-0.92)) as was continuity of specialty care (HR = 0.93 (0.91-0.95)). High vs. low continuity of primary care was associated also with a reduced risk of a hospital admission (HR = 0.94 (0.92-0.96)) as was continuity of specialty care (HR = 0.92 (0.90-0.94)). The effect of continuity of specialty care was moderately stronger among patients who saw four or more physician specialties. Conclusion Higher continuity of primary physician and specialty physician care had independent, protective effects of similar magnitude against emergency department use and hospital admissions. Improving continuity of specialty care should be a priority alongside improving continuity of primary care in complex, older adult populations with significant specialist use.	[Jones, Aaron; Seow, Hsien; Junek, Mats; Costa, Andrew P.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Bronskill, Susan E.] ICES, Toronto, ON, Canada; [Bronskill, Susan E.] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Seow, Hsien] McMaster Univ, Dept Oncol, Hamilton, ON, Canada; [Feeny, David] McMaster Univ, Dept Econ, Hamilton, ON, Canada; [Costa, Andrew P.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; University of Toronto; University of Toronto; McMaster University; McMaster University; McMaster University	Jones, A (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.	jonesa13@mcmaster.ca	Jones, Aaron/AAG-1427-2020; Seow, Hsien/AAQ-1438-2021	Jones, Aaron/0000-0002-6282-3614; Seow, Hsien/0000-0001-6701-1714; Junek, Mats/0000-0001-8416-3955	Canadian Institutes of Health Research [148933]; ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	AC received a grant for this research from the Canadian Institutes of Health Research (148933) (https://cihr-irsc.gc.ca/e/193.html).This study was supported by ICES (www.ices.on.ca), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The analyses, conclusions, opinions and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred. Parts of this material are based on data and/or information compiled and provided by the Canadian Institute for Health Information (CIHI)(www.cihi.ca).However, the analyses, conclusions, opinions and statements expressed in the material are those of the authors, and not necessarily those of CIHI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres C, 2016, CAN FAM PHYSICIAN, V62, P116; [Anonymous], ADV PROF CONT CAR; [Anonymous], 2014, DIABETES CARE, V1, pS14; Bauman M., 2017, MULTIPLE CHRONIC CON; Bayliss EA, 2015, ANN FAM MED, V13, P123, DOI 10.1370/afm.1739; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; Blecker S, 2014, INT J QUAL HEALTH C, V26, P530, DOI 10.1093/intqhc/mzu065; Bodenheimer T, 2009, HEALTH AFFAIR, V28, P64, DOI 10.1377/hlthaff.28.1.64; Chen LM, 2014, JAMA INTERN MED, V174, P749, DOI 10.1001/jamainternmed.2013.14331; Costa AP, 2015, J AM GERIATR SOC, V63, P763, DOI 10.1111/jgs.13336; Dall TM, 2013, HEALTH AFFAIR, V32, P2013, DOI 10.1377/hlthaff.2013.0714; Dufour I, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1197-9; Emond M, 2017, CAN GERIATR J, V20, P10, DOI 10.5770/cgj.20.246; Engamba SA, 2019, BRIT J GEN PRACT, V69, P92, DOI 10.3399/bjgp19X701201; Foebel AD, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-457; Gray DP, 2003, J ROY SOC MED, V96, P160, DOI 10.1258/jrsm.96.4.160; Gray E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017593; Haggerty JL, 2012, ANN FAM MED, V10, P443, DOI 10.1370/afm.1378; Haggerty JL, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5915; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; HARTMAIER SL, 1995, J GERONTOL A-BIOL, V50, pM128, DOI 10.1093/gerona/50A.2.M128; Hirdes JP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-277; HOENIG HM, 1991, J AM GERIATR SOC, V39, P220, DOI 10.1111/j.1532-5415.1991.tb01632.x; Hoertel N, 2014, EUR PSYCHIAT, V29, P358, DOI 10.1016/j.eurpsy.2013.12.001; Hwang U, 2013, HEALTH AFFAIR, V32, P2116, DOI 10.1377/hlthaff.2013.0670; Justiniano CF, 2017, DIS COLON RECTUM, V60, P1147, DOI 10.1097/DCR.0000000000000919; Kuluski K, 2017, INT J INTEGR CARE, V17, DOI 10.5334/ijic.2944; Lancet Global Health, 2019, LANCET GLOB HEALTH, V7, pe1; Landi F, 2000, MED CARE, V38, P1184, DOI 10.1097/00005650-200012000-00005; McWhinney I R, 1975, J Fam Pract, V2, P373; Milenkovic M, 2006, HEALTHCARE COST UTIL; Mondor L, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002249; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; National Prevention Council, 2016, HLTH AG ACT ADV NAT; Nguyen Hai, 2019, J Comorb, V9, p2235042X19870934, DOI 10.1177/2235042X19870934; Nutting Paul A, 2003, Ann Fam Med, V1, P149, DOI 10.1370/afm.63; Nyweide DJ, 2013, JAMA INTERN MED, V173, P1879, DOI 10.1001/jamainternmed.2013.10059; Palmer W, 2018, IMPROVING ACCESS CON; Pefoyo AJK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1733-2; Pollack CE, 2016, MED CARE, V54, pE30, DOI 10.1097/MLR.0000000000000018; Poss J W, 2008, Healthc Manage Forum, V21, P33; Price M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-309; Saultz John W, 2003, Ann Fam Med, V1, P134, DOI 10.1370/afm.23; Saultz JW, 2005, ANN FAM MED, V3, P159, DOI 10.1370/afm.285; Saultz JW, 2004, ANN FAM MED, V2, P445, DOI 10.1370/afm.91; Schiotz Michaela L, 2016, J Comorb, V6, P95, DOI 10.15256/joc.2016.6.81; Starfleld B, 2005, ANN FAM MED, V3, P215, DOI 10.1370/afm.307; van Walraven C, 2010, J EVAL CLIN PRACT, V16, P947, DOI 10.1111/j.1365-2753.2009.01235.x; Vetrano DL, 2019, J GERONTOL A-BIOL, V74, P659, DOI 10.1093/gerona/gly110; Wallace E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h176; Weir DL, 2016, MED CARE, V54, P386, DOI 10.1097/MLR.0000000000000493; WHO, 2018, CONT COORD CAR PRACT; Wu S-Y, 2000, PROJECTION CHRONIC I, P18	53	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234205	10.1371/journal.pone.0234205	http://dx.doi.org/10.1371/journal.pone.0234205			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559214	Green Published, gold			2022-12-26	WOS:000543261600020
J	Lin, HP; Lynk, N; Moore, LL; Cabral, HJ; Heffernan, KS; Dumas, AK; Hruska, B; Zajdel, RA; Gump, BB; Spartano, NL				Lin, Hsuan-Ping; Lynk, Nicole; Moore, Lynn L.; Cabral, Howard J.; Heffernan, Kevin S.; Dumas, Amy K.; Hruska, Bryce; Zajdel, Rachel A.; Gump, Brooks B.; Spartano, Nicole L.			A pragmatic approach to the comparison of wrist-based cutpoints of physical activity intensity for the MotionWatch8 accelerometer in children	PLOS ONE			English	Article							CALIBRATION; VALIDATION; ACTIGRAPH; MONITORS; OBESITY	Background A variety of wearable monitors are available for objectively assessing physical activity but there is a lack of established values for the activity intensity of MotionWatch8 (MW8) and a similar lack of studies on comparability across devices. Our study aimed to establish activity intensity cutpoints for the MW8 accelerometer in children, which are necessary to determine whether they are meeting physical activity guidelines. Methods Children (n = 39, ages 9-13 years) were asked to wear two different accelerometers (MW8 and ActiGraph) simultaneously on the same dominant wrist as they performed different activities designed to mimic activities of variable intensity that a child might perform in a free-living environment. Linear regression and receiver operating characteristic (ROC) curves were performed to assess sensitivity and specificity of the identified MW8 intensity cutpoints compared to established ActiGraph cutpoints. Results Mean values for each activity were positively correlated using the MW8 and ActiGraph monitors (r = 0.85, p<0.001). The optimal cutpoints for differentiating sedentary from light physical activity, light from moderate, and moderate from vigorous activity were <= 32 counts, >= 371.5 counts, and >= 859.5 counts per 30 seconds, respectively. Conclusions Our study demonstrated the ability of MW8 to discriminate different intensity activities and provided the first cutoff values for researchers using the MW8 to measure physical activity patterns among children.	[Lin, Hsuan-Ping; Moore, Lynn L.] Boston Univ, Sch Med, Dept Med Preventat Med & Epidemiol, Boston, MA 02118 USA; [Lynk, Nicole; Dumas, Amy K.; Hruska, Bryce; Zajdel, Rachel A.; Gump, Brooks B.] Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, Syracuse, NY USA; [Cabral, Howard J.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Heffernan, Kevin S.] Syracuse Univ, Dept Exercise Sci, Syracuse, NY USA; [Spartano, Nicole L.] Boston Univ, Sch Med, Dept Med, Sect Endocrinol Diabet Nutr & Weight Management, Boston, MA 02118 USA	Boston University; Syracuse University; Boston University; Syracuse University; Boston University	Spartano, NL (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Endocrinol Diabet Nutr & Weight Management, Boston, MA 02118 USA.	spartano@bu.edu	; Spartano, Nicole/Y-3344-2018	Hruska, Bryce/0000-0002-8651-5827; Dumas, Amy/0000-0003-0561-4979; Heffernan, Kevin/0000-0002-3499-1477; Spartano, Nicole/0000-0002-0724-8629	National Institutes of Health [R15-ES15619, R01-ES023252, T32-HL07224]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this study was provided by the National Institutes of Health, which had no role in collection, analysis, or interpretation of the data, nor did they have a right to approve/disapprove publication of the final manuscript: R15-ES15619 (BBG), R01-ES023252 (BBG) and T32-HL07224 (NLS).	Adamo KB, 2009, INT J PEDIATR OBES, V4, P2, DOI 10.1080/17477160802315010; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; BERK RA, 1976, J EXP EDUC, V45, P4, DOI 10.1080/00220973.1976.11011567; Crouter SE, 2015, MED SCI SPORT EXER, V47, P944, DOI 10.1249/MSS.0000000000000502; Dishman RK, 2001, QUEST, V53, P295, DOI 10.1080/00336297.2001.10491746; Dollman J, 2009, J SCI MED SPORT, V12, P518, DOI 10.1016/j.jsams.2008.09.007; Fairclough SJ, 2016, MED SCI SPORT EXER, V48, P245, DOI 10.1249/MSS.0000000000000771; Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Gump BB, 2017, ENVIRON RES, V158, P576, DOI 10.1016/j.envres.2017.06.033; Hanggi JM, 2013, J SCI MED SPORT, V16, P40, DOI 10.1016/j.jsams.2012.05.012; Janssen X, 2015, MEAS PHYS EDUC EXERC, V19, P116, DOI 10.1080/1091367X.2015.1045908; JEQUIER E, 1987, ANNU REV NUTR, V7, P187, DOI 10.1146/annurev.nu.07.070187.001155; Johansson E, 2015, PEDIATR OBES, V10, P1, DOI 10.1111/j.2047-6310.2013.00213.x; Karnik S, 2012, INT J PREVENTIVE MED, V3, P1; Kelly Louise A, 2013, BMC Med Phys, V13, P5, DOI 10.1186/1756-6649-13-5; Landry GJ, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00165; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID AM; Preiser JC, 2014, BRIT J ANAESTH, V113, P945, DOI 10.1093/bja/aeu187; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Rideout V.J., 2010, HENRY J KAIS FAM FOU; Schaefer CA, 2014, J PHYS ACT HEALTH, V11, P604, DOI 10.1123/jpah.2011-0411; Schrack JA, 2016, J GERONTOL A-BIOL, V71, P1039, DOI 10.1093/gerona/glw026; Sirard JR, 2001, SPORTS MED, V31, P439, DOI 10.2165/00007256-200131060-00004; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Trost SG, 2007, AM J LIFESTYLE MED, V1, P299, DOI 10.1177/1559827607301686; Van Remoortel H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-84; Westerterp KS, 1999, MED SCI SPORT EXER, V31, pS522, DOI 10.1097/00005768-199911001-00006; ZWEIG MH, 1993, CLIN CHEM, V39, P561; 2014, REG ANESTH PAIN MED, V9	32	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234725	10.1371/journal.pone.0234725	http://dx.doi.org/10.1371/journal.pone.0234725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559207	gold, Green Published			2022-12-26	WOS:000543261600030
J	Pathak, S; Stewart, WCL; Burd, CE; Hester, ME; Greenberg, DA				Pathak, Shilpa; Stewart, William C. L.; Burd, Christin E.; Hester, Mark E.; Greenberg, David A.			Brd2haploinsufficiency extends lifespan and healthspan in C57B6/J mice	PLOS ONE			English	Article							BROMODOMAIN INHIBITOR OTX015; DOSE-ESCALATION; PROTEIN BRD2; SIRT1; GENE; INFLAMMATION; AGE; TRANSCRIPTION; DISRUPTION; EXPRESSION	Aging in mammals is the gradual decline of an organism's physical, mental, and physiological capacity. Aging leads to increased risk for disease and eventually to death. Here, we show thatBrd2haploinsufficiency (Brd2+/-) extends lifespan and increases healthspan in C57B6/J mice. InBrd2+/- mice, longevity is increased by 23% (p<0.0001), and, relative to wildtype animals (Brd2+/+), cancer incidence is reduced by 43% (p<0.001). In addition, relative to age-matched wildtype mice,Brd2heterozygotes show healthier aging including: improved grooming, extended period of fertility, and lack of age-related decline in kidney function and morphology. Our data support a role for haploinsufficiency ofBrd2in promoting healthy aging. We hypothesize that Brd2 affects aging by protecting against the accumulation of molecular and cellular damage. Given the recent advances in the development of BET inhibitors, our research provides impetus to test drugs that target BRD2 as a way to understand and treat/prevent age-related diseases.	[Pathak, Shilpa; Stewart, William C. L.; Greenberg, David A.] Nationwide Childrens Hosp, Battelle Ctr Math Med, Abigail Wexner Res Inst, Columbus, OH 43205 USA; [Stewart, William C. L.; Greenberg, David A.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Stewart, William C. L.] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Burd, Christin E.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Burd, Christin E.] Ohio State Univ, Dept Mol Biol & Canc Genet, Columbus, OH 43210 USA; [Hester, Mark E.] Nationwide Childrens Hosp, Steve & Cindy Rasmussen Inst Genom Med, Abigail Wexner Res Inst, Columbus, OH USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Greenberg, DA (corresponding author), Nationwide Childrens Hosp, Battelle Ctr Math Med, Abigail Wexner Res Inst, Columbus, OH 43205 USA.; Greenberg, DA (corresponding author), Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA.	David.Greenberg@NationwideChildrens.org	Pathak, Shilpa/AAX-4833-2021; Hester, Mark/AAY-8611-2020	Pathak, Shilpa/0000-0001-6341-089X; 				Amorim S, 2016, LANCET HAEMATOL, V3, pE196, DOI 10.1016/S2352-3026(16)00021-1; Andrieu Guillaume, 2016, Drug Discov Today Technol, V19, P45, DOI 10.1016/j.ddtec.2016.06.004; [Anonymous], 2013, CLIN DIABETOLOGY, V2, pA12; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2011, CANC DISCOV; Arai Y, 2015, EBIOMEDICINE, V2, P1549, DOI 10.1016/j.ebiom.2015.07.029; Belkina AC, 2014, J LEUKOCYTE BIOL, V95, P451, DOI 10.1189/jlb.1112588; Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Berthon C, 2016, LANCET HAEMATOL, V3, pE186, DOI 10.1016/S2352-3026(15)00247-1; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103; Chachua T, 2014, GENES BRAIN BEHAV, V13, P702, DOI 10.1111/gbb.12160; Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Eischen C.M., 2016, COLD SPRING HARB PER, V6, P6; Erol A, 2007, PPAR RES, V2007, DOI 10.1155/2007/39654; Flurkey K., 2007, MOUSE BIOMEDICAL RES; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gomes P, 2009, OXID MED CELL LONGEV, V2, P138, DOI 10.4161/oxim.2.3.8819; GREENBERG DA, 1988, GENET EPIDEMIOL, V5, P81, DOI 10.1002/gepi.1370050204; Greenwald RJ, 2004, BLOOD, V103, P1475, DOI 10.1182/blood-2003-06-2116; Guan Y, 2016, KIDNEY DIS-BASEL, V1, P258, DOI 10.1159/000440967; Gyuris A, 2009, BBA-GENE REGUL MECH, V1789, P413, DOI 10.1016/j.bbagrm.2009.03.005; Hasegawa K, 2013, NAT MED, V19, P1496, DOI 10.1038/nm.3363; Herskovits AZ, 2014, NEURON, V81, P471, DOI 10.1016/j.neuron.2014.01.028; Hnilicova J, 2013, MOL BIOL CELL, V24, P3557, DOI 10.1091/mbc.E13-06-0303; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Jahagirdar R, 2017, MOL PHARMACOL, V92, P694, DOI 10.1124/mol.117.110379; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kokkola T, 2015, CHEMBIOCHEM, V16, P1997, DOI 10.1002/cbic.201500272; Lenburg ME, 2007, J BIOL CHEM, V282, P4803, DOI 10.1074/jbc.M605870200; Li XL, 2011, INT J BIOL SCI, V7, P575, DOI 10.7150/ijbs.7.575; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Liao CY, 2012, CELL RES, V22, P1215, DOI 10.1038/cr.2012.62; Loganathan SN, 2016, ONCOTARGET, V7, P43504, DOI 10.18632/oncotarget.9762; Marx JO, 2013, J AM ASSOC LAB ANIM, V52, P782; Mercken EM, 2014, AGING CELL, V13, P193, DOI 10.1111/acel.12151; Michaeloudes C, 2014, J IMMUNOL, V192, P4913, DOI 10.4049/jimmunol.1301984; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Moskalev AA, 2014, CELL CYCLE, V13, P1063, DOI 10.4161/cc.28433; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Pal DK, 2003, AM J HUM GENET, V73, P261, DOI 10.1086/377006; Petkovich DA, 2017, CELL METAB, V25, P954, DOI 10.1016/j.cmet.2017.03.016; Porcher C, 2015, BLOOD, V125, P2739, DOI 10.1182/blood-2015-03-630830; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Shang EY, 2009, DEV DYNAM, V238, P908, DOI 10.1002/dvdy.21911; Velisek L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023656; Wang FN, 2010, BIOCHEM J, V425, P71, DOI 10.1042/BJ20090928; Watroba M, 2016, ADV MED SCI-POLAND, V61, P52, DOI 10.1016/j.advms.2015.09.003; Wu CY, 2012, HUM MOL GENET, V21, P3956, DOI 10.1093/hmg/dds210; Yang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046364; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yuan R, 2011, ILAR J, V52, P4, DOI 10.1093/ilar.52.1.4; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883; Zou D, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-1094-z	62	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234910	10.1371/journal.pone.0234910	http://dx.doi.org/10.1371/journal.pone.0234910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559200	gold, Green Published			2022-12-26	WOS:000543261600003
J	Aljumaah, MR; Alkhulaifi, MM; Abudabos, AM; Aljumaah, RS; Alsaleh, AN; Stanley, D				Aljumaah, Mashael R.; Alkhulaifi, Manal M.; Abudabos, Alaeldein M.; Aljumaah, Riyadh S.; Alsaleh, Asma N.; Stanley, Dragana			Bacillus subtilisPB6 based probiotic supplementation plays a role in the recovery after the necrotic enteritis challenge	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; ANTIMICROBIAL GROWTH PROMOTERS; BROILER-CHICKENS; CLOSTRIDIUM-PERFRINGENS; GASTROINTESTINAL-TRACT; INTESTINAL HEALTH; GUT MICROBIOTA; BUTYRIC-ACID; ANIMAL FEED; PERFORMANCE	In poultry production, birds are raised under intensive conditions, which can enable rapid spread of infections, withClostridium perfringens-caused necrotic enteritis (NE) being one of the most devastating for the industry. The current investigation was conducted to evaluate the effectiveness ofBacillus subtilisPB6 probiotic supplementation on bird's post NE recovery, based on chicken performance, cecal microbiota composition, ileum histomorphometric measurements, and short-chain fatty acid production in the cecum of the birds that were challenged with NE mid-production. Birds were split into four groups, including a negative control, positive control challenged withC.perfringens, group supplemented withB.subtilisprobiotic, and NE challenged birds supplemented withB.subtilisprobiotic. Following NE challenge birds were allowed to reach the end of production time at 40 days, and samples were collected to estimate if probiotic supplementation resulted in better post-NE recovery. Intestinal lesion score across the duodenum, jejunum, and ileum indicated that at the end of production timeline NE challenged birds supplemented withB.subtilisprobiotic had lower intestinal lesion scores compared to NE challenged birds without probiotic supplementation implying improved recovery. Probiotic supplementation improved performance of NE challenged birds only in the post-NE recovery stage. NE challenged birds had a significant increase in cecal propionic acid, which was not observed in NE challenged birds supplemented withB.subtilus. BothB.subtilissupplemented groups (challenged and unchanged) were characterized by a significant rise in cecal acetic and butyric acid. Our results demonstrate thatB.subtilissupplementation can assist the birds in dealing with NE outbreak and long term recovery.	[Aljumaah, Mashael R.; Alkhulaifi, Manal M.; Alsaleh, Asma N.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh, Saudi Arabia; [Abudabos, Alaeldein M.; Aljumaah, Riyadh S.] King Saud Univ, Coll Food & Agr Sci, Dept Anim Prod, Riyadh, Saudi Arabia; [Stanley, Dragana] Cent Queensland Univ, Inst Future Farming Syst, Rockhampton, Qld, Australia	King Saud University; King Saud University; Central Queensland University	Stanley, D (corresponding author), Cent Queensland Univ, Inst Future Farming Syst, Rockhampton, Qld, Australia.	D.Stanley@cqu.edu.au	Abudabos, Alaeldein M/E-7222-2014; Alsaleh, Asma/ABD-1640-2020	Abudabos, Alaeldein M/0000-0001-7998-0344; Stanley, Dragana/0000-0001-7019-4726	Deanship of scientific research through the initiative of DSR Graduate Students Research Support (GSR)	Deanship of scientific research through the initiative of DSR Graduate Students Research Support (GSR)	This project was supported by the Deanship of scientific research through the initiative of DSR Graduate Students Research Support (GSR).	Abudabos AM, 2013, INT J AGRIC BIOL, V15, P978; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Baptista DF, 2007, HYDROBIOLOGIA, V575, P83, DOI 10.1007/s10750-006-0286-x; Bbosa G. S., 2014, Health, V6, P410, DOI 10.4236/health.2014.65059; Butaye P, 2003, CLIN MICROBIOL REV, V16, P175, DOI 10.1128/CMR.16.2.175-188.2003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cogliani C, 2011, MICROBE, V6, P274, DOI DOI 10.1128/MICROBE.6.274.1; Corr SC, 2007, P NATL ACAD SCI USA, V104, P7617, DOI 10.1073/pnas.0700440104; Craven SE, 2001, AVIAN DIS, V45, P887, DOI 10.2307/1592868; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dongarra ML, 2013, CURR ALLERGY ASTHM R, V13, P19, DOI 10.1007/s11882-012-0313-0; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Dunkley KD, 2007, POULTRY SCI, V86, P801, DOI 10.1093/ps/86.5.801; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Gaggia F, 2010, INT J FOOD MICROBIOL, P141, DOI [10.1016/j.ijfoodmicro.2010.09.011, DOI 10.1016/J.IJFOODMICRO.2010.09.011]; Gharib-Naseri K, 2019, POULTRY SCI, V98, P6422, DOI 10.3382/ps/pez480; Gholamiandehkordi AR, 2007, AVIAN PATHOL, V36, P375, DOI 10.1080/03079450701589118; Harrison C., 2010, QUANTIFICATION SHORT; Hassan H.M.A., 2018, INT J POULT SCI, V17, P255; Havenstein GB, 2003, POULTRY SCI, V82, P1500, DOI 10.1093/ps/82.10.1500; He LQ, 2018, J CHROMATOGR B, V1092, P359, DOI 10.1016/j.jchromb.2018.06.028; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Hoving LR, 2018, METHODS MOL BIOL, V1730, P247, DOI 10.1007/978-1-4939-7592-1_17; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Jayaraman S, 2013, POULTRY SCI, V92, P370, DOI 10.3382/ps.2012-02528; Johnson JR, 2006, J INFECT DIS, V194, P71, DOI 10.1086/504921; Kloos DP, 2014, RAPID COMMUN MASS SP, V28, P1507, DOI 10.1002/rcm.6923; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Landoni MF, 2015, VET J, V205, P21, DOI 10.1016/j.tvjl.2015.04.016; Lee K, 2010, J POULT SCI, V47, P106, DOI 10.2141/jpsa.009096; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; M'Sadeq SA, 2015, ANIM NUTR, V1, P1, DOI 10.1016/j.aninu.2015.02.004; Montagne L, 2003, ANIM FEED SCI TECH, V108, P95, DOI 10.1016/S0377-8401(03)00163-9; Montassier E, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0301-4; MOORE PR, 1946, J BIOL CHEM, V165, P437; Panda AK, 2009, ASIAN AUSTRAL J ANIM, V22, P1026, DOI 10.5713/ajas.2009.80298; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Redondo LM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00118; Rehman HU, 2007, ARCH ANIM NUTR, V61, P319, DOI 10.1080/17450390701556817; Roberts T, 2015, J APPL POULTRY RES, V24, P257, DOI 10.3382/japr/pfv023; Samanya M, 2002, COMP BIOCHEM PHYS A, V133, P95, DOI 10.1016/S1095-6433(02)00121-6; Scher JU, 2015, ARTHRITIS RHEUMATOL, V67, P128, DOI 10.1002/art.38892; Shareef AM, 2009, IRAQI J VET SCI, V23, P45; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; Teo AYL, 2006, J APPL POULTRY RES, V15, P229, DOI 10.1093/japr/15.2.229; Timbermont L, 2010, AVIAN PATHOL, V39, P117, DOI 10.1080/03079451003610586; Torres-Rodriguez A, 2005, J APPL POULTRY RES, V14, P665, DOI 10.1093/japr/14.4.665; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; van der Wielen PWJJ, 2000, APPL ENVIRON MICROB, V66, P2536, DOI 10.1128/AEM.66.6.2536-2540.2000; Wegener HC, 2003, CURR OPIN MICROBIOL, V6, P439, DOI 10.1016/j.mib.2003.09.009; Willis WL, 2007, POULTRY SCI, V86, P1856, DOI 10.1093/ps/86.9.1856; Xue GD, 2018, POULTRY SCI, V97, P1334, DOI 10.3382/ps/pex444; Yang Y, 2009, WORLD POULTRY SCI J, V65, P97, DOI 10.1017/S0043933909000008; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580; 2016, INT J PHYS MED REHAB, V4, p3S	60	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0232781	10.1371/journal.pone.0232781	http://dx.doi.org/10.1371/journal.pone.0232781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555739	Green Published, gold			2022-12-26	WOS:000543273200039
J	Aly, O; Zaki, HH; Herzalla, MR; Fathy, A; Raafat, N; Hafez, MM				Aly, Omnia; Zaki, Hanan Hassan; Herzalla, Mohamed R.; Fathy, Ahmed; Raafat, Nermin; Hafez, Mohamed M.			Gene polymorphisms of Patatin-like phospholipase domain containing 3 (PNPLA3), adiponectin, leptin in diabetic obese patients	PLOS ONE			English	Article							FATTY LIVER-DISEASE; I148M POLYMORPHISM; METABOLIC SYNDROME; ASSOCIATION; PLASMA; DENSITY; GLUCOSE; RISK; CHOLESTEROL; ADIPONUTRIN	Obesity leads a crucial importance in metabolic disorders, as well as type 2 diabetes mellitus. Our present study was designed to assess the potential role of irisin, adiponectin, leptin and gene polymorphism of PNPLA3, leptin and adiponectin as predictive markers of diabetes associated with obesity. One hundred eighty subjects were distributed to three groups including; healthy non-diabetic non obese volunteers as a control group, diabetic non obese group, and diabetic obese group (n = 60 for each group). Fasting blood samples of all groups were collected to determine fasting blood glucose, insulin levels, insulin resistance, total cholesterol, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), triacylglycerol, irisin, adiponectin, leptin; as well as, polymorphism of PNPLA3, adiponectin and leptin. The results showed that glucose, insulin resistance, total cholesterol, irisin, leptin, LDL-C, triacylglycerol concentrations were significantly increased, however, insulin, HDL-C, adiponectin were significantly decreased in diabetic obese patients in relation to diabetic non-obese patients as well as in healthy volunteers. The polymorphism of PNPLA3 rs738409 was linearly related to irisin and leptin but was not related with circulating concentrations of adiponectin. We concluded that increased irisin and leptin levels can predict the insulin resistance in obese patients. Moreover, patients who have mutant genotype ofPNPLA3I148 gene (rs738409) C>G, ADIPOQ gene (rs266729) G>C and LEP gene (rs2167270) G>A showed a significant higher susceptibility rate for DM in obese people than those with wild type. This could be considered as an adjustable retort to counter the impact of obesity on glucose homeostasis.	[Aly, Omnia; Zaki, Hanan Hassan] Natl Res Ctr, Dept Med Biochem, Cairo, Egypt; [Herzalla, Mohamed R.; Fathy, Ahmed] Zagazig Univ, Fac Med, Dept Internal Med, Zagazig, Egypt; [Raafat, Nermin] Zagazig Univ, Fac Med, Med Biochem Dept, Zagazig, Egypt; [Hafez, Mohamed M.] Ahram Canadian Univ, Fac Pharm, Biochem Dept, 6th Of October City, Egypt	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Zagazig University; Egyptian Knowledge Bank (EKB); Zagazig University	Hafez, MM (corresponding author), Ahram Canadian Univ, Fac Pharm, Biochem Dept, 6th Of October City, Egypt.	mohkhalifa2000@yahoo.com	Raafat, Nermin/AAP-3413-2020	Raafat, Nermin/0000-0003-0616-1262; gomaa, ahmed/0000-0003-0247-3234; Herzalla, Mohamed/0000-0002-9617-7825; Hafez, Mohamed/0000-0003-0403-8033; Aly, Omnia/0000-0003-2754-6073				Al-Amodi HS, 2018, DIABETES METAB SYND, V12, P357, DOI 10.1016/j.dsx.2017.12.030; Alam Uazman, 2014, Handb Clin Neurol, V126, P211, DOI 10.1016/B978-0-444-53480-4.00015-1; Alkhateeb A, 2013, GENE, V512, P61, DOI 10.1016/j.gene.2012.09.095; ALLAIN CC, 1974, CLIN CHEM, V20, P470; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; [Anonymous], 2017, INT J MOL SCI, V18, pE961; [Anonymous], 2009, COMMUNICATION TECHNO, V09, P88; [Anonymous], 2016, SPIEGEL, V8, P10; Aydin S, 2014, PEPTIDES, V56, P94, DOI 10.1016/j.peptides.2014.03.021; BERSON SA, 1961, AM J MED, V31, P874, DOI 10.1016/0002-9343(61)90029-8; Brown WV, 2009, AM J MED, V122, pS4, DOI 10.1016/j.amjmed.2009.01.002; Choi YK, 2013, DIABETES RES CLIN PR, V100, P96, DOI 10.1016/j.diabres.2013.01.007; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cox AJ, 2011, DIABETES METAB, V37, P452, DOI 10.1016/j.diabet.2011.05.001; Darvall KAL, 2007, EUR J VASC ENDOVASC, V33, P223, DOI 10.1016/j.ejvs.2006.10.006; de Grooth GJ, 2004, ATHEROSCLEROSIS, V173, P261, DOI 10.1016/j.atherosclerosis.2003.11.020; Dongiovanni P, 2013, WORLD J GASTROENTERO, V19, P6969, DOI 10.3748/wjg.v19.i41.6969; Eicher S, 2019, J CHINESE HIST, V3, P1, DOI 10.1017/jch.2017.39; Enns JE, 2011, J OBES, V2011, DOI 10.1155/2011/168659; Foucan L, 2014, J DIABETES INVEST, V5, P192, DOI 10.1111/jdi.12133; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GLICK MR, 1986, CLIN CHEM, V32, P470; Garcia-Chapa EG, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3937893; Hew-Butler T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12262; Huang YC, 2011, J BIOL CHEM, V286, P37085, DOI 10.1074/jbc.M111.290114; Jia DM, 2004, METABOLISM, V53, P405, DOI 10.1016/j.metabol.2003.10.006; Karamfilova V, 2019, J GASTROINTEST LIVER, V28, P433, DOI 10.15403/jgld-506; Kockx M, 2018, CARDIOL CLIN, V36, P265, DOI 10.1016/j.ccl.2017.12.008; Krarup NT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040376; Kuchler EC, 2012, J APPL ORAL SCI, V20, P467, DOI 10.1590/S1678-77572012000400013; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; LOPESVIRELLA MF, 1977, CLIN CHEM, V23, P882; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mtiraoui N, 2012, DIABETES RES CLIN PR, V97, P290, DOI 10.1016/j.diabres.2012.02.015; Neeli H, 2009, CURR DIABETES REP, V9, P11, DOI 10.1007/s11892-009-0004-y; Nguyen D., 2011, CELL DEATH DIS, V2, pe240; Palmer CNA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039362; Pawlik A, 2017, J ASSIST REPROD GEN, V34, P511, DOI 10.1007/s10815-016-0866-2; Paz-Pacheco E, 2009, DIABETES VASC DIS RE, V6, P231, DOI 10.1177/1479164109344933; Pingitore P, 2014, BBA-MOL CELL BIOL L, V1841, P574, DOI 10.1016/j.bbalip.2013.12.006; Pirazzi C, 2012, J HEPATOL, V57, P1276, DOI 10.1016/j.jhep.2012.07.030; Sahin-Efe A, 2018, METABOLISM, V79, P24, DOI 10.1016/j.metabol.2017.10.011; Sainz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006808; Sampson M, 2004, CARDIOVASC DIABETOL, V3, DOI 10.1186/1475-2840-3-7; Santoro N, 2010, HEPATOLOGY, V52, P1281, DOI 10.1002/hep.23832; Tinkov AA, 2017, SCI TOTAL ENVIRON, V601, P741, DOI 10.1016/j.scitotenv.2017.05.224; Titov V. N., 2011, Klinicheskaya Laboratornaya Diagnostika, P4; TRINDER P, 1969, J CLIN PATHOL, V22, P158, DOI 10.1136/jcp.22.2.158; Valenti L, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-111; Winberg ME, 2014, BIOCHEM BIOPH RES CO, V446, P1114, DOI 10.1016/j.bbrc.2014.03.078; Zadjali F, 2013, GENE, V527, P663, DOI 10.1016/j.gene.2013.06.057; Zhou ZW, 2018, CLIN CHIM ACTA, V476, P98, DOI 10.1016/j.cca.2017.11.023	53	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234465	10.1371/journal.pone.0234465	http://dx.doi.org/10.1371/journal.pone.0234465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544194	Green Published, gold			2022-12-26	WOS:000542957200046
J	Juga, AJC; Hens, N; Osman, N; Aerts, M				Juga, Adelino J. C.; Hens, Niel; Osman, Nafissa; Aerts, Marc			Factors associated with HIV serodiscordance among couples in Mozambique: Comparison of the 2009 INSIDA and 2015 IMASIDA surveys	PLOS ONE			English	Article							RISK-FACTORS; DISCORDANCE	Recent studies suggest that a large proportion of new HIV-1 infections in mature epidemics occurs within discordant couples, making discordancy a major contributor to the spread of HIV/AIDS in Africa. This paper aims at assessing changes over a five-year period (2009-2015) on the (risk) factors associated with HIV serodiscordance among couples in Mozambique, using cross-sectional data from the INSIDA and IMASIDA surveys. The pooled data of both surveys were analyzed using a joint model for three parameters characterizing in a particular way disagreement and sero(con/dis)corance between the HIV statuses of couples, as introduced by Aerts et al.: the probability that the female partner is HIV positive, given that both partners differ in their HIV status, the probability that only one partner is HIV positive, given that at least one of the two partners is positive ("positive" serodiscordance), and the probability that both partners are negative given that at most one of the two partners is positive ("negative" seroconcordance). The results reveal similar significant factors and estimates as in Aerts et al. (HIV prevalence, union number for woman, STI for man, condom use by woman and wealth index), but the additional significant factors "condom use by man" (no use had a negative effect on the positive serodiscordance) and "union number for man" (for couples where the man has been married or co-habiting with a woman before had a decreased negative seroconcordance) were identified. The only factor that had a different effect over time (IMASIDA as compared to INSIDA) was the effect of "HIV prevalence of province" on the negative seroconcordance. The negative effect of a higher HIV prevalence was less pronounced in 2015 for negative seroconcordance.	[Juga, Adelino J. C.] Eduardo Mondlane Univ, Fac Sci, Dept Math & Informat, Maputo, Mozambique; [Juga, Adelino J. C.; Hens, Niel; Aerts, Marc] Hasselt Univ, Data Sci Inst, I BioStat, Diepenbeek, Belgium; [Hens, Niel] Univ Antwerp, Ctr Hlth Econ Res & Modelling Infect Dis, Vaccine & Infect Dis Inst VAXINFECTIO, Antwerp, Belgium; [Hens, Niel] Univ Antwerp, Fac Med & Hlth Sci, Epidemiol & Social Med ESOC, Antwerp, Belgium; [Osman, Nafissa] Maputo Cent Hosp, Dept Obstet & Gynecol, Maputo, Mozambique; [Osman, Nafissa] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique	Eduardo Mondlane University; Hasselt University; University of Antwerp; University of Antwerp; Eduardo Mondlane University	Juga, AJC (corresponding author), Eduardo Mondlane Univ, Fac Sci, Dept Math & Informat, Maputo, Mozambique.; Juga, AJC (corresponding author), Hasselt Univ, Data Sci Inst, I BioStat, Diepenbeek, Belgium.	adelino.juga@gmail.com	Hens, Niel/M-4445-2017	Hens, Niel/0000-0003-1881-0637	Flemish Interuniversity Council (VLIR-UOS); Eduardo Mondlane University (UEM) through the DESAFIO Program, in Mozambique	Flemish Interuniversity Council (VLIR-UOS); Eduardo Mondlane University (UEM) through the DESAFIO Program, in Mozambique	This study was financially supported by the Flemish Interuniversity Council (VLIR-UOS) in collaboration with Eduardo Mondlane University (UEM) through the DESAFIO Program, in Mozambique to AJCJ.	Aerts M, 2019, STAT METHODS MED RES, V28, P3086, DOI 10.1177/0962280218796252; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Bunnell R, 2006, JAMA-J AM MED ASSOC, V296, P855, DOI 10.1001/jama.296.7.855; Eyawo O, 2010, LANCET INFECT DIS, V10, P770, DOI 10.1016/S1473-3099(10)70189-4; Faes C, 2008, J AM STAT ASSOC, V103, P149, DOI 10.1198/016214507000000419; Fishel J. D., 2012, J INT AIDS SOC; Fishel JD, 2011, HIV COUPLES MOZAMBIQ; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Habte Ermias, 2015, J Int Assoc Provid AIDS Care, V14, P234, DOI 10.1177/2325957413488177; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Juga AJC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172959; Kaiser R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017842; Reed J. C., 2018, IMASIDA MALARIA HIV; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Tadesse Moges, 2014, BMC Res Notes, V7, P893, DOI 10.1186/1756-0500-7-893; Ujah IAO, 2015, AFR J REPROD HEALTH, V19, P108; Tam VV, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0124-9; Zhang YJ, 2015, J MED VIROL, V87, P553, DOI 10.1002/jmv.24093	18	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234723	10.1371/journal.pone.0234723	http://dx.doi.org/10.1371/journal.pone.0234723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544170	Green Published, gold			2022-12-26	WOS:000542957200008
J	Durschmid, S; Reichert, C; Walter, N; Hinrichs, H; Heinze, HJ; Ohl, FW; Tononi, G; Deliano, M				Duerschmid, Stefan; Reichert, Christoph; Walter, Nike; Hinrichs, Hermann; Heinze, Hans-Jochen; Ohl, Frank W.; Tononi, Giulio; Deliano, Matthias			Self-regulated critical brain dynamics originate from high frequency-band activity in the MEG	PLOS ONE			English	Article							NEURONAL AVALANCHES; MEDITATION; MINDFULNESS; EXPERIENCE; ATTENTION; EEG	Brain function requires the flexible coordination of billions of neurons across multiple scales. This could be achieved by scale-free, critical dynamics balanced at the edge of order and disorder. Criticality has been demonstrated in several, often reduced neurophysiological model systems. In the intact human brain criticality has yet been only verified for the resting state. A more direct link between the concept of criticality and oscillatory brain physiology, which is strongly related to cognition, is yet missing. In the present study we therefore carried out a frequency-specific analysis of criticality in the MEG, recorded while subjects were in a defined cognitive state through mindfulness meditation. In a two-step approach we assessed whether the macroscopic neural avalanche dynamics is scale-free by evaluating the goodness of a power-law fits of cascade size and duration distributions of MEG deflections in different frequency bands. In a second step we determined the closeness of the power-law exponents to a critical value of -1.5. Power-law fitting was evaluated by permutation testing, fitting of alternative distributions, and cascade shape analysis. Criticality was verified by defined relationships of exponents of cascade size and duration distributions. Behavioral relevance of criticality was tested by correlation of indices of criticality with individual scores of the Mindful Attention Awareness Scale. We found that relevant scale-free near-critical dynamics originated only from broad-band high-frequency (> 100 Hz) MEG activity, which has been associated with action potential firing, and therefore links criticality on the macroscopic level of MEG to critical spike avalanches on a microscopic level. Whereas a scale-free dynamics was found under mindfulness meditation and rest, avalanche dynamics shifted towards a critical point during meditation by reduction of neural noise. Together with our finding that during mindfulness meditation avalanches show differences in topography relative to rest, our results show that self-regulated attention as required during meditation can serve as a control parameter of criticality in scale-free brain dynamics.	[Duerschmid, Stefan; Reichert, Christoph; Hinrichs, Hermann; Heinze, Hans-Jochen; Deliano, Matthias] Leibniz Inst Neurobiol, Dept Behav Neurol, Magdeburg, Germany; [Duerschmid, Stefan; Hinrichs, Hermann; Heinze, Hans-Jochen] Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Reichert, Christoph; Hinrichs, Hermann; Heinze, Hans-Jochen] Otto Von Guericke Univ, Forschungscampus STIMULATE, Magdeburg, Germany; [Reichert, Christoph; Hinrichs, Hermann; Heinze, Hans-Jochen] Otto Von Guericke Univ, CBBS Ctr Behav Brain Sci, Magdeburg, Germany; [Walter, Nike] Univ Med Ctr, Dept Psychosomat Med, Res Sect Appl Consciousness Sci, Regensburg, Germany; [Hinrichs, Hermann; Heinze, Hans-Jochen; Ohl, Frank W.] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany; [Ohl, Frank W.] Leibniz Inst Neurobiol LIN, Dept Syst Physiol Learning SPL, Magdeburg, Germany; [Ohl, Frank W.] Otto Von Guericke Univ, Inst Biol IBIO, Magdeburg, Germany; [Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Tononi, Giulio] Univ Wisconsin, Ctr Sleep & Consciousness, Madison, WI USA	Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; University of Regensburg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Durschmid, S; Deliano, M (corresponding author), Leibniz Inst Neurobiol, Dept Behav Neurol, Magdeburg, Germany.; Durschmid, S (corresponding author), Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany.	stefan.duerschmid@googlemail.com; matthias.deliano@lin-magdeburg.de		Reichert, Christoph/0000-0002-8649-9791; Walter, Nike/0000-0002-0654-2076	Deutsche Forschungsgemeinschaft [DFG-SFB 779]; BMBF [13GW0095D]; 'Autonomie im Alter' project - State of Saxony-Anhalt; European Union (EFRE)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); 'Autonomie im Alter' project - State of Saxony-Anhalt; European Union (EFRE)(European Commission)	The study was supported by Deutsche Forschungsgemeinschaft DFG-SFB 779, BMBF Grant 13GW0095D, 'Autonomie im Alter' project funded by the State of Saxony-Anhalt and the European Union (EFRE).	[Anonymous], 2016, UKRAINSKA ENTOMOFAUN; [Anonymous], 2008, ENDOCR-RELAT CANCER, V15, P351; [Anonymous], 2011, DTSCH ARZTEBL, V108; Arcangelis L De, 2010, LEARNING PHENOMENON; Bak P., 1996, NATURE WORKS; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beggs JM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00163; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cahn BR, 2009, INT J PSYCHOPHYSIOL, V72, P51, DOI 10.1016/j.ijpsycho.2008.03.013; Cocchi L, 2017, PROG NEUROBIOL, V158, P132, DOI 10.1016/j.pneurobio.2017.07.002; Dam NT Van, 2017, MIND HYPE CRITICAL E; FAAIR Scientific Advisory Panel, 2002, CLIN INFECT DIS S3, V34, pS76; Fagerholm ED, 2015, J NEUROSCI, V35, P4626, DOI 10.1523/JNEUROSCI.3694-14.2015; Feldman Louis H., 2000, F JOSEPHUS TRANSLATI, V3, pXI; Fox KCR, 2016, NEUROSCI BIOBEHAV R, V65, P208, DOI 10.1016/j.neubiorev.2016.03.021; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Hasenkamp W, 2012, NEUROIMAGE, V59, P750, DOI 10.1016/j.neuroimage.2011.07.008; Irrmischer M, 2018, CONTROLLING TEMPORAL, P1825; Kakumanu RJ, 2018, BIOL PSYCHOL, V135, P65, DOI 10.1016/j.biopsycho.2018.03.004; Kerr CE, 2011, BRAIN RES BULL, V85, P96, DOI 10.1016/j.brainresbull.2011.03.026; Kucyi A, 2013, P NATL ACAD SCI USA, V110, P18692, DOI 10.1073/pnas.1312902110; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Mittner M, 2014, J NEUROSCI, V34, P16286, DOI 10.1523/JNEUROSCI.2062-14.2014; Moore A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00018; Muthukumaraswamy SD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00138; Oken B, 2006, CLIN NEUROPHYSIOL; Pagnoni G, 2007, NEUROBIOL AGING, V28, P1623, DOI 10.1016/j.neurobiolaging.2007.06.008; Shew WL, 2009, NEURONAL AVALANCHES; Shew WL, 2012, NEUROSCIENTIST FUNCT; Shriki O, 2013, J NEUROSCI, V33, P7079, DOI 10.1523/JNEUROSCI.4286-12.2013; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Solovey G, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00044; Ward AF, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00650; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Zhou XQ, 2018, NEUROSCI BULL, V34, P1017, DOI 10.1007/s12264-018-0278-7; 2019, J CROHNS COLITIS S1, V13	41	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0233589	10.1371/journal.pone.0233589	http://dx.doi.org/10.1371/journal.pone.0233589			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QL	32525940	Green Published, gold			2022-12-26	WOS:000542036800009
J	Horvat, A; Fogliano, V; Luning, PA				Horvat, Andrijana; Fogliano, Vincenzo; Luning, Pieternel A.			Modifying the Bass diffusion model to study adoption of radical new foods-The case of edible insects in the Netherlands	PLOS ONE			English	Article							SYSTEM DYNAMICS; INNOVATION DIFFUSION; SENSORY-LIKING; EAT INSECTS; PRODUCTS; MEAT; WILLINGNESS; INFORMATION; CONSUMERS; OPPORTUNITIES	Developing new food products is a complex process. Even if a company performs new product development activities successfully, it is still uncertain if consumers will adopt the product. The Bass diffusion model has often been used to study product adoption. However, existing modifications of the Bass diffusion model do not capture the complexity of consumer food choice and they have limitations in situations where there is no sales data. To avoid these challenges, the system dynamics approach can be employed. This paper aimed at extending the existing system dynamics Bass diffusion model to investigate the dynamic adoption process of insect-based food from a consumer research perspective. We performed a structured review of the literature on edible insects to build the model. The model was used to study adoption of the product amongst consumers in the Netherlands. Simulations revealed that diffusion of a radical innovation, such as an insect-based burger, can proceed for many years before there are observable adopters in the total population, under the currently reported practices in the Netherlands. Expanding awareness of this innovation requires many decades, which can be quickened by developing strategies aimed at increasing word-of-mouth. Nevertheless, the low likelihood to adopt such food remains a challenge towards full adoption, even when the sensory quality of products is improved. To fully explore how to improve the diffusion outcome of edible insects, more knowledge on mechanisms related to positive and negative word-of-mouth, and adoption of insect-based burgers by people who initially reject them, is needed. Our study demonstrated that system dynamics models could have potential in designing new food product strategies in companies, as they facilitate decision-making and uncover knowledge gaps.	[Horvat, Andrijana; Fogliano, Vincenzo; Luning, Pieternel A.] Wageningen Univ & Res, Food Qual & Design Grp, Dept Agrotechnol & Food Sci, Wageningen, Netherlands	Wageningen University & Research	Horvat, A (corresponding author), Wageningen Univ & Res, Food Qual & Design Grp, Dept Agrotechnol & Food Sci, Wageningen, Netherlands.	andrijana.horvat@wur.nl	fogliano, vincenzo/A-1419-2009	fogliano, vincenzo/0000-0001-8786-9355				[Anonymous], 2015, INSECTS FOOD SOMETHI; [Anonymous], 2001, FOOD PRODUCT DEV; Baker MA, 2016, PSYCHOL MARKET, V33, P94, DOI 10.1002/mar.20847; Balzan S, 2016, BRIT FOOD J, V118, P318, DOI 10.1108/BFJ-04-2015-0156; Barlas Y, 1996, SYST DYNAM REV, V12, P183, DOI 10.1002/(SICI)1099-1727(199623)12:3<183::AID-SDR103>3.0.CO;2-4; Barlas Y., 2009, ENCY LIFE SUPPORT SY, V1, P1; BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; Behdani B, 2012, P 2012 WINT SIM C 20, P3630; Borshchev A, 2004, P 22 INT C SYST DYN; CBS StatLine, 2017, BEV KERNC; Dagevos H, 2012, 2012029 LEI; Damsbo-Svendsen M, 2017, APPETITE, V113, P358, DOI 10.1016/j.appet.2017.02.032; de-Magistris T, 2015, BRIT FOOD J, V117, P1777, DOI 10.1108/BFJ-06-2014-0222; Delre SA, 2007, J BUS RES, V60, P826, DOI 10.1016/j.jbusres.2007.02.002; Derkzen PHM, 2011, INT CONS SCI RES C C; Derwisch S, 2016, FUTURES, V81, P161, DOI 10.1016/j.futures.2015.08.011; Dicke M, 2014, 1 INT C INS FEED WOR; Dijksterhuis G, 2016, TRENDS FOOD SCI TECH, V50, P243, DOI 10.1016/j.tifs.2016.01.016; Dobermann D, 2017, NUTR BULL, V42, P293, DOI 10.1111/nbu.12291; Dutta A, 2017, TECHNOL FORECAST SOC, V118, P28, DOI 10.1016/j.techfore.2017.01.024; Duval Y., 2002, Agribusiness (New York), V18, P23, DOI 10.1002/agr.10005; Fallah-Fini S, 2014, AM J PUBLIC HEALTH, V104, P1230, DOI 10.2105/AJPH.2014.301882; Ford A., 1999, MODELING ENV INTRO S; Frattini F, 2014, J PROD INNOVAT MANAG, V31, P466, DOI 10.1111/jpim.12108; GATIGNON H, 1985, J CONSUM RES, V11, P849, DOI 10.1086/209021; Gerber P. J., 2013, TACKLING CLIMATE CHA, P139; Glover D, 2015, EDIBLE INSECTS FUTUR; Goldenberg J., 2009, ENCY COMPLEXITY SYST, P5377; Grunert KG, 2015, CURR OPIN FOOD SCI, V3, P19, DOI 10.1016/j.cofs.2014.11.003; Hamerman EJ, 2016, APPETITE, V96, P319, DOI 10.1016/j.appet.2015.09.029; Hartmann C, 2015, FOOD QUAL PREFER, V44, P148, DOI 10.1016/j.foodqual.2015.04.013; Hoek AC, 2011, FOOD QUAL PREFER, V22, P371, DOI 10.1016/j.foodqual.2011.01.008; HOMER JB, 1987, TECHNOL FORECAST SOC, V31, P197, DOI 10.1016/0040-1625(87)90011-4; Huang YS, 2015, INT J SYST SCI, V46, P1010, DOI 10.1080/00207721.2013.807382; Jimenez M, 2016, ENERGY, V111, P818, DOI 10.1016/j.energy.2016.06.051; Kim J, 2003, R&D MANAGE, V33, P15, DOI 10.1111/1467-9310.00278; Kim SW, 2019, ANNU REV ANIM BIOSCI, V7, P221, DOI 10.1146/annurev-animal-030117-014838; Kreng VB, 2013, TECHNOL FORECAST SOC, V80, P77, DOI 10.1016/j.techfore.2012.08.002; Loo S, 2013, PARALLAX, V19, P12, DOI 10.1080/13534645.2013.743290; Looy H., 2006, J ENV ED, V37, P37, DOI [10.3200/JOEE.37.2.37-48, DOI 10.3200/JOEE.37.2.37-48]; MAHAJAN V, 1990, J MARKETING, V54, P1, DOI 10.2307/1252170; Benvenutti LMM, 2017, J CLEAN PROD, V164, P1571, DOI 10.1016/j.jclepro.2017.07.051; Martin RL, 2013, HARVARD BUS REV; Martins Y, 2006, APPETITE, V46, P75, DOI 10.1016/j.appet.2005.09.001; Martins Y, 2005, APPETITE, V45, P214, DOI 10.1016/j.appet.2005.08.002; Meade N, 2006, INT J FORECASTING, V22, P519, DOI 10.1016/j.ijforecast.2006.01.005; Megido RC, 2016, FOOD QUAL PREFER, V52, P237, DOI 10.1016/j.foodqual.2016.05.004; Megido RC, 2014, J SENS STUD, V29, P14, DOI 10.1111/joss.12077; Milling PM, 1996, SYST DYNAM REV, V12, P211, DOI 10.1002/(SICI)1099-1727(199623)12:3<211::AID-SDR105>3.0.CO;2-8; Milling PM, 2009, ENCY COMPLEXITY SYST, P1956; Mohseni O, 2017, CONGRESS ON TECHNICAL ADVANCEMENT 2017: INFRASTRUCTURE RESILIENCE AND ENERGY, P69; Olatunji BO, 2008, J RES PERS, V42, P1243, DOI 10.1016/j.jrp.2008.03.009; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445; Pascucci S, 2013, INT FOOD AGRIBUS MAN, V16, P1; Pitt D. B., 2014, American Entomologist, V60, P97; Pruyt E, 2013, SMALL SYSTEM DYNAMIC; Repenning NP, 2002, ORGAN SCI, V13, P109, DOI 10.1287/orsc.13.2.109.535; Richardson G.P., 1981, INTRO SYSTEM DYNAMIC; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Ruby MB, 2015, J INSECTS FOOD FEED, V1, P215, DOI 10.3920/JIFF2015.0029; Saguy IS, 2016, J FOOD ENG, V176, P2, DOI 10.1016/j.jfoodeng.2015.07.012; Schmidt MJ, 2002, SYST DYNAM REV, V18, P359, DOI 10.1002/sdr.257; Schosler H, 2012, APPETITE, V58, P39, DOI 10.1016/j.appet.2011.09.009; Schouteten JJ, 2016, FOOD QUAL PREFER, V52, P27, DOI 10.1016/j.foodqual.2016.03.011; Shelomi M, 2015, TRENDS FOOD SCI TECH, V45, P311, DOI 10.1016/j.tifs.2015.06.008; Sogari G, 2019, WOODH PUBL SER CONS, P47, DOI 10.1016/B978-0-08-100944-4.00004-5; Sterman J.D., 2004, BUSINESS DYNAMICS SY; Tan HSG, 2017, FOOD RES INT, V92, P95, DOI 10.1016/j.foodres.2016.12.021; Tan HSG, 2016, FOOD QUAL PREFER, V48, P293, DOI 10.1016/j.foodqual.2015.11.001; Tan HSG, 2015, FOOD QUAL PREFER, V42, P78, DOI 10.1016/j.foodqual.2015.01.013; van Huis A, 2016, P NUTR SOC, V75, P294, DOI 10.1017/S0029665116000069; van Rossum C., 2020, DIET DUTCH RESULTS D, DOI [10.21945/RIVM-2020-0083, DOI 10.21945/RIVM-2020-0083]; Vanhonacker F, 2013, APPETITE, V62, P7, DOI 10.1016/j.appet.2012.11.003; Vantomme P, 2013, EDIBLE INSECTS FUTUR; Vensim DSS, 2018, VENS DSS; Verbeke W, 2015, FOOD QUAL PREFER, V39, P147, DOI 10.1016/j.foodqual.2014.07.008; Warren K., 2008, STRATEG MANAG; Yen Alan L., 2009, Entomological Research, V39, P289, DOI 10.1111/j.1748-5967.2009.00239.x; Yucel G, 2011, TECHNOL FORECAST SOC, V78, P358, DOI 10.1016/j.techfore.2010.11.004; Zhao R, 2015, ECOL INDIC, V51, P98, DOI 10.1016/j.ecolind.2014.08.030; 2016, MALAYS ORTHOP J, V0010, P00047	81	10	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234538	10.1371/journal.pone.0234538	http://dx.doi.org/10.1371/journal.pone.0234538			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QL	32525950	Green Published, gold			2022-12-26	WOS:000542036800056
J	Izuhara, K; Fukui, K; Murakawa, T; Baba, S; Kumasaka, T; Uchiyama, K; Yano, T				Izuhara, Keisuke; Fukui, Kenji; Murakawa, Takeshi; Baba, Seiki; Kumasaka, Takashi; Uchiyama, Kazuhisa; Yano, Takato			A Lynch syndrome-associated mutation at a Bergerat ATP-binding fold destabilizes the structure of the DNA mismatch repair endonuclease MutL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA mismatch repair; Lynch syndrome; MutL; postmeiotic segregation increased 2 (PMS2); X-ray crystal structure; ATPase; cancer; Aquifex aeolicus; Bergerat fold; DNA-binding protein; X-ray crystallography; protein stability	NONPOLYPOSIS COLORECTAL-CANCER; N-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; PROTEIN MUTS; ALPHA; PMS2; IDENTIFICATION; FEATURES; DIMERIZATION; HYDROLYSIS	In humans, mutations in genes encoding homologs of the DNA mismatch repair endonuclease MutL cause a hereditary cancer that is known as Lynch syndrome. Here, we determined the crystal structures of the N-terminal domain (NTD) of MutL from the thermophilic eubacteriumAquifex aeolicus(aqMutL) complexed with ATP analogs at 1.69-1.73 angstrom. The structures revealed significant structural similarities to those of a human MutL homolog, postmeiotic segregation increased 2 (PMS2). We introduced five Lynch syndrome-associated mutations clinically found in human PMS2 into the aqMutL NTD and investigated the protein stability, ATPase activity, and DNA-binding ability of these protein variants. Among the mutations studied, the most unexpected results were obtained for the residue Ser34. Ser34 (Ser46 in PMS2) is located at a previously identified Bergerat ATP-binding fold. We found that the S34I aqMutL NTD retains ATPase and DNA-binding activities. Interestingly, CD spectrometry and trypsin-limited proteolysis indicated the disruption of a secondary structure element of the S34I NTD, destabilizing the overall structure of the aqMutL NTD. In agreement with this, the recombinant human PMS2 S46I NTD was easily digested in the hostEscherichia colicells. Moreover, other mutations resulted in reduced DNA-binding or ATPase activity. In summary, using the thermostable aqMutL protein as a model molecule, we have experimentally determined the effects of the mutations on MutL endonuclease; we discuss the pathological effects of the corresponding mutations in human PMS2.	[Izuhara, Keisuke; Fukui, Kenji; Murakawa, Takeshi; Yano, Takato] Osaka Med Coll, Dept Biochem, Takatsuki, Osaka, Japan; [Izuhara, Keisuke; Uchiyama, Kazuhisa] Osaka Med Coll, Dept Gen & Gastroenterol Surg, Takatsuki, Osaka, Japan; [Baba, Seiki; Kumasaka, Takashi] Japan Synchrotron Radiat Res Inst, Prot Crystal Anal Div, Sayo, Hyogo, Japan	Osaka Medical College; Osaka Medical College; Japan Synchrotron Radiation Research Institute	Fukui, K; Yano, T (corresponding author), Osaka Med Coll, Dept Biochem, Takatsuki, Osaka, Japan.	k.fukui@osaka-med.ac.jp; med013@osaka-med.ac.jp	Kumasaka, Takashi/D-7428-2018	Kumasaka, Takashi/0000-0001-9289-1557; Fukui, Kenji/0000-0003-2463-7578; baba, seiki/0000-0002-2589-232X	JSPS KAKENHI [JP19K07376]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant number JP19K07376 (to K. F.). The crystallographic experiments were performed at BL38B1 in SPring-8 (proposal 2017B2544).	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arana ME, 2010, DNA REPAIR, V9, P448, DOI 10.1016/j.dnarep.2010.01.010; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Borras E, 2013, J MED GENET, V50, P552, DOI 10.1136/jmedgenet-2012-101511; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Clendenning M, 2006, HUM MUTAT, V27, P490, DOI 10.1002/humu.20318; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fishel R, 2015, J BIOL CHEM, V290, P26395, DOI 10.1074/jbc.R115.660142; Friedhoff P, 2016, DNA REPAIR, V38, P50, DOI 10.1016/j.dnarep.2015.11.013; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; Fukui K, 2017, BBA-PROTEINS PROTEOM, V1865, P1178, DOI 10.1016/j.bbapap.2017.06.024; Fukui K, 2016, J BIOL CHEM, V291, P16990, DOI 10.1074/jbc.M116.739664; Fukui K, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/260512; Genschel J, 2017, P NATL ACAD SCI USA, V114, P4930, DOI 10.1073/pnas.1702561114; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; Iino H, 2015, EXTREMOPHILES, V19, P643, DOI 10.1007/s00792-015-0745-2; Iino H, 2011, BIOSCIENCE REP, V31, P309, DOI 10.1042/BSR20100116; Ishii S, 2013, BIOCHEMISTRY-US, V52, P2545, DOI 10.1021/bi3017069; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2000, CURR OPIN GENET DEV, V10, P157, DOI 10.1016/S0959-437X(00)00066-6; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrova LY, 2016, DNA REPAIR, V38, P42, DOI 10.1016/j.dnarep.2015.11.023; Kolodner RD, 2016, DNA REPAIR, V38, P3, DOI 10.1016/j.dnarep.2015.11.009; Kosinski J, 2008, J MOL BIOL, V382, P610, DOI 10.1016/j.jmb.2008.06.056; Kosinski J, 2010, HUM MUTAT, V31, P975, DOI 10.1002/humu.21301; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; LYNCH HT, 1985, CANCER, V56, P934, DOI 10.1002/1097-0142(19850815)56:4<934::AID-CNCR2820560439>3.0.CO;2-I; Minobe A, 2019, DNA REPAIR, V75, P29, DOI 10.1016/j.dnarep.2019.01.005; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pillon MC, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv918; Pillon MC, 2011, DNA REPAIR, V10, P87, DOI 10.1016/j.dnarep.2010.10.003; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; Shimada A, 2013, FEBS J, V280, P3467, DOI 10.1111/febs.12344; Spampinato C, 2000, J BIOL CHEM, V275, P9863, DOI 10.1074/jbc.275.13.9863; Suerink M, 2016, GENET MED, V18, P405, DOI 10.1038/gim.2015.83; Thompson E, 2004, CLIN GENET, V65, P215, DOI 10.1111/j.1399-0004.2004.00214.x; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Umar A, 2004, DIS MARKERS, V20, P179, DOI 10.1155/2004/486032; van der Klift HM, 2016, HUM MUTAT, V37, P1162, DOI 10.1002/humu.23052; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Wu H, 2015, ACTA CRYSTALLOGR F, V71, P981, DOI 10.1107/S2053230X15010183; Zierer BK, 2016, NAT STRUCT MOL BIOL, V23, P1020, DOI 10.1038/nsmb.3305; Zurawska A, 2010, BBA-MOL CELL RES, V1803, P575, DOI 10.1016/j.bbamcr.2010.03.002	59	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11643	11655		10.1074/jbc.RA120.013576	http://dx.doi.org/10.1074/jbc.RA120.013576			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32571878	Green Published, hybrid			2022-12-26	WOS:000563922500022
J	Feyrer, LJ; Zhao, ST; Whitehead, H; Matthews, CJD				Feyrer, Laura Joan; Zhao, Shu Ting; Whitehead, Hal; Matthews, Cory J. D.			Prolonged maternal investment in northern bottlenose whales alters our understanding of beaked whale reproductive life history	PLOS ONE			English	Article							MESOPLODON-DENSIROSTRIS; HYPEROODON-AMPULLATUS; ZIPHIUS-CAVIROSTRIS; PARENTAL INVESTMENT; DIVING BEHAVIOR; SEX-DIFFERENCES; FEEDING-HABITS; WEANING AGE; CARBON; DELTA-N-15	Nursing and weaning periods are poorly understood in cetaceans due to the difficulty of assessing underwater behaviour in the wild. However, the onset and completion of weaning are critical turning points for individual development and survival, with implications for a species' life history including reproductive potential. delta N-15 and delta C-13 deposited in odontocete teeth annuli provide a lifetime record of diet, offering an opportunity to investigate variation and trends in fundamental biology. While available reproductive parameters for beaked whales have largely been inferred from single records of stranded or hunted animals and extrapolated across species, here we examine the weaning strategy and nursing duration in northern bottlenose whales (Hyperoodon ampullatus) by measuring stable isotopes deposited in dentine growth layer groups (GLGs). Using a collection ofH.ampullatusteeth taken from whales killed during the whaling era (N = 48) and from two stranded specimens, we compared ontogenetic variation of delta N-15 and delta C-13 found in annual GLGs across all individuals, by sex and by region. We detected age-based trends in both delta N-15 and delta C-13 that are consistent across regions and males and females, and indicate that nursing is prolonged and weaning does not conclude until whales are 3-4 years old, substantially later than previous estimates of 1 year. Incorporating a prolonged period of maternal care intoH.ampullatuslife history significantly reduces their reproductive potential, with broad implications for models of beaked whale life history, energetics and the species' recovery from whaling.	[Feyrer, Laura Joan; Whitehead, Hal] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Zhao, Shu Ting; Matthews, Cory J. D.] Fisheries & Oceans Canada, Arctic Aquat Res Div, Winnipeg, MB, Canada	Dalhousie University; Fisheries & Oceans Canada	Feyrer, LJ (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	ljfeyrer@dal.ca	Feyrer, Laura Joan/H-5144-2016	Feyrer, Laura Joan/0000-0002-9300-1947	Fisheries and Oceans Species at Risk program; Natural Sciences and Engineering Research Council of Canada; Killam Trusts	Fisheries and Oceans Species at Risk program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Killam Trusts	LJF, HW and CJDM received funding from Fisheries and Oceans Species at Risk program (https://www.dfo-mpo.gc.ca/speciesespeces/sara-lep/index-eng.html) for this work. In addition, LJF received funding from the Natural Sciences and Engineering Research Council of Canada and Killam Trusts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the contributions of the GG Hatch Lab to the analysis of these samples, and support of Dr. Steve Ferguson, DFO. Teeth specimens from whaled animals were contributed by Nils Oien, Institute of Marine Research Norway. Samples from stranded whales were generously contributed by Wayne Ledwell, of the Newfoundland Stranding network.	AHLQUIST DA, 1984, J COMP PHYSIOL B, V155, P75, DOI 10.1007/BF00688794; [Anonymous], 2020, PROLONGED MATERNAL I, DOI [10.5061/dryad.k98sf7m3j, DOI 10.5061/DRYAD.K98SF7M3J]; [Anonymous], 2015, DTSCH VIERTELJAHRESS, V89, P41; [Anonymous], 2017, REPROD MAMM FEM; Baird R.W., 2019, ETHOLOGY BEHAVIOURAL, P1, DOI [10.1007/978-3-030-16663-2_14, DOI 10.1007/978-3-030-16663-2_14]; Barley J, 2007, VET REC, V160, P452, DOI 10.1136/vr.160.13.452-a; Bates D, LME4 LINEAR MIXED EF; Benjaminsen T., 1979, Behavior of Marine Animals, V3, P143; BENJAMINSEN T, 1972, Norwegian Journal of Zoology, V20, P233; Best P.B., 1984, Reports of the International Whaling Commission Special Issue, P51; CHRISTENSEN I, 1973, Norwegian Journal of Zoology, V21, P331; Clutton-Brock T., 2016, MAMMAL SOC; CLUTTONBROCK TH, 1981, NATURE, V289, P487, DOI 10.1038/289487a0; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; EFSA J, 2010, EFSA J, V8, P1; Einfeldt AL, 2019, J MAMMAL, V100, P1671, DOI 10.1093/jmammal/gyz131; Ellis R, 2017, BEAKED WHALES: A COMPLETE GUIDE TO THEIR BIOLOGY AND CONSERVATION, P1; English PA, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00014; Evacitas FC, 2017, MAR MAMMAL SCI, V33, P748, DOI 10.1111/mms.12396; Feyrer LJ, 2019, ECOL EVOL, V9, P13567, DOI 10.1002/ece3.5813; Gero S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1113; Goldbogen JA, 2017, ANNU REV MAR SCI, V9, P367, DOI 10.1146/annurev-marine-122414-033905; Gowans S, 2001, ANIM BEHAV, V62, P369, DOI 10.1006/anbe.2001.1756; Gowans SE, 1999, SOCIAL ORG POPULATIO, P1; Grove T, 2020, MAR MAMMAL SCI, V36, P1033, DOI 10.1111/mms.12689; Hooker SK, 2019, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00514; Hooker SK, 2009, RESP PHYSIOL NEUROBI, V167, P235, DOI 10.1016/j.resp.2009.04.023; Hooker SK, 1999, P ROY SOC B-BIOL SCI, V266, P671, DOI 10.1098/rspb.1999.0688; Hooker SK, 2001, CAN J ZOOL, V79, P1442, DOI 10.1139/cjz-79-8-1442; Huang SL, 2011, MAR MAMMAL SCI, V27, P182, DOI 10.1111/j.1748-7692.2010.00392.x; Klevezal G.A., 1996, RECORDING STRUCTURES; LEE PC, 1991, J ZOOL, V225, P99, DOI 10.1111/j.1469-7998.1991.tb03804.x; Luque Sebastian P., 2007, Aquatic Mammals, V33, P241, DOI 10.1578/AM.33.2.2007.241; Magozzi S, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1763; Matthews CJD, 2015, J MAMMAL, V96, P425, DOI 10.1093/jmammal/gyv046; MAYNARDSMITH J, 1980, BEHAV ECOL SOCIOBIOL, V7, P247; McSweeney DJ, 2007, MAR MAMMAL SCI, V23, P666, DOI 10.1111/j.1748-7692.2007.00135.x; Mendes S, 2007, OECOLOGIA, V151, P605, DOI 10.1007/s00442-006-0612-z; New LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068725; Newsome SD, 2006, MAR MAMMAL SCI, V22, P556, DOI 10.1111/j.1748-7692.2006.00043.x; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Newsome SD, 2009, MAR ECOL PROG SER, V374, P229, DOI 10.3354/meps07747; Oftedal OT, 1997, J MAMMARY GLAND BIOL, V2, P205, DOI 10.1023/A:1026328203526; Perrin W.F., 1984, Reports of the International Whaling Commission Special Issue, P97; Pierce K.V., 1980, International Whaling Commission Report of the Commission, P99; Quay P, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001817; Read F. L., 2018, NAMMCO SCI PUBLICATI, V10, P1; Rendell L, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0066; Riofrio-Lazo M, 2012, MAR ECOL PROG SER, V450, P229, DOI 10.3354/meps09562; Rossman S, 2015, OECOLOGIA, V178, P415, DOI 10.1007/s00442-015-3241-6; Scheffer V.B., 1980, International Whaling Commission Report of the Commission, P51; Simonis AE, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2020.0070; Smithi KJ, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00388; Tonnesen P, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-018-2570-y; TRIVERS RL, 1974, AM ZOOL, V14, P249; Trivers RL., 1972, SEXUAL SELECTION DES; Trueman CN, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0669; Trueman CN, 2019, PEERJ, V7, DOI 10.7717/peerj.7912; Trueman CN, 2018, TRACKING ANIMAL MIGR, P137; Whitehead H., 2000, CETACEAN SOC FIELD S	62	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235114	10.1371/journal.pone.0235114	http://dx.doi.org/10.1371/journal.pone.0235114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574188	gold, Green Published			2022-12-26	WOS:000544972400055
J	Mauer, K; Hellmann, SL; Groth, M; Frobius, AC; Zischler, H; Hankeln, T; Herlyn, H				Mauer, Katharina; Hellmann, Soeren Lukas; Groth, Marco; Froebius, Andreas C.; Zischler, Hans; Hankeln, Thomas; Herlyn, Holger			The genome, transcriptome, and proteome of the fish parasitePomphorhynchus laevis(Acanthocephala)	PLOS ONE			English	Article							POMPHORHYNCHUS-LAEVIS ACANTHOCEPHALA; COMPLETE MITOCHONDRIAL GENOME; COLOSSOMA-MACROPOMUM CUVIER; NUCLEAR-DNA CONTENT; PHYLOGENETIC-RELATIONSHIPS; ENDOPARASITIC ACANTHOCEPHALA; DEGENERATE TETRAPLOIDY; HELMINTH-PARASITES; DEFINITIVE HOST; RAINBOW-TROUT	Thorny-headed worms (Acanthocephala) are endoparasites exploiting Mandibulata (Arthropoda) and Gnathostomata (Vertebrata). Despite their world-wide occurrence and economic relevance as a pest, genome and transcriptome assemblies have not been published before. However, such data might hold clues for a sustainable control of acanthocephalans in animal production. For this reason, we present the first draft of an acanthocephalan nuclear genome, besides the mitochondrial one, using the fish parasitePomphorhynchus laevis(Palaeacanthocephala) as a model. Additionally, we have assembled and annotated the transcriptome of this species and the proteins encoded. A hybrid assembly of long and short reads resulted in a near-completeP.laevisdraft genome of ca. 260 Mb, comprising a large repetitive portion of ca. 63%. Numbers of transcripts and translated proteins (35,683) were within the range of other members of the Rotifera-Acanthocephala clade. Our data additionally demonstrate a significant reorganization of the acanthocephalan gene repertoire. Thus, more than 20% of the usually conserved metazoan genes were lacking inP.laevis. Ontology analysis of the retained genes revealed many connections to the incorporation of carotinoids. These are probably taken up via the surface together with lipids, thus accounting for the orange coloration ofP.laevis. Furthermore, we found transcripts and protein sequences to be more derived inP.laevisthan in rotifers from Monogononta and Bdelloidea. This was especially the case in genes involved in energy metabolism, which might reflect the acanthocephalan ability to use the scarce oxygen in the host intestine for respiration and simultaneously carry out fermentation. Increased plasticity of the gene repertoire through the integration of foreign DNA into the nuclear genome seems to be another underpinning factor of the evolutionary success of acanthocephalans. In any case, energy-related genes and their proteins may be considered as candidate targets for the acanthocephalan control.	[Mauer, Katharina; Zischler, Hans; Herlyn, Holger] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut iomE, Anthropol, Mainz, Germany; [Hellmann, Soeren Lukas; Hankeln, Thomas] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut iomE, Mol Genet & Genom Anal Grp, Mainz, Germany; [Groth, Marco] Fritz Lipmann Inst, CF DNA Sequencing, Leibniz Inst Aging, Jena, Germany; [Froebius, Andreas C.] Justus Liebig Univ Giessen, Biomed Res Ctr Seltersberg BFS, Mol Androl, Giessen, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Justus Liebig University Giessen	Mauer, K; Herlyn, H (corresponding author), Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut iomE, Anthropol, Mainz, Germany.	kamauer@uni-mainz.de; herlyn@uni-mainz.de		Hellmann, Lukas/0000-0003-4958-1419; Zischler, Hans/0000-0002-3440-8376	Johannes Gutenberg University Mainz	Johannes Gutenberg University Mainz	The only funding resource involved in this project was a so-called Stufe 1 funding by Johannes Gutenberg University Mainz to Holger Herlyn, as declared already. This funding was internal and has no extra number. It is just "Stufe 1". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no additional specific funding for this work.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Abrusan G, 2009, BIOINFORMATICS, V25, P1329, DOI 10.1093/bioinformatics/btp084; Ahlrichs WH, 1997, ZOOMORPHOLOGY, V117, P41, DOI 10.1007/s004350050028; Amin OM, 2013, COMP PARASITOL, V80, P39, DOI 10.1654/4562.1; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2015, ENERGY MALAYSIA, V6, P5; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; [Anonymous], 2010, J CLIN APHERESIS, V25, P1, DOI DOI 1671-8755(2010)04-0001-04; Arkhipova IR, 2005, P NATL ACAD SCI USA, V102, P11781, DOI 10.1073/pnas.0505333102; Bakker TCM, 1997, ECOLOGY, V78, P1098, DOI 10.1890/0012-9658(1997)078[1098:PICIBA]2.0.CO;2; BARRETT J, 1973, EXPERIENTIA, V29, P651, DOI 10.1007/BF01944752; BARRETT J, 1968, COMP BIOCHEM PHYSIOL, V27, P575, DOI 10.1016/0010-406X(68)90254-5; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Bininda-Emonds Olaf R. P., 2016, Life-Basel, V6, P38, DOI 10.3390/life6030038; Blommaert J, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5859-y; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boschetti C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003035; Brand T.von., 1940, Journal of Parasitology Urbana, V26, P301, DOI 10.2307/3272103; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; BULLOCK W. L., 1969, Problems in systematics of parasites., P9; BULLOCK WL, 1949, J MORPHOL, V84, P201, DOI 10.1002/jmor.1050840203; CALUMPANG SMF, 1995, B ENVIRON CONTAM TOX, V55, P494, DOI 10.1007/BF00196027; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cevrimel DS, 2017, SU URUN DERG, V34, P255, DOI 10.12714/egejfas.2017.34.3.02; Chakraborty M, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw654; Choi CJ, 2010, KOREAN J PARASITOL, V48, P139, DOI 10.3347/kjp.2010.48.2.139; Cobbs C, 2013, MOL PHYLOGENET EVOL, V68, P221, DOI 10.1016/j.ympev.2013.03.012; Coghlan A, 2019, NAT GENET, V51, P163, DOI 10.1038/s41588-018-0262-1; CROMPTON DW, 1967, NATURE, V215, P964, DOI 10.1038/215964b0; Cushion MT, 2004, J EUKARYOT MICROBIOL, V51, P30, DOI 10.1111/j.1550-7408.2004.tb00158.x; de la Cruz CPP, 2012, ASIA LIFE SCI, V21, P287; de Matos LV, 2017, PARASITOL RES, V116, P1029, DOI 10.1007/s00436-017-5384-3; Costa CMD, 2018, REV BRAS PARASITOL V, V27, P562, DOI [10.1590/S1984-296120180079, 10.1590/s1984-296120180079]; Diaz Cosin D.J., 1972, Boletin R Soc esp Hist nat (Biol), V70, P239; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dunagan T.T., 1991, P299; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Evans DW, 2001, J FISH BIOL, V59, P166, DOI 10.1111/j.1095-8649.2001.tb02346.x; Eyres I, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0202-9; Eyres I, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-148; Ferraz de Lima CLB., 1990, B TEC CEPTA, V2, P43; Flot JF, 2013, NATURE, V500, P453, DOI 10.1038/nature12326; Fontaneo D, 2015, HDB ZOOLOGY, P2017; Fortmann Michel, 2001, REV INT STRATEGIQUE, V44, P41; Franch-Gras L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34188-y; Frobius AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004004; Frobius AC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00020-w; Garcia-Varela M, 2005, J PARASITOL, V91, P1401, DOI 10.1645/GE-523R.1; Garcia-Varela M, 2006, MOL PHYLOGENET EVOL, V40, P61, DOI 10.1016/j.ympev.2006.02.010; Garey JR, 1996, J MOL EVOL, V43, P287, DOI 10.1007/BF02338837; Gazi M, 2016, ZOOL SCR, V45, P437, DOI 10.1111/zsc.12160; Gazi M, 2015, PARASITOL INT, V64, P64, DOI 10.1016/j.parint.2015.01.009; Gazi M, 2012, PARASITOL INT, V61, P307, DOI 10.1016/j.parint.2011.12.001; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Goater TM, 2014, PARASITISM: THE DIVERSITY AND ECOLOGY OF ANIMAL PARASITES, 2ND EDITION, P1; Goubert C, 2015, GENOME BIOL EVOL, V7, P1192, DOI 10.1093/gbe/evv050; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRAFF D, 1963, J PARASITOL, V49, P204, DOI 10.2307/3275984; Gribble KE, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3540-x; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hackl T, 2014, BIOINFORMATICS, V30, P3004, DOI 10.1093/bioinformatics/btu392; Haffner K. v., 1950, Zoologischer Anzeiger Erganzungsb, V145, P243; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hamann O, 1891, JENA Z NATURW, V1, P113; HAMMOND RA, 1966, J EXP BIOL, V45, P203; Han J, 2019, AQUAT TOXICOL, V214, DOI 10.1016/j.aquatox.2019.105230; Herlyn H, 1997, ZOOMORPHOLOGY, V117, P135, DOI 10.1007/s004350050038; Herlyn H, 2003, MOL PHYLOGENET EVOL, V26, P155, DOI 10.1016/S1055-7903(02)00309-3; Herlyn H, 2017, ZOOMORPHOLOGY, V136, P425, DOI 10.1007/s00435-017-0369-4; Herlyn H, 2017, PARASITOL RES, V116, P1207, DOI 10.1007/s00436-017-5398-x; HINE PM, 1974, J FISH BIOL, V6, P521, DOI 10.1111/j.1095-8649.1974.tb04569.x; Hoff KJ, 2013, NUCLEIC ACIDS RES, V41, pW123, DOI 10.1093/nar/gkt418; HORVATH K, 1971, J PARASITOL, V57, P132, DOI 10.2307/3277767; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hubley R., 2013, REPEATMASKER OPEN 40; Hur JH, 2009, MOL BIOL EVOL, V26, P375, DOI 10.1093/molbev/msn260; Jeronimo GT, 2017, AQUACULTURE, V469, P124, DOI 10.1016/j.aquaculture.2016.11.027; Juhling F, 2012, NUCLEIC ACIDS RES, V40, P2833, DOI 10.1093/nar/gkr1131; Kado T, 2018, GENOME BIOL EVOL, V10, P3196, DOI 10.1093/gbe/evy219; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Kaldonski N, 2009, P ROY SOC B-BIOL SCI, V276, P169, DOI 10.1098/rspb.2008.0798; Kayis S, 2009, ISR J AQUACULT-BAMID, V61, P93; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keen NT, 1998, P NATL ACAD SCI USA, V95, P4789, DOI 10.1073/pnas.95.9.4789; KENNEDY CR, 1978, J FISH BIOL, V13, P265, DOI 10.1111/j.1095-8649.1978.tb03434.x; Kennedy CR, 1999, FOLIA PARASIT, V46, P111; KENNEDY CR, 1989, J FISH BIOL, V34, P607, DOI 10.1111/j.1095-8649.1989.tb03339.x; Kennedy CR, 2006, ECOLOGY OF THE ACANTHOCEPHALA, P1, DOI 10.2277/ 0521850088; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kim HS, 2018, MOL ECOL RESOUR, V18, P646, DOI 10.1111/1755-0998.12768; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; KORTING W, 1972, J PARASITOL, V58, P45, DOI 10.2307/3278239; Kriventseva EV, 2003, TRENDS GENET, V19, P124, DOI 10.1016/S0168-9525(03)00023-4; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; LAURIE JOHN S., 1959, EXPTL PARASITOL, V8, P188, DOI 10.1016/0014-4894(59)90018-9; Le TH, 2002, TRENDS PARASITOL, V18, P206, DOI 10.1016/S1471-4922(02)02252-3; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Mabuchi K, 2006, AQUACULTURE, V257, P68, DOI 10.1016/j.aquaculture.2006.03.040; Malta Jose Celso de Oliveira, 2001, Acta Amazonica, V31, P133, DOI 10.1590/1809-43922001311143; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Marijic VF, 2013, SCI TOTAL ENVIRON, V463, P772, DOI 10.1016/j.scitotenv.2013.06.041; Marinho RGB, 2013, ARQ BRAS MED VET ZOO, V65, P1192, DOI 10.1590/S0102-09352013000400035; Marletaz F, 2006, CURR BIOL, V16, pR577, DOI 10.1016/j.cub.2006.07.016; Martins M. L., 2001, Brazilian Journal of Biology, V61, P517, DOI 10.1590/S1519-69842001000300022; Mathison BA, 2016, CLIN INFECT DIS, V63, P1357, DOI 10.1093/cid/ciw543; Mehlhorn H, 2012, PARASITEN TIERE; MEYER A., 1931, ZOOL JAHRB ABT SYST OKOL U GEOGR TIERE, V62, P53; Miquelis A, 2000, CR ACAD SCI III-VIE, V323, P925, DOI 10.1016/S0764-4469(00)01230-0; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Mounsey KE, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-3; Muller A, 2017, BIOINFORMATICS, V33, P3740, DOI 10.1093/bioinformatics/btx520; Nagayasu E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058458; Near TJ, 2002, INTEGR COMP BIOL, V42, P668, DOI 10.1093/icb/42.3.668; Near TJ, 1998, MOL PHYLOGENET EVOL, V10, P287, DOI 10.1006/mpev.1998.0569; Nikishin VP, 2004, BIOL BULL+, V31, P598, DOI 10.1023/B:BIBU.0000049733.16236.79; Nowell RW, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004830; O'Mahony EM, 2004, PARASITOLOGY, V129, P341, DOI 10.1017/S0031182004005748; Oliveira LCD, 2019, J FISH DIS, V42, P765, DOI 10.1111/jfd.12980; Osada T, 2011, CANCER RES, V71, P4172, DOI 10.1158/0008-5472.CAN-10-3978; Pan TS, 2013, FOLIA PARASIT, V60, P181, DOI 10.14411/fp.2013.021; Pan TingShuang, 2014, Acta Hydrobiologica Sinica, V38, P351; Park JC, 2020, AQUAT TOXICOL, V221, DOI 10.1016/j.aquatox.2020.105443; Pereira JN, 2018, ACTA AMAZON, V48, P42, DOI 10.1590/1809-4392201702411; Perrot-Minnot MJ, 2011, INT J PARASITOL, V41, P173, DOI 10.1016/j.ijpara.2010.08.006; Petrochenko VI, 1971, ACANTHOCEPHALA WILD, V1; Poulin R, 2000, J ZOOL, V250, P551, DOI 10.1017/S0952836900004118; Poulin R, 2007, BIOL J LINN SOC, V90, P637, DOI 10.1111/j.1095-8312.2006.00754.x; Poulin R, 2015, PARASITOLOGY, V142, P791, DOI 10.1017/S0031182014001917; Poulin R, 2015, PARASITOLOGY, V142, pS6, DOI 10.1017/S0031182013001674; Reier S, 2019, INT J PARASITOL-PAR, V8, P145, DOI 10.1016/j.ijppaw.2019.01.009; Riegerl RM, 2009, INVERTEBR BIOL, V114, P186; ROGERS WP, 1949, AUST J SCI RES SER B, V2, P157, DOI 10.1071/BI9490157; Roncalli V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186794; Rosny HS., 2016, INT J FISH AQUAT, V4, P188, DOI [10.22271/fish.2016.v4.i3c.746, DOI 10.22271/FISH.2016.V4.I3C.746]; Ruckert S, 2008, J APPL ICHTHYOL, V24, P321, DOI 10.1111/j.1439-0426.2008.01064.x; SANFORD SE, 1978, CAN VET J, V19, P234; SAZ HJ, 1981, ANNU REV PHYSIOL, V43, P323, DOI 10.1146/annurev.ph.43.030181.001543; Schell T, 2017, GENOME BIOL EVOL, V9, P585, DOI 10.1093/gbe/evx032; SCHMIDT GD, 1971, J PARASITOL, V57, P582, DOI 10.2307/3277920; Sielaff M, 2016, MOL PHYLOGENET EVOL, V96, P79, DOI 10.1016/j.ympev.2015.11.017; Silva-Gomes AL, 2017, LAT AM J AQUAT RES, V45, P496, DOI 10.3856/vol45-issue2-fulltext-25; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smit AFA., REPEATMODELER OPEN 1; Soler-Jimenez LC, 2017, J HELMINTHOL, V91, P110, DOI 10.1017/S0022149X16000833; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Starling J.A., 1985, P125; Steinauer ML, 2005, J MOL EVOL, V60, P706, DOI 10.1007/s00239-004-0159-8; Steinstraesser W, 1936, Z FISCHEREI, P177; Stelzer CP, 2011, HYDROBIOLOGIA, V662, P77, DOI 10.1007/s10750-010-0487-1; Struck TH, 2014, MOL BIOL EVOL, V31, P1833, DOI 10.1093/molbev/msu143; Suga K, 2008, MOL BIOL EVOL, V25, P1129, DOI 10.1093/molbev/msn058; Sures B, 2000, INT J PARASITOL, V30, P1071, DOI 10.1016/S0020-7519(00)00094-1; Sures B, 2002, INT J PARASITOL, V32, P1117, DOI 10.1016/S0020-7519(02)00083-8; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Taraschewski H, 2000, ADV PARASIT, V46, P1, DOI 10.1016/S0065-308X(00)46008-2; TARASCHEWSKI H, 1990, PARASITOL RES, V76, P619, DOI 10.1007/BF00932573; TARASCHEWSKI H, 1991, PARASITOL RES, V77, P536, DOI 10.1007/BF00928423; TARASCHEWSKI H, 1991, PARASITOL RES, V77, P247, DOI 10.1007/BF00930867; Taraschewski H, 2015, HBK ZOOL, P301; TIELENS AGM, 1994, PARASITOL TODAY, V10, P346, DOI 10.1016/0169-4758(94)90245-3; Tielens AGM, 2010, INT J PARASITOL, V40, P387, DOI 10.1016/j.ijpara.2009.12.006; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; Urry L.A., 2017, CAMPBELL BIOL; Vurture GW, 2017, BIOINFORMATICS, V33, P2202, DOI 10.1093/bioinformatics/btx153; Wallace RL, 2002, INTEGR COMP BIOL, V42, P660, DOI 10.1093/icb/42.3.660; Wang XZ, 2012, SCI CHINA LIFE SCI, V55, P761, DOI 10.1007/s11427-012-4366-z; Wang Y, 2015, NUCLEIC ACIDS RES, V43, pW78, DOI 10.1093/nar/gkv487; WARD HL, 1952, J PARASITOL, V38, P493, DOI 10.2307/3273932; Weber M, 2000, J ZOO WILDLIFE MED, V31, P503, DOI 10.1638/1042-7260(2000)031[0503:IATOMC]2.0.CO;2; Weber M, 2013, MOL PHYLOGENET EVOL, V66, P182, DOI 10.1016/j.ympev.2012.09.017; Welch DBM, 2008, P NATL ACAD SCI USA, V105, P5145, DOI 10.1073/pnas.0800972105; Welch DBM, 2000, INVERTEBR BIOL, V119, P17; Welch DBM, 2003, BIOL J LINN SOC, V79, P85, DOI 10.1046/j.1095-8312.2003.00180.x; Wey-Fabrizius AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088618; Wey-Fabrizius AR, 2013, MOL PHYLOGENET EVOL, V69, P365, DOI 10.1016/j.ympev.2012.12.015; Wiecaszek B, 2019, ACTA ICHTHYOL PISCAT, V49, P65, DOI 10.3750/AIEP/02392; WINNEPENNINCKX B, 1995, MOL BIOL EVOL, V12, P1132; Witek A, 2009, MOL PHYLOGENET EVOL, V53, P1037, DOI 10.1016/j.ympev.2009.07.031; Witek A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-345; Woo PTK, 2012, FISH PARASITES: PATHOBIOLOGY AND PROTECTION, P1, DOI 10.1079/9781845938062.0000; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wurmbach H., 1937, FISCH HILFSWISS, V35, P217; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yamaguti S, 1963, SYSTEMA HELMINTHUM, VV; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yasumoto S, 1996, FISH PATHOL, V31, P235, DOI 10.3147/jsfp.31.235; Ye CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep19688; Ye J, 2018, NUCLEIC ACIDS RES, V46, pW71, DOI 10.1093/nar/gky400; Zhang JZ, 2006, NAT GENET, V38, P819, DOI 10.1038/ng1812; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140; Ziolkowska Marta, 2003, Acta Ichthyologica et Piscatoria, V33, P37	196	8	8	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0232973	10.1371/journal.pone.0232973	http://dx.doi.org/10.1371/journal.pone.0232973			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574180	gold, Green Published			2022-12-26	WOS:000544972400009
J	Aubry, A; Pearson, JD; Huang, K; Livne-Bar, I; Ahmad, M; Jagadeesan, M; Khetan, V; Ketela, T; Brown, KR; Yu, T; Lu, SY; Wrana, JL; Moffat, J; Bremner, R				Aubry, Arthur; Pearson, Joel D.; Huang, Katherine; Livne-Bar, Izhar; Ahmad, Mohammad; Jagadeesan, Madhavan; Khetan, Vikas; Ketela, Troy; Brown, Kevin R.; Yu, Tao; Lu, Suying; Wrana, Jeffrey L.; Moffat, Jason; Bremner, Rod			Functional genomics identifies new synergistic therapies for retinoblastoma	ONCOGENE			English	Article							DNA-REPAIR; TUMOR-SUPPRESSOR; INTRAVITREAL CHEMOTHERAPY; HOMOLOGOUS RECOMBINATION; BRCA1 INTERACTS; RB INACTIVATION; VITREOUS SEEDS; CELL-DEATH; PATHWAY; PROTEIN	Local intravitreal or intra-arterial chemotherapy has improved therapeutic success for the pediatric cancer retinoblastoma (RB), but toxicity remains a major caveat. RB initiates primarily withRB1loss or, rarely,MYCNamplification, but the critical downstream networks are incompletely understood. We set out to uncover perturbed molecular hubs, identify synergistic drug combinations to target these vulnerabilities, and expose and overcome drug resistance. We applied dynamic transcriptomic analysis to identify network hubs perturbed in RB versus normal fetal retina, and performed in vivo RNAi screens inRB1(null)andRB1(wt);MYCN(amp)orthotopic xenografts to pinpoint essential hubs. We employed in vitro and in vivo studies to validate hits, define mechanism, develop new therapeutic modalities, and understand drug resistance. We identified BRCA1 and RAD51 as essential for RB cell survival. Their oncogenic activity was independent of BRCA1 functions in centrosome, heterochromatin, or ROS regulation, and instead linked to DNA repair. RAD51 depletion or inhibition with the small molecule inhibitor, B02, killed RB cells in a Chk1/Chk2/p53-dependent manner. B02 further synergized with clinically relevant topotecan (TPT) to engage this pathway, activating p53-BAX mediated killing of RB but not human retinal progenitor cells. Paradoxically, a B02/TPT-resistant tumor exhibited more DNA damage than sensitive RB cells. Resistance reflected dominance of the p53-p21 axis, which mediated cell cycle arrest instead of death. Deleting p21 or applying the BCL2/BCL2L1 inhibitor Navitoclax re-engaged the p53-BAX axis, and synergized with B02, TPT or both to override resistance. These data expose new synergistic therapies to trigger p53-induced killing in diverse RB subtypes.	[Aubry, Arthur; Pearson, Joel D.; Huang, Katherine; Ahmad, Mohammad; Yu, Tao; Lu, Suying; Wrana, Jeffrey L.; Bremner, Rod] Sinai Hlth, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Aubry, Arthur; Pearson, Joel D.; Bremner, Rod] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Pearson, Joel D.; Livne-Bar, Izhar; Bremner, Rod] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [Livne-Bar, Izhar] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada; [Jagadeesan, Madhavan] Sankara Nethralaya, Vis Res Fdn, Chennai, Tamil Nadu, India; [Khetan, Vikas] Sankara Nethralaya, Dept Vitroretina & Ocular Oncol, Chennai, Tamil Nadu, India; [Ketela, Troy; Brown, Kevin R.; Moffat, Jason] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Wrana, Jeffrey L.; Moffat, Jason] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Jagadeesan, Madhavan] Dualhelix Genet Diagnost, Chennai, Tamil Nadu, India	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Bremner, R (corresponding author), Sinai Hlth, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada.; Bremner, R (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	bremner@lunenfeld.ca	Bremner, Rod/I-6490-2012; Pearson, Joel/AFK-9248-2022; Moffat, Jason/AAC-1110-2020	Bremner, Rod/0000-0001-9184-7212; Moffat, Jason/0000-0002-5663-8586; Aubry, Arthur/0000-0002-4344-1194; Khetan, Vikas/0000-0003-4396-9877	Canadian Institutes for Health Research (CIHR) [153128]; Cancer Research Society; Krembil Foundation	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; Krembil Foundation	This work was funded by grants to RB from the Canadian Institutes for Health Research (CIHR) Grant #153128, The Cancer Research Society, and the Krembil Foundation.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Abramson DH, 2015, JAMA OPHTHALMOL, V133, P1341, DOI 10.1001/jamaophthalmol.2015.3108; Anderson SN, 2007, J BIOMOL SCREEN, V12, P938, DOI 10.1177/1087057107306130; Aubry A, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-0237-8; Banerjee R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5527; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Bouwman P, 2012, NAT REV CANCER, V12, P587, DOI 10.1038/nrc3342; Camp DA, 2019, J AAPOS, V23, P241, DOI 10.1016/j.jaapos.2019.03.002; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chu WK, 2016, P NATL ACAD SCI USA, V113, P14396, DOI 10.1073/pnas.1617427113; Clairmont CS, 2020, NAT CELL BIOL, V22, P87, DOI 10.1038/s41556-019-0442-y; Cook R, 2015, CELL REP, V10, P2006, DOI 10.1016/j.celrep.2015.02.059; Corella AN, 2020, CLIN CANCER RES, V26, P1667, DOI 10.1158/1078-0432.CCR-19-0775; Corson TW, 2007, GENE CHROMOSOME CANC, V46, P617, DOI 10.1002/gcc.20457; De Francesco S, 2015, INT OPHTHALMOL, V35, P887, DOI 10.1007/s10792-015-0129-8; Deng CX, 2002, ONCOGENE, V21, P6222, DOI 10.1038/sj.onc.1205713; Dimaras H, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.21; Dizin E, 2006, J BIOL CHEM, V281, P24236, DOI 10.1074/jbc.M602176200; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Downward J, 2004, ONCOGENE, V23, P8376, DOI 10.1038/sj.onc.1208073; Elison JR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1269, DOI 10.1001/archopht.124.9.1269; Etemadmoghadam D, 2013, P NATL ACAD SCI USA, V110, P19489, DOI 10.1073/pnas.1314302110; FITZSIMMONS J, 1994, EARLY HUM DEV, V38, P121, DOI 10.1016/0378-3782(94)90223-2; Foucquier J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.149; Francis JH, 2017, OPHTHALMOLOGY, V124, P1548, DOI 10.1016/j.ophtha.2017.04.010; Francis JH, 2015, OPHTHALMOLOGY, V122, P1173, DOI 10.1016/j.ophtha.2015.01.017; Garsed DW, 2018, CLIN CANCER RES, V24, P569, DOI 10.1158/1078-0432.CCR-17-1621; Gavande NS, 2016, PHARMACOL THERAPEUT, V160, P65, DOI 10.1016/j.pharmthera.2016.02.003; Gong XQ, 2019, CANCER DISCOV, V9, P248, DOI 10.1158/2159-8290.CD-18-0469; Gorrini C, 2013, J EXP MED, V210, P1529, DOI 10.1084/jem.20121337; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100993; Huang F, 2011, ACS CHEM BIOL, V6, P628, DOI 10.1021/cb100428c; Jin P, 1996, J CELL BIOL, V134, P963, DOI 10.1083/jcb.134.4.963; Knudsen ES, 2006, CURR MOL MED, V6, P749; Landreville S, 2010, CURR EYE RES, V35, P435, DOI 10.3109/02713680903509428; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; Lasorella A, 2002, CANCER RES, V62, P301; Laurie NA, 2007, CURR CANCER DRUG TAR, V7, P689, DOI 10.2174/156800907782418266; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lemaitre S, 2020, CLIN EXP OPHTHALMOL, V48, P500, DOI 10.1111/ceo.13711; Liang TY, 2020, INT J OPHTHALMOL-CHI, V13, P257, DOI 10.18240/ijo.2020.02.09; Liu JC, 2018, CELL REP, V23, P112, DOI 10.1016/j.celrep.2018.03.039; Lochmann TL, 2018, CLIN CANCER RES, V24, P360, DOI 10.1158/1078-0432.CCR-17-1606; Maclay T, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-363; MacPherson D, 2004, GENE DEV, V18, P1681, DOI 10.1101/gad.1203304; Marshall AE, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00105-19; MIYASHITA T, 1995, CELL, V80, P293; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Munier FL, 2012, BRIT J OPHTHALMOL, V96, P1078, DOI 10.1136/bjophthalmol-2011-301450; Nam C, 2010, HISTOL HISTOPATHOL, V25, P485, DOI 10.14670/HH-25.485; Oser MG, 2019, CANCER DISCOV, V9, P230, DOI 10.1158/2159-8290.CD-18-0389; Pajovic S, 2011, INVEST OPHTH VIS SCI, V52, P7618, DOI 10.1167/iovs.11-7989; Pickering MT, 2006, ONCOGENE, V25, P746, DOI 10.1038/sj.onc.1209103; Qi DL, 2017, ONCOGENE, V36, P1760, DOI 10.1038/onc.2016.350; Rasmussen RD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13398; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Sangwan M, 2012, ONCOGENE, V31, P5019, DOI 10.1038/onc.2011.654; Schuster A, 2019, TRENDS BIOTECHNOL, V37, P38, DOI 10.1016/j.tibtech.2018.08.002; Shepard T.H., 1975, GROWTH DEV HUMAN EMB; Shields CL, 2014, JAMA OPHTHALMOL, V132, P319, DOI 10.1001/jamaophthalmol.2013.7666; Sims D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r104; Suvarna V, 2019, EUR J PHARMACOL, V862, DOI 10.1016/j.ejphar.2019.172655; Suzuki A, 1999, MOL CELL BIOL, V19, P3842; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Thangavel C, 2014, CLIN CANCER RES, V20, P5468, DOI 10.1158/1078-0432.CCR-14-0326; To KH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-69; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Tsui JY, 2008, INVEST OPHTH VIS SCI, V49, P490, DOI 10.1167/iovs.07-0653; Velez-Cruz R, 2016, GENE DEV, V30, P2500, DOI 10.1101/gad.288282.116; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; WINDLE JJ, 1990, NATURE, V343, P665, DOI 10.1038/343665a0; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Yang Y, 2013, INT J MOL MED, V32, P137, DOI 10.3892/ijmm.2013.1374; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	81	12	12	3	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 30	2020	39	31					5338	5357		10.1038/s41388-020-1372-7	http://dx.doi.org/10.1038/s41388-020-1372-7		JUN 2020	20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MT1TS	32572160	hybrid, Green Published			2022-12-26	WOS:000542723000002
J	Jung, JY; Ro, H; Chang, JH; Kim, AJ; Lee, HH; Han, SH; Yoo, TH; Lee, KB; Kim, YH; Kim, SW; Park, SK; Chae, DW; Oh, KH; Ahn, C; Chung, W				Jung, Ji Yong; Ro, Han; Chang, Jae Hyun; Kim, Ae Jin; Lee, Hyun Hee; Han, Seung Hyeok; Yoo, Tae-Hyun; Lee, Kyu-Beck; Kim, Yeong Hoon; Kim, Soo Wan; Park, Sue Kyung; Chae, Dong-Wan; Oh, Kook-Hwan; Ahn, Curie; Chung, Wookyung			Mediation of the relationship between proteinuria and serum phosphate: Insight from the KNOW-CKD study	PLOS ONE			English	Article							PHOSPHORUS HOMEOSTASIS; SOLUBLE KLOTHO; ALBUMIN; FGF23; MICROALBUMINURIA; HYPOPHOSPHATEMIA; REABSORPTION; PARAMETERS; DISEASE; FGF-23	Proteinuria and hyperphosphatemia are risk factors for cardiovascular disease in patients with chronic kidney disease (CKD). Although the interaction between proteinuria and the serum phosphate level is well established, the mechanistic link between the two, particularly the extent to which this interaction is mediated by phosphate-regulating factors, remains poorly understood. In this study, we examined the association between proteinuria and the serum phosphate level, as well as potential mediators, including circulating fibroblast growth factor (FGF23)/klotho, the 24-h urinary phosphate excretion rate to glomerular filtration rate ratio (EP/GFR), and the 24-h tubular phosphate reabsorption rate to GFR ratio (TRP/GFR). The analyses were performed with data from 1793 patients in whom 24-h urine protein and phosphate, serum phosphate, FGF23, and klotho levels were measured simultaneously, obtained from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD). Multivariable linear regression and mediation analyses were performed. Total, direct, and indirect effects were also estimated. Patients with high serum phosphate levels were found to be more likely to exhibit greater proteinuria, higher FGF23 levels, and lower klotho levels. The 24-h EP/GFR increased and the 24-h TRP/GFR decreased with increasing proteinuria and CKD progression. Simple mediation analyses showed that 15.4% and 67.9% of the relationship between proteinuria and the serum phosphate level were mediated by the FGF23/klotho ratio and 24-h EP/GFR, respectively. Together, these two factors accounted for 73.1% of the relationship between serum markers. These findings suggest that proteinuria increases the 24-h EP/GFR via the FGF23/klotho axis as a compensatory mechanism for the increased phosphate burden well before the reduction in renal function is first seen.	[Jung, Ji Yong; Ro, Han; Chang, Jae Hyun; Kim, Ae Jin; Lee, Hyun Hee; Chung, Wookyung] Gachon Univ, Dept Internal Med, Gil Med Ctr, Incheon, South Korea; [Jung, Ji Yong; Ro, Han; Chang, Jae Hyun; Kim, Ae Jin; Lee, Hyun Hee; Chung, Wookyung] Gachon Univ, Coll Med, Incheon, South Korea; [Han, Seung Hyeok; Yoo, Tae-Hyun] Yonsei Univ, Inst Kidney Dis Res, Dept Internal Med, Coll Med, Seoul, South Korea; [Lee, Kyu-Beck] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Sch Med, Seoul, South Korea; [Kim, Yeong Hoon] Inje Univ, Busan Paik Hosp, Dept Internal Med, Coll Med, Busan, South Korea; [Kim, Soo Wan] Chonnam Natl Univ, Dept Internal Med, Sch Med, Gwangju, South Korea; [Park, Sue Kyung] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Chae, Dong-Wan] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seoul, South Korea; [Oh, Kook-Hwan; Ahn, Curie] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea	Gachon University; Gachon University; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Inje University; Chonnam National University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Jung, JY (corresponding author), Gachon Univ, Dept Internal Med, Gil Med Ctr, Incheon, South Korea.; Jung, JY (corresponding author), Gachon Univ, Coll Med, Incheon, South Korea.	jyjung@gachon.ac.kr	; Han, Seung Hyeok/K-4559-2018	Yoo, Tae-Hyun/0000-0002-9183-4507; Han, Seung Hyeok/0000-0001-7923-5635; Jung, Ji Yong/0000-0003-1271-8012	Korea Centers for Disease Control and Prevention [2011E3300300, 2012E3301100, 2013E3301600, 2013E3301601, 2013E3301602, 2016E3300200, 2016E3300201, 2016E3300202, 2019E320100]	Korea Centers for Disease Control and Prevention	This work was supported by the Research Program funded by the Korea Centers for Disease Control and Prevention (2011E3300300, 2012E3301100, 2013E3301600, 2013E3301601, 2013E3301602, 2016E3300200, 2016E3300201, 2016E3300202, and 2019E320100).	Bachmann S, 2004, J AM SOC NEPHROL, V15, P892, DOI 10.1097/01.ASN.0000120389.09938.21; Chang AR, 2017, AM J KIDNEY DIS, V69, P200, DOI 10.1053/j.ajkd.2016.08.029; de Seigneux S, 2015, J AM SOC NEPHROL, V26, P1608, DOI 10.1681/ASN.2014010104; Dermaku-Sopjani M, 2011, CELL PHYSIOL BIOCHEM, V28, P251, DOI 10.1159/000331737; Di Iorio BR, 2013, NEPHROL DIAL TRANSPL, V28, P632, DOI 10.1093/ndt/gfs477; Feinstein S, 2006, PEDIATR NEPHROL, V21, P1406, DOI 10.1007/s00467-006-0195-2; Fernandez-Fernandez B, 2018, NEPHROL DIAL TRANSPL, V33, P1712, DOI 10.1093/ndt/gfx376; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Gekle M, 1998, NEWS PHYSIOL SCI, V13, P5; Hayes A. F., 2018, INTRO MEDIATION MODE; Ide N, 2018, AM J PHYSIOL-RENAL, V315, pF1261, DOI 10.1152/ajprenal.00650.2017; Ide N, 2016, KIDNEY INT, V90, P348, DOI 10.1016/j.kint.2016.04.009; Karalliedde J, 2013, CLIN J AM SOC NEPHRO, V8, P1899, DOI 10.2215/CJN.02700313; Kawasaki T, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0118-1; Kim H, 2020, NEPHROL DIAL TRANSPL, V35, P438, DOI 10.1093/ndt/gfy403; Kim JH, 2017, J AM SOC NEPHROL, V28, P140, DOI 10.1681/ASN.2015080888; Kuro-o M, 2019, NAT REV NEPHROL, V15, P27, DOI 10.1038/s41581-018-0078-3; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Kuro-o M, 2010, PEDIATR NEPHROL, V25, P583, DOI 10.1007/s00467-009-1260-4; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lim SC, 2014, J RENIN-ANGIO-ALDO S, V15, P487, DOI 10.1177/1470320313475905; Lundberg S, 2012, CLIN J AM SOC NEPHRO, V7, P727, DOI 10.2215/CJN.10331011; MARONI BJ, 1985, KIDNEY INT, V27, P58, DOI 10.1038/ki.1985.10; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Mathew S, 2008, J AM SOC NEPHROL, V19, P1092, DOI 10.1681/ASN.2007070760; Miyagawa A, 2018, KIDNEY INT, V93, P1073, DOI 10.1016/j.kint.2017.11.022; Nomura K, 2014, J AM SOC NEPHROL, V25, P761, DOI 10.1681/ASN.2013060569; Oh KH, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-80; Ozeki M, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-147; Phelps KR, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050427; Phelps KR, 2015, CLIN NEPHROL, V83, P208, DOI 10.5414/CN108380; Phelps KR, 2015, CLIN NEPHROL, V83, P167, DOI 10.5414/CN108367; Phelps KR, 2012, CLIN NEPHROL, V77, P484, DOI 10.5414/CN107298; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Scialla JJ, 2014, NAT REV NEPHROL, V10, P268, DOI 10.1038/nrneph.2014.49; Silva AP, 2017, INT UROL NEPHROL, V49, P1809, DOI 10.1007/s11255-017-1646-3; Smith ER, 2012, J CLIN ENDOCR METAB, V97, P3357, DOI 10.1210/jc.2012-1811; Sophie D, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14509; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Tan SJ, 2017, CLIN KIDNEY J, V10, P397, DOI 10.1093/ckj/sfw146; Tenten V, 2013, J AM SOC NEPHROL, V24, P1966, DOI 10.1681/ASN.2013010018; Vervloet MG, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-20; Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yilmaz MI, 2014, AM J NEPHROL, V40, P208, DOI 10.1159/000366169	47	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235077	10.1371/journal.pone.0235077	http://dx.doi.org/10.1371/journal.pone.0235077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569271	Green Published, gold			2022-12-26	WOS:000543547900053
J	Laws, MB; Lee, YJ; Rogers, WS; Taubin, T; Wilson, IB				Laws, M. Barton; Lee, Yoojin; Rogers, William S.; Taubin, Tatiana; Wilson, Ira B.			An instrument to assess HIV-related knowledge and adjustment to HIV plus status, and their association with anti-retroviral adherence	PLOS ONE			English	Article							INTERACTIVE TOXICITY BELIEFS; FUNCTIONAL HEALTH LITERACY; SELF-EFFICACY; THERAPY; IDENTITY; NEED; ALCOHOL; STIGMA; ACCESS; CARE	Background Findings on the association between health literacy and anti-retroviral (ARV) adherence are inconsistent. Health literacy is usually operationalized with simple tests of basic literacy, but more complex conceptions of health literacy include content knowledge. People living with chronic illness also conceptualize and experience illness in ways other than biomedical or mechanistic models of disease. Objective There are no instruments that comprehensively assess knowledge of people living with HIV concerning HIV disease and treatment; or psychological adjustment to being HIV+. Little is known about the relationship between factual knowledge, or positive identification as HIV+, and anti-retroviral (ARV) adherence. Methods Formative work with in-depth semi-structured interviews, and cognitive testing, to develop a structured instrument assessing HIV-related knowledge, and personal meanings of living with HIV. Pilot administration of the instrument to a convenience sample of 101 respondents. Key results Respondents varied considerably in their expressed need for in-depth knowledge, the accuracy of their understanding of relevant scientific concepts and facts about ARV treatment, and psychological adjustment and acceptance of HIV+ status. Most knowledge domains were not significantly related to self-reported ARV adherence, but accurate knowledge specifically about ARV treatment was (r = 0.25, p = .02), as was an adapted version of the Need for Cognition scale (r = .256, p = .012). Negative feelings about living with HIV (r = .33, p = .0012), and medication taking (r = .276, p = .008) were significantly associated with non-adherence. Conclusion The instrument may be useful in diagnosing addressable reasons for non-adherence, as a component of psychoeducational interventions, and for evaluation of such interventions.	[Laws, M. Barton; Lee, Yoojin; Taubin, Tatiana; Wilson, Ira B.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Rogers, William S.] Tufts Univ, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA	Brown University; Tufts University	Laws, MB (corresponding author), Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA.	Michael_Barton_Laws@brown.edu			National Institute of Mental Health [5R21MH092781-02]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by a grant from the National Institute of Mental Health, Grant #5R21MH092781-02, to MBL. https://www.nimh.nih.gov/index.shtml The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner LM, 2007, QUAL HEALTH RES, V17, P919, DOI 10.1177/1049732307305881; BECKER MH, 1975, MED CARE, V13, P10, DOI 10.1097/00005650-197501000-00002; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; CACIOPPO JT, 1984, J PERS ASSESS, V48, P306, DOI 10.1207/s15327752jpa4803_13; Cacioppo JT, 1996, PSYCHOL BULL, V119, P197, DOI 10.1037/0033-2909.119.2.197; Caplan A. L., 2004, HLTH DIS ILLNESS CON; Charmaz K, 1983, Sociol Health Illn, V5, P168, DOI 10.1111/1467-9566.ep10491512; Colbert AM, 2013, J ADV NURS, V69, P295, DOI 10.1111/j.1365-2648.2012.06007.x; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Davis T C, 1993, Fam Med, V25, P391; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Fowler FJ, 2014, FIELD METHOD; Glass TR, 2008, ANTIVIR THER, V13, P77; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Kalichman SC, 1999, J GEN INTERN MED, V14, P267, DOI 10.1046/j.1525-1497.1999.00334.x; Kalichman SC, 2012, J ASSOC NURSE AIDS C, V23, P511, DOI 10.1016/j.jana.2011.11.005; Kalichman Seth C, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P317, DOI 10.1177/1545109708328130; Kalichman SC, 2009, AIDS PATIENT CARE ST, V23, P449, DOI 10.1089/apc.2008.0184; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Kleinman A., 1981, PATIENTS HEALERS CON; Kralik D, 2003, J ADV NURS, V42, P11, DOI 10.1046/j.1365-2648.2003.02505.x; Laws MB, 2015, AIDS BEHAV, V19, P635, DOI 10.1007/s10461-014-0931-8; Laws MB, 2016, AIDS BEHAV; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Murphy DA, 2010, PATIENT EDUC COUNS, V79, P25, DOI 10.1016/j.pec.2009.07.014; Osborn CY, 2007, AM J PREV MED, V33, P374, DOI 10.1016/j.amepre.2007.07.022; Paasche-Orlow MK, 2007, AM J HEALTH BEHAV, V31, pS19; Paasche-Orlow MK, 2006, J GEN INTERN MED, V21, P835, DOI 10.1111/j.1525-1497.2006.00527.x; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Petty R.E., 2009, HDB INDIVIDUAL DIFFE, P318; Soubelet A, 2017, ASSESSMENT, V24, P987, DOI 10.1177/1073191116636449; Stryker S, 2000, SOC PSYCHOL QUART, V63, P284, DOI 10.2307/2695840; Waite KR, 2008, J GEN INTERN MED, V23, P1367, DOI 10.1007/s11606-008-0662-5; Wilson IB, 2016, AIDS BEHAV; Wilson IB, 2014, AIDS BEHAV, V18, P2349, DOI 10.1007/s10461-013-0610-1; Wilson IB, 2010, JAIDS-J ACQ IMM DEF, V53, P338, DOI 10.1097/QAI.0b013e3181c7a245; Wolf MS, 2007, PATIENT EDUC COUNS, V65, P253, DOI 10.1016/j.pec.2006.08.006	40	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0227722	10.1371/journal.pone.0227722	http://dx.doi.org/10.1371/journal.pone.0227722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569272	Green Published, Green Submitted, gold			2022-12-26	WOS:000543547900017
J	Bagnaresi, P; Cattivelli, L				Bagnaresi, Paolo; Cattivelli, Luigi			Ab initioGO-based mining for non-tandem-duplicated functional clusters in three model plant diploid genomes	PLOS ONE			English	Article							METABOLIC GENE CLUSTERS; IDENTIFICATION; PREDICTION; EVOLUTION; BIOSYNTHESIS; ANNOTATION; SYNTHASE; RICE	A functional Non-Tandem Duplicated Cluster (FNTDC) is a group of non-tandem-duplicated genes that are located closer than expected by mere chance and have a role in the same biological function. The identification of secondary-compounds-related FNTDC has gained increased interest in recent years, but littleab-initioattempts aiming to the identification of FNTDCs covering all biological functions, including primary metabolism compounds, have been carried out. We report an extensive FNTDC dataset accompanied by a detailed assessment on parameters used for genome scanning and their impact on FNTDC detection. We propose 70% identity and 70% alignment coverage as intermediate settings to exclude tandem duplicated genes and a dynamic scanning window of 24 genes. These settings were applied to rice, arabidopsis and grapevine genomes to call for FNTDCs. Besides the best-known secondary metabolism clusters, we identified many FNTDCs associated to primary metabolism ranging from macromolecules synthesis/editing, TOR signalling, ubiquitination, proton and electron transfer complexes. Using the intermediate FNTDC setting parameters (atP-value1e(-6)), 130, 70 and 140 candidate FNTDCs were called in rice, arabidopsis and grapevine, respectively, and 20 to 30% of GO tags associated to called FNTDC were common among the 3 genomes. The datasets developed along with this work provide a rich framework for pinpointing candidate FNTDCs reflecting all GO-BP tags covering both primary and secondary metabolism with large macromolecular complexes/metabolons as the most represented FNTDCs. Noteworthy, several FNTDCs are tagged with GOs referring to organelle-targeted multi-enzyme complex, a finding that suggest the migration of endosymbiont gene chunks towards nuclei could be at the basis of these class of candidate FNTDCs. Most FNTDC appear to have evolved prior of genome duplication events. More than one-third of genes interspersed/adjacent to called FNTDCs lacked any functional annotation; however, their co-localization may provide hints towards a candidate biological role.	[Bagnaresi, Paolo; Cattivelli, Luigi] CREA Res Ctr Genom & Bioinformat, Fiorenzuola Darda, Italy		Bagnaresi, P (corresponding author), CREA Res Ctr Genom & Bioinformat, Fiorenzuola Darda, Italy.	paolo.bagnaresi@crea.gov.it	cattivelli, luigi/AAE-7046-2020	cattivelli, luigi/0000-0002-6067-4600; Bagnaresi, Paolo/0000-0001-8466-4805				Blin K, 2017, NUCLEIC ACIDS RES, V45, pW36, DOI 10.1093/nar/gkx319; Bodenhofer U, 2015, BIOINFORMATICS, V31, P3997, DOI 10.1093/bioinformatics/btv494; Boycheva S, 2014, TRENDS PLANT SCI, V19, P447, DOI 10.1016/j.tplants.2014.01.013; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Field B, 2011, P NATL ACAD SCI USA, V108, P16116, DOI 10.1073/pnas.1109273108; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Ghanbarian AT, 2015, MOL BIOL EVOL, V32, P1748, DOI 10.1093/molbev/msv053; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hiscock SJ, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-reviews1004; Jonczyk R, 2008, PLANT PHYSIOL, V146, P1053, DOI 10.1104/pp.107.111237; Kautsar SA, 2017, NUCLEIC ACIDS RES, V45, pW55, DOI 10.1093/nar/gkx305; Kurotani A, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu176; Ling QH, 2015, BBA-BIOENERGETICS, V1847, P939, DOI 10.1016/j.bbabio.2015.02.017; Ling QH, 2012, SCIENCE, V338, P655, DOI 10.1126/science.1225053; Maccaferri M, 2019, NAT GENET, V51, P885, DOI 10.1038/s41588-019-0381-3; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Matsuba Y, 2013, PLANT CELL, V25, P2022, DOI 10.1105/tpc.113.111013; Niehaus TD, 2015, PLANT PHYSIOL, V169, P1436, DOI 10.1104/pp.15.00959; Nintemann SJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02028; Nutzmann HW, 2014, CURR OPIN BIOTECH, V26, P91, DOI 10.1016/j.copbio.2013.10.009; Nutzmann HW, 2018, ANNU REV GENET, V52, P159, DOI 10.1146/annurev-genet-120417-031237; Nutzmann HW, 2016, NEW PHYTOL, V211, P771, DOI 10.1111/nph.13981; Schlapfer P, 2017, PLANT PHYSIOL, V173, P2041, DOI 10.1104/pp.16.01942; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Takos AM, 2011, PLANT J, V68, P273, DOI 10.1111/j.1365-313X.2011.04685.x; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Topfer N, 2017, NUCLEIC ACIDS RES, V45, P7049, DOI 10.1093/nar/gkx404; von Rad U, 2001, PLANT J, V28, P633, DOI 10.1046/j.1365-313x.2001.01161.x; Wada M, 2012, GENE, V503, P56, DOI 10.1016/j.gene.2012.04.043; Wilderman PR, 2007, J AM CHEM SOC, V129, P15736, DOI 10.1021/ja074977g; Wilderman PR, 2004, PLANT PHYSIOL, V135, P2098, DOI 10.1104/pp.104.045971; Yi G, 2007, BIOINFORMATICS, V23, P1053, DOI 10.1093/bioinformatics/btl673; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu N, 2016, NUCLEIC ACIDS RES, V44, P2255, DOI 10.1093/nar/gkw100; Zerbe P, 2015, TRENDS BIOTECHNOL, V33, P419, DOI 10.1016/j.tibtech.2015.04.006	37	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234782	10.1371/journal.pone.0234782	http://dx.doi.org/10.1371/journal.pone.0234782			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559249	Green Published, gold			2022-12-26	WOS:000543261600063
J	Hasegawa, R; Ebina, T; Tanaka, YR; Kobayashi, K; Matsuzaki, M				Hasegawa, Ryota; Ebina, Teppei; Tanaka, Yasuhiro R.; Kobayashi, Kenta; Matsuzaki, Masanori			Structural dynamics and stability of corticocortical and thalamocortical axon terminals during motor learning	PLOS ONE			English	Article							DENDRITIC SPINES; LONG-TERM; SYNAPTIC PLASTICITY; THALAMIC NUCLEI; LAYER 1; NEURONS; CORTEX; REORGANIZATION; ORGANIZATION; PROJECTIONS	Synaptic plasticity is the cellular basis of learning and memory. When animals learn a novel motor skill, synaptic modifications are induced in the primary motor cortex (M1), and new postsynaptic dendritic spines relevant to motor memory are formed in the early stage of learning. However, it is poorly understood how presynaptic axonal boutons are formed, eliminated, and maintained during motor learning, and whether long-range corticocortical and thalamocortical axonal boutons show distinct structural changes during learning. In this study, we conducted two-photon imaging of presynaptic boutons of long-range axons in layer 1 (L1) of the mouse M1 during the 7-day learning of an accelerating rotarod task. The training-period-averaged rate of formation of boutons on axons projecting from the secondary motor cortical area increased, while the average rate of elimination of those from the motor thalamus (thalamic boutons) decreased. In particular, the elimination rate of thalamic boutons during days 4-7 was lower than that in untrained mice, and the fraction of pre-existing thalamic boutons that survived until day 7 was higher than that in untrained mice. Our results suggest that the late stabilization of thalamic boutons in M1 contributes to motor skill learning.	[Hasegawa, Ryota; Ebina, Teppei; Tanaka, Yasuhiro R.; Matsuzaki, Masanori] Natl Inst Basic Biol, Div Brain Circuits, Okazaki, Aichi, Japan; [Hasegawa, Ryota] Natl Inst Basic Biol, Div Behav Neurobiol, Okazaki, Aichi, Japan; [Hasegawa, Ryota; Matsuzaki, Masanori] SOKENDAI Grad Univ Adv Studies, Dept Basic Biol, Okazaki, Aichi, Japan; [Hasegawa, Ryota; Ebina, Teppei; Tanaka, Yasuhiro R.; Matsuzaki, Masanori] Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo, Japan; [Tanaka, Yasuhiro R.] Tamagawa Univ, Brain Sci Inst, Tokyo, Japan; [Kobayashi, Kenta] Natl Inst Physiol Sci, Sect Viral Vector Dev, Okazaki, Aichi, Japan; [Matsuzaki, Masanori] RIKEN Ctr Brain Sci, Brain Funct Dynam Collaborat Lab, Saitama, Japan; [Matsuzaki, Masanori] Univ Tokyo, Int Res Ctr Neurointelligence WPI IRCN, Inst Adv Study, Tokyo, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); RIKEN; University of Tokyo	Matsuzaki, M (corresponding author), Natl Inst Basic Biol, Div Brain Circuits, Okazaki, Aichi, Japan.; Matsuzaki, M (corresponding author), SOKENDAI Grad Univ Adv Studies, Dept Basic Biol, Okazaki, Aichi, Japan.; Matsuzaki, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo, Japan.; Matsuzaki, M (corresponding author), RIKEN Ctr Brain Sci, Brain Funct Dynam Collaborat Lab, Saitama, Japan.; Matsuzaki, M (corresponding author), Univ Tokyo, Int Res Ctr Neurointelligence WPI IRCN, Inst Adv Study, Tokyo, Japan.	mzakim@m.u-tokyo.ac.jp		Ebina, Teppei/0000-0002-3097-0513; Matsuzaki, Masanori/0000-0003-3872-4322	Ministry of Education, Culture, Sports, Science, and Technology, Japan [17H06309, 19H01037]; AMED [JP18dm0207027, JP19dm0107150]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (17H06309 to M.M.) and for Scientific Research (A) (19H01037 to M.M.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; AMED (JP18dm0207027 and JP19dm0107150 to M.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Aoki S, 2019, ELIFE, V8, DOI 10.7554/eLife.49995; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Biane JS, 2016, NEURON, V89, P1173, DOI 10.1016/j.neuron.2016.02.001; Bopp R, 2017, J NEUROSCI, V37, P2435, DOI 10.1523/JNEUROSCI.2557-16.2017; Cao VY, 2015, NEURON, V86, P1385, DOI 10.1016/j.neuron.2015.05.022; Chen SX, 2015, NAT NEUROSCI, V18, P1109, DOI 10.1038/nn.4049; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2609; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; FRIEDLANDER MJ, 1991, J NEUROSCI, V11, P3268; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Gala R, 2017, ELIFE, V6, DOI 10.7554/eLife.29315; Gong WK, 2020, NEUROBIOL LEARN MEM, V168, DOI 10.1016/j.nlm.2019.107156; Grillo FW, 2013, P NATL ACAD SCI USA, V110, pE1514, DOI 10.1073/pnas.1218731110; Harms KJ, 2008, J NEUROSCI, V28, P5686, DOI 10.1523/JNEUROSCI.0584-08.2008; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hayashi-Takagi A, 2015, NATURE, V525, P333, DOI 10.1038/nature15257; Hira R, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00055; Hira R, 2013, J NEUROSCI, V33, P1377, DOI 10.1523/JNEUROSCI.2550-12.2013; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Hooks BM, 2013, J NEUROSCI, V33, P748, DOI 10.1523/JNEUROSCI.4338-12.2013; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; IRIKI A, 1989, SCIENCE, V245, P1385, DOI 10.1126/science.2551038; Jejeli M, 2003, NEUROSCI RES, V47, P309, DOI 10.1016/S0168-0102(03)00224-4; Johnson CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10785; Kaneda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018452; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/NMETH.1784, 10.1038/nmeth.1784]; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kobayashi K, 2016, NEUROSCI LETT, V630, P45, DOI 10.1016/j.neulet.2016.07.020; Kubota Y, 2007, J NEUROSCI, V27, P1139, DOI 10.1523/JNEUROSCI.3846-06.2007; Kuramoto E, 2015, CEREB CORTEX, V25, P221, DOI 10.1093/cercor/bht216; Kuramoto E, 2011, EUR J NEUROSCI, V33, P95, DOI 10.1111/j.1460-9568.2010.07481.x; Kuramoto E, 2009, CEREB CORTEX, V19, P2065, DOI 10.1093/cercor/bhn231; Liston C, 2013, NAT NEUROSCI, V16, P698, DOI 10.1038/nn.3387; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Masamizu Y, 2014, NAT NEUROSCI, V17, P987, DOI 10.1038/nn.3739; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; Paxinos G, 2013, PAXINOS FRANKLINS MO; Qiao Q, 2016, DEV NEUROBIOL, V76, P252, DOI 10.1002/dneu.22311; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shibata H, 2005, BRAIN RES, V1059, P93, DOI 10.1016/j.brainres.2005.08.025; Sun YJ, 2019, P NATL ACAD SCI USA, V116, P21812, DOI 10.1073/pnas.1914661116; Suter BA, 2015, J NEUROSCI, V35, P2959, DOI 10.1523/JNEUROSCI.4287-14.2015; Tanaka YH, 2018, NEURON, V100, P244, DOI 10.1016/j.neuron.2018.08.016; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Ueta Y, 2014, CEREB CORTEX, V24, P2362, DOI 10.1093/cercor/bht088; Wang XH, 2017, CELL, V171, P440, DOI 10.1016/j.cell.2017.08.014; WHITE EL, 1987, J COMP NEUROL, V262, P13, DOI 10.1002/cne.902620103; Wright NF, 2013, J COMP NEUROL, V521, P2966, DOI 10.1002/cne.23325; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yamawaki N, 2014, ELIFE, V3, DOI 10.7554/eLife.05422; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yang Y, 2016, NAT NEUROSCI, V19, P1348, DOI 10.1038/nn.4370; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; 1993, ADVERSE REACTIONS PL, V10, P1	69	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234930	10.1371/journal.pone.0234930	http://dx.doi.org/10.1371/journal.pone.0234930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559228	Green Submitted, Green Published, gold			2022-12-26	WOS:000543261600047
J	Ortiz-Comino, L; Fernandez-Lao, C; Speksnijder, CM; Lozano-Lozano, M; Tovar-Martin, I; Arroyo-Morales, M; Martin-Martin, L				Ortiz-Comino, Lucia; Fernandez-Lao, Carolina; Speksnijder, Caroline M.; Lozano-Lozano, Mario; Tovar-Martin, Isabel; Arroyo-Morales, Manuel; Martin-Martin, Lydia			Upper body motor function and swallowing impairments and its association in survivors of head and neck cancer: A cross-sectional study	PLOS ONE			English	Article							SHOULDER FUNCTION; DISSECTION; RELIABILITY; TRISMUS; DYSFUNCTION; CARCINOMA; MOTION; RANGE	Background Upper body motor function and swallowing may be affected after curative treatment for head and neck cancer. The aims of this study are to compare maximum mouth opening (MMO), temporomandibular dysfunction (TMD), cervical and shoulder active range of motion (AROM) and strength, and swallowing difficulty between survivors of head and neck cancer (sHNC) and healthy matched controls (HMC) and to examine the correlations between these outcomes in sHNC. Methods Thirty-two sHNC and 32 HMC participated on the study. MMO, TMD, cervical and shoulder AROM, cervical and shoulder strength, the SPADI shoulder pain and disability indices, the Eating Assessment Tool (EAT-10) score, swallowing difficulty as determined using a visual analogue scale (VAS), and the location of disturbances in swallowing, were recorded. Results MMO and cervical and shoulder AROM and strength were significantly lower in sHNC, whereas FAI, SPADI score, EAT-10 and VAS were higher. The MMO, TMD, cervical and shoulder AROM, and cervical shoulder strength values showed significant correlations (some direct, others inverse) with one another. Swallowing difficulty was inversely associated with the MMO, cervical AROM and shoulder strength. Conclusion Compared with controls, sHNC present smaller MMO, lower cervical and shoulder AROM, lower cervical and shoulder strength and higher perception of TMD, shoulder pain and disability and swallowing difficulty. sHNC suffer impaired swallowing related to lower MMO, presence of TMD, cervical AROM and shoulder strength values. Improving these variables via physiotherapy may reduce the difficulty in swallowing experienced by some sHNC.	[Ortiz-Comino, Lucia] Univ Granada, Dept Phys Therapy, Granada, Spain; [Fernandez-Lao, Carolina; Arroyo-Morales, Manuel] Univ Granada, Inst Biosanitario Granada IBS Granada, Inst Mixto Deporte & Salud iMUDS, Dept Phys Therapy, Granada, Spain; [Speksnijder, Caroline M.] Univ Utrecht, Univ Med Ctr Utrecht, Canc Ctr, Dept Head & Neck Surg Oncol, Utrecht, Netherlands; [Speksnijder, Caroline M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Oral & Maxillofacial Surg & Special Dent Car, Utrecht, Netherlands; [Speksnijder, Caroline M.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Lozano-Lozano, Mario; Martin-Martin, Lydia] Univ Granada, Inst Biosanitario Granada IBS Granada, Dept Phys Therapy, Granada, Spain; [Tovar-Martin, Isabel] Virgen de las Nieves Univ Hosp, Radiat Oncol Dept, Granada, Spain	University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Hospital Universitario Virgen de las Nieves	Fernandez-Lao, C (corresponding author), Univ Granada, Inst Biosanitario Granada IBS Granada, Inst Mixto Deporte & Salud iMUDS, Dept Phys Therapy, Granada, Spain.	carolinafl@ugr.es	Speksnijder, Caroline/C-7921-2009; Martin-Martin, Lydia M/L-8955-2014; Lozano-Lozano, Mario/G-2564-2016	Speksnijder, Caroline/0000-0003-0540-3741; Lozano-Lozano, Mario/0000-0001-5854-3567; Fernandez Lao, Carolina/0000-0002-9392-1532	Fondos Estructurales de la Union Europea (FEDER); Unit of Excellence on Exercise and Health (UCEES), University of Granada	Fondos Estructurales de la Union Europea (FEDER); Unit of Excellence on Exercise and Health (UCEES), University of Granada	This research was supported by the Fondos Estructurales de la Union Europea (FEDER) and Unit of Excellence on Exercise and Health (UCEES), University of Granada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, LANCET ONCOL, V18, P1, DOI 10.1016/S1470-2045(16)30642-8; [Anonymous], 2006, J AM ACAD ORTHOP S1, V15, p104S; Baggi F, 2014, ACTA OTORHINOLARYNGO, V34, P230; Belafsky PC, 2008, ANN OTO RHINOL LARYN, V117, P919, DOI 10.1177/000348940811701210; Bensadoun RJ, 2010, SUPPORT CARE CANCER, V18, P1033, DOI 10.1007/s00520-010-0847-4; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; da Fonseca DM, 1994, RGO REV GAUC ODONTOL, V42, P23; Membrilla-Mesa MD, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0397-z; Domenech MA, 2011, PM&R, V3, P105, DOI 10.1016/j.pmrj.2010.10.023; Douma JAJ, 2020, ACTA ONCOL, V59, P342, DOI 10.1080/0284186X.2019.1675906; Duncan M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015860; Felten DL, 2016, NETTERS ATLAS NEUROS, VThird, P153, DOI [10.1016/B978-0-323-26511-9.00009-6, DOI 10.1016/B978-0-323-26511-9.00009-6]; Gane EM, 2017, EJSO-EUR J SURG ONC, V43, P1199, DOI 10.1016/j.ejso.2016.10.026; Gane EM, 2019, OTOLARYNG HEAD NECK, V160, P1009, DOI 10.1177/0194599818821885; Ghiam MK, 2017, SUPPORT CARE CANCER, V25, P2085, DOI 10.1007/s00520-017-3603-1; Giordano L, 2012, ACTA OTORHINOLARYNGO, V32, P376; Giraldi L, 2017, ANN ONCOL, V28, P2843, DOI 10.1093/annonc/mdx486; Harris KD, 2005, PHYS THER, V85, P1349, DOI 10.1093/ptj/85.12.1349; Hauer-Jensen M, 2004, CRIT CARE MED, V32, pS325, DOI 10.1097/01.CCM.0000126358.15697.75; Heijnen BJ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6086894; Hislop H., 2013, DANIELS WORTHINGHAMS; Logemann JA, 2018, BRAIN INJ MED, V26, P203, DOI [10.1891/9781617050572.0066, DOI 10.1891/9781617050572.0066]; Maghami E, 2018, MULTIDISCIPLINARY CA, V174, DOI [10.1007/978-3-319-65421-8_5, DOI 10.1007/978-3-319-65421-8_5]; McNeely ML, 2004, HEAD NECK-J SCI SPEC, V26, P518, DOI 10.1002/hed.20010; Mullaney Michael J., 2010, Physiotherapy Theory and Practice, V26, P327, DOI 10.3109/09593980903094230; Namaki S, 2011, J PLAST SURG HAND SU, V45, P136, DOI 10.3109/2000656X.2011.569198; Norkin C., 2006, GONIOMETRIA EVALUACI; Okeson J., 2012, MANAGEMENT TEMPOROMA; Ortigara GB, 2019, OR SURG OR MED OR PA, V128, P235, DOI 10.1016/j.oooo.2019.05.009; Oz B, 2009, EUR J CANCER CARE, V18, P179, DOI 10.1111/j.1365-2354.2008.00950.x; Pauli N, 2019, HEAD NECK-J SCI SPEC, V41, P3570, DOI 10.1002/hed.25878; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Rapidis AD, 2015, CLIN OTOLARYNGOL, V40, P516, DOI 10.1111/coa.12488; Riekki R, 2002, ARCH DERMATOL RES, V294, P178, DOI 10.1007/s00403-002-0306-2; Robbins KT, 2002, ARCH OTOLARYNGOL, V128, P751, DOI 10.1001/archotol.128.7.751; Roy JS, 2009, ARTHRIT RHEUM-ARTHR, V61, P623, DOI 10.1002/art.24396; Shah J, 2019, HEAD NECK SURG ONCOL; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sobin LHGM., 2009, TNM CLASSIFICATION M, V7th; Soldatova L, 2019, ANN OTO RHINOL LARYN, V128, P802, DOI 10.1177/0003489419842256; Speksnijder CM, 2013, HEAD NECK-J SCI SPEC, V35, P1303, DOI 10.1002/hed.23131; Tashiro M, 2017, GERIATR GERONTOL INT, V17, P2565, DOI 10.1111/ggi.13097; van der Geer SJ, 2019, HEAD NECK-J SCI SPEC, V41, P64, DOI 10.1002/hed.25369; van Hinte G, 2019, SUPPORT CARE CANCER, V27, P2553, DOI 10.1007/s00520-018-4534-1; von Piekartz H, 2016, MANUAL THER, V26, P208, DOI 10.1016/j.math.2016.09.001; Wetzels JWGH, 2014, HEAD NECK-J SCI SPEC, V36, P1754, DOI 10.1002/hed.23534; Yokogawa N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109838; Young D, 2015, ORAL ONCOL, V51, P727, DOI 10.1016/j.oraloncology.2015.03.015	48	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234467	10.1371/journal.pone.0234467	http://dx.doi.org/10.1371/journal.pone.0234467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559241	Green Published, gold			2022-12-26	WOS:000543261600054
J	Khoshnevis, M; Carozzo, C; Brown, R; Bardies, M; Bonnefont-Rebeix, C; Belluco, S; Nennig, C; Maroon, L; Tillement, O; Gehan, H; Louis, C; Zahi, I; Buronfosse, T; Roger, T; Ponce, F				Khoshnevis, Mehrdad; Carozzo, Claude; Brown, Richard; Bardies, Manuel; Bonnefont-Rebeix, Catherine; Belluco, Sara; Nennig, Christophe; Maroon, Lionel; Tillement, Olivier; Gehan, Helene; Louis, Cedric; Zahi, Ilyes; Buronfosse, Thierry; Roger, Thierry; Ponce, Frederique			Feasibility of intratumoral (165)Holmium siloxane delivery to induced U87 glioblastoma in a large animal model, the Yucatan minipig	PLOS ONE			English	Article							RADIOTHERAPY PLUS CONCOMITANT; MALIGNANT GLIOMAS; RADIATION-THERAPY; TEMOZOLOMIDE; BRACHYTHERAPY; MICROSPHERES; SURVIVAL; CHEMOTHERAPY; MECHANISMS; XENOGRAFT	Glioblastoma is the most aggressive primary brain tumor leading to death in most of patients. It comprises almost 50-55% of all gliomas with an incidence rate of 2-3 per 100,000. Despite its rarity, overall mortality of glioblastoma is comparable to the most frequent tumors. The current standard treatment combines surgical resection, radiotherapy and chemotherapy with temozolomide. In spite of this aggressive multimodality protocol, prognosis of glioblastoma is poor and the median survival remains about 12-14.5 months. In this regard, new therapeutic approaches should be developed to improve the life quality and survival time of the patient after the initial diagnosis. Before switching to clinical trials in humans, all innovative therapeutic methods must be studied first on a relevant animal model in preclinical settings. In this regard, we validated the feasibility of intratumoral delivery of a holmium (Ho) microparticle suspension to an induced U87 glioblastoma model. Among the different radioactive beta emitters,Ho-166 emits high-energy beta(-) radiation and low-energy gamma radiation. beta(-) radiation is an effective means for tumor destruction and gamma rays are well suited for imaging (SPECT) and consequent dosimetry. In addition, the paramagnetic Ho nucleus is a good asset to perform MRI imaging. In this study, five minipigs, implanted with our glioblastoma model were used to test the injectability of(165)Ho (stable) using a bespoke injector and needle. The suspension was produced in the form of Ho microparticles and injected inside the tumor by a technique known as microbrachytherapy using a stereotactic system. At the end of this trial, it was found that the(165)Ho suspension can be injected successfully inside the tumor with absence or minimal traces of Ho reflux after the injections. This injection technique and the use of the(165)Ho suspension needs to be further assessed with radioactive(166)Ho in future studies.	[Khoshnevis, Mehrdad; Carozzo, Claude; Bonnefont-Rebeix, Catherine; Belluco, Sara; Roger, Thierry; Ponce, Frederique] Univ Lyon1, UPSP 2016 A104, VetAgro Sup, ICE Interact Cellules Environm, Marcy Letoile, France; [Brown, Richard; Bardies, Manuel] INSERM, UMR1037, CRCT, Toulouse, France; [Nennig, Christophe] EVEON, Montbonnot St Martin, France; [Maroon, Lionel; Tillement, Olivier] UCBL, Inst Lumiere Matiere, UMR CNRS 5306, Campus LyonTech La Doua, Villeurbanne, France; [Gehan, Helene; Louis, Cedric] NanoH SAS, St Quentin Fallavier, France; [Zahi, Ilyes] Adv Accelerator Applicat, St Genis Pouilly, France; [Buronfosse, Thierry] Univ Lyon1, Dept Endocrinol, VetAgro Sup, Marcy Letoile, France; [Ponce, Frederique] Univ Lyon1, Clin Oncol Unit, VetAgro Sup, Marcy Letoile, France; [Khoshnevis, Mehrdad] INSERM, BrainTech Lab U1205, Grenoble, France	VetAgro Sup; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; VetAgro Sup; Institut National de la Sante et de la Recherche Medicale (Inserm)	Khoshnevis, M (corresponding author), Univ Lyon1, UPSP 2016 A104, VetAgro Sup, ICE Interact Cellules Environm, Marcy Letoile, France.; Khoshnevis, M (corresponding author), INSERM, BrainTech Lab U1205, Grenoble, France.	dvm.khoshnevis@gmail.com	Bardies, Manuel/L-3136-2014	Bardies, Manuel/0000-0002-1766-727X; Marcon, Lionel/0000-0002-3190-3224; Brown, Richard/0000-0001-6989-9200; Khoshnevis, Mehrdad/0000-0003-0609-0898	BPifrance [ISI 2013-2018]	BPifrance	This work was supported by the BPifrance [ISI 2013-2018]. The funder provided support in the form of salaries for authors [Christophe Nennig, Lionel Marcon, Olivier Tillement, Helene Gehan, Cedric Louis, Ilyes Zahi], and did have additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alifieris C, 2015, PHARMACOL THERAPEUT, V152, P63, DOI 10.1016/j.pharmthera.2015.05.005; Amelio Dante, 2012, Cancers (Basel), V4, P257, DOI 10.3390/cancers4010257; AMMIRATI M, 1987, NEUROSURGERY, V21, P201, DOI 10.1227/00006123-198708000-00012; Barbarite E, 2017, NEUROSURG REV, V40, P195, DOI 10.1007/s10143-016-0727-6; Beauchesne P, 2010, NEURO-ONCOLOGY, V12, P595, DOI 10.1093/neuonc/noq008; BRANDES A, 1991, ANTICANCER RES, V11, P719; Brandes AA, 2008, NEURO-ONCOLOGY, V10, P361, DOI 10.1215/15228517-2008-008; Brown K, 2017, INTED PROC, P450; Bult W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052178; Buonerba C, 2011, CRIT REV ONCOL HEMAT, V80, P54, DOI 10.1016/j.critrevonc.2010.09.001; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Castro BA, 2014, NEURO-ONCOLOGY, V16, P4, DOI 10.1093/neuonc/not233; Chang Julie E, 2007, Clin Adv Hematol Oncol, V5, P894; Chen L, 2013, BBA-REV CANCER, V1836, P158, DOI 10.1016/j.bbcan.2013.04.003; Chen MY, 1999, J NEUROSURG, V90, P315, DOI 10.3171/jns.1999.90.2.0315; Collingridge DR, 1999, RADIOTHER ONCOL, V53, P127, DOI 10.1016/S0167-8140(99)00121-8; Davis ME, 2016, CLIN J ONCOL NURS, V20, P2, DOI 10.1188/16.CJON.S1.2-8; Dempsey JF, 1998, INT J RADIAT ONCOL, V42, P421, DOI 10.1016/S0360-3016(98)00215-6; Faramarz-Allandini, 2010, WORLD NEUROSURG, V73, P128, DOI 10.1016/j.wneu.2009.06.001; Fisher JL, 2007, NEUROL CLIN, V25, P867, DOI 10.1016/j.ncl.2007.07.002; Gilbert MR, 2013, J CLIN ONCOL, V31, P4085, DOI 10.1200/JCO.2013.49.6968; Gzell C, 2017, CLIN ONCOL-UK, V29, P15, DOI 10.1016/j.clon.2016.09.015; Hong YD, 2002, NUCL MED BIOL, V29, P833, DOI 10.1016/S0969-8051(02)00329-3; Hottinger AF, 2014, CHIN J CANCER, V33, P32, DOI 10.5732/cjc.013.10207; Howells DW, 2010, J CEREBR BLOOD F MET, V30, P1412, DOI 10.1038/jcbfm.2010.66; Huh R, 2005, YONSEI MED J, V46, P51, DOI 10.3349/ymj.2005.46.1.51; Jacobs VL, 2011, ASN NEURO, V3, DOI 10.1042/AN20110014; Kelley K, 2016, CANCERS, V8, DOI 10.3390/cancers8040042; Kesari S, 2011, SEMIN ONCOL, V38, pS2, DOI 10.1053/j.seminoncol.2011.09.005; Khoshnevis M, 2017, J NEUROSCI METH, V282, P61, DOI 10.1016/j.jneumeth.2017.03.007; Knisely JPS, 2002, NEUROIMAG CLIN N AM, V12, P525, DOI 10.1016/S1052-5149(02)00032-1; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Laperriere N, 2002, RADIOTHER ONCOL, V64, P259, DOI 10.1016/S0167-8140(02)00078-6; Lee CY, 2017, ONCOTARGETS THER, V10, P265, DOI 10.2147/OTT.S120662; Lee YH., 1998, J KOREAN SOC RADIOL, V38, P83, DOI [10.3348/jkrs.1998.38.1.83, DOI 10.3348/JKRS.1998.38.1.83]; Marcon L, 2017, J NANOMED NANOTECHNO, V8, P460; Miller IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095885; Minniti G, 2010, RADIOTHER ONCOL, V97, P377, DOI 10.1016/j.radonc.2010.08.020; Mujokoro B, 2016, MAT SCI ENG C-MATER, V69, P1092, DOI 10.1016/j.msec.2016.07.080; Nijsen JFW, 2004, RADIOLOGY, V231, P491, DOI 10.1148/radiol.2312030594; Nupponen N. N., 2006, CURRENT DIAGNOSTIC P, V12, P394; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Patel S, 2000, NEUROSURGERY, V46, P1123, DOI 10.1097/00006123-200005000-00019; Plowman PN, 1999, BRIT J NEUROSURG, V13, P256, DOI 10.1080/02688699943655; SALAZAR OM, 1979, INT J RADIAT ONCOL, V5, P1733, DOI 10.1016/0360-3016(79)90554-6; Selek L, 2014, J NEUROSCI METH, V221, P159, DOI 10.1016/j.jneumeth.2013.10.002; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Srinivas N., 1994, Evolutionary Computation, V2, P221, DOI 10.1162/evco.1994.2.3.221; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suzuki M, 2003, JPN J CLIN ONCOL, V33, P271, DOI 10.1093/jjco/hyg053; Suzuki YS, 1998, J NUCL MED, V39, P2161; Tatter SB, 2003, J NEUROSURG, V99, P297, DOI 10.3171/jns.2003.99.2.0297; Thomas AA, 2012, CANCER J, V18, P59, DOI 10.1097/PPO.0b013e3182431a73; Tso CL, 2006, CANCER RES, V66, P159, DOI 10.1158/0008-5472.CAN-05-0077; Tysnes BB, 2001, J NEURO-ONCOL, V53, P129; Urbanska K, 2014, WSPOLCZESNA ONKOL, V18, P307, DOI 10.5114/wo.2014.40559; van Nimwegen SA, 2018, VET COMP ONCOL, V16, P114, DOI 10.1111/vco.12319; van Tellingen O, 2015, DRUG RESIST UPDATE, V19, P1, DOI 10.1016/j.drup.2015.02.002; Vente MAD, 2010, EUR RADIOL, V20, P862, DOI 10.1007/s00330-009-1613-1; Villa S, 2014, CHIN J CANCER, V33, P25, DOI 10.5732/cjc.013.10216; Walid Mohammad Sami, 2008, Perm J, V12, P45; WALKER MD, 1978, J NEUROSURG, V49, P333, DOI 10.3171/jns.1978.49.3.0333; WALKER MD, 1979, INT J RADIAT ONCOL, V5, P1725, DOI 10.1016/0360-3016(79)90553-4; Waters JD, 2013, J NEURO-ONCOL, V113, P467, DOI 10.1007/s11060-013-1139-x; Weathers SP, 2014, F1000PRIME REP, V6; Weiss T, 2016, EXPERT REV ANTICANC, V16, P1087, DOI 10.1080/14737140.2016.1229600; Zielhuis SW, 2007, BIOMATERIALS, V28, P4591, DOI 10.1016/j.biomaterials.2007.07.012	67	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234772	10.1371/journal.pone.0234772	http://dx.doi.org/10.1371/journal.pone.0234772			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555746	Green Published, gold			2022-12-26	WOS:000543273200066
J	Sosa-Moreno, A; Comstock, SS; Sugino, KY; Ma, TF; Paneth, N; Davis, Y; Olivero, R; Schein, R; Maurer, J; Zhang, LX				Sosa-Moreno, Andrea; Comstock, Sarah S.; Sugino, Kameron Y.; Ma, Teng F.; Paneth, Nigel; Davis, Yelena; Olivero, Rosemary; Schein, Rebecca; Maurer, Joel; Zhang, Lixin			Perinatal risk factors for fecal antibiotic resistance gene patterns in pregnant women and their infants	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; GUT MICROBIOME; 1ST YEAR; RESISTOME; PREVALENCE; DIVERSITY	Perinatal factors can shape fecal microbiome patterns among pregnant women and their infants. However, there is scarce information about the effect of maternal demographics and perinatal exposures on antibiotic resistance genes (ARG) and mobile genetic element (MGE) patterns in pregnant women and infants. We examined fecal samples from pregnant women during their third trimester of pregnancy (n = 51) and 6-month-old infants (n = 40). Of the 91 participants, 72 represented 36 maternal-infant dyads, 15 were additional pregnant women, and 4 were additional infants. We assessed the effects of demographics, pre-pregnancy BMI, smoking and parity in the pregnancy resistome and the effects of demographics, delivery mode, feeding habits and prenatal antibiotic treatment on the infancy resistome. ARG and MGE richness and abundance were assessed using a SmartChip qPCR-array. Alpha diversity (Shannon and Inverse Simpson index) and beta diversity (Sorensen and Bray-Curtis index) were calculated. The Wilcoxon and the Kruskal non-parametric test were used for comparisons. There is a high variability in shared resistome patterns between pregnant women and their infants. An average of 29% of ARG and 24% of MGE were shared within dyads. Infants had significantly greater abundance and higher diversity of ARG and MGE compared to pregnant women. Pregnancy and infancy samples differed in ARG and MGE gene composition and structure. Composition of the fecal resistome was significantly associated with race in pregnant women, with non-white women having different patterns than white women, and, in infants, with extent of solid food consumption. Our data showed that the pregnancy and infancy resistome had different structure and composition patterns, with maternal race and infant solid food consumption as possible contributors to ARG. By characterizing resistome patterns, our results can inform the mechanism of antibiotic resistome development in pregnant women and their infants.	[Sosa-Moreno, Andrea; Ma, Teng F.; Paneth, Nigel; Zhang, Lixin] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Comstock, Sarah S.; Sugino, Kameron Y.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Davis, Yelena; Maurer, Joel] Michigan State Univ, Coll Human Med, Dept Obstet Gynecol & Reprod Biol, E Lansing, MI 48824 USA; [Davis, Yelena; Olivero, Rosemary] Helen DeVos Childrens Hosp Spectrum Hlth, Grand Rapids, MI USA; [Olivero, Rosemary; Schein, Rebecca] Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, E Lansing, MI 48824 USA; [Sosa-Moreno, Andrea] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University College of Human Medicine; Michigan State University; Michigan State University College of Human Medicine; University of Michigan System; University of Michigan	Zhang, LX (corresponding author), Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.	lxzhang@msu.edu	Moreno, Andrea Sosa/ABG-2370-2020	Moreno, Andrea Sosa/0000-0002-4687-426X	Environmental influences on Child Health Outcomes (ECHO) - National Institutes of Health (NIH); Office of the Director [UG3 OD023285, UH3OD023285]; Offices of Vice Presidents for Research (Michigan State University) within the Child Health Advances from Research with Mothers Coalition (CHARM); Offices of Vice Presidents for Research (University of Michigan) within the Child Health Advances from Research with Mothers Coalition (CHARM); Offices of Vice Presidents for Research (Wayne State University) within the Child Health Advances from Research with Mothers Coalition (CHARM); Blue Cross Blue Shield of Michigan Foundation [002789]	Environmental influences on Child Health Outcomes (ECHO) - National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director(National Science Foundation (NSF)NSF - Office of the Director (OD)); Offices of Vice Presidents for Research (Michigan State University) within the Child Health Advances from Research with Mothers Coalition (CHARM); Offices of Vice Presidents for Research (University of Michigan) within the Child Health Advances from Research with Mothers Coalition (CHARM); Offices of Vice Presidents for Research (Wayne State University) within the Child Health Advances from Research with Mothers Coalition (CHARM); Blue Cross Blue Shield of Michigan Foundation	This research was financially supported by funds provided to NP by the Environmental influences on Child Health Outcomes (ECHO), which is a nationwide research program supported by the National Institutes of Health (NIH); Office of the Director to enhance child health (UG3 OD023285 and UH3OD023285) as well as an investigator grant awarded to SSC and LZ from the Offices of Vice Presidents for Research from three universities (Michigan State University, the University of Michigan and Wayne State University) within the Child Health Advances from Research with Mothers Coalition (CHARM); and Blue Cross Blue Shield of Michigan Foundation ((grant number: 002789) (https://www.bcbsm.com/foundation/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; [Anonymous], ANT RES THREATS US 2; [Anonymous], 2012, NUCLEIC ACIDS RES, V41, pD43; Arboleya S, 2015, J PEDIATR-US, V166, P538, DOI 10.1016/j.jpeds.2014.09.041; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Broe A, 2014, BJOG-INT J OBSTET GY, V121, P988, DOI 10.1111/1471-0528.12806; Brooks AW, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006842; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5; de Vries LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021644; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Feng J, 2018, ENVIRON MICROBIOL, V20, P355, DOI 10.1111/1462-2920.14009; Gardete S, 2014, J CLIN INVEST, V124, P2836, DOI 10.1172/JCI68834; Gasparrini AJ, 2016, GUT MICROBES, V7, P443, DOI 10.1080/19490976.2016.1218584; Gibson MK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.24, 10.1038/nmicrobiol.2016.24]; Gomez-Arango LF, 2017, SCI REP-UK, V7, DOI 10.1038/srep43481; Gosalbes MJ, 2016, J DEV ORIG HLTH DIS, V7, P35, DOI 10.1017/S2040174415001506; Greenwood C, 2014, J PEDIATR-US, V165, P23, DOI 10.1016/j.jpeds.2014.01.010; Guo XP, 2018, ENVIRON SCI TECHNOL, V52, P8165, DOI 10.1021/acs.est.8b01667; Hasperhoven G, 2020, BJOG-INT J OBSTET GY, V127, P1039, DOI 10.1111/1471-0528.16251; Hollister EB, 2014, GASTROENTEROLOGY, V146, P1449, DOI 10.1053/j.gastro.2014.01.052; Hu YF, 2016, APPL ENVIRON MICROB, V82, P6672, DOI 10.1128/AEM.01802-16; Hyman RW, 2014, REPROD SCI, V21, P32, DOI 10.1177/1933719113488838; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Johnson CL, 2012, PEDIATRICS, V129, P950, DOI 10.1542/peds.2011-2736; Karami N, 2006, ANTIMICROB AGENTS CH, V50, P156, DOI 10.1128/AAC.50.1.156-161.2006; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kuperman A, 2020, BJOG-INT J OBSTET GY, V127, P159, DOI 10.1111/1471-0528.15896; Laursen MF, 2017, FRONT MICROBIOL, P8, DOI 10.3389/fmicb.2017.00356/full 28144237; Li B, 2015, ISME J, V9, P2490, DOI 10.1038/ismej.2015.59; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Moore AM, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0090-9; Moore RE, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190128; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Oldenburg CE, 2020, CLIN INFECT DIS, V70, P525, DOI 10.1093/cid/ciz455; Olesen J, 2018, CEPHALALGIA, V38, P1, DOI 10.1177/0333102417738202; Parnanen K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06393-w; Qin SS, 2012, ANTIMICROB AGENTS CH, V56, P5332, DOI 10.1128/AAC.00809-12; Ravi A, 2015, SCI REP-UK, V5, DOI 10.1038/srep15317; Rose G, 2017, PEERJ, V5, DOI 10.7717/peerj.2928; Stearns JC, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0421-5; Stedtfeld RD, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy130; Steinke D, 2001, CLIN INFECT DIS, V33, pS193, DOI 10.1086/321848; Su JQ, 2015, ENVIRON SCI TECHNOL, V49, P7356, DOI 10.1021/acs.est.5b01012; Sugino KY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213733; Wang SC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01406; Werner G, 2001, ANTIMICROB AGENTS CH, V45, P3267, DOI 10.1128/AAC.45.11.3267-3269.2001; WHO (WorldHealthOrganization), 2018, WHO FACT SHEETS; World Health Organization, 2014, ANT RES GLOB REP SUR; Xi CW, 2009, APPL ENVIRON MICROB, V75, P5714, DOI 10.1128/AEM.00382-09; Yang R, 2019, PHYSIOL GENOMICS, V51, P368, DOI 10.1152/physiolgenomics.00026.2019; Yassour M, 2018, CELL HOST MICROBE, V24, P146, DOI 10.1016/j.chom.2018.06.007; Zhu YG, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.270	55	9	9	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234751	10.1371/journal.pone.0234751	http://dx.doi.org/10.1371/journal.pone.0234751			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555719	Green Published, gold			2022-12-26	WOS:000543273200014
J	McGetrick, J; Brucks, D; Marshall-Pescini, S; Range, F				McGetrick, Jim; Brucks, Desiree; Marshall-Pescini, Sarah; Range, Friederike			No evidence for a relationship between breed cooperativeness and inequity aversion in dogs	PLOS ONE			English	Article							CANIS-FAMILIARIS; GRAY WOLVES; MONKEYS; EVOLUTION; CHIMPANZEES; BEHAVIOR; SEX; RECIPROCATION; AGGRESSION; TOLERANCE	Inequity aversion, the resistance to inequitable outcomes, has been demonstrated in a wide variety of animal species. Inequity aversion was hypothesised to have co-evolved with cooperation but only limited evidence supports this. Dogs provide a suitable model species to test this hypothesis as dogs were previously shown to be inequity averse and dog breeds vary in the extent to which they were selected for cooperativeness. Here, we compared the response of 12 individuals of "cooperative worker" breeds with that of 12 individuals of "independent worker" breeds in the "paw task" previously used to demonstrate inequity aversion in dogs. We also compared the two breed groups' subsequent social behaviours in a food tolerance test and free interaction session. Although subjects in both breed groups were inequity averse, we found no considerable difference between the groups in the extent of the negative response to inequity or in the impact of the inequity on subsequent social behaviours. However, we found differences between the breed groups in the response to reward omission with cooperative breeds tending to work for longer than independent breeds. Additionally, in the free interaction session, individuals of cooperative breeds spent more time in proximity to their partner in the baseline condition than individuals of independent breeds. Overall, our results do not provide support for the hypothesis that inequity aversion and cooperation co-evolved. However, they illuminate potential differences in selection pressures experienced by cooperative worker and independent worker dog breeds throughout their evolutionary history.	[McGetrick, Jim; Marshall-Pescini, Sarah; Range, Friederike] Univ Vet Med, Konrad Lorenz Inst Ethol, Domesticat Lab, Vienna, Austria; [McGetrick, Jim; Brucks, Desiree; Marshall-Pescini, Sarah; Range, Friederike] Med Univ Vienna, Univ Vet Med, Messerli Res Inst, Comparat Cognit Unit, Vienna, Austria; [McGetrick, Jim; Brucks, Desiree; Marshall-Pescini, Sarah; Range, Friederike] Univ Vienna, Vienna, Austria; [Brucks, Desiree] Swiss Fed Inst Technol, Inst Agr Sci, Zurich, Switzerland	University of Veterinary Medicine Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; Swiss Federal Institutes of Technology Domain; ETH Zurich	McGetrick, J (corresponding author), Univ Vet Med, Konrad Lorenz Inst Ethol, Domesticat Lab, Vienna, Austria.; McGetrick, J (corresponding author), Med Univ Vienna, Univ Vet Med, Messerli Res Inst, Comparat Cognit Unit, Vienna, Austria.; McGetrick, J (corresponding author), Univ Vienna, Vienna, Austria.	Jim.McGetrick@vetmeduni.ac.at	Brucks, Désirée/AAF-6788-2020	McGetrick, Jim/0000-0001-5468-934X; Range, Friederike/0000-0003-3127-5536; Brucks, Desiree/0000-0003-3146-5110	DOC fellowship of the Austrian Academy of Sciences at the Messerli Research Institute; Austrian Science Fund (FWF) [W1262-B29]; European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant [311870]	DOC fellowship of the Austrian Academy of Sciences at the Messerli Research Institute; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant	JMcG was funded by a DOC fellowship of the Austrian Academy of Sciences at the Messerli Research Institute, and by the Austrian Science Fund (FWF) number W1262-B29. DB and SMP were funded by the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement n. [311870]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2003, BEHAVIOUR, V140, P519, DOI 10.1163/156853903322127968; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Boesch C, 2002, HUM NATURE-INT BIOS, V13, P27, DOI 10.1007/s12110-002-1013-6; BOINSKI S, 1987, BEHAV ECOL SOCIOBIOL, V21, P13, DOI 10.1007/BF00324430; Boinski S, 2002, BEHAVIOUR, V139, P227, DOI 10.1163/156853902760102663; Brauer J, 2006, P ROY SOC B-BIOL SCI, V273, P3123, DOI 10.1098/rspb.2006.3693; Brauer J, 2009, AM J PRIMATOL, V71, P175, DOI 10.1002/ajp.20639; Brosnan SF, 2016, BEHAVIOUR, V153, P1267, DOI 10.1163/1568539X-00003355; Brosnan SF, 2014, SCIENCE, V346, P314, DOI 10.1126/science.1251776; Brosnan SF, 2013, P NATL ACAD SCI USA, V110, P10416, DOI 10.1073/pnas.1301194110; Brosnan SF, 2011, FOLIA PRIMATOL, V82, P56, DOI 10.1159/000328142; Brosnan SF, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00043; Brosnan SF, 2010, ANIM BEHAV, V79, P1229, DOI 10.1016/j.anbehav.2010.02.019; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Brosnan SF, 2002, HUM NATURE-INT BIOS, V13, P129, DOI 10.1007/s12110-002-1017-2; Brucks D, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00270; Brucks D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153799; Bshary R, 2008, J EVOLUTION BIOL, V21, P405, DOI 10.1111/j.1420-9101.2007.01482.x; Cassidy KA, 2017, BEHAV PROCESS, V136, P64, DOI 10.1016/j.beproc.2017.01.011; Cassidy KA, 2016, ANIM COGN, V19, P939, DOI 10.1007/s10071-016-0994-1; Cassidy KA, 2015, BEHAV ECOL, V26, P1352, DOI 10.1093/beheco/arv081; Chalmeau R, 1997, INT J PRIMATOL, V18, P23, DOI 10.1023/A:1026337006136; CONNOR RC, 1995, BIOL REV, V70, P427, DOI 10.1111/j.1469-185X.1995.tb01196.x; Connor RC, 2010, PHILOS T R SOC B, V365, P2687, DOI 10.1098/rstb.2010.0150; Coppinger R, 1995, EVOLUTION WORKING DO; Crockford C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2765; Cronin KA, 2008, ANIM BEHAV, V75, P245, DOI 10.1016/j.anbehav.2007.04.032; Dale R, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2339-8; Dale R, 2017, CURR ZOOL, V63, P323, DOI 10.1093/cz/zow111; de Waal F. B. M., 1977, Zeitschrift Tierpsychol, V44, P225; DEWAAL FBM, 1993, AM J PRIMATOL, V29, P73, DOI 10.1002/ajp.1350290108; Dufour V, 2009, BIOL LETTERS, V5, P172, DOI 10.1098/rsbl.2008.0644; Dugatkin L.A., 1997, COOPERATION ANIMALS; Essler JL, 2017, CURR BIOL, V27, P1861, DOI 10.1016/j.cub.2017.05.061; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Gacsi M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-31; Gamer M, 2012, IRR VARIOUS COEFFICI; Gilby IC, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0005; Gilby IC, 2013, BEHAV ECOL SOCIOBIOL, V67, P373, DOI 10.1007/s00265-012-1457-6; Gumert MD, 2008, PRIMATES, V49, P176, DOI 10.1007/s10329-008-0089-y; Gumert MD, 2007, ANIM BEHAV, V74, P1655, DOI 10.1016/j.anbehav.2007.03.009; Hart Benjamin L., 1995, P65; Heaney M, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160461; Heaney M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169799; Heberlein MTE, 2017, J COMP PSYCHOL, V131, P19, DOI 10.1037/com0000050; Horowitz A, 2012, SOC JUSTICE RES, V25, P195, DOI 10.1007/s11211-012-0158-7; IZAWA K, 1980, Primates, V21, P443, DOI 10.1007/BF02373834; Jahn-Eimermacher A, 2011, BEHAV BRAIN RES, V221, P271, DOI 10.1016/j.bbr.2011.03.007; Jakovcevic A, 2010, BEHAV PROCESS, V84, P602, DOI 10.1016/j.beproc.2010.04.003; Jelbert SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133253; Kaburu SSK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20634; Kassambara A, 2018, SURVMINER DRAWING SU; Krasheninnikova A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52780-8; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Langergraber KE, 2017, P NATL ACAD SCI USA, V114, P7337, DOI 10.1073/pnas.1701582114; LEHMAN N, 1992, BEHAV ECOL SOCIOBIOL, V30, P83; Machanda ZP, 2014, ANIM BEHAV, V87, P165, DOI 10.1016/j.anbehav.2013.10.028; MacNulty DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112884; Massen JJM, 2019, NEUROSCI BIOBEHAV R, V107, P370, DOI 10.1016/j.neubiorev.2019.09.027; Massen JJM, 2012, AM J PRIMATOL, V74, P145, DOI 10.1002/ajp.21014; McAuliffe K, 2015, ANIM BEHAV, V103, P65, DOI 10.1016/j.anbehav.2015.02.014; McAuliffe K, 2014, ANIM COGN, V17, P1289, DOI 10.1007/s10071-014-0764-x; McGetrick J, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00413; McGetrick J, 2018, LEARN BEHAV, V46, P479, DOI 10.3758/s13420-018-0338-x; Mech L.D., 2015, WOLVES HUNT BEHAV WO; Mehrkam LR, 2014, APPL ANIM BEHAV SCI, V155, P12, DOI 10.1016/j.applanim.2014.03.005; MITCHELL CL, 1994, BEHAVIOUR, V130, P169, DOI 10.1163/156853994X00514; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Oberliessen L, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00133; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Passalacqua C, 2011, ANIM BEHAV, V82, P1043, DOI 10.1016/j.anbehav.2011.07.039; R Core Team, 2021, R LANGUAGE ENV STAT; Raihani NJ, 2012, ANIM BEHAV, V84, P665, DOI 10.1016/j.anbehav.2012.06.023; Range F, 2009, P NATL ACAD SCI USA, V106, P340, DOI 10.1073/pnas.0810957105; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Romero T, 2019, PHYSIOL BEHAV, V201, P104, DOI 10.1016/j.physbeh.2018.12.023; Samuni L, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1643; Samuni L, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0142-3; Schino G, 2009, ETHOLOGY, V115, P70, DOI 10.1111/j.1439-0310.2008.01581.x; Schino G, 2009, AM J PRIMATOL, V71, P101, DOI 10.1002/ajp.20627; Schwing R, 2016, ANIM COGN, V19, P1093, DOI 10.1007/s10071-016-1017-y; Skinner B. F., 1953, SCI HUMAN BEHAV; Surbeck M, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22641; Therneau T., 2015, PACKAGE SURVIVAL ANA; Therneau T.M., 2000, MODELING SURVIVAL DA; Udell MAR, 2014, ANIM BEHAV, V89, P99, DOI 10.1016/j.anbehav.2013.12.012; Ulber J, 2017, J EXP CHILD PSYCHOL, V155, P48, DOI 10.1016/j.jecp.2016.10.013; van Leeuwen EJC, 2011, BIOL LETTERS, V7, P39, DOI 10.1098/rsbl.2010.0482; Van Noordwijk MA, 2001, BEHAVIOUR, V138, P359, DOI 10.1163/15685390152032505; van Wolkenten M, 2007, P NATL ACAD SCI USA, V104, P18854, DOI 10.1073/pnas.0707182104; Venables WN., 2002, MODERN APPL STAT S, V4; Volter CJ, 2015, ANIM BEHAV, V100, P126, DOI 10.1016/j.anbehav.2014.11.025; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; West Eberhard M.J., 1975, Quarterly Review of Biology, V50, P1; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willis MB, 1995, DOMESTIC DOG ITS EVO, P21; Wilsson E, 1997, APPL ANIM BEHAV SCI, V53, P279, DOI 10.1016/S0168-1591(96)01174-4; Wittig RM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3096; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/	105	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0233067	10.1371/journal.pone.0233067	http://dx.doi.org/10.1371/journal.pone.0233067			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB7DG	32555709	Green Published, gold			2022-12-26	WOS:000542759600015
J	Zawiah, M; Yousef, AM; Khan, AH; AL-Ashwal, FY; Matar, A; ALKhawaldeh, B; Nassar, R; Abduljabbar, R; Ahmed, AAA				Zawiah, Mohammed; Yousef, Al-Motassem; Khan, Amer Hayat; AL-Ashwal, Fahmi Y.; Matar, Amal; ALKhawaldeh, Batool; Nassar, Rand; Abduljabbar, Rami; Ahmed, Abdullah Abdulmajid Abdo			Food-drug interactions: Knowledge among pharmacists in Jordan	PLOS ONE			English	Article							HEALTH-CARE; WARFARIN; THERAPY; INHIBITOR; CAFFEINE	Background Pharmacists have crucial role in providing drug information and medication counseling to patients. This survey aimed to benchmark the current knowledge of the pharmacists concerning food-drug interactions (FDIs) in Jordan. Methods A cross-sectional study was conducted in Amman, the capital and largest city of Jordan, using a validated questionnaire. It was distributed to pharmacists working in community and hospital pharmacies using a convenience sampling technique. Descriptive and inferential statistics were performed in this study. Results A total of 340 questionnaires distributed, 300 (88%) pharmacists responded. Over 50% of pharmacists claimed that they have sufficient knowledge regarding FDI. Virtually, the overall median (interquartile range) knowledge score was 18 (15-21), approximately 60%. The highest knowledge scores were for alcohol-drug interactions section (66.6%) followed by both common food-drug interactions and the timing of drug intake to food consumption sections with a score of (58.3%) for each, reflecting a suboptimal knowledge of FDIs among the pharmacists. Conclusion Pharmacists had unsatisfactory knowledge about common FDIs, with no significant difference between hospital and community pharmacists. Therefore, more attention and efforts should be played to improve awareness about potential food-drug interactions.	[Zawiah, Mohammed; Khan, Amer Hayat; AL-Ashwal, Fahmi Y.] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia; [Yousef, Al-Motassem; Matar, Amal; ALKhawaldeh, Batool; Nassar, Rand] Univ Jordan, Sch Pharm, Dept Biopharmaceut & Clin Pharm, Amman, Jordan; [Abduljabbar, Rami] Yemeni Univ Sci & Technol, Coll Pharm, Taizz, Yemen; [Ahmed, Abdullah Abdulmajid Abdo] Int Islamic Univ, Dept Pharm Practice, Kulliyyah Pharm, Gombak, Malaysia	Universiti Sains Malaysia; University of Jordan	Yousef, AM (corresponding author), Univ Jordan, Sch Pharm, Dept Biopharmaceut & Clin Pharm, Amman, Jordan.	ayousef@ju.edu.jo	Zawiah, Mohammed/AAE-7309-2020; Khan, Amer Hayat/O-5310-2018; Al-Ashwal, Fahmi/AAX-5385-2021; Yousef, Al-Motassem/F-1781-2015	Zawiah, Mohammed/0000-0002-3325-1442; Khan, Amer Hayat/0000-0003-4802-6181; Al-Ashwal, Fahmi/0000-0003-2076-0771; Yousef, Al-Motassem/0000-0002-3841-4132	Institute of post graduate studies of Universiti Sains Malaysia	Institute of post graduate studies of Universiti Sains Malaysia	We would like to thank Institute of post graduate studies of Universiti Sains Malaysia for providing fellowship during the course of doctoral studies of Mr. Mohammed Hussein.	Abbasinazari M, 2011, IRAN J PHARM RES, V10, P173; Abdollahi M, 2018, EVID BASED CARE, V8, P27; Agosti S, 2012, AM J EMERG MED, V30, DOI 10.1016/j.ajem.2010.08.031; [Anonymous], 2009, MED LETT DRUGS THER, V51, P65; Ansari Ja, 2010, J Young Pharm, V2, P326, DOI 10.4103/0975-1483.66807; Bailey DG, 2013, CAN MED ASSOC J, V185, P309, DOI 10.1503/cmaj.120951; Benni JM, 2012, INT J PHARM CLIN SCI, V1, P97; Bonner L, 2017, PHARM TODAY, V23, P18; BRUCE M, 1992, ARCH GEN PSYCHIAT, V49, P867; Cooper M, 2004, PSYCHOL REP, V95, P183, DOI 10.2466/PR0.95.5.183-191; Couris RR, 2000, J AM COLL NUTR, V19, P439, DOI 10.1080/07315724.2000.10718944; Deng JY, 2017, DRUGS, V77, P1833, DOI 10.1007/s40265-017-0832-z; Dixit A, 2019, ANN CARD ANAESTH, V22, P162, DOI 10.4103/aca.ACA_65_18; El Lassy RBM, EFFECT FOOD DRUG INT; Enwerem NM, 2015, INT J NURS STUD, V2, P1; Enwerem NM, 2017, INT J HIGHER ED, V6, P122; Flisch R., 2009, AGRARFORSCHUNG, V16, P1; de Carvalho REFL, 2013, ACTA PAUL ENFERM, V26, P150, DOI 10.1590/S0103-21002013000200008; Genser D, 2008, ANN NUTR METAB, V52, P29, DOI 10.1159/000115345; Hourani HA, 2011, FOOD NUTR PROFILE JO; Johnson Bankole A, 2014, Handb Clin Neurol, V125, P543, DOI 10.1016/B978-0-444-62619-6.00031-8; Joint Commission on Accreditation of Health Care Organizations (PF1.5), 1986, JCAH PERSP, P1994; Kinoshita Y, 2018, J NEUROGASTROENTEROL, V24, P182, DOI 10.5056/jnm18001; Lenz TL, 2013, AM J LIFESTYLE MED, V7, P250, DOI 10.1177/1559827613483956; LEWIS CW, 1995, J AM DIET ASSOC, V95, P309, DOI 10.1016/S0002-8223(95)00079-8; Macedo R, 2013, PROCEEDINGS OF 2013 INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND SYSTEMS MANAGEMENT (IEEE-IESM 2013), P19; Mallhi TH, 2015, TROP J PHARM RES, V14, P1927, DOI 10.4314/tjpr.v14i10.27; Mazokopakis EE, 2008, INTERN MED J, V38, P364, DOI 10.1111/j.1445-5994.2007.01550.x; Moore Alison A, 2007, Am J Geriatr Pharmacother, V5, P64, DOI 10.1016/j.amjopharm.2007.03.006; Nazer LH, 2017, CAN J HOSP PHARM, V70, P150; Nelson ML, 2011, ANN NY ACAD SCI, V1241, P17, DOI 10.1111/j.1749-6632.2011.06354.x; Neves S. J. F., 2016, Journal of Chemical and Pharmaceutical Research, V8, P965; Ngo ASY, 2010, J MED TOXICOL, V6, P431, DOI 10.1007/s13181-010-0101-y; Nutescu EA, 2006, EXPERT OPIN DRUG SAF, V5, P433, DOI 10.1517/14740338.5.3.433; Quadra GR, 2020, ENVIRON POLLUT, V256, DOI 10.1016/j.envpol.2019.113343; Radwan A, 2018, INT J CLIN PHARM-NET, V40, P668, DOI 10.1007/s11096-018-0640-x; Roberts GW., 2004, AUST PRESCR, V27, P75, DOI [10.18773/austprescr.2004.061, DOI 10.18773/AUSTPRESCR.2004.061]; Roth JA, 2015, PHARMACOEPIDEM DR S, V24, P619, DOI 10.1002/pds.3769; Schmidt LE, 2002, DRUGS, V62, P1481, DOI 10.2165/00003495-200262100-00005; Sorensen JM, 2002, J ALTERN COMPLEM MED, V8, P293, DOI 10.1089/10755530260127989; Stargrove M.B, 2008, HERB DRUG INTERACTIO, P487; Teodoro AJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3765986; Trailokya Abhijit, 2017, J Assoc Physicians India, V65, P100; Virmani Tuhin, 2016, J Clin Mov Disord, V3, P8, DOI 10.1186/s40734-016-0036-9; Wenzler E, 2018, DRUG INTERACTIONS IN, P87; Won CS, 2012, PHARMACOL THERAPEUT, V136, P186, DOI 10.1016/j.pharmthera.2012.08.001	46	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234779	10.1371/journal.pone.0234779	http://dx.doi.org/10.1371/journal.pone.0234779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555684	Green Published, gold			2022-12-26	WOS:000542759600042
J	Eordegh, G; Pertich, A; Tarnok, Z; Nagy, P; Bodosi, B; Giricz, Z; Hegedus, O; Merkl, D; Nyujto, D; Olah, S; Oze, A; Vidomusz, R; Nagy, A				Eordegh, Gabriella; Pertich, Akos; Tarnok, Zsanett; Nagy, Peter; Bodosi, Balazs; Giricz, Zsofia; Hegedus, Orsolya; Merkl, Dora; Nyujto, Diana; Olah, Szabina; Oze, Attila; Vidomusz, Reka; Nagy, Attila			Impairment of visually guided associative learning in children with Tourette syndrome	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; 35 YEAR PERSPECTIVE; BASAL GANGLIA; EXECUTIVE FUNCTION; HYPERACTIVITY DISORDER; ACQUIRED EQUIVALENCE; MEMORY-SYSTEMS; PREVALENCE; ADHD; ABNORMALITIES	The major symptoms of Tourette syndrome are motor and vocal tics, but Tourette syndrome is occasionally associated with cognitive alterations as well. Although Tourette syndrome does not affect the majority of cognitive functions, some of them improve. There is scarce evidence on the impairment of learning functions in patients with Tourette syndrome. The core symptoms of Tourette syndrome are related to dysfunction of the basal ganglia and the frontostriatal loops. Acquired equivalence learning is a kind of associative learning that is related to the basal ganglia and the hippocampi. The modified Rutgers Acquired Equivalence Test was used in the present study to observe the associative learning function of patients with Tourette syndrome. The cognitive learning task can be divided into two main phases: the acquisition and test phases. The latter is further divided into two parts: retrieval and generalization. The acquisition phase of the associative learning test, which mainly depends on the function of the basal ganglia, was affected in the entire patient group, which included patients with Tourette syndrome with attention deficit hyperactivity disorder, obsessive compulsive disorder, autism spectrum disorder, or no comorbidities. Patients with Tourette syndrome performed worse in building associations. However, the retrieval and generalization parts of the test phase, which primarily depend on the function of the hippocampus, were not worsened by Tourette syndrome.	[Eordegh, Gabriella] Univ Szeged, Fac Hlth Sci & Social Studies, Szeged, Hungary; [Pertich, Akos; Bodosi, Balazs; Giricz, Zsofia; Nyujto, Diana; Oze, Attila; Nagy, Attila] Univ Szeged, Fac Med, Dept Physiol, Szeged, Hungary; [Tarnok, Zsanett; Nagy, Peter; Hegedus, Orsolya; Merkl, Dora; Olah, Szabina; Vidomusz, Reka] Vadaskert Child & Adolescent Psychiat, Budapest, Hungary	Szeged University; Szeged University	Nagy, A (corresponding author), Univ Szeged, Fac Med, Dept Physiol, Szeged, Hungary.	nagy.attila.1@med.u-szeged.hu		Nagy, Peter/0000-0002-0256-3304	Faculty Research Fund, Albert Szent-Gyorgyi Grant, Faculty of Medicine, University of Szeged; University of Szeged Open Access Fund [4780]; SZTEA OK-KKA grant [2019/270-62-2]	Faculty Research Fund, Albert Szent-Gyorgyi Grant, Faculty of Medicine, University of Szeged; University of Szeged Open Access Fund; SZTEA OK-KKA grant	AN) Faculty Research Fund, Albert Szent-Gyorgyi Grant, Faculty of Medicine, University of Szeged. SZTEA OK-KKA grant No: 2019/270-62-2. http://www.med.u-szeged.hu/karunkrol/kari-palyazatok/aok-kari-kutatasi-alap-181005 The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Emese Bognar, Kristof Kollar, Andras Puszta, Xenia Katona, Nora Cserhati, Nandor Gorog and Dora Dozsai for their help in conducting the investigation and data collection and all the participants for engaging in the research. The open access publication was founded by the University of Szeged Open Access Fund, Grant number: 4780.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; [Anonymous], 1918, AM J OPHTHALMOL, V1, P457, DOI DOI 10.1016/S0002-9394(18)90663-X; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; Barkley RA, 1997, J DEV BEHAV PEDIATR, V18, P271; Battle DE, 2013, CODAS, V25, P191; Bodi N, 2009, COGN BEHAV NEUROL, V22, P89, DOI 10.1097/WNN.0b013e318192ccf0; Brand N, 2002, J PEDIATR PSYCHOL, V27, P203, DOI 10.1093/jpepsy/27.2.203; Burd Larry, 2005, BMC Pediatr, V5, P34, DOI 10.1186/1471-2431-5-34; Channon S, 2003, NEUROPSYCHOLOGY, V17, P247, DOI 10.1037/0894-4105.17.2.247; Crawford S, 2005, J CHILD PSYCHOL PSYC, V46, P1327, DOI 10.1111/j.1469-7610.2005.01419.x; Da Cunha C, 2015, NEUROSCI BIOBEHAV R, V58, P186, DOI 10.1016/j.neubiorev.2015.02.003; Denckla MB, 2006, J CHILD NEUROL, V21, P701, DOI 10.1177/08830738060210080701; DUBE WV, 1989, J EXP ANAL BEHAV, V51, P65, DOI 10.1901/jeab.1989.51-65; Eddy CM, 2017, J ATTEN DISORD, V21, P824, DOI 10.1177/1087054714545536; Eddy CM, 2012, PSYCHIAT RES, V200, P46, DOI 10.1016/j.psychres.2012.05.023; Goodman J, 2014, J CHILD PSYCHOL PSYC, V55, P582, DOI 10.1111/jcpp.12169; Groenewegen HJ, 2003, BRAIN DEV-JPN, V25, pS3, DOI 10.1016/S0387-7604(03)90001-5; Harris E L, 1995, J Int Neuropsychol Soc, V1, P511; Hirschtritt ME, 2015, JAMA PSYCHIAT, V72, P325, DOI 10.1001/jamapsychiatry.2014.2650; Jeter CB, 2015, J CHILD PSYCHOL PSYC, V56, P193, DOI 10.1111/jcpp.12298; Keri S, 2005, SCHIZOPHR RES, V77, P321, DOI 10.1016/j.schres.2005.03.024; Keri S, 2002, NEUROPSYCHOLOGIA, V40, P1356, DOI 10.1016/S0028-3932(01)00210-X; Kim S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40133-4; Lange F, 2017, DEV COGN NEUROS-NETH, V27, P78, DOI 10.1016/j.dcn.2017.08.008; Leckman JF, 1997, J CHILD PSYCHOL PSYC, V38, P119, DOI 10.1111/j.1469-7610.1997.tb01508.x; Mahone EM, 2001, J INT NEUROPSYCH SOC, V7, P102, DOI 10.1017/S1355617701711101; Makki MI, 2008, MOVEMENT DISORD, V23, P2349, DOI 10.1002/mds.22264; Makki MI, 2009, J CHILD NEUROL, V24, P669, DOI 10.1177/0883073808327838; Marsh R, 2004, ARCH GEN PSYCHIAT, V61, P1259, DOI 10.1001/archpsyc.61.12.1259; Marsh R, 2009, AM J PSYCHIAT, V166, P664, DOI 10.1176/appi.ajp.2009.08091354; MARTIN AW, 1954, J CONSULT PSYCHOL, V18, P143; Mink JW, 2001, PEDIATR NEUROL, V25, P190, DOI 10.1016/S0887-8994(01)00262-4; Moustafa AA, 2009, BRAIN RES, V1276, P180, DOI 10.1016/j.brainres.2009.04.020; Muller-Vahl KR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-47; Myers CE, 2008, NEUROPSYCHOLOGY, V22, P681, DOI 10.1037/0894-4105.22.5.681; Myers CE, 2003, J COGNITIVE NEUROSCI, V15, P185, DOI 10.1162/089892903321208123; Openneer TJC, 2020, CORTEX, V124, P176, DOI 10.1016/j.cortex.2019.11.007; Osmon DC, 2005, BEHAV MODIF, V29, P746, DOI 10.1177/0145445505279380; Oze A, 2017, CEPHALALGIA, V37, P532, DOI 10.1177/0333102416651286; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Palminteri S, 2013, INT REV NEUROBIOL, V112, P131, DOI 10.1016/B978-0-12-411546-0.00005-6; Palminteri S, 2011, BRAIN, V134, P2287, DOI 10.1093/brain/awr147; Pappert EJ, 2003, NEUROLOGY, V61, P936, DOI 10.1212/01.WNL.0000086370.10186.7C; Peterson BS, 2007, ARCH GEN PSYCHIAT, V64, P1281, DOI 10.1001/archpsyc.64.11.1281; Peterson BS, 2003, ARCH GEN PSYCHIAT, V60, P415, DOI 10.1001/archpsyc.60.4.415; Plessen KJ, 2009, J PSYCHOSOM RES, V67, P559, DOI 10.1016/j.jpsychores.2009.07.005; Robertson MM, 2008, J PSYCHOSOM RES, V65, P461, DOI 10.1016/j.jpsychores.2008.03.006; Robertson MM, 2015, LANCET PSYCHIAT, V2, P68, DOI 10.1016/S2215-0366(14)00132-1; Robertson MM, 2015, LANCET PSYCHIAT, V2, P88, DOI 10.1016/S2215-0366(14)00133-3; Rozsa S., 2006, RAVEN PROGRESSZIV MA; Rozsa S., 2006, PSZICHOLOGIAI MERES; Salvador A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06547-8; Scharf JM, 2015, MOVEMENT DISORD, V30, P221, DOI 10.1002/mds.26089; Shephard E, 2019, J NEUROPSYCHOL, V13, P529, DOI 10.1111/jnp.12167; Shephard E, 2016, J NEUROPSYCHOL, V10, P223, DOI 10.1111/jnp.12071; Spencer T, 1998, J CHILD PSYCHOL PSYC, V39, P1037, DOI 10.1017/S0021963098002984; Takacs A, 2018, CORTEX, V100, P84, DOI 10.1016/j.cortex.2017.08.037; Takacs A, 2017, BRAIN COGNITION, V117, P33, DOI 10.1016/j.bandc.2017.06.009; Termine C, 2016, PSYCHIAT RES, V243, P263, DOI 10.1016/j.psychres.2016.06.048; Tremblay L, 2015, MOVEMENT DISORD, V30, P1155, DOI 10.1002/mds.26199; Ullman MT, 2015, NEUROSCI BIOBEHAV R, V51, P205, DOI 10.1016/j.neubiorev.2015.01.008; Yaniv A, 2018, PSYCHIAT RES, V262, P527, DOI 10.1016/j.psychres.2017.09.038	63	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234724	10.1371/journal.pone.0234724	http://dx.doi.org/10.1371/journal.pone.0234724			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB9ZQ	32544176	gold, Green Published, Green Accepted			2022-12-26	WOS:000542957200015
J	Liebing, J; Volker, I; Curland, N; Wohlsein, P; Baumgartner, W; Braune, S; Runge, M; Moss, A; Rautenschlein, S; Jung, A; Ryll, M; Raue, K; Strube, C; Schulz, J; Heffels-Redmann, U; Fischer, L; Gethoffer, F; Voigt, U; Lierz, M; Siebert, U				Liebing, J.; Voelker, I; Curland, N.; Wohlsein, P.; Baumgaertner, W.; Braune, S.; Runge, M.; Moss, A.; Rautenschlein, S.; Jung, A.; Ryll, M.; Raue, K.; Strube, C.; Schulz, J.; Heffels-Redmann, U.; Fischer, L.; Gethoeffer, F.; Voigt, U.; Lierz, M.; Siebert, U.			Health status of free-ranging ring-necked pheasant chicks (Phasianus colchicus) in North-Western Germany	PLOS ONE			English	Article							FARMLAND BIRDS; PERDIX-PERDIX; MYCOPLASMAS; PARASITES; PREVALENCE; MORTALITY; HEPATITIS; EVOLUTION; PREDATION; FIELDS	Being a typical ground-breeding bird of the agricultural landscape in Germany, the pheasant has experienced a strong and persistent population decline with a hitherto unexplained cause. Contributing factors to the ongoing negative trend, such as the effects of pesticides, diseases, predation, increase in traffic and reduced fallow periods, are currently being controversially discussed. In the present study, 62 free-ranging pheasant chicks were caught within a two-year period in three federal states of Germany; Lower Saxony, North Rhine-Westphalia and Schleswig-Holstein. The pheasant chicks were divided into three age groups to detect differences in their development and physical constitution. In addition, pathomorphological, parasitological, virological, bacteriological and toxicological investigations were performed. The younger chicks were emaciated, while the older chicks were of moderate to good nutritional status. However, the latter age group was limited to a maximum of three chicks per hen, while the youngest age class comprised up to ten chicks. The majority of chicks suffered from dermatitis of the periocular and caudal region of the head (57-94%) of unknown origin. In addition, intestinal enteritis (100%), pneumonia (26%), hepatitis (24%), perineuritis (6%), tracheitis (24%), muscle degeneration (1%) and myositis (1%) were found. In 78% of the cases, various Mycoplasma spp. were isolated.Mycoplasma gallisepticum(MG) was not detected using an MG-specific PCR. Parasitic infections included Philopteridae (55%),Coccidia(48%),Heterakis/Ascaridiaspp. (8%) andSyngamus trachea(13%). A total of 8% of the chicks were Avian metapneumovirus (AMPV) positive using RT-PCR, 16% positive for infectious bronchitis virus (IBV) using RT-PCR, and 2% positive for haemorrhagic enteritis virus (HEV) using PCR. All samples tested for avian encephalomyelitis virus (AEV), infectious bursal disease virus (IBDV) or infectious laryngotracheitis virus (ILTV) were negative. The pool samples of the ten chicks were negative for all acid, alkaline-free and derivative substances, while two out of three samples tested were positive for the herbicide glyphosate. Pheasant chick deaths may often have been triggered by poor nutritional status, probably in association with inflammatory changes in various tissues and organs as well as bacterial and parasitic pathogens. Theses impacts may have played a major role in the decline in pheasant populations.	[Liebing, J.; Curland, N.; Gethoeffer, F.; Voigt, U.; Siebert, U.] Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res, Hannover, Germany; [Voelker, I; Wohlsein, P.; Baumgaertner, W.] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Braune, S.; Runge, M.] Food & Vet Inst Braunschweig Hannover, Lower Saxony State Off Consumer Protect & Food Sa, Hannover, Germany; [Moss, A.] Food & Vet Inst Oldenburg, Lower Saxony State Off Consumer Protect & Food Sa, Oldenburg, Germany; [Rautenschlein, S.; Jung, A.; Ryll, M.] Univ Vet Med Hannover, Clin Poultry, Hannover, Germany; [Raue, K.; Strube, C.] Univ Vet Med Hannover, Ctr Infect Med, Inst Parasitol, Hannover, Germany; [Schulz, J.] Univ Vet Med Hannover, Inst Anim Hyg Anim Welf & Farm Anim Behav, Hannover, Germany; [Heffels-Redmann, U.; Fischer, L.; Lierz, M.] Justus Liebig Univ Giessen, Clin Birds Reptiles Amphibians & Fish, Giessen, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Justus Liebig University Giessen	Siebert, U (corresponding author), Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res, Hannover, Germany.	ursula.siebert@tiho-hannover.de	Schulz, Jochen/AAA-7340-2021	Schulz, Jochen/0000-0002-9747-6763; Strube, Christina/0000-0002-9093-1006; Voigt, Ulrich/0000-0002-9505-4612	Lower Saxony Ministry of Food, Agriculture andConsumer Protection; State Agency for Nature, Environment and Consumer Protection of North Rhine-Westphalia; Ministry of Energy, Agriculture, the Environment and Rural Areas of Schleswig-Holstein; hunting association of Lower Saxony; hunting association of North Rhine-Westphalia; hunting association of Schleswig-Holstein	Lower Saxony Ministry of Food, Agriculture andConsumer Protection; State Agency for Nature, Environment and Consumer Protection of North Rhine-Westphalia; Ministry of Energy, Agriculture, the Environment and Rural Areas of Schleswig-Holstein; hunting association of Lower Saxony; hunting association of North Rhine-Westphalia; hunting association of Schleswig-Holstein	Funding was partly provided by Lower Saxony Ministry of Food, Agriculture andConsumer Protection, the State Agency for Nature, Environment and Consumer Protection of North Rhine-Westphalia and the Ministry of Energy, Agriculture, the Environment and Rural Areas of Schleswig-Holstein. No additional external funding was received for this study."; We wish to thank the hunting associations of Lower Saxony, North Rhine-Westphalia and Schleswig-Holstein for supporting the study. Furthermore, special thanks go to the laboratory personnel for their excellent technical assistance in the laboratory investigations.	Aebischer NJ, 1997, PROC BRIGHTON CROP, P915; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2004, CURRENT BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; [Anonymous], 2007, AAPS J, V9, pE336; Birrer S, 2007, J ORNITHOL, V148, pS295, DOI 10.1007/s10336-007-0237-y; Borg C, 2000, J APPL ECOL, V37, P557, DOI 10.1046/j.1365-2664.2000.00510.x; Bradbury JM, 1998, METH MOL B, V104, P45; Choo K, 2003, ECOL LETT, V6, P310, DOI 10.1046/j.1461-0248.2003.00425.x; Contreras M., 2006, Poultry International, V45, P16; Curland N, 2018, EUR J WILDLIFE RES, V64, DOI 10.1007/s10344-018-1173-2; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Elsmo EJ, 2016, J WILDLIFE DIS, V52, P582, DOI 10.7589/2015-05-129; Forrester CA, 2011, AVIAN PATHOL, V40, P581, DOI 10.1080/03079457.2011.618822; Gehle T., 2011, SCHRIFTENREIHE LANDE, V18, P13; Gethoffer F, 2011, WILD JAGD LANDESJAGD, P56; Glutz von Blotzheim U. N., 1973, HDB VOGEL MITTELEURO, V5; Goldova Maria, 2006, Veterinarski Arhiv, V76, pS83; Graber R, 2010, ANAL RUCKGANGS UNPUB; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Hawes C, 2003, PHILOS T ROY SOC B, V358, P1899, DOI 10.1098/rstb.2003.1406; Heard MS, 2003, PHILOS T ROY SOC B, V358, P1819, DOI 10.1098/rstb.2003.1402; Hill D. A., 1998, PHEASANT ECOLOGY MAN; Himmel L, 2014, VET PATHOL, V51, P1171, DOI 10.1177/0300985813519653; Irvine RJ, 2006, ANIM SCI, V82, P775, DOI 10.1017/ASC2006106; Jansson DS, 2008, J ZOO WILDLIFE MED, V39, P428, DOI 10.1638/2007-0176.1; Jha R, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00082; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Kurukulasuriya S, 2017, VACCINE, V35, P882, DOI 10.1016/j.vaccine.2017.01.005; Landwirtschaftskammer Niedersachsen, 2013, EEG STEELT KULT KOPF; LATSHAW JD, 1991, VET IMMUNOL IMMUNOP, V30, P111, DOI 10.1016/0165-2427(91)90012-2; Lierz M, 2007, AVIAN PATHOL, V36, P145, DOI 10.1080/03079450701213347; Mariappan AK, 2018, VET WORLD, V11, P112, DOI 10.14202/vetworld.2018.112-117; Moreby SJ, 1999, AGR ECOSYST ENVIRON, V72, P285, DOI 10.1016/S0167-8809(99)00007-9; Morelli F., 2017, BIRDS ARE USEFUL IND; Murray DL, 2002, J ANIM ECOL, V71, P614, DOI 10.1046/j.1365-2656.2002.00632.x; Newey S, 2005, INT J PARASITOL, V35, P367, DOI 10.1016/j.ijpara.2004.12.003; Ohlsson T, 2001, PHYSIOL BIOCHEM ZOOL, V74, P212, DOI 10.1086/319657; Pain D.J, 1997, FARMING BIRDS EUROPE; Pennycott T, 2001, IN PRACTICE, V23, P132, DOI 10.1136/inpract.23.3.132; Ramirez AS, 2008, VET MICROBIOL, V128, P279, DOI 10.1016/j.vetmic.2007.10.023; Roberto MagalhAes P, 2004, REVIS BRASIL ZOOL, P961, DOI [10.1590/S0101-81752004000400034, DOI 10.1590/S0101-81752004000400034]; Seppala O, 2008, P ROY SOC B-BIOL SCI, V275, P1611, DOI 10.1098/rspb.2008.0152; Siegmann O, 2012, KOMPENDIUM GEFLUGELK; Taha-Abdelaziz K, 2018, VET IMMUNOL IMMUNOP, V201, P1, DOI 10.1016/j.vetimm.2018.05.001; VANKUPPEVELD FJM, 1992, APPL ENVIRON MICROB, V58, P2606, DOI 10.1128/AEM.58.8.2606-2615.1992; Welsch U, 2010, ROMEIS MIKROSKOPISCH; Williams PD, 2001, P ROY SOC B-BIOL SCI, V268, P2331, DOI 10.1098/rspb.2001.1795; Wittmann P, 1891, EDELFASAN PHASIANUS; WOODARD AE, 1977, POULTRY SCI, V56, P1492, DOI 10.3382/ps.0561492; Yohannes T., 2013, Open Journal of Veterinary Medicine, V3, P252, DOI 10.4236/ojvm.2013.35040	50	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234044	10.1371/journal.pone.0234044	http://dx.doi.org/10.1371/journal.pone.0234044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544211	gold, Green Published			2022-12-26	WOS:000542957200016
J	Lawn, RB; Sallis, HM; Wootton, RE; Taylor, AE; Demange, P; Fraser, A; Penton-Voak, IS; Munafo, MR				Lawn, Rebecca B.; Sallis, Hannah M.; Wootton, Robyn E.; Taylor, Amy E.; Demange, Perline; Fraser, Abigail; Penton-Voak, Ian S.; Munafo, Marcus R.			The effects of age at menarche and first sexual intercourse on reproductive and behavioural outcomes: A Mendelian randomization study	PLOS ONE			English	Article							LIFE-HISTORY; MENTAL-HEALTH; ASSOCIATION; CHILDHOOD; DETERMINANTS; INSTRUMENTS; INSIGHTS; PUBERTY; GENES; RISKY	There is substantial variation in the timing of significant reproductive life events such as menarche and first sexual intercourse. Life history theory explains this variation as an adaptive response to an individual's environment and it is important to examine how traits within life history strategies affect each other. Here we applied Mendelian randomization (MR) methods to investigate whether there is a causal effect of variation in age at menarche and age at first sexual intercourse (markers or results of exposure to early life adversity) on outcomes related to reproduction, education and risky behaviour in UK Biobank (N = 114 883-181 255). Our results suggest that earlier age at menarche affects some traits that characterize life history strategies including earlier age at first and last birth, decreased educational attainment, and decreased age at leaving education (for example, we found evidence for a 0.26 year decrease in age at first birth per year decrease in age at menarche, 95% confidence interval: -0.34 to -0.17; p < 0.001). We find no clear evidence of effects of age at menarche on other outcomes, such as risk taking behaviour. Age at first sexual intercourse was also related to many life history outcomes, although there was evidence of horizontal pleiotropy which violates an assumption of MR and we therefore cannot infer causality from this analysis. Taken together, these results highlight how MR can be applied to test predictions of life history theory and to better understand determinants of health and social behaviour.	[Lawn, Rebecca B.; Sallis, Hannah M.; Wootton, Robyn E.; Taylor, Amy E.; Munafo, Marcus R.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Lawn, Rebecca B.; Sallis, Hannah M.; Wootton, Robyn E.; Demange, Perline; Penton-Voak, Ian S.; Munafo, Marcus R.] Univ Bristol, Sch Psychol Sci, Bristol, Avon, England; [Sallis, Hannah M.; Fraser, Abigail] Univ Bristol, Bristol Med Sch, Dept Populat Hlth Sci, Bristol, Avon, England; [Wootton, Robyn E.; Penton-Voak, Ian S.; Munafo, Marcus R.] NIHR Biomed Res Ctr Univ Hosp Bristol NHS Fdn Tru, Bristol, Avon, England; [Wootton, Robyn E.; Penton-Voak, Ian S.; Munafo, Marcus R.] Univ Bristol, Bristol, Avon, England; [Demange, Perline] Ecole Normale Super, Dept Etud Cognit, Paris, France	University of Bristol; University of Bristol; University of Bristol; University of Bristol; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Lawn, RB (corresponding author), Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England.; Lawn, RB (corresponding author), Univ Bristol, Sch Psychol Sci, Bristol, Avon, England.	rebecca.lawn@bristol.ac.uk	Wootton, Robyn/DPZ-8634-2022; Munafo, Marcus/AAE-2306-2020	Munafo, Marcus/0000-0002-4049-993X; Penton-Voak, Ian/0000-0003-4232-0953; Sallis, Hannah/0000-0002-4793-6290; Demange, Perline/0000-0002-7061-8354; Fraser, Abigail/0000-0002-7741-9470; Lawn, Rebecca/0000-0002-4353-4155	Medical Research Council [MC_UU_00011/7]; University of Bristol [MC_UU_00011/7]; UK Medical Research Council [MR/M009351/1]; NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust; University of Bristol; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research, under UK Clinical Research Collaboration; MRC [MC_UU_00011/7, MR/M009351/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust; University of Bristol; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research, under UK Clinical Research Collaboration(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RL, AF, REW, HMS, AET, and MRM work in the Medical Research Council Integrative Epidemiology Unit at the University of Bristol, which is supported by the Medical Research Council and the University of Bristol and funds RL's PhD studentship (grant number: MC_UU_00011/7). AF is supported by Career Development Awards from the UK Medical Research Council (MR/M009351/1). MRM is a member of the UK Centre for Tobacco and Alcohol Studies, a UKCRC Public Health Research: Centre of Excellence. This study was supported by the NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. Funding from British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This research has been conducted using the UK Biobank Resource under Application number 6326. The authors would like to thank Dr Jack Bowden and Mr Wes Spiller for their technical assistance and Dr Ian Stephen for his helpful comments. The authors also thank Dr Ruth Mitchell, Dr Gibran Hemani, Mr Tom Dudding and Dr Lavinia Paternoster for conducting the quality control filtering of UK Biobank data.	Allen NE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008601; Anderson K, 2010, AUST NZ J OBSTET GYN, V50, P8, DOI 10.1111/j.1479-828X.2009.01119.x; [Anonymous], 2018, BMJ, V362, pk3210; [Anonymous], 2018, TOXICOL ANAL CLIN, V30, P1; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; Bowden J, 2018, INT J EPIDEMIOL, V47, P1264, DOI [10.1093/ije/dyy265, 10.1093/ije/dyy101]; Bowden J, 2019, RES SYNTH METHODS, V10, P486, DOI 10.1002/jrsm.1346; Bowden J, 2017, STAT MED, V36, P1783, DOI 10.1002/sim.7221; Bowden J, 2016, INT J EPIDEMIOL, V45, P1961, DOI 10.1093/ije/dyw220; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Burgess S, 2016, GENET EPIDEMIOL, V40, P597, DOI 10.1002/gepi.21998; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Burgess S, 2013, INT J EPIDEMIOL, V42, P1134, DOI 10.1093/ije/dyt093; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Dalvie S, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0706-0; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Day FR, 2017, NAT GENET, V49, P834, DOI 10.1038/ng.3841; Day FR, 2016, NAT GENET, V48, P617, DOI 10.1038/ng.3551; Eggert J, 2004, FERTIL STERIL, V81, P379, DOI 10.1016/j.fertnstert.2003.06.018; Ellis BJ, 2004, PSYCHOL BULL, V130, P920, DOI 10.1037/0033-2909.130.6.920; Ellis BJ, 2012, DEV PSYCHOL, V48, P591, DOI 10.1037/a0027651; Figueredo AJ, 2005, PERS INDIV DIFFER, V39, P1349, DOI 10.1016/j.paid.2005.06.009; Forman MR, 2013, ADOLESC HEALTH MED T, V4, P1, DOI 10.2147/AHMT.S15946; Gage S. H., 2016, PSYCHOL MED, V47, P1; Gill D, 2017, BEHAV GENET, V47, P480, DOI 10.1007/s10519-017-9862-2; Gill D, 2018, INT J OBESITY, V42, P1574, DOI 10.1038/s41366-018-0048-7; Hartwig FP, 2017, INT J EPIDEMIOL, V46, P1985, DOI 10.1093/ije/dyx102; Hawes ZC, 2010, J SEX RES, V47, P137, DOI 10.1080/00224490903509399; Haworth S, 2018, COMMON GENETIC VARIA; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; James J, 2012, DEV PSYCHOL, V48, P687, DOI 10.1037/a0026427; Ketelaar T, 2000, PSYCHOL INQ, V11, P1, DOI 10.1207/S15327965PLI1101_01; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lawlor DA, 2016, INT J EPIDEMIOL, V45, P1866, DOI 10.1093/ije/dyw314; Lawlor DA, 2016, INT J EPIDEMIOL, V45, P908, DOI 10.1093/ije/dyw127; Lenciauskiene I, 2008, SCAND J PUBLIC HEALT, V36, P607, DOI 10.1177/1403494807088460; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Magnus MC, 2018, J EPIDEMIOL COMMUN H, V72, P34, DOI 10.1136/jech-2017-209488; Mitchell R, 2017, UK BIOBANK GENETIC D; Munafo MR, 2018, INT J EPIDEMIOL, V47, P226, DOI 10.1093/ije/dyx206; Nettle D, 2006, P ROY SOC B-BIOL SCI, V273, P611, DOI 10.1098/rspb.2005.3349; Nettle D, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0040; Nettle D, 2012, DEV PSYCHOL, V48, P718, DOI 10.1037/a0027507; Nettle D, 2011, P ROY SOC B-BIOL SCI, V278, P1721, DOI 10.1098/rspb.2010.1726; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Richardson GB, 2018, EVOL HUM BEHAV, V39, P437, DOI 10.1016/j.evolhumbehav.2018.03.009; Schulz KM, 2016, NEUROSCI BIOBEHAV R, V70, P148, DOI 10.1016/j.neubiorev.2016.07.036; Sequeira ME, 2017, BRIT J PSYCHIAT, V210, P39, DOI 10.1192/bjp.bp.115.168617; Simpson JA, 2012, DEV PSYCHOL, V48, P674, DOI 10.1037/a0027293; Smith GD, 2006, J EPIDEMIOL COMMUN H, V60, P382, DOI 10.1136/jech.2004.031880; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Sng O, 2017, J PERS SOC PSYCHOL, V112, P736, DOI 10.1037/pspi0000086; US Foodlink, 2016, US FOODLINK, V12, P1, DOI DOI 10.1016/j.jalz.2016.03.001; Wain LV, 2015, LANCET RESP MED, V3, P769, DOI 10.1016/S2213-2600(15)00283-0; Waldron M, 2015, J ADOLESCENT HEALTH, V56, P550, DOI 10.1016/j.jadohealth.2015.01.011; Warrington NM, 2018, INT J EPIDEMIOL, V47, P1229, DOI 10.1093/ije/dyy015; 2016, BMJ, V352	60	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234488	10.1371/journal.pone.0234488	http://dx.doi.org/10.1371/journal.pone.0234488			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB6AZ	32542040	Green Published, gold, Green Submitted			2022-12-26	WOS:000542685100044
J	Otani, K; Higa, Y; Kitano, T; Nabeshima, Y; Takeuchi, M				Otani, Kyoko; Higa, Yukie; Kitano, Tetsuji; Nabeshima, Yosuke; Takeuchi, Masaaki			Prediction of cardiac events using fully automated GLS and BNP titers in patients with known or suspected heart failure	PLOS ONE			English	Article							GLOBAL LONGITUDINAL STRAIN; VENTRICULAR EJECTION FRACTION; IMPAIRED SYSTOLIC FUNCTION; ALL-CAUSE MORTALITY; NATRIURETIC PEPTIDE; ECHOCARDIOGRAPHY; PERFORMANCE; TRACKING; OUTCOMES; DEATH	Background Although global longitudinal strain (GLS) measurements provide useful predictive information, measurement variability is still a major concern. We sought to determine whether fully automated GLS measurements could predict future cardiac events in patients with known or suspected heart failure (HF). Methods GLS was measured using fully automated 2D speckle tracking analysis software (AutoStrain, TomTec) in 3,150 subjects who had undergone clinically indicated brain natriuretic peptide (BNP) assays and echocardiographic examinations. Among 1,514 patients in the derivation cohort, optimal cut-off values of BNP and GLS for cardiac death (CD) and major adverse cardiovascular events (MACEs) were determined using survival classification and regression tree (CART) analysis. The remaining 1,636 patients, comprising the validation cohort, were stratified into subgroups according to predefined cut-off values, and survival curves were compared. Results Survival CART analysis selected GLS with cut-off values of 6.2% and 14.0% for predicting CD. GLS of 6.9% and 13.9% and BNP of 83.2 pg/mL and 206.3 pg/mL were selected for predicting MACEs. For simplicity, we defined GLS of 7% and 14% and BNP of 100 pg/mL and 200 pg/mL as cut-off values. These cut-off values stratify high-risk patients in the validation cohort with known or suspected HF for both CD and MACEs. Conclusions In addition to BNP, fully automated GLS measurements provide prognostic information for patients with known or suspected HF, and this approach facilitates clinical work flow.	[Otani, Kyoko; Higa, Yukie; Takeuchi, Masaaki] Hosp Univ Occupat & Environm Hlth, Sch Med, Dept Lab & Transfus Med, Kitakyushu, Fukuoka, Japan; [Kitano, Tetsuji; Nabeshima, Yosuke] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Otani, K (corresponding author), Hosp Univ Occupat & Environm Hlth, Sch Med, Dept Lab & Transfus Med, Kitakyushu, Fukuoka, Japan.	kyoko-o@med.uoeh-u.ac.jp	Kitano, Tetsuji/AAR-7390-2021	Takeuchi, Masaaki/0000-0001-7606-1537	Charitable Trust Laboratory Medicine Research Foundation of Japan; TomTec	Charitable Trust Laboratory Medicine Research Foundation of Japan; TomTec	KO received a Grant-in-Aid from Charitable Trust Laboratory Medicine Research Foundation of Japan. MT received an equipment grant from TomTec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe TB, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0680-5; [Anonymous], 2013, J AM SOC ECHOCARDIOG, V26, pA21; Buggey J, 2017, ESC HEART FAIL, V4, P432, DOI 10.1002/ehf2.12159; Cho GY, 2009, J AM COLL CARDIOL, V54, P618, DOI 10.1016/j.jacc.2009.04.061; Curtis JP, 2003, J AM COLL CARDIOL, V42, P736, DOI 10.1016/S0735-1097(03)00789-7; Dorosz JL, 2012, J AM COLL CARDIOL, V59, P1799, DOI 10.1016/j.jacc.2012.01.037; Ersboll M, 2013, J AM COLL CARDIOL, V61, P2365, DOI 10.1016/j.jacc.2013.02.061; Gerber Y, 2015, JAMA INTERN MED, V175, P996, DOI 10.1001/jamainternmed.2015.0924; Giolo SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037392; Huang WT, 2017, AM J CARDIOL, V119, P2017, DOI 10.1016/j.amjcard.2017.03.032; Kasahara S, 2018, HEART VESSELS, V33, P997, DOI 10.1007/s00380-018-1150-4; Kim M, 2018, J AM COLL CARDIOL, V71, P1399, DOI 10.1016/S0735-1097(18)31940-5; Knackstedt C, 2015, J AM COLL CARDIOL, V66, P1456, DOI 10.1016/j.jacc.2015.07.052; Kraigher-Krainer E, 2014, J AM COLL CARDIOL, V63, P447, DOI 10.1016/j.jacc.2013.09.052; Logeart D, 2004, J AM COLL CARDIOL, V43, P635, DOI 10.1016/j.jacc.2003.09.044; Medvedofsky D, 2017, ECHOCARDIOGR-J CARD, V34, P365, DOI 10.1111/echo.13446; Morris DA, 2012, CIRC-HEART FAIL, V5, P610, DOI 10.1161/CIRCHEARTFAILURE.112.966564; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268; Salem K, 2017, ESC HEART FAIL, V4, P259, DOI 10.1002/ehf2.12156; Sengelov M, 2015, JACC-CARDIOVASC IMAG, V8, P1351, DOI 10.1016/j.jcmg.2015.07.013; Shah AM, 2015, CIRCULATION, V132, P402, DOI 10.1161/CIRCULATIONAHA.115.015884; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; The Lancet Haematology, 2018, LANCET HAEMATOL, V5, pe127; Tsuchida K, 2008, J CARDIOL, V52, P212, DOI 10.1016/j.jjcc.2008.07.007; van Veldhuisen DJ, 2013, J AM COLL CARDIOL, V61, P1498, DOI 10.1016/j.jacc.2012.12.044	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234294	10.1371/journal.pone.0234294	http://dx.doi.org/10.1371/journal.pone.0234294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542005	Green Published, gold			2022-12-26	WOS:000542685100010
J	Majidian, S; Kahaei, MH; de Ridder, D				Majidian, Sina; Kahaei, Mohammad Hossein; de Ridder, Dick			Minimum error correction-based haplotype assembly: Considerations for long read data	PLOS ONE			English	Article							GENOME SEQUENCE; SNP FRAGMENTS; ALGORITHMS	The single nucleotide polymorphism (SNP) is the most widely studied type of genetic variation. A haplotype is defined as the sequence of alleles at SNP sites on each haploid chromosome. Haplotype information is essential in unravelling the genome-phenotype association. Haplotype assembly is a well-known approach for reconstructing haplotypes, exploiting reads generated by DNA sequencing devices. The Minimum Error Correction (MEC) metric is often used for reconstruction of haplotypes from reads. However, problems with the MEC metric have been reported. Here, we investigate the MEC approach to demonstrate that it may result in incorrectly reconstructed haplotypes for devices that produce error-prone long reads. Specifically, we evaluate this approach for devices developed by Illumina, Pacific BioSciences and Oxford Nanopore Technologies. We show that imprecise haplotypes may be reconstructed with a lower MEC than that of the exact haplotype. The performance of MEC is explored for different coverage levels and error rates of data. Our simulation results reveal that in order to avoid incorrect MEC-based haplotypes, a coverage of 25 is needed for reads generated by Pacific BioSciences RS systems.	[Majidian, Sina; Kahaei, Mohammad Hossein] Iran Univ Sci & Technol, Sch Elect Engn, Tehran, Iran; [de Ridder, Dick] Wageningen Univ, Bioinformat Grp, Wageningen, Netherlands	Iran University Science & Technology; Wageningen University & Research	Kahaei, MH (corresponding author), Iran Univ Sci & Technol, Sch Elect Engn, Tehran, Iran.	kahaei@iust.ac.ir	Kahaei, Mohammad Hossein/T-3022-2018; Majidian, Sina/AAF-2257-2019	Majidian, Sina/0000-0001-5345-6982				Bansal V, 2008, BIOINFORMATICS, V24, pI153, DOI 10.1093/bioinformatics/btn298; Bansal V, 2008, GENOME RES, V18, P1336, DOI 10.1101/gr.077065.108; Berger E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003502; Bonizzoni P, 2016, J COMPUT BIOL, V23, P718, DOI 10.1089/cmb.2015.0220; Chen ZZ, 2013, BIOINFORMATICS, V29, P1938, DOI 10.1093/bioinformatics/btt349; Das S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1408-5; Deng F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S2-S2; Duitama J, 2012, NUCLEIC ACIDS RES, V40, P2041, DOI 10.1093/nar/gkr1042; Edge P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12493-y; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; He D, 2010, BIOINFORMATICS, V26, pi183, DOI 10.1093/bioinformatics/btq215; Hesseling PB, 2012, PEDIATR HEMAT ONCOL, V29, P119, DOI 10.3109/08880018.2011.644881; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Kreyszig E, 1989, INTRO FUNCTIONAL ANA, V1; Kuleshov V, 2014, BIOINFORMATICS, V30, pI379, DOI 10.1093/bioinformatics/btu484; Lancia G., 2001, Algorithms - ESA 2001. 9th Annual European Symposium. Proceedings (Lecture Notes in Computer Science Vol.2161), P182; LANDER E S, 1988, Genomics, V2, P231; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Majidian S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214455; Motazedi E, 2018, BIOINFORMATICS, V34, P3864, DOI 10.1093/bioinformatics/bty442; Motazedi E, 2018, BRIEF BIOINFORM, V19, P387, DOI 10.1093/bib/bbw126; Porubsky D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01389-4; Schneider VA, 2017, GENOME RES, V27, P849, DOI 10.1101/gr.213611.116; Schwartz R, 2010, COMMUN INF SYST, V10, P23; Shendure J, 2017, NATURE, V550, P345, DOI 10.1038/nature24286; Si H, 2017, IEEE T INFORM THEORY, V63, P3468, DOI 10.1109/TIT.2017.2686884; Snyder MW, 2015, NAT REV GENET, V16, P344, DOI 10.1038/nrg3903; Tyler AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29334-5; Wang RS, 2005, BIOINFORMATICS, V21, P2456, DOI 10.1093/bioinformatics/bti352; Zhang XS, 2006, EVOL BIOINFORM, V2, P261	34	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234470	10.1371/journal.pone.0234470	http://dx.doi.org/10.1371/journal.pone.0234470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530974	Green Published, Green Submitted, gold			2022-12-26	WOS:000542037200008
J	Fritz, SE; Ranganathan, S; Wang, CRD; Hogg, JR				Fritz, Sarah E.; Ranganathan, Soumya; Wang, Clara D.; Hogg, J. Robert			The RNA-binding protein PTBP1 promotes ATPase-dependent dissociation of the RNA helicase UPF1 to protect transcripts from nonsense-mediated mRNA decay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nonsense-mediated mRNA decay; UPF1; RNA helicase; ATPase; polypyrimidine tract-binding protein 1 (PTBP1); hnRNP L; poly(A)-binding protein; kinetic proofreading; 3 '-untranslated region; transcriptomics; RNA metabolism; RNA degradation; RNA turnover; RNA-protein interaction	EXON JUNCTION COMPLEX; HNRNP L; BIOCHEMICAL-CHARACTERIZATION; TRANSLATION TERMINATION; REPRESSION; TARGET; LENGTH; GENE; DNA	The sequence-specific RNA-binding proteins PTBP1 (polypyrimidine tract-binding protein 1) and HNRNP L (heterogeneous nuclear ribonucleoprotein L) protect mRNAs from nonsense-mediated decay (NMD) by preventing the UPF1 RNA helicase from associating with potential decay targets. Here, by analyzingin vitrohelicase activity, dissociation of UPF1 from purified mRNPs, and transcriptome-wide UPF1 RNA binding, we present the mechanistic basis for inhibition of NMD by PTBP1. Unlike mechanisms of RNA stabilization that depend on direct competition for binding sites among protective RNA-binding proteins and decay factors, PTBP1 promotes displacement of UPF1 already bound to potential substrates. Our results show that PTBP1 directly exploits the tendency of UPF1 to release RNA upon ATP binding and hydrolysis. We further find that UPF1 sensitivity to PTBP1 is coordinated by a regulatory loop in domain 1B of UPF1. We propose that the UPF1 regulatory loop and protective proteins control kinetic proofreading of potential NMD substrates, presenting a new model for RNA helicase regulation and target selection in the NMD pathway.	[Fritz, Sarah E.; Ranganathan, Soumya; Wang, Clara D.; Hogg, J. Robert] NHLBI, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hogg, JR (corresponding author), NHLBI, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	j.hogg@nih.gov	Hogg, J. Robert/AAE-6539-2021; Fritz, Sarah/AAR-9924-2021; Hogg, J. Robert/O-2327-2018	Fritz, Sarah/0000-0001-6318-4319; Ranganathan, Soumya/0000-0002-5655-223X; Hogg, J. Robert/0000-0001-5729-5135	Intramural Research Program of the NHLBI, National Institutes of Health	Intramural Research Program of the NHLBI, National Institutes of Health	This work was supported by the Intramural Research Program of the NHLBI, National Institutes of Health and utilized the computational resources of the National Institutes of Health High-Performance Computing Biowulf cluster. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amir-Ahmady B, 2005, RNA, V11, P699, DOI 10.1261/rna.2250405; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Baker SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173980; Bedale WA, 1996, J BIOL CHEM, V271, P5725, DOI 10.1074/jbc.271.10.5725; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; Bhattacharya A, 2000, RNA, V6, P1226, DOI 10.1017/S1355838200000546; Blatter M, 2015, J MOL BIOL, V427, P3001, DOI 10.1016/j.jmb.2015.05.020; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Brunel F, 1996, NUCLEIC ACIDS RES, V24, P1608, DOI 10.1093/nar/24.9.1608; Burgess RR, 2009, METHOD ENZYMOL, V463, P331, DOI 10.1016/S0076-6879(09)63020-2; Chakrabarti S, 2011, MOL CELL, V41, P693, DOI 10.1016/j.molcel.2011.02.010; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Cheng ZH, 2007, EMBO J, V26, P253, DOI 10.1038/sj.emboj.7601464; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CZAPLINSKI K, 1995, RNA, V1, P610; Devarkar SC, 2018, MOL CELL, V72, P355, DOI 10.1016/j.molcel.2018.08.021; Durand S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12434; Fiorini F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8581; Fiorini F, 2013, NUCLEIC ACIDS RES, V41, P2404, DOI 10.1093/nar/gks1320; Fiorini F, 2012, METHOD ENZYMOL, V511, P255, DOI 10.1016/B978-0-12-396546-2.00012-7; Franks TM, 2010, CELL, V143, P938, DOI 10.1016/j.cell.2010.11.043; Fritz SE, 2018, RNA, V24, P982, DOI 10.1261/rna.065730.118; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Ge ZY, 2016, ELIFE, V5, DOI 10.7554/eLife.11155; Goetz AE, 2017, CELL MOL LIFE SCI, V74, P3509, DOI 10.1007/s00018-017-2537-6; Gowravaram M, 2018, NUCLEIC ACIDS RES, V46, P2648, DOI 10.1093/nar/gky040; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hilleren P, 1999, RNA, V5, P711, DOI 10.1017/S1355838299990519; Hogg JR, 2010, CELL, V143, P379, DOI 10.1016/j.cell.2010.10.005; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Hui JY, 2003, NAT STRUCT BIOL, V10, P33, DOI 10.1038/nsb875; Hurt JA, 2013, GENOME RES, V23, P1636, DOI 10.1101/gr.157354.113; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; Kim YK, 2019, RNA, V25, P407, DOI 10.1261/rna.070136.118; Kishor A, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1548; Kishor A, 2019, EMBO J, V38, DOI 10.15252/embj.201899128; Kurosaki T, 2019, NAT REV MOL CELL BIO, V20, P406, DOI 10.1038/s41580-019-0126-2; Kurosaki T, 2014, GENE DEV, V28, P1900, DOI 10.1101/gad.245506.114; Lee SR, 2015, MOL CELL, V59, P413, DOI 10.1016/j.molcel.2015.06.036; Lim F, 2001, J BIOL CHEM, V276, P22507, DOI 10.1074/jbc.M102411200; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Majumder M, 2009, MOL CELL BIOL, V29, P2899, DOI 10.1128/MCB.01774-08; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Paz I, 2014, NUCLEIC ACIDS RES, V42, pW361, DOI 10.1093/nar/gku406; Rakotondrafara AM, 2011, NAT PROTOC, V6, P563, DOI 10.1038/nprot.2011.314; Sausen CW, 2019, METHODS MOL BIOL, V1999, P245, DOI 10.1007/978-1-4939-9500-4_15; Semlow DR, 2012, TRENDS BIOCHEM SCI, V37, P263, DOI 10.1016/j.tibs.2012.04.001; Serdar LD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms14021; Weng YM, 1998, RNA, V4, P205; Weng YM, 1996, MOL CELL BIOL, V16, P5477; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; Zund D, 2013, NAT STRUCT MOL BIOL, V20, P936, DOI 10.1038/nsmb.2635	53	14	14	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11613	11625		10.1074/jbc.RA120.013824	http://dx.doi.org/10.1074/jbc.RA120.013824			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32571872	Green Published, hybrid			2022-12-26	WOS:000563922500020
J	Jayakar, SS; Chiara, DC; Zhou, XJ; Wu, B; Bruzik, KS; Miller, KW; Cohen, JB				Jayakar, Selwyn S.; Chiara, David C.; Zhou, Xiaojuan; Wu, Bo; Bruzik, Karol S.; Miller, Keith W.; Cohen, Jonathan B.			Photoaffinity labeling identifies an intersubunit steroid-binding site in heteromeric GABA type A (GABA(A)) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurosteroid; GABA-A receptor; general anesthetics; allosteric modulator; photoaffinity labeling; gamma-aminobutyric acid; allopregnanolone; anticonvulsant; lipid-protein interaction; GABA receptor; steroid; anesthetic; allosteric regulation; Cys-loop receptor; gamma-aminobutyric acid (GABA)	GAMMA-AMINOBUTYRIC-ACID; H-3 FLUNITRAZEPAM BINDING; GATED ION CHANNELS; NEUROSTEROID MODULATION; TRANSMEMBRANE DOMAIN; NEUROACTIVE STEROIDS; PREGNANOLONE; ANTAGONISM; DISTINCT; ANALOGS	Allopregnanolone (3 alpha 5 alpha-P), pregnanolone, and their synthetic derivatives are potent positive allosteric modulators (PAMs) of GABA(A)receptors (GABA(A)Rs) within vivoanesthetic, anxiolytic, and anti-convulsant effects. Mutational analysis, photoaffinity labeling, and structural studies have provided evidence for intersubunit and intrasubunit steroid-binding sites in the GABA(A)R transmembrane domain, but revealed only little definition of their binding properties. Here, we identified steroid-binding sites in purified human alpha 1 beta 3 and alpha 1 beta 3 gamma 2 GABA(A)Rs by photoaffinity labeling with [H-3]21-[4-(3-(trifluoromethyl)-3H-diazirine-3-yl)benzoxy]allopregnanolone ([H-3]21-pTFDBzox-AP), a potent GABA(A)R PAM. Protein microsequencing established 3 alpha 5 alpha-P inhibitable photolabeling of amino acids near the cytoplasmic end of the beta subunit M4 (beta 3Pro-415, beta 3Leu-417, and beta 3Thr-418) and M3 (beta 3Arg-309) helices located at the base of a pocket in the beta(+)-alpha(-)subunit interface that extends to the level of alpha Gln-242, a steroid sensitivity determinant in the alpha M1 helix. Competition photolabeling established that this site binds with high affinity a structurally diverse group of 3 alpha-OH steroids that act as anesthetics, anti-epileptics, and anti-depressants. The presence of a 3 alpha-OH was crucial: 3-acetylated, 3-deoxy, and 3-oxo analogs of 3 alpha 5 alpha-P, as well as 3 beta-OH analogs that are GABA(A)R antagonists, bound with at least 1000-fold lower affinity than 3 alpha 5 alpha-P. Similarly, for GABA(A)R PAMs with the C-20 carbonyl of 3 alpha 5 alpha-P or pregnanolone reduced to a hydroxyl, binding affinity is reduced by 1,000-fold, whereas binding is retained after deoxygenation at the C-20 position. These results provide a first insight into the structure-activity relationship at the GABA(A)R beta(+)-alpha(-) subunit interface steroid-binding site and identify several steroid PAMs that act via other sites.	[Jayakar, Selwyn S.; Chiara, David C.; Cohen, Jonathan B.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Zhou, Xiaojuan; Miller, Keith W.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Wu, Bo; Bruzik, Karol S.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cohen, JB (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu			National Institutes of Health [GM-58448]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant GM-58448. The content is solely the responsibility of the authors and does not necessarily represents the views of the National Institutes of Health.	Akk G, 2004, J PHYSIOL-LONDON, V558, P59, DOI 10.1113/jphysiol.2004.066571; Akk G, 2008, MOL PHARMACOL, V74, P614, DOI 10.1124/mol.108.048520; Akk G, 2007, PHARMACOL THERAPEUT, V116, P35, DOI 10.1016/j.pharmthera.2007.03.004; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Belelli D, 1996, NEUROPHARMACOLOGY, V35, P1223, DOI 10.1016/S0028-3908(96)00066-4; Belelli D, 2020, NEUROBIOL STRESS, V12, DOI 10.1016/j.ynstr.2019.100207; Blanco MJ, 2018, BIOORG MED CHEM LETT, V28, P61, DOI 10.1016/j.bmcl.2017.11.043; Botella GM, 2017, J MED CHEM, V60, P7810, DOI 10.1021/acs.jmedchem.7b00846; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Carter RB, 1997, J PHARMACOL EXP THER, V280, P1284; Chen Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06361-4; Chen ZW, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000157; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; COTTRELL GA, 1987, BRIT J PHARMACOL, V90, P491, DOI 10.1111/j.1476-5381.1987.tb11198.x; DEMIRGOREN S, 1991, NEUROSCIENCE, V45, P127, DOI 10.1016/0306-4522(91)90109-2; Dostalova Z, 2014, PROTEIN SCI, V23, P157, DOI 10.1002/pro.2401; Dostalova Z, 2010, PROTEIN SCI, V19, P1728, DOI 10.1002/pro.456; Edgar DM, 1997, J PHARMACOL EXP THER, V282, P420; Estrada-Mondragon A, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00055; Evers AS, 2010, J PHARMACOL EXP THER, V333, P404, DOI 10.1124/jpet.109.164079; Forman SA, 2016, ANESTH ANALG, V123, P1263, DOI 10.1213/ANE.0000000000001368; Garrett KM, 1998, J PHARMACOL EXP THER, V285, P680; GOODNOUGH DB, 1995, EUR J PHARM-MOLEC PH, V288, P157, DOI 10.1016/0922-4106(95)90190-6; Hamouda AK, 2013, J NEUROSCI, V33, P485, DOI 10.1523/JNEUROSCI.3483-12.2013; HARRISON NL, 1987, J PHARMACOL EXP THER, V241, P346; HAWKINSON JE, 1994, MOL PHARMACOL, V46, P977; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; HillVenning C, 1996, NEUROPHARMACOLOGY, V35, P1209, DOI 10.1016/S0028-3908(96)00069-X; Hogenkamp DJ, 2014, PSYCHOPHARMACOLOGY, V231, P3517, DOI 10.1007/s00213-014-3494-5; Hosie AM, 2007, PHARMACOL THERAPEUT, V116, P7, DOI 10.1016/j.pharmthera.2007.03.011; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Jayakar SS, 2019, MOL PHARMACOL, V95, P615, DOI 10.1124/mol.118.114975; Jayakar SS, 2015, J BIOL CHEM, V290, P23432, DOI 10.1074/jbc.M115.672006; Jayakar SS, 2014, J BIOL CHEM, V289, P27456, DOI 10.1074/jbc.M114.581728; Katona BW, 2008, EUR J MED CHEM, V43, P107, DOI 10.1016/j.ejmech.2007.02.017; Kelley SP, 2007, EUR J PHARMACOL, V572, P94, DOI 10.1016/j.ejphar.2007.06.028; Laverty D, 2019, NATURE, V565, P516, DOI 10.1038/s41586-018-0833-4; Laverty D, 2017, NAT STRUCT MOL BIOL, V24, P977, DOI 10.1038/nsmb.3477; Li P, 2009, BRIT J PHARMACOL, V158, P1322, DOI 10.1111/j.1476-5381.2009.00390.x; Lynagh T, 2012, TRENDS PHARMACOL SCI, V33, P432, DOI 10.1016/j.tips.2012.05.002; Maitra R, 1998, CAN J PHYSIOL PHARM, V76, P909, DOI 10.1139/cjpp-76-9-909; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Mascia MP, 2005, EUR J PHARMACOL, V516, P204, DOI 10.1016/j.ejphar.2005.05.006; Masiulis S, 2019, NATURE, V565, P454, DOI 10.1038/s41586-018-0832-5; Mennerick S, 2004, MOL PHARMACOL, V65, P1191, DOI 10.1124/mol.65.5.1191; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Miller PS, 2017, NAT STRUCT MOL BIOL, V24, P986, DOI 10.1038/nsmb.3484; Nourmahnad A, 2016, ANESTHESIOLOGY, V125, P1144, DOI 10.1097/ALN.0000000000001390; Park-Chung M, 1999, BRAIN RES, V830, P72, DOI 10.1016/S0006-8993(99)01381-5; PETERS JA, 1988, BRIT J PHARMACOL, V94, P1257, DOI 10.1111/j.1476-5381.1988.tb11646.x; PRINCE RJ, 1992, NEUROSCI LETT, V135, P273, DOI 10.1016/0304-3940(92)90454-F; PRINCE RJ, 1993, NEUROPHARMACOLOGY, V32, P59, DOI 10.1016/0028-3908(93)90130-U; PUIA G, 1990, NEURON, V4, P759, DOI 10.1016/0896-6273(90)90202-Q; PURDY RH, 1990, J MED CHEM, V33, P1572, DOI 10.1021/jm00168a008; Rahman M, 2006, EUR J PHARMACOL, V547, P37, DOI 10.1016/j.ejphar.2006.07.039; Reddy DS, 2016, TRENDS PHARMACOL SCI, V37, P543, DOI 10.1016/j.tips.2016.04.003; Reddy DS, 2010, J PHARMACOL EXP THER, V334, P1031, DOI 10.1124/jpet.110.169854; Savechenkov PY, 2017, EUR J MED CHEM, V136, P334, DOI 10.1016/j.ejmech.2017.04.043; Savechenkov PY, 2012, J MED CHEM, V55, P6554, DOI 10.1021/jm300631e; SCOTT MG, 1988, BIOCHEM BIOPH RES CO, V155, P1353, DOI 10.1016/S0006-291X(88)81290-7; Slavikova B, 2013, J MED CHEM, V56, P2323, DOI 10.1021/jm3016365; Tsai SE, 2017, HETEROATOM CHEM, V28, DOI 10.1002/hc.21372; TURNER DM, 1989, J PHARMACOL EXP THER, V248, P960; Wang MD, 2002, J NEUROSCI, V22, P3366; Wang MD, 2007, EUR J PHARMACOL, V557, P124, DOI 10.1016/j.ejphar.2006.11.071; Wu B, 2019, EUR J MED CHEM, V162, P810, DOI 10.1016/j.ejmech.2018.11.019; Ziegler E, 2009, N-S ARCH PHARMACOL, V380, P277, DOI 10.1007/s00210-009-0440-x; Ziemba AM, 2018, ANESTHESIOLOGY, V128, P338, DOI 10.1097/ALN.0000000000001978	69	7	7	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11495	11512		10.1074/jbc.RA120.013452	http://dx.doi.org/10.1074/jbc.RA120.013452			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32540960	hybrid, Green Published			2022-12-26	WOS:000563922500012
J	Mravcakova, D; Kisidayova, S; Kopcakova, A; Pristas, P; Pisarcikova, J; Bryszak, M; Cieslak, A; Varady, M; Varadyova, Z				Mravcakova, Dominika; Kisidayova, Svetlana; Kopcakova, Anna; Pristas, Peter; Pisarcikova, Jana; Bryszak, Magda; Cieslak, Adam; Varady, Marian; Varadyova, Zora			Can the foregut nematodeHaemonchus contortusand medicinal plants influence the fecal microbial community of the experimentally infected lambs?	PLOS ONE			English	Article							HAEMONCHUS-CONTORTUS; ANTHELMINTIC RESISTANCE; FERMENTATION; IMPACT; SHEEP; RUMEN; PARAMETERS; NEMATODES; PARASITES; MODEL	The abomasal parasitic nematodeHaemonchus contortuscan influence the abomasal microbiome of the host. On the other hand, no information occurs on the influence of the parasite on the hindgut microbiome of the host. We evaluated the impact ofHaemonchus contortuson the fecal microbial community of the experimentally infected lambs treated with a mixture of medicinal herbs to ameliorate the haemonchosis. Twenty-four female lambs were divided into four groups: infected animals (Inf), infected animals supplemented with a blend of medicinal herbs (Inf+Herb), uninfected control animals (Control), and uninfected animals supplemented with medicinal herbs (C+Herb). Inf and Inf+Herb lambs were infected orally with approximately 5000 L3 larvae of a strain ofH.contortussusceptible to anthelmintics (MHco1). Herb blend (Herbmix) consisted of dry medicinal plants ofAlthaea officinalis,Petasites hybridus,Inula helenium,Malva sylvestris,Chamomilla recutita,Plantago lanceolata,Rosmarinus officinalis,Solidago virgaurea,Fumaria officinalis,Hyssopus officinalis,Melisa officinalis,Foeniculum vulgare, andArtemisia absinthium. Each animal was fed meadow hay and a commercial concentrate (600 + 350 g DM/d). Inf+Herb and C+Herb lambs were fed Herbmix (100 g DM/d and animal). Treatment lasted for 50 days. The fecal microbial fermentation parameters (short-chain fatty acids, ammonia, and pH) were evaluated at intervals of 0, 20, 32, and 50 days. The fecal eubacterial populations were evaluated by denaturing gradient gel electrophoresis (DGGE) at day 32 whenH.contortusinfection was the highest. No substantial effects of theH.contortusinfection and the herbal treatment on fecal microbial fermentation parameters and fecal eubacterial populations were observed. Evaluation of DGGE patterns by Principal component analysis pointed to the tendency to branch the C+Herb group from the other experimental groups on Day 32. The results indicate that hindgut microbial activity was not disturbed byH.contortusinfection and herbal treatment.	[Mravcakova, Dominika; Kisidayova, Svetlana; Kopcakova, Anna; Pristas, Peter; Pisarcikova, Jana; Varadyova, Zora] Slovak Acad Sci, Inst Anim Physiol, Ctr Biosci, Kosice, Slovakia; [Bryszak, Magda; Cieslak, Adam] Poznan Univ Life Sci, Dept Anim Nutr, Poznan, Poland; [Varady, Marian] Slovak Acad Sci, Inst Parasitol, Kosice, Slovakia	Slovak Academy of Sciences; Poznan University of Life Sciences; Slovak Academy of Sciences	Kisidayova, S (corresponding author), Slovak Acad Sci, Inst Anim Physiol, Ctr Biosci, Kosice, Slovakia.	kisiday@saske.sk	Várady, Marián/AAN-6094-2020; Pristas, Peter/K-7512-2016; Kopcakova Vandzurova, Anna/GZH-1902-2022; Kišidayová, Svetlana/B-7652-2008; Batťányi, Dominika/AFV-4822-2022; Varadyova, Zora/P-2806-2016	Várady, Marián/0000-0001-6589-8219; Pristas, Peter/0000-0002-7948-2617; Kopcakova Vandzurova, Anna/0000-0002-3054-7010; Kišidayová, Svetlana/0000-0001-6608-4903; Batťányi, Dominika/0000-0002-9070-0558; Varadyova, Zora/0000-0003-3675-8641; Cieslak, Adam/0000-0001-7518-579X	Slovak Research and Development Agency [APVV 140169, APVV 18-0131]; Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic [VEGA 2/0069/17]; Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Academy of Sciences [VEGA 2/0069/17]	Slovak Research and Development Agency(Slovak Research and Development Agency); Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic; Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Academy of Sciences	The funding sources were: Slovak Research and Development Agency (APVV 140169): ZV Slovak Research and Development Agency (APVV 18-0131): MV Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and the Slovak Academy of Sciences (VEGA 2/0069/17): SK The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, OBSTET GYNECOL, V13, pe49; AOAC, 1996, OFFICIAL METHODS ANA, V16th; Bashir MEH, 2002, J IMMUNOL, V169, P3284, DOI 10.4049/jimmunol.169.6.3284; Besier RB, 2016, ADV PARASIT, V93, P95, DOI 10.1016/bs.apar.2016.02.022; Besier RB, 2003, AUST J EXP AGR, V43, P1383, DOI 10.1071/EA02229; Cantacessi C, 2014, J INFECT DIS, V210, P1431, DOI 10.1093/infdis/jiu256; Cortes A, 2018, TRENDS PARASITOL, V34, P640, DOI 10.1016/j.pt.2018.05.009; Domke AVM, 2012, PARASITOL RES, V111, P185, DOI 10.1007/s00436-012-2817-x; Durmic Z, 2012, ANIM FEED SCI TECH, V176, P150, DOI 10.1016/j.anifeedsci.2012.07.018; El-Ashram S, 2017, VET RES COMMUN, V41, P263, DOI 10.1007/s11259-017-9698-5; El-Ashram S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00171-2; Green SJ, 2010, HDB HYDROCARBON LIPI, P4137, DOI DOI 10.1007/978-3-540-77587-4_323; Harris EV, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007891; HONDE C, 1982, EXP PARASITOL, V54, P371, DOI 10.1016/0014-4894(82)90046-7; Hoste H, 2015, VET PARASITOL, V212, P5, DOI 10.1016/j.vetpar.2015.06.026; Hunter MM, 2005, J IMMUNOL, V174, P7368, DOI 10.4049/jimmunol.174.11.7368; Leung JM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00843; Li RW, 2016, SCI REP-UK, V6, DOI 10.1038/srep20606; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Loisel P, 2006, ENVIRON MICROBIOL, V8, P720, DOI 10.1111/j.1462-2920.2005.00950.x; Maizels RM, 2005, CURR OPIN IMMUNOL, V17, P656, DOI 10.1016/j.coi.2005.09.001; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Mravcakova D, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-2050-2; Nubel U, 1996, J BACTERIOL, V178, P5636; Odhaib KJ, 2018, TROP ANIM HEALTH PRO, V50, P1011, DOI 10.1007/s11250-018-1525-7; Patra A, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0145-9; Peachey LE, 2018, INT J PARASITOL, V48, P403, DOI 10.1016/j.ijpara.2017.11.003; Plieskatt JL, 2013, FASEB J, V27, P4572, DOI 10.1096/fj.13-232751; Rapin A, 2018, TRENDS IMMUNOL, V39, P724, DOI 10.1016/j.it.2018.06.002; Rashid S, 2020, J HELMINTHOL, V94, DOI 10.1017/S0022149X19000117; Rook Graham A. W., 2013, Evolution Medicine and Public Health, P46, DOI 10.1093/emph/eot004; Schallig HDFH, 2000, PARASITOLOGY, V120, pS63, DOI 10.1017/S003118209900579X; Slapeta J, 2015, INT J PARASITOL, V45, P585, DOI 10.1016/j.ijpara.2015.04.001; Spiegler V, 2017, NAT PROD REP, V34, P627, DOI 10.1039/c6np00126b; Suguitan Jr AL, 2011, PLOS ONE, V6; Szulc P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231516; Tirabassi AH, 2016, SEMIN-CIENC AGRAR, V37, P4097, DOI 10.5433/1679-0359.2016v37n6p4097; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Varadyova Z, 2017, SMALL RUMINANT RES, V151, P124, DOI 10.1016/j.smallrumres.2017.04.023; Varadyova Z, 2018, EXP PARASITOL, V195, P71, DOI 10.1016/j.exppara.2018.10.009; Varadyova Z, 2018, J ANIM PHYSIOL AN N, V102, P1131, DOI 10.1111/jpn.12940; Varadyova Z, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1405-4; Walshe N, 2019, INT J PARASITOL, V49, P489, DOI 10.1016/j.ijpara.2019.02.003; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wencelova M, 2016, CZECH J ANIM SCI, V61, P551, DOI 10.17221/17/2016-CJAS; Wencelova M, 2015, SMALL RUMINANT RES, V125, P64, DOI 10.1016/j.smallrumres.2015.01.028; Wencelova M, 2014, J ANIM PLANT SCI, V24, P1388; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010	48	1	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235072	10.1371/journal.pone.0235072	http://dx.doi.org/10.1371/journal.pone.0235072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574178	gold, Green Published			2022-12-26	WOS:000544972400047
J	Ouyang, JB; Yang, MH; Gong, T; Ou, JL; Tan, YN; Zhang, Z; Li, S				Ouyang, Jiabi; Yang, Mohui; Gong, Tian; Ou, Jinlai; Tan, Yani; Zhang, Zhen; Li, Sha			Doxorubicin-loading core-shell pectin nanocell: A novel nanovehicle for anticancer agent delivery with multidrug resistance reversal	PLOS ONE			English	Article							BREAST-CANCER CELLS; DRUG-DELIVERY; LIGAND MODIFICATION; NANOPARTICLES; LIPOSOMES; ENCAPSULATION; COMBINATION; STRATEGIES; EFFICACY; ACID	Tumor is a prevalent great threat to public health worldwide and multidrug resistance (MDR) of tumor is a leading cause of chemotherapy failure. Nanomedicine has shown prospects in overcoming the problem. Doxorubicin (DOX), a broad-spectrum anticancer drug, showed limited efficacy due to MDR. Herein, a doxorubicin containing pectin nanocell (DOX-PEC-NC) of core-shell structure, a pectin nanoparticle encapsulated with liposome-like membrane was developed. The DOX-PEC-NC, spheroid in shape and sized around 150 nm, exerted better sustained release behavior than doxorubicin loading pectin nanoparticle (DOX-PEC-NP) or liposome (DOX-LIP).In vitroanticancer study showed marked accumulation of doxorubicin in different tumor cells as well as reversal of MDR in HepG2/ADR cells and MCF-7/ADR cells caused by treatment of DOX-PEC-NC. In H(22)tumor-bearing mice, DOX-PEC-NC showed higher anticancer efficacy and lower toxicity than doxorubicin. DOX-PEC-NC can improve anticancer activity and reduce side effect of doxorubicin due to increased intracellular accumulation and reversal of MDR in tumor cells, which may be a promising nanoscale drug delivery vehicle for chemotherapeutic agents.	[Ouyang, Jiabi; Yang, Mohui; Gong, Tian; Ou, Jinlai; Tan, Yani; Zhang, Zhen; Li, Sha] Jinan Univ, Coll Pharm, Guangzhou, Peoples R China; [Li, Sha] Jinan Univ, Int Cooperat Lab Tradit Chinese Med Modernizat &, Chinese Minist Educ, Coll Pharm, Guangzhou, Peoples R China; [Li, Sha] Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou, Peoples R China	Jinan University; Jinan University	Li, S (corresponding author), Jinan Univ, Coll Pharm, Guangzhou, Peoples R China.; Li, S (corresponding author), Jinan Univ, Int Cooperat Lab Tradit Chinese Med Modernizat &, Chinese Minist Educ, Coll Pharm, Guangzhou, Peoples R China.; Li, S (corresponding author), Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou, Peoples R China.	tlisha@jnu.edu.cn			projects of Science and Technology Program of Guangzhou, China [201704020087, 201704020198]; Natural Science Foundation of Guangdong Province [2020A1515010990]	projects of Science and Technology Program of Guangzhou, China; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was financially supported by projects of Science and Technology Program of Guangzhou, China (No. 201704020087 and No. 201704020198) and Natural Science Foundation of Guangdong Province (No. 2020A1515010990) to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak MI, 2016, INT J PHARMACEUT, V506, P201, DOI 10.1016/j.ijpharm.2016.04.050; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Arias JL, 2008, MOLECULES, V13, P2340, DOI 10.3390/molecules13102340; Bahrami B, 2017, IMMUNOL LETT, V190, P64, DOI 10.1016/j.imlet.2017.07.015; Betancourt T, 2007, NANOMEDICINE-UK, V2, P219, DOI 10.2217/17435889.2.2.219; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Carmona-Ribeiro AM, 1999, COLLOID SURFACE A, V153, P355, DOI 10.1016/S0927-7757(98)00532-9; Deng ZT, 2014, J CONTROL RELEASE, V174, P109, DOI 10.1016/j.jconrel.2013.11.018; Devendiran RM, 2016, RSC ADV, V6, P29757, DOI 10.1039/c6ra01698g; Gautier J, 2013, J CONTROL RELEASE, V169, P48, DOI 10.1016/j.jconrel.2013.03.018; Gong T, 2016, J PHARM BIOMED SCI, V6, P338, DOI DOI 10.3109/02652048.2011.559286; Gu YJ, 2012, NANOMED-NANOTECHNOL, V8, P204, DOI 10.1016/j.nano.2011.06.005; Gungor-Ordueri NE, 2019, PHARMACOL REP, V71, P591, DOI 10.1016/j.pharep.2019.02.018; Injac R, 2009, BIOMATERIALS, V30, P1184, DOI 10.1016/j.biomaterials.2008.10.060; Khames A, 2017, EUR J PHARMACOL, V805, P118, DOI 10.1016/j.ejphar.2017.02.046; Khanniri E, 2016, CRIT REV FOOD SCI, V56, P484, DOI 10.1080/10408398.2013.779571; Kibria G, 2014, ARCH PHARM RES, V37, P4, DOI 10.1007/s12272-013-0276-2; Klemetsrud T, 2013, COLLOID SURFACE B, V103, P158, DOI 10.1016/j.colsurfb.2012.10.012; Kumar A, 2019, EUR J MED CHEM, V176, P268, DOI 10.1016/j.ejmech.2019.05.027; Li L, 2018, INT J PHARMACEUT, V536, P450, DOI 10.1016/j.ijpharm.2017.12.018; Liu LS, 2003, BIOMATERIALS, V24, P3333, DOI 10.1016/S0142-9612(03)00213-8; Maeki M, 2018, ADV DRUG DELIVER REV, V128, P84, DOI 10.1016/j.addr.2018.03.008; Mastria EM, 2018, J CONTROL RELEASE, V269, P364, DOI 10.1016/j.jconrel.2017.11.021; Moya S, 2000, MACROMOLECULES, V33, P4538, DOI 10.1021/ma9914974; [欧金来 Ou Jinlai], 2014, [暨南大学学报. 自然科学与医学版, Journal of Jinan University. Natural Science & Medicine Edition], V35, P330; Renu K, 2018, EUR J PHARMACOL, V818, P241, DOI 10.1016/j.ejphar.2017.10.043; Rodrigues ARO, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11010010; Seidi K, 2018, J CONTROL RELEASE, V275, P142, DOI 10.1016/j.jconrel.2018.02.020; Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smistad G, 2012, CARBOHYD POLYM, V90, P1337, DOI 10.1016/j.carbpol.2012.07.002; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tao JY, 2019, MOL PHARMACEUT, V16, P786, DOI 10.1021/acs.molpharmaceut.8b01056; Thakkar S, 2020, ACTA BIOMATER, V101, P43, DOI 10.1016/j.actbio.2019.09.009; Wen ShaoHong, 2015, Journal of Pharmaceutical and Biomedical Sciences, V5, P385; Wilhelm S, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.14; Xia YQ, 2017, COLLOID SURFACE B, V159, P427, DOI 10.1016/j.colsurfb.2017.08.011; Ying XY, 2011, J MAGN MAGN MATER, V323, P1088, DOI 10.1016/j.jmmm.2010.12.019; Zahednezhad F, 2019, J CONTROL RELEASE, V305, P194, DOI 10.1016/j.jconrel.2019.05.030; Zhang YX, 2015, CARBOHYD POLYM, V133, P31, DOI 10.1016/j.carbpol.2015.06.102; Zheng WP, 2018, BIOMED PHARMACOTHER, V108, P565, DOI 10.1016/j.biopha.2018.09.039; Zhou XT, 2015, INT J PHARMACEUT, V479, P391, DOI 10.1016/j.ijpharm.2014.12.068; Zhu JZ, 2019, FOOD HYDROCOLLOID, V95, P562, DOI 10.1016/j.foodhyd.2018.04.042; Zong L, 2019, J PHARMACEUT BIOMED, V165, P268, DOI 10.1016/j.jpba.2018.11.057	44	3	3	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235090	10.1371/journal.pone.0235090	http://dx.doi.org/10.1371/journal.pone.0235090			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569270	Green Published, gold			2022-12-26	WOS:000543547900014
J	de Carvalho, P; Bonecker, M; Tello, G; Abanto, J; Oliveira, LB; Braga, MM				de Carvalho, Patricia; Bonecker, Marcelo; Tello, Gustavo; Abanto, Jenny; Oliveira, Luciana Butini; Braga, Mariana Minatel			Inclusion of initial caries lesions in a population-based sample of Brazilian preschool children: Impact on estimates and treatment needs	PLOS ONE			English	Article							ASSESSMENT SYSTEM ICDAS; DENTAL-CARIES; EPIDEMIOLOGIC SURVEYS; INTERNATIONAL CARIES; PREVALENCE; TRENDS; INJURIES; KAPPA; RISK	This study aimed to assess changes in epidemiological estimates and treatment needed when initial caries lesions are included in a population-based survey of preschool children. A cross-sectional survey was conducted in a Brazilian municipality, collecting data of preschool children in 16 health centers. Caries detection used the merged codes (epi-codes) for ICDAS/ICCMS. An option for treatment, according to ICCMS, was chosen during the examination. Caries experience (dmft/dmfs) and prevalence were estimated considering three thresholds (A- initial, moderate, and severe lesions, B- only moderate and severe lesions and C- severe lesions). Incremental need for non-operative care was also verified. The sample consisted of 663 children aged 2-4 years (response rate of 99.85%). Including initial lesions, a 2-fold increase in dmft was observed (A: 3.36, B: 1.02, p<0.001). With the inclusion, the caries prevalence increased to 75% compared to threshold B only (28%). The majority (76%) of children who required any intervention (56%) should be scheduled for non-operative care. We suggest that including initial caries lesions in an epidemiological survey may significantly impact assessment of population caries experience.	[de Carvalho, Patricia; Bonecker, Marcelo; Tello, Gustavo; Abanto, Jenny; Braga, Mariana Minatel] Univ Sao Paulo, Sch Dent, Dept Orthodont & Pediat Dent, Sao Paulo, Brazil; [Oliveira, Luciana Butini] Fac Sao Leopoldo Mand, Div Pediat Dent, Campinas, Brazil	Universidade de Sao Paulo; Faculdade Sao Leopoldo Mandic	de Carvalho, P (corresponding author), Univ Sao Paulo, Sch Dent, Dept Orthodont & Pediat Dent, Sao Paulo, Brazil.	patcarvalho@usp.br	Bonecker, Marcelo/I-9393-2012	Bonecker, Marcelo/0000-0001-9786-6473; Carvalho, Patricia/0000-0001-8263-5314; Tello, Gustavo/0000-0003-0120-6388	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [400736/2014-4, 309817/2015-3, 304319/2018-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (400736/2014-4), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (309817/2015-3, 304319/2018-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanto J, 2015, INT J PAEDIATR DENT, V25, P18, DOI 10.1111/ipd.12092; Assaf AV, 2006, COMMUNITY DENT ORAL, V34, P213, DOI 10.1111/j.1600-0528.2006.00278.x; Bonecker M, 2010, INT J PAEDIATR DENT, V20, P125, DOI 10.1111/j.1365-263X.2009.01030.x; Bonecker M, 2002, Int J Paediatr Dent, V12, P183; Braga MM, 2009, CARIES RES, V43, P245, DOI 10.1159/000217855; Cadavid Alexandra Saldarriaga, 2010, Braz. oral res., V24, P211, DOI 10.1590/S1806-83242010000200014; Cortes A, 2017, ACTA ODONTOL SCAND, V75, P12, DOI 10.1080/00016357.2016.1242154; Pinto-Sarmento TCD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150116; Bonini GADC, 2009, DENT TRAUMATOL, V25, P594, DOI 10.1111/j.1600-9657.2009.00826.x; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Gimenez T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164903; Guedes RS, 2018, CARIES RES, V52, P32, DOI 10.1159/000479824; Guedes RS, 2016, INT J PAEDIATR DENT, V26, P116, DOI 10.1111/ipd.12166; Gulliford MC, 2005, J CLIN EPIDEMIOL, V58, P246, DOI 10.1016/j.jclinepi.2004.08.012; IBGE, IND SOC MUN 2010 INC; Ismail AI, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/1472-6831-15-S1-S9; Martignon Stefania, 2018, Braz. Dent. J., V29, P374, DOI 10.1590/0103-6440201801949; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Murakami C, 2016, INT J PAEDIATR DENT, V26, P60, DOI 10.1111/ipd.12159; Oliveira LB, 2008, EUR J ORAL SCI, V116, P37, DOI 10.1111/j.1600-0722.2007.00507.x; Piovesan C, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-49; Piovesan C, 2013, COMMUNITY DENT ORAL, V41, P204, DOI 10.1111/cdoe.12004; Pitchika V, 2016, COMMUNITY DENT ORAL, V44, P354, DOI 10.1111/cdoe.12219; Pitts NB, 2013, COMMUNITY DENT ORAL, V41, pe41, DOI 10.1111/cdoe.12025; Pitts NB, ICCMSTM GUIDE PRACTI; Pitts Nigel, 2004, Community Dent Health, V21, P193; [SB Brasil Ministerio da Saude. Secretaria de AtencAo a Saude. Secretaria de Vigilancia em Saude], 2012, PESQ NAC SAUD BUC; Tello G, 2016, DENT TRAUMATOL, V32, P274, DOI 10.1111/edt.12255; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Xie ZJ, 2007, ORAL SURG ORAL MED O, V103, pE44, DOI 10.1016/j.tripleo.2006.12.028	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234122	10.1371/journal.pone.0234122	http://dx.doi.org/10.1371/journal.pone.0234122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559191	Green Published, gold			2022-12-26	WOS:000543261600037
J	Chu, PL; Liu, HS; Wang, CK; Lin, CY				Chu, Pei-Lun; Liu, Hui-Shan; Wang, Chikang; Lin, Chien-Yu			Association between acrylamide exposure and sex hormones in males: NHANES, 2003-2004	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; ANTI-MULLERIAN HORMONE; BINDING GLOBULIN; BODY-COMPOSITION; INHIBIN B; MEN; AGE; NEUROTOXICITY; TESTOSTERONE; ADDUCTS	Introduction Acrylamide is widely present in heat-processed food, cigarette smoke and environment. Reproductive toxicity was reported in animals treated with acrylamide, particularly in males. The reproductive toxicity of acrylamide and its active metabolite, glycidamide, was reported to be mainly mediated through DNA damage in spermatocytes. However, the effect of acrylamide on sex hormones in men is unknown. Methods There were 468 male subjects (age >= 12 years) enrolled to determine the relationships between hemoglobin adducts of acrylamide (HbAA) and hemoglobin adducts of glycidamide (HbGA) with several sex hormones using the National Health and Nutrition Examination Survey (NHANES), 2003 to 2004. All potential confounding variables in the data set were properly adjusted. Results We found that one unit increase in the natural log-transformed HbAA level was associated with an increase in natural log transformed serum inhibin B level by 0.10 (SE = 0.05;P= 0.046), and natural log transformed serum sex hormone binding globulin (SHBG) by 0.15 (SE = 0.15;P= 0.036). With respect to HbGA, one unit increase in the natural log-transformed HbGA level was associated with an increase in natural log transformed serum anti-Mullerian Hormone (AMH) level by 0.31 (SE = 0.00;P= 0.003). Conclusion In this representative cohort, we identified positive associations between acrylamide exposure and several sex hormones in men. The HbAA is positively associated with inhibin B and SHBG, and HbGA is positively associated with AMH. Other than genotoxicity, our findings suggested that altered sex hormones might also play a role in acrylamide-related reproductive toxicity in males.	[Chu, Pei-Lun; Lin, Chien-Yu] Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan; [Chu, Pei-Lun] Fu Jen Catholic Univ, Fu Jen Catholic Univ Hosp, Dept Internal Med, New Taipei, Taiwan; [Liu, Hui-Shan] Hsinchu Cathay Gen Hosp, Dept Gynecol & Obstet, Hsinchu, Taiwan; [Wang, Chikang; Lin, Chien-Yu] Yuanpei Univ Med Technol, Dept Environm Engn & Hlth, Hsinchu, Taiwan; [Lin, Chien-Yu] En Chu Kong Hosp, Dept Internal Med, New Taipei, Taiwan	Fu Jen Catholic University; Fu Jen Catholic University; Fu Jen Catholic University Hospital; Cathay General Hospital	Lin, CY (corresponding author), Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan.; Lin, CY (corresponding author), Yuanpei Univ Med Technol, Dept Environm Engn & Hlth, Hsinchu, Taiwan.; Lin, CY (corresponding author), En Chu Kong Hosp, Dept Internal Med, New Taipei, Taiwan.	lin7010@mail2000.com.tw			Fu Jen Catholic University Hospital [PL-201705006-V]	Fu Jen Catholic University Hospital	The study was partly supported by the Fu Jen Catholic University Hospital, PL-201705006-V to Pei-Lun Chu. The funder plays no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ahmed EA, 2009, BIOL REPROD, V80, P1084, DOI 10.1095/biolreprod.108.071662; Andersson AM, 1997, J CLIN ENDOCR METAB, V82, P3976, DOI 10.1210/jc.82.12.3976; [Anonymous], 2017, CANCER DISCOV, V7, pOF12; [Anonymous], 2003, J PAIN PALLIAT CARE, V17, P1; [Anonymous], 2008, NHANES 2003 2004; [Anonymous], 2005, AN REP GUID; Bjellaas T, 2007, TOXICOL SCI, V98, P110, DOI 10.1093/toxsci/kfm091; El-Halawaty S, 2011, GYNECOL ENDOCRINOL, V27, P401, DOI 10.3109/09513590.2010.495433; Exon J H, 2006, J Toxicol Environ Health B Crit Rev, V9, P397, DOI 10.1080/10937400600681430; Gates MA, 2013, J CLIN ENDOCR METAB, V98, P2442, DOI 10.1210/jc.2012-2582; Goulis DG, 2008, GYNECOL ENDOCRINOL, V24, P158, DOI 10.1080/09513590701672314; Hamdy SM, 2012, HUM EXP TOXICOL, V31, P483, DOI 10.1177/0960327111417267; He ZH, 2018, INT J OBESITY, V42, P1366, DOI 10.1038/s41366-018-0033-1; Hogervorst JG, 2013, CANCER EPIDEM BIOMAR, V22, P2024, DOI 10.1158/1055-9965.EPI-13-0509; Klingmuller D, 1997, HUM REPROD, V12, P2376, DOI 10.1093/humrep/12.11.2376; Le TN, 2012, TRENDS ENDOCRIN MET, V23, P32, DOI 10.1016/j.tem.2011.09.005; Lin CY, 2009, DIABETES CARE, V32, P2206, DOI 10.2337/dc09-0309; Mannaa F, 2006, J APPL TOXICOL, V26, P198, DOI 10.1002/jat.1128; Mojska Hanna, 2013, Rocz Panstw Zakl Hig, V64, P173; Nagata C, 2018, AM J EPIDEMIOL, V187, P75, DOI 10.1093/aje/kwx197; Nagata C, 2015, CANCER EPIDEM BIOMAR, V24, P249, DOI 10.1158/1055-9965.EPI-14-0935; Rougier C, 2019, ANN ENDOCRINOL-PARIS, V80, P234, DOI 10.1016/j.ando.2019.06.002; Song Hong-Xiu, 2008, Zhonghua Nan Ke Xue, V14, P406; Tyl RW, 2000, REPROD TOXICOL, V14, P147, DOI 10.1016/S0890-6238(00)00066-6; US EPA, 2010, TOX REV ACR; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Wallace IR, 2013, CLIN ENDOCRINOL, V78, P321, DOI 10.1111/cen.12086; Weitzman M, 2005, CIRCULATION, V112, P862, DOI 10.1161/CIRCULATIONAHA.104.520650; WHO, 2018, GLOB DAT CHILD GROWT; Wirfalt E, 2008, EUR J CLIN NUTR, V62, P314, DOI 10.1038/sj.ejcn.1602704; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yilmaz BO, 2017, HUM EXP TOXICOL, V36, P1225, DOI 10.1177/0960327116686818; ZENICK H, 1986, J TOXICOL ENV HEALTH, V17, P457, DOI 10.1080/15287398609530840	33	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234622	10.1371/journal.pone.0234622	http://dx.doi.org/10.1371/journal.pone.0234622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555690	Green Published, gold			2022-12-26	WOS:000543273200074
J	Park, J; Choi, JY; Shin, A; Lee, SA; Lee, M; Choi, J; Lee, JK; Kang, D				Park, JooYong; Choi, Ji-Yeob; Shin, Aesun; Lee, Sang-Ah; Lee, Miyoung; Choi, Jaesung; Lee, Jong-koo; Kang, Daehee			Patterns of leisure time and household physical activity and the risk of mortality among middle-aged Korean adults	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; HEALTH-BENEFITS; OLDER-ADULTS; METAANALYSIS; ASSOCIATION; PREVALENCE; COHORT; WORK	Background Although many studies have focused on leisure time physical activity (LTPA), household physical activity (HPA) can contribute to health benefits. This study aimed to compare LTPA and HPA patterns and to examine the association of these types of activities with the risk of mortality in Korea. Methods A total of 125,299 participants 40 to 69 years old and enrolled in the Health Examinees (HEXA) study from 2004 to 2012 were included in this study. The sex-specific LTPA and HPA categories were defined based on a questionnaire. A multinomial logistic regression was used to examine the LTPA and HPA correlates. Hazard ratios (HR) with 95% confidence intervals (95% CIs) of all-cause mortality were estimated using the Cox proportional hazard model. Results Overall, the LTPA and HPA patterns differed by age, income, and history of chronic diseases. LTPA reduced the risk of death, and lower risks were observed in more time spent engaged in or a vigorous LTPA intensity. The subjects who participated only in HPA and were not involved in LTPA also had lower risks of mortality (HR = 0.72, 95% CIs: 0.60-0.85 for men, and HR = 0.84, 95% CIs: 0.69-1.02 for women) than those who did not participate in both LTPA and HPA. Conclusions HPA reduced the risks of mortality in middle-aged Korean adults and could even decrease the risk of death in those who did not participate in LTPA.	[Park, JooYong; Choi, Ji-Yeob; Choi, Jaesung; Kang, Daehee] Seoul Natl Univ, Dept Biomed Sci, Grad Sch, Seoul, South Korea; [Park, JooYong; Choi, Ji-Yeob; Choi, Jaesung] BK21plus Biomed Sci Project, Seoul, South Korea; [Choi, Ji-Yeob; Shin, Aesun; Kang, Daehee] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Choi, Ji-Yeob; Shin, Aesun; Kang, Daehee] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Lee, Sang-Ah] Kangwon Natl Univ, Dept Prevent Med, Sch Med, Chuncheon Si, South Korea; [Lee, Miyoung] Kookmin Univ, Coll Phys Educ & Sport Sci, Seoul, South Korea; [Lee, Jong-koo] Seoul Natl Univ, JW Lee Ctr Global Med, Coll Med, Seoul, South Korea; [Lee, Jong-koo] Seoul Natl Univ, Dept Family Med, Coll Med, Seoul, South Korea; [Kang, Daehee] Seoul Natl Univ, Inst Environm Med, Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Kookmin University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Choi, JY (corresponding author), Seoul Natl Univ, Dept Biomed Sci, Grad Sch, Seoul, South Korea.; Choi, JY (corresponding author), BK21plus Biomed Sci Project, Seoul, South Korea.; Choi, JY (corresponding author), Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.; Choi, JY (corresponding author), Seoul Natl Univ, Canc Res Inst, Seoul, South Korea.	jiyeob.choi@gmail.com		Lee, Jong-koo/0000-0003-4833-1178; Kang, Daehee/0000-0003-4031-5878	National Research Foundation of Korea - Korea government [NRF-2018R1A2A3075397]; Seoul National University Hospital; Korea Centers for Disease Control and Prevention [2004-E71004-00, 2005-E71011-00, 2005-E71009-00];  [2006-E71001-00];  [2006-E71004-00];  [2006-E71010-00];  [2006-E71003-00];  [2007-E71004-00];  [2007-E71006-00];  [2008-E71006-00];  [2008-E71008-00];  [2009-E71009-00];  [2010-E71006-00];  [2011-E71006-00];  [2012-E71001-00];  [2013-E71009-00];  [2014-E71008-00];  [2014-E71008-01]	National Research Foundation of Korea - Korea government(National Research Foundation of KoreaKorean Government); Seoul National University Hospital; Korea Centers for Disease Control and Prevention; ; ; ; ; ; ; ; ; ; ; ; ; ; ; 	This work was supported by the Research Program that is funded by the Korea Centers for Disease Control and Prevention (2004-E71004-00, 2005-E71011-00, 2005-E71009-00, 2006-E71001-00, 2006-E71004-00, 2006-E71010-00, 2006-E71003-00, 2007-E71004-00, 2007-E71006-00, 2008-E71006-00, 2008-E71008-00, 2009-E71009-00, 2010-E71006-00, 2011-E71006-00, 2012-E71001-00, 2013-E71009-00, 2014-E71008-00, and 2014-E71008-01), by the National Research Foundation of Korea grant funded by the Korea government (NRF-2018R1A2A3075397), and by the Seoul National University Hospital (2019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Aijo M, 2016, J SPORT HEALTH SCI, V5, P437, DOI 10.1016/j.jshs.2015.09.008; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; [Anonymous], 2015, ASIAN PAC J CANCER P, V16, P1591, DOI DOI 10.7314/APJCP.2015.16.4.1591; [Anonymous], 2010, DRUG DISCOV TODAY TE, V7, pe1; Arrieta A, 2008, ANN EPIDEMIOL, V18, P889, DOI 10.1016/j.annepidem.2008.09.007; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Chen LJ, 2012, ASIA-PAC J PUBLIC HE, V24, P795, DOI 10.1177/1010539511404397; Choi J, 2019, J EPIDEMIOL, V29, P125, DOI 10.2188/jea.JE20170296; Choi J, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4255-2; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Csizmadi I, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-110; Engberg E, 2012, SPORTS MED, V42, P433, DOI 10.2165/11597610-000000000-00000; Eyler AE, 2002, J WOMEN HEALTH GEN-B, V11, P239, DOI 10.1089/152460902753668448; Gebel K, 2015, JAMA INTERN MED, V175, P970, DOI 10.1001/jamainternmed.2015.0541; Gillum RF, 2010, ANN EPIDEMIOL, V20, P251, DOI 10.1016/j.annepidem.2010.01.005; Hendelman D, 2000, MED SCI SPORT EXER, V32, pS442, DOI 10.1097/00005768-200009001-00002; Hosmer DW, 2000, APPL LOGISTIC REGRES, P274; Jurj AL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-213; Kim Y, 2017, INT J EPIDEMIOL, V46, P1350, DOI 10.1093/ije/dyx105; Kirk MA, 2011, AM J PREV MED, V40, P476, DOI 10.1016/j.amepre.2010.12.015; Koeneman MA, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-142; Koolhaas CM, 2018, INT J EPIDEMIOL, V47, P1705, DOI 10.1093/ije/dyy058; Ku PW, 2006, PREV MED, V43, P454, DOI 10.1016/j.ypmed.2006.04.011; Lahti J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101548; Lawlor DA, 2002, J EPIDEMIOL COMMUN H, V56, P473, DOI 10.1136/jech.56.6.473; Liu Y, 2018, INT J EPIDEMIOL, V47, P771, DOI 10.1093/ije/dyy024; Livingstone MBE, 2001, PUBLIC HEALTH NUTR, V4, P1107, DOI 10.1079/PHN2001192; Huerta JM, 2016, PREV MED, V85, P106, DOI 10.1016/j.ypmed.2016.02.009; Martinez-Gomez D, 2014, PREV MED, V61, P14, DOI 10.1016/j.ypmed.2014.01.006; Nang EEK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-644; National Institute of Agricultural Sciences, 2013, KOR STAND FOOD COMP; Ng SW, 2012, OBES REV, V13, P659, DOI 10.1111/j.1467-789X.2011.00982.x; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Norman A, 2002, INT J OBESITY, V26, P670, DOI 10.1038/sj.ijo.0801955; Ottenbacher AJ, 2012, J AM GERIATR SOC, V60, P1085, DOI 10.1111/j.1532-5415.2012.03995.x; Peters TM, 2010, MED SCI SPORT EXER, V42, P2222, DOI 10.1249/MSS.0b013e3181e1fcd5; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; Rhodes RE, 1999, SPORTS MED, V28, P397, DOI 10.2165/00007256-199928060-00003; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Shi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14901; Sobal J., 2010, INT J SOCIOL FAM, V36, P181, DOI [10.2307/23028828, DOI 10.2307/23028828]; Stamatakis E, 2007, AM J PREV MED, V32, P320, DOI 10.1016/j.amepre.2006.12.020; Teh CH, 2014, PUBLIC HEALTH, V128, P416, DOI 10.1016/j.puhe.2013.10.008; Trinh OTH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-204; Venous Forum of the Royal Society of Medicine, 2011, PHLEBOLOGY, V26, P91; Warburton DER, 2017, CURR OPIN CARDIOL, V32, P541, DOI 10.1097/HCO.0000000000000437; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; West SL, 2010, AHRQ METHODS EFFECTI; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Zhou Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep39939	53	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234852	10.1371/journal.pone.0234852	http://dx.doi.org/10.1371/journal.pone.0234852			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555644	gold, Green Published			2022-12-26	WOS:000543273200050
J	Steiner, BL; Alonso, N; Grillas, P; Jorda, C; Piques, G; Tillier, M; Rovira, N				Steiner, Bigna L.; Alonso, Natalia; Grillas, Patrick; Jorda, Christophe; Piques, Gael; Tillier, Margaux; Rovira, Nuria			Languedoc lagoon environments and man: Building a modern analogue botanical macroremain database for understanding the role of water and edaphology in sedimentation dynamics of archaeobotanical remains at the Roman port ofLattara(Lattes, France)	PLOS ONE			English	Article							EASTERN-CENTRAL EUROPE; SEED BANK; SPATIAL-DISTRIBUTION; STANDING VEGETATION; SURFACE SEDIMENTS; ASSEMBLAGES; DELTA; LAKE; DUNG; LIVESTOCK	A new method to evaluate archaeological wetland sites in a more objective way was tested. Different wetland environments have been sampled in areas of a nature reserve and their macroremain content analysed to build a modern analogue dataset. This dataset was then used to characterise archaeological samples from a navigation channel from the Roman port cityLattara. In the modern analogue samples, the different wetland types (saline/brackish or fresh water) could be differentiated in the correspondence analysis. Within these groups, the sampled area of the littoral (submerged, shoreline, unsubmerged) could also be differentiated. This dataset can therefore provide a basis for the interpretation of the nature and degree of aquatic influence and layer formation processes in archaeobotanical records of coastal sites. In the tested archaeological samples from the navigation channel ofLattara, changes in space and time could be tracked using the modern analogue dataset and geoarchaeological information. The channel lost its fresh water supply and silted up over a short period of time (approx. 100 years).	[Steiner, Bigna L.] Univ Basel, Integrat Prehist & Archaeol Sci IPAS, Dept Environm Sci, Basel, Switzerland; [Steiner, Bigna L.; Jorda, Christophe; Piques, Gael; Tillier, Margaux; Rovira, Nuria] Paul Valery Univ Montpellier, UMR5140, CNRS, Archeol Soc Mediterraneennes ASM, Montpellier, France; [Alonso, Natalia] Univ Lleida, Grp Invest Prehist, Dept Hist, Lleida, Catalonia, Spain; [Grillas, Patrick] Res Inst Conservat Mediterranean Wetlands, Tour du Valet, Arles, France; [Jorda, Christophe] Inrap Mediterranee, Parc Actipolis, Villeneuve Les Beziers, France; [Tillier, Margaux] Inst Sci Evolut Montpellier ISEM, Montpellier, France	University of Basel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universitat de Lleida; Universite de Montpellier	Steiner, BL (corresponding author), Univ Basel, Integrat Prehist & Archaeol Sci IPAS, Dept Environm Sci, Basel, Switzerland.; Steiner, BL (corresponding author), Paul Valery Univ Montpellier, UMR5140, CNRS, Archeol Soc Mediterraneennes ASM, Montpellier, France.	bigna.steiner@unibas.ch	Alonso, Natàlia/ABI-5269-2020	Rovira, Nuria/0000-0001-8139-7000	Swiss National Science Foundation [P2BSP1_178658]; LabEx ARCHIMEDE from "Investissement d'Avenir" program [ANR-11-LABX-0032-01]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); LabEx ARCHIMEDE from "Investissement d'Avenir" program(French National Research Agency (ANR))	This research was funded by the Swiss National Science Foundation (http://www.snf.ch/; early postdoc mobility grant to BLS, project nr. P2BSP1_178658) and supported by the LabEx ARCHIMEDE from "Investissement d'Avenir" program ANR-11-LABX-0032-01 (https://archimede.cnrs.fr/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeret o, 2000, THESIS; Alagich R, 2018, J ARCHAEOL SCI, V93, P135, DOI 10.1016/j.jas.2018.03.006; Alonso N., 2008, GALLIA, V65, P193; Alonso N, 2016, VEG HIST ARCHAEOBOT, V25, P323, DOI 10.1007/s00334-015-0553-8; [Anonymous], 1989, DET REF STAT, V2; [Anonymous], 1992, ACT UP LA NEWS, V5, P9; [Anonymous], LATTARA; [Anonymous], 1998, INDEX BOT ECOLOGIQUE; Antolin F, 2017, J ARCHAEOL SCI-REP, V12, P323, DOI 10.1016/j.jasrep.2017.02.008; Antolin F, 2015, J ARCHAEOL SCI, V61, P36, DOI 10.1016/j.jas.2015.04.019; Auderset Joye D., 2012, ROTE LISTE ARMLEUCHT; Azuara J, 2015, CLIM PAST, V11, P1769, DOI 10.5194/cp-11-1769-2015; Bagan G, 2010, QUATERNAIRE, V21, P85, DOI 10.4000/quaternaire.5470; Balbo AL, 2017, WIRES WATER, V4, DOI 10.1002/wat2.1238; Banas D, 2005, HYDROBIOLOGIA, V551, P3, DOI 10.1007/s10750-005-4446-1; Bogaard A, 2016, VEG HIST ARCHAEOBOT, V25, P57, DOI 10.1007/s00334-015-0524-0; Bollinger T, 1981, THESIS; Bullock P, 1990, HDB SOIL THIN SECTIO; BUXO R, 1991, LATTARA, V4, P101; Cappers R.T., 2012, DIGITALE ZADENATLAS, V4th ed.; Cappers R. T. J., 2005, PALAEOHISTORIA, V47, P429; Cappers RTJ, 1995, VEG HIST ARCHAEOBOT, V4, P249; Cappers RTJ, 1993, VEG HIST ARCHAEOBOT, P173, DOI DOI 10.1007/8F00198588; Carrion JS, 2002, REV PALAEOBOT PALYNO, V120, P217, DOI 10.1016/S0034-6667(02)00073-8; Chabal L, 2003, LATTARA, V16, P219; Charles M, 2003, LEVANT, V35, P213, DOI DOI 10.1179/lev.2003.35.1.213; Cheiron A, 2018, RAPPORT ACTIVITE 201; Court-Picon M, 2005, REV PALAEOBOT PALYNO, V135, P13, DOI 10.1016/j.revpalbo.2005.02.003; Cui LJ, 2016, ECOL ENG, V96, P45, DOI 10.1016/j.ecoleng.2016.03.040; Dieffenbacher-Krall AC, 2000, J PALEOLIMNOL, V24, P213, DOI 10.1023/A:1008164614818; Edgeworth M., 2011, FLUID PASTS ARCHAEOL; Friesem DE, 2017, QUATERNARY SCI REV, V171, P85, DOI 10.1016/j.quascirev.2017.07.002; Friesem DE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164185; Gardeisen A, 2008, GALLIA, V65, P185; Goman M, 2001, J PALEOLIMNOL, V26, P393, DOI 10.1023/A:1012687113269; GRILLAS P, 1993, OECOLOGIA, V94, P1, DOI 10.1007/BF00317293; Grillas P, 2000, AQ SCI M AM SOC LIMN; Grillas P, 2016, ADAPTATION GRILLES D; Grillas P, 2010, ETUDE PILOTE EVALUAT; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hannon GE, 1997, J PALEOLIMNOL, V18, P15, DOI 10.1023/A:1007958511729; Hillman GC., 1984, PLANTS ANCIENT MAN S, P1; Hodder I, 2012, ENTANGLED ARCHAEOLOG; HOLYOAK DT, 1984, NEW PHYTOL, V98, P405, DOI 10.1111/j.1469-8137.1984.tb02750.x; Homeier J, 2017, FOR ECOSYST, V4, DOI 10.1186/s40663-017-0097-8; Hopfensperger KN, 2007, OIKOS, V116, P1438, DOI [10.1111/j.2007.0030-1299.15818.x, 10.1111/j.0030-1299.2007.15818.x]; Hosch S, 2003, J ARCHAEOL SCI, V30, P849, DOI 10.1016/S0305-4403(02)00263-7; Jacomet S., 2013, OXFORD HDB WETLAND A, P497; Jacomet S, 1985, BOT MAKRORESTE SEDIM; Jones G, 2010, J ARCHAEOL SCI, V37, P70, DOI 10.1016/j.jas.2009.08.017; Jones GEM., 1990, CIRCAEA, V6, P91; Jorda C., 2008, GALLIA, V65, P11, DOI DOI 10.3406/GALIA.2008.3328; Jutila HM, 2002, ANN BOT FENN, V39, P49; KAUTSKY L, 1990, HOLARCTIC ECOL, V13, P143; KEDDY PA, 1986, J GREAT LAKES RES, V12, P25, DOI 10.1016/S0380-1330(86)71697-3; Knorzer K-H, 1996, DECHENIANA, V149, P81; Koff Tiiu, 2008, Estonian Journal of Ecology, V57, P5, DOI 10.3176/eco.2008.1.01; Kreuz A, 2002, VEG HIST ARCHAEOBOT, V11, P177, DOI 10.1007/s003340200019; Kunes P, 2008, J BIOGEOGR, V35, P2223, DOI 10.1111/j.1365-2699.2008.01974.x; Kuster H, 1991, MODELLING ECOLOGICAL, P17; Liu GH, 2006, FRESHWATER BIOL, V51, P1862, DOI 10.1111/j.1365-2427.2006.01621.x; Lorber D, 2007, CONTRIBUTION ANAL FO; Magyari EOK, 2014, QUATERNARY SCI REV, V95, P60, DOI 10.1016/j.quascirev.2014.04.020; Verges JM, 2016, QUATERN INT, V414, P304, DOI 10.1016/j.quaint.2016.01.032; Menotti F., 2015, END LAKE DWELLINGS C; Menotti F., 2013, OXFORD HDB WETLAND A; Mesleard F, 1996, MEDWET SERIES CONSER, V6; Molinier R., 1970, PRODROME UNITES PHYT; Mouronval J.-B., 2010, PLANTES AQUATIQUES C; Nilsson C, 2002, ECOLOGY, V83, P2878, DOI 10.1890/0012-9658(2002)083[2878:DIRFBR]2.0.CO;2; Oberdorfer E., 2001, PFLANZENSOZIOLOGISCH; ODUM WE, 1988, ANNU REV ECOL SYST, V19, P147, DOI 10.1146/annurev.es.19.110188.001051; Paczyski A, 1992, ACTA SOC BOT POL, V61, P115; Persat H, 1996, ADV LIF SCI-SERIES, P321; Petit L. Garcia, 1999, LATTARA, V12, P609; Picon B., 2006, GESTION RISQUE INOND; Picon B, 1979, REV ECOL, P31; Piques G, 2010, LATTARA, V21, P387; Piques G, 2016, LATTARA LATTES HERAU; Piques G, 2018, ZONE PORTUAIRE LATTA; Piques G, 2019, ZONE PORTUAIRE LATTA; Piques G, 2017, ZONE PORTUAIRE LATTA; Puertas O, 1998, LATTARA, P11; Py M, 1993, GALLIA, P1; Py M., 2009, LATTARA LATTES HERAU; Py M, 1997, LATTARA, V10; Rovira N, 2017, ZONE PORTUAIRE LATTA; Rovira N, 2010, PLANTS SNAILS; Rovira N, 2018, ZONE PORTUAIRE LATTA; Rovira N, 2016, LATTARA LATTES HERAU; Rovira N, 2018, VEG HIST ARCHAEOBOT, V27, P85, DOI 10.1007/s00334-017-0619-x; Sabatier F., 2003, GEOMORPHOLOGIE, V4, P283, DOI DOI 10.3406/M0RF0.2003.1191; Salel Tiphaine, 2016, Revue de Micropaleontologie, V59, P425, DOI 10.1016/j.revmic.2016.09.001; Schaal C, 2018, REV SCI BOURGOGNE FR, V16, P29; Schepers M, 2015, ENVIRON ARCHAEOL, V20, P66, DOI 10.1179/1749631414Y.0000000030; Schepers M, 2013, VEG HIST ARCHAEOBOT, V22, P243, DOI 10.1007/s00334-012-0370-2; Schnitzler A., 2006, FORET MEDITERRANEENN, VXXVII, P43; Schnitzler-Lenoble A, 2007, FORETS ALLUVIALES DE; Seabloom EW, 1998, PLANT ECOL, V138, P203, DOI 10.1023/A:1009711919757; Steiner BL, 2018, VEG HIST ARCHAEOBOT, V27, P45, DOI 10.1007/s00334-017-0613-3; Steiner BL, 2015, J ARCHAEOL SCI-REP, V2, P310, DOI 10.1016/j.jasrep.2015.02.012; Steinhardt T, 2007, ESTUAR COAST SHELF S, V74, P205, DOI 10.1016/j.ecss.2007.04.004; Styring AK, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.76; Tillier M, 2019, THESIS; Tillier M, 2013, THESIS; TisoN J.-M., 2014, FLORA GALLICA; TISON J.-M., 2014, FLORE FRANCE MEDITER; Tolar T, 2010, VEG HIST ARCHAEOBOT, V19, P53, DOI 10.1007/s00334-009-0221-y; Vandorpe P, 2007, ENVIRON ARCHAEOL, V12, P207, DOI 10.1179/174963107x226462; VAQUER A, 1989, Annales de Limnologie, V25, P25; Vassio E, 2012, PALAIOS, V27, P779, DOI 10.2110/palo.2012.p12-050r; Vella C, 2005, MAR GEOL, V222, P235, DOI 10.1016/j.margeo.2005.06.028; Walsh K, 2014, ARCHAEOLOGY OF MEDITERRANEAN LANDSCAPES: HUMAN-ENVIRONMENT INTERACTION FROM THE NEOLITHIC TO THE ROMAN PERIOD, P1; Weisskopf A, 2018, QUATERN INT, V489, P80, DOI 10.1016/j.quaint.2016.09.028; Weisskopf A, 2014, J ARCHAEOL SCI, V51, P43, DOI 10.1016/j.jas.2013.04.026; Wiemann P., 2012, J WETLAND ARCHAEOLOG, V12, P58, DOI DOI 10.1179/JWA.2012.12.1.004; Willm L, 2018, RIPISYLVE TOURTOULEN; Willm L, 2003, RIPISYLVE TOURTOULEN; Yuan LY, 2007, PLANT ECOL, V189, P127, DOI 10.1007/s11258-006-9170-z; Zanon M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00253; Zibulski P., 2010, HORGENZEITLICHE SIED, P236	121	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234853	10.1371/journal.pone.0234853	http://dx.doi.org/10.1371/journal.pone.0234853			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555679	Green Published, gold			2022-12-26	WOS:000543273200051
J	Euler, A; Martini, K; Baessler, B; Eberhard, M; Schoeck, F; Alkadhi, H; Frauenfelder, T				Euler, Andre; Martini, Katharina; Baessler, Bettina; Eberhard, Matthias; Schoeck, Friederike; Alkadhi, Hatem; Frauenfelder, Thomas			1024-pixel image matrix for chest CT - Impact on image quality of bronchial structures in phantoms and patients	PLOS ONE			English	Article							RESOLUTION; NOISE	Objectives To compare objective and subjective image quality of bronchial structures between a 512-pixel and a 1024-pixel image matrix for chest CT in phantoms and in patients. Materials and methods First, a two-size chest phantom was imaged at two radiation doses on a 192-slice CT scanner. Datasets were reconstructed with 512-, 768-, and 1024-pixel image matrices and a sharp reconstruction kernel (Bl64). Image sharpness and normalized noise power spectrum (nNPS) were quantified. Second, chest CT images of 100 patients were reconstructed with 512- and 1024-pixel matrices and two blinded readers independently assessed objective and subjective image quality. In each patient dataset, the highest number of visible bronchi was counted for each lobe of the right lung. A linear mixed effects model was applied in the phantom study and a Welch's t-test in the patient study. Results Objective image sharpness and image noise increased with increasing matrix size and were highest for the 1024-matrix in phantoms and patients (all, P<0.001). nNPS was comparable among the three matrices. Objective image noise was on average 16% higher for the 1024-matrix compared to the 512-matrix in patients (P<0.0001). Subjective evaluation in patients yielded improved sharpness but increased image noise for the 1024- compared to the 512-matrix (both, P<0.001). There was no significant difference between highest-order visible bronchi (P>0.07) and the overall bronchial image quality between the two matrices (P>0.22). Conclusion Our study demonstrated superior image sharpness and higher image noise for a 1024- compared to a 512-pixel matrix, while there was no significant difference in the depiction and subjective image quality of bronchial structures for chest CT.	[Euler, Andre; Martini, Katharina; Baessler, Bettina; Eberhard, Matthias; Alkadhi, Hatem; Frauenfelder, Thomas] Univ Zurich, Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland; [Martini, Katharina] Univ Paris 05, Grp Hosp Cochin Broca, Radiol Dept, Hotel Dieu, Paris, France; [Schoeck, Friederike] Siemens Healthcare GmbH, Forchheim, Germany	University of Zurich; University Zurich Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Siemens AG	Euler, A (corresponding author), Univ Zurich, Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland.	and.euler@gmail.com	Euler, Andre/N-5739-2019; Martini, Katharina/AAW-7995-2020; Frauenfelder, Thomas/O-1734-2016	Euler, Andre/0000-0001-5019-4585; Baessler, Bettina/0000-0002-3244-3864; Frauenfelder, Thomas/0000-0002-3295-6619	Siemens Healthcare	Siemens Healthcare(Siemens AG)	Dr. Friederike Schoeck is an employee of Siemens Healthcare GmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. No funding or grant support was received for this study. Siemens Healthcare provided support in the form of salaries for author F.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Bartlett DJ, 2019, INVEST RADIOL, V54, P129, DOI 10.1097/RLI.0000000000000524; Cocconcelli E, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030399; Euler A, 2018, AM J ROENTGENOL, V210, P1301, DOI 10.2214/AJR.17.19102; Hata A, 2018, ACAD RADIOL, V25, P869, DOI 10.1016/j.acra.2017.11.017; Kawashima H, 2020, MED PHYS, V47, P488, DOI 10.1002/mp.13949; Kim GHJ, 2020, EUR RADIOL, V30, P726, DOI 10.1007/s00330-019-06402-6; Lin ZY, 2019, J MAGN RESON IMAGING, V50, P1843, DOI 10.1002/jmri.26752; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Solomon J, 2015, MED PHYS, V42, P4941, DOI 10.1118/1.4923172; Solomon JB, 2012, MED PHYS, V39, P6048, DOI 10.1118/1.4752209; Suzuki A, 2019, AM J ROENTGENOL, V213, P104, DOI 10.2214/AJR.18.20967; Tanabe N, 2018, RESPIR INVESTIG, V56, P489, DOI 10.1016/j.resinv.2018.07.008; von Spiczak J, 2018, INVEST RADIOL, V53, P486, DOI 10.1097/RLI.0000000000000485; von Spiczak J, 2013, J CARDIOVASC COMPUT, V7, P215, DOI 10.1016/j.jcct.2013.08.003; Yanagawa M, 2018, EUR RADIOL, V28, P5060, DOI 10.1007/s00330-018-5491-2; Zhu HY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172688	16	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234644	10.1371/journal.pone.0234644	http://dx.doi.org/10.1371/journal.pone.0234644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544172	Green Published, Green Accepted, gold			2022-12-26	WOS:000542957200011
J	Zubizarreta, L; Quintana, L; Hernandez, D; de Mello, FT; Meerhoff, M; Honji, RM; Moreira, RG; Silva, A				Zubizarreta, Lucia; Quintana, Laura; Hernandez, Daniel; de Mello, Franco Teixeira; Meerhoff, Mariana; Honji, Renato Massaaki; Moreira, Renata Guimaraes; Silva, Ana			Seasonal and social factors associated with spacing in a wild territorial electric fish	PLOS ONE			English	Article							SEXUAL SELECTION; BODY-SIZE; RESOURCE VALUE; HOME-RANGE; AGGRESSION; BEHAVIOR; TESTOSTERONE; MODULATION; SIGNAL; POPULATION	In this study, we focused on the seasonal variation of the determinants of territory size in the weakly electric fishGymnotus omarorum. This species is a seasonal breeder that displays year-round territorial aggression. Female and male dyads exhibit indistinguishable non-breeding territorial agonistic behavior and body size is the only significant predictor of contest outcome. We conducted field surveys across seasons that included the identification of individual location, measurements of water physico-chemical variables, characterization of individual morphometric and physiological traits, and their correlation to spatial distribution.G.omarorumtolerates a wide range of dissolved oxygen concentration, and territory size correlated positively with dissolved oxygen in both seasons. In the non-breeding season, territory size was sexually monomorphic and correlated only with body size. In the breeding season, territory size no longer correlated with body size but differed between sexes: (i) the overall spatial arrangement was sexually biased, (ii) territory size depended on gonadal hormones in both sexes, which was expected for males, but not previously reported in females, (iii) female territory size showed a positive relationship with gonadal size, and (iv) females showed relatively larger territories than males. This study demonstrates seasonal changes in the determinants of territory size and thus contributes to the understanding of the mechanisms underlying the behavioral plasticity natural territorial behavior.	[Zubizarreta, Lucia] Univ Republica, Fac Med, Dept Fisiol, Lab Neurofisiol Celular & Sinapt, Montevideo, Uruguay; [Zubizarreta, Lucia; Quintana, Laura; Silva, Ana] Inst Invest Biol Clemente Estable, Dept Neurofisiol Celular & Mol, Unidad Bases Neurales Conducta, Montevideo, Uruguay; [Hernandez, Daniel] CETP UTU, Lab Control Ambiental, Polo Educat Tecnol Arrayanes, Maldonado, Uruguay; [de Mello, Franco Teixeira; Meerhoff, Mariana] Univ Republ, Ctr Univ Reg Este, Dept Ecol & Gest Ambiental, Maldonado, Uruguay; [Meerhoff, Mariana] Aarhus Univ, Dept BioSci, Silkeborg, Denmark; [Honji, Renato Massaaki] Univ Sao Paulo CEBIMar USP, Ctr Biol Marinha, Rodovia Manoel Hipolito do Rego, Sao Sebastiao, SP, Brazil; [Moreira, Renata Guimaraes] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Rua Matao, Sao Paulo, SP, Brazil; [Silva, Ana] Univ Republica, Fac Ciencias, Lab Neurociencias, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Universidad de la Republica, Uruguay; Aarhus University; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidad de la Republica, Uruguay	Silva, A (corresponding author), Inst Invest Biol Clemente Estable, Dept Neurofisiol Celular & Mol, Unidad Bases Neurales Conducta, Montevideo, Uruguay.; Silva, A (corresponding author), Univ Republica, Fac Ciencias, Lab Neurociencias, Montevideo, Uruguay.	asilva@fcien.edu.uy	Honji, Renato Massaaki/F-3485-2012; Mello, Franco Teixeira-de/AAA-4869-2019; Moreira, Renata Guimarães/K-3122-2012	Honji, Renato Massaaki/0000-0001-7198-7728; Mello, Franco Teixeira-de/0000-0003-4904-6985; Moreira, Renata Guimarães/0000-0001-8139-1776; Silva, Ana/0000-0003-2890-0353	Agencia Nacional de Investigacion e Innovacion (ANII), Fondo Clemente Estable grants [ANII_FCE_6180, ANII_FCE_136381, FCE_4272]; Programa de Desarrollo de las Ciencias Basicas; Universidad de la Republica	Agencia Nacional de Investigacion e Innovacion (ANII), Fondo Clemente Estable grants; Programa de Desarrollo de las Ciencias Basicas; Universidad de la Republica	This research was funded by Agencia Nacional de Investigacion e Innovacion (ANII), Fondo Clemente Estable grants to AS (ANII_FCE_6180; FCE_4272) and LQ (ANII_FCE_136381). Programa de Desarrollo de las Ciencias Basicas gave support to LZ, MM, FTM, LQ and AS and Universidad de la Republica gave support to AS, MM and FTM.	Adams ES, 2001, ANNU REV ECOL SYST, V32, P277, DOI 10.1146/annurev.ecolsys.32.081501.114034; Adkins-Regan E., 2005, HORMONES ANIMAL SOCI; ALBERT DJ, 1990, PHYSIOL BEHAV, V47, P659, DOI 10.1016/0031-9384(90)90074-E; Allen CR, 2006, ECOL LETT, V9, P630, DOI 10.1111/j.1461-0248.2006.00902.x; Anderson RO, 1983, FISH FARMIN HDB, P237; [Anonymous], 1995, BONE S, V17, p505S; [Anonymous], 1995, ELEMENTA, V2, P131; [Anonymous], 1992, AEQUATIONES MATH, V43, P297; Batista G, 2012, ETHOLOGY, V118, P398, DOI 10.1111/j.1439-0310.2012.02022.x; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Brown J.L., 1970, ANNU REV ECOL SYST, V1, P239; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Butchart SHM, 1999, J ANIM ECOL, V68, P928, DOI 10.1046/j.1365-2656.1999.00341.x; CALDWELL GS, 1984, P NATL ACAD SCI-BIOL, V81, P5255, DOI 10.1073/pnas.81.16.5255; Caputi AA, 2006, J COMP PHYSIOL A, V192, P587, DOI 10.1007/s00359-006-0100-2; CARDWELL JR, 1991, HORM BEHAV, V25, P1, DOI 10.1016/0018-506X(91)90035-G; Conover William Jay, 1998, PRACTICAL NONPARAMET, V350; Crampton WGR, 1998, J FISH BIOL, V53, P307, DOI 10.1111/j.1095-8649.1998.tb01034.x; Demas G. E., 2007, BEHAV NEUROCHEMISTRY, P337, DOI [10.1007/978-0-387-30405-2_8, DOI 10.1007/978-0-387-30405-2_8]; Dunlap KD, 2000, BRAIN BEHAV EVOLUT, V55, P152, DOI 10.1159/000006649; ELLIOTT JM, 1990, J ANIM ECOL, V59, P803, DOI 10.2307/5015; Scaia MF, 2018, PHYSIOL BEHAV, V194, P481, DOI 10.1016/j.physbeh.2018.06.028; Fox HE, 1997, J NEUROSCI, V17, P6463; Gavassa S, 2012, ANIM BEHAV, V83, P935, DOI 10.1016/j.anbehav.2012.01.012; Gavassa S, 2011, HORM BEHAV, V60, P420, DOI 10.1016/j.yhbeh.2011.07.009; GWINNER E, 1994, BEHAV ECOL SOCIOBIOL, V34, P321, DOI 10.1007/BF01209778; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hirschenhauser K, 2006, ANIM BEHAV, V71, P265, DOI 10.1016/j.anbehav.2005.04.014; Hurd PL, 2006, J THEOR BIOL, V241, P639, DOI 10.1016/j.jtbi.2006.01.001; Jalabert C, 2015, HORM BEHAV, V72, P60, DOI 10.1016/j.yhbeh.2015.05.003; Jasnow AM, 2000, HORM BEHAV, V38, P102, DOI 10.1006/hbeh.2000.1604; Keeley ER, 2000, ANIM BEHAV, V59, P477, DOI 10.1006/anbe.1999.1288; Kohda M, 2008, J ANIM ECOL, V77, P859, DOI 10.1111/j.1365-2656.2008.01414.x; La VT, 2011, REV FISH SCI, V19, P21, DOI 10.1080/10641262.2010.531793; LOGAN CA, 1990, HORM BEHAV, V24, P568, DOI 10.1016/0018-506X(90)90042-V; Markham MR, 2016, INTEGR COMP BIOL, V56, P889, DOI 10.1093/icb/icw104; Marroni S, 2014, HYDROBIOLOGIA, V735, P263, DOI 10.1007/s10750-013-1714-3; McCullagh P, 1989, GEN LINEAR MODELS; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McLeod A., 2011, BESTGLM BEST SUBSET; Metcalfe NB, 2016, J FISH BIOL, V88, P298, DOI 10.1111/jfb.12699; Migliaro A, 2018, BIOL OPEN, V7, DOI 10.1242/bio.036319; Monaghan EP, 1992, BEHAV ENDOCRINOL, V134, P692; MOORE MC, 1987, GEN COMP ENDOCR, V65, P225, DOI 10.1016/0016-6480(87)90170-5; MORAES G., 2002, Braz. J. Biol., V62, P633, DOI 10.1590/S1519-69842002000400011; Mougeot F, 2003, J ANIM ECOL, V72, P1073, DOI 10.1046/j.1365-2656.2003.00781.x; Nelson RJ, 2005, INTRO BEHAV ENDOCRIN, Vxvii, P822; Nolen ZJ, 2017, BEHAV PROCESS, V138, P1, DOI 10.1016/j.beproc.2017.01.020; Odreitz U, 2015, BEHAV ECOL SOCIOBIOL, V69, P593, DOI 10.1007/s00265-014-1870-0; Oliveira RF, 2009, INTEGR COMP BIOL, V49, P423, DOI 10.1093/icb/icp055; Osorio R, 2006, J FISH BIOL, V69, P233, DOI 10.1111/j.1095-8649.2006.01095.x; Parn H, 2008, BEHAV ECOL SOCIOBIOL, V62, P1665, DOI 10.1007/s00265-008-0595-3; Pedraja F, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/6/065002; Perrone R, 2019, ACTA ETHOL, V22, P79, DOI 10.1007/s10211-019-00309-7; Perrone R, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00001; Piper WH, 2015, ANIM BEHAV, V104, P155, DOI 10.1016/j.anbehav.2015.03.013; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Quintana L, 2004, J EXP BIOL, V207, P1843, DOI 10.1242/jeb.00954; Quintana Laura, 2016, J Physiol Paris, V110, P224, DOI 10.1016/j.jphysparis.2016.11.009; R Core Team, 2012, R LANG ENV STAT COMP; Rendon NM, 2017, FUNCT ECOL, V31, P1071, DOI 10.1111/1365-2435.12816; Richer-de-Forges MM, 2009, COPEIA, P538, DOI 10.1643/CI-07-103; Rubenstein DR, 2005, HORM BEHAV, V48, P329, DOI 10.1016/j.yhbeh.2005.04.006; Salazar VL, 2008, J EXP BIOL, V211, P1012, DOI 10.1242/jeb.014795; Silva A, 2003, ENVIRON BIOL FISH, V66, P329, DOI 10.1023/A:1023986600069; Silva A, 2007, PHYSIOL BEHAV, V90, P525, DOI 10.1016/j.physbeh.2006.11.003; Silva AC, 2013, J EXP BIOL, V216, P2412, DOI 10.1242/jeb.082180; Simon N.G., 2006, BIOL AGGRESSION, P211; Sinervo B, 2000, HORM BEHAV, V38, P222, DOI 10.1006/hbeh.2000.1622; Sink TD, 2008, FISH PHYSIOL BIOCHEM, V34, P95, DOI 10.1007/s10695-007-9150-9; SMITH DC, 1985, ANIM BEHAV, V33, P417, DOI 10.1016/S0003-3472(85)80066-X; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Soma KK, 1999, GEN COMP ENDOCR, V115, P442, DOI 10.1006/gcen.1999.7334; Tobias JA, 2011, J EVOLUTION BIOL, V24, P2118, DOI 10.1111/j.1420-9101.2011.02345.x; Tobias JA, 2012, PHILOS T R SOC B, V367, P2274, DOI 10.1098/rstb.2011.0280; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014; Vullioud P, 2013, HORM BEHAV, V64, P430, DOI 10.1016/j.yhbeh.2013.06.007; WATSON A, 1981, ORNIS SCAND, V12, P55, DOI 10.2307/3675905; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; WHITTINGHAM LA, 1992, AUK, V109, P928, DOI 10.2307/4088178; WINGFIELD JC, 1994, HORM BEHAV, V28, P146, DOI 10.1006/hbeh.1994.1012; Woodley SK, 1999, HORM BEHAV, V35, P205, DOI 10.1006/hbeh.1999.1514; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Zubizarreta L, 2020, PHYSIOL BEHAV, V220, DOI 10.1016/j.physbeh.2020.112883; Zubizarreta L, 2015, ETHOLOGY, V121, P8, DOI 10.1111/eth.12299; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	87	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0228976	10.1371/journal.pone.0228976	http://dx.doi.org/10.1371/journal.pone.0228976			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB6AZ	32542049	Green Submitted, Green Published, gold			2022-12-26	WOS:000542685100019
J	Yi, HY; Li, GP; Long, YK; Liang, WZ; Cui, HN; Zhang, B; Tan, Y; Li, YF; Shen, LC; Deng, DQ; Tang, YS; Mao, CY; Tian, SY; Cai, YT; Zhu, QH; Hu, YH; Chen, W; Fang, L				Yi, Hongyang; Li, Guipeng; Long, Yongkang; Liang, Weizheng; Cui, Huanhuan; Zhang, Bin; Tan, Ying; Li, Yunfei; Shen, Luochen; Deng, Daqi; Tang, Yisen; Mao, Chenyu; Tian, Shuye; Cai, Yunting; Zhu, Qionghua; Hu, Yuhui; Chen, Wei; Fang, Liang			Integrative multi-omics analysis of a colon cancer cell line with heterogeneous Wnt activity revealed RUNX2 as an epigenetic regulator of EMT	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CONSENSUS MOLECULAR SUBTYPES; TRANSCRIPTION FACTOR RUNX2; STEM-CELLS; TGF-BETA; OSTEOBLAST DIFFERENTIATION; INTRATUMOR HETEROGENEITY; EXPRESSION; GENERATION; PLASTICITY	Epithelial-mesenchymal transition (EMT) program, which facilitates tumor metastasis, stemness and therapy resistance, is a reversible biological process that is largely orchestrated at the epigenetic level under the regulation of different cell signaling pathways. EMT state is often heterogeneous within individual tumors, though the epigenetic drivers underlying such heterogeneity remain elusive. In colon cancer, hyperactivation of the Wnt/beta-catenin signaling not only drives tumor initiation, but also promotes metastasis in late stage by promoting EMT program. However, it is unknown whether the intratumorally heterogeneous Wnt activity could directly drive EMT heterogeneity, and, if so, what are the underlying epigenetic driver(s). Here, by analyzing a phenotypically and molecularly heterogeneous colon cancer cell line using single-cell RNA sequencing, we identified two distinct cell populations with positively correlated Wnt activity and EMT state. Integrative multi-omics analysis of these two cell populations revealed RUNX2 as a critical transcription factor epigenetically driving the EMT heterogeneity. Both in vitro and in vivo genetic perturbation assays validated the EMT-enhancing effect of RUNX2, which remodeled chromatin landscape and activated a panel of EMT-associated genes through binding to their promoters and/or potential enhancers. Finally, by exploring the clinical data, we showed that RUNX2 expression is positively correlated with metastasis development and poor survival of colon cancer patients, as well as patients afflicted with other types of cancer. Taken together, our work revealed RUNX2 as a new EMT-promoting epigenetic regulator in colon cancer, which may potentially serve as a prognostic marker for tumor metastasis.	[Yi, Hongyang; Liang, Weizheng] Harbin Inst Technol, Harbin, Peoples R China; [Yi, Hongyang; Li, Guipeng; Long, Yongkang; Liang, Weizheng; Cui, Huanhuan; Tan, Ying; Li, Yunfei; Shen, Luochen; Deng, Daqi; Tang, Yisen; Mao, Chenyu; Tian, Shuye; Cai, Yunting; Zhu, Qionghua; Hu, Yuhui; Chen, Wei; Fang, Liang] Southern Univ Sci & Technol, Dept Biol, Shenzhen, Peoples R China; [Li, Guipeng; Cui, Huanhuan; Hu, Yuhui; Chen, Wei; Fang, Liang] Southern Univ Sci & Technol, Acad Adv Interdisciplinary Studies, Shenzhen, Peoples R China; [Zhang, Bin] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore	Harbin Institute of Technology; Southern University of Science & Technology; Southern University of Science & Technology; National University of Singapore	Hu, YH; Chen, W; Fang, L (corresponding author), Southern Univ Sci & Technol, Dept Biol, Shenzhen, Peoples R China.; Hu, YH; Chen, W; Fang, L (corresponding author), Southern Univ Sci & Technol, Acad Adv Interdisciplinary Studies, Shenzhen, Peoples R China.	huyh@sustech.edu.cn; chenw@sustech.edu.cn; fangl@sustech.edu.cn	chen, wei/AFV-4999-2022; Fang, Liang/V-5019-2018	Fang, Liang/0000-0003-4502-1756; Cui, Huanhuan/0000-0002-6190-6135; Long, Yongkang/0000-0003-0953-7325; Li, Guipeng/0000-0002-3244-5499	National Natural Science Foundation of China [31701237]; Shenzhen Science and Technology Program [JCYJ20170817110925887, KQTD20180411143432337, GJHZ20170310161947503]; Center for Computational Science and Engineering of Southern University of Science and Technology; Laboratory Animal Center of Southern University of Science and Technology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Program; Center for Computational Science and Engineering of Southern University of Science and Technology; Laboratory Animal Center of Southern University of Science and Technology	This work was supported by the National Natural Science Foundation of China (Grant No. 31701237) and the Shenzhen Science and Technology Program (Grant No. JCYJ20170817110925887, KQTD20180411143432337, and GJHZ20170310161947503). Bioinformatic analysis was supported by the Center for Computational Science and Engineering of Southern University of Science and Technology. Animal experiments were supported by the Laboratory Animal Center of Southern University of Science and Technology.	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Nieto MA, 2009, INT J DEV BIOL, V53, P1541, DOI 10.1387/ijdb.072410mn; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Baniwal SK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-258; Barnes GL, 2004, CANCER RES, V64, P4506, DOI 10.1158/0008-5472.CAN-03-3851; Barnes GL, 2003, CANCER RES, V63, P2631; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Bian SH, 2018, SCIENCE, V362, P1060, DOI 10.1126/science.aao3791; Blois SM, 2014, MUCOSAL IMMUNOL, V7, P348, DOI 10.1038/mi.2013.53; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Chimge NO, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3073; Melo FDE, 2017, NATURE, V543, P676, DOI 10.1038/nature21713; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Fang L, 2016, CANCER RES, V76, P891, DOI 10.1158/0008-5472.CAN-15-1519; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hinohara K, 2018, CANCER CELL, V34, P939, DOI 10.1016/j.ccell.2018.10.014; Hu Y, 2018, GENE CHROMOSOME CANC, V57, P140, DOI 10.1002/gcc.22512; Inman CK, 2003, J BIOL CHEM, V278, P48684, DOI 10.1074/jbc.M308001200; Jagan I, 2013, ONCOGENE, V32, P1305, DOI 10.1038/onc.2012.140; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Krebs AM, 2017, NAT CELL BIOL, V19, P518, DOI 10.1038/ncb3513; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; Ligorio M, 2019, CELL, V178, P160, DOI 10.1016/j.cell.2019.05.012; Lin CW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13867; Magnani L, 2011, TRENDS GENET, V27, P465, DOI 10.1016/j.tig.2011.07.002; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Niu DF, 2012, LAB INVEST, V92, P1181, DOI 10.1038/labinvest.2012.84; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Pistore C, 2017, ONCOGENE, V36, P5551, DOI 10.1038/onc.2017.159; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Rahman MS, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.5; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Selvamurugan N, 2004, J BIOL CHEM, V279, P27764, DOI 10.1074/jbc.M312870200; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Soares Kevin C, 2014, J Vis Exp, P51677, DOI 10.3791/51677; Stark AL, 2010, AM J HUM GENET, V87, P829, DOI 10.1016/j.ajhg.2010.10.018; Sveen A, 2018, CLIN CANCER RES, V24, P794, DOI 10.1158/1078-0432.CCR-17-1234; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Staalduinen J, 2018, ONCOGENE, V37, P6195, DOI 10.1038/s41388-018-0378-x; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; Yang J, 2001, CANCER RES, V61, P5652; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yeung F, 2002, J BIOL CHEM, V277, P2468, DOI 10.1074/jbc.M105947200; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304	67	14	14	0	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 9	2020	39	28					5152	5164		10.1038/s41388-020-1351-z	http://dx.doi.org/10.1038/s41388-020-1351-z		JUN 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MH4RK	32535615				2022-12-26	WOS:000539953300003
J	Awah, CU; Chen, L; Bansal, M; Mahajan, A; Winter, J; Lad, M; Warnke, L; Gonzalez-Buendia, E; Park, C; Zhang, D; Feldstein, E; Yu, D; Zannikou, M; Balyasnikova, IV; Martuscello, R; Konerman, S; Gyorffy, B; Burdett, KB; Scholtens, DM; Stupp, R; Ahmed, A; Hsu, P; Sonabend, AM				Awah, Chidiebere U.; Chen, Li; Bansal, Mukesh; Mahajan, Aayushi; Winter, Jan; Lad, Meeki; Warnke, Louisa; Gonzalez-Buendia, Edgar; Park, Cheol; Zhang, Daniel; Feldstein, Eric; Yu, Dou; Zannikou, Markella; Balyasnikova, Irina, V; Martuscello, Regina; Konerman, Silvana; Gyorffy, Balazs; Burdett, Kirsten B.; Scholtens, Denise M.; Stupp, Roger; Ahmed, Atique; Hsu, Patrick; Sonabend, Adam M.			Ribosomal protein S11 influences glioma response to TOP2 poisons	ONCOGENE			English	Article							SCALE CRISPR-CAS9 KNOCKOUT; BRAIN-BARRIER DISRUPTION; DNA TOPOISOMERASE-II; METRONOMIC CHEMOTHERAPY; ORAL ETOPOSIDE; PHASE-II; GLIOBLASTOMA; DOXORUBICIN; ACTIVATION; ULTRASOUND	Topoisomerase II poisons are one of the most common class of chemotherapeutics used in cancer. We and others had shown that a subset of glioblastomas, the most malignant of all primary brain tumors in adults, is responsive to TOP2 poisons. To identify genes that confer susceptibility to this drug in gliomas, we performed a genome-scale CRISPR knockout screen with etoposide. Genes involved in protein synthesis and DNA damage were implicated in etoposide susceptibility. To define potential biomarkers for TOP2 poisons, CRISPR hits were overlapped with genes whose expression correlates with susceptibility to this drug across glioma cell lines, revealing ribosomal protein subunit RPS11, 16, and 18 as putative biomarkers for response to TOP2 poisons. Loss of RPS11 led to resistance to etoposide and doxorubicin and impaired the induction of proapoptotic gene APAF1 following treatment. The expression of these ribosomal subunits was also associated with susceptibility to TOP2 poisons across cell lines from gliomas and multiple other cancers.	[Awah, Chidiebere U.; Chen, Li; Warnke, Louisa; Gonzalez-Buendia, Edgar; Park, Cheol; Zhang, Daniel; Feldstein, Eric; Yu, Dou; Zannikou, Markella; Balyasnikova, Irina, V; Scholtens, Denise M.; Stupp, Roger; Ahmed, Atique; Sonabend, Adam M.] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Bansal, Mukesh] Psychogen Inc, Paramus, NJ USA; [Mahajan, Aayushi] Columbia Univ, Dept Neurol Surg, Med Ctr, New York, NY USA; [Winter, Jan] German Ctr Canc Res, Funct Genom & Signaling, Heidelberg, Germany; [Lad, Meeki] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Martuscello, Regina] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Konerman, Silvana; Hsu, Patrick] Salk Inst Biol Studies, Mol & Cell Biol, La Jolla, CA USA; [Gyorffy, Balazs] Hungarian Acad Sci, MTA TTK Lendulet Canc Biomarker Res Grp, Inst Enzymol, Budapest, Hungary; [Gyorffy, Balazs] Semmelweis Univ, Dept Pediat 2, Budapest, Hungary; [Burdett, Kirsten B.] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Columbia University; Columbia University; Columbia University; Salk Institute; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University; Northwestern University	Sonabend, AM (corresponding author), Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA.	adam.sonabend@nm.org	Hsu, Patrick/ABD-5749-2021; Feldstein, Eric/GLS-1215-2022; Mahajan, Aayushi/ABC-1481-2021; Gyorffy, Balazs/AAA-9135-2021	Mahajan, Aayushi/0000-0003-3966-2936; Gyorffy, Balazs/0000-0002-5772-3766; Feldstein, Eric/0000-0002-1952-4555; Zhang, Daniel Yang/0000-0001-9962-9295	SPORE for Translational Approaches to Brain Cancer [5DP5OD021356-05, P50CA221747]; Robert H. Lurie NCI Cancer Center Support Grant [P30CA060553]; NCI CCSG [P30 CA060553]; NVKP [16-1-2016-0037]	SPORE for Translational Approaches to Brain Cancer; Robert H. Lurie NCI Cancer Center Support Grant; NCI CCSG; NVKP	This work was funded by 5DP5OD021356-05 (AMS), P50CA221747 SPORE for Translational Approaches to Brain Cancer (AMS), and Developmental funds from The Robert H. Lurie NCI Cancer Center Support Grant #P30CA060553 (AMS), and generous philanthropic support from Dan and Sharon Moceri. We thank Dr. Ichiro Nakano (University of Alabama), Dr. Charles David James (Northwestern University), and Dr. Shi-Yuan Cheng (Northwestern University) for the kind gift of the GBM xenografts. We thank Dr. Peng Zhang (Northwestern University) for technical support with culture of GBM PDX. We thank Synthego, CA, USA, for the gifts of RPS11 sgRNA guides. Immunofluorescence imaging work was performed at the Center for Advanced Microscopy/Nikon Imaging Center and RHLCCC - Flow Cytometry Core, Northwestern University supported by NCI CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center. BG was supported by the NVKP 16-1-2016-0037 grant.	Alli S, 2018, J CONTROL RELEASE, V281, P29, DOI 10.1016/j.jconrel.2018.05.005; Barnoud D, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.27038; Carpentier A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6086; Ceccaldi R, 2016, NAT REV MOL CELL BIO, V17, P337, DOI 10.1038/nrm.2016.48; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Dennis G, 2003, GENOME BIOL, V4; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Forbes S A, 2016, Curr Protoc Hum Genet, V91, DOI 10.1002/cphg.21; Forester CM, 2018, P NATL ACAD SCI USA, V115, P2353, DOI 10.1073/pnas.1707514115; Franceschi E, 2004, BRIT J CANCER, V91, P1038, DOI 10.1038/sj.bjc.6602105; Girling DJ, 1996, LANCET, V348, P563, DOI 10.1016/S0140-6736(96)02005-3; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Haapaniemi E, 2018, NAT MED, V24, P927, DOI 10.1038/s41591-018-0049-z; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Idbaih A, 2019, CLIN CANCER RES, V25, P3793, DOI 10.1158/1078-0432.CCR-18-3643; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Kesari S, 2007, NEURO-ONCOLOGY, V9, P354, DOI 10.1215/15228517-2007-006; Koschmann C, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac8228; Krisp C, 2018, BR J CANC; Leonard A, 2013, ANTICANCER RES, V33, P3307; Lin YL, 2018, J PHARMACEUT BIOMED, V149, P482, DOI 10.1016/j.jpba.2017.11.047; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Mainprize T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36340-0; Mehta A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00459; Michlits G, 2017, NAT METHODS, V14, P1191, DOI [10.1038/NMETH.4466, 10.1038/nmeth.4466]; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; Mjelle R, 2015, DNA REPAIR, V30, P53, DOI 10.1016/j.dnarep.2015.03.007; Moreno P, 2018, MOL ONCOL, V12, P1778, DOI 10.1002/1878-0261.12369; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Pitz MW, 2011, J NEURO-ONCOL, V104, P629, DOI 10.1007/s11060-011-0564-y; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Pop C, 2005, CELL, V123, P192, DOI 10.1016/j.cell.2005.10.010; Reardon DA, 2009, BRIT J CANCER, V101, P1986, DOI 10.1038/sj.bjc.6605412; Sapio RT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09002-w; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sonabend AM, 2019, CLIN CANCER RES, V25, P3750, DOI 10.1158/1078-0432.CCR-19-0932; Sonabend AM, 2014, NEURO-ONCOLOGY, V16, P1210, DOI 10.1093/neuonc/nou026; STEWART DJ, 1984, J NEURO-ONCOL, V2, P133; Stransky N, 2015, NATURE, V528, P84, DOI 10.1038/nature15736; Stupp R, 2017, JAMA-J AM MED ASSOC, V318, P2306, DOI 10.1001/jama.2017.18718; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sun T, 2017, P NATL ACAD SCI USA, V114, pE10281, DOI 10.1073/pnas.1713328114; Tsai Cheng-Han, 2018, Oncotarget, V9, P30731, DOI 10.18632/oncotarget.24578; Uuskula-Reimand L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1043-8; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wijdeven RH, 2015, CANCER RES, V75, P4176, DOI 10.1158/0008-5472.CAN-15-0380; Winter J, 2017, CRIS PRANALYZER INTE; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022; ZUCCHETTI M, 1991, ANN ONCOL, V2, P63, DOI 10.1093/oxfordjournals.annonc.a057826	52	10	10	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 2	2020	39	27					5068	5081		10.1038/s41388-020-1342-0	http://dx.doi.org/10.1038/s41388-020-1342-0		JUN 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ME5NL	32528131	Green Submitted, Green Accepted			2022-12-26	WOS:000539817600002
J	Ligon, C; Seong, E; Schroeder, EJ; DeKorver, NW; Yuan, L; Chaudoin, TR; Cai, Y; Buch, S; Bonasera, SJ; Arikkath, J				Ligon, Cheryl; Seong, Eunju; Schroeder, Ethan J.; DeKorver, Nicholas W.; Yuan, Li; Chaudoin, Tammy R.; Cai, Yu; Buch, Shilpa; Bonasera, Stephen J.; Arikkath, Jyothi			delta-Catenin engages the autophagy pathway to sculpt the developing dendritic arbor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						delta-catenin; hippocampal neurons; dendrite; autophagy; dendritic arbor; catenin delta 2 (CTNND2); autism; neuronal development; ATG7; neuron; development; hippocampus	PYRAMIDAL NEURONS; REGULATES SPINE; NEURODEGENERATION; INTEGRATION; MORPHOGENESIS; COMPLEX; CTNND2; CARGO; MACROAUTOPHAGY; COMPARTMENT	The development of the dendritic arbor in pyramidal neurons is critical for neural circuit function. Here, we uncovered a pathway in which delta-catenin, a component of the cadherin-catenin cell adhesion complex, promotes coordination of growth among individual dendrites and engages the autophagy mechanism to sculpt the developing dendritic arbor. Using a rat primary neuron model, time-lapse imaging, immunohistochemistry, and confocal microscopy, we found that apical and basolateral dendrites are coordinately sculpted during development. Loss or knockdown of delta-catenin uncoupled this coordination, leading to retraction of the apical dendrite without altering basolateral dendrite dynamics. Autophagy is a key cellular pathway that allows degradation of cellular components. We observed that the impairment of the dendritic arbor resulting from delta-catenin knockdown could be reversed by knockdown of autophagy-related 7 (ATG7), a component of the autophagy machinery. We propose that delta-catenin regulates the dendritic arbor by coordinating the dynamics of individual dendrites and that the autophagy mechanism may be leveraged by delta-catenin and other effectors to sculpt the developing dendritic arbor. Our findings have implications for the management of neurological disorders, such as autism and intellectual disability, that are characterized by dendritic aberrations.	[Ligon, Cheryl; Seong, Eunju] Univ Nebraska Med Ctr, Munroe Meyer Instb, Dev Neurosci, Omaha, NE USA; [Schroeder, Ethan J.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [DeKorver, Nicholas W.; Yuan, Li; Cai, Yu; Buch, Shilpa] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Chaudoin, Tammy R.; Bonasera, Stephen J.] Univ Nebraska Med Ctr, Div Geriatr, Omaha, NE USA; [Arikkath, Jyothi] Howard Univ, Dept Anat, Washington, DC 20059 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Howard University	Arikkath, J (corresponding author), Howard Univ, Dept Anat, Washington, DC 20059 USA.	Jyothi.arikkath@howard.edu	Seong, Eunju/ABH-2705-2020; Cai, Yu/AAS-5927-2020	Cai, Yu/0000-0001-7787-8610; Bonasera, Stephen/0000-0001-6808-2821	Munroe-Meyer Institute; Alzheimer's association; Nebraska Research Initiative; Institutional Development Award (IDeA) under NIGMS, National Institutes of Health [5P20GM103471-10]; Nebraska EPSCoR Grant [EPS-1004094]; National Institutes of Health [1R03MH110726-01]; Edna Ittner Pediatric Research Fund; University of Nebraska Medical Center; NIA, National Institutes of Health [AG031158]; NIMH, National Institutes of Health [MH106425]	Munroe-Meyer Institute; Alzheimer's association(Alzheimer's Association); Nebraska Research Initiative; Institutional Development Award (IDeA) under NIGMS, National Institutes of Health; Nebraska EPSCoR Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edna Ittner Pediatric Research Fund; University of Nebraska Medical Center; NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Startup funds from the Munroe-Meyer Institute and grants from the Alzheimer's association, the Nebraska Research Initiative, an Institutional Development Award (IDeA) under NIGMS, National Institutes of Health, Grant 5P20GM103471-10 (to C. L., E. S., and J. A.), Nebraska EPSCoR Grant EPS-1004094 (to J. A.), RO3 from National Institutes of Health Grant 1R03MH110726-01 (to J. A.), and the Edna Ittner Pediatric Research Fund. L. Y. and E. S. were supported in part by a graduate student fellowship from the University of Nebraska Medical Center. This work was also supported by NIA, National Institutes of Health, Grant AG031158 (to N. W. D., T. R. C., and S. J. B.) and NIMH, National Institutes of Health, Grant MH106425 (to S. J. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Arikkath J, 2008, J NEUROSCI, V28, P7047, DOI 10.1523/JNEUROSCI.0451-08.2008; Arikkath J, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00061; Arikkath J, 2009, J NEUROSCI, V29, P5435, DOI 10.1523/JNEUROSCI.0835-09.2009; Ashkenazi A, 2017, NATURE, V545, P108, DOI 10.1038/nature22078; Ban BK, 2013, MOL CELL BIOL, V33, P3907, DOI 10.1128/MCB.00627-13; Basu R, 2017, NEURON, V96, P160, DOI 10.1016/j.neuron.2017.09.009; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Belcaro C, 2015, GENE, V565, P146, DOI 10.1016/j.gene.2015.03.054; Bento CF, 2016, ANNU REV BIOCHEM, V85, P685, DOI 10.1146/annurev-biochem-060815-014556; Bian WJ, 2015, CELL, V162, P808, DOI 10.1016/j.cell.2015.07.018; Biever A, 2019, CURR OPIN NEUROBIOL, V57, P141, DOI 10.1016/j.conb.2019.02.008; Bloss EB, 2016, NEURON, V89, P1016, DOI 10.1016/j.neuron.2016.01.029; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; Brigidi GS, 2014, NAT NEUROSCI, V17, P522, DOI 10.1038/nn.3657; Cai Y, 2016, J CELL BIOL, V215, P245, DOI 10.1083/jcb.201605065; Cai Y, 2016, AUTOPHAGY, V12, P225, DOI 10.1080/15548627.2015.1121360; Dang T, 2018, MOL PSYCHIATR, V23, P747, DOI 10.1038/mp.2016.253; Duman JG, 2019, ELIFE, V8, DOI 10.7554/eLife.47566; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Gao FB, 2017, EMBO J, V36, P2931, DOI 10.15252/embj.201797568; Gilbert J, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0238-16.2016; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Hernandez D, 2012, NEURON, V74, P277, DOI 10.1016/j.neuron.2012.02.020; Hoffmann S, 2019, J NEUROSCI, V39, P2163, DOI 10.1523/JNEUROSCI.1317-18.2019; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2006, BRAIN CELL BIOL, V35, P29, DOI 10.1007/s11068-006-9003-y; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Ivankovic D, 2020, AUTOPHAGY, V16, P391, DOI 10.1080/15548627.2019.1615302; Kim H, 2008, J BIOL CHEM, V283, P977, DOI 10.1074/jbc.M707158200; Knecht E, 2010, AUTOPHAGY, V6, P991, DOI [10.4161/auto.6.7.13308, 10.4161/auto6.7.13308]; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kononenko NL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14819; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Kupferman JV, 2014, CELL, V158, P1335, DOI 10.1016/j.cell.2014.07.035; Lefebvre JL, 2015, ANNU REV CELL DEV BI, V31, P741, DOI 10.1146/annurev-cellbio-100913-013020; Li MY, 2017, NEURON, V94, P1155, DOI 10.1016/j.neuron.2017.05.022; Lu Q, 2016, HUM GENET, V135, P1107, DOI 10.1007/s00439-016-1705-3; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; Maday S, 2014, DEV CELL, V30, P71, DOI 10.1016/j.devcel.2014.06.001; Maday S, 2012, AUTOPHAGY, V8, P858, DOI 10.4161/auto.20055; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; Makara JK, 2013, NEURON, V80, P1438, DOI 10.1016/j.neuron.2013.10.033; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nassif M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00442; O'Neill KM, 2017, CELL MOL LIFE SCI, V74, P4369, DOI 10.1007/s00018-017-2589-7; Okerlund ND, 2018, NEURON, V97, P727, DOI 10.1016/j.neuron.2018.01.010; Okerlund ND, 2017, NEURON, V93, P897, DOI 10.1016/j.neuron.2017.01.026; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Patel MV, 2018, MOL NEUROBIOL, V55, P6269, DOI 10.1007/s12035-017-0849-z; Payeur A, 2019, CURR OPIN NEUROBIOL, V58, P78, DOI 10.1016/j.conb.2019.07.006; Ramesh N, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00263; Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Schmidt-Hieber C, 2017, NAT NEUROSCI, V20, P1114, DOI 10.1038/nn.4582; Sheffield MEJ, 2019, CURR OPIN NEUROBIOL, V54, P1, DOI 10.1016/j.conb.2018.07.004; Shimell JJ, 2019, CELL REP, V29, P2422, DOI 10.1016/j.celrep.2019.10.065; Soukup SF, 2016, NEURON, V92, P829, DOI 10.1016/j.neuron.2016.09.037; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stuart GJ, 2015, NAT NEUROSCI, V18, P1713, DOI 10.1038/nn.4157; Tang GM, 2014, NEURON, V83, P1131, DOI 10.1016/j.neuron.2014.07.040; Tasset I, 2016, FEBS J, V283, P2403, DOI 10.1111/febs.13677; Tomoda T, 2020, BIOL PSYCHIAT, V87, P787, DOI 10.1016/j.biopsych.2019.07.018; Turner TN, 2015, NATURE, V520, P51, DOI 10.1038/nature14186; Vijayan V, 2017, J CELL BIOL, V216, P1895, DOI 10.1083/jcb.201611113; Wakatsuki S, 2017, J CELL BIOL, V216, P477, DOI 10.1083/jcb.201606020; Wang T, 2015, J NEUROSCI, V35, P6179, DOI 10.1523/JNEUROSCI.3757-14.2015; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Wong YC, 2015, J CELL SCI, V128, P1259, DOI 10.1242/jcs.161216; Wu YK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118482; Yadav S, 2017, NEURON, V93, P379, DOI 10.1016/j.neuron.2016.12.006; Yamawaki N, 2019, NAT NEUROSCI, V22, P618, DOI 10.1038/s41593-019-0355-x; Yang Y, 2013, TRENDS NEUROSCI, V36, P418, DOI 10.1016/j.tins.2013.04.001; Yuan L, 2018, J BIOL CHEM, V293, P11625, DOI 10.1074/jbc.RA118.001966; Yuan L, 2015, J BIOL CHEM, V290, P10947, DOI 10.1074/jbc.M114.632679; Yuan Y, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00314; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9	83	2	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					10988	11001		10.1074/jbc.RA120.013058	http://dx.doi.org/10.1074/jbc.RA120.013058			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32554807	Green Published, hybrid			2022-12-26	WOS:000562757100009
J	Shim, GH; Kim, SY; Cheung, PY; Lee, TF; O'Reilly, M; Schmolzer, GM				Shim, Gyu-Hong; Kim, Seung Yeun; Cheung, Po-Yin; Lee, Tze-Fun; O'Reilly, Megan; Schmolzer, Georg M.			Effects of sustained inflation pressure during neonatal cardiopulmonary resuscitation of asphyxiated piglets	PLOS ONE			English	Article							DELIVERY ROOM RESUSCITATION; BIRTH-WEIGHT INFANTS; CHEST COMPRESSIONS; PORCINE MODEL; RESPIRATORY SUPPORT; VENTILATION RATIO; PRETERM INFANTS; TIDAL VOLUME; RECOVERY; SURVIVAL	Background Sustained inflation (SI) during chest compression (CC = CC+SI) has been recently shown as an alternative method during cardiopulmonary resuscitation in neonates. However, the optimal peak inflation pressure (PIP) of SI during CC+SI to improve ROSC and hemodynamic recovery is unknown. Objective To examine if different PIPs of SI during CC+SI will improve ROSC and hemodynamic recovery in severely asphyxiated piglets. Methods Twenty-nine newborn piglets (1-3 days old) were anesthetized, intubated, instrumented and exposed to 30-min normocapnic hypoxia followed by asphyxia. Piglets were randomized into four groups: CC+SI with a PIP of 10 cmH(2)O (CC+SI_PIP_10, n = 8), a PIP of 20 cmH(2)O (CC+SI_PIP_20, n = 8), a PIP of 30 cmH(2)O (CC+SI_PIP_30, n = 8), and a sham-operated control group (n = 5). Heart rate, arterial blood pressure, carotid blood flow, cerebral oxygenation, and respiratory parameters were continuously recorded throughout the experiment. Results Baseline parameters were similar between all groups. There was no difference in asphyxiation (duration and degree) between intervention groups. PIP correlated positively with tidal volume (V-T) and inversely with exhaled CO(2)during cardiopulmonary resuscitation. Time to ROSC and rate of ROSC were similar between piglets resuscitated with CC+SI_PIP_10, CC+SI_PIP_20, and CC+SI_PIP_30 cmH(2)O: median (IQR) 75 (63-193) sec, 94 (78-210) sec, and 85 (70-90) sec; 5/8 (63%), 7/8 (88%), and 3/8 (38%) (p = 0.56 and p = 0.12, respectively). All piglets that achieved ROSC survived to four hours post-resuscitation. Piglets resuscitated with CC+SI_PIP_30 cmH(2)O exhibited increased concentrations of pro-inflammatory cytokines interleukin-1 beta and tumour necrosis factor-alpha in the frontoparietal cerebral cortex (both p<0.05 vs. sham-operated controls). Conclusion In asphyxiated term newborn piglets resuscitated by CC+SI, the use of different PIPs resulted in similar time to ROSC, but PIP at 30 cmH(2)O showed a larger V(T)delivery, lower exhaled CO(2)and increased tissue inflammatory markers in the brain.	[Shim, Gyu-Hong; Kim, Seung Yeun; Cheung, Po-Yin; Lee, Tze-Fun; O'Reilly, Megan; Schmolzer, Georg M.] Royal Alexandra Hosp, Neonatal Res Unit, Ctr Studies Asphyxia & Resuscitat, Edmonton, AB, Canada; [Shim, Gyu-Hong] Inje Univ, Dept Pediat, Sanggye Paik Hosp, Seoul, South Korea; [Kim, Seung Yeun] Eulji Univ Hosp, Dept Pediat, Daejeon, South Korea; [Cheung, Po-Yin; Lee, Tze-Fun; O'Reilly, Megan; Schmolzer, Georg M.] Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB, Canada	Royal Alexandra Hospital; Inje University; Eulji University; University of Alberta	Schmolzer, GM (corresponding author), Royal Alexandra Hosp, Neonatal Res Unit, Ctr Studies Asphyxia & Resuscitat, Edmonton, AB, Canada.; Schmolzer, GM (corresponding author), Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB, Canada.	georg.schmoelzer@me.com	Schmölzer, Georg M/E-7883-2010	Schmölzer, Georg M/0000-0001-9798-2415; Shim, Gyu Hong/0000-0001-5805-8764; Kim, Seung Yeon/0000-0002-7004-4821	SickKids Foundation; Canadian Institutes of Health Research (CIHR -Institute of Human Development, Child and Youth Health (IHDCYH)), New Investigator Research Grant Program [NI17-033]; Stollery Children's Hospital Foundation	SickKids Foundation; Canadian Institutes of Health Research (CIHR -Institute of Human Development, Child and Youth Health (IHDCYH)), New Investigator Research Grant Program(Canadian Institutes of Health Research (CIHR)); Stollery Children's Hospital Foundation	We would like to thank the public for donating money to our funding agencies: GMS is a recipient of the Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation, a National New Investigator of the Heart and Stroke Foundation Canada and an Alberta New Investigator of the Heart and Stroke Foundation Alberta. The study was supported by a Grant from the SickKids Foundation in partnership with the Canadian Institutes of Health Research (CIHR -Institute of Human Development, Child and Youth Health (IHDCYH)), New Investigator Research Grant Program (Grant number -No. NI17-033). This research has been facilitated by the Women and Children's Health Research Institute through the generous support of the Stollery Children's Hospital Foundation.	Andersen CC, 2011, J APPL PHYSIOL, V111, P775, DOI 10.1152/japplphysiol.00214.2011; [Anonymous], 2015, CIRCULATION S2, V132, pS414; [Anonymous], 2015, CIRCULATION S2, V132, pS414; Aziz K, 2008, RESUSCITATION, V79, P444, DOI 10.1016/j.resuscitation.2008.08.004; Barton SK, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00097; Chalak LF, 2011, PEDIATR RES, V69, P401, DOI 10.1203/PDR.0b013e3182125f7f; Cheung PY, 2011, JOVE-J VIS EXP, DOI 10.3791/3166; Dammann O, 2001, PEDIATR RES, V49, P388, DOI 10.1203/00006450-200103000-00013; DeMauro SB, 2011, J PEDIATR-US, V159, P546, DOI 10.1016/j.jpeds.2011.03.025; Finer NN, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.4.e40; Garcia-Hidalgo C, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00400; Harrington DJ, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.10.877; Kapadia V, 2012, CLIN PERINATOL, V39, P833, DOI 10.1016/j.clp.2012.09.011; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kirpalani H, 2019, JAMA-J AM MED ASSOC, V321, P1165, DOI 10.1001/jama.2019.1660; Klingenberg C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003666.pub4; Li ES, 2017, NEONATOLOGY, V112, P337, DOI 10.1159/000477998; Li ES, 2015, ARCH DIS CHILD-FETAL, V100, pF530, DOI 10.1136/archdischild-2015-308363; Mian Q, 2019, ARCH DIS CHILD-FETAL, V104, pF57, DOI 10.1136/archdischild-2017-313864; Mustofa J, 2018, RESUSCITATION, V129, P82, DOI 10.1016/j.resuscitation.2018.06.013; Pasquin MP, 2018, NEONATOLOGY, V114, P37, DOI 10.1159/000487988; Pichler G, 2013, J PEDIATR-US, V163, P1558, DOI 10.1016/j.jpeds.2013.07.007; Polglase GR, 2014, PEDIATR RES, V75, P682, DOI 10.1038/pr.2014.40; Polglase GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039535; Polglase GR, 2012, J APPL PHYSIOL, V112, P481, DOI 10.1152/japplphysiol.00995.2011; Schmolzer GM, 2014, RESUSCITATION, V85, P270, DOI 10.1016/j.resuscitation.2013.10.011; Schmolzer GM, 2013, CIRCULATION, V128, P2495, DOI 10.1161/CIRCULATIONAHA.113.002289; Schmolzer GM, 2010, ARCH DIS CHILD-FETAL, V95, pF295, DOI 10.1136/adc.2009.165878; Schmolzer GM, 2008, J PEDIATR-US, V153, P741, DOI 10.1016/j.jpeds.2008.08.016; Schmolzer GM, 2019, JACC-BASIC TRANSL SC, V4, P116, DOI 10.1016/j.jacbts.2018.12.004; Schmolzer GM, 2018, ARCH DIS CHILD-FETAL, V103, pF455, DOI 10.1136/archdischild-2017-313037; Shah PS, 2009, J PERINATOL, V29, P693, DOI 10.1038/jp.2009.70; Shah PS, 2009, J PERINATOL, V29, P655, DOI 10.1038/jp.2009.71; SK AZ, 2016, DIABETOL STOFFWECHS, V11, pS01; Sobotka KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146574; Solevag AL, 2017, ARCH DIS CHILD-FETAL, V102, pF85, DOI 10.1136/archdischild-2016-311043; Solevag AL, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00003; Solevag AL, 2016, RESUSCITATION, V106, P7, DOI 10.1016/j.resuscitation.2016.06.014; Solevag AL, 2016, ARCH DIS CHILD-FETAL, V101, pF272, DOI 10.1136/archdischild-2015-309761; Tracy M, 2004, ARCH DIS CHILD-FETAL, V89, pF84, DOI 10.1136/fn.89.1.F84; Tsui BCH, 2015, RESUSCITATION, V92, P148, DOI 10.1016/j.resuscitation.2015.02.021; van Os S, 2014, ACTA PAEDIATR, V103, P796, DOI 10.1111/apa.12650; Wyckoff M, 2000, PEDIATRICS, V106, P618, DOI 10.1542/peds.106.3.618; Wyckoff MH, 2012, J PEDIATR-US, V160, P239, DOI 10.1016/j.jpeds.2011.07.041; Wyllie J, 2015, RESUSCITATION, V95, pE169, DOI 10.1016/j.resuscitation.2015.07.045	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0228693	10.1371/journal.pone.0228693	http://dx.doi.org/10.1371/journal.pone.0228693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574159	Green Submitted, gold, Green Published			2022-12-26	WOS:000544972400023
J	Nichols, PH; Pan, Y; May, B; Pavlicova, M; Rausch, JC; Mencin, AA; Thaker, VV				Nichols, Presley H.; Pan, Yue; May, Benjamin; Pavlicova, Martina; Rausch, John C.; Mencin, Ali A.; Thaker, Vidhu V.			Effect of TSH on Non-Alcoholic Fatty Liver Disease (NAFLD) independent of obesity in children of predominantly Hispanic/Latino ancestry by causal mediation analysis	PLOS ONE			English	Article							SUBCLINICAL HYPOTHYROIDISM; PEDIATRIC GASTROENTEROLOGY; HEART-DISEASE; RISK; ADOLESCENTS; CHILDHOOD; DIAGNOSIS; GROWTH; SAS	Background Nonalcoholic Fatty Liver Disease (NAFLD) is a common co-morbidity of obesity. Elevated TSH levels (eTSH), also associated with obesity, may contribute to the dysmetabolic state that predisposes to NAFLD. Objective To assess the relationship between TSH levels and NAFLD in children with biopsy-proven NAFLD compared to controls. Design and methods In this retrospective study of children with biopsy-proven NAFLD and age-matched controls, the association of eTSH with NAFLD was investigated and the role of TSH as a mediator between obesity and NAFLD was assessed. Results Sixty-six cases and 4067 controls (69.7 vs 59% Hispanic/Latino ancestry, p = 0.1) of the same age range seen in the same time duration at an urban Children's Hospital were studied. Children with NAFLD were more likely to be male (74.6 vs 39.4%, p < 0.001), have higher modified BMI-z scores (median 2.4 (IQR 1.7) vs 1.9 (IQR 1.7), p < 0.001), and abnormal metabolic parameters (TSH, ALT, HDL-C, non-HDL-C, and TG). Multivariate analyses controlling for age, sex and severity of obesity showed significant association between the 4(th)quartile of TSH and NAFLD. Causal mediation analysis demonstrates that TSH mediates 33.8% of the effect of modified BMI-z score on NAFLD. This comprises of 16.0% (OR = 1.1, p = 0.002) caused by the indirect effect of TSH and its interaction with modified BMI-z, and 17.7% (OR = 1.1, p = 0.05) as an autonomous effect of TSH on NAFLD. Overall, 33.8% of the effect can be eliminated by removing the mediator, TSH (p = 0.001). Conclusions The association of eTSH and biopsy-proven NAFLD is demonstrated in children of Hispanic/Latino ancestry. Further, a causal mediation analysis implicates an effect of TSH on NAFLD, independent of obesity.	[Nichols, Presley H.; Rausch, John C.] New York Presbyterian Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY USA; [Pan, Yue; Pavlicova, Martina] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [May, Benjamin] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Irving Med Ctr, New York, NY USA; [Rausch, John C.; Mencin, Ali A.; Thaker, Vidhu V.] Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY 10027 USA	NewYork-Presbyterian Hospital; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Thaker, VV (corresponding author), Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY 10027 USA.	vvt2114@cumc.columbia.edu		Rausch, John/0000-0002-1916-641X; Thaker, Vidhu/0000-0002-3537-2782	NIH-NIDDK, National Institutes of Diabetes and Digestive and Kidney Diseases [K23 DK 110539]; Irving Institute for Clinical and Translational Medicine at Columbia University Medical Center - National Center for Advancing Translational Sciences, NIH [UL1TR001873]	NIH-NIDDK, National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Irving Institute for Clinical and Translational Medicine at Columbia University Medical Center - National Center for Advancing Translational Sciences, NIH	VVT received funding from NIH-NIDDK K23 DK 110539, National Institutes of Diabetes and Digestive and Kidney Diseases, https://www.niddk.nih.gov/.The statistical analysis was supported by the Irving Institute for Clinical and Translational Medicine at Columbia University Medical Center supported by the the National Center for Advancing Translational Sciences, NIH, through Grant Number UL1TR001873. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterio A, 2014, HORM RES PAEDIAT, V82, P283, DOI 10.1159/000365192; Anderson EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140908; Aypak C, 2013, J PEDIATR ENDOCR MET, V26, P703, DOI 10.1515/jpem-2012-0384; Bilgin H, 2014, J CLIN RES PEDIATR E, V6, P152, DOI [10.4274/Jcrpe.1488, 10.4274/jcrpe.1488]; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; BURMAN KD, 1980, J CLIN ENDOCR METAB, V51, P106, DOI 10.1210/jcem-51-1-106; Centers for Disease Control and Prevention, 2016, SAS PROGRAM 2000 CDC; Cerbone M, 2014, J CLIN ENDOCR METAB, V99, P2697, DOI 10.1210/jc.2014-1761; Cerbone M, 2011, EUR J ENDOCRINOL, V164, P591, DOI 10.1530/EJE-10-0979; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; Dahl M, 2017, J CLIN RES PEDIATR E, V9, P8, DOI 10.4274/jcrpe.3319; Denzer C, 2013, EUR J ENDOCRINOL, V168, P601, DOI 10.1530/EJE-12-0703; Fernandes DM, 2018, J PEDIATR-US, V200, P174, DOI 10.1016/j.jpeds.2018.04.047; Ferrandino G, 2017, P NATL ACAD SCI USA, V114, pE9172, DOI 10.1073/pnas.1707797114; Freedman DS, 2017, OBESITY, V25, P739, DOI 10.1002/oby.21782; Gao N, 2013, ATHEROSCLEROSIS, V227, P18, DOI 10.1016/j.atherosclerosis.2012.10.070; Gencer B, 2012, CIRCULATION, V126, P1040, DOI 10.1161/CIRCULATIONAHA.112.096024; Gulati AK, 2012, PEDIATRICS, V130, P1136, DOI 10.1542/peds.2012-0596; Guo ZQ, 2018, DIGEST LIVER DIS, V50, P1153, DOI 10.1016/j.dld.2018.08.012; Harris M, 2001, J CLIN INVEST, V107, P111, DOI 10.1172/JCI10741; Kaltenbach TEM, 2017, PEDIATR OBES, V12, P67, DOI 10.1111/ijpo.12110; Lee MK, 2019, ENDOCRINE, V65, P608, DOI 10.1007/s12020-019-01942-9; Licenziati MR, 2019, J CLIN ENDOCR METAB, V104, P2757, DOI 10.1210/jc.2018-02399; Monzani A, 2013, EUR J ENDOCRINOL, V168, pR1, DOI 10.1530/EJE-12-0656; Nobili V, 2015, JAMA PEDIATR, V169, P170, DOI 10.1001/jamapediatrics.2014.2702; PACIFICO L, 2013, INT J ENDOCRINOL, DOI DOI 10.1155/2013/381014; Radetti G, 2006, J PEDIATR-US, V149, P827, DOI 10.1016/j.jpeds.2006.08.045; Razvi S, 2010, J CLIN ENDOCR METAB, V95, P1734, DOI 10.1210/jc.2009-1749; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; Salerno M, 2016, NAT REV ENDOCRINOL, V12, P734, DOI 10.1038/nrendo.2016.100; Schwimmer JB, 2013, ALIMENT PHARM THER, V38, P1267, DOI 10.1111/apt.12518; Sert A, 2013, PEDIATR CARDIOL, V34, P1166, DOI 10.1007/s00246-013-0638-z; Sinha RA, 2018, NAT REV ENDOCRINOL, V14, P259, DOI 10.1038/nrendo.2018.10; Song YF, 2015, J HEPATOL, V62, P1171, DOI 10.1016/j.jhep.2014.12.006; Torun E, 2014, J CLIN RES PEDIATR E, V6, P34, DOI 10.4274/Jcrpe.1155; Valeri L, 2015, EPIDEMIOLOGY, V26, pE23, DOI 10.1097/EDE.0000000000000253; Valeri L, 2013, PSYCHOL METHODS, V18, P137, DOI 10.1037/a0031034; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P749, DOI 10.1097/EDE.0000000000000121; Vos MB, 2017, J PEDIATR GASTR NUTR, V64, P319, DOI 10.1097/MPG.0000000000001482; Wang XL, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1249630; Wasniewska M, 2009, EUR J ENDOCRINOL, V160, P417, DOI 10.1530/EJE-08-0625; Yan F, 2014, J HEPATOL, V61, P1358, DOI 10.1016/j.jhep.2014.06.037; Zhang W, 2009, J CELL MOL MED, V13, P4636, DOI 10.1111/j.1582-4934.2008.00670.x; Zhang XJ, 2015, J LIPID RES, V56, P963, DOI 10.1194/jlr.M047654	45	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234985	10.1371/journal.pone.0234985	http://dx.doi.org/10.1371/journal.pone.0234985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569304	gold, Green Published			2022-12-26	WOS:000543547900049
J	Yadav, C; Smith, ML; Yack, JE				Yadav, Chanchal; Smith, Myron L.; Yack, Jayne E.			Transcriptome analysis of a social caterpillar,Drepana arcuata: De novo assembly, functional annotation and developmental analysis	PLOS ONE			English	Article							GENE-EXPRESSION; MEDIATED TERRITORIALITY; BEHAVIOR; CATERPILLAR; EVOLUTION; BRAIN	The masked birch caterpillar,Drepana arcuata, provides an excellent opportunity to study mechanisms mediating developmental changes in social behaviour. Larvae transition from being social to solitary during the 3(rd)instar, concomitant with shifts in their use of acoustic communication. In this study we characterize the transcriptome ofD.arcuatato initiate sociogenomic research of this lepidopteran insect. We assembled and annotated the combined larval transcriptome of "social" early and "solitary" late instars using next generation Illumina sequencing, and used this transcriptome to conduct differential gene expression analysis of the two behavioural phenotypes. A total of 211,012,294 reads generated by RNA sequencing were assembled into 231,348 transcripts and 116,079 unigenes for the functional annotation of the transcriptome. Expression analysis revealed 3300 transcripts that were differentially expressed between early and late instars, with a large proportion associated with development and metabolic processes. We independently validated differential expression patterns of selected transcripts using RT-qPCR. The expression profiles of social and solitary larvae revealed differentially expressed transcripts coding for gene products that have been previously reported to influence social behaviour in other insects (e.g. cGMP- and cAMP- dependent kinases, and bioamine receptors). This study provides the first transcriptomic resources for a lepidopteran species belonging to the superfamily Drepanoidea, and gives insight into genetic factors mediating grouping behaviour in insects.	[Yadav, Chanchal; Smith, Myron L.; Yack, Jayne E.] Carleton Univ, Dept Biol, Ottawa, ON, Canada	Carleton University	Yack, JE (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON, Canada.	jayneyack@cunet.carleton.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [201405947, 2014-05436]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/index_eng.asp) Discovery grant numbers: 201405947 to JEY and 2014-05436 to MLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ament SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002596; [Anonymous], 2017, Hepatol Int, V11, P1, DOI 10.1007/s12072-016-9783-9; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; [Anonymous], 2017, PHARMACOEPIDEMIO SS2, V26, P1, DOI DOI 10.1007/s11665-016-2478-5; [Anonymous], GENOMICS PHYSL BEHAV; [Anonymous], 2012, P NATL ACAD SCI USA, V109, pE1377; [Anonymous], 2015, HLTH PROT REP, V9, P1, DOI DOI 10.1186/1752-4458-9-1; [Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Anstey LJ, 2002, CAN ENTOMOL, V134, P529, DOI 10.4039/Ent134529-4; Badisco L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028110; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Berens AJ, 2015, MOL BIOL EVOL, V32, P690, DOI 10.1093/molbev/msu330; Bloch G, 2001, J BIOL RHYTHM, V16, P444, DOI 10.1177/074873001129002123; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borzoui E, 2018, J ECON ENTOMOL, V111, P942, DOI 10.1093/jee/tox360; Bowen JL, 2008, PHYSIOL ENTOMOL, V33, P238, DOI 10.1111/j.1365-3032.2008.00627.x; Bryant DM, 2017, CELL REP, V18, P762, DOI 10.1016/j.celrep.2016.12.063; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Costa J., 2006, OTHER INSECT SOC; Costa JT, 2018, CURR OPIN INSECT SCI, V28, P40, DOI 10.1016/j.cois.2018.04.008; Costa James T., 1997, P407; Cremer Sylvia, 2018, Annual Review of Entomology, V63, P105, DOI 10.1146/annurev-ento-020117-043110; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Despland E, 2007, ENTOMOL EXP APPL, V122, P181, DOI 10.1111/j.1570-7458.2006.00512.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fitzpatrick MJ, 2005, TRENDS ECOL EVOL, V20, P96, DOI 10.1016/j.tree.2004.11.017; Goldstein PZ, 2017, INSECT BIODIVERSITY: SCIENCE AND SOCIETY, VOL I, 2ND EDITION, P463; Gospocic J, 2017, CELL, V170, P748, DOI 10.1016/j.cell.2017.07.014; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guedes RNC, 2012, J COMP PHYSIOL A, V198, P325, DOI 10.1007/s00359-012-0711-8; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Hewlett SE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205686; Hill DS, 1983, AGR INSECT PESTS TRO, P551; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kato T, 2006, PIGM CELL RES, V19, P337, DOI 10.1111/j.1600-0749.2006.00316.x; Kocher SD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06824-8; Kucharski R, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0007; Leonhardt SD, 2016, CELL, V164, P1277, DOI 10.1016/j.cell.2016.01.035; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu XN, 2006, PESTIC BIOCHEM PHYS, V84, P127, DOI 10.1016/j.pestbp.2005.06.002; Ma ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08036; Markert MJ, 2016, G3-GENES GENOM GENET, V6, P905, DOI 10.1534/g3.116.027029; McClure M, 2011, NATURWISSENSCHAFTEN, V98, P425, DOI 10.1007/s00114-011-0788-x; Minet Joel, 1999, Handbuch der Zoologie (Berlin), V4, P301; Miura T, 2004, ECOL RES, V19, P141, DOI 10.1111/j.1440-1703.2003.00618.x; Mougenot F, 2012, ANIM BEHAV, V84, P391, DOI 10.1016/j.anbehav.2012.05.008; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Okamoto S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-396; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Pearce SL, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0402-6; Peterson B, 2019, GENE, V710, P387, DOI 10.1016/j.gene.2019.05.048; Ratchford SG, 1998, ANIM BEHAV, V56, P1027, DOI 10.1006/anbe.1998.0869; Robinson GE, 2005, NAT REV GENET, V6, P257, DOI 10.1038/nrg1575; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scott JL, 2012, EUR J ENTOMOL, V109, P411, DOI 10.14411/eje.2012.053; Scott JL, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.5401; Scott Jessica R., 2012, THESIS; Sen Zeng R, 2007, J CHEM ECOL, V33, P449, DOI 10.1007/s10886-006-9238-1; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Surlykke A, 2003, J EXP BIOL, V206, P2653, DOI 10.1242/jeb.00469; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80; Triant DA, 2018, CURR OPIN INSECT SCI, V25, P99, DOI 10.1016/j.cois.2017.12.004; Trible W, 2017, CELL, V170, P727, DOI 10.1016/j.cell.2017.07.001; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wada-Katsumata A, 2011, J EXP BIOL, V214, P1707, DOI 10.1242/jeb.051565; Wallbank RWR, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002353; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; WILSON EO, 1985, SCIENCE, V228, P1489, DOI 10.1126/science.228.4707.1489; WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 17 STUDY GROUP, 2017, Amyotroph Lateral Scler Frontotemporal Degener, V18, P20, DOI 10.1080/21678421.2017.1362000; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yack JE, 2014, ETHOLOGY, V120, P354, DOI 10.1111/eth.12210; Yack JE, 2001, P NATL ACAD SCI USA, V98, P11371, DOI 10.1073/pnas.191378898; Yadav C, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2280-x; Yan H, 2017, CELL, V170, P736, DOI 10.1016/j.cell.2017.06.051	76	6	6	8	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234903	10.1371/journal.pone.0234903	http://dx.doi.org/10.1371/journal.pone.0234903			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569288	gold, Green Published			2022-12-26	WOS:000543547900050
J	Nollet, EA; Cardo-Vila, M; Ganguly, SS; Tran, JD; Schulz, VV; Cress, A; Corey, E; Miranti, CK				Nollet, Eric A.; Cardo-Vila, Marina; Ganguly, Sourik S.; Tran, Jack D.; Schulz, Veronique V.; Cress, Anne; Corey, Eva; Miranti, Cindy K.			Androgen receptor-induced integrin alpha 6 beta 1 and Bnip3 promote survival and resistance to PI3K inhibitors in castration-resistant prostate cancer	ONCOGENE			English	Article							PLASMINOGEN-ACTIVATOR; GROWTH-FACTOR; AUTOPHAGY; INDUCTION; TRANSCRIPTION; EXPRESSION; PROTEIN; MITOPHAGY; PATHWAYS; CLEAVAGE	The androgen receptor (AR) is the major driver of prostate cancer growth and survival. However, almost all patients relapse with castration-resistant disease (CRPC) when treated with anti-androgen therapy. In CRPC, AR is often aberrantly activated independent of androgen. Targeting survival pathways downstream of AR could be a viable strategy to overcome CRPC. Surprisingly, little is known about how AR drives prostate cancer survival. Furthermore, CRPC tumors in which Pten is lost are also resistant to eradication by PI3K inhibitors. We sought to identify the mechanism by which AR drives tumor survival in CRPC to identify ways to overcome resistance to PI3K inhibition. We found that integrins alpha 6 beta 1 and Bnip3 are selectively elevated in CRPC downstream of AR. While integrin alpha 6 promotes survival and is a direct transcriptional target of AR, the ability of AR to induce Bnip3 is dependent on adhesion to laminin and integrin alpha 6 beta 1-dependent nuclear translocation of HIF1 alpha. Integrins alpha 6 beta 1 and Bnip3 were found to promote survival of CRPC cells selectively on laminin through the induction of autophagy and mitophagy. Furthermore, blocking Bnip3 or integrin alpha 6 beta 1 restored sensitivity to PI3K inhibitors in Pten-negative CRPC. We identified an AR driven pathway that cooperates with laminin and hypoxia to drive resistance to PI3K inhibitors. These findings can help explain in part why PI3K inhibitors have failed in clinical trials to overcome AR-dependent CRPC.	[Nollet, Eric A.; Schulz, Veronique V.; Miranti, Cindy K.] Van Andel Res Inst, Grand Rapids, MI 49503 USA; [Cardo-Vila, Marina; Ganguly, Sourik S.; Tran, Jack D.; Cress, Anne; Miranti, Cindy K.] Univ Arizona, Ctr Canc, Dept Cellular & Mol Med, Tucson, AZ 85721 USA; [Cardo-Vila, Marina; Ganguly, Sourik S.; Tran, Jack D.; Cress, Anne; Miranti, Cindy K.] Univ Arizona, Ctr Canc, Prostate Canc Res Program, Tucson, AZ 85721 USA; [Corey, Eva] Univ Washington, Dept Urol, Seattle, WA 98195 USA	Van Andel Institute; University of Arizona; University of Arizona; University of Washington; University of Washington Seattle	Miranti, CK (corresponding author), Van Andel Res Inst, Grand Rapids, MI 49503 USA.; Miranti, CK (corresponding author), Univ Arizona, Ctr Canc, Dept Cellular & Mol Med, Tucson, AZ 85721 USA.; Miranti, CK (corresponding author), Univ Arizona, Ctr Canc, Prostate Canc Res Program, Tucson, AZ 85721 USA.	cmiranti@email.arizona.edu		Corey, Eva/0000-0002-9244-3807	NIH/NCI [CA159406]; Van Andel Research Institute	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Van Andel Research Institute	We would like to thank Drs. Sander Frank and Don Tindall for feedback and constructive suggestions and Penny Berger for technical expertise. Special thanks to Scott Peterson for supplying the PX-866. These studies were supported by funding from NIH/NCI R01CA154835, P30CA023074 (CKM, SSG, EAN, and VVS), and the Van Andel Research Institute. Additional support was provided by NIH/NCI CA159406 (AC).	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Anastasiadis Aristotelis G, 2002, Curr Urol Rep, V3, P222, DOI 10.1007/s11934-002-0068-6; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Berger PL, 2014, CANCER RES, V74, P3357, DOI 10.1158/0008-5472.CAN-13-3076; Boddy JL, 2005, CLIN CANCER RES, V11, P7658, DOI 10.1158/1078-0432.CCR-05-0460; Brooks DLP, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0510-x; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chen Q, 2006, CANCER LETT, V244, P274, DOI 10.1016/j.canlet.2005.12.027; Chen XQ, 2010, CANCER RES, V70, P2728, DOI 10.1158/0008-5472.CAN-09-3718; CRESS AE, 1995, CANCER METAST REV, V14, P219, DOI 10.1007/BF00690293; Crumbaker M, 2017, CANCERS, V9, DOI 10.3390/cancers9040034; Demetriou MC, 2004, EXP CELL RES, V294, P550, DOI 10.1016/j.yexcr.2003.11.023; Feng Q, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00858; Frank SB, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0341-x; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Galletti G, 2017, CANCER TREAT REV, V57, P16, DOI 10.1016/j.ctrv.2017.04.008; Glick D, 2012, MOL CELL BIOL, V32, P2570, DOI 10.1128/MCB.00167-12; Gu YC, 2003, BLOOD, V101, P877, DOI 10.1182/blood-2002-03-0796; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Harryman WL, 2016, BBA-REV CANCER, V1866, P221, DOI 10.1016/j.bbcan.2016.09.005; Hiraga T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113523; Hong DS, 2012, CLIN CANCER RES, V18, P4173, DOI 10.1158/1078-0432.CCR-12-0714; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Ihle NT, 2005, MOL CANCER THER, V4, P1349, DOI 10.1158/1535-7163.MCT-05-0149; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lamb LE, 2011, CANCER RES, V71, P2739, DOI 10.1158/0008-5472.CAN-10-2745; Lee SH, 2015, J BIOL CHEM, V290, P2759, DOI 10.1074/jbc.M114.607846; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Mazure NM, 2009, AUTOPHAGY, V5, P868, DOI 10.4161/auto.9042; Neri P, 2012, CURR CANCER DRUG TAR, V12, P776, DOI 10.2174/156800912802429337; Pietrocola F, 2013, SEMIN CANCER BIOL, V23, P310, DOI 10.1016/j.semcancer.2013.05.008; Pontes-Junior Jose, 2009, J Carcinog, V8, P3; Ports MO, 2009, CANCER RES, V69, P5007, DOI 10.1158/0008-5472.CAN-09-0354; Qi WQ, 2015, ONCOTARGET, V6, P41976, DOI 10.18632/oncotarget.5659; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Shabsigh A, 2001, J CELL BIOCHEM, V81, P437, DOI 10.1002/1097-4644(20010601)81:3<437::AID-JCB1057>3.3.CO;2-Y; Shaw J, 2008, P NATL ACAD SCI USA, V105, P20734, DOI 10.1073/pnas.0807735105; Sinha RA, 2015, AUTOPHAGY, V11, P1341, DOI 10.1080/15548627.2015.1061849; Sobocinski GP, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-42; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tang D, 2017, SCI REP-UK, V7, DOI 10.1038/srep43926; Thomas C, 2013, MOL CANCER THER, V12, P2342, DOI 10.1158/1535-7163.MCT-13-0032; Toth RK, 2019, AM J CLIN EXP UROL, V7, P297; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Veeramani S, 2008, ONCOGENE, V27, P5057, DOI 10.1038/onc.2008.143; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; Wang DP, 2011, METHODS MOL BIOL, V776, P25, DOI 10.1007/978-1-61779-243-4_2; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Yoo NJ, 2010, TUMORI J, V96, P138, DOI 10.1177/030089161009600122; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhang J, 2012, AUTOPHAGY, V8, P1325, DOI 10.4161/auto.20764; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	57	10	10	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 30	2020	39	31					5390	5404		10.1038/s41388-020-1370-9	http://dx.doi.org/10.1038/s41388-020-1370-9		JUN 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MT1TS	32565538	Green Accepted			2022-12-26	WOS:000541695700001
J	Jamaloddin, M; Rani, CVD; Swathi, G; Anuradha, C; Vanisri, S; Rajan, CPD; Raju, SK; Bhuvaneshwari, V; Jagadeeswar, R; Laha, GS; Prasad, MS; Satyanarayana, PV; Cheralu, C; Rajani, G; Ramprasad, E; Sravanthi, P; Kumar, NAP; Kumari, KA; Yamini, KN; Mahesh, D; Rao, DS; Sundaram, RM; Madhav, MS				Jamaloddin, Md; Rani, Ch V. Durga; Swathi, G.; Anuradha, Ch; Vanisri, S.; Rajan, C. P. D.; Raju, S. Krishnam; Bhuvaneshwari, V; Jagadeeswar, R.; Laha, G. S.; Prasad, M. S.; Satyanarayana, P., V; Cheralu, C.; Rajani, G.; Ramprasad, E.; Sravanthi, P.; Kumar, N. Arun Prem; Kumari, K. Aruna; Yamini, K. N.; Mahesh, D.; Rao, D. Sanjeev; Sundaram, R. M.; Madhav, M. Sheshu			Marker Assisted Gene Pyramiding (MAGP) for bacterial blight and blast resistance into mega rice variety "Tellahamsa"	PLOS ONE			English	Article							SELECTION; IDENTIFICATION; LOCUS	Bacterial blight (BB) and fungal blast diseases are the major biotic constraints that limit rice productivity. To sustain yield improvement in rice, it is necessary to developed yield potential of the rice varieties by incorporation of biotic stress resistance genes. Tellahamsa is a well-adapted popular high yielding rice variety in Telangana state, India. However, the variety is highly susceptible to BB and blast. In this study, simultaneous stepwise transfer of genes through marker-assisted backcross breeding (MABB) strategy was used to introgress two major BB (Xa21andxa13) and two major blast resistance genes (Pi54andPi1) into Tellahamsa. In each generation (from F(1)to ICF3) foreground selection was done using gene-specific markers viz., pTA248 (Xa21),xa13prom(xa13),Pi54MAS(Pi54) and RM224 (Pi1). Two independent BC(2)F(1)lines of Tellahamsa/ISM (Cross-I) and Tellahamsa/NLR145 (Cross-II) possessing 92% and 94% recurrent parent genome (RPG) respectively were intercrossed to develop ICF1-ICF(3)generations. These gene pyramided lines were evaluated for key agro-morphological traits, quality, and resistance against blast at three different hotspot locations as well as BB at two locations. Two ICF(3)gene pyramided lines viz., TH-625-159 and TH-625-491 possessing four genes exhibited a high level of resistance to BB and blast. In the future, these improved Tellahamsa lines could be developed as mega varieties for different agro-climatic zones and also as potential donors for different pre-breeding rice research.	[Jamaloddin, Md; Rani, Ch V. Durga; Swathi, G.; Anuradha, Ch; Vanisri, S.; Cheralu, C.; Rajani, G.; Ramprasad, E.; Sravanthi, P.; Kumar, N. Arun Prem; Kumari, K. Aruna; Yamini, K. N.; Mahesh, D.] PJTSAU, Inst Biotechnol IBT, Hyderabad, India; [Jamaloddin, Md] Int Rice Res Inst IRRI, Los Banos, Philippines; [Rajan, C. P. D.] ANGRAU, Agr Res Stn ARS, Nellore, India; [Raju, S. Krishnam; Bhuvaneshwari, V; Satyanarayana, P., V] ANGRAU, Andhra Pradesh Rice Res Inst APRRI, West Godavari, India; [Jagadeeswar, R.] PJTSAU, Agr Res Inst ARI, Hyderabad, India; [Laha, G. S.; Prasad, M. S.; Rao, D. Sanjeev; Sundaram, R. M.; Madhav, M. Sheshu] Indian Inst Rice Res ICAR IIRR, Hyderabad, India	CGIAR; International Rice Research Institute (IRRI); Acharya N. G. Ranga Agricultural University; Acharya N. G. Ranga Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Rice Research	Rani, CVD (corresponding author), PJTSAU, Inst Biotechnol IBT, Hyderabad, India.; Madhav, MS (corresponding author), Indian Inst Rice Res ICAR IIRR, Hyderabad, India.	ranivenkata2@gmail.com; sheshu24@gmail.com		Vutukuri, Bhuvaneswari/0000-0002-0399-1183	Department of Biotechnology (DBT), Government of India [BT/PR11705/AGR/02/646/2008]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	The authors would like to acknowledge Department of Biotechnology (DBT), Government of India, for the financial support to conduct research on rice breeding through the grant BT/PR11705/AGR/02/646/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Department of Biotechnology (DBT), Government of India, for the financial support to conduct research on rice breeding. The authors would like to acknowledge Professor Jayashankar Telangana State Agricultural University (PJTSAU) for providing necessary facilities and also like to acknowledge ANGRAU and IIRR for extending facilities to screen the breeding material.	[Anonymous], 2013, B CONSTITUTIONAL CAS, V2, P308; Arunakumari K, 2016, RICE SCI, V23, P306, DOI 10.1016/j.rsci.2016.04.005; Babujee L, 2000, CURR SCI INDIA, V78, P248; Balachiranjeevi CH, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0348-8; Bao JS, 2006, STARCH-STARKE, V58, P259, DOI 10.1002/star.200500469; Basavaraj SH, 2009, INDIAN J GENET PL BR, V69, P10; Das G, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00985; Devi SJSR, 2020, RICE, V13, DOI 10.1186/s12284-020-00378-4; Divya B, 2014, EUPHYTICA, V200, P61, DOI 10.1007/s10681-014-1146-9; Ellur RK, 2015, PLANT SCI, DOI [10.1016/j.linesci.2015.08.020, DOI 10.1016/J.LINESCI.2015.08.020]; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Flores A, 2008, AGR RES, P22; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; Hua LX, 2012, THEOR APPL GENET, V125, P1047, DOI 10.1007/s00122-012-1894-7; Huang N, 1997, THEOR APPL GENET, V95, P313, DOI 10.1007/s001220050565; IRRI (International rice research institute), 1996, STAND EV SYST RIC; Jiang HC, 2012, MOL BREEDING, V30, P1679, DOI 10.1007/s11032-012-9751-6; Joseph M, 2004, MOL BREEDING, V13, P377, DOI 10.1023/B:MOLB.0000034093.63593.4c; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Khan GH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22246-4; Khanna A, 2015, THEOR APPL GENET, V128, P1243, DOI 10.1007/s00122-015-2502-4; Kumar VA, 2016, J PLANT BIOCHEM BIOT, V25, P400, DOI 10.1007/s13562-016-0352-z; Laha GS, 2009, DRR TECHNICAL B, V41; Liu WD, 2014, ANNU REV PHYTOPATHOL, V52, P213, DOI 10.1146/annurev-phyto-102313-045926; Madhavi KR, 2012, INDIAN J PLANT PROT, V40, P52; Ni DH, 2015, FIELD CROP RES, V184, P1, DOI 10.1016/j.fcr.2015.07.018; Ou SH, 1985, RICE DIS; Pandey P, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01348; Patroti P, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2487-1; Pradhan SK, 2015, RICE, V8, DOI 10.1186/s12284-015-0051-8; Prasad MS, 2011, USDA TECHNICAL B; Ramkumar G, 2011, MOL BREEDING, V27, P129, DOI 10.1007/s11032-010-9538-6; Ratna M K, 2011, IND J PLANT PROT, V39, P124; RONALD PC, 1992, MOL GEN GENET, V236, P113, DOI 10.1007/BF00279649; RoyChowdhury M, 2012, PHYTOPATHOLOGY, V102, P700, DOI 10.1094/PHYTO-02-12-0026-R; Shanti M. L., 2010, International Journal of Plant Pathology, V1, P58; Singh S, 2001, THEOR APPL GENET, V102, P1011, DOI 10.1007/s001220000495; Singh VK, 2013, PLANT BREEDING, V132, P486, DOI 10.1111/pbr.12077; Srikanth S., 2017, INT J DEV RES, V06, P8366; Subudhi H. N., 2012, Journal of Agricultural Science (Toronto), V4, P269; Sundaram RM, 2008, EUPHYTICA, V160, P411, DOI 10.1007/s10681-007-9564-6; Swathi G, 2019, MOL BREEDING, V39, DOI 10.1007/s11032-019-0950-2; Tabien RE, 2002, THEOR APPL GENET, V105, P313, DOI 10.1007/s00122-002-0940-2; Tanweer FA, 2015, CR BIOL, V338, P321, DOI 10.1016/j.crvi.2015.03.001; van Berloo R, 1999, J HERED, V90, P328, DOI 10.1093/jhered/90.2.328; Vanisree S., 2012, INT S 100 YEARS RIC, V1, P108; Vasudevan K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00505; Vikal Y., 2017, ADV INT RICE RES, DOI [10.5772/67361, DOI 10.5772/67361]; Yugander A, 2017, EUR J PLANT PATHOL, V149, P171, DOI 10.1007/s10658-017-1176-y; Yugander A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198260; Zheng K., 1995, IRRI DISCUSSION PAPE; 2012, J I CHINESE LIT PHIL, V22, P5	53	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234088	10.1371/journal.pone.0234088	http://dx.doi.org/10.1371/journal.pone.0234088			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559183	Green Published, gold			2022-12-26	WOS:000543261600031
J	Lim, SL; Xu, L; Han, BC; Shyamsunder, P; Chng, WJ; Koeffler, HP				Lim, Su-Lin; Xu, Liang; Han, Bing-Chen; Shyamsunder, Pavithra; Chng, Wee-Joo; Koeffler, H. Phillip			Multiple myeloma: Combination therapy of BET proteolysis targeting chimeric molecule with CDK9 inhibitor	PLOS ONE			English	Article							TRANSCRIPTION	Cyclin Dependent Kinase 9 (CDK9) associates with Bromodomain and Extra-Terminal Domain (BET) proteins to promote transcriptional elongation by phosphorylation of serine 2 of RNAP II C-terminal domain. We examined the therapeutic potential of selective CDK9 inhibitors (AZD 4573 and MC180295) against human multiple myeloma cellsin vitro. Short-hairpin RNA silencing of CDK9 in Multiple Myeloma (MM) cell lines reduced cell viability compared to control cells showing the dependency of MM cells on CDK9. In order to explore synergy with the CDK9 inhibitor, proteolysis targeting chimeric molecule (PROTAC) ARV 825 was added. This latter drug causes ubiquitination of BET proteins resulting in their rapid and efficient degradation. Combination treatment of MM cells with ARV 825 and AZD 4573 markedly reduced their protein expression of BRD 2, BRD 4, MYC and phosphorylated RNA pol II as compared to each single agent alone. Combination treatment synergistically inhibited multiple myeloma cells bothin vitroandin vivowith insignificant weight loss. The combination also resulted in marked increase of apoptotic cells at low dose compared to single agent alone. Taken together, our studies show for the first time that the combination of a BET PROTAC (ARV 825) plus AZD 4573 (CDK9 inhibitor) is effective against MM cells.	[Lim, Su-Lin; Han, Bing-Chen; Koeffler, H. Phillip] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Xu, Liang; Shyamsunder, Pavithra; Chng, Wee-Joo; Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore	Cedars Sinai Medical Center; National University of Singapore	Lim, SL (corresponding author), Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.	sulin_lim_86@hotmail.com	Xu, Liang/I-9877-2014	Xu, Liang/0000-0002-2700-4840; Lim, Su Lin/0000-0001-6885-2451	Aaron Eshman and Melmed family, Morgan Stanley Inc.; Leukemia and Lymphoma Society (LLS) [9002-16]; Department of Defense (DoD) Award [W81XWH-17-1-0093]; UCLA Clinical and Translational Institute (CTSI) voucher V159; National Research Foundation Singapore under Singapore Translational Research (STaR) [NMRC/STaR/0021/2014]; RNA Biology Center at the Cancer Science Institute of Singapore, NUS, Singapore Ministry of Education's Tier 3 grants [MOE2014-T3-1-006]	Aaron Eshman and Melmed family, Morgan Stanley Inc.; Leukemia and Lymphoma Society (LLS)(Leukemia and Lymphoma Society); Department of Defense (DoD) Award; UCLA Clinical and Translational Institute (CTSI) voucher V159; National Research Foundation Singapore under Singapore Translational Research (STaR); RNA Biology Center at the Cancer Science Institute of Singapore, NUS, Singapore Ministry of Education's Tier 3 grants(Ministry of Education, SingaporeNational University of Singapore)	The sources of funding for this study are as follows: 1. Aaron Eshman and Melmed family, Morgan Stanley Inc. Recipient: H.P.K. 2. Leukemia and Lymphoma Society (LLS) Grant ID: 9002-16. Recipient: H.P.K. 3. Department of Defense (DoD) Award W81XWH-17-1-0093. Recipient: H.P.K. 4. UCLA Clinical and Translational Institute (CTSI) voucher V159. Recipient: H.P.K. 5. National Research Foundation Singapore under Singapore Translational Research (STaR). Investigator Award (NMRC/STaR/0021/2014) and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC), the NMRC Centre. Grant awarded to National University Cancer Institute of Singapore, the National Research Foundation Singapore and the Singapore Ministry of Education under its Research Centers of Excellence initiatives. Recipient: H.P.K. 6. RNA Biology Center at the Cancer Science Institute of Singapore, NUS, Singapore Ministry of Education's Tier 3 grants, grant number MOE2014-T3-1-006. Recipient: H.P.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boffo S, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0704-8; Chou TC, 2005, COMPUSYN DRUG COMBIN; Cidado J, 2018, CANC RES, V78; Conroy A, 2009, CANCER CHEMOTH PHARM, V64, P723, DOI 10.1007/s00280-008-0921-5; Dai Y, 2003, CURR OPIN PHARMACOL, V3, P362, DOI 10.1016/S1471-4892(03)00079-1; Dai Y, 2009, BLOOD, V114, P125; Gerlach D, 2018, ONCOGENE, V37, P2687, DOI 10.1038/s41388-018-0150-2; Hofmeister CC, 2015, BLOOD, V126, P3052; Kazandjian D, 2016, SEMIN ONCOL, V43, P676, DOI 10.1053/j.seminoncol.2016.11.004; Lim SL, 2019, HAEMATOLOGICA, V104, P1209, DOI 10.3324/haematol.2018.201483; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lu HS, 2015, ELIFE, V4, DOI 10.7554/eLife.06535; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Ma HZ, 2019, EBIOMEDICINE, V39, P182, DOI 10.1016/j.ebiom.2018.12.022; Morales F, 2016, CELL CYCLE, V15, P519, DOI 10.1080/15384101.2016.1138186; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rule S., 2018, J CLIN ONCOL, V36, pTPS7588; Shu SK, 2016, COLD SH Q B, V81, P123, DOI 10.1101/sqb.2016.81.030908; Zhang HH, 2018, CELL, V175, P1244, DOI 10.1016/j.cell.2018.09.051; Zhang XH, 2018, LEUKEMIA, V32, P2224, DOI 10.1038/s41375-018-0044-x; Zhang Y, 2017, ONCOTARGET, V8, P59476, DOI 10.18632/oncotarget.19761	21	5	5	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0232068	10.1371/journal.pone.0232068	http://dx.doi.org/10.1371/journal.pone.0232068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559187	Green Published, gold, Green Submitted			2022-12-26	WOS:000543261600035
J	Loiselle, AR; de Kleine, E; van Dijk, P; Jansonius, NM				Loiselle, Allison R.; de Kleine, Emile; van Dijk, Pim; Jansonius, Nomdo M.			Intraocular and intracranial pressure in glaucoma patients taking acetazolamide	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; PRODUCT OTOACOUSTIC EMISSIONS; NORMAL-TENSION GLAUCOMA; HYPERTENSION; POSTURE	The alternative mechanical theory of glaucoma, in which an increased pressure difference across the lamina cribrosa (difference between intraocular and intracranial pressure; IOP and ICP), rather than solely an elevated IOP, leads to structural and functional vision loss, is still controversial. If the theory is true, a drug that simultaneously lowers both the IOP and ICP may be ineffective. The aim of this study was to determine how acetazolamide (AAZ; a drug prescribed in glaucoma that aims to lower the IOP) affects both IOP and ICP in glaucoma patients and to compare the magnitude and time course of the induced pressure changes with those of healthy subjects not taking AAZ. IOP and noninvasive ICP (measured through emissions from the ear) were measured in 20 glaucoma patients taking 125 mg of AAZ twice daily. Measurements were taken for 30 minutes before taking the drug and for 2 hours post-ingestion. Comparisons were made with 13 age-similar controls. After 12 hours with no anti-glaucoma medication, AAZ did not further reduce IOP in glaucoma patients compared to controls (P = 0.58) but did reduce ICP compared to controls (P = 0.035), by approximately 4 mmHg. Our findings suggest that there are periods during the day when the pressure difference across the lamina cribrosa is larger in case of AAZ use. Future studies should focus on improving the noninvasive ICP testing, different doses and dosing schedules of AAZ, and the time course of IOP in glaucoma patients not taking AAZ.	[Loiselle, Allison R.; Jansonius, Nomdo M.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [de Kleine, Emile; van Dijk, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol Head & Neck Surg, Groningen, Netherlands	University of Groningen; University of Groningen	Jansonius, NM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	n.m.jansonius@umcg.nl	Van Dijk, Pim/E-8019-2010; de Kleine, Emile/P-2350-2014	Van Dijk, Pim/0000-0002-8023-7571; de Kleine, Emile/0000-0001-9525-3032; Jansonius, Nomdo/0000-0002-6495-6568; Loiselle, Allison/0000-0003-2686-0634	European Union (EU) Horizon 2020 grant European Glaucoma Research Training Program (EGRET) [661883]; Uitzicht grant (ANVVB) [2015-11]; Uitzicht grant (Glaucoomfonds) [2015-11]; Uitzicht grant (LSBS) [2015-11]; Uitzicht grant (Novartisfonds) [2015-11]; Uitzicht grant (Oogfonds) [2015-11]; Uitzicht grant (Stichting Blinden-Penning) [2015-11]	European Union (EU) Horizon 2020 grant European Glaucoma Research Training Program (EGRET); Uitzicht grant (ANVVB); Uitzicht grant (Glaucoomfonds); Uitzicht grant (LSBS); Uitzicht grant (Novartisfonds); Uitzicht grant (Oogfonds); Uitzicht grant (Stichting Blinden-Penning)	N.M. Jansonius received the funding for this study from the European Union (EU) Horizon 2020 grant No 661883 European Glaucoma Research Training Program (EGRET) and by Uitzicht grant No 2015-11 (ANVVB, Glaucoomfonds, LSBS, Novartisfonds, Oogfonds, Stichting Blinden-Penning). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALM A, 1982, ACTA OPHTHALMOL, V60, P24; [Anonymous], 1955, BMJ-BRIT MED J, V2, P479; Avan P, 2011, HEARING RES, V277, P88, DOI 10.1016/j.heares.2011.03.006; BECKER B, 1954, AM J OPHTHALMOL, V37, P13, DOI 10.1016/0002-9394(54)92027-9; BECKER B, 1954, AM J OPHTHALMOL, V38, P109, DOI 10.1016/0002-9394(54)90051-3; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bershad EM, 2014, NEUROSURGERY, V75, P445, DOI 10.1227/NEU.0000000000000449; Buki B, 2000, HEARING RES, V140, P202, DOI 10.1016/S0378-5955(99)00202-6; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P341, DOI 10.1111/j.1442-9071.2012.02773.x; Chaaban MR, 2013, INT FORUM ALLERGY RH, V3, P718, DOI 10.1002/alr.21188; Costagliola C, 2009, EXPERT OPIN PHARMACO, V10, P2859, DOI 10.1517/14656560903300129; DAVID R, 1992, BRIT J OPHTHALMOL, V76, P280, DOI 10.1136/bjo.76.5.280; ELVIDGE AR, 1957, J NEUROSURG, V14, P628, DOI 10.3171/jns.1957.14.6.0628; FRIEDLAND BR, 1977, ARCH OPHTHALMOL-CHIC, V95, P1809; Friedman DI, 2014, J NEURO-OPHTHALMOL, V34, P107, DOI 10.1097/WNO.0000000000000114; Heeg GP, 2005, ACTA OPHTHALMOL SCAN, V83, P46, DOI 10.1111/j.1600-0420.2005.00423.x; Jonas JB, 2015, PROG BRAIN RES, V221, P33, DOI 10.1016/bs.pbr.2015.06.002; KASS MA, 1982, ARCH OPHTHALMOL-CHIC, V100, P941, DOI 10.1001/archopht.1982.01030030949010; KATAVISTO MARTTI, 1964, ACTA OPHTHALMOL, P1; Kattah JC, 2015, J NEUROL, V262, P2271, DOI 10.1007/s00415-015-7838-9; Linden C, 2018, OPHTHALMOLOGY, V125, P361, DOI 10.1016/j.ophtha.2017.09.022; Loiselle AR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204939; Lusthaus J, 2019, MED J AUSTRALIA, V210, P180, DOI 10.5694/mja2.50020; MACDONALD MJ, 1977, BRIT J OPHTHALMOL, V61, P345, DOI 10.1136/bjo.61.5.345; Maus TL, 1997, ARCH OPHTHALMOL-CHIC, V115, P45, DOI 10.1001/archopht.1997.01100150047008; Pircher A, 2017, ACTA OPHTHALMOL, V95, pE524, DOI 10.1111/aos.13302; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; RUBIN RC, 1966, J NEUROSURG, V25, P430, DOI 10.3171/jns.1966.25.4.0430; Stamper RL, 2009, BECKER SHAFFER S DIA, P407, DOI [10.1016/b978-0-323-02394-8.00026-7, DOI 10.1016/B978-0-323-02394-8.00026-7]; Supuran CT, 2015, EXPERT REV NEUROTHER, V15, P851, DOI 10.1586/14737175.2015.1066675; van Gestel A, 2010, VALUE HEALTH, V13, P358, DOI 10.1111/j.1524-4733.2009.00678.x; Voss SE, 2010, HEARING RES, V263, P43, DOI 10.1016/j.heares.2010.03.003; Williams MA, 2016, AEROSP MED HUM PERF, V87, P844, DOI 10.3357/AMHP.4572.2016; Zinkernagel MS, 2009, J OCUL PHARMACOL TH, V25, P141, DOI 10.1089/jop.2008.0077	35	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234690	10.1371/journal.pone.0234690	http://dx.doi.org/10.1371/journal.pone.0234690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555666	Green Published, gold			2022-12-26	WOS:000543273200060
J	Asemahagn, MA				Asemahagn, Mulusew Andualem			Epidemiology of hepatitis B and C virus infections among patients who booked for surgical procedures at Felegehiwot referral hospital, Northwest Ethiopia	PLOS ONE			English	Article							PREVALENCE	Background Hepatitis B virus(HBV) and hepatitis C virus(HCV) are the main causes of cirrhosis, liver cancer, and death. This study aimed to determine the seroprevalence and associated factors of HBV surface antigen(HBsAg) and anti-HCV among patients screened for surgery at Felegehiwot referral hospital, Northwest Ethiopia. Methods A hospital-based cross-sectional study was conducted among 433 patients in 2018. Data on socio-demographic and risk factors were collected by an exit interview using a pretested structured questionnaire. A venous blood sample of 5ml was collected from each participant, and serum was tested for HBsAg and anti-HCV using one-step rapid test kits and enzyme-linked immunosorbent assay. Multivariable logistic regression analysis was computed to identify factors associated with HBV and HCV infections. The odds ratio with 95%CI was used to describe the strength of association and statistical significance. Results A total of 422 patients gave data and included in the analysis. The mean age of patients was 36 +/- 5 years. About two-thirds, 269(64%) and 274(65%) patients were males, and from rural areas, respectively. The seroprevalence of HBsAg was 34(8%) followed by 18(4.3%) anti-HCV and 4(0.9%) co-infections. Being single(AOR = 1.96, 95%CI = 1.12-3.10), rural residence (AOR = 2.68, 95%CI = 1.28-5.61), ever heard about HBV (AOR = 2.41, 95%CI = 1.18-5.20), having multiple sexual partners(AOR = 2.85, 95%CI = 1.30-5.58), HIV positive(AOR = 3.14, 95%CI = 1.31-7.61), history of tooth extraction(AOR = 3.0, 95%CI = 1.40-6.56), hospitalization history(AOR = 2.95, 95%CI = 1.26-5.81), sharing of sharp instruments (AOR = 3.86, 95%CI = 1.82-8.79), and had blood contact(AOR = 2.64, 95%CI = 1.14-5.42) were statistically significant factors to HBV infection. Similarly, sharing of sharp instruments(AOR = 4.65, 95%CI = 1.32-15.1), tooth extraction practice(AOR = 2.81, 95%CI = 1.12-6.56), surgical history (AOR = 3.68, 95%CI = 1.64-9.82), hospitalization history(AOR = 4.51, 95%CI = 1.62-8.35) and had blood contact(AOR = 3.2, 95%CI = 1.56-8.51) were significant factors to HCV infection. Conclusion The seroprevalence of HBsAg and ant-HCV was high compared to WHO and previous study findings. Giving special attention to awareness creation, rural settings, improving personal behaviors, infection prevention activities of health facilities, quality of healthcare procedures is crucial to prevent viral hepatitis infection.	[Asemahagn, Mulusew Andualem] Bahir Dar Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Bahir Dar, Ethiopia	Bahir Dar University	Asemahagn, MA (corresponding author), Bahir Dar Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.	muler.hi@gmail.com			Bahir Dar University	Bahir Dar University	Bahir Dar University covered the budget, but it has no technical role in the research processes.	Ameha Z, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4727-9; [Anonymous], 2018, 2018 AMH REG HLTH BU; [Anonymous], 2017, WHO GLOB HEP REP 201; [Anonymous], 2017, ONCOGENESIS, V6, pe345; [Anonymous], 2019, IMMUNE NETW, V19, pe34; [Anonymous], 2018, J WOMENS HLTH CARE; Ayele AG, 2013, ISRN TROPICAL MED, V2013, P7, DOI DOI 10.1155/2013/563821; Badawi MM, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1060-1; Bafa TA, 2020, SAGE OPEN MED, V8, DOI 10.1177/2050312119900870; Binder A, 2013, DOUBLE ANTIBODY SAND, P4; Chernet Asrat, 2017, BMC Res Notes, V10, P418, DOI 10.1186/s13104-017-2702-x; Chisenga CC, 2018, J CLIN VIROL, V98, P5, DOI [10.1016/j.jcv.2017.11.005, 10.101]; Dabsu R, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4792584; Ejeta E, 2019, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00366; Ethiopian Public Health Institute, 2016, ETH PUBL HLTH I NAT; European Centre for Disease Prevention and Control, 2018, HEP B C EP SEL POP G; Ford DA, 2014, ASSOC OPER ROOM NURS, V99, P107, DOI 10.1016/j.aorn.2013.11.013; Hofstraat SHI, 2017, EPIDEMIOL INFECT, V145, P2873, DOI [10.1017/S0950268817001947, 10.1017/s0950268817001947]; Iklaki C. U., 2015, British Journal of Medicine and Medical Research, V8, P324, DOI 10.9734/BJMMR/2015/16397; Javed K, 2006, BLOOD TRANSFUS, V50, P32; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Liu WC, 2014, WORLD J GASTROENTERO, V20, P6252, DOI 10.3748/wjg.v20.i20.6252; Mele A, 2001, J HEPATOL, V35, P284, DOI 10.1016/S0168-8278(01)00111-8; Metaferia Y, 2016, EPIDEMIOLOGY HLTH, V38, P7; Saravanan S, 2009, J MICROBIOL IMMUNOL, V42, P122; Shiferaw E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214755; Taye M, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4456-0; Tsatsralt-Od B, 2005, J MED VIROL, V77, P491, DOI 10.1002/jmv.20482; WHO, 1990, PROT ASS PREV HEP B; WHO, 2013, GLOB POL REP PREV CO, P536289; WHO, 2017, WHO HEP; WHO, 2017, GUID HEP B C VIR TES; Woldegiorgis AE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226890; World Health Organization, 2016, GLOB HLTH SECT STRAT	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234822	10.1371/journal.pone.0234822	http://dx.doi.org/10.1371/journal.pone.0234822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555634	gold, Green Published			2022-12-26	WOS:000542759600050
J	Fearon, E; Tenza, S; Mokoena, C; Moodley, K; Smith, AD; Bourne, A; Weatherburn, P; Palanee-Phillips, T				Fearon, Elizabeth; Tenza, Siyanda; Mokoena, Cecilia; Moodley, Kerushini; Smith, Adrian D.; Bourne, Adam; Weatherburn, Peter; Palanee-Phillips, Thesla			HIV testing, care and viral suppression among men who have sex with men and transgender individuals in Johannesburg, South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TREATMENT CASCADE; PREVENTION; HIV/AIDS; COVERAGE; NETWORK; WORKERS; TRENDS; LOAD	Introduction Men who have sex with men and transgender individuals (MSM/TG) carry a disproportionately high burden of HIV, including in South Africa. However, there are few empirical population-representative estimates of viral suppression and the HIV care cascade including HIV testing among this population, nor of factors associated with these outcomes. Methods We conducted a respondent driven sampling (RDS) survey among 301 MSM/TG in Johannesburg in 2017. Participants gave blood samples for HIV testing and viral load. Participants self-completed a survey including sociodemographics, HIV testing history, and engagement in care. We calculated RDS-II weighted estimates of the percentage of HIV-negative MSM/TG reporting HIV testing in the previous 6 months, their testing experience and preferences. Among those HIV-positive, we estimated the percentage status-aware, on ART, and virally suppressed (<50 viral copies/ml plasma). We conducted RDS-weighted robust Poisson regression to obtain weighted prevalence ratios of factors associated with 1) HIV testing among those HIV-negative; and 2) viral suppression among those HIV-positive. Results There were 118/300 HIV-positive MSM/TG, (37.5%). Of the HIV-negative MSM/TG, 61.5% reported that they had tested for HIV in the previous 6 months, which was associated with selling sex to men (Prevalence Ratio = 1.67, 95% CI 1.36-2.05). There were 76/118 HIV-positive MSM/TG (56.5%) who reported having previously tested positive for HIV and 39/118 (30.0%) who reported current ART. There were 58/118 HIV-positive MSM/TG with viral loads <50 copies/ml plasma (46.9%). Viral suppression was associated with older age (adjusted PR = 1.03, 95% CI 1.00-1.06 for each year), neighbourhood, and having bought sex from men (adjusted PR = 1.53, 95% CI 1.12-2.08). Conclusions HIV prevalence was very high. Viral suppression among those HIV-positive was similar to the general male population in South Africa, but remains far short of national and international targets. A majority of HIV-negative MSM/TG had HIV tested in the previous 6 months, though there is room for improvement.	[Fearon, Elizabeth] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Tenza, Siyanda; Mokoena, Cecilia; Moodley, Kerushini; Palanee-Phillips, Thesla] Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Smith, Adrian D.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Bourne, Adam] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; [Weatherburn, Peter] London Sch Hyg & Trop Med, Dept Publ Hlth Environm & Soc, London, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; La Trobe University; University of London; London School of Hygiene & Tropical Medicine	Fearon, E (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England.	Elizabeth.Fearon@lshtm.ac.uk	Palanee-Phillips, Thesla/ABD-2449-2020	Weatherburn, Peter/0000-0002-4950-6163; Smith, Adrian/0000-0003-0036-1490; Palanee-Phillips, Thesla/0000-0002-0052-5830; Fearon, Elizabeth/0000-0001-5574-251X	Evidence for HIV prevention in Southern Africa (EHPSA) programme - UK aid from the Department for International Development, and Sweden, through the Swedish International Development Agency (SIDA) [MM/EHPSA/WHC/0116029]	Evidence for HIV prevention in Southern Africa (EHPSA) programme - UK aid from the Department for International Development, and Sweden, through the Swedish International Development Agency (SIDA)	This study was funded through the Evidence for HIV prevention in Southern Africa (EHPSA) programme (http://www.ehpsa.org/, grant number MM/EHPSA/WHC/0116029, PI Thesla Palanee-Phillips) funded by UK aid from the Department for International Development, and Sweden, through the Swedish International Development Agency (SIDA), mandated to represent the Norwegian Agency for Development Cooperation (Norad), and managed by Mott Macdonald. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDSinfo, 2018, COUNTR FACTSH S AFR; [Anonymous], 2018, DEV COGN NEUROSCI, V21, DOI 10.1016/S1878-9293(18)30129-4; [Anonymous], 2014, ARTHRITIS RHEUM S, V66, pS690; [Anonymous], 2013, AM J KIDNEY DIS    S, V63, pe1; Babor T.F., 1992, AUDIT ALCOHOL USE DI; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Beyrer C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002154; Beyrer C, 2016, LANCET, V388, P198, DOI 10.1016/S0140-6736(16)30781-4; Charurat ME, 2015, JAIDS-J ACQ IMM DEF, V68, pS114, DOI 10.1097/QAI.0000000000000439; Chen WS, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0519-5; Cloete A., 2014, S AFRICAN MARANG MEN; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cowan FM, 2017, JAIDS-J ACQ IMM DEF, V74, P375, DOI 10.1097/qai.0000000000001255; Fearon E, 2019, U NAIR COLL M HIV ST; Fogel JM, 2018, AIDS BEHAV; Friedman MR, 2015, AIDS, V29, P1087, DOI 10.1097/QAD.0000000000000657; Gile KJ, 2015, J R STAT SOC A STAT, V178, P241, DOI 10.1111/rssa.12059; Hakim AJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207363; Handcock MS, 2019, RDS RESPONDENT DRIVE; Hermans LE, 2018, LANCET INFECT DIS, V18, P188, DOI 10.1016/S1473-3099(17)30681-3; Hladik W, 2017, AIDS BEHAV, V21, P1478, DOI 10.1007/s10461-016-1535-2; Hoots BE, 2019, AIDS, V33, P913, DOI 10.1097/QAD.0000000000002147; Jobson G, 2018, AIDS CARE, V30, P1421, DOI 10.1080/09540121.2018.1465175; Johnson LF, 2018, EPIDEMIOL INFECT, V146, P1036, DOI 10.1017/S0950268818000961; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lane T, 2008, SEX TRANSM INFECT, V84, P430, DOI 10.1136/sti.2008.031567; Lane T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111063; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Lippman SA, 2018, JAIDS-J ACQ IMM DEF, V77, P279, DOI [10.1097/QAI.0000000000001601, 10.1097/qai.0000000000001601]; Lumley T., 2018, SURVEY ANAL COMPLEX; Makusha T, 2017, PUBLIC HEALTH, V143, P1, DOI 10.1016/j.puhe.2016.10.017; Mooney AC, 2018, AIDS BEHAV; National Department of Health Republic of South Africa, 2019, 2019 ART CLIN GUID M; R Core Team, 2013, R LANG ENV STAT COMP; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Rees K, 2017, SEX TRANSM DIS, V44, P768, DOI 10.1097/OLQ.0000000000000679; Reniers G, 2014, AIDS, V28, pS533, DOI 10.1097/QAD.0000000000000496; Risher K, 2015, CURR OPIN HIV AIDS, V10, P420, DOI 10.1097/COH.0000000000000200; Rodger AJ, 2019, LANCET; Sabin KM, 2014, CURR OPIN HIV AIDS, V9, P101, DOI 10.1097/COH.0000000000000046; Scheibe A, 2018, AIDS BEHAV, V22, P853, DOI 10.1007/s10461-017-1773-y; Shaver John, 2017, J Int Assoc Provid AIDS Care, V16, P562, DOI 10.1177/2325957417736611; Siegler AJ, 2015, AIDS CARE, V27, P229, DOI 10.1080/09540121.2014.947914; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Solomon SS, 2016, LANCET HIV, V3, pE183, DOI 10.1016/S2352-3018(16)00019-9; South African Demographic Health Survey, 2017, S AFR DEM HLTH SURV, P1; South African National AIDS Council, 2017, LET OUR ACT COUNT S; Stannah J, 2019, LANCET HIV, V6, pE769, DOI 10.1016/S2352-3018(19)30239-5; StataCorp, 2011, STAT STAT SOFTW REL; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; UNAIDS, 2014, UND FAST TRACK ACC A; UNAIDS, 2018, FACT SHEET HIV MEN S; University of California San Francisco, 2015, REP S AFR MEN WHO HA; Volz E, 2008, J OFF STAT, V24, P79; WHO, 2018, FOC KEY POP NAT HIV; Witzel TC, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4370-0; Zahn R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147156	57	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234384	10.1371/journal.pone.0234384	http://dx.doi.org/10.1371/journal.pone.0234384			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB7DG	32555703	Green Published, gold			2022-12-26	WOS:000542759600057
J	Van Wilgenburg, SL; Mahon, CL; Campbell, G; McLeod, L; Campbell, M; Evans, D; Easton, W; Francis, CM; Hache, S; Machtans, CS; Mader, C; Pankratz, RF; Russell, R; Smith, AC; Thomas, P; Toms, JD; Tremblay, JA				Van Wilgenburg, Steven L.; Mahon, C. Lisa; Campbell, Greg; McLeod, Logan; Campbell, Margaret; Evans, Dean; Easton, Wendy; Francis, Charles M.; Hache, Samuel; Machtans, Craig S.; Mader, Caitlin; Pankratz, Rhiannon F.; Russell, Rich; Smith, Adam C.; Thomas, Peter; Toms, Judith D.; Tremblay, Junior A.			A cost efficient spatially balanced hierarchical sampling design for monitoring boreal birds incorporating access costs and habitat stratification	PLOS ONE			English	Article							CLIMATE-CHANGE; EXISTING DATA; BIODIVERSITY; COMMUNITIES; PATTERNS; FUTURE	Predicting and mitigating impacts of climate change and development within the boreal biome requires a sound understanding of factors influencing the abundance, distribution, and population dynamics of species inhabiting this vast biome. Unfortunately, the limited accessibility of the boreal biome has resulted in sparse and spatially biased sampling, and thus our understanding of boreal bird population dynamics is limited. To implement effective conservation of boreal birds, a cost-effective approach to sampling the boreal biome will be needed. Our objective was to devise a sampling scheme for monitoring boreal birds that would improve our ability to model species-habitat relationships and monitor changes in population size and distribution. A statistically rigorous design to achieve these objectives would have to be spatially balanced and hierarchically structured with respect to ecozones, ecoregions and political jurisdictions. Therefore, we developed a multi-stage hierarchically structured sampling design known as the Boreal Optimal Sampling Strategy (BOSS) that included cost constraints, habitat stratification, and optimization to provide a cost-effective alternative to other common monitoring designs. Our design provided similar habitat and spatial representation to habitat stratification and equal-probability spatially balanced designs, respectively. Not only was our design able to achieve the desired habitat representation and spatial balance necessary to meet our objectives, it was also significantly less expensive (1.3-2.6 times less) than the alternative designs we considered. To further balance trade-offs between cost and representativeness prior to field implementation, we ran multiple iterations of the BOSS design and selected the one which minimized predicted costs while maximizing a multi-criteria evaluation of representativeness. Field implementation of the design in three vastly different regions over three field seasons showed that the approach can be implemented in a wide variety of logistical scenarios and ecological conditions. We provide worked examples and scripts to allow our approach to be implemented or adapted elsewhere. We also provide recommendations for possible future refinements to our approach, but recommend that our design now be implemented to provide unbiased information to assess the status of boreal birds and inform conservation and management actions.	[Van Wilgenburg, Steven L.] Environm & Climate Change Canada, Saskatoon, SK, Canada; [Mahon, C. Lisa; McLeod, Logan; Campbell, Margaret; Machtans, Craig S.] Environm & Climate Change Canada, Whitehorse, YT, Canada; [Mahon, C. Lisa; Toms, Judith D.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Campbell, Greg] Environm & Climate Change Canada, Mt Pearl, NF, Canada; [Evans, Dean; Hache, Samuel; Pankratz, Rhiannon F.] Environm & Climate Change Canada, Yellowknife, NT, Canada; [Easton, Wendy] Environm & Climate Change Canada, Vancouver, BC, Canada; [Francis, Charles M.; Russell, Rich; Smith, Adam C.] Environm & Climate Change Canada, Ottawa, ON, Canada; [Mader, Caitlin; Toms, Judith D.] Environm & Climate Change Canada, Edmonton, AB, Canada; [Thomas, Peter] Environm & Climate Change Canada, Sackville, NB, Canada; [Tremblay, Junior A.] Environm & Climate Change Canada, Quebec City, PQ, Canada	Environment & Climate Change Canada; Environment & Climate Change Canada; University of Alberta; Environment & Climate Change Canada; Environment & Climate Change Canada; Environment & Climate Change Canada; Environment & Climate Change Canada; Environment & Climate Change Canada; Environment & Climate Change Canada; Environment & Climate Change Canada	Van Wilgenburg, SL (corresponding author), Environm & Climate Change Canada, Saskatoon, SK, Canada.	steven.vanwilgenburg@Canada.ca	Smith, Adam/GPS-8322-2022; McLeod, Logan/GRO-4319-2022; Tremblay, Junior A./AAX-7353-2020	McLeod, Logan/0000-0003-4528-1523; Tremblay, Junior A./0000-0003-4930-0939	Environment and Climate Change Canada	Environment and Climate Change Canada	This work was supported with funding from Environment and Climate Change Canada.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2019, BMJ, V365, pl1494, DOI 10.1136/bmj.l149430940623; Barker NKS, 2015, WILDLIFE SOC B, V39, P480, DOI 10.1002/wsb.567; Bart J, 2004, J WILDLIFE MANAGE, V68, P611, DOI 10.2193/0022-541X(2004)068[0611:GASFET]2.0.CO;2; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Brandt JP, 2009, ENVIRON REV, V17, P101, DOI 10.1139/A09-004; Buckland ST, 2008, BIRD CONSERV INT, V18, pS91, DOI 10.1017/S0959270908000294; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Clark RG, 2013, J SURV STAT METHODOL, V1, P6, DOI DOI 10.1093/JSSAM/SMT002; Cochran W.G., 1977, SAMPLING TECHNIQUE, V3rd ed.; COSEWIC, 2014, COSEWIC STAT APPR SU; Cumming SG, 2014, ECOGRAPHY, V37, P137, DOI 10.1111/j.1600-0587.2013.00299.x; Delmelle, 2009, SAGE HDB SPATIAL ANA, P183; Delmelle EM, 2009, GEODERMA, V153, P205, DOI 10.1016/j.geoderma.2009.08.007; Fancy SG, 2009, ENVIRON MONIT ASSESS, V151, P161, DOI 10.1007/s10661-008-0257-y; Foster SD, 2017, METHODS ECOL EVOL, V8, P1433, DOI 10.1111/2041-210X.12782; Freeman SN, 2007, BIRD STUDY, V54, P61, DOI 10.1080/00063650709461457; GeoInsight Corporation, 1999, STAT ENV REP OCC PAP; Gitzen RA, 2012, DESIGN ANAL LONG TER, P3; Government of Canada. Ecological Land Classification, 2017, 9780660245010 GOV CA; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hobson KA, 2000, FOREST ECOL MANAG, V136, P121, DOI 10.1016/S0378-1127(99)00287-X; Hudson MAR, 2017, CONDOR, V119, P526, DOI 10.1650/CONDOR-17-62.1; KALTON G, 1986, J ROY STAT SOC A STA, V149, P65, DOI 10.2307/2981886; Kerr JT, 2004, ECOL APPL, V14, P743, DOI 10.1890/02-5117; Kincaid T. M, 2019, SPSURVEY SPATIAL SUR; Langham GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135350; Latifovic R., 2012, REMOTE SENSING LAND; LITTLE RJA, 1983, J AM STAT ASSOC, V78, P596, DOI 10.2307/2288125; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Machtans Craig S., 2014, Avian Conservation and Ecology, V9, P5; Mahon CL, 2019, ECOL APPL, V29, DOI 10.1002/eap.1895; Mahon CL, 2016, FOREST ECOL MANAG, V361, P99, DOI 10.1016/j.foreco.2015.11.007; Mahon CL, 2014, FOREST ECOL MANAG, V312, P28, DOI 10.1016/j.foreco.2013.10.025; Marler RT, 2010, STRUCT MULTIDISCIP O, V41, P853, DOI 10.1007/s00158-009-0460-7; Matsuoka SM, 2014, CONDOR, V116, P599, DOI 10.1650/CONDOR-14-108.1; Mccabe JD, 2018, IBIS, V160, P528, DOI 10.1111/ibi.12561; Metzger MJ, 2013, ECOL INDIC, V33, P26, DOI 10.1016/j.ecolind.2012.11.009; Morissette JL, 2018, WETLANDS, V38, P1299, DOI 10.1007/s13157-018-1054-1; Nahorniak M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131765; Neyman J, 1934, J R STAT SOC, V97, P558, DOI 10.2307/2342192; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olsen A.R., 2012, DESIGN ANAL LONG TER, P126, DOI [10.1017/CBO9781139022422.010, DOI 10.1017/CBO9781139022422.010]; Parisien MA, 2014, ECOL APPL, V24, P1341, DOI 10.1890/13-1477.1; Pfeffermann D, 1998, J ROY STAT SOC B, V60, P23, DOI 10.1111/1467-9868.00106; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; R Core Team, 2021, R LANGUAGE ENV STAT; Ralph CJ, 1993, USDA FOREST SERV UNL, V144, P1; Rice J, 2003, OCEAN COAST MANAGE, V46, P235, DOI 10.1016/S0964-5691(03)00006-1; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Samuel R, 2018, CAP MARK LAW J, V13, P3, DOI 10.1093/cmlj/kmx043; Shonfield J, 2017, AVIAN CONSERV ECOL, V12, DOI 10.5751/ACE-00974-120114; Siegel RB, 2007, TECHNIQUES METHODS U; Smith ANH, 2017, ECOGRAPHY, V40, P1251, DOI 10.1111/ecog.02821; Solymos P, 2020, CONDOR, V122, DOI 10.1093/condor/duaa007; Stehman SV, 1994, ENV SAMPLING MONITOR; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stralberg D, 2015, DIVERS DISTRIB, V21, P1112, DOI 10.1111/ddi.12356; Synes N.W., 2016, CURRENT LANDSCAPE EC, V1, P146, DOI [10.1007/s40823-016-0016-7, DOI 10.1007/S40823-016-0016-7]; Taylor MFJ, 2005, BIOSCIENCE, V55, P360, DOI 10.1641/0006-3568(2005)055[0360:TEOTES]2.0.CO;2; Thompson W.L., 1998, MONITORING VERTEBRAT; Tulloch AIT, 2013, DIVERS DISTRIB, V19, P465, DOI 10.1111/j.1472-4642.2012.00947.x; van Turnhout Chris A.M., 2008, Revista Catalana d'Ornitologia, V24, P15; Van Wilgenburg SL, 2017, AVIAN CONSERV ECOL, V12, DOI 10.5751/ACE-00975-120113; Van Wilgenburg SL, 2015, AVIAN CONSERV ECOL, V10, DOI 10.5751/ACE-00777-100205; Vold ST, 2017, WILDLIFE SOC B, V41, P566, DOI 10.1002/wsb.785; Watson JEM, 2018, NAT ECOL EVOL, V2, P599, DOI 10.1038/s41559-018-0490-x; Weber J, 2005, BUS WEEK, P98; Westwood AR, 2019, UBC LAW REV, V52, P243; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; ZEILEIS A., 2006, J STAT SOFTW, V16, P1, DOI DOI 10.18637/JSS.V016.I09	75	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234494	10.1371/journal.pone.0234494	http://dx.doi.org/10.1371/journal.pone.0234494			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544173	Green Published, gold			2022-12-26	WOS:000542957200029
J	Brewer, VN; Lane, SJ; Sewall, KB; Mabry, KE				Brewer, Valerie N.; Lane, Samuel J.; Sewall, Kendra B.; Mabry, Karen E.			Effects of low-density urbanization on genetic structure in the Song Sparrow	PLOS ONE			English	Article							MELOSPIZA-MELODIA; POPULATION-STRUCTURE; MICROSATELLITE LOCI; URBAN; DIVERSITY; DIFFERENTIATION; PERMEABILITY; DISPERSAL; LANDSCAPE; MOVEMENTS	Urbanization fragments landscapes and can impede the movement of organisms through their environment, which can decrease population connectivity. Reduction in connectivity influences gene flow and allele frequencies, and can lead to a reduction in genetic diversity and the fixation of certain alleles, with potential negative effects for populations. Previous studies have detected effects of urbanization on genetic diversity and structure in terrestrial animals living in landscapes that vary in their degree of urbanization, even over very short distances. We investigated the effects of low-intensity urbanization on genetic diversity and genetic structure in Song Sparrows (Melospiza melodia). We captured 208 Song Sparrows at seven sites along a gradient of urbanization in and around Blacksburg, VA, USA, then genotyped them using a panel of fifteen polymorphic microsatellite loci. We found that genetic diversity was comparable among the seven study sites, and there was no evidence of genetic structuring among sites. These findings suggest that over a gradient of urbanization characterized by low density urban development, Song Sparrows likely exist in a single panmictic population.	[Brewer, Valerie N.; Mabry, Karen E.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Lane, Samuel J.; Sewall, Kendra B.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	New Mexico State University; Virginia Polytechnic Institute & State University	Mabry, KE (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	kmabry@nmsu.edu	Brewer, Valerie/GVR-8493-2022	Mabry, Karen/0000-0001-8138-8999	Howard Hughes Medical Institute's 2014 Science Education grant [52008103]; NIH [GM07667-40]; Virginia Tech Multicultural Academic Opportunities Program; Virginia Tech Global Change Center and Fralin Life Sciences Institute; UTEP NIH award [G12MD007592]	Howard Hughes Medical Institute's 2014 Science Education grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Tech Multicultural Academic Opportunities Program; Virginia Tech Global Change Center and Fralin Life Sciences Institute; UTEP NIH award	This research was funded by fellowships awarded to VNB through the Howard Hughes Medical Institute's 2014 Science Education grant 52008103 to New Mexico State University, NIH GM07667-40 to New Mexico State University, and the Virginia Tech Multicultural Academic Opportunities Program. KBS and SJL also received support from the Virginia Tech Global Change Center and Fralin Life Sciences Institute. This material is based upon work while KEM was serving at the National Science Foundation. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. Additional fragment analysis was conducted at the New Mexico State University Molecular Biology Core Facility. University of Texas at El Paso request that the following statement be included on work conducted at their facility, but no funding was received from the UTEP NIH award: "Our work was supported by Grant G12MD007592 to the University of Texas at El Paso from the National Institutes on Minority Health and Health Disparities (NIMHD), a component of the National Institutes of Health (NIH)." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2010, QUICKFACTS RADF CIT; ARCESE P, 1989, ANIM BEHAV, V38, P958, DOI 10.1016/S0003-3472(89)80137-X; Belisle M, 2002, CONSERV ECOL, V5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brinkley ES, 2007, NATL WILDLIFE FEDERA; Chan Y, 2002, AUK, V119, P641, DOI 10.1642/0004-8038(2002)119[0641:SDACOS]2.0.CO;2; Combs M, 2018, MOL ECOL, V27, P83, DOI 10.1111/mec.14437; Davies S, 2018, HORM BEHAV, V98, P8, DOI 10.1016/j.yhbeh.2017.11.010; Davies S, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0315; Delaney KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012767; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Guillot G, 2012, SYST BIOL, V61, P897, DOI 10.1093/sysbio/sys038; Han JI, 2009, AUK, V126, P779, DOI 10.1525/auk.2009.08203; Janes JK, 2017, MOL ECOL, V26, P3594, DOI 10.1111/mec.14187; Jeffery KJ, 2001, MOL ECOL NOTES, V1, P11, DOI 10.1046/j.1471-8278.2000.00005.x; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Keller LF, 1998, EVOLUTION, V52, P240, DOI 10.1111/j.1558-5646.1998.tb05157.x; Lindsay DL, 2008, MOL ECOL, V17, P2122, DOI 10.1111/j.1365-294X.2008.03673.x; MacDougall-Shackleton EA, 2011, CONSERV GENET, V12, P1195, DOI 10.1007/s10592-011-0222-0; McCartney-Melstad E, 2018, MOL ECOL, V27, P4430, DOI 10.1111/mec.14892; Miles LS, 2019, MOL ECOL, V28, P4138, DOI 10.1111/mec.15221; Mueller JC, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0206; Munshi-South J, 2013, PEERJ, V1, DOI 10.7717/peerj.64; Munshi-South J, 2010, MOL ECOL, V19, P4242, DOI 10.1111/j.1365-294X.2010.04816.x; Nice M.M., 1937, T LINNAEAN SOC NEW Y, V4, P1; Nietlisbach P, 2015, MOL ECOL RESOUR, V15, P1486, DOI 10.1111/1755-0998.12414; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier C, 2018, EVOL APPL, V11, P593, DOI 10.1111/eva.12580; Porlier M, 2009, PHILOS T R SOC B, V364, P1543, DOI 10.1098/rstb.2009.0010; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reid JM, 2007, P ROY SOC B-BIOL SCI, V274, P697, DOI 10.1098/rspb.2006.0092; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sardell RJ, 2010, MOL ECOL, V19, P4352, DOI 10.1111/j.1365-294X.2010.04805.x; Seress G, 2014, LANDSCAPE URBAN PLAN, V131, P42, DOI 10.1016/j.landurbplan.2014.07.010; Tang Q, 2018, EVOL APPL, V11, P1598, DOI 10.1111/eva.12650; Tremblay MA, 2011, J APPL ECOL, V48, P679, DOI 10.1111/j.1365-2664.2011.01978.x; Tremblay MA, 2009, J APPL ECOL, V46, P1314, DOI 10.1111/j.1365-2664.2009.01717.x; Unfried TM, 2013, CONSERV GENET, V14, P41, DOI 10.1007/s10592-012-0422-2; Vangestel C, 2012, HEREDITY, V109, P163, DOI 10.1038/hdy.2012.26; Vangestel C, 2011, MOL ECOL, V20, P4643, DOI 10.1111/j.1365-294X.2011.05316.x; Wilson AG, 2011, CONSERV GENET, V12, P213, DOI 10.1007/s10592-010-0134-4; Wright S, 1943, GENETICS, V28, P114	48	4	4	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0234008	10.1371/journal.pone.0234008	http://dx.doi.org/10.1371/journal.pone.0234008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530950	Green Published, gold			2022-12-26	WOS:000542037200023
J	Funder, ED; Albaek, N; Moisan, A; Sewing, S; Koch, T				Funder, Erik Daa; Albaek, Nanna; Moisan, Annie; Sewing, Sabine; Koch, Troels			Refining LNA safety profile by controlling phosphorothioate stereochemistry	PLOS ONE			English	Article							ANTISENSE OLIGONUCLEOTIDES; STEREOSELECTIVE-SYNTHESIS; IN-VITRO; OLIGODEOXYNUCLEOTIDES; EVOLUTION; SEQUENCE; DNA	Drug discovery with phosphorothioate oligonucleotides is an area of intensive research. In this study we have controlled the stereochemistry of the phosphorothioate backbone of LNA oligonucleotides to investigate the differences in safety profile, target mRNA knock down, and cellular uptakein vitro. The study reveals that controlling only four stereocenters in an isomeric phosphorothioate mixture can improve the therapeutic index significantly by improving safety without compromising activity.	[Funder, Erik Daa; Albaek, Nanna; Koch, Troels] Roche Innovat Ctr Copenhagen AS, Horsholm, Denmark; [Moisan, Annie; Sewing, Sabine] Roche Innovat Ctr Basel, Basel, Switzerland	Roche Holding	Funder, ED (corresponding author), Roche Innovat Ctr Copenhagen AS, Horsholm, Denmark.	erik.funder@roche.com		Moisan, Annie/0000-0002-4944-4548				Bohr HG, 2017, MOL THER-NUCL ACIDS, V8, P428, DOI 10.1016/j.omtn.2017.05.011; Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2; Burel SA, 2016, NUCLEIC ACIDS RES, V44, P2093, DOI 10.1093/nar/gkv1210; Burgers PM, 1976, P NATL ACAD SCI USA, V73, P2987; BURGERS PMJ, 1978, TETRAHEDRON LETT, P3835; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chan JHP, 2006, CLIN EXP PHARMACOL P, V33, P533, DOI 10.1111/j.1440-1681.2006.04403.x; Dieckmann A, 2018, MOL THER-NUCL ACIDS, V10, P45, DOI 10.1016/j.omtn.2017.11.004; Eckstein F, 2000, ANTISENSE NUCLEIC A, V10, P117, DOI 10.1089/oli.1.2000.10.117; Hagedorn PH, 2017, NUCLEIC ACIDS RES, V45, P2262, DOI 10.1093/nar/gkx056; Hagedorn PH, 2013, NUCLEIC ACID THER, V23, P302, DOI 10.1089/nat.2013.0436; Iwamoto N, 2017, NAT BIOTECHNOL, V35, P845, DOI 10.1038/nbt.3948; Iyer RP, 1998, TETRAHEDRON LETT, V39, P2491, DOI 10.1016/S0040-4039(98)00380-3; Khvorova A, 2017, NAT BIOTECHNOL, V35, P238, DOI 10.1038/nbt.3765; Koch T, 2014, NUCLEIC ACID THER, V24, P139, DOI 10.1089/nat.2013.0465; Li M, 2017, CHEM COMMUN, V53, P541, DOI 10.1039/c6cc08473g; MATSUKURA M, 1987, P NATL ACAD SCI USA, V84, P7706, DOI 10.1073/pnas.84.21.7706; Moisan A, 2017, MOL THER-NUCL ACIDS, V6, P89, DOI 10.1016/j.omtn.2016.11.006; Oka N, 2003, J AM CHEM SOC, V125, P8307, DOI 10.1021/ja034502z; Oka N, 2008, J AM CHEM SOC, V130, P16031, DOI 10.1021/ja805780u; Ostergaard ME, 2020, NUCLEIC ACIDS RES; Papargyri N, 2020, MOL THER-NUCL ACIDS, V19, P706, DOI 10.1016/j.omtn.2019.12.011; Pedersen L, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2013.72; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; UHLMANN E, 1990, CHEM REV, V90, P543, DOI 10.1021/cr00102a001; Wan WB, 2016, J MED CHEM, V59, P9645, DOI 10.1021/acs.jmedchem.6b00551; Wan WB, 2014, NUCLEIC ACIDS RES, V42, P13456, DOI 10.1093/nar/gku1115; Wang JC, 1997, TETRAHEDRON LETT, V38, P3797, DOI 10.1016/S0040-4039(97)00749-1; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; WILK A, 1995, NUCLEIC ACIDS RES, V23, P530, DOI 10.1093/nar/23.3.530; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101	32	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0232603	10.1371/journal.pone.0232603	http://dx.doi.org/10.1371/journal.pone.0232603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530964	Green Published, gold			2022-12-26	WOS:000542037200052
J	Zan, FG; Zhang, YB; Wu, ZD; Zhao, J; Wu, CW; Zhao, Y; Chen, XK; Zhao, LP; Qin, W; Yao, L; Xia, HM; Zhao, PF; Yang, K; Liu, JY; Yang, XP				Zan, Fenggang; Zhang, Yuebin; Wu, Zhuandi; Zhao, Jun; Wu, Caiwen; Zhao, Yong; Chen, Xuekuan; Zhao, Liping; Qin, Wei; Yao, Li; Xia, Hongming; Zhao, Peifang; Yang, Kun; Liu, Jiayong; Yang, Xiping			Genetic analysis of agronomic traits in elite sugarcane (Saccharum spp.) germplasm	PLOS ONE			English	Article							GENOME STRUCTURE; AFLP; DISSECTION; RESISTANCE; DIVERSITY; MARKERS; COMPLEX; QTLS	Sugarcane (Saccharumspp.) is an important economic crop, supplying up to 80% of the table sugar and similar to 60% of bio-ethanol worldwide. Due to population growth and dwindling fossil-fuel reserves, the demand for sugar and bio-ethanol requires significant improvement in sugarcane production. Breeding sugarcane cultivars with high-performance agronomic traits is undoubtedly the most efficient way to achieve this goal. Therefore, evaluating agronomic traits and dissecting underlying loci are critically important for this aim steps in providing genetic resources and molecular markers for selection. In this study, we assembled a diversity panel of 236 elite sugarcane germplasms originally collected from 12 countries. We evaluated 28 agronomic traits in the diversity panel with three replicates. The diversity panel was genotyped using amplified fragment length polymorphism markers, and a total of 1,359 markers were generated. Through the genome-wide association study, we identified three markers significantly associated with three traits evaluated at a stringent threshold (P< 0.05 after Bonferroni correction). The genotypes of the three associated markers grouped respective trait values into two distinct groups, supporting the reliability of these markers for breeding selection. Our study provides putative molecular markers linked to agronomic traits for breeding robust sugarcane cultivars. Additionally, this study emphasized the importance of sugarcane germplasm introduced from other countries and suggested that the use of these germplasms in breeding programs depends on local industrial needs.	[Zan, Fenggang; Zhang, Yuebin; Wu, Zhuandi; Zhao, Jun; Wu, Caiwen; Zhao, Yong; Chen, Xuekuan; Zhao, Liping; Qin, Wei; Yao, Li; Xia, Hongming; Zhao, Peifang; Yang, Kun; Liu, Jiayong] Yunnan Acad Agr Sci, Yunnan Prov Key Lab Sugarcane Genet Improvement, Sugarcane Res Inst, Kaiyuan, Yunnan, Peoples R China; [Yang, Xiping] Guangxi Univ, Guangxi Key Lab Sugarcane Biol, Nanning, Guangxi, Peoples R China; [Yang, Xiping] Univ Florida, Dept Agron, Gainesville, FL 32611 USA	Yunnan Academy of Agricultural Sciences; Guangxi University; State University System of Florida; University of Florida	Liu, JY (corresponding author), Yunnan Acad Agr Sci, Yunnan Prov Key Lab Sugarcane Genet Improvement, Sugarcane Res Inst, Kaiyuan, Yunnan, Peoples R China.; Yang, XP (corresponding author), Guangxi Univ, Guangxi Key Lab Sugarcane Biol, Nanning, Guangxi, Peoples R China.; Yang, XP (corresponding author), Univ Florida, Dept Agron, Gainesville, FL 32611 USA.	lljjyy1976@163.com; xipingyang@ufl.edu		Yang, Xiping/0000-0002-3452-211X	Less Developed Regions of the National Natural Science Foundation of China [31860405]; Earmarked Fund for China Agriculture Research System [CARS-170101]; Provincial Innovation Team of Sugarcane Germplasm Innovation and New Variety Breeding of Yunnan Academy of Agricultural Sciences [2019HC013]; Yunnan province Innovation team [2014HC015]; Overseas top talents project Sugarcane genetic improvement and extension; Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences [1630052019001, 1630052017020-4]; Applied Basic Research Projects in Yunnan Province [2016FB071]; Applied Basic Research Projects of Yunnan Academy of Agricultural Sciences [YJM201705]; 'One Hundred Person' Project of Guangxi	Less Developed Regions of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for China Agriculture Research System; Provincial Innovation Team of Sugarcane Germplasm Innovation and New Variety Breeding of Yunnan Academy of Agricultural Sciences; Yunnan province Innovation team; Overseas top talents project Sugarcane genetic improvement and extension; Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences; Applied Basic Research Projects in Yunnan Province; Applied Basic Research Projects of Yunnan Academy of Agricultural Sciences; 'One Hundred Person' Project of Guangxi	This work was supported by Less Developed Regions of the National Natural Science Foundation of China (No. 31860405) to JL, Earmarked Fund for China Agriculture Research System (No. CARS-170101) and Provincial Innovation Team of Sugarcane Germplasm Innovation and New Variety Breeding of Yunnan Academy of Agricultural Sciences (No. 2019HC013) to CW, Yunnan province Innovation team (No. 2014HC015) and Overseas top talents project Sugarcane genetic improvement and extension to YZ, Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences (No. 1630052019001) to FZ, Central Public-interest Scientific Institution Basal Research Fund for Chinese Academy of Tropical Agricultural Sciences (No. 1630052017020-4), the Applied Basic Research Projects in Yunnan Province (No. 2016FB071) and Applied Basic Research Projects of Yunnan Academy of Agricultural Sciences (No. YJM201705) to ZW, and the 'One Hundred Person' Project of Guangxi to XY.	Acevedo A, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1908-2; Besse P, 1998, GENETICA, V104, P143, DOI 10.1023/A:1003436403678; Cai Q, 2006, DESCRIPTORS DATA STA; D'Hont A, 2005, CYTOGENET GENOME RES, V109, P27, DOI 10.1159/000082378; D'Hont A, 2002, CHROMOSOME RES, V10, P253, DOI 10.1023/A:1015204424287; Dahlquist E., 2013, BIOMASS ENERGY SOURC; Debibakas S, 2014, THEOR APPL GENET, V127, P1719, DOI 10.1007/s00122-014-2334-7; deMendiburu F., 2019, R PACKAGE VERSION 1; DEREN CW, 1995, CROP SCI, V35, P1195, DOI 10.2135/cropsci1995.0011183X003500040047x; DHont A, 1996, MOL GEN GENET, V250, P405, DOI [10.1007/BF02174028, 10.1007/s004380050092]; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; FAO, 2013, FAO STAT DAT 2013; FAO, 2014, FAO STAT DAT 2014; Harrell FE., 2018, HMISC HARRELL MISCEL; Hoarau JY, 2002, THEOR APPL GENET, V105, P1027, DOI 10.1007/s00122-002-1047-5; Hoarau JY, 2001, THEOR APPL GENET, V103, P84, DOI 10.1007/s001220000390; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kozich JJ, 2013, APPL ENVIRON MICROB, P13; Lima MLA, 2002, THEOR APPL GENET, V104, P30, DOI 10.1007/s001220200003; Liu HL, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-018-2127-1; McNeil MD, 2011, MOL BREEDING, V27, P395, DOI 10.1007/s11032-010-9441-1; R Core Team, 2021, R LANGUAGE ENV STAT; Rosyara UR, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.08.0073; Selvi A, 2006, GENET RESOUR CROP EV, V53, P831, DOI 10.1007/s10722-004-6376-6; Selvi A, 2005, CROP SCI, V45, P1750, DOI 10.2135/cropsci2004.0528; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Todd J, 2015, HIST USE CULTIVARS P; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Yang X, 2018, GENOME WIDE ASS STUD, P387001; Yang XP, 2019, PLANT BIOTECHNOL J, V17, P488, DOI 10.1111/pbi.12992; Yang XP, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00350; You Q, 2013, SCI WORLD J, DOI 10.1155/2013/613062	34	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0233752	10.1371/journal.pone.0233752	http://dx.doi.org/10.1371/journal.pone.0233752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32526769	Green Published, gold			2022-12-26	WOS:000542036800035
J	Hausrath, AC; Ramirez, NA; Ly, AT; McEvoy, MM				Hausrath, Andrew C.; Ramirez, Nicholas A.; Ly, Alan T.; McEvoy, Megan M.			The bacterial copper resistance protein CopG contains a cysteine-bridged tetranuclear copper cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper; metalloprotein; oxidation-reduction; structure-function; thioredoxin; metal homeostasis; metal resistance; Pseudomonas aeruginosa; oxidation-reduction (redox); P; aeruginosa; metal ion homeostasis	THIOL-DISULFIDE OXIDOREDUCTASES; TRANSPOSON MUTANT LIBRARY; ESCHERICHIA-COLI; IRON-SULFUR; THIOREDOXIN; FOLD; SITE; CLASSIFICATION; IDENTIFICATION; CYTOCHROME	CopG is an uncharacterized protein ubiquitous in Gram-negative bacteria whose gene frequently occurs in clusters of copper resistance genes and can be recognized by the presence of a conserved CxCC motif. To investigate its contribution to copper resistance, here we undertook a structural and biochemical characterization of the CopG protein fromPseudomonas aeruginosa. Results from biochemical analyses of CopG purified under aerobic conditions indicate that it is a green copper-binding protein that displays absorbance maxima near 411, 581, and 721 nm and is monomeric in solution. Determination of the three-dimensional structure by X-ray crystallography revealed that CopG consists of a thioredoxin domain with a C-terminal extension that contributes to metal binding. We noted that adjacent to the CxCC motif is a cluster of four copper ions bridged by cysteine sulfur atoms. Structures of CopG in two oxidation states support the assignment of this protein as an oxidoreductase. On the basis of these structural and spectroscopic findings and also genetic evidence, we propose that CopG has a role in interconverting Cu(I) and Cu(II) to minimize toxic effects and facilitate export by the Cus RND transporter efflux system.	[Hausrath, Andrew C.; Ly, Alan T.; McEvoy, Megan M.] Univ Calif Los Angeles, Inst Soc & Genet, Los Angeles, CA 90095 USA; [Hausrath, Andrew C.; McEvoy, Megan M.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Ramirez, Nicholas A.; McEvoy, Megan M.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	McEvoy, MM (corresponding author), Univ Calif Los Angeles, Inst Soc & Genet, Los Angeles, CA 90095 USA.; McEvoy, MM (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; McEvoy, MM (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.	mcevoymm@ucla.edu		McEvoy, Megan/0000-0002-4132-7355	National Institutes of Health [GM079192]; National Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; NIH-ORIP HEI grant [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; NIH [P30 DK089507]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH-ORIP HEI grant; DOE Office of Science(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the National Institutes of Health (GM079192) for support to M. M. M. Diffraction data were collected at the Northeastern Collaborative Access Team beamlines 24-ID-E and -C, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P41 GM103403). The Pilatus 6M detector on 24-ID-C beam line is funded by an NIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. Pseudomonas strains were obtained from the University of Washington Transposon Mutant Collection, supported by NIH P30 DK089507. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Bagai I, 2008, BIOCHEMISTRY-US, V47, P11408, DOI 10.1021/bi801638m; Bagai I, 2007, J BIOL CHEM, V282, P35695, DOI 10.1074/jbc.M703937200; Bewley KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122466; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Brown K, 2000, NAT STRUCT BIOL, V7, P191; Casey AL, 2010, J HOSP INFECT, V74, P72, DOI 10.1016/j.jhin.2009.08.018; Chacon KN, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0181-9; Chacon KN, 2014, P NATL ACAD SCI USA, V111, P15373, DOI 10.1073/pnas.1411475111; Denoncin K, 2013, ANTIOXID REDOX SIGN, V19, P63, DOI 10.1089/ars.2012.4864; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabianek RA, 2000, FEMS MICROBIOL REV, V24, P303, DOI 10.1111/j.1574-6976.2000.tb00544.x; Fisher OS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06681-5; Gomis-Ruth FX, 1998, EMBO J, V17, P7404, DOI 10.1093/emboj/17.24.7404; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Gutierrez-Barranquero JA, 2013, APPL ENVIRON MICROB, V79, P1028, DOI 10.1128/AEM.02644-12; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Hao XL, 2015, APPL MICROBIOL BIOT, V99, P5817, DOI 10.1007/s00253-015-6749-0; Held K, 2012, J BACTERIOL, V194, P6387, DOI 10.1128/JB.01479-12; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Jacobi A, 1997, J BIOL CHEM, V272, P21692, DOI 10.1074/jbc.272.35.21692; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; JOHNSON WC, 1992, METHOD ENZYMOL, V210, P426; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Kim EH, 2010, NAT PROD REP, V27, P711, DOI 10.1039/b906681k; Kinch LN, 2003, PROTEINS, V52, P323, DOI 10.1002/prot.10425; King JD, 2014, ARCH BIOCHEM BIOPHYS, V564, P237, DOI 10.1016/j.abb.2014.10.003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LaCroix LB, 1996, J AM CHEM SOC, V118, P7755, DOI 10.1021/ja961217p; Lazary A, 2014, INT J INFECT DIS, V24, P23, DOI 10.1016/j.ijid.2014.01.022; Lee SM, 2002, BIOCHEM BIOPH RES CO, V295, P616, DOI 10.1016/S0006-291X(02)00726-X; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Liu J, 2014, CHEM REV, V114, P4366, DOI 10.1021/cr400479b; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Marrero K, 2012, MICROBIOL-SGM, V158, P2005, DOI 10.1099/mic.0.059345-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mealman TD, 2012, CURR TOP MEMBR, V69, P163, DOI 10.1016/B978-0-12-394390-3.00007-0; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Novoa-Aponte L, 2019, J BIOL CHEM, V294, P4934, DOI 10.1074/jbc.RA118.006316; Padilla-Benavides T, 2014, J BIOL CHEM, V289, P20492, DOI 10.1074/jbc.M114.577668; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pontel LB, 2009, MOL MICROBIOL, V73, P212, DOI 10.1111/j.1365-2958.2009.06763.x; Qi Y, 2005, PROTEINS, V58, P376, DOI 10.1002/prot.20329; Quintana J, 2017, J BIOL CHEM, V292, P15691, DOI 10.1074/jbc.M117.804492; Roger M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098941; Rubino JT, 2012, J INORG BIOCHEM, V107, P129, DOI 10.1016/j.jinorgbio.2011.11.024; Santo CE, 2011, APPL ENVIRON MICROB, V77, P794, DOI 10.1128/AEM.01599-10; Savelieff MG, 2010, J BIOL INORG CHEM, V15, P461, DOI 10.1007/s00775-010-0625-2; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Solomon EI, 2006, INORG CHEM, V45, P8012, DOI 10.1021/ic060450d; Sommerhalter M, 2005, INORG CHEM, V44, P770, DOI 10.1021/ic0485256; Staehlin BM, 2016, GENOME BIOL EVOL, V8, P811, DOI 10.1093/gbe/evw031; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Su CC, 2011, PROTEIN SCI, V20, P6, DOI 10.1002/pro.532; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Teitzel GM, 2006, J BACTERIOL, V188, P7242, DOI 10.1128/JB.00837-06; Vincent M, 2018, J APPL MICROBIOL, V124, P1032, DOI 10.1111/jam.13681; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wright BW, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1441-7	72	10	10	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11364	11376		10.1074/jbc.RA120.013907	http://dx.doi.org/10.1074/jbc.RA120.013907			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32571874	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000562757100035
J	de Faria, FR; Miranda, VPN; Howe, CA; Sasaki, JE; Amorim, PRD				de Faria, Fernanda Rocha; Neves Miranda, Valter Paulo; Howe, Cheryl A.; Sasaki, Jeffer Eidi; dos Santos Amorim, Paulo Roberto			Behavioral classes related to physical activity and sedentary behavior on the evaluation of health and mental outcomes among Brazilian adolescents	PLOS ONE			English	Article							LATENT CLASS ANALYSIS; PATTERNS; CHILDREN; OBESITY; SLEEP	Latent Class Analysis can assist researchers interested in a better understanding of behavioral patterns and their association with health outcomes. This study aimed to identify lifestyle latent classes related to distinct domains of physical activity (PA) and sedentary behavior (SB) among adolescents and their association with health outcomes. This cross-sectional study included 217 Brazilian adolescents (15 to 18 years old, 49.3% female). The classes were based on moderate-to-vigorous physical activity (MVPA), light physical activity (LPA), number of steps, sedentary behavior (SB), and screen time (ST). To assess these behaviors, participants wore an accelerometer for one week. ST, demographic characteristics, socioeconomic status, and signs of common mental disorders (CMD) were evaluated through questionnaires. Latent Class Analysis was used to identify lifestyle classes. Three classes were recognized: "Active-Non-sedentary" (class 1) with 28.1% of adolescents; "Inactive-Non-sedentary" (class 2), 48.85%; and "Inactive-Sedentary" (class 3), 23.04%. Sex and signs of CMD were associated with the prevalence of the classes. Female adolescents presented 4.48 (95% CI 2.04-9.77) times more chance of belonging to the "Inactive-Sedentary" (class 3). Adolescents who presented CMD had 11.35 (95% CI 3.45-101.1) times more chance of belonging to the "Inactive-Non-sedentary" (class 2). The interaction between sex and signs of CMD showed that girls with signs of CMD were 9.20 (95% CI 1.17-71.52) more likely to belong to the Inactive-Sedentary class than the "Active-Non-sedentary". Results indicate that sex and signs of CMD can affect the prevalence of the classes. Our findings highlight that physical inactivity and SB can be associated with signs of CMD, especially in female adolescents.	[de Faria, Fernanda Rocha; Neves Miranda, Valter Paulo; dos Santos Amorim, Paulo Roberto] Univ Fed Vicosa, Dept Phys Educ, Vicosa, MG, Brazil; [Howe, Cheryl A.] Ohio Univ, Sch Appl Hlth Sci & Wellness, Athens, OH 45701 USA; [Sasaki, Jeffer Eidi] Univ Fed Triangulo Mineiro, Dept Sports Sci, Uberaba, MG, Brazil	Universidade Federal de Vicosa; University System of Ohio; Ohio University; Universidade Federal do Triangulo Mineiro	de Faria, FR (corresponding author), Univ Fed Vicosa, Dept Phys Educ, Vicosa, MG, Brazil.	frfaria.ef@gmail.com	Howe, Cheryl/ABC-1936-2020					Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Biddle SJH, 2010, PREV MED, V51, P345, DOI 10.1016/j.ypmed.2010.07.018; Champion KE, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00135; Chaput JP, 2017, OBES REV, V18, P7, DOI 10.1111/obr.12508; Corder K, 2008, J APPL PHYSIOL, V105, P977, DOI 10.1152/japplphysiol.00094.2008; Council on Communications and Media, 2011, Pediatrics, V128, P201, DOI 10.1542/peds.2011-1066; Cureau FV, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S01518-8787.2016050006683, 10.1590/s01518-8787.2016050006683]; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Evenson K. R., 2016, International Journal of Behavioral Nutrition and Physical Activity, V13; Fleary SA, 2017, J SCHOOL HEALTH, V87, P182, DOI 10.1111/josh.12481; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Huh J, 2011, OBESITY, V19, P652, DOI 10.1038/oby.2010.228; Iannotti RJ, 2013, J ADOLESCENT HEALTH, V53, P280, DOI 10.1016/j.jadohealth.2013.03.007; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Jenkins GP, 2017, MED SCI SPORT EXER, V49, P1826, DOI 10.1249/MSS.0000000000001310; Kim Y, 2016, J EPIDEMIOL, V26, P137, DOI 10.2188/jea.JE20150068; Kongsted Alice, 2017, J Physiother, V63, P55, DOI 10.1016/j.jphys.2016.05.018; Kremer P, 2014, J SCI MED SPORT, V17, P183, DOI 10.1016/j.jsams.2013.03.012; Krokstad S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3993-x; Lavie CJ, 2019, CIRC RES, V124, P799, DOI 10.1161/CIRCRESAHA.118.312669; Linzer DA, 2011, J STAT SOFTW, V42, P1, DOI 10.18637/jss.v042.i10; Lohman T.J., 1988, ANTHROPOMETRIC STAND; Lopes CS, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S01518-8787.2016050006690, 10.1590/s01518-8787.2016050006690]; Malachias M V B, 2016, Arq Bras Cardiol, V107, P7, DOI 10.5935/abc.20160152; MARI JD, 1985, PSYCHOL MED, V15, P651; Martinez-Gonzalez M., 2009, BIOESTADISTICA AMIGA, V2, P373; Miranda VPN, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6488-8; Oliveira Juliana Souza, 2016, Rev. Saúde Pública, V50, p7s, DOI 10.1590/s01518-8787.2016050006680; Paruthi S, 2016, J CLIN SLEEP MED, V12, P785, DOI 10.5664/jcsm.5866; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; R Code Team and R Development Code Team, 2014, LANG ENV STAT COMP; Romanzini M, 2014, EUR J SPORT SCI, V14, P91, DOI 10.1080/17461391.2012.732614; Tenório Maria Cecília Marinho, 2010, Rev. bras. epidemiol., V13, P105, DOI 10.1590/S1415-790X2010000100010; Thivel D, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00288; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-78; Ussher MH, 2007, SOC PSYCH PSYCH EPID, V42, P851, DOI 10.1007/s00127-007-0232-x; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2008, WAIST CIRCUMFERENCE	41	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234374	10.1371/journal.pone.0234374	http://dx.doi.org/10.1371/journal.pone.0234374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569320	Green Published, gold			2022-12-26	WOS:000543547900036
J	Du, RJ; Huang, CT; Chen, HY; Liu, KD; Xiang, P; Yao, N; Yang, L; Zhou, LT; Wu, Q; Zheng, YQ; Xin, MX; Dong, ZG; Li, X				Du, Ruijuan; Huang, Chuntian; Chen, Hanyong; Liu, Kangdong; Xiang, Pu; Yao, Ning; Yang, Lu; Zhou, Liting; Wu, Qiong; Zheng, Yaqiu; Xin, Mingxia; Dong, Zigang; Li, Xiang			SDCBP/MDA-9/syntenin phosphorylation by AURKA promotes esophageal squamous cell carcinoma progression through the EGFR-PI3K-Akt signaling pathway	ONCOGENE			English	Article							AURORA-A; MDA-9/SYNTENIN; PROTEIN; SYNTENIN; OVEREXPRESSION; PROLIFERATION; ACTIVATION; MIGRATION; SPECIFICITY; INHIBITION	SDCBP is an adapter protein containing two tandem PDZ domains mediating cell adhesion. The role and underlying molecular mechanism of SDCBP in ESCC remain obscure. Here, we report that SDCBP is frequently overexpressed in ESCC tissues and cells compared to normal controls and that its overexpression is correlated with late clinical stage and predicts poor prognosis in ESCC patients. Functionally, high expression of SDCBP is positively related to ESCC progression both in vitro and in vivo. Furthermore, mechanistic studies show that SDCBP activates the EGFR-PI3K-Akt signaling pathway by binding to EGFR and preventing EGFR internalization. Moreover, we provide evidence that AURKA binds to SDCBP and phosphorylates it at the Ser131 and Thr200 sites to inhibit ubiquitination-mediated SDCBP degradation. More importantly, the sites at which AURKA phosphorylates SDCBP are crucial for the EGFR signaling-mediated oncogenic function of SDCBP. Taken together, we propose that SDCBP phosphorylation by AURKA prevents SDCBP degradation and promotes ESCC tumor growth through the EGFR-PI3K-Akt signaling pathway. Our findings unveil a new AURKA-SDCBP-EGFR axis that is involved in ESCC progression and provide a promising therapeutic target for ESCC treatment in the clinic.	[Du, Ruijuan; Huang, Chuntian; Liu, Kangdong; Zhou, Liting; Wu, Qiong; Dong, Zigang; Li, Xiang] Zhengzhou Univ, Sch Basic Med Sci, Dept Pathophysiol, Zhengzhou 450001, Henan, Peoples R China; [Du, Ruijuan; Huang, Chuntian; Liu, Kangdong; Yao, Ning; Yang, Lu; Zhou, Liting; Wu, Qiong; Zheng, Yaqiu; Xin, Mingxia; Dong, Zigang; Li, Xiang] China US Henan Hormel Canc Inst, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China; [Chen, Hanyong] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Liu, Kangdong; Dong, Zigang; Li, Xiang] Collaborat Innovat Ctr Henan Prov Canc Chemopreve, Zhengzhou, Peoples R China; [Liu, Kangdong; Dong, Zigang; Li, Xiang] Zhengzhou Univ, State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou, Henan, Peoples R China; [Xiang, Pu] Zhengzhou Univ, Dept Hematol, Affiliated Canc Hosp, Zhengzhou 450008, Henan, Peoples R China; [Xiang, Pu] Henan Canc Hosp, Zhengzhou 450008, Henan, Peoples R China	Zhengzhou University; University of Minnesota System; Zhengzhou University; Zhengzhou University; Zhengzhou University	Dong, ZG; Li, X (corresponding author), Zhengzhou Univ, Sch Basic Med Sci, Dept Pathophysiol, Zhengzhou 450001, Henan, Peoples R China.; Dong, ZG; Li, X (corresponding author), China US Henan Hormel Canc Inst, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China.; Dong, ZG; Li, X (corresponding author), Collaborat Innovat Ctr Henan Prov Canc Chemopreve, Zhengzhou, Peoples R China.; Dong, ZG; Li, X (corresponding author), Zhengzhou Univ, State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou, Henan, Peoples R China.	dongzg@zzu.edu.cn; lixiang@zzu.edu.cn			National Natural Science Foundation of China [81802795, 31301144]; Key Scientific Research Project Plan of Colleges and Universities in Henan Province [18A310034]; Science and Technology Project of Henan Province [182102310324, 202102310206]; Training plan for Young Backbone Teachers of Zhengzhou University [2018ZDGGJS037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Scientific Research Project Plan of Colleges and Universities in Henan Province; Science and Technology Project of Henan Province; Training plan for Young Backbone Teachers of Zhengzhou University	This study was supported by the National Natural Science Foundation of China (Nos. 81802795 and 31301144); the Key Scientific Research Project Plan of Colleges and Universities in Henan Province (No. 18A310034); the Science and Technology Project of Henan Province (Nos. 182102310324 and 202102310206); and the Training plan for Young Backbone Teachers of Zhengzhou University (No. 2018ZDGGJS037).	Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Boukerche H, 2010, ONCOGENE, V29, P3054, DOI 10.1038/onc.2010.65; Boukerche H, 2008, P NATL ACAD SCI USA, V105, P15914, DOI 10.1073/pnas.0808171105; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Choi Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep36818; Cui L, 2016, ONCOTARGET, V7, P82634, DOI 10.18632/oncotarget.13020; Das SK, 2012, FRONT BIOSCI-LANDMRK, V17, P1, DOI 10.2741/3911; Dasgupta S, 2013, CLIN CANCER RES, V19, P4621, DOI 10.1158/1078-0432.CCR-13-0585; Dutertre S, 2002, ONCOGENE, V21, P6175, DOI 10.1038/sj.onc.1205775; Egea-Jimenez AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12101; Fancelli D, 2006, J MED CHEM, V49, P7247, DOI 10.1021/jm060897w; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Gangemi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029989; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Guan Z, 2007, CANCER RES, V67, P10436, DOI 10.1158/0008-5472.CAN-07-1379; Humphrey SJ, 2015, TRENDS ENDOCRIN MET, V26, P676, DOI 10.1016/j.tem.2015.09.013; Kamran M, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2016.80; Kang BS, 2003, STRUCTURE, V11, P845, DOI 10.1016/S0969-2126(03)00125-4; Kang BS, 2003, STRUCTURE, V11, P459, DOI 10.1016/S0969-2126(03)00052-2; Kegelman TP, 2017, P NATL ACAD SCI USA, V114, P370, DOI 10.1073/pnas.1616100114; Kegelman TP, 2014, NEURO-ONCOLOGY, V16, P50, DOI 10.1093/neuonc/not157; Koo TH, 2002, ONCOGENE, V21, P4080, DOI 10.1038/sj.onc.1205514; Liu JH, 2018, EUR J MED CHEM, V154, P354, DOI 10.1016/j.ejmech.2018.05.015; Lopez-Saez JF, 1998, HISTOL HISTOPATHOL, V13, P1197, DOI 10.14670/HH-13.1197; Luyten A, 2008, MOL BIOL CELL, V19, P1594, DOI 10.1091/mbc.E07-08-0832; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Melhado Rachel E, 2010, Cancers (Basel), V2, P1379, DOI 10.3390/cancers2031379; Mori H, 1999, MUTAT RES-FUND MOL M, V428, P291, DOI 10.1016/S1383-5742(99)00055-1; Ohno K, 2004, MOL CELL NEUROSCI, V26, P518, DOI 10.1016/j.mcn.2004.04.007; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Oyesanya Regina A, 2014, Oncoscience, V1, P725; Qian XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060046; Qina L, 2009, CANCER LETT, V275, P77, DOI 10.1016/j.canlet.2008.10.011; Radivojac P, 2008, BIOINFORMATICS, V24, pI241, DOI 10.1093/bioinformatics/btn267; Rajesh S, 2011, J BIOL CHEM, V286, P39606, DOI 10.1074/jbc.M111.262402; Sala-Valdes M, 2012, J CELL SCI, V125, P1235, DOI 10.1242/jcs.094912; Talukdar S, 2018, P NATL ACAD SCI USA, V115, P5768, DOI 10.1073/pnas.1721650115; Tanaka E, 2005, CLIN CANCER RES, V11, P1827, DOI 10.1158/1078-0432.CCR-04-1627; Tong T, 2004, CLIN CANCER RES, V10, P7304, DOI 10.1158/1078-0432.CCR-04-0806; Wang J, 2017, J CELL SCI, V130, P1078, DOI 10.1242/jcs.196790; Wang J, 2017, BMC BIOL, V15, DOI 10.1186/s12915-016-0335-5; Wang LK, 2016, ONCOTARGET, V7, P386, DOI 10.18632/oncotarget.6299; Wang XX, 2012, MOL CANCER RES, V10, P588, DOI 10.1158/1541-7786.MCR-11-0416; Yang H, 2006, INT J CANCER, V119, P2304, DOI 10.1002/ijc.22154; Yang SB, 2007, ONCOL REP, V17, P1083; Yao JE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-95; Yoshida GJ, 2018, P NATL ACAD SCI USA, V115, pE7652, DOI 10.1073/pnas.1810152115; Zeng HM, 2018, LANCET GLOB HEALTH, V6, pE555, DOI 10.1016/S2214-109X(18)30127-X; Zhong D, 2012, ASIAN PAC J CANCER P, V13, P2897, DOI 10.7314/APJCP.2012.13.6.2897; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	52	12	12	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 30	2020	39	31					5405	5419		10.1038/s41388-020-1369-2	http://dx.doi.org/10.1038/s41388-020-1369-2		JUN 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MT1TS	32572158				2022-12-26	WOS:000542723000003
J	Piruzyan, M; Shitanda, I; Shimauchi, Y; Okita, G; Tsurekawa, Y; Moriuchi, M; Nakano, Y; Teramoto, K; Suico, MA; Shuto, T; Kai, HR				Piruzyan, Mariam; Shitanda, Ihori; Shimauchi, Yuichiro; Okita, Go; Tsurekawa, Yu; Moriuchi, Masataka; Nakano, Yoshio; Teramoto, Keisuke; Suico, Mary Ann; Shuto, Tsuyoshi; Kai, Hirofumi			A novel condition of mild electrical stimulation exerts immunosuppression via hydrogen peroxide production that controls multiple signaling pathway	PLOS ONE			English	Article							NF-KAPPA-B; T-LYMPHOCYTES; HYPERTHERMIA; CYCLOSPORINE; EXPRESSION; PROTEINS; ARREST; INJURY; CELLS	Different modes of exogenous electrical stimulation at physiological strength has been applied to various diseases. Previously, we extensively demonstrated the usability of mild electrical stimulation (MES) with low frequency pulse current at 55 pulses per second (MES55) for several disease conditions. Here we found that MES with high frequency pulse-current (5500 pulse per second; MES5500) suppressed the overproduction of pro-inflammatory cytokines induced by phorbol myristate acetate/ionomycin in Jurkat T cells and primary splenocytes. MES(5500)also suppressed the overproduction of inflammatory cytokines, improved liver damage and reduced mouse spleen enlargement in concanavalin-A-treated BALB/c mice. The molecular mechanism underlying these effects included the ability of MES(5500)to induce modest amount of hydrogen peroxide and control multiple signaling pathways important for immune regulation, such as NF-kappa B, NFAT and NRF2. In the treatment of various inflammatory and immune-related diseases, suppression of excessive inflammatory cytokines is key, but because immunosuppressive drugs used in the clinical setting have serious side effects, development of safer methods of inhibiting cytokines is required. Our finding provides evidence that physical medicine in the form of MES(5500)may be considered as a novel therapeutic tool or as adjunctive therapy for inflammatory and immune-related diseases.	[Piruzyan, Mariam; Shitanda, Ihori; Shimauchi, Yuichiro; Okita, Go; Tsurekawa, Yu; Moriuchi, Masataka; Nakano, Yoshio; Teramoto, Keisuke; Suico, Mary Ann; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto, Japan; [Piruzyan, Mariam; Tsurekawa, Yu; Moriuchi, Masataka; Nakano, Yoshio; Teramoto, Keisuke; Kai, Hirofumi] Kumamoto Univ, Program Leading Grad Sch HIGO Hlth Life Sci Inter, Kumamoto, Japan	Kumamoto University; Kumamoto University	Kai, HR (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto, Japan.; Kai, HR (corresponding author), Kumamoto Univ, Program Leading Grad Sch HIGO Hlth Life Sci Inter, Kumamoto, Japan.	hirokai@gpo.kumamoto-u.ac.jp		Shuto, Tsuyoshi/0000-0003-1275-4988	Japan Society for the Promotion Science (JSPS) KAKENHI [JP26460098, JP17K08309]; JSPS Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers [S2803]	Japan Society for the Promotion Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers	Funding was provided by the Japan Society for the Promotion Science (JSPS) KAKENHI (Grant Nos. JP26460098 and JP17K08309 (to M.A.S.)), and JSPS Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (Grant No. S2803 (to H.K.)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2015, FREE RADICAL BIO MED, V79, P28, DOI 10.1016/j.freeradbiomed.2014.11.014; AEBI H, 1968, BIOCHEM GENET, V2, P245, DOI 10.1007/BF01474764; [Anonymous], 2014, EURASIAN CARDIOLOGIC, V1, P80; Antoniv TT, 2011, IMMUNOLOGY, V132, P567, DOI 10.1111/j.1365-2567.2010.03402.x; Avrahami R, 2015, WOUNDS, V27, P199; Busquets-Cortes C, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121920; Bussel B, 2015, ANN PHYS REHABIL MED, V58, P198, DOI 10.1016/j.rehab.2015.04.008; Doerfler Maria, 2015, SYRIAC ENCOUNTERS PA, V20, P259; Du PH, 2016, CHEMOSPHERE, V144, P1674, DOI 10.1016/j.chemosphere.2015.10.038; Fukuda R, 2016, J AM SOC NEPHROL, V27, P144, DOI 10.1681/ASN.2014111109; Fukuda R, 2013, J BIOL CHEM, V288, P16117, DOI 10.1074/jbc.M112.442442; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Heymann F, 2015, LAB ANIM-UK, V49, P12, DOI 10.1177/0023677215572841; Hoorn EJ, 2011, NAT MED, V17, P1304, DOI 10.1038/nm.2497; Horiba M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42208; Hoyer KK, 2008, IMMUNOL REV, V226, P19, DOI 10.1111/j.1600-065X.2008.00697.x; Huang JH, 2013, EUR J NEUROSCI, V38, P3691, DOI 10.1111/ejn.12370; Kai H, 2009, INT J HYPERTHER, V25, P655, DOI 10.3109/02656730903039605; Kitahara K, 2007, CURR OPIN RHEUMATOL, V19, P238, DOI 10.1097/BOR.0b013e328099af80; Koga T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043852; Kondo T, 2012, DIABETES, V61, P838, DOI 10.2337/db11-1098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matsuyama S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114690; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Morino S, 2008, J PHARMACOL SCI, V108, P222, DOI 10.1254/jphs.08180SC; Morino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004068; Morzadec C, 2014, FREE RADICAL BIO MED, V71, P133, DOI 10.1016/j.freeradbiomed.2014.03.006; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Oba M, 2010, J SURG RES, V162, P213, DOI 10.1016/j.jss.2009.03.093; Odell RH, 2008, PAIN PHYSICIAN, V11, P891; Pandey AN, 2014, BIORESEARCH OPEN ACC, V3, P183, DOI 10.1089/biores.2014.0013; ROSS R, 1994, P NATL ACAD SCI USA, V91, P2879, DOI 10.1073/pnas.91.8.2879; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; Schmitt J, 2007, J EUR ACAD DERMATOL, V21, P606, DOI 10.1111/j.1468-3083.2006.02023.x; Sies H, 2017, REDOX BIOL, V11, P613, DOI 10.1016/j.redox.2016.12.035; Suico MA, 2014, J BIOL CHEM, V289, P26143, DOI 10.1074/jbc.M114.580209; Sultana ST, 2015, SCI REP-UK, V5, DOI 10.1038/srep14908; Tsurekawa Y, 2018, EXP DERMATOL, V27, P1092, DOI 10.1111/exd.13720; Wollbold J, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0101-7; Yano S, 2011, J PHARMACOL SCI, V115, P94, DOI 10.1254/jphs.10185SC; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	45	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234867	10.1371/journal.pone.0234867	http://dx.doi.org/10.1371/journal.pone.0234867			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569300	Green Published, gold			2022-12-26	WOS:000543547900051
J	Browne, MA; Ros, M; Johnston, EL				Browne, Mark Anthony; Ros, Macarena; Johnston, Emma L.			Pore-size and polymer affect the ability of filters for washing-machines to reduce domestic emissions of fibres to sewage	PLOS ONE			English	Article							MICROPLASTICS; RELEASE	When clothes are worn and washed, they emit fibres into the ecosystem via discharges of sewage that have been linked to the global dispersion of clothing fibres. Facilities that treat sewage divert some fibres from sewage effluent to sludge, but no current methods of filtration eliminate their environmental release. While filters for washing-machines are sold to consumers with the argument they will reduce the emissions of fibres from clothes to the environment, there is insufficient scientific peer-reviewed evidence assessing their ability to retain fibres from washed clothes and reduce environmental contamination. To improve our understanding and develop more realistic methods to assess the efficiency of filters, we washed replicate cotton and polyester garments in replicate domestic front-loaded washing-machines with and without replicate filters (micro- and milli-meter-sized pores), and then quantified the masses of the fibres retained by the filters and those released in the effluent. Here we show micrometer-sized filters significantly reduced the mass of cotton by 67% (F-2,F-6= 11.69, P<0.01) compared to effluent from appliances with no filters, whilst filters in general reduced polyester fibres in their effluent by more than 65% (micrometer-sized pores) and 74% (millimeter-sized pores) compared to effluent from appliances with no filters (F-2,F-12= 5.20, P<0.05). While filters with micrometer-sized pores caught larger masses and total proportions of fibres than filters with millimeter-sized pores, the differences were only significant for the total proportions of cotton (t = 4.799 df = 4, P<0.01). For tests with garments of either types of polymer, the filtered effluent still contained up to a third of the original masses of fibres released from the garments. Given the diversity of clothes, polymers, appliances and filters currently sold to consumers, our work shows the value of increasing the rigour (e.g. more levels of replication) when testing filters and the need for further studies that test an even greater diversity of materials and methods in order to meet the growing demand for knowledge from governments, industry and the public.	[Browne, Mark Anthony; Johnston, Emma L.] Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Ros, Macarena] Univ Cadiz, Fac Ciencias Mar & Ambientales, Dept Biol, Puerto Real, Spain	University of New South Wales Sydney; Universidad de Cadiz	Browne, MA (corresponding author), Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	m.browne@unsw.edu.au	Johnston, Emma/AAC-2878-2022; Ros, Macarena/AAD-4589-2021	Johnston, Emma/0000-0002-2117-366X; Ros, Macarena/0000-0001-8074-0778; Browne, Mark Anthony/0000-0002-7508-1015	Eileen Fisher; Mosman Council; NSW EPA (Waste Less, Recycle More initiative from waste-levy); Australian Research Council [DP150103272, LP170100313]; Spanish Government fellowship [CAS17/00482]	Eileen Fisher; Mosman Council; NSW EPA (Waste Less, Recycle More initiative from waste-levy); Australian Research Council(Australian Research Council); Spanish Government fellowship	MAB received funding in the form of a grant from Eileen Fisher (www.eileenfisher.com).MAB and ELJ received funding from Mosman Council (www.mosman.nsw.gov.au), NSW EPA (Waste Less, Recycle More initiative funded from waste-levy; https://www.epa.nsw.gov.au/yourenvironment/recycling-and-reuse/waste-less-recycle-more), Australian Research Council (DP150103272, LP170100313; www.arc.gov.au).MR received funding from Spanish Government fellowship (Jose Castillejo CAS17/00482; www.mecd.gob.es).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 00 The manuscript was written through contributions of all authors reflected by the order of authorship. All authors approved the final version of the manuscript. We thank B. Jollimore (at Environmental Enhancements for providing all filters for free), N. Garg, A. Bugnot, M. Gil, M. Mayer-Pinto, E. Marzinelli, L. Martin (for the use of their homes/appliances), M.Todesco (microscopic observations of the physical construction of the garments) and R. Stamminger (for advice and helpful comments). This work was supported by grants from Eileen Fisher, Mosman Council, NSW EPA (Waste Less, Recycle More initiative funded from waste-levy) and the Australian Research Council (DP150103272, LP170100313) to MAB, ELJ and a Spanish Government fellowship to MR (Jose Castillejo CAS17/00482). Sources of funding and Environmental Enhancements were not involved in the collection, analysis and interpretation of data, in report-writing or the decision to submit for publication.	Almroth BMC, 2018, ENVIRON SCI POLLUT R, V25, P1191, DOI 10.1007/s11356-017-0528-7; [Anonymous], 2019, FABR; [Anonymous], 2011, 604562011 EN; Australian Competition and Consumer Commission, 2019, GREEN MARK AUSTR CON; Browne MA, 2015, NY TIMES; Browne MA, 2008, ENVIRON SCI TECHNOL, V42, P5026, DOI 10.1021/es800249a; Browne MA, 2015, MARINE ANTHROPOGENIC LITTER, P229, DOI 10.1007/978-3-319-16510-3_9; Browne MA, 2015, ENVIRON SCI TECHNOL, V49, P7082, DOI 10.1021/es5060572; Browne MA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2929; Browne MA, 2013, CURR BIOL, V23, P2388, DOI 10.1016/j.cub.2013.10.012; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Carmichael A, 2019, MAN MADE FIBRES CONT; De Falco F, 2018, ENVIRON POLLUT, V236, P916, DOI 10.1016/j.envpol.2017.10.057; El Backly RM, 2013, TISSUE ENG PT A, V19, P152, DOI [10.1089/ten.tea.2012.0357, 10.1089/ten.TEA.2012.0357]; Fisher R.A., 1930, IMPERIAL BUREAU SOIL, V10, P437; Gatoo MA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/498420; Gosney ML, 1979, IND RELATION LAW J, V3, P102, DOI 10.15779/Z38N03T; Halstead JE, 2018, ENVIRON POLLUT, V234, P552, DOI 10.1016/j.envpol.2017.11.085; Hartline NL, 2016, ENVIRON SCI TECHNOL, V50, P11532, DOI 10.1021/acs.est.6b03045; Hernandez E, 2017, ENVIRON SCI TECHNOL, V51, P7036, DOI 10.1021/acs.est.7b01750; Hsiao IL, 2011, SCI TOTAL ENVIRON, V409, P1219, DOI 10.1016/j.scitotenv.2010.12.033; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Hussain N, 2001, ADV DRUG DELIVER REV, V50, P107, DOI 10.1016/S0169-409X(01)00152-1; Lusher AL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14947; McIlwraith HK, 2019, MAR POLLUT BULL, V139, P40, DOI 10.1016/j.marpolbul.2018.12.012; Murphy F, 2016, ENVIRON SCI TECHNOL, V50, P5800, DOI 10.1021/acs.est.5b05416; Murray F, 2011, MAR POLLUT BULL, V62, P1207, DOI 10.1016/j.marpolbul.2011.03.032; Muthu SS, 2017, TEXT INST BOOK SER, pXV; Napper IE, 2016, MAR POLLUT BULL, V112, P39, DOI 10.1016/j.marpolbul.2016.09.025; Oerlikon, 2009, FIBR YEAR 2008 09 WO; Oner E, 2019, FIBER POLYM, V20, P2416, DOI 10.1007/s12221-019-9119-1; Pirc U, 2016, ENVIRON SCI POLLUT R, V23, P22206, DOI 10.1007/s11356-016-7703-0; Senate Environment and Communications References Committee, TOX TID THREAT MAR P; Sillanpaa M, 2017, ENVIRON SCI POLLUT R, V24, P19313, DOI 10.1007/s11356-017-9621-1; Stamminger R, 2018, RESOUR CONSERV RECY, V131, P206, DOI 10.1016/j.resconrec.2017.11.014; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Underwood AJ, 2017, ANAL METHODS-UK, V9, P1332, DOI 10.1039/c6ay02641a; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Woodall LC, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140317	39	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234248	10.1371/journal.pone.0234248	http://dx.doi.org/10.1371/journal.pone.0234248			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559201	Green Published, gold			2022-12-26	WOS:000543261600023
J	Maharani, A; Dawes, P; Nazroo, J; Tampubolon, G; Pendleton, N				Maharani, Asri; Dawes, Piers; Nazroo, James; Tampubolon, Gindo; Pendleton, Neil		SENSE-Cog WP1 Grp	Trajectories of recall memory as predictive of hearing impairment: A longitudinal cohort study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MINI-MENTAL STATE; PHYSICAL-ACTIVITY; OLDER-ADULTS; RISK-FACTORS; DEMENTIA; DECLINE; AGE; HEALTH; INTELLIGENCE	Objectives Accumulating evidence points to a relationship between hearing function and cognitive ability in later life. However, the exact mechanisms of this relationship are still unclear. This study aimed to characterise latent cognitive trajectories in recall memory and identify their association with subsequent risk of hearing impairment. Methods We analysed data from the English Longitudinal Study of Ageing Wave 1 (2002/03) until Wave 7 (2014/15). The study population consisted of 3,615 adults aged 50+ who participated in the first wave of the English Longitudinal Study of Ageing, who had no self-reported hearing impairment in Wave 1, and who underwent a hearing test in Wave 7. Respondents were classified as having hearing impairment if they failed to hear tones quieter than 35 dB HL in the better ear. Results The trajectories of recall memory scores were grouped using latent class growth mixture modelling and were related to the presence of hearing impairment in Wave 7. Models estimating 1-class through 5-class recall memory trajectories were compared and the best-fitting models were 4-class trajectories. The different recall memory trajectories represent different starting points and mean of the memory scores. Compared to respondents with the highest recall memory trajectory, other trajectories were increasingly likely to develop later hearing impairment. Conclusions Long-term changes in cognitive ability predict hearing impairment. Further research is required to identify the mechanisms explaining the association between cognitive trajectories and hearing impairment, as well as to determine whether intervention for maintenance of cognitive function also give benefit on hearing function among older adults.	[Maharani, Asri; Pendleton, Neil] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Neurosci & Expt Psychol, Manchester, Lancs, England; [Dawes, Piers] Univ Manchester, Div Human Commun Dev & Hearing, Manchester, Lancs, England; [Nazroo, James; Tampubolon, Gindo] Univ Manchester, Cathie Marsh Inst Social Res, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Maharani, A (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Neurosci & Expt Psychol, Manchester, Lancs, England.	asri.maharani@manchester.ac.uk	Delcourt, Cecile/I-2627-2013; Pendleton, Neil/F-2333-2015; Maharani, Asri/U-7663-2017	Delcourt, Cecile/0000-0002-2099-0481; Dawes, Piers/0000-0003-3180-9884; Pendleton, Neil/0000-0003-0794-2386; Tampubolon, Gindo/0000-0002-9081-2349; Maharani, Asri/0000-0002-5931-8692	Horizon 2020 Framework Programme [633491, 668648]; UK National Institute for Health Research [01A1-CSPP04-014]	Horizon 2020 Framework Programme; UK National Institute for Health Research(National Institute for Health Research (NIHR))	SENSE-Cog project has received funding from the Horizon 2020 Framework Programme (633491) research and innovation programme under grant agreement No 668648. PD is supported by the UK National Institute for Health Research (01A1-CSPP04-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimoni C, 2010, AUDIOL NEURO-OTOL, V15, P111, DOI 10.1159/000231636; Amieva H, 2015, J AM GERIATR SOC, V63, P2099, DOI 10.1111/jgs.13649; Anstey KJ, 2003, PSYCHOL AGING, V18, P714, DOI 10.1037/0882-7974.18.4.714; Anstey KJ, 2001, J GERONTOL B-PSYCHOL, V56, pP3, DOI 10.1093/geronb/56.1.P3; Armstrong NM, 2020, J GERONTOL A-BIOL, V75, P574, DOI 10.1093/gerona/gly268; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Bakk Z, 2013, SOCIOL METHODOL, V43, P272, DOI 10.1177/0081175012470644; Baloyannis SJ, 2005, J NEUROL SCI, V229, P51, DOI 10.1016/j.jns.2004.11.025; Baloyannis SJ, 2011, ACTA OTO-LARYNGOL, V131, P610, DOI 10.3109/00016489.2010.539626; Baloyannis SJ, 2011, ACTA OTO-LARYNGOL, V131, P359, DOI 10.3109/00016489.2010.539267; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Benova L, 2015, J GERONTOL B-PSYCHOL, V70, P443, DOI 10.1093/geronb/gbu024; Bizley JK, 2013, NAT REV NEUROSCI, V14, P693, DOI 10.1038/nrn3565; Buschkuehl M, 2008, PSYCHOL AGING, V23, P743, DOI 10.1037/a0014342; Davies HR, 2017, J AM GERIATR SOC, V65, P2074, DOI 10.1111/jgs.14986; DAVIS AC, 1989, INT J EPIDEMIOL, V18, P911, DOI 10.1093/ije/18.4.911; Deary IJ, 1997, TRENDS NEUROSCI, V20, P365, DOI 10.1016/S0166-2236(97)01070-9; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Golob EJ, 2007, BRAIN, V130, P740, DOI 10.1093/brain/awl375; GordonSalant S, 1997, J SPEECH LANG HEAR R, V40, P423, DOI 10.1044/jslhr.4002.423; Griffiths TD, 2004, NAT REV NEUROSCI, V5, P887, DOI 10.1038/nrn1538; Gurgel RK, 2014, OTOL NEUROTOL, V35, P775, DOI 10.1097/MAO.0000000000000313; Heinrich A, 2020, EAR HEARING, V41, P907, DOI 10.1097/AUD.0000000000000812; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Hull RH, 2010, AM J AUDIOL, V19, P9, DOI 10.1044/1059-0889(2010/08-0040); Inst Med, 2015, COGNITIVE AGING: PROGRESS IN UNDERSTANDING AND OPPORTUNITIES FOR ACTION, P1; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kiely KM, 2012, J GERONTOL A-BIOL, V67, P997, DOI 10.1093/gerona/gls066; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin FR, 2012, JAMA-J AM MED ASSOC, V307, P1147, DOI 10.1001/jama.2012.321; Lin FR, 2011, J GERONTOL A-BIOL, V66, P582, DOI 10.1093/gerona/glr002; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Lindenberger U, 2009, PSYCHOL AGING, V24, P1, DOI 10.1037/a0014986; Maharani A, 2020, J GERONTOL B-PSYCHOL, V75, P1230, DOI 10.1093/geronb/gbz043; Maharani A, 2018, AGE AGEING, V47, P575, DOI 10.1093/ageing/afy061; Marmot M., 2015, ENGLISH LONGITUDINAL, DOI [10.5255/UKDA-SN-5050-10., DOI 10.5255/UKDA-SN-5050-10, http://dx.doi.org/10.5255/UKDA-SN-5050-10]; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; McGarrigle R, 2014, INT J AUDIOL, V53, P433, DOI 10.3109/14992027.2014.890296; Miles L, 2007, NUTR BULL, V32, P314, DOI 10.1111/j.1467-3010.2007.00668.x; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Nondahl DM, 1998, AUDIOLOGY, V37, P295; Parving A., 2008, AUDIOLOGICAL MED, V6, P115, DOI DOI 10.1080/16513860801995633; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Rosenberg A, 2018, ALZHEIMERS DEMENT, V14, P263, DOI 10.1016/j.jalz.2017.09.006; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Schneider B. A., 2000, IMPLICATIONS PERCEPT; Scholes S, 2014, HLTH SURV ENGL; Society for Endocrinology MaDoSAS, 2017, J ENDOCRINOL METAB D, V21, pS1; Spiby J, 2014, EXTERNAL REV PROGRAM; Sun R., 2006, COGNITION MULTIAGENT, P79; Tampubolon G, 2017, EUR GERIATR MED, V8, P454, DOI 10.1016/j.eurger.2017.08.001; Twamley EW, 2006, J INT NEUROPSYCH SOC, V12, P707, DOI 10.1017/S1355617706060863; UHLMANN RF, 1989, J AM GERIATR SOC, V37, P223, DOI 10.1111/j.1532-5415.1989.tb06811.x; Wayne RV, 2015, AGEING RES REV, V23, P154, DOI 10.1016/j.arr.2015.06.002; Wickett JC, 2000, PERS INDIV DIFFER, V29, P1095, DOI 10.1016/S0191-8869(99)00258-5; Wilson BS, 2017, LANCET, V390, P2503, DOI 10.1016/S0140-6736(17)31073-5; Wingfield A, 1996, J Am Acad Audiol, V7, P175	62	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234623	10.1371/journal.pone.0234623	http://dx.doi.org/10.1371/journal.pone.0234623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555743	gold, Green Published			2022-12-26	WOS:000543273200072
J	Ping, WW; Zheng, JZ; Niu, XH; Guo, CZ; Zhang, JF; Yang, H; Shi, Y				Ping, Weiwei; Zheng, Jianzhong; Niu, Xiaohong; Guo, Chongzheng; Zhang, Jinfang; Yang, Hui; Shi, Yan			Evaluation of health-related quality of life using EQ-5D in China during the COVID-19 pandemic	PLOS ONE			English	Article							GENERAL-POPULATION; QUESTIONNAIRE; VALIDITY; EUROQOL; ADULTS; SF-12	Objective Since December 2019, an increasing number of cases of the 2019 novel coronavirus disease (COVID-19) infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been identified in Wuhan, Hubei Province, China. Now, more cases have been reported in 200 other countries and regions. The pandemic disease not only affects physical health who suffered it, but also affects the mental health of the general population. This study aims to know about the impact of the COVID-19 epidemic on the health-related quality of life (HRQOL) of living using EQ-5D in general population in China. Methods An online-based survey was developed and participants were recruited via social media. The questionnaires included demographic and socioeconomic data, health status, the condition epidemic situation and EQ-5D scale. The relationships of all factors and the scores of EQ-5D were analyzed. Logistic regression model were used to the five health dimensions. Results The respondents obtained a mean EQ-5D index score of 0.949 and a mean VAS score of 85.52.The most frequently reported problem were pain/discomfort (19.0%) and anxiety/depression (17.6%). Logistic regression models showed that the risk of pain/discomfort and anxiety/depression among people with aging, with chronic disease, lower income, epidemic effects, worry about get COVID-19 raised significantly. Conclusion The article provides important evidence on HRQOL during the COVID-19 pandemic. The risk of pain/discomfort and anxiety/depression in general population in China raised significantly with aging, with chronic disease, lower income, epidemic effects, worried about get COVID-19 during the COVID-19 pandemic. The results from each categorical data can be used for future healthcare measures among general population.	[Ping, Weiwei; Zheng, Jianzhong; Guo, Chongzheng; Yang, Hui; Shi, Yan] Changzhi Med Coll, Dept Prevent Med, Changzhi, Shanxi, Peoples R China; [Niu, Xiaohong; Zhang, Jinfang] Changzhi Med Coll, Heji Hosp, Changzhi, Shanxi, Peoples R China	Changzhi Medical College; Changzhi Medical College	Ping, WW (corresponding author), Changzhi Med Coll, Dept Prevent Med, Changzhi, Shanxi, Peoples R China.	weiweip@czmc.edu.cn			Soft Science Project of Shanxi of China [2018041033-1, 2017041040-4]; prevention and control COVID-19 project of Changzhi Medical College [XG202004]	Soft Science Project of Shanxi of China; prevention and control COVID-19 project of Changzhi Medical College	The study was funded by the Soft Science Project of Shanxi of China (2017041040-4), the Soft Science Project of Shanxi of China (2018041033-1) to WP, and by the prevention and control COVID-19 project of Changzhi Medical College by XN (XG202004).	Abdin E, 2013, QUAL LIFE RES, V22, P2983, DOI 10.1007/s11136-013-0405-x; Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; [Anonymous], 2020, LANCET INFECT DIS, V20, P192, DOI [10.1016/S1473-3099(20)30483-7, DOI 10.1016/S1473-3099(20)30483-7, DOI 10.1056/NEJMoa2021756]; Burstrom K, 2001, QUAL LIFE RES, V10, P621, DOI 10.1023/A:1013171831202; Chang TJ, 2007, J FORMOS MED ASSOC, V106, P1023, DOI 10.1016/S0929-6646(08)60078-9; Chinese Center for Disease Control and Prevention, HLTH TOP INF DIS COR; FEENY D, 1995, PHARMACOECONOMICS, V7, P490, DOI 10.2165/00019053-199507060-00004; Fujikawa Ai, 2011, Environmental Health and Preventive Medicine, V16, P25, DOI 10.1007/s12199-010-0162-1; Golicki D, 2010, POL ARCH MED WEWN, V120, P276, DOI 10.20452/pamw.945; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Huang WD, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030224; Jelsma J, 2004, B WORLD HEALTH ORGAN, V82, P206; JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437; Jeong H, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016048; Johnson JA, 1998, QUAL LIFE RES, V7, P155, DOI 10.1023/A:1008809610703; Johnson JA, 2000, MED CARE, V38, P115, DOI 10.1097/00005650-200001000-00013; Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Kontodimopoulos N, 2008, VALUE HEALTH, V11, P1162, DOI 10.1111/j.1524-4733.2008.00356.x; Liu GG, 2014, VALUE HEALTH, V17, P597, DOI 10.1016/j.jval.2014.05.007; Liu XH, 2012, COMPR PSYCHIAT, V53, P15, DOI 10.1016/j.comppsych.2011.02.003; Luo N, 2005, MED CARE, V43, P1078, DOI 10.1097/01.mlr.0000182493.57090.c1; National Bureau of Statistics of China, NAT DAT; National Health Commission of the People`s Republic of China, COR DIS COVID 19 PAN; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Sorensen J, 2009, SCAND J PUBLIC HEALT, V37, P467, DOI 10.1177/1403494809105286; SPRANGERS MAG, 1993, QUAL LIFE RES, V2, P287, DOI 10.1007/BF00434800; Su M, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0868-0; Sun S, 2011, QUAL LIFE RES, V20, P309, DOI 10.1007/s11136-010-9762-x; Tan XD, 2019, GLOB HEALTH PROMOT, V26, P96, DOI 10.1177/1757975917743533; Taylor S, 2020, J ANXIETY DISORD, V72, DOI 10.1016/j.janxdis.2020.102232; Teris Cheung, COVID 19 SARS CLOUD, DOI [10.1111/JPM.12639, DOI 10.1111/JPM.12639]; Wang H, 2005, QUAL LIFE RES, V14, P119, DOI 10.1007/s11136-004-0612-6; Wong ELY, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032544; World Health Organization, COR DIS COVID 19 PAN; Yu ST, 2015, QUAL LIFE RES, V24, P2541, DOI 10.1007/s11136-015-0978-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zhuang Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229652; 2014, REG ANESTH PAIN MED, V9	39	105	105	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234850	10.1371/journal.pone.0234850	http://dx.doi.org/10.1371/journal.pone.0234850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4QJ	32555642	gold, Green Published			2022-12-26	WOS:000543273200062
J	Rhee, KY; Chawla, R; Lele, PP				Rhee, Kathy Y.; Chawla, Ravi; Lele, Pushkar P.			Protein expression-independent response of intensity-based pH-sensitive fluorophores inEscherichia coli	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; CYTOPLASMIC PH; INTRACELLULAR PH; BACTERIA; HOMEOSTASIS; ADAPTATION; SURVIVAL; STRESS; LIGHT	Fluorescent proteins that modulate their emission intensities when protonated serve as excellent probes of the cytosolic pH. Since the total fluorescence output fluctuates significantly due to variations in the fluorophore levels in cells, eliminating the dependence of the signal on protein concentration is crucial. This is typically accomplished with the aid of ratiometric fluorescent proteins such as pHluorin. However, pHluorin is excited by blue light, which can complicate pH measurements by adversely impacting bacterial physiology. Here, we characterized the response of intensity-based, pH-sensitive fluorescent proteins that excite at longer wavelengths where the blue light effect is diminished. The pH-response was interpreted in terms of an analytical model that assumed two emission states for each fluorophore: a low intensity protonated state and a high intensity deprotonated state. The model suggested a scaling to eliminate the dependence of the signal on the expression levels as well as on the illumination and photon-detection settings. Experiments successfully confirmed the scaling predictions. Thus, the internal pH can be readily determined with intensity-based fluorophores with appropriate calibrations irrespective of the fluorophore concentration and the signal acquisition setup. The framework developed in this work improves the robustness of intensity-based fluorophores for internal pH measurements inE.coli, potentially extending their applications.	[Rhee, Kathy Y.; Chawla, Ravi; Lele, Pushkar P.] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA; [Chawla, Ravi] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Texas A&M University System; Texas A&M University College Station; Scripps Research Institute	Lele, PP (corresponding author), Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA.	plele@tamu.edu	Chawla, Ravi/GMX-1615-2022	Chawla, Ravi/0000-0003-1867-9528	National Institute of General Medical Sciences [R01-GM123085]; DOD ACC-APG-RTP Division [W911NF1810353]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOD ACC-APG-RTP Division	PPL acknowledges support from the National Institute of General Medical Sciences (R01-GM123085) and the DOD ACC-APG-RTP Division (W911NF1810353). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1967, J GEN MICROBIOL, V46, P175, DOI 10.1099/00221287-46-2-175; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Awaji T, 2001, BIOCHEM BIOPH RES CO, V289, P457, DOI 10.1006/bbrc.2001.6004; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Beales N, 2004, COMPR REV FOOD SCI F, V3, P1, DOI 10.1111/j.1541-4337.2004.tb00057.x; Bednarska NG, 2013, MICROBIOL-SGM, V159, P1795, DOI 10.1099/mic.0.069575-0; Bencina M, 2013, SENSORS-BASEL, V13, P16736, DOI 10.3390/s131216736; BENJAMIN MM, 1995, APPL ENVIRON MICROB, V61, P1669, DOI 10.1128/AEM.61.4.1669-1672.1995; Booth I. R., 1989, MECH ACTION FOOD PRE, P119; BOOTH IR, 1983, BIOCHEM SOC T, V11, P70, DOI 10.1042/bst0110070; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; BULTHUIS BA, 1993, ANTON LEEUW INT J G, V63, P1, DOI 10.1007/BF00871725; Campbell Tessa N., 2001, Molecular Biology Today, V2, P1; Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362; Chawla R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05521-8; Chen JS, 2011, MICROBIOL-SGM, V157, P3150, DOI 10.1099/mic.0.049619-0; Dai TH, 2012, DRUG RESIST UPDATE, V15, P223, DOI 10.1016/j.drup.2012.07.001; dos Anjos C, 2019, PHOTODIAGN PHOTODYN, V27, P51, DOI 10.1016/j.pdpdt.2019.05.014; Fallingborg J, 1999, DAN MED BULL, V46, P183; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; FOSTER JW, 1995, ANNU REV MICROBIOL, V49, P145, DOI 10.1146/annurev.micro.49.1.145; Hall H K, 1995, Adv Microb Physiol, V37, P229, DOI 10.1016/S0065-2911(08)60147-2; Hanson GT, 2002, BIOCHEMISTRY-US, V41, P15477, DOI 10.1021/bi026609p; Hughes BS, 2007, EVOLUTION, V61, P1725, DOI 10.1111/j.1558-5646.2007.00139.x; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Lele PP, 2015, BIOPHYS J, V108, P1275, DOI 10.1016/j.bpj.2015.02.004; Lele PP, 2012, P NATL ACAD SCI USA, V109, P20018, DOI 10.1073/pnas.1212327109; Li H, 2011, MOL MICROBIOL, V80, P886, DOI 10.1111/j.1365-2958.2011.07557.x; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Lipovsky A, 2010, LASER SURG MED, V42, P467, DOI 10.1002/lsm.20948; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Lund P, 2014, FEMS MICROBIOL REV, V38, P1091, DOI 10.1111/1574-6976.12076; Maclean M, 2009, APPL ENVIRON MICROB, V75, P1932, DOI 10.1128/AEM.01892-08; Martinez KA, 2012, APPL ENVIRON MICROB, V78, P3706, DOI 10.1128/AEM.00354-12; Martynov VI, 2018, BBA-GEN SUBJECTS, V1862, P2924, DOI 10.1016/j.bbagen.2018.09.013; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Olsen KN, 2002, APPL ENVIRON MICROB, V68, P4145, DOI 10.1128/AEM.68.8.4145-4147.2002; PADAN E, 1981, BIOCHIM BIOPHYS ACTA, V650, P151, DOI 10.1016/0304-4157(81)90004-6; PARKINSON JS, 1978, J BACTERIOL, V135, P45, DOI 10.1128/JB.135.1.45-53.1978; Rosado CJ, 2008, AUTOPHAGY, V4, P205, DOI 10.4161/auto.5331; Shen Y, 2014, J CELL BIOL, V207, P419, DOI 10.1083/jcb.201404107; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; SLONCZEWSKI JL, 1982, J BACTERIOL, V152, P384; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; SMITH JJ, 1994, APPL ENVIRON MICROB, V60, P2977, DOI 10.1128/AEM.60.8.2977-2984.1994; Stijlemans B, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003561; Strauber H, 2010, CYTOM PART A, V77A, P623, DOI 10.1002/cyto.a.20920; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593; VanEngelenburg SB, 2008, CURR OPIN CHEM BIOL, V12, P60, DOI 10.1016/j.cbpa.2008.01.020; Vorob'eva LI, 2004, APPL BIOCHEM MICRO+, V40, P217, DOI 10.1023/B:ABIM.0000025941.11643.19; Wang YiQian, 2017, Chinese Journal of Zoonoses, V33, P1; WARD WW, 1982, PHOTOCHEM PHOTOBIOL, V35, P803, DOI 10.1111/j.1751-1097.1982.tb02651.x; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Yang JY, 2020, P NATL ACAD SCI USA, V117, P6114, DOI 10.1073/pnas.1916974117; Young B, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-27; Yuan JH, 2012, NATURE, V484, P233, DOI 10.1038/nature10964; ZILBERSTEIN D, 1984, J BACTERIOL, V158, P246, DOI 10.1128/JB.158.1.246-252.1984	59	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234849	10.1371/journal.pone.0234849	http://dx.doi.org/10.1371/journal.pone.0234849			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555627	gold, Green Published			2022-12-26	WOS:000543273200044
J	Adedokun, O; Badru, T; Khamofu, H; Negedu-Momoh, OR; Iwara, E; Agbakwuru, C; Atobatele, A; Merrigan, M; Ukpong, D; Nzelu, C; Ashefor, G; Pandey, SR; Torpey, K				Adedokun, Oluwasanmi; Badru, Titilope; Khamofu, Hadiza; Negedu-Momoh, Olubunmi Ruth; Iwara, Emem; Agbakwuru, Chinedu; Atobatele, Akinyemi; Merrigan, Mike; Ukpong, Dominic; Nzelu, Charles; Ashefor, Gregory; Pandey, Satish Raj; Torpey, Kwasi			Akwa Ibom AIDS indicator survey: Key findings and lessons learnt	PLOS ONE			English	Article							EPIDEMIC	Background The burden of HIV/AIDS epidemic is huge, but this varies widely by population in Nigeria. Data that could be used to guide the scale up of HIV prevention and control strategies has significant gaps. The study sought to estimate the prevalence of HIV and its associated determinants in Akwa Ibom state. Methods Akwa Ibom AIDS Indicator Survey (AKAIS) is a population based cross-sectional survey, with a two-stage probability sampling. The survey had both behavioural and biological components. Tablet-based questionnaire was used to collect data on participant's household information, demographics, socio-economic, and behavioral risk factors associated with HIV; while the biological component involved collection of venous blood samples for participants who were over 19months. For children aged 18months on less, capillary blood from finger prick sample was used. Participants were tested for HIV. Other biomarker tests for HIV positive participants included CD4, HIV-1 RNA viral load and incidence assays. Results In all 15,609 people (8,963 adults aged 15 years and older (55% females), 6,646 individuals less than 15 years (51% males), from 4,313 households, participated in AKAIS. Overall, 2.8% (423 persons; 422 HIV-1 and 1 HIV-2) were found to be HIV positive. HIV prevalence was 4.8% in adults (15 years and above) and 0.4% in pediatric (< = 14 years) participants. HIV prevalence was significantly higher in females (5.6%) than males (3.7%) aged 15 years and older (p <0.001). Overall HIV incidence was 0.41% Conclusions HIV prevalence among adults was 4.8% with an overall incidence of 0.41%. These estimates are essential to inform strategic control and prevention of HIV epidemic in Akwa Ibom state targeting the affected populations.	[Adedokun, Oluwasanmi; Badru, Titilope; Khamofu, Hadiza; Pandey, Satish Raj] FHI 360, Abuja, Nigeria; [Negedu-Momoh, Olubunmi Ruth] Publ Hlth England Nigeria, Abuja, Nigeria; [Iwara, Emem; Agbakwuru, Chinedu] Univ Maryland, MGIC, Maryland Global Initiat Corp, UMB, Abuja, Nigeria; [Atobatele, Akinyemi] US Agcy Int Dev, Abuja, Nigeria; [Merrigan, Mike] FHI 360, Durham, NC USA; [Ukpong, Dominic] Akwa Ibom State Govt, Uyo, Akwa Ibom State, Nigeria; [Nzelu, Charles] Fed Minist Hlth, Abuja, Nigeria; [Ashefor, Gregory] Natl Agcy Control AIDS, Abuja, Nigeria; [Torpey, Kwasi] Univ Ghana, Coll Hlth Sci, Accra, Ghana	United States Agency for International Development (USAID); FHI 360; University of Ghana	Torpey, K (corresponding author), Univ Ghana, Coll Hlth Sci, Accra, Ghana.	ktorpey@hotmail.com		Adedokun, Oluwasanmi/0000-0002-4678-9735; Iwara, Emem/0000-0001-8826-1464	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) [AID-620-A-00002]	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was carried out using data from a project funded by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) under the Cooperative Agreement AID-620-A-00002, managed by an FHI 360-led consortium. The funder had no role in the study design, data collection and analysis, and in interpretation of the data. The views expressed in this article are those of the authors and not the funding agency.	[Anonymous], 2016, HIV EST UNC BOUNDS 1; Awofala AA, 2018, SAUDI J BIOL SCI, V25, P697, DOI 10.1016/j.sjbs.2016.03.006; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Curtis KA, 2016, AIDS RES HUM RETROV, V32, P561, DOI [10.1089/aid.2015.0247, 10.1089/AID.2015.0247]; Federal Ministry of Health (Nigeria) Federal Ministry of Health Nigeria, 2013, NAT HIV AIDS REPR HL; FMOH, 2010, NAT GUID PREV MOTH C, P1; Idoko J, 2010, LIST CONTRIBUTORS FM, P1; Joint United Nations Programme on HIV/AIDS UNAIDS 2017, 2017, GLOB AIDS UPD; Lopman BA, 2009, SEX TRANSM INFECT, V85, pI41, DOI 10.1136/sti.2008.033043; Mahy M, 2014, AIDS, V28, pS461, DOI 10.1097/QAD.0000000000000456; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Montana LS, 2008, SEX TRANSM INFECT, V84, pI78, DOI 10.1136/sti.2008.030106; National Agency for the Control of AIDS (NACA), 2019, NAIIS S S FACTSH; National Health and Family Planning Commission of the People's Republic of China, 2010, PRACT GUID PREC ULTR, P1; National Population Commission (NPC) [Nigeria] ICF, 2019, NIG DEM HLTH SURV 20; Neumann R, 2016, INT J PLASTICITY, V77, P1, DOI 10.1016/j.ijplas.2015.09.003; Nigerian National Petroleum Corporation (NNPC), 2016, JOINT VENT OP NIG; Sidibe M, 2016, J INT AIDS SOC; Stockton E, 2012, COMPASS-REV TOP THEO, V46, P34; Vercauteren G, 2011, USE ASSAYS RECENT IN, VWX, P147; WHO,UNAIDS, 2003, REC ANT CLINC BAS SU	21	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234079	10.1371/journal.pone.0234079	http://dx.doi.org/10.1371/journal.pone.0234079			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555584	Green Published, gold			2022-12-26	WOS:000542759600014
J	Alhassani, AA; Al-Zahrani, MS				Alhassani, Ahmed A.; Al-Zahrani, Mohammad S.			Is inadequate sleep a potential risk factor for periodontitis?	PLOS ONE			English	Article							DURATION; MORTALITY; DISEASE; METAANALYSIS; ASSOCIATION; METABOLISM; STRESS; HEALTH; ADULTS	This study was undertaken to investigate the potential association between sleep duration and periodontitis. The study population consisted of 10,291 individuals who participated in the United States National Health and Nutrition Examination Survey (NHANES) from the 2009-2014 cycles. Sleep duration was categorized into sleep deficient (< 7 hours), sleep adequate (7-8 hours), and sleep excessive (> 8 hours). We used the Center for Disease Control and Prevention (CDC) and the American Academy of Periodontology (AAP) periodontitis case definition. Descriptive statistics and logistic regression models were used for data analyses. The prevalence of periodontitis was 36% higher in individuals who reported sleep deficiency when compared to the sleep adequate group (odds Ratio (OR) = 1.36, 95% confidence interval (CI): 1.23-1.50). Those who reported excessive sleep had 41% higher odds of periodontitis (OR: 1.40, 95% CI: 1.16-1.71). After adjusting for confounding factors, sleep deficient individuals were 19% more likely to have periodontitis when compared to sleep adequate individuals (OR: 1.19, 95% CI: 1.06-1.38). Among sleep excessive individuals, the association was non-significant (OR: 1.16, 95% CI: 0.94-1.43). Sleep deficiency was associated with a higher prevalence of periodontitis in this study population. The association however needs to be confirmed in longitudinal studies.	[Alhassani, Ahmed A.; Al-Zahrani, Mohammad S.] King Abdulaziz Univ, Dept Periodont, Fac Dent, Jeddah, Saudi Arabia	King Abdulaziz University	Alhassani, AA (corresponding author), King Abdulaziz Univ, Dept Periodont, Fac Dent, Jeddah, Saudi Arabia.	aalhassani@kau.edu.sa; msalzahrani@kau.edu.sa		Al-Zahrani, Mohammad/0000-0003-1720-9372; Alhassani, Ahmed/0000-0002-3007-0128				Albandar Jasim M, 2005, Dent Clin North Am, V49, P517, DOI 10.1016/j.cden.2005.03.003; [Anonymous], 2014, RADIOL TECHNOL, V85, p523CT; [Anonymous], 2012, PACIFIC AM STUDIES, V12, P20; [Anonymous], 2016, THE TOTAL AUDIENCE R; BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; Besedovsky L, 2012, PFLUG ARCH EUR J PHY, V463, P121, DOI 10.1007/s00424-011-1044-0; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Cekici A, 2014, PERIODONTOL 2000, V64, P57, DOI 10.1111/prd.12002; Cepeda MS, 2016, J CLIN SLEEP MED, V12, P813, DOI 10.5664/jcsm.5876; Cespedes EM, 2016, AM J EPIDEMIOL, V183, P561, DOI 10.1093/aje/kwv251; Coughlin JW, 2014, INT REV PSYCHIATR, V26, P177, DOI 10.3109/09540261.2014.911150; Covassin N, 2016, SLEEP MED CLIN, V11, P81, DOI 10.1016/j.jsmc.2015.10.007; Eke PI, 2018, J AM DENT ASSOC, V149, P576, DOI 10.1016/j.adaj.2018.04.023; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Ferrie JE, 2007, SLEEP, V30, P1659, DOI 10.1093/sleep/30.12.1659; Fuller GE, 2004, WASH QUART, V27, P51, DOI 10.1162/016366004323090250; Grandner MA, 2015, OBESITY, V23, P2491, DOI 10.1002/oby.21247; Grover Vishakha, 2015, J Indian Soc Periodontol, V19, P304, DOI 10.4103/0972-124X.154173; Han K, 2018, GAC SANIT, V32, P143, DOI 10.1016/j.gaceta.2017.01.013; Hirotsu C, 2015, SLEEP SCI, V8, P143, DOI 10.1016/j.slsci.2015.09.002; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Hublin C, 2007, SLEEP, V30, P1245, DOI 10.1093/sleep/30.10.1245; Karaaslan F, 2019, J PERIODONTOL, V90, P1133, DOI 10.1002/JPER.19-0034; Khumaedi AI, 2019, DIABETES METAB SYND, V13, P1675, DOI 10.1016/j.dsx.2019.03.023; Koyama S, 2018, SLEEP MED, V52, P18, DOI 10.1016/j.sleep.2018.07.020; Krysta K, 2017, J NEURAL TRANSM, V124, pS179, DOI 10.1007/s00702-015-1492-3; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Papapanou PN, 2015, INT DENT J, V65, P283, DOI 10.1111/idj.12185; Pink C, 2015, J CLIN PERIODONTOL, V42, P988, DOI 10.1111/jcpe.12473; Romandini M, 2017, J CLIN PERIODONTOL, V44, P490, DOI 10.1111/jcpe.12713; Sabbah W, 2018, PERIODONTOL 2000, V78, P154, DOI 10.1111/prd.12238; Sanz M, 2020, J CLIN PERIODONTOL, V47, P268, DOI 10.1111/jcpe.13189; Shan ZL, 2015, DIABETES CARE, V38, P529, DOI 10.2337/dc14-2073; Shearer WT, 2001, J ALLERGY CLIN IMMUN, V107, P165, DOI 10.1067/mai.2001.112270; Slots J, 2017, PERIODONTOL 2000, V75, P7, DOI 10.1111/prd.12221; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Watson NF, 2015, SLEEP, V38, P1161, DOI 10.5665/sleep.4886; Yu YH, 2015, J CLIN PERIODONTOL, V42, P21, DOI 10.1111/jcpe.12335; Zhou XD, 2015, ARCH ORAL BIOL, V60, P667, DOI 10.1016/j.archoralbio.2014.11.008; 2016, CANC DISCOV, V6	42	6	6	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234487	10.1371/journal.pone.0234487	http://dx.doi.org/10.1371/journal.pone.0234487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544165	gold, Green Published			2022-12-26	WOS:000542957200017
J	Wang, YH; Zhang, YR				Wang, Yuan-Hui; Zhang, Ya-Ru			Variations in compositions and antioxidant activities of essential oils from leaves of LuodianBlumea balsamiferafrom different harvest times in China	PLOS ONE			English	Article							HIGH-PURITY (-)-BORNEOL; BLUMEA-BALSAMIFERA; VOLATILE OIL; FLAVONOIDS; EXTRACTS	Xanthoxylin was the main compound (content 44.92% of total volatiles) in the leaves of LuodianB.balsamifera, which might be the key cause of failure in collecting essential oil (EO) of the leaves using general hydrodistillation in Clevenger apparatus. A modified hydrodistillation equipped with Clevenger apparatus was designed for isolating EO from the leaves. Six EOs of LuodianB.balsamiferaharvested once a month from September to next February were collected successfully. The main components of EOs were delta-elemene,alpha-cubenene, caryophyllene, caryophyllene epoxide,gamma-eudesmol, xanthoxylin, and alpha-eudesmol. The EOs of LuodianB.balsamiferacollected from October to December had higher antioxidant activities (ACs). Combining the principal component analysis of chemical components with the results of ACs and the yields of six EOs, the leaves of LuodianB.balsamiferawere suitable to be harvested in November and December to obtain EO with high quality.	[Wang, Yuan-Hui; Zhang, Ya-Ru] Henan Univ Technol, Sch Food Sci & Technol, Zhengzhou, Peoples R China	Henan University of Technology	Wang, YH (corresponding author), Henan Univ Technol, Sch Food Sci & Technol, Zhengzhou, Peoples R China.	wyhhngydx2014@163.com		Wang, Yuan-Hui/0000-0001-9799-1514	Chinese Innovation Fund for Technology Based Firms; Guizhou's Innovation Fund for Technology Based Firms; Henan University of Technology under Henan University of Technology High-level Talents Fund [2015BS009]	Chinese Innovation Fund for Technology Based Firms; Guizhou's Innovation Fund for Technology Based Firms; Henan University of Technology under Henan University of Technology High-level Talents Fund	The leaves of Luodian Blumea balsamifera were collected from planting base belonging to Gui Zhou Ai Yuan Eco-Pharmaceutical Development Co. Ltd. (abbreviation: Ai Yuan). Ai Yuan received the support of the local government and the support of Chinese Innovation Fund for Technology Based Firms and Guizhou's Innovation Fund for Technology Based Firms. The authors have a confidential cooperative relationship with Ai Yuan. This work was supported by Henan University of Technology under Henan University of Technology High-level Talents Fund (2015BS009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2007, IDENTIFICATION ESSEN, V4th; [Anonymous], 1999, NICOTINE TOBACCO RES, V1, pS123; Bhatt V, 2017, NAT PROD COMMUN, V12, P1643, DOI 10.1177/1934578x1701201030; Bhuiyan MNI, 2009, BANGL J BOT, V38, P107; Bicchi C, 2008, FLAVOUR FRAG J, V23, P382, DOI 10.1002/ffj.1905; Chen M, 2010, PLANTA MED, V76, P897, DOI 10.1055/s-0029-1240800; Chu SS, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/289874; Costa R, 2008, FLAVOUR FRAG J, V23, P40, DOI 10.1002/ffj.1854; de Boer HJ, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-128; Du Ping, 2009, Chemistry and Industry of Forest Products, V29, P115; European Directorate For The Quality Of Medicine (EDQM), 2008, EUROPEAN PHARMACOPOE; Hao X, 2000, J GUIYANG MED COLL, P120; Kubota H, 2009, AM J CHINESE MED, V37, P843, DOI 10.1142/S0192415X09007326; Lin R, 1979, FLORA REPUBLICAE POP, V75; Nessa F, 2010, PHARM BIOL, V48, P1405, DOI 10.3109/13880209.2010.487281; Nguyen T.T., 2004, TAP CHI DUOC HOC, V42, P12; RUANGRUNGSI N, 1985, J NAT PROD, V48, P529, DOI 10.1021/np50040a003; Rubiolo P, 2010, FLAVOUR FRAG J, V25, P282, DOI 10.1002/ffj.1984; Saewan N, 2011, J MED PLANTS RES, V5, P1018; Sakee U, 2011, NAT PROD RES, V25, P1849, DOI 10.1080/14786419.2010.485573; Shirota O, 2011, J NAT PROD, V74, P470, DOI 10.1021/np100646n; Wang YH, 2018, J ESSENT OIL BEAR PL, V21, P1511, DOI [10.1080/0972060x.2019.1571948, 10.1080/0972060X.2019.1571948]; Wang YH, 2014, TROP J PHARM RES, V13, P41, DOI 10.4314/tjpr.v13i1.6; Wang YH, 2014, SEP SCI TECHNOL, V49, P1535, DOI 10.1080/01496395.2014.891613; Yuan Y, 2016, MOLECULES, V21, DOI 10.3390/molecules21081024; Zhou H., 2011, J GUIYANG COLL TRAD, V33	26	7	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234661	10.1371/journal.pone.0234661	http://dx.doi.org/10.1371/journal.pone.0234661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544201	Green Published, gold			2022-12-26	WOS:000542957200050
J	Adams, AM; Islam, R; Yusuf, SS; Panasci, A; Crowell, N				Adams, Alayne M.; Islam, Rubana; Yusuf, Sifat Shahana; Panasci, Anthony; Crowell, Nancy			Healthcare seeking for chronic illness among adult slum dwellers in Bangladesh: A descriptive cross-sectional study in two urban settings	PLOS ONE			English	Article							COUNTRIES; SERVICES	Introduction Accompanying rapid urbanization in Bangladesh are inequities in health and healthcare which are most visibly manifested in slums or low-income settlements. This study examines socioeconomic, demographic and geographic patterns of self-reported chronic illness and healthcare seeking among adult slum dwellers in Bangladesh. Understanding these patterns is critical in designing more equitable urban health systems and in enabling the country's goal of Universal Health Coverage by 2030. Methods This descriptive cross-sectional study compares survey data from slum settlements located in two urban sites in Bangladesh, Tongi and Sylhet. Reported chronic illness symptoms and associated healthcare-seeking strategies are compared, and the catastrophic impact of household healthcare expenditures are assessed. Results Significant differences in healthcare-seeking for chronic illness were apparent both within and between slum settlements related to sex, wealth score (PPI), and location. Women were more likely to use private clinics than men. Compared to poorer residents, those from wealthier households sought care to a greater extent in private clinics, while poorer households relied more on drug shops and public hospitals. Chronic symptoms also differed. A greater prevalence of musculoskeletal, respiratory, digestive and neurological symptoms was reported among those with lower PPIs. In both slum sites, reliance on the private healthcare market was widespread, but greater in industrialized Tongi. Tongi also experienced a higher probability of catastrophic expenditure than Sylhet. Conclusions Study results point to the value of understanding context-specific health-seeking patterns for chronic illness when designing delivery strategies to address the growing burden of NCDs in slum environments. Slums are complex social and geographic entities and cannot be generalized. Priority attention should be focused on developing chronic care services that meet the needs of the working poor in terms of proximity, opening hours, quality, and cost.	[Adams, Alayne M.] McGill Univ, Dept Family Med, Montreal, PQ, Canada; [Adams, Alayne M.; Yusuf, Sifat Shahana] Icddr B, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh; [Islam, Rubana] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Panasci, Anthony] Georgetown Univ, Sch Nursing & Hlth Studies, Dept Global Hlth, Washington, DC USA; [Crowell, Nancy] Georgetown Univ, Sch Nursing & Hlth Studies, Washington, DC USA	McGill University; International Centre for Diarrhoeal Disease Research (ICDDR); University of New South Wales Sydney; Georgetown University; Georgetown University	Adams, AM (corresponding author), McGill Univ, Dept Family Med, Montreal, PQ, Canada.; Adams, AM (corresponding author), Icddr B, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh.	alayne.adams@gmail.com	Crowell, Nancy/AAL-7243-2021	Crowell, Nancy/0000-0002-8569-4333; Adams, Alayne/0000-0002-0961-9825; Yusuf, Salim/0000-0003-4776-5601; Islam, Rubana/0000-0002-9538-5390; Yusuf, Sifat/0000-0002-9458-139X	Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ); Department for International Development (DFID)	Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ); Department for International Development (DFID)	AMA received funding from the Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ-https://www.giz.de/en/html/index.html) and the Department for International Development (DFID -https://www.gov.uk/government/organisations/department-for-internationaldevelopment).Support from GIZ, a commercial funder, was used to cover the costs of research, such as human resources, travel, the purchase tablets for survey administration as well as institutional overhead. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Gratitude is extended to Maud Mazaniello-Chezol for her help in preparing this manuscript, to the dedicated team of field staff and researchers involved in survey design and implementation and finally, to study participants in Tongi and Sylhet. icddr,b is grateful to the Governments of Bangladesh, Canada, Sweden and the UK for providing core/unrestricted support.	Adams AM, 2015, HEALTH POLICY PLANN, V30, pi32, DOI 10.1093/heapol/czu094; Adams AM, 2015, MAPPING URBAN HEALTH; Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; Aleemi AR, 2018, ASIA-PAC J PUBLIC HE, V30, P479, DOI 10.1177/1010539518772132; [Anonymous], 2021, IDF DIABETES ATLAS, V10th; [Anonymous], 2018, LANCET, DOI DOI 10.1016/S0140-6736(18)32203-7; [Anonymous], 2019, GLOB HLTH EXP DAT OU; Bangladesh Bureau of Statistics, 2013, BANGL BUR STAT PRES; Bangladesh Bureau of Statistics Ministry of Planning, 2011, REP HOUS INC EXP SUR; Bird J, 2017, OXFORD REV ECON POL, V33, P496, DOI 10.1093/oxrep/grx036; Biswas T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167140; Chen MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103799; Dodd W, 2016, SOC SCI MED, V161, P118, DOI 10.1016/j.socscimed.2016.05.035; Ezeh A, 2017, LANCET, V389, P547, DOI 10.1016/S0140-6736(16)31650-6; Government of Bangladesh, 2011, POP HOUS CENS 2011; Gupta M, 2008, J URBAN HEALTH, V85, P291, DOI 10.1007/s11524-007-9250-y; Habitat U.N, 2013, STAT WORLDS CIT 2012; Harpham T., 2001, Progress in Development Studies, V1, P113, DOI 10.1177/146499340100100202; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Heeringa S., 2017, APPL SURVEY DATA ANA, VSecond, DOI DOI 10.1201/9781315153278; Hossain I, 2005, PAKISTAN J SOCIAL SC, V3, P469; Hossain M, 2019, 154 ICCDDR; Hossain S., 2007, INT J DEV ISSUES, V6, P50, DOI DOI 10.1108/14468950710830554; Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-474; Hulton LA, 2007, SOC SCI MED, V64, P2083, DOI 10.1016/j.socscimed.2007.01.019; [Innovations for Poverty Action PPI], 2019, INN POV ACT PPI; Islam R, 2014, HEALTHCARE SEEKING P; Khalequzzaman M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014710; Khan JAM, 2017, HEALTH POLICY PLANN, V32, P359, DOI 10.1093/heapol/czw131; Khan Zulfia, 2012, Indian J Community Med, V37, P50, DOI 10.4103/0970-0218.94027; Lance P, 2012, BANGLADESH SMILING S; Mitra and Associates ICF International, 2016, BANGL DEM HLTH SURV; National Institute of Population Research and Training (NIPORT) icddrb MEASURE Evaluation, 2015, ICDDR B MEAS EV BANG; National Institute of Population Research and Training (NIPORT) MEASURE Evaluation International Centre for Diarrhoeal Disease Research Bangladesh (ICDDRB) International and Associates for Community and Population Research (ACPR)., 2008, BANGL URB HLTH SURV; NCCN Clinical Practice, 2018, ACUTE MYELOID LEUKEM, VV2, pMS28; Niessen LW, 2018, LANCET, V391, P2036, DOI [10.1016/S0140-6736(18)30482-3, 10.1016/s0140-6736(18)30482-3]; O'Donnell O., 2008, Analyzing health equity using household survey data: a guide to techniques and their implementation; Rahman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056873; Rajib Mondal, 2019, Chronic Diseases Journal, V7, P170; Rawal LB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184967; Russell S, 2005, SOC SCI MED, V61, P1396, DOI 10.1016/j.socscimed.2004.11.077; StataCorp LLC, 2017, STAT SURV DAT REF MA; Sundar R., 2002, ECON POLIT WEEKLY, V37, P4729; UN-Habitat, 2007, SUST URB LOC ACT URB; United Nations Department of Economic and Social Affairs Population Division, 2019, A421 STESASER; United Nations Human Settlements Programme, 2003, CHALL SLUMGLOB REP; Wang H, 2018, B WORLD HEALTH ORGAN, V96, P610, DOI 10.2471/BLT.18.209858; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2016, GLOB REP URB HLTH EQ; World Health Organization, 2015, NONCOMMUNICABLE DIS; World Health Organization, 2013, GLOB ACT PLAN PREV C; Zaman MM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1938-4; Zaman Mohammad Mostafa, 2016, Indian J Public Health, V60, P17, DOI 10.4103/0019-557X.177290	53	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0233635	10.1371/journal.pone.0233635	http://dx.doi.org/10.1371/journal.pone.0233635			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB6AZ	32542043	Green Published, gold			2022-12-26	WOS:000542685100035
J	Balogh, A; Milibak, T; Szabo, V; Nagy, ZZ; Resch, MD				Balogh, Aniko; Milibak, Tibor; Szabo, Viktoria; Nagy, Zoltan Zsolt; Resch, Miklos D.			Position of macula lutea and presence of proliferative vitreoretinopathy affect vitreous cytokine expression in rhegmatogenous retinal detachment	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; STEM-CELL FACTOR; CHEMOKINES; INDUCTION	Our purpose was to evaluate the concentrations of vitreous cytokines in patients with rhegmatogenous retinal detachment (RRD). We hypothesized that patients with macula on RRD have lower levels of cytokines compared to patients with macula off RRD and proliferative vitreoretinopathy (PVR). Vitreous fluids were collected during 23G pars plana vitrectomy from 58 eyes of 58 patients. Indication for vitrectomy included macula off and macula on RRD, PVR, and idiopathic epiretinal membrane (ERM). A multiplex chemiluminescent immunoassay was performed to measure the concentrations of 48 cytokines, chemokines, and growth factors. Levels of HGF, IL-6, IL-8, IL-16, IFN-gamma, MCP-1, and MIF were significantly higher in all groups of retinal detachment compared to ERM. Levels of CTACK, eotaxin, G-CSF, IP-10, MIG, SCF, SCGF-beta, SDF-1alpha were significantly higher in PVR compared to macula on RRD and ERM. Levels of IL-1ra, IL-5, IL-9, M-CSF, MIP-1alpha, and TRIAL were significantly higher in PVR compared to macula on RRD. Our results indicate that the position of macula lutea and the presence of PVR significantly influence vitreous cytokine expression. The detected proteins may serve as biomarkers to estimate the possibility of PVR formation and may help to invent personalized therapeutic strategies to slow down or prevent PVR.	[Balogh, Aniko; Szabo, Viktoria; Nagy, Zoltan Zsolt; Resch, Miklos D.] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary; [Balogh, Aniko; Milibak, Tibor] Uzsoki Hosp, Dept Ophthalmol, Budapest, Hungary	Semmelweis University	Resch, MD (corresponding author), Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary.	miklosresch@gmail.com	Szabó, Viktória/GSD-4921-2022	Resch, Miklos/0000-0002-8285-1153	new national excellence program of the Ministry for Innovation and Technology [UNKP19-3-I]	new national excellence program of the Ministry for Innovation and Technology	This study was supported by the UNKP19-3-I new national excellence program of the Ministry for Innovation and Technology.	Abu El-Asrar AM, 2006, EUR CYTOKINE NETW, V17, P155, DOI 10.1684/ecn.2006.0033; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2018, LANCET ONCOL, V19, pe581; Asaria RHY, 2001, OPHTHALMOLOGY, V108, P1179, DOI 10.1016/S0161-6420(01)00589-9; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; Duarte RF, 2000, BLOOD, V96, P3422; Garweg JG, 2019, ACTA OPHTHALMOL, V97, pE580, DOI 10.1111/aos.13998; Garweg JG, 2013, SURV OPHTHALMOL, V58, P321, DOI 10.1016/j.survophthal.2012.12.004; Grierson I, 2000, PROG RETIN EYE RES, V19, P779, DOI 10.1016/S1350-9462(00)00015-X; HILTON G, 1983, OPHTHALMOLOGY, V90, P121, DOI 10.1016/s0161-6420(83)34588-7; HOFFMAN R, 1993, STEM CELLS, V11, P76; Huen AC, 2012, ADV WOUND CARE, V1, P244, DOI 10.1089/wound.2011.0355; Ito C, 2003, BONE MARROW TRANSPL, V32, P391, DOI 10.1038/sj.bmt.1704152; Josifovska N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217548; KAUFMAN PL, 1976, ACTA OPHTHALMOL, V54, P61; Kawahara S, 2008, DIABETES, V57, P2784, DOI 10.2337/db08-0302; Khan MA, 2015, RETINA-J RET VIT DIS, V35, P165, DOI 10.1097/IAE.0000000000000447; Kunikata H, 2013, AM J OPHTHALMOL, V155, P1028, DOI 10.1016/j.ajo.2013.01.013; Lashkari K, 1999, INVEST OPHTH VIS SCI, V40, P149; Lumi X, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0390-2; Markus B, 2017, FEBS OPEN BIO, V7, P1166, DOI 10.1002/2211-5463.12252; Matsuda-Hashii Y, 2004, EXP HEMATOL, V32, P955, DOI 10.1016/j.exphem.2004.06.012; MORSTYN G, 1994, ONCOLOGY, V51, P205, DOI 10.1159/000227335; Pastor JC, 2008, BRIT J OPHTHALMOL, V92, P378, DOI 10.1136/bjo.2007.129437; Pastor JC, 1998, SURV OPHTHALMOL, V43, P3, DOI 10.1016/S0039-6257(98)00023-X; Pennock S, 2013, AM J PATHOL, V182, P1659, DOI 10.1016/j.ajpath.2013.01.052; Pollreisz A, 2015, INVEST OPHTH VIS SCI, V56, P5493, DOI 10.1167/iovs.15-17068; Rasier R, 2010, CURR EYE RES, V35, P505, DOI 10.3109/02713681003597248; Ricker LJAG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019141; Roybal CN, 2018, AM J OPHTHALMOL, V186, P152, DOI 10.1016/j.ajo.2017.11.025; Sadaka A, 2016, CLIN OPHTHALMOL, V10, P1811, DOI 10.2147/OPTH.S111893; Takai K, 1997, BLOOD, V89, P1560, DOI 10.1182/blood.V89.5.1560.1560_1560_1565; Ward SG, 1998, BIOCHEM J, V333, P457, DOI 10.1042/bj3330457; Wladis EJ, 2013, RETINA-J RET VIT DIS, V33, P807, DOI 10.1097/IAE.0b013e31826d350a; Yates CC, 2009, WOUND REPAIR REGEN, V17, P34, DOI 10.1111/j.1524-475X.2008.00439.x; Zandi S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214674	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234525	10.1371/journal.pone.0234525	http://dx.doi.org/10.1371/journal.pone.0234525			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542038	Green Published, gold			2022-12-26	WOS:000542685100024
J	Fukuda, T; Sakurai, H; Kashiwagi, M				Fukuda, Tomohide; Sakurai, Hironori; Kashiwagi, Masanori			Efforts to reduce the length of stay in a low-intensity ICU: Changes in the ICU brought about by collaboration between Certified Nurse Specialists as head nurses and intensivists	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; OUTCOMES	Certified Nurse Specialists (CNS) are advanced practice nurses that often play a role in management. This study aims to investigate whether cooperation between CNSs in the position of Intensive Care Unit (ICU) head nurse and intensivists change the length of stay for ICU patients. A single centered retrospective cohort study design was followed. A multivariable regression analysis was performed to determine whether there is a difference in patients' length of ICU stay for two years before and after CNS as ICU head nurse and an intensivist started collaborating. The patients' diagnosis, age, gender, scheduled/emergency admission, surgical history, length of ICU stay, usage of ventilator, and details of ICU treatment were collected from the institution's electronic medical records. During the study period (April 2015 to March 2019), 3,135 patients were admitted to ICU, with 1,471 in the before collaboration group and 1,664 in the after-collaboration group. Collaboration between the CNS as head nurse and intensivists was significantly associated with shorter length of ICU stay (coefficient -0.03 [95% CI, -0.05-0.01],p< 0.001,t-statistic -3.29). Our main finding illustrates that in low-intensity ICUs, collaboration between CNSs as head nurses and intensivists may reduce patients' length of ICU stay.	[Fukuda, Tomohide] Kyoritsu Womens Univ, Fac Nursing, Tokyo, Japan; [Sakurai, Hironori] Natl Hosp Org Tokyo Med Ctr, Dept Anesthesiol, Tokyo, Japan; [Kashiwagi, Masanori] Tokyo Saiseikai Cent Hosp, Dept Anesthesiol, Tokyo, Japan	Tokyo Saiseikai Central Hospital	Fukuda, T (corresponding author), Kyoritsu Womens Univ, Fac Nursing, Tokyo, Japan.	tfukuda@kyoritsu-wu.ac.jp	Fukuda, Tomohide/AAY-6641-2020	Fukuda, Tomohide/0000-0001-8066-4998	JSPS KAKENHI [JP 19K24268]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP 19K24268. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NURS PRACT ADV PRACT; Asegid A, 2014, NURS RES PRACT, V2014, DOI 10.1155/2014/909768; Coen J, 2016, CRIT CARE NURS Q, V39, P335, DOI 10.1097/CNQ.0000000000000127; Crosbie R, 2014, J LARYNGOL OTOL, V128, P171, DOI 10.1017/S0022215114000024; Fukuda T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228458; Japan Nursing Association, 2017, LIST REG PERS POS HO; Kirk AP, 2015, CLIN NURSE SPEC, V29, P321, DOI 10.1097/NUR.0000000000000163; Knowles S, 2015, BMC NURS, V14, DOI 10.1186/s12912-015-0056-z; McCallin AM, 2010, J NURS MANAGE, V18, P319, DOI 10.1111/j.1365-2834.2010.01067.x; Morita K, 2017, J CRIT CARE, V41, P209, DOI 10.1016/j.jcrc.2017.05.025; Negley KD, 2016, CLIN NURSE SPEC, V30, P271, DOI 10.1097/NUR.0000000000000231; Newhouse RP, 2011, NURS ECON, V29, P5; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Salamanca-Balen N, 2018, PALLIATIVE MED, V32, P447, DOI 10.1177/0269216317711570; Singer Jonathan P, 2010, J Intensive Care Med, V25, P233, DOI 10.1177/0885066610366933; Spruce K, 2017, CLIN NURSE SPEC, V31, P319, DOI 10.1097/NUR.0000000000000334; Warshawsky N, 2019, J NURS ADMIN, V49, P249, DOI 10.1097/NNA.0000000000000746	17	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234879	10.1371/journal.pone.0234879	http://dx.doi.org/10.1371/journal.pone.0234879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542030	Green Published, gold			2022-12-26	WOS:000542685100009
J	Pushin, DM; Salikhova, TY; Zlobina, KE; Guria, GT				Pushin, Denis M.; Salikhova, Tatiana Y.; Zlobina, Ksenia E.; Guria, Georgy Th.			Platelet activation via dynamic conformational changes of von Willebrand factor under shear	PLOS ONE			English	Article							THROMBUS FORMATION; SELF-ASSOCIATION; AGGREGATION; STRESS; BIORHEOLOGY; MECHANISMS; MULTIMERS; EXPOSURE; CLEAVAGE; ADHESION	Shear-induced conformational changes of von Willebrand factor (VWF) play an important role in platelet activation. A novel approach describing VWF unfolding on the platelet surface under dynamic shear stress is proposed. Cumulative effect of dynamic shear on platelet activation via conformational changes of VWF is analysed. The critical condition of shear-induced platelet activation is formulated. The explicit expression for the threshold value of cumulative shear stress as a function of VWF multimer size is derived. The results open novel prospects for pharmacological regulation of shear-induced platelet activation through control of VWF multimers size distribution.	[Pushin, Denis M.; Zlobina, Ksenia E.; Guria, Georgy Th.] Natl Res Ctr Hematol, Moscow, Russia; [Pushin, Denis M.; Salikhova, Tatiana Y.; Guria, Georgy Th.] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia	Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Moscow Institute of Physics & Technology	Guria, GT (corresponding author), Natl Res Ctr Hematol, Moscow, Russia.; Guria, GT (corresponding author), Moscow Inst Phys & Technol, Dolgoprudnyi, Russia.	guria@blood.ru	Salikhova, Tatiana/GYU-1578-2022; Zlobina, Ksenia/G-6767-2014; Guria, Georgy/L-6873-2013	Zlobina, Ksenia/0000-0001-6592-0965; Salikhova, Tatiana/0000-0001-7432-9659; Pushin, Denis/0000-0002-3908-2002; Guria, Georgy/0000-0002-5579-9820	Russian Science Foundation [1911-00260]; Russian Science Foundation [19-11-00260] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	The work was supported by grant No 1911-00260 of Russian Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzenberg N, 2005, J AM COLL CARDIOL, V45, P1753, DOI 10.1016/j.jacc.2004.10.079; Andrews RK, 1997, INT J BIOCHEM CELL B, V29, P91, DOI 10.1016/S1357-2725(96)00122-7; [Anonymous], 2019, DIABETES CARE, V40, pS13; Arnold VI, 1978, MATH METHODS CLASSIC, P15; Avtaeva YN, 2018, B EXP BIOL MED+, V165, P157, DOI 10.1007/s10517-018-4119-5; Bark DL, 2010, J BIOMECH, V43, P2970, DOI 10.1016/j.jbiomech.2010.07.011; Batchelor GK, 2000, INTRO FLUID DYNAMICS, P131; Bluestein D, 1997, ANN BIOMED ENG, V25, P344, DOI 10.1007/BF02648048; Bortot M, 2019, ARTERIOSCL THROM VAS, V39, P1831, DOI 10.1161/ATVBAHA.119.312814; Brass LF, 2016, J THROMB HAEMOST, V14, P906, DOI 10.1111/jth.13280; Buguin A, 1996, MACROMOLECULES, V29, P4937, DOI 10.1021/ma9600769; Caro CG, 2012, MECH CIRCULATION, P31; Casa LDC, 2017, ANNU REV BIOMED ENG, V19, P415, DOI 10.1146/annurev-bioeng-071516-044539; Casa LDC, 2014, CARDIOVASC ENG TECHN, V5, P154, DOI 10.1007/s13239-014-0180-z; Chen JM, 2011, J CLIN INVEST, V121, P593, DOI 10.1172/JCI41062; Chen ZS, 2016, ARTIF ORGANS, V40, P659, DOI 10.1111/aor.12606; Chiu WC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39897-6; Consolo F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05130-5; De Gennes PG, 1979, SCALING CONCEPTS POL, P165; De Meyer Simon F., 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P9; Fu HX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00230-2; Fuchs G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45121-2; Girdhar G, 2008, EXPERT REV MED DEVIC, V5, P167, DOI 10.1586/17434440.5.2.167; Goto S, 1999, CIRCULATION, V99, P608, DOI 10.1161/01.CIR.99.5.608; GOTO S, 1995, J BIOL CHEM, V270, P23352, DOI 10.1074/jbc.270.40.23352; Hansen KB, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029580; HELLUMS JD, 1994, ANN BIOMED ENG, V22, P445, DOI 10.1007/BF02367081; Holme PA, 1997, ARTERIOSCL THROM VAS, V17, P646, DOI 10.1161/01.ATV.17.4.646; Jain A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10176; Kasirer-Friede A, 2002, J BIOL CHEM, V277, P11949, DOI 10.1074/jbc.M108727200; KONSTANTOPOULOS K, 1995, THROMB HAEMOSTASIS, V74, P1329; Kroll MH, 1996, BLOOD, V88, P1525; Lee H, 2019, CLIN HEMORHEOL MICRO, V71, P249, DOI 10.3233/CH-189416; Lippok S, 2016, BIOPHYS J, V110, P545, DOI 10.1016/j.bpj.2015.12.023; Miyazaki Y, 1996, BLOOD, V88, P3456, DOI 10.1182/blood.V88.9.3456.bloodjournal8893456; MOAKE JL, 1986, J CLIN INVEST, V78, P1456, DOI 10.1172/JCI112736; Mody NA, 2008, BIOPHYS J, V95, P2556, DOI [10.1529/biophysj.107.128520, 10.1529/biophysj.107.12X520]; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; OBRIEN JR, 1990, LANCET, V335, P711, DOI 10.1016/0140-6736(90)90815-M; OP026, 2016, J CROHNS COLITIS, V10, pS21; Rahman S, 2020, COLLOIDS SURF B, DOI 10.1016/j.colsurfb.2020.111118; RAMSTACK JM, 1979, J BIOMECH, V12, P113, DOI 10.1016/0021-9290(79)90150-7; Rana A, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00141; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sakariassen KS, 2015, FUTUR SCI OA, V1, DOI [10.4155/FSO.15.28, 10.4155/fso.15.28]; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Shadden SC, 2015, ANN BIOMED ENG, V43, P41, DOI 10.1007/s10439-014-1070-0; Shadden SC, 2013, BIOMECH MODEL MECHAN, V12, P467, DOI 10.1007/s10237-012-0417-4; Shankaran H, 2003, BLOOD, V101, P2637, DOI 10.1182/blood-2002-05-1550; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Singh I, 2009, BIOPHYS J, V96, P2313, DOI 10.1016/j.bpj.2008.12.3900; Spiel AO, 2008, CIRCULATION, V117, P1449, DOI 10.1161/CIRCULATIONAHA.107.722827; Stockschlaeder M, 2014, BLOOD COAGUL FIBRIN, V25, P206, DOI 10.1097/MBC.0000000000000065; Tambasco M, 2003, ANN BIOMED ENG, V31, P1054, DOI 10.1114/1.1603257; Tovar-Lopez FJ, 2010, LAB CHIP, V10, P291, DOI 10.1039/b916757a; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Wang Y, 2019, BIOPHYS J, V116, P2092, DOI 10.1016/j.bpj.2019.04.025; Wellings P. J., 2012, CARDIOVASC ENG TECHN, V3, P161, DOI DOI 10.1007/S13239-012-; Westein E, 2013, P NATL ACAD SCI USA, V110, P1357, DOI 10.1073/pnas.1209905110; Wu WT, 2020, INT J ENG SCI, V147, DOI 10.1016/j.ijengsci.2019.103206; Wu WT, 2016, SCI REP-UK, V6, DOI 10.1038/srep38025; WURZINGER LJ, 1985, THROMB HAEMOSTASIS, V54, P381; Wurzinger LJ, 1983, FLUID DYNAMICS LOCAL, P91; Yazdani A, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005291; Yin W, 2011, THROMB RES, V127, P235, DOI 10.1016/j.thromres.2010.11.021; Zhang CJ, 2019, BLOOD ADV, V3, P957, DOI 10.1182/bloodadvances.2018030122; Zhang JN, 2003, THROMB HAEMOSTASIS, V90, P672, DOI 10.1160/TH03-03-0145; Zhang P, 2014, CELL MOL BIOENG, V7, P552, DOI 10.1007/s12195-014-0356-5; Zlobina KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30508	69	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234501	10.1371/journal.pone.0234501	http://dx.doi.org/10.1371/journal.pone.0234501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525962	Green Published, gold			2022-12-26	WOS:000542036800077
J	Remon, J; Swalduz, A; Planchard, D; Ortiz-Cuaran, S; Mezquita, L; Lacroix, L; Jovelet, C; Rouleau, E; Leonce, C; De Kievit, F; Morris, C; Jones, G; Mercier, K; Howarth, K; Green, E; Perol, M; Saintigny, P; Besse, B				Remon, Jordi; Swalduz, Aurelie; Planchard, David; Ortiz-Cuaran, Sandra; Mezquita, Laura; Lacroix, Ludovic; Jovelet, Cecile; Rouleau, Etienne; Leonce, Camille; De Kievit, Frank; Morris, Clive; Jones, Greg; Mercier, Kelly; Howarth, Karen; Green, Emma; Perol, Maurice; Saintigny, Pierre; Besse, Benjamin			Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay	PLOS ONE			English	Article							CELL LUNG-CANCER; RESPONSE EVALUATION CRITERIA; MULTICENTER; ERLOTINIB; THERAPY	Circulating tumor DNA (ctDNA)-based molecular profiling is rapidly gaining traction in clinical practice of advanced cancer patients with multi-gene next-generation sequencing (NGS) panels. However, clinical outcomes remain poorly described and deserve further validation with personalized treatment of patients with genomic alterations detected in plasma ctDNA. Here, we describe the outcomes, disease control rate (DCR) at 3 months and progression-free survival (PFS) in oncogenic-addicted advanced NSCLC patients with actionable alterations identified in plasma by ctDNA liquid biopsy assay, InVisionFirst (R)-Lung. A pooled retrospective analysis was completed of 81 advanced NSCLC patients with all classes of alterations predicting response to current FDA approved drugs: sensitizing common EGFR mutations (78%, n = 63) with T790M (73%, 46/63), ALK / ROS1 gene fusions (17%, n = 14) and BRAF V600E mutations (5%, n = 4). Actionable driver alterations detected in liquid biopsy were confirmed by prior tissue genomic profiling in all patients, and all patients received personalized treatment. Of 82 patients treated with matched targeted therapies, 10% were at first-line, 41% at second-line, and 49% beyond second-line. Acquired T790M at TKI relapse was detected in 73% (46/63) of patients, and all prospective patients (34/46) initiated osimertinib treatment based on ctDNA results. The 3-month DCR was 86% in 81 evaluable patients. The median PFS was of 14.8 months (12.1-22.9m). Baseline ctDNA allelic fraction of genomic driver did not correlate with the response rate of personalized treatment (p = 0.29). ctDNA molecular profiling is an accurate and reliable tool for the detection of clinically relevant molecular alterations in advanced NSCLC patients. Clinical outcomes with targeted therapies endorse the use of liquid biopsy by amplicon-based NGS ctDNA analysis in first line and relapse testing for advanced NSCLC patients.	[Remon, Jordi; Planchard, David; Mezquita, Laura; Rouleau, Etienne; Besse, Benjamin] Gustave Roussy, Dept Canc Med, Villejuif, France; [Swalduz, Aurelie; Ortiz-Cuaran, Sandra; Leonce, Camille; Perol, Maurice; Saintigny, Pierre] Ctr Leon Berard, Lyon, France; [Lacroix, Ludovic; Jovelet, Cecile] Gustave Roussy, Lab Rech Translat, Villejuif, France; [De Kievit, Frank; Morris, Clive; Jones, Greg; Mercier, Kelly; Howarth, Karen; Green, Emma] Inivata, Granta Pk, Cambridge, England; [Besse, Benjamin] Univ Paris Sud, Orsay, France	UNICANCER; Gustave Roussy; UNICANCER; Centre Leon Berard; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay	Besse, B (corresponding author), Gustave Roussy, Dept Canc Med, Villejuif, France.; Besse, B (corresponding author), Univ Paris Sud, Orsay, France.	Benjamin.BESSE@gustaveroussy.fr		MEZQUITA, LAURA/0000-0003-0936-7338; Ortiz-Cuaran, Sandra/0000-0003-1152-5681	Inivata	Inivata	FdK and KM received funding in the form of salaries, as employees of Inivata. CM, GJ, KH, and EG received funding in the form of salaries, as employees and shareholders of Inivata. The specific roles of the authors are articulated in the author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal C, 2019, JAMA ONCOL, V5, P173, DOI 10.1001/jamaoncol.2018.4305; [Anonymous], 2020, NCCN CLIN PRACTICE G; [Anonymous], 2017, NEW ENGL J MED, V376, P629; [Anonymous], 2003, EPILEPSIA, V44, pS12; Chouaid C, 2014, LUNG CANCER, V86, P170, DOI 10.1016/j.lungcan.2014.08.016; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fan JS, 2018, CANCER MED-US, V7, P4993, DOI 10.1002/cam4.1768; Gutierrez ME, 2017, CLIN LUNG CANCER, V18, P651, DOI 10.1016/j.cllc.2017.04.004; Kuderer NM, 2017, JAMA ONCOL, V3, P996, DOI 10.1001/jamaoncol.2016.4983; Leighl NB, 2019, CLIN CANCER RES, V25, P4691, DOI 10.1158/1078-0432.CCR-19-0624; McCoach CE, 2017, ANN ONCOL, V28, P2707, DOI 10.1093/annonc/mdx414; Oxnard GR, 2016, J CLIN ONCOL, V34, P3375, DOI 10.1200/JCO.2016.66.7162; Park K, 2016, JAMA ONCOL, V2, P305, DOI 10.1001/jamaoncol.2015.4921; Plagnol V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193802; Planchard D, 2018, ANN ONCOL, V29, P192, DOI 10.1093/annonc/mdy275; Pritchett M, 2019, JCO PRECIS ONCOL, V3, DOI [10.1200/P0.18.00299, 10.1200/PO.18.00299]; Raynaud F, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007669; Remon J, 2017, ANN ONCOL, V28, P784, DOI 10.1093/annonc/mdx017; Remon J, 2019, JCO PRECIS ONCOL, V3, P1, DOI 10.1200/PO.18.00211; Rolfo C, 2018, J THORAC ONCOL, V13, P1248, DOI 10.1016/j.jtho.2018.05.030; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; SRIDHARA R, 2018, J CLIN ONCOL S, V36; Stetson D, 2019, JCO PRECIS ONCOL, V3, DOI 10.1200/PO.18.00191; Torga G, 2018, JAMA ONCOL, V4, P868, DOI 10.1001/jamaoncol.2017.4027; Tredan O, 2019, ANN ONCOL, V30, P757, DOI 10.1093/annonc/mdz080; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zill OA, 2018, CLIN CANCER RES, V24, P3528, DOI 10.1158/1078-0432.CCR-17-3837; Zugazagoitia J, 2019, ANN ONCOL, V30, P290, DOI 10.1093/annonc/mdy512	29	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234302	10.1371/journal.pone.0234302	http://dx.doi.org/10.1371/journal.pone.0234302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525942	gold, Green Published			2022-12-26	WOS:000542036800076
J	Tahir, W; Abdulrahman, B; Abdelaziz, DH; Thapa, S; Walia, R; Schatzl, HM				Tahir, Waqas; Abdulrahman, Basant; Abdelaziz, Dalia H.; Thapa, Simrika; Walia, Rupali; Schaetzl, Hermann M.			An astrocyte cell line that differentially propagates murine prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prion; prion infection; astrocytes; Creutzfeldt-Jakob disease; scrapie; bovine spongiform encephalopathy; neurodegeneration; protein misfolding; prion disease; astrocyte; neurodegenerative disease; prion strain	CREUTZFELDT-JAKOB-DISEASE; SCRAPIE INFECTION; NEUROBLASTOMA-CELLS; TRANSGENIC MICE; NEURONAL PRP; EARLY-STAGE; PROTEIN; REPLICATION; EXPRESSION; STRAIN	Prion diseases are fatal infectious neurodegenerative disorders in human and animals caused by misfolding of the cellular prion protein (PrP(C)) into the pathological isoform PrPSc. Elucidating the molecular and cellular mechanisms underlying prion propagation may help to develop disease interventions. Cell culture systems for prion propagation have greatly advanced molecular insights into prion biology, but translation ofin vitrotoin vivofindings is often disappointing. A wider range of cell culture systems might help overcome these shortcomings. Here, we describe an immortalized mouse neuronal astrocyte cell line (C8D1A) that can be infected with murine prions. Both PrP(C)protein and mRNA levels in astrocytes were comparable with those in neuronal and non-neuronal cell lines permitting persistent prion infection. We challenged astrocytes with three mouse-adapted prion strains (22L, RML, and ME7) and cultured them for six passages. Immunoblotting results revealed that the astrocytes propagated 22L prions well over all six passages, whereas ME7 prions did not replicate, and RML prions replicated only very weakly after five passages. Immunofluorescence analysis indicated similar results for PrPSc. Interestingly, when we used prion conversion activity as a readout in real-time quaking-induced conversion assays with RML-infected cell lysates, we observed a strong signal over all six passages, comparable with that for 22L-infected cells. These data indicate that the C8D1A cell line is permissive to prion infection. Moreover, the propagated prions differed in conversion and proteinase K-resistance levels in these astrocytes. We propose that the C8D1A cell line could be used to decipher prion strain biology.	[Tahir, Waqas; Abdulrahman, Basant; Abdelaziz, Dalia H.; Thapa, Simrika; Walia, Rupali; Schaetzl, Hermann M.] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada; [Tahir, Waqas; Abdulrahman, Basant; Abdelaziz, Dalia H.; Thapa, Simrika; Walia, Rupali; Schaetzl, Hermann M.] Univ Calgary, Calgary Prion Res Unit, Calgary, AB, Canada; [Tahir, Waqas; Abdulrahman, Basant; Abdelaziz, Dalia H.; Thapa, Simrika; Walia, Rupali; Schaetzl, Hermann M.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Abdulrahman, Basant; Abdelaziz, Dalia H.] Helwan Univ, Fac Pharm, Dept Biochem & Mol Biol, Cairo 11795, Egypt	University of Calgary; University of Calgary; University of Calgary; Egyptian Knowledge Bank (EKB); Helwan University	Schatzl, HM (corresponding author), Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada.; Schatzl, HM (corresponding author), Univ Calgary, Calgary Prion Res Unit, Calgary, AB, Canada.; Schatzl, HM (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	hschaetz@ucalgary.ca		Tahir, Waqas/0000-0003-3030-5625	Alberta Innovates - Health Solutions Grants APRI [201900008, APRI 201600010]	Alberta Innovates - Health Solutions Grants APRI	This work was supported by Alberta Innovates - Health Solutions Grants APRI 201900008 and APRI 201600010 (to H. M. S.).	Abdulrahman BA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17770-8; Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Aguzzi A, 2017, J EXP MED, V214, P3477, DOI 10.1084/jem.20172045; Allen NJ, 2018, SCIENCE, V362, P181, DOI 10.1126/science.aat0473; Archer F, 2004, J VIROL, V78, P482, DOI 10.1128/JVI.78.1.482-490.2004; Balkema-Buschmann A, 2011, J TOXICOL ENV HEAL A, V74, P103, DOI 10.1080/15287394.2011.529060; Baron GS, 2006, J VIROL, V80, P2106, DOI 10.1128/JVI.80.5.2106-2117.2006; Bosque PJ, 2000, J VIROL, V74, P4377, DOI 10.1128/JVI.74.9.4377-4386.2000; Bourkas MEC, 2019, J BIOL CHEM, V294, P4911, DOI 10.1074/jbc.RA118.007135; BROWN P, 1986, ANN NEUROL, V20, P597, DOI 10.1002/ana.410200507; Budka H, 2003, BRIT MED BULL, V66, P121, DOI 10.1093/bmb/66.1.121; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; deVillemeur TB, 1996, NEUROLOGY, V47, P690, DOI 10.1212/WNL.47.3.690; DIEDRICH JF, 1991, P NATL ACAD SCI USA, V88, P375, DOI 10.1073/pnas.88.2.375; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Falsig J, 2008, NAT PROTOC, V3, P555, DOI 10.1038/nprot.2008.13; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; Follet J, 2002, J VIROL, V76, P2434, DOI 10.1128/JVI.76.5.2434-2439.2002; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Grassmann A, 2013, VIRUSES-BASEL, V5, P374, DOI 10.3390/v5010374; Greenlee JJ, 2019, VET PATHOL, V56, P6, DOI 10.1177/0300985818794247; Greil CS, 2008, VIROLOGY, V379, P284, DOI 10.1016/j.virol.2008.07.006; Groveman BR, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0742-2; Hannaoui S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006619; Hannaoui S, 2013, J VIROL, V87, P2535, DOI 10.1128/JVI.03082-12; HECKER R, 1992, GENE DEV, V6, P1213, DOI 10.1101/gad.6.7.1213; Hernandez RS, 2014, CELL TISSUE RES, V358, P57, DOI 10.1007/s00441-014-1928-3; Homma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04504; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; Imberdis T, 2014, EMBO J, V33, P1506, DOI 10.15252/embj.201489071; Jeffrey M, 2004, ANN NEUROL, V55, P781, DOI 10.1002/ana.20093; John TR, 2013, PRION, V7, P253, DOI 10.4161/pri.24430; Kaczmarczyk L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154604; Kercher L, 2004, AM J PATHOL, V165, P2055, DOI 10.1016/S0002-9440(10)63256-7; Krauss Sybille, 2013, Int J Cell Biol, V2013, P704546, DOI 10.1155/2013/704546; Krejciova Z, 2017, J EXP MED, V214, P3481, DOI 10.1084/jem.20161547; Lansbury PT, 1996, CURR BIOL, V6, P914, DOI 10.1016/S0960-9822(02)00624-3; Lehmann Sylvain, 2004, V299, P227; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Maas E, 2007, J BIOL CHEM, V282, P18702, DOI 10.1074/jbc.M701309200; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Marella M, 2004, J NEUROSCI, V24, P620, DOI 10.1523/JNEUROSCI.4303-03.2004; MCKINLEY MP, 1991, LAB INVEST, V65, P622; Milhavet O, 2000, P NATL ACAD SCI USA, V97, P13937, DOI 10.1073/pnas.250289197; Miyazawa K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179317; Monzon M, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010320; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Munoz-Gutierrez JF, 2015, VIRUS RES, V198, P35, DOI 10.1016/j.virusres.2014.10.028; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Nunziante M, 2003, CHEMBIOCHEM, V4, P1268, DOI 10.1002/cbic.200300704; Orru CD, 2012, PRION, V6, P147, DOI 10.4161/pri.19430; Paquet S, 2007, J VIROL, V81, P10786, DOI 10.1128/JVI.01137-07; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Qi YP, 1997, J NEUROSCI, V17, P1217; Rabinovici GD, 2006, NEUROLOGY, V66, P286, DOI 10.1212/01.wnl.0000196440.00297.67; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; RUBENSTEIN R, 1984, J GEN VIROL, V65, P2191, DOI 10.1099/0022-1317-65-12-2191; RUBENSTEIN R, 1992, J GEN VIROL, V73, P3027, DOI 10.1099/0022-1317-73-11-3027; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sajnani G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002547; Schatzl HM, 1997, J VIROL, V71, P8821; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; Torres M, 2015, J BIOL CHEM, V290, P23631, DOI 10.1074/jbc.M114.635565; Tranulis MA, 2011, TOP CURR CHEM, V305, P23, DOI 10.1007/128_2011_161; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Veith NM, 2009, EUR J CELL BIOL, V88, P45, DOI 10.1016/j.ejcb.2008.08.001; Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016; Vorberg I, 2004, J BIOL CHEM, V279, P29218, DOI 10.1074/jbc.M402576200; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Vorberg I, 2019, CURR OPIN PHARMACOL, V44, P28, DOI 10.1016/j.coph.2019.02.002; Wadsworth JDF, 2011, ACTA NEUROPATHOL, V121, P69, DOI 10.1007/s00401-010-0735-5; Walia R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47629-z; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Yamasaki T, 2014, VIROLOGY, V450, P324, DOI 10.1016/j.virol.2013.11.007	81	11	11	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11572	11583		10.1074/jbc.RA120.012596	http://dx.doi.org/10.1074/jbc.RA120.012596			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32561641	hybrid, Green Published			2022-12-26	WOS:000563922500017
J	Okuda, EK; Gonzales-Zubiate, FA; Gadal, O; Oliveira, CC				Okuda, Ellen K.; Gonzales-Zubiate, Fernando A.; Gadal, Olivier; Oliveira, Carla C.			Nucleolar localization of the yeast RNA exosome subunit Rrp44 hints at early pre-rRNA processing as its main function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribosomal RNA processing (rRNA processing); RNA degradation; nucleus; nucleolus; nuclear translocation; exosome complex	HUMAN PM-SCL; MESSENGER-RNA; NUCLEAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; SYSTEMATIC IDENTIFICATION; PROTEIN COMPLEXES; GENE-EXPRESSION; GLOBAL ANALYSIS; DEGRADATION; DIS3	The RNA exosome is a multisubunit protein complex involved in RNA surveillance of all classes of RNA, and is essential for pre-rRNA processing. The exosome is conserved throughout evolution, present in archaea and eukaryotes from yeast to humans, where it localizes to the nucleus and cytoplasm. The catalytically active subunit Rrp44/Dis3 of the exosome in budding yeast (Saccharomyces cerevisiae) is considered a protein present in these two subcellular compartments, and here we report that it not only localizes mainly to the nucleus, but is concentrated in the nucleolus, where the early pre-rRNA processing reactions take place. Moreover, we show by confocal microscopy analysis that the core exosome subunits Rrp41 and Rrp43 also localize largely to the nucleus and strongly accumulate in the nucleolus. These results shown here shed additional light on the localization of the yeast exosome and have implications regarding the main function of this RNase complex, which seems to be primarily in early pre-rRNA processing and surveillance.	[Okuda, Ellen K.; Gonzales-Zubiate, Fernando A.; Oliveira, Carla C.] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Gadal, Olivier] Univ Toulouse, Ctr Biol Integrat CBI, Lab Biol Mol Eucaryote, UPS,CNRS, Toulouse, France; [Gonzales-Zubiate, Fernando A.] Yachay Tech Univ, Sch Biol Sci & Engn, San Miguel De Urcuqui, Ecuador	Universidade de Sao Paulo; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Oliveira, CC (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.	ccoliv@iq.usp.br	Gadal, Olivier/A-4731-2008; Gonzales-Zubiate, Fernando A/O-2709-2014; Oliveira, Carla/F-2323-2011	Gadal, Olivier/0000-0001-9421-0831; Gonzales-Zubiate, Fernando A/0000-0001-9519-4079; Oliveira, Carla/0000-0002-1098-9241	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [15/06477-9]; Centre de Biologie Integrative, Toulouse; CNPq [17/17777-9]; FAPESP [17/17777-9]; Research Internships Abroad Grant [18/19451-6]; Centre National de la Recherche Scientifique	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Centre de Biologie Integrative, Toulouse; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Research Internships Abroad Grant; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grant-15/06477-9 (to C. C. O.), and the Centre de Biologie Integrative, Toulouse (to O. G.). E. K. O. was supported by CNPq and FAPESP Fellowship Master's 17/17777-9, Research Internships Abroad Grant 18/19451-6, and the Centre National de la Recherche Scientifique). F. A. G.-Z. was suppported by FAPESP postdoctoral fellowship 12/50196-6.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Aloy P, 2002, EMBO REP, V3, P628, DOI 10.1093/embo-reports/kvf135; Azzouz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006760; Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Bachellier-Bassi S, 2008, J STRUCT BIOL, V162, P248, DOI 10.1016/j.jsb.2008.01.002; Bakhrat A, 2006, J BIOL CHEM, V281, P12218, DOI 10.1074/jbc.M600238200; Barandun J, 2018, CURR OPIN STRUC BIOL, V49, P85, DOI 10.1016/j.sbi.2018.01.008; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; Berger AB, 2008, NAT METHODS, V5, P1031, DOI 10.1038/nmeth.1266; Boeck R, 1998, MOL CELL BIOL, V18, P5062, DOI 10.1128/MCB.18.9.5062; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Cepeda LPP, 2019, J BIOL CHEM, V294, P19365, DOI 10.1074/jbc.RA119.010193; Chlebowski A, 2013, BBA-GENE REGUL MECH, V1829, P552, DOI 10.1016/j.bbagrm.2013.01.006; Choque E, 2018, NUCLEIC ACIDS RES, V46, P4699, DOI 10.1093/nar/gky116; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; Darriere T, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008157; Das B, 2003, MOL CELL BIOL, V23, P5502, DOI 10.1128/MCB.23.16.5502-5515.2003; Dez C, 2006, EMBO J, V25, P1534, DOI 10.1038/sj.emboj.7601035; Drazkowska K, 2013, NUCLEIC ACIDS RES, V41, P3845, DOI 10.1093/nar/gkt060; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fries T, 2007, J BIOL CHEM, V282, P19292, DOI 10.1074/jbc.M700217200; Fromm L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01786-9; Gasse L, 2015, MOL CELL, V60, P808, DOI 10.1016/j.molcel.2015.10.021; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Gonzales-Zubiate FA, 2017, J BIOL CHEM, V292, P12267, DOI 10.1074/jbc.M116.772376; Graham AC, 2009, TRAFFIC, V10, P499, DOI 10.1111/j.1600-0854.2009.00888.x; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Januszyk K, 2014, CURR OPIN STRUC BIOL, V24, P132, DOI 10.1016/j.sbi.2014.01.011; Jin R, 2008, MOL BIOL CELL, V19, P284, DOI 10.1091/mbc.E07-05-0519; Kilchert C, 2016, NAT REV MOL CELL BIO, V17, P227, DOI 10.1038/nrm.2015.15; Klinge S, 2019, NAT REV MOL CELL BIO, V20, P116, DOI 10.1038/s41580-018-0078-y; Konikkat S, 2017, BIOCHEM J, V474, P195, DOI 10.1042/BCJ20160516; Kornprobst M, 2016, CELL, V166, P380, DOI 10.1016/j.cell.2016.06.014; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Laporte D, 2016, MOL BIOL CELL, V27, P1875, DOI 10.1091/mbc.E16-01-0069; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lee C, 2006, ADV EXP MED BIOL, V581, P145; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Makino DL, 2015, NATURE, V524, P54, DOI 10.1038/nature14865; Mamolen M, 2010, NUCLEIC ACIDS RES, V38, P5507, DOI 10.1093/nar/gkq295; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Ohmayer U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068412; Oliveira CC, 2002, NUCLEIC ACIDS RES, V30, P4186, DOI 10.1093/nar/gkf545; Raijmakers R, 2004, EUR J CELL BIOL, V83, P175, DOI 10.1078/0171-9335-00385; Rodriguez-Galan O, 2015, RNA BIOL, V12, P838, DOI 10.1080/15476286.2015.1058477; Schneider C, 2013, TRENDS BIOCHEM SCI, V38, P485, DOI 10.1016/j.tibs.2013.06.013; Suel KE, 2009, J BIOL CHEM, V284, P15416, DOI 10.1074/jbc.M809384200; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Sung MK, 2008, YEAST, V25, P301, DOI 10.1002/yea.1588; Thoms M, 2015, CELL, V162, P1029, DOI 10.1016/j.cell.2015.07.060; Tran EJ, 2014, BBA-MOL CELL RES, V1843, P2784, DOI 10.1016/j.bbamcr.2014.08.003; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Wang RJ, 2016, J CELL SCI, V129, P4480, DOI 10.1242/jcs.188250; Yao RW, 2019, MOL CELL, V76, P767, DOI 10.1016/j.molcel.2019.08.014; Zanchin NIT, 1999, MOL CELL BIOL, V19, P1518; Zhang E, 2019, EMBO J, V38, DOI 10.15252/embj.2018100640; Zhang LM, 2016, GENE DEV, V30, P718, DOI 10.1101/gad.274688.115; Zinder JC, 2016, MOL CELL, V64, P734, DOI 10.1016/j.molcel.2016.09.038	70	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11195	11213		10.1074/jbc.RA120.013589	http://dx.doi.org/10.1074/jbc.RA120.013589			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32554806	hybrid, Green Published			2022-12-26	WOS:000562757100023
J	Kelly, JA; Olson, AN; Neupane, K; Munshi, S; San Emeterio, J; Pollack, L; Woodside, MT; Dinman, JD				Kelly, Jamie A.; Olson, Alexandra N.; Neupane, Krishna; Munshi, Sneha; San Emeterio, Josue; Pollack, Lois; Woodside, Michael T.; Dinman, Jonathan D.			Structural and functional conservation of the programmed-1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						coronavirus disease 2019 (COVID-19); coronavirus; programmed-1 ribosomal frameshifting (-1 PRF); translation; RNA; RNA structure; virus; (+) ssRNA; inhibitor; small molecule inhibitor; mRNA pseudoknot	CONFORMATIONAL PLASTICITY; LIGAND	Approximately 17 years after the severe acute respiratory syndrome coronavirus (SARS-CoV) epidemic, the world is currently facing the COVID-19 pandemic caused by SARS corona virus 2 (SARS-CoV-2). According to the most optimistic projections, it will take more than a year to develop a vaccine, so the best short-term strategy may lie in identifying virus-specific targets for small molecule-based interventions. All coronaviruses utilize a molecular mechanism called programmed -1 ribosomal frameshift (-1 PRF) to control the relative expression of their proteins. Previous analyses of SARS-CoV have revealed that it employs a structurally unique three-stemmed mRNA pseudoknot that stimulates high -1 PRF rates and that it also harbors a -1 PRF attenuation element. Altering -1 PRF activity impairs virus replication, suggesting that this activity may be therapeutically targeted. Here, we comparatively analyzed the SARS-CoV and SARS-CoV-2 frameshift signals. Structural and functional analyses revealed that both elements promote similar -1 PRF rates and that silent coding mutations in the slippery sites and in all three stems of the pseudoknot strongly ablate -1 PRF activity. We noted that the upstream attenuator hairpin activity is also functionally retained in both viruses, despite differences in the primary sequence in this region. Small-angle X-ray scattering analyses indicated that the pseudoknots in SARS-CoV and SARS-CoV-2 have the same conformation. Finally, a small molecule previously shown to bind the SARS-CoV pseudoknot and inhibit -1 PRF was similarly effective against -1 PRF in SARS-CoV-2, suggesting that such frameshift inhibitors may be promising lead compounds to combat the current COVID-19 pandemic.	[Kelly, Jamie A.; Olson, Alexandra N.; Dinman, Jonathan D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Neupane, Krishna; Munshi, Sneha; Woodside, Michael T.] Univ Alberta, Dept Phys, Edmonton, AB, Canada; [San Emeterio, Josue; Pollack, Lois] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA	University System of Maryland; University of Maryland College Park; University of Alberta; Cornell University	Dinman, JD (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.; Woodside, MT (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB, Canada.; Pollack, L (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.	lp26@cornell.edu; mwoodsid@ualberta.ca; dinman@umd.edu	Kelly, Jamie/AAK-6150-2021	Kelly, Jamie/0000-0003-2416-2496; Dinman, Jonathan/0000-0002-2402-9698; Olson, Alexandra/0000-0002-8533-1946	Defense Threat Reduction Agency [HDTRA1-13-1-0005]; NIGMS, National Institutes of Health [R01 GM117177]; University of Maryland Coronavirus Research Program Seed Grant; Canadian Institutes of Health Research [OV3-170709]; National Institutes of Health [P30 GM133893, S10 OD012331, BER-BO 070, 2T32AI051967-06A1]; National Science Foundation [DBI-1930046]; Department of Energy [BES-FWP-PS001]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Maryland Coronavirus Research Program Seed Grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE))	This work was supported by Defense Threat Reduction Agency Grant HDTRA1-13-1-0005; NIGMS, National Institutes of Health Grant R01 GM117177; a University of Maryland Coronavirus Research Program Seed Grant (to J. D. D.); Canadian Institutes of Health Research Grant OV3-170709 (to M. T. W.); and National Institutes of Health Institutional Training Grant 2T32AI051967-06A1 (to J. A. K.). The solution scattering work was supported by National Science Foundation Award DBI-1930046 (to L. P.). Support for work performed at Beamline LIX (16ID) of the Center for BioMolecular Structure at National Synchrotron Light Source II was provided by National Institutes of Health Grants P30 GM133893, S10 OD012331, and BER-BO 070. National Synchrotron Light Source II is supported by Department of Energy Grant BES-FWP-PS001. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn DG, 2011, ANTIVIR RES, V91, P1, DOI 10.1016/j.antiviral.2011.04.009; Atkins JF, 2016, NUCLEIC ACIDS RES, V44, P7007, DOI 10.1093/nar/gkw530; Baranov PV, 2005, VIROLOGY, V332, P498, DOI 10.1016/j.virol.2004.11.038; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; BRIERLEY I, 1987, EMBO J, V6, P3779, DOI 10.1002/j.1460-2075.1987.tb02713.x; Brierley I, 2006, VIRUS RES, V119, P29, DOI 10.1016/j.virusres.2005.10.008; Chen YL, 2019, J PHYS CHEM B, V123, P9773, DOI 10.1021/acs.jpcb.9b07502; Cho CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062283; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Halma MTJ, 2019, P NATL ACAD SCI USA, V116, P19500, DOI 10.1073/pnas.1905258116; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; Ishimaru D, 2013, NUCLEIC ACIDS RES, V41, P2594, DOI 10.1093/nar/gks1361; JACKS T, 1985, SCIENCE, V230, P1237, DOI 10.1126/science.2416054; Jacobs JL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh157; Park SJ, 2011, J AM CHEM SOC, V133, P10094, DOI 10.1021/ja1098325; Plant EP, 2005, PLOS BIOL, V3, P1012, DOI 10.1371/journal.pbio.0030172; Plant EP, 2013, VIRUSES-BASEL, V5, P279, DOI 10.3390/v5010279; Plant EP, 2010, J VIROL, V84, P4330, DOI 10.1128/JVI.02480-09; PUGLISI JD, 1988, NATURE, V331, P283, DOI 10.1038/331283a0; Ritchie DB, 2014, J AM CHEM SOC, V136, P2196, DOI 10.1021/ja410344b; Ritchie DB, 2012, P NATL ACAD SCI USA, V109, P16167, DOI 10.1073/pnas.1204114109; Rodnina MV, 2020, NUCLEIC ACIDS RES, V48, P1056, DOI 10.1093/nar/gkz783; Yang L, 2020, J SYNCHROTRON RADIAT, V27, P804, DOI 10.1107/S1600577520002362	24	85	85	6	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10741	10748		10.1074/jbc.AC120.013449	http://dx.doi.org/10.1074/jbc.AC120.013449			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32571880	hybrid, Green Published			2022-12-26	WOS:000560405600018
J	Clausen, LPW; Hansen, OFH; Oturai, NB; Syberg, K; Hansen, SF				Clausen, Lauge Peter Westergaard; Hansen, Oliver Foss Hessner; Oturai, Nikoline Bang; Syberg, Kristian; Hansen, Steffen Foss			Stakeholder analysis with regard to a recent European restriction proposal on microplastics	PLOS ONE			English	Article							EU; POLICY; SUCCESS	Stakeholder involvement is pivotal EU governance. In this paper, we complete a stakeholder analysis of the European Chemicals Agency's recent Annex XV restriction proposal process on intentionally added microplastics. The aim of this study is to map the interests, influence and importance of active stakeholders in order to understand the arguments being put forward by different stakeholders and provide recommendations to policy-makers on how to ensure a balanced consideration of all stakeholder perspectives. Stakeholders were identified through niche media analysis and by scrutinising comments from the public consultation on the restriction proposal. Their importance and influence were mapped using three approaches: "scale from low to high", "psychometric scale" and "qualitative ranking". We identified 205 different stakeholders out of which 77 were industry and trade associations, 25 were large companies and only four were small and medium-sized enterprises. National authorities and researchers did not comment on the restriction proposal, whilst large companies were very active providing comments. Industry trade associations and sports-related non-governmental organizations articulated anxiety about the costs associated with the implementation of the restriction proposal. Among environmental non-governmental organizations, there was consensus that plastics should be handled like other substances under EU's chemical regulation. Primary stakeholders identified exhibited high importance, but varying degrees of influence, while the opposite applied to the major European institutions. Based on our analysis, we recommend that: The European Chemicals Agency implement measures to include "silent" stakeholders and invite guest experts to participate in their committees on Risk Assessment and Socio-Economic Analysis; Researchers should be more active in the public consultation; and that special emphasis should be put on helping small and medium-sized enterprises. With regards to stakeholder consultation, we find that media analysis is a good supplement to stakeholder analysis and that a more objective top-down measure of stakeholder importance and influence is needed.	[Clausen, Lauge Peter Westergaard; Hansen, Oliver Foss Hessner; Hansen, Steffen Foss] Tech Univ Denmark, Dept Environm Engn, Lyngby, Denmark; [Oturai, Nikoline Bang; Syberg, Kristian] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark	Technical University of Denmark; Roskilde University	Clausen, LPW (corresponding author), Tech Univ Denmark, Dept Environm Engn, Lyngby, Denmark.	lpwc@env.dtu.dk	Foss Hansen, Steffen/L-8182-2019; Clausen, Lauge Peter Westergaard/G-6370-2019	Foss Hansen, Steffen/0000-0003-4342-7779; Clausen, Lauge Peter Westergaard/0000-0001-9710-2588	Velux Foundation [25084]	Velux Foundation(Velux Fonden)	We acknowledge MarinePlastic, a Danish Centre for research in marine plastic pollution, sponsored by the Velux Foundation, grant number 25084, for providing the funding for this research.	Achterkamp Marjolein C., 2008, International Journal of Project Management, V26, P749, DOI 10.1016/j.ijproman.2007.10.001; [Anonymous], 1996, CONTAGION J VIOLENCE; [Anonymous], 2003, EUR J CARDIOVASC S1, V10, pS1; [Anonymous], 1998, AOAC OFFICIAL METHOD, V1; Backhaus T, 2020, GLOB CHALL, V4, DOI 10.1002/gch2.201900022; Brugha R, 2000, HEALTH POLICY PLANN, V15, P239, DOI 10.1093/heapol/15.3.239; Crosby B., 1992, STAKEHOLDER ANAL VIT; Cuspedes-Lorente J., 2003, SCAND J MANAG, V19, P333, DOI [10.1016/S0956-5221(02)00034-9, DOI 10.1016/S0956-5221(02)00034-9]; D'AGOSTINO M., 2013, SCRIPTA, V6, P41; Dreser A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1051; Dur A, 2008, EUR UNION POLIT, V9, P559, DOI 10.1177/1465116508095151; Dur A, 2008, WEST EUR POLIT, V31, P1212, DOI 10.1080/01402380802372662; Dur Andreas., 2007, J PUBLIC POLICY, V27, P79, DOI DOI 10.1017/S0143814X0700061X; Eden C, 2013, MAKING STRATEGY JOUR; European Commission, 2019, CIRC EC PLAST INS RE, DOI [10.2777/269031, DOI 10.2777/269031]; European Commission, 2018, SWD201816 EUR COMM; European Commission, 2001, COM2001428; Eurostat, 2018, SMALL MED SIZ ENT OV; Fassin Y, 2009, J BUS ETHICS, V84, P113, DOI 10.1007/s10551-008-9677-4; Freeman R. E., 1984, STRATEGIC MANAGEMENT; Frooman J, 1999, ACAD MANAGE REV, V24, P191; Galbraith J. K., 1983, CHALLENGE, V26, P26; Hansen SF, 2015, NANOETHICS, V9, P297, DOI 10.1007/s11569-015-0245-y; Ielite I, 2015, 2015 IEEE SEVENTH INTERNATIONAL CONFERENCE ON INTELLIGENT COMPUTING AND INFORMATION SYSTEMS (ICICIS), P251, DOI 10.1109/IntelCIS.2015.7397229; Jones TM, 2018, ACAD MANAGE REV, V43, P371, DOI 10.5465/amr.2016.0111; Junk WM, 2016, J EUR PUBLIC POLICY, V23, P236, DOI 10.1080/13501763.2015.1041416; Kluver H, 2011, EUR UNION POLIT, V12, P483, DOI 10.1177/1465116511413163; Maguire B, 2012, MAR POLICY, V36, P246, DOI 10.1016/j.marpol.2011.05.012; Manowong E., 2010, CONSTRUCTION STAKEHO, P121, DOI [10.1002/9781444315349.ch8, DOI 10.1002/9781444315349.CH8]; Norwegian Environmental Agency, 2019, ANN 15 RSTR REP PROS; Olander S., 2005, International Journal of Project Management, V23, P321, DOI 10.1016/j.ijproman.2005.02.002; Orach K, 2017, ENVIRON SCI POLICY, V76, P90, DOI 10.1016/j.envsci.2017.06.010; Padhyoti Y., 2018, Journal of Agriculture and Environment, V19, P80; Pesendorfer D, 2006, ENVIRON POLIT, V15, P95, DOI 10.1080/09644010500418803; Pomeroy R, 2008, MAR POLICY, V32, P816, DOI 10.1016/j.marpol.2008.03.017; Reed MS, 2009, J ENVIRON MANAGE, V90, P1933, DOI 10.1016/j.jenvman.2009.01.001; Roed M, 2018, JCMS-J COMMON MARK S, V56, P1446, DOI 10.1111/jcms.12754; Sabatier PA, 1998, J EUR PUBLIC POLICY, V5, P98, DOI 10.1080/13501768880000051; Sabatier PA, 2007, ADVOCACY COALITION F, P189; Selin H, 2007, GLOBAL ENVIRON POLIT, V7, P63, DOI 10.1162/glep.2007.7.3.63; Van den Brande L, 2017, REACHING OUT EU CITI; van Straalen NM, 2018, SCIENCE, V360, P958, DOI 10.1126/science.aat0567; Varvasovszky Z, 2000, HEALTH POLICY PLANN, V15, P338, DOI 10.1093/heapol/15.3.338; Walker D. H. T., 2005, MANAG DECIS, V43, P649, DOI DOI 10.1108/00251740510597680; Xanthos D, 2017, MAR POLLUT BULL, V118, P17, DOI 10.1016/j.marpolbul.2017.02.048; Zhang Wen-liang, 2007, Proceedings of the CSEE, V27, P1	80	7	8	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235062	10.1371/journal.pone.0235062	http://dx.doi.org/10.1371/journal.pone.0235062			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569303	Green Published, gold			2022-12-26	WOS:000543547900026
J	Ni, DJ; Ai, ZY; Munoz-Sandoval, D; Suresh, R; Ellis, PR; Chen, YQ; Sharp, PA; Butterworth, PJ; Yu, Z; Corpe, CP				Ni, Dejiang; Ai, Zeyi; Munoz-Sandoval, Diana; Suresh, Reshma; Ellis, Peter R.; Chen Yuqiong; Sharp, Paul A.; Butterworth, Peter J.; Yu, Zhi; Corpe, Christopher P.			Inhibition of the facilitative sugar transporters (GLUTs) by tea extracts and catechins	FASEB JOURNAL			English	Article						catechins; facilitative glucose transporters (GLUTs); glucose uptake; sodium-dependent glucose transporter (SGLT1); tea extract	DECREASE GLUCOSE-UPTAKE; GREEN TEA; BRUSH-BORDER; BLACK TEA; DIABETES-MELLITUS; POLYPHENOLS; EXPRESSION; METABOLISM; ABSORPTION; INTESTINE	Tea polyphenolics have been suggested to possess blood glucose lowering properties by inhibiting sugar transporters in the small intestine and improving insulin sensitivity. In this report, we studied the effects of teas and tea catechins on the small intestinal sugar transporters, SGLT1 and GLUTs (GLUT1, 2 and 5). Green tea extract (GT), oolong tea extract (OT), and black tea extract (BT) inhibited glucose uptake into the intestinal Caco-2 cells with GT being the most potent inhibitor (IC50: 0.077 mg/mL), followed by OT (IC50: 0.136 mg/mL) and BT (IC50: 0.56 mg/mL). GT and OT inhibition of glucose uptake was partial non-competitive, with an inhibitor constant (K-i) = 0.0317 and 0.0571 mg/mL, respectively, whereas BT was pure non-competitive,K-i = 0.36 mg/mL. Oocytes injected to express small intestinal GLUTs were inhibited by teas, but SGLT1 was not. Furthermore, catechins present in teas were the predominant inhibitor of glucose uptake into Caco-2 cells, and gallated catechins the most potent: CG > ECG > EGCG >= GCG when compared to the non-gallated catechins (C, EC, GC, and EGC). In Caco-2 cells, individual tea catechins reduced the SGLT1 gene, but not protein expression levels. In contrast, GLUT2 gene and protein expression levels were reduced after 2 hours exposure to catechins but increased after 24 hours. These in vitro studies suggest teas containing catechins may be useful dietary supplements capable of blunting postprandial glycaemia in humans, including those with or at risk to Type 2 diabetes mellitus.	[Ni, Dejiang; Ai, Zeyi; Chen Yuqiong; Yu, Zhi] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Peoples R China; [Ni, Dejiang; Ellis, Peter R.; Butterworth, Peter J.] Kings Coll London, Dept Biochem & Nutr, Fac Life Sci & Med, London, England; [Ai, Zeyi] Jiangsu Acad Agr Sci, Inst Leisure Agr, Nanjing, Peoples R China; [Munoz-Sandoval, Diana; Suresh, Reshma; Sharp, Paul A.; Corpe, Christopher P.] Kings Coll London, Fac Life Sci & Med, Dept Nutr Sci, Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England	Huazhong Agricultural University; University of London; King's College London; Jiangsu Academy of Agricultural Sciences; University of London; King's College London	Corpe, CP (corresponding author), Kings Coll London, Fac Life Sci & Med, Dept Nutr Sci, Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England.	Christopher.corpe@kcl.ac.uk		Sharp, Paul Anthony/0000-0003-3400-6702; Munoz Sandoval, Diana/0000-0001-8350-3989; corpe, christopher/0000-0003-1994-8312	National Natural Science Foundation of China [31270732]; Biotechnology and Biological Sciences Research Council, United Kingdom [BB/H004866/1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	National Natural Science Foundation of China, Grant/Award Number: 31270732; Biotechnology and Biological Sciences Research Council, United Kingdom, Grant/Award Number: BB/H004866/1	Ai ZY, 2017, J FOOD SCI TECH MYS, V54, P1212, DOI 10.1007/s13197-017-2558-z; Boyer S, 1996, FEBS LETT, V396, P218, DOI 10.1016/0014-5793(96)01102-7; Bryans JA, 2007, J AM COLL NUTR, V26, P471, DOI 10.1080/07315724.2007.10719638; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; BURANT CF, 1994, J CLIN INVEST, V93, P578, DOI 10.1172/JCI117010; Castro-Acosta ML, 2016, P NUTR SOC, V75, P342, DOI 10.1017/S0029665116000240; Chen HX, 2009, EUR FOOD RES TECHNOL, V229, P629, DOI 10.1007/s00217-009-1088-y; Corpe CP, 1996, PFLUG ARCH EUR J PHY, V432, P192, DOI 10.1007/s004240050124; Diamant Michaela, 2006, Curr Diab Rep, V6, P279, DOI 10.1007/s11892-006-0061-4; Drozdowski LA, 2006, WORLD J GASTROENTERO, V12, P1657, DOI 10.3748/wjg.v12.i11.1657; Feng WY, 2006, CURR DRUG METAB, V7, P755, DOI 10.2174/138920006778520552; Fu QY, 2017, MOLECULES, V22, DOI 10.3390/molecules22050849; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Grefner N. M., 2010, Cell and Tissue Biology, V4, P354, DOI 10.1134/S1990519X10040085; Harbowy ME, 1997, CRIT REV PLANT SCI, V16, P415, DOI 10.1080/713608154; Hashimoto T, 1999, BIOSCI BIOTECH BIOCH, V63, P2252, DOI 10.1271/bbb.63.2252; He Q, 2007, FOOD CHEM, V101, P1178, DOI 10.1016/j.foodchem.2006.03.020; Hirayama BA, 2001, BRIT J PHARMACOL, V134, P484, DOI 10.1038/sj.bjp.0704274; Hossain SJ, 2002, J AGR FOOD CHEM, V50, P5215, DOI 10.1021/jf020252e; Johnston K, 2005, FEBS LETT, V579, P1653, DOI 10.1016/j.febslet.2004.12.099; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Kobayashi Y, 2000, J AGR FOOD CHEM, V48, P5618, DOI 10.1021/jf0006832; Koh LW, 2010, J AGR FOOD CHEM, V58, P148, DOI 10.1021/jf903011g; Kwon O, 2007, FASEB J, V21, P366, DOI 10.1096/fj.06-6620com; Liu J, 2011, J AGR FOOD CHEM, V59, P4582, DOI 10.1021/jf200355q; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lochocka K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12015; Lotfy M, 2017, CURR DIABETES REV, V13, P3, DOI 10.2174/1573399812666151016101622; Ros JL, 2015, PLANTA MED, V81, P975, DOI 10.1055/s-0035-1546131; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MAHRAOUI L, 1994, BIOCHEM J, V298, P629, DOI 10.1042/bj2980629; Manzano S, 2010, MOL NUTR FOOD RES, V54, P1773, DOI 10.1002/mnfr.201000019; Mi YS, 2017, FASEB J, V31, P4998, DOI 10.1096/fj.201700400RR; Moreira L, 2013, EXP CELL RES, V319, P1784, DOI 10.1016/j.yexcr.2013.05.001; Ochiai H, 2009, BIOCHEM PHARMACOL, V78, P1069, DOI 10.1016/j.bcp.2009.06.007; Qu FF, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801039; ROBERTS EAH, 1949, BIOCHEM J, V45, P538, DOI 10.1042/bj0450538; Shi Z, 1997, TEA PROCESSING; Shimizu M, 2000, BIOFACTORS, V13, P61, DOI 10.1002/biof.5520130111; Snoussi C, 2014, J NUTR BIOCHEM, V25, P557, DOI 10.1016/j.jnutbio.2014.01.006; Solayman M, 2016, CURR PHARM DESIGN, V22, P549, DOI 10.2174/1381612822666151125001111; SOREQ H, 1992, METHOD ENZYMOL, V207, P225; Sterrett JJ, 2016, AM J MED SCI, V351, P342, DOI 10.1016/j.amjms.2016.01.019; Sun LJ, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700324; Tang WP, 2013, J FUNCT FOODS, V5, P1784, DOI 10.1016/j.jff.2013.08.007; ter Horst KW, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090981; Thounaojam MC, 2015, EVID-BASED COMPL ALT, V2015, P2; Wan X.C, 2003, TEA BIOCH; Wang J, 2017, ONCOTARGET, V8, P16875, DOI 10.18632/oncotarget.15171; Waring W.S, 2016, MEDICINE, V44, P138, DOI [10.1016/J.MPMED.2015.12.011, DOI 10.1016/J.MPMED.2015.12.011]; WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698; Whiteley CG, 1999, BIOCHEM EDUC, V27, P15, DOI 10.1016/S0307-4412(98)00265-9; WITHYCOMBE WA, 1965, BIOCHEM J, V94, P384, DOI 10.1042/bj0940384; WRIGHT EM, 1993, ANNU REV PHYSIOL, V55, P575, DOI 10.1146/annurev.ph.55.030193.003043; Xing LJ, 2019, J AGR FOOD CHEM, V67, P1029, DOI 10.1021/acs.jafc.8b06146; Xu HB, 2020, INT J BIOL MACROMOL, V145, P527, DOI 10.1016/j.ijbiomac.2019.12.161; Zhou DR, 2009, FOOD CHEM, V113, P110, DOI 10.1016/j.foodchem.2008.07.033; Zimmet P, 2016, NAT REV ENDOCRINOL, V12, P616, DOI 10.1038/nrendo.2016.105; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8	62	19	19	8	31	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9995	10010		10.1096/fj.202000057RR	http://dx.doi.org/10.1096/fj.202000057RR		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32564472	Green Published, hybrid			2022-12-26	WOS:000541821100001
J	Madewell, ZJ; Lopez, MR; Espinosa-Bode, A; Brouwer, KC; Sanchez, CG; McCracken, JP				Madewell, Zachary J.; Lopez, Maria Renee; Espinosa-Bode, Andres; Brouwer, Kimberly C.; Sanchez, Cesar G.; McCracken, John P.			Inverse association between dengue, chikungunya, and Zika virus infection and indicators of household air pollution in Santa Rosa, Guatemala: A case-control study, 2011-2018	PLOS ONE			English	Article							RISK-FACTORS; ANOPHELES-GAMBIAE; GUINEA-BISSAU; MALARIA; WOODSMOKE; SEROPREVALENCE; TRANSMISSION; SENSITIVITY; MOSQUITOS; CHILDREN	Background Dengue, chikungunya, and Zika viruses are increasingly important public health problems. Burning vegetation, leaves, and other plant products have been shown to be effective mosquito repellents for their vector,Aedes spp., but there has been scant research on whether firewood cooking smoke in households influences mosquito populations or mosquito-borne diseases. About 2.9 billion people worldwide use biomass fuel for household cooking and heating, resulting in an estimated 1.6 million deaths annually from household air pollution (HAP)-related diseases. Global health agencies now encourage households to transition from biomass to clean fuels, but it is unclear whether such interventions may actually increase risk for mosquito-borne diseases. This retrospective case-control study evaluated associations between arboviral infections and cooking with firewood in Santa Rosa, Guatemala. Method Vigilancia Integrada Comunitaria(VICo) was a prospective public health surveillance system for bacterial, parasitic, and viral causes of diarrheal, neurological, respiratory, and febrile illnesses in hospitals and clinics in the department of Santa Rosa, Guatemala. Enrolled VICo in-patients and out-patients during 2011-2018 were interviewed using standardized questionnaires on demographics and household characteristics. Blood and stool specimens were collected and tested to identify the etiologies presenting symptoms. Cases were defined as laboratory-positive for dengue, chikungunya, or Zika virus infections. Controls were laboratory-positive for bacterial and viral diarrheal illnesses (e.g.,Salmonella,Shigella,Campylobacter,Escherichia coli, rotavirus, norovirus, sapovirus, or astrovirus). Cooking with firewood, kitchen location, stove type, and firewood cooking frequency were the independent exposure variables. Logistic regression models were used to analyze unadjusted and adjusted associations between arboviral infections and exposures of interest. Result There were 311 arboviral cases and 1,239 diarrheal controls. Arboviral infections were inversely associated with cooking with firewood in the main house (AOR: 0.22; 95% CI: 0.08-0.57), cooking with firewood on an open hearth (AOR: 0.50; 95% CI: 0.33-0.78), and cooking with firewood >= 5 times per week (AOR: 0.54; 95% CI: 0.36-0.81), adjusting for age, sex, ethnicity, socioeconomic status index, number of people per household, community population density, community elevation, recruitment location, season, and admission year. Conclusion Several primary determinants of HAP exposure were inversely associated with arboviral infections. Additional studies are needed to understand whether interventions to reduce HAP might actually increase risk for mosquito-borne infectious diseases, which would warrant improved education and mosquito control efforts in conjunction with fuel interventions.	[Madewell, Zachary J.; Lopez, Maria Renee; McCracken, John P.] Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala; [Madewell, Zachary J.] Univ Calif San Diego, PhD Program Publ Hlth Epidemiol, San Diego, CA 92103 USA; [Madewell, Zachary J.] San Diego State Univ, San Diego, CA 92182 USA; [Espinosa-Bode, Andres] Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA USA; [Brouwer, Kimberly C.] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Global Hlth, San Diego, CA 92103 USA; [Sanchez, Cesar G.] Minist Salud Publ & Asistencia Social, Guatemala City, Guatemala	Universidad del Valle de Guatemala; University of California System; University of California San Diego; California State University System; San Diego State University; Centers for Disease Control & Prevention - USA; University of California System; University of California San Diego	Madewell, ZJ (corresponding author), Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala.; Madewell, ZJ (corresponding author), Univ Calif San Diego, PhD Program Publ Hlth Epidemiol, San Diego, CA 92103 USA.; Madewell, ZJ (corresponding author), San Diego State Univ, San Diego, CA 92182 USA.	zmadewel@ucsd.edu	Madewell, Zachary/AAM-4921-2020	Madewell, Zachary/0000-0002-5667-9660	Global Disease Detection initiative of the Center for Global Health, Centers for Disease Control and Prevention; Universidad del Valle de Guatemala (UVG) Centro de Estudios En Salud [1U01GH000028-01, 1U01GH00100301]; Fogarty International Center of the National Institutes of Health (NIH) [D43TW009343]; University of California Global Health Institute (UCGHI)	Global Disease Detection initiative of the Center for Global Health, Centers for Disease Control and Prevention; Universidad del Valle de Guatemala (UVG) Centro de Estudios En Salud; Fogarty International Center of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of California Global Health Institute (UCGHI)	This study was funded by the Global Disease Detection initiative of the Center for Global Health, Centers for Disease Control and Prevention. Funds for field activities were provided through Cooperative Agreements with the Universidad del Valle de Guatemala (UVG) Centro de Estudios En Salud (1U01GH000028-01 and 1U01GH00100301). ZM was supported by the Fogarty International Center of the National Institutes of Health (NIH) under Award Number D43TW009343 and the University of California Global Health Institute (UCGHI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the CDC, UVG, NIH, or UCGHI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmonem A.A.., 2019, PRACTICAL MULTIVARIA, V6; Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135; Alpern JD, 2016, MED CLIN N AM, V100, P303, DOI 10.1016/j.mcna.2015.08.019; [Anonymous], 2019, LANCET DIGITAL HLTH; [Anonymous], 2016, CHINA, V3, P30; [Anonymous], 2016, MICROB BIOTECHNOL, V9, P527; [Anonymous], CHIK INF HEALTHC PRO; [Anonymous], 2013, CRIT CARE, V17, pR76; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Barnard D.R., 2006, INSECT REPELLENTS PR; Benoit SR, 2014, J EPIDEMIOL GLOB HEA, V4, P51, DOI 10.1016/j.jegh.2013.10.001; Biran A, 2007, T ROY SOC TROP MED H, V101, P1065, DOI 10.1016/j.trstmh.2007.07.010; BOCKARIE MJ, 1994, ACTA TROP, V57, P337, DOI 10.1016/0001-706X(94)90080-9; Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586; Centers for Disease Control and Prevention, KEY MESS ZIK VIR DIS; Centers for Disease Control and Prevention, 2018, MAL AN MOSQ 2018; Centers for Disease Control and Prevention, 2018, MAL BIOL 2018; Centers for Disease Control and Prevention, 2012, DENG AED AE MOSQ 201; Che-Mendoza A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006283; Climate-Data, 2019, CLIM SANT ROS 2019; Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023; Consortium for Spatial Information (CGIAR-CSI), 2018, SRTM30 EL DAT 2018; Cortes J, 2012, TROP MED INT HEALTH, V17, P254, DOI 10.1111/j.1365-3156.2011.02911.x; DAVIS EE, 1994, J AM MOSQUITO CONTR, V10, P316; Diaz-Menendez M, 2017, ZIKA VIRUS INFECT RI; Dube FF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-375; Engle PL, 1997, HUM ORGAN, V56, P408, DOI 10.17730/humo.56.4.d125333382k63v83; Estevez A, 2013, J MED VIROL, V85, P1293, DOI 10.1002/jmv.23578; Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002; Gama Z. P., 2013, Open Journal of Animal Sciences, V3, P11; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Global Alliance for Clean Cookstoves, 2013, GUAT COOKST FUELS MA; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Health Effects Institute, 2019, STAT GLOB AIR 2019; Hiscox A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062769; Instituto Nacional de Estadistica, 2019, GUAT EST POBL TOT PE; JAENSON TGT, 1994, T ROY SOC TROP MED H, V88, P620, DOI 10.1016/0035-9203(94)90197-X; Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011; Jarquin C, 2016, AM J TROP MED HYG, V94, P912, DOI 10.4269/ajtmh.15-0555; Kelly FJ, 2003, OCCUP ENVIRON MED, V60, P612, DOI 10.1136/oem.60.8.612; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; LINDSAY SW, 1990, ANN TROP MED PARASIT, V84, P553, DOI 10.1080/00034983.1990.11812510; Lipsett M, 1997, ENVIRON HEALTH PERSP, V105, P216, DOI 10.2307/3433245; Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X; Lorono-Pino MA, 2018, J TROP MED-US, V2018, DOI 10.1155/2018/4054501; Mansournia MA, 2013, INT J EPIDEMIOL, V42, P860, DOI 10.1093/ije/dyt083; Mengist Hylemariam Mihiretie, 2018, BMC Res Notes, V11, P276, DOI 10.1186/s13104-018-3380-z; Ministerio de Salud Publica Instituto Nacional de Estadistica, 2017, 6 ENC NAC SAL MAT IN; Ministerio de Salud Publica y Asistencia Social, 2018, SIT EP ARB GUAT NO 3; Naeher LP, 2007, INHAL TOXICOL, V19, P67, DOI 10.1080/08958370600985875; Nagao Y, 2003, TROP MED INT HEALTH, V8, P650, DOI 10.1046/j.1365-3156.2003.01075.x; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530; Palsson K, 1999, ACTA TROP, V72, P39, DOI 10.1016/S0001-706X(98)00083-7; Pan American Health Organization, CHIK DAT MAPS STAT 2; Pan American Health Organization, 2018, ZIK SUSP CONF CAS RE; Paru R., 1995, Papua New Guinea Medical Journal, V38, P215; Pearce N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i969; Ramos-De La Medina A, 2011, GASTROENT HEPAT-BARC, V34, P243, DOI 10.1016/j.gastrohep.2011.01.012; Seyoum A, 2002, T ROY SOC TROP MED H, V96, P225, DOI 10.1016/S0035-9203(02)90084-2; Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8; Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646; Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066; Smith KR, 2010, J EXPO SCI ENV EPID, V20, P406, DOI 10.1038/jes.2009.30; SNOW RW, 1987, ANN TROP MED PARASIT, V81, P449, DOI 10.1080/00034983.1987.11812143; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Takken W., 1990, ENV MEASURES MALARIA; Thavara U, 2001, J VECTOR ECOL, V26, P172; Velasco-Salas ZI, 2014, AM J TROP MED HYG, V91, P1039, DOI 10.4269/ajtmh.14-0127; Ventura VH, 2014, ENERGY EFFICIENCY CE; Verani JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083600; Vernede Raoul, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P771; Vicenti- Gonzalez MF, 2017, PLOS NEGLECT TROP D, V11, P1; WEBER R, 1991, J CLIN MICROBIOL, V29, P1323, DOI 10.1128/JCM.29.7.1323-1327.1991; Weng HY, 2009, AM J EPIDEMIOL, V169, P1182, DOI 10.1093/aje/kwp035; WHO, DENG SEV DENG 2019; World Health Organisation, HOUS AIR POLL HLTH 2; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2019, HOUS AIR POLL HLTH I; World Health Organization (WHO), DENG SEV DENG 2018; WorldPop, 2015, GUAT 100M POP 2015 M; Yung CF, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1662-4	83	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234399	10.1371/journal.pone.0234399	http://dx.doi.org/10.1371/journal.pone.0234399			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4LX	32559225	Green Published, gold			2022-12-26	WOS:000543261600013
J	Maffei, V; Indovina, I; Mazzarella, E; Giusti, MA; Macaluso, E; Lacquaniti, F; Viviani, P				Maffei, Vincenzo; Indovina, Iole; Mazzarella, Elisabetta; Giusti, Maria Assunta; Macaluso, Emiliano; Lacquaniti, Francesco; Viviani, Paolo			Sensitivity of occipito-temporal cortex, premotor and Broca's areas to visible speech gestures in a familiar language	PLOS ONE			English	Article							HUMAN EXTRASTRIATE CORTEX; AUDIOVISUAL SPEECH; VISUAL SPEECH; AUDITORY-CORTEX; BIOLOGICAL MOTION; HEARING LIPS; HUMAN BRAIN; FMRI GROUP; PERCEPTION; FACE	When looking at a speaking person, the analysis of facial kinematics contributes to language discrimination and to the decoding of the time flow of visual speech. To disentangle these two factors, we investigated behavioural and fMRI responses to familiar and unfamiliar languages when observing speech gestures with natural or reversed kinematics. Twenty Italian volunteers viewed silent video-clips of speech shown as recorded (Forward, biological motion) or reversed in time (Backward, non-biological motion), in Italian (familiar language) or Arabic (non-familiar language). fMRI revealed that language (Italian/Arabic) and time-rendering (Forward/Backward) modulated distinct areas in the ventral occipito-temporal cortex, suggesting that visual speech analysis begins in this region, earlier than previously thought. Left premotor ventral (superior subdivision) and dorsal areas were preferentially activated with the familiar language independently of time-rendering, challenging the view that the role of these regions in speech processing is purely articulatory. The left premotor ventral region in the frontal operculum, thought to include part of the Broca's area, responded to the natural familiar language, consistent with the hypothesis of motor simulation of speech gestures.	[Maffei, Vincenzo; Indovina, Iole; Mazzarella, Elisabetta; Lacquaniti, Francesco; Viviani, Paolo] IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Maffei, Vincenzo; Giusti, Maria Assunta; Lacquaniti, Francesco; Viviani, Paolo] Univ Roma Tor Vergata, Ctr Space BioMed, Rome, Italy; [Maffei, Vincenzo; Giusti, Maria Assunta; Lacquaniti, Francesco; Viviani, Paolo] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Maffei, Vincenzo] Poste Italiane, DOT Technol, Data Lake & BI, Rome, Italy; [Indovina, Iole] St Camillus Int Univ Hlth & Med Sci, Dept Fac Med & Surg, Rome, Italy; [Macaluso, Emiliano] Lyon Neurosci Res Ctr, ImpAct Team, Lyon, France; [Macaluso, Emiliano] IRCCS Santa Lucia Fdn, Lab Neuroimaging, Rome, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); IRCCS Santa Lucia	Indovina, I (corresponding author), IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy.; Indovina, I (corresponding author), St Camillus Int Univ Hlth & Med Sci, Dept Fac Med & Surg, Rome, Italy.	i.indovina@hsantalucia.it		maffei, vincenzo/0000-0003-0957-6615	Italian Ministry of Health (Ricerca corrente, IRCCS Fondazione Santa Lucia) [PE-2013-02355372]; Italian Ministry of University and Research [2017CBF8NJ_005]; Italian Space Agency [I/006/06/0, 2019-11-U.0]	Italian Ministry of Health (Ricerca corrente, IRCCS Fondazione Santa Lucia); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Space Agency(Agenzia Spaziale Italiana (ASI))	This work was supported by the Italian Ministry of Health (Ricerca corrente, IRCCS Fondazione Santa Lucia and PE-2013-02355372), Italian Ministry of University and Research (PRIN grant 2017CBF8NJ_005), Italian Space Agency (I/006/06/0 grant and 2019-11-U.0).	Abercrombie D, 1971, ELEMENTS GEN PHONETI; Amunts K, 2012, TRENDS COGN SCI, V16, P418, DOI 10.1016/j.tics.2012.06.005; [Anonymous], 1996, ELAPHE, V4, P58, DOI DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Balestrucci P, 2017, EXP BRAIN RES, V235, P1999, DOI 10.1007/s00221-017-4942-3; Basile A, 2017, CURRENT TRENDS AND FUTURE DEVELOPMENTS ON (BIO-) MEMBRANES: SILICA MEMBRANES: PREPARATION, MODELLING, APPLICATION, AND COMMERCIALIZATION, P1; Berner LA, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00395; Bernstein L. E., 1986, J ACOUSTICAL SOC S1, V80, pS78; Bernstein LE, 2000, PERCEPT PSYCHOPHYS, V62, P233, DOI 10.3758/BF03205546; Bernstein LE, 2008, NEUROIMAGE, V39, P423, DOI 10.1016/j.neuroimage.2007.08.035; Bernstein LE, 2011, HUM BRAIN MAPP, V32, P1660, DOI 10.1002/hbm.21139; Bhat J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00173; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bobick AF, 1997, PHILOS T ROY SOC B, V352, P1257, DOI 10.1098/rstb.1997.0108; Borowiak K, 2018, NEUROIMAGE-CLIN, V20, P1078, DOI 10.1016/j.nicl.2018.09.019; Callan DE, 2003, NEUROREPORT, V14, P2213, DOI 10.1097/00001756-200312020-00016; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Calvert GA, 2003, READING SPEECH STILL, P57; Campbell CS, 1997, PERCEPTION, V26, P627, DOI 10.1068/p260627; Campbell R, 2001, COGNITIVE BRAIN RES, V12, P233, DOI 10.1016/S0926-6410(01)00054-4; Campbell R, 2008, PHILOS T R SOC B, V363, P1001, DOI 10.1098/rstb.2007.2155; Campbell R, 2011, BRIT J PSYCHOL, V102, P704, DOI 10.1111/j.2044-8295.2011.02021.x; Capek CM, 2008, NEUROPSYCHOLOGIA, V46, P1233, DOI 10.1016/j.neuropsychologia.2007.11.026; CARAMAZZA A, 1976, BRAIN LANG, V3, P572, DOI 10.1016/0093-934X(76)90048-1; Cerri G, 2015, HUM BRAIN MAPP, V36, P1010, DOI 10.1002/hbm.22682; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cross ES, 2012, HUM BRAIN MAPP, V33, P2238, DOI 10.1002/hbm.21361; Dale A, 1997, HUM BRAIN MAPP; Daselaar SM, 2003, BRAIN, V126, P43, DOI 10.1093/brain/awg005; Dias JW, 2016, ATTEN PERCEPT PSYCHO, V78, P317, DOI 10.3758/s13414-015-0982-6; Downing PE, 2011, COGN NEUROSCI-UK, V2, P186, DOI 10.1080/17588928.2011.582945; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Egner T, 2010, J NEUROSCI, V30, P16601, DOI 10.1523/JNEUROSCI.2770-10.2010; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; ERBER NP, 1975, J SPEECH HEAR DISORD, V40, P481, DOI 10.1044/jshd.4004.481; Fedorenko E, 2016, ANN NY ACAD SCI, V1369, P132, DOI 10.1111/nyas.13046; Fedorenko E, 2012, CURR BIOL, V22, P2059, DOI 10.1016/j.cub.2012.09.011; Fedorenko E, 2012, BRAIN LANG, V120, P187, DOI 10.1016/j.bandl.2011.01.001; Flinker A, 2015, P NATL ACAD SCI USA, V112, P2871, DOI 10.1073/pnas.1414491112; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Fridriksson J, 2008, NEUROIMAGE, V41, P605, DOI 10.1016/j.neuroimage.2008.02.046; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Friston KJ, 1997, HUM BRAIN MAPP, P1; Fuertinger S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002209; Furl N, 2010, CEREB CORTEX, V20, P694, DOI 10.1093/cercor/bhp140; Galantucci B, 2006, PSYCHON B REV, V13, P742, DOI 10.3758/BF03193990; Gardner T, 2015, J NEUROSCI, V35, P1561, DOI 10.1523/JNEUROSCI.2942-14.2015; Ghazali S, 2004, P INT 2004, P1613; Gonzalez-Franco M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04201-x; GRACCO VL, 1988, J NEUROSCI, V8, P4628; GREEN KP, 1987, PERCEPT PSYCHOPHYS, V42, P587, DOI 10.3758/BF03207990; Grill-Spector K, 2014, NAT REV NEUROSCI, V15, P536, DOI 10.1038/nrn3747; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Hagoort P, 2014, CURR OPIN NEUROBIOL, V28, P136, DOI 10.1016/j.conb.2014.07.013; Hasson U, 2007, NEURON, V56, P1116, DOI 10.1016/j.neuron.2007.09.037; Hauswald A, 2018, CURR BIOL, V28, P1453, DOI 10.1016/j.cub.2018.03.044; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Henson R., 2006, STAT PARAMETRIC MAPP, P193; Hickok G, 2011, J COGNITIVE NEUROSCI, V23, P2629, DOI 10.1162/jocn_a_00044; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jastorff J, 2009, J NEUROSCI, V29, P7315, DOI 10.1523/JNEUROSCI.4870-08.2009; Jeffers J., 1971, SPEECHREADING LIPREA; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Koster-Hale J, 2013, NEURON, V79, P836, DOI 10.1016/j.neuron.2013.08.020; Lemon R, 2015, BRAIN, V138, P2109, DOI DOI 10.1093/BRAIN/AWV131; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Lindquist MA, 2008, STAT SCI, V23, P439, DOI 10.1214/09-STS282; Lingnau A, 2015, TRENDS COGN SCI, V19, P268, DOI 10.1016/j.tics.2015.03.006; Macmillan NA, 2005, DETECTION THEORY USE; Maffei V, 2015, CEREB CORTEX, V25, P2022, DOI 10.1093/cercor/bhu008; Maffei V, 2015, NEUROIMAGE, V104, P221, DOI 10.1016/j.neuroimage.2014.10.006; Mahon BZ, 2011, TRENDS COGN SCI, V15, P97, DOI 10.1016/j.tics.2011.01.004; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Mikl M, 2008, MAGN RESON IMAGING, V26, P490, DOI 10.1016/j.mri.2007.08.006; Murphy K, 2004, NEUROIMAGE, V21, P219, DOI 10.1016/j.neuroimage.2003.09.016; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Negri GAL, 2007, COGN NEUROPSYCHOL, V24, P795, DOI 10.1080/02643290701707412; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; OSTRY DJ, 1989, ARCH ORAL BIOL, V34, P685, DOI 10.1016/0003-9969(89)90074-5; Paulesu E, 2003, J NEUROPHYSIOL, V90, P2005, DOI 10.1152/jn.00926.2002; Pekkola J, 2005, NEUROREPORT, V16, P125, DOI 10.1097/00001756-200502080-00010; Penny W.D., 2004, HUMAN BRAIN FUNCTION, P843; Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; Pike K., 1945, INTONATION AM ENGLIS, DOI DOI 10.HTTPS://D0I.0RG/10.1111/J.1360-6441; Pinsk MA, 2009, J NEUROPHYSIOL, V101, P2581, DOI 10.1152/jn.91198.2008; Ponton CW, 2009, BRAIN TOPOGR, V21, P207, DOI 10.1007/s10548-009-0094-5; Pritchett BL, 2018, J NEUROPHYSIOL, V120, P2555, DOI 10.1152/jn.00222.2018; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Ramus F, 1999, COGNITION, V73, P265, DOI 10.1016/S0010-0277(99)00058-X; Ramus F, 1999, J ACOUST SOC AM, V105, P512, DOI 10.1121/1.424522; Ramus F., 2002, ANN REV LANGUAGE ACQ, V2, P85, DOI [10.1075/arla.2.05ram, DOI 10.1075/ARLA.2.05RAM]; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Reinl M, 2014, NEUROIMAGE, V102, P407, DOI 10.1016/j.neuroimage.2014.08.011; Reisberg D., 1987, HEARING EYE PSYCHOL, P97; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1998, LANGUAGE OUR GRASP, V2236, P1667, DOI [10.1016/S0166-2236(98)01260-0, DOI 10.1016/S0166-2236(98)01260-0]; Rogalsky C, 2011, J COGNITIVE NEUROSCI, V23, P1664, DOI 10.1162/jocn.2010.21530; Ronquest RE, 2010, ATTEN PERCEPT PSYCHO, V72, P1601, DOI 10.3758/APP.72.6.1601; Rosenblum LD, 1996, J EXP PSYCHOL HUMAN, V22, P318, DOI 10.1037/0096-1523.22.2.318; Ruytjens L, 2006, EUR J NEUROSCI, V24, P1835, DOI 10.1111/j.1460-9568.2006.05072.x; Santi A, 2003, J COGNITIVE NEUROSCI, V15, P800, DOI 10.1162/089892903322370726; Schippers MB, 2010, P NATL ACAD SCI USA, V107, P9388, DOI 10.1073/pnas.1001791107; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shapiro KA, 2001, J COGNITIVE NEUROSCI, V13, P713, DOI 10.1162/08989290152541386; Skipper JI, 2007, CEREB CORTEX, V17, P2387, DOI 10.1093/cercor/bhl147; Skipper JI, 2005, NEUROIMAGE, V25, P76, DOI 10.1016/j.neuroimage.2004.11.006; Soto-Faraco S, 2007, PERCEPT PSYCHOPHYS, V69, P218, DOI 10.3758/BF03193744; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Sunaert S, 1999, EXP BRAIN RES, V127, P355, DOI 10.1007/s002210050804; Tajima K, 1999, P 14 ICPHS SAN FRANC, P3; Turner TH, 2009, NEUROREPORT, V20, P492, DOI 10.1097/WNR.0b013e32832940a0; VANSON N, 1994, J ACOUST SOC AM, V96, P1341, DOI 10.1121/1.411324; Venezia JH, 2016, NEUROIMAGE, V126, P196, DOI 10.1016/j.neuroimage.2015.11.038; Venezia JH, 2009, LANG LINGUIST COMPAS, V3, P1403, DOI 10.1111/j.1749-818x.2009.00169.x; Venezia JH, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00157; Viviani P, 2002, ATTENTION PERFORM, V19, P406; Viviani P, 2011, EXP BRAIN RES, V215, P141, DOI 10.1007/s00221-011-2883-9; Viviani P, 2011, EXP BRAIN RES, V214, P93, DOI 10.1007/s00221-011-2809-6; Watkins KE, 2003, NEUROPSYCHOLOGIA, V41, P989, DOI 10.1016/S0028-3932(02)00316-0; Weikum WM, 2007, SCIENCE, V316, P1159, DOI 10.1126/science.1137686; Weiner KS, 2013, PSYCHOL RES-PSYCH FO, V77, P74, DOI 10.1007/s00426-011-0392-x; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Wu T, 2011, HUM BRAIN MAPP, V32, P1443, DOI 10.1002/hbm.21118; Wurm MF, 2015, J NEUROSCI, V35, P7727, DOI 10.1523/JNEUROSCI.0188-15.2015; Xiang HD, 2010, CEREB CORTEX, V20, P549, DOI 10.1093/cercor/bhp119; Zhu LL, 2017, J NEUROSCI, V37, P2697, DOI 10.1523/JNEUROSCI.2914-16.2017; 2014, FRONT PSYCHOL, V5, P1	137	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2020	15	6							e0234695	10.1371/journal.pone.0234695	http://dx.doi.org/10.1371/journal.pone.0234695			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC4LX	32559213	gold, Green Published			2022-12-26	WOS:000543261600053
J	Fang, CP; Liu, TH; Chung, RH; Tsou, HH; Kuo, HW; Wang, SC; Liu, CC; Liu, SC; Chen, ACH; Liu, YL				Fang, Chiu-Ping; Liu, Tung-Hsia; Chung, Ren-Hua; Tsou, Hsiao-Hui; Kuo, Hsiang-Wei; Wang, Sheng-Chang; Liu, Chia-Chen; Liu, Shu Chih; Chen, Andrew C. H.; Liu, Yu-Li			Genetic variants in NECTIN4 encoding an adhesion molecule are associated with continued opioid use	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; METHADONE; PVRL4; ADAM17/TACE; EXPRESSION; HISTAMINE; MUTATION; RECEPTOR	Methadone is a synthetic opioid used as maintenance treatment for patients addicted to heroin. Skin irritation is one of the adverse events caused by opioid use. 344 methadone maintenance treatment (MMT) patients were recruited with records and measurements on methadone dose, plasma methadone concentrations, and treatment emergent symptom scales (TESS). 15 patients reported with skin irritation. Five SNPs located within theNECTIN4genetic region were genotyped. TheNECTIN4gene within the adherens junction interaction pathway was associated with methadone dose in pathway-based genome wide association analyses (P= 0.0008). Three highly-linked SNPs, rs11265549, rs3820097, and rs4656978, were significantly associated with methadone dose (P= 0.0003), plasma concentrations ofR,S-methadone (P= 0.0004) and TNF-alpha (P= 0.010) in all 344 MMT patients, and with self-report skin irritation symptom scores (P= 0.010) in the 15 MMT patients who reported with skin irritation. To identify the possible roles of plasma level of Nectin-4 in the responses to MMT and opioid use, additional age- and gender-matched 51 controls and 83 methadone-free abstinent former heroin users were recruited. Plasma level of Nectin-4 was the highest in MMT patients among the three groups. The results suggest involvement of genetic variants onNECTIN4in methadone dose. Plasma Nectin-4 level is likely an indicator for continued use of opioids.	[Fang, Chiu-Ping; Liu, Tung-Hsia; Kuo, Hsiang-Wei; Wang, Sheng-Chang; Liu, Chia-Chen; Liu, Shu Chih; Liu, Yu-Li] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Miaoli County, Taiwan; [Chung, Ren-Hua; Tsou, Hsiao-Hui] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Miaoli County, Taiwan; [Tsou, Hsiao-Hui] China Med Univ, Grad Inst Biostat, Taichung, Taiwan; [Chen, Andrew C. H.] Northwell Hlth, Dept Psychiat, Zucker Hillside Hosp, Glen Oaks, NY USA; [Chen, Andrew C. H.] Hofstra Univ, Feinstein Inst Med Res, Hofstra Northwell Sch Med, Manhasset, NY USA; [Liu, Yu-Li] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; Northwell Health; Hofstra University; Northwell Health; China Medical University Taiwan	Liu, YL (corresponding author), Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Miaoli County, Taiwan.; Liu, YL (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.	ylliou@nhri.org.tw		Liu, Yu-Li/0000-0001-7519-2965	National Research Program for Genomic Medicine [NSC 100-3112-B-400-015]; National Science Council [NSC 100-2314-B-400-002-MY3]; Ministry of Science and Technology [MOST 106-2320-B-400-012]; National Health Research Institutes, Taiwan [NP-107-PP-06, NP-108-PP-06, NP-109-PP-07, NP-107-SP-04, NP-108-SP-04, NP-109-SP-04]	National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants from the National Research Program for Genomic Medicine (NSC 100-3112-B-400-015); National Science Council (NSC 100-2314-B-400-002-MY3); Ministry of Science and Technology (MOST 106-2320-B-400-012) and the National Health Research Institutes, Taiwan (NP-107-PP-06, NP-108-PP-06, NP-109-PP-07, NP-107-SP-04, NP-108-SP-04, and NP-109-SP-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2013, MOL THER, V21, pe1; Baldo BA, 2012, ANAESTH INTENS CARE, V40, P216, DOI 10.1177/0310057X1204000204; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bigliardi PL, 2014, FRONT NEUROSCI, P305; Bigliardi-Qi M, 2004, DERMATOLOGY, V209, P183, DOI 10.1159/000079887; Brancati F, 2010, AM J HUM GENET, V87, P265, DOI 10.1016/j.ajhg.2010.07.003; Buchanan PC, 2017, J BIOL CHEM, V292, P6339, DOI 10.1074/jbc.M116.746859; Chan YY, 2015, PSYCHIAT RES, V226, P230, DOI 10.1016/j.psychres.2014.12.053; Dennis BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086114; Doehring A, 2009, PHARMACOGENET GENOM, V19, P407, DOI 10.1097/FPC.0b013e328320a3fd; Gutierrez-Lopez MD, 2011, CELL MOL LIFE SCI, V68, P3275, DOI 10.1007/s00018-011-0639-0; Dursteler-MacFarland KM, 2010, J SUBST ABUSE TREAT, V38, P328, DOI 10.1016/j.jsat.2010.01.008; Florian R, 2018, INT J DERMATOL, V57, P223, DOI 10.1111/ijd.13862; Fonseca F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019527; Guinea-Viniegra J, 2009, GENE DEV, V23, P2663, DOI 10.1101/gad.543109; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Irie K, 2004, SEMIN CELL DEV BIOL, V15, P643, DOI 10.1016/j.semcdb.2004.09.002; Jelani M, 2011, J HUM GENET, V56, P352, DOI 10.1038/jhg.2011.18; Levran O, 2013, PHARMACOGENOMICS, V14, P755, DOI [10.2217/PGS.13.58, 10.2217/pgs.13.58]; Li MX, 2012, AM J HUM GENET, V91, P478, DOI 10.1016/j.ajhg.2012.08.004; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; Miyoshi J, 2007, AM J NEPHROL, V27, P590, DOI 10.1159/000108103; Nagel M, 2018, NAT GENET, V50, P920, DOI 10.1038/s41588-018-0151-7; Rzymski T, 2012, ONCOGENE, V31, P3621, DOI 10.1038/onc.2011.522; Smith AH, 2017, MOL PSYCHIATR, V22, P346, DOI 10.1038/mp.2016.257; Smith DJ, 2016, MOL PSYCHIATR, V21, P749, DOI 10.1038/mp.2016.49; Stotts AL, 2009, EXPERT OPIN PHARMACO, V10, P1727, DOI 10.1517/14656560903037168; Theunis J, 2008, ACTA DERM-VENEREOL, V88, P455, DOI 10.2340/00015555-0482; Tsai HJ, 2014, PHARMACOGENOMICS, V15, P977, DOI 10.2217/pgs.14.19; Wang SC, 2018, INT J NEUROPSYCHOPH, V21, P910, DOI 10.1093/ijnp/pyy066; Wang SC, 2013, OMICS, V17, P519, DOI 10.1089/omi.2012.0068; Wang SC, 2010, BIOMED CHROMATOGR, V24, P782, DOI 10.1002/bmc.1363; Yang HC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005910	35	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234549	10.1371/journal.pone.0234549	http://dx.doi.org/10.1371/journal.pone.0234549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555608	Green Published, gold			2022-12-26	WOS:000543273200079
J	Foster, E; Malloy, MJ; Jokubaitis, VG; Wrede, CDH; Butzkueven, H; Sasadeusz, J; Van Doornum, S; Macrae, F; Unglik, G; Brotherton, JML; van der Walt, A				Foster, Emma; Malloy, Michael J.; Jokubaitis, Vilija G.; Wrede, C. David H.; Butzkueven, Helmut; Sasadeusz, Joe; Van Doornum, Sharon; Macrae, Finlay; Unglik, Gary; Brotherton, Julia M. L.; van der Walt, Anneke			Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; WOMEN; RESPONSES; NEOPLASIA; CANCER	Background Autoimmune conditions (AICs) and/or their treatment may alter risk of human papilloma virus (HPV) infection and females with AICs are therefore at an increased risk of cervical dysplasia. However, inclusion of these at-risk populations in cervical cancer screening and HPV-vaccination guidelines, are mostly lacking. This study aimed to determine the prevalence of cervical dysplasia in a wide range of AICs and compare that to HIV and immunocompetent controls to support the optimisation of cervical cancer preventive health measures. Methods Data linkage was used to match cervical screening episodes to emergency department records of females with AICs or HIV to immunocompetent controls over a 14-year period. The primary outcome was histologically confirmed high-grade cervical disease. Results, measured as rates by cytology and histology classification per 1,000 females screened, were analysed per disease group, and intergroup comparisons were performed. Results Females with inflammatory bowel disease (2,683), psoriatic and enteropathic arthropathies (1,848), multiple sclerosis (MS) (1,426), rheumatoid arthritis (1,246), systemic lupus erythematosus and/or mixed connective tissue disease (SLE/MCTD) (702), HIV (44), and 985,383 immunocompetent controls were included. SLE/MCTD and HIV groups had greater rates of high-grade histological and cytological abnormalities compared to controls. Increased rates of low-grade cytological abnormalities were detected in all females with AICs, with the exception of the MS group. Conclusions Females with SLE/MCTD or HIV have increased rates of high-grade cervical abnormalities. The increased low-grade dysplasia rate seen in most females with AICs is consistent with increased HPV infection. These findings support expansion of cervical cancer preventative programs to include these at-risk females.	[Foster, Emma; Jokubaitis, Vilija G.; Butzkueven, Helmut; van der Walt, Anneke] Alfred Hlth, Dept Neurol MS & Neuroimmunol Serv, Melbourne, Vic, Australia; [Foster, Emma; Jokubaitis, Vilija G.; Butzkueven, Helmut; van der Walt, Anneke] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Foster, Emma; van der Walt, Anneke] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia; [Malloy, Michael J.; Brotherton, Julia M. L.] VCS Fdn, VCS Populat Hlth, Victorian Cerv Screening Registry, Melbourne, Vic, Australia; [Malloy, Michael J.; Brotherton, Julia M. L.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Wrede, C. David H.] Royal Women S Hosp, Dept Oncol & Dysplasia, Melbourne, Vic, Australia; [Wrede, C. David H.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Sasadeusz, Joe] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia; [Van Doornum, Sharon] Royal Melbourne Hosp, Rheumatol Dept, Melbourne, Vic, Australia; [Van Doornum, Sharon] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Macrae, Finlay] Royal Melbourne Hosp, Colorectal Med & Genet, Melbourne, Vic, Australia; [Unglik, Gary] Royal Melbourne Hosp, Dept Clin Immunol & Allergy, Melbourne, Vic, Australia	Monash University; Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; Royal Melbourne Hospital	van der Walt, A (corresponding author), Alfred Hlth, Dept Neurol MS & Neuroimmunol Serv, Melbourne, Vic, Australia.; van der Walt, A (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia.; van der Walt, A (corresponding author), Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia.; Brotherton, JML (corresponding author), VCS Fdn, VCS Populat Hlth, Victorian Cerv Screening Registry, Melbourne, Vic, Australia.; Brotherton, JML (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.	jbrother@vcs.org.au; anneke.vanderwalt@monash.edu			Victorian Department of Health and Human Services	Victorian Department of Health and Human Services	The data linkage for this study was funded by the Victorian Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW NCSP, 2017, CANC SERIES, V105; Allegretti JR, 2015, INFLAMM BOWEL DIS, V21, P1089, DOI 10.1097/MIB.0000000000000338; [Anonymous], 2011, 1269 0 STANDARD AUST; [Anonymous], 2011, 1270055006 AUSTR BUR; [Anonymous], 2017, VICT CERV CYT REG ST; [Anonymous], 2018, HOSP ADM EM DEP VIS; Australian Bureau of Statistics, 2016, SOC IND AR SEIFA CAT; Australian Bureau of Statistics, 2006, 32350 AUSTR BUR STAT; Bossingham D, 2003, LUPUS, V12, P327, DOI 10.1191/0961203303lu381xx; Brotherton JML, 2016, MED J AUSTRALIA, V204, P184, DOI 10.5694/mja15.01038; Cancer Council Australia, 2014, CERV CANC PREV POL C; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Dugue PA, 2015, INT J CANCER, V136, pE711, DOI 10.1002/ijc.29209; Garland SM, 2017, PAPILLOMAVIRUS RES, V4, P35, DOI 10.1016/j.pvr.2017.06.002; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hall MT, 2019, LANCET PUBLIC HEALTH, V4, pE19, DOI 10.1016/S2468-2667(18)30183-X; Hemmer B, 2015, LANCET NEUROL, V14, P406, DOI 10.1016/S1474-4422(14)70305-9; Kelly HA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174117; Liu HL, 2011, RHEUMATOLOGY, V50, P343, DOI 10.1093/rheumatology/keq304; Mackie FE, 2015, LUPUS, V24, P66, DOI 10.1177/0961203314552118; Marrie RA, 2015, MULT SCLER J, V21, P294, DOI 10.1177/1352458514564489; Pencina MJ, 2007, STAT MED, V26, P1343, DOI 10.1002/sim.2699; Reusser NM, 2015, J CLIN MED, V4, P260, DOI 10.3390/jcm4020260; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Schmidt RE, 2018, NAT REV RHEUMATOL, V14, P7, DOI 10.1038/nrrheum.2017.198; Stanley M, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0268; Stanley MA, 2012, CLIN MICROBIOL REV, V25, P215, DOI 10.1128/CMR.05028-11; Velentzis LS, CLIMACTERIC, V2019, P1; Wadstrom H, 2016, ANN RHEUM DIS, V75, P1272, DOI 10.1136/annrheumdis-2015-208263; Wheeler CM, 2008, OBSTET GYN CLIN N AM, V35, P519, DOI 10.1016/j.ogc.2008.09.006; World Hlth Org, 2017, VACCINE, V35, P5753, DOI 10.1016/j.vaccine.2017.05.069	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234813	10.1371/journal.pone.0234813	http://dx.doi.org/10.1371/journal.pone.0234813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555638	Green Published, gold			2022-12-26	WOS:000543273200057
J	Qiao, CC; Qian, HY; Wang, J; Zhao, TT; Ma, PY; Wang, SC; Zhang, T; Liu, XS				Qiao, Chuchu; Qian, Hongyan; Wang, Jue; Zhao, Tingting; Ma, Pengyu; Wang, Sicen; Zhang, Tao; Liu, Xinshe			PD173074 blocks G1/S transition via CUL3-mediated ubiquitin protease in HepG2 and Hep3B cells	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR RECEPTOR-4; CONTROLS S-PHASE; TARGETS CYCLIN-E; HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; CANCER; EXPRESSION; BINDING; PROLIFERATION	Fibroblast growth factor receptors (FGFRs) are frequently altered in a variety of human cancer cells and are overexpressed in hepatocellular carcinoma (HCC). Several literatures have proven that they are efficacious for HCC therapy, however, the underlying mechanism remains unclear. Here, we found FGFR4 was overexpressed in HCC cell lines HepG2 and Hep3B and we used PD173074, an FGFR4 inhibitor, to explore the role of FGFR4 and its underlying mechanism in these cell lines. The results showed that PD173074 significantly arrested HepG2 and Hep3B cells in G1 phase and inhibited cell proliferation. Furthermore, Western blot analysis revealed that PD173074 decreased the levels of P-FRS2 alpha, P-ERK, CDK2, cyclin E and NF-kappa B (p65) in the nucleus while it increased the levels of ubiquitin and CUL3, an E3 ubiquitin ligase which involves in cyclin E degradation. Meanwhile, the data from RT-qPCR showed that PD173074 also decreased miR-141 level. In conclusion, these results suggest that FGFR4 is involved in HCC by ERK/CUL3/cyclin E signaling pathway, and the finding may provide a potential theoretical basis for treatment by targeting FGFR4 in HCC.	[Qiao, Chuchu; Wang, Jue; Zhao, Tingting; Ma, Pengyu; Wang, Sicen; Zhang, Tao] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Xian, Shaanxi, Peoples R China; [Qian, Hongyan; Liu, Xinshe] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Forens Sci & Med, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Zhang, T (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Xian, Shaanxi, Peoples R China.; Liu, XS (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Forens Sci & Med, Xian, Shaanxi, Peoples R China.	lxins@xjtu.edu.cn; taozhang@xjtu.edu.cn	Wang, Jue/GVU-0480-2022		National Natural Science Foundation of China [81471818, 81430048, 81202495, 81230079]; Natural Science Foundation of Shaanxi Province [2017JM8098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province)	This work was supported by the National Natural Science Foundation of China (No. 81471818, 81430048, 81202495, 81230079) and the Natural Science Foundation of Shaanxi Province (No. 2017JM8098). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen ZX, 2013, INT J MED SCI, V10, P1868, DOI 10.7150/ijms.6868; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; DESAI D, 1995, MOL CELL BIOL, V15, P345, DOI 10.1128/MCB.15.1.345; Ezzat S, 2005, CLIN CANCER RES, V11, P1336; Helsten T, 2016, CLIN CANCER RES, V22, P259, DOI 10.1158/1078-0432.CCR-14-3212; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Ho HK, 2009, J HEPATOL, V50, P118, DOI 10.1016/j.jhep.2008.08.015; Icard P, 2019, TRENDS BIOCHEM SCI, V44, P490, DOI 10.1016/j.tibs.2018.12.007; Ito Y, 1999, HEPATOLOGY, V30, P90, DOI 10.1002/hep.510300114; Jeon YJ, 2015, P NATL ACAD SCI USA, V112, pE3355, DOI 10.1073/pnas.1504630112; Keenan SM, 2001, J BIOL CHEM, V276, P22404, DOI 10.1074/jbc.M100409200; Kim J, 2019, FEBS J, V286, P4443, DOI 10.1111/febs.14946; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Koziczak M, 2004, J BIOL CHEM, V279, P50004, DOI 10.1074/jbc.M404252200; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Liu Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.64; Masaki T, 2003, HEPATOLOGY, V37, P534, DOI 10.1053/jhep.2003.50112; McEvoy JD, 2007, MOL CELL BIOL, V27, P3651, DOI 10.1128/MCB.00720-06; Mo J, 2020, CANCER RES TREAT, V52, P74, DOI 10.4143/crt.2019.062; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nguyen PT, 2013, BRIT J CANCER, V109, P2248, DOI 10.1038/bjc.2013.550; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; POON RYC, 1995, SCIENCE, V270, P90, DOI 10.1126/science.270.5233.90; Porta R, 2017, CRIT REV ONCOL HEMAT, V113, P256, DOI 10.1016/j.critrevonc.2017.02.018; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Scheffner M, 1998, UBIQUITIN CONJUGATIO; Shi XP, 2020, FOOD CHEM TOXICOL, V136, DOI 10.1016/j.fct.2019.110960; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Suguitan Jr AL, 2011, PLOS ONE, V6; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang WB, 2013, CELL PHYSIOL BIOCHEM, V32, P1655, DOI 10.1159/000356601; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; VAINIKKA S, 1994, J BIOL CHEM, V269, P18320; van Jaarsveld MTM, 2013, ONCOGENE, V32, P4284, DOI 10.1038/onc.2012.433; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wu AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017868	38	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0234708	10.1371/journal.pone.0234708	http://dx.doi.org/10.1371/journal.pone.0234708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555680	Green Published, gold			2022-12-26	WOS:000543273200001
J	Panahi, B; Hejazi, MA				Panahi, Bahman; Hejazi, Mohammad Amin			Integrative analysis of gene expression and alternative splicing in microalgae grown under heterotrophic condition	PLOS ONE			English	Article							DESATURASE GENE; EVENTS; TOOL	Heterotrophic cultures are the most effective approach to overcome low growth rate challenge in the most commercial microalgae. However, the mechanism through which heterotrophic condition regulates algae metabolism are not completely clear. Alternative Splicing (AS) is a common posttranscriptional process by which transcriptome and proteome plasticity increases at different environmental conditions. To identify and characterize of AS events inAuxenochlorella protothecoidesmicroalga grown in autotrophic and heterotrophic, RNA-Seq data were analysed. We found that AS increased with the transition from autotrophic to heterotrophic condition. 705 and 660 differentially expressed (DEG) and spliced (DAS) genes were identified forA.protothecoideswas transferred from autotrophic to heterotrophic condition, respectively. Moreover, there was slight coverage between DEG and DAS genes. Furthermore, functional analysis showed that the DAS genes are most frequently related to ion binding and stimulus response. The results also indicated that prevalence of Intron retention is associated with down-regulation of the genes involved in carotenoid biosynthesis. This study provides valuable insights into transcriptional and posttranscriptional plasticity of microalgae during growth mode change.	[Panahi, Bahman] Agr Res Educ & Extens Org AREEO, Dept Genom, Branch Northwest & West Reg, Agr Biotechnol Res Inst Iran ABRII, Tabriz, Iran; [Hejazi, Mohammad Amin] Agr Res Educ & Extens Org AREEO, Dept Food Biotechnol, Branch Northwest & West Reg, Agr Biotechnol Res Inst Iran ABRII, Tabriz, Iran		Panahi, B (corresponding author), Agr Res Educ & Extens Org AREEO, Dept Genom, Branch Northwest & West Reg, Agr Biotechnol Res Inst Iran ABRII, Tabriz, Iran.	panahibahman@ymail.com	Panahi, Bahman/HHN-6671-2022	Panahi, Bahman/0000-0001-8523-994X				Akubude V. C., 2019, Materials Science for Energy Technologies, V2, P216, DOI 10.1016/j.mset.2018.12.006; Alvarez D, 2016, PLANT PHYSIOL, V172, P2314, DOI 10.1104/pp.16.01262; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2019, PROG RETIN EYE RES; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Foissac S, 2007, NUCLEIC ACIDS RES, V35, pW297, DOI 10.1093/nar/gkm311; GLADUE RM, 1994, J APPL PHYCOL, V6, P131, DOI 10.1007/BF02186067; Harun R, 2010, RENEW SUST ENERG REV, V14, P1037, DOI 10.1016/j.rser.2009.11.004; Huang BR, 2015, CROP SCI, V55, P1405, DOI 10.2135/cropsci2014.07.0508; Huang JC, 2008, J PHYCOL, V44, P684, DOI 10.1111/j.1529-8817.2008.00511.x; James AB, 2012, PLANT CELL, V24, P961, DOI 10.1105/tpc.111.093948; Kianianmomeni A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1117; Klamczynska B, 2017, SUSTAINABLE PROTEIN SOURCES, P327, DOI 10.1016/B978-0-12-802778-3.00020-2; Li RJ, 2017, PLANT SCI, V262, P39, DOI 10.1016/j.plantsci.2017.05.014; Ling Y, 2017, PLANT J, V89, P291, DOI 10.1111/tpj.13383; Liu J, 2016, CHIN J OCEANOL LIMN, V34, P405, DOI 10.1007/s00343-015-4321-5; Lodato P, 2003, APPL ENVIRON MICROB, V69, P4676, DOI 10.1128/AEM.69.8.4676-4682.2003; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Panahi B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0225677; Panahi B, 2015, FEBS LETT, V589, P3564, DOI 10.1016/j.febslet.2015.09.023; Panahi B, 2014, PHYSIOL MOL BIOL PLA, V20, P323, DOI 10.1007/s12298-014-0245-3; Pimentel H, 2016, NUCLEIC ACIDS RES, V44, P838, DOI 10.1093/nar/gkv1168; Santelia D, 2005, FEBS LETT, V579, P5399, DOI 10.1016/j.febslet.2005.08.061; Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115; Shang XD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020432; Xiao YB, 2018, MAR DRUGS, V16, DOI 10.3390/md16080283; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yun S, 2015, IEEE ANTENN WIREL PR, V14, P36, DOI 10.1109/LAWP.2014.2354517	31	3	3	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234710	10.1371/journal.pone.0234710	http://dx.doi.org/10.1371/journal.pone.0234710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555718	gold, Green Published			2022-12-26	WOS:000542759600006
J	Ransom, CJ; Jolley, VD; Blair, TA; Sutton, LE; Hopkins, BG				Ransom, Curtis J.; Jolley, Von D.; Blair, Trenton A.; Sutton, Lloyd E.; Hopkins, Bryan G.			Nitrogen release rates from slow- and controlled-release fertilizers influenced by placement and temperature	PLOS ONE			English	Article							POLYMER-COATED UREA; NUTRIENT RELEASE; SOIL; EFFICIENCY; PATTERNS; MOISTURE; SYSTEM; YIELD; MODEL	Controlled-release and slow-release fertilizers can effectively supply nitrogen (N) while mitigating N loss. To determine the suitability of these fertilizers for plants in semi-arid environments, these fertilizers need to be evaluated under varying placement and temperature conditions. Several urea fertilizers were evaluated, including: uncoated, sulfur-coated (SCU), polymer-coated-sulfur-coated (PCSCU), and polymer-coated (PCU) with projected release timings between 45 and 180 d. Nitrogen release was measured under daily fluctuating or static temperatures applied either to the surface or buried in the soil. A second experiment consisted of two PCU sources and added a hanging bag placement comparison and low and high soil moisture treatments. For the first Experiment, the N in uncoated urea released shortly after application. The SCU and PCSCU treatments released > 80% of the N before the first sampling date. With fluctuating temperatures, the PCU 45, 75, 120, and 180 incorporated into the soil released N within +9, +9, -22, and -68 d of their expected timing. However, they released their N within 35 d when surface applied. Conversely, with static temperatures, PCU products released slowly, releasing under 80% for the entire study. The second experiment verified these results and showed no difference between low and high moisture and minimal release with fertilizer not in contact with soil. Each coated fertilizer in these studies exhibited slow/control release properties, but the PCU (surface applied) and SCU/PCSCU (surface applied or incorporated in soil) release was much more rapid than expected. Our research suggests that, although the SCU and PCSCU showed minimal slow-release properties (regardless of placement), the PCU fertilizers incorporated in the soil do have a controlled release approximate to what is expected, but have a much more rapid release when surface applied.	[Ransom, Curtis J.; Jolley, Von D.; Blair, Trenton A.; Sutton, Lloyd E.; Hopkins, Bryan G.] Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA; [Ransom, Curtis J.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA	Brigham Young University; University of Missouri System; University of Missouri Columbia	Ransom, CJ (corresponding author), Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA.; Ransom, CJ (corresponding author), Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA.	curtisransom@gmail.com	Hopkins, Bryan G./F-3670-2011	Hopkins, Bryan G./0000-0001-7313-055X; Ransom, Curtis/0000-0002-1268-7247	Brigham Young University	Brigham Young University	Funding for this project came from Brigham Young University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C, 2013, J PLANT NUTR SOIL SC, V176, P76, DOI 10.1002/jpln.201200156; budras Corinna, 2008, FRANKFURTER ALLGEMEI, V7, pC5; Buss J, 2016, POLYM COATED UREA KE; Cameron KC, 2013, ANN APPL BIOL, V162, P145, DOI 10.1111/aab.12014; Campbell G.S., 1998, INTRO ENV BIOPHYSICS, Vsecond, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; Carroll DA, 2017, IRRIGATION SCI, V35, P549, DOI 10.1007/s00271-017-0558-4; Carson LC, 2012, HORTTECHNOLOGY, V22, P20, DOI 10.21273/HORTTECH.22.1.20; CHRISTIANSON CB, 1988, FERT RES, V16, P273, DOI 10.1007/BF01051376; Du CW, 2006, J POLYM ENVIRON, V14, P223, DOI 10.1007/s10924-006-0025-4; Ellison E., 2013, P 2013 W NUTRIENT MA, P17; Fernandez FG, 2015, J ENVIRON QUAL, V44, P415, DOI 10.2134/jeq2013.12.0496; Fujinuma R, 2009, SOIL SCI SOC AM J, V73, P2043, DOI 10.2136/sssaj2009.0085; Geary B, 2015, J PLANT NUTR, V38, P41, DOI 10.1080/01904167.2014.912323; Golden B, 2011, COMMUN SOIL SCI PLAN, V42, P1809, DOI 10.1080/00103624.2011.587568; Halvorson AD, 2014, AGRON J, V106, P681, DOI 10.2134/agronj2013.0001; Halvorson AD, 2014, AGRON J, V106, P715, DOI 10.2134/agronj2013.0081; HASHIMOTO I, 1979, SOIL SCI SOC AM J, V43, P1165, DOI 10.2136/sssaj1979.03615995004300060021x; Hopkins BG, 2020, ACHIEVING SUSTAINABL; Hopkins BG, 2007, AM J POTATO RES, V84, P19, DOI 10.1007/BF02986295; Huett DO, 2000, COMMUN SOIL SCI PLAN, V31, P959, DOI 10.1080/00103620009370490; Husby CE, 2003, HORTSCIENCE, V38, P387, DOI 10.21273/HORTSCI.38.3.387; JARRELL WM, 1979, SOIL SCI SOC AM J, V43, P1044, DOI 10.2136/sssaj1979.03615995004300050046x; Kissel DE, 1988, MANAGEMENT UREA FERT; KOCHBA M, 1990, SOIL SCI, V149, P339, DOI 10.1097/00010694-199006000-00004; LeMonte JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204090; LeMonte JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146761; Lenth RV., 2021, EMMEANS ESTIMATED MA; Liu YH, 2008, POWDER TECHNOL, V183, P88, DOI 10.1016/j.powtec.2007.11.022; LUNT O. R., 1962, SOIL SCI SOC AMER PROC, V26, P584; Milesi C, 2005, ENVIRON MANAGE, V36, P426, DOI 10.1007/s00267-004-0316-2; Mulvaney RL, 2009, J ENVIRON QUAL, V38, P2295, DOI 10.2134/jeq2008.0527; Nash PR, 2012, AGRON J, V104, P1074, DOI 10.2134/agronj2011.0235; Nelson KA, 2014, J AGRON CROP SCI, V200, P54, DOI 10.1111/jac.12040; Olson BM, 2009, J ENVIRON QUAL, V38, P2218, DOI 10.2134/jeq2008.0519; Ransom CJ, 2014, NITROGEN USE EFFICIE; Shen YZ, 2015, APPL ENG AGRIC, V31, P247; SHOJI S, 1991, SOIL SCI SOC AM J, V55, P1468, DOI 10.2136/sssaj1991.03615995005500050045x; Stevens WB, 2007, AGRON J, V99, P1252, DOI 10.2134/agronj2006.0357; Tong X, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010119; Trenkel M.E., 2010, SLOW CONTROLLED RELE; Trenkel ME, 1997, CONTROLLED RELEASE S; Wilson ML, 2009, HORTSCIENCE, V44, P492, DOI 10.21273/HORTSCI.44.2.492; Zhang YS, 2011, J ENVIRON MANAGE, V92, P480, DOI 10.1016/j.jenvman.2010.09.018; Zvomuya F, 2003, J ENVIRON QUAL, V32, P480, DOI 10.2134/jeq2003.0480	44	21	21	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234544	10.1371/journal.pone.0234544	http://dx.doi.org/10.1371/journal.pone.0234544			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555670	gold, Green Published			2022-12-26	WOS:000542759600051
J	Soltesz, B; Piko, P; Sandor, J; Kosa, Z; Adany, R; Fiatal, S				Soltesz, Beata; Piko, Peter; Sandor, Janos; Kosa, Zsigmond; Adany, Roza; Fiatal, Szilvia			The genetic risk for hypertension is lower among the Hungarian Roma population compared to the general population	PLOS ONE			English	Article							METABOLIC SYNDROME; BLOOD-PRESSURE; MINORITY POPULATION; MOLECULAR-GENETICS; ASSOCIATION; PREVALENCE; HEALTH; POLYMORPHISMS; PREDICTION; DISEASE	Estimating the prevalence of cardiovascular diseases (CVDs) and risk factors among the Roma population, the largest minority in Europe, and investigating the role of genetic or environmental/behavioral risk factors in CVD development are important issues in countries where they are significant minority. This study was designed to estimate the genetic susceptibility of the Hungarian Roma (HR) population to essential hypertension (EH) and compare it to that of the general (HG) population. Twenty EH associated SNPs (inAGT,FMO3,MTHFR-NPPB,NPPA,NPPA-AS1,AGTR1,ADD1,NPR3-C5orf23,NOS3,CACNB2,PLCE1,ATP2B1,GNB3,CYP1A1-ULK3,UMODandGNAS-EDN3) were genotyped using DNA samples obtained from HR (N = 1176) and HG population (N = 1178) subjects assembled by cross-sectional studies. Allele frequencies and genetic risk scores (unweighted and weighted genetic risk scores (GRS and wGRS, respectively) were calculated for the study groups and compared to examine the joint effects of the SNPs. The susceptibility alleles were more frequent in the HG population, and both GRS and wGRS were found to be higher in the HG population than in the HR population (GRS: 18.98 +/- 3.05 vs. 18.25 +/- 2.97, p<0.001; wGRS: 1.4 [IQR: 0.93-1.89] vs. 1.52 [IQR: 0.99-2.00], p<0.01). Twenty-seven percent of subjects in the HR population were in the bottom fifth (GRS <= 16) of the risk allele count compared with 21% of those in the HG population. Thirteen percent of people in the HR group were in the top fifth (GRS >= 22) of the GRS compared with 21% of those in the HG population (p<0.001), i.e., the distribution of GRS was found to be left-shifted in the HR population compared to the HG population. The Roma population seems to be genetically less susceptible to EH than the general one. These results support preventive efforts to lower the risk of developing hypertension by encouraging a healthy lifestyle.	[Soltesz, Beata] Univ Debrecen, Fac Publ Hlth, Doctoral Sch Hlth Sci, Dept Prevent Med, Debrecen, Hungary; [Piko, Peter; Adany, Roza] Univ Debrecen, Hungarian Acad Sci, MTA DE Publ Hlth Res Grp, Fac Publ Hlth, Debrecen, Hungary; [Sandor, Janos; Adany, Roza; Fiatal, Szilvia] Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, Debrecen, Hungary; [Sandor, Janos; Adany, Roza; Fiatal, Szilvia] Univ Debrecen, Fac Publ Hlth, WHO Collaborating Ctr Vulnerabil & Hlth, Dept Prevent Med, Debrecen, Hungary; [Kosa, Zsigmond] Univ Debrecen, Fac Hlth, Dept Hlth Visitor Methodol & Publ Hlth, Nyiregyhaza, Hungary	University of Debrecen; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Hungarian Academy of Sciences; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Fiatal, S (corresponding author), Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, Debrecen, Hungary.; Fiatal, S (corresponding author), Univ Debrecen, Fac Publ Hlth, WHO Collaborating Ctr Vulnerabil & Hlth, Dept Prevent Med, Debrecen, Hungary.	fiatal.szilvia@sph.unideb.hu	Dr Fiatal, Szilvia/GQH-2653-2022; Piko, Peter/AAG-5784-2021	Piko, Peter/0000-0001-5539-907X; Fiatal, Szilvia/0000-0002-2797-9621	TAMOP 'Social Renewal Operational Programme - IGEN-HUNGARIAN' [4.2.2.A-11/1/KONV-2012-0031]; European Union; European Regional Development Fund;  [GINOP-2.3.2-15-2016-00005]	TAMOP 'Social Renewal Operational Programme - IGEN-HUNGARIAN'; European Union(European Commission); European Regional Development Fund(European Commission); 	This research was supported by the TAMOP 4.2.2.A-11/1/KONV-2012-0031 'Social Renewal Operational Programme - IGEN-HUNGARIAN' and the GINOP-2.3.2-15-2016-00005 project. The projects were co-financed by the European Union and the European Regional Development Fund.	Adany Roza, 2013, Eur J Public Health, V23, P529, DOI 10.1093/eurpub/ckt095; Babinska I, 2013, INT J PUBLIC HEALTH, V58, P417, DOI 10.1007/s00038-013-0463-4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benjafield AV, 1998, HYPERTENSION, V32, P1094, DOI 10.1161/01.HYP.32.6.1094; Bushueva O, 2014, INT J HYPERTENS, V2014, DOI 10.1155/2014/712169; Carrasco-Garrido P, 2011, EUR J PUBLIC HEALTH, V21, P793, DOI 10.1093/eurpub/ckq153; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Che Ronglin, 2013, Frontiers in Genetics, V4, P138, DOI 10.3389/fgene.2013.00138; Cui JSS, 2003, HYPERTENSION, V41, P207, DOI 10.1161/01.HYP.0000044938.94050.E3; Cusi D, 1997, LANCET, V349, P1353, DOI 10.1016/S0140-6736(97)01029-5; de Courten BV, 2003, DIABETES RES CLIN PR, V62, P95, DOI 10.1016/S0168-8227(03)00162-1; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Enache G., 2016, Romanian Journal of Diabetes Nutrition and Metabolic Diseases, V23, P27; European Commission, 2011, EU FRAM NAT ROM INT; Fiatal S, 2019, THROMB RES, V179, P37, DOI 10.1016/j.thromres.2019.04.031; Fiatal S, 2018, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00358; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Gualdi-Russo E, 2009, J TRAVEL MED, V16, P88, DOI 10.1111/j.1708-8305.2008.00280.x; Helis E, 2011, EUR J CARDIOV PREV R, V18, P347, DOI 10.1177/1741826710389361; Humphries SE, 2008, CURR OPIN LIPIDOL, V19, P128, DOI 10.1097/MOL.0b013e3282f5283e; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Johnson AD, 2010, BIOINFORMATICS, V26, P1386, DOI 10.1093/bioinformatics/btq098; Johnson T., 2012, EFFICIENT CALCULATIO; Kosa Z, 2015, EUR J PUBLIC HEALTH, V25, P299, DOI 10.1093/eurpub/cku157; Krajcovicova-Kudlackova M, 2004, Bratisl Lek Listy, V105, P256; Kunz R, 1997, HYPERTENSION, V30, P1331, DOI 10.1161/01.HYP.30.6.1331; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; MIALL WE, 1963, BRIT MED J, P75; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Penzes J., 2018, TER LETI STATISZTIKA, V58, P3, DOI [10.15196/TS580101, DOI 10.15196/TS580101]; Per Di Qua, 2011, RIV ITAL NUTR PARENT, V29, pS2; Pereira TV, 2008, HYPERTENSION, V51, P778, DOI 10.1161/HYPERTENSIONAHA.107.100370; Piko P, 2019, GENE, V686, P187, DOI 10.1016/j.gene.2018.11.067; Piko P, 2017, ATHEROSCLEROSIS, V263, P119, DOI 10.1016/j.atherosclerosis.2017.05.028; Salvi E, 2012, HYPERTENSION, V59, P248, DOI 10.1161/HYPERTENSIONAHA.111.181990; Sebastiani Paola, 2012, Frontiers in Genetics, V3, P26, DOI 10.3389/fgene.2012.00026; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singh M, 2016, CLIN EXP HYPERTENS, V38, P268, DOI 10.3109/10641963.2015.1116543; Snieder H, 2000, HYPERTENSION, V35, P574, DOI 10.1161/01.HYP.35.2.574; Szeles G, 2005, EUR J PUBLIC HEALTH, V15, P26, DOI 10.1093/eurpub/cki107; Szigethy E, 2012, PUBLIC HEALTH, V126, P143, DOI 10.1016/j.puhe.2011.11.003; Talmud PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4838; Tanira M, 2005, J HUM HYPERTENS, V19, P7, DOI 10.1038/sj.jhh.1001780; Templeton GF, 2011, COMMUN ASSOC INF SYS, V28, P41; Timberlake DS, 2001, CURR OPIN NEPHROL HY, V10, P71, DOI 10.1097/00041552-200101000-00012; Wang WYS, 1997, CLIN GENET, V51, P31; Welter Danielle, 2014, Nucleic Acids Res, V42, pD1001, DOI 10.1093/nar/gkt1229; World Health Organization, 2013, GLOB ACT PLAN PREV C; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zeljko H, 2008, COLLEGIUM ANTROPOL, V32, P667; Zeljko HM, 2013, ECON HUM BIOL, V11, P326, DOI 10.1016/j.ehb.2012.02.007; Zheng J, 2015, APPL INFORM, V2, P10, DOI [10.1186/s40535-015-0013-7, DOI 10.1186/S40535-015-0013-7]	58	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234547	10.1371/journal.pone.0234547	http://dx.doi.org/10.1371/journal.pone.0234547			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MB7DG	32555714	Green Published, gold			2022-12-26	WOS:000542759600049
J	Yassumoto, TI; Nakatsukasa, M; Nagano, AJ; Yasugi, M; Yoshimura, T; Shinomiya, A				Yassumoto, Tamiris, I; Nakatsukasa, Mana; Nagano, Atsushi J.; Yasugi, Masaki; Yoshimura, Takashi; Shinomiya, Ai			Genetic analysis of body weight in wild populations of medaka fish from different latitudes	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ORYZIAS-LATIPES; GEOGRAPHIC-VARIATION; BERGMANNS RULE; OBESITY; ARCHITECTURE; DIVERSITY; PROTEIN; TOOL; QTL	The genetic bases of growth and body weight are of economic and scientific interest, and teleost fish models have proven useful in such investigations. TheOryzias latipesspecies complex (medaka) is an abundant freshwater fish in Japan and suitable for genetic studies. We compared two wild medaka stocks originating from different latitudes. The Maizuru population from higher latitudes weighed more than the Ginoza population. We investigated the genetic basis of body weight, using quantitative trait locus (QTL) analysis of the F(2)offspring of these populations. We detected one statistically significant QTL for body weight on medaka chromosome 4 and identified 12 candidate genes that might be associated with body weight or growth. Nine of these 12 genes had at least one single nucleotide polymorphism that caused amino acid substitutions in protein-coding regions, and we estimated the effects of these substitutions. The present findings might contribute to the marker-assisted selection of economically important aquaculture species.	[Yassumoto, Tamiris, I; Nakatsukasa, Mana; Yoshimura, Takashi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Integrat Physiol, Nagoya, Aichi, Japan; [Nakatsukasa, Mana; Yoshimura, Takashi; Shinomiya, Ai] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Seasonal Biol, Okazaki, Aichi, Japan; [Nagano, Atsushi J.] Ryukoku Univ, Fac Agr, Otsu, Shiga, Japan; [Yasugi, Masaki] Natl Inst Nat Sci, Natl Inst Basic Biol, Lab Neurophysiol, Okazaki, Aichi, Japan; [Yoshimura, Takashi] Nagoya Univ, Inst Transformat BioMol WPI ITbM, Nagoya, Aichi, Japan; [Yasugi, Masaki] Utsunomiya Univ, Fac Engn, Utsunomiya, Tochigi, Japan; [Shinomiya, Ai] Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst, Okazaki, Aichi, Japan	Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Ryukoku University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Nagoya University; Utsunomiya University; National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS)	Yoshimura, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Integrat Physiol, Nagoya, Aichi, Japan.; Yoshimura, T; Shinomiya, A (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Div Seasonal Biol, Okazaki, Aichi, Japan.; Yoshimura, T (corresponding author), Nagoya Univ, Inst Transformat BioMol WPI ITbM, Nagoya, Aichi, Japan.; Shinomiya, A (corresponding author), Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst, Okazaki, Aichi, Japan.	takashiy@agr.nagoya-u.ac.jp; aishinom@nibb.ac.jp	Nagano, Atsushi J./A-2957-2019; Yoshimura, Takashi/C-8306-2012	Nagano, Atsushi J./0000-0001-7891-5049; Yoshimura, Takashi/0000-0001-7018-9652; SHINOMIYA, Ai/0000-0003-3784-0532; Yasugi, Masaki/0000-0001-7876-405X	JSPS KAKENHI [15K07163, 19K06785, 26000013, 19H05643]; Human Frontier Science Program [RGP0030/2015]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Human Frontier Science Program(Human Frontier Science Program)	This work was supported by a JSPS KAKENHI Grant-in-Aid for Scientific Research (C) (15K07163, 19K06785) to AS, Grants-in-Aid for Specially Promoted Research (26000013), and for Scientific Research (S) (19H05643) to TY, and the Human Frontier Science Program (RGP0030/2015) to TY. There was no additional external funding received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Asai T, 2011, ICHTHYOL EXPLOR FRES, V22, P289; Ashton KG, 2000, AM NAT, V156, P390, DOI 10.1086/303400; Ashton KG, 2003, EVOLUTION, V57, P1151, DOI 10.1111/j.0014-3820.2003.tb00324.x; Ashton KG, 2002, GLOBAL ECOL BIOGEOGR, V11, P505, DOI 10.1046/j.1466-822X.2002.00313.x; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Chahal J, 2008, ENDOCRINOLOGY, V149, P4829, DOI 10.1210/en.2007-1693; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Dhana K, 2018, AM J EPIDEMIOL, V187, P1662, DOI 10.1093/aje/kwy025; Falk RE, 2007, AM J MED GENET C, V145C, P357, DOI 10.1002/ajmg.c.30153; Fall T, 2014, MOL CELL ENDOCRINOL, V382, P740, DOI 10.1016/j.mce.2012.08.018; Feng X, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4613-1; Ghasemi M, 2019, ANIMAL, V13, P1797, DOI 10.1017/S1751731118003610; Glass K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04191; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Gutierrez AP, 2012, AQUACULTURE, V358, P61, DOI 10.1016/j.aquaculture.2012.06.017; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hosoya S, 2013, EVOLUTION, V67, P590, DOI 10.1111/j.1558-5646.2012.01781.x; Ishikawa Y, 1999, BRAIN BEHAV EVOLUT, V53, P2, DOI 10.1159/000006577; Kagawa N, 2014, ZOOL SCI, V31, P116, DOI 10.2108/zsj.31.116; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Katsumura T, 2019, G3-GENES GENOM GENET, V9, P217, DOI 10.1534/g3.118.200779; Kawajiri M, 2015, G3-GENES GENOM GENET, V5, P2875, DOI 10.1534/g3.115.021956; Kawajiri M, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-015-0032-1; Kimura T, 2007, GENETICS, V177, P2379, DOI 10.1534/genetics.106.068460; Kimura T, 2012, G3-GENES GENOM GENET, V2, P1317, DOI 10.1534/g3.112.003236; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Loos RJF, 2018, CURR OPIN GENET DEV, V50, P86, DOI 10.1016/j.gde.2018.02.009; Matsuda M, 1997, ZOOL SCI, V14, P517, DOI 10.2108/zsj.14.517; Meiri S, 2003, J BIOGEOGR, V30, P331, DOI 10.1046/j.1365-2699.2003.00837.x; Naba A, 2018, KNOCKOUT GENE ENCODI, P440081, DOI DOI 10.1101/440081V1; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Sakaguchi S, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0944-0; SAKAIZUMI M, 1983, COPEIA, P311, DOI 10.2307/1444373; Seale LA, 2015, ANTIOXID REDOX SIGN, V23, P761, DOI 10.1089/ars.2015.6277; Shalata A, 2013, AM J HUM GENET, V93, P1061, DOI 10.1016/j.ajhg.2013.10.025; Shimada Y, 2014, INT J OBESITY, V38, P1053, DOI 10.1038/ijo.2013.217; Takehana Y, 2003, ZOOL SCI, V20, P1279, DOI 10.2108/zsj.20.1279; Tselykh TV, 2005, EXP CELL RES, V307, P354, DOI 10.1016/j.yexcr.2005.03.037; Tsuboko S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112527; Wang P, 2016, SCI REP, V6, P1, DOI DOI 10.1038/s41598-016-0001-8; Wenne R, 2018, AQUAT LIVING RESOUR, V31, DOI 10.1051/alr/2017043; Yue GH, 2014, FISH FISH, V15, P376, DOI 10.1111/faf.12020; Zhang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159504; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066569; Zhou X, 2012, CELL MOL LIFE SCI, V69, P819, DOI 10.1007/s00018-011-0794-3	51	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234803	10.1371/journal.pone.0234803	http://dx.doi.org/10.1371/journal.pone.0234803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544202	gold, Green Published			2022-12-26	WOS:000542957200013
J	Ci, SS; Xia, W; Liang, WC; Qin, LH; Zhang, YL; Dianov, GL; Wang, MN; Zhao, XQ; Wu, CY; Alagamuthu, KK; Hu, ZG; He, LF; Pan, FY; Guo, ZG				Ci, Shusheng; Xia, Wen; Liang, Weichu; Qin, Lihong; Zhang, Yilan; Dianov, Grigory L.; Wang, Meina; Zhao, Xingqi; Wu, Congye; Alagamuthu, Karthick Kumar; Hu, Zhigang; He, Lingfeng; Pan, Feiyan; Guo, Zhigang			Src-mediated phosphorylation of GAPDH regulates its nuclear localization and cellular response to DNA damage	FASEB JOURNAL			English	Article						base excision repair; chemotherapy; DNA damage; GAPDH; Pol beta; Src	HUMAN GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BASE EXCISION-REPAIR; BETA-GENE MUTATION; POLYMERASE-BETA; PROTEIN; CANCER; ACTIVATION; EXPRESSION; RESISTANCE; KINASE	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a key enzyme involved in energy metabolism. Recently, GAPDH has been suggested to have extraglycolytic functions in DNA repair, but the underlying mechanism for the GAPDH response to DNA damage remains unclear. Here, we demonstrate that the tyrosine kinase Src is activated under DNA damage stress and phosphorylates GAPDH at Tyr41. This phosphorylation of GAPDH is essential for its nuclear translocation and DNA repair function. Blocking the nuclear import of GAPDH by suppressing Src signaling or through a GAPDH Tyr41 mutation impairs its response to DNA damage. Nuclear GAPDH is recruited to DNA lesions and associates with DNA polymerase beta (Pol beta) to function in DNA repair. Nuclear GAPDH promotes Pol beta polymerase activity and increases base excision repair (BER) efficiency. Furthermore, GAPDH knockdown dramatically decreases BER efficiency and sensitizes cells to DNA damaging agents. Importantly, the knockdown of GAPDH in colon cancer SW480 cells and xenograft models effectively enhances their sensitivity to the chemotherapeutic drug 5-FU. In summary, our findings provide mechanistic insight into the new function of GAPDH in DNA repair and suggest a potential therapeutic target in chemotherapy.	[Ci, Shusheng; Xia, Wen; Liang, Weichu; Zhang, Yilan; Dianov, Grigory L.; Wang, Meina; Zhao, Xingqi; Alagamuthu, Karthick Kumar; Hu, Zhigang; He, Lingfeng; Pan, Feiyan; Guo, Zhigang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, 1 Wen Yuan Rd, Nanjing 210023, Peoples R China; [Qin, Lihong] 7 Peoples Hosp ChangZhou, Dept Oncol, Changzhou, Jiangsu, Peoples R China; [Dianov, Grigory L.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia; [Dianov, Grigory L.] Univ Oxford, Oxford Inst Radiat Oncol, Dept Oncol, Oxford, England; [Wu, Congye] Nanjing Med Univ, Nanjing First Hosp, Dept Oncol, Nanjing, Peoples R China	Nanjing Normal University; Novosibirsk State University; University of Oxford; Nanjing Medical University	Pan, FY; Guo, ZG (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, 1 Wen Yuan Rd, Nanjing 210023, Peoples R China.	panfeiyan@njnu.edu.cn; guozgang@gmail.com		He, Lingfeng/0000-0002-9668-419X	National Natural Science Foundation of China [81872284]; Changzhou Sci Tech Program [CE20175035]; Jiangsu Key Research and Development Program [BE2018714]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [18KJA180006]; Priority Academic Program Development of Jiangsu Higher Education Institution; Russian Science Foundation [19-74-20069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changzhou Sci Tech Program; Jiangsu Key Research and Development Program; Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institution; Russian Science Foundation(Russian Science Foundation (RSF))	National Natural Science Foundation of China, Grant/Award Number: 81872284; Changzhou Sci & Tech Program, Grant/Award Number: CE20175035; Jiangsu Key Research and Development Program, Grant/Award Number: BE2018714; Natural Science Foundation of the Jiangsu Higher Education Institutions of China, Grant/Award Number: 18KJA180006; Priority Academic Program Development of Jiangsu Higher Education Institution; Russian Science Foundation, Grant/Award Number: 19-74-20069	Abdel-Fatah TMA, 2014, MOL ONCOL, V8, P520, DOI 10.1016/j.molonc.2014.01.001; Azam S, 2008, J BIOL CHEM, V283, P30632, DOI 10.1074/jbc.M801401200; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Bergoglio V, 2002, CANCER RES, V62, P3511; Bohr VA, 2002, J INHERIT METAB DIS, V25, P215, DOI 10.1023/A:1015681929316; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; BRUNS GAP, 1976, SCIENCE, V192, P55, DOI 10.1126/science.176725; Chang CM, 2015, MOL CELL, V60, P930, DOI 10.1016/j.molcel.2015.10.037; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Dastoor Z, 2001, J CELL SCI, V114, P1643; DOBASHI Y, 1994, CANCER RES, V54, P2827; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; Elsberger B, 2010, CURR CANCER DRUG TAR, V10, P683, DOI 10.2174/156800910793605802; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hasan S, 2002, MOL CELL, V10, P1213, DOI 10.1016/S1097-2765(02)00745-1; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hou XW, 2017, FASEB J, V31, P3179, DOI 10.1096/fj.201601082R; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Kosova AA, 2015, MUTAT RES-FUND MOL M, V779, P46, DOI 10.1016/j.mrfmmm.2015.06.005; KUMAR A, 1990, BIOCHEMISTRY-US, V29, P7156, DOI 10.1021/bi00483a002; Kuo LJ, 2008, IN VIVO, V22, P305; Lai YH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12465; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Matsuzaki J, 1996, MOL CARCINOGEN, V15, P38, DOI 10.1002/(SICI)1098-2744(199601)15:1<38::AID-MC6>3.0.CO;2-O; Miyamoto H, 1999, INT J CANCER, V83, P708, DOI 10.1002/(SICI)1097-0215(19991126)83:5<708::AID-IJC24>3.0.CO;2-C; MURPHY SM, 1993, MOL CELL BIOL, V13, P5290, DOI 10.1128/MCB.13.9.5290; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; Nicholls C, 2012, CLIN EXP PHARMACOL P, V39, P674, DOI 10.1111/j.1440-1681.2011.05599.x; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pearl LH, 2015, NAT REV CANCER, V15, P166, DOI 10.1038/nrc3891; Ray S, 2018, NUCLEIC ACIDS RES, V46, P242, DOI 10.1093/nar/gkx1147; Revillion F, 2000, EUR J CANCER, V36, P1038, DOI 10.1016/S0959-8049(00)00051-4; Roskoski R, 2015, PHARMACOL RES, V94, P9, DOI 10.1016/j.phrs.2015.01.003; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Sobol RW, 2001, PROG NUCLEIC ACID RE, V68, P57; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Stabile LP, 2013, CLIN CANCER RES, V19, P380, DOI 10.1158/1078-0432.CCR-12-1555; Sukhanova M, 2010, MUTAT RES-FUND MOL M, V685, P80, DOI 10.1016/j.mrfmmm.2009.08.009; Tisdale EJ, 2004, J BIOL CHEM, V279, P54046, DOI 10.1074/jbc.M409472200; Tisdale EJ, 2007, TRAFFIC, V8, P733, DOI 10.1111/j.1600-0854.2007.00569.x; TOKUI T, 1991, J BIOL CHEM, V266, P10820; TOKUNAGA K, 1987, CANCER RES, V47, P5616; Wong HK, 2005, J CELL BIOCHEM, V95, P794, DOI 10.1002/jcb.20448; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	48	8	8	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10443	10461		10.1096/fj.201902904RR	http://dx.doi.org/10.1096/fj.201902904RR		JUN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32539222	Bronze			2022-12-26	WOS:000541637300001
J	Lee, J; Walker, ME; Gabriel, KP; Vasan, RS; Xanthakis, V				Lee, Joowon; Walker, Maura E.; Gabriel, Kelley P.; Vasan, Ramachandran S.; Xanthakis, Vanessa			Associations of accelerometer-measured physical activity and sedentary time with chronic kidney disease: The Framingham Heart Study	PLOS ONE			English	Article							OBESITY; INACTIVITY; RISK; CKD	Background Few studies examined the individual and conjoint associations of accelerometer-measured physical activity (PA) and sedentary times with the prevalence of chronic kidney disease (CKD) among older adults. Methods We evaluated 1,268 Framingham Offspring Study participants (mean age 69.2 years, 53.8% women) between 2011 and 2014. CKD was defined as an estimated glomerular filtration rate (eGFR) <60 ml/min/1.73(2)and/or urine albumin-to-creatinine ratio (UACR) >= 25/35 mu g/mg (men/women). We used multivariable logistic regression models to relate time spent being sedentary and active with the odds of CKD. We then performed compositional data analysis to estimate the change in the eGFR and UACR when a fixed proportion of time in one activity behavior (among the following: moderate to vigorous physical activity [MVPA], light intensity physical activity [LIPA], and sedentary) is reallocated to another activity behavior. Results Overall, 258 participants had prevalent CKD (20.4%; 120 women). Higher total PA ([MVPA+LIPA], adjusted-odds ratio [OR] per 30 minutes/day increase, 0.86; 95% CI, 0.78-0.96) and higher LIPA (OR per 30 minutes/day increase, 0.87; 95% CI, 0.76-0.99) were associated with lower odds of CKD. Additionally, higher sedentary time (OR per 30 minutes/day increase, 1.16; 95% CI, 1.04-1.29) was associated with higher odds of CKD. Reallocating 5% of the time from LIPA to sedentary was associated with the largest predicted difference in eGFR (-1.06 ml/min/1.73m(2)). Reallocating 1% of time spent in MVPA to sedentary status predicted the largest difference in UACR (14.37 mu g/mg). Conclusion The findings suggest that increasing LIPA and maintaining MVPA at the expense of sedentary time may be associated with a lower risk of CKD in community-based older adults.	[Lee, Joowon; Walker, Maura E.; Vasan, Ramachandran S.; Xanthakis, Vanessa] Boston Univ, Sch Med, Dept Med, Sect Prevent Med, Boston, MA 02118 USA; [Gabriel, Kelley P.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Vasan, Ramachandran S.; Xanthakis, Vanessa] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Xanthakis, Vanessa] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA	Boston University; University of Alabama System; University of Alabama Birmingham; Boston University; Framingham Heart Study; Boston University	Xanthakis, V (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Prevent Med, Boston, MA 02118 USA.; Xanthakis, V (corresponding author), Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA.; Xanthakis, V (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	vanessax@bu.edu		Lee, Joowon/0000-0001-8993-8959; Walker, Maura/0000-0001-9935-4113	NHLBI NIH HHS [T32 HL125232] Funding Source: Medline; NIDDK NIH HHS [P30 DK079626] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2012, DRUG DISCOV TODAY TE; Bello AK, 2017, KIDNEY INT SUPPL, V7, P122, DOI 10.1016/j.kisu.2017.07.007; Bharakhada N, 2012, AM J KIDNEY DIS, V60, P583, DOI 10.1053/j.ajkd.2012.04.024; Chastin SFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139984; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Crouter SE, 2008, BRIT J SPORT MED, V42, P217, DOI 10.1136/bjsm.2006.033399; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Fuller T, 2015, CHALLENGES CHRONIC K; Gabriel KP, 2018, AM J EPIDEMIOL, V187, P2145, DOI 10.1093/aje/kwy117; Go AS, 2018, CLIN J AM SOC NEPHRO, V13, P833, DOI 10.2215/CJN.12591117; Hallan S, 2006, AM J KIDNEY DIS, V47, P396, DOI 10.1053/j.ajkd.2005.11.027; Hawkins MS, 2011, MED SCI SPORT EXER, V43, P1457, DOI 10.1249/MSS.0b013e31820c0130; Heil DP, 2006, RES Q EXERCISE SPORT, V77, P64, DOI 10.5641/027013606X13080769703920; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Lee S, 2017, GERIATR GERONTOL INT, V17, P730, DOI 10.1111/ggi.12779; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 2007, J AM SOC NEPHROLOGY; Martens RJH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195306; Parsons TJ, 2017, AGE AGEING, V46, P1010, DOI 10.1093/ageing/afx091; Robinson-Cohen C, 2014, J AM SOC NEPHROL, V25, P399, DOI 10.1681/ASN.2013040392; Robinson-Cohen C, 2009, ARCH INTERN MED, V169, P2116, DOI 10.1001/archinternmed.2009.438; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Saran R, 2017, AM J KIDNEY DIS, V69, DOI 10.1053/j.ajkd.2016.12.004; Sowers JR, 2011, CARDIORENAL MED, V1, P5, DOI 10.1159/000322822; Stengel B, 2003, EPIDEMIOLOGY, V14, P479, DOI 10.1097/01.EDE.0000071413.55296.c4; Szczech LA, 2004, KIDNEY INT, V66, pS3, DOI 10.1111/j.1523-1755.2004.09002.x; Tejada T, 2008, KIDNEY INT, V73, P1385, DOI 10.1038/ki.2008.109; Thomas TR, 2010, J APPL PHYSIOL, V109, P3, DOI 10.1152/japplphysiol.01361.2009; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; van den Boogaart KG, 2008, COMPUT GEOSCI-UK, V34, P320, DOI 10.1016/j.cageo.2006.11.017; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; White SL, 2011, NUTR METAB CARDIOVAS, V21, P104, DOI 10.1016/j.numecd.2009.08.010; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21	34	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0234825	10.1371/journal.pone.0234825	http://dx.doi.org/10.1371/journal.pone.0234825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542048	gold, Green Published			2022-12-26	WOS:000542685100029
J	Nguyen, TN; Nguyen, HQ; Le, DH				Nguyen, Tran N.; Nguyen, Ha Q.; Le, Duc-Hau			Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CHEMICAL CARCINOGENS; OXIDATIVE STRESS; DOWN-REGULATION; GLUTATHIONE; SURVIVAL; DISEASE; CONTRIBUTES; PROGRESSION; CELLS	Tyrosine is mainly degraded in the liver by a series of enzymatic reactions. Abnormal expression of the tyrosine catabolic enzyme tyrosine aminotransferase (TAT) has been reported in patients with hepatocellular carcinoma (HCC). Despite this, aberration in tyrosine metabolism has not been investigated in cancer development. In this work, we conduct comprehensive cross-platform study to obtain foundation for discoveries of potential therapeutics and preventative biomarkers of HCC. We explore data from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), Gene Expression Profiling Interactive Analysis (GEPIA), Oncomine and Kaplan Meier plotter (KM plotter) and performed integrated analyses to evaluate the clinical significance and prognostic values of the tyrosine catabolic genes in HCC. We find that five tyrosine catabolic enzymes are downregulated in HCC compared to normal liver at mRNA and protein level. Moreover, low expression of these enzymes correlates with poorer survival in patients with HCC. Notably, we identify pathways and upstream regulators that might involve in tyrosine catabolic reprogramming and further drive HCC development. In total, our results underscore tyrosine metabolism alteration in HCC and lay foundation for incorporating these pathway components in therapeutics and preventative strategies.	[Nguyen, Tran N.; Le, Duc-Hau] Vingrp Big Data Inst, Dept Computat Biomed, Hanoi, Vietnam; [Nguyen, Ha Q.] Vingrp Big Data Inst, Dept Comp Vis, Hanoi, Vietnam		Nguyen, TN (corresponding author), Vingrp Big Data Inst, Dept Computat Biomed, Hanoi, Vietnam.	v.tranNN3@vinbdi.org			Vingroup Big Data Institute	Vingroup Big Data Institute	This work was supported by Vingroup Big Data Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Borrelli A, 2018, REDOX BIOL, V15, P467, DOI 10.1016/j.redox.2018.01.009; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Cantor KP, 2010, ENVIRON HEALTH PERSP, V118, P1545, DOI 10.1289/ehp.1002206; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9; Cheng J, 2017, COMB CHEM HIGH T SCR, V20, P133, DOI 10.2174/1386207319666161220115409; Cheng Z, 2019, CELL RES, V29, P124, DOI 10.1038/s41422-018-0111-x; De Matteis S, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7512159; DeWaal D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02733-4; Fitian AI, 2017, WORLD J HEPATOL, V9, P1, DOI 10.4254/wjh.v9.i1.1; Fu L, 2010, HEPATOLOGY, V51, P1624, DOI 10.1002/hep.23540; Gan L, 2018, BBA-REV CANCER, V1869, P97, DOI 10.1016/j.bbcan.2017.12.006; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; de Cedron MG, 2017, MOL ONCOL, V11, P1768, DOI 10.1002/1878-0261.12142; Gong L, 2012, MED ONCOL, V29, P909, DOI 10.1007/s12032-011-9841-z; Hay N, 2016, NAT REV CANCER, V16, P635, DOI 10.1038/nrc.2016.77; Herman S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40186-5; HIRAYAMA C, 1987, BIOCHEM MED METAB B, V38, P127, DOI 10.1016/0885-4505(87)90071-5; Iansante V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8882; Ipson BR, 2016, AGEING RES REV, V27, P93, DOI 10.1016/j.arr.2016.03.005; Jahn SC, 2016, BBA-GEN SUBJECTS, V1860, P1202, DOI 10.1016/j.bbagen.2016.01.024; James MO, 2017, PHARMACOL THERAPEUT, V170, P166, DOI 10.1016/j.pharmthera.2016.10.018; Kim SZ, 2000, J INHERIT METAB DIS, V23, P791, DOI 10.1023/A:1026756501669; Lai HS, 2005, SEMIN CANCER BIOL, V15, P267, DOI 10.1016/j.semcancer.2005.04.003; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; Lee NCW, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00138; LEE WH, 1994, P NATL ACAD SCI USA, V91, P11733, DOI 10.1073/pnas.91.24.11733; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; LI X, 2017, BIOMED RES INT, V2017, DOI DOI 10.1155/2017/5202684; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Liu FY, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0698-4; Liu YP, 2017, ONCOL REP, V37, P2593, DOI 10.3892/or.2017.5549; Loeb LA, 2008, CANCER RES, V68, P6863, DOI 10.1158/0008-5472.CAN-08-2852; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Na TY, 2009, HEPATOLOGY, V49, P1122, DOI 10.1002/hep.22740; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Niu DD, 2009, MOL ONCOL, V3, P67, DOI 10.1016/j.molonc.2008.10.002; Piao Z, 1999, BRIT J CANCER, V80, P850, DOI 10.1038/sj.bjc.6690431; R Core Team, 2019, R LANG ENV STAT COMP; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; RUSSO P, 1990, AM J HUM GENET, V47, P317; Santacatterina F, 2016, ONCOTARGET, V7, P490, DOI 10.18632/oncotarget.6357; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tanguay RM, 1996, ACTA BIOCHIM POL, V43, P209; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WATANABE A, 1984, CANCER, V54, P1875, DOI 10.1002/1097-0142(19841101)54:9<1875::AID-CNCR2820540918>3.0.CO;2-O; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wiggins T, 2015, CANCER EPIDEM BIOMAR, V24, P32, DOI 10.1158/1055-9965.EPI-14-0980; Zhang HT, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0337-8; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030181; Zhang J, 2018, AGING-US, V10, P1366, DOI 10.18632/aging.101473; Zhang YJ, 2005, CANCER LETT, V221, P135, DOI 10.1016/j.canlet.2004.08.028; Zhao J, 2018, ONCOL LETT, V16, P2693, DOI 10.3892/ol.2018.8892; Zhu CY, 2016, LIFE SCI, V166, P34, DOI 10.1016/j.lfs.2016.10.002; Zhu TY, 2015, BIOMED PHARMACOTHER, V75, P123, DOI 10.1016/j.biopha.2015.07.023	67	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2020	15	6							e0229276	10.1371/journal.pone.0229276	http://dx.doi.org/10.1371/journal.pone.0229276			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB6AZ	32542016	Green Published, Green Submitted, gold			2022-12-26	WOS:000542685100001
J	Feng, X; Guo, KL; Gao, HC				Feng, Xue; Guo, Kailun; Gao, Haichun			Plasticity of the peroxidase AhpC links multiple substrates to diverse disulfide-reducing pathways inShewanella oneidensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peroxiredoxin; thioredoxin; thiol; oxidative stress; redox regulation; hydroperoxide; alkyl hydroperoxide reductase; peroxiredoxin	ALKYL HYDROPEROXIDE REDUCTASE; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; SHEWANELLA-ONEIDENSIS; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; ALKYLHYDROPEROXIDE REDUCTASE; THIOREDOXIN REDUCTASE; PEROXIREDOXIN; CATALYSIS	AhpC is a bacterial representative of 2-Cys peroxiredoxins (Prxs) with broad substrate specificity and functional plasticity. However, details underpinning these two important attributes of AhpC remain unclear. Here, we studied the functions and mechanisms of regulation of AhpC in the facultative Gram-negative anaerobic bacteriumShewanella oneidensis, in which AhpC's physiological roles can be conveniently assessed through its suppression of a plating defect due to the genetic loss of a major catalase. We show that successful suppression can be achieved only when AhpC is produced in a dose- and time-dependent manner through a complex mechanism involving activation of the transcriptional regulator OxyR, transcription attenuation, and translation reduction. By analyzing AhpC truncation variants, we demonstrate that reactivity with organic peroxides (OPs) rather than H(2)O(2)is resilient to mutagenesis, implying that OP reduction is the core catalytic function of AhpC. Intact AhpC could be recycled only by its cognate reductase AhpF, and AhpC variants lacking the Prx domain or the extreme C-terminal five residues became promiscuous electron acceptors from the thioredoxin reductase TrxR and the GSH reductase Gor in addition to AhpF, implicating an additional dimension to functional plasticity of AhpC. Finally, we show that the activity ofS. oneidensisAhpC is less affected by mutations than that of itsEscherichia colicounterpart. These findings suggest that the physiological roles of bacterial AhpCs are adapted to different oxidative challenges, depending on the organism, and that its functional plasticity is even more extensive than previously reported.	[Feng, Xue; Guo, Kailun; Gao, Haichun] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Gao, HC (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou, Zhejiang, Peoples R China.	haichung@zju.edu.cn	Gao, Haichun/A-2160-2014; Gao, Haichun/AFU-4588-2022	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563	National Natural Science Foundation of China [31930003, 41976087]; Natural Science Foundation of Zhejiang Province [LZ17C010001]; Ten Thousand Talent Program of China; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Ten Thousand Talent Program of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by National Natural Science Foundation of China Grants 31930003 and 41976087, by Natural Science Foundation of Zhejiang Province Grant LZ17C010001, by the Ten Thousand Talent Program of China, and by the Fundamental Research Funds for the Central Universities.	Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Baker LMS, 2003, J BIOL CHEM, V278, P9203, DOI 10.1074/jbc.M209888200; Barr Ian, 2015, Bio Protoc, V5; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Bsat N, 1996, J BACTERIOL, V178, P6579, DOI 10.1128/jb.178.22.6579-6586.1996; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Dip PV, 2014, BBA-BIOENERGETICS, V1837, P1932, DOI 10.1016/j.bbabio.2014.08.007; Dip PV, 2014, ACTA CRYSTALLOGR D, V70, P2848, DOI 10.1107/S1399004714019233; Dong Yu-lin, 2012, PLoS One, V7, pe34435, DOI 10.1371/journal.pone.0034435; Dubbs James M., 2007, V44, P143; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P13349, DOI 10.1021/bi9713658; Faulkner MJ, 2008, P NATL ACAD SCI USA, V105, P6735, DOI 10.1073/pnas.0801986105; Feng X, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01700-19; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Fu HH, 2015, ARCH BIOCHEM BIOPHYS, V584, P28, DOI 10.1016/j.abb.2015.08.012; Fu HH, 2015, MOL MICROBIOL, V95, P410, DOI 10.1111/mmi.12865; Fu HH, 2014, ENVIRON MICROBIOL, V16, P3181, DOI 10.1111/1462-2920.12457; Fu HH, 2013, ENVIRON MICROBIOL, V15, P2198, DOI 10.1111/1462-2920.12091; Fukumori F, 2001, J GEN APPL MICROBIOL, V47, P269, DOI 10.2323/jgam.47.269; Guo KL, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01989-19; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Hugo M, 2014, J BIOL CHEM, V289, P5228, DOI 10.1074/jbc.M113.510248; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; JACOBSON FS, 1989, J BIOL CHEM, V264, P1488; Jaeger T, 2004, ARCH BIOCHEM BIOPHYS, V423, P182, DOI 10.1016/j.abb.2003.11.021; Jiang YM, 2014, J BACTERIOL, V196, P445, DOI 10.1128/JB.01077-13; Jin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075610; Kamariah N, 2017, J BIOL CHEM, V292, P6667, DOI 10.1074/jbc.M117.775858; Kamariah N, 2016, SCI REP-UK, V6, DOI 10.1038/srep37610; Kamariah N, 2016, J STRUCT BIOL, V193, P13, DOI 10.1016/j.jsb.2015.11.004; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; Lee HS, 2015, J MICROBIOL BIOTECHN, V25, P1380, DOI 10.4014/jmb.1503.03031; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Li N, 2014, ENVIRON MICROBIOL, V16, P1821, DOI 10.1111/1462-2920.12418; Liu Y, 2019, ACS SYNTH BIOL, V8, P264, DOI 10.1021/acssynbio.8b00485; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Meng Q, 2018, BBA-MOL CELL BIOL L, V1863, P1153, DOI 10.1016/j.bbalip.2018.06.020; Mitra A, 2011, NUCLEIC ACIDS RES, V39, pD129, DOI 10.1093/nar/gkq971; Nartey W, 2015, FEBS J, V282, P4620, DOI 10.1111/febs.13522; Nelson KJ, 2018, ANTIOXID REDOX SIGN, V28, P521, DOI 10.1089/ars.2016.6922; Parsonage D, 2008, P NATL ACAD SCI USA, V105, P8209, DOI 10.1073/pnas.0708308105; Parsonage D, 2015, BIOCHEMISTRY-US, V54, P1567, DOI 10.1021/bi501515w; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Poole LB, 1996, BIOCHEMISTRY-US, V35, P56, DOI 10.1021/bi951887s; POOLE LB, 1989, J BIOL CHEM, V264, P12330; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Reyes AM, 2011, FREE RADICAL BIO MED, V51, P464, DOI 10.1016/j.freeradbiomed.2011.04.023; Reynolds CM, 2000, BIOCHEMISTRY-US, V39, P8859, DOI 10.1021/bi000826d; Ritz D, 2001, SCIENCE, V294, P158, DOI 10.1126/science.1063143; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Shi MM, 2015, J BACTERIOL, V197, P2179, DOI 10.1128/JB.00154-15; STORZ G, 1989, J BACTERIOL, V171, P2049, DOI 10.1128/jb.171.4.2049-2055.1989; TARTAGLIA LA, 1990, J BIOL CHEM, V265, P10535; Wan F, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00439; Wan F, 2018, J BIOL CHEM, V293, P4085, DOI 10.1074/jbc.RA117.001530; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Wong CF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05354-5; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Yamamoto Y, 2008, MOL CELL, V29, P36, DOI 10.1016/j.molcel.2007.11.029; Yin JH, 2015, MICROBIOLOGYOPEN, V4, P84, DOI 10.1002/mbo3.224; Zhou GQ, 2013, ISME J, V7, P1752, DOI 10.1038/ismej.2013.62	63	4	4	3	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11118	11130		10.1074/jbc.RA120.014010	http://dx.doi.org/10.1074/jbc.RA120.014010			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32532818	Green Published, hybrid			2022-12-26	WOS:000562757100017
J	Sisay, BG; Haile, D; Hassen, HY; Gebreyesus, SH				Sisay, Binyam Girma; Haile, Demewoz; Hassen, Hamid Yimam; Gebreyesus, Seifu Hagos			Performance of mid-upper arm circumference as a screening tool for identifying adolescents with overweight and obesity	PLOS ONE			English	Article							HEIGHT RATIO; CHILDREN; MORBIDITY; GROWTH; BMI	Background Adolescent overweight and obesity is a global public health problem, associated with an increased risk of metabolic syndrome. Recently, mid-upper arm circumference (MUAC) has been suggested as a screening tool to identify overweight and obesity among school-age children and early adolescents (5-14 years). However, little is known about the potential use of MUAC in the late adolescence period (15-19 years). Therefore, the present study aimed to evaluate the performance of MUAC to identify overweight (including obesity) in the late adolescence period in Ethiopia. Methods We conducted a cross-sectional study among 851 adolescents aged 15 to 19 years. We collected anthropometric data including MUAC, weight and height with the help of trained field workers. The receiver operating characteristic (ROC) curve analysis was used to examine the validity of MUAC compared to BMI Z score in identifying adolescents with overweight or obesity. Furthermore, we calculated the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), proportion of correctly classified, positive, and negative likelihood ratio for the proposed optimal cut-offs. Results MUAC was strongly correlated with BMI Z score with a correlation coefficient (r) of 0.81 (95% CI; 0.79-0.84). The optimal MUAC cut-off for identifying adolescents with overweight or obesity was 27.7 cm for males and 27.9 cm for females. The area under the ROC curve (AUC) was 0.96 (95% CI; 0.93-0.98) for males and 0.96 (95% CI; 0.94-0.98) for females. The accuracy level of MUAC to identify adolescents with overweight (including obesity) was high for both sexes (overall a sensitivity of 91.1% and a specificity of 90.3%). Conclusions MUAC has relatively equivalent accuracy with BMI Z score to identify overweight and obesity in adolescents. Hence, MUAC could be used as an alternative tool for surveillance and screening of overweight in adolescents aged 15-19 years.	[Sisay, Binyam Girma; Haile, Demewoz; Gebreyesus, Seifu Hagos] Addis Ababa Univ, Sch Publ Hlth, Dept Nutr & Dietet, Addis Ababa, Ethiopia; [Hassen, Hamid Yimam] Univ Antwerp, Fac Med & Hlth Sci, Dept Primary & Interdisciplinary Care, Antwerp, Belgium	Addis Ababa University; University of Antwerp	Gebreyesus, SH (corresponding author), Addis Ababa Univ, Sch Publ Hlth, Dept Nutr & Dietet, Addis Ababa, Ethiopia.	seif_h23@yahoo.com	; Hassen, Hamid/A-1105-2019	Sisay, Binyam/0000-0002-9310-8170; Hassen, Hamid/0000-0001-6485-4193	Addis Ababa University	Addis Ababa University	BGS have received financial support from Addis Ababa University for data collection. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2010, ENDNOTES, V2, P144; [Anonymous], 2008, SUMM STAT REP 2007 P; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; CHAPUT J-P, 2017, PEDIAT OBES, V12, P439, DOI DOI 10.1111/IJP0.12162; Craig E, 2014, ARCH DIS CHILD, V99, P763, DOI 10.1136/archdischild-2013-305137; Almeida Carlos A.N. de, 2003, J. Pediatr. (Rio J.), V79, P455, DOI 10.1590/S0021-75572003000500014; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Souza MFC., 2016, J HUM GROWTH DEV, V26, P260, DOI [DOI 10.7322/jhgd.119302, 10.7322/jhgd.119302, DOI 10.7322/JHGD.119302]; Efron B., 1994, INTRO BOOTSTRAP; Fakier A, 2017, SAMJ S AFR MED J, V107, P606, DOI [10.7196/SAMJ.2017.v107i7.12255, 10.7196/samj.2017.vi7.12255]; Freedman DS, 2013, AM J CLIN NUTR, V98, P1417, DOI 10.3945/ajcn.113.065961; Inge TH, 2013, PEDIATRICS, ppeds 2013; Jaiswal M, 2017, J CLIN DIAGN RES, V11, pSC5, DOI 10.7860/JCDR/2017/27442.10422; JAMES WPT, 1994, EUR J CLIN NUTR, V48, P883; Kumar S, 2017, MAYO CLIN P; Levin A, 2010, PEDIATR INT, V52, P347, DOI 10.1111/j.1442-200X.2009.02972.x; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Lu Q, 2014, PEDIATR NEONATOL, V55, P14, DOI 10.1016/j.pedneo.2013.05.004; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Neovius M, 2004, Obes Rev, V5, P105, DOI 10.1111/j.1467-789X.2004.00136.x; O'Donohue WT., 2013, HDB ADOLESCENT HLTH; Rerksuppaphol S, 2017, CLIN MED RES, V15, P53, DOI 10.3121/cmr.2017.1365; Shegaze M, 2015, J FOOD NUTR SCI, V3, P166; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Talma H, 2019, ARCH DIS CHILD, V104, P159, DOI 10.1136/archdischild-2017-313528; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; Wohlfahrt-Veje C, 2014, EUR J CLIN NUTR, V68, P664, DOI 10.1038/ejcn.2013.282; World Health Organization, 2020, GROWTH REF 5 19 YEAR; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zaidi SMH, 2016, SAMPL SIZ EST DIAGN; 2006, CLIN BIOCH REV, V27, pS7	31	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2020	15	6							e0235063	10.1371/journal.pone.0235063	http://dx.doi.org/10.1371/journal.pone.0235063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME9KK	32574192	Green Published, gold			2022-12-26	WOS:000544972400035
J	Dzurendova, S; Zimmermann, B; Kohler, A; Tafintseva, V; Slany, O; Certik, M; Shapaval, V				Dzurendova, Simona; Zimmermann, Boris; Kohler, Achim; Tafintseva, Valeria; Slany, Ondrej; Certik, Milan; Shapaval, Volha			Microcultivation and FTIR spectroscopy-based screening revealed a nutrient-induced co-production of high-value metabolites in oleaginous Mucoromycota fungi	PLOS ONE			English	Article							GAMMA-LINOLENIC ACID; MULTIPLICATIVE SIGNAL CORRECTION; FILAMENTOUS FUNGI; VIBRATIONAL SPECTROSCOPY; SACCHAROMYCES-CEREVISIAE; BIOCHEMICAL-COMPOSITION; COMPONENT ANALYSIS; ARACHIDONIC-ACID; LIPID PRODUCTION; CARBON SOURCE	Mucoromycotafungi possess a versatile metabolism and can utilize various substrates for production of industrially important products, such as lipids, chitin/chitosan, polyphosphates, pigments, alcohols and organic acids. However, as far as commercialisation is concerned, establishing industrial biotechnological processes based onMucoromycotafungi is still challenging due to the high production costs compared to the final product value. Therefore, the development of co-production concept is highly desired since more than one valuable product could be produced at the time and the process has a potentially higher viability. To develop such biotechnological strategy, we applied a high throughput approach consisting of micro-titre cultivation and FTIR spectroscopy. This approach allows single-step biochemical fingerprinting of either fungal biomass or growth media without tedious extraction of metabolites. The influence of two types of nitrogen sources and different levels of inorganic phosphorus on the co-production of lipids, chitin/chitosan and polyphosphates for nine different oleaginousMucoromycotafungi was evaluated. FTIR analysis of biochemical composition ofMucoromycotafungi and biomass yield showed that variation in inorganic phosphorus had higher effect when inorganic nitrogen source-ammonium sulphate-was used. It was observed that: (1)Umbelopsis vinaceareached almost double biomass yield compared to other strains when yeast extract was used as nitrogen source while phosphorus limitation had little effect on the biomass yield; (2)Mucor circinelloides,Rhizopus stolonifer,Amylomyces rouxii,Absidia glaucaandLichtheimia corymbiferaoverproduced chitin/chitosan under the low pH caused by the limitation of inorganic phosphorus; (3)Mucor circinelloides,Amylomyces rouxii,Rhizopus stoloniferandAbsidia glaucawere able to store polyphosphates in addition to lipids when high concentration of inorganic phosphorus was used; (4) the biomass and lipid yield of high-value lipid producersMortierella alpinaandMortierella hyalinawere significantly increased when high concentrations of inorganic phosphorus were combined with ammonium sulphate, while the same amount of inorganic phosphorus combined with yeast extract showed negative impact on the growth and lipid accumulation. FTIR spectroscopy revealed the co-production potential of several oleaginousMucoromycotafungi forming lipids, chitin/chitosan and polyphosphates in a single cultivation process.	[Dzurendova, Simona; Zimmermann, Boris; Kohler, Achim; Tafintseva, Valeria; Shapaval, Volha] Norwegian Univ Life Sci, Fac Sci & Technol, As, Norway; [Slany, Ondrej; Certik, Milan] Slovak Tech Univ, Fac Chem & Food Technol, Bratislava, Slovakia	Norwegian University of Life Sciences; Slovak University of Technology Bratislava	Dzurendova, S (corresponding author), Norwegian Univ Life Sci, Fac Sci & Technol, As, Norway.	simona.dzurendova@gmail.com	Zimmermann, Boris/N-8297-2014; Zimmermann, Boris/GVS-6235-2022	Zimmermann, Boris/0000-0001-5046-520X; Zimmermann, Boris/0000-0001-5046-520X; Kohler, Achim/0000-0001-5759-1989	Research Council of Norway - FMETEKN Grant [257622]; BIONAER Grant [268305, 305215]; DAAD Grant [309220]; Slovak Ministry of Education, Science, Research and Sport [VEGA 1/0323/19]	Research Council of Norway - FMETEKN Grant(Research Council of Norway); BIONAER Grant; DAAD Grant; Slovak Ministry of Education, Science, Research and Sport	The study was funded by the Research Council of Norway - FMETEKN Grant, project number 257622; BIONAER Grant, project numbers 268305, 305215; DAAD Grant, project number 309220 and by the Slovak Ministry of Education, Science, Research and Sport-grant VEGA 1/0323/19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Afseth NK, 2012, CHEMOMETR INTELL LAB, V117, P92, DOI 10.1016/j.chemolab.2012.03.004; Ami D, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-12; Andre A, 2010, IND CROP PROD, V31, P407, DOI 10.1016/j.indcrop.2009.12.011; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2008, SIDRA, V23, P83; [Anonymous], 2001, INTENSIVE CARE MED; Appels L, 2010, BIORESOURCE TECHNOL, V101, P5743, DOI 10.1016/j.biortech.2010.02.068; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; BARTNICKIGARCIA S, 1969, SCIENCE, V165, P302, DOI 10.1126/science.165.3890.302; Beever R. E., 1980, Advances in Botanical Research, V8, P127, DOI 10.1016/S0065-2296(08)60034-8; Bignell E, 2012, ADV APPL MICROBIOL, V79, P1, DOI 10.1016/B978-0-12-394318-7.00001-2; Botha A, 1997, SYST APPL MICROBIOL, V20, P165, DOI 10.1016/S0723-2020(97)80062-8; Brar KK, 2017, BIORESOURCE TECHNOL, V242, P161, DOI 10.1016/j.biortech.2017.03.155; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Cardenas G, 2004, J APPL POLYM SCI, V93, P1876, DOI 10.1002/app.20647; Cardoso A, 2012, MOLECULES, V17, P4904, DOI 10.3390/molecules17054904; Cherubini F, 2010, ENERG CONVERS MANAGE, V51, P1412, DOI 10.1016/j.enconman.2010.01.015; Correa-Garcia S, 2014, ANAL METHODS-UK, V6, P1855, DOI 10.1039/c3ay42322k; Corte L, 2014, COLLOID SURFACE B, V116, P761, DOI 10.1016/j.colsurfb.2014.01.054; de Lima MAB, 2003, BRAZ J MICROBIOL, V34, P363, DOI 10.1590/S1517-83822003000400016; Demsar J, 2013, J MACH LEARN RES, V14, P2349; Di Mario F, 2008, INT J BIOL MACROMOL, V43, P8, DOI 10.1016/j.ijbiomac.2007.10.005; El Wali M, 2019, CHINESE J CHEM ENG, V27, P1219, DOI 10.1016/j.cjche.2018.09.004; Enshaeieh M., 2012, J BIOL TODAYS WORLD, V1, P82, DOI DOI 10.15412/J.JBTW.01010203; Erukhimovitch V, 2005, J PHARMACEUT BIOMED, V37, P1105, DOI 10.1016/j.jpba.2004.08.010; Ferreira JA, 2013, BIORESOURCE TECHNOL, V135, P523, DOI 10.1016/j.biortech.2012.09.064; Forfang K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170611; Guillen MD, 1998, J AGR FOOD CHEM, V46, P1788, DOI 10.1021/jf9705274; Gupta VK, 2016, TRENDS BIOCHEM SCI, V41, P633, DOI 10.1016/j.tibs.2016.04.006; Harrington PD, 2005, ANAL CHIM ACTA, V544, P118, DOI 10.1016/j.aca.2005.02.042; Hu KJ, 2004, CARBOHYD POLYM, V58, P45, DOI 10.1016/j.carbpol.2004.06.015; Jebsen C, 2012, PHYSIOL PLANTARUM, V146, P427, DOI 10.1111/j.1399-3054.2012.01636.x; Karimi S, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10093296; Kavadia A, 2001, J AM OIL CHEM SOC, V78, P341, DOI 10.1007/s11746-001-0266-3; Khoshmanesh A, 2012, ANALYST, V137, P3704, DOI 10.1039/c2an35289c; Khot M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-71; Kim W.J., 2001, BIOTECHNOLOGY BIOPRO, V6, P6, DOI DOI 10.1007/BF02942243; Kohler A, 2005, APPL SPECTROSC, V59, P707, DOI 10.1366/0003702054280649; Kosa G, 2018, APPL MICROBIOL BIOT, V102, P4915, DOI 10.1007/s00253-018-8920-x; Kosa G, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1070-7; Kosa G, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0817-3; Kosa G, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0716-7; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1; Lecellier A, 2015, FOOD MICROBIOL, V45, P126, DOI 10.1016/j.fm.2014.01.002; Li JC, 2016, MECH MACH SCI, V36, P769; Liao W, 2008, BIORESOURCE TECHNOL, V99, P5859, DOI 10.1016/j.biortech.2007.10.006; LINDBERG AM, 1991, APPL MICROBIOL BIOT, V36, P26, DOI 10.1007/BF00164693; Liu JY, 2013, J CHEM TECHNOL BIOT, V88, P1807, DOI 10.1002/jctb.4027; Liu Y, 2008, J APPL MICROBIOL, V105, P1521, DOI 10.1111/j.1365-2672.2008.03913.x; Lu JM, 2011, APPL BIOCHEM BIOTECH, V164, P979, DOI 10.1007/s12010-011-9189-z; Mayers JJ, 2013, BIORESOURCE TECHNOL, V148, P215, DOI 10.1016/j.biortech.2013.08.133; Meyer Vera, 2016, Fungal Biol Biotechnol, V3, P6, DOI 10.1186/s40694-016-0024-8; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Ojeda Jesus J, 2012, Methods Mol Biol, V881, P187, DOI 10.1007/978-1-61779-827-6_8; Papanikolaou S, 2007, EUR J LIPID SCI TECH, V109, P1060, DOI 10.1002/ejlt.200700169; Raghukumar S., 2017, FUNGI COASTAL OCEANI; Ratledge C, 2004, BIOCHIMIE, V86, P807, DOI 10.1016/j.biochi.2004.09.017; Ratledge C., 2010, Single cell oils: microbial and algal oils, P3; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Safaei Z, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091429; Sakuradani E, 2009, J BIOTECHNOL, V144, P31, DOI 10.1016/j.jbiotec.2009.04.012; Salman A, 2010, SPECTROSC-INT J, V24, P261, DOI 10.1155/2010/723489; Santek M.I., 2018, ADV BIOFUELS BIOENER, P137; Santos C, 2010, RES MICROBIOL, V161, P168, DOI 10.1016/j.resmic.2009.12.007; Satari B, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030302; Schmitt J, 1998, INT BIODETER BIODEGR, V41, P1, DOI 10.1016/S0964-8305(98)80002-4; Seufferheld MJ, 2008, APPL ENVIRON MICROB, V74, P5867, DOI 10.1128/AEM.00501-08; Shaligram NS, 2009, PROCESS BIOCHEM, V44, P939, DOI 10.1016/j.procbio.2009.04.009; Shapaval V, 2013, ANALYST, V138, P4129, DOI 10.1039/c3an00304c; Shapaval V, 2013, J APPL MICROBIOL, V114, P788, DOI 10.1111/jam.12092; Shapaval V, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1481-0; Shapaval V, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-86; Shapaval V, 2010, J BIOPHOTONICS, V3, P512, DOI 10.1002/jbio.201000014; SHINMEN Y, 1989, APPL MICROBIOL BIOT, V31, P11, DOI 10.1007/BF00252518; Signori L, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0467-x; Smilde AK, 2005, BIOINFORMATICS, V21, P3043, DOI 10.1093/bioinformatics/bti476; Tan SC, 1996, CARBOHYD POLYM, V30, P239, DOI 10.1016/S0144-8617(96)00052-5; Tang MJ, 2013, ANAL BIOANAL CHEM, V405, P1577, DOI 10.1007/s00216-012-6556-8; Teng WL, 2001, CARBOHYD RES, V332, P305, DOI 10.1016/S0008-6215(01)00084-2; Toplak M., 2017, Synchrotron Radiation News, V30, P40, DOI 10.1080/08940886.2017.1338424; Veale EL, 2007, BIOTECHNOL PROGR, V23, P494, DOI 10.1021/bp060306v; Vongsangnak W, 2013, GENE, V521, P180, DOI 10.1016/j.gene.2013.03.012; Vongsvivut J, 2013, ANALYST, V138, P6016, DOI 10.1039/c3an00485f; Wagner H, 2010, J BIOPHOTONICS, V3, P557, DOI 10.1002/jbio.201000019; Walther G, 2019, J FUNGI, V5, DOI 10.3390/jof5040106; Wang LP, 2005, BIOTECHNOL ADV, V23, P115, DOI 10.1016/j.biotechadv.2004.11.001; Werner TP, 2007, FUNGAL GENET BIOL, V44, P845, DOI 10.1016/j.fgb.2007.01.008; WHITE SA, 1979, APPL ENVIRON MICROB, V38, P323, DOI 10.1128/AEM.38.2.323-328.1979; Wu T, 2005, J AGR FOOD CHEM, V53, P3888, DOI 10.1021/jf048202s; Xiong Y, 2019, IEEE ACCESS, V7, P132763, DOI 10.1109/ACCESS.2019.2941704; Xiong Y, 2019, SLAS TECHNOL, V24, P583, DOI 10.1177/2472630319861361; Yadav A.N., 2019, RECENT ADVANCEMENT W; Ye YL, 2015, APPL BIOCHEM BIOTECH, V177, P1127, DOI 10.1007/s12010-015-1801-1; Yehia RS, 2017, APPL BIOCHEM MICRO+, V53, P94, DOI 10.1134/S0003683817010045; Zeng Y, 2012, BIOPROC BIOSYST ENG, V35, P683, DOI 10.1007/s00449-011-0648-2; Zimmermann B, 2013, APPL SPECTROSC, V67, P892, DOI 10.1366/12-06723; Zininga JT, 2019, BIORESOURCE TECHNOL, V272, P545, DOI 10.1016/j.biortech.2018.10.035	99	21	21	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234870	10.1371/journal.pone.0234870	http://dx.doi.org/10.1371/journal.pone.0234870			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569317	Green Published, gold			2022-12-26	WOS:000543547900010
J	Foster, CE; Kok, M; Flores, AR; Minard, CG; Luna, RA; Lamberth, LB; Kaplan, SL; Hulten, KG				Foster, Catherine E.; Kok, Melissa; Flores, Anthony R.; Minard, Charles G.; Luna, Ruth A.; Lamberth, Linda B.; Kaplan, Sheldon L.; Hulten, Kristina G.			Adhesin genes and biofilm formation among pediatricStaphylococcus aureus isolates from implant-associated infections	PLOS ONE			English	Article							QUANTIFICATION; EPIDEMIOLOGY; SURVEILLANCE; PROTEINS; CRITERIA; PLATES	Background Microbial surface component recognizing adhesive matrix molecules (MSCRAMMs) facilitateStaphylococcus aureusadherence to host tissue. We hypothesized thatS.aureusisolates from implant-associated infections (IAIs) would differ in MSCRAMM profile and biofilm formationin vitrocompared to skin and soft tissue infection (SSTI) isolates. Methods Pediatric patients and their isolates were identified retrospectively. IAI and SSTI isolates were matched (1:4). Pulsed field gel electrophoresis was performed to group isolates as USA300 vs. non-USA300. Whole genome sequencing was performed and raw sequence data were interrogated for presence of MSCRAMMs (clfA,clfB,cna,ebh,efb,fnbpA,fnbpB,isdA,isdB,sdrC,sdrD,sdrE), biofilm-associated (icaA,D,B,C), and Panton-Valentine leukocidin (lukSF-PV) genes, accessory gene regulator group, and multilocus sequence types.In vitrobiofilm formation was assessed for 47 IAI and 47 SSTI isolates using a microtiter plate assay. Conditional logistic regression was performed for analysis of matched data (STATA11, College Station, TX). Results Forty-seven IAI and 188 SSTI isolates were studied. IAI isolates were more often methicillin susceptibleS.aureusand non-USA300 vs. SSTI isolates [34 (72%) vs. 79 (42%), p = 0.001 and 38 (81%) vs. 57 (30%) p <0.001, respectively]. Greater than 98% of isolates carriedclfA,clfB,efb,isdA,isdB, andicaA,D,B,Cwhilecnawas more frequently found among IAI vs. SSTI isolates (p = 0.003). Most isolates were strong biofilm producers. Conclusions S.aureusIAI isolates were significantly more likely to be MSSA and non-USA300 than SSTI isolates. Carriage of MSCRAMMs and biofilm formation did not differ significantly between isolates. Evaluation of genetic polymorphisms and gene expression profiles are needed to further delineate the role of adhesins in the pathogenesis of IAIs.	[Foster, Catherine E.; Kok, Melissa; Lamberth, Linda B.; Kaplan, Sheldon L.; Hulten, Kristina G.] Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA; [Foster, Catherine E.; Kok, Melissa; Minard, Charles G.; Luna, Ruth A.; Lamberth, Linda B.; Kaplan, Sheldon L.; Hulten, Kristina G.] Texas Childrens Hosp, Houston, TX 77030 USA; [Flores, Anthony R.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Ctr Antimicrobial Resistance & Microbial Genom, Div Infect Dis,McGovern Med Sch, Houston, TX 77030 USA; [Minard, Charles G.] Baylor Coll Med, Inst Clin & Translat Res, Houston, TX 77030 USA; [Luna, Ruth A.] Baylor Coll Med, Dept Pediat, Sect Pathol & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine	Foster, CE (corresponding author), Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA.; Foster, CE (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.	catherine.foster@bcm.edu	Flores, Anthony/W-3797-2017	Flores, Anthony/0000-0002-6402-4269; Foster, Catherine/0000-0002-2657-039X; Minard, Charles/0000-0003-4631-6943; Kok, Melissa/0000-0002-4635-4459				Arciola CR, 2018, NAT REV MICROBIOL, V16, P397, DOI 10.1038/s41579-018-0019-y; Arciola CR, 2005, FEMS MICROBIOL LETT, V246, P81, DOI 10.1016/j.femsle.2005.03.035; Bartlett AH, 2010, PEDIATR INFECT DIS J, V29, P860, DOI 10.1097/INF.0b013e3181ef2477; Bocchini CE, 2006, PEDIATRICS, V117, P433, DOI 10.1542/peds.2005-0566; Carrillo-Marquez MA, 2010, PEDIATR INFECT DIS J, V29, P410, DOI 10.1097/INF.0b013e3181c767b6; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130; Deny A, 2016, ORTHOP TRAUMATOL-SUR, V102, P919, DOI 10.1016/j.otsr.2016.08.012; Foster CE, 2019, PEDIATR INFECT DIS J, V38, P808, DOI 10.1097/INF.0000000000002349; Foster T, 2016, EUR J CLIN MICROBIOL, V35, P1923, DOI 10.1007/s10096-016-2763-0; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Ghasemian Abdolmajid, 2015, Iran J Pathol, V10, P258; Gonzalez BE, 2005, CLIN INFECT DIS, V41, P583, DOI 10.1086/432475; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hulten KG, 2006, PEDIATR INFECT DIS J, V25, P349, DOI 10.1097/01.inf.0000207404.50143.1e; Hulten KG, 2020, PEDIATR INFECT DIS J, V39, P30, DOI 10.1097/INF.0000000000002499; Hulten KG, 2018, PEDIATR INFECT DIS J, V37, P235, DOI 10.1097/INF.0000000000001753; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Lamberet A, 2018, PEDIATR INFECT DIS J, V37, P511, DOI [10.1097/INF.0000000000001812, 10.1097/inf.0000000000001812]; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; McCarthy H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00001; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Robinson DA, 2005, J BACTERIOL, V187, P8312, DOI 10.1128/JB.187.24.8312-8321.2005; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Tan T, 2019, FEIGIN CHERRYS TXB P, P725; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Von Eiff C, 2006, INT J ARTIF ORGANS, V29, P360, DOI 10.1177/039139880602900405; Zapotoczna M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005671	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0235115	10.1371/journal.pone.0235115	http://dx.doi.org/10.1371/journal.pone.0235115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569268	Green Published, gold			2022-12-26	WOS:000543547900054
J	Lysholm, S; Wensman, JJ; Munyeme, M; Fischer, K				Lysholm, Sara; Johansson Wensman, Jonas; Munyeme, Musso; Fischer, Klara			Perceptions and practices among Zambian sheep and goat traders concerning small ruminant health and disease	PLOS ONE			English	Article							AFRICAN-SWINE-FEVER; DES-PETITS RUMINANTS; AVIAN INFLUENZA; FARMERS; INFECTION; KNOWLEDGE; ATTITUDES; SPREAD	Trade in animals and animal products is a key factor in the transmission of infectious diseases. Livestock traders play an important role in this process, yet there is little knowledge of traders' perceptions of animal disease or their associated actions. The aim of this study was to investigate perceptions and practices of Zambian small ruminant traders with regard to sheep and goat health and disease. It also analysed how existing perceptions and practices might affect risks of disease transmission through trade. A case study was performed at the two largest small livestock markets in Zambia: the Lusaka market in the capital and the Kasumbalesa market near the border with the Democratic Republic of Congo. Semi-structured interviews with 47 traders performed in April-May and September 2018 represent the core material. Zambian small ruminant traders frequently trade animals that have clinical signs of disease, either because they appear unaware or indifferent to the associated risks, experience financial constraints or assign responsibility for disease prevention to other value chain actors. In their decision about whether or not to sell a visibly sick small ruminant, traders appear to consider whether the clinical sign is perceived as 'natural' or the result of an illness, whether the buyer is aware of the animal's health condition, and whether the animal is sold for consumption or breeding purposes. Traders appear to regard the veterinary certificate required to transport small ruminants in Zambia as proof of health, placing the responsibility for potential disease in traded animals on the veterinary authorities. In their description of a model trader, taking good care of and being sensitive to customer needs was emphasized, indicating that an efficient way to encourage traders to change their behaviour is to influence customer demands. In contrast to the focus in previous studies on identifying and filling knowledge gaps, the present study show that lack of knowledge is not central to why traders engage in disease-transmitting behaviour. Greater awareness of other reasons for certain perceptions and practices could lead to the formulation of risk communication strategies and mitigation measures that are relevant for the local context, as well as alternative strategies for changing trader behaviour.	[Lysholm, Sara; Johansson Wensman, Jonas] Swedish Univ Agr Sci SLU, Sect Ruminant Med, Dept Clin Sci, Uppsala, Sweden; [Munyeme, Musso] Univ Zambia, Dept Dis Control, Lusaka, Zambia; [Fischer, Klara] Swedish Univ Agr Sci SLU, Div Rural Dev, Dept Urban & Rural Dev, Uppsala, Sweden	Swedish University of Agricultural Sciences; University of Zambia; Swedish University of Agricultural Sciences	Lysholm, S (corresponding author), Swedish Univ Agr Sci SLU, Sect Ruminant Med, Dept Clin Sci, Uppsala, Sweden.	sara.lysholm@slu.se	MUNYEME, MUSSO/AAJ-2469-2021; Fischer, Klara/I-2962-2019	Fischer, Klara/0000-0001-6590-4025; Johansson Wensman, Jonas/0000-0002-6957-7110; Lysholm, Sara/0000-0002-0392-1572	Swedish Research Council [201803956, 2016-05667, 348-2014-4293]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by the Swedish Research Council (www.vr.se), grant no 201803956 awarded to JJW and MM, 2016-05667 awarded to JJW and 348-2014-4293 awarded to JJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, CANC DISCOVERY, V7, pOF12; Birindwa BA, 2017, J ADV VET ANIM RES, V4, P348, DOI 10.5455/javar.2017.d233; Bowen GA, 2006, INT J QUAL METH, V5, P12, DOI [DOI 10.1177/160940690600500304, 10.1177/160940690600500304]; Burton RJF, 2004, SOCIOL RURALIS, V44, P195, DOI 10.1111/j.1467-9523.2004.00270.x; Chenais E, 2017, TRANSBOUND EMERG DIS, V64, P101, DOI 10.1111/tbed.12347; Chipasha H., 2017, African Journal of Food, Agriculture, Nutrition and Development, V17, P11691, DOI 10.18697/ajfand.77.16175; Chota A, 2019, TROP ANIM HLTH PROD; Delgado C, 1999, 28 IFPRI AGR ENV; Dione M, 2016, PREV VET MED, V135, P102, DOI 10.1016/j.prevetmed.2016.11.001; Elelu N, 2017, INT J VET SCI MED, V5, P47, DOI 10.1016/j.ijvsm.2017.03.002; FAO, 2012, VET RECORD, V171; Fevre EM, 2001, LANCET, V358, P625, DOI 10.1016/S0140-6736(01)05778-6; Fischer K, 2019, J DAIRY SCI, V102, P2724, DOI 10.3168/jds.2018-15015; Garforth CJ, 2013, PREV VET MED, V110, P456, DOI 10.1016/j.prevetmed.2013.02.018; Gillham B., 2000, CONTINUUM-J MEDIA CU; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Hamilton L., 2018, Food Ethics, V1, P221, DOI 10.1007/s41055-017-0011-7; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; ILRI, 2002, ILR STRAT 2010; Jansen J, 2009, PREV VET MED, V92, P210, DOI 10.1016/j.prevetmed.2009.08.015; Karimuribo E. D., 2011, RES OPIN ANIM VET SC, V1, P184; Kgotlele T., 2019, Comparative Clinical Pathology, V28, P755, DOI 10.1007/s00580-018-2848-5; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kivaria FM, 2013, ONDERSTEPOORT J VET, V80, DOI 10.4102/ojvr.v80i1.593; Leslie EEC, 2016, ACTA TROP, V155, P95, DOI 10.1016/j.actatropica.2015.12.014; Lichoti JK, 2017, PREV VET MED, V140, P87, DOI 10.1016/j.prevetmed.2017.03.005; MILES M, 1994, NEW YORK TIMES BK R, P26; Muhangi D., 2014, LIVESTOCK RES RURAL, V26, P5; Muse EA, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i2.457; Namonje-Kapembwa N, 2016, 117 IAPRI; Naylor R, 2016, SOCIOL RURALIS, V58, P3; Neupane D, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-76; OIE, 2013, EV SUMM PEST PET RUM; Parida S, 2016, SMALL RUMINANT RES, V142, P16, DOI 10.1016/j.smallrumres.2016.02.018; Porten K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-147; Saunders FP, 2016, SOCIOL RURALIS, V56, P391, DOI 10.1111/soru.12115; Shortall O, 2018, SOCIOL RURALIS, V58, P583, DOI 10.1111/soru.12205; Siamupa C, 2018, TROP ANIM HEALTH PRO, V50, P177, DOI 10.1007/s11250-017-1419-0; Southwold-Llewellyn S, 2002, METHODS TECHNIQUES F; Sutherland LA, 2012, J RURAL STUD, V28, P232, DOI 10.1016/j.jrurstud.2012.03.003; Swai ES, 2013, TROP ANIM HEALTH PRO, V45, P1603, DOI 10.1007/s11250-013-0405-4; Yin R. K., 1994, CASE STUDY RES DESIG; Yu Q, 2013, EMERG INFECT DIS, V19, P313, DOI 10.3201/eid1902.120251	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0233611	10.1371/journal.pone.0233611	http://dx.doi.org/10.1371/journal.pone.0233611			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569297	Green Published, gold			2022-12-26	WOS:000543547900045
J	Ortiz-Barrios, M; Alfaro-Saiz, JJ				Ortiz-Barrios, Miguel; Alfaro-Saiz, Juan-Jose			An integrated approach for designing in-time and economically sustainable emergency care networks: A case study in the public sector	PLOS ONE			English	Article							DISCRETE-EVENT SIMULATION; WAITING TIME; 6 SIGMA; SYSTEMS	Emergency Care Networks (ECNs) were created as a response to the increased demand for emergency services and the ever-increasing waiting times experienced by patients in emergency rooms. In this sense, ECNs are called to provide a rapid diagnosis and early intervention so that poor patient outcomes, patient dissatisfaction, and cost overruns can be avoided. Nevertheless, ECNs, as nodal systems, are often inefficient due to the lack of coordination between emergency departments (EDs) and the presence of non-value added activities within each ED. This situation is even more complex in the public healthcare sector of low-income countries where emergency care is provided under constraint resources and limited innovation. Notwithstanding the tremendous efforts made by healthcare clusters and government agencies to tackle this problem, most of ECNs do not yet provide nimble and efficient care to patients. Additionally, little progress has been evidenced regarding the creation of methodological approaches that assist policymakers in solving this problem. In an attempt to address these shortcomings, this paper presents a three-phase methodology based on Discrete-event simulation, payment collateral models, and lean six sigma to support the design of in-time and economically sustainable ECNs. The proposed approach is validated in a public ECN consisting of 2 hospitals and 8 POCs (Point of Care). The results of this study evidenced that the average waiting time in an ECN can be substantially diminished by optimizing the cooperation flows between EDs.	[Ortiz-Barrios, Miguel] Univ Costa CUC, Dept Ind Management Agroind & Operat, Barranquilla, Colombia; [Alfaro-Saiz, Juan-Jose] Univ Politecn Valencia, Res Ctr Prod Management & Engn, Valencia, Spain	Universidad de la Costa; Universitat Politecnica de Valencia	Ortiz-Barrios, M (corresponding author), Univ Costa CUC, Dept Ind Management Agroind & Operat, Barranquilla, Colombia.	mortiz1@cuc.edu.co	Barrios, Miguel Ángel Ortíz/AAW-2705-2021	Ortiz Barrios, Miguel Angel/0000-0001-6890-7547				Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Ahmed Selim, 2013, Reviews on Environmental Health, V28, P189, DOI 10.1515/reveh-2013-0015; Al Owad A, 2014, ADV MATER RES-SWITZ, V835-836, P1893, DOI 10.4028/www.scientific.net/AMR.834-836.1893; Ortiz-Barrios MA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082664; [Anonymous], 2015, PS-POLIT SCI POLIT, V48, P557, DOI 10.1017/S1049096515000694; [Anonymous], 2017, ARTIFICIAL ORGANS, V41, pE141; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2016, UNCERTAINTY MODELLIN; [Anonymous], 2016, AIP C P; [Anonymous], 2015, 6 INT C MOD SIM APPL; [Anonymous], 2018, IEEE INT C IND ENG E; Baier N, 2019, HEALTH POLICY, V123, P1, DOI 10.1016/j.healthpol.2018.11.001; Baril C, 2019, J OPER RES SOC, V70, P2019, DOI 10.1080/01605682.2018.1510805; Barrios MAO, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0577-3; Becker JB, 2015, REV ESC ENFERM USP, V49, P779, DOI 10.1590/S0080-623420150000500011; Bedoya-Valencia L, 2016, SIMUL-T SOC MOD SIM, V92, P1041, DOI 10.1177/0037549716673150; Calvello EJB, 2013, ACAD EMERG MED, V20, P1278, DOI 10.1111/acem.12266; Furterer SL, 2018, QUAL ENG, V30, P389, DOI 10.1080/08982112.2018.1464657; Gartner D, 2020, J OPER RES SOC, V71, P1087, DOI 10.1080/01605682.2019.1571005; Gaviria A, 2015, INFORM NACL CALIDAD; Gillespie J, 2016, J OPER RES SOC, V67, P1239, DOI 10.1057/jors.2015.114; Glickman SW, 2010, ACAD EMERG MED, V17, P1297, DOI 10.1111/j.1553-2712.2010.00930.x; Gul M, 2020, J OPER RES SOC, V71, P733, DOI 10.1080/01605682.2019.1582588; Habidin NF, 2015, INT J PHARM SCI REV, V35, P151; Harrop Nick, 2005, Inform Prim Care, V13, P223; Hawkins Robert C, 2007, Clin Biochem Rev, V28, P179; Hussein NA, 2017, OPER RES HEALTH CARE, V15, P1, DOI 10.1016/j.orhc.2017.06.003; Ibrahim I.M., 2018, INDIAN J PUBLIC HLTH, V9, P1558, DOI [10.5958/0976-5506.2018.01670.4, DOI 10.5958/0976-5506.2018.01670.4]; Isfahani HM, 2019, INT J LEAN SIX SIG, V10, P161, DOI 10.1108/IJLSS-05-2017-0051; Karnon J, 2012, VALUE HEALTH, V15, P821, DOI 10.1016/j.jval.2012.04.013; Kaushal A, 2015, SOCIO-ECON PLAN SCI, V50, P18, DOI 10.1016/j.seps.2015.02.002; Konder MT, 2016, INTERFACE-BOTUCATU, V20, P879, DOI 10.1590/1807-57622015.0519; Kuo YH, 2016, FLEX SERV MANUF J, V28, P120, DOI 10.1007/s10696-014-9198-7; Mandahawi N, 2017, J IND PROD ENG, V34, P495, DOI 10.1080/21681015.2017.1367728; Martinez R, 2010, ACAD EMERG MED, V17, P1346, DOI 10.1111/j.1553-2712.2010.00945.x; Modeling the Healthcare Services in Hilla Emergency Department, 2018, ICOASE 2018 INT C AD; Morley C, 2018, INT EMERG NURS, V38, P34, DOI 10.1016/j.ienj.2017.09.001; Navein J, 2003, EMERG MED J, V20, P192, DOI 10.1136/emj.20.2.192; NNDSS Annual Report Working Group, 2016, COMMUN DIS INTELL, V40, pE48; Nunez-Perez N, 2017, LECT NOTES COMPUT SC, V10586, P352, DOI 10.1007/978-3-319-67585-5_37; Ortiz Barrios Miguel, 2014, Ambient Assisted Living and Daily Activities. 6th International Work-Conference, IWAAL 2014. Proceedings: LNCS 8868, P413, DOI 10.1007/978-3-319-13105-4_62; Ortiz Barrios M.A., 2014, PROSPECTIVA, V12, P73, DOI [10.15665/RP.V12I2.291, DOI 10.15665/RP.V12I2.291]; Barrios MAO, 2015, LECT NOTES COMPUT SC, V9456, P247, DOI 10.1007/978-3-319-26508-7_24; Ortiz-Barrios MA, 2018, MANAGE DECIS, V56, P2187, DOI 10.1108/MD-09-2017-0917; Porter ME, 2019, MANAGING SUSTAINABLE, P323, DOI DOI 10.1007/978-94-024-1144-7_16; Regione Umbria, 2009, B UFFICIALE, V25, P1; Romero-Conrado Alfonso R., 2017, Dyna rev.fac.nac.minas, V84, P129, DOI 10.15446/dyna.v84n201.57504; s NA, 2018, LANCET INFECT DIS, V18, pe228; Salisbury C, 2010, EMERG MED J, V27, P186, DOI 10.1136/emj.2009.073056; Sheard S, 2018, HEALTH ECON POLICY L, V13, P226, DOI 10.1017/S1744133117000366; Steventon A, 2018, BRIEFING EMERGENCY H; Stoner MJ, 2018, ACAD EMERG MED, V25, P1336, DOI 10.1111/acem.13656; Turner J., 2015, WHAT EVIDENCE IS THE; Wilson KJ, 2013, QUAL MANAG HEALTH CA, V22, P2, DOI 10.1097/QMH.0b013e31827dea50; 2017, BEHAV SOC NETW, V15, P91	56	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0234984	10.1371/journal.pone.0234984	http://dx.doi.org/10.1371/journal.pone.0234984			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC8RX	32569319	Green Published, gold			2022-12-26	WOS:000543547900046
J	Shaban, M; Ogur, Z; Mahmoud, A; Switala, A; Shalaby, A; Abu Khalifeh, H; Ghazal, M; Fraiwan, L; Giridharan, G; Sandhu, H; El-Baz, AS				Shaban, Mohamed; Ogur, Zeliha; Mahmoud, Ali; Switala, Andrew; Shalaby, Ahmed; Abu Khalifeh, Hadil; Ghazal, Mohammed; Fraiwan, Luay; Giridharan, Guruprasad; Sandhu, Harpal; El-Baz, Ayman S.			A convolutional neural network for the screening and staging of diabetic retinopathy	PLOS ONE			English	Article							DIAGNOSIS	Diabetic retinopathy (DR) is a serious retinal disease and is considered as a leading cause of blindness in the world. Ophthalmologists use optical coherence tomography (OCT) and fundus photography for the purpose of assessing the retinal thickness, and structure, in addition to detecting edema, hemorrhage, and scars. Deep learning models are mainly used to analyze OCT or fundus images, extract unique features for each stage of DR and therefore classify images and stage the disease. Throughout this paper, a deep Convolutional Neural Network (CNN) with 18 convolutional layers and 3 fully connected layers is proposed to analyze fundus images and automatically distinguish between controls (i.e. no DR), moderate DR (i.e. a combination of mild and moderate Non Proliferative DR (NPDR)) and severe DR (i.e. a group of severe NPDR, and Proliferative DR (PDR)) with a validation accuracy of 88%-89%, a sensitivity of 87%-89%, a specificity of 94%-95%, and a Quadratic Weighted Kappa Score of 0.91-0.92 when both 5-fold, and 10-fold cross validation methods were used respectively. A prior pre-processing stage was deployed where image resizing and a class-specific data augmentation were used. The proposed approach is considerably accurate in objectively diagnosing and grading diabetic retinopathy, which obviates the need for a retina specialist and expands access to retinal care. This technology enables both early diagnosis and objective tracking of disease progression which may help optimize medical therapy to minimize vision loss.	[Shaban, Mohamed] Univ S Alabama, Elect & Comp Engn, Mobile, AL 36688 USA; [Ogur, Zeliha; Mahmoud, Ali; Switala, Andrew; Shalaby, Ahmed; Giridharan, Guruprasad; El-Baz, Ayman S.] Univ Louisville, Bioengn Dept, Louisville, KY 40292 USA; [Abu Khalifeh, Hadil; Ghazal, Mohammed; Fraiwan, Luay] Abu Dhabi Univ, Abu Dhabi, U Arab Emirates; [Sandhu, Harpal] Univ Louisville, Dept Ophthalmol & Visual Sci, Louisville, KY 40292 USA	University of South Alabama; University of Louisville; Abu Dhabi University; University of Louisville	El-Baz, AS (corresponding author), Univ Louisville, Bioengn Dept, Louisville, KY 40292 USA.	ayman.elbaz@louisville.edu	El-Baz, Ayman/AAC-6689-2019	El-Baz, Ayman/0000-0001-7264-1323; Ghazal, Mohammed/0000-0002-9045-6698; Abu Khalifeh, Hadil/0000-0003-1133-3647				Acharya UR, 2009, P I MECH ENG H, V223, P545, DOI 10.1243/09544119JEIM486; Asia Pacific Tele-Ophthalmology Society, 2019, APTOS 2019 BLINDN DE; Ben-David A, 2008, EXPERT SYST APPL, V34, P825, DOI 10.1016/j.eswa.2006.10.022; Boucher MC, 2003, CAN J OPHTHALMOL, V38, P557, DOI 10.1016/S0008-4182(03)80109-6; Dekhil Omar, 2019, IEEE INT C IM SYST T; Deng Jia, 2009, IEEE C COMP VIS PATT; Gao ZT, 2019, IEEE ACCESS, V7, P3360, DOI 10.1109/ACCESS.2018.2888639; Hu JJ, 2019, IEEE T MED IMAGING, V38, P269, DOI 10.1109/TMI.2018.2863562; Jaafar HF, 2010, EUR SIGNAL PR CONF, P1622; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Mizutani A., 2009, P SPIE; Molina-Fernández E., 2008, Arch Soc Esp Oftalmol, V83, P23; Mookiah MRK, 2013, COMPUT BIOL MED, V43, P2136, DOI 10.1016/j.compbiomed.2013.10.007; Nayak J, 2008, J MED SYST, V32, P107, DOI 10.1007/s10916-007-9113-9; O'Shea K., 2016, NEURAL EVOLUTIONARY; Pachiyappan A, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-73; Pratt H., 2016, INT C MED IM UND AN INT C MED IM UND AN; Sabour S., 2017, NIPS P; Shaban M., 2018, IEEE INT S SIGN PROC; Tan JH, 2016, MED PHYS, V43, DOI 10.1118/1.4945413; U RA, 2008, J MED SYST, V32, P481, DOI 10.1007/s10916-008-9154-8	21	27	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2020	15	6							e0233514	10.1371/journal.pone.0233514	http://dx.doi.org/10.1371/journal.pone.0233514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC8RX	32569310	Green Published, gold			2022-12-26	WOS:000543547900021
J	Azab, E; Chandler, KB; Uda, Y; Sun, NY; Hussein, A; Shuwaikan, R; Lu, V; Costello, CE; McComb, ME; Pajevic, PD				Azab, Ehab; Chandler, Kevin Brown; Uda, Yuhei; Sun, Ningyuan; Hussein, Amira; Shuwaikan, Raghad; Lu, Veronica; Costello, Catherine E.; McComb, Mark E.; Pajevic, Paola Divieti			Osteocytes control myeloid cell proliferation and differentiation through Gs alpha-dependent and -independent mechanisms	FASEB JOURNAL			English	Article						Gs alpha; macrophages; myeloid cells; neuropilin-1; osteoclast; osteocytes	GRANULIN-EPITHELIN PRECURSOR; DEMINERALIZED BONE-MATRIX; ENDOTHELIAL GROWTH-FACTOR; COLONY-STIMULATING FACTOR; INHIBITOR SCLEROSTIN; CERULOPLASMIN LEVELS; TARGETED ABLATION; GENE-EXPRESSION; PROGRANULIN; INTERLEUKIN-1	Osteocytes, the bone cells embedded in the mineralized matrix, control bone modeling, and remodeling through direct contact with adjacent cells and via paracrine and endocrine factors that affect cells in the bone marrow microenvironment or distant organs. Osteocytes express numerous G protein-coupled receptors (GPCRs) and thus mice lacking the stimulatory subunit of G-protein (Gs alpha) in osteocytes (Dmp1-Gs alpha(KO)mice) have abnormal myelopoiesis, osteopenia, and reduced adipose tissue. We previously reported that the severe osteopenia and the changes in adipose tissue present in these mice were mediated by increased sclerostin, which suppress osteoblast functions and promote browning of white adipocytes. Inversely, the myeloproliferation was driven by granulocyte colony-stimulating factor (G-CSF) and administration of neutralizing antibodies against G-CSF only partially restored the myeloproliferation, suggesting that additional osteocyte-derived factors might be involved. We hypothesized that osteocytes secrete Gs alpha-dependent factor(s) which regulate the myeloid cells proliferation. To identify osteocyte-secreted proteins, we used the osteocytic cell line Ocy454 expressing or lacking Gs alpha expression (Ocy454-Gs alpha(cont)and Ocy454-Gs alpha(KO)) to delineate the osteocyte "secretome" and its regulation by Gs alpha. Here we reported that factors secreted by osteocytes increased the number of myeloid colonies and promoted macrophage proliferation. The proliferation of myeloid cells was further promoted by osteocytes lacking Gs alpha expression. Myeloid cells can differentiate into bone-resorbing osteoclasts, therefore, we hypothesized that osteocyte-secreted factors might also regulate osteoclastogenesis in a Gs alpha-dependent manner. Conditioned medium (CM) from Ocy454 (both Gs alpha(cont)and Gs alpha(KO)) significanlty increased the proliferation of bone marrow mononuclear cells (BMNC) and, at the same time, inhibited their differentiation into mature osteoclasts via a Gs alpha-dependent mechanism. Proteomics analysis of CM from Ocy454 Gs alpha(cont)and Gs alpha(KO)cells identified neuropilin-1 (Nrp-1) and granulin (Grn) as osteocytic-secreted proteins upregulated in Ocy454-Gs alpha(KO)cells compared to Ocy454-Gs alpha(cont), whereas semaphorin3A was significantly suppressed. Treatment of Ocy454-Gs alpha(cont)cells with recombinant proteins or knockdown of Nrp-1 and Grn in Ocy454-Gs alpha(KO)cells partially rescued the inhibition of osteoclasts, demonstrating that osteocytes control osteoclasts differentiation through Nrp-1 and Grn which are regulated by Gs alpha signaling.	[Azab, Ehab; Uda, Yuhei; Sun, Ningyuan; Shuwaikan, Raghad; Lu, Veronica; Pajevic, Paola Divieti] Boston Univ, Dept Translat Dent Med, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA; [Chandler, Kevin Brown; Costello, Catherine E.; McComb, Mark E.] Boston Univ, Ctr Biomed Mass Spectrometry, Sch Med, Boston, MA 02118 USA; [Hussein, Amira] Boston Univ, Dept Orthoped, Sch Med, Boston, MA 02118 USA; [Azab, Ehab] Umm Al Qura Univ, Sch Dent Med, Dept Basic & Clin Oral Sci, Periodontol Div, Mecca, Saudi Arabia	Boston University; Boston University; Boston University; Umm Al Qura University	Pajevic, PD (corresponding author), Boston Univ, Dept Translat Dent Med, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA.	pdivieti@bu.edu	Azab, Ehab/F-5269-2019; Azab, Ehab/GQH-9122-2022; Uda, Yuhei/AAZ-4978-2021	Azab, Ehab/0000-0002-1122-3942; Uda, Yuhei/0000-0003-4705-6215; Chandler, Kevin/0000-0001-5514-9652	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR06221]; National Institute of General Medical Sciences (NIGMS) [GM104603]; National Center for Advancing Translational Science (NCATS) [TR001430]	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Advancing Translational Science (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR06221; National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM104603; National Center for Advancing Translational Science (NCATS), Grant/Award Number: TR001430	AARDEN EM, 1994, J CELL BIOCHEM, V55, P287, DOI 10.1002/jcb.240550304; Bachelder RE, 2001, CANCER RES, V61, P5736; Behring JB, 2014, FASEB J, V28, P1975, DOI 10.1096/fj.13-233445; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; CANNISTRA SA, 1988, BLOOD, V71, P672; Cherian PP, 2003, J BIOL CHEM, V278, P43146, DOI 10.1074/jbc.M302993200; CONFORTI A, 1983, PHARMACOL RES COMMUN, V15, P859, DOI 10.1016/S0031-6989(83)80093-9; COZZOLINO F, 1989, P NATL ACAD SCI USA, V86, P2369, DOI 10.1073/pnas.86.7.2369; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; DESHMUKH VK, 1985, PHARMACOL RES COMMUN, V17, P633, DOI 10.1016/0031-6989(85)90070-0; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Fulzele K, 2018, BONE, V117, P138, DOI 10.1016/j.bone.2018.09.021; Fulzele K, 2017, J BONE MINER RES, V32, P373, DOI 10.1002/jbmr.3001; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Gagnon ML, 2000, P NATL ACAD SCI USA, V97, P2573, DOI 10.1073/pnas.040337597; Gu GL, 2005, BIOCHEM BIOPH RES CO, V335, P1095, DOI 10.1016/j.bbrc.2005.06.211; Guerra RR, 2007, GROWTH FACTORS, V25, P280, DOI 10.1080/08977190701781222; Harris SE, 2012, BONE, V50, P42, DOI 10.1016/j.bone.2011.09.038; Hayashi M, 2019, CELL METAB, V29, P627, DOI 10.1016/j.cmet.2018.12.021; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; He ZH, 1999, CANCER RES, V59, P3222; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Heino Terhi J, 2009, Technol Health Care, V17, P49, DOI 10.3233/THC-2009-0534; Heino TJ, 2002, J CELL BIOCHEM, V85, P185, DOI 10.1002/jcb.10109; HEYWORTH CM, 1990, J CELL SCI, P57; Holt DJ, 2012, ADV DRUG DELIVER REV, V64, P1123, DOI 10.1016/j.addr.2012.04.002; Juppner H, 2006, J PEDIATR ENDOCR MET, V19, P641; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kampen KR, 2013, CELL MOL LIFE SCI, V70, P1307, DOI 10.1007/s00018-012-1085-3; Kang SJ, 2013, SEMIN CELL DEV BIOL, V24, P163, DOI 10.1016/j.semcdb.2012.09.008; KAUSHANSKY K, 1988, J CLIN INVEST, V81, P92, DOI 10.1172/JCI113316; Kim AY, 2017, CELL TRANSPLANT, V26, P115, DOI 10.3727/096368916X693338; KOEFFLER HP, 1987, BLOOD, V70, P55; KOHLER P, 1986, ACTA ORTHOP SCAND, V57, P141; Kulkarni RN, 2010, CALCIFIED TISSUE INT, V87, P461, DOI 10.1007/s00223-010-9407-7; Marotti G, 1996, Ital J Anat Embryol, V101, P25; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Okura H, 2010, J ATHEROSCLER THROMB, V17, P568, DOI 10.5551/jat.3921; Parikh AA, 2004, AM J PATHOL, V164, P2139, DOI 10.1016/S0002-9440(10)63772-8; Piacibello W, 1997, LEUKEMIA, V11, P531, DOI 10.1038/sj.leu.2400603; Powell WF, 2011, J ENDOCRINOL, V209, P21, DOI 10.1530/JOE-10-0308; SOUZA LM, 1986, SCIENCE, V232, P61, DOI 10.1126/science.2420009; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Verlinden L, 2016, MOL CELL ENDOCRINOL, V432, P76, DOI 10.1016/j.mce.2015.09.009; Wein Marc N, 2015, J Bone Miner Res, V30, P400, DOI 10.1002/jbmr.2381; Weinstein LS, 2002, ANN NY ACAD SCI, V968, P173, DOI 10.1111/j.1749-6632.2002.tb04335.x; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wildemann B., 2007, Cell and Tissue Banking, V8, P107, DOI 10.1007/s10561-006-9021-0; Wildemann B, 2007, J BIOMED MATER RES A, V81A, P437, DOI 10.1002/jbm.a.31085; YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0; Yao CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144025; Yao CX, 2015, INT J MASS SPECTROM, V378, P347, DOI 10.1016/j.ijms.2014.10.006; Yao QQ, 2017, BIOCHEM BIOPH RES CO, V488, P634, DOI 10.1016/j.bbrc.2016.11.011; ZSEBO KM, 1988, BLOOD, V71, P99	58	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10191	10211		10.1096/fj.202000366R	http://dx.doi.org/10.1096/fj.202000366R		JUN 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32557809	Green Accepted, Bronze			2022-12-26	WOS:000541762000001
J	Nguyen, Q; Babanezhad, M; Nakhjiri, AT; Rezakazemi, M; Shirazian, S				Quyen Nguyen; Babanezhad, Meisam; Nakhjiri, Ali Taghvaie; Rezakazemi, Mashallah; Shirazian, Saeed			Prediction of thermal distribution and fluid flow in the domain with multi-solid structures using Cubic-Interpolated Pseudo-Particle model	PLOS ONE			English	Article							LATTICE BOLTZMANN SIMULATION; CONVECTIVE HEAT-TRANSFER; NATURAL-CONVECTION; NUMERICAL-SIMULATION; TRANSFER ENHANCEMENT; CO2 SEPARATION; NANOFLUIDS; ENCLOSURES; ABSORBENTS	A nanofluid is a suspension of very small solid particles in a continuous fluid with significant improvement of heat transfer characteristics in the main liquid. In general, in industrial equipment, the heat transfer rate can be improved with optimization of equipment including the domain structure and using the different types of nanofluids. Still, there is a big challenge to analyze the heat transfer and fluid circulation in the domain. Having nanofluids with experimental observation as using sensors and probes are destructive for the liquid stream and they are costly to observe the details of particles and the original fluid. Over the 20 years, different numerical methods have been implemented in the modeling of the heat and fluid distribution in industrial equipment containing nanofluids. Among all mathematical and numerical methods, Cubic-Interpolated Pseudo-Particle (CIP) model provides a strong potential in the prediction of the fluid structure and heat analysis, when there is a complex structure of thermal walls and high concentration of nanoparticles. However, this method is not frequently used by researchers in nanofluids analysis. In this study, the Cubic-Interpolated Pseudo-Particle model is applied to predict the flow in the square domain. different thermal walls (multi-solid structure) and hot cylindrical wall are specifically used to observe the fluid flow and heat distribution in the domain. Additionally, for a better understanding of the flow in the domain, different numbers of cylinders are used and also different amounts of nanofluid in the continuous fluid are added. The results show that adding more walls in the domain causes the change in the vortex structure. Furthermore, using nanofluid results in better heat transfer rate in the system. The CIP method is also a capable tool to predict the heat and fluid flow in the multi-solid structure domain.	[Quyen Nguyen] Duy Tan Univ, Inst Res & Dev, Danang, Vietnam; [Babanezhad, Meisam] Islamic Azad Univ, Fac Mech Engn, Dept Energy, South Tehran Branch, Tehran, Iran; [Nakhjiri, Ali Taghvaie] Islamic Azad Univ, Dept Petr & Chem Engn, Sci & Res Branch, Tehran, Iran; [Rezakazemi, Mashallah] Shahrood Univ Technol, Fac Chem & Mat Engn, Shahrood, Iran; [Shirazian, Saeed] Ton Duc Thang Univ, Dept Management Sci & Technol Dev, Ho Chi Minh City, Vietnam; [Shirazian, Saeed] Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam	Duy Tan University; Islamic Azad University; Islamic Azad University; Shahrood University of Technology; Ton Duc Thang University; Ton Duc Thang University	Shirazian, S (corresponding author), Ton Duc Thang Univ, Dept Management Sci & Technol Dev, Ho Chi Minh City, Vietnam.; Shirazian, S (corresponding author), Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam.	saeed.shirazian@tdtu.edu.vn	Taghvaie Nakhjiri, Ali/ABG-2176-2021; babanezhad, Meisam/ABB-2400-2020; Rezakazemi, Mashallah/H-4046-2017	Taghvaie Nakhjiri, Ali/0000-0001-6244-3446; babanezhad, Meisam/0000-0003-4303-7412; Rezakazemi, Mashallah/0000-0002-9980-6682				Abu-Nada E, 2009, INT J HEAT FLUID FL, V30, P679, DOI 10.1016/j.ijheatfluidflow.2009.02.003; [Anonymous], 2011, WORLD APPL SCI J; [Anonymous], 2012, DIABETES CARE S1, V35, pS11; Aydin O, 2000, INT J NUMER METHOD H, V10, P518, DOI 10.1108/09615530010338196; Azwadi CSN, 2013, INT J MECH MAT ENG, V8, P58; Bararnia H, 2011, INT COMMUN HEAT MASS, V38, P1436, DOI 10.1016/j.icheatmasstransfer.2011.07.012; Dagtekin I, 2007, INT COMMUN HEAT MASS, V34, P502, DOI 10.1016/j.icheatmasstransfer.2007.01.003; Das S, 2002, INT J NUMER METHOD H, V12, P126, DOI 10.1108/09615530210418294; Daungthongsuk W, 2007, RENEW SUST ENERG REV, V11, P797, DOI 10.1016/j.rser.2005.06.005; DAVIS GD, 1983, INT J NUMER METH FL, V3, P249; Delavar MA, 2010, INT J HYDROGEN ENERG, V35, P9306, DOI 10.1016/j.ijhydene.2010.02.126; Ding YL, 2007, KONA, V25, P23, DOI 10.14356/kona.2007006; Eastman JA, 1997, MATER RES SOC SYMP P, V457, P3, DOI 10.1557/PROC-457-3; Fard MH, 2010, INT COMMUN HEAT MASS, V37, P91, DOI 10.1016/j.icheatmasstransfer.2009.08.003; Fattahi E, 2012, INT J THERM SCI, V52, P137, DOI 10.1016/j.ijthermalsci.2011.09.001; He YR, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-184; Kefayati GHR, 2012, INT J THERM SCI, V52, P91, DOI 10.1016/j.ijthermalsci.2011.09.005; Kefayati GR, 2011, INT COMMUN HEAT MASS, V38, P798, DOI 10.1016/j.icheatmasstransfer.2011.03.005; Khanafer K, 2003, INT J HEAT MASS TRAN, V46, P3639, DOI 10.1016/S0017-9310(03)00156-X; Khodadadi JM, 2007, INT COMMUN HEAT MASS, V34, P534, DOI 10.1016/j.icheatmasstransfer.2007.02.005; Khodadai J, 2013, NANOSTRUCTURE ENHANC; Lai FH, 2011, INT J THERM SCI, V50, P1930, DOI 10.1016/j.ijthermalsci.2011.04.015; Mahmoodi M, 2011, INT J THERM SCI, V50, P1731, DOI 10.1016/j.ijthermalsci.2011.04.009; Mohammed HA, 2011, RENEW SUST ENERG REV, V15, P2921, DOI 10.1016/j.rser.2011.02.019; Nabavitabatabayi M, 2011, INT COMMUN HEAT MASS, V38, P128, DOI 10.1016/j.icheatmasstransfer.2010.09.008; Nakhjiri AT, 2019, J IND ENG CHEM, V78, P106, DOI 10.1016/j.jiec.2019.06.031; Nakhjiri AT, 2018, J MEMBRANE SCI, V565, P1, DOI 10.1016/j.memsci.2018.07.095; Nakhjiri AT, 2018, J ENVIRON CHEM ENG, V6, P1500, DOI 10.1016/j.jece.2018.01.068; Nemati H, 2010, INT COMMUN HEAT MASS, V37, P1528, DOI 10.1016/j.icheatmasstransfer.2010.08.004; Oztop HF, 2008, INT J HEAT FLUID FL, V29, P1326, DOI 10.1016/j.ijheatfluidflow.2008.04.009; Poliseno L, 2012, SCI SIGNAL, V5, pre5; Pourtousi M, 2012, SIMULATION PARTICLE; Safdari A, 2018, COMPUT FLUIDS, V164, P102, DOI 10.1016/j.compfluid.2017.05.029; Schmid G., 2011, NANOPARTICLES THEORY; Shi Y, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066310; Shirazian S, 2012, ENG COMPUT-GERMANY, V28, P189, DOI 10.1007/s00366-011-0237-7; Shirazian S, 2009, SIMUL MODEL PRACT TH, V17, P708, DOI 10.1016/j.simpat.2008.12.002; Taherri-Garavand A., 2010, INT J CHEM ENG APPL, V1, P1; Wang XQ, 2008, BRAZ J CHEM ENG, V25, P613, DOI 10.1590/S0104-66322008000400001; Xuan YM, 2005, HEAT MASS TRANSFER, V41, P199, DOI 10.1007/s00231-004-0539-z; Xuan YM, 2000, INT J HEAT FLUID FL, V21, P58, DOI 10.1016/S0142-727X(99)00067-3; Yan YY, 2008, INT J HEAT MASS TRAN, V51, P2519, DOI 10.1016/j.ijheatmasstransfer.2007.07.053; Zhou LJ, 2010, INT J MULTIPHAS FLOW, V36, P364, DOI 10.1016/j.ijmultiphaseflow.2010.01.005	43	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2020	15	6							e0233850	10.1371/journal.pone.0233850	http://dx.doi.org/10.1371/journal.pone.0233850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC4QJ	32555730	Green Published, gold			2022-12-26	WOS:000543273200081
J	Cheng, KJG; Rivera, AS; Lam, HY; Ulitin, AR; Nealon, J; Dizon, R; Wu, DBC				Cheng, Kent Jason Go; Rivera, Adovich Sarmiento; Lam, Hilton Yu; Ulitin, Allan Rodriguez; Nealon, Joshua; Dizon, Ruby; Wu, David Bin-Chia			Influenza-associated excess mortality in the Philippines, 2006-2015	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; SEASONAL INFLUENZA; SOUTHERN; CHILDREN	Influenza-associated mortality has not been quantified in the Philippines. Here, we constructed multiple negative binomial regression models to estimate the overall and age-specific excess mortality rates (EMRs) associated with influenza in the Philippines from 2006 to 2015. The regression analyses used all-cause mortality as the dependent variable and meteorological controls, time, influenza A and B positivity rates (lagged for up to two time periods), and annual and semiannual cyclical seasonality controls as independent variables. The regression models closely matched observed all-cause mortality. Influenza was estimated to account for a mean of 5,347 excess deaths per year (1.1% of annual all-cause deaths) in the Philippines, most of which (67.1%) occurred in adults aged >= 60 years. Influenza A accounted for 85.7% of all estimated excess influenza deaths. The annual estimated influenza-attributable EMR was 5.09 (95% CI: 2.20-5.09) per 100,000 individuals. The EMR was highest for individuals aged >= 60 years (44.63 [95% CI: 4.51-44.69] per 100,000), second highest for children aged less than 5 years (2.14 [95% CI: 0.44-2.19] per 100,000), and lowest for individuals aged 10 to 19 years (0.48 [95% CI: 0.10-0.50] per 100,000). Estimated numbers of excess influenza-associated deaths were considerably higher than the numbers of influenza deaths registered nationally. Our results suggest that influenza causes considerable mortality in the Philippines-to an extent far greater than observed from national statistics-especially among older adults and young children.	[Cheng, Kent Jason Go] Syracuse Univ, Maxwell Sch Citizenship & Publ Affairs, Social Sci Dept, Syracuse, NY 13244 USA; [Rivera, Adovich Sarmiento] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Lam, Hilton Yu; Ulitin, Allan Rodriguez] Univ Philippines Manila, Inst Hlth Policy & Dev Studies, Natl Inst Hlth, Manila, Philippines; [Nealon, Joshua] Sanofi Pasteur, Vaccines Epidemiol & Modeling, Singapore, Singapore; [Dizon, Ruby] Sanofi Pasteur, Med Affairs, Taguig City, Metropolitan Ma, Philippines; [Wu, David Bin-Chia] Monash Univ Malaysia, Fac Pharm & Pharmaceut Sci, Subang Jaya, Selangor, Malaysia; [Wu, David Bin-Chia] Monash Univ Malaysia, Asian Ctr Evidence Synth Populat Implementat & Cl, Hlth & Well Being Cluster, Global Asia 21st Century Platform, Bandar Sunway, Selangor, Malaysia	Syracuse University; Northwestern University; Feinberg School of Medicine; University of the Philippines System; University of the Philippines Manila; Sanofi-Aventis; Monash University; Monash University Sunway; Monash University; Monash University Sunway	Cheng, KJG (corresponding author), Syracuse Univ, Maxwell Sch Citizenship & Publ Affairs, Social Sci Dept, Syracuse, NY 13244 USA.	kgcheng@syr.edu	Rivera, Adovich/AAK-9850-2021; Cheng, Kent Jason/ABA-4933-2020		Sanofi Pasteur	Sanofi Pasteur	Research funding was provided by Sanofi Pasteur. The funder also provided support in the form of salaries for authors (JN and RD), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. All authors had full access to the data in the study and take responsibility for the integrity of the data and accuracy of its analysis.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2019, R LANG ENV STAT COMP; Aungkulanon S, 2015, INFLUENZA OTHER RESP, V9, P298, DOI 10.1111/irv.12344; Barmania S, 2014, LANCET, V383, P1197, DOI 10.1016/S0140-6736(14)60590-0; Carter KL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-9; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Emukule GO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180890; Fleming DM, 2005, J EPIDEMIOL COMMUN H, V59, P586, DOI 10.1136/jech.2004.026450; Hufana L, 2009, ASSESSING PRODUCTION; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; Jennings LC, 2013, INFLUENZA OTHER RESP, V7, P44, DOI 10.1111/irv.12180; Lucero MG, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2087-9; Newman LP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193263; Park Minah, 2016, Am J Prev Med, V50, pe111, DOI 10.1016/j.amepre.2015.09.028; Philippine Atmospheric Geophysical and Astronomical Services Administration, 2017, DAIL CLIM REP ALL WE; Philippine Statistics Authority, 2012, CIV REG PROC 2012; Republic of the Philippines Department of Health, 2016, DOH ANN REP 2016; Freitas ARR, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01903; Saha S, 2014, B WORLD HEALTH ORGAN, V92, P318, DOI 10.2471/BLT.13.124412; Tallo VL, 2014, INFLUENZA OTHER RESP, V8, P159, DOI 10.1111/irv.12223; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; United Nations, 2017, WORLD POPULATION PRO; Wang H, 2014, VACCINE, V32, P973, DOI 10.1016/j.vaccine.2013.12.013; Wang X, 2020, LANCET GLOB HEALTH, V8, pE497, DOI 10.1016/S2214-109X(19)30545-5; World Health Organization, 2020, WHO SURV CAS DEF ILI; World Health Organization, 2018, INFL SEAS; World Health Organization, 2018, FLUNET; World Meteorological Organization, 2019, GUID CLIM PRACT 2011; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	31	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234715	10.1371/journal.pone.0234715	http://dx.doi.org/10.1371/journal.pone.0234715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555618	Green Published, gold			2022-12-26	WOS:000542759600008
J	Xie, LH; Varathan, P; Nho, K; Saykin, AJ; Salama, P; Yan, JW				Xie, Linhui; Varathan, Pradeep; Nho, Kwangsik; Saykin, Andrew J.; Salama, Paul; Yan, Jingwen			Identification of functionally connected multi-omic biomarkers for Alzheimer's disease using modularity-constrained Lasso	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; SHC ADAPTER PROTEINS; MINI-MENTAL STATE; INSULIN-RESISTANCE; REGRESSION; SHRINKAGE; CYTOSCAPE; PATHWAYS; GENES; ROLES	Large-scale genome wide association studies (GWASs) have led to discovery of many genetic risk factors in Alzheimer's disease (AD), such asAPOE,TOMM40andCLU. Despite the significant progress, it remains a major challenge to functionally validate these genetic findings and translate them into targetable mechanisms. Integration of multiple types of molecular data is increasingly used to address this problem. In this paper, we proposed a modularity-constrained Lasso model to jointly analyze the genotype, gene expression and protein expression data for discovery of functionally connected multi-omic biomarkers in AD. With a prior network capturing the functional relationship between SNPs, genes and proteins, the newly introduced penalty term maximizes the global modularity of the subnetwork involving selected markers and encourages the selection of multi-omic markers with dense functional connectivity, instead of individual markers. We applied this new model to the real data collected in the ROS/MAP cohort where the cognitive performance was used as disease quantitative trait. A functionally connected subnetwork involving 276 multi-omic biomarkers, including SNPs, genes and proteins, were identified to bear predictive power. Within this subnetwork, multiple trans-omic paths from SNPs to genes and then proteins were observed. This suggests that cognitive performance deterioration in AD patients can be potentially a result of genetic variations due to their cascade effect on the downstream transcriptome and proteome level.	[Xie, Linhui; Salama, Paul] Indiana Univ Purdue Univ, Dept Elect & Comp Engn, Indianapolis, IN 46202 USA; [Nho, Kwangsik; Saykin, Andrew J.; Yan, Jingwen] Indiana Univ Sch Med, Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Varathan, Pradeep; Yan, Jingwen] Indiana Univ Purdue Univ, Dept BioHlth Informat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Yan, JW (corresponding author), Indiana Univ Sch Med, Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA.; Yan, JW (corresponding author), Indiana Univ Purdue Univ, Dept BioHlth Informat, Indianapolis, IN 46202 USA.	jingyan@iupui.edu	Xie, Linhui/AAA-3577-2022	Xie, Linhui/0000-0003-1238-8789; Salama, Paul/0000-0002-7643-3879	NIH [R21 AG066135, R01 EB022574, R01 AG019771, P30 AG010133]; NSF CRII [1755836]; Indiana University Collaborative Research Grant (IUCRG); Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [UL1TR001108]; NIA [P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, U01AG46152]; Illinois Department of Public Health; Translational Genomics Research Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CRII(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Indiana University Collaborative Research Grant (IUCRG); Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; Translational Genomics Research Institute	This research was supported by NIH grants R21 AG066135, R01 EB022574, R01 AG019771, P30 AG010133, NSF CRII 1755836 and Indiana University Collaborative Research Grant (IUCRG). This project was also funded, in part, with support from the Indiana Clinical and Translational Sciences Institute funded, in part by Grant Number UL1TR001108 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award. The results published here are in whole or in part based on data obtained from the AMP-AD Knowledge Portal (doi:10.7303/syn2580853). Study data were provided by the Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago. Data collection was supported through funding by NIA grants P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, U01AG46152, the Illinois Department of Public Health, and the Translational Genomics Research Institute.	Ali-Rahmani F, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.014; Andreev VP, 2012, J PROTEOME RES, V11, P3053, DOI 10.1021/pr3001546; Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Caltagarone J, 2007, BBA-MOL BASIS DIS, V1772, P438, DOI 10.1016/j.bbadis.2006.11.007; Cattaneo E, 1998, TRENDS NEUROSCI, V21, P476, DOI 10.1016/S0166-2236(98)01282-X; Chan YK, 2011, 22 INT JOINT C ART I; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; De Jager PL, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.033; Dumbacher M, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0283-3; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Ekblad LL, 2018, NEUROLOGY, V90, pE1150, DOI 10.1212/WNL.0000000000005214; Engelman CD, 2013, J ALZHEIMERS DIS, V36, P749, DOI 10.3233/JAD-130482; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Gabbouj S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00629; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Global Health Estimates 2016, 2018, GLOBAL HLTH ESTIMATE; Grosenick L, 2013, NEUROIMAGE, V72, P304, DOI 10.1016/j.neuroimage.2012.12.062; Hasin Y, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1215-1; Hedges D, 2016, CLIN EEG NEUROSCI, V47, P48, DOI 10.1177/1550059414550567; Hildebrand R, 2008, ARXIV08061896; Horgusluoglu-Moloch E, 2017, NEUROBIOL AGING, V60, P92, DOI 10.1016/j.neurobiolaging.2017.08.010; Huang J, 2016, FRONT GENET, V7, DOI [10.3389/fgene.2016.00084, 10.3389/fgene.2017.00084]; Jacob L., 2009, P 26 ANN INT C MACH, P26, DOI DOI 10.1145/1553374.1553431; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kerrisk ME, 2014, PROG BRAIN RES, V214, P101, DOI 10.1016/B978-0-444-63486-3.00005-0; Kim S, 2012, ANN APPL STAT, V6, P1095, DOI 10.1214/12-AOAS549; Kirouac L, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0149-16.2017; Kumar S, 2017, NUCLEIC ACIDS RES, V45, pD139, DOI 10.1093/nar/gkw1064; Meng XZ, 2011, PROCEEDINGS OF THE 16TH INTERNATIONAL SYMPOSIUM ON ADVANCEMENT OF CONSTRUCTION MANAGEMENT AND REAL ESTATE (CRIOCM2011), P352; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nho K, 2013, MOL PSYCHIATR, V18, P781, DOI [10.1038/mp.2013.24, 10.1038/mp.2013.81]; Perez-Canamas A, 2016, NEUROBIOL AGING, V48, P1, DOI 10.1016/j.neurobiolaging.2016.08.009; Petyuk VA, 2010, METHODS, V50, P77, DOI 10.1016/j.ymeth.2009.07.009; POLICH J, 1990, ELECTROEN CLIN NEURO, V77, P179, DOI 10.1016/0168-5597(90)90036-D; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; Saucier C, 2002, ONCOGENE, V21, P1800, DOI 10.1038/sj.onc.1205261; Schneider T, 2001, J CLIMATE, V14, P853, DOI 10.1175/1520-0442(2001)014<0853:AOICDE>2.0.CO;2; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Thung KH, 2014, NEUROIMAGE, V91, P386, DOI 10.1016/j.neuroimage.2014.01.033; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Willette AA, 2015, ALZHEIMERS DEMENT, V11, P504, DOI 10.1016/j.jalz.2014.03.011; Wu CC, 2013, BIOINFORMATICS, V29, P1174, DOI 10.1093/bioinformatics/btt131; YOKOTE K, 1994, J BIOL CHEM, V269, P15337; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426	53	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234748	10.1371/journal.pone.0234748	http://dx.doi.org/10.1371/journal.pone.0234748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555747	Green Published, Green Submitted, gold			2022-12-26	WOS:000542759600052
J	Yu, J; Hu, B				Yu, Jie; Hu, Bo			Influence of the combination of big data technology on the Spark platform with deep learning on elevator safety monitoring efficiency	PLOS ONE			English	Article								To effectively minimize elevator safety accidents, big data technology is combined with deep learning technology based on the Spark platform. This study first introduces the relevant theories of elevator safety monitoring technology, namely big data technology and deep learning technology. Then, the fault types that occur in the running state of the elevator are identified, and a finite state machine model is established. An elevator fault monitoring method based on the Spark platform is proposed, namely finite state machine (FSM), and the results of elevator safety fault monitoring are evaluated. Based on deep learning, an elevator fault warning model is constructed and its early warning performance is evaluated. The results show that the study can realize real-time and effective monitoring in the operation state of the elevator, and can determine the fault type of the elevator by binding the abnormal operation state with the corresponding fault. The feasibility of the elevator safety monitoring efficiency is evaluated based on three indexes: mutual information, accuracy, and false positives. Compared with other algorithms, the proposed FSM algorithm has the largest mutual information (0.1337), the highest accuracy (0.9899), the lowest false positive rate (0.0624), and the lowest false negative rate (0.1126); compared with other models, the elevator fault warning model proposed in this study has the lowest root mean-square error (RMSE) value (0.0201), the highest accuracy (0.9834), the lowest Loss value (0.0012), and the shortest convergence time (88.2608s), indicating that the elevator safety monitoring system and elevator fault warning model are feasible. This study establishes a good direction for elevator safety monitoring efficiency in China.	[Yu, Jie; Hu, Bo] Fudan Univ, Inst Informat Sci & Technol, Shanghai, Peoples R China	Fudan University	Yu, J (corresponding author), Fudan Univ, Inst Informat Sci & Technol, Shanghai, Peoples R China.	yujienuaa@163.com						Bertini JR, 2019, INFORM FUSION, V45, P66, DOI 10.1016/j.inffus.2018.01.003; Davila Delgado J M, 2019, J CONSTR ENG M ASCE, V146; Dou Y., 2019, INT WORKSH ADV MAN A, P309; El Mazouri FZ, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-018-0165-0; Garcia O, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040826; Ham S, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19235160; Jabari SE, 2020, TRANSPORT SCI, V54, P1, DOI 10.1287/trsc.2019.0920; Jesse N, 2018, AI SOC, V33, P229, DOI 10.1007/s00146-018-0807-y; Lin J, 2019, DESTECH T COMPUTER S, P22; Liu C, 2017, AUTOMATION CONTROL I, V5, P50; Loukas G, 2018, IEEE ACCESS, V6, P3491, DOI 10.1109/ACCESS.2017.2782159; Ming ZH, 2018, INT J ONLINE ENG, V14, P121, DOI 10.3991/ijoe.v14i08.9179; Olalere IO, 2018, S AFR J IND ENG, V29, P17, DOI 10.7166/29-4-1947; Skog I, 2017, IEEE SENS J, V17, P5198, DOI 10.1109/JSEN.2017.2719630; Subbu KP, 2017, BIG DATA RES, V10, P33, DOI 10.1016/j.bdr.2017.10.002; Wang HM, 2017, CHINA COMMUN, V14, P39, DOI 10.1109/CC.2017.8233649; Wang YQ, 2019, INT J OCCUP SAF ERGO, V25, P362, DOI 10.1080/10803548.2017.1371408; Waseem HM, 2019, APPL PHYS B-LASERS O, V125, DOI 10.1007/s00340-019-7142-y; Wen P., 2016, ENGINEERING, V8, P761, DOI 10.4236/eng.2016.811068; You Zhou, 2018, Procedia Computer Science, V131, P541, DOI 10.1016/j.procs.2018.04.262; Zhong BT, 2020, AUTOMAT CONSTR, V113, DOI 10.1016/j.autcon.2020.103089	21	2	3	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2020	15	6							e0234824	10.1371/journal.pone.0234824	http://dx.doi.org/10.1371/journal.pone.0234824			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB7DG	32555687	gold, Green Published			2022-12-26	WOS:000542759600056
J	Cai, ZM; Chen, YQ; Liao, JJ; Wang, DD				Cai, Zhaoming; Chen, Yuanqing; Liao, Jingjing; Wang, Diandong			Genome-wide identification and expression analysis of jasmonate ZIM domain gene family in tuber mustard (Brassica junceavar.tumida)	PLOS ONE			English	Article							BACTERIAL-BLIGHT; JAZ PROTEIN; ARABIDOPSIS; RESISTANCE	Tuber mustard, which is the raw material of Fuling pickle, is a crop with great economic value. However, during growth and development, tuber mustard is frequently attacked by the pathogenPlasmodiophora brassicaeand frequently experiences salinity stress. Jasmonic acid (JA) is a hormone related to plant resistance to biotic and abiotic stress. Jasmonate ZIM domain proteins (JAZs) are crucial components of the JA signaling pathway and play important roles in plant responses to biotic and abiotic stress. To date, no information is available about the characteristics of theJAZfamily genes in tuber mustard. Here, 38BjJAZgenes were identified in the whole genome of tuber mustard. TheBjJAZgenes are located on 17 of 18 chromosomes in the tuber mustard genome. The gene structures and protein motifs of theBjJAZgenes are conserved between tuber mustard andArabidopsis. The results of qRT-PCR analysis showed thatBjuA030800was specifically expressed in root, andBjuA007483was specifically expressed in leaf. In addition, 13BjJAZgenes were transiently induced byP.brassicaeat 12 h, and 7BjJAZgenes were induced by salt stress from 12 to 24 h. These results provide valuable information for further studies on the role ofBjJAZgenes in the regulation of plant growth and development and in the response to biotic and abiotic stress.	[Cai, Zhaoming; Chen, Yuanqing; Liao, Jingjing; Wang, Diandong] Yangtze Normal Univ, Coll Life Sci & Technol, Chongqing, Peoples R China	Yangtze Normal University	Wang, DD (corresponding author), Yangtze Normal Univ, Coll Life Sci & Technol, Chongqing, Peoples R China.	wangdiandong@yznu.com		Cai, Zhaoming/0000-0001-8307-6171	National Natural Science Foundation of China [31701451, 31770407, 31800311]; Chongqing Basic Research and Frontier Exploration Project [cstc2019jcyjmsxmX0285]; Science and Technology Research Program of Chongqing Municipal Education Commission [KJQN201901406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Basic Research and Frontier Exploration Project; Science and Technology Research Program of Chongqing Municipal Education Commission	This work is supported by the National Natural Science Foundation of China (Program Nos. 31701451, 31770407 and 31800311), Zhaoming Cai, Diandong Wang and Jingjing Liao; the Chongqing Basic Research and Frontier Exploration Project (Program No.cstc2019jcyjmsxmX0285), Zhaoming Cai; the Science and Technology Research Program of Chongqing Municipal Education Commission (Grant No. KJQN201901406), Zhaoming Cai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2016, Aesthet Surg J, V36 Suppl 1, P1, DOI 10.1093/asj/36.Supplement_1.1; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Carvalhais LC, 2017, CURR OPIN MICROBIOL, V37, P42, DOI 10.1016/j.mib.2017.03.009; Chini A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177381; Chini A, 2009, PLANT J, V59, P77, DOI 10.1111/j.1365-313X.2009.03852.x; Demianski AJ, 2012, MOL PLANT PATHOL, V13, P46, DOI 10.1111/j.1364-3703.2011.00727.x; Garrido-Bigotes A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205060; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Huang H, 2017, J EXP BOT, V68, P1349, DOI 10.1093/jxb/erw495; Huang Z, 2016, PEERJ, V4, DOI 10.7717/peerj.2620; Ishiga Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075728; Jing YX, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42177-y; Kong XP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-433; Li XQ, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0808-z; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu SH, 2019, PLANT SCI, V280, P1, DOI 10.1016/j.plantsci.2018.11.004; Medicines and Healthcare products Regulatory Agency (UK), 2018, YELLOW CARD IT DRUG, V11, P7, DOI DOI 10.3233/PRM-160424; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Niwa T, 2018, BIOSCI BIOTECH BIOCH, V82, P292, DOI 10.1080/09168451.2017.1422107; Peethambaran PK, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1521-0; Ruan JJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102479; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Song SS, 2011, PLANT CELL, V23, P1000, DOI 10.1105/tpc.111.083089; Sun H, 2017, PLANT CELL PHYSIOL, V58, P2139, DOI 10.1093/pcp/pcx148; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taniguchi S, 2014, PLANT CELL ENVIRON, V37, P451, DOI 10.1111/pce.12169; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thireault C, 2015, PLANT J, V82, P669, DOI 10.1111/tpj.12841; Wang YK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3582-0; Xia WX, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00493; Xu L, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00750; Xu L, 2019, NUCLEIC ACIDS RES, V47, pW52, DOI 10.1093/nar/gkz333; Yamada S, 2012, PLANT CELL PHYSIOL, V53, P2060, DOI 10.1093/pcp/pcs145; Yang JH, 2016, NAT GENET, V48, P1225, DOI 10.1038/ng.3657; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Yu TW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-563; Zhang LH, 2015, J PLANT RES, V128, P995, DOI 10.1007/s10265-015-0755-2; Zhao Y, 2014, PLANT PHYSIOL, V164, P1068, DOI 10.1104/pp.113.227595; Zhu D, 2012, BIOCHEM BIOPH RES CO, V426, P273, DOI 10.1016/j.bbrc.2012.08.086	40	6	6	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2020	15	6							e0234738	10.1371/journal.pone.0234738	http://dx.doi.org/10.1371/journal.pone.0234738			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB9ZQ	32544205	gold, Green Published			2022-12-26	WOS:000542957200027
J	Lee, LW; Lu, HK; Chen, YY; Lai, CL; Chu, LP; Hsieh, MC; Hsieh, KC				Lee, Li-Wen; Lu, Hsueh-Kuan; Chen, Yu-Yawn; Lai, Chung-Liang; Chu, Lee-Ping; Hsieh, Meng-Che; Hsieh, Kuen-Chang			Prediction and discrimination of skeletal muscle function by bioelectrical impedance vector analysis using a standing impedance analyzer in healthy Taiwanese adults	PLOS ONE			English	Article							HANDGRIP STRENGTH; BODY-COMPOSITION; GRIP STRENGTH; BIOIMPEDANCE; MASS; PRINCIPLES; SARCOPENIA; NUTRITION; CONSENSUS; CACHEXIA	Background Bioelectrical impedance vector analysis (BIVA) has been used for prediction of muscle performance. However, little is known about BIVA in Asian adults, and even less is known about using standing BIVA devices. Standing impedance analyzer allows quicker and more convenient way to gather data than conventional supine analyzer and is more suitable for clinical practice. This study aimed to investigate the relations between muscle function and BIVA parameters measured with a standing impedance analyzer in healthy Taiwanese adults. Methods A total of 406 healthy subjects (age 34.5 +/- 17.3 years, body mass index 24.1 +/- 4.1 kg/m(2)) were recruited for BIVA and handgrip strength (HGS) measurements. Impedance parameters, including resistance (R) and reactance (Xc), were measured and normalized to body size by dividing by height (H). The resulting phase angle (PhA) was calculated. HGS in the dominant, left, and right hands were referred to as HGS(DH), HGS(LH), and HGS(RH), respectively. All subjects were divided into 5 grades according to HGS. Results Muscle strength in the dominant, right, and left arms was correlated with variables in the order of sex, weight, age, height, Xc/H, and R/H (all, p < 0.001). Using all 6 variables, the determination coefficients were 0.792, 0.782, and 0.745, respectively, whereas the standard errors of estimates were 56.89, 58.01, and 56.67 N for HGS(DH), HGS(LH), and HGS(RH), respectively. HGS was positively correlated with PhA, and negatively correlated with Xc/H and R/H. Conclusions BIVA parameters measured with a standing impedance analyzer and anthropometric variables can predict and discriminate muscle function with good performance in healthy Asian adults.	[Lee, Li-Wen] Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi, Taiwan; [Lu, Hsueh-Kuan] Natl Taiwan Univ Sport, Gen Educ Ctr, Taichung, Taiwan; [Chen, Yu-Yawn] Natl Taiwan Univ Sport, Dept Phys Educ, Taichung, Taiwan; [Chen, Yu-Yawn] Natl Taitung Jr Coll, Dept Food Sci & Technol, Taitung, Taiwan; [Lai, Chung-Liang] Minist Hlth & Welf, Puzi Hosp, Dept Phys Med & Rehabil, Chiayi, Taiwan; [Lai, Chung-Liang] Asia Univ, Dept Occupat Therapy, Taichung, Taiwan; [Chu, Lee-Ping] China Med Univ Hosp, Dept Orthoped, Taichung, Taiwan; [Hsieh, Meng-Che; Hsieh, Kuen-Chang] Charder Elect Co Ltd, Res Ctr, Taichung, Taiwan; [Hsieh, Kuen-Chang] Natl Chin Yi Univ Technol, Fundamental Educ Ctr, Taichung, Taiwan	Chang Gung Memorial Hospital; National Taiwan University of Sport; National Taiwan University of Sport; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Chin-Yi University of Technology	Hsieh, KC (corresponding author), Charder Elect Co Ltd, Res Ctr, Taichung, Taiwan.; Hsieh, KC (corresponding author), Natl Chin Yi Univ Technol, Fundamental Educ Ctr, Taichung, Taiwan.	abaqus0927@yahoo.com.tw	Lee, Li-Wen/AAY-3542-2021	Chu, Lee-ping/0000-0002-4500-9936	National Science Council of Taiwan [NSC100-2410-H-H-028-MY3]; Ministry of Health and Welfare of Taiwan [PG10601-0241]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare of Taiwan	This work was supported by grant NSC100-2410-H-H-028-MY3 from the National Science Council of Taiwan and grant PG10601-0241 from Ministry of Health and Welfare of Taiwan.	Ali NA, 2008, AM J RESP CRIT CARE, V178, P261, DOI 10.1164/rccm.200712-1829OC; Asselin MC, 1998, APPL RADIAT ISOTOPES, V49, P495, DOI 10.1016/S0969-8043(97)00179-6; Baldwin CE, 2012, JPEN-PARENTER ENTER, V36, P306, DOI 10.1177/0148607111433055; Castillo ML, 2007, NUTRITION, V23, P412, DOI DOI 10.1016/j.nut.2007.02.005; Castillo-Martinez L, 2012, NUTRITION, V28, P886, DOI 10.1016/j.nut.2011.11.024; Castizo-Olier J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197957; Chertow GM, 1997, J RENAL NUTR, V7, P204, DOI DOI 10.1016/S1051-2276(97)90020-0; CHRISTIE PM, 1990, GASTROENTEROLOGY, V99, P730, DOI 10.1016/0016-5085(90)90962-Z; CHUMLEA WC, 1988, AM J CLIN NUTR, V48, P7, DOI 10.1093/ajcn/48.1.7; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; De Miguel-Etayo P, 2014, INT J OBESITY, V38, pS57, DOI 10.1038/ijo.2014.136; Distefano G, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029785; Dodds RM, 2016, AGE AGEING, V45, P209, DOI 10.1093/ageing/afv192; Frontera WR, 2015, CALCIFIED TISSUE INT, V96, P183, DOI 10.1007/s00223-014-9915-y; GLEICHAUF CN, 1989, AM J CLIN NUTR, V50, P903, DOI 10.1093/ajcn/50.5.903; Gonzalez MC, 2017, J CACHEXIA SARCOPENI, V8, P187, DOI 10.1002/jcsm.12159; Gudivaka R, 1996, J APPL PHYSIOL, V81, P838, DOI 10.1152/jappl.1996.81.2.838; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Janssen I, 2000, J APPL PHYSIOL, V89, P81; JONES DA, 1989, Q J EXP PHYSIOL CMS, V74, P233, DOI 10.1113/expphysiol.1989.sp003268; Keele AM, 1997, GUT, V40, P393, DOI 10.1136/gut.40.3.393; Koury JC, 2014, INT J SPORT PHYSIOL, V9, P798, DOI [10.1123/IJSPP.2013-0397, 10.1123/ijspp.2013-0397]; KUSHNER RF, 1992, J AM COLL NUTR, V11, P199; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Laurson KR, 2017, J STRENGTH COND RES, V31, P2075, DOI 10.1519/JSC.0000000000001678; Lee SY, 2008, CURR OPIN CLIN NUTR, V11, P566, DOI 10.1097/MCO.0b013e32830b5f23; Leong DP, 2016, J CACHEXIA SARCOPENI, V7, P535, DOI 10.1002/jcsm.12112; MAW GJ, 1995, ACTA PHYSIOL SCAND, V155, P157, DOI 10.1111/j.1748-1716.1995.tb09960.x; McGregor Robin A, 2014, Longev Healthspan, V3, P9, DOI 10.1186/2046-2395-3-9; Mendes J, 2014, JPEN-PARENTER ENTER, V38, P481, DOI 10.1177/0148607113486007; Mereu E, 2018, EXP GERONTOL, V102, P145, DOI 10.1016/j.exger.2017.11.011; Micheli ML, 2014, INT J SPORT PHYSIOL, V9, P532, DOI [10.1123/ijspp.2013-0119, 10.1123/IJSPP.2013-0119]; Mitchell WK, 2016, ADV NUTR, V7, p828S, DOI 10.3945/an.115.011650; Norman K, 2014, EUR J CLIN NUTR, V68, P155, DOI 10.1038/ejcn.2013.261; Norman K, 2012, CLIN NUTR, V31, P854, DOI 10.1016/j.clnu.2012.05.008; Norman K, 2011, CLIN NUTR, V30, P135, DOI 10.1016/j.clnu.2010.09.010; Norman K, 2009, CLIN NUTR, V28, P78, DOI 10.1016/j.clnu.2008.11.001; ORGAN LW, 1994, J APPL PHYSIOL, V77, P98, DOI 10.1152/jappl.1994.77.1.98; Oshima Y, 2006, EUR J CLIN NUTR, V60, P938, DOI 10.1038/sj.ejcn.1602402; Peng S, 2007, AM J CLIN NUTR, V85, P1257, DOI 10.1093/ajcn/85.5.1257; Piccoli A, 2004, KIDNEY INT, V65, P1050, DOI 10.1111/j.1523-1755.2004.00467.x; Piccoli A, 2002, NUTRITION, V18, P153, DOI 10.1016/S0899-9007(01)00665-7; PICCOLI A, 1994, KIDNEY INT, V46, P534, DOI 10.1038/ki.1994.305; Reid KF, 2012, EXERC SPORT SCI REV, V40, P4, DOI 10.1097/JES.0b013e31823b5f13; Roberts HC, 2012, AGE AGEING, V41, P641, DOI 10.1093/ageing/afs089; Rodriguez-Rodriguez F, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070407; Saragat B, 2014, EXP GERONTOL, V50, P52, DOI 10.1016/j.exger.2013.11.016; Soeters PB, 2008, CLIN NUTR, V27, P706, DOI 10.1016/j.clnu.2008.07.009; Sun G, 2005, AM J CLIN NUTR, V81, P74; White JV, 2012, JPEN-PARENTER ENTER, V36, P275, DOI 10.1177/0148607112440285; Wirth R, 2010, ARCH GERONTOL GERIAT, V51, P290, DOI 10.1016/j.archger.2009.12.002; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; Wu CS, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0041-0	53	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2020	15	6							e0231604	10.1371/journal.pone.0231604	http://dx.doi.org/10.1371/journal.pone.0231604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QP	32530912	Green Submitted, gold, Green Published			2022-12-26	WOS:000542037200016
J	Baker, CA; Lee, S; De, JK; Jeong, KC; Schneider, KR				Baker, Christopher A.; Lee, Shinyoung; De, Jaysankar; Jeong, Kwangcheol C.; Schneider, Keith R.			Survival ofEscherichia coliO157 in autoclaved and natural sandy soil mesocosms	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; MICROBIAL COMMUNITY; E.-COLI; DIVERSITY; SALMONELLA; MANURE; STERILIZATION; TEMPERATURE; O157/H7; IMPACT	While the soil microbiome may influence pathogen survival, determining the major contributors that reduce pathogen survival is inconclusive. This research was performed to determine the survival ofE.coliO157 in autoclaved and natural (unautoclaved) sandy soils. Soils were inoculated with three differentE.coliO157 strains (stx1+/stx2+,stx1-/stx2-,and stx1-/stx2+), and enumerated until extinction at 30 degrees C. There was a significant difference in the survival ofE.coliO157 based on soil treatment (autoclaved versus natural) at 30 degrees C on days 1 (P= 0.00022), 3, (P= 2.53e-14), 7 (P= 5.59e-16), 14 (P= 1.072e-12), 30 (P= 7.18e-9), and 56 (P= 0.00029), with greater survival in autoclaved soils. The time to extinction (two consecutive negative enrichments) for all three strains was 169 and 84 days for autoclaved and natural soils, respectively. A separateE.coliO157 trial supplemented with 16S rRNA gene sequencing of the soil microbiome was performed at 15 degrees C and 30 degrees C on days 0, 7, 14, and 28 for each soil treatment. Greater species richness (Chao1,P= 2.2e-16) and diversity (Shannon,P= 2.2e-16) was observed in natural soils in comparison with autoclaved soils. Weighted UniFrac (beta-diversity) showed a clear distinction between soil treatments (P= 0.001). The greatest reduction ofE.coliO157 was observed in natural soils at 30 degrees C, and several bacterial taxa positively correlated (relative abundance) with time (day 0 to 28) in these soils (P< 0.05), suggesting that the presence of those bacteria might cause the reduction ofE.coliO157. Taken together, a clear distinction inE.coliO157 survival, was observed between autoclaved and natural soils along with corresponding differences in microbial diversity in soil treatments. This research provides further insights into the bacterial taxa that may influenceE.coliO157 in soils.	[Baker, Christopher A.; De, Jaysankar; Schneider, Keith R.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Lee, Shinyoung; Jeong, Kwangcheol C.] Univ Florida, Dept Anim Sci, Emerging Pathogens Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Schneider, KR (corresponding author), Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA.	keiths29@ufl.edu	De, Jaysankar/G-8386-2011	De, Jaysankar/0000-0001-9799-9401				Albuquerque L, 2011, SYST APPL MICROBIOL, V34, P595, DOI 10.1016/j.syapm.2011.07.001; [Anonymous], 2010, INDIAN J MICROBIOL, V50, P425; Baker CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217445; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bouyoucos GJ, 1936, SOIL SCI, V42, P225, DOI 10.1097/00010694-193609000-00007; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Centers for Disease Control and Prevention, 2019, OUTBR E COL INF LINK; Centers for Disease Control and Prevention, 2006, MULT OUTBR E COL O15; Centers for Disease Control and Prevention, 2018, MULT OUTBR E COL O15; Cools D, 2001, APPL SOIL ECOL, V17, P53, DOI 10.1016/S0929-1393(00)00133-5; Franz E, 2011, APPL ENVIRON MICROB, V77, P8088, DOI 10.1128/AEM.00745-11; FRATAMICO PM, 1995, J FOOD PROTECT, V58, P160, DOI 10.4315/0362-028X-58.2.160; Fratamico PM, 1996, J FOOD SAFETY, V16, P161, DOI 10.1111/j.1745-4565.1996.tb00157.x; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Ibekwe AM, 2011, SCI TOTAL ENVIRON, V409, P3740, DOI 10.1016/j.scitotenv.2011.06.033; Ibekwe AM, 2011, INT J MICROBIOL, P421379; Jafari N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/182945; Jay MT, 2007, EMERG INFECT DIS, V13, P1908, DOI 10.3201/eid1312.070763; Jiang XP, 2002, APPL ENVIRON MICROB, V68, P2605, DOI 10.1128/AEM.68.5.2605-2609.2002; Kim J, 2011, BIORESOURCE TECHNOL, V102, P9619, DOI 10.1016/j.biortech.2011.07.055; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166; Ma JC, 2013, FEMS MICROBIOL ECOL, V84, P542, DOI 10.1111/1574-6941.12083; Mallon CA, 2018, ISME J, V12, P728, DOI 10.1038/s41396-017-0003-y; Mauro SA, 2011, TOXINS, V3, P608, DOI 10.3390/toxins3060608; Moynihan EL, 2015, APPL SOIL ECOL, V89, P76, DOI 10.1016/j.apsoil.2015.01.011; Moynihan P. J., 2013, Abstracts of the General Meeting of the American Society for Microbiology, V113, P249; SALONIUS PO, 1967, PLANT SOIL, V27, P239, DOI 10.1007/BF01373392; Semenov AV, 2007, FEMS MICROBIOL ECOL, V60, P419, DOI 10.1111/j.1574-6941.2007.00306.x; Severino R, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.840; Sockett RE, 2009, ANNU REV MICROBIOL, V63, P523, DOI 10.1146/annurev.micro.091208.073346; Suguitan Jr AL, 2011, PLOS ONE, V6; Tanaka S, 2003, SOIL SCI PLANT NUTR, V49, P603, DOI 10.1080/00380768.2003.10410050; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; U. S. Food and Drug Administration (FDA) Department of Health and Human Services, 2015, STAND GROW HARV PACK; Underthun K, 2018, J FOOD PROTECT, V81, P150, DOI 10.4315/0362-028X.JFP-17-226; US Food and Drug Administration (FDA), 2018, FED REG; van Elsas JD, 2007, ISME J, V1, P204, DOI 10.1038/ismej.2007.21; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80; Vidovic S, 2007, CAN J MICROBIOL, V53, P822, DOI 10.1139/W07-041; Vivant AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076991; WILLIAMSLINERA G, 1984, PLANT SOIL, V82, P263, DOI 10.1007/BF02220253; Wolf D. C., 2018, METHODS SOIL ANAL 2, P41, DOI [10.2136/sssabookser5.2.c3, DOI 10.2136/sssabookser5.2.c3]; Xiao Y, 2011, J BACTERIOL, V193, P4626, DOI 10.1128/JB.05052-11	47	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234562	10.1371/journal.pone.0234562	http://dx.doi.org/10.1371/journal.pone.0234562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525952	Green Published, gold			2022-12-26	WOS:000542036800047
